Citrus Sinensis ID: 038249

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-
Protein Sequence
ACSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccEEEEEEEccccEEEEEEEcHHHHHHHHHHHHHHHHHHHHHHcccccEEccccEEEEccEEEEEEEEccccccHHHHHHcccccHHHHHHHHHHHHHHHHHHHccccEEcccccccccccccccEEEccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccEEccccccccHHHHHHHHHHcccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHEEEEEEEEEccccEEEEEEEccccEEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccEccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHcccHHHccccHHHHccc
Coil and Loop (DISEMBL)
acsevsakekkrwtlndfdigkplgrgkfghVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQshlrhpnilrlygyfyDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYChgkhvihrdikpenlligaqgelkiadfgwsvhtfnrrrtmcgtldylppemvesvehdanvdiWSLGVLCYEflygvppfeakehsdtYRRIVQVdlkfppkpivsSAAKDLISQMLvkdssqrlplhkllehpwiiqnadpsgvyrg
Flexible Loop (DISEMBL)
acsevsakekkrwtlndfdigkplgrGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVeiqshlrhpnilrLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLhkllehpwiiqnadpsgvyrg
Low Complexity Region (SEG)
ACSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG
Disordered region (IsUnstruct)
************WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK****RLPLHKLLEHPWIIQ**********
Disordered Region (DISOPRED)
*****************FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS*VYR*
Disordered Region (DISEMBL)
**********KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ*********LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG
Disordered Region (DISPRO)
***********RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGV*RG
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
ACSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	281	2.2.26 [Sep-21-2011]
Q9M077	294	Serine/threonine-protein	yes	no	0.964	0.921	0.948	1e-155
Q683C9	282	Serine/threonine-protein	no	no	0.985	0.982	0.920	1e-154
Q91820	407	Aurora kinase A-A OS=Xeno	N/A	no	0.935	0.646	0.669	1e-106
O64629	288	Serine/threonine-protein	no	no	0.971	0.947	0.630	1e-106
P97477	395	Aurora kinase A OS=Mus mu	yes	no	0.950	0.675	0.669	1e-106
Q91819	408	Aurora kinase A-B OS=Xeno	N/A	no	0.935	0.644	0.669	1e-106
P59241	397	Aurora kinase A OS=Rattus	yes	no	0.950	0.672	0.669	1e-105
Q9N0X0	344	Aurora kinase B OS=Sus sc	yes	no	0.914	0.747	0.676	1e-105
Q2TA06	402	Aurora kinase A OS=Bos ta	yes	no	0.960	0.671	0.659	1e-105
Q6GPL3	368	Aurora kinase B-B OS=Xeno	N/A	no	0.957	0.730	0.647	1e-104

>sp|Q9M077|AUR1_ARATH Serine/threonine-protein kinase Aurora-1 OS=Arabidopsis thaliana GN=AUR1 PE=1 SV=1

 Score =  548 bits (1412), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 257/271 (94%), Positives = 270/271 (99%)

Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +KRWTL+DFDIGKPLGRGKFGHVYLAREKRSNH+VALKVLFKSQLQQSQVEHQLRREVEI
Sbjct: 23  QKRWTLSDFDIGKPLGRGKFGHVYLAREKRSNHVVALKVLFKSQLQQSQVEHQLRREVEI 82

Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
           QSHLRHPNILRLYGYFYDQKRVYLILEYAA+GELYK+LQKCKYFSERRAATYVASLARAL
Sbjct: 83  QSHLRHPNILRLYGYFYDQKRVYLILEYAARGELYKDLQKCKYFSERRAATYVASLARAL 142

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE 189
           IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE
Sbjct: 143 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE 202

Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           HDA+VDIWSLG+LCYEFLYGVPPFEA EHSDTYRRIVQVDLKFPPKPI+S++AKDLISQM
Sbjct: 203 HDASVDIWSLGILCYEFLYGVPPFEAMEHSDTYRRIVQVDLKFPPKPIISASAKDLISQM 262

Query: 250 LVKDSSQRLPLHKLLEHPWIIQNADPSGVYR 280
           LVK+SSQRLPLHKLLEHPWI+QNADPSG+YR
Sbjct: 263 LVKESSQRLPLHKLLEHPWIVQNADPSGIYR 293

Phosphorylates specifically 'Ser-10' of histone H3 in vitro and colocalizes with phosphorylated histone H3 during mitosis. Associates with cytoskeletal structures that are necessary for cytokinesis and with the microtubule spindle. Might also colocalize with gamma-tubulin and function in microtubule organizing centers (MTOCs). In contrast with the mammalian B-type Aurora, AUR1 has no kinase activity toward 'Ser-28' of histone H3.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q683C9|AUR2_ARATH Serine/threonine-protein kinase Aurora-2 OS=Arabidopsis thaliana GN=AUR2 PE=2 SV=2

 Score =  543 bits (1398), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 255/277 (92%), Positives = 270/277 (97%)

Query: 5   VSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR 64
            S   +KRWT +DFDIGKPLGRGKFGHVYLAREKRS+HIVALKVLFK+QLQQSQVEHQLR
Sbjct: 6   ASEAAQKRWTTSDFDIGKPLGRGKFGHVYLAREKRSDHIVALKVLFKAQLQQSQVEHQLR 65

Query: 65  REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS 124
           REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYA +GELYKELQKCKYFSERRAATYVAS
Sbjct: 66  REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAVRGELYKELQKCKYFSERRAATYVAS 125

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEM 184
           LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEM
Sbjct: 126 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEM 185

Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
           VESVEHDA+VDIWSLG+LCYEFLYGVPPFEA+EHS+TY+RIVQVDLKFPPKPIVSS+AKD
Sbjct: 186 VESVEHDASVDIWSLGILCYEFLYGVPPFEAREHSETYKRIVQVDLKFPPKPIVSSSAKD 245

Query: 245 LISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG 281
           LISQMLVK+S+QRL LHKLLEHPWI+QNADPSG+YRG
Sbjct: 246 LISQMLVKESTQRLALHKLLEHPWIVQNADPSGLYRG 282

Phosphorylates specifically 'Ser-10' of histone H3 in vitro. Associates with cytoskeletal structures that are necessary for cytokinesis and with the microtubule spindle. Might colocalize with gamma-tubulin and function in microtubule organizing centers (MTOCs).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q91820|AURAA_XENLA Aurora kinase A-A OS=Xenopus laevis GN=aurka-a PE=1 SV=1

 Score =  385 bits (989), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 178/266 (66%), Positives = 218/266 (81%), Gaps = 3/266 (1%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +KK+W L DF+IG+PLG+GKFG+VYLARE+ S  I+ALKVLFKSQL+++ VEHQLRREVE
Sbjct: 131 KKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGVEHQLRREVE 190

Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLIL+YA  GEL++ELQKC  F ++R+A Y+  LA A
Sbjct: 191 IQSHLRHPNILRLYGYFHDASRVYLILDYAPGGELFRELQKCTRFDDQRSAMYIKQLAEA 250

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L+YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 251 LLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 310

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFE   H +TYRRI +V+ ++P  P VS  A+DL+S
Sbjct: 311 RMHDETVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYP--PYVSEEARDLVS 368

Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNA 273
           ++L  + + RLPL  +LEHPWII+N+
Sbjct: 369 KLLKHNPNHRLPLKGVLEHPWIIKNS 394

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Phosphorylates numerous target proteins. Important for microtubule formation and/or stabilization.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64629|AUR3_ARATH Serine/threonine-protein kinase Aurora-3 OS=Arabidopsis thaliana GN=AUR3 PE=2 SV=1

 Score =  385 bits (989), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 172/273 (63%), Positives = 228/273 (83%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
           +   +K+W+L DF+IG+PLG+GKFG VYLARE +S +IVALKV+FK Q+++ ++ HQLRR
Sbjct: 10  AGNTEKQWSLADFEIGRPLGKGKFGRVYLAREAKSKYIVALKVIFKEQIEKYKIHHQLRR 69

Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
           E+EIQ+ LRHPNILRL+G+F+D +R++LILEYA  GELY  L++  + +E++AATY+ASL
Sbjct: 70  EMEIQTSLRHPNILRLFGWFHDNERIFLILEYAHGGELYGVLKQNGHLTEQQAATYIASL 129

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV 185
           ++AL YCHGK VIHRDIKPENLL+  +G LKIADFGWSV + N+R+TMCGTLDYL PEMV
Sbjct: 130 SQALAYCHGKCVIHRDIKPENLLLDHEGRLKIADFGWSVQSSNKRKTMCGTLDYLAPEMV 189

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
           E+ +HD  VD W+LG+LCYEFLYG PPFEA+   DT++RI+++DL FP  P VS  AK+L
Sbjct: 190 ENRDHDYAVDNWTLGILCYEFLYGNPPFEAESQKDTFKRILKIDLSFPLTPNVSEEAKNL 249

Query: 246 ISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGV 278
           ISQ+LVKD S+RL + K+++HPWI++NADP GV
Sbjct: 250 ISQLLVKDPSKRLSIEKIMQHPWIVKNADPKGV 282

Phosphorylates in vitro histone H3 at 'Ser-10' and 'Ser-28', but not at 'Thr-3' or 'Thr-11'. Colocalizes with phosphorylated histone H3 during mitosis. Associates with cytoskeletal structures that are necessary for cytokinesis and with the microtubule spindle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P97477|AURKA_MOUSE Aurora kinase A OS=Mus musculus GN=Aurka PE=1 SV=1

 Score =  385 bits (988), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 182/272 (66%), Positives = 220/272 (80%), Gaps = 5/272 (1%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++WTL DFDIG+PLG+GKFG+VYLARE++S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 115 KKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKANVEHQLRREVE 174

Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 175 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 234

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR TMCGTLDYLPPEM+E 
Sbjct: 235 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTMCGTLDYLPPEMIEG 294

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G+PPFEA  + +TYRRI +V+  FP    V+  A+DLIS
Sbjct: 295 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP--DFVTEGARDLIS 352

Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD--PSG 277
           ++L  ++SQRL L ++LEHPWI  N+   P+G
Sbjct: 353 RLLKHNASQRLTLAEVLEHPWIKANSSKPPTG 384

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity. Necessary for proper cilia disassembly prior to mitosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q91819|AURAB_XENLA Aurora kinase A-B OS=Xenopus laevis GN=aurka-b PE=2 SV=3

 Score =  384 bits (986), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 178/266 (66%), Positives = 218/266 (81%), Gaps = 3/266 (1%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +KK+W L DF+IG+PLG+GKFG+VYLARE+ S  I+ALKVLFKSQL+++ VEHQLRREVE
Sbjct: 131 KKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGVEHQLRREVE 190

Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLIL+YA  GEL++ELQKC  F ++R+A Y+  LA A
Sbjct: 191 IQSHLRHPNILRLYGYFHDACRVYLILDYAPGGELFRELQKCTRFDDQRSALYIKQLAEA 250

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L+YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 251 LLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 310

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFE   H +TYRRI +V+ ++P  P VS  AKDL+S
Sbjct: 311 RMHDEKVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYP--PYVSEEAKDLVS 368

Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNA 273
           ++L  + + RLPL  +LEHPWI++N+
Sbjct: 369 KLLKHNPNHRLPLKGVLEHPWIVKNS 394

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Phosphorylates numerous target proteins. Important for microtubule formation and/or stabilization.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P59241|AURKA_RAT Aurora kinase A OS=Rattus norvegicus GN=Aurka PE=1 SV=1

 Score =  380 bits (977), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 182/272 (66%), Positives = 218/272 (80%), Gaps = 5/272 (1%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++WTL DFDIG+PLG+GKFG+VYLAREK+S  I+ALKVLFK QL+++ VEHQLRREVE
Sbjct: 117 KKRQWTLEDFDIGRPLGKGKFGNVYLAREKQSKFILALKVLFKVQLEKAGVEHQLRREVE 176

Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 177 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 236

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDY PPEM+E 
Sbjct: 237 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYQPPEMIEG 296

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G+PPFEA  + +TYRRI +V+  FP    V+  A+DLIS
Sbjct: 297 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP--DFVTEGARDLIS 354

Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD--PSG 277
           ++L  +SSQRL L ++LEHPWI  N+   P+G
Sbjct: 355 RLLKHNSSQRLTLAEVLEHPWIKANSSKPPTG 386

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (By similarity). Necessary for proper cilia disassembly prior to mitosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9N0X0|AURKB_PIG Aurora kinase B OS=Sus scrofa GN=AURKB PE=2 SV=2

 Score =  380 bits (977), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 176/260 (67%), Positives = 218/260 (83%), Gaps = 3/260 (1%)

Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           + +T++DF+IG+PLG+GKFG+VYLAREK+S+ IVALKVLFKSQ+++  VEHQLRRE+EIQ
Sbjct: 70  RSFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQ 129

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           +HL+HPNILRLY YFYD++R+YLILEYA +GELYKELQKC+ F E+R AT +  LA ALI
Sbjct: 130 AHLQHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKCRTFDEQRTATIMEELADALI 189

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLDYLPPEMVESVE 189
           YCHGK VIHRDIKPENLL+G QGELKIADFGWSVH  + RR+TMCGTLDYLPPEM+E   
Sbjct: 190 YCHGKKVIHRDIKPENLLLGLQGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRT 249

Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           H+  VD+W +GVLCYE L G PPFE+  H++TYRRI +VDLKFPP   V + A+DLIS++
Sbjct: 250 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIGKVDLKFPPS--VPAGAQDLISKL 307

Query: 250 LVKDSSQRLPLHKLLEHPWI 269
           L  + S RLPL ++  HPW+
Sbjct: 308 LKHNPSDRLPLAQVSAHPWV 327

Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Involved in the bipolar attachment of spindle microtubules to kinetochores and is a key regulator for the onset of cytokinesis during mitosis. Required for central/midzone spindle assembly and cleavage furrow formation. AURKB phosphorylates the CPC complex subunits BIRC5/survivin, CDCA8/borealin and INCENP. Phosphorylation of INCENP leads to increased AURKB activity. Other known AURKB substrates involved in centromeric functions and mitosis are CENPA, DES/desmin, GPAF, KIF2C, NSUN2, RACGAP1, SEPT1, VIM/vimentin, GSG2/Haspin and histone H3. A positive feedback loop involving GSG2 and AURKB contributes to localization of CPC to centromeres. Phosphorylation of VIM controls vimentin filament segregation in cytokinetic process, whereas histone H3 is phosphorylated at 'Ser-10' and 'Ser-28' during mitosis. AURKB is also required for kinetochore localization of BUB1 and SGOL1. Phosphorylation of p53/TP53 negatively regulates its transcriptional activity.

Sus scrofa (taxid: 9823)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2TA06|AURKA_BOVIN Aurora kinase A OS=Bos taurus GN=AURKA PE=2 SV=1

 Score =  380 bits (976), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/273 (65%), Positives = 216/273 (79%), Gaps = 3/273 (1%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 124 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 183

Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 184 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTATYITELANA 243

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 244 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 303

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TYRRI +V+  FP    V   A+DLIS
Sbjct: 304 RMHDEKVDLWSLGVLCYEFLVGKPPFEADTYQETYRRISRVEFTFP--DCVPEGARDLIS 361

Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYR 280
           ++L  + SQR  L ++LEHPWII N+ PS   +
Sbjct: 362 RLLKHNPSQRPTLKEVLEHPWIIANSKPSSCQK 394

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (By similarity). Necessary for proper cilia disassembly prior to mitosis.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6GPL3|AUKBB_XENLA Aurora kinase B-B OS=Xenopus laevis GN=aurkb-b PE=2 SV=1

 Score =  379 bits (974), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 176/272 (64%), Positives = 224/272 (82%), Gaps = 3/272 (1%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           + ++   K+++T++DFDIG+PLG+GKFG+VYLAREK++  I+ALKVLFKSQL++  VEHQ
Sbjct: 85  TALAEAPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 144

Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           LRRE+EIQSHLRHPNILR+Y YF+D+KR+YL+LE+A +GELYKELQK   F E+R+AT++
Sbjct: 145 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 204

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLDYLP 181
             LA AL YCH + VIHRDIKPENLL+G +GELKIADFGWSVH  + RRRTMCGTLDYLP
Sbjct: 205 EELADALQYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLP 264

Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           PEM+E   HD  VD+W  GVLCYEFL G+PPF++  HS+T+RRIV VDLKFP  P +S  
Sbjct: 265 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHSETHRRIVNVDLKFP--PFLSEG 322

Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +KDLIS++L    +QRLPL  ++EHPW+  N+
Sbjct: 323 SKDLISKLLRYHPAQRLPLKGVMEHPWVKANS 354

Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Involved in the bipolar attachment of spindle microtubules to kinetochores and is a key regulator for the onset of cytokinesis during mitosis. Required for central/midzone spindle assembly and cleavage furrow formation. Phosphorylates 'Ser-10' of histone H3 during mitosis.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	281
255550892	293	Serine/threonine-protein kinase, putativ	1.0	0.959	0.960	1e-160
225429402	293	PREDICTED: serine/threonine-protein kina	1.0	0.959	0.967	1e-160
147799032	293	hypothetical protein VITISV_023325 [Viti	1.0	0.959	0.967	1e-160
224088986	293	predicted protein [Populus trichocarpa]	1.0	0.959	0.957	1e-159
224141611	293	predicted protein [Populus trichocarpa]	1.0	0.959	0.935	1e-156
297802712	290	hypothetical protein ARALYDRAFT_913154 [	0.989	0.958	0.946	1e-156
356507947	296	PREDICTED: serine/threonine-protein kina	0.982	0.932	0.952	1e-155
363808342	298	uncharacterized protein LOC100803678 [Gl	0.982	0.926	0.949	1e-154
449436900	294	PREDICTED: serine/threonine-protein kina	1.0	0.955	0.918	1e-154
297825667	288	ATAUR2 [Arabidopsis lyrata subsp. lyrata	0.985	0.961	0.931	1e-153

>gi|255550892|ref|XP_002516494.1| Serine/threonine-protein kinase, putative [Ricinus communis] gi|223544314|gb|EEF45835.1| Serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  569 bits (1467), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 270/281 (96%), Positives = 278/281 (98%)

Query: 1   ACSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
           A +EV+A EK+RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE
Sbjct: 13  ASTEVAATEKRRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 72

Query: 61  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
           HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT
Sbjct: 73  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 132

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 180
           YVASLARALIYCHGKHVIHRDIKPENLL+GAQGELKIADFGWSVHTFNRRRTMCGTLDYL
Sbjct: 133 YVASLARALIYCHGKHVIHRDIKPENLLVGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 192

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
           PPEMVESVEHDA+VDIWSLGVLCYEFLYG PPFEAKEHSDTYRRIVQVDLKFPPKPIVSS
Sbjct: 193 PPEMVESVEHDASVDIWSLGVLCYEFLYGSPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 252

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG 281
           +AKDLISQMLVKDSSQRLPLHKLLEHPWI+QNADPSG+YRG
Sbjct: 253 SAKDLISQMLVKDSSQRLPLHKLLEHPWIVQNADPSGLYRG 293

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225429402|ref|XP_002275382.1| PREDICTED: serine/threonine-protein kinase Aurora-1 [Vitis vinifera] gi|296081593|emb|CBI20598.3| unnamed protein product [Vitis vinifera]

 Score =  569 bits (1466), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 272/281 (96%), Positives = 276/281 (98%)

Query: 1   ACSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
           A S+V A EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE
Sbjct: 13  ASSDVPAVEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 72

Query: 61  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
           HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT
Sbjct: 73  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 132

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 180
           YVASLARALIYCHGKHVIHRDIKPENLL+GAQGELKIADFGWSVHTFNRRRTMCGTLDYL
Sbjct: 133 YVASLARALIYCHGKHVIHRDIKPENLLVGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 192

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
           PPEMVESVEHDA+VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS
Sbjct: 193 PPEMVESVEHDASVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 252

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG 281
            AKDLISQMLVKDSSQRLPLHKLLEHPWI+QNADPSGVYR 
Sbjct: 253 TAKDLISQMLVKDSSQRLPLHKLLEHPWIVQNADPSGVYRA 293

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147799032|emb|CAN74836.1| hypothetical protein VITISV_023325 [Vitis vinifera]

 Score =  568 bits (1465), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 272/281 (96%), Positives = 276/281 (98%)

Query: 1   ACSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
           A S+V A EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE
Sbjct: 13  ASSDVPAVEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 72

Query: 61  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
           HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT
Sbjct: 73  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 132

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 180
           YVASLARALIYCHGKHVIHRDIKPENLL+GAQGELKIADFGWSVHTFNRRRTMCGTLDYL
Sbjct: 133 YVASLARALIYCHGKHVIHRDIKPENLLVGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 192

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
           PPEMVESVEHDA+VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS
Sbjct: 193 PPEMVESVEHDASVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 252

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG 281
            AKDLISQMLVKDSSQRLPLHKLLEHPWI+QNADPSGVYR 
Sbjct: 253 TAKDLISQMLVKDSSQRLPLHKLLEHPWIVQNADPSGVYRA 293

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224088986|ref|XP_002308590.1| predicted protein [Populus trichocarpa] gi|118486608|gb|ABK95142.1| unknown [Populus trichocarpa] gi|222854566|gb|EEE92113.1| predicted protein [Populus trichocarpa]

 Score =  568 bits (1463), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 269/281 (95%), Positives = 279/281 (99%)

Query: 1   ACSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
           A +EVS +EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE
Sbjct: 13  ASTEVSGEEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 72

Query: 61  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
           HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT
Sbjct: 73  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 132

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 180
           YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR+TMCGTLDYL
Sbjct: 133 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRQTMCGTLDYL 192

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
           PPEMVESVEHDA+VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS
Sbjct: 193 PPEMVESVEHDASVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 252

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG 281
           AAKDLISQMLVKDS++RLPLHKLL+HPWI+QNADPSG++RG
Sbjct: 253 AAKDLISQMLVKDSAERLPLHKLLDHPWIVQNADPSGIFRG 293

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224141611|ref|XP_002324160.1| predicted protein [Populus trichocarpa] gi|222865594|gb|EEF02725.1| predicted protein [Populus trichocarpa]

 Score =  558 bits (1437), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 263/281 (93%), Positives = 275/281 (97%)

Query: 1   ACSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
           A ++VS  EKKRWTLNDFD+GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE
Sbjct: 13  ARTDVSGAEKKRWTLNDFDMGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 72

Query: 61  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
           HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQ+CKYFSERRAAT
Sbjct: 73  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQRCKYFSERRAAT 132

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 180
           YVASLARALIYCH KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL
Sbjct: 133 YVASLARALIYCHSKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 192

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
           PPEMV+SVEHDA+VDIWSLGVLCYEFLYG+PPFEAKEHSDTY+RIVQVDLKFPPKPIVSS
Sbjct: 193 PPEMVQSVEHDASVDIWSLGVLCYEFLYGIPPFEAKEHSDTYKRIVQVDLKFPPKPIVSS 252

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG 281
           AAKDLISQMLVKDS +RLPLHKLLEHPWI+QN DPSG++RG
Sbjct: 253 AAKDLISQMLVKDSVERLPLHKLLEHPWIVQNVDPSGIFRG 293

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297802712|ref|XP_002869240.1| hypothetical protein ARALYDRAFT_913154 [Arabidopsis lyrata subsp. lyrata] gi|297315076|gb|EFH45499.1| hypothetical protein ARALYDRAFT_913154 [Arabidopsis lyrata subsp. lyrata]

 Score =  556 bits (1432), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 263/278 (94%), Positives = 273/278 (98%)

Query: 4   EVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQL 63
           E S   +KRWTL+DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQL
Sbjct: 13  EASDAAQKRWTLSDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQL 72

Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA 123
           RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAA+GELYKELQKCKYFSERRAATYVA
Sbjct: 73  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAARGELYKELQKCKYFSERRAATYVA 132

Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE 183
           SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE
Sbjct: 133 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE 192

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
           MVESVEHDA+VDIWSLG+LCYEFLYGVPPFEA EHSDTYRRIVQVDLKFPPKPIVS++AK
Sbjct: 193 MVESVEHDASVDIWSLGILCYEFLYGVPPFEAMEHSDTYRRIVQVDLKFPPKPIVSASAK 252

Query: 244 DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG 281
           DLISQMLVK+SSQRLPLHKLLEHPWI+QNADPSG+YRG
Sbjct: 253 DLISQMLVKESSQRLPLHKLLEHPWIVQNADPSGIYRG 290

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356507947|ref|XP_003522724.1| PREDICTED: serine/threonine-protein kinase Aurora-1-like [Glycine max]

 Score =  553 bits (1424), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 263/276 (95%), Positives = 271/276 (98%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
           SA E++RWTLNDFDIGKPLGRGKFGHVYLAREK SNHIVALKVLFKSQLQQSQV HQLRR
Sbjct: 21  SAAEQRRWTLNDFDIGKPLGRGKFGHVYLAREKTSNHIVALKVLFKSQLQQSQVVHQLRR 80

Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
           EVEIQSHLRHP+ILRLYGYFYDQKRVYLILEYA KGELYKELQKCKYFSERRAATYVASL
Sbjct: 81  EVEIQSHLRHPHILRLYGYFYDQKRVYLILEYAPKGELYKELQKCKYFSERRAATYVASL 140

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV 185
           ARALIYCHGKHVIHRDIKPENLLIG+QGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV
Sbjct: 141 ARALIYCHGKHVIHRDIKPENLLIGSQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV 200

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
           ESVEHDA+VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI+QVDLKFPPKPIVSSAAKDL
Sbjct: 201 ESVEHDASVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIIQVDLKFPPKPIVSSAAKDL 260

Query: 246 ISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG 281
           ISQMLVKDSSQRLPLHKLLEHPWI+QNA+PSGVYR 
Sbjct: 261 ISQMLVKDSSQRLPLHKLLEHPWIVQNAEPSGVYRS 296

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363808342|ref|NP_001242251.1| uncharacterized protein LOC100803678 [Glycine max] gi|255634475|gb|ACU17602.1| unknown [Glycine max]

 Score =  550 bits (1418), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 262/276 (94%), Positives = 269/276 (97%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
           SA E++RWTLNDFDIGKPLGRGKFGHVYLAREK SNHIVALKVLFKSQLQQSQV HQLRR
Sbjct: 23  SAAEQRRWTLNDFDIGKPLGRGKFGHVYLAREKTSNHIVALKVLFKSQLQQSQVVHQLRR 82

Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
           EVEIQSHLRHP+ILRLYGYFYDQKRVYLILEYA KGELYKELQKCKYFSERRA TYVASL
Sbjct: 83  EVEIQSHLRHPHILRLYGYFYDQKRVYLILEYAPKGELYKELQKCKYFSERRAVTYVASL 142

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV 185
           ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV
Sbjct: 143 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV 202

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
           ESVEHDA+VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI+QVDLKFPPKPIVSSAAKDL
Sbjct: 203 ESVEHDASVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIIQVDLKFPPKPIVSSAAKDL 262

Query: 246 ISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG 281
           ISQMLVKDSSQRLPLHKL EHPWI+QNA+PSGVYR 
Sbjct: 263 ISQMLVKDSSQRLPLHKLFEHPWIVQNAEPSGVYRS 298

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449436900|ref|XP_004136230.1| PREDICTED: serine/threonine-protein kinase Aurora-1-like [Cucumis sativus] gi|449502835|ref|XP_004161756.1| PREDICTED: serine/threonine-protein kinase Aurora-1-like [Cucumis sativus]

 Score =  549 bits (1415), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 258/281 (91%), Positives = 271/281 (96%)

Query: 1   ACSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
             +E SA EK+RWTLNDFDIGKPLGRGKFGHVYLAREK+SNHIVALKVLFKSQLQQSQVE
Sbjct: 14  TTTEASAVEKRRWTLNDFDIGKPLGRGKFGHVYLAREKKSNHIVALKVLFKSQLQQSQVE 73

Query: 61  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
           HQLRREVEIQSHLRH NILRLYGYFYDQKR+YL+LEYA +GELYKELQKCKYFSERRAAT
Sbjct: 74  HQLRREVEIQSHLRHSNILRLYGYFYDQKRIYLVLEYAPRGELYKELQKCKYFSERRAAT 133

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 180
           YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL
Sbjct: 134 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 193

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
           PPEMVESVEHDA+VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP +PI+SS
Sbjct: 194 PPEMVESVEHDASVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPQRPIISS 253

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG 281
            AKDLISQMLVKD SQRLPLHK+LEHPWI+QNA+PSGVY+ 
Sbjct: 254 TAKDLISQMLVKDCSQRLPLHKVLEHPWIVQNAEPSGVYKS 294

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297825667|ref|XP_002880716.1| ATAUR2 [Arabidopsis lyrata subsp. lyrata] gi|297326555|gb|EFH56975.1| ATAUR2 [Arabidopsis lyrata subsp. lyrata]

 Score =  548 bits (1412), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 258/277 (93%), Positives = 272/277 (98%)

Query: 5   VSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR 64
           VS   +KRWT +DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFK+QLQQSQVEHQLR
Sbjct: 12  VSEAAQKRWTTSDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKTQLQQSQVEHQLR 71

Query: 65  REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS 124
           REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAA+GELYKELQKCKYFSERRAATYVAS
Sbjct: 72  REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAARGELYKELQKCKYFSERRAATYVAS 131

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEM 184
           LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEM
Sbjct: 132 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEM 191

Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
           VESVEHDA+VDIWSLG+LCYEFLYGVPPFEA+EHS+TY+RIVQVDLKFPPKPIVSS AKD
Sbjct: 192 VESVEHDASVDIWSLGILCYEFLYGVPPFEAREHSETYKRIVQVDLKFPPKPIVSSYAKD 251

Query: 245 LISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYRG 281
           LISQMLVK+S++RLPLHKLLEHPWI+QNADPSG+YRG
Sbjct: 252 LISQMLVKESTRRLPLHKLLEHPWIVQNADPSGLYRG 288

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	281
TAIR|locus:2134103	294	AUR1 "ataurora1" [Arabidopsis	0.978	0.935	0.938	5.3e-143
UNIPROTKB|Q91820	407	aurka-a "Aurora kinase A-A" [X	0.935	0.646	0.669	7.4e-98
UNIPROTKB|Q91819	408	aurka-b "Aurora kinase A-B" [X	0.935	0.644	0.669	9.4e-98
UNIPROTKB|I3LFX5	344	AURKB "Aurora kinase B" [Sus s	0.914	0.747	0.680	2e-97
MGI|MGI:894678	395	Aurka "aurora kinase A" [Mus m	0.950	0.675	0.669	2e-97
UNIPROTKB|F1LN52	418	Aurka "Aurora kinase A" [Rattu	0.950	0.638	0.672	3.2e-97
TAIR|locus:2043624	288	AUR3 "ataurora3" [Arabidopsis	0.957	0.934	0.639	4.1e-97
UNIPROTKB|Q9N0X0	344	AURKB "Aurora kinase B" [Sus s	0.914	0.747	0.676	1.1e-96
RGD|628895	397	Aurka "aurora kinase A" [Rattu	0.950	0.672	0.669	1.4e-96
UNIPROTKB|Q2TA06	402	AURKA "Aurora kinase A" [Bos t	0.975	0.681	0.658	2.9e-96

TAIR|locus:2134103 AUR1 "ataurora1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1398 (497.2 bits), Expect = 5.3e-143, P = 5.3e-143
 Identities = 258/275 (93%), Positives = 272/275 (98%)

Query:     6 SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
             +A  +KRWTL+DFDIGKPLGRGKFGHVYLAREKRSNH+VALKVLFKSQLQQSQVEHQLRR
Sbjct:    19 AAAAQKRWTLSDFDIGKPLGRGKFGHVYLAREKRSNHVVALKVLFKSQLQQSQVEHQLRR 78

Query:    66 EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
             EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAA+GELYK+LQKCKYFSERRAATYVASL
Sbjct:    79 EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAARGELYKDLQKCKYFSERRAATYVASL 138

Query:   126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV 185
             ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV
Sbjct:   139 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV 198

Query:   186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
             ESVEHDA+VDIWSLG+LCYEFLYGVPPFEA EHSDTYRRIVQVDLKFPPKPI+S++AKDL
Sbjct:   199 ESVEHDASVDIWSLGILCYEFLYGVPPFEAMEHSDTYRRIVQVDLKFPPKPIISASAKDL 258

Query:   246 ISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYR 280
             ISQMLVK+SSQRLPLHKLLEHPWI+QNADPSG+YR
Sbjct:   259 ISQMLVKESSQRLPLHKLLEHPWIVQNADPSGIYR 293

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005819 "spindle" evidence=IDA

GO:0016572 "histone phosphorylation" evidence=RCA;IDA

GO:0035175 "histone kinase activity (H3-S10 specific)" evidence=IDA

GO:0005874 "microtubule" evidence=IDA

GO:0009504 "cell plate" evidence=IDA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0006342 "chromatin silencing" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

UNIPROTKB|Q91820 aurka-a "Aurora kinase A-A" [Xenopus laevis (taxid:8355)]

 Score = 972 (347.2 bits), Expect = 7.4e-98, P = 7.4e-98
 Identities = 178/266 (66%), Positives = 218/266 (81%)

Query:     9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
             +KK+W L DF+IG+PLG+GKFG+VYLARE+ S  I+ALKVLFKSQL+++ VEHQLRREVE
Sbjct:   131 KKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGVEHQLRREVE 190

Query:    69 IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
             IQSHLRHPNILRLYGYF+D  RVYLIL+YA  GEL++ELQKC  F ++R+A Y+  LA A
Sbjct:   191 IQSHLRHPNILRLYGYFHDASRVYLILDYAPGGELFRELQKCTRFDDQRSAMYIKQLAEA 250

Query:   129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
             L+YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct:   251 LLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 310

Query:   188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
               HD  VD+WSLGVLCYEFL G PPFE   H +TYRRI +V+ ++PP   VS  A+DL+S
Sbjct:   311 RMHDETVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYPP--YVSEEARDLVS 368

Query:   248 QMLVKDSSQRLPLHKLLEHPWIIQNA 273
             ++L  + + RLPL  +LEHPWII+N+
Sbjct:   369 KLLKHNPNHRLPLKGVLEHPWIIKNS 394

GO:0000922 "spindle pole" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005813 "centrosome" evidence=IDA

GO:0005876 "spindle microtubule" evidence=IDA

GO:0008017 "microtubule binding" evidence=IDA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IMP

GO:0019894 "kinesin binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IMP

GO:0090307 "spindle assembly involved in mitosis" evidence=IMP

UNIPROTKB|Q91819 aurka-b "Aurora kinase A-B" [Xenopus laevis (taxid:8355)]

 Score = 971 (346.9 bits), Expect = 9.4e-98, P = 9.4e-98
 Identities = 178/266 (66%), Positives = 218/266 (81%)

Query:     9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
             +KK+W L DF+IG+PLG+GKFG+VYLARE+ S  I+ALKVLFKSQL+++ VEHQLRREVE
Sbjct:   131 KKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGVEHQLRREVE 190

Query:    69 IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
             IQSHLRHPNILRLYGYF+D  RVYLIL+YA  GEL++ELQKC  F ++R+A Y+  LA A
Sbjct:   191 IQSHLRHPNILRLYGYFHDACRVYLILDYAPGGELFRELQKCTRFDDQRSALYIKQLAEA 250

Query:   129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
             L+YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct:   251 LLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 310

Query:   188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
               HD  VD+WSLGVLCYEFL G PPFE   H +TYRRI +V+ ++PP   VS  AKDL+S
Sbjct:   311 RMHDEKVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYPP--YVSEEAKDLVS 368

Query:   248 QMLVKDSSQRLPLHKLLEHPWIIQNA 273
             ++L  + + RLPL  +LEHPWI++N+
Sbjct:   369 KLLKHNPNHRLPLKGVLEHPWIVKNS 394

GO:0000922 "spindle pole" evidence=ISS

GO:0004672 "protein kinase activity" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0005813 "centrosome" evidence=ISS

GO:0005876 "spindle microtubule" evidence=ISS

GO:0008017 "microtubule binding" evidence=ISS

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISS

GO:0019894 "kinesin binding" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=ISS

GO:0090307 "spindle assembly involved in mitosis" evidence=ISS

UNIPROTKB|I3LFX5 AURKB "Aurora kinase B" [Sus scrofa (taxid:9823)]

 Score = 968 (345.8 bits), Expect = 2.0e-97, P = 2.0e-97
 Identities = 177/260 (68%), Positives = 219/260 (84%)

Query:    11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
             + +T++DF+IG+PLG+GKFG+VYLAREK+S+ IVALKVLFKSQ+++  VEHQLRRE+EIQ
Sbjct:    70 RSFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQ 129

Query:    71 SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
             +HL+HPNILRLY YFYD++R+YLILEYA +GELYKELQKC+ F E+R AT +  LA ALI
Sbjct:   130 AHLQHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKCRTFDEQRTATIMEELADALI 189

Query:   131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLDYLPPEMVESVE 189
             YCHGK VIHRDIKPENLL+G QGELKIADFGWSVH  + RR+TMCGTLDYLPPEM+E   
Sbjct:   190 YCHGKKVIHRDIKPENLLLGLQGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRT 249

Query:   190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
             H+  VD+W +GVLCYE L G PPFE+  H++TYRRIV+VDLKFPP   V + A+DLIS++
Sbjct:   250 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPPS--VPAGAQDLISKL 307

Query:   250 LVKDSSQRLPLHKLLEHPWI 269
             L  + S RLPL ++  HPW+
Sbjct:   308 LKHNPSDRLPLAQVSAHPWV 327

GO:0071777 "positive regulation of cell cycle cytokinesis" evidence=IEA

GO:0051256 "spindle midzone assembly involved in mitosis" evidence=IEA

GO:0036089 "cleavage furrow formation" evidence=IEA

GO:0034644 "cellular response to UV" evidence=IEA

GO:0034501 "protein localization to kinetochore" evidence=IEA

GO:0032133 "chromosome passenger complex" evidence=IEA

GO:0010369 "chromocenter" evidence=IEA

GO:0002903 "negative regulation of B cell apoptotic process" evidence=IEA

GO:0000780 "condensed nuclear chromosome, centromeric region" evidence=IEA

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:894678 Aurka "aurora kinase A" [Mus musculus (taxid:10090)]

 Score = 968 (345.8 bits), Expect = 2.0e-97, P = 2.0e-97
 Identities = 182/272 (66%), Positives = 220/272 (80%)

Query:     9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
             +K++WTL DFDIG+PLG+GKFG+VYLARE++S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct:   115 KKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKANVEHQLRREVE 174

Query:    69 IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
             IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct:   175 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 234

Query:   129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
             L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR TMCGTLDYLPPEM+E 
Sbjct:   235 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTMCGTLDYLPPEMIEG 294

Query:   188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
               HD  VD+WSLGVLCYEFL G+PPFEA  + +TYRRI +V+  FP    V+  A+DLIS
Sbjct:   295 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD--FVTEGARDLIS 352

Query:   248 QMLVKDSSQRLPLHKLLEHPWIIQNAD--PSG 277
             ++L  ++SQRL L ++LEHPWI  N+   P+G
Sbjct:   353 RLLKHNASQRLTLAEVLEHPWIKANSSKPPTG 384

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000278 "mitotic cell cycle" evidence=IMP

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO

GO:0005819 "spindle" evidence=ISO

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005874 "microtubule" evidence=IEA

GO:0005876 "spindle microtubule" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0007049 "cell cycle" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030030 "cell projection organization" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=ISO

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0031647 "regulation of protein stability" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0051301 "cell division" evidence=IEA

UNIPROTKB|F1LN52 Aurka "Aurora kinase A" [Rattus norvegicus (taxid:10116)]

 Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
 Identities = 183/272 (67%), Positives = 219/272 (80%)

Query:     9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
             +K++WTL DFDIG+PLG+GKFG+VYLAREK+S  I+ALKVLFK QL+++ VEHQLRREVE
Sbjct:   138 KKRQWTLEDFDIGRPLGKGKFGNVYLAREKQSKFILALKVLFKVQLEKAGVEHQLRREVE 197

Query:    69 IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
             IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct:   198 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 257

Query:   129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
             L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct:   258 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 317

Query:   188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
               HD  VD+WSLGVLCYEFL G+PPFEA  + +TYRRI +V+  FP    V+  A+DLIS
Sbjct:   318 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD--FVTEGARDLIS 375

Query:   248 QMLVKDSSQRLPLHKLLEHPWIIQNAD--PSG 277
             ++L  +SSQRL L ++LEHPWI  N+   P+G
Sbjct:   376 RLLKHNSSQRLTLAEVLEHPWIKANSSKPPTG 407

GO:0000278 "mitotic cell cycle" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005876 "spindle microtubule" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0031647 "regulation of protein stability" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

TAIR|locus:2043624 AUR3 "ataurora3" [Arabidopsis thaliana (taxid:3702)]

 Score = 965 (344.8 bits), Expect = 4.1e-97, P = 4.1e-97
 Identities = 172/269 (63%), Positives = 227/269 (84%)

Query:    10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
             +K+W+L DF+IG+PLG+GKFG VYLARE +S +IVALKV+FK Q+++ ++ HQLRRE+EI
Sbjct:    14 EKQWSLADFEIGRPLGKGKFGRVYLAREAKSKYIVALKVIFKEQIEKYKIHHQLRREMEI 73

Query:    70 QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
             Q+ LRHPNILRL+G+F+D +R++LILEYA  GELY  L++  + +E++AATY+ASL++AL
Sbjct:    74 QTSLRHPNILRLFGWFHDNERIFLILEYAHGGELYGVLKQNGHLTEQQAATYIASLSQAL 133

Query:   130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE 189
              YCHGK VIHRDIKPENLL+  +G LKIADFGWSV + N+R+TMCGTLDYL PEMVE+ +
Sbjct:   134 AYCHGKCVIHRDIKPENLLLDHEGRLKIADFGWSVQSSNKRKTMCGTLDYLAPEMVENRD 193

Query:   190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
             HD  VD W+LG+LCYEFLYG PPFEA+   DT++RI+++DL FP  P VS  AK+LISQ+
Sbjct:   194 HDYAVDNWTLGILCYEFLYGNPPFEAESQKDTFKRILKIDLSFPLTPNVSEEAKNLISQL 253

Query:   250 LVKDSSQRLPLHKLLEHPWIIQNADPSGV 278
             LVKD S+RL + K+++HPWI++NADP GV
Sbjct:   254 LVKDPSKRLSIEKIMQHPWIVKNADPKGV 282

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000775 "chromosome, centromeric region" evidence=IDA

GO:0005819 "spindle" evidence=IDA

GO:0016572 "histone phosphorylation" evidence=RCA;IDA

GO:0035175 "histone kinase activity (H3-S10 specific)" evidence=IDA

GO:0043987 "histone H3-S10 phosphorylation" evidence=IDA

GO:0043988 "histone H3-S28 phosphorylation" evidence=IDA

GO:0044022 "histone kinase activity (H3-S28 specific)" evidence=IDA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006342 "chromatin silencing" evidence=RCA

GO:0009640 "photomorphogenesis" evidence=RCA

GO:0010388 "cullin deneddylation" evidence=RCA

GO:0016567 "protein ubiquitination" evidence=RCA

GO:0016571 "histone methylation" evidence=RCA

GO:0016579 "protein deubiquitination" evidence=RCA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

UNIPROTKB|Q9N0X0 AURKB "Aurora kinase B" [Sus scrofa (taxid:9823)]

 Score = 961 (343.3 bits), Expect = 1.1e-96, P = 1.1e-96
 Identities = 176/260 (67%), Positives = 218/260 (83%)

Query:    11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
             + +T++DF+IG+PLG+GKFG+VYLAREK+S+ IVALKVLFKSQ+++  VEHQLRRE+EIQ
Sbjct:    70 RSFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQ 129

Query:    71 SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
             +HL+HPNILRLY YFYD++R+YLILEYA +GELYKELQKC+ F E+R AT +  LA ALI
Sbjct:   130 AHLQHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKCRTFDEQRTATIMEELADALI 189

Query:   131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLDYLPPEMVESVE 189
             YCHGK VIHRDIKPENLL+G QGELKIADFGWSVH  + RR+TMCGTLDYLPPEM+E   
Sbjct:   190 YCHGKKVIHRDIKPENLLLGLQGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRT 249

Query:   190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
             H+  VD+W +GVLCYE L G PPFE+  H++TYRRI +VDLKFPP   V + A+DLIS++
Sbjct:   250 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIGKVDLKFPPS--VPAGAQDLISKL 307

Query:   250 LVKDSSQRLPLHKLLEHPWI 269
             L  + S RLPL ++  HPW+
Sbjct:   308 LKHNPSDRLPLAQVSAHPWV 327

GO:0005737 "cytoplasm" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005634 "nucleus" evidence=ISS

GO:0036089 "cleavage furrow formation" evidence=ISS

GO:0034644 "cellular response to UV" evidence=ISS

GO:0002903 "negative regulation of B cell apoptotic process" evidence=ISS

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=ISS

GO:0071777 "positive regulation of cell cycle cytokinesis" evidence=ISS

GO:0051256 "spindle midzone assembly involved in mitosis" evidence=ISS

GO:0034501 "protein localization to kinetochore" evidence=ISS

GO:0005819 "spindle" evidence=IEA

GO:0000775 "chromosome, centromeric region" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

RGD|628895 Aurka "aurora kinase A" [Rattus norvegicus (taxid:10116)]

 Score = 960 (343.0 bits), Expect = 1.4e-96, P = 1.4e-96
 Identities = 182/272 (66%), Positives = 218/272 (80%)

Query:     9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
             +K++WTL DFDIG+PLG+GKFG+VYLAREK+S  I+ALKVLFK QL+++ VEHQLRREVE
Sbjct:   117 KKRQWTLEDFDIGRPLGKGKFGNVYLAREKQSKFILALKVLFKVQLEKAGVEHQLRREVE 176

Query:    69 IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
             IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct:   177 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 236

Query:   129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
             L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDY PPEM+E 
Sbjct:   237 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYQPPEMIEG 296

Query:   188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
               HD  VD+WSLGVLCYEFL G+PPFEA  + +TYRRI +V+  FP    V+  A+DLIS
Sbjct:   297 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD--FVTEGARDLIS 354

Query:   248 QMLVKDSSQRLPLHKLLEHPWIIQNAD--PSG 277
             ++L  +SSQRL L ++LEHPWI  N+   P+G
Sbjct:   355 RLLKHNSSQRLTLAEVLEHPWIKANSSKPPTG 386

GO:0000278 "mitotic cell cycle" evidence=ISO

GO:0000922 "spindle pole" evidence=IEA

GO:0004672 "protein kinase activity" evidence=ISO;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO;IDA

GO:0005819 "spindle" evidence=IDA

GO:0005874 "microtubule" evidence=IEA

GO:0005876 "spindle microtubule" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0007049 "cell cycle" evidence=TAS

GO:0007067 "mitosis" evidence=IEA

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030030 "cell projection organization" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=ISO

GO:0031625 "ubiquitin protein ligase binding" evidence=ISO

GO:0031647 "regulation of protein stability" evidence=ISO

GO:0032355 "response to estradiol stimulus" evidence=IEP

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0051301 "cell division" evidence=IEA

UNIPROTKB|Q2TA06 AURKA "Aurora kinase A" [Bos taurus (taxid:9913)]

 Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
 Identities = 183/278 (65%), Positives = 218/278 (78%)

Query:     1 ACSEVSAKEKKR-WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV 59
             A  + + + KKR W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ V
Sbjct:   115 ASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 174

Query:    60 EHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA 119
             EHQLRREVEIQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R A
Sbjct:   175 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTA 234

Query:   120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLD 178
             TY+  LA AL YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLD
Sbjct:   235 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLD 294

Query:   179 YLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
             YLPPEM+E   HD  VD+WSLGVLCYEFL G PPFEA  + +TYRRI +V+  FP    V
Sbjct:   295 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEADTYQETYRRISRVEFTFPD--CV 352

Query:   239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                A+DLIS++L  + SQR  L ++LEHPWII N+ PS
Sbjct:   353 PEGARDLISRLLKHNPSQRPTLKEVLEHPWIIANSKPS 390

GO:0004672 "protein kinase activity" evidence=ISS

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0031647 "regulation of protein stability" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0005876 "spindle microtubule" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0030030 "cell projection organization" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q6BVA0	IPL1_DEBHA	2, ., 7, ., 1, 1, ., 1	0.5300	0.9252	0.6310	yes	no
P97477	AURKA_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6691	0.9501	0.6759	yes	no
Q8SRL5	IPL1_ENCCU	2, ., 7, ., 1, 1, ., 1	0.4866	0.9145	0.9448	yes	no
O01427	AIR2_CAEEL	2, ., 7, ., 1, 1, ., 1	0.5984	0.9110	0.8393	yes	no
Q54WX4	AURK_DICDI	2, ., 7, ., 1, 1, ., 1	0.6074	0.9501	0.6953	yes	no
Q2TA06	AURKA_BOVIN	2, ., 7, ., 1, 1, ., 1	0.6593	0.9608	0.6716	yes	no
Q6C3J2	IPL1_YARLI	2, ., 7, ., 1, 1, ., 1	0.5475	0.9217	0.6981	yes	no
A4IGM9	AURKB_XENTR	2, ., 7, ., 1, 1, ., 1	0.6528	0.9323	0.7277	yes	no
P59241	AURKA_RAT	2, ., 7, ., 1, 1, ., 1	0.6691	0.9501	0.6725	yes	no
O14965	AURKA_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6591	0.9395	0.6550	yes	no
O59790	ARK1_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6100	0.9074	0.7183	yes	no
Q61XD3	AIR2_CAEBR	2, ., 7, ., 1, 1, ., 1	0.5641	0.9608	0.8940	N/A	no
Q755C4	IPL1_ASHGO	2, ., 7, ., 1, 1, ., 1	0.5038	0.9110	0.6975	yes	no
Q683C9	AUR2_ARATH	2, ., 7, ., 1, 1, ., 1	0.9205	0.9857	0.9822	no	no
Q9M077	AUR1_ARATH	2, ., 7, ., 1, 1, ., 1	0.9483	0.9644	0.9217	yes	no
Q9N0X0	AURKB_PIG	2, ., 7, ., 1, 1, ., 1	0.6769	0.9145	0.7470	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.993
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00032134001 SubName- Full=Chromosome chr4 scaffold_6, whole genome shotgun sequence; (293 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	281
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-101
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-86
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-82
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-81
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-76
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-67
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-66
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-64
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-64
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-63
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-62
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-62
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-62
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-60
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-60
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-58
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-58
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-55
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-54
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-54
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-51
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-51
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-51
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-51
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-50
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-50
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-50
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-50
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-49
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-49
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-49
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-48
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-47
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-47
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-47
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-47
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-47
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-46
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-46
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-46
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-46
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-46
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-46
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-45
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-45
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-45
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-45
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-44
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-44
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-44
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-44
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-44
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-44
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-43
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-42
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-42
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-41
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-41
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-41
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-41
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-41
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-41
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-41
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-41
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-40
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-39
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-39
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-39
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-39
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-39
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-38
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-38
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-38
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-38
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-38
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-37
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-37
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-37
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-37
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-37
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-37
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-36
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-36
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-36
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-36
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-36
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-35
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-35
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-35
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-35
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-35
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-35
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-35
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-35
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-34
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-33
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-33
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-33
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-33
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-33
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-33
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-32
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-32
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-32
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-32
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-32
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-32
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-32
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-31
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-31
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-31
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-31
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-31
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-31
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-31
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-31
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-31
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-31
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-30
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-30
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-30
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-30
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-30
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-29
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-29
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-29
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-29
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-29
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-29
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-28
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-28
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-28
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-28
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-28
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-28
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-28
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-28
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-28
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-28
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-28
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-27
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-27
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-27
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-27
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-27
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-27
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-27
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-27
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-27
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-26
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-26
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-26
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-26
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-26
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-26
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-26
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-26
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-26
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-26
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-26
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-26
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-26
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-26
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-26
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-26
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-25
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-25
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-25
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-25
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-25
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-24
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-24
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-24
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-24
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-24
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-24
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-24
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-24
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-24
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-23
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-23
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-23
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-22
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-22
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-22
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-21
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-21
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-20
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-20
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-20
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-19
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-19
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-18
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-18
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-17
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-17
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-17
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-17
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-16
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-15
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-13
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-12
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-11
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-07
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	8e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	4e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  295 bits (759), Expect = e-101
 Identities = 101/256 (39%), Positives = 157/256 (61%), Gaps = 6/256 (2%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           ++I + LG G FG VYLAR+K++  +VA+KV+ K +    +   ++ RE++I   L+HPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKK--IKKDRERILREIKILKKLKHPN 58

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+RLY  F D+ ++YL++EY   G+L+  L+K    SE  A  Y+  +  AL Y H K +
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 138 IHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESVEHDANVD 195
           +HRD+KPEN+L+   G +K+ADFG +  +    +  T  GT +Y+ PE++    +   VD
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 196 IWSLGVLCYEFLYGVPPFEAKEH-SDTYRRIVQVDLKFPPKPI-VSSAAKDLISQMLVKD 253
           IWSLGV+ YE L G PPF   +   + +++I +    FPP    +S  AKDLI ++LVKD
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKD 238

Query: 254 SSQRLPLHKLLEHPWI 269
             +RL   + L+HP+ 
Sbjct: 239 PEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  258 bits (661), Expect = 2e-86
 Identities = 101/251 (40%), Positives = 149/251 (59%), Gaps = 8/251 (3%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V L R+K +  + A+KVL K ++ + +       E  I S + HP I++L+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            F  ++++YL+LEYA  GEL+  L K   FSE RA  Y A +  AL Y H   +I+RD+K
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 144 PENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
           PEN+L+ A G +K+ DFG +       +R  T CGT +YL PE++    +   VD WSLG
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG 180

Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL-- 258
           VL YE L G PPF A++  + Y +I++  L+FP    +S  A+DLIS +L KD ++RL  
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF--LSPEARDLISGLLQKDPTKRLGS 238

Query: 259 -PLHKLLEHPW 268
               ++  HP+
Sbjct: 239 GGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  246 bits (631), Expect = 7e-82
 Identities = 96/261 (36%), Positives = 142/261 (54%), Gaps = 10/261 (3%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++ + LG G FG VY A+ K +  IVA+K+L K   ++S+ +   RRE+ I   L HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+RL   F D+  +YL++EY   G+L+  L +    SE  A      + R L Y H   +
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPE-MVESVEHDAN 193
           IHRD+KPEN+L+   G +KIADFG +        ++    GT  Y+ PE ++    +   
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-----VDLKFPPKPIVSSAAKDLISQ 248
           VD+WSLGV+ YE L G PPF  +   D  + I +     ++   P     S  AKDLI +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 249 MLVKDSSQRLPLHKLLEHPWI 269
            L KD S+R    ++L+HPW 
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  247 bits (632), Expect = 1e-81
 Identities = 105/259 (40%), Positives = 147/259 (56%), Gaps = 9/259 (3%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLR 74
           +DF+  K LG G FG V L R K S    ALK+L K++ ++  QVEH +  E  I   +R
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQSIR 59

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HP ++ LYG F D   +YL++EY   GEL+  L+K   F E  A  Y A +  AL Y H 
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
             +++RD+KPENLL+ + G +KI DFG++     R  T+CGT +YL PE++ S  +   V
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAV 179

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           D W+LG+L YE L G PPF        Y +I++  ++FP     S  AKDLI  +L  D 
Sbjct: 180 DWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF--FSPDAKDLIRNLLQVDL 237

Query: 255 SQRLPLHK-----LLEHPW 268
           ++RL   K     +  HPW
Sbjct: 238 TKRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  234 bits (598), Expect = 1e-76
 Identities = 94/281 (33%), Positives = 146/281 (51%), Gaps = 30/281 (10%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-R 74
           +DF  GK +G G F  V LA+EK +N   A+K+L K QL + +    ++ E E+ + L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HP I++LY  F D++ +Y +LEYA  GEL + ++K     E+    Y A +  AL Y H 
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHT-----------------------FNRRR 171
           K +IHRD+KPEN+L+     +KI DFG +                            R  
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK 231
           +  GT +Y+ PE++       + D+W+LG + Y+ L G PPF       T+++I++++  
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Query: 232 FPPKPIVSSAAKDLISQMLVKDSSQRLPLHK----LLEHPW 268
           FPP       AKDLI ++LV D   RL +++    L  HP+
Sbjct: 241 FPPN--FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  209 bits (535), Expect = 2e-67
 Identities = 93/256 (36%), Positives = 144/256 (56%), Gaps = 13/256 (5%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G FG V L + K  N   ALK + K  + ++  +  +  E EI     HP I++LY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            F D+K +Y+++EY   GEL+  L+    F E  A  Y+A +  A  Y H + +I+RD+K
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 144 PENLLIGAQGELKIADFGWSVHTFNRRR--TMCGTLDYLPPEMVESVEHDANVDIWSLGV 201
           PENLL+ + G +K+ DFG++    + ++  T CGT +Y+ PE++ +  +D +VD WSLG+
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGI 180

Query: 202 LCYEFLYGVPPFEAKEHSD--TYRRIVQVD--LKFPPKPIVSSAAKDLISQMLVKDSSQR 257
           L YE L G PPF   +      Y  I++ +  L+FP    +  AAKDLI Q+L ++  +R
Sbjct: 181 LLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY--IDKAAKDLIKQLLRRNPEER 238

Query: 258 LPLHK-----LLEHPW 268
           L   K     + +H W
Sbjct: 239 LGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  205 bits (525), Expect = 8e-66
 Identities = 90/260 (34%), Positives = 143/260 (55%), Gaps = 14/260 (5%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           + +G +G V+LA++K +  I A+KV+ K+ + +     Q+  E +I S  + P +++LY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            F  +K +YL++EY   G+L   L+      E  A  Y+A +  AL Y H   +IHRD+K
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 144 PENLLIGAQGELKIADFGWSVHTFNRRRTM-----------CGTLDYLPPEMVESVEHDA 192
           P+N+LI + G LK+ DFG S     RR+              GT DY+ PE++    H  
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
            VD WSLG + YEFL G+PPF  +   + ++ I+   +++P    VS  A DLIS++LV 
Sbjct: 181 TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP 240

Query: 253 DSSQRL---PLHKLLEHPWI 269
           D  +RL    + ++  HP+ 
Sbjct: 241 DPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  203 bits (519), Expect = 4e-64
 Identities = 99/255 (38%), Positives = 146/255 (57%), Gaps = 4/255 (1%)

Query: 5   VSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQL 63
            +  +   W L+DF++G+ LG G FG V +A+ K +    A+K L K + L+  QV+H +
Sbjct: 7   FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-V 65

Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA 123
            +E  I   L HP I+ +   F D+ RVY +LE+   GEL+  L+K   F    A  Y A
Sbjct: 66  AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA 125

Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE 183
            L  A  Y H K +I+RD+KPENLL+  +G +K+ DFG++    +R  T+CGT +YL PE
Sbjct: 126 ELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPE 185

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
           +++S  H   VD W++GVL YEF+ G PPF        Y +I+   LKFP        A+
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP--NWFDGRAR 243

Query: 244 DLISQMLVKDSSQRL 258
           DL+  +L  D ++RL
Sbjct: 244 DLVKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  201 bits (513), Expect = 5e-64
 Identities = 86/262 (32%), Positives = 133/262 (50%), Gaps = 11/262 (4%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           ++  G+ LGRG FG VYLA +K +  ++A+K +  S   + ++E  L RE+ I S L+HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE-ALEREIRILSSLQHP 59

Query: 77  NILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           NI+R YG   D  +  + + LEY + G L   L+K     E     Y   +   L Y H 
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFG-----WSVHTFNRRRTMCGTLDYLPPEMVESVE 189
             ++HRDIK  N+L+ + G +K+ADFG       + T     ++ GT  ++ PE++   E
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 190 HDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPKPI-VSSAAKDLIS 247
           +    DIWSLG    E   G PP+ E         +I       P  P  +S  AKD + 
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-PEIPEHLSEEAKDFLR 238

Query: 248 QMLVKDSSQRLPLHKLLEHPWI 269
           + L +D  +R    +LL+HP++
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  198 bits (507), Expect = 4e-63
 Identities = 91/267 (34%), Positives = 127/267 (47%), Gaps = 12/267 (4%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVL-FKSQLQQSQVEHQLRREVEIQSHLR 74
           +D +  K LG+G  G VY  R K +  I ALK +         +   QL RE++      
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCE 57

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P +++ YG FY +  + ++LEY   G L   L+K     E   A     + + L Y H 
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 135 K-HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTMCGTLDYLPPEMVESVEH 190
           K H+IHRDIKP NLLI ++GE+KIADFG S    N      T  GT+ Y+ PE ++   +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY---RRIVQVDLKFPPKPIVSSAAKDLIS 247
               DIWSLG+   E   G  PF        +   + I        P    S   +D IS
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237

Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
             L KD  +R    +LL+HP+ I+ AD
Sbjct: 238 ACLQKDPKKRPSAAELLQHPF-IKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  198 bits (506), Expect = 1e-62
 Identities = 91/243 (37%), Positives = 143/243 (58%), Gaps = 4/243 (1%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVL-FKSQLQQSQVEHQLRREVEIQSHLRH 75
           D +  K +G G FG V+L R++ S H  ALKV+     ++  Q +H +  E  +   + H
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH-VHNEKRVLKEVSH 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           P I+RL+   +DQ+ +Y+++EY   GEL+  L+    FS      Y + +  AL Y H K
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVD 195
            +++RD+KPEN+L+  +G +K+ DFG++    +R  T+CGT +YL PE+++S  H+  VD
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVD 180

Query: 196 IWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSS 255
            W+LG+L YE L G PPF        Y +I+   L+FP    +   AKDLI ++LV D +
Sbjct: 181 WWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH--LDLYAKDLIKKLLVVDRT 238

Query: 256 QRL 258
           +RL
Sbjct: 239 RRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  200 bits (510), Expect = 2e-62
 Identities = 104/289 (35%), Positives = 151/289 (52%), Gaps = 38/289 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLR 74
           +DF++ K +GRG FG V+L R+K +  + A+KVL KS  ++++Q+ H +R E +I +   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADAD 59

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I++LY  F D++ +YL++EY   G+L   L +   F E  A  Y+A L  AL   H 
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS----------------------------VHT 166
              IHRDIKP+N+LI A G +K+ADFG                                 
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179

Query: 167 FNRRRTMC----GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY 222
             +RR       GT DY+ PE++    +    D WSLGV+ YE LYG PPF +    +TY
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239

Query: 223 RRIV--QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL-PLHKLLEHPW 268
            +I+  +  L+FPP P VS  A DLI   L+ D   RL    ++  HP+
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLI-CRLLCDPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  195 bits (497), Expect = 4e-62
 Identities = 86/250 (34%), Positives = 125/250 (50%), Gaps = 41/250 (16%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G FG VYLAR+K++   VA+K++ K     S +  +L RE+EI   L HPNI++LYG
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS--SSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            F D+  +YL++EY   G L   L++     SE      +  +   L Y H   +IHRD+
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 143 KPENLLIGA-QGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVES-VEHDANVDIW 197
           KPEN+L+ +  G++K+ADFG S       +  +T+ GT  Y+ PE++     +    DIW
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
           SLGV+ YE                                     KDLI +ML KD  +R
Sbjct: 179 SLGVILYEL---------------------------------PELKDLIRKMLQKDPEKR 205

Query: 258 LPLHKLLEHP 267
               ++LEH 
Sbjct: 206 PSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  192 bits (490), Expect = 1e-60
 Identities = 86/261 (32%), Positives = 147/261 (56%), Gaps = 11/261 (4%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            ++I K +G+G FG VYL R K    +  LK +  S + + + E     EV+I   L HP
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE-DALNEVKILKKLNHP 59

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARALIYC 132
           NI++ Y  F ++ ++ +++EYA  G+L ++++K K     F E +   +   L  AL Y 
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVE 189
           H + ++HRDIKP+N+ + + G +K+ DFG S     T +  +T+ GT  YL PE+ ++  
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179

Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP-IVSSAAKDLISQ 248
           ++   DIWSLG + YE      PFE +   +   +I++   ++PP P   SS  ++L+S 
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYPPIPSQYSSELRNLVSS 237

Query: 249 MLVKDSSQRLPLHKLLEHPWI 269
           +L KD  +R  + ++L+ P+I
Sbjct: 238 LLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  193 bits (492), Expect = 3e-60
 Identities = 94/290 (32%), Positives = 147/290 (50%), Gaps = 38/290 (13%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            F   K LG+G  G V+L R K +  + ALKVL K ++ +     ++  E EI + L HP
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQK--CKYFSERRAATYVASLARALIYCHG 134
            +  LY  F  +  + L+++Y   GEL++ LQ+   K  SE  A  Y A +  AL Y H 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHT-----------FNRRRTMC--------- 174
             +++RD+KPEN+L+   G + ++DF  S  +               R            
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 175 ------------GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY 222
                       GT +Y+ PE++    H + VD W+LG+L YE LYG  PF+     +T+
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241

Query: 223 RRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHK----LLEHPW 268
             I++ ++ FP  P VSS+A+DLI ++LVKD S+RL   +    + +HP+
Sbjct: 242 SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  186 bits (475), Expect = 2e-58
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 7/257 (2%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           ++ +G  +GRG FG VY      +   VA+K +   ++++  ++  + +E+++  +L+HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALK-SIMQEIDLLKNLKHP 59

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
           NI++  G       +Y+ILEYA  G L + ++K   F E   A YV  + + L Y H + 
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPPEMVESVEHDAN 193
           VIHRDIK  N+L    G +K+ADFG +           ++ GT  ++ PE++E       
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179

Query: 194 VDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
            DIWSLG    E L G PP ++    +  + RIVQ D    P+ I S   KD + Q   K
Sbjct: 180 SDIWSLGCTVIELLTGNPPYYDLNPMAALF-RIVQDDHPPLPEGI-SPELKDFLMQCFQK 237

Query: 253 DSSQRLPLHKLLEHPWI 269
           D + R    +LL+HPWI
Sbjct: 238 DPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  185 bits (472), Expect = 6e-58
 Identities = 80/257 (31%), Positives = 134/257 (52%), Gaps = 9/257 (3%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            F+I + +G+G FG VY AR KR+   VA+KV+   +L+  + + ++  E++I    +HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCKHP 57

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGK 135
           NI++ YG +  +  +++++E+ + G L   L+   +  +E + A     L + L Y H  
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRDIK  N+L+ + GE+K+ DFG S        R TM GT  ++ PE++    +D  
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSD-TYRRIVQVDLKFPPKPIVSSA-AKDLISQMLV 251
            DIWSLG+   E   G PP+  +        +I          P   S   KD + + L 
Sbjct: 178 ADIWSLGITAIELAEGKPPYS-ELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236

Query: 252 KDSSQRLPLHKLLEHPW 268
           K+  +R    +LL+HP+
Sbjct: 237 KNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  179 bits (456), Expect = 9e-55
 Identities = 88/242 (36%), Positives = 143/242 (59%), Gaps = 8/242 (3%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQL-RREVEIQSHLRHPNIL 79
           K +G+G FG V LA+ K      A+KVL K   L++ + +H +  R V +++ ++HP ++
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKN-VKHPFLV 59

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIH 139
            L+  F    ++Y +L+Y   GEL+  LQ+ + F E RA  Y A +A AL Y H  ++I+
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY 119

Query: 140 RDIKPENLLIGAQGELKIADFGWSVHTFNRRR---TMCGTLDYLPPEMVESVEHDANVDI 196
           RD+KPEN+L+ +QG + + DFG         +   T CGT +YL PE++    +D  VD 
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Query: 197 WSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           W LG + YE LYG+PPF +++ ++ Y  I+   L+  P   +S +A+ L+  +L KD ++
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN--ISVSARHLLEGLLQKDRTK 237

Query: 257 RL 258
           RL
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  176 bits (447), Expect = 3e-54
 Identities = 90/255 (35%), Positives = 136/255 (53%), Gaps = 11/255 (4%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQL--RREVEIQSHLRHPNI 78
           KP+ +G FG VYLA+++ +    A+KVL KS +  ++QV +    R  + IQ     P +
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYV 59

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVI 138
            +LY  F  +  +YL++EY   G+    ++      E  A  Y+A +   +   H + +I
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119

Query: 139 HRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWS 198
           HRDIKPENLLI   G LK+ DFG S +    ++   GT DYL PE +  V  D   D WS
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-FVGTPDYLAPETILGVGDDKMSDWWS 178

Query: 199 LGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAKDLISQMLVKDSSQ 256
           LG + +EFL+G PPF A+     +  I+   + +P   K   S  A DLI+++L  D ++
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238

Query: 257 RLPLHKLLE---HPW 268
           RL  +   E   HP+
Sbjct: 239 RLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  175 bits (447), Expect = 4e-54
 Identities = 78/259 (30%), Positives = 129/259 (49%), Gaps = 9/259 (3%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           F++ + +G+G FG V + +++ +  + A+K + K +  +      +  E  I   L HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           ++ L+  F D++ +YL+++    G+L   L +   FSE +   ++  +  AL Y H K +
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT--MCGTLDYLPPEMVESVEHDANVD 195
           IHRDIKP+N+L+  QG + I DF  +        T    GT  Y+ PE++    +   VD
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVD 181

Query: 196 IWSLGVLCYEFLYGVPPFEAK--EHSDTYRRI-VQVDLKFPPKPIVSSAAKDLISQMLVK 252
            WSLGV  YE L G  P+        D  R      D+ +P     S+ A D I+++L +
Sbjct: 182 WWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW--STEAIDAINKLLER 239

Query: 253 DSSQRL--PLHKLLEHPWI 269
           D  +RL   L  L  HP+ 
Sbjct: 240 DPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  173 bits (438), Expect = 1e-51
 Identities = 98/288 (34%), Positives = 148/288 (51%), Gaps = 31/288 (10%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            + I + LG G FG VYLAR+++   +VALKVL K    +S+   +  RE++I + L HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 77  -NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY---FSERRAATYVASLARALIYC 132
            NI++LY +F D+  +YL++EY   G L   L+K       SE  A   +A +  AL Y 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 133 HGKHVIHRDIKPENLLIGAQG-ELKIADFG---------WSVHTFNRRRTMCGTLDYLPP 182
           H K +IHRDIKPEN+L+   G  +K+ DFG          +        T  GT  Y+ P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 183 EMVESVEH---DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI-- 237
           E++  +      ++ DIWSLG+  YE L G+PPFE +++S    + +++ L+ P   +  
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 238 ---------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                    +S AA DL+ ++L KD   RL     L H  +       
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285

Length = 384

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  171 bits (434), Expect = 2e-51
 Identities = 91/241 (37%), Positives = 133/241 (55%), Gaps = 7/241 (2%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSHLRHPNILR 80
           K LG+G FG V L REK +    A+K+L K  +  + +V H L  E  +  + RHP +  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLQNTRHPFLTA 59

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           L   F    R+  ++EYA  GEL+  L + + FSE RA  Y A +  AL Y H   V++R
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVEHDANVDIW 197
           D+K ENL++   G +KI DFG      +   TM   CGT +YL PE++E  ++   VD W
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
            LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L++ +L KD  QR
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQR 237

Query: 258 L 258
           L
Sbjct: 238 L 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  168 bits (429), Expect = 3e-51
 Identities = 86/255 (33%), Positives = 136/255 (53%), Gaps = 18/255 (7%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE-HQLRREVEIQSHLRHPNILRLY 82
           +G+G FG VY A +KR+N +VA+KV+    L++++ E   +++E++  S  R P I + Y
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVI---DLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
           G F    ++++I+EY   G    +L K     E   A  +  +   L Y H +  IHRDI
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDI 124

Query: 143 KPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K  N+L+  +G++K+ADFG S     T ++R T  GT  ++ PE+++   +D   DIWSL
Sbjct: 125 KAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSL 184

Query: 200 GVLCYEFLYGVPPFEAKEHSDTY-RRIVQVDLK-FPPK---PIVSSAAKDLISQMLVKDS 254
           G+   E   G PP      SD +  R++ +  K  PP       S   KD +S  L KD 
Sbjct: 185 GITAIELAKGEPP-----LSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDP 239

Query: 255 SQRLPLHKLLEHPWI 269
            +R    +LL+H +I
Sbjct: 240 KERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  169 bits (429), Expect = 7e-51
 Identities = 84/257 (32%), Positives = 139/257 (54%), Gaps = 15/257 (5%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQL--RREVEIQSHLRHPNI 78
           K LG+G FG V LA  K ++ + A+KVL K   LQ   VE  +  +R + +    +HP +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVI 138
            +L+  F  + R++ ++EY   G+L   +Q+   F E RA  Y A +   L + H + +I
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118

Query: 139 HRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVD 195
           +RD+K +N+L+ ++G +KIADFG     +       T CGT DY+ PE++    +   VD
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVD 178

Query: 196 IWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSS 255
            W+LGVL YE L G  PFE  +  + ++ I++ ++++P    +S  AK ++   L K+  
Sbjct: 179 WWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW--LSKEAKSILKSFLTKNPE 236

Query: 256 QRLPLHK-----LLEHP 267
           +RL         +  HP
Sbjct: 237 KRLGCLPTGEQDIKGHP 253

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  168 bits (427), Expect = 2e-50
 Identities = 99/267 (37%), Positives = 136/267 (50%), Gaps = 16/267 (5%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
            DFD+   +GRG FG V + REK +  I A+KV+ KS L   +       E +I S    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           P I +L   F D+  +YL++EY   G+L   L + +  F E  A  Y+A L  A+   H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM-----CGTLDYLPPEMVESVE 189
              +HRDIKPEN+LI   G +K+ADFG S       + +      GT DY+ PE++ ++ 
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179

Query: 190 ------HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSA 241
                 +    D WSLGV+ YE +YG  PF     + TY  I+  Q  LKFP  P VSS 
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239

Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPW 268
             DLI Q L+    +RL    L  HP+
Sbjct: 240 FLDLI-QSLLCGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  168 bits (427), Expect = 2e-50
 Identities = 88/260 (33%), Positives = 138/260 (53%), Gaps = 8/260 (3%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHLR 74
            DF I   +G+G +G V+LA++K +  IVALK + KS L + ++V H L  E +I +  +
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT-ERDILTTTK 59

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
              +++L   F D + +YL +EY   G+    L      SE  A  Y+A +  A+   H 
Sbjct: 60  SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE 119

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
              IHRD+KPEN LI A G +K+ DFG S        ++ G+ DY+ PE++    +D  V
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTV 179

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTY------RRIVQVDLKFPPKPIVSSAAKDLISQ 248
           D WSLG + YEFL G PPF     ++T+      +  +Q  +   P+  +S  A DLI++
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239

Query: 249 MLVKDSSQRLPLHKLLEHPW 268
           ++   S +   L  +  HP+
Sbjct: 240 LINDPSRRFGSLEDIKNHPF 259

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  167 bits (425), Expect = 3e-50
 Identities = 89/244 (36%), Positives = 141/244 (57%), Gaps = 9/244 (3%)

Query: 22  KPLGRGKFGHVYLAR---EKRSNHIVALKVLFKSQLQQSQVE-HQLRREVEIQSHLRHPN 77
           K LG+G +G V+  R      +  I A+KVL K+ + ++Q +    + E  I   ++HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+ L   F    ++YLILEY + GEL+  L++   F E  A  Y++ ++ AL + H + +
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 138 IHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
           I+RD+KPEN+L+ AQG +K+ DFG    S+H      T CGT++Y+ PE++    H   V
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAV 181

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           D WSLG L Y+ L G PPF A+    T  +I++  L  P  P ++  A+DL+ ++L ++ 
Sbjct: 182 DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP--PYLTPEARDLLKKLLKRNP 239

Query: 255 SQRL 258
           S RL
Sbjct: 240 SSRL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  168 bits (427), Expect = 6e-50
 Identities = 100/300 (33%), Positives = 154/300 (51%), Gaps = 49/300 (16%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLR 74
           +DF+  K +GRG FG V L ++K + HI A+K L KS+ L++ QV H +R E +I +   
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAH-VRAERDILAEAD 59

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           +P +++LY  F D+  +YLI+EY   G++   L K   F+E     Y+A    A+   H 
Sbjct: 60  NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK 119

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------------------------------- 163
              IHRDIKP+NLL+ A+G +K++DFG                                 
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179

Query: 164 -----VHTFNRRRTM-----CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPF 213
                  T+ R R        GT DY+ PE+     ++   D WSLGV+ YE L G PPF
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239

Query: 214 EAKEHSDTYRRIV--QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLP---LHKLLEHPW 268
            +    +TYR+I+  +  L+FP +  +S  AKDLI + L  ++ +RL    ++++  HP+
Sbjct: 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLI-KRLCCEAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  165 bits (419), Expect = 1e-49
 Identities = 81/298 (27%), Positives = 142/298 (47%), Gaps = 46/298 (15%)

Query: 4   EVSAKEKKRWTLND----FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV 59
           E+ A  K   +  D    +   + +G G  G VY A ++ +   VA+K +      + Q 
Sbjct: 3   ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM----RLRKQN 58

Query: 60  EHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRA 118
           +  +  E+ I    +HPNI+  Y  +     +++++EY   G L   + +     +E + 
Sbjct: 59  KELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI 118

Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCG 175
           A     + + L Y H ++VIHRDIK +N+L+   G +K+ADFG++       ++R ++ G
Sbjct: 119 AYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG 178

Query: 176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP- 234
           T  ++ PE+++  ++   VDIWSLG++C E   G PP+                L+ PP 
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY----------------LREPPL 222

Query: 235 --------KPI--------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                   K I         S   KD +++ LVKD  +R    +LL+HP+ ++ A P 
Sbjct: 223 RALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF-LKKACPK 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  163 bits (415), Expect = 8e-49
 Identities = 89/241 (36%), Positives = 138/241 (57%), Gaps = 6/241 (2%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFK-SQLQQSQVEHQLRREVEIQSHLRHPNILR 80
           K +G+G FG V LA+ K      A+KVL K + L++ +  H +     +  +L+HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           L+  F   +++Y +L+Y   GEL+  LQ+ + F E RA  Y A +A A+ Y H  ++I+R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 141 DIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           D+KPEN+L+ +QG + + DFG     V       T CGT +YL PE++    +D  VD W
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWW 180

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
            LG + YE LYG+PPF +++ S  Y  I+   L+ P     + AA DL+  +L KD  +R
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK--TVAACDLLVGLLHKDQRRR 238

Query: 258 L 258
           L
Sbjct: 239 L 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  164 bits (415), Expect = 9e-49
 Identities = 86/241 (35%), Positives = 142/241 (58%), Gaps = 6/241 (2%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRHPNILR 80
           K +G+G FG V LAR K      A+KVL K   L++ + +H +     +  +++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           L+  F    ++Y +L+Y   GEL+  LQ+ + F E RA  Y A +A AL Y H  ++++R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 141 DIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           D+KPEN+L+ +QG + + DFG    ++       T CGT +YL PE++    +D  VD W
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 180

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
            LG + YE LYG+PPF ++  ++ Y  I+   L+   KP ++++A+ L+  +L KD ++R
Sbjct: 181 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL--KPNITNSARHLLEGLLQKDRTKR 238

Query: 258 L 258
           L
Sbjct: 239 L 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  160 bits (406), Expect = 7e-48
 Identities = 88/268 (32%), Positives = 132/268 (49%), Gaps = 18/268 (6%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D+++ + +G+G FG V   R K    I+  K +    + + + + QL  EV I   L+HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ-QLVSEVNILRELKHP 59

Query: 77  NILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARALI 130
           NI+R Y    D   + +Y+++EY   G+L + +QKCK    Y  E      +  L  AL 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 131 YCH-----GKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPP 182
            CH     G  V+HRD+KP N+ + A   +K+ DFG +    H  +  +T  GT  Y+ P
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179

Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP-IVSSA 241
           E +  + +D   DIWSLG L YE     PPF A+       +I +   KF   P   SS 
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--KFRRIPYRYSSE 237

Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWI 269
             ++I  ML  D  +R    +LL+ P I
Sbjct: 238 LNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  160 bits (406), Expect = 1e-47
 Identities = 92/272 (33%), Positives = 147/272 (54%), Gaps = 24/272 (8%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQLQQSQ--VEHQLRREVEIQ 70
           +F++ + LG G +G V+L R K   H    + A+KVL K+ + Q     EH  R E ++ 
Sbjct: 1   NFELLRVLGTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVL 58

Query: 71  SHLRH-PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
             +R  P ++ L+  F    +++LIL+Y   GEL+  L + ++F+E     Y+A +  AL
Sbjct: 59  EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS----VHTFNRRRTMCGTLDYLPPEMV 185
            + H   +I+RDIK EN+L+ ++G + + DFG S         R  + CGT++Y+ PE++
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 186 ESVE--HDANVDIWSLGVLCYEFLYGVPPF----EAKEHSDTYRRIVQVDLKFPPKPIVS 239
                 HD  VD WSLGVL +E L G  PF    E    S+  RRI++    FP    +S
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT--MS 236

Query: 240 SAAKDLISQMLVKDSSQRL---PLHKLLEHPW 268
           + A+D I ++L KD  +RL      ++  HP+
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  161 bits (408), Expect = 1e-47
 Identities = 83/241 (34%), Positives = 137/241 (56%), Gaps = 6/241 (2%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFK-SQLQQSQVEHQLRREVEIQSHLRHPNILR 80
           K LG+G FG V LA  K ++ + A+KVL K   LQ   V+  +  +  +    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           L+  F  + R++ ++EY   G+L  ++Q+ + F E R+  Y A +  AL++ H   VI+R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 141 DIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           D+K +N+L+ A+G  K+ADFG     +       T CGT DY+ PE+++ +E+  +VD W
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWW 180

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
           +LGVL YE + G PPFEA    D +  I+  D+ +P    +S  A  ++   + K+ ++R
Sbjct: 181 ALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP--VWLSKEAVSILKAFMTKNPNKR 238

Query: 258 L 258
           L
Sbjct: 239 L 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  160 bits (407), Expect = 2e-47
 Identities = 93/273 (34%), Positives = 146/273 (53%), Gaps = 10/273 (3%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHI-VALKVLFKSQL-QQSQVE 60
           S    K K +    DF+  + LG G FG V LA  K  +   VA+K   KS++ +Q QV+
Sbjct: 17  STKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76

Query: 61  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
           H    E +I +++ HP  + LYG F D+  +YL+LE+   GE +  L++ K F       
Sbjct: 77  HVFS-ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF 135

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 180
           Y A +     Y    ++++RD+KPENLL+   G +K+ DFG++     R  T+CGT +Y+
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYI 195

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
            PE++ +V H    D W+LG+  YE L G PPF A E    Y++I++  + FP    + +
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP--KFLDN 253

Query: 241 AAKDLISQMLVKDSSQRL-----PLHKLLEHPW 268
             K L+ ++L  D ++R          + EHPW
Sbjct: 254 NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  159 bits (404), Expect = 5e-47
 Identities = 86/255 (33%), Positives = 143/255 (56%), Gaps = 10/255 (3%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRHPNILR 80
           K +G+G FG V LA+ K      A+KVL K   L + + +H +     +  +++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           L+  F   +++Y +L++   GEL+  LQ+ + F E RA  Y A +A AL Y H  ++++R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 141 DIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           D+KPEN+L+ +QG + + DFG     +   +   T CGT +YL PE++    +D  VD W
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW 180

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
            LG + YE LYG+PPF  ++ ++ Y  I+   L    +P  S  A  ++ ++L KD  +R
Sbjct: 181 CLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL--RPGASLTAWSILEELLEKDRQRR 238

Query: 258 L----PLHKLLEHPW 268
           L       ++ EHP+
Sbjct: 239 LGAKEDFLEIQEHPF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  159 bits (403), Expect = 6e-47
 Identities = 84/245 (34%), Positives = 140/245 (57%), Gaps = 13/245 (5%)

Query: 22  KPLGRGKFGHVYLAREKR---SNHIVALKVLFKSQLQQSQVEHQLRREVE--IQSHLRHP 76
           K LG+G FG V+L R+     +  + A+KVL K+ L+   V  ++R ++E  I + + HP
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHP 58

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
            I++L+  F  + ++YLIL++   G+L+  L K   F+E     Y+A LA AL + H   
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
           +I+RD+KPEN+L+  +G +K+ DFG S   +    +  + CGT++Y+ PE+V    H  +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
            D WS GVL +E L G  PF+ K+  +T   I++  L  P    +S  A+ L+  +  ++
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP--QFLSPEAQSLLRALFKRN 236

Query: 254 SSQRL 258
            + RL
Sbjct: 237 PANRL 241

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  157 bits (399), Expect = 2e-46
 Identities = 88/239 (36%), Positives = 137/239 (57%), Gaps = 7/239 (2%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSHLRHPNILRLY 82
           +G+G FG V   R++ +  I ALK + K+ +  +S+V H L  E  + + +  P I+ L 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-ERTVLAQVNCPFIVPLK 59

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
             F   +++YL+L +   GEL+  LQ+   F   RA  Y A L  AL   H  +VI+RD+
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 143 KPENLLIGAQGELKIADFG---WSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           KPEN+L+  QG + + DFG    ++   ++  T CGT +YL PE++    +   VD W+L
Sbjct: 120 KPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTL 179

Query: 200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL 258
           GVL YE L G+PPF  +  ++ YR+I+Q  L+FP        AKDL+  +L +D ++RL
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG--FDRDAKDLLIGLLSRDPTRRL 236

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  155 bits (394), Expect = 2e-46
 Identities = 85/256 (33%), Positives = 126/256 (49%), Gaps = 9/256 (3%)

Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           G+ LG G FG VY           A+K V      Q  Q E   QL +E+ + S L+HPN
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQ-EAVKQLEQEIALLSKLQHPN 63

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I++  G   ++  +Y+ LE    G L K L+K   F E     Y   +   L Y H ++ 
Sbjct: 64  IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 138 IHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV-EHDANV 194
           +HRDIK  N+L+   G +K+ADFG +  V  F+  ++  G+  ++ PE++     +    
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP-IVSSAAKDLISQMLVKD 253
           DIWSLG    E   G PP+   E      +I +   + PP P  +S  AKD I + L +D
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELPPIPDHLSDEAKDFILKCLQRD 242

Query: 254 SSQRLPLHKLLEHPWI 269
            S R    +LLEHP++
Sbjct: 243 PSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  158 bits (401), Expect = 4e-46
 Identities = 93/257 (36%), Positives = 128/257 (49%), Gaps = 12/257 (4%)

Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           R    DFD+ K +GRG FG V L R K S  + A+K+L K ++ +         E +I +
Sbjct: 39  RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
           H     I++L+  F D K +Y+++EY   G+L   L       E+ A  Y A +  AL  
Sbjct: 99  HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDA 157

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT----FNRRRTMCGTLDYLPPEMVES 187
            H    IHRD+KP+N+L+   G LK+ADFG  +        R  T  GT DY+ PE+++S
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Query: 188 VEHDA----NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSA 241
              D       D WS+GV  YE L G  PF A     TY +I+  +  L FP    +S  
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277

Query: 242 AKDLISQMLVKDSSQRL 258
           AKDLI   L  D   RL
Sbjct: 278 AKDLICAFLT-DREVRL 293

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  157 bits (397), Expect = 5e-46
 Identities = 90/241 (37%), Positives = 134/241 (55%), Gaps = 7/241 (2%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSHLRHPNILR 80
           K LG+G FG V L REK +    A+K+L K  +  + +V H +  E  +  + RHP +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPFLTA 59

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           L   F    R+  ++EYA  GEL+  L + + F+E RA  Y A +  AL Y H + V++R
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVEHDANVDIW 197
           DIK ENL++   G +KI DFG      +   TM   CGT +YL PE++E  ++   VD W
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
            LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L++ +L KD  QR
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQR 237

Query: 258 L 258
           L
Sbjct: 238 L 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  157 bits (397), Expect = 5e-46
 Identities = 91/256 (35%), Positives = 142/256 (55%), Gaps = 12/256 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQL-RREVEIQSHLRH-PNILR 80
           +G+G FG VY  R+K +  I A+KVL K ++  + +V H +  R + +++ L   P I+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           L   F     +YL+ +Y + GEL+  LQK   FSE RA  Y+A L  AL + H   +++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRR---TMCGTLDYLPPE-MVESVEHDANVDI 196
           D+KPEN+L+ A G + + DFG S       +   T CGT +YL PE +++   +  +VD 
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 197 WSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           WSLGVL +E   G  PF A++    YR I    ++F PK ++S   +  +  +L ++   
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGLLNRNPQH 239

Query: 257 RLPLH----KLLEHPW 268
           RL  H    +L EHP+
Sbjct: 240 RLGAHRDAVELKEHPF 255

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  157 bits (397), Expect = 5e-46
 Identities = 91/241 (37%), Positives = 134/241 (55%), Gaps = 7/241 (2%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSHLRHPNILR 80
           K LG+G FG V L REK S    A+K+L K  +  + +V H L  E  +  + RHP +  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLKNTRHPFLTS 59

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           L   F  + R+  ++EY   GEL+  L + + FSE R   Y A +  AL Y H   +++R
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVEHDANVDIW 197
           D+K ENL++   G +KI DFG          TM   CGT +YL PE++E  ++   VD W
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
            LGV+ YE + G  PF  ++H   +  I+  D+KFP    +S+ AK L+S +L+KD ++R
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT--LSADAKSLLSGLLIKDPNKR 237

Query: 258 L 258
           L
Sbjct: 238 L 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  155 bits (394), Expect = 1e-45
 Identities = 87/255 (34%), Positives = 138/255 (54%), Gaps = 12/255 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRHPNILRLY 82
           LG+G FG V LAR K S  + A+KVL K   LQ   VE  +  +  +     HP + +LY
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
             F    R++ ++E+   G+L   +QK + F E RA  Y A +  AL++ H K +I+RD+
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122

Query: 143 KPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K +N+L+  +G  K+ADFG     +       T CGT DY+ PE+++ + +  +VD W++
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAM 182

Query: 200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLP 259
           GVL YE L G  PFEA+   D +  I+  ++ +P    +S  A D++   + K+ + RL 
Sbjct: 183 GVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLSQDAVDILKAFMTKNPTMRLG 240

Query: 260 L------HKLLEHPW 268
                    +L HP+
Sbjct: 241 SLTLGGEEAILRHPF 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  155 bits (395), Expect = 1e-45
 Identities = 82/241 (34%), Positives = 131/241 (54%), Gaps = 9/241 (3%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQL--RREVEIQSHLRHPNILR 80
           LGRG FG V LA  K++  + A+K L K   + + +VE  +  +R  E  +  RHP ++ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           L+  F  +  V  ++EYAA G+L   +     FSE RA  Y A +   L Y H   +++R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 141 DIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           D+K +NLL+  +G +KIADFG     +   +R  T CGT ++L PE++    +   VD W
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWW 185

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
            LGVL YE L G  PF   +  + +  IV  ++++P    +S  A  ++ ++L ++  +R
Sbjct: 186 GLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP--RFLSREAISIMRRLLRRNPERR 243

Query: 258 L 258
           L
Sbjct: 244 L 244

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  153 bits (389), Expect = 2e-45
 Identities = 84/265 (31%), Positives = 135/265 (50%), Gaps = 22/265 (8%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVL-FKSQLQQSQVEHQLRREVEIQSHLR 74
             FDI + LG G +G VY A  K +  +VA+KV+  +  LQ+      + +E+ I     
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIKEISILKQCD 56

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCH 133
            P I++ YG ++    +++++EY   G +   ++   K  +E   A  +    + L Y H
Sbjct: 57  SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEH 190
               IHRDIK  N+L+  +G+ K+ADFG S     T  +R T+ GT  ++ PE+++ + +
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY--RRIVQVDLKFPP---KPI-VSSAAKD 244
           +   DIWSLG+   E   G PP     +SD +  R I  +  K PP    P   S    D
Sbjct: 177 NNKADIWSLGITAIEMAEGKPP-----YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFND 231

Query: 245 LISQMLVKDSSQRLPLHKLLEHPWI 269
            + + LVKD  +R    +LL+HP+I
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  153 bits (390), Expect = 3e-45
 Identities = 88/282 (31%), Positives = 135/282 (47%), Gaps = 42/282 (14%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQ----LQQSQVEHQLRREVEIQSHLRHPNIL 79
           LG G +G VY AR+K++  IVALK +        +  + +     RE+ +   L+HPNI+
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL-----REISLLKELKHPNIV 61

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVI 138
           +L    + ++++YL+ EY    +L K L K     S     + +  L R L YCH   ++
Sbjct: 62  KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120

Query: 139 HRDIKPENLLIGAQGELKIADFGWS-VHTFNRRR--TMCGTLDYLPPE-MVESVEHDANV 194
           HRD+KP+N+LI   G LK+ADFG +       R       TL Y  PE ++ S  +   V
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAV 180

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------DL--------KFP 233
           DIWS+G +  E + G P F      D   +I Q+              L        KFP
Sbjct: 181 DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP 240

Query: 234 PK------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           PK      P +     DL+S+ML  + ++R+   + L+HP+ 
Sbjct: 241 PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  151 bits (383), Expect = 1e-44
 Identities = 83/257 (32%), Positives = 124/257 (48%), Gaps = 9/257 (3%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF + K LG+G +G VY  +    N   ALK +    + Q + E  +  E+ I + + HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY----FSERRAATYVASLARALIYC 132
           NI+     F D  ++ +++EYA  G+L K + K K       E+        L R L   
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGTLDYLPPEMVESVEHD 191
           H + ++HRD+K  N+L+ A   +KI D G S V   N  +T  GT  Y+ PE+ +   + 
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYS 179

Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA-AKDLISQML 250
              DIWSLG L YE     PPFEA+   D   ++ +   K+PP P + S   ++ I  ML
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYPPIPPIYSQDLQNFIRSML 237

Query: 251 VKDSSQRLPLHKLLEHP 267
                 R    K+L  P
Sbjct: 238 QVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  151 bits (383), Expect = 2e-44
 Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 14/266 (5%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D +    LG G  G V     + +  I+A+K +         ++ Q+ RE++I      
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNS 58

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHG 134
           P I+  YG FY+   + + +EY   G L K L++      ER       ++ + L Y H 
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH +IHRD+KP N+L+ ++G++K+ DFG S    N   +T  GT  Y+ PE ++  ++  
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTY-------RRIVQVDLKFPPKPIVSSAAKDL 245
             DIWSLG+   E   G  P+     +D         + IV       P    S   +D 
Sbjct: 179 KSDIWSLGLSLIELATGRFPY--PPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236

Query: 246 ISQMLVKDSSQRLPLHKLLEHPWIIQ 271
           ++  L+KD  +R    +LLEHP+I +
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  151 bits (383), Expect = 2e-44
 Identities = 90/258 (34%), Positives = 147/258 (56%), Gaps = 19/258 (7%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQL-QQSQVEHQLRREVEIQS 71
           +F++ K LG G +G V+L R K S H    + A+KVL K+ + Q+++     R E ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVR-KVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59

Query: 72  HLRH-PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           H+R  P ++ L+  F    +++LIL+Y   GEL+  L + + F E+    Y   +  AL 
Sbjct: 60  HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRR--TMCGTLDYLPPEMVE 186
           + H   +I+RDIK EN+L+ + G + + DFG S   H     R  + CGT++Y+ P++V 
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179

Query: 187 SVE--HDANVDIWSLGVLCYEFLYGVPPF----EAKEHSDTYRRIVQVDLKFPPKPIVSS 240
             +  HD  VD WS+GVL YE L G  PF    E    ++  RRI++ +  +P +  +S+
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSA 237

Query: 241 AAKDLISQMLVKDSSQRL 258
            AKD+I ++L+KD  +RL
Sbjct: 238 LAKDIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  152 bits (385), Expect = 3e-44
 Identities = 85/256 (33%), Positives = 141/256 (55%), Gaps = 16/256 (6%)

Query: 17  DFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSH 72
           +F++ K LG G +G V+L R+     +  + A+KVL K+ L Q+++     R E  +  H
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 73  LRH-PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
           +R  P ++ L+  F  + +++LIL+Y + GE++  L +   FSE     Y   +  AL +
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN----RRRTMCGTLDYLPPEMVES 187
            H   +++RDIK EN+L+ ++G + + DFG S    +    R  + CGT++Y+ PE++  
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPF----EAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
              H   VD WSLG+L +E L G  PF    E    S+  RRI++ D  FP    +   A
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--SFIGPEA 238

Query: 243 KDLISQMLVKDSSQRL 258
           +DL+ ++L KD  +RL
Sbjct: 239 QDLLHKLLRKDPKKRL 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  150 bits (381), Expect = 3e-44
 Identities = 72/270 (26%), Positives = 123/270 (45%), Gaps = 18/270 (6%)

Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           RW   +      +G G FG VY A    +  ++A+K +         ++ ++  E+++  
Sbjct: 1   RWQRGNK-----IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-EIADEMKVLE 54

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
            L+HPN+++ YG    +++VY+ +EY + G L + L+  +   E     Y   L   L Y
Sbjct: 55  LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAY 114

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR-------TMCGTLDYLPPEM 184
            H   ++HRDIKP N+ +   G +K+ DFG +V   N          ++ GT  Y+ PE+
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 185 V---ESVEHDANVDIWSLGVLCYEFLYGVPPFEA--KEHSDTYRRIVQVDLKFPPKPIVS 239
           +   +   H    DIWSLG +  E   G  P+     E    +          P    +S
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS 234

Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
              KD + + L  D  +R    +LL+HP++
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  152 bits (384), Expect = 4e-44
 Identities = 91/242 (37%), Positives = 135/242 (55%), Gaps = 8/242 (3%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSHLRHPNILR 80
           K LG+G FG V L +EK +    A+K+L K  +  + +V H L     +Q+  RHP +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTA 59

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG-KHVIH 139
           L   F    R+  ++EYA  GEL+  L + + FSE RA  Y A +  AL Y H  K+V++
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 140 RDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDI 196
           RD+K ENL++   G +KI DFG     +      +T CGT +YL PE++E  ++   VD 
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179

Query: 197 WSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           W LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L+S +L KD  Q
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LSPEAKSLLSGLLKKDPKQ 237

Query: 257 RL 258
           RL
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  150 bits (381), Expect = 1e-43
 Identities = 81/248 (32%), Positives = 136/248 (54%), Gaps = 10/248 (4%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQL--RREVEIQSHL 73
           DF+    LG+G FG V LA  K ++ + A+K+L K   +Q   VE  +  +R + +    
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-- 58

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           + P + +L+  F    R+Y ++EY   G+L   +Q+   F E  A  Y A +A  L + H
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRTMCGTLDYLPPEMVESVEH 190
            K +I+RD+K +N+++ A+G +KIADFG            RT CGT DY+ PE++    +
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
             +VD W+ GVL YE L G PPF+ ++  + ++ I++ ++ +P    +S  A  +   +L
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS--LSKEAVSICKGLL 236

Query: 251 VKDSSQRL 258
            K  ++RL
Sbjct: 237 TKHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  146 bits (369), Expect = 3e-42
 Identities = 81/267 (30%), Positives = 140/267 (52%), Gaps = 14/267 (5%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
             D    +G G  G V +A +K +   VA+K   K  L++ Q    L  EV I    +HP
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQHP 76

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
           NI+ +Y  +     +++++E+   G L   +   +  +E + AT   ++ +AL + H + 
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQG 135

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRTMCGTLDYLPPEMVESVEHDAN 193
           VIHRDIK +++L+ + G +K++DFG+         RR+++ GT  ++ PE++  + +   
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK----PIVSSAAKDLISQM 249
           VDIWSLG++  E + G PP+  +      +RI   D   PPK      VS   +  + +M
Sbjct: 196 VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI--RDNL-PPKLKNLHKVSPRLRSFLDRM 252

Query: 250 LVKDSSQRLPLHKLLEHPWIIQNADPS 276
           LV+D +QR    +LL HP++ +   PS
Sbjct: 253 LVRDPAQRATAAELLNHPFLAKAGPPS 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  145 bits (369), Expect = 3e-42
 Identities = 88/281 (31%), Positives = 131/281 (46%), Gaps = 35/281 (12%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
             +G G +G VY AR+K +  IVA+K   K + +   +     RE+++   L HPNI++L
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKK-IKLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVIHR 140
              F  +  +YL+ E+    +LYK ++  +    E    +Y+  L + L +CH   ++HR
Sbjct: 64  LDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122

Query: 141 DIKPENLLIGAQGELKIADFGW--SVHTFNRRRT-MCGTLDYLPPE-MVESVEHDANVDI 196
           D+KPENLLI  +G LK+ADFG   S  +  R  T    T  Y  PE ++    +   VDI
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182

Query: 197 WSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------------DLKFPPK-- 235
           WS+G +  E L   P F  K   D   +I +                       FP K  
Sbjct: 183 WSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAG 242

Query: 236 -------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                  P  S  A DL+SQML  D  +R+   + L HP+ 
Sbjct: 243 MPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  144 bits (365), Expect = 1e-41
 Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 36/286 (12%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            + I   +G G  G V+ A+++ +   VALK +   +L+   + +Q  RE++     +HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-IPNQALREIKALQACQHP 59

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGK 135
            +++L   F       L++EY     L + L+   +   E +  +Y+  L + + Y H  
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM----CGTLDYLPPEMV-ESVEH 190
            ++HRD+KP NLLI A G LKIADFG +         +      T  Y  PE++  + ++
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------------DLK 231
           D  VD+W++G +  E L G P F  +   +    + +                     + 
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238

Query: 232 FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
           FP           P  S  A DL+  +LV D S+RL   + L HP+
Sbjct: 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  143 bits (362), Expect = 2e-41
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 27/274 (9%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE-HQLRREVEIQSHLR 74
           +D+++ + +G G    VY A    +N  VA+K +    L++ Q    +LR+EV+  S   
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY----FSERRAATYVASLARALI 130
           HPN+++ Y  F     ++L++ Y + G L  ++ K  Y      E   AT +  + + L 
Sbjct: 58  HPNVVKYYTSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLE 116

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-------RRRTMCGTLDYLPPE 183
           Y H    IHRDIK  N+L+G  G +KIADFG S    +        R+T  GT  ++ PE
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 184 MVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP-------K 235
           ++E V  +D   DIWS G+   E   G  P+            +Q D   PP        
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---PPSLETGADY 233

Query: 236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
              S + + +IS  L KD S+R    +LL+H + 
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  144 bits (365), Expect = 2e-41
 Identities = 85/243 (34%), Positives = 131/243 (53%), Gaps = 10/243 (4%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQL--RREVEIQSHLRHPNI 78
           K LG+G FG V LA  K +N   A+K L K   L+   VE  +  RR + +     HP +
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW--EHPFL 58

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVI 138
             L+  F  ++ ++ ++EY   G+L   +Q    F E RA  Y A +   L + H K +I
Sbjct: 59  THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118

Query: 139 HRDIKPENLLIGAQGELKIADFGWSVHTFNRRR---TMCGTLDYLPPEMVESVEHDANVD 195
           +RD+K +N+L+   G +KIADFG      N      T CGT DY+ PE+++  +++ +VD
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVD 178

Query: 196 IWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSS 255
            WS GVL YE L G  PF  ++  + +  I+  D    P+ I S  AKD +S++  +D +
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFDSIL-NDRPHFPRWI-SKEAKDCLSKLFERDPT 236

Query: 256 QRL 258
           +RL
Sbjct: 237 KRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  142 bits (359), Expect = 7e-41
 Identities = 88/281 (31%), Positives = 134/281 (47%), Gaps = 38/281 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ---SH 72
             F++ + +G G +G VY AR K++  +VA+K+           + +   + E      +
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKI------MDIIEDEEEEIKEEYNILRKY 59

Query: 73  LRHPNILRLYGYFY------DQKRVYLILEYAAKG---ELYKELQKC-KYFSERRAATYV 122
             HPNI   YG F       +  +++L++E    G   +L K L+K  K   E   A  +
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDY 179
               R L Y H   VIHRDIK +N+L+    E+K+ DFG S     T  RR T  GT  +
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179

Query: 180 LPPEMVESVE-----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP 234
           + PE++   E     +DA  D+WSLG+   E   G PP     H    R + ++  + PP
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-CDMHPM--RALFKI-PRNPP 235

Query: 235 KPIVSSAAK------DLISQMLVKDSSQRLPLHKLLEHPWI 269
            P + S         D IS+ L+K+  QR  + +LLEHP+I
Sbjct: 236 -PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  144 bits (364), Expect = 7e-41
 Identities = 95/297 (31%), Positives = 151/297 (50%), Gaps = 46/297 (15%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLR 74
           +DF+  K +GRG FG V L ++K + HI A+K+L K+  L++ QV H +R E +I     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAH-IRAERDILVEAD 59

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
              +++++  F D++ +YLI+E+   G++   L K    SE     Y+A    A+   H 
Sbjct: 60  GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFG------------------------WSVHTFNRR 170
              IHRDIKP+NLL+ A+G +K++DFG                        +S    N +
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179

Query: 171 R--------------TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAK 216
           R              +  GT DY+ PE+     ++   D WSLGV+ YE L G PPF ++
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 217 EHSDTYRRIV--QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL---PLHKLLEHPW 268
              +TYR+++  +  L FPP+  +S  AKDLI +    DS  R+    + ++  HP+
Sbjct: 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  141 bits (358), Expect = 7e-41
 Identities = 75/262 (28%), Positives = 125/262 (47%), Gaps = 13/262 (4%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           L +F I K +G+G+F  VY A       +VALK +   ++  ++      +E+++   L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARALI 130
           HPN+++    F +   + ++LE A  G+L + ++  K       ER    Y   L  AL 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM-----CGTLDYLPPEMV 185
           + H K ++HRDIKP N+ I A G +K+ D G  +  F   +T       GT  Y+ PE +
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLG--LGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS--DTYRRIVQVDLKFPPKPIVSSAAK 243
               ++   DIWSLG L YE      PF   + +     ++I + D    P    S   +
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238

Query: 244 DLISQMLVKDSSQRLPLHKLLE 265
           DL+S+ +  D  +R  +  +L+
Sbjct: 239 DLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 8e-41
 Identities = 80/260 (30%), Positives = 134/260 (51%), Gaps = 16/260 (6%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH---PNILR 80
           +GRG +G VY  +   +  +VALK++         V   ++REV + S LR    PNI +
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKII-NLDTPDDDVS-DIQREVALLSQLRQSQPPNITK 66

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
            YG +    R+++I+EYA  G + + L K    +E+  +  +  +  AL Y H   VIHR
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHR 125

Query: 141 DIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-ESVEHDANVDI 196
           DIK  N+L+   G +K+ DFG +       ++R T  GT  ++ PE++ E   +D   DI
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADI 185

Query: 197 WSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK---PIVSSAAKDLISQMLVKD 253
           WSLG+  YE   G PP+ +    D +R ++ +    PP+      S   ++ ++  L ++
Sbjct: 186 WSLGITIYEMATGNPPY-SDV--DAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEE 242

Query: 254 SSQRLPLHKLLEHPWIIQNA 273
             +RL   +LL+  WI  ++
Sbjct: 243 PKERLSAEELLKSKWIKAHS 262

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  143 bits (361), Expect = 9e-41
 Identities = 81/252 (32%), Positives = 135/252 (53%), Gaps = 7/252 (2%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRHPNILR 80
           K LG+G FG V+LA  K +N   A+K L K   L    VE  +  +  +     HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           LY  F  ++ ++ ++EY   G+L   +Q C  F   RA  Y A +   L + H K +++R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           D+K +N+L+   G +KIADFG          +  T CGT DY+ PE++   +++ +VD W
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
           S GVL YE L G  PF   +  + ++ I ++D    P+  ++  AKD++ ++ V++  +R
Sbjct: 181 SFGVLLYEMLIGQSPFHGHDEEELFQSI-RMDNPCYPR-WLTREAKDILVKLFVREPERR 238

Query: 258 LPLH-KLLEHPW 268
           L +   + +HP+
Sbjct: 239 LGVKGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  143 bits (362), Expect = 3e-40
 Identities = 86/303 (28%), Positives = 139/303 (45%), Gaps = 54/303 (17%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRHP 76
           F   K +G G FG V L R+  +N + A+K L K+  L ++Q  H ++ E +I +   + 
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH-VKAERDILAEADNE 61

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
            +++LY  F D+  +Y +++Y   G++   L +   F E  A  Y+A L  A+   H   
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121

Query: 137 VIHRDIKPENLLIGAQGELKIADFG------WS--------------------------- 163
            IHRDIKP+N+LI   G +K+ DFG      W+                           
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181

Query: 164 ---VHTFNRRR----------TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGV 210
              +    RRR          ++ GT +Y+ PE++    +    D WS+GV+ YE L G 
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Query: 211 PPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE--- 265
           PPF A   ++T  +++  +  L  P +  +S  A DLI + L   +  RL  +   E   
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKA 300

Query: 266 HPW 268
           HP+
Sbjct: 301 HPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  140 bits (354), Expect = 1e-39
 Identities = 79/249 (31%), Positives = 135/249 (54%), Gaps = 12/249 (4%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRH 75
           DF+    LG+G FG V LA  K ++ + A+K+L K   +Q   VE  +  +  +    + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           P + +L+  F    R+Y ++EY   G+L  ++Q+   F E  A  Y A +A  L + H K
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 136 HVIHRDIKPENLLIGAQGELKIADFG------WSVHTFNRRRTMCGTLDYLPPEMVESVE 189
            +I+RD+K +N+++ ++G +KIADFG      W   T    +T CGT DY+ PE++    
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT---TKTFCGTPDYIAPEIIAYQP 177

Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           +  +VD W+ GVL YE L G  PFE ++  + ++ I++ ++ +P    +S  A  +   +
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS--MSKEAVAICKGL 235

Query: 250 LVKDSSQRL 258
           + K   +RL
Sbjct: 236 MTKHPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  138 bits (349), Expect = 5e-39
 Identities = 77/246 (31%), Positives = 136/246 (55%), Gaps = 6/246 (2%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRH 75
           DF+    LG+G FG V LA  K ++ + A+K+L K   +Q   VE  +  +  +    + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           P + +L+  F    R+Y ++EY   G+L   +Q+   F E +A  Y A ++  L + H +
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDA 192
            +I+RD+K +N+++ ++G +KIADFG     +      RT CGT DY+ PE++    +  
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK 180

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
           +VD W+ GVL YE L G PPF+ ++  + ++ I++ ++ +P    +S  A  +   ++ K
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS--LSKEAVSICKGLMTK 238

Query: 253 DSSQRL 258
             S+RL
Sbjct: 239 HPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  136 bits (345), Expect = 5e-39
 Identities = 82/258 (31%), Positives = 130/258 (50%), Gaps = 11/258 (4%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF+I   +G+G FG V+    K    + A+K +  S++ + + E  +  E  + + L   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHG 134
            I+R Y  F D+ ++ +++EYA  G+L+K L  Q+ +   E +   +   +   L + H 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTMCGTLDYLPPEMVESVEH 190
           K ++HRDIK  NL + A   +KI D G     S +T N   T+ GT  YL PE+ E   +
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NFANTIVGTPYYLSPELCEDKPY 178

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA-KDLISQM 249
           +   D+W+LGV+ YE   G  PF+A        +I++    FPP   + S     LI Q 
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VFPPVSQMYSQQLAQLIDQC 236

Query: 250 LVKDSSQRLPLHKLLEHP 267
           L KD  QR    +LL +P
Sbjct: 237 LTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  136 bits (345), Expect = 8e-39
 Identities = 83/272 (30%), Positives = 135/272 (49%), Gaps = 35/272 (12%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQSHLRHPNILR 80
           LG G FG VY A+ K +    A K++      Q + E +L     E++I S  +HPNI+ 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKII------QIESEEELEDFMVEIDILSECKHPNIVG 66

Query: 81  LYGYFYDQKRVYLILEYAAKGEL---YKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           LY  ++ + ++++++E+   G L     EL++    +E +       +  AL + H   V
Sbjct: 67  LYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFLHSHKV 124

Query: 138 IHRDIKPENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMV-----ESVE 189
           IHRD+K  N+L+   G++K+ADFG S     T  +R T  GT  ++ PE+V     +   
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY--RRIVQVDLKFPPKPIV-----SSAA 242
           +D   DIWSLG+   E     PP     H +    R ++++ LK  P  +      SS+ 
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP-----HHELNPMRVLLKI-LKSEPPTLDQPSKWSSSF 238

Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
            D +   LVKD   R    +LL+HP++   +D
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 9e-39
 Identities = 89/273 (32%), Positives = 141/273 (51%), Gaps = 25/273 (9%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +DF+I K +GRG FG V + + K +  + A+K+L K ++ +       R E ++  +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSER----RAATYVASLARALIY 131
             I  L+  F D+  +YL+++Y   G+L   L K   F +R     A  Y+A +  A+  
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDS 117

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM-----CGTLDYLPPEMVE 186
            H    +HRDIKP+N+L+   G +++ADFG S        T+      GT DY+ PE+++
Sbjct: 118 VHQLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Query: 187 SVE-----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPK-PIV 238
           ++E     +    D WSLGV  YE LYG  PF A+   +TY +I+  +   +FPP    V
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236

Query: 239 SSAAKDLISQMLVKDSSQRL---PLHKLLEHPW 268
           S  AKDLI +++      RL    L    +HP+
Sbjct: 237 SEEAKDLIRRLICS-PETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 2e-38
 Identities = 81/269 (30%), Positives = 134/269 (49%), Gaps = 29/269 (10%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D+++ + +G G +G VY AR+  +  +VA+KV+   +L+       +++E+ +    RHP
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHP 60

Query: 77  NILRLYGYFYDQKRVYLILEYAAKG---ELYKELQKCKYFSERRAATYVASLA-RALIYC 132
           NI+  +G +  + ++++++EY   G   ++Y+        SE + A YV     + L Y 
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT--RGPLSELQIA-YVCRETLKGLAYL 117

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVE--- 186
           H    IHRDIK  N+L+   G++K+ADFG S     T  +R++  GT  ++ PE+     
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY-RRIVQVDLK--FPP-----KPIV 238
              +D   DIW+LG+   E     PP       D +  R + +  K  FPP     K   
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP-----MFDLHPMRALFLISKSNFPPPKLKDKEKW 232

Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHP 267
           S    D I + L KD  +R    KLL+HP
Sbjct: 233 SPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  136 bits (345), Expect = 3e-38
 Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 47/299 (15%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSHLRHPNIL 79
           KP+G G +G V  A +KR+   VA+K +    +    +    R  RE+++  HLRH NI+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISN--VFDDLI-DAKRILREIKLLRHLRHENII 62

Query: 80  RLYGYFYDQKR-----VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            L              VY++ E     +L+K ++  +  ++     ++  + R L Y H 
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCG---TLDYLPPE-MVES 187
            +VIHRD+KP N+L+ +  +LKI DFG +       + +  +     T  Y  PE ++ S
Sbjct: 122 ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEH-----------------------SDTYRR 224
             +   +DIWS+G +  E L   P F  +++                       S+  R 
Sbjct: 182 SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARN 241

Query: 225 IVQVDLKFPPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSG 277
            ++   K P KP+       S  A DL+ +MLV D  +R+   + L HP++ Q  DP  
Sbjct: 242 YLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  135 bits (341), Expect = 4e-38
 Identities = 77/261 (29%), Positives = 140/261 (53%), Gaps = 18/261 (6%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G  G V +AREK S   VA+K++    L++ Q    L  EV I    +H N++ +Y 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +   + +++++E+   G L   + + +  +E + AT   S+ +AL Y H + VIHRDIK
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQGVIHRDIK 144

Query: 144 PENLLIGAQGELKIADFGWSVHTFN---RRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +++L+   G +K++DFG+         +R+++ GT  ++ PE++    +   VDIWSLG
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG 204

Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK------DLISQMLVKDS 254
           ++  E + G PP+ +       +R     L+  P P + +A K      D + +ML ++ 
Sbjct: 205 IMVIEMVDGEPPYFSDSPVQAMKR-----LRDSPPPKLKNAHKISPVLRDFLERMLTREP 259

Query: 255 SQRLPLHKLLEHPWIIQNADP 275
            +R    +LL+HP+++Q   P
Sbjct: 260 QERATAQELLDHPFLLQTGLP 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  137 bits (345), Expect = 5e-38
 Identities = 89/271 (32%), Positives = 140/271 (51%), Gaps = 42/271 (15%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRH 75
           DF+  K +GRG FG V L ++K + H+ A+K+L K+  L++ QV H +R E +I      
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGH-IRAERDILVEADS 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
             +++++  F D+  +YLI+E+   G++   L K    +E     Y+A    A+   H  
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW---------------------SVHTF------- 167
             IHRDIKP+NLL+ ++G +K++DFG                      S  TF       
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 168 -------NRRR---TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE 217
                  NRR+   +  GT DY+ PE+     ++   D WSLGV+ YE L G PPF ++ 
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 218 HSDTYRRIV--QVDLKFPPKPIVSSAAKDLI 246
             +TY++++  +  L FPP+  +S  AKDLI
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  134 bits (339), Expect = 6e-38
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 20/222 (9%)

Query: 22  KPLGRGKFGHVYLAREKRSN---HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           K LG G FG VY  + K  +     VA+K L K    + + +    +E  +   L HPN+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERK-DFLKEARVMKKLGHPNV 58

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCK---------YFSERRAATYVASLARAL 129
           +RL G   +++ +YL+LEY   G+L   L+K +           S +   ++   +A+ +
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP-----PEM 184
            Y   K  +HRD+   N L+G    +KI+DFG S   ++       T   LP     PE 
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 185 VESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           ++     +  D+WS GVL +E F  G  P+    + +    +
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  133 bits (338), Expect = 2e-37
 Identities = 84/286 (29%), Positives = 137/286 (47%), Gaps = 38/286 (13%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSHLRH 75
           ++ GK LG G +  VY AR+K +  IVA+K +   + ++++  +     RE+++   L+H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHG 134
           PNI+ L   F  +  + L+ E+    +L K ++ K    +     +Y+    R L Y H 
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRT-MCGTLDYLPPEMVESVEH 190
             ++HRD+KP NLLI + G LK+ADFG +  +F   NR+ T    T  Y  PE++    H
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLA-RSFGSPNRKMTHQVVTRWYRAPELLFGARH 179

Query: 191 -DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI---------------------VQV 228
               VD+WS+G +  E L  VP        D   +I                     V+ 
Sbjct: 180 YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239

Query: 229 DLKFPPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
              FPP P+       S  A DL+ ++L  + ++R+   + LEHP+
Sbjct: 240 K-PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  135 bits (341), Expect = 2e-37
 Identities = 90/265 (33%), Positives = 135/265 (50%), Gaps = 15/265 (5%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D+D+ K +GRG FG V L R K S  + A+K+L K ++ +         E +I +    P
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
            +++L+  F D K +Y+++EY   G+L   L       E+ A  Y A +  AL   H   
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHT----FNRRRTMCGTLDYLPPEMVESVEHDA 192
           +IHRD+KP+N+L+   G LK+ADFG  +        R  T  GT DY+ PE+++S   D 
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 193 ----NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSAAKDLI 246
                 D WS+GV  +E L G  PF A     TY +I+  +  L FP    +S  AK+LI
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLI 282

Query: 247 SQMLVKDSSQRL---PLHKLLEHPW 268
              L  D   RL    + ++ +HP+
Sbjct: 283 CAFLT-DREVRLGRNGVEEIKQHPF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 2e-37
 Identities = 87/283 (30%), Positives = 130/283 (45%), Gaps = 45/283 (15%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSHLRHPNILRL 81
           +G G +G VY AR+K +  IVALK   K +L+     V     RE+ +   L HPNI+RL
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALK---KIRLETEDEGVPSTAIREISLLKELNHPNIVRL 63

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKYFS--ERRAATYVASLARALIYCHGKHVIH 139
               + + ++YL+ E+    +L K +              +Y+  L + + YCH   V+H
Sbjct: 64  LDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLH 122

Query: 140 RDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
           RD+KP+NLLI  +G LK+ADFG +      V T+        TL Y  PE++      + 
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEILLGSRQYST 179

Query: 194 -VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------DLK--FP- 233
            VDIWS+G +  E +   P F      D   RI +                 D K  FP 
Sbjct: 180 PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239

Query: 234 --------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                     P +     DL+S+MLV D ++R+     L+HP+
Sbjct: 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  132 bits (334), Expect = 3e-37
 Identities = 71/251 (28%), Positives = 118/251 (47%), Gaps = 19/251 (7%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHI----VALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +GK LG G FG VY  + K         VA+K L K    + Q+E +  RE  I   L H
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIE-EFLREARIMRKLDH 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           PN+++L G   +++ +Y+++EY   G+L   L+K +   S     ++   +AR + Y   
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTMCGTLDYLPPEMVESVEH 190
           K+ IHRD+   N L+G    +KI+DFG         + R+R     + ++ PE ++  + 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 191 DANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
            +  D+WS GVL +E F  G  P+    + +    +        P+P   +   +L   M
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG--YRLPQP--PNCPPELYDLM 236

Query: 250 L---VKDSSQR 257
           L    +D   R
Sbjct: 237 LQCWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  132 bits (333), Expect = 3e-37
 Identities = 77/249 (30%), Positives = 127/249 (51%), Gaps = 7/249 (2%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG   L R    + +V  K +  ++L + +    L  E+ I S L+HPNI+  Y 
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHPNIIAYYN 66

Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
           +F D   + + +EYA  G LY ++  QK + F E     Y+  +  A+ Y H   ++HRD
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRD 126

Query: 142 IKPENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWS 198
           IK  N+ +   G +K+ DFG S      ++   T+ GT  Y+ PE+ + V+++   DIW+
Sbjct: 127 IKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWA 186

Query: 199 LGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL 258
           LG + YE L     F+A    +   +IVQ +   P   + SS    L+  +L +D  +R 
Sbjct: 187 LGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRP 245

Query: 259 PLHKLLEHP 267
              ++L+ P
Sbjct: 246 TADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  132 bits (333), Expect = 4e-37
 Identities = 78/262 (29%), Positives = 131/262 (50%), Gaps = 16/262 (6%)

Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALK-VLF--KSQLQQSQVEHQLRREVEIQSHLRHPN 77
           G+ LG G F   Y AR+ ++  ++A+K V +   +  +Q +V   LR+E+ + + L HP+
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+R+ G   +     L +E+ A G +   L K   F E     Y   L R L Y H   +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 138 IHRDIKPENLLIGAQGE-LKIADFGWSVHTFNRRRT--------MCGTLDYLPPEMVESV 188
           IHRD+K  NLLI + G+ L+IADFG +      + T        + GT+ ++ PE++   
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI---VSSAAKDL 245
           ++  + D+WS+G +  E     PP+ A++HS+    I ++        I   +S   +D+
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243

Query: 246 ISQMLVKDSSQRLPLHKLLEHP 267
             + L      R P  +LL+HP
Sbjct: 244 TLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  131 bits (333), Expect = 4e-37
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 20/252 (7%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHI----VALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +GK LG G FG VY    K         VA+K L K    + Q+E +  RE  I   L H
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIE-EFLREARIMRKLDH 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCH 133
           PNI++L G   +++ + +++EY   G+L   L+K +    S     ++   +AR + Y  
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD----YLPPEMVESVE 189
            K+ IHRD+   N L+G    +KI+DFG S   ++              ++ PE ++  +
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 190 HDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
             +  D+WS GVL +E F  G  P+    +++    + +      PKP   +   +L   
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG--YRLPKP--PNCPPELYKL 236

Query: 249 ML---VKDSSQR 257
           ML    +D   R
Sbjct: 237 MLQCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 9e-37
 Identities = 94/309 (30%), Positives = 147/309 (47%), Gaps = 58/309 (18%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSHLR 74
            DF   K +G+G FG V L ++K +  I A+K L KS++ ++ Q+ H ++ E ++ +   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAESD 59

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P ++ LY  F D + +YLI+E+   G+L   L K   FSE     Y+A    A+   H 
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------------------------------- 163
              IHRDIKP+N+LI   G +K++DFG S                               
Sbjct: 120 LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179

Query: 164 --------------VHTFNR-RRTMC----GTLDYLPPEMVESVEHDANVDIWSLGVLCY 204
                         + T+ + RR M     GT DY+ PE+     +    D WSLG + +
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239

Query: 205 EFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL---P 259
           E L G PPF ++   +TYR+I+  +  L FP    +S  A+DLI + L+ ++  RL    
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR-LITNAENRLGRGG 298

Query: 260 LHKLLEHPW 268
            H++  HP+
Sbjct: 299 AHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  131 bits (331), Expect = 1e-36
 Identities = 82/267 (30%), Positives = 123/267 (46%), Gaps = 27/267 (10%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G  G V   R K +  I ALK +         ++ Q+ RE+EI    + P I++ YG
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 84  YFYDQK--RVYLILEYAAKGEL---YKELQK-CKYFSERRAATYVASLARALIYCHGKHV 137
            F D+    + + +EY   G L   YK+++K      E+       S+ + L Y H + +
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI 126

Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNR-RRTMCGTLDYLPPEMVESVEHDANVDI 196
           IHRDIKP N+L+  +G++K+ DFG S    N    T  GT  Y+ PE ++   +    D+
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDV 186

Query: 197 WSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL------KFPPK-------PIV-SSAA 242
           WSLG+   E      PF      +    +  ++L         P+        I  S   
Sbjct: 187 WSLGLTLLEVAQNRFPFPP----EGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEF 242

Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWI 269
           KD I Q L KD ++R     +LEHPWI
Sbjct: 243 KDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  130 bits (329), Expect = 1e-36
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 13/217 (5%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +GK LG G FG VY    K         VA+K L K    + + E +   E  I   L H
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEERE-EFLEEASIMKKLSH 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
           PNI+RL G     + +Y++ EY   G+L   L+K     + +        +A+ + Y   
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLD---YLPPEMVESVE 189
           K+ +HRD+   N L+     +KI+DFG S  ++  +  R   G      ++ PE ++  +
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 190 HDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
             +  D+WS GVL +E F  G  P+    + +    +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217

Length = 258

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  132 bits (333), Expect = 1e-36
 Identities = 90/260 (34%), Positives = 139/260 (53%), Gaps = 16/260 (6%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +DF+I K +GRG FG V + + K +  I A+K+L K ++ +       R E  +  +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
             I  L+  F D+  +YL+++Y   G+L   L K +    E  A  Y+A +  A+   H 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM-----CGTLDYLPPEMVESVE 189
            H +HRDIKP+N+L+   G +++ADFG S    N+  T+      GT DY+ PE+++++E
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179

Query: 190 -----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP-PKPI--VSSA 241
                +    D WSLGV  YE LYG  PF A+   +TY +I+  + +F  P  I  VS  
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239

Query: 242 AKDLISQMLVKDSSQRLPLH 261
           AKDLI Q L+    +RL  +
Sbjct: 240 AKDLI-QRLICSRERRLGQN 258

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  129 bits (328), Expect = 5e-36
 Identities = 80/304 (26%), Positives = 130/304 (42%), Gaps = 69/304 (22%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR------------- 64
           ++    +G G +G VY AR K++  +VALK              ++R             
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK--------------KIRMENEKEGFPITAI 46

Query: 65  REVEIQSHLRHPNILRLYGYFYDQKR--VYLILEYAA---KGELYKELQKCKYFSERRAA 119
           RE+++   LRHPNI+RL      + +  +Y++ EY      G L     K   F+E +  
Sbjct: 47  REIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIK 103

Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---- 175
            Y+  L   L Y H   ++HRDIK  N+LI   G LK+ADFG +     R          
Sbjct: 104 CYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Query: 176 TLDYLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------ 228
           TL Y PPE ++ +  +   VD+WS+G +  E   G P F+     +   +I ++      
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223

Query: 229 -------DLKF-----PPKP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLE 265
                   L +     P KP           ++  +A DL+ ++L  D  +R+   + L+
Sbjct: 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283

Query: 266 HPWI 269
           H + 
Sbjct: 284 HEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 5e-36
 Identities = 84/281 (29%), Positives = 123/281 (43%), Gaps = 38/281 (13%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G V   R K +  IVA+K  FK       V+    REV++   LRH NI+ L  
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKK-FKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA-TYVASLARALIYCHGKHVIHRDI 142
            F  + R+YL+ EY  +  L + L+         A  +Y+  L +A+ YCH  ++IHRDI
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDI 126

Query: 143 KPENLLIGAQGELKIADFGW--SVHTFNRRR--TMCGTLDYLPPE-MVESVEHDANVDIW 197
           KPEN+L+   G LK+ DFG+  ++             T  Y  PE +V    +   VD+W
Sbjct: 127 KPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVW 186

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------------DLKFPPKP-- 236
           ++G +  E L G P F      D    I +                     + FP     
Sbjct: 187 AIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQP 246

Query: 237 ---------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                     VSS A D +   L  D  +RL   +LL+HP+
Sbjct: 247 ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  129 bits (324), Expect = 8e-36
 Identities = 80/258 (31%), Positives = 140/258 (54%), Gaps = 17/258 (6%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE-HQLRREVEIQSHLRHPNILRLY 82
           +G+G FG V+   + R+  +VA+K++    L++++ E   +++E+ + S    P + + Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKII---DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
           G +    ++++I+EY   G    +L +   F E + AT +  + + L Y H +  IHRDI
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127

Query: 143 KPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K  N+L+  QG++K+ADFG +     T  +R T  GT  ++ PE+++   +D+  DIWSL
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSL 187

Query: 200 GVLCYEFLYGVPPFEAKEHSDTY-RRIVQVDLKFPPKPIV---SSAAKDLISQMLVKDSS 255
           G+   E   G PP     +SD +  R++ +  K  P  +    S   K+ I   L KD S
Sbjct: 188 GITAIELAKGEPP-----NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPS 242

Query: 256 QRLPLHKLLEHPWIIQNA 273
            R    +LL+H +I++NA
Sbjct: 243 FRPTAKELLKHKFIVKNA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  129 bits (325), Expect = 2e-35
 Identities = 81/247 (32%), Positives = 134/247 (54%), Gaps = 13/247 (5%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF+I K +GRG FG V + + K ++ + A+K+L K ++ +       R E ++  +  + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGK 135
            I  L+  F D+  +YL+++Y   G+L   L K +    E  A  Y+A +  A+   H  
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFN----RRRTMCGTLDYLPPEMVESVE-- 189
           H +HRDIKP+N+L+   G +++ADFG  +        +     GT DY+ PE+++++E  
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 190 ---HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPI-VSSAAK 243
              +    D WSLGV  YE LYG  PF A+   +TY +I+  +   +FP +   VS  AK
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAK 241

Query: 244 DLISQML 250
           DLI +++
Sbjct: 242 DLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  128 bits (324), Expect = 2e-35
 Identities = 79/241 (32%), Positives = 127/241 (52%), Gaps = 6/241 (2%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRHPNILR 80
           K LG+G FG V LA  K      A+K L K   L    VE  +  +  +     +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           LY  F  ++ ++ ++E+   G+L   +Q    F   RA  Y A +   L + H K +I+R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 141 DIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           D+K +N+++   G +KIADFG    +V   NR  T CGT DY+ PE+++ +++  +VD W
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWW 180

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
           S GVL YE L G  PF   +  + +  I +VD    P+ I    +KD++ ++  +D ++R
Sbjct: 181 SFGVLLYEMLIGQSPFHGDDEDELFESI-RVDTPHYPRWITKE-SKDILEKLFERDPTRR 238

Query: 258 L 258
           L
Sbjct: 239 L 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  130 bits (327), Expect = 2e-35
 Identities = 88/270 (32%), Positives = 133/270 (49%), Gaps = 15/270 (5%)

Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           R    D+++ K +GRG FG V L R K +  + A+K+L K ++ +         E +I +
Sbjct: 39  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
               P +++L+  F D + +Y+++EY   G+L   L       E+ A  Y A +  AL  
Sbjct: 99  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDA 157

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT----FNRRRTMCGTLDYLPPEMVES 187
            H    IHRD+KP+N+L+   G LK+ADFG  +        R  T  GT DY+ PE+++S
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217

Query: 188 VEHDA----NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSA 241
              D       D WS+GV  YE L G  PF A     TY +I+  +  L FP    +S  
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277

Query: 242 AKDLISQMLVKDSSQRL---PLHKLLEHPW 268
           AK+LI   L  D   RL    + ++  H +
Sbjct: 278 AKNLICAFLT-DREVRLGRNGVEEIKRHLF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  127 bits (322), Expect = 4e-35
 Identities = 74/277 (26%), Positives = 134/277 (48%), Gaps = 22/277 (7%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
            DF+  K +  G +G VYL R K +    A+K + K  L       Q+  E +I +   +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           P ++ ++  F  ++ + +++EY   G+    L+         A  Y A    AL Y H  
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT------------------MCGTL 177
            ++HRD+KP+NLLI + G +K+ DFG S        T                  +CGT 
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180

Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP-KP 236
           +Y+ PE++    +   VD W++G++ YEFL G  PF      + + +++  D+++P    
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240

Query: 237 IVSSAAKDLISQMLVKDSSQRL---PLHKLLEHPWII 270
            + + A+DLIS++L ++  +RL      ++ +H + +
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  126 bits (318), Expect = 4e-35
 Identities = 73/254 (28%), Positives = 132/254 (51%), Gaps = 9/254 (3%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG   L + K       +K +  S++   + E + R+EV + S+++HPNI++ 
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE-ESRKEVAVLSNMKHPNIVQY 64

Query: 82  YGYFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIH 139
              F +   +Y++++Y   G+LYK++  Q+   F E +   +   +  AL + H + ++H
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124

Query: 140 RDIKPENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVESVEHDANVDI 196
           RDIK +N+ +   G +K+ DFG +     T    RT  GT  YL PE+ E+  ++   DI
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184

Query: 197 WSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI-VSSAAKDLISQMLVKDSS 255
           W+LG + YE       FEA    +   +I++    +PP     S   ++L+SQ+  ++  
Sbjct: 185 WALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYPPVSSHYSYDLRNLVSQLFKRNPR 242

Query: 256 QRLPLHKLLEHPWI 269
            R  ++ +LE  +I
Sbjct: 243 DRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  127 bits (320), Expect = 6e-35
 Identities = 92/284 (32%), Positives = 137/284 (48%), Gaps = 46/284 (16%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSHLRHPNILRL 81
           +G G +G VY AR++ +N  +ALK   K +L+Q    V     RE+ +   ++H NI+RL
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKYFSE--RRAATYVASLARALIYCHGKHVIH 139
               + +KR+YL+ EY    +L K +     F++  R   TY+  + R + YCH   V+H
Sbjct: 67  QDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLH 125

Query: 140 RDIKPENLLIG-AQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESVEHDA 192
           RD+KP+NLLI      LK+ADFG +      V TF        TL Y  PE++    H +
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---TLWYRAPEILLGSRHYS 182

Query: 193 N-VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------DL----- 230
             VDIWS+G +  E +   P F      D   +I ++                D      
Sbjct: 183 TPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFP 242

Query: 231 KFPPK------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
           K+PPK      P +  A  DL+S+ML  D S+R+     LEH +
Sbjct: 243 KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  127 bits (319), Expect = 7e-35
 Identities = 81/260 (31%), Positives = 136/260 (52%), Gaps = 14/260 (5%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G  G V +A EK +   VA+K   K  L++ Q    L  EV I     H N++ +Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++E+   G L   +   +  +E + AT   S+ RAL Y H + VIHRDIK
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 144 PENLLIGAQGELKIADFGWSVHTFN---RRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +++L+ + G +K++DFG+         +R+++ GT  ++ PE++  + +   VDIWSLG
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLG 205

Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK----PIVSSAAKDLISQMLVKDSSQ 256
           ++  E + G PP+  +      RRI       PP+      VSS  +  +  MLV++ SQ
Sbjct: 206 IMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDLMLVREPSQ 262

Query: 257 RLPLHKLLEHPWIIQNADPS 276
           R    +LL+HP++     PS
Sbjct: 263 RATAQELLQHPFLKLAGPPS 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  128 bits (323), Expect = 8e-35
 Identities = 79/277 (28%), Positives = 136/277 (49%), Gaps = 24/277 (8%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           L++ +    +G G  G VY    + +  + ALKV++ +   +  V  Q+ RE+EI   + 
Sbjct: 73  LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN 130

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR----ALI 130
           HPN+++ +  F     + ++LE+   G L    +      E+    ++A +AR     + 
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQ----FLADVARQILSGIA 182

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVES 187
           Y H +H++HRDIKP NLLI +   +KIADFG S     T +   +  GT+ Y+ PE + +
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242

Query: 188 VEHDANV-----DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
             +         DIWSLGV   EF  G  PF      D    +  + +  PP+   +++ 
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302

Query: 243 --KDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSG 277
             +  IS  L ++ ++R    +LL+HP+I++     G
Sbjct: 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQG 339

Length = 353

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 5e-34
 Identities = 89/292 (30%), Positives = 129/292 (44%), Gaps = 51/292 (17%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEH--QLRREVEIQSH 72
           + + K LG G FG VYLAR K +  +VA+K +   F S       E    LR   E++S 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS------WEECMNLR---EVKSL 51

Query: 73  LR---HPNILRLYGYFYDQKRVYLILEYAAKGELYK--ELQKCKYFSERRAATYVASLAR 127
            +   HPNI++L   F +   +Y + EY  +G LY+  + +K K FSE    + +  + +
Sbjct: 52  RKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RTMCGTLDYLPPEMV 185
            L + H     HRD+KPENLL+     +KIADFG +    +R        T  Y  PE++
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEIL 170

Query: 186 -ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV---------------- 228
             S  + + VDIW+LG +  E     P F      D   +I  V                
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230

Query: 229 ---DLKFPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                +FP           P  S  A DLI  ML  D  +R    + L+HP+
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  123 bits (309), Expect = 2e-33
 Identities = 76/262 (29%), Positives = 136/262 (51%), Gaps = 14/262 (5%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G  G V +A  K S  +VA+K   K  L++ Q    L  EV I    +H N++ +Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++E+   G L   +   +  +E + A    ++ +AL   H + VIHRDIK
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 144 PENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +++L+   G +K++DFG+         RR+++ GT  ++ PE++  + +   VDIWSLG
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203

Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK----PIVSSAAKDLISQMLVKDSSQ 256
           ++  E + G PP+  +      + I       PPK      VS + K  + ++LV+D +Q
Sbjct: 204 IMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260

Query: 257 RLPLHKLLEHPWIIQNADPSGV 278
           R    +LL+HP++ +   PS +
Sbjct: 261 RATAAELLKHPFLAKAGPPSCI 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  121 bits (306), Expect = 2e-33
 Identities = 76/250 (30%), Positives = 124/250 (49%), Gaps = 9/250 (3%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +GRG FG V+L R K    +V +K +   Q+ + +     + E ++   L HPNI+  Y 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLSHPNIIEYYE 66

Query: 84  YFYDQKRVYLILEYAAKGELYKELQK-CK-YFSERRAATYVASLARALIYCHGKHVIHRD 141
            F + K + +++EYA  G L + +QK C     E     +   +  AL + H K ++HRD
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRD 126

Query: 142 IKPENLLIGA-QGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWS 198
           +K +N+L+   +  +KI DFG S  + + ++  T+ GT  Y+ PE+ E   ++   DIW+
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWA 186

Query: 199 LGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP-KPIVSSAAKDLISQMLVKDSSQR 257
           LG + YE       FEA        +I+     F P     S   + LI  ML  D S+R
Sbjct: 187 LGCVLYELASLKRAFEAANLPALVLKIMSG--TFAPISDRYSPDLRQLILSMLNLDPSKR 244

Query: 258 LPLHKLLEHP 267
             L +++  P
Sbjct: 245 PQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 3e-33
 Identities = 75/282 (26%), Positives = 124/282 (43%), Gaps = 39/282 (13%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNILR 80
           +G G +G VY AR+  +   VALK + +  L +  +     RE+ +   L    HPNI+R
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 81  LYG--YFYDQKR---VYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCH 133
           L    +     R   + L+ E+  + +L   L KC             +  L R + + H
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMC-GTLDYLPPEMVESVEHD 191
              ++HRD+KP+N+L+ + G++KIADFG + +++F    T    TL Y  PE++    + 
Sbjct: 125 SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYA 184

Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI-------------VQVDLK---FPPK 235
             VD+WS+G +  E     P F     +D   +I               V L    FP  
Sbjct: 185 TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSY 244

Query: 236 PIVS---------SAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
              S             DL+ +ML  +  +R+   + L+HP+
Sbjct: 245 TPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  122 bits (307), Expect = 3e-33
 Identities = 72/243 (29%), Positives = 122/243 (50%), Gaps = 10/243 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V   + K +  + A K L K +L++ + E     E +I   +    I+ L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRD 141
            F  +  + L++     G+L   +       F E RA  Y A +   L + H + +++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 142 IKPENLLIGAQGELKIADFGWSVHTFNRRRTM--CGTLDYLPPEMVESVEHDANVDIWSL 199
           +KPEN+L+   G ++I+D G +V     ++     GT  Y+ PE+++   +D +VD ++L
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 200 GVLCYEFLYGVPPF----EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSS 255
           G   YE + G  PF    E  E  +  RR +++ +++P K   S  AKDL   +L KD  
Sbjct: 181 GCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK--FSPEAKDLCEALLQKDPE 238

Query: 256 QRL 258
           +RL
Sbjct: 239 KRL 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  121 bits (306), Expect = 6e-33
 Identities = 90/293 (30%), Positives = 141/293 (48%), Gaps = 50/293 (17%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSHLR 74
           D+   + +G G +G VY  R K++  IVA+K   K +L+  +  V     RE+ +   L+
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK---KIRLESEEEGVPSTAIREISLLKELQ 57

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYK---ELQKCKYFSERRAATYVASLARALIY 131
           HPNI+ L      + R+YLI E+ +  +L K    L K +Y       +Y+  + + +++
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWS--------VHTFNRRRTMCGTLDYLPPE 183
           CH + V+HRD+KP+NLLI  +G +K+ADFG +        V+T         TL Y  PE
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHE-----VVTLWYRAPE 171

Query: 184 -MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------- 228
            ++ S  +   VDIWS+G +  E     P F      D   RI ++              
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231

Query: 229 --DLK--FP--PKPIVSSAAK-------DLISQMLVKDSSQRLPLHKLLEHPW 268
             D K  FP   K  + SA K       DL+ +ML+ D ++R+   K L HP+
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  121 bits (305), Expect = 7e-33
 Identities = 81/283 (28%), Positives = 136/283 (48%), Gaps = 45/283 (15%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSHLRHPNILRL 81
           +G G +G V+ A+ + ++ IVALK   + +L      V     RE+ +   L+H NI+RL
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHR 140
           Y   +  K++ L+ EY  + +L K    C          +++  L + L +CH  +V+HR
Sbjct: 65  YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHR 123

Query: 141 DIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESVE-HDAN 193
           D+KP+NLLI   GELK+ADFG +      V  ++       TL Y PP+++   + +  +
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV---TLWYRPPDVLFGAKLYSTS 180

Query: 194 VDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQV----------------DLKFPPK- 235
           +D+WS G +  E    G P F   +  D  +RI ++                D K  P  
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240

Query: 236 ----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                     P ++S  +DL+  +LV +  QR+   + L+HP+
Sbjct: 241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  120 bits (302), Expect = 1e-32
 Identities = 79/256 (30%), Positives = 131/256 (51%), Gaps = 17/256 (6%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE-HQLRREVEIQSHLRHPNILRLY 82
           +G+G FG VY   + R+  +VA+K++    L++++ E   +++E+ + S    P I R Y
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKII---DLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
           G +    ++++I+EY   G    +L K     E   AT +  + + L Y H +  IHRDI
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127

Query: 143 KPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K  N+L+  QG++K+ADFG +     T  +R T  GT  ++ PE+++   +D   DIWSL
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187

Query: 200 GVLCYEFLYGVPPFEAKEHSDTY--RRIVQVDLKFPP--KPIVSSAAKDLISQMLVKDSS 255
           G+   E   G PP      SD +  R +  +    PP  +   S   K+ +   L KD  
Sbjct: 188 GITAIELAKGEPPN-----SDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPR 242

Query: 256 QRLPLHKLLEHPWIIQ 271
            R    +LL+H +I +
Sbjct: 243 FRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  120 bits (303), Expect = 1e-32
 Identities = 74/255 (29%), Positives = 130/255 (50%), Gaps = 18/255 (7%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G  G VY A +  +   VA+K +    LQQ   +  +  E+ +    +HPNI+    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPNIVNYLD 83

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++EY A G L   + +     E + A       +AL + H   VIHRDIK
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142

Query: 144 PENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +N+L+G  G +K+ DFG+        ++R TM GT  ++ PE+V    +   VDIWSLG
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQV------DLKFPPKPIVSSAAKDLISQMLVKDS 254
           ++  E + G PP+    + +  R +  +      +L+ P K  +S+  +D +++ L  D 
Sbjct: 203 IMAIEMVEGEPPY---LNENPLRALYLIATNGTPELQNPEK--LSAIFRDFLNRCLEMDV 257

Query: 255 SQRLPLHKLLEHPWI 269
            +R    +LL+HP++
Sbjct: 258 EKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  120 bits (302), Expect = 1e-32
 Identities = 76/269 (28%), Positives = 129/269 (47%), Gaps = 22/269 (8%)

Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALKVL--------FKSQLQQSQVEHQLRREVEIQSH 72
           G+ +G+G +G VYLA    +  ++A+K +             Q+  V+  LR E+E    
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVK-ALRSEIETLKD 64

Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
           L H NI++  G+   ++ + + LEY   G +   L+    F E+    +   +   L Y 
Sbjct: 65  LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRRTMCGTLDYLPPEMVES 187
           H K ++HRD+K +NLL+ A G  KI+DFG S  + +     +  +M G++ ++ PE++ S
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184

Query: 188 VE--HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP-----IVSS 240
               + A VDIWSLG +  E   G  P+  +E      ++       PP P      +S 
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-SAPPIPPDVSMNLSP 243

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            A D ++     +   R    +LL+HP+I
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  119 bits (299), Expect = 2e-32
 Identities = 72/259 (27%), Positives = 130/259 (50%), Gaps = 10/259 (3%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           ++I K +G G FG +YLA+ K  +    +K +  +++   + E   ++EV + + ++HPN
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHPN 60

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGK 135
           I+  +  F +  R+++++EY   G+L K + + +   FSE +  ++   ++  L + H +
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 136 HVIHRDIKPENLLIGAQGEL-KIADFGWSVHTFNRR----RTMCGTLDYLPPEMVESVEH 190
            ++HRDIK +N+ +   G + K+ DFG      N       T  GT  YL PE+ ++  +
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFG-IARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           +   DIWSLG + YE      PFE         +I Q     P  P  S   + LISQ+ 
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLF 238

Query: 251 VKDSSQRLPLHKLLEHPWI 269
                 R  +  +L+ P++
Sbjct: 239 KVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 3e-32
 Identities = 68/270 (25%), Positives = 122/270 (45%), Gaps = 24/270 (8%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHL 73
            ++  GK LG+G FG VYL  +  +   +A+K +          +    L  E+++  +L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           +H  I++ YG   D + + + +EY   G +  +L+     +E     Y   +   + Y H
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC----------GTLDYLPPE 183
              ++HRDIK  N+L  + G +K+ DFG S     R +T+C          GT  ++ PE
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGAS----KRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI----VS 239
           ++    +    D+WS+G    E L   PP+   E      +I       P  P     VS
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA----TQPTNPQLPSHVS 233

Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
             A++ + +  V+++ +R    +LL H ++
Sbjct: 234 PDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  119 bits (299), Expect = 3e-32
 Identities = 80/264 (30%), Positives = 124/264 (46%), Gaps = 16/264 (6%)

Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVEHQ-----LRREVEIQSHLR 74
           G  +G G FG VYL     S  ++A+K V   S    S+   +     L RE+ +   L+
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H NI++  G   D   + + LEY   G +   L     F E     +V  + + L Y H 
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS-------VHTFNR--RRTMCGTLDYLPPEMV 185
           + +IHRDIK  N+L+  +G +KI+DFG S       + T     R ++ G++ ++ PE+V
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
           +   +    DIWSLG L  E L G  PF          +I +      P  I SS A D 
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI-SSEAIDF 243

Query: 246 ISQMLVKDSSQRLPLHKLLEHPWI 269
           + +    D ++R    +LL+HP++
Sbjct: 244 LEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  119 bits (300), Expect = 4e-32
 Identities = 80/287 (27%), Positives = 130/287 (45%), Gaps = 53/287 (18%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ-VEHQLRREVEIQSHLRHPNILRLY 82
           LG G +  VY  R + +  IVALK +    L   +       RE+ +   L+H NI+RL+
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRLH 64

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRA------ATYVASLARALIYCHGK 135
              + + ++ L+ EY     + K+L+K       R A       ++   L + + +CH  
Sbjct: 65  DVIHTENKLMLVFEY-----MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPE-MVESV 188
            V+HRD+KP+NLLI  +GELK+ADFG +      V+TF+       TL Y  P+ ++ S 
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPDVLLGSR 176

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------------------DL 230
            +  ++DIWS+G +  E + G P F    + D   +I ++                    
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236

Query: 231 KFPPKPIVSSA---------AKDLISQMLVKDSSQRLPLHKLLEHPW 268
            FP  P                DL+ ++L  +   R+  H  L+HPW
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  119 bits (299), Expect = 1e-31
 Identities = 70/248 (28%), Positives = 129/248 (52%), Gaps = 15/248 (6%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-QSHLRHPNILRLY 82
           +GRG +  V L R K++  I A+KV+ K  +   +    ++ E  + +    HP ++ L+
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
             F  + R++ ++EY   G+L   +Q+ +   E  A  Y A ++ AL Y H + +I+RD+
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 143 KPENLLIGAQGELKIADFGWSVHTFNRRRT---MCGTLDYLPPEMVESVEHDANVDIWSL 199
           K +N+L+ ++G +K+ D+G          T    CGT +Y+ PE++   ++  +VD W+L
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182

Query: 200 GVLCYEFLYGVPPFEAKEHSDT---------YRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           GVL +E + G  PF+    SD          ++ I++  ++ P    +S  A  ++   L
Sbjct: 183 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFL 240

Query: 251 VKDSSQRL 258
            KD  +RL
Sbjct: 241 NKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  123 bits (309), Expect = 1e-31
 Identities = 60/160 (37%), Positives = 93/160 (58%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F I KP+ RG FG VYL R+K ++ + A+KV+ K+ +    + HQ++ E +  +  
Sbjct: 2   SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           + P I+ LY        VYL++EY   G++   L    YF E  A  Y++ +A AL Y H
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM 173
              +IHRD+KP+N+LI  +G +K+ DFG S  T NR   M
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  117 bits (293), Expect = 2e-31
 Identities = 75/258 (29%), Positives = 135/258 (52%), Gaps = 17/258 (6%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE-HQLRREVEIQSHLRHPNILRLY 82
           +G+G FG V+   + R+  +VA+K++    L++++ E   +++E+ + S    P + + Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKII---DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
           G +    ++++I+EY   G     L+      E + AT +  + + L Y H +  IHRDI
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKIHRDI 127

Query: 143 KPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K  N+L+   GE+K+ADFG +     T  +R T  GT  ++ PE+++   +D+  DIWSL
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187

Query: 200 GVLCYEFLYGVPPFEAKEHSDTY--RRIVQVDLKFPP--KPIVSSAAKDLISQMLVKDSS 255
           G+   E   G PP     HS+ +  + +  +    PP  +   S   K+ +   L K+ S
Sbjct: 188 GITAIELAKGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 242

Query: 256 QRLPLHKLLEHPWIIQNA 273
            R    +LL+H +I++ A
Sbjct: 243 FRPTAKELLKHKFIVRFA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  117 bits (293), Expect = 3e-31
 Identities = 78/256 (30%), Positives = 120/256 (46%), Gaps = 17/256 (6%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           L +F I K +GRG+F  VY A        VALK +   ++  ++      +E+++   L 
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFS-------ERRAATYVASLAR 127
           HPN+++    F +   + ++LE A  G+L    Q  KYF        ER    Y   L  
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLS---QMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT----MCGTLDYLPPE 183
           A+ + H + V+HRDIKP N+ I A G +K+ D G     F+ + T    + GT  Y+ PE
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVGTPYYMSPE 176

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS--DTYRRIVQVDLKFPPKPIVSSA 241
            +    ++   DIWSLG L YE      PF   + +     ++I Q D    P    S  
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236

Query: 242 AKDLISQMLVKDSSQR 257
            ++L+S  +  D  QR
Sbjct: 237 LRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  117 bits (294), Expect = 3e-31
 Identities = 74/266 (27%), Positives = 135/266 (50%), Gaps = 17/266 (6%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G +G VY    + +   +A+K + + +L +S+  +Q+  E++I      P I+  YG
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKF-NQIIMELDILHKAVSPYIVDFYG 66

Query: 84  YFYDQKRVYLILEYAAKG---ELYKELQKCKYFSERRAATYVASLARALIYCHGKH-VIH 139
            F+ +  VY+ +EY   G   +LY      +   E        ++ + L +   +H +IH
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126

Query: 140 RDIKPENLLIGAQGELKIADFGWSVHTFNR-RRTMCGTLDYLPPEMVESVEHDANV---- 194
           RD+KP N+L+   G++K+ DFG S +      +T  G   Y+ PE ++S   + N     
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTV 186

Query: 195 --DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLISQML 250
             D+WSLG+   E   G  P+  + +++ + ++  +    PP      S  A+D +++ L
Sbjct: 187 QSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCL 246

Query: 251 VKDSSQRLPLHKLLEHPWII--QNAD 274
            K  ++R    +LLEHPW++  +NAD
Sbjct: 247 NKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  117 bits (294), Expect = 3e-31
 Identities = 87/280 (31%), Positives = 132/280 (47%), Gaps = 37/280 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-QSHLR 74
           + ++I + +G+G +G VY    K+   + A+K+L       S V+ ++  E  I QS   
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLPN 77

Query: 75  HPNILRLYGYFYDQKR-----VYLILEYAAKG---ELYKELQKC-KYFSERRAATYVASL 125
           HPN+++ YG FY   +     ++L+LE    G   EL K L  C +   E   +  +   
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPP 182
              L + H   +IHRD+K  N+L+  +G +K+ DFG S     T  RR T  GT  ++ P
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Query: 183 EMVESVE-----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PK 235
           E++   +     +DA  D+WSLG+   E   G PP     H       V+   K P  P 
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL-FDMHP------VKTLFKIPRNPP 250

Query: 236 PIVSSAAK------DLISQMLVKDSSQRLPLHKLLEHPWI 269
           P +    K        ISQ L+KD   R  +  LLEHP+I
Sbjct: 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  117 bits (296), Expect = 3e-31
 Identities = 74/265 (27%), Positives = 138/265 (52%), Gaps = 23/265 (8%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-QSHLRHPNILRLY 82
           +GRG +  V L   K++  I A+KV+ K  +   +    ++ E  + ++   HP ++ L+
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
             F  + R++ ++E+ + G+L   +Q+ +   E  A  Y A ++ AL + H + +I+RD+
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 143 KPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K +N+L+ A+G +K+ D+G     +   +   T CGT +Y+ PE++   ++  +VD W+L
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182

Query: 200 GVLCYEFLYGVPPFE---AKEHSD--TYRRIVQVDLKFPPKPI-----VSSAAKDLISQM 249
           GVL +E + G  PF+     ++ D  T   + QV L+   K I     +S  A  ++   
Sbjct: 183 GVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---KQIRIPRSLSVKASSVLKGF 239

Query: 250 LVKDSSQRLPLHK------LLEHPW 268
           L KD  +RL  H       +  HP+
Sbjct: 240 LNKDPKERLGCHPQTGFRDIKSHPF 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  118 bits (297), Expect = 4e-31
 Identities = 90/307 (29%), Positives = 138/307 (44%), Gaps = 46/307 (14%)

Query: 10  KKRWTLND-FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--RE 66
           K  W + D +    P+G G +G V  A + ++   VA+K L  S+  QS   H  R  RE
Sbjct: 8   KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL--SRPFQS-AIHAKRTYRE 64

Query: 67  VEIQSHLRHPNILRLYGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
           + +  H+ H N++ L   F       D + VYL+       +L   + KC+  S+     
Sbjct: 65  LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIV-KCQKLSDDHIQF 122

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 180
            V  + R L Y H   +IHRD+KP N+ +    ELKI DFG + HT +       T  Y 
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYR 182

Query: 181 PPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----DLKFPPK 235
            PE M+  + ++  VDIWS+G +  E L G   F   +H D  +RI+ +    D +   K
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242

Query: 236 PIVSSAAK--------------------------DLISQMLVKDSSQRLPLHKLLEHPWI 269
            I S +A+                          DL+ +MLV D  +R+   + L HP++
Sbjct: 243 -ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301

Query: 270 IQNADPS 276
            +  DP 
Sbjct: 302 AEYHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  116 bits (293), Expect = 4e-31
 Identities = 72/268 (26%), Positives = 118/268 (44%), Gaps = 15/268 (5%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D +    LG G  G V   +   +  ++A KV+      +S V  Q+ RE++I    R P
Sbjct: 6   DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSP 63

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
            I+  YG F ++  + + +E+   G L +  +K              ++   L Y +  H
Sbjct: 64  YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 137 -VIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-RRTMCGTLDYLPPEMVESVEHDANV 194
            ++HRDIKP N+L+ ++G++K+ DFG S    N    T  GT  Y+ PE ++  ++    
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKS 183

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHS-----------DTYRRIVQVDLKFPPKPIVSSAAK 243
           D+WSLG+   E   G  PF                 D  ++IVQ      P        +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243

Query: 244 DLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
           D +   L+KD ++R    +L   P  IQ
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAMPPFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  116 bits (291), Expect = 8e-31
 Identities = 82/285 (28%), Positives = 132/285 (46%), Gaps = 49/285 (17%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L HPNI++L  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 84  YFYDQKRVYLILEYAAKGELYKELQK---CKYFSERRAA---TYVASLARALIYCHGKHV 137
             + + ++YL+ E+     L+++L+K       S        +Y+  L + L +CH   V
Sbjct: 67  VIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121

Query: 138 IHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y  PE++   ++ 
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEILLGCKYY 178

Query: 192 AN-VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------DL------- 230
           +  VDIWSLG +  E +     F      D   RI +               L       
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238

Query: 231 -KFPPK------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
            K+  +      P +    +DL+SQML  D ++R+     L HP+
Sbjct: 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  115 bits (291), Expect = 1e-30
 Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 26/280 (9%)

Query: 8   KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR-- 65
            +K    LND +    +G G  G VY  R K++ H++A+K     Q++++  + + +R  
Sbjct: 7   GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRIL 61

Query: 66  ---EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAK--GELYKELQKCKYFSERRAAT 120
              +V ++SH   P I++ YGYF     V++ +E  +    +L K +Q      E     
Sbjct: 62  MDLDVVLKSH-DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQG--PIPEDILGK 118

Query: 121 YVASLARALIYCHGKH-VIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGT 176
              ++ +AL Y   KH VIHRD+KP N+L+ A G +K+ DFG S   V +  + R+  G 
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGC 177

Query: 177 LDYLPPEMVE----SVEHDANVDIWSLGVLCYEFLYGVPPFE-AKEHSDTYRRIVQVDL- 230
             Y+ PE ++    + ++D   D+WSLG+   E   G  P++  K   +   +I+Q +  
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237

Query: 231 KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII 270
             PP    S      +   L KD  +R    +LL+HP+I 
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  115 bits (290), Expect = 2e-30
 Identities = 87/306 (28%), Positives = 135/306 (44%), Gaps = 60/306 (19%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSH 72
           ++ FDI   +G G +G VY AR+K +  +VALK   K +L   +    +   RE++I   
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQ 62

Query: 73  LRHPNILRLY----------GYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATY 121
           L H NI+ L            +  D+   YL+ EY    +L   L+    +FSE    ++
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSF 121

Query: 122 VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCG---TL 177
           +  L   L YCH K+ +HRDIK  N+L+  +G++K+ADFG + ++     R       TL
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181

Query: 178 DYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEH------------------ 218
            Y PPE++   E +   +D+WS G +  E     P F+A +                   
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241

Query: 219 ---------------SDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKL 263
                             YRR ++ +  F P P     A DL+  ML  D S+R    + 
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTP-----ALDLLDHMLTLDPSKRCTAEEA 296

Query: 264 LEHPWI 269
           L  PW+
Sbjct: 297 LNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 2e-30
 Identities = 81/286 (28%), Positives = 136/286 (47%), Gaps = 47/286 (16%)

Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ-VEHQLRREVEIQSHLRHPNILRL 81
            LG G +  VY  R K +  +VALK +   +L+  +       RE  +   L+H NI+ L
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIVTL 68

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHR 140
           +   + +K + L+ EY    +L + +  C    S      ++  L R L YCH + V+HR
Sbjct: 69  HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127

Query: 141 DIKPENLLIGAQGELKIADFGW----SV--HTFNRRRTMCGTLDYLPPE-MVESVEHDAN 193
           D+KP+NLLI  +GELK+ADFG     SV   T++       TL Y PP+ ++ S E+  +
Sbjct: 128 DLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV---TLWYRPPDVLLGSTEYSTS 184

Query: 194 VDIWSLGVLCYEFLYGVPPFE-AKEHSDTYRRIVQV-------------------DLKFP 233
           +D+W +G + YE   G P F  + +  D   +I +V                      FP
Sbjct: 185 LDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFP 244

Query: 234 ---PKPIVSSA--------AKDLISQMLVKDSSQRLPLHKLLEHPW 268
              P+P+++ A         ++L  + L  +  +R+   + ++HP+
Sbjct: 245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  115 bits (290), Expect = 2e-30
 Identities = 73/245 (29%), Positives = 130/245 (53%), Gaps = 11/245 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-QSHLRHPNILRLY 82
           +GRG +  V L R K+++ I A+KV+ K  +   +    ++ E  + +    +P ++ L+
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
             F    R++L++EY   G+L   +Q+ +   E  A  Y A +  AL + H + +I+RD+
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 143 KPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K +N+L+ A G +K+ D+G     +   +   T CGT +Y+ PE++   E+  +VD W+L
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182

Query: 200 GVLCYEFLYGVPPFEA---KEHSDTYRRIVQVDLKFP---PKPIVSSAAKDLISQMLVKD 253
           GVL +E + G  PF+        +T   + QV L+ P   P+  +S  A  ++   L KD
Sbjct: 183 GVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR-FLSVKASHVLKGFLNKD 241

Query: 254 SSQRL 258
             +RL
Sbjct: 242 PKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  114 bits (288), Expect = 2e-30
 Identities = 82/286 (28%), Positives = 129/286 (45%), Gaps = 45/286 (15%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HP 76
           +GK +G G F  V  A+ +++    A+K + K   +  +  + LR   EIQ+  R   HP
Sbjct: 4   LGK-IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLR---EIQALRRLSPHP 58

Query: 77  NILRLYGYFYDQK--RVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCH 133
           NILRL    +D+K  R+ L+ E      LY+ ++  K    E+R  +Y+  L ++L + H
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC---GTLDYLPPE-MVESVE 189
              + HRDIKPEN+LI     LK+ADFG S      +        T  Y  PE ++    
Sbjct: 118 RNGIFHRDIKPENILI-KDDILKLADFG-SCRGIYSKPPYTEYISTRWYRAPECLLTDGY 175

Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------------------DLK 231
           +   +DIW++G + +E L   P F      D   +I  V                  +  
Sbjct: 176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235

Query: 232 FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
           FP K         P  S+   DL+ ++L  D  +R+   + L HP+
Sbjct: 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  112 bits (281), Expect = 2e-29
 Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 25/271 (9%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           F++ + +G G +G VY  R  ++  + A+KV+  ++ ++ +++ ++     ++ +  H N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM---LKKYSHHRN 74

Query: 78  ILRLYGYFYDQK------RVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARAL 129
           I   YG F  +       +++L++E+   G +   ++  K     E   A     + R L
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPPEMVE 186
            + H   VIHRDIK +N+L+    E+K+ DFG S     T  RR T  GT  ++ PE++ 
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194

Query: 187 SVE-----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
             E     +D   DIWSLG+   E   G PP     H    R +  +    PPK      
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPL-CDMHP--MRALFLIPRNPPPKLKSKKW 251

Query: 242 AK---DLISQMLVKDSSQRLPLHKLLEHPWI 269
           +K   D I   LVK+   R    +LL+HP+I
Sbjct: 252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  114 bits (286), Expect = 2e-29
 Identities = 83/281 (29%), Positives = 130/281 (46%), Gaps = 54/281 (19%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRHPNILR 80
           K LG G FG V LAR+  +  + A+K L K   L ++QV H ++ E +I +   +  ++R
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAH-VKAERDILAEADNEWVVR 65

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           LY  F D+  +Y +++Y   G++   L +   F E  A  Y+A L  A+   H    IHR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 141 DIKPENLLIGAQGELKIADFG------WS------------------------------- 163
           DIKP+N+LI   G +K+ DFG      W+                               
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185

Query: 164 ---VHTFNRR----------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGV 210
              +    RR           ++ GT +Y+ PE++    +    D WS+GV+ YE L G 
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245

Query: 211 PPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSAAKDLISQM 249
           PPF A+   +T  +++  Q  L  PP+  +S  A DLI ++
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  114 bits (286), Expect = 2e-29
 Identities = 79/281 (28%), Positives = 133/281 (47%), Gaps = 54/281 (19%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRHPNILR 80
           K LG G FG V LA +  ++ + A+K L K   L ++QV H ++ E +I +   +  +++
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAH-VKAERDILAEADNEWVVK 65

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           LY  F D+  +Y +++Y   G++   L + + F E  A  Y+A L  A+   H    IHR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125

Query: 141 DIKPENLLIGAQGELKIADFG------WS------------------------------- 163
           DIKP+N+LI   G +K+ DFG      W+                               
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC 185

Query: 164 ---VHTFNRR----------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGV 210
              + T  +R           ++ GT +Y+ PE++    +    D WS+GV+ +E L G 
Sbjct: 186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245

Query: 211 PPFEAKEHSDTYRRIVQVD--LKFPPKPIVSSAAKDLISQM 249
           PPF A   ++T  +++  +  L  PP+  +S  A DLI+++
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  111 bits (279), Expect = 2e-29
 Identities = 77/255 (30%), Positives = 122/255 (47%), Gaps = 15/255 (5%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           L +F I K +GRG+F  VY A        VALK +    L  ++      +E+++   L 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARALI 130
           HPN+++ Y  F +   + ++LE A  G+L + ++  K       E+    Y   L  AL 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT----MCGTLDYLPPEMVE 186
           + H + V+HRDIKP N+ I A G +K+ D G     F+ + T    + GT  Y+ PE + 
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS--DTYRRIVQVDLKFPPKPI--VSSAA 242
              ++   DIWSLG L YE      PF   + +     ++I Q D  +PP P    S   
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEEL 237

Query: 243 KDLISQMLVKDSSQR 257
           + L++  +  D  +R
Sbjct: 238 RQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  110 bits (277), Expect = 5e-29
 Identities = 71/247 (28%), Positives = 121/247 (48%), Gaps = 10/247 (4%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            +++ + +G G FG   L +   S+   A+K + +     S VE   R+E  + + ++HP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDS-RKEAVLLAKMKHP 58

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKE--LQKCKYFSERRAATYVASLARALIYCHG 134
           NI+     F     +Y+++EY   G+L ++  LQ+ K F E     +   +   + + H 
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHD 191
           K V+HRDIK +N+ +   G++K+ DFG +           T  GT  Y+PPE+ E++ ++
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI-VSSAAKDLISQML 250
              DIWSLG + YE      PF+A    +   ++ Q   K  P P   S   + LI QM 
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--PLPSHYSYELRSLIKQMF 236

Query: 251 VKDSSQR 257
            ++   R
Sbjct: 237 KRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  110 bits (277), Expect = 8e-29
 Identities = 74/256 (28%), Positives = 131/256 (51%), Gaps = 20/256 (7%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G  G V+ A +  +   VA+K +    LQ+   +  +  E+ +   L++PNI+    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 84  YFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            F     +++++EY A G L   + + C    E + A       +AL + H   VIHRDI
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLHANQVIHRDI 141

Query: 143 KPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K +N+L+G  G +K+ DFG+        ++R TM GT  ++ PE+V    +   VDIWSL
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201

Query: 200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQV------DLKFPPKPIVSSAAKDLISQMLVKD 253
           G++  E + G PP+    + +  R +  +      +L+ P K  +S   +D +++ L  D
Sbjct: 202 GIMAIEMVEGEPPY---LNENPLRALYLIATNGTPELQNPEK--LSPIFRDFLNRCLEMD 256

Query: 254 SSQRLPLHKLLEHPWI 269
             +R    +LL+HP++
Sbjct: 257 VEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  110 bits (276), Expect = 1e-28
 Identities = 80/286 (27%), Positives = 122/286 (42%), Gaps = 50/286 (17%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G V   + K +  IVA+K   +S+     V+    RE+ +   LRH N++ L  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESE-DDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 84  YFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            F  +KR+YL+ E+     L  +L+K      E R   Y+  + R + +CH  ++IHRDI
Sbjct: 68  VFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDI 126

Query: 143 KPENLLIGAQGELKIADFGWSVHTFNRRRTMCG----------TLDYLPPEM-VESVEHD 191
           KPEN+L+   G +K+ DFG++       RT+            T  Y  PE+ V   ++ 
Sbjct: 127 KPENILVSQSGVVKLCDFGFA-------RTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK---------------- 235
             VDIW++G L  E L G P F      D    I++      P+                
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239

Query: 236 -------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                        P +S    DL  Q L  D   R    +LL H +
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  110 bits (275), Expect = 1e-28
 Identities = 73/256 (28%), Positives = 131/256 (51%), Gaps = 20/256 (7%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G  G VY A +  +   VA+K   +  LQQ   +  +  E+ +    ++PNI+    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIK---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 84  YFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            +     +++++EY A G L   + + C    E + A       +AL + H   VIHRDI
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLHSNQVIHRDI 141

Query: 143 KPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K +N+L+G  G +K+ DFG+        ++R TM GT  ++ PE+V    +   VDIWSL
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201

Query: 200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQV------DLKFPPKPIVSSAAKDLISQMLVKD 253
           G++  E + G PP+    + +  R +  +      +L+ P +  +S+  +D +++ L  D
Sbjct: 202 GIMAIEMVEGEPPY---LNENPLRALYLIATNGTPELQNPER--LSAVFRDFLNRCLEMD 256

Query: 254 SSQRLPLHKLLEHPWI 269
             +R    +LL+HP++
Sbjct: 257 VDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  110 bits (276), Expect = 2e-28
 Identities = 80/284 (28%), Positives = 139/284 (48%), Gaps = 48/284 (16%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ------LRREVEIQSHLRHPN 77
           LG G +  V+  R K + ++VALK        + ++EH+        REV +   L+H N
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALK--------EIRLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKH 136
           I+ L+   +  K + L+ EY  K +L + +  C    S      ++  + R L YCH + 
Sbjct: 66  IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---TLDYLPPE-MVESVEHDA 192
           V+HRD+KP+NLLI  +GELK+ADFG +       +T      TL Y PP+ ++ S E+  
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Query: 193 NVDIWSLGVLCYEFLYGVPPF-----EAKEH----------SDTYRRIVQVDL------- 230
            +D+W +G + +E   G P F     E + H           +T+  I   D        
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP 244

Query: 231 KFPPKPIVSSAAK------DLISQMLVKDSSQRLPLHKLLEHPW 268
           K+ P+P+++ A +      +L+++ L  +S +R+   + ++H +
Sbjct: 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  110 bits (277), Expect = 2e-28
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 36/287 (12%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           +P+G G FG V  AR++ +   VA+K + K       +  +  RE+++  HLRH NI+ L
Sbjct: 16  QPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLRHENIISL 74

Query: 82  YGYFYD-QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
              F    + +Y + E     +L++ L   +   ++    ++  + R L Y H   V+HR
Sbjct: 75  SDIFISPLEDIYFVTELLGT-DLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHR 132

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDANVDIWSL 199
           D+KP N+LI    +LKI DFG +     +      T  Y  PE M+   ++D  VDIWS 
Sbjct: 133 DLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192

Query: 200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS------------------- 240
           G +  E L G P F  K+H + +  I  + L  PP  ++++                   
Sbjct: 193 GCIFAEMLEGKPLFPGKDHVNQFSIITDL-LGTPPDDVINTICSENTLRFVQSLPKREPV 251

Query: 241 -----------AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                      +A DL+ +MLV D  +R+   + L HP++    DP+
Sbjct: 252 PFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  109 bits (275), Expect = 2e-28
 Identities = 81/300 (27%), Positives = 131/300 (43%), Gaps = 41/300 (13%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF+    LG G  G V     + S  I+A K L   +++ + + +Q+ RE+++      P
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARK-LIHLEIKPA-IRNQIIRELKVLHECNSP 59

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
            I+  YG FY    + + +E+   G L + L+K     E        ++ R L Y   KH
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119

Query: 137 -VIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-RRTMCGTLDYLPPEMVESVEHDANV 194
            ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +    
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQS 179

Query: 195 DIWSLGVLCYEFL---YGVPPFEAKE-----------------------HSDTYRR---- 224
           DIWSLG+   E     Y +PP +AKE                       H     R    
Sbjct: 180 DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239

Query: 225 ------IVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGV 278
                 IV       P    S   +D + + L K+  +R  L +L +HP+ I+ A+   V
Sbjct: 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF-IKRAELEEV 298

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  109 bits (273), Expect = 4e-28
 Identities = 80/284 (28%), Positives = 139/284 (48%), Gaps = 48/284 (16%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ------LRREVEIQSHLRHPN 77
           LG G +  VY  R K ++++VALK        + ++EH+        REV +   L+H N
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALK--------EIRLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKH 136
           I+ L+   + +K + L+ EY  K +L + L  C    +      ++  L R L YCH + 
Sbjct: 66  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---TLDYLPPE-MVESVEHDA 192
           V+HRD+KP+NLLI  +GELK+ADFG +       +T      TL Y PP+ ++ S ++  
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Query: 193 NVDIWSLGVLCYEFLYGVPPF-----EAKEH----------SDTYRRIVQVDL------- 230
            +D+W +G + YE   G P F     E + H           +T+  I+  +        
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244

Query: 231 KFPPKPIVSSAAK------DLISQMLVKDSSQRLPLHKLLEHPW 268
           K+    + + A +      +L+S++L  +  +R+   + ++HP+
Sbjct: 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  108 bits (271), Expect = 4e-28
 Identities = 79/272 (29%), Positives = 132/272 (48%), Gaps = 23/272 (8%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQSHLR 74
           ++I   LG G FG VY A+ K +  + A KV+       ++ E +L     E++I +   
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVI------DTKSEEELEDYMVEIDILASCD 60

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGEL---YKELQKCKYFSERRAATYVASLARALIY 131
           HPNI++L   FY +  +++++E+ A G +     EL++    +E +          AL Y
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNY 118

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV--- 185
            H   +IHRD+K  N+L    G++K+ADFG S     T  RR +  GT  ++ PE+V   
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 186 --ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV-SSAA 242
             +   +D   D+WSLG+   E     PP           +I + +     +P   SS  
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238

Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           KD + + L K+   R    +LL+HP++  N++
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  108 bits (272), Expect = 5e-28
 Identities = 81/264 (30%), Positives = 128/264 (48%), Gaps = 29/264 (10%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQSHLRHPNILR 80
           LG G FG VY A+ K +  + A KV+      +++ E +L     E+EI +   HP I++
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVI------ETKSEEELEDYMVEIEILATCNHPYIVK 73

Query: 81  LYGYFYDQKRVYLILEYAAKGEL-YKELQKCKYFSERRAATYVASLARALIYCHGKHVIH 139
           L G FY   ++++++E+   G +    L+  +  +E +       +  AL Y H   +IH
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133

Query: 140 RDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-----ESVEHD 191
           RD+K  N+L+   G++K+ADFG S   V T  RR +  GT  ++ PE+V     +   +D
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193

Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK------DL 245
              DIWSLG+   E     PP     H     R++    K  P P +S  +K      D 
Sbjct: 194 YKADIWSLGITLIEMAQIEPP----HHELNPMRVLLKIAKSEP-PTLSQPSKWSMEFRDF 248

Query: 246 ISQMLVKDSSQRLPLHKLLEHPWI 269
           +   L K    R    +LLEHP++
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFV 272

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  107 bits (269), Expect = 6e-28
 Identities = 75/255 (29%), Positives = 124/255 (48%), Gaps = 11/255 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ--SHLRHPNILRL 81
           LG+G FG VYL ++K++     LKVL +  + +      ++   E Q  S L HP I++ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKY----FSERRAATYVASLARALIYCHGKHV 137
           +  F ++    +I EY    +L  +L++ K+     SE +   +   L   + Y H + +
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127

Query: 138 IHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
           +HRD+K +N+ +     LKI DFG S   + + +   T  GT  Y+ PE ++   +D+  
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKS 186

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           DIWSLG + YE       FE +       RIV+      P+   S     ++  ML KD 
Sbjct: 187 DIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE-TYSRQLNSIMQSMLNKDP 245

Query: 255 SQRLPLHKLLEHPWI 269
           S R    ++L +P+I
Sbjct: 246 SLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 8e-28
 Identities = 79/272 (29%), Positives = 134/272 (49%), Gaps = 29/272 (10%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVE-HQLRREVEIQSHLR 74
           ++ +GK LGRG FG VYL  +  +   +A+K V F    Q++  E + L  E+++  +LR
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 75  HPNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
           H  I++ YG   D  +K++ + +EY   G +  +L+     +E     Y   + + + Y 
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC----------GTLDYLPP 182
           H   ++HRDIK  N+L  + G +K+ DFG S     R +T+C          GT  ++ P
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGAS----KRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI----V 238
           E++    +    D+WS+     E L   PP+   E      +I       P KP+    V
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ----PTKPMLPDGV 234

Query: 239 SSAAKDLISQMLVKDSSQRLPLHK-LLEHPWI 269
           S A +D + Q+ V++  +R P  + LL HP++
Sbjct: 235 SDACRDFLKQIFVEE--KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  108 bits (273), Expect = 8e-28
 Identities = 82/300 (27%), Positives = 136/300 (45%), Gaps = 54/300 (18%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+GRG +G V  A+   +N  VA+K +  +   +   +  L RE+++  HL H N++ +
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLRHLDHENVIAI 69

Query: 82  YGYFYDQKR-----VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
                   R     VY++ E     +L++ ++  +  S+     ++  L R L Y H  +
Sbjct: 70  KDIMPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN 128

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL-----------PPEMV 185
           V+HRD+KP NLL+ A  +LKI DFG +       RT     D++           P  ++
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLA-------RTTSEKGDFMTEYVVTRWYRAPELLL 181

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------DLKF------ 232
              E+   +D+WS+G +  E L   P F  K++    + I ++       DL F      
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241

Query: 233 -------PPKPIVSSAAK---------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                  P  P  S A           DL+ +MLV D S+R+ + + L HP++    DPS
Sbjct: 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 1e-27
 Identities = 87/315 (27%), Positives = 129/315 (40%), Gaps = 73/315 (23%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ---LR--REVEIQS 71
            +     +G G +G V  A  K +   VA+K +       S  EHQ    R  RE++I  
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREIKILR 58

Query: 72  HLRHPNILRLY-----GYFYDQKRVYLILEYAAKGELYKEL-------QKCKYFSERRAA 119
             +H NI+ +        F     VY++ E   + +LYK +          +YF      
Sbjct: 59  RFKHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYF------ 111

Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGTLD 178
            Y   + R L Y H  +V+HRD+KP NLL+    +LKI DFG + +       T  G L 
Sbjct: 112 LY--QILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT--GFLT 167

Query: 179 -------YLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-- 228
                  Y  PE M+ S  +   +DIWS+G +  E L   P F  K++      I+ V  
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227

Query: 229 --------------------DLKFPPK-------PIVSSAAKDLISQMLVKDSSQRLPLH 261
                                L F PK       P     A DL+ +ML  +  +R+ + 
Sbjct: 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE 287

Query: 262 KLLEHPWIIQNADPS 276
           + L HP++ Q  DPS
Sbjct: 288 EALAHPYLEQYHDPS 302

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  106 bits (265), Expect = 2e-27
 Identities = 73/257 (28%), Positives = 125/257 (48%), Gaps = 14/257 (5%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ--SHLRHPNIL 79
           + +G+G +G V L R +       +K   K  L+ +    +   E E Q  S L+HPNI+
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIK---KLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62

Query: 80  RLYGYFYDQK-RVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKH 136
                +  +   +Y+++ +   G+LY +L  QK K   E +   +   +A AL Y H KH
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
           ++HRD+K +N+ +     +K+ D G +    +  +   T+ GT  Y+ PE+  +  ++  
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI-VSSAAKDLISQMLVK 252
            D+W+LG   YE       F AK+ +    RI++   K PP P   S    +LI+ ML K
Sbjct: 183 SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--KLPPMPKDYSPELGELIATMLSK 240

Query: 253 DSSQRLPLHKLLEHPWI 269
              +R  +  +L  P+I
Sbjct: 241 RPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  108 bits (270), Expect = 2e-27
 Identities = 84/291 (28%), Positives = 130/291 (44%), Gaps = 43/291 (14%)

Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSHLRHPNILR 80
           P+G G +G V  A + ++   VA+K L  S+  QS + H  R  RE+ +  H++H N++ 
Sbjct: 24  PVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSII-HAKRTYRELRLLKHMKHENVIG 80

Query: 81  LYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           L   F   +       VYL+      G     + KC+  ++      +  + R L Y H 
Sbjct: 81  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDAN 193
             +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++  
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 198

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP---KPIVSSAAK------- 243
           VDIWS+G +  E L G   F   +H D  + I+++         K I S +A+       
Sbjct: 199 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 258

Query: 244 -------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
                              DL+ +MLV DS +R+   + L H +  Q  DP
Sbjct: 259 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  106 bits (265), Expect = 3e-27
 Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           F++ + +G G +G VY  R  ++  + A+KV+  +  ++ +++ ++     ++ +  H N
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM---LKKYSHHRN 64

Query: 78  ILRLYGYFYDQK------RVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARAL 129
           I   YG F  +       +++L++E+   G +   ++  K     E   A     + R L
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPPEMVE 186
            + H   VIHRDIK +N+L+    E+K+ DFG S     T  RR T  GT  ++ PE++ 
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184

Query: 187 SVE-----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
             E     +D   D+WSLG+   E   G PP       D +       +   P P + S 
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPL-----CDMHPMRALFLIPRNPAPRLKSK 239

Query: 242 A-----KDLISQMLVKDSSQRLPLHKLLEHPWI 269
                 +  I   LVK+ SQR    +L++HP+I
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  106 bits (266), Expect = 3e-27
 Identities = 80/284 (28%), Positives = 135/284 (47%), Gaps = 48/284 (16%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ------LRREVEIQSHLRHPN 77
           LG G +  V+  R K + ++VALK        + ++EH+        REV +  +L+H N
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALK--------EIRLEHEEGAPCTAIREVSLLKNLKHAN 64

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKH 136
           I+ L+   + ++ + L+ EY    +L + L  C    S      ++  L R L YCH + 
Sbjct: 65  IVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---TLDYLPPE-MVESVEHDA 192
           ++HRD+KP+NLLI  +GELK+ADFG +       +T      TL Y PP+ ++ S E+  
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 193 NVDIWSLGVLCYEFLYGVPPFEA---KEHSDTYRRIVQVDLK----------------FP 233
            +D+W +G + YE   G P F     KE      R++    +                FP
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243

Query: 234 ---PKPIVSSAAK------DLISQMLVKDSSQRLPLHKLLEHPW 268
               +P+++ A +      DL+S +L+ ++  R+     L H +
Sbjct: 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  107 bits (267), Expect = 3e-27
 Identities = 61/196 (31%), Positives = 99/196 (50%), Gaps = 6/196 (3%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           + +G G FG VY AR+ R++ +VA+K +  S  Q ++    + +EV     LRHPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 82  YGYFYDQKRVYLILEYA-AKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
            G +  +   +L++EY         E+ K K   E   A       + L Y H  ++IHR
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESV---EHDANVDIW 197
           D+K  N+L+   G +K+ DFG S           GT  ++ PE++ ++   ++D  VD+W
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVW 198

Query: 198 SLGVLCYEFLYGVPPF 213
           SLG+ C E     PP 
Sbjct: 199 SLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 3e-27
 Identities = 70/244 (28%), Positives = 118/244 (48%), Gaps = 12/244 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V   + + +  + A K L K ++++ + E     E +I   +    ++ L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 84  YFYDQKRVY-LILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCHGKHVIHR 140
           Y Y+ K    L+L     G+L   +       F E RA  Y A +   L   H + +++R
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR 126

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFN--RRRTMCGTLDYLPPEMVESVEHDANVDIWS 198
           D+KPEN+L+   G ++I+D G +V        R   GT+ Y+ PE+V++  +  + D W 
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWG 186

Query: 199 LGVLCYEFLYGVPPFEAKEH----SDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           LG L YE + G  PF  ++      +  RR+ +   ++  K   S AA+ +  Q+L KD 
Sbjct: 187 LGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK--FSEAARSICRQLLTKDP 244

Query: 255 SQRL 258
             RL
Sbjct: 245 GFRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  106 bits (267), Expect = 4e-27
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G FG VY AR+ R+N +VA+K +  S  Q ++    + +EV     LRHPN +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 84  YFYDQKRVYLILEY---AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
            +  +   +L++EY   +A   L  E+ K K   E   A       + L Y H    IHR
Sbjct: 83  CYLREHTAWLVMEYCLGSASDIL--EVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHR 139

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESV---EHDANVDIW 197
           DIK  N+L+   G +K+ADFG S    +   +  GT  ++ PE++ ++   ++D  VD+W
Sbjct: 140 DIKAGNILLTEPGTVKLADFG-SASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 198

Query: 198 SLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           SLG+ C E     PP F     S  Y  I Q D         S   ++ +   L K    
Sbjct: 199 SLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQD 257

Query: 257 RLPLHKLLEHPWIIQNADPS 276
           R    +LL+H ++++   P+
Sbjct: 258 RPSSEELLKHRFVLRERPPT 277

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  107 bits (268), Expect = 4e-27
 Identities = 86/292 (29%), Positives = 130/292 (44%), Gaps = 43/292 (14%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSHLRHPNIL 79
            P+G G +G V  A + R    VA+K L  S+  QS + H  R  RE+ +  H++H N++
Sbjct: 21  TPVGSGAYGSVCSAYDTRLRQKVAVKKL--SRPFQSLI-HARRTYRELRLLKHMKHENVI 77

Query: 80  RLYGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F       +   VYL+      G     + KC+  S+      +  L R L Y H
Sbjct: 78  GLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP N+ +    EL+I DFG +    +       T  Y  PE M+  + ++ 
Sbjct: 136 SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQ 195

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------DL--------------KF 232
            VDIWS+G +  E L G   F   ++ D  +RI++V      ++                
Sbjct: 196 TVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSL 255

Query: 233 PPKP------IVSSA---AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           P  P      I   A   A DL+ +MLV DS +R+   + L HP+  Q  DP
Sbjct: 256 PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  105 bits (264), Expect = 6e-27
 Identities = 81/288 (28%), Positives = 128/288 (44%), Gaps = 39/288 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           N F++   +G G +G V   R K +  IVA+K  FK   +  +V+    RE+++   L+ 
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKK-FKDSEENEEVKETTLRELKMLRTLKQ 59

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKG--ELYKELQKCKYFSERRAATYVASLARALIYCH 133
            NI+ L   F  + ++YL+ EY  K   EL +E+         +  +Y+  L +A+ +CH
Sbjct: 60  ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCH 117

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGW----SVHTFNRRRTMCGTLDYLPPEMVESVE 189
              ++HRDIKPENLLI     LK+ DFG+    S  +         T  Y  PE++    
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------------DL 230
           +   VD+WS+G +  E   G P F  +   D    I +V                    L
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237

Query: 231 KFP----PKP-------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHP 267
           +FP    P+        I+S    DL+  +L  + + R    + L HP
Sbjct: 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  105 bits (264), Expect = 9e-27
 Identities = 71/254 (27%), Positives = 122/254 (48%), Gaps = 6/254 (2%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           + +G G FG VY AR+ R+N +VA+K +  S  Q ++    + +EV+    ++HPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 82  YGYFYDQKRVYLILEYA-AKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
            G +  +   +L++EY         E+ K K   E   A       + L Y H  ++IHR
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHR 149

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESV---EHDANVDIW 197
           DIK  N+L+   G++K+ADFG S    +   +  GT  ++ PE++ ++   ++D  VD+W
Sbjct: 150 DIKAGNILLTEPGQVKLADFG-SASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 208

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
           SLG+ C E     PP            I Q +         S   ++ +   L K    R
Sbjct: 209 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDR 268

Query: 258 LPLHKLLEHPWIIQ 271
               +LL+H ++++
Sbjct: 269 PTSEELLKHMFVLR 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  104 bits (261), Expect = 2e-26
 Identities = 70/246 (28%), Positives = 124/246 (50%), Gaps = 13/246 (5%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V   + + +  + A K L K +L++ +       E  I + +    I+ L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 84  YFYDQKRVYLILEYAAKGEL----YKELQKCKYFSERRAATYVASLARALIYCHGKHVIH 139
            F  +  + L++     G+L    Y   ++   F E RA  Y A +   L + H + +I+
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 140 RDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEHDANVDI 196
           RD+KPEN+L+   G ++I+D G +V      ++ +   GT  ++ PE+++  E+D +VD 
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180

Query: 197 WSLGVLCYEFLYGVPPFEAK----EHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
           ++LGV  YE +    PF A+    E+ +  +RI+   + +P K   S A+K     +L K
Sbjct: 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK--FSPASKSFCEALLAK 238

Query: 253 DSSQRL 258
           D  +RL
Sbjct: 239 DPEKRL 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  104 bits (260), Expect = 2e-26
 Identities = 72/250 (28%), Positives = 125/250 (50%), Gaps = 16/250 (6%)

Query: 24  LGRGKFGHVYLAREK-RSNHIVALKVLF-------KSQLQQSQVEHQLRREVE-IQSHLR 74
           LG G FG VY  R+K    +++ALK +        K + ++ +    +  EV  I+  LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 75  HPNILRLYGYFYDQKRVYLILEY---AAKGELYKEL-QKCKYFSERRAATYVASLARALI 130
           HPNI+R Y  F +  R+Y++++    A  GE +  L +K + F+E R       +  AL 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 131 YCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR--TMCGTLDYLPPEMVES 187
           Y H  K ++HRD+ P N+++G   ++ I DFG +       +  ++ GT+ Y  PE+V++
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN 187

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             +    D+W+ G + Y+     PPF +        +IV+   +  P+ + S    D+I+
Sbjct: 188 EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVIT 247

Query: 248 QMLVKDSSQR 257
             L  D+  R
Sbjct: 248 SCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  104 bits (261), Expect = 2e-26
 Identities = 72/256 (28%), Positives = 130/256 (50%), Gaps = 20/256 (7%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G  G VY A +  +   VA++ +    LQQ   +  +  E+ +    ++PNI+    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 84  YFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            +     +++++EY A G L   + + C    E + A       +AL + H   VIHRDI
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHRDI 142

Query: 143 KPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K +N+L+G  G +K+ DFG+        ++R TM GT  ++ PE+V    +   VDIWSL
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202

Query: 200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQV------DLKFPPKPIVSSAAKDLISQMLVKD 253
           G++  E + G PP+    + +  R +  +      +L+ P K  +S+  +D +++ L  D
Sbjct: 203 GIMAIEMIEGEPPY---LNENPLRALYLIATNGTPELQNPEK--LSAIFRDFLNRCLDMD 257

Query: 254 SSQRLPLHKLLEHPWI 269
             +R    +LL+H ++
Sbjct: 258 VEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  105 bits (263), Expect = 2e-26
 Identities = 85/292 (29%), Positives = 127/292 (43%), Gaps = 44/292 (15%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G +G V  A +KR+   VA+K L +   Q      +  RE+ +  H++H N++ L
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHMQHENVIGL 79

Query: 82  YGYFYDQ------KRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCH 133
              F         +  YL++ Y     +  +LQK      SE +    V  +   L Y H
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH 134

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEH-DA 192
              +IHRD+KP NL +    ELKI DFG + H          T  Y  PE++ +  H + 
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQ 194

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD----------------------- 229
            VDIWS+G +  E L G   F+ K++ D   +I++V                        
Sbjct: 195 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSL 254

Query: 230 LKFPPK------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
            K+P K      P  S  A DL+ +ML  D  +RL   + LEHP+     D 
Sbjct: 255 PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  104 bits (262), Expect = 2e-26
 Identities = 83/313 (26%), Positives = 125/313 (39%), Gaps = 66/313 (21%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVEHQLRREVEIQSH 72
            L D++I   LG G FG VY AR+ ++  +VALK +L  ++     +     RE++I   
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL--REIKILKK 63

Query: 73  LRHPNILRLYGYFYDQ--------KRVYLILEYAAK---GELYKELQKCKYFSERRAATY 121
           L+HPN++ L     ++          VY++  Y      G L     K    +E +   Y
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCY 120

Query: 122 VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH------------TFNR 169
           +  L   + Y H  H++HRDIK  N+LI  QG LKIADFG +                  
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180

Query: 170 RR--TMCGTLDYLPPEMVESVEHDAN----VDIWSLGVLCYEFLYGVPPFEAKEHSDTYR 223
           R+   +  T  Y PPE+   +  +      VDIW +G +  E     P  + K   D   
Sbjct: 181 RKYTNLVVTRWYRPPEL---LLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237

Query: 224 RI--------------------VQVDLKFPPKP--------IVSSAAKDLISQMLVKDSS 255
            I                     +    F   P         +     DL+S++L  D  
Sbjct: 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297

Query: 256 QRLPLHKLLEHPW 268
           +RL     LEHP+
Sbjct: 298 KRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  104 bits (262), Expect = 2e-26
 Identities = 77/290 (26%), Positives = 124/290 (42%), Gaps = 43/290 (14%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSHLRHPNILRL 81
           +G G +G VY AR+  S  IVALK   K ++   +  +     RE+ +  +LRHPNI+ L
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALK---KVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71

Query: 82  YGYFYDQK--RVYLILEYAAK--GELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
                 +    ++L++EY  +    L   +     FSE +    +  L R L Y H   +
Sbjct: 72  KEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHENFI 129

Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---TLDYLPPEMV-ESVEHDAN 193
           IHRD+K  NLL+  +G LKIADFG +       + M     TL Y  PE++     +   
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTA 189

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------------DLKFPP 234
           +D+W++G +  E L   P    K   +    I+Q+                       P 
Sbjct: 190 IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPK 249

Query: 235 KPI---------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           +P          +S A   L++ +L+ D  +R    + LE  +  +   P
Sbjct: 250 QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  105 bits (263), Expect = 2e-26
 Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 39/290 (13%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G +G V  A ++R+   VA+K L++   Q      +  RE+ +  H++H N++ L
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHENVIGL 79

Query: 82  YGYFYDQKRV------YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F     +      YL++ +   G    +L K +  SE R    V  + + L Y H  
Sbjct: 80  LDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA 137

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEH-DANV 194
            +IHRD+KP NL +    ELKI DFG +  T +       T  Y  PE++ +  H    V
Sbjct: 138 GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTV 197

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD-------------------LKFPPK 235
           DIWS+G +  E L G P F+  +H D    I++V                    +K  P+
Sbjct: 198 DIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPR 257

Query: 236 ----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
                     P  +  A +++ +MLV D+  R+   + L HP+  +  DP
Sbjct: 258 FRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  103 bits (258), Expect = 3e-26
 Identities = 76/262 (29%), Positives = 122/262 (46%), Gaps = 25/262 (9%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G +G VY AR+  +   +A+K + +   +  Q  H+   E+ + S+L+H NI++  G
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQYLG 72

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKY----FSERRAATYVASLARALIYCHGKHVIH 139
              +     + +E    G L   L + K+     +E+    Y   +   L Y H   ++H
Sbjct: 73  SDSENGFFKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 140 RDIKPENLLIGA-QGELKIADFGWSVHTFNRR--------RTMCGTLDYLPPEMVESVE- 189
           RDIK +N+L+    G +KI+DFG S     +R         T  GTL Y+ PE+++    
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP-IVSSAAKDLIS 247
            + A  DIWSLG    E   G PPF            V +    P  P  +S+ AK+ I 
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246

Query: 248 QMLVKDSSQRLPLHKLLEHPWI 269
           +    D  +R   H LL+ P++
Sbjct: 247 RCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  103 bits (259), Expect = 3e-26
 Identities = 73/274 (26%), Positives = 133/274 (48%), Gaps = 26/274 (9%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D ++ + LGRG +G V   R   +  I+A+K + ++ +  SQ + +L  +++I      
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVN-SQEQKRLLMDLDISMRSVD 58

Query: 76  -PNILRLYGYFYDQKRVYLILEY--AAKGELYKE-LQKCKYFSERRAATYVASLARALIY 131
            P  +  YG  + +  V++ +E    +  + YK+   K     E        S+ +AL Y
Sbjct: 59  CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118

Query: 132 CHGK-HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD-----YLPPEMV 185
            H K  VIHRD+KP N+LI   G++K+ DFG S +  +   ++  T+D     Y+ PE +
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKTIDAGCKPYMAPERI 175

Query: 186 ----ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP----PKPI 237
                   +D   D+WSLG+   E   G  P++       ++++ QV ++ P    P   
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYD--SWKTPFQQLKQV-VEEPSPQLPAEK 232

Query: 238 VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
            S   +D +++ L K+  +R    +LL+HP+   
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  104 bits (260), Expect = 3e-26
 Identities = 70/242 (28%), Positives = 117/242 (48%), Gaps = 26/242 (10%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G FG VY A    +N +VA+K +  S  Q ++    + +EV+    L+HPN +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 84  YFYDQKRVYLILEYA-AKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            +  +   +L++EY         E+ K K   E   A       + L Y H  ++IHRDI
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147

Query: 143 KPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESV---EHDANVDIWSL 199
           K  N+L+   G++K+ADFG S    +   +  GT  ++ PE++ ++   ++D  VD+WSL
Sbjct: 148 KAGNILLTEPGQVKLADFG-SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 206

Query: 200 GVLCYEF---------------LYGV-----PPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
           G+ C E                LY +     P  ++ E +D++R  V   L+  P+   +
Sbjct: 207 GITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPA 266

Query: 240 SA 241
           SA
Sbjct: 267 SA 268

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  104 bits (261), Expect = 3e-26
 Identities = 75/304 (24%), Positives = 138/304 (45%), Gaps = 50/304 (16%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V+    K S  I+A K++    L+ +  + +Q+ RE+++     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLI---HLEIKPAIRNQIIRELQVLHECN 61

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y   
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121

Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +  
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 181

Query: 193 NVDIWSLGVLCYEFLYG---VPPFEAKEHSDTYRRIVQVD---LKFPPKP---------- 236
             DIWS+G+   E   G   +PP +AKE    +   V+ D    +  P+P          
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSY 241

Query: 237 ----------------------------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                                       +  +  +D +++ L+K+ ++R  L +L+ H +
Sbjct: 242 GPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301

Query: 269 IIQN 272
           I ++
Sbjct: 302 IKRS 305

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  103 bits (259), Expect = 3e-26
 Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 49/289 (16%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           + K +G G +G V+  R + +  IVA+K   +S+     ++    RE+ +   L+HPN++
Sbjct: 6   LSK-IGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALREIRMLKQLKHPNLV 63

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIH 139
            L   F  +++++L+ EY     L +  +  +   E      +    +A+ +CH  + IH
Sbjct: 64  NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123

Query: 140 RDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD----------YLPPEM-VESV 188
           RD+KPEN+LI  QG++K+ DFG++       R + G  D          Y  PE+ V   
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFA-------RILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK------------- 235
           ++   VD+W++G +  E L G P +  K   D    I +      P+             
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236

Query: 236 ----------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                           P +SS A   +   L  D ++RL   +LLEHP+
Sbjct: 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  102 bits (257), Expect = 5e-26
 Identities = 74/259 (28%), Positives = 116/259 (44%), Gaps = 34/259 (13%)

Query: 27  GKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE------HQLRREVEIQSHLRHPNILR 80
           GKFG V + + K +      K+  +  ++           HQL ++        +PN ++
Sbjct: 27  GKFGKVSVLKHKPTQ-----KLFVQKIIKAKNFNAIEPMVHQLMKD--------NPNFIK 73

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           LY      K   LI++Y   G+L+  L+K    SE      +  L  AL   H  ++IH 
Sbjct: 74  LYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHN 133

Query: 141 DIKPENLLI-GAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           DIK EN+L   A+  + + D+G             GTLDY  PE ++   +D + D W++
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCKII-GTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192

Query: 200 GVLCYEFLYGVPPFEAKEHSDTY-------RRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
           GVL YE L G  PF  KE  D         +R  +   K P    VS  A D +  ML  
Sbjct: 193 GVLTYELLTGKHPF--KEDEDEELDLESLLKRQQK---KLPFIKNVSKNANDFVQSMLKY 247

Query: 253 DSSQRLPLHK-LLEHPWII 270
           + + RL  +  +++HP++ 
Sbjct: 248 NINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  102 bits (256), Expect = 6e-26
 Identities = 72/262 (27%), Positives = 120/262 (45%), Gaps = 19/262 (7%)

Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVE-HQLRREVEIQSHLRHPNI 78
           GK LG+G FG VYL  +  +   +A K V F  +  ++  E   L  E+++  +L+H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 79  LRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
           ++ YG   D  +K + + +EY   G +  +L+     +E     Y   +   + Y H   
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC----------GTLDYLPPEMVE 186
           ++HRDIK  N+L  + G +K+ DFG S     R +T+C          GT  ++ PE++ 
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGAS----KRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              +    D+WSLG    E L   PP+   E      +I            +S  A+D +
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242

Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
             + V ++  R    +LL HP+
Sbjct: 243 GCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  103 bits (258), Expect = 7e-26
 Identities = 72/285 (25%), Positives = 126/285 (44%), Gaps = 49/285 (17%)

Query: 27  GKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL----Y 82
           G +G VY AR+K++  IVALK L K + ++        RE+ I   L+HPNI+ +     
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV 74

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVIHRD 141
           G   +  ++Y+++EY  + +L   ++  K  F +      +  L   + + H   ++HRD
Sbjct: 75  GS--NLDKIYMVMEYV-EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRD 131

Query: 142 IKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV-EHDANV 194
           +K  NLL+  +G LKI DFG +      +  + +   +  TL Y  PE++    E+   +
Sbjct: 132 LKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ---LVVTLWYRAPELLLGAKEYSTAI 188

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDT------------------YRRIVQVDLKFPPKP 236
           D+WS+G +  E L   P F  K   D                   +  +     K   K 
Sbjct: 189 DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248

Query: 237 ------------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                        +S    DL++++L  D ++R+     L+HP+ 
Sbjct: 249 PYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  102 bits (256), Expect = 8e-26
 Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 24/264 (9%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G  G VY A    +  I+A+KV+      +LQ+     Q+  E+EI      P I+ 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK-----QIMSELEILYKCDSPYIIG 63

Query: 81  LYGYFYDQKRVYLILEYAAKGEL--YKELQKCKYFSERRAATYVASLARALIYCHGKHVI 138
            YG F+ + R+ +  E+   G L  Y+++       E        ++ + L Y     ++
Sbjct: 64  FYGAFFVENRISICTEFMDGGSLDVYRKI------PEHVLGRIAVAVVKGLTYLWSLKIL 117

Query: 139 HRDIKPENLLIGAQGELKIADFGWSVHTFNR-RRTMCGTLDYLPPEMVESVEHDANVDIW 197
           HRD+KP N+L+  +G++K+ DFG S    N   +T  GT  Y+ PE +   ++  + D+W
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVW 177

Query: 198 SLGVLCYEFLYG---VPPFEAKEHSDTYRRIVQ--VDLKFPPKPI--VSSAAKDLISQML 250
           SLG+   E   G    P  +  + S    +++Q  VD   P  P+   S      I+Q +
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCM 237

Query: 251 VKDSSQRLPLHKLLEHPWIIQNAD 274
            K   +R     L++HP+I+Q  D
Sbjct: 238 RKQPKERPAPENLMDHPFIVQYND 261

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  106 bits (265), Expect = 9e-26
 Identities = 79/273 (28%), Positives = 136/273 (49%), Gaps = 41/273 (15%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           LN++++ K +G G+FG V+L + KR+      K +    L++ + + QL  EV +   L+
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE-KSQLVIEVNVMRELK 70

Query: 75  HPNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKC-KYF---SERRAATYVASLARA 128
           H NI+R    F ++  +++Y+++E+   G+L + +QKC K F    E         L  A
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 129 LIYCH-------GKHVIHRDIKPENLL----------IGAQGE-------LKIADFGWS- 163
           L YCH       G+ V+HRD+KP+N+           I AQ          KI DFG S 
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 164 -VHTFNRRRTMCGTLDYLPPEMV--ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD 220
            +   +   +  GT  Y  PE++  E+  +D   D+W+LG + YE   G  PF     ++
Sbjct: 191 NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF---HKAN 247

Query: 221 TYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
            + +++  +LK  P   +   +K+L   +L+K+
Sbjct: 248 NFSQLIS-ELKRGPDLPIKGKSKEL--NILIKN 277

Length = 1021

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  103 bits (258), Expect = 1e-25
 Identities = 83/307 (27%), Positives = 130/307 (42%), Gaps = 71/307 (23%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR----REVEIQSHLRHPNIL 79
           +G G +G V  A + RS   VA+K     ++  +     L     RE++I  H +H NI+
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRHFKHDNII 67

Query: 80  RLYGYFY----DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
            +         D K VY++++   + +L+  +   +  +E     ++  L R L Y H  
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA 126

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC--------------GTLDYLP 181
           +VIHRD+KP NLL+    EL+I DFG +       R +                T  Y  
Sbjct: 127 NVIHRDLKPSNLLVNEDCELRIGDFGMA-------RGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFL---------------------YGVPPFEAKEH- 218
           PE ++   E+   +D+WS+G +  E L                      G P  E     
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239

Query: 219 -SDTYRRIVQVDLKFPPKPIV---------SSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
            SD  R+ +Q     P K  V         S  A DL+SQML  D  +R+ + + L+HP+
Sbjct: 240 GSDRVRKYIQ---NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296

Query: 269 IIQNADP 275
           + Q  DP
Sbjct: 297 LAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  103 bits (257), Expect = 1e-25
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 9/217 (4%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V   + K S  I+A K++    L+ +  + +Q+ RE+++     
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLI---HLEIKPAIRNQIIRELQVLHECN 61

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L++ K   E        ++ R L Y   
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 121

Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +  
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 181

Query: 193 NVDIWSLGVLCYEFL---YGVPPFEAKEHSDTYRRIV 226
             DIWS+G+   E     Y +PP +AKE    + R V
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPV 218

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  102 bits (255), Expect = 1e-25
 Identities = 77/278 (27%), Positives = 132/278 (47%), Gaps = 37/278 (13%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL---- 73
           ++I + +G+G +G V+    K++    A+K+L           H +  E+E + ++    
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--------DPIHDIDEEIEAEYNILKAL 71

Query: 74  -RHPNILRLYGYFYDQK-----RVYLILEYAAKG---ELYKE-LQKCKYFSERRAATYVA 123
             HPN+++ YG +Y +      +++L+LE    G   +L K  L++ +   E   A  + 
Sbjct: 72  SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131

Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYL 180
                L + H    IHRD+K  N+L+  +G +K+ DFG S     T  RR T  GT  ++
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191

Query: 181 PPEMVESVE-----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
            PE++   +     +DA  D+WSLG+   E   G PP  A  H    R + ++    PP 
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP--MRALFKIPRNPPPT 248

Query: 236 ----PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                + S+   D I + L KD  +R  +  LL+H +I
Sbjct: 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  102 bits (256), Expect = 2e-25
 Identities = 85/316 (26%), Positives = 136/316 (43%), Gaps = 72/316 (22%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNH--IVALK----VLFKSQLQQSQVEHQLRREVEIQS 71
           +++ K LG+G +G V  AR   ++    VA+K    V  K  L +  +     RE+++  
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLLR 56

Query: 72  HLR-HPNILRLYGY---FYDQKR-VYLILEYAAKGELYKELQKC---------KYFSERR 117
           H R H NI  LY     F      +YL          Y+EL +          +  ++  
Sbjct: 57  HFRGHKNITCLYDMDIVFPGNFNELYL----------YEELMEADLHQIIRSGQPLTDAH 106

Query: 118 AATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTM 173
             +++  +   L Y H  +V+HRD+KP NLL+ A  ELKI DFG    +S +       M
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166

Query: 174 CG---TLDYLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV- 228
                T  Y  PE M+    +   +D+WS+G +  E L   P F+ K++ D   +I+QV 
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226

Query: 229 ---------------------DLKFPPK-------PIVSSAAKDLISQMLVKDSSQRLPL 260
                                 L   PK       P  +  A DL+ ++L  D ++R+ +
Sbjct: 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV 286

Query: 261 HKLLEHPWIIQNADPS 276
            + LEHP++    DP 
Sbjct: 287 EEALEHPYLAIWHDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  100 bits (250), Expect = 4e-25
 Identities = 69/262 (26%), Positives = 119/262 (45%), Gaps = 14/262 (5%)

Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALK--VLFKSQLQQSQVEHQ-LRREVEIQSHLRHPN 77
           G+ LG+G +G VY         ++A+K   L  S +  ++ E++ L+ EV++   L+H N
Sbjct: 5   GEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I++  G   D   + + +E+   G +   L +     E     Y   +   + Y H   V
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 138 IHRDIKPENLLIGAQGELKIADFG------W---SVHTFNRRRTMCGTLDYLPPEMVESV 188
           +HRDIK  N+++   G +K+ DFG      W        N  ++M GT  ++ PE++   
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP-IVSSAAKDLIS 247
            +    DIWS+G   +E   G PP  + +       I       P  P   S+AA D ++
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVT 243

Query: 248 QMLVKDSSQRLPLHKLLEHPWI 269
             L +D  +R    +LL H ++
Sbjct: 244 SCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 99.7 bits (248), Expect = 6e-25
 Identities = 71/269 (26%), Positives = 127/269 (47%), Gaps = 23/269 (8%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVE-HQLRREVEIQSHLR 74
           ++ +GK LG+G FG VYL  +  +   +A+K V F  +  ++  E + L  E+++  +L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 75  HPNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
           H  I++ YG   D  ++ + + +E+   G +  +L+     +E     Y   +   + Y 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC----------GTLDYLPP 182
           H   ++HRDIK  N+L  + G +K+ DFG S     R +T+C          GT  ++ P
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGAS----KRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ--VDLKFPPKPIVSS 240
           E++    +    DIWS+G    E L   PP+   E      +I     +   PP   VS 
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH--VSD 236

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
             +D + ++ V ++  R    +LL H ++
Sbjct: 237 HCRDFLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =   99 bits (250), Expect = 2e-24
 Identities = 83/308 (26%), Positives = 142/308 (46%), Gaps = 60/308 (19%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HP 76
           ++I + LG+G +G V+ A ++R+  +VALK +F +  + +    +  RE+     L  HP
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTFREIMFLQELGDHP 67

Query: 77  NILRLYGYF--YDQKRVYLILEYAA-------KGELYKELQKCKYFSERRAATYVA-SLA 126
           NI++L       + K +YL+ EY         +  + +++ K           Y+   L 
Sbjct: 68  NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR----------YIMYQLL 117

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYL---- 180
           +AL Y H  +VIHRD+KP N+L+ +   +K+ADFG   S+             DY+    
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 181 --PPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------DL 230
              PE ++ S  +   VD+WS+G +  E L G P F      +   +I++V       D+
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 231 -------------KFPPKPIV---------SSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                          P +P           S  A DL+ ++LV + ++RL   + LEHP+
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297

Query: 269 IIQNADPS 276
           + Q  +PS
Sbjct: 298 VAQFHNPS 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  101 bits (252), Expect = 2e-24
 Identities = 87/304 (28%), Positives = 140/304 (46%), Gaps = 57/304 (18%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           + +G  +G G FG VY A    ++  VA+K +    LQ  Q ++   RE+ I  +L H N
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKN---RELLIMKNLNHIN 120

Query: 78  ILRLYGYFY------DQKRVYL--ILEYAAKGELYKELQKCKYFSERRAAT-------YV 122
           I+ L  Y+Y      ++K ++L  ++E+  +  ++K +   K+++    A        Y 
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYM---KHYARNNHALPLFLVKLYS 176

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGE-LKIADFGWSVHTFNRRRT---MCGTLD 178
             L RAL Y H K + HRD+KP+NLLI      LK+ DFG + +    +R+   +C    
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFY 236

Query: 179 YLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV---------- 228
             P  M+ +  +  ++D+WSLG +  E + G P F  +   D   RI+QV          
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296

Query: 229 -------DLKFP---PKPI-------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                  D+KFP   PK +           A + ISQ L  +  +RL   + L  P+   
Sbjct: 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356

Query: 272 NADP 275
             DP
Sbjct: 357 LRDP 360

Length = 440

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 98.6 bits (245), Expect = 2e-24
 Identities = 70/268 (26%), Positives = 126/268 (47%), Gaps = 14/268 (5%)

Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           +R    DF++ + +G G +G VY AR   +  + A+KV+   +L+  +    +++E+ + 
Sbjct: 4   RRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMM 60

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
              +H NI+  +G +  + ++++ +E+   G L          SE + A       + L 
Sbjct: 61  KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPPEMVES 187
           Y H K  +HRDIK  N+L+   G +K+ADFG S     T  +R++  GT  ++ PE V +
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE-VAA 179

Query: 188 VEHDAN----VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP---KPIVSS 240
           VE         DIW++G+   E     PP            + + + + P    K   S+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN 239

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPW 268
           +    +   L K+  +R    KLL+HP+
Sbjct: 240 SFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 98.2 bits (244), Expect = 4e-24
 Identities = 68/247 (27%), Positives = 125/247 (50%), Gaps = 12/247 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE---VEIQSHLRHPNILR 80
           +GRG FG VY  R+  +  + A+K L K +++  Q E     E   + + S    P I+ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           +   F+   ++  IL+    G+L+  L +   FSE+    Y   +   L + H + V++R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRR--TMCGTLDYLPPEMVES-VEHDANVDIW 197
           D+KP N+L+   G ++I+D G +   F++++     GT  Y+ PE+++    +D++ D +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWF 180

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTY---RRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           SLG + ++ L G  PF   +  D +   R  + V+++ P     S   K L+  +L +D 
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS--FSPELKSLLEGLLQRDV 238

Query: 255 SQRLPLH 261
           S+RL   
Sbjct: 239 SKRLGCL 245

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 98.5 bits (245), Expect = 4e-24
 Identities = 61/196 (31%), Positives = 97/196 (49%), Gaps = 6/196 (3%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           + LG G +  VY    + +  +VALKV+  S   +  V     RE  +   L+H NI+ L
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
           +   + ++ +  + EY         +Q            ++  L R L Y HG+H++HRD
Sbjct: 69  HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRD 128

Query: 142 IKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---TLDYLPPE-MVESVEHDANVDIW 197
           +KP+NLLI   GELK+ADFG +       +T      TL Y PP+ ++ + ++ + +DIW
Sbjct: 129 LKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIW 188

Query: 198 SLGVLCYEFLYGVPPF 213
             G +  E L G P F
Sbjct: 189 GAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 97.5 bits (243), Expect = 5e-24
 Identities = 71/250 (28%), Positives = 114/250 (45%), Gaps = 13/250 (5%)

Query: 17  DFDIGKPLGRGKFGHVYLA--REKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           D  +G+ +G G+FG VY        +  I VA+K   K+    S  E  L+ E  I    
Sbjct: 7   DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKT-CKNCTSPSVREKFLQ-EAYIMRQF 64

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYC 132
            HP+I++L G   +   V++++E A  GEL   LQ  KY         Y   L+ AL Y 
Sbjct: 65  DHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESV 188
             K  +HRDI   N+L+ +   +K+ DFG S      ++ +       + ++ PE +   
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183

Query: 189 EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
              +  D+W  GV  +E L  GV PF+  +++D   RI   + + P  P        L++
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMT 242

Query: 248 QMLVKDSSQR 257
           +    D S+R
Sbjct: 243 KCWAYDPSKR 252

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 98.3 bits (245), Expect = 7e-24
 Identities = 78/326 (23%), Positives = 135/326 (41%), Gaps = 62/326 (19%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVL----FKSQLQQSQ--- 58
           S    +R+       G  LG G +G V  A +  +  IVA+K +      + + + +   
Sbjct: 3   SFSISERYIQ----KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLV 58

Query: 59  ----VEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFS 114
               +     RE++I + ++H NI+ L   + +   + L+++  A  +L K + +    +
Sbjct: 59  GMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLT 117

Query: 115 ERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--------VHT 166
           E +    +  +   L   H  + +HRD+ P N+ I ++G  KIADFG +          T
Sbjct: 118 ESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177

Query: 167 FNRRRTMCG---------TLDYLPPEMVESVE--HDANVDIWSLGVLCYEFLYGVPPFEA 215
            ++  TM           TL Y  PE++   E  H A VD+WS+G +  E L G P F  
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFA-VDMWSVGCIFAELLTGKPLFPG 236

Query: 216 KEHSDTYRRIVQV-----------DLKFP---------PK------PIVSSAAKDLISQM 249
           +   D   RI ++             K P         PK      P  S  A DL+  +
Sbjct: 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSL 296

Query: 250 LVKDSSQRLPLHKLLEHPWIIQNADP 275
           L  +  +R+   + L+H +   +  P
Sbjct: 297 LKLNPLERISAKEALKHEYFKSDPLP 322

Length = 335

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 97.4 bits (242), Expect = 8e-24
 Identities = 69/244 (28%), Positives = 121/244 (49%), Gaps = 12/244 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V   + + +  + A K L K ++++ + E     E +I   +    ++ L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66

Query: 84  YFYDQKRVY-LILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCHGKHVIHR 140
           Y Y+ K    L+L     G+L   +       F E RA  Y A +   L   H + +++R
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEHDANVDIWS 198
           D+KPEN+L+   G ++I+D G +VH    +  +   GT+ Y+ PE+V++  +  + D W+
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 186

Query: 199 LGVLCYEFLYGVPPFEAK----EHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           LG L YE + G  PF+ +    +  +  R + +V  ++  K   S  A+ L   +L KD 
Sbjct: 187 LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK--FSPDARSLCKMLLCKDP 244

Query: 255 SQRL 258
            +RL
Sbjct: 245 KERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =   99 bits (249), Expect = 8e-24
 Identities = 82/290 (28%), Positives = 133/290 (45%), Gaps = 35/290 (12%)

Query: 1   ACSEVSAKE--KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ 58
           A  E +AKE  KK W      I + LG G  G V  A+        A+KV+    ++   
Sbjct: 21  AKDEATAKEQAKKYW------ISRVLGSGATGTVLCAKRVSDGEPFAVKVV---DMEGMS 71

Query: 59  VEHQLRREVEIQSHLR--HPNILRLYGYF-YDQKR-------VYLILEYAAKGELYKELQ 108
              + R + E+   L     +I++ +  F     R       + L+L+YA  G+L +E++
Sbjct: 72  EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIK 131

Query: 109 K----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV 164
                 + F E  A      +  A+ + H KH+IHRDIK  N+L+ + G +K+ DFG+S 
Sbjct: 132 SRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191

Query: 165 HTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS 219
                      RT CGT  Y+ PE+     +    D++SLGVL YE L    PF+ +   
Sbjct: 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME 251

Query: 220 DTYRRIV--QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHP 267
           +   + +  + D   P  P +S   +++++ +L  D  +R    KLL  P
Sbjct: 252 EVMHKTLAGRYD---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 96.8 bits (241), Expect = 9e-24
 Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 21/230 (9%)

Query: 24  LGRGKFGHVYLAREKRS-----NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           LGRG+FG V+LA+ K         +V +K L K++ +  Q E   RRE+++   L H N+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE--FRRELDMFRKLSHKNV 70

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQ---------KCKYFSERRAATYVASLARAL 129
           +RL G   + +  Y+ILEY   G+L + L+         K    S ++       +A  +
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----RTMCGTLDYLPPEMV 185
            +      +HRD+   N L+ +Q E+K++    S   +N      R     L +L PE V
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190

Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPP 234
           +  +     D+WS GVL +E F  G  PF      +   R+    L+ P 
Sbjct: 191 QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 95.6 bits (238), Expect = 4e-23
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 27/237 (11%)

Query: 24  LGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           LG G FG V+L        +    +VA+K L ++    ++ + +  RE E+ ++ +H NI
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFE--REAELLTNFQHENI 70

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKEL--------------QKCKYFSERRAATYVAS 124
           ++ YG   +     ++ EY   G+L K L                    +  +       
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTL---DY 179
           +A  ++Y   +H +HRD+   N L+G    +KI DFG S  V+T +  R    T+    +
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190

Query: 180 LPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
           +PPE +   +     D+WS GV+ +E F YG  P+    + +    I Q  L   P+
Sbjct: 191 MPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR 247

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 95.9 bits (238), Expect = 4e-23
 Identities = 69/221 (31%), Positives = 113/221 (51%), Gaps = 29/221 (13%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ-VEHQLRREVEIQSHLRHPNILRLY 82
           LG G +  VY  + K +  +VALKV+   +LQ+ +       RE  +   L+H NI+ L+
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLLH 69

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSER-------RAATYVASLARALIYCHGK 135
              + ++ + L+ EY     ++ +L  C+Y  +            ++  L R L Y H +
Sbjct: 70  DIIHTKETLTLVFEY-----VHTDL--CQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPE-MVESV 188
           +++HRD+KP+NLLI   GELK+ADFG +       HT++       TL Y PP+ ++ S 
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV---TLWYRPPDVLLGST 179

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEA-KEHSDTYRRIVQV 228
           E+   +D+W +G +  E + GV  F   K+  D   RI  V
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV 220

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 94.7 bits (235), Expect = 9e-23
 Identities = 69/244 (28%), Positives = 117/244 (47%), Gaps = 12/244 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V   + + +  + A K L K ++++ + E     E +I   +    ++ L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66

Query: 84  YFYDQKRVY-LILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCHGKHVIHR 140
           Y Y+ K    L+L     G+L   +       F E RA  Y A +   L   H ++ ++R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR 126

Query: 141 DIKPENLLIGAQGELKIADFGWSVHT--FNRRRTMCGTLDYLPPEMVESVEHDANVDIWS 198
           D+KPEN+L+   G ++I+D G +V        R   GT+ Y+ PE++ +  +  + D W 
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWG 186

Query: 199 LGVLCYEFLYGVPPFEAKEH----SDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           LG L YE + G  PF  ++      +  RR+++ +  +  K   S  AK +   +L KD 
Sbjct: 187 LGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK--FSEEAKSICKMLLTKDP 244

Query: 255 SQRL 258
            QRL
Sbjct: 245 KQRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 94.3 bits (234), Expect = 1e-22
 Identities = 68/244 (27%), Positives = 117/244 (47%), Gaps = 12/244 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V   + + +  + A K L K ++++ + E     E  I   +    ++ L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 84  YFYDQKRVY-LILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCHGKHVIHR 140
           Y Y+ K    L+L     G+L   +       F E+RA  Y A L   L     + +++R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126

Query: 141 DIKPENLLIGAQGELKIADFGWSVHT--FNRRRTMCGTLDYLPPEMVESVEHDANVDIWS 198
           D+KPEN+L+  +G ++I+D G +V        R   GT+ Y+ PE++ + ++  + D W 
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWG 186

Query: 199 LGVLCYEFLYGVPPF----EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           LG L YE + G  PF    E  +  +  RR+ +   ++  K   S  AK +   +L K+ 
Sbjct: 187 LGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK--FSEDAKSICRMLLTKNP 244

Query: 255 SQRL 258
            +RL
Sbjct: 245 KERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 93.3 bits (232), Expect = 1e-22
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 10/209 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G FG VY    K  N  VA+K   +S L        L+ E EI     HPNI++L G
Sbjct: 3   IGKGNFGDVYKGVLK-GNTEVAVKTC-RSTLPPDLKRKFLQ-EAEILKQYDHPNIVKLIG 59

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDI 142
               ++ +Y+++E    G L   L+K K   + ++        A  + Y   K+ IHRD+
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119

Query: 143 KPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP-----PEMVESVEHDANVDIW 197
              N L+G    LKI+DFG S        T+   L  +P     PE +    + +  D+W
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179

Query: 198 SLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           S G+L +E F  G  P+    +  T  RI
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQTRERI 208

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 93.9 bits (233), Expect = 1e-22
 Identities = 67/262 (25%), Positives = 125/262 (47%), Gaps = 16/262 (6%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+++ + +G G +G VY AR   +  + A+K++   +L+       +++E+ +    +H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKH 65

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
            NI+  +G +  ++++++ +EY   G L          SE + A       + L Y H K
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPPEMVESVEHDA 192
             +HRDIK  N+L+   G++K+ADFG +     T  +R++  GT  ++ PE V +VE + 
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE-VAAVEKNG 184

Query: 193 N----VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAKD 244
                 DIW++G+   E     PP            + + + + PP    K   SS   +
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-PPKLKDKTKWSSTFHN 243

Query: 245 LISQMLVKDSSQRLPLHKLLEH 266
            +   L K+  +R    +LL H
Sbjct: 244 FVKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 93.5 bits (232), Expect = 2e-22
 Identities = 70/259 (27%), Positives = 131/259 (50%), Gaps = 17/259 (6%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE---VEIQSHLRHPNILR 80
           +GRG FG VY  R+  +  + A+K L K +++  Q E     E   + + S    P I+ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           +   F+   ++  IL+    G+L+  L +   FSE     Y A +   L + H + V++R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRR--TMCGTLDYLPPEMVES-VEHDANVDIW 197
           D+KP N+L+   G ++I+D G +   F++++     GT  Y+ PE+++  V +D++ D +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 180

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTY---RRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           SLG + ++ L G  PF   +  D +   R  + + ++ P     S   + L+  +L +D 
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDV 238

Query: 255 SQRLPLH-----KLLEHPW 268
           ++RL        ++ EHP+
Sbjct: 239 NRRLGCLGRGAQEVKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 91.3 bits (227), Expect = 1e-21
 Identities = 72/262 (27%), Positives = 123/262 (46%), Gaps = 19/262 (7%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE-IQSHLRHPNILRLY 82
           +GRG FG V     K S  I+A+K +  +  ++ Q   +L  +++ +      P I++ Y
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ--KRLLMDLDVVMRSSDCPYIVKFY 69

Query: 83  GYFYDQKRVYLILEY--AAKGELYK---ELQKCKYFSERRAATYVASLARALIYCHGK-H 136
           G  + +   ++ +E    +  + YK   E+ K     E        +  +AL Y   +  
Sbjct: 70  GALFREGDCWICMELMDISLDKFYKYVYEVLK-SVIPEEILGKIAVATVKALNYLKEELK 128

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-RRTM-CGTLDYLPPEMVESVE---HD 191
           +IHRD+KP N+L+   G +K+ DFG S    +   +T   G   Y+ PE ++      +D
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYD 188

Query: 192 ANVDIWSLGVLCYEFLYGVPPFEA-KEHSDTYRRIVQVD---LKFPPKPIVSSAAKDLIS 247
              D+WSLG+  YE   G  P+       D   ++V+ D   L    +   S +  + I+
Sbjct: 189 VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFIN 248

Query: 248 QMLVKDSSQRLPLHKLLEHPWI 269
             L+KD S+R    +LLEHP+I
Sbjct: 249 LCLIKDESKRPKYKELLEHPFI 270

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 93.2 bits (231), Expect = 2e-21
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 16/214 (7%)

Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKY---FSERRAA 119
           R E+   +   H  I++ +  F    ++ LI+EY + G+L K++ Q+ K    F E    
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMC 174
                +  AL   H + ++HRD+K  N+ +   G +K+ DFG+S       + +   + C
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL--KF 232
           GT  YL PE+ E   +    D+WSLGV+ YE L    PF+        R I+Q  L  K+
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKY 288

Query: 233 PPKPI-VSSAAKDLISQMLVKDSSQRLPLHKLLE 265
            P P  VSS  K L+  +L K+ + R    +LL 
Sbjct: 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322

Length = 478

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 75/318 (23%), Positives = 130/318 (40%), Gaps = 71/318 (22%)

Query: 18  FDIGKPLGRGKFGHVYLAREK--RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           ++I   +GRG +G VY A+ K  +     A+K     + Q + +     RE+ +   L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI--- 130
            N++ L   F +   K VYL+ +YA     +   Q  K+  + +  +   S+ ++L+   
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 131 -----YCHGKHVIHRDIKPENLLI----GAQGELKIADFGWSVHTFNRRRTMCG------ 175
                Y H   V+HRD+KP N+L+      +G +KI D G +       + +        
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 176 TLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKE---------HSDTYRRI 225
           T+ Y  PE++    H    +DIW++G +  E L   P F+ +E           D   RI
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237

Query: 226 VQV----------DLKFPP-------------------------KPIVSSAAKDLISQML 250
            +V          D+K  P                              S   DL+ ++L
Sbjct: 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297

Query: 251 VKDSSQRLPLHKLLEHPW 268
             D ++R+   + LEHP+
Sbjct: 298 EYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 89.9 bits (223), Expect = 3e-21
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 29/227 (12%)

Query: 13  WTLNDFDI--GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W +   DI     LG G++G VY    K+ +  VA+K L +  ++      +  +E  + 
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVM 56

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LAR 127
             ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++ 
Sbjct: 57  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISS 115

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT----------- 176
           A+ Y   K+ IHRD+   N L+G    +K+ADFG S       R M G            
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-------RLMTGDTYTAHAGAKFP 168

Query: 177 LDYLPPEMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTY 222
           + +  PE +   +     D+W+ GVL +E   YG+ P+   + S  Y
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 215

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 90.0 bits (223), Expect = 4e-21
 Identities = 64/244 (26%), Positives = 115/244 (47%), Gaps = 11/244 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V   + K +  + A K L K +L++   E     E EI   +  P I+ L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 84  YFYDQK-RVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHR 140
           Y ++ K  + L++     G+L   +     +     R   Y A +   +++ H   +++R
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTM--CGTLDYLPPEMVESVEHDANVDIWS 198
           D+KPEN+L+  QG  +++D G +V   + +      GT  Y+ PE+++   +   VD ++
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFA 179

Query: 199 LGVLCYEFLYGVPPF----EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           +G   YE + G  PF    E     +  RR ++ ++KF  +   +  +KD+    L K  
Sbjct: 180 MGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNF-TEESKDICRLFLAKKP 238

Query: 255 SQRL 258
             RL
Sbjct: 239 EDRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.4 bits (219), Expect = 1e-20
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 11/220 (5%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G+FG V+L  + R+   VA+K +     + +  E     E ++   L HP +++L
Sbjct: 10  KELGSGQFGVVHLG-KWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQL 64

Query: 82  YGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
           YG    QK +Y++ E+   G L   L Q+    S+    +    +   + Y      IHR
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEMVESVEHDANVDI 196
           D+   N L+ + G +K++DFG + +  +   T   G    + + PPE+    ++ +  D+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 197 WSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
           WS GVL +E F  G  PFE K + +    I +    + PK
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 88.2 bits (219), Expect = 1e-20
 Identities = 59/220 (26%), Positives = 88/220 (40%), Gaps = 23/220 (10%)

Query: 22  KPLGRGKFGHVYLAREKRSN--HI-VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           K LG G FG V       S    I VA+K L   +L     +    +E  I   L H N+
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD--FLKEAAIMHSLDHENL 58

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKH 136
           +RLYG       + ++ E A  G L   L+K    +F       Y   +A  + Y   K 
Sbjct: 59  IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWS----------VHTFNRRRTMCGTLDYLPPEMVE 186
            IHRD+   N+L+ +  ++KI DFG            V   + +        +  PE + 
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV----PFAWCAPESLR 173

Query: 187 SVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           +       D+W  GV  +E F YG  P+     S   ++I
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 1e-20
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 17/216 (7%)

Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILR 80
            K LG G+FG V+L + +     VA+K++ +  +     E     E ++   L HPN+++
Sbjct: 9   LKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQ 63

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA----RALIYCHGKH 136
           LYG    Q+ ++++ EY A G L   L++ K    +    ++  +      A+ Y     
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNG 120

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC-GT---LDYLPPEMVESVEHDA 192
            IHRD+   N L+G    +K++DFG + +  + + T   GT   + + PPE+ +     +
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 193 NVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
             D+WS GVL +E F  G  P+E   +S+    +  
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 87.8 bits (217), Expect = 1e-20
 Identities = 63/241 (26%), Positives = 107/241 (44%), Gaps = 10/241 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +GRG FG V+  R +  N  VA+K     +     ++ +  +E  I     HPNI+RL G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 84  YFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
               ++ +Y+++E    G+    L+ +      +     V + A  + Y   KH IHRD+
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 143 KPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP-----PEMVESVEHDANVDIW 197
              N L+  +  LKI+DFG S    +      G +  +P     PE +    + +  D+W
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVW 180

Query: 198 SLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L +E F  G  P+    +  T R  ++  ++ P   +   A   L+ +    D  Q
Sbjct: 181 SFGILLWEAFSLGAVPYANLSNQQT-REAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ 239

Query: 257 R 257
           R
Sbjct: 240 R 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 87/310 (28%), Positives = 136/310 (43%), Gaps = 59/310 (19%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSHLRHPNIL 79
           KP+G G  G V  A +  +   VA+K L  S+  Q+ V H  R  RE+ +   + H NI+
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQN-VTHAKRAYRELVLMKLVNHKNII 78

Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F  QK       VYL++E      L + +Q        R +  +  +   + + H
Sbjct: 79  GLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM--DLDHERMSYLLYQMLCGIKHLH 135

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---TLDYLPPEMVESVEH 190
              +IHRD+KP N+++ +   LKI DFG +  T      M     T  Y  PE++  + +
Sbjct: 136 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVVTRYYRAPEVILGMGY 194

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV---------------------- 228
             NVDIWS+G +  E + G   F   +H D + +I++                       
Sbjct: 195 KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVEN 254

Query: 229 --------------DLKFPP-----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                         D+ FPP       + +S A+DL+S+MLV D  +R+ +   L+HP+I
Sbjct: 255 RPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314

Query: 270 IQNADPSGVY 279
               DPS V 
Sbjct: 315 NVWYDPSEVE 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 87.2 bits (216), Expect = 3e-20
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 11/212 (5%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G+FG V   +  R  + VA+K++     + S  E +   E ++   L H  +++L
Sbjct: 10  KELGTGQFGVVKYGKW-RGQYDVAIKMI----KEGSMSEDEFIEEAKVMMKLSHEKLVQL 64

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHR 140
           YG    Q+ +Y++ EY + G L   L++  K F   +       +   + Y   K  IHR
Sbjct: 65  YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC-GT---LDYLPPEMVESVEHDANVDI 196
           D+   N L+  QG +K++DFG S +  +   T   G+   + + PPE++   +  +  D+
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184

Query: 197 WSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           W+ GVL +E +  G  P+E   +S+T  ++ Q
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 87.1 bits (216), Expect = 3e-20
 Identities = 68/232 (29%), Positives = 104/232 (44%), Gaps = 31/232 (13%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHI-VALKVLFKSQLQQSQVEHQLRREV 67
           E+ R    +F + + LG G FG V+    K  N + VA+K+L KS     Q + Q   EV
Sbjct: 2   ERPRE---EFTLERKLGSGYFGEVWEGLWK--NRVRVAIKIL-KSDDLLKQQDFQK--EV 53

Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-- 125
           +    LRH +++ L+      + VY+I E   KG L   L+      E +    VASL  
Sbjct: 54  QALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS----PEGQVLP-VASLID 108

Query: 126 -----ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW------SVHTFNRRRTMC 174
                A  + Y   ++ IHRD+   N+L+G     K+ADFG        V+  + ++   
Sbjct: 109 MACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-- 166

Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
               +  PE           D+WS G+L YE F YG  P+    + + Y +I
Sbjct: 167 -PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 87.1 bits (216), Expect = 4e-20
 Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 21/221 (9%)

Query: 20  IGKPLGRGKFGHVYLAREK-RSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHP 76
           + + LG G FG VY    + R    V L+V  K+  +    Q E     E  I S   H 
Sbjct: 10  LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARAL 129
           NI+RL G  +++   +++LE  A G+L   L++ +   ER ++  +  L       A+  
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 130 IYCHGKHVIHRDIKPENLLI---GAQGELKIADFGWSVHTFN----RR--RTMCGTLDYL 180
            Y    H IHRDI   N L+   G     KIADFG +   +     R+  R M   + ++
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML-PIKWM 188

Query: 181 PPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSD 220
           PPE        +  D+WS GVL +E F  G  P+  + + +
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 88.2 bits (218), Expect = 4e-20
 Identities = 79/314 (25%), Positives = 131/314 (41%), Gaps = 74/314 (23%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R  V ++  + H NI+ L
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC-VNHKNIISL 85

Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKY----FSERRAATYVASLARALIY 131
              F  QK       VYL++E         +   C+         R +  +  +   + +
Sbjct: 86  LNVFTPQKSLEEFQDVYLVMELM-------DANLCQVIHMELDHERMSYLLYQMLCGIKH 138

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---------TLDYLPP 182
            H   +IHRD+KP N+++ +   LKI DFG +       RT C          T  Y  P
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------RTACTNFMMTPYVVTRYYRAP 191

Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------- 228
           E++  + +  NVDIWS+G +  E + G   F+  +H D + ++++               
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251

Query: 229 ----------------------DLKFPPKP----IVSSAAKDLISQMLVKDSSQRLPLHK 262
                                 D  FP +     + +S A+DL+S+MLV D  +R+ + +
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311

Query: 263 LLEHPWIIQNADPS 276
            L HP+I    DP+
Sbjct: 312 ALRHPYITVWYDPA 325

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 86.9 bits (215), Expect = 5e-20
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 39/283 (13%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ---SHLRHPNILR 80
           +G G +G VY AR+  S H VALK + + Q  +  +     REV +        HPNI+R
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 81  LYGYF----YDQK-RVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCH 133
           L         D++ +V L+ E+  + +L   L K              +    R L + H
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-MCGTLDYLPPEMVESVEHD 191
              ++HRD+KPEN+L+ + G++K+ADFG + +++     T +  TL Y  PE++    + 
Sbjct: 126 ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYA 185

Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI-------------VQVDL---KFPPK 235
             VD+WS+G +  E     P F     +D   +I               V L    F P+
Sbjct: 186 TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPR 245

Query: 236 ---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                    P +  +   L+ +ML  +  +R+   + L+HP+ 
Sbjct: 246 GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 5e-20
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 13/202 (6%)

Query: 22  KPLGRGKFGHVYLA--REKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           K LG G FG V       K    + VA+K L +  +   + E    RE  + + L HP I
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE--FLREASVMAQLDHPCI 58

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVI 138
           +RL G     + + L++E A  G L K L+K +             +A  + Y   KH +
Sbjct: 59  VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 139 HRDIKPENLLIGAQGELKIADFGWS----VHTFNRRRTMCGT--LDYLPPEMVESVEHDA 192
           HRD+   N+L+  + + KI+DFG S      +   R T  G   L +  PE +   +  +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177

Query: 193 NVDIWSLGVLCYE-FLYGVPPF 213
             D+WS GV  +E F YG  P+
Sbjct: 178 KSDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 85.1 bits (211), Expect = 3e-19
 Identities = 79/297 (26%), Positives = 119/297 (40%), Gaps = 59/297 (19%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLY- 82
           +G+G FG V+ AR K++  IVALK +     ++      LR E++I   L+H N++ L  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 78

Query: 83  -------GYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
                   Y   +   YL+ E+    +L   L      F+       +  L   L Y H 
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR 137

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTF--------NRRRTMCGTLDYLPPEMVE 186
             ++HRD+K  N+LI   G LK+ADFG +   F        NR      TL Y PPE++ 
Sbjct: 138 NKILHRDMKAANILITKDGILKLADFGLA-RAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196

Query: 187 SVEH-DANVDIWSLGVLCYEF---------------------LYG------------VPP 212
                   +D+W  G +  E                      L G            +  
Sbjct: 197 GERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLEL 256

Query: 213 FEAKEHSDTYRRIVQVDLKFPPKPIVSSA-AKDLISQMLVKDSSQRLPLHKLLEHPW 268
           F+  E     +R V+  L    KP V    A DLI ++LV D ++R+     L H +
Sbjct: 257 FKKMELPQGQKRKVKERL----KPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 84.8 bits (210), Expect = 3e-19
 Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 29/229 (12%)

Query: 12  RWTLNDFDIGKPLGRGKFGHVY-----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE 66
              L+     + LG G FG VY        E+ S   VA+K L ++   + Q E   R+E
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE--FRQE 58

Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATY----- 121
            E+ S L+HPNI+ L G    ++   ++ EY A G+L++ L +    S+  A +      
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 122 -----------VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFN 168
                         +A  + Y    H +HRD+   N L+G    +KI+DFG S  +++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178

Query: 169 RRRTMCGTL---DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
             R    +L    ++PPE +   +     DIWS GV+ +E F YG+ P+
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 85.9 bits (212), Expect = 4e-19
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 52/303 (17%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88

Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------------------------- 228
           VDIWS+G +  E + G   F   +H D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 265

Query: 229 -----------DLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325

Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 84.4 bits (209), Expect = 4e-19
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 16/204 (7%)

Query: 22  KPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           K LG G FG V L R       +   VA+K L  S  +Q + +    RE+EI   L H N
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD--FEREIEILRTLDHEN 67

Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G         + LI+EY   G L   LQ+ +   + +R   + + + + + Y   
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGTLDYLP-----PEMVESV 188
           +  IHRD+   N+L+ ++  +KI+DFG + V   ++           P     PE + + 
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 189 EHDANVDIWSLGVLCYE-FLYGVP 211
           +  +  D+WS GV  YE F YG P
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 86.4 bits (214), Expect = 5e-19
 Identities = 67/233 (28%), Positives = 105/233 (45%), Gaps = 34/233 (14%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +DI + +G+G  G VYLA +   +  VALK + +   +   ++ +  RE +I + L HP 
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKEL-----QKCKYFSERRAATYVASLARALI-- 130
           I+ +Y    D   VY  + Y  +G   K L     QK     E    T V +        
Sbjct: 64  IVPVYSICSDGDPVYYTMPYI-EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 131 -----YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-----------TFNRRRTM- 173
                Y H K V+HRD+KP+N+L+G  GE+ I D+G ++              + R    
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 174 ---------CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE 217
                     GT DY+ PE +  V    + DI++LGV+ Y+ L    P+  K+
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235

Length = 932

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 83.9 bits (207), Expect = 6e-19
 Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 31/231 (13%)

Query: 24  LGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           LG G FG V+LA       ++   +VA+K L K   + ++ + Q  RE E+ + L+H +I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQ--REAELLTVLQHQHI 69

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYK---------------ELQKCKYFSERRAATYVA 123
           +R YG   + + + ++ EY   G+L +               E       +  +     +
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR------RTMCGTL 177
            +A  ++Y    H +HRD+   N L+G    +KI DFG S   ++        RTM   +
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-PI 188

Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
            ++PPE +   +     DIWS GV+ +E F YG  P+    +++    I Q
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.9 bits (207), Expect = 6e-19
 Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 31/286 (10%)

Query: 17  DFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           D  + + LG G FG V+LA        +   +VA+K L    L   +     +RE E+ +
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLT 62

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYK----------------ELQKCKYFSE 115
           +L+H +I++ YG   D   + ++ EY   G+L K                  Q       
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 116 RRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG 175
            +     + +A  ++Y   +H +HRD+   N L+GA   +KI DFG S   ++      G
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 176 -----TLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVD 229
                 + ++PPE +   +     D+WS GV+ +E F YG  P+    +++    I Q  
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242

Query: 230 LKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           +   P+ +      D++     ++  QRL + ++ +    +  A P
Sbjct: 243 VLERPR-VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 8e-19
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 35/218 (16%)

Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W +N  +  +G  +G+G+FG V L   +     VA+K L K     +Q       E  + 
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCL-KDDSTAAQ---AFLAEASVM 54

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL----- 125
           + LRHPN+++L G       +Y++ EY AKG L   L+     S  RA   +A       
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR-----SRGRAVITLAQQLGFAL 109

Query: 126 --ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD--YLP 181
                + Y   K+ +HRD+   N+L+      K++DFG +       +      D   LP
Sbjct: 110 DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA-------KEASQGQDSGKLP 162

Query: 182 -----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
                PE +   +     D+WS G+L +E + +G  P+
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 83.9 bits (207), Expect = 9e-19
 Identities = 72/243 (29%), Positives = 116/243 (47%), Gaps = 34/243 (13%)

Query: 3   SEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHI--VALKVLFKSQ 53
           SE    E  RW +  +   +GKPLG G FG V +A      +++ N +  VA+K+L KS 
Sbjct: 3   SEYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSD 61

Query: 54  LQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQ---- 108
             +  +   L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L+    
Sbjct: 62  ATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 120

Query: 109 ------------KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELK 156
                         +  S +   +    +AR + Y   K  IHRD+   N+L+     +K
Sbjct: 121 PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 180

Query: 157 IADFGWS--VHTFN-RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGV 210
           IADFG +  +H  +  ++T  G L   ++ PE +    +    D+WS GVL +E F  G 
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 240

Query: 211 PPF 213
            P+
Sbjct: 241 SPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 82.6 bits (204), Expect = 2e-18
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 35/236 (14%)

Query: 16  NDFDIGKPLGRGKFGHVYLARE-----KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           N+ +  + +G+G FG V+ AR           +VA+K+L +      Q + Q  RE  + 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ--REAALM 62

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL----- 125
           +   HPNI++L G     K + L+ EY A G+L + L+     ++   +   +S      
Sbjct: 63  AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 126 -----------------ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN 168
                            A  + Y   +  +HRD+   N L+G    +KIADFG S + ++
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 169 RRRTMCGTLD-----YLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEH 218
                    D     ++PPE +    +    D+W+ GV+ +E F YG+ P+    H
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 82.8 bits (205), Expect = 2e-18
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 42/237 (17%)

Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLA-------REKRSNHIVALKVLFKSQLQQSQVEHQ 62
            W L  +   +GKPLG G FG V  A         + S   VA+K+L     +    E  
Sbjct: 6   EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETST--VAVKML-----KDDATEKD 58

Query: 63  LR---REVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL-------QKCK 111
           L     E+E+   + +H NI+ L G    +  +Y+++EYAA G L   L       +   
Sbjct: 59  LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYAS 118

Query: 112 Y---------FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW 162
                      +++   ++   +AR + +   K  IHRD+   N+L+     +KIADFG 
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGL 178

Query: 163 S--VHTFN-RRRTMCGTLDY--LPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
           +  +H  +  R+T  G L    + PE +    +    D+WS GVL +E F  G  P+
Sbjct: 179 ARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 83.2 bits (205), Expect = 2e-18
 Identities = 77/305 (25%), Positives = 132/305 (43%), Gaps = 52/305 (17%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81

Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 138

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258

Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP                + +S A+DL+S+MLV D ++R+ + + L+HP+I    
Sbjct: 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318

Query: 274 DPSGV 278
           DP+ V
Sbjct: 319 DPAEV 323

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 81.8 bits (202), Expect = 3e-18
 Identities = 63/266 (23%), Positives = 104/266 (39%), Gaps = 27/266 (10%)

Query: 24  LGRGKFGHVYLAREKRSNHI------VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           LG G FG VY                VA+K L K    Q + E    +E  + S+  HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE--FLKEAHLMSNFNHPN 60

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALI 130
           I++L G     +  Y+I+E    G+L   L+  +          +  L       A+  +
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 131 YCHGKHVIHRDIKPENLLIGAQGE-----LKIADFG-----WSVHTFNRRRTMCGTLDYL 180
           Y    H IHRD+   N L+  +G      +KI DFG     +    + +       + ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
            PE +   +     D+WS GVL +E L  G  P+ A  + +  +  V    +        
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-VTAGGRLQKPENCP 239

Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLE 265
                L++    +D S+R    ++ E
Sbjct: 240 DKIYQLMTNCWAQDPSERPTFDRIQE 265

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 81.2 bits (200), Expect = 4e-18
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 11/208 (5%)

Query: 22  KPLGRGKFGHVY--LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
             LG G FG V   + + K+S   VA+K+L K+      ++ +L RE  +   L +P I+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIH 139
           R+ G   + +   L++E A  G L K LQK K+ +E+     V  ++  + Y    + +H
Sbjct: 60  RMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 140 RDIKPENLLIGAQGELKIADFGWSV------HTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
           RD+   N+L+  Q   KI+DFG S       + +  +      + +  PE +   +  + 
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178

Query: 194 VDIWSLGVLCYE-FLYGVPPFEAKEHSD 220
            D+WS GVL +E F YG  P++  + ++
Sbjct: 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNE 206

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 80.8 bits (199), Expect = 5e-18
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 15/210 (7%)

Query: 24  LGRGKFGHVYLA--REKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           +G G+FG V+L    EKR       KV  K+  + +  E     E ++   L HP +++L
Sbjct: 12  IGSGQFGLVWLGYWLEKR-------KVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQL 64

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHR 140
           YG   ++  + L+ E+   G L   L+  +  FS+         +   + Y    +VIHR
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124

Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC-GT---LDYLPPEMVESVEHDANVDI 196
           D+   N L+G    +K++DFG +    + + T   GT   + +  PE+    ++ +  D+
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184

Query: 197 WSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           WS GVL +E F  G  P+E + +S+    I
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETI 214

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 81.3 bits (200), Expect = 6e-18
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 27/230 (11%)

Query: 22  KPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           + LG G FG V+LA       ++   +VA+K L  +            RE E+ ++L+H 
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHE 67

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQK-------------CKYFSERRAATYVA 123
           +I++ YG   +   + ++ EY   G+L K L+                  ++ +      
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG-----TLD 178
            +A  ++Y   +H +HRD+   N L+G    +KI DFG S   ++      G      + 
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 179 YLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           ++PPE +   +     D+WSLGV+ +E F YG  P+    +++    I Q
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 80.8 bits (199), Expect = 6e-18
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 14/207 (6%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLRHPNILR 80
           K LG G+FG V++     S   VA+K L    +  Q+ +E     E  +   L+H  ++R
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLE-----EANLMKTLQHDKLVR 65

Query: 81  LYGYFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVI 138
           LY     ++ +Y+I EY AKG L   L   +       +   + A +A  + Y   K+ I
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125

Query: 139 HRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
           HRD++  N+L+      KIADFG +     + +  R      + +  PE +         
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 195 DIWSLGVLCYEFL-YGVPPFEAKEHSD 220
           D+WS G+L YE + YG  P+    +SD
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSD 212

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.4 bits (198), Expect = 7e-18
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 9/196 (4%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V+    K     VA+K   K  L Q +++ +   E  I     HPNI++L G
Sbjct: 3   LGKGNFGEVFKGTLKDKTP-VAVKTC-KEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDI 142
               ++ +Y+++E    G+    L+K K     ++   +    A  + Y   K+ IHRD+
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119

Query: 143 KPENLLIGAQGELKIADFGWSVHTFNRRRTMCG----TLDYLPPEMVESVEHDANVDIWS 198
              N L+G    LKI+DFG S    +   +  G     + +  PE +    + +  D+WS
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWS 179

Query: 199 LGVLCYE-FLYGVPPF 213
            G+L +E F  GV P+
Sbjct: 180 YGILLWETFSLGVCPY 195

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 81.2 bits (200), Expect = 7e-18
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 38/244 (15%)

Query: 4   EVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLA------REKRSNHI-VALKVLFKSQL 54
           E    E  RW    +   +GKPLG G FG V +A      ++K    + VA+K+L     
Sbjct: 1   EYELPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60

Query: 55  QQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-- 111
           ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L+  +  
Sbjct: 61  EKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 118

Query: 112 ----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
                            F +  + TY   +AR + Y   +  IHRD+   N+L+     +
Sbjct: 119 GMEYSYDIARVPDEQMTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVM 176

Query: 156 KIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYG 209
           KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F  G
Sbjct: 177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 236

Query: 210 VPPF 213
             P+
Sbjct: 237 GSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 81.0 bits (200), Expect = 8e-18
 Identities = 74/294 (25%), Positives = 128/294 (43%), Gaps = 58/294 (19%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH-PNILRLY 82
           +G G +G VY AR+K +  +VALK   + ++ +  +     RE+ +   L     I+RL 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 83  GYFYDQKR-----VYLILEYAAKGELYKELQK---------CKYFSERRAATYVASLARA 128
              + +++     +YL+ EY     L  +L+K          +    +   +++  L + 
Sbjct: 68  DVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS------VHTFNRRRTMCGTLDYLP 181
           + +CH   V+HRD+KP+NLL+  Q   LKIAD G        V ++        TL Y  
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV---TLWYRA 179

Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPF----EAKEHSDTYR------------- 223
           PE ++ S  +   VDIWS+G +  E     P F    E ++    ++             
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239

Query: 224 ---RIVQVDLKFPPK------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
              R      ++ P+      P +S    DL+ +ML  D ++R+     L HP+
Sbjct: 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 80.8 bits (199), Expect = 8e-18
 Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)

Query: 24  LGRGKFGHVYLARE-KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNIL 79
           +G G +G V+ AR+ K     VALK + + Q  +  +     REV +  HL    HPN++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 80  RLYGYFY-----DQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYC 132
           RL+          + ++ L+ E+  + +L   L K              +  L R L + 
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-MCGTLDYLPPEMVESVEH 190
           H   V+HRD+KP+N+L+ + G++K+ADFG + +++F    T +  TL Y  PE++    +
Sbjct: 127 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY 186

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------DLKFP-----P 234
              VD+WS+G +  E     P F      D   +I+ V           D+  P      
Sbjct: 187 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 246

Query: 235 KPI---------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
           K           +    KDL+ + L  + ++R+  +  L HP+
Sbjct: 247 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.6 bits (199), Expect = 1e-17
 Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 23/202 (11%)

Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQ--LRREVEIQSHLRHPN 77
           LG+G FG V L R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVK-----KLQHSTAEHLRDFEREIEILKSLQHDN 66

Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + L++EY   G L   LQK +     R+   Y + + + + Y   
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSV-------HTFNRRRTMCGTLDYLPPEMVES 187
           K  +HRD+   N+L+ ++  +KI DFG +        +   R         Y P  + ES
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186

Query: 188 VEHDANVDIWSLGVLCYE-FLY 208
               A+ D+WS GV+ YE F Y
Sbjct: 187 KFSVAS-DVWSFGVVLYELFTY 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 81.3 bits (201), Expect = 1e-17
 Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 54/299 (18%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHL 73
           D +  +P+G G FG V+   + R    VALK +   F++ +   +V     RE+++    
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRV----FRELKMLCFF 56

Query: 74  RHPNILR--------LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
           +H N+L             F   + +Y++ E   + +L+K +   +  S      ++  +
Sbjct: 57  KHDNVLSALDILQPPHIDPF---EEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQI 112

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCG---TLDYLP 181
            R L Y H   ++HRDIKP NLL+ +   LKI DFG + V   +  + M     T  Y  
Sbjct: 113 LRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 182 PEMVESVEHDAN-VDIWSLGVLCYEFL---------------------YGVPPFEAKEH- 218
           PE++    H  + VDIWS+G +  E L                      G P  EA    
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232

Query: 219 -SDTYRRIVQVDLKFPPKPIV-------SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                  I++   K P  P++       +  A  L+ +MLV D  +R+     L HP++
Sbjct: 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 80.5 bits (198), Expect = 2e-17
 Identities = 70/250 (28%), Positives = 115/250 (46%), Gaps = 48/250 (19%)

Query: 21  GKPLGRGKFGHVYLAREK--RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           G  +GRG +GHVY A+ K  +     ALK     Q++ + +     RE+ +   L+HPN+
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALK-----QIEGTGISMSACREIALLRELKHPNV 60

Query: 79  LRLYGYF--YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI------ 130
           + L   F  +  ++V+L+ +YA + +L+  +   K+    +A      L R+++      
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYA-EHDLWHII---KFHRASKANKKPMQLPRSMVKSLLYQ 116

Query: 131 ------YCHGKHVIHRDIKPENLLIGAQ----GELKIADFGWSVHTFNRRRTMCGTLD-- 178
                 Y H   V+HRD+KP N+L+  +    G +KIAD G++   FN        LD  
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDPV 175

Query: 179 -----YLPPEMVESVEHDAN-VDIWSLGVLCYEFLYGVPPFEAKE---------HSDTYR 223
                Y  PE++    H    +DIW++G +  E L   P F  ++         H D   
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235

Query: 224 RIVQVDLKFP 233
           RI  V + FP
Sbjct: 236 RIFSV-MGFP 244

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 80/309 (25%), Positives = 128/309 (41%), Gaps = 63/309 (20%)

Query: 18  FDIG------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G      +PLG G  G V+ A +   +  VA+K +  +  Q   V+H LR E++I  
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--VKHALR-EIKIIR 57

Query: 72  HLRHPNILRLYGYFYDQKR--------------VYLILEYAAKGELYKELQKCKYFSERR 117
            L H NI+++Y                      VY++ EY  + +L   L++    SE  
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGP-LSEEH 115

Query: 118 AATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWS-------VHTFNR 169
           A  ++  L R L Y H  +V+HRD+KP N+ I  +   LKI DFG +        H    
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175

Query: 170 RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI--- 225
              +     Y  P ++ S  +    +D+W+ G +  E L G P F      +  + I   
Sbjct: 176 SEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234

Query: 226 -------------------VQVDLKFPPKPI------VSSAAKDLISQMLVKDSSQRLPL 260
                              V+ D   P +P+      V+  A D + Q+L  +   RL  
Sbjct: 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294

Query: 261 HKLLEHPWI 269
            + L HP++
Sbjct: 295 EEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 79.7 bits (196), Expect = 3e-17
 Identities = 70/250 (28%), Positives = 115/250 (46%), Gaps = 48/250 (19%)

Query: 21  GKPLGRGKFGHVYLAREK--RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           G  +GRG +GHVY A+ K  + +   ALK     Q++ + +     RE+ +   L+HPN+
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALK-----QIEGTGISMSACREIALLRELKHPNV 60

Query: 79  LRLYGYF--YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI------ 130
           + L   F  +  ++V+L+ +YA + +L+  +   K+    +A      L R ++      
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYA-EHDLWHII---KFHRASKANKKPVQLPRGMVKSLLYQ 116

Query: 131 ------YCHGKHVIHRDIKPENLLIGAQ----GELKIADFGWSVHTFNRRRTMCGTLD-- 178
                 Y H   V+HRD+KP N+L+  +    G +KIAD G++   FN        LD  
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDPV 175

Query: 179 -----YLPPEMVESVEHDAN-VDIWSLGVLCYEFLYGVPPFEAKE---------HSDTYR 223
                Y  PE++    H    +DIW++G +  E L   P F  ++         H D   
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235

Query: 224 RIVQVDLKFP 233
           RI  V + FP
Sbjct: 236 RIFNV-MGFP 244

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 78.9 bits (194), Expect = 6e-17
 Identities = 67/232 (28%), Positives = 107/232 (46%), Gaps = 30/232 (12%)

Query: 12  RWTLN--DFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLR 64
           +W L+     +GKPLG G FG V +A      + + N  V + V         +    L 
Sbjct: 6   KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65

Query: 65  REVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQ------------KCK 111
            E+E+   + +H NI+ L G       +Y+++EYA+KG L + L+             CK
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125

Query: 112 YFSERRAATYVAS----LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VH 165
              E+     + S    +AR + Y   +  IHRD+   N+L+     +KIADFG +  VH
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185

Query: 166 TFN-RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
             +  ++T  G L   ++ PE +    +    D+WS GVL +E F  G  P+
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 78.2 bits (193), Expect = 7e-17
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 24/215 (11%)

Query: 13  WTL--NDFDIGKPLGRGKFGHVY--LAREKRSNHI---VALKVLFKSQLQQSQVEHQLRR 65
           W L      + + LG+G FG VY  LA+          VA+K + ++   + ++E     
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE--FLN 58

Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSER--------- 116
           E  +       +++RL G     +   +++E  AKG+L   L+  +  +E          
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118

Query: 117 -RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT 172
            +     A +A  + Y   K  +HRD+   N ++     +KI DFG +   +     R+ 
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178

Query: 173 MCGTLD--YLPPEMVESVEHDANVDIWSLGVLCYE 205
             G L   ++ PE ++        D+WS GV+ +E
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE 213

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 76.2 bits (187), Expect = 3e-16
 Identities = 65/236 (27%), Positives = 107/236 (45%), Gaps = 22/236 (9%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHI--VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +GK LG G+FG V   +  + + I  VA+K +  +   +S++E  L  E        HPN
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLS-EAVCMKEFDHPN 61

Query: 78  ILRLYGYFYD--QKRVY----LILEYAAKGEL-----YKELQKC-KYFSERRAATYVASL 125
           ++RL G      +   Y    +IL +   G+L     Y  L  C +Y   +    ++  +
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-- 183
           A  + Y   K  IHRD+   N ++     + +ADFG S   +N      G +  +P +  
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 184 MVESVE---HDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYRRIVQVD-LKFPP 234
            +ES+    +    D+WS GV  +E    G  P+   E+S+ Y  + Q + LK PP
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 76.2 bits (187), Expect = 6e-16
 Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 50/233 (21%)

Query: 20  IGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL- 73
           +GKPLG G FG V  A      + R +  V + V         +    L  E+E+   + 
Sbjct: 16  LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGEL---------------------------YKE 106
           +H NI+ L G    +  +Y+I+EYAAKG L                           +K+
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 107 LQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--V 164
           L  C Y            +AR + Y   +  IHRD+   N+L+     +KIADFG +  V
Sbjct: 136 LVSCAY-----------QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184

Query: 165 HTFN-RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
           H  +  ++T  G L   ++ PE +    +    D+WS G+L +E F  G  P+
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 76.0 bits (187), Expect = 7e-16
 Identities = 72/263 (27%), Positives = 123/263 (46%), Gaps = 25/263 (9%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           + I + +G+G +G V  A +  +   VA+K +     +      ++ RE+++   LRHP+
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 78  ILRLYGYFY-----DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
           I+ +          + K +Y++ E   + +L++ ++     +      ++  L RAL Y 
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL------PPEMVE 186
           H  +V HRD+KP+N+L  A  +LKI DFG +   FN   T     DY+       PE+  
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 187 SV--EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA--- 241
           S   ++   +DIWS+G +  E L G P F  K  +  ++  +  DL   P P   S    
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLITDLLGTPSPETISRVRN 237

Query: 242 --AKDLISQMLVKDS---SQRLP 259
             A+  +S M  K     SQ+ P
Sbjct: 238 EKARRYLSSMRKKQPVPFSQKFP 260

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.5 bits (183), Expect = 1e-15
 Identities = 66/254 (25%), Positives = 106/254 (41%), Gaps = 22/254 (8%)

Query: 20  IGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLR---REVEIQSHL 73
           I + +G G+FG V   R K   +    VA+K L     +    E Q R    E  I    
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-----KSGYTEKQRRDFLSEASIMGQF 62

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYC 132
            HPNI+ L G     + V +I E+   G L   L Q    F+  +    +  +A  + Y 
Sbjct: 63  DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR--TMCGTLD------YLPPEM 184
              + +HRD+   N+L+ +    K++DFG S    +     T   +L       +  PE 
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 185 VESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
           +   +  +  D+WS G++ +E + YG  P+    + D    I Q D + PP     +A  
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLPPPMDCPTALH 241

Query: 244 DLISQMLVKDSSQR 257
            L+     KD + R
Sbjct: 242 QLMLDCWQKDRNAR 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 74.6 bits (183), Expect = 1e-15
 Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 22/233 (9%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-R 74
           ND      +G G FG V  AR K+    +   +    +            E+E+   L  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYF--------SERRAAT------ 120
           HPNI+ L G    +  +YL +EYA  G L   L+K +          +   A+T      
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 121 --YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-HTFNRRRTMCGTL 177
             + A +AR + Y   K  IHRD+   N+L+G     KIADFG S       ++TM G L
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRL 185

Query: 178 D--YLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQ 227
              ++  E +    +  N D+WS GVL +E +  G  P+     ++ Y ++ Q
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 41/244 (16%)

Query: 18  FDIGKPLGRGKFGHVYLAR---EKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            +  K LG G FG VY      E     I VA+KVL +    ++  E  +  E  + + +
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE--ILDEAYVMASV 66

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA-------TYVASLA 126
            HP+++RL G      +V LI +    G L        Y    +          +   +A
Sbjct: 67  DHPHVVRLLGICL-SSQVQLITQLMPLGCLLD------YVRNHKDNIGSQYLLNWCVQIA 119

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW---------SVHTFNRRRTMCGTL 177
           + + Y   K ++HRD+   N+L+     +KI DFG            H    +      +
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV----PI 175

Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFE---AKEHSDTYRRIVQVDLKFP 233
            ++  E +    +    D+WS GV  +E + +G  P+E   A E  D    +++   + P
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD----LLEKGERLP 231

Query: 234 PKPI 237
             PI
Sbjct: 232 QPPI 235

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.8 bits (181), Expect = 3e-15
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 17/200 (8%)

Query: 22  KPLGRGKFGHVYLAREK----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           + LG G FG V L R       +   VA+K L K +   + +   L++E+EI  +L H N
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIA-DLKKEIEILRNLYHEN 67

Query: 78  ILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G   +     + LI+E+   G L + L + K   + ++   Y   + + + Y   
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLD-----YLPPEMVES 187
           +  +HRD+   N+L+ ++ ++KI DFG   ++ T     T+   LD     Y P  +++S
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 188 VEHDANVDIWSLGVLCYEFL 207
             + A+ D+WS GV  YE L
Sbjct: 188 KFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 74.6 bits (183), Expect = 3e-15
 Identities = 49/154 (31%), Positives = 71/154 (46%), Gaps = 17/154 (11%)

Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
           E  I   + HP+I++L G F   K   LIL    K +LY     C Y + +R       L
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLY-----C-YLAAKRNIAICDIL 185

Query: 126 A------RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCG 175
           A      RA+ Y H   +IHRDIK EN+ I   G++ + DFG +        N+     G
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245

Query: 176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYG 209
           T+    PE++    +   VDIWS G++ +E    
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 73.5 bits (181), Expect = 4e-15
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 25/212 (11%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           IGK         V+LA+ K +N +VA+K   K  L     E    L++E+     L+HPN
Sbjct: 6   IGKCFEDLMI--VHLAKHKPTNTLVAVK---KINLDSCSKEDLKLLQQEIITSRQLQHPN 60

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR----ALIYCH 133
           IL     F     +Y++    A G    E     +F E      +A + +    AL Y H
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSC--EDLLKTHFPEGLPELAIAFILKDVLNALDYIH 118

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRTMCG-------TLDYLPPE 183
            K  IHR +K  ++L+   G++ ++   +SV       R+R +          L +L PE
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178

Query: 184 MVESVEH--DANVDIWSLGVLCYEFLYGVPPF 213
           +++      +   DI+S+G+   E   G  PF
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 74.1 bits (182), Expect = 4e-15
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 17/195 (8%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           + + K L  G  G V++A +      V LK+    Q   + +E  L + V       HP+
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNVN------HPS 118

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKH 136
           ++R+           ++L +    +LY  L K  +     +A      +   L Y H + 
Sbjct: 119 VIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM----CGTLDYLPPEMVESVEHDA 192
           +IHRD+K EN+ I    ++ I D G +   F           GT++   PE++   ++++
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAA--QFPVVAPAFLGLAGTVETNAPEVLARDKYNS 235

Query: 193 NVDIWSLGVLCYEFL 207
             DIWS G++ +E L
Sbjct: 236 KADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 72.7 bits (178), Expect = 4e-15
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 13/207 (6%)

Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W LN  +  + + +G+G+FG V L  + R N  VA+K +      Q+ +      E  + 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLG-DYRGNK-VAVKCIKNDATAQAFLA-----EASVM 53

Query: 71  SHLRHPNILRLYGYFYDQK-RVYLILEYAAKGEL--YKELQKCKYFSERRAATYVASLAR 127
           + LRH N+++L G   ++K  +Y++ EY AKG L  Y   +            +   +  
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES 187
           A+ Y    + +HRD+   N+L+      K++DFG +    + + T    + +  PE +  
Sbjct: 114 AMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE 173

Query: 188 VEHDANVDIWSLGVLCYE-FLYGVPPF 213
            +     D+WS G+L +E + +G  P+
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 8e-15
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 22/204 (10%)

Query: 22  KPLGRGKFGHVYLAREKRSNHI--VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           + LG G+FG V+   E   N+   VA+K L    +           E +I   LRHP ++
Sbjct: 12  RKLGAGQFGEVW---EGLWNNTTPVAVKTLKPGTMDPKD----FLAEAQIMKKLRHPKLI 64

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQK-----CKYFSERRAATYVASLARALIYCHG 134
           +LY     ++ +Y++ E    G L + LQ       K       A  VAS    + Y   
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS---GMAYLEA 121

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS----VHTFNRRRTMCGTLDYLPPEMVESVEH 190
           ++ IHRD+   N+L+G     K+ADFG +       +  R      + +  PE       
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRF 181

Query: 191 DANVDIWSLGVLCYEFL-YGVPPF 213
               D+WS G+L  E + YG  P+
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 1e-14
 Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 16/229 (6%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
               + + LG G+FG V++         VA+K L       +       +E +I   LRH
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTW-NGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRH 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQK--CKYFSERRAATYVASLARALIYCH 133
             +++LY    +++ +Y++ EY +KG L   L+    K     +     A +A  + Y  
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC-GT---LDYLPPEMVESVE 189
            ++ IHRD+   N+L+G     KIADFG +    +   T   G    + +  PE      
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR 180

Query: 190 HDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFP-PKP 236
                D+WS G+L  E   YG  P+    + +    + QV+  +  P+P
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQVERGYRMPRP 226

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 71.6 bits (175), Expect = 2e-14
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 26/207 (12%)

Query: 30  GHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK 89
           GH+YL     +  +VA+K L    +   Q   + ++E  + + L HPNI+ L G    ++
Sbjct: 24  GHLYLPGMDHA-QLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80

Query: 90  RVYLILEYAAKGELYKELQKCKYFSE-----RRAATYVASL------------ARALIYC 132
            V ++ EY  +G+L++ L      S+         T  +SL            A  + Y 
Sbjct: 81  PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTL---DYLPPEMVES 187
                +H+D+   N+LIG Q  +KI+D G S  +++ +  R    +L    ++PPE +  
Sbjct: 141 SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200

Query: 188 VEHDANVDIWSLGVLCYE-FLYGVPPF 213
            +  ++ DIWS GV+ +E F +G+ P+
Sbjct: 201 GKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 70.8 bits (174), Expect = 2e-14
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 12/209 (5%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           +   I K +G G+FG V   R K   +    VA+K L K+     Q    L  E  I   
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLT-EASIMGQ 61

Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIY 131
             HPNI+RL G     + V +I EY   G L K L++    F+  +    +  +A  + Y
Sbjct: 62  FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---RTMCG--TLDYLPPEMVE 186
               + +HRD+   N+L+ +    K++DFG S    +      T  G   + +  PE + 
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181

Query: 187 SVEHDANVDIWSLGVLCYEFL-YGVPPFE 214
             +  +  D+WS G++ +E + YG  P+ 
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYW 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 70.0 bits (171), Expect = 4e-14
 Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 40/271 (14%)

Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W LN     +G+ +G G+FG V     + +   VA+K +      Q+ +E     E  + 
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAFLE-----ETAVM 53

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR-AL 129
           + L H N++RL G       +Y+++E  +KG L   L+     +  RA   V  L + +L
Sbjct: 54  TKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQFSL 107

Query: 130 IYCHG------KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTL--DYLP 181
               G      K ++HRD+   N+L+   G  K++DFG +             L   +  
Sbjct: 108 DVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA--RVGSMGVDNSKLPVKWTA 165

Query: 182 PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF---EAKEHSDTYRRIVQVDLKFPPK-- 235
           PE ++  +  +  D+WS GVL +E F YG  P+     KE  +   +  +++   PP+  
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME---PPEGC 222

Query: 236 -PIVSSAAKDLISQMLVKDSSQRLPLHKLLE 265
              V      L++     +  +R   HKL E
Sbjct: 223 PADVYV----LMTSCWETEPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 70.3 bits (172), Expect = 5e-14
 Identities = 57/196 (29%), Positives = 87/196 (44%), Gaps = 15/196 (7%)

Query: 24  LGRGKFGHVYLAREKRSN----HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           LG G FG V L     +N     +VA+K L K +  Q Q     ++E+ I   L H NI+
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQ-QNTSGWKKEINILKTLYHENIV 69

Query: 80  RLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           +  G   +Q  K + LI+EY   G L   L K K  +  +   +   +   + Y H +H 
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQHY 128

Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHT------FNRRRTMCGTLDYLPPEMVESVEHD 191
           IHRD+   N+L+     +KI DFG +         +  R      + +   E ++  +  
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFS 188

Query: 192 ANVDIWSLGVLCYEFL 207
              D+WS GV  YE L
Sbjct: 189 YASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.4 bits (175), Expect = 6e-14
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 18/234 (7%)

Query: 40  SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLY--GYFYDQKRVYLILEY 97
           + H VA+K+L     ++     + RRE  + + L HPNI+ L   G       ++ + EY
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEY 60

Query: 98  AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---E 154
                L + L              +  +  AL   H + ++HRD+KP+N+++   G    
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 155 LKIADFGWS----------VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCY 204
            K+ DFG            V T  R   + GT  Y  PE +       N D+++ G++  
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 205 EFLYGVPPFEAKEHSDT-YRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
           E L G    +    ++  Y+++  VD+  PP  I       ++ + L KD  QR
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVDVSLPPW-IAGHPLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 69.6 bits (170), Expect = 7e-14
 Identities = 63/247 (25%), Positives = 107/247 (43%), Gaps = 14/247 (5%)

Query: 22  KPLGRGKFGHVY---LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           K +G G+FG V+   L    R    VA+K L     ++ + +     E  I     H NI
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD--FLSEASIMGQFSHHNI 68

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHV 137
           +RL G     K   +I EY   G L K L+     FS  +    +  +A  + Y    + 
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY 128

Query: 138 IHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGTLDYLP-----PEMVESVEHD 191
           +HRD+   N+L+ +  E K++DFG S V   +   T   +   +P     PE +   +  
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Query: 192 ANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           +  D+WS G++ +E + +G  P+    + +  + I     + P      SA   L+ Q  
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSAVYQLMLQCW 247

Query: 251 VKDSSQR 257
            +D ++R
Sbjct: 248 QQDRARR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 69.2 bits (169), Expect = 7e-14
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 17/203 (8%)

Query: 24  LGRGKFG----HVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           LG G FG     VY  R+K+ +  VA+KVL K++ ++S V  ++ RE EI   L +P I+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQID--VAIKVL-KNENEKS-VRDEMMREAEIMHQLDNPYIV 58

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHVI 138
           R+ G   + + + L++E A+ G L K L  K    +       +  ++  + Y  GK+ +
Sbjct: 59  RMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117

Query: 139 HRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCG-TLDYLPPEMVESVEHDA 192
           HRD+   N+L+  Q   KI+DFG S       ++ + R+     L +  PE +   +  +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 193 NVDIWSLGVLCYE-FLYGVPPFE 214
             D+WS G+  +E F YG  P++
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 69.6 bits (170), Expect = 9e-14
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 20/224 (8%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLY 82
           +G G FG V  A  K+    +   +    +            E+E+   L  HPNI+ L 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYF----------------SERRAATYVASLA 126
           G   ++  +Y+ +EYA  G L   L+K +                  + ++   + + +A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD--YLPPEM 184
             + Y   K  IHRD+   N+L+G     KIADFG S       +   G L   ++  E 
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIES 189

Query: 185 VESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQ 227
           +    +    D+WS GVL +E +  G  P+     ++ Y ++ Q
Sbjct: 190 LNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 68.9 bits (168), Expect = 1e-13
 Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 20/224 (8%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLY 82
           +G G FG V  AR K+    +   +    +            E+E+   L  HPNI+ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYF----------------SERRAATYVASLA 126
           G    +  +YL +EYA  G L   L+K +                  S ++   + A +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD--YLPPEM 184
           R + Y   K  IHRD+   N+L+G     KIADFG S       +   G L   ++  E 
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 182

Query: 185 VESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQ 227
           +    +  N D+WS GVL +E +  G  P+     ++ Y ++ Q
Sbjct: 183 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 56/235 (23%), Positives = 96/235 (40%), Gaps = 45/235 (19%)

Query: 20  IGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQSHL 73
           +GK LG G+FG V  A   R         VA+K+L ++    S  E + L  E  +   +
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQV 60

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-----CKYFSERRAA--------- 119
            HP++++LYG       + LI+EYA  G L   L++       Y                
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 120 ----------TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR 169
                     ++   ++R + Y     ++HRD+   N+L+    ++KI+DFG S   +  
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 170 RRTMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYEFLY-------GVPP 212
              +  +   +P      E +    +    D+WS GVL +E +        G+ P
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.0 bits (166), Expect = 2e-13
 Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 24/236 (10%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSHLRHPNIL 79
             +G G FG V L    R   +   +V+ K     +  + QL   +EV+    L HPN+L
Sbjct: 1   DEIGNGWFGKVLLGEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV-----ASLARALIYCHG 134
           +  G   +     L+LE+   G+L   L+  +    + A   V       +A  L++ H 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVE 189
              IH D+   N  + A   +KI D+G ++  +       +      L +L PE+VE   
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 190 HDANV-------DIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIV-QVDLKFPPKP 236
            D          +IWSLGV  +E F     P+         +++V + D+K  PKP
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL-PKP 233

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 67.6 bits (165), Expect = 3e-13
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 13/199 (6%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G+FG V++       H    KV  KS  Q S        E  +   L+HP ++RL
Sbjct: 12  KKLGAGQFGEVWMGYYN--GH---TKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL 66

Query: 82  YGYFYDQKRVYLILEYAAKGEL--YKELQKCKYFSERRAATYVASLARALIYCHGKHVIH 139
           Y     Q+ +Y+I EY   G L  + +  +    +  +     A +A  + +   K+ IH
Sbjct: 67  YAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH 125

Query: 140 RDIKPENLLIGAQGELKIADFGWS----VHTFNRRRTMCGTLDYLPPEMVESVEHDANVD 195
           RD++  N+L+      KIADFG +     + +  R      + +  PE +         D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185

Query: 196 IWSLGVLCYEFL-YGVPPF 213
           +WS G+L  E + YG  P+
Sbjct: 186 VWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 67.6 bits (165), Expect = 3e-13
 Identities = 61/239 (25%), Positives = 111/239 (46%), Gaps = 23/239 (9%)

Query: 18  FDIGKPLGRGKFGHV---YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           F +G+ LG+G+FG V    L  E  S   VA+K+L       S +E +  RE        
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFD 59

Query: 75  HPNILRLYG---YFYDQKRV---YLILEYAAKGELYKELQKCKY------FSERRAATYV 122
           HPN+++L G       + R+    +IL +   G+L+  L   +          +    ++
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGT---L 177
             +A  + Y   K+ IHRD+   N ++     + +ADFG S  +++ +  R  C +   +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVD-LKFPP 234
            +L  E +    +  + D+W+ GV  +E +  G  P+   E+S+ Y  +++ + LK PP
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 67.9 bits (166), Expect = 4e-13
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 20/219 (9%)

Query: 12  RWTL--NDFDIGKPLGRGKFGHVY------LAREKRSNHIVALKVLFKSQLQQSQVEHQL 63
           +W    N+   GK LG G FG V       L++       VA+K+L K     S+ E  L
Sbjct: 29  KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMK-VAVKML-KPTAHSSERE-AL 85

Query: 64  RREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAAT 120
             E++I SHL  H NI+ L G       + +I EY   G+L   L++ +  + +     +
Sbjct: 86  MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 180
           +   +A+ + +   K+ IHRD+   N+L+     +KI DFG +    N    +      L
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 181 P-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
           P     PE + +  +    D+WS G+L +E F  G  P+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 66.8 bits (163), Expect = 4e-13
 Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 13/199 (6%)

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PN++ L+ Y   +  V+L+L++A  G+L+  + K     E     + A +  AL   H +
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 136 HVIHRDIKPENLLIGAQGELKIADFG-WSVHTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
            ++ RD+ P N+L+  +G +++  F  WS    +        + Y  PE+    E     
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-YCAPEVGGISEETEAC 163

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           D WSLG + +E L G    E   H         +++   P+  VS  A+ L+ Q+L  + 
Sbjct: 164 DWWSLGAILFELLTGKTLVEC--HPSGINTHTTLNI---PE-WVSEEARSLLQQLLQFNP 217

Query: 255 SQRL-----PLHKLLEHPW 268
           ++RL      +  +  HP+
Sbjct: 218 TERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.0 bits (163), Expect = 5e-13
 Identities = 58/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 14  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 69  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127

Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   K+  +
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEE 246

Query: 257 R 257
           R
Sbjct: 247 R 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 67.0 bits (163), Expect = 6e-13
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 13/211 (6%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G+FG V++A   +       KV  K+    S        E  +   L+H  +++L
Sbjct: 12  KKLGAGQFGEVWMATYNKHT-----KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKYFSER--RAATYVASLARALIYCHGKHVIH 139
           +     ++ +Y+I E+ AKG L   L+  +   +   +   + A +A  + +   ++ IH
Sbjct: 67  HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125

Query: 140 RDIKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVD 195
           RD++  N+L+ A    KIADFG +     + +  R      + +  PE +         D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185

Query: 196 IWSLGVLCYEFL-YGVPPFEAKEHSDTYRRI 225
           +WS G+L  E + YG  P+    + +  R +
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 9e-13
 Identities = 55/235 (23%), Positives = 95/235 (40%), Gaps = 33/235 (14%)

Query: 18  FDIGKPLGRGKFGHVYLA--REKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           ++I   L  G  G V++           V +K +   +           RE++I   + H
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISH 145

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
             I+ L   +  +  V +++    K +L+  + +       +A T    L  AL Y HG+
Sbjct: 146 RAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR 204

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC----------GTLDYLPPEMV 185
            +IHRD+K EN+ +       + DFG +                     GTL+   PE++
Sbjct: 205 GIIHRDVKTENIFLDEPENAVLGDFGAACKL-----DAHPDTPQCYGWSGTLETNSPELL 259

Query: 186 ESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYR-----RIVQV-DLKFP 233
               + A  DIWS G++ +E     V  F  +  S + +     R +QV  L+FP
Sbjct: 260 ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314

Length = 392

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 29/229 (12%)

Query: 24  LGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           LG  +FG VY               VA+K L K + +    E + + E  ++S L+HPNI
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLRE-EFKHEAMMRSRLQHPNI 70

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT----------------YV 122
           + L G    ++ + +I  Y +  +L++ L      S+  +                   V
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTL--- 177
             +A  + +    HV+H+D+   N+L+  +  +KI+D G    V+  +  + M  +L   
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190

Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
            ++ PE +   +   + DIWS GV+ +E F YG+ P+    + D    I
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 1/94 (1%)

Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP 234
           GT DYL PE++    H   VD W+LGV  +EFL G+PPF  +     ++ I+  D+ +P 
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601

Query: 235 -KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHP 267
            +  +S  A++ I  +L  D ++R  L +L +HP
Sbjct: 602 GEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 63.9 bits (155), Expect = 5e-12
 Identities = 49/190 (25%), Positives = 85/190 (44%), Gaps = 12/190 (6%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +      KV  K+    + +     +E +I   LRH  ++ LY 
Sbjct: 14  LGQGCFGEVWMGTWNGTT-----KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 84  YFYDQKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ E+  KG L   L++   KY    +     A +A  + Y    + IHRD
Sbjct: 69  VVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     KIADFG +     + +  R+     + +  PE           D+W
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 198 SLGVLCYEFL 207
           S G+L  E +
Sbjct: 188 SFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 64.2 bits (156), Expect = 5e-12
 Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 20/252 (7%)

Query: 20  IGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLR---REVEIQSHL 73
           I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I    
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-----KAGYTEKQRRDFLSEASIMGQF 62

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            HPNI+ L G     K V ++ EY   G L   L+K    F+  +    +  +A  + Y 
Sbjct: 63  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPPEMVE 186
                +HRD+   N+L+ +    K++DFG S    +       T      + +  PE + 
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 187 SVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
             +  +  D+WS G++ +E + YG  P+    + D  + I +   + P      +A   L
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GYRLPAPMDCPAALHQL 241

Query: 246 ISQMLVKDSSQR 257
           +     KD ++R
Sbjct: 242 MLDCWQKDRNER 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.5 bits (154), Expect = 8e-12
 Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 12/192 (6%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G+FG V++      N  VA+K L    +           E +I   LRH  +++L
Sbjct: 12  KKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQL 66

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQ--KCKYFSERRAATYVASLARALIYCHGKHVIH 139
           Y     ++ +Y++ EY +KG L   L+  + +           A +A  + Y    + IH
Sbjct: 67  YAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH 125

Query: 140 RDIKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVD 195
           RD++  N+L+G     KIADFG +     + +  R+     + +  PE           D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 196 IWSLGVLCYEFL 207
           +WS G+L  E +
Sbjct: 186 VWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 63.9 bits (156), Expect = 9e-12
 Identities = 49/171 (28%), Positives = 73/171 (42%), Gaps = 29/171 (16%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHI----------------VALKVLFKSQLQQSQVEHQL 63
             + LG G+FG V+L                         VA+KVL       ++ +   
Sbjct: 9   FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED--F 66

Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--- 120
            +EV+I S L  PNI RL G       + +I+EY   G+L + LQK    +   A     
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 121 -------YVAS-LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS 163
                  Y+A+ +A  + Y    + +HRD+   N L+G    +KIADFG S
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 61.8 bits (150), Expect = 4e-11
 Identities = 62/271 (22%), Positives = 114/271 (42%), Gaps = 25/271 (9%)

Query: 18  FDIGKPLGRGKFGHVY---LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
             +GK LG G+FG V    L+++  S   VA+K +       S++E  L  E        
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFD 59

Query: 75  HPNILRLYGYFY---DQKRV---YLILEYAAKGELYKEL------QKCKYFSERRAATYV 122
           HPN+++L G  +     +++    +IL +   G+L+  L         +    +    ++
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPP 182
             +A  + Y   ++ IHRD+   N ++     + +ADFG S   ++      G +  +P 
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 183 E--MVESVE---HDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVD-LKFPPK 235
           +   +ES+    + +  D+W+ GV  +E    G  P+   E+ + Y  +   + LK P  
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239

Query: 236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
            +      DL+      D   R    KL E 
Sbjct: 240 CL--DELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 61.5 bits (149), Expect = 5e-11
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 29/211 (13%)

Query: 24  LGRGKFGHVYLAR--------EKRSNHIVALKVLFKSQLQQSQVEHQLR----REVEIQS 71
           LG G+FG V+L           + +       VL   ++ ++ V    R    +E++I S
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA--- 128
            L++PNI+RL G       + +I EY   G+L + L + +  S    A  + S++ A   
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 129 ---------LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY 179
                    + Y    + +HRD+   N L+G    +KIADFG S + ++           
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAV 192

Query: 180 LPPEMV--ESV---EHDANVDIWSLGVLCYE 205
           LP   +  ES+   +     D+W+ GV  +E
Sbjct: 193 LPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.3 bits (149), Expect = 5e-11
 Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 33/216 (15%)

Query: 27  GKFGHVY---LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           G FG ++   L  EK            K    + QV   L+    +   L H NIL +  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG-LSHQNILPILH 75

Query: 84  Y-FYDQKRVYLILEYAAKGELYKELQKCKY--------FSERRAATYVASLARALIYCHG 134
               D +  +++  Y   G L   LQ+C+          S ++       +A  + Y H 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---------NRRRTMCGTLDYLPPEMV 185
           + VIH+DI   N +I  + ++KI D   S   F         N  R     + ++  E +
Sbjct: 136 RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR----PVKWMALESL 191

Query: 186 ESVEHDANVDIWSLGVLCYEF--LYGVP-----PFE 214
            + E+ +  D+WS GVL +E   L   P     PFE
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 61.5 bits (149), Expect = 6e-11
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 29/213 (13%)

Query: 24  LGRG--KFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPNIL 79
           +GRG      VYLAR   +  +V +++   + L+    EH   L+ EV +    RHPNI+
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRI---TDLENCTEEHLKALQNEVVLSHFFRHPNIM 62

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL----ARALIYCHGK 135
             +  F     +++I  + A G     L+   YF E  +   + ++     R L Y H  
Sbjct: 63  TSWTVFTTGSWLWVISPFMAYGSANSLLKT--YFPEGMSEALIGNILFGALRGLNYLHQN 120

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW------------SVHTFNRRRTMCGTLDYLPPE 183
             IHR+IK  ++LI   G + ++                 V+ F +  T    L +L PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST--SVLPWLSPE 178

Query: 184 MVESVEHDANV--DIWSLGVLCYEFLYGVPPFE 214
           ++    +  NV  DI+S+G+   E   G  PF+
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 37/254 (14%)

Query: 33  YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK--- 89
            + +   +N  V ++   K       +      E++    +   NIL++YG+  D     
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 90  -RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR-DIKP--- 144
            R+ LILEY  +G L + L K       +  ++   L  A+  C G + +++   KP   
Sbjct: 95  PRLSLILEYCTRGYLREVLDK------EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKN 148

Query: 145 ---ENLLIGAQGELKIADFG----WSVHTFNRRRTMCGTLDYLPPEMVESV--EHDANVD 195
               + L+    +LKI   G     S   F     M     Y   +M+  +  E+    D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDD 204

Query: 196 IWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ--VDLKFP---PKPIVSSAAKDLISQML 250
           I+SLGV+ +E   G  PFE     + Y  I+     LK P   P  I     K ++    
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEI-----KCIVEACT 259

Query: 251 VKDSSQRLPLHKLL 264
             DS +R  + ++L
Sbjct: 260 SHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 27/161 (16%)

Query: 122 VASLARALI----YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT----- 172
           V ++AR L+    Y HG+ +IHRDIK EN+L+    ++ + DFG +        T     
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEF------LYGVPPFEAKEHSDT-YRRI 225
           + GT+D   PE++    +  +VDIWS G++ +E       L+     + +   D    RI
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI 381

Query: 226 VQ-----VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLH 261
           ++     VD +FP       A   L+SQ   + +  R P +
Sbjct: 382 IRQAQVHVD-EFPQH-----AGSRLVSQYRHRAARNRRPAY 416

Length = 461

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.4 bits (141), Expect = 6e-10
 Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 29/167 (17%)

Query: 24  LGRGKFGHVYLAREK----------------RSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           LG G+FG V+L   +                    +VA+K+L +   + ++  +   +E+
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR--NDFLKEI 70

Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYK-----ELQKCKYFSERRAATY- 121
           +I S L+ PNI+RL         + +I EY   G+L +     E Q+    ++    +Y 
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 122 -----VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS 163
                   +A  + Y    + +HRD+   N L+G    +KIADFG S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.0 bits (140), Expect = 8e-10
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 30/222 (13%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH--LRHPNIL 79
           K +G G FG V L   + ++     +V+ K     + V+ Q++   E Q +  L+H N+L
Sbjct: 1   KEIGNGWFGKVILG--EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSE--------RRAATYVASLARALIY 131
           +  G   +     L++E+   G+L   L+ C+            +R A  +A     L++
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL---GLLH 115

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP-----PEMVE 186
            H  + IH D+   N L+ A   +KI D+G S + +     +     ++P     PE+V+
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 187 SVEHDANV-------DIWSLGVLCYE-FLYGVPPFEAKEHSD 220
            V  +  V       ++WSLGV  +E F  G  P+  +  SD
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY--RHLSD 215

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.5 bits (139), Expect = 1e-09
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 35/213 (16%)

Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFK-SQLQQSQVEHQLRREVEIQSHLRHPNI 78
           +G+G FG VY    +  + +  H  A+K L + + L++  VE  L+ E  I     HPN+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIH-CAVKSLNRITDLEE--VEQFLK-EGIIMKDFSHPNV 58

Query: 79  LRLYGYFYDQKRVYLI-LEYAAKGELYKELQKCKYFSERRAAT------YVASLARALIY 131
           L L G     +   L+ L Y   G+L   ++     SE    T      +   +A+ + Y
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIR-----SETHNPTVKDLIGFGLQVAKGMEY 113

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFG----------WSVHTFNRRRTMCGTLDYLP 181
              K  +HRD+   N ++     +K+ADFG          +SVH     +     + ++ 
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL---PVKWMA 170

Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLY-GVPPF 213
            E +++ +     D+WS GVL +E +  G PP+
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 18/164 (10%)

Query: 57  SQVEHQLRREVEIQSHLRHPNILRL--------YGYFYDQKRVYLILEYAAKGELYKELQ 108
           S+   QL  E+     L H NIL++          Y   QK  + +  +        + +
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF--DWK 261

Query: 109 KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN 168
                 + RA   +  L  A+ Y H K +IHRDIK EN+ +   G++ + DFG +   F 
Sbjct: 262 DRPLLKQTRAI--MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFE 318

Query: 169 RRRT-----MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL 207
           + R        GT+    PE++    +    DIWS G++  + L
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 55.0 bits (132), Expect = 8e-09
 Identities = 44/204 (21%), Positives = 81/204 (39%), Gaps = 22/204 (10%)

Query: 22  KPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           + LG+G FG VY    K          VA+K + ++   + ++E     E  +       
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFNCH 69

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSE----------RRAATYVASLA 126
           +++RL G     +   +I+E   +G+L   L+  +   E          ++       +A
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP----- 181
             + Y +    +HRD+   N ++     +KI DFG +   +       G    LP     
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 182 PEMVESVEHDANVDIWSLGVLCYE 205
           PE ++        D+WS GV+ +E
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWE 213

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 14/205 (6%)

Query: 22  KPLGRGKFGHVY---LAREKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           K LG G FG VY      E  +  I VA+K+L ++   ++ VE     E  I + + HP+
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPH 70

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKH 136
           ++RL G       + L+ +    G L   + + K     +    +   +A+ ++Y   + 
Sbjct: 71  LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCG---TLDYLPPEMVESVEHD 191
           ++HRD+   N+L+ +   +KI DFG +  +    +     G    + ++  E +   +  
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 192 ANVDIWSLGVLCYEFL-YGVPPFEA 215
              D+WS GV  +E + +G  P++ 
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 55/259 (21%), Positives = 94/259 (36%), Gaps = 24/259 (9%)

Query: 24  LGRGKFGHVYLAR------EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           LG+G F ++Y                  + V+ K      +          + S L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA-SLARALIYCHGKH 136
           +++LYG     + + ++ EY   G L   L + K          VA  LA AL Y   K 
Sbjct: 63  LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121

Query: 137 VIHRDIKPENLLI-------GAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVE--S 187
           ++H ++  +N+L+       G    +K++D G  + T   R      + ++ PE +    
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-TVLSREERVERIPWIAPECIRNGQ 180

Query: 188 VEHDANVDIWSLGVLCYEFLYGVP-PFEAKEHSDTYRRI-VQVDLKFPPKPIVSSAAKDL 245
                  D WS G    E       P      S+  R    Q  L  P    +++    L
Sbjct: 181 ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELAN----L 236

Query: 246 ISQMLVKDSSQRLPLHKLL 264
           I+Q    D ++R     +L
Sbjct: 237 INQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 49/176 (27%), Positives = 77/176 (43%), Gaps = 39/176 (22%)

Query: 24  LGRGKFGHVYLAR----------------EKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           LG G+FG V+L                   K    +VA+K+L     + ++  +   +EV
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR--NDFLKEV 70

Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERR---------- 117
           +I S L+ PNI+RL G   D+  + +I EY   G+L + L    +  ++           
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSS-HHLDDKEENGNDAVPPA 129

Query: 118 ----AATYVASLARALIYCHGK------HVIHRDIKPENLLIGAQGELKIADFGWS 163
               A +Y + L  AL    G       + +HRD+   N L+G    +KIADFG S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 51.9 bits (124), Expect = 8e-08
 Identities = 46/204 (22%), Positives = 85/204 (41%), Gaps = 22/204 (10%)

Query: 22  KPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           + LG+G FG VY    +      +   VA+K + +S   + ++E     E  +       
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 69

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSE----------RRAATYVASLA 126
           +++RL G     +   +++E  A G+L   L+  +  +E          +      A +A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP----- 181
             + Y + K  +HRD+   N ++     +KI DFG +   +       G    LP     
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 182 PEMVESVEHDANVDIWSLGVLCYE 205
           PE ++      + D+WS GV+ +E
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWE 213

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 58/259 (22%), Positives = 110/259 (42%), Gaps = 15/259 (5%)

Query: 17  DFDIGKPLGRGKFGHVYLA---REKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           +F   K LG G FG VY      E     I VA+K L   +    +   ++  E  + + 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMAS 65

Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIY 131
           + +P++ RL G       V LI +    G L   +++ K     +    +   +A+ + Y
Sbjct: 66  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE--MVESVE 189
              + ++HRD+   N+L+     +KI DFG +       +        +P +   +ES+ 
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 190 HDA---NVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
           H       D+WS GV  +E + +G  P++    S+    I++   + P  PI +     +
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDVYMI 243

Query: 246 ISQMLVKDSSQRLPLHKLL 264
           + +  + D+  R    +L+
Sbjct: 244 MVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 19/211 (9%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL--FKSQLQQSQVEHQLRREVEIQSHLRH 75
           F I   LG G FG V  A +++     A+K++       + +++E Q   +V        
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADR 190

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
             ++++  YF ++     I+       L   + K   FS R  A  +     AL Y H +
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE 250

Query: 136 -HVIHRDIKPENLLIGAQG----------------ELKIADFGWSVHTFNRRRTMCGTLD 178
            H++H D+KPEN+L+                     ++I D G      + R  +  T  
Sbjct: 251 LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRH 310

Query: 179 YLPPEMVESVEHDANVDIWSLGVLCYEFLYG 209
           Y  PE+V  +    + D+WS+G + YE   G
Sbjct: 311 YRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 48.6 bits (116), Expect = 4e-07
 Identities = 31/148 (20%), Positives = 55/148 (37%), Gaps = 15/148 (10%)

Query: 19  DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
              K L  G    VYL   K  +++  LK          +      REV I   L    +
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDEDYV--LK-----INPSREKGADREREVAILQLLARKGL 53

Query: 79  L--RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERR-AATYVASLARALIYCHGK 135
              ++          YL++E+  +GE   E+ + +        A  +A L +  +     
Sbjct: 54  PVPKVLASGESDGWSYLLMEWI-EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV--- 109

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS 163
            + H D+ P N+L+     L I D+ ++
Sbjct: 110 -LCHGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 49.2 bits (117), Expect = 8e-07
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 25/211 (11%)

Query: 24  LGRG--KFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           +GRG      V LAR K +   V ++ +         V   L+ E+ +     HPNI+  
Sbjct: 6   IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTF-LQGELHVSKLFNHPNIVPY 64

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKYF----SERRAATYVASLARALIYCHGKHV 137
              F     ++++  + A G   K+L  C +F    SE   A  +  + +AL Y H    
Sbjct: 65  RATFIADNELWVVTSFMAYGSA-KDL-ICTHFMDGMSELAIAYILQGVLKALDYIHHMGY 122

Query: 138 IHRDIKPENLLIGAQGE---------LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV 185
           +HR +K  ++LI   G+         L + + G     VH F +       L +L PE++
Sbjct: 123 VHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVK--VLPWLSPEVL 180

Query: 186 ES--VEHDANVDIWSLGVLCYEFLYGVPPFE 214
           +     +DA  DI+S+G+   E   G  PF+
Sbjct: 181 QQNLQGYDAKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 29/80 (36%), Positives = 42/80 (52%), Gaps = 14/80 (17%)

Query: 115 ERRAATYVASLARALIY----CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----- 165
           ++R    +  + R ++      H   ++HRDIKPENLL+   G++KI DFG +V      
Sbjct: 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI 363

Query: 166 TFNRRRTMCGTLD--YLPPE 183
            FN    + G LD  Y PPE
Sbjct: 364 NFN---PLYGMLDPRYSPPE 380

Length = 507

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.4 bits (115), Expect = 1e-06
 Identities = 46/209 (22%), Positives = 91/209 (43%), Gaps = 20/209 (9%)

Query: 21  GKPLGRGKFGHVYLA---REKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            K LG G FG V+      E  S  I VA+K +     +Q+    ++   +     L H 
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF--QEITDHMLAMGSLDHA 69

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGK 135
            I+RL G       + L+ + +  G L   +++ +     +R   +   +A+ + Y    
Sbjct: 70  YIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS--------VHTFNRRRTMCGTLDYLPPEMVES 187
            ++HR++   N+L+ +   ++IADFG +         + ++  +T    + ++  E +  
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT---PIKWMALESILF 185

Query: 188 VEHDANVDIWSLGVLCYEFL-YGVPPFEA 215
             +    D+WS GV  +E + YG  P+  
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 6/99 (6%)

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRRTMCG 175
           Y   +AR + +   +  IHRD+   N+L+     +KI DFG +   +      R+ +   
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 176 TLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
            L ++ PE +    +    D+WS GVL +E F  G  P+
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 40/177 (22%), Positives = 73/177 (41%), Gaps = 11/177 (6%)

Query: 96  EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
           E A + +LYK     K  +      Y   +A+ + +   +  IHRD+   N+L+     +
Sbjct: 164 EEAEQEDLYK-----KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVV 218

Query: 156 KIADFGWSVHTFN-----RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYG 209
           KI DFG +   +      R+      L ++ PE +    +    D+WS GVL +E F  G
Sbjct: 219 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 278

Query: 210 VPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
             P+   +  + + R ++   +       +      +      + SQR    +L+EH
Sbjct: 279 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.4 bits (110), Expect = 9e-06
 Identities = 47/197 (23%), Positives = 87/197 (44%), Gaps = 17/197 (8%)

Query: 24  LGRGKFGHVYLAREKRSN-HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLY 82
           + RGK G  Y  +  ++    V  ++   + +  S++   + +       L+HPNI++L 
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIA-DMGK-------LQHPNIVKLI 749

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH-GKHVIHRD 141
           G    +K  YLI EY     L + L+   +   R+ A  +A   R L +C     V+  +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFL-HCRCSPAVVVGN 808

Query: 142 IKPENLLIGAQGE--LKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           + PE ++I  + E  L+++  G              +  Y+ PE  E+ +     DI+  
Sbjct: 809 LSPEKIIIDGKDEPHLRLSLPG----LLCTDTKCFISSAYVAPETRETKDITEKSDIYGF 864

Query: 200 GVLCYEFLYGVPPFEAK 216
           G++  E L G  P +A+
Sbjct: 865 GLILIELLTGKSPADAE 881

Length = 968

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 41/190 (21%), Positives = 73/190 (38%), Gaps = 52/190 (27%)

Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---- 65
           +  +  +DF +GK LG G FG VY             K    ++  + + ++ L++    
Sbjct: 126 RPSFKKDDFVLGKKLGEGAFGVVY-------------KASLVNKQSKKEGKYVLKKATEY 172

Query: 66  -EVEI--QSHLRH--PNILRLYGY-FY------DQKRVYLILEYAAKGELYKELQKCKYF 113
             VEI     +R   PN    + Y F        +   +L+  Y  +  L  +L + K F
Sbjct: 173 GAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLA-DLMQSKEF 231

Query: 114 -----------------SERRAATYVASLARALIYC----HGKHVIHRDIKPENLLIG-A 151
                               R    + ++ R +++     H   ++HRD+KP+N++    
Sbjct: 232 PYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG 291

Query: 152 QGELKIADFG 161
            G  KI D G
Sbjct: 292 SGSFKIIDLG 301

Length = 566

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 9/112 (8%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQL 63
           EK  +  ++   GK LG G FG V  A      ++ +   VA+K+L K+     + E  L
Sbjct: 31  EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML-KASAHTDERE-AL 88

Query: 64  RREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYF 113
             E++I SHL +H NI+ L G       V +I EY   G+L   L +K + F
Sbjct: 89  MSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 42.7 bits (100), Expect = 9e-05
 Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 22/269 (8%)

Query: 22  KPLGRGKFGHVY---LAREKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           K LG G FG VY      +  +  I VA+KVL ++   ++  E  +  E  + + +  P 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE--ILDEAYVMAGVGSPY 70

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKH 136
           + RL G       V L+ +    G L   +++ K     +    +   +A+ + Y     
Sbjct: 71  VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE--MVESVEH---D 191
           ++HRD+   N+L+ +   +KI DFG +                +P +   +ES+ H    
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 192 ANVDIWSLGVLCYEFL-YGVPPFE---AKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
              D+WS GV  +E + +G  P++   A+E  D    +++   + P  PI +     ++ 
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD----LLEKGERLPQPPICTIDVYMIMV 245

Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           +  + DS  R P  + L   +     DPS
Sbjct: 246 KCWMIDSECR-PRFRELVDEFSRMARDPS 273

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 6/100 (6%)

Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRRTMC 174
           +Y   +AR + +   +  IHRD+   N+L+     +KI DFG +   +      R+    
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
             L ++ PE +    +    D+WS GVL +E F  G  P+
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 8/99 (8%)

Query: 20  IGKPLGRGKFGHVYLA-----REKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL- 73
           +G+ LG G FG V  A        +S   VA+K+L KS  + S+ +  L  E++I SHL 
Sbjct: 41  LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKML-KSTARSSE-KQALMSELKIMSHLG 98

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY 112
            H NI+ L G       +Y+I EY   G+L   L + K+
Sbjct: 99  PHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.1 bits (96), Expect = 3e-04
 Identities = 53/252 (21%), Positives = 96/252 (38%), Gaps = 22/252 (8%)

Query: 20  IGKPLGRGKFGHV---YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           I + LG G+FG +    L    +    VA+  L ++     Q       E        H 
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQ-RRGFLAEALTLGQFDHS 66

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGK 135
           NI+RL G       + ++ EY + G L   L+K +      +    +  LA  + Y    
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126

Query: 136 HVIHRDIKPENLLIGAQGELKIADFG-------WSVHTFNRRRTMCGTLDYL--PPEMVE 186
             +H+ +    +L+ +    KI+ F         +++T     TM G    L   PE ++
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT-----TMSGKSPVLWAAPEAIQ 181

Query: 187 SVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
                +  D+WS G++ +E + YG  P+      D   + V+   + P      +    L
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-KAVEDGFRLPAPRNCPNLLHQL 240

Query: 246 ISQMLVKDSSQR 257
           +     K+  +R
Sbjct: 241 MLDCWQKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.0 bits (96), Expect = 3e-04
 Identities = 47/203 (23%), Positives = 84/203 (41%), Gaps = 22/203 (10%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH-QLRREVEIQSHLRHPNILRLY 82
           +G G FG V L+ E  ++  VA  V+ + +   S  E  +  ++ +    L+HPNIL+  
Sbjct: 3   IGNGWFGKVLLS-EIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV------ASLARALIYCHGKH 136
           G   +     L+ EY   G+L   L   +    RR +  +        +A  + + H  +
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYL--SQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119

Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVES---- 187
            +H D+   N  + +   +K+ D+G     +           C  L +L PE+V      
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179

Query: 188 ---VEHDANVDIWSLGVLCYEFL 207
               E     ++W+LGV  +E  
Sbjct: 180 LITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 40.1 bits (94), Expect = 4e-04
 Identities = 30/144 (20%), Positives = 52/144 (36%), Gaps = 12/144 (8%)

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHD 191
                 +HR  K  N+L+   G LK+   G     F           ++ PE+++   + 
Sbjct: 27  LGALRELHRQAKSGNILLTWDGLLKL--DG--SVAFKTPEQSRPDPYFMAPEVIQGQSYT 82

Query: 192 ANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRI-------VQVDLKFPPKPIVSSAAK 243
              DI+SLG+  YE L Y +P  E +E S     +          D         + + +
Sbjct: 83  EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFE 142

Query: 244 DLISQMLVKDSSQRLPLHKLLEHP 267
           D +     +   +R   +  L H 
Sbjct: 143 DFMRLCASRLPQRREAANHYLAHC 166

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 9/100 (9%)

Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL-KIADFGWSVHTFNRRRTMCGTLD 178
           ++   +AR + +   K+ +HRD+   N+L+ AQG++ KI DFG +    +    +     
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGST 299

Query: 179 YLP-----PEMVESVEHDANVDIWSLGVLCYEF--LYGVP 211
           +LP     PE +    +    D+WS G+L +E   L G P
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.1 bits (91), Expect = 0.001
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 21/204 (10%)

Query: 24  LGRGKFGHVYLA-REKRSNHI------VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           LG+G F  ++   R +  ++       V LKVL KS    S+          + S L H 
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE---SFFEAASMMSQLSHK 59

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA-SLARALIYCHGK 135
           +++  YG         ++ EY   G L   L+K K          VA  LA AL +   K
Sbjct: 60  HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119

Query: 136 HVIHRDIKPENLLIGAQGE--------LKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES 187
            + H ++  +N+L+  + +        +K++D G S+ T   +  +   + ++PPE +E+
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI-TVLPKEILLERIPWVPPECIEN 178

Query: 188 VEHDA-NVDIWSLGVLCYEFLYGV 210
            ++ +   D WS G   +E   G 
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFSGG 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 27/95 (28%), Positives = 43/95 (45%), Gaps = 6/95 (6%)

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP--- 181
           +A+ + +   K+ IHRD+   N+L+      KI DFG +    N    +      LP   
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKW 280

Query: 182 --PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
             PE +    +    D+WS G+L +E F  G  P+
Sbjct: 281 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 6/95 (6%)

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP--- 181
           +A  + +   K+ +HRD+   N+LI     +KI DFG +         +     +LP   
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307

Query: 182 --PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
             PE + +  +    D+WS G+L +E F  G  P+
Sbjct: 308 MAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 6/104 (5%)

Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQQSQVEHQLRRE 66
           RW    +   +G+ LG G FG V         RS  ++ + V       +S  +  L  E
Sbjct: 31  RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSE 90

Query: 67  VEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK 109
           ++I +HL  H NI+ L G       +Y+I EY   G+L   L K
Sbjct: 91  LKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHK 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	281
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.94
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
smart00090	237	RIO RIO-like kinase.	99.85
PRK10345	210	hypothetical protein; Provisional	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG1243	690	consensus Protein kinase [General function predict	99.65
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.52
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.49
KOG3087	229	consensus Serine/threonine protein kinase [General	99.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.39
COG4248	637	Uncharacterized protein with protein kinase and he	99.36
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.32
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.25
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.23
PRK09902	216	hypothetical protein; Provisional	99.07
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.04
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.03
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.8
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.77
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.74
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.72
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.5
PF01636	239	APH: Phosphotransferase enzyme family This family	98.48
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.48
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.46
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.37
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.24
PLN02876	822	acyl-CoA dehydrogenase	98.2
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.17
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.07
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.07
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.02
KOG2270	520	consensus Serine/threonine protein kinase involved	98.02
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.98
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.98
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.85
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.84
PRK05231	319	homoserine kinase; Provisional	97.81
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.8
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.74
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.63
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.54
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.45
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.33
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.28
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.2
PLN02236	344	choline kinase	97.15
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	97.13
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.08
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.9
PTZ00384	383	choline kinase; Provisional	96.76
PLN02756	418	S-methyl-5-thioribose kinase	96.6
PRK10593	297	hypothetical protein; Provisional	96.49
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.48
PRK11768	325	serine/threonine protein kinase; Provisional	95.93
PRK06148	1013	hypothetical protein; Provisional	95.92
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.89
PTZ00296	442	choline kinase; Provisional	95.74
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.62
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.19
PRK12396	409	5-methylribose kinase; Reviewed	94.33
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.32

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-59  Score=396.68  Aligned_cols=260  Identities=35%  Similarity=0.678  Sum_probs=246.4

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      .+|...+.||+|+|+++|.+++..+|+.||+|++.+..+......+.+.+||++-++++|||||+++++|++.+.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            45999999999999999999999999999999999888888888899999999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~  172 (281)
                      |.|+.++|.++++.++++++.+++.++.||+.||.|||+++|+|||||..|++++++.++||+|||++....   .....
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            999999999999999999999999999999999999999999999999999999999999999999997765   34567


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      .||||+|.|||++....++..+||||+||++|-|+.|++||+..+-.++++.+....+..|.  .++.+.++||.+||.+
T Consensus       178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~  255 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRP  255 (592)
T ss_pred             ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--ccCHHHHHHHHHHhcC
Confidence            79999999999999999999999999999999999999999999999999999998887777  6999999999999999


Q ss_pred             CCCCCCChhhhhcCCccccCCCCCC
Q 038249          253 DSSQRLPLHKLLEHPWIIQNADPSG  277 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~~~~~~  277 (281)
                      ||.+|||+++||.|+||.+...|++
T Consensus       256 ~P~~Rpsl~~vL~h~Ff~~g~~p~~  280 (592)
T KOG0575|consen  256 NPSERPSLDEVLDHPFFKSGFTPAR  280 (592)
T ss_pred             CcccCCCHHHHhcCHhhhCCCcCCC
Confidence            9999999999999999987765554

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-58  Score=368.42  Aligned_cols=263  Identities=33%  Similarity=0.519  Sum_probs=233.8

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-   89 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-   89 (281)
                      .....++.+.++.||+|..|+||+++++.+++.+|+|++...  .++...+++.+|++++++++|||||++++.|..++ 
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            345567899999999999999999999999999999999433  34556788999999999999999999999999998 


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      .+.++||||++|+|...++..+.+++..+..++.++++||.|||+ ++|+||||||+|++++..|.+||+|||.+....+
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            599999999999999999998889999999999999999999995 8999999999999999999999999999876555


Q ss_pred             C-cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCC-----CchHHHHHHhhccccCCCCCCCCHHH
Q 038249          169 R-RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAK-----EHSDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       169 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                      . .....||..|||||.+.+..|+.++||||||++++|+++|+.|+...     ...++...+..+.....+...++.++
T Consensus       232 S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef  311 (364)
T KOG0581|consen  232 SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF  311 (364)
T ss_pred             hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence            4 36678999999999999999999999999999999999999999774     44456666666544333333589999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      ++||..||+.||.+|||+.+++.|||+++..++
T Consensus       312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            999999999999999999999999999987654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-58  Score=371.85  Aligned_cols=262  Identities=35%  Similarity=0.574  Sum_probs=230.8

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchH----HHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ----VEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      +.....|.+.+.||.|+||.|-+|..+++|+.||+|.+.........    ....+.+|+++|++++|||||+++++|..
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            33456799999999999999999999999999999999765543211    22346799999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC---CcEEEeeecCcc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSV  164 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~---~~~~l~dfg~~~  164 (281)
                      .+..|+|+||++||.|.+.+-..+.+.++.-..++.|++.|+.|||++||.||||||+||++..+   -.+||.|||++.
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999877   579999999997


Q ss_pred             ccc--CCcccccCcCCccCCccccCCCC--C-CcccHHhHHHHHHHHHhCCCCCCCCCchH-HHHHHhhccccCC--CCC
Q 038249          165 HTF--NRRRTMCGTLDYLPPEMVESVEH--D-ANVDIWSLGVLCYEFLYGVPPFEAKEHSD-TYRRIVQVDLKFP--PKP  236 (281)
Q Consensus       165 ~~~--~~~~~~~~~~~~~aPE~~~~~~~--~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~--~~~  236 (281)
                      ...  .-.+..||||.|.|||++.+...  . .+.|+|||||++|-+++|.+||.....+. ..+++.++.+.+.  .|.
T Consensus       328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~  407 (475)
T KOG0615|consen  328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD  407 (475)
T ss_pred             ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence            763  33567899999999999966553  3 37799999999999999999998877776 7888888877654  456


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .++++..++|++||..||++|||+.|+|+||||+..+
T Consensus       408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            7999999999999999999999999999999999665

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-56  Score=355.96  Aligned_cols=259  Identities=39%  Similarity=0.681  Sum_probs=239.7

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      ....++|++++.||+|+||+|+.++.+++++.+|+|++.+.........+....|..++.+++||.||+++-.|.+.+.+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            56789999999999999999999999999999999999888777666677889999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc---cC
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT---FN  168 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~---~~  168 (281)
                      |+|++|+.||.|...+++.+.++++.+..++.+|+.||.|||+.||+|||+||+|||+|.+|+++|+|||++...   ..
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998643   33


Q ss_pred             CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                      .+...+||+.|+|||++.+..++..+|.||||+++|+|++|.+||...+.....+.+...+...++ ..++.+.+++|++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p-~~ls~~ardll~~  259 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP-GYLSEEARDLLKK  259 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-ccCCHHHHHHHHH
Confidence            456679999999999999999999999999999999999999999999999999999888743333 2699999999999


Q ss_pred             hcccCCCCCC----ChhhhhcCCcccc
Q 038249          249 MLVKDSSQRL----PLHKLLEHPWIIQ  271 (281)
Q Consensus       249 ~l~~~p~~Rp----s~~eil~~~~~~~  271 (281)
                      +|+.||++|.    ++++|.+||||..
T Consensus       260 LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  260 LLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             HhccCHHHhcCCCCChHHhhcCccccc
Confidence            9999999996    6999999999984

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-55  Score=339.65  Aligned_cols=258  Identities=40%  Similarity=0.705  Sum_probs=247.2

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      ..+++|++++.||.|+||+|.+++++.+|..+|+|++.......-...+...+|.++|+.+.||.++++.+.+.+.+.++
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            67899999999999999999999999999999999998888777777788899999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCccc
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT  172 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~  172 (281)
                      +||||++||.|.+++++.+.+++..++.++.+|+.|++|||+++|++||+||+|||+|.+|.+|+.|||++....+.+-.
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~T  200 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWT  200 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      .||||.|+|||++...+++.++|.|+||+++|||+.|.+||-..++.++++++..+...+|.  ..+.++++||+++|+.
T Consensus       201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~--~fs~~~kdLl~~LL~v  278 (355)
T KOG0616|consen  201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS--YFSSDAKDLLKKLLQV  278 (355)
T ss_pred             ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc--ccCHHHHHHHHHHHhh
Confidence            99999999999999999999999999999999999999999999999999999999888877  6999999999999999


Q ss_pred             CCCCCC-----ChhhhhcCCccccC
Q 038249          253 DSSQRL-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       253 ~p~~Rp-----s~~eil~~~~~~~~  272 (281)
                      |-.+|.     -.++|..||||...
T Consensus       279 D~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  279 DLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             hhHhhhcCcCCCccccccCcccccc
Confidence            999994     47899999999843

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-54  Score=359.45  Aligned_cols=258  Identities=37%  Similarity=0.648  Sum_probs=237.5

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKR   90 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~   90 (281)
                      ....++|..++.||.|+|++|++|.++.++..||||++.+.-+..+.-...+..|-+.|.++ .||.|++++-.|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            55678999999999999999999999999999999999777666655556677888888888 89999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      +|+|+||+++|.|.+++++.+.+++.-++.++.+|+.||+|||++||+||||||+||++|.+++++|.|||.+....+..
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999874332211


Q ss_pred             ----------------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC
Q 038249          171 ----------------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP  234 (281)
Q Consensus       171 ----------------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (281)
                                      ...+||..|.+||++.....++.+|+|+|||++|+|+.|.+||...+.--+++.++.-.+.++.
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~  308 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE  308 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence                            2357899999999999999999999999999999999999999999999999999998877777


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          235 KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                        ..++..++||+++|..||++|+++.+|.+||||..
T Consensus       309 --~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  309 --GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             --CCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence              69999999999999999999999999999999984

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.7e-55  Score=339.02  Aligned_cols=255  Identities=29%  Similarity=0.521  Sum_probs=218.6

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      |+.|+.+..+|+|+||.||+++++.+|+.||||++..+. ++....+...+||++|++++|+|+|.++.+|.....+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            678999999999999999999999999999999997765 4455567778999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---
Q 038249           95 LEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---  170 (281)
                      +|||+. ++.+.++.. ..++.+.+..++.|++.|+.|+|+++++||||||+||+++.+|.+||+|||+++......   
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            999998 555555543 458999999999999999999999999999999999999999999999999987655322   


Q ss_pred             ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc------------------
Q 038249          171 RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK------------------  231 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  231 (281)
                      ...+.|-+|.|||.+.+ .+|+.+.|||++||++.||++|.+.|.+.+.-+++..+...-..                  
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            22356889999999865 88999999999999999999999999998888776554432111                  


Q ss_pred             -CCCC----------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          232 -FPPK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       232 -~~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                       .|..          +..+.-+.+++++||..||++|++.+++|+||||..
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence             1111          235667899999999999999999999999999963

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-53  Score=344.23  Aligned_cols=259  Identities=32%  Similarity=0.622  Sum_probs=234.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ...+|.+.+.||+|+|++||+|+++.++..||||.+..... .....+.+..|+.+|+.++|||||.+++++..++.+++
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            45789999999999999999999999999999999987754 34556778899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC------CcEEEeeecCccccc
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ------GELKIADFGWSVHTF  167 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~------~~~~l~dfg~~~~~~  167 (281)
                      |||||+||+|.++++..+.+++..++.++.||+.|+++||+++|+||||||+||+++..      -.+||.|||+++...
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999875      358999999997765


Q ss_pred             CC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCC-CCCCHHHHH
Q 038249          168 NR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK-PIVSSAAKD  244 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~  244 (281)
                      +.  ....+|+|-|||||++....|+.++|+||+|+++|++++|+.||...+..+++..+.++....+.. ...+..+.+
T Consensus       167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~  246 (429)
T KOG0595|consen  167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRE  246 (429)
T ss_pred             chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhh
Confidence            44  355689999999999999999999999999999999999999999999999998877765544433 246777889


Q ss_pred             HHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          245 LISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      ++...|+.+|..|.+..+-+.|+++..++
T Consensus       247 Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  247 LLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            99999999999999999999999998763

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.7e-53  Score=354.64  Aligned_cols=262  Identities=38%  Similarity=0.643  Sum_probs=240.7

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      +.+...++|++++.||+|+||.||+|+.+.||+.+|+|++.++.+........++.|-.+|...++++||+++-.|.+.+
T Consensus       135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            34667899999999999999999999999999999999999998888777888999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc---
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT---  166 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~---  166 (281)
                      .+|+||||.+||++..++...+.|+++.++.++.+++.|+..+|+.|++|+||||+|+++|..|++||+|||++...   
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999986210   


Q ss_pred             -----------------------cC---Cc---------------------ccccCcCCccCCccccCCCCCCcccHHhH
Q 038249          167 -----------------------FN---RR---------------------RTMCGTLDYLPPEMVESVEHDANVDIWSL  199 (281)
Q Consensus       167 -----------------------~~---~~---------------------~~~~~~~~~~aPE~~~~~~~~~~~Di~sl  199 (281)
                                             ..   ..                     ...+|||.|+|||++.+..|+..+|.|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                   00   00                     11358999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccCCCCCCCCHHHHHHHHHhcccCCCCCCC---hhhhhcCCccccC
Q 038249          200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPIVSSAAKDLISQMLVKDSSQRLP---LHKLLEHPWIIQN  272 (281)
Q Consensus       200 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~~~~~~~~  272 (281)
                      |||+|||+.|.+||...++.++++.+...+  +.+|....++++..+||.+||. ||++|.-   ++||..||||+..
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            999999999999999999999999998876  6777777899999999999999 9999985   9999999999853

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=353.47  Aligned_cols=257  Identities=35%  Similarity=0.733  Sum_probs=234.0

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeeccccc-c-hHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCC
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-Q-SQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQK   89 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~-~-~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~   89 (281)
                      ....+|.+++.||.|+||.|+.|.+..++..||+|.+...... . ....+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567999999999999999999999999999999977654221 1 133456778999999999 999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC-CcEEEeeecCcccc--
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-GELKIADFGWSVHT--  166 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~-~~~~l~dfg~~~~~--  166 (281)
                      .+++||||+.||.|.+++...+++.+.+++.++.||+.|++|+|++||+||||||+|++++.+ +++||+|||++...  
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999999999999998899999999999999999999999999999999999999999 99999999998765  


Q ss_pred             -cCCcccccCcCCccCCccccCCC-CC-CcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCC-CHHH
Q 038249          167 -FNRRRTMCGTLDYLPPEMVESVE-HD-ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV-SSAA  242 (281)
Q Consensus       167 -~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l  242 (281)
                       .......+|++.|+|||++.+.. |+ .++||||+|+++|-|++|..||...+...+...+..+.+..+..  + +.++
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~--~~S~~~  251 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY--LLSPEA  251 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC--cCCHHH
Confidence             34557789999999999998876 75 68999999999999999999999999999999988888888775  5 9999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      ++++.+||.+||.+|+++.+|++||||+.
T Consensus       252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  252 RSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999999998

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-52  Score=353.36  Aligned_cols=263  Identities=37%  Similarity=0.688  Sum_probs=236.9

Q ss_pred             hhhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249            7 AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus         7 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      ..+...|.+++|++.+.||.|++|.||+|+++.+++.+|+|.+...........+.+.+|+.++++++||||+++++.+.
T Consensus         9 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   88 (329)
T PTZ00263          9 KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ   88 (329)
T ss_pred             ccccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            34677889999999999999999999999999999999999997654444444567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           87 DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      ..+..++||||+.+++|.+.+...+.+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        89 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263         89 DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             cCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999998766


Q ss_pred             cCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          167 FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                      ........+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+.  .++.++.++|
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li  246 (329)
T PTZ00263        169 PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--WFDGRARDLV  246 (329)
T ss_pred             CCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC--CCCHHHHHHH
Confidence            55555567899999999999888999999999999999999999999888877777777766555443  5889999999


Q ss_pred             HHhcccCCCCCCC-----hhhhhcCCcccc
Q 038249          247 SQMLVKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       247 ~~~l~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      .+||+.||++||+     +++++.||||.+
T Consensus       247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            9999999999997     799999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-55  Score=336.51  Aligned_cols=248  Identities=30%  Similarity=0.528  Sum_probs=220.6

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeee-EEEe-CC
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG-YFYD-QK   89 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~-~~~~-~~   89 (281)
                      .....+|++++.||.|+||+||++....+|..+|.|.+....+ +....+.+..|+.+|++++||||+++++ .+.+ ..
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            3456789999999999999999999999999999999986654 4456788999999999999999999998 4444 44


Q ss_pred             EEEEEEeccCCCChhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh--cC--ceecCCCCCCeEeCCCCcEEEeeec
Q 038249           90 RVYLILEYAAKGELYKELQKC----KYFSERRAATYVASLARALIYCHG--KH--VIHRDIKPENLLIGAQGELKIADFG  161 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~--~~--i~H~di~~~Ni~~~~~~~~~l~dfg  161 (281)
                      .+++|||+|++|+|..+++..    +.+++..+|.++.|++.||+.+|+  ..  ++|+||||.||+++.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            589999999999999998743    459999999999999999999998  44  9999999999999999999999999


Q ss_pred             CcccccCCc---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCC
Q 038249          162 WSVHTFNRR---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV  238 (281)
Q Consensus       162 ~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (281)
                      +++......   -..+|||.||+||.+...+|+.+|||||+||+++||+.-.+||.+.+-.++..++.++.+...+...+
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~Y  253 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHY  253 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHh
Confidence            986654443   34579999999999999999999999999999999999999999999999999999987654554579


Q ss_pred             CHHHHHHHHHhcccCCCCCCCh
Q 038249          239 SSAAKDLISQMLVKDSSQRLPL  260 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~  260 (281)
                      |.+++.+|..|+.+||+.||+.
T Consensus       254 S~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  254 STDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hhHHHHHHHHHccCCcccCCCc
Confidence            9999999999999999999985

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-52  Score=343.79  Aligned_cols=254  Identities=36%  Similarity=0.668  Sum_probs=229.0

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||+|.++.+++.+|+|.+...........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999997654433344567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccccC
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG  175 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (281)
                      ||+++++|.+++...+.+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||++...........+
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~g  160 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG  160 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccccC
Confidence            99999999999998888999999999999999999999999999999999999999999999999998765555555678


Q ss_pred             cCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 038249          176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSS  255 (281)
Q Consensus       176 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  255 (281)
                      ++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+......++.  .++..+.++|++||+.||.
T Consensus       161 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dp~  238 (291)
T cd05612         161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR--HLDLYAKDLIKKLLVVDRT  238 (291)
T ss_pred             ChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc--cCCHHHHHHHHHHcCCCHH
Confidence            99999999998888999999999999999999999999988887877777776555544  4789999999999999999


Q ss_pred             CCCC-----hhhhhcCCcccc
Q 038249          256 QRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       256 ~Rps-----~~eil~~~~~~~  271 (281)
                      +||+     ++++++||||..
T Consensus       239 ~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         239 RRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HccCCccCCHHHHhcCccccC
Confidence            9995     999999999974

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-53  Score=346.69  Aligned_cols=259  Identities=30%  Similarity=0.494  Sum_probs=224.2

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCC
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQK   89 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~   89 (281)
                      .+..+++|+++++||.|.||.||+|+.+.+|+.||||.+.......++ . .-.+|+..|+++. ||||+++.+++.+.+
T Consensus         5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~-~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-C-MNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-H-HHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            456789999999999999999999999999999999999765433222 2 2356999999998 999999999999887


Q ss_pred             -EEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           90 -RVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        90 -~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                       .+++||||++. +|+++++.+ +++++..++.|+.||+.||+++|++|++|||+||+||++.....+||.|||+++...
T Consensus        83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence             99999999977 999999876 569999999999999999999999999999999999999999999999999997765


Q ss_pred             CCcc--cccCcCCccCCccc-cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc----------------
Q 038249          168 NRRR--TMCGTLDYLPPEMV-ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------  228 (281)
Q Consensus       168 ~~~~--~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------------  228 (281)
                      ....  ..+.|-+|.|||++ .++.|+.+.|+|++||+++|+++-++.|.+.+..+++.++...                
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence            5443  34679999999995 6777999999999999999999999999998888877665442                


Q ss_pred             ---cccCCCC---------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          229 ---DLKFPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       229 ---~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                         .+.++..         +..+.++.++|.+||++||++|||+.++|+||||+..
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence               1222221         3478899999999999999999999999999999966

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-53  Score=319.26  Aligned_cols=263  Identities=70%  Similarity=1.225  Sum_probs=247.3

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ...+|.+++|++++.||.|.||.||+|+.++++..+|+|++.++.+......+.+.+|+++.+.++||||++++++|.+.
T Consensus        15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            34789999999999999999999999999999999999999988887777888999999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           89 KRVYLILEYAAKGELYKELQ--KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      ..+|+++||...|++...+.  ....+++...+.++.|++.|+.|+|..+++||||+|+|++++.+|.+|+.|||.+...
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999999999998  4567999999999999999999999999999999999999999999999999998776


Q ss_pred             c-CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          167 F-NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       167 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                      + +.....|||..|.+||...+..++...|+|++|++.+|++.|.+||+..+..++++.+.+....++.  .++.+.+++
T Consensus       175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~--~is~~a~dl  252 (281)
T KOG0580|consen  175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS--TISGGAADL  252 (281)
T ss_pred             CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc--ccChhHHHH
Confidence            4 4456678999999999999999999999999999999999999999999999999999999888774  799999999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      |.+||..+|.+|.+..|++.|||+.++.
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~a~~  280 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIVANG  280 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHHhcC
Confidence            9999999999999999999999998764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-51  Score=334.25  Aligned_cols=257  Identities=32%  Similarity=0.558  Sum_probs=216.9

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC--EEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK--RVY   92 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~   92 (281)
                      ..++..++.||+|+||.||++.+.++|..+|+|.+.....   ...+.+.+|+++|++++|||||++++.....+  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            4568899999999999999999999999999999966521   22677899999999999999999999754444  699


Q ss_pred             EEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-CCcEEEeeecCcccccC--
Q 038249           93 LILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-QGELKIADFGWSVHTFN--  168 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-~~~~~l~dfg~~~~~~~--  168 (281)
                      +.|||+++|+|.++++..+ .+++..++.+..||+.||.|||++||+|+||||+||+++. ++.+||.|||.+.....  
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999876 7999999999999999999999999999999999999999 79999999998865442  


Q ss_pred             ----CcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCC-CchHHHHHHhhccccCCCCCCCCHHH
Q 038249          169 ----RRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAK-EHSDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       169 ----~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                          ......||+.|+|||++..+ ...+.+|||||||++.||+||..||... ...+..-.+.........+..++.+.
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence                12345689999999998853 3445899999999999999999999873 44333333333322223344699999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      ++||.+|+..||++|||++++|+|||.++...
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999987654

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-51  Score=343.84  Aligned_cols=262  Identities=33%  Similarity=0.615  Sum_probs=232.0

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSN-HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~-~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      .......++|++.+.||.|++|.||+|.++.++ ..+|+|.+.............+.+|+.+++.++||||+++++++.+
T Consensus        23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD  102 (340)
T ss_pred             cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence            345667789999999999999999999987655 6799999866544344445668889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      .+..++||||+.+++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999999999999988889999999999999999999999999999999999999999999999999987655


Q ss_pred             CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          168 NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      .......+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.......+.......+.  .++.++.++|+
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~  260 (340)
T PTZ00426        183 TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK--FLDNNCKHLMK  260 (340)
T ss_pred             CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHH
Confidence            5455567899999999998888899999999999999999999999988887777777766544443  58899999999


Q ss_pred             HhcccCCCCCC-----ChhhhhcCCccccC
Q 038249          248 QMLVKDSSQRL-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       248 ~~l~~~p~~Rp-----s~~eil~~~~~~~~  272 (281)
                      +||+.||++|+     +++++++||||.+.
T Consensus       261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999995     89999999999853

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.3e-51  Score=312.66  Aligned_cols=257  Identities=30%  Similarity=0.507  Sum_probs=221.2

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      .+|...+.||+|.||.||+|++..+|+.||||++...+. .+.......+||..|+.++|+||+.++|+|...+.+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            579999999999999999999999999999999977653 3334566788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc---
Q 038249           96 EYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR---  171 (281)
Q Consensus        96 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~---  171 (281)
                      ||++. +|+..++.. ..++..++..++.++++|++|||++.|+|||+||.|++++.+|.+|+.|||+++.......   
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            99977 999999865 4699999999999999999999999999999999999999999999999999866543322   


Q ss_pred             cccCcCCccCCcccc-CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc--cccCCCC-------------
Q 038249          172 TMCGTLDYLPPEMVE-SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--DLKFPPK-------------  235 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~-------------  235 (281)
                      ..+-|-+|.|||.+. ...|+...|+||.||++.||+.|.+.|.+.++-+++..+...  ......|             
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            225688999999875 455899999999999999999999999998888877665442  1111111             


Q ss_pred             -----------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          236 -----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       236 -----------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                                 +..+.++.+++.+||.+||.+|+++.++|+|+||.+.+-
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence                       226677899999999999999999999999999997543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-51  Score=344.82  Aligned_cols=257  Identities=29%  Similarity=0.504  Sum_probs=229.8

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ..|+..+.||+|+.|.||.|....+++.||+|.+........   +-+.+|+.+++..+|+|||.+++.|.-.+.+|+||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            468888999999999999999999999999999977765443   46889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~  172 (281)
                      ||++||+|.+.+.... +++.++..++.+++.||.|||.+||+|+|||.+||+++.+|.+||+|||++.+....   ...
T Consensus       350 Eym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             eecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            9999999999988755 899999999999999999999999999999999999999999999999998664433   345


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHH-HhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRR-IVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ..|||.|||||+.....|+++.||||||++.+||+.|.+||-..++..-... ...+.........++.++++||.+||+
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~  508 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV  508 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence            6799999999999999999999999999999999999999987666554444 355667777777899999999999999


Q ss_pred             cCCCCCCChhhhhcCCccccCCCCC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                      .|+.+|+|+.|+|+||||+....++
T Consensus       509 ~dv~~RasA~eLL~HpFl~~a~p~s  533 (550)
T KOG0578|consen  509 VDVEQRASAKELLEHPFLKMAKPES  533 (550)
T ss_pred             cchhcCCCHHHHhcChhhhhcCCHH
Confidence            9999999999999999997654433

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-50  Score=340.52  Aligned_cols=257  Identities=33%  Similarity=0.527  Sum_probs=227.0

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997654444444567888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccccC
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG  175 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (281)
                      ||+++++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++...........+
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~g  160 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVG  160 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999998765555555678


Q ss_pred             cCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc--cCCCC----CCCCHHHHHHHHHh
Q 038249          176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL--KFPPK----PIVSSAAKDLISQM  249 (281)
Q Consensus       176 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~l~~li~~~  249 (281)
                      ++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.....  ..+..    ..++.++.++|.+|
T Consensus       161 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  240 (333)
T cd05600         161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL  240 (333)
T ss_pred             CccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHH
Confidence            9999999999888999999999999999999999999998877776665544321  11111    24689999999999


Q ss_pred             cccCCCCCCChhhhhcCCccccC
Q 038249          250 LVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       250 l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      |..+|++||+++++++||||.+.
T Consensus       241 l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         241 INDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             hhChhhhcCCHHHHHhCcccCCC
Confidence            99999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-51  Score=346.95  Aligned_cols=263  Identities=33%  Similarity=0.601  Sum_probs=238.8

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ..-.+.-|++++.||.|+.|.|-+|++..||+..|||.+......+......+.+||-+++.+.|||++++++++.+..+
T Consensus         7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen    7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            34456778899999999999999999999999999999976533344445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      +|+|.||++||-|.+++-..+++++.++.+.++||+.|+.|+|..+|+|+|++|+|+++|..+++||.|||++....+. 
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999998554443 


Q ss_pred             -cccccCcCCccCCccccCCCCC-CcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHD-ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                       ....||.|-|.+||+..+.+|+ .++||||.|+|++.|++|++||++.+-..++.++..+.+..|  ..++.+.++||+
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP--s~Is~eaQdLLr  244 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP--SNISSEAQDLLR  244 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC--CcCCHHHHHHHH
Confidence             4667999999999999998874 689999999999999999999998888888889988877766  479999999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      +||..||.+|+|.+||++|||++.+...
T Consensus       245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  245 RMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             HHhccCccccccHHHHhhCchhhcCCCC
Confidence            9999999999999999999999987443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=329.56  Aligned_cols=263  Identities=29%  Similarity=0.461  Sum_probs=229.9

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ..-.....+|++...||.|..++||+|+....++.||||++..+....+  ...+.+|++.++.++||||++.+..|..+
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            3344556899999999999999999999999999999999988775544  67899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           89 KRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      ..+|+||+|+.+|++.++++..  ..+++..|..+++++++||.|||.+|.+|||||+.||+++.+|.++|+|||.+...
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            9999999999999999999875  33899999999999999999999999999999999999999999999999976433


Q ss_pred             cCCc-------ccccCcCCccCCccc--cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc------
Q 038249          167 FNRR-------RTMCGTLDYLPPEMV--ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK------  231 (281)
Q Consensus       167 ~~~~-------~~~~~~~~~~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------  231 (281)
                      ....       ....+++.|+|||++  .-..|+.++||||||++..||.+|..||....+.+.+-..++....      
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            2211       345789999999995  3445889999999999999999999999999999887766665543      


Q ss_pred             --CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          232 --FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       232 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                        ......++..++.+|..||..||++|||+.++|+|+||++..
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence              222235778899999999999999999999999999999764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.1e-50  Score=338.14  Aligned_cols=248  Identities=36%  Similarity=0.616  Sum_probs=219.9

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG  101 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~  101 (281)
                      +.||+|+||.||+|.++.+|+.+|+|++.............+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997654434444556778999999999999999999999999999999999999


Q ss_pred             ChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCcccccCcCC
Q 038249          102 ELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLD  178 (281)
Q Consensus       102 ~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~~~~~~~  178 (281)
                      +|.+.+...+.+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++....   .......+++.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            999999888889999999999999999999999999999999999999999999999999875422   12234568999


Q ss_pred             ccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 038249          179 YLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL  258 (281)
Q Consensus       179 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  258 (281)
                      |+|||.+.+..++.++|+|||||++++|++|..||...+.......+......++.  .++.++.++|.+||+.||++||
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~  238 (323)
T cd05571         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcC
Confidence            99999999888999999999999999999999999888777777766665544443  6899999999999999999999


Q ss_pred             -----ChhhhhcCCcccc
Q 038249          259 -----PLHKLLEHPWIIQ  271 (281)
Q Consensus       259 -----s~~eil~~~~~~~  271 (281)
                           ++.++++||||..
T Consensus       239 ~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         239 GGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             CCCCCCHHHHHcCCCcCC
Confidence                 8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-50  Score=334.06  Aligned_cols=259  Identities=29%  Similarity=0.468  Sum_probs=222.5

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--   88 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--   88 (281)
                      .+...+.|+.+++||+|.||.||+|++..+|+.||+|++..+.. .+.......+||.+|++++||||+++.++....  
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~  190 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS  190 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence            34556789999999999999999999999999999999977653 344566788999999999999999999999876  


Q ss_pred             CEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           89 KRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      +.+|+|+||++. +|..++... -.+++.++..++.||+.||.|+|++||+|||||..||++|.+|.+||.|||++....
T Consensus       191 ~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  191 GSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             ceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            799999999998 898888874 359999999999999999999999999999999999999999999999999997443


Q ss_pred             CCc----ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc--cccCCCC-----
Q 038249          168 NRR----RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--DLKFPPK-----  235 (281)
Q Consensus       168 ~~~----~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~-----  235 (281)
                      ...    ...+-|.+|.|||++.+ ..|+...|+||.|||+.||+.|++.|.+.+..+++..+..-  ......|     
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            332    23456889999999754 56899999999999999999999999999998888766442  1111111     


Q ss_pred             --------------------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          236 --------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       236 --------------------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                                          ..++....+|+..||+.||.+|.|+.++|.++||..
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                                237788899999999999999999999999999943

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=332.82  Aligned_cols=251  Identities=27%  Similarity=0.485  Sum_probs=221.1

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcE-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-   89 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~-~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-   89 (281)
                      .....+..+.+.||.|+||+||++.++  |+. +|+|.+......... .+.+.+|+.++++++||||++++|++.+.. 
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            344567788888999999999999999  666 999999777655554 778999999999999999999999999887 


Q ss_pred             EEEEEEeccCCCChhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC-ceecCCCCCCeEeCCCC-cEEEeeecCccc
Q 038249           90 RVYLILEYAAKGELYKELQK--CKYFSERRAATYVASLARALIYCHGKH-VIHRDIKPENLLIGAQG-ELKIADFGWSVH  165 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~-i~H~di~~~Ni~~~~~~-~~~l~dfg~~~~  165 (281)
                      ..++||||+++|+|.+++..  .+.++...+..++.+|++||.|||+++ |+|+||||+||+++.++ ++||+|||++..
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            79999999999999999987  577999999999999999999999999 99999999999999998 999999999865


Q ss_pred             ccC---CcccccCcCCccCCcccc--CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCH
Q 038249          166 TFN---RRRTMCGTLDYLPPEMVE--SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       166 ~~~---~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
                      ...   ......||..|||||++.  ...++.++||||||+++|||+||..||......+....+............++.
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~  273 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP  273 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            442   333367899999999998  678999999999999999999999999999997766666555444444445999


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhc
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .+..++.+||+.||..||++.+|+.
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            9999999999999999999999885

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.8e-49  Score=338.53  Aligned_cols=256  Identities=31%  Similarity=0.548  Sum_probs=222.2

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||+|++|+||+|.++.+++.+|+|++.............+..|+.++++++|+||+++++.+.+...+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997654444445567888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC------
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR------  169 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~------  169 (281)
                      ||+++++|.+++...+.+++..+..++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999987532110      


Q ss_pred             --------------------------------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCC
Q 038249          170 --------------------------------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE  217 (281)
Q Consensus       170 --------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  217 (281)
                                                      ....+||+.|+|||.+.+..++.++|+|||||++++|++|..||...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                                            012368999999999988889999999999999999999999999888


Q ss_pred             chHHHHHHhhc--cccCCCCCCCCHHHHHHHHHhcccCCC---CCCChhhhhcCCccccC
Q 038249          218 HSDTYRRIVQV--DLKFPPKPIVSSAAKDLISQMLVKDSS---QRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       218 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~---~Rps~~eil~~~~~~~~  272 (281)
                      ..+....+...  ...++....++.++.++|.+|+. +|+   .||+++||++||||+..
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            87777776653  23344444578999999999876 444   46899999999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.9e-51  Score=341.16  Aligned_cols=254  Identities=33%  Similarity=0.589  Sum_probs=234.5

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      |++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+..... ...+.+.+|++++++++||||+.+++.|+...++++|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            689999999999999999999999999999999998766443 3467899999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---c
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---R  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---~  171 (281)
                      .||+.| +|..+++..+.++++.+..++.+++.||.|||+++|.|+|++|.||+++.+|.+|++|||+++.+...+   .
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            999988 999999999999999999999999999999999999999999999999999999999999987655443   3


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ...|||.|||||.+.+.+|+..+|+|||||++||++.|++||-..+-.+..+.+......++.  ..+..+.++++.+|.
T Consensus       159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~  236 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS--TASSSFVNFLQGLLI  236 (808)
T ss_pred             eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc--cccHHHHHHHHHHhh
Confidence            346899999999999999999999999999999999999999988888888888887666665  799999999999999


Q ss_pred             cCCCCCCChhhhhcCCccccC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .||..|.+-.+++.|||.+..
T Consensus       237 kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  237 KDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             cChhhcccHHHHhcChHHhhh
Confidence            999999999999999999854

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-50  Score=340.53  Aligned_cols=256  Identities=39%  Similarity=0.697  Sum_probs=227.3

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|+||+|++..+++.||+|++.............+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999997655444344567888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-----
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-----  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-----  170 (281)
                      ||+++++|.+++...+.+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||++.......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999875433221     


Q ss_pred             ---------------------------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHH
Q 038249          171 ---------------------------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR  223 (281)
Q Consensus       171 ---------------------------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  223 (281)
                                                 ....+++.|+|||.+.+..++.++|||||||++++|++|..||...+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                                       23458899999999998899999999999999999999999999888777777


Q ss_pred             HHhh--ccccCCCCCCCCHHHHHHHHHhcccCCCCCCC-hhhhhcCCccccC
Q 038249          224 RIVQ--VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLP-LHKLLEHPWIIQN  272 (281)
Q Consensus       224 ~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~eil~~~~~~~~  272 (281)
                      .+..  .....+....++.++.++|.+||. ||.+||+ ++++++||||++.
T Consensus       241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            7666  444455555579999999999997 9999999 9999999999853

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-50  Score=318.36  Aligned_cols=260  Identities=28%  Similarity=0.453  Sum_probs=222.1

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--CEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--KRV   91 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~   91 (281)
                      .+++|+.+..|++|+||.||+|+++.+++.||+|++..+. ..+...-.-.+||.+|.+++|||||.+..+...+  +.+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            4578999999999999999999999999999999996654 3333334567899999999999999999998864  579


Q ss_pred             EEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           92 YLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      |+||||++. +|..++.+.+ ++...++..++.|+++|++|||.+.|+|||+||+|++++..|.+|++|||+++..... 
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999999988 9999998775 7999999999999999999999999999999999999999999999999999776555 


Q ss_pred             --cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc--cccCCCC---------
Q 038249          170 --RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--DLKFPPK---------  235 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~---------  235 (281)
                        ....+-|.+|.|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+.+..+++..+.+.  ......|         
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence              233456889999999754 55899999999999999999999999999888887766543  1111111         


Q ss_pred             -----------------C--CCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          236 -----------------P--IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       236 -----------------~--~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                       +  .+++.-.+|++.+|.+||++|.|++|.|+|+||.+.+.+
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence                             0  155888999999999999999999999999999986544

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.6e-50  Score=322.83  Aligned_cols=263  Identities=38%  Similarity=0.620  Sum_probs=240.6

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ....+.++.|++++.||+|.-|+||++..+.++..+|+|++.+..+....-...+..|-++|+.++||.+.+++..++.+
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD  149 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence            44567788999999999999999999999999999999999988877766677788899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           89 KRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      ...|++||||+||+|..+++++  +.+++..++.++.+++.||+|||-.||+.||+||+|||+-++|++-|+||+++...
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999999999999999876  45999999999999999999999999999999999999999999999999986211


Q ss_pred             c----------------------------------CCc-------------------------ccccCcCCccCCccccC
Q 038249          167 F----------------------------------NRR-------------------------RTMCGTLDYLPPEMVES  187 (281)
Q Consensus       167 ~----------------------------------~~~-------------------------~~~~~~~~~~aPE~~~~  187 (281)
                      .                                  ...                         ...+||-.|+|||+..+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            0                                  000                         11347888999999999


Q ss_pred             CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC----hhhh
Q 038249          188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLP----LHKL  263 (281)
Q Consensus       188 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~ei  263 (281)
                      ...+.+.|.|+||+++|||+.|..||.+.++.+++.+++.....++..+..+.++++||+++|..||++|..    +.||
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            999999999999999999999999999999999999999999999998889999999999999999999998    9999


Q ss_pred             hcCCcccc
Q 038249          264 LEHPWIIQ  271 (281)
Q Consensus       264 l~~~~~~~  271 (281)
                      -+||||+-
T Consensus       390 K~HpFF~g  397 (459)
T KOG0610|consen  390 KRHPFFEG  397 (459)
T ss_pred             hcCccccC
Confidence            99999983

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-52  Score=315.73  Aligned_cols=259  Identities=32%  Similarity=0.602  Sum_probs=232.9

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      .-.++|++-+.||+|+|+.|+++.+..+|+.+++|.+....+... .-+++.+|+++-+.++||||+++.+.+...+..+
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   86 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence            344789999999999999999999999999999999876655443 4678999999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC---CcEEEeeecCcccccCC
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTFNR  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~---~~~~l~dfg~~~~~~~~  169 (281)
                      +|+|++.|+.|-.-+-.+-..++..+-..+.||+++|.|+|.+||+|+|++|+|+++-..   .-+||+|||++....+.
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            999999999997776665667899999999999999999999999999999999999543   35999999999776643


Q ss_pred             c--ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCCCHHHHHH
Q 038249          170 R--RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIVSSAAKDL  245 (281)
Q Consensus       170 ~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l  245 (281)
                      .  ....|||.|+|||++...+++.++|||+-|++++-|+.|.+||.+.+...+++.+.++.+..+  .+++++++.++|
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L  246 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL  246 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence            2  345689999999999999999999999999999999999999999999999999999877665  478899999999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCccccC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +++||..||.+|+|+.|+|+|||+.+-
T Consensus       247 vrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  247 IRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHhccChhhhccHHHHhCCchhcch
Confidence            999999999999999999999999864

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-49  Score=330.61  Aligned_cols=247  Identities=35%  Similarity=0.608  Sum_probs=218.7

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCCh
Q 038249           24 LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGEL  103 (281)
Q Consensus        24 ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  103 (281)
                      ||+|+||.||+|.+..+++.+|+|.+.............+..|+.++++++||||+++++.+...+..++|+||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999999765444444456678899999999999999999999999999999999999999


Q ss_pred             hHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---CcccccCcCCcc
Q 038249          104 YKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRTMCGTLDYL  180 (281)
Q Consensus       104 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~  180 (281)
                      .+.+...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....   ......+++.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            99998888899999999999999999999999999999999999999999999999998754222   223346899999


Q ss_pred             CCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC--
Q 038249          181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL--  258 (281)
Q Consensus       181 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp--  258 (281)
                      |||.+.+..++.++||||||+++++|++|..||...+..+....+.......+.  .++.++.++|.+||..||++||  
T Consensus       161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~  238 (312)
T cd05585         161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGY  238 (312)
T ss_pred             CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCC
Confidence            999999888999999999999999999999999988877777777666554443  6899999999999999999997  


Q ss_pred             -ChhhhhcCCccccC
Q 038249          259 -PLHKLLEHPWIIQN  272 (281)
Q Consensus       259 -s~~eil~~~~~~~~  272 (281)
                       ++.+++.||||.+.
T Consensus       239 ~~~~e~l~hp~~~~~  253 (312)
T cd05585         239 NGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCHHHHHcCCCcCCC
Confidence             47999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-50  Score=341.00  Aligned_cols=258  Identities=34%  Similarity=0.624  Sum_probs=238.4

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCC
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQK   89 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~   89 (281)
                      .++.+++|.+++.||+|+||.|+++..+.+++.+|||++.+..+-.++..+....|.+++... +||.++.++..|...+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            578899999999999999999999999999999999999999888777788888899888877 5999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc--
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF--  167 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~--  167 (281)
                      ++++||||+.||++.... ..+.+++..+..++..++.||+|||++||++||||.+||++|.+|++||.|||++....  
T Consensus       443 ~l~fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            999999999999954443 44569999999999999999999999999999999999999999999999999986543  


Q ss_pred             -CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          168 -NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       168 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                       +.+...||||.|+|||++....|+...|.||||+++|+|+.|..||.+.+..+.+..++.....+|.  .++.+..+++
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~--~ls~ea~~il  599 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSKEAIAIM  599 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--cccHHHHHHH
Confidence             4467789999999999999999999999999999999999999999999999999999998887777  5999999999


Q ss_pred             HHhcccCCCCCCC-----hhhhhcCCcccc
Q 038249          247 SQMLVKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       247 ~~~l~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      +++|..+|++|.-     +++|..||||..
T Consensus       600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence            9999999999995     589999999984

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-49  Score=338.17  Aligned_cols=256  Identities=36%  Similarity=0.624  Sum_probs=223.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|+||+||+|++..+++.||+|++.............+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997654444444566788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-----
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-----  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-----  170 (281)
                      ||+++++|.+++...+.+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.......     
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999874321110     


Q ss_pred             ------------------------------------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCC
Q 038249          171 ------------------------------------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFE  214 (281)
Q Consensus       171 ------------------------------------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  214 (281)
                                                          ....||+.|+|||++.+..++.++|+|||||++++|++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence                                                12358999999999988889999999999999999999999999


Q ss_pred             CCCchHHHHHHhhcc--ccCCCCCCCCHHHHHHHHHhcccCCCCCCC---hhhhhcCCccccC
Q 038249          215 AKEHSDTYRRIVQVD--LKFPPKPIVSSAAKDLISQMLVKDSSQRLP---LHKLLEHPWIIQN  272 (281)
Q Consensus       215 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~~~~~~~~  272 (281)
                      ..+..+....+....  ...+....++.++.++|.+||. +|.+|++   +++++.||||...
T Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            888777766665433  2333444578999999999997 9999998   9999999999753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-50  Score=318.90  Aligned_cols=258  Identities=32%  Similarity=0.520  Sum_probs=220.3

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-----CCE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-----QKR   90 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~   90 (281)
                      ..|...+.||.|++|.|..+.++.+|+.||+|++.... ...-..+...+|+.+++.++|+||+.+.+++..     -+.
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            45555799999999999999999999999999996443 444455667789999999999999999999865     457


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC--
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN--  168 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~--  168 (281)
                      +|+|+|+++. +|...++.+..++++.+..++.||++||.|+|+.|++|+|+||.|++++.+..+|++|||+++....  
T Consensus       101 vYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  101 VYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             eEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            8999999955 9999999988899999999999999999999999999999999999999999999999999977643  


Q ss_pred             ---CcccccCcCCccCCccc-cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC------------
Q 038249          169 ---RRRTMCGTLDYLPPEMV-ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF------------  232 (281)
Q Consensus       169 ---~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------  232 (281)
                         .......|-+|.|||++ ....|+...||||+||+++||++|++.|.+.+..++++.++..-...            
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence               22334568899999996 66679999999999999999999999999988877766554431110            


Q ss_pred             -----------CC------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          233 -----------PP------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       233 -----------~~------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                 +.      .+..+....+|+.+||..||.+|+|++|+|.|||+...-++
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence                       00      14578889999999999999999999999999999977444

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.7e-49  Score=330.38  Aligned_cols=249  Identities=36%  Similarity=0.625  Sum_probs=219.2

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG  101 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~  101 (281)
                      +.||+|+||.||++.++.+|..||+|.+.............+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999997654333344556778999999999999999999999999999999999999


Q ss_pred             ChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cccccCcCC
Q 038249          102 ELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTMCGTLD  178 (281)
Q Consensus       102 ~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~  178 (281)
                      +|...+...+.+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++......   .....+++.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            99999988888999999999999999999999999999999999999999999999999987542221   233458899


Q ss_pred             ccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 038249          179 YLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL  258 (281)
Q Consensus       179 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  258 (281)
                      |+|||.+.+..++.++|+||||+++++|++|..||...+.......+.......+.  .++.++.++|.+||..||++|+
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~  238 (323)
T cd05595         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHHHhC
Confidence            99999998888999999999999999999999999888777777766655444443  6899999999999999999998


Q ss_pred             -----ChhhhhcCCccccC
Q 038249          259 -----PLHKLLEHPWIIQN  272 (281)
Q Consensus       259 -----s~~eil~~~~~~~~  272 (281)
                           ++.++++||||.+.
T Consensus       239 ~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         239 GGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CCCCCCHHHHHcCCCcCCC
Confidence                 89999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.2e-48  Score=328.73  Aligned_cols=253  Identities=32%  Similarity=0.596  Sum_probs=222.1

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeeeeeEEEeCCEEEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH-PNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +|++.+.||.|++|.||+|++..+++.+|+|++...........+.+..|++++..+.| ++|+++++++...+.+++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999976544334445667788889988876 46888999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~  172 (281)
                      ||+++++|.+.+...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....   .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            999999999999888889999999999999999999999999999999999999999999999999875321   22234


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ..+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+.  .++.++.+++.+||+.
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~  238 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLLTK  238 (324)
T ss_pred             ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhc
Confidence            46899999999999888999999999999999999999999988888888777766554443  5899999999999999


Q ss_pred             CCCCCCCh-----hhhhcCCcccc
Q 038249          253 DSSQRLPL-----HKLLEHPWIIQ  271 (281)
Q Consensus       253 ~p~~Rps~-----~eil~~~~~~~  271 (281)
                      ||++|++.     +++++||||..
T Consensus       239 ~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         239 HPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCC
Confidence            99999986     89999999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.3e-49  Score=330.33  Aligned_cols=248  Identities=35%  Similarity=0.624  Sum_probs=219.0

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG  101 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~  101 (281)
                      +.||+|+||.||++.+..+++.+|+|++.............+.+|+.+++.++||||+++.+.+...+.+++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997654444444567788999999999999999999999999999999999999


Q ss_pred             ChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---CcccccCcCC
Q 038249          102 ELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRTMCGTLD  178 (281)
Q Consensus       102 ~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~  178 (281)
                      +|...+...+.+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.....   ......+++.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            9999998888899999999999999999999999999999999999999999999999998754322   1233468999


Q ss_pred             ccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 038249          179 YLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL  258 (281)
Q Consensus       179 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  258 (281)
                      |+|||.+.+..++.++||||||+++++|++|..||...+..+....+.......+.  .++.++.++|++||..||++|+
T Consensus       161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~  238 (328)
T cd05593         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRL  238 (328)
T ss_pred             ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC--CCCHHHHHHHHHHcCCCHHHcC
Confidence            99999998888999999999999999999999999888777777666655444443  6899999999999999999997


Q ss_pred             -----ChhhhhcCCcccc
Q 038249          259 -----PLHKLLEHPWIIQ  271 (281)
Q Consensus       259 -----s~~eil~~~~~~~  271 (281)
                           ++.++++||||..
T Consensus       239 ~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         239 GGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCCCCCHHHHhcCCCcCC
Confidence                 8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=326.92  Aligned_cols=262  Identities=35%  Similarity=0.621  Sum_probs=229.2

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccc-----------hHHHHHHHHHHHHHHhCCCCcee
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-----------SQVEHQLRREVEIQSHLRHPNIL   79 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~h~~i~   79 (281)
                      ....+++|++.+.||.|.||.|-+|++..+++.||+|++.+.....           .-..+.+.+||.+++++.|+|||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            4456799999999999999999999999999999999996544211           11135789999999999999999


Q ss_pred             eeeeEEEe--CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEE
Q 038249           80 RLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKI  157 (281)
Q Consensus        80 ~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l  157 (281)
                      +++.+..+  .+.+|+|+|||..|.+...-.....+++.+++.++.+++.||+|||.+||+||||||.|++++.+|++||
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence            99999875  4689999999998877665554444999999999999999999999999999999999999999999999


Q ss_pred             eeecCcccccCC--------cccccCcCCccCCccccCCC----CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 038249          158 ADFGWSVHTFNR--------RRTMCGTLDYLPPEMVESVE----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI  225 (281)
Q Consensus       158 ~dfg~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  225 (281)
                      +|||.+......        .....|||.|+|||......    .+.+.||||+|++||.|+.|+.||-+....+++.++
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            999987543111        23367999999999975422    356789999999999999999999999999999999


Q ss_pred             hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ......++..+.+..+++++|.+||..||+.|.+..+|..|||.-+.
T Consensus       332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            99999999888899999999999999999999999999999999877

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-48  Score=335.46  Aligned_cols=257  Identities=30%  Similarity=0.502  Sum_probs=220.6

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.|++++.||+|+||+||+|++..+++.+|+|++.............+.+|+.+++.++|+||+++++.+.+.+.+++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            46999999999999999999999999999999997655444455667889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-------
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-------  168 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-------  168 (281)
                      ||+++++|.+++...+.+++..++.++.||+.||++||+.||+|+||||+||+++.+++++|+|||++.....       
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999998632100       


Q ss_pred             -------------------------------------------CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHH
Q 038249          169 -------------------------------------------RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE  205 (281)
Q Consensus       169 -------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~  205 (281)
                                                                 ......||+.|+|||.+.+..++.++|||||||++++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                       0012358899999999988889999999999999999


Q ss_pred             HHhCCCCCCCCCchHHHHHHhh--ccccCCCCCCCCHHHHHHHHHhcc--cCCCCCCChhhhhcCCccccC
Q 038249          206 FLYGVPPFEAKEHSDTYRRIVQ--VDLKFPPKPIVSSAAKDLISQMLV--KDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       206 l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~--~~p~~Rps~~eil~~~~~~~~  272 (281)
                      |++|..||...+..+....+..  .....+....++.++.++|.+|+.  .++..|+++.+++.||||.+.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            9999999988777665555443  233444444689999999999664  555569999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9.1e-49  Score=324.16  Aligned_cols=253  Identities=30%  Similarity=0.493  Sum_probs=211.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||+|+++.+++.+|+|++..... .......+.+|+.+++.++|+||+++++++...+..++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            479999999999999999999999999999999865532 2233556788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC----cc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR----RR  171 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~----~~  171 (281)
                      ||++++++..+......+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++......    ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            99998777666555567999999999999999999999999999999999999999999999999998654322    12


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc-------------------ccC
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD-------------------LKF  232 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~  232 (281)
                      ...+++.|+|||.+.+..++.++|+||||+++++|++|.+||...+..+....+....                   ...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            2357889999999988889999999999999999999999998766544332221100                   000


Q ss_pred             CC-----------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          233 PP-----------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       233 ~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +.           ...++.++.++|++||++||++|||++++|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00           11367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.2e-48  Score=328.03  Aligned_cols=261  Identities=25%  Similarity=0.448  Sum_probs=221.0

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +..++|++.+.||.|++|.||++++..++..+|+|.+....  .......+.+|++++++++||||+++++++...+..+
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            34588999999999999999999999999999999986542  2344567889999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCCCcEEEeeecCcccccC-Cc
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RR  170 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-~~  170 (281)
                      +||||+++++|.+++...+.+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||++..... ..
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  159 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence            9999999999999999888899999999999999999999986 699999999999999999999999998754322 22


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhh-----------------------
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-----------------------  227 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----------------------  227 (281)
                      ....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+..                       
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence            334678999999999988899999999999999999999999976554433222110                       


Q ss_pred             -----------------------ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          228 -----------------------VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       228 -----------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                             ..........++.++.+||.+||..||++|||++|+++||||++....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~  310 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVE  310 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccc
Confidence                                   000111122478899999999999999999999999999999976543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-49  Score=336.83  Aligned_cols=255  Identities=34%  Similarity=0.580  Sum_probs=220.2

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++++.||.|+||+||++.++.+++.||+|++.............+.+|++++++++||||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999986654434444567888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC------
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR------  169 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~------  169 (281)
                      ||+++++|.+++...+.+++..++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999987421100      


Q ss_pred             --------------------------------------------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHH
Q 038249          170 --------------------------------------------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE  205 (281)
Q Consensus       170 --------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~  205 (281)
                                                                  .....||+.|+|||.+.+..++.++|+|||||++++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE  240 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence                                                        001358899999999988889999999999999999


Q ss_pred             HHhCCCCCCCCCchHHHHHHhhc--cccCCCCCCCCHHHHHHHHHhcccCCCCC---CChhhhhcCCcccc
Q 038249          206 FLYGVPPFEAKEHSDTYRRIVQV--DLKFPPKPIVSSAAKDLISQMLVKDSSQR---LPLHKLLEHPWIIQ  271 (281)
Q Consensus       206 l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~eil~~~~~~~  271 (281)
                      |++|..||...+..+....+...  ....+....++.++.++|.+||. +|.+|   +++.+++.||||..
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            99999999887777766666542  23334444588999999999998 66665   59999999999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.1e-49  Score=329.05  Aligned_cols=248  Identities=35%  Similarity=0.636  Sum_probs=217.9

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||+|++|+||+|+++.+++.||+|++...........+.+..|..+++.. +||||+++++++...+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999765433333445667788888776 699999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~~~~~~  177 (281)
                      ++|...+...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++....   .......+++
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875422   1223446899


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+.  .++.++.++|++||+.||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R  238 (320)
T cd05590         161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLSQDAVDILKAFMTKNPTMR  238 (320)
T ss_pred             cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcccCHHHC
Confidence            999999999888999999999999999999999999988888888777766554443  589999999999999999999


Q ss_pred             CCh------hhhhcCCcccc
Q 038249          258 LPL------HKLLEHPWIIQ  271 (281)
Q Consensus       258 ps~------~eil~~~~~~~  271 (281)
                      |++      ++++.||||..
T Consensus       239 ~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         239 LGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             CCCCCCCCHHHHHcCCCcCC
Confidence            998      99999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.8e-49  Score=334.73  Aligned_cols=260  Identities=35%  Similarity=0.546  Sum_probs=224.8

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      .....++|++.+.||.|++|.||+++++.+++.+|+|.+.............+.+|+.+++.++||||+++++++.+.+.
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            44567899999999999999999999999999999999965543333444567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      .++|+||+++++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...... 
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999999999999998764 4899999999999999999999999999999999999999999999999997554322 


Q ss_pred             ---cccccCcCCccCCccccCC----CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccCCCCCCCCH
Q 038249          170 ---RRTMCGTLDYLPPEMVESV----EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPIVSS  240 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  240 (281)
                         .....+++.|+|||.+.+.    .++.++|+|||||++++|++|..||...+.......+....  ..++....++.
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK  276 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence               2334689999999997543    36789999999999999999999999888777777766533  34444446899


Q ss_pred             HHHHHHHHhcccCCCC--CCChhhhhcCCcccc
Q 038249          241 AAKDLISQMLVKDSSQ--RLPLHKLLEHPWIIQ  271 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~--Rps~~eil~~~~~~~  271 (281)
                      ++.++|.+||..+|++  |+++++++.||||++
T Consensus       277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            9999999999999988  999999999999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-48  Score=321.77  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=215.5

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      .|++.+.||.|+||.||++.+..+++.+|+|.+.............+.+|+.++++++|++++++.+.+.+.+..++|+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            48899999999999999999999999999999876554433444567789999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--ccc
Q 038249           97 YAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRT  172 (281)
Q Consensus        97 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~~  172 (281)
                      |+++++|...+...  ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            99999998877543  35899999999999999999999999999999999999999999999999998654322  233


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhh--ccccCCCCCCCCHHHHHHHHHhc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ--VDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ..++..|+|||.+.+..++.++||||||+++++|++|..||...........+..  ..........++.++.+||++||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  240 (285)
T cd05631         161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL  240 (285)
T ss_pred             CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence            4578999999999988999999999999999999999999987654322222111  11112223358899999999999


Q ss_pred             ccCCCCCCC-----hhhhhcCCccccC
Q 038249          251 VKDSSQRLP-----LHKLLEHPWIIQN  272 (281)
Q Consensus       251 ~~~p~~Rps-----~~eil~~~~~~~~  272 (281)
                      +.||++||+     ++++++||||...
T Consensus       241 ~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         241 TKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             hcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            999999997     8999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-48  Score=335.39  Aligned_cols=256  Identities=31%  Similarity=0.528  Sum_probs=221.4

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++++.||+|+||+||+|++..+++.+|+|.+.............+.+|+.++++++|+||+++++.+.+.+.+++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            36999999999999999999999999999999997654444445667889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-------
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-------  168 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-------  168 (281)
                      ||+++++|.+++...+.+++..++.++.||+.||++||++||+|+||+|+||+++.++.++|+|||++.....       
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            9999999999998878899999999999999999999999999999999999999999999999998632100       


Q ss_pred             -------------------------------------------CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHH
Q 038249          169 -------------------------------------------RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE  205 (281)
Q Consensus       169 -------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~  205 (281)
                                                                 ......||+.|+|||++.+..++.++|||||||++++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                       0012357899999999988889999999999999999


Q ss_pred             HHhCCCCCCCCCchHHHHHHhhc--cccCCCCCCCCHHHHHHHHHhcccCCCCCCC---hhhhhcCCccccC
Q 038249          206 FLYGVPPFEAKEHSDTYRRIVQV--DLKFPPKPIVSSAAKDLISQMLVKDSSQRLP---LHKLLEHPWIIQN  272 (281)
Q Consensus       206 l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~~~~~~~~  272 (281)
                      |++|..||...+..+....+...  ....+....++.++.++|.+|+ .+|.+|++   ++++++||||+..
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            99999999887776666555542  2334444568999999999987 59999997   9999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.8e-48  Score=321.40  Aligned_cols=254  Identities=29%  Similarity=0.521  Sum_probs=211.3

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      .++++|++.+.||.|++|.||+|.++.++..||+|.+......  .....+.+|++++++++||||+++++++...+..+
T Consensus         2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT   79 (288)
T ss_pred             CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            3578999999999999999999999999999999998644322  12345678999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           93 LILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      +|+||+++ +|.+.+... ..++...++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||++......  
T Consensus        80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            99999986 888888654 45789999999999999999999999999999999999999999999999987543222  


Q ss_pred             -cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-----------------
Q 038249          170 -RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-----------------  230 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------  230 (281)
                       .....+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+..+....+.....                 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence             223456889999998754 5678899999999999999999999987766555443322100                 


Q ss_pred             --cCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          231 --KFP---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       231 --~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                        ..+         ..+.++.++.++|++||+.||++|||++|+++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence              000         113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.1e-49  Score=331.01  Aligned_cols=255  Identities=38%  Similarity=0.616  Sum_probs=222.6

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||+|++|+||++.++.+++.+|+|.+.............+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999997665444445667888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc----
Q 038249           96 EYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~----  170 (281)
                      ||+++++|.++++.. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            999999999999876 679999999999999999999999999999999999999999999999999985443221    


Q ss_pred             ccccCcCCccCCcccc------CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccCCCCCCCCHHH
Q 038249          171 RTMCGTLDYLPPEMVE------SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPIVSSAA  242 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l  242 (281)
                      ....+++.|+|||.+.      ...++.++||||||+++++|++|..||...+.......+....  ..++..+.++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            2345789999999985      4557789999999999999999999998888777776665432  3344445689999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      .++|.+||. +|++||++++++.||||.+
T Consensus       241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            999999998 9999999999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-48  Score=325.23  Aligned_cols=259  Identities=39%  Similarity=0.678  Sum_probs=236.4

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ..|++.+.||.|.||.||.++.+.+|+.+|+|.+.............+.+|+.+++++. ||||+.+.+.++....+++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            57999999999999999999999999999999998777655555678999999999998 99999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC----CcEEEeeecCcccccC--
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ----GELKIADFGWSVHTFN--  168 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~----~~~~l~dfg~~~~~~~--  168 (281)
                      ||++.||.|.+.+... .+++..+..++.||+.++.|||+.|++|+|++|+|+++...    +.++++|||++.....  
T Consensus       115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~  193 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE  193 (382)
T ss_pred             EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence            9999999999999876 49999999999999999999999999999999999999654    4799999999977665  


Q ss_pred             CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc--CCCCCCCCHHHHHHH
Q 038249          169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK--FPPKPIVSSAAKDLI  246 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li  246 (281)
                      .....+||+.|+|||++....++...||||+|+++|.|++|.+||...+.......+..+.+.  .+.++.++..+.++|
T Consensus       194 ~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i  273 (382)
T KOG0032|consen  194 RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFI  273 (382)
T ss_pred             eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHH
Confidence            345678999999999999999999999999999999999999999999999998888887664  446778999999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      +.||..||.+|+|+.++|.|||+......
T Consensus       274 ~~ll~~dp~~R~ta~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  274 RKLLEFDPRKRLTAAQALQHPWIKSIGEA  302 (382)
T ss_pred             HHhcccCcccCCCHHHHhcCccccCCccc
Confidence            99999999999999999999999976333

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-48  Score=327.08  Aligned_cols=248  Identities=34%  Similarity=0.621  Sum_probs=218.6

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||.|+||.||+|+++.+++.+|+|++.............+..|.++++.+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999765444444455667788888766 799999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---CcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~  177 (281)
                      ++|...+...+.+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.....   ......+++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            99999998888899999999999999999999999999999999999999999999999998754321   223345789


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+.  .++.++.++|.+||+.||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dp~~R  238 (321)
T cd05591         161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--WLSKEAVSILKAFMTKNPNKR  238 (321)
T ss_pred             cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHc
Confidence            999999999888999999999999999999999999998888888877776554443  588999999999999999999


Q ss_pred             C-------ChhhhhcCCcccc
Q 038249          258 L-------PLHKLLEHPWIIQ  271 (281)
Q Consensus       258 p-------s~~eil~~~~~~~  271 (281)
                      |       +++++++||||..
T Consensus       239 ~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         239 LGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CCCCCCCCCHHHHhcCCccCC
Confidence            9       8999999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.7e-48  Score=326.59  Aligned_cols=252  Identities=33%  Similarity=0.608  Sum_probs=217.5

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHH---HhCCCCceeeeeeEEEeCCEEEEE
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ---SHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l---~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      |++.+.||+|++|.||+|.+..+++.||+|++...........+.+..|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78899999999999999999999999999999765433333344566665554   566899999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCcc
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRR  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~  171 (281)
                      |||+++++|...+.. +.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....   ....
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            999999999888765 458999999999999999999999999999999999999999999999999875422   1223


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ...+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+.  .++.++.++|.+||+
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~  237 (324)
T cd05589         160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSREAISIMRRLLR  237 (324)
T ss_pred             ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhh
Confidence            456889999999998888999999999999999999999999988888777777666554443  589999999999999


Q ss_pred             cCCCCCC-----ChhhhhcCCccccC
Q 038249          252 KDSSQRL-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       252 ~~p~~Rp-----s~~eil~~~~~~~~  272 (281)
                      .||++||     ++.++++||||.+.
T Consensus       238 ~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         238 RNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             cCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            9999999     69999999999763

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-48  Score=335.34  Aligned_cols=255  Identities=30%  Similarity=0.518  Sum_probs=220.1

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++++.||.|++|.||+|++..+++.+|+|.+.............+.+|+.++++++|+||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999986544333334566788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-------
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-------  168 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-------  168 (281)
                      ||+++++|.+++...+.+++..++.++.||+.||++||++||+|+||+|+||+++.++.++|+|||++.....       
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999998631100       


Q ss_pred             ---------------------------------------CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhC
Q 038249          169 ---------------------------------------RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYG  209 (281)
Q Consensus       169 ---------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g  209 (281)
                                                             ......|++.|+|||++.+..++.++|||||||++++|++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G  240 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG  240 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence                                                   00123588999999999988899999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHhhc--cccCCCCCCCCHHHHHHHHHhcccCCCCCC---ChhhhhcCCcccc
Q 038249          210 VPPFEAKEHSDTYRRIVQV--DLKFPPKPIVSSAAKDLISQMLVKDSSQRL---PLHKLLEHPWIIQ  271 (281)
Q Consensus       210 ~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~eil~~~~~~~  271 (281)
                      ..||...+..+....+...  ....+....++.++.++|.+|+ .+|.+|+   ++.+++.||||..
T Consensus       241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            9999988776665555432  2233344468899999999987 5999999   9999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-49  Score=329.85  Aligned_cols=257  Identities=27%  Similarity=0.495  Sum_probs=235.0

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE-EE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR-VY   92 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~   92 (281)
                      .+++|..++.+|+|+||.+++++++.++..+++|.+......... .+...+|+.++++++||||+.+.+.|..++. .+
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            478999999999999999999999999999999999877755443 4578889999999999999999999999888 99


Q ss_pred             EEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           93 LILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      |||+|++||++.+.++..+  .++++.+..|+.||+.|+.|||++.|.|+||++.||+++.++.++|+|||++....+..
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999998654  58999999999999999999999999999999999999999999999999997765553


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                         ....|||.|++||++.+.+|+.++|||||||+++||++-+++|...+-..+...+.... ..+.+..++.+++.+|+
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~  239 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVK  239 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHH
Confidence               45679999999999999999999999999999999999999999999999999988876 34455589999999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .||..+|..||++.++|.+|.++..
T Consensus       240 ~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  240 SMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHhhcCCccCCCHHHHhhChhhhhH
Confidence            9999999999999999999988744

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.5e-48  Score=324.59  Aligned_cols=253  Identities=31%  Similarity=0.576  Sum_probs=221.3

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +|++.+.||+|+||.||+|.++.+++.+|+|.+................|..++..+ .|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            589999999999999999999999999999999765433333344566677777776 5899999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~  172 (281)
                      ||+++++|...+...+.+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||++....   .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999875432   12234


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ..+++.|+|||.+.+..++.++|+|||||++++|++|..||...+..+....+.......+.  .++.++.+++.+||+.
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~l~~  238 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTK  238 (323)
T ss_pred             CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHccc
Confidence            56899999999999989999999999999999999999999988888888777766554443  5899999999999999


Q ss_pred             CCCCCCCh-----hhhhcCCcccc
Q 038249          253 DSSQRLPL-----HKLLEHPWIIQ  271 (281)
Q Consensus       253 ~p~~Rps~-----~eil~~~~~~~  271 (281)
                      ||++|+++     .++++||||..
T Consensus       239 ~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         239 HPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             CHHhcCCCCCCCHHHHhcCCCcCC
Confidence            99999985     89999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-48  Score=331.80  Aligned_cols=255  Identities=35%  Similarity=0.603  Sum_probs=222.2

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|+||+|.++.+++.+|+|++.............+..|+.++..++|++++++++.+.+.+.+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997654444445567888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC------
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR------  169 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~------  169 (281)
                      ||+++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999986432110      


Q ss_pred             --------------------------------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCC
Q 038249          170 --------------------------------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE  217 (281)
Q Consensus       170 --------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  217 (281)
                                                      .....||+.|+|||++.+..++.++|+|||||++++|++|..||...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                                            012358899999999999899999999999999999999999999888


Q ss_pred             chHHHHHHhhc--cccCCCCCCCCHHHHHHHHHhcccCCCCCCC---hhhhhcCCcccc
Q 038249          218 HSDTYRRIVQV--DLKFPPKPIVSSAAKDLISQMLVKDSSQRLP---LHKLLEHPWIIQ  271 (281)
Q Consensus       218 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~~~~~~~  271 (281)
                      ..+....+...  ...++....++.++.++|.+|+. ||.+|++   +++++.||||..
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence            87777766643  23344444578999999999875 9999994   799999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.4e-48  Score=328.43  Aligned_cols=249  Identities=36%  Similarity=0.615  Sum_probs=218.9

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG  101 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~  101 (281)
                      +.||+|+||.||++.+..++..+|+|.+.............+.+|+++++.++||||+++.+.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997655444444566778999999999999999999999999999999999999


Q ss_pred             ChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCcccccC---CcccccCcC
Q 038249          102 ELYKELQKCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRTMCGTL  177 (281)
Q Consensus       102 ~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~  177 (281)
                      +|...+...+.+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....   ......+++
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            999999888889999999999999999999997 7999999999999999999999999998754221   223346899


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+.  .++.++.++|.+||+.||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R  238 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLSGLLKKDPKQR  238 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhhcCHHHh
Confidence            999999998888999999999999999999999999888777777766655544443  589999999999999999999


Q ss_pred             C-----ChhhhhcCCccccC
Q 038249          258 L-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       258 p-----s~~eil~~~~~~~~  272 (281)
                      +     ++.++++||||...
T Consensus       239 ~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         239 LGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             CCCCCCCHHHHhcCCCcCCC
Confidence            7     89999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.5e-48  Score=329.57  Aligned_cols=262  Identities=33%  Similarity=0.556  Sum_probs=222.9

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ......++|++.+.||+|+||.||++.++.+++.+|+|.+.............+.+|+.+++.++||||+++++.+.+++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34456689999999999999999999999999999999986544333334456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ..++||||+++++|.+++... .+++..+..++.||+.||++||++||+|+||+|+||+++.++.++|+|||++......
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            999999999999999999765 4899999999999999999999999999999999999999999999999998654322


Q ss_pred             ----cccccCcCCccCCccccCC----CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccCCCCCCCC
Q 038249          170 ----RRTMCGTLDYLPPEMVESV----EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPIVS  239 (281)
Q Consensus       170 ----~~~~~~~~~~~aPE~~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~  239 (281)
                          .....+|+.|+|||.+.+.    .++.++|+||||+++++|++|..||...+.......+....  ...+....++
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  275 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS  275 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence                1244689999999998653    36789999999999999999999999888777777766533  3344444678


Q ss_pred             HHHHHHHHHhcccCCCC--CCChhhhhcCCccccC
Q 038249          240 SAAKDLISQMLVKDSSQ--RLPLHKLLEHPWIIQN  272 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~--Rps~~eil~~~~~~~~  272 (281)
                      ..+.+++.+||..++++  |+++.++++||||+..
T Consensus       276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            99999999999855544  8999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.3e-48  Score=323.11  Aligned_cols=249  Identities=30%  Similarity=0.550  Sum_probs=214.2

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH-LRHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~-~~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||.|+||.||+|+++.+|+.+|+|.+................|..++.. .+|++|+++++.+...+.+++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999999999999999976543222233455667777765 4899999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc---cCCcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~---~~~~~~~~~~~  177 (281)
                      ++|...+...+.+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++...   ........+++
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            999999988888999999999999999999999999999999999999999999999999987532   12223456899


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+.  .++.++.++|.+||+.||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R  238 (316)
T cd05620         161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--WITKESKDILEKLFERDPTRR  238 (316)
T ss_pred             CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHccCCHHHc
Confidence            999999999889999999999999999999999999988877777776655444433  588999999999999999999


Q ss_pred             CCh-hhhhcCCccccC
Q 038249          258 LPL-HKLLEHPWIIQN  272 (281)
Q Consensus       258 ps~-~eil~~~~~~~~  272 (281)
                      |++ ++++.||||...
T Consensus       239 ~~~~~~~~~h~~f~~~  254 (316)
T cd05620         239 LGVVGNIRGHPFFKTI  254 (316)
T ss_pred             CCChHHHHcCCCcCCC
Confidence            997 588899999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.5e-48  Score=323.39  Aligned_cols=249  Identities=33%  Similarity=0.601  Sum_probs=218.2

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||.|+||+||+|.++.+++.+|+|.+.............+..|+.+++.+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999765443344455667788888877 799999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~~~~~~  177 (281)
                      ++|...+...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......+++
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875321   1223345789


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+.  .++.++.++|.+||..||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R  238 (318)
T cd05570         161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--WLSKEAKSILKSFLTKNPEKR  238 (318)
T ss_pred             cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHccCCHHHc
Confidence            999999999989999999999999999999999999988877777776665544433  589999999999999999999


Q ss_pred             CCh-----hhhhcCCccccC
Q 038249          258 LPL-----HKLLEHPWIIQN  272 (281)
Q Consensus       258 ps~-----~eil~~~~~~~~  272 (281)
                      |++     .++++||||.+.
T Consensus       239 ~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         239 LGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCCCCCCHHHHhcCCCcCCC
Confidence            999     999999999763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.8e-49  Score=318.05  Aligned_cols=254  Identities=35%  Similarity=0.661  Sum_probs=236.0

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .-++|++.+.||.|.||.|-+|.....|..||||.+.++.+.+++..-.+.+||++++.++||||+.++.+|++.+.+.+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            34789999999999999999999999999999999999988888877789999999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--cc
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RR  171 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~  171 (281)
                      ||||..+|.|++++..++.+++.+++.++.||..|+.|+|+++++|+|++.+||++|+++++||.|||++-.....  ..
T Consensus       131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence            9999999999999999999999999999999999999999999999999999999999999999999998554333  35


Q ss_pred             cccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          172 TMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ..||.|.|.+||+.++.+| ++..|.||||+++|-|..|..||++.+...+.+++..+.+..+.   .|.+..-||++||
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwmL  287 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGLIRWML  287 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHHHHHHH
Confidence            5789999999999999998 57899999999999999999999999999999999888765544   6788999999999


Q ss_pred             ccCCCCCCChhhhhcCCccc
Q 038249          251 VKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       251 ~~~p~~Rps~~eil~~~~~~  270 (281)
                      -.||++|.|+++|..|=|+.
T Consensus       288 mVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  288 MVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             hcCcccchhHHHHhhhheee
Confidence            99999999999999998875

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-49  Score=306.34  Aligned_cols=259  Identities=29%  Similarity=0.529  Sum_probs=232.0

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccc-----cchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~-----~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      -.+.|...+.||.|..+.|-++.++.+|+.+++|++.....     ...+..++-..|+.+|+++ .||+|+++.|.++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            45789999999999999999999999999999999854332     1234456667899999998 79999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      +..+++|+|.++.|.|.+++.+.-.+++.+.++|+.|++.|+.|||.++|+|+|+||+||+++.+.+++|+|||++++..
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999998876


Q ss_pred             CCc--ccccCcCCccCCccc------cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC--CCCCC
Q 038249          168 NRR--RTMCGTLDYLPPEMV------ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPI  237 (281)
Q Consensus       168 ~~~--~~~~~~~~~~aPE~~------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~  237 (281)
                      ...  ...||||+|+|||.+      ....|+...|+|+.|+++|-|+.|.+||.-..+.-.++.++++++++  +.|..
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad  254 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD  254 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence            654  456899999999987      34457778999999999999999999998888888888898887755  46778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          238 VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ++++.+++|.+||+.||++|.|++|+|.||||++.
T Consensus       255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            99999999999999999999999999999999654

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.9e-48  Score=320.62  Aligned_cols=257  Identities=29%  Similarity=0.468  Sum_probs=207.6

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      +.++|++.+.||.|++|.||+|.++.+++.+|+|++.......  ....+.+|+++++.++||||+++++++.++...++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            4578999999999999999999999999999999986443221  12346789999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---C
Q 038249           94 ILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---R  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~  169 (281)
                      |+||+.+ +|.+.+... +.++...++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||++.....   .
T Consensus        81 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          81 VFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            9999965 777766553 5689999999999999999999999999999999999999999999999998753221   1


Q ss_pred             cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhc--cc--------------c
Q 038249          170 RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQV--DL--------------K  231 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~--~~--------------~  231 (281)
                      .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...... +....+...  ..              .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            233457889999999754 45788999999999999999999999875442 222211110  00              0


Q ss_pred             ---C----C-------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          232 ---F----P-------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       232 ---~----~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                         .    +       ....++.++.+++++||+.||++|||++|+++||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence               0    0       0012456789999999999999999999999999998763

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.9e-48  Score=324.40  Aligned_cols=248  Identities=35%  Similarity=0.659  Sum_probs=214.0

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE-IQSHLRHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||+|++|+||+|+++.+|+.+|+|.+.............+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999997654333333334444444 56788999999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---CcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~  177 (281)
                      ++|...+...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....   ......+++
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            99999998888899999999999999999999999999999999999999999999999998754322   223346899


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+  +.++.++.++|.+||+.||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R  238 (323)
T cd05575         161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK--PNISVSARHLLEGLLQKDRTKR  238 (323)
T ss_pred             hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhhcCHHhC
Confidence            99999999888899999999999999999999999998887777777766544433  3579999999999999999999


Q ss_pred             CCh----hhhhcCCcccc
Q 038249          258 LPL----HKLLEHPWIIQ  271 (281)
Q Consensus       258 ps~----~eil~~~~~~~  271 (281)
                      |++    +++++||||..
T Consensus       239 ~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         239 LGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             CCCCCCHHHHHcCCCcCC
Confidence            997    69999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-47  Score=324.69  Aligned_cols=256  Identities=27%  Similarity=0.451  Sum_probs=209.0

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-----CEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-----KRV   91 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~   91 (281)
                      +|++.+.||.|++|.||+|++..++..||+|.+.... ........+.+|+++++.++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            5899999999999999999999999999999986432 2222345678899999999999999999988643     358


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      ++|+||+. ++|.+.+.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999996 5899999888889999999999999999999999999999999999999999999999999975432211 


Q ss_pred             -----ccccCcCCccCCccccC--CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc---------------
Q 038249          171 -----RTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV---------------  228 (281)
Q Consensus       171 -----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------  228 (281)
                           ....+++.|+|||.+.+  ..++.++||||||+++++|++|.+||...+.......+...               
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                 22357889999999865  56888999999999999999999999766543322211100               


Q ss_pred             -----------cccC---CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          229 -----------DLKF---PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       229 -----------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                                 ....   ...+..+.++.++|.+||+.||++|||++|+++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                       0000   011346788999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-50  Score=327.41  Aligned_cols=257  Identities=27%  Similarity=0.468  Sum_probs=228.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ..|+..+.||+|+||.||+|.+..+++.||+|++..+...  .....+..|+.++.+++++||.++++.+..+..++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            5688889999999999999999999999999999776533  33577899999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~  172 (281)
                      ||+.||++.++++.++.+++..+..++.+++.|+.|||..+.+|+||++.||++..+|.++|.|||.+.+....   ...
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            99999999999999988899999999999999999999999999999999999999999999999998665443   355


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ..|||.|||||+.....|+.++||||||++.+||++|.+|+....+......+-+........ .++..+++|+..||..
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~-~~S~~~kEFV~~CL~k  249 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG-DFSPPFKEFVEACLDK  249 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc-ccCHHHHHHHHHHhhc
Confidence            689999999999998899999999999999999999999999988865554444433322222 6889999999999999


Q ss_pred             CCCCCCChhhhhcCCccccCCCC
Q 038249          253 DSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      ||+.||||.++|+|+|+++....
T Consensus       250 ~P~~RpsA~~LLKh~FIk~a~k~  272 (467)
T KOG0201|consen  250 NPEFRPSAKELLKHKFIKRAKKT  272 (467)
T ss_pred             CcccCcCHHHHhhhHHHHhcCCc
Confidence            99999999999999999985433

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-47  Score=320.98  Aligned_cols=248  Identities=33%  Similarity=0.604  Sum_probs=212.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH-LRHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~-~~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||.|+||.||+|.+..+++.||+|++................|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999976543333333444556666654 4899999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---CcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~  177 (281)
                      ++|...++..+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....   ......+++
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999854322   223446899


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+  ..++.++.++|.+||+.||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~ll~~~l~~~P~~R  238 (316)
T cd05592         161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP--RWISKEAKDCLSKLFERDPTKR  238 (316)
T ss_pred             cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHccCCHHHc
Confidence            99999999888899999999999999999999999998888777776665444333  3588999999999999999999


Q ss_pred             CCh-hhhhcCCcccc
Q 038249          258 LPL-HKLLEHPWIIQ  271 (281)
Q Consensus       258 ps~-~eil~~~~~~~  271 (281)
                      |++ .+++.||||..
T Consensus       239 ~~~~~~l~~h~~~~~  253 (316)
T cd05592         239 LGVDGDIRQHPFFRG  253 (316)
T ss_pred             CCChHHHHcCcccCC
Confidence            986 58889999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.2e-47  Score=323.15  Aligned_cols=248  Identities=27%  Similarity=0.549  Sum_probs=212.2

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||+|+||.||+|.++.+++.||+|.+.............+..|..+++.+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999765544444556678899999888 799999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc---cCCcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~---~~~~~~~~~~~  177 (281)
                      ++|...+...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++...   ........+++
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            999999888788999999999999999999999999999999999999999999999999987532   12233456899


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc---------hHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH---------SDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||.....         ....+.+.......+  ..++.++.++|.+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~  238 (329)
T cd05588         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKASSVLKG  238 (329)
T ss_pred             cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC--CCCCHHHHHHHHH
Confidence            99999999988899999999999999999999999963221         122333444433333  3588999999999


Q ss_pred             hcccCCCCCCC------hhhhhcCCcccc
Q 038249          249 MLVKDSSQRLP------LHKLLEHPWIIQ  271 (281)
Q Consensus       249 ~l~~~p~~Rps------~~eil~~~~~~~  271 (281)
                      ||+.||.+|++      ++++++||||..
T Consensus       239 ~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         239 FLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            99999999997      689999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-47  Score=321.31  Aligned_cols=250  Identities=35%  Similarity=0.650  Sum_probs=217.4

Q ss_pred             cceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           21 GKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      ++.||+|+||.||++++.   .+++.+|+|.+...... .......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999874   46889999999754432 22234556789999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---Ccccc
Q 038249           97 YAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRTM  173 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~~  173 (281)
                      |+++++|.+.+...+.+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.....   .....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            999999999998888899999999999999999999999999999999999999999999999998753221   12334


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD  253 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  253 (281)
                      .+++.|+|||.+.+..++.++||||||+++++|++|..||...+.......+.......+.  .++.++.++|.+||++|
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~  238 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP--YLTPEARDLLKKLLKRN  238 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHcccC
Confidence            6889999999998888899999999999999999999999988887777777766554443  58999999999999999


Q ss_pred             CCCCC-----ChhhhhcCCccccC
Q 038249          254 SSQRL-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       254 p~~Rp-----s~~eil~~~~~~~~  272 (281)
                      |++||     +++++++||||...
T Consensus       239 p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         239 PSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HhHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.9e-47  Score=320.09  Aligned_cols=249  Identities=32%  Similarity=0.605  Sum_probs=214.0

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH-LRHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~-~~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||+|+||+||+|.+..+++.||+|.+................|..+++. .+||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999976533222233445567777765 4899999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~~~~~~  177 (281)
                      ++|...+.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....   .......+++
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            9999999887789999999999999999999999999999999999999999999999999875421   2223445789


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      .|+|||.+.+..++.++|+||+|+++++|++|..||...+..+..+.+.......+.  .++.++.++|.+||+.||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R  238 (316)
T cd05619         161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--WLTREAKDILVKLFVREPERR  238 (316)
T ss_pred             cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHhccCHhhc
Confidence            999999998888999999999999999999999999988877777766555443333  588999999999999999999


Q ss_pred             CChh-hhhcCCccccC
Q 038249          258 LPLH-KLLEHPWIIQN  272 (281)
Q Consensus       258 ps~~-eil~~~~~~~~  272 (281)
                      |++. +++.||||.+.
T Consensus       239 ~~~~~~l~~h~~~~~~  254 (316)
T cd05619         239 LGVKGDIRQHPFFREI  254 (316)
T ss_pred             CCChHHHHcCcccCCC
Confidence            9996 89999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.5e-47  Score=314.48  Aligned_cols=255  Identities=39%  Similarity=0.704  Sum_probs=227.4

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||.+.+..+++.+++|.+.............+.+|++++++++||||+++++.+...+..++|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997655444445567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccccC
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG  175 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (281)
                      ||+++++|.+++.....+++..+..++.||+.||.+||+.|++|+||+|.||+++.++.++|+|||++...........+
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  160 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG  160 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCC
Confidence            99999999999988888999999999999999999999999999999999999999999999999998765555555568


Q ss_pred             cCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 038249          176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSS  255 (281)
Q Consensus       176 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  255 (281)
                      ++.|++||.+.+...+.++|+||||+++++|++|..||...+.......+.......+.  .++..+.++|.+||+.||+
T Consensus       161 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~  238 (290)
T cd05580         161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS--FFSPDAKDLIRNLLQVDLT  238 (290)
T ss_pred             CccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc--cCCHHHHHHHHHHccCCHH
Confidence            88999999998888889999999999999999999999887766666666655444333  5789999999999999999


Q ss_pred             CCC-----ChhhhhcCCccccC
Q 038249          256 QRL-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       256 ~Rp-----s~~eil~~~~~~~~  272 (281)
                      +|+     +++|+++||||.+.
T Consensus       239 ~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         239 KRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             HccCcccCCHHHHHcCcccccC
Confidence            999     89999999999865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.9e-47  Score=326.48  Aligned_cols=262  Identities=32%  Similarity=0.539  Sum_probs=223.1

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ......++|++.+.||+|+||.||++.++.+++.+|+|++.............+.+|+.+++.++||||+++++.+...+
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            35566789999999999999999999999999999999986544333344456778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ..++||||+++++|.++++.. .+++..+..++.||+.||.+||++||+|+||+|+||+++.++.++|+|||++......
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            999999999999999998765 4899999999999999999999999999999999999999999999999998654322


Q ss_pred             ----cccccCcCCccCCccccCCC----CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccCCCCCCCC
Q 038249          170 ----RRTMCGTLDYLPPEMVESVE----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPIVS  239 (281)
Q Consensus       170 ----~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~  239 (281)
                          .....+|+.|+|||.+.+..    ++.++|+|||||++++|++|..||...+.......+....  ..++....++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence                22446899999999986433    6789999999999999999999999888777777766533  3444545689


Q ss_pred             HHHHHHHHHhcccCCCC--CCChhhhhcCCccccC
Q 038249          240 SAAKDLISQMLVKDSSQ--RLPLHKLLEHPWIIQN  272 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~--Rps~~eil~~~~~~~~  272 (281)
                      .++.++|.+||..++.+  |++++++++||||++.
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            99999999999844433  7899999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-47  Score=307.19  Aligned_cols=262  Identities=31%  Similarity=0.506  Sum_probs=220.2

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeeeeeEEEeCC----
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN-ILRLYGYFYDQK----   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~----   89 (281)
                      +..|+.+++||+|+||+||+|+++.+|+.||+|++..+.-. +.......+|+.++++++|+| |+.+++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            67799999999999999999999999999999999665421 223455788999999999999 999999998877    


Q ss_pred             --EEEEEEeccCCCChhHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           90 --RVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        90 --~~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                        .+++|+||.+. +|..++...+    .++...+..++.||+.||+|||+++|+||||||+|++++.+|.+||+|||++
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              88999999977 8999998755    4777899999999999999999999999999999999999999999999998


Q ss_pred             cccc---CCcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc--ccc------
Q 038249          164 VHTF---NRRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--DLK------  231 (281)
Q Consensus       164 ~~~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------  231 (281)
                      ....   ........|.+|.|||++.+. .|+...||||+||+++||+++...|.+....++...+...  ...      
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            5332   122344678899999998666 6899999999999999999999999998887776655432  111      


Q ss_pred             ----------CCCC----------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCCCC
Q 038249          232 ----------FPPK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGV  278 (281)
Q Consensus       232 ----------~~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~~~  278 (281)
                                ++.+          +....+..+++.+||+.+|.+|.|++.+|.||||.+...+.+.
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~  314 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ  314 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence                      1111          1133478899999999999999999999999999998776654

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-47  Score=308.05  Aligned_cols=254  Identities=25%  Similarity=0.452  Sum_probs=219.0

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ++|++.+.||.|++|.||.+.+..+++.+++|.+.......  ......+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999999999999999986543222  2234568889999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---  170 (281)
                      ++||+++++|.+.+...+.+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.......   
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999875432211   


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                         ....++..|+|||.+.+..++.++|+||||++++++++|+.||...+....................++.++.++|.
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  241 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR  241 (263)
T ss_pred             ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHH
Confidence               22346778999999988889999999999999999999999998776665555444433333334468899999999


Q ss_pred             HhcccCCCCCCChhhhhcCCcc
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +||..+|++|||+.++++||||
T Consensus       242 ~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         242 RTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.5e-47  Score=319.53  Aligned_cols=253  Identities=31%  Similarity=0.581  Sum_probs=220.4

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +|+..+.||.|++|+||+|.++.+++.||+|++...........+.+..|..+++.+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788999999999999999999999999999997654333334455677888888875 577888999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---Cccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~  172 (281)
                      ||+++++|.+.+...+.+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||++.....   ....
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            9999999999998888899999999999999999999999999999999999999999999999998754321   2233


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ..+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+.......+.......+.  .++.++.+++.+||+.
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~  238 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLMTK  238 (323)
T ss_pred             ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHccc
Confidence            45889999999998888999999999999999999999999988888887777766554443  5889999999999999


Q ss_pred             CCCCCCC-----hhhhhcCCcccc
Q 038249          253 DSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       253 ~p~~Rps-----~~eil~~~~~~~  271 (281)
                      +|++|++     .+++++||||..
T Consensus       239 ~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         239 HPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             CHhhCCCCCCCCHHHHhcCcccCC
Confidence            9999997     478999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.8e-47  Score=320.86  Aligned_cols=249  Identities=28%  Similarity=0.560  Sum_probs=210.9

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||+|+||.||+|.++.+++.+|+|.+.............+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999765444444456677888888776 899999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~~~~~~  177 (281)
                      ++|...+...+.+++..++.++.+|+.||.|||++|++|+||+|+||+++.++.++|+|||++....   .......+++
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            9999998888889999999999999999999999999999999999999999999999999875422   2223446899


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc---------hHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH---------SDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||.....         ......+.......+  ..++.++.++|.+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~ll~~  238 (329)
T cd05618         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASVLKS  238 (329)
T ss_pred             cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC--CCCCHHHHHHHHH
Confidence            99999999988899999999999999999999999953111         112333344333333  3688999999999


Q ss_pred             hcccCCCCCCCh------hhhhcCCccccC
Q 038249          249 MLVKDSSQRLPL------HKLLEHPWIIQN  272 (281)
Q Consensus       249 ~l~~~p~~Rps~------~eil~~~~~~~~  272 (281)
                      ||+.||++||++      .++++||||.+.
T Consensus       239 ~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         239 FLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999999984      799999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.4e-47  Score=318.80  Aligned_cols=258  Identities=26%  Similarity=0.471  Sum_probs=216.9

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||.|++|.||++.+..++..+++|.+....  .......+.+|++++++++|+||+++++++..++..++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            4578999999999999999999999999999999886542  23345678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCCCcEEEeeecCcccccCC-cc
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-RR  171 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-~~  171 (281)
                      ||||+.+++|.+++...+.+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~  160 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  160 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccc
Confidence            999999999999999888899999999999999999999975 7999999999999999999999999987543222 23


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHH--------------------------
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI--------------------------  225 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------------------------  225 (281)
                      ...++..|+|||.+.+..++.++|+||||+++++|++|..||......+....+                          
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (333)
T cd06650         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS  240 (333)
T ss_pred             cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhh
Confidence            345788999999998888999999999999999999999999765443222111                          


Q ss_pred             ------------------hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          226 ------------------VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       226 ------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                                        ............++.++.++|.+||+.||++|||+.|++.||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                              000000011123678899999999999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-47  Score=324.19  Aligned_cols=253  Identities=25%  Similarity=0.353  Sum_probs=208.3

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      ...++|++.+.||.|++|.||+|.+..+++.||+|....         ..+.+|++++++++||||+++++++......+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            445789999999999999999999999999999997521         23568999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC----
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN----  168 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~----  168 (281)
                      +|+|++. ++|..++.....++...++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....    
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9999996 58888888777899999999999999999999999999999999999999999999999999854322    


Q ss_pred             CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc-------hHHHHHHhh--------------
Q 038249          169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH-------SDTYRRIVQ--------------  227 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~--------------  227 (281)
                      ......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+-....       ......+..              
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            12234689999999999888899999999999999999999877643211       111111100              


Q ss_pred             ------------ccccCC-------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          228 ------------VDLKFP-------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       228 ------------~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                  .....+       ....++.++.++|.+||+.||++|||++|+|+||||++.+.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence                        000000       001256789999999999999999999999999999986544

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-47  Score=311.87  Aligned_cols=255  Identities=26%  Similarity=0.419  Sum_probs=215.7

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|+||++.+..+++.+|+|.+.............+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48899999999999999999999999999999976544444444567789999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--ccc
Q 038249           97 YAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRT  172 (281)
Q Consensus        97 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~~  172 (281)
                      |+.+++|.+.+...  ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999999887543  45899999999999999999999999999999999999999999999999987653222  223


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc--cccCCCCCCCCHHHHHHHHHhc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--DLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ..+++.|+|||.+.+..++.++|+||+|+++++|++|..||...........+...  .........++..+.+++.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL  240 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence            46788999999998888999999999999999999999999876654433222211  1111222358899999999999


Q ss_pred             ccCCCCCC-----ChhhhhcCCcccc
Q 038249          251 VKDSSQRL-----PLHKLLEHPWIIQ  271 (281)
Q Consensus       251 ~~~p~~Rp-----s~~eil~~~~~~~  271 (281)
                      ..||++||     ++++++.||||.+
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         241 TKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             cCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            99999999     8999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.2e-47  Score=321.15  Aligned_cols=260  Identities=28%  Similarity=0.477  Sum_probs=212.6

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      .....+++|+.++.||.|++|.||++++..+++.||+|++....  .......+.+|+++++.++|+||+++++++...+
T Consensus        68 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  145 (353)
T PLN00034         68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG  145 (353)
T ss_pred             CCCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence            34456788999999999999999999999999999999985442  2344567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .+++|+||+++++|...    ...++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus       146 ~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             eEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            99999999999988642    23577888999999999999999999999999999999999999999999987543322


Q ss_pred             ---cccccCcCCccCCccccC-----CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhh--ccccCCCCCCCC
Q 038249          170 ---RRTMCGTLDYLPPEMVES-----VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ--VDLKFPPKPIVS  239 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~  239 (281)
                         .....++..|+|||.+..     ...+.++||||||+++|+|++|..||......+.......  ..........++
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence               233468899999998743     2234689999999999999999999975443332222111  111222234688


Q ss_pred             HHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      .++.++|.+||+.||++|||+.|+++||||.+....
T Consensus       302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            999999999999999999999999999999988543

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-47  Score=321.47  Aligned_cols=248  Identities=34%  Similarity=0.638  Sum_probs=215.7

Q ss_pred             cceecccCceEEEEEEEc---cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEec
Q 038249           21 GKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEY   97 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   97 (281)
                      ++.||+|++|.||++++.   .+|+.+|+|++....... .....+..|++++++++||||+++++++..++..++|+||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            367999999999998863   578999999997654322 2234567799999999999999999999999999999999


Q ss_pred             cCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccccc
Q 038249           98 AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTMC  174 (281)
Q Consensus        98 ~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~~~  174 (281)
                      +++++|.+.+.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......   .....
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  159 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC  159 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence            999999999988778999999999999999999999999999999999999999999999999987554322   23346


Q ss_pred             CcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 038249          175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS  254 (281)
Q Consensus       175 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  254 (281)
                      +++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+.  .++.++.++|++||+.||
T Consensus       160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~P  237 (318)
T cd05582         160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRALFKRNP  237 (318)
T ss_pred             CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCH
Confidence            789999999998888899999999999999999999999988887777777665544433  589999999999999999


Q ss_pred             CCCCC-----hhhhhcCCcccc
Q 038249          255 SQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       255 ~~Rps-----~~eil~~~~~~~  271 (281)
                      ++||+     +++++.||||.+
T Consensus       238 ~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         238 ANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             hHcCCCCCCCHHHHhCCCCcCC
Confidence            99999     677999999975

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7e-47  Score=319.13  Aligned_cols=254  Identities=32%  Similarity=0.602  Sum_probs=211.9

Q ss_pred             CceecceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~-~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~   91 (281)
                      +|++.+.||+|++|.||++++.   .++..+|+|++...... .....+.+..|+.+++.+ +|++|+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999998874   46889999998654322 223345677899999999 589999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      ++||||+++++|.+.+.....+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            999999999999999988888999999999999999999999999999999999999999999999999987543221  


Q ss_pred             --cccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCch----HHHHHHhhccccCCCCCCCCHHH
Q 038249          170 --RRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHS----DTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                        .....+++.|+|||.+.+. .++.++||||||+++++|++|..||......    .....+.....  +....++.++
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  238 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--PFPSFIGPEA  238 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHH
Confidence              2234689999999998765 4788999999999999999999999653322    22233333322  2233689999


Q ss_pred             HHHHHHhcccCCCCCC-----ChhhhhcCCccccC
Q 038249          243 KDLISQMLVKDSSQRL-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rp-----s~~eil~~~~~~~~  272 (281)
                      .++|.+||+.||++||     +++++++||||++.
T Consensus       239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999999999     78899999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.6e-47  Score=319.88  Aligned_cols=248  Identities=34%  Similarity=0.635  Sum_probs=213.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHH-HHHHhCCCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREV-EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||.|+||+||+|+++.+|+.+|+|++.............+..|. .+++.++||||+++++.+...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999999999999999999655333333333444444 456788999999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~~~~~~  177 (281)
                      ++|...+...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......+++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            9999999888889999999999999999999999999999999999999999999999999875422   2223446889


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+........  +..+.++.++|.+||..+|++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~ll~~~p~~R  238 (325)
T cd05604         161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR--PGASLTAWSILEELLEKDRQRR  238 (325)
T ss_pred             hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC--CCCCHHHHHHHHHHhccCHHhc
Confidence            99999999988899999999999999999999999998887777777766544333  3588999999999999999999


Q ss_pred             CCh----hhhhcCCcccc
Q 038249          258 LPL----HKLLEHPWIIQ  271 (281)
Q Consensus       258 ps~----~eil~~~~~~~  271 (281)
                      |++    .++++||||..
T Consensus       239 ~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         239 LGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             CCCCCCHHHHhcCCCcCC
Confidence            986    58999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1e-46  Score=310.83  Aligned_cols=247  Identities=28%  Similarity=0.428  Sum_probs=208.1

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCCh
Q 038249           24 LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGEL  103 (281)
Q Consensus        24 ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  103 (281)
                      ||.|+||+||++.++.+++.+|+|.+.............+..|+.+++.++|+||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999999999765544444445677899999999999999999999999999999999999999


Q ss_pred             hHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cccccCc
Q 038249          104 YKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTMCGT  176 (281)
Q Consensus       104 ~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~  176 (281)
                      ...+..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+......   .....++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            877742    345899999999999999999999999999999999999999999999999987543222   2234678


Q ss_pred             CCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHH----HHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          177 LDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT----YRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       177 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      +.|+|||.+.+..++.++|+||||+++++|++|..||........    .........  .....++.++.+++.+||+.
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~  238 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV--TYPDKFSPASKSFCEALLAK  238 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC--CCcccCCHHHHHHHHHHhcC
Confidence            899999999988999999999999999999999999976543322    222222222  22235889999999999999


Q ss_pred             CCCCCC-----ChhhhhcCCccccC
Q 038249          253 DSSQRL-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       253 ~p~~Rp-----s~~eil~~~~~~~~  272 (281)
                      ||++||     +++++++||||+..
T Consensus       239 ~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         239 DPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             CHHHhcCCCCCCHHHHhcChhhhcC
Confidence            999999     78999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-46  Score=316.97  Aligned_cols=256  Identities=32%  Similarity=0.553  Sum_probs=215.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|+||+||+++++.+++.+|+|++...........+.+.+|+.+++.++|+||+++++.+.+++.+++|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            57999999999999999999999999999999997544333444566788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc----
Q 038249           96 EYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~----  170 (281)
                      ||+++++|.+++.. ...+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999976 4568999999999999999999999999999999999999999999999999875432221    


Q ss_pred             ccccCcCCccCCccccC-----CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc--cCC-CCCCCCHHH
Q 038249          171 RTMCGTLDYLPPEMVES-----VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL--KFP-PKPIVSSAA  242 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~l  242 (281)
                      ....+++.|+|||.+..     ..++.++|+||||+++++|++|..||...+..+....+.....  ..+ ....++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            22458999999999853     4567899999999999999999999988777776666554322  222 223478999


Q ss_pred             HHHHHHhcccCCCC--CCChhhhhcCCcccc
Q 038249          243 KDLISQMLVKDSSQ--RLPLHKLLEHPWIIQ  271 (281)
Q Consensus       243 ~~li~~~l~~~p~~--Rps~~eil~~~~~~~  271 (281)
                      +++|++||..++++  |++++++++||||..
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            99999999764443  789999999999975

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.7e-47  Score=317.41  Aligned_cols=248  Identities=35%  Similarity=0.634  Sum_probs=212.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHH-HHHHhCCCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREV-EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||.|++|.||+|++..+++.+|+|++.............+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999755433333333444444 467889999999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~~~~~~  177 (281)
                      ++|...+.....+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++....   .......+++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            9999998887889999999999999999999999999999999999999999999999999875421   1223346789


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+  +..+.++.++|.+||+.||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R  238 (321)
T cd05603         161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP--GGKTVAACDLLVGLLHKDQRRR  238 (321)
T ss_pred             ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHccCCHhhc
Confidence            99999999888899999999999999999999999998877777777665544333  3588999999999999999999


Q ss_pred             CCh----hhhhcCCcccc
Q 038249          258 LPL----HKLLEHPWIIQ  271 (281)
Q Consensus       258 ps~----~eil~~~~~~~  271 (281)
                      |++    .++++||||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         239 LGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             CCCCCCHHHHhCCCCcCC
Confidence            975    49999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.1e-46  Score=319.42  Aligned_cols=258  Identities=28%  Similarity=0.458  Sum_probs=209.6

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC---
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK---   89 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~---   89 (281)
                      ...++|++.+.||.|+||.||++.+..+|..+|+|.+..... .......+.+|+.+++.++||||+++++++....   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            456899999999999999999999999999999999865432 2333456778999999999999999999986443   


Q ss_pred             ---EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           90 ---RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        90 ---~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                         ..++|+||+++ ++...+..  .++...+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence               57999999976 56665543  4789999999999999999999999999999999999999999999999998543


Q ss_pred             cCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhh-----------------
Q 038249          167 FNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-----------------  227 (281)
Q Consensus       167 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----------------  227 (281)
                      ...  .....+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+.+..+..                 
T Consensus       174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            222  2334578899999999988999999999999999999999999987665433222111                 


Q ss_pred             -----ccccCC------------------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          228 -----VDLKFP------------------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       228 -----~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                           .....+                  .....+.+++++|.+||+.||++|||+.|+|.||||..+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence                 000000                  01124678999999999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-47  Score=310.65  Aligned_cols=251  Identities=37%  Similarity=0.661  Sum_probs=212.6

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEec
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEY   97 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   97 (281)
                      |++++.||+|++|+||++++..+++.+|+|.+......... ......|+..+++++|+||+++++++......++++|+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            78999999999999999999999999999999776543332 33345599999999999999999999999999999999


Q ss_pred             cCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc---ccCCccccc
Q 038249           98 AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMC  174 (281)
Q Consensus        98 ~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~---~~~~~~~~~  174 (281)
                      +.+++|.+++...+.++...++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..   .........
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999777899999999999999999999999999999999999999999999999999863   223334456


Q ss_pred             CcCCccCCcccc-CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch---HHHHHHhhccccCCC--CCCCCHHHHHHHHH
Q 038249          175 GTLDYLPPEMVE-SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS---DTYRRIVQVDLKFPP--KPIVSSAAKDLISQ  248 (281)
Q Consensus       175 ~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~l~~li~~  248 (281)
                      ++..|.|||.+. +...+.++|+||||+++++|++|..||......   ...............  ....+.++.++|.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            788999999998 788899999999999999999999999877322   222222222111111  11234899999999


Q ss_pred             hcccCCCCCCChhhhhcCCcc
Q 038249          249 MLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ||+.||++|||++++++||||
T Consensus       240 ~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  240 MLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HSSSSGGGSTTHHHHHTSGGG
T ss_pred             HccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-46  Score=315.91  Aligned_cols=248  Identities=28%  Similarity=0.545  Sum_probs=211.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||+|++|.||+|++..+++.+|+|++...........+.+.+|+.++.++ +|++|+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999766544445556678899888888 699999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~~~~~~  177 (281)
                      ++|...+...+.+++..++.++.||+.|+++||++|++|+||+|+||+++.++.++|+|||++....   .......+++
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            9999999887889999999999999999999999999999999999999999999999999875422   2233456899


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCC------c-hHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------H-SDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      .|+|||.+.+..++.++|+||||+++++|++|..||....      . ....+.+.......  ...++..+.++|.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~li~~~L  238 (327)
T cd05617         161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI--PRFLSVKASHVLKGFL  238 (327)
T ss_pred             ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC--CCCCCHHHHHHHHHHh
Confidence            9999999998899999999999999999999999996422      1 12233333333333  2358899999999999


Q ss_pred             ccCCCCCCC------hhhhhcCCcccc
Q 038249          251 VKDSSQRLP------LHKLLEHPWIIQ  271 (281)
Q Consensus       251 ~~~p~~Rps------~~eil~~~~~~~  271 (281)
                      +.||++|++      ++++++||||..
T Consensus       239 ~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         239 NKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             ccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            999999998      469999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-46  Score=313.20  Aligned_cols=257  Identities=36%  Similarity=0.633  Sum_probs=225.1

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+...........+.+.+|++.++.++|+||+++++.+......++++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999997765554445667889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC----
Q 038249           96 EYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR----  169 (281)
Q Consensus        96 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~----  169 (281)
                      ||+.+++|.+++...  ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++......    
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998764  46899999999999999999999999999999999999999999999999986432111    


Q ss_pred             ----------------------------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHH
Q 038249          170 ----------------------------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT  221 (281)
Q Consensus       170 ----------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  221 (281)
                                                  .....++..|+|||.+.+..++.++|+||||+++++|++|..||...+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                        0112467789999999888889999999999999999999999988887777


Q ss_pred             HHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC----hhhhhcCCccccC
Q 038249          222 YRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLP----LHKLLEHPWIIQN  272 (281)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~eil~~~~~~~~  272 (281)
                      ...+.......+....++.++.++|.+||..||++||+    +++++.||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            77666555555554457999999999999999999999    9999999999875

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-46  Score=316.73  Aligned_cols=248  Identities=35%  Similarity=0.664  Sum_probs=212.2

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHH-HHHHhCCCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREV-EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||+|+||+||+|++..+++.+|+|++.............+..+. .+++.++|+||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4799999999999999999999999999755433222233334343 456888999999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~~~~~~  177 (281)
                      ++|.+.+...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++....   .......+++
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875422   2233446899


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      .|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.......  .+.++.++.++|.+||+.||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R  238 (325)
T cd05602         161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL--KPNITNSARHLLEGLLQKDRTKR  238 (325)
T ss_pred             cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC--CCCCCHHHHHHHHHHcccCHHHC
Confidence            9999999998889999999999999999999999999888777777766554333  34689999999999999999999


Q ss_pred             CChh----hhhcCCcccc
Q 038249          258 LPLH----KLLEHPWIIQ  271 (281)
Q Consensus       258 ps~~----eil~~~~~~~  271 (281)
                      +++.    ++++|+||..
T Consensus       239 ~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         239 LGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             CCCCCCHHHHhcCcccCC
Confidence            9876    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-47  Score=320.02  Aligned_cols=248  Identities=35%  Similarity=0.603  Sum_probs=211.1

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           24 LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL---RHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        24 ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~---~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      ||+|+||+||+|+++.+++.+|+|++................|..++...   +||||+++++.+......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999655433333333444566666555   699999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---CcccccCcC
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRTMCGTL  177 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~  177 (281)
                      ++|...+...+.+++..++.++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++.....   ......+++
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            99999998888899999999999999999999999999999999999999999999999998754222   223456899


Q ss_pred             CccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 038249          178 DYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ  256 (281)
Q Consensus       178 ~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  256 (281)
                      .|+|||.+.+. .++.++||||||+++++|++|..||...+..+....+..+....+. ..++.++.++|.+||+.||++
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~  239 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK-NVLSDEGRQFVKGLLNRNPQH  239 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC-ccCCHHHHHHHHHHcCCCHHH
Confidence            99999998654 4788999999999999999999999888877777776665544443 357899999999999999999


Q ss_pred             CC----ChhhhhcCCccccC
Q 038249          257 RL----PLHKLLEHPWIIQN  272 (281)
Q Consensus       257 Rp----s~~eil~~~~~~~~  272 (281)
                      ||    +++++++||||.+.
T Consensus       240 R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         240 RLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCCCCCCHHHHhcCccccCC
Confidence            98    68999999999753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4e-46  Score=327.91  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=218.9

Q ss_pred             cCCceecceecccCceEEEEEEEccC-CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRS-NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~-~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ...|.+.+.||+|++|.||.|.+..+ ++.+++|.+...   .......+.+|+.+++.++||||+++++.+..++..++
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            34599999999999999999999887 788899887443   23334567789999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           94 ILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ||||+++++|.+.+..    ..++++..+..++.||+.||.+||++||+|+||+|+||+++.++.++|+|||++......
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999999887753    356899999999999999999999999999999999999999999999999998654322


Q ss_pred             -----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHH
Q 038249          170 -----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       170 -----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (281)
                           ....+|++.|+|||.+.+..++.++|||||||++++|++|..||...+..+....+..+... +....++.++.+
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~  301 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKA  301 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHH
Confidence                 23345899999999998888999999999999999999999999888877777766655433 222358899999


Q ss_pred             HHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          245 LISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      +|.+||+.||++||++.+++.+||++.
T Consensus       302 li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        302 LLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999999999863

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.1e-47  Score=321.98  Aligned_cols=251  Identities=28%  Similarity=0.491  Sum_probs=216.5

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-C-----CceeeeeeEEEeCCE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-H-----PNILRLYGYFYDQKR   90 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h-----~~i~~~~~~~~~~~~   90 (281)
                      +|.+++.||+|+||.|.+|.+.++++.||||++...    ....+....|+.+|..++ |     -|+|+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            799999999999999999999999999999999543    344556677999999886 3     589999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC--cEEEeeecCcccc
Q 038249           91 VYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG--ELKIADFGWSVHT  166 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~--~~~l~dfg~~~~~  166 (281)
                      +|+|+|..+. +|+++++..  ..++...++.++.||+.+|.+||+.||+|+||||+|||+..-+  .+||+|||.++..
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999999965 999999876  4589999999999999999999999999999999999997654  6999999999887


Q ss_pred             cCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc---------------
Q 038249          167 FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK---------------  231 (281)
Q Consensus       167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------  231 (281)
                      .........+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+.+..+++..++.....               
T Consensus       342 ~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf  421 (586)
T KOG0667|consen  342 SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF  421 (586)
T ss_pred             CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence            77766777788999999999999999999999999999999999999998888877655443000               


Q ss_pred             -------------------------------------CC-CC-------C-CCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          232 -------------------------------------FP-PK-------P-IVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       232 -------------------------------------~~-~~-------~-~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                                                           .+ ..       . .....+.++|.+||..||.+|+|..++|+
T Consensus       422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN  501 (586)
T ss_pred             hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                                                 00 00       0 12345789999999999999999999999


Q ss_pred             CCccccC
Q 038249          266 HPWIIQN  272 (281)
Q Consensus       266 ~~~~~~~  272 (281)
                      ||||...
T Consensus       502 Hpfl~~~  508 (586)
T KOG0667|consen  502 HPFLTGT  508 (586)
T ss_pred             Ccccccc
Confidence            9999943

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-47  Score=317.39  Aligned_cols=246  Identities=24%  Similarity=0.441  Sum_probs=215.5

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..+.++.++.||+|-||.||.+.+.. ...+|+|.+....+..    +.+.+|++++++++|++||++++++..++-++|
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence            33667889999999999999999983 3479999997765433    346799999999999999999999999889999


Q ss_pred             EEeccCCCChhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc
Q 038249           94 ILEYAAKGELYKELQK--CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR  171 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~  171 (281)
                      ||||+..|+|.++++.  +..++..+++.++.||+.|++||++++++||||...||+++++..+||+|||+++...+...
T Consensus       279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            9999999999999997  45699999999999999999999999999999999999999999999999999984332221


Q ss_pred             ----cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          172 ----TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       172 ----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                          ..--+..|+|||.+.-+.++.+|||||||++|||++| |+.|+...+..+.++.+..+. ..+.+..+|+++.+++
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy-Rlp~P~~CP~~vY~lM  437 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY-RLPRPEGCPDEVYELM  437 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC-cCCCCCCCCHHHHHHH
Confidence                1123557999999999999999999999999999996 999999999999999988774 3444558999999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      ..||+.+|++|||++.+..
T Consensus       438 ~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  438 KSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHhhCCcccCCCHHHHHH
Confidence            9999999999999987763

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.8e-46  Score=307.05  Aligned_cols=252  Identities=21%  Similarity=0.249  Sum_probs=216.0

Q ss_pred             ccccCCceec--ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--
Q 038249           12 RWTLNDFDIG--KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--   87 (281)
Q Consensus        12 ~~~~~~y~~~--~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--   87 (281)
                      ....++++..  ..|++|+++.||+|++  +|+.||+|.+...........+.+.+|+.++++++||||+++++++.+  
T Consensus        14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~   91 (283)
T PHA02988         14 CIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV   91 (283)
T ss_pred             ecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence            3344555555  7899999999999988  488999999976655555556778899999999999999999999876  


Q ss_pred             --CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           88 --QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        88 --~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                        ....++|+||+++++|.+++...+.+++.....++.+++.|+.+||+. +++|+||+|+||+++.++.++++|||++.
T Consensus        92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~  171 (283)
T PHA02988         92 DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK  171 (283)
T ss_pred             cCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence              357899999999999999999888899999999999999999999984 99999999999999999999999999986


Q ss_pred             cccCCcccccCcCCccCCccccC--CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHH
Q 038249          165 HTFNRRRTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       165 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                      ..........++..|+|||.+.+  ..++.++||||||+++|+|++|..||...+..+....+.......+.....+.++
T Consensus       172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l  251 (283)
T PHA02988        172 ILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEI  251 (283)
T ss_pred             hhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHH
Confidence            55444445567889999999865  6789999999999999999999999998887777776655444433334689999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .+++.+||+.||++|||+.|+++
T Consensus       252 ~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        252 KCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHHHhcCCcccCcCHHHHHH
Confidence            99999999999999999999985

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.7e-46  Score=311.75  Aligned_cols=257  Identities=28%  Similarity=0.515  Sum_probs=212.4

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      .++++|++.+.||.|++|.||+|.++.+++.+|+|.+.......  ....+.+|++++++++|+||+++++++..++..+
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            45789999999999999999999999999999999986543221  2234667999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           93 LILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      +|+||+++ +|.+.+... ..++...++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            99999976 787777654 45899999999999999999999999999999999999999999999999987543221  


Q ss_pred             -cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc------------------
Q 038249          170 -RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD------------------  229 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  229 (281)
                       .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+..+....+....                  
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence             223456889999998754 457889999999999999999999998776655443332110                  


Q ss_pred             -ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          230 -LKFP---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       230 -~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                       ...+         ..+.++.++.++|.+||+.||++|||+.|+++||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence             0000         113478899999999999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-46  Score=305.00  Aligned_cols=257  Identities=30%  Similarity=0.488  Sum_probs=221.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||++++..+++.+++|.+.....  ......+.+|+++++.++|+|++++.+++.++...++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            479999999999999999999999999999999865432  233456788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~  172 (281)
                      ||+++++|.+++... ++++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++++|||.+......   ...
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999999876 6899999999999999999999999999999999999999999999999987554332   233


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ..+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.......+............++.++.+++.+||..
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  237 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK  237 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhC
Confidence            45677899999998888999999999999999999999999877766555554444322222223789999999999999


Q ss_pred             CCCCCCChhhhhcCCccccCCCC
Q 038249          253 DSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      +|++||+++++++||||++..+.
T Consensus       238 ~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         238 DPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             ChhhCcCHHHHhhChhhcCCCcc
Confidence            99999999999999999987553

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.5e-46  Score=308.49  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=203.5

Q ss_pred             CCceecceecccCceEEEEEEEcc-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeeeeeEEEe----
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKR-SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL---RHPNILRLYGYFYD----   87 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~-~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~---~h~~i~~~~~~~~~----   87 (281)
                      ++|++.+.||.|++|.||+|.+.. ++..+|+|.+........ ......+|+.+++.+   +||||+++++++..    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999864 467899999865432221 123344566665554   79999999998852    


Q ss_pred             -CCEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           88 -QKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        88 -~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                       ....++|+||+++ +|.+++...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence             4568999999975 888888653  348999999999999999999999999999999999999999999999999875


Q ss_pred             cccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-----cCC----
Q 038249          165 HTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-----KFP----  233 (281)
Q Consensus       165 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~----  233 (281)
                      .....  .....+++.|+|||.+.+..++.++|+||||+++++|++|.+||......+....+.....     .++    
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            43322  2334578899999999888899999999999999999999999998877666555443210     000    


Q ss_pred             ----------------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          234 ----------------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       234 ----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                                      ..+.++..+.+++.+||+.||++|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                            012467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1e-45  Score=308.81  Aligned_cols=259  Identities=26%  Similarity=0.443  Sum_probs=216.9

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||++.+..++..+++|.+....  .......+.+|++++++++||||+++++++..++..++|+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999999999999999986432  2334566888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-cccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-RRTM  173 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-~~~~  173 (281)
                      ||+++++|.++++..+.+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...... ....
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  158 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence            999999999999888889999999999999999999997 59999999999999999999999999987543222 2334


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-------------------------
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------------------  228 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------------  228 (281)
                      .++..|+|||.+.+..++.++|+||||+++++|++|..||...+...........                         
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA  238 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence            5788999999998888899999999999999999999998755433322211110                         


Q ss_pred             -----------cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          229 -----------DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       229 -----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                                 .....+...++.++.+++.+||..+|++||++.+++.||||.++..++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  297 (308)
T cd06615         239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEE  297 (308)
T ss_pred             HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccccc
Confidence                       000001113678899999999999999999999999999999875543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.7e-46  Score=305.11  Aligned_cols=248  Identities=25%  Similarity=0.422  Sum_probs=206.1

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCCh
Q 038249           24 LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGEL  103 (281)
Q Consensus        24 ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  103 (281)
                      ||.|+||.||++.++.+|+.+|+|.+.............+..|++++++++||||+++.+.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999999999999999999655443333344556799999999999999999999999999999999999999


Q ss_pred             hHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--cccccCcCCc
Q 038249          104 YKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRTMCGTLDY  179 (281)
Q Consensus       104 ~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~  179 (281)
                      .+.+...  ..++...+..++.||+.|+++||+.|++|+||+|+||+++.++.++|+|||++......  .....+++.|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            8887643  34889999999999999999999999999999999999999999999999987544322  1234578899


Q ss_pred             cCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch----HHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 038249          180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS----DTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSS  255 (281)
Q Consensus       180 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  255 (281)
                      +|||.+.+..++.++|+||||+++++|++|..||......    +............ ....++.++.+++++||+.||+
T Consensus       161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~  239 (277)
T cd05607         161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPE  239 (277)
T ss_pred             cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHHhccCHh
Confidence            9999998888999999999999999999999999764332    2222222222222 2236899999999999999999


Q ss_pred             CCCCh----hhhhcCCccccC
Q 038249          256 QRLPL----HKLLEHPWIIQN  272 (281)
Q Consensus       256 ~Rps~----~eil~~~~~~~~  272 (281)
                      +||++    ++++.||||+..
T Consensus       240 ~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         240 DRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             hCCCCccchhhhhcChhhcCC
Confidence            99999    678899999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.1e-46  Score=313.24  Aligned_cols=256  Identities=32%  Similarity=0.561  Sum_probs=216.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||+|+||+||+++++.+++.+|+|.+.............+.+|+.++..++|++|+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999986544333344456788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC----c
Q 038249           96 EYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR----R  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~----~  170 (281)
                      ||+++++|.+++.. ...+++..++.++.||+.|+.+||++|++|+||+|+||+++.++.++|+|||++......    .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999976 456899999999999999999999999999999999999999999999999987543221    1


Q ss_pred             ccccCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc--CCC-CCCCCHHH
Q 038249          171 RTMCGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK--FPP-KPIVSSAA  242 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~l  242 (281)
                      ....+++.|+|||.+.     ...++.++|+||||+++++|++|..||...+..+....+......  .+. ...++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            2346899999999975     345788999999999999999999999988877777776554322  222 23578999


Q ss_pred             HHHHHHhcccCCCC--CCChhhhhcCCcccc
Q 038249          243 KDLISQMLVKDSSQ--RLPLHKLLEHPWIIQ  271 (281)
Q Consensus       243 ~~li~~~l~~~p~~--Rps~~eil~~~~~~~  271 (281)
                      .++|++||..++++  |++++++++||||..
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            99999999765444  689999999999984

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.6e-46  Score=313.82  Aligned_cols=256  Identities=32%  Similarity=0.541  Sum_probs=216.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||+|+||+||+++++.+++.+|+|.+.............+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999986543333334456788899999999999999999999999999999


Q ss_pred             eccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc----
Q 038249           96 EYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~----  170 (281)
                      ||+.+++|.+++.. ...+++..+..++.|++.||.+||++||+|+||+|+||+++.++.++|+|||++.......    
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999999987 4678999999999999999999999999999999999999999999999999875433221    


Q ss_pred             ccccCcCCccCCccccC-----CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc--CCC-CCCCCHHH
Q 038249          171 RTMCGTLDYLPPEMVES-----VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK--FPP-KPIVSSAA  242 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~l  242 (281)
                      ....+++.|+|||.+.+     ..++.++|+||||+++++|++|..||...+..+....+......  .+. ...++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            23458999999999865     45778999999999999999999999887777777666553322  222 23478999


Q ss_pred             HHHHHHhcccCCCC--CCChhhhhcCCcccc
Q 038249          243 KDLISQMLVKDSSQ--RLPLHKLLEHPWIIQ  271 (281)
Q Consensus       243 ~~li~~~l~~~p~~--Rps~~eil~~~~~~~  271 (281)
                      .++|.+||..++++  |++++++++||||+.
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            99999999866554  568999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.2e-46  Score=306.46  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=214.4

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      .|++.+.||.|+||.||++.+..+++.+|+|.+.............+..|+.++++++|++++++.+.+...+..++|+|
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47888999999999999999999999999999876554444444567789999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--cc
Q 038249           97 YAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RT  172 (281)
Q Consensus        97 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--~~  172 (281)
                      |+.+++|.+.+...  ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            99999999888643  358999999999999999999999999999999999999999999999999875433222  23


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH---HHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD---TYRRIVQVDLKFPPKPIVSSAAKDLISQM  249 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~  249 (281)
                      ..++..|+|||.+.+..++.++|+||+|+++++|++|..||.......   ........ ........++.++.+++.+|
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~  239 (285)
T cd05630         161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSLCKML  239 (285)
T ss_pred             CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHHHHHH
Confidence            467889999999988889999999999999999999999998654322   22222111 11122345889999999999


Q ss_pred             cccCCCCCCC-----hhhhhcCCcccc
Q 038249          250 LVKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       250 l~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      |+.||++|||     ++|+++||||++
T Consensus       240 l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         240 LCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             hhcCHHHccCCCCCchHHHHcChhhhc
Confidence            9999999999     899999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.6e-46  Score=326.90  Aligned_cols=261  Identities=27%  Similarity=0.422  Sum_probs=222.5

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ..+...++|++.+.||+|+||+||+|++..+++.||+|.+...... ......+.+|+..+..++|+|++++++.+...+
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            3345558999999999999999999999999999999999765543 334566788999999999999999988775322


Q ss_pred             --------EEEEEEeccCCCChhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEE
Q 038249           90 --------RVYLILEYAAKGELYKELQKC----KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKI  157 (281)
Q Consensus        90 --------~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l  157 (281)
                              .+++|+||+++++|.+.+...    .++++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence                    478999999999999988643    46899999999999999999999999999999999999999999999


Q ss_pred             eeecCcccccC-----CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC
Q 038249          158 ADFGWSVHTFN-----RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF  232 (281)
Q Consensus       158 ~dfg~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  232 (281)
                      +|||++.....     ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+........... 
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-  263 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-  263 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-
Confidence            99999754322     123456899999999999988999999999999999999999999988777777666554432 


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +..+.++.++.+++.+||+.||++||++.++++|||++..
T Consensus       264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            2334689999999999999999999999999999998753

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-46  Score=316.43  Aligned_cols=258  Identities=29%  Similarity=0.466  Sum_probs=211.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC------
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ------   88 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------   88 (281)
                      .++|++.+.||.|+||+||+|.+..+++.||+|.+..... .......+.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3789999999999999999999999999999999865432 222345567899999999999999999987543      


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      ...+++++++ +++|.++++. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            3578999988 6688887765 4589999999999999999999999999999999999999999999999999876655


Q ss_pred             CcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-----------------
Q 038249          169 RRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-----------------  230 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------  230 (281)
                      ......+++.|+|||.+.+ ..++.++||||||+++++|++|..||...+..+....+.....                 
T Consensus       171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07878         171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK  250 (343)
T ss_pred             CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence            5555678999999999866 5678899999999999999999999987665544433321100                 


Q ss_pred             ------cCC------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          231 ------KFP------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       231 ------~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                            ..+      .....+..+.++|.+||..||++|||+.|++.||||.+...+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence                  000      011356678999999999999999999999999999976443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.6e-46  Score=318.68  Aligned_cols=254  Identities=27%  Similarity=0.409  Sum_probs=211.1

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-----EE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-----RV   91 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~   91 (281)
                      +|++.+.||.|++|.||++.+..+++.||+|.+.... ........+.+|+.+++.++|+||+++++++...+     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            5889999999999999999999999999999985432 22233456788999999999999999999998766     78


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      ++|+||+.+ +|.+.+.....++...++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            999999965 88888887778999999999999999999999999999999999999999999999999987543222  


Q ss_pred             --cccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc------------------
Q 038249          170 --RRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------------------  228 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------  228 (281)
                        .....+++.|+|||.+.+. .++.++|||||||++++|++|+.||...+..+....+...                  
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence              1223467889999998664 4788999999999999999999999887765554433211                  


Q ss_pred             -----cccC-------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          229 -----DLKF-------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       229 -----~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                           ....       ......+.++.++|.+||+.||++|||+.|+++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                 0000       1112357889999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2e-45  Score=299.11  Aligned_cols=251  Identities=29%  Similarity=0.486  Sum_probs=218.0

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||+|++|.||++.++.+++.+++|.+...... ......+.+|+++++.++|||++++++.+.+.+..++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            588999999999999999999999999999998655433 3345678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           97 YAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        97 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      |+++++|.+++...  ..++...++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......   ..
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999998764  56899999999999999999999999999999999999999999999999987543322   12


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ...+++.|+|||...+..++.++|+||||+++++|++|..||...+..+.............. ..++.++.+++.+||+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~  238 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-QMYSQQLAQLIDQCLT  238 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-cccCHHHHHHHHHHcc
Confidence            335678899999998888999999999999999999999999888776666665554332222 2688999999999999


Q ss_pred             cCCCCCCChhhhhcCCcc
Q 038249          252 KDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~  269 (281)
                      .+|++||++.++++|||+
T Consensus       239 ~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         239 KDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCcccCcCHHHHhhCCCC
Confidence            999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-45  Score=301.11  Aligned_cols=252  Identities=29%  Similarity=0.492  Sum_probs=215.3

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccc------hHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ------SQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      +|.+.+.||.|++|.||.|.+..+++.+++|.+.......      ......+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4788899999999999999999899999999986543321      2234568889999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      .++++||+++++|.+++...+.++...+..++.+++.|+++||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            9999999999999999988888999999999999999999999999999999999999999999999999987544311 


Q ss_pred             --------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          170 --------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       170 --------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                              .....++..|+|||.+.+..++.++|+||||+++++|++|..||...+............. ......++.+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  239 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS-PEIPSNISSE  239 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC-CcCCcccCHH
Confidence                    1122467789999999888889999999999999999999999987766555444433211 1222358899


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +.++|.+||++||++||++.++++||||
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         240 AIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.4e-46  Score=325.60  Aligned_cols=255  Identities=24%  Similarity=0.431  Sum_probs=204.7

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC------CCceeeeeeEEEe
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR------HPNILRLYGYFYD   87 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~   87 (281)
                      ..++|++.+.||.|+||+||+|.+..+++.||||++....    ........|+++++.++      |.+++++++++..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3478999999999999999999999999999999985321    12233445666666554      4568899998875


Q ss_pred             C-CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCC------------
Q 038249           88 Q-KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQG------------  153 (281)
Q Consensus        88 ~-~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~------------  153 (281)
                      . .++++|++++ +++|.+++...+.+++..++.++.||+.||.|||+ .||+|+||||+||+++.++            
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            4 5789999988 66899888887889999999999999999999998 5999999999999998765            


Q ss_pred             ----cEEEeeecCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc
Q 038249          154 ----ELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD  229 (281)
Q Consensus       154 ----~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (281)
                          .+||+|||.+...........+|+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+....
T Consensus       282 ~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL  361 (467)
T ss_pred             CCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence                4999999987655444555678999999999999899999999999999999999999998777655443322110


Q ss_pred             ccCC-----------------------C-----------------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          230 LKFP-----------------------P-----------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       230 ~~~~-----------------------~-----------------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ...+                       .                 ....+..+.+||.+||..||++|||++|+|+||||
T Consensus       362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~  441 (467)
T PTZ00284        362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV  441 (467)
T ss_pred             CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence            0000                       0                 00123557899999999999999999999999999


Q ss_pred             ccCC
Q 038249          270 IQNA  273 (281)
Q Consensus       270 ~~~~  273 (281)
                      .+..
T Consensus       442 ~~~~  445 (467)
T PTZ00284        442 LKYY  445 (467)
T ss_pred             cccC
Confidence            9853

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-45  Score=315.28  Aligned_cols=256  Identities=28%  Similarity=0.438  Sum_probs=210.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-----
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-----   88 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----   88 (281)
                      ..++|++.+.||+|++|.||.+.+..+++.+|+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            46899999999999999999999999999999999865432 233345677899999999999999999987543     


Q ss_pred             -CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           89 -KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        89 -~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                       ...++||||+++ +|...+..  .++...+..++.|++.||++||++||+|+||+|+||+++.++.++|+|||++....
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             357999999976 67776653  47899999999999999999999999999999999999999999999999986543


Q ss_pred             CC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc---------------
Q 038249          168 NR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL---------------  230 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  230 (281)
                      ..  .....+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.....               
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence            32  2234578899999999998999999999999999999999999987766555444322100               


Q ss_pred             -------cC------------------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          231 -------KF------------------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       231 -------~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                             ..                  ......+.+++++|.+||+.||++|||+.++|.||||..+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~  325 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  325 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence                   00                  00012356789999999999999999999999999998653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.8e-46  Score=315.48  Aligned_cols=257  Identities=27%  Similarity=0.414  Sum_probs=209.7

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC----
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ----   88 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----   88 (281)
                      ...++|++.+.||+|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            456899999999999999999999999999999999865432 233345677899999999999999999988643    


Q ss_pred             --CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           89 --KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        89 --~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                        ...++||||+++ ++...+..  .++...+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence              357999999976 66666653  4789999999999999999999999999999999999999999999999998654


Q ss_pred             cCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc----------------
Q 038249          167 FNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------  228 (281)
Q Consensus       167 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------------  228 (281)
                      ...  .....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+........                
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            332  23345788999999998888999999999999999999999999876654433222110                


Q ss_pred             ------ccc------------------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          229 ------DLK------------------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       229 ------~~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                            ...                  .......+.++.++|.+||..||++|||+.|+|.||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence                  000                  000112456789999999999999999999999999998653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4e-45  Score=304.91  Aligned_cols=256  Identities=29%  Similarity=0.545  Sum_probs=220.8

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||++.++.+++.|++|.+.............+.+|+++++.++||||+++++.+...+..++|+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987654433444567888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC------
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR------  169 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~------  169 (281)
                      ||++|++|.++++..+.+++..+..++.+++.|+.+||+.|++|+||+|.||+++.++.++++|||++......      
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999986421100      


Q ss_pred             ------------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCC-C
Q 038249          170 ------------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK-P  236 (281)
Q Consensus       170 ------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~  236 (281)
                                  .....++..|+|||.+....++.++|+||||+++++|++|..||.+....+............+.. .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE  240 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence                        011345778999999988888999999999999999999999998877777666665544333322 2


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC---hhhhhcCCcccc
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLP---LHKLLEHPWIIQ  271 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps---~~eil~~~~~~~  271 (281)
                      .++.++.++|.+||+.||++||+   +.++++||||..
T Consensus       241 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            57899999999999999999998   789999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-45  Score=303.55  Aligned_cols=256  Identities=29%  Similarity=0.505  Sum_probs=218.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||++.+..++..+++|.+...   .......+..|+.++++++|+|++++++.+..+...++|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            5799999999999999999999989999999998543   2334466788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---Ccc
Q 038249           96 EYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRR  171 (281)
Q Consensus        96 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~  171 (281)
                      ||+++++|.+++... .++++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.....   ...
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            999999999998764 5699999999999999999999999999999999999999999999999998644322   223


Q ss_pred             cccCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-cCCCCCCCCHHHHHH
Q 038249          172 TMCGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-KFPPKPIVSSAAKDL  245 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  245 (281)
                      ...+++.|++||.+.     ...++.++|+||||+++|+|++|..||...+..+....+..... .......++.++.++
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF  241 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence            345788999999874     34467789999999999999999999988777666555554432 222234588999999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      |.+||+.+|.+||+++++++||||.+..+
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         242 LKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             HHHHhccChhhCcCHHHHhcChhhcccch
Confidence            99999999999999999999999998743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.3e-46  Score=322.20  Aligned_cols=252  Identities=29%  Similarity=0.478  Sum_probs=204.3

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-----
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-----   88 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----   88 (281)
                      ...+|++++.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++|+||+++++++...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3467999999999999999999999999999999985432       1234689999999999999999887432     


Q ss_pred             ---CEEEEEEeccCCCChhHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-cEEEeee
Q 038249           89 ---KRVYLILEYAAKGELYKELQ----KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADF  160 (281)
Q Consensus        89 ---~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-~~~l~df  160 (281)
                         ..+++||||+++ +|.+.+.    ....+++..++.++.||+.||+|||+.||+||||+|+||+++.++ .++|+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               256799999976 6766664    345689999999999999999999999999999999999998765 6999999


Q ss_pred             cCcccccCC--cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--------
Q 038249          161 GWSVHTFNR--RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--------  229 (281)
Q Consensus       161 g~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------  229 (281)
                      |++......  .....+++.|+|||.+.+ ..++.++|||||||++++|++|.+||.+....+....+....        
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            998654322  233467889999998755 468899999999999999999999998877665544433210        


Q ss_pred             ---------ccCCC----------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          230 ---------LKFPP----------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       230 ---------~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                               ..++.          ....+.++.+||.+||.+||.+|||+.|+|.||||.+..
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                     00111          123678999999999999999999999999999998653

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.4e-45  Score=300.43  Aligned_cols=253  Identities=28%  Similarity=0.485  Sum_probs=211.6

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+....  .......+.+|++++++++|||++++++.+...+..++|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            47899999999999999999999999999999986542  2334567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-Cccccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMC  174 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-~~~~~~  174 (281)
                      ||+++++|...    ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  154 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV  154 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence            99999988654    3468889999999999999999999999999999999999999999999998754332 233456


Q ss_pred             CcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-------HHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-------DTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       175 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      ++..|+|||.+.+..++.++|+||||+++++|++|..||......       .....+.............+.++.+++.
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT  234 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence            788999999998888999999999999999999999999653322       1122222222222223357889999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      +||+.+|++||+++|++.||||.+...
T Consensus       235 ~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         235 QCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             HHhhCChhhCCCHHHHhcCcccccccC
Confidence            999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.1e-45  Score=306.06  Aligned_cols=259  Identities=29%  Similarity=0.524  Sum_probs=213.2

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      .++++|++.+.||.|++|.||+|.+..+++.||+|.+.......  ....+.+|+.+++.++|+||+++++++...+..+
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~   80 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   80 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence            46789999999999999999999999999999999986443221  2334678999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           93 LILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      +|+||+++ +|...+... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            99999975 888887653 56899999999999999999999999999999999999999999999999987543221  


Q ss_pred             -cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc------------------
Q 038249          170 -RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD------------------  229 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  229 (281)
                       .....+++.|+|||.+.+ ..++.++|+||||+++++|++|.+||...+..+....+....                  
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence             123346789999998754 447889999999999999999999998776655443322110                  


Q ss_pred             -ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          230 -LKFP---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       230 -~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                       ...+         ..+.++.++.++|.+||+.||.+|||+.|++.||||+...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence             0001         11347888999999999999999999999999999987654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.6e-45  Score=296.27  Aligned_cols=251  Identities=27%  Similarity=0.491  Sum_probs=214.0

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-CCEEEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-QKRVYLIL   95 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~   95 (281)
                      +|++.+.||.|++|.||.+.++.+++.+++|.+...... ....+.+.+|++++++++|+|++++.+.+.. +...++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            589999999999999999999999999999998654432 3345668889999999999999999998764 45689999


Q ss_pred             eccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---c
Q 038249           96 EYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---R  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~  170 (281)
                      ||+++++|.+.+...  ..+++.+++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......   .
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            999999999988763  45899999999999999999999999999999999999999999999999987543221   2


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..........+... .....++.++.+++.+||
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l  238 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-PMPKDYSPELGELIATML  238 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHHHHHHHHh
Confidence            2345788999999998888899999999999999999999999877666655555444332 223368899999999999


Q ss_pred             ccCCCCCCChhhhhcCCcc
Q 038249          251 VKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       251 ~~~p~~Rps~~eil~~~~~  269 (281)
                      ++||++||++.++++||||
T Consensus       239 ~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         239 SKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ccCcccCCCHHHHhcCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.6e-45  Score=299.60  Aligned_cols=249  Identities=36%  Similarity=0.633  Sum_probs=216.5

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCCh
Q 038249           24 LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGEL  103 (281)
Q Consensus        24 ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  103 (281)
                      ||.|++|.||++.+..+++.+++|.+...........+.+.+|+.+++.++|+||+++++.+.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            68999999999999999999999999766554445567789999999999999999999999999999999999999999


Q ss_pred             hHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--cccccCcCCccC
Q 038249          104 YKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRTMCGTLDYLP  181 (281)
Q Consensus       104 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~a  181 (281)
                      .+.+.....++...+..++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||.+......  .....+++.|++
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  160 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA  160 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence            999988777999999999999999999999999999999999999999999999999987654332  233457889999


Q ss_pred             CccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCC--chHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 038249          182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE--HSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLP  259 (281)
Q Consensus       182 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  259 (281)
                      ||.+.+..++.++|+||+|+++++|++|..||....  ..+....+..+..........+.++.++|.+||+.+|++||+
T Consensus       161 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         161 PEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             hhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence            999888888999999999999999999999998776  455555555322223333345899999999999999999999


Q ss_pred             -----hhhhhcCCccccC
Q 038249          260 -----LHKLLEHPWIIQN  272 (281)
Q Consensus       260 -----~~eil~~~~~~~~  272 (281)
                           ++|+++||||.+.
T Consensus       241 ~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         241 NLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             CcccCHHHHhcChhhhCC
Confidence                 9999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.7e-45  Score=298.53  Aligned_cols=252  Identities=25%  Similarity=0.450  Sum_probs=213.4

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeeccccc---chHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ---QSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      +|++.+.||.|++|.||+|.+. +++.+|+|.+......   ..+....+.+|++.+++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5889999999999999999875 7888999988644321   23334668899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-----
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----  168 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-----  168 (281)
                      ++||+++++|.+++....++++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+.....     
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            999999999999998877899999999999999999999999999999999999999999999999998743211     


Q ss_pred             ----CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-cccCCCCCCCCHHHH
Q 038249          169 ----RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-DLKFPPKPIVSSAAK  243 (281)
Q Consensus       169 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~  243 (281)
                          ......++..|+|||.+.+..++.++|+||||+++++|++|..||...+........... .........++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence                112234678899999998888899999999999999999999999876655544333322 112223345889999


Q ss_pred             HHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ++|.+||..+|++||++.+++.||||
T Consensus       240 ~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         240 DFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-45  Score=301.13  Aligned_cols=251  Identities=29%  Similarity=0.515  Sum_probs=218.9

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+...........+.+.+|++.+++++|||++++++.+.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999976655454556788999999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--ccccc
Q 038249           97 YAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRTMC  174 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~~~~  174 (281)
                      |+.+++|.+.+....++++..+..++.+|+.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......  .....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  160 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS  160 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence            9999999999988778999999999999999999999999999999999999999999999999987554332  23345


Q ss_pred             CcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc---hHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH---SDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       175 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ++..|+|||.+.+..++.++|+||||+++++|++|..||.....   ..........  ........+.++.++|.+||.
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~  238 (258)
T cd05578         161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA--DVLYPATWSTEAIDAINKLLE  238 (258)
T ss_pred             CChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc--cccCcccCcHHHHHHHHHHcc
Confidence            77889999999888889999999999999999999999987764   2222222222  223334688999999999999


Q ss_pred             cCCCCCCCh--hhhhcCCcc
Q 038249          252 KDSSQRLPL--HKLLEHPWI  269 (281)
Q Consensus       252 ~~p~~Rps~--~eil~~~~~  269 (281)
                      .||.+||++  .|+++||||
T Consensus       239 ~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         239 RDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             CChhHcCCccHHHHhcCCCC
Confidence            999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-47  Score=299.90  Aligned_cols=263  Identities=37%  Similarity=0.629  Sum_probs=242.8

Q ss_pred             hhhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249            7 AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus         7 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      .+.+.++.|++|+.++.||+|.||.|-+++.+.+++.+|+|++.+.-+........-..|-+.|+..+||.+..+.-.|.
T Consensus       159 ~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ  238 (516)
T KOG0690|consen  159 AKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ  238 (516)
T ss_pred             ccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence            44567789999999999999999999999999999999999998777665555566677999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           87 DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      ..+.+|+||||..||.|.-.++..+.++++..+.+...|+.||.|||+++|+.+|+|.+|.|+|.+|++|+.|||++...
T Consensus       239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999999999999988888888999999999999999999999999999999999999999999999999998543


Q ss_pred             ---cCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHH
Q 038249          167 ---FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK  243 (281)
Q Consensus       167 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  243 (281)
                         .......||||.|+|||++....|+.+.|.|.+|+++|+|++|.+||-..+...++..++.....+|.  .++.+.+
T Consensus       319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr--~ls~eAk  396 (516)
T KOG0690|consen  319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR--TLSPEAK  396 (516)
T ss_pred             ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc--cCCHHHH
Confidence               34467789999999999999999999999999999999999999999999999999999999888877  6999999


Q ss_pred             HHHHHhcccCCCCCC-----ChhhhhcCCcccc
Q 038249          244 DLISQMLVKDSSQRL-----PLHKLLEHPWIIQ  271 (281)
Q Consensus       244 ~li~~~l~~~p~~Rp-----s~~eil~~~~~~~  271 (281)
                      .|+..+|..||++|.     .+.||.+|+||..
T Consensus       397 tLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  397 TLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            999999999999998     4999999999974

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-45  Score=304.69  Aligned_cols=251  Identities=27%  Similarity=0.469  Sum_probs=202.5

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHh---CCCCceeeeeeEEEe-----C
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH---LRHPNILRLYGYFYD-----Q   88 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~---~~h~~i~~~~~~~~~-----~   88 (281)
                      +|++.+.||.|++|+||+|.++.+++.+|+|.+....... .......+|+.+++.   ++||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5899999999999999999999999999999986543221 112234455555554   479999999998864     3


Q ss_pred             CEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           89 KRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      ...++++|++.+ +|.+++...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            468999999976 888888764  34899999999999999999999999999999999999999999999999987543


Q ss_pred             cCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-----c--------
Q 038249          167 FNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-----K--------  231 (281)
Q Consensus       167 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~--------  231 (281)
                      ...  .....++..|+|||.+.+..++.++|+||||+++++|++|.+||......+....+.....     .        
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            322  2234568899999999888899999999999999999999999987766655444332100     0        


Q ss_pred             ---C---------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          232 ---F---------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       232 ---~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                         .         ...+.++.++.++|.+||++||++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence               0         0113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6e-45  Score=298.14  Aligned_cols=254  Identities=26%  Similarity=0.463  Sum_probs=213.1

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--CCEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL--QQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--QKRV   91 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~   91 (281)
                      .+|++.+.||.|++|.||+|.+..++..+++|.+.....  ........+.+|+.++++++|+||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            579999999999999999999999999999999864432  122344568889999999999999999999875  4678


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---  168 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---  168 (281)
                      ++++||+++++|.+.+...+.++...++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++.....   
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            99999999999999998877899999999999999999999999999999999999999999999999998754321   


Q ss_pred             ---CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          169 ---RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       169 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                         ......++..|+|||.+.+..++.++|+||+|+++++|++|..||......+.................++..+.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence               11223467889999999888889999999999999999999999987766665554433222222223477889999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCccc
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                      | +||..+|++||+++|+++||||+
T Consensus       242 i-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         242 L-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             H-HHhcCChhhCcCHHHHhcCcccc
Confidence            9 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-46  Score=300.71  Aligned_cols=251  Identities=33%  Similarity=0.554  Sum_probs=210.2

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-----EE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-----RV   91 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~   91 (281)
                      .|...+.+|.|+||.||.|+...+++.+|||+...+..-.       -+|+++++.++|||||++.-+|....     ..
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            3889999999999999999999999999999986554322       25899999999999999999886422     45


Q ss_pred             EEEEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC-CcEEEeeecCcccc
Q 038249           92 YLILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-GELKIADFGWSVHT  166 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~-~~~~l~dfg~~~~~  166 (281)
                      .+|+||++. +|...++.    +..++...++-+++||++|+.|||+.||+||||||.|+++|.+ |.+||+|||.+...
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            789999987 99998884    4568999999999999999999999999999999999999987 89999999999765


Q ss_pred             cCCccc--ccCcCCccCCccc-cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc------------cc-
Q 038249          167 FNRRRT--MCGTLDYLPPEMV-ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------------DL-  230 (281)
Q Consensus       167 ~~~~~~--~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------~~-  230 (281)
                      .....+  ...+-.|.|||.+ ....|+.+.||||.||++.||+-|++.|.+.+..+++..+.+.            .. 
T Consensus       177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            444332  3467789999986 4556899999999999999999999999998887776555442            00 


Q ss_pred             ----cCC----------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          231 ----KFP----------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       231 ----~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                          .++          .....+.+..+|+.++|.++|++|.++.|++.||||..--++
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                001          113488999999999999999999999999999999976544

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.5e-45  Score=305.04  Aligned_cols=259  Identities=27%  Similarity=0.456  Sum_probs=218.9

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ..+|++.+.||.|++|.||++++..+++.+++|.+......   ..+.+.+|+.+++.++|+|++++++.+..++..++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            37899999999999999999999999999999998654322   235578899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      +||+++++|.+++.. ..+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++++|||++......   ..
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence            999999999999876 35799999999999999999999999999999999999999999999999987543222   12


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhh-ccccCCCCCCCCHHHHHHHHHhc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-VDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ...+++.|++||.+.+..++.++|+||||++++++++|..||...+.......... ..........++..+.+++.+||
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  253 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL  253 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHc
Confidence            34578889999999888889999999999999999999999976655433222211 22222233457889999999999


Q ss_pred             ccCCCCCCChhhhhcCCccccCCCCCC
Q 038249          251 VKDSSQRLPLHKLLEHPWIIQNADPSG  277 (281)
Q Consensus       251 ~~~p~~Rps~~eil~~~~~~~~~~~~~  277 (281)
                      ..+|++||++.+++.||||++....++
T Consensus       254 ~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         254 EMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             cCChhhCcCHHHHhcCchhcccccccc
Confidence            999999999999999999998866544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.2e-45  Score=301.97  Aligned_cols=253  Identities=28%  Similarity=0.504  Sum_probs=210.9

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||++.++.+++.+++|++...... ....+.+.+|+.++++++|+|++++++++......++|+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            4799999999999999999999999999999998654321 222345778999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---cc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---RT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---~~  172 (281)
                      ||+++++|..+......+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.......   ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            999998888887776679999999999999999999999999999999999999999999999999875543322   23


Q ss_pred             ccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-------------------cC
Q 038249          173 MCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-------------------KF  232 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~  232 (281)
                      ..++..|+|||.+.+ ..++.++|+||||+++++|++|..||......+....+.....                   ..
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            346778999999765 4578899999999999999999999987766554433221100                   00


Q ss_pred             CC----------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          233 PP----------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       233 ~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +.          .+.++..+.++|.+||+++|++||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00          12467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-45  Score=310.90  Aligned_cols=249  Identities=23%  Similarity=0.399  Sum_probs=202.8

Q ss_pred             cCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQ   88 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~   88 (281)
                      .++|++.+.||.|+||.||+|.+.     .++..||+|.+....  .......+.+|+.+++++ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            368999999999999999999853     345679999986432  223346688999999999 899999999988754


Q ss_pred             -CEEEEEEeccCCCChhHHHHhC---------------------------------------------------------
Q 038249           89 -KRVYLILEYAAKGELYKELQKC---------------------------------------------------------  110 (281)
Q Consensus        89 -~~~~~v~e~~~~~~L~~~~~~~---------------------------------------------------------  110 (281)
                       +.++++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999988642                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-----ccccCcCCcc
Q 038249          111 -----KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-----RTMCGTLDYL  180 (281)
Q Consensus       111 -----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~  180 (281)
                           .++++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......     ....+++.|+
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence                 237788899999999999999999999999999999999999999999999986432211     1223457899


Q ss_pred             CCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 038249          181 PPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLP  259 (281)
Q Consensus       181 aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  259 (281)
                      |||.+.+..++.++||||||+++++|++ |..||......+.................++.++.+++.+||+.||++|||
T Consensus       244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs  323 (338)
T cd05102         244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT  323 (338)
T ss_pred             CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence            9999988889999999999999999996 999998766544433333222223334468899999999999999999999


Q ss_pred             hhhhhc
Q 038249          260 LHKLLE  265 (281)
Q Consensus       260 ~~eil~  265 (281)
                      +.++++
T Consensus       324 ~~el~~  329 (338)
T cd05102         324 FSALVE  329 (338)
T ss_pred             HHHHHH
Confidence            999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.2e-45  Score=301.38  Aligned_cols=256  Identities=26%  Similarity=0.403  Sum_probs=215.7

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      .|+..+.||.|+||+||.+.+..+++.+|+|.+.............+.+|+++++.++|++++.+.+.+..++..++++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            47888999999999999999999999999999866544444444557789999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--ccc
Q 038249           97 YAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRT  172 (281)
Q Consensus        97 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~~  172 (281)
                      |+.+++|.+.+...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG  160 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence            99999998887543  35899999999999999999999999999999999999999999999999987543222  233


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccCCCCCCCCHHHHHHHHHhc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ..++..|+|||.+.+..++.++|+||||+++++|++|..||...........+....  ........++.++.+++.+||
T Consensus       161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05632         161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL  240 (285)
T ss_pred             CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHc
Confidence            467899999999988889999999999999999999999998766544333322211  111223458899999999999


Q ss_pred             ccCCCCCCC-----hhhhhcCCccccC
Q 038249          251 VKDSSQRLP-----LHKLLEHPWIIQN  272 (281)
Q Consensus       251 ~~~p~~Rps-----~~eil~~~~~~~~  272 (281)
                      +.||++||+     +.+++.|+||.+.
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         241 TKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             cCCHhHcCCCcccChHHHHcChhhhcC
Confidence            999999999     8899999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.1e-45  Score=299.22  Aligned_cols=253  Identities=25%  Similarity=0.447  Sum_probs=212.9

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      ...++|++.+.||.|++|.||.|.+..+++.+++|.+....   ......+.+|+.+++.++|||++++++.+...+..+
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            34568999999999999999999999999999999986543   122345778999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---C
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---R  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~  169 (281)
                      +++||+++++|.+++...+.+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.....   .
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence            9999999999999998888899999999999999999999999999999999999999999999999998744322   2


Q ss_pred             cccccCcCCccCCcccc---CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC---CCCCCCHHHH
Q 038249          170 RRTMCGTLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP---PKPIVSSAAK  243 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~  243 (281)
                      .....++..|+|||.+.   ...++.++|+||||+++++|++|..||....+..............+   ....++..+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            23446788999999873   45578899999999999999999999866554443333322222221   1224778999


Q ss_pred             HHHHHhcccCCCCCCChhhhhcCCc
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEHPW  268 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~~~  268 (281)
                      ++|.+||+.+|++||++++++.|||
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.3e-44  Score=294.37  Aligned_cols=251  Identities=29%  Similarity=0.489  Sum_probs=219.9

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||.+++..+++.+++|.+....... .....+.+|++++++++|+||+++++++.+.+..++++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            5899999999999999999999999999999986554333 345667899999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---c
Q 038249           97 YAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---R  171 (281)
Q Consensus        97 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---~  171 (281)
                      |+++++|.+.+...  ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++++|||++.......   .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999999765  458999999999999999999999999999999999999999999999999875433222   3


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ...+++.|.|||.+.+..++.++|+||||+++++|++|..||......+....+..+..... ...++.++.++|.+||.
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~  238 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV-VSVYSSELISLVHSLLQ  238 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-ccccCHHHHHHHHHHcc
Confidence            34578899999999888888999999999999999999999988777777766665544332 24688999999999999


Q ss_pred             cCCCCCCChhhhhcCCcc
Q 038249          252 KDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~  269 (281)
                      .+|++||++++++++||+
T Consensus       239 ~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         239 QDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cCcccCCCHHHHhhCcCC
Confidence            999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.9e-45  Score=307.80  Aligned_cols=254  Identities=22%  Similarity=0.346  Sum_probs=206.6

Q ss_pred             eecceeccc--CceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           19 DIGKPLGRG--KFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        19 ~~~~~ig~g--~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      ++++.||+|  ++++||++.++.+|+.||+|.+...... ......+.+|+++++.++||||+++++++..++..++|+|
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            357889999  6789999999999999999998655432 3445678889999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC------
Q 038249           97 YAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN------  168 (281)
Q Consensus        97 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~------  168 (281)
                      |+++++|.+++...  +.+++..++.++.||+.||+|||++|++|+||+|+||+++.++.+++.||+.......      
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            99999999998653  4589999999999999999999999999999999999999999999999975422211      


Q ss_pred             ----CcccccCcCCccCCccccC--CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc-----------
Q 038249          169 ----RRRTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK-----------  231 (281)
Q Consensus       169 ----~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  231 (281)
                          ......++..|+|||.+.+  ..++.++||||||+++++|++|..||......+...........           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE  239 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence                1122345677999999865  45888999999999999999999999765544433222211100           


Q ss_pred             ---------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          232 ---------------------------------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       232 ---------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                                                       .+....++.++.++|.+||+.||++|||+.++++||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                             001113567899999999999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.6e-45  Score=302.31  Aligned_cols=254  Identities=26%  Similarity=0.455  Sum_probs=216.6

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ..+|++.+.||.|++|.||++++..++..+++|.+......   ....+.+|+.+++.+.|+|++++++.+......++|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            36899999999999999999999999999999998654422   235678899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      +||+++++|.+++... .++..++..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......   ..
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             ecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            9999999999998754 5899999999999999999999999999999999999999999999999987543222   12


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhh-ccccCCCCCCCCHHHHHHHHHhc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-VDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ...+++.|+|||.+.+..++.++|+||||+++++|++|..||.............. ..........++..+.+++.+||
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence            34578899999999888889999999999999999999999987665443333222 22222233457889999999999


Q ss_pred             ccCCCCCCChhhhhcCCccccC
Q 038249          251 VKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       251 ~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ..+|++||++.+++.||||...
T Consensus       255 ~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         255 DMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             cCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.2e-45  Score=297.20  Aligned_cols=252  Identities=31%  Similarity=0.475  Sum_probs=215.2

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|+||+|.+..++..+++|++.......  ....+.+|+..++.++|+|++++++.+...+..++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999999899999999986544322  4567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--
Q 038249           96 EYAAKGELYKELQKC---KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--  170 (281)
                      |++++++|.+++...   ..+++..++.++.||+.|+.+||+.|++|+|++|+||+++.++.++|+|||++.......  
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   358999999999999999999999999999999999999999999999999874433221  


Q ss_pred             -----ccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc-CCC---CCCCCH
Q 038249          171 -----RTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK-FPP---KPIVSS  240 (281)
Q Consensus       171 -----~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~  240 (281)
                           ....++..|++||.+... .++.++|+||||+++++|++|..||...+..+........... ...   ...++.
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence                 223578889999998766 6888999999999999999999999877766655554443221 111   125788


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ++.+++.+||..||++||++++++.||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-44  Score=298.50  Aligned_cols=253  Identities=28%  Similarity=0.484  Sum_probs=214.7

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEec
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEY   97 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   97 (281)
                      |++.+.||.|++|.||++.+..++..+++|.+....   ......+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            688999999999999999999999999999985432   33456678899999999999999999999999999999999


Q ss_pred             cCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cccc
Q 038249           98 AAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTM  173 (281)
Q Consensus        98 ~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~~  173 (281)
                      +++++|...+.. ..++++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||++......   ....
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            999999887754 456899999999999999999999999999999999999999999999999987543221   2334


Q ss_pred             cCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-cCCCCCCCCHHHHHHHH
Q 038249          174 CGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-KFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       174 ~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  247 (281)
                      .+++.|+|||.+.     +..++.++|+||+|+++++|++|..||...+..+.......... .......++.++.++|.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK  243 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence            5788999999873     44567899999999999999999999988776665555544332 22233458899999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +||+.||.+||++.+++.||||....
T Consensus       244 ~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         244 KCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHccCChhhCcCHHHHhcCCCEeccC
Confidence            99999999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.3e-45  Score=299.08  Aligned_cols=251  Identities=24%  Similarity=0.427  Sum_probs=210.4

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ..+|++.+.||.|++|.||+|.+..+++.+++|++.....   .....+.+|+.++++++|+|++++++.+...+..++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            3679999999999999999999999999999999864421   2234577899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      +||+++++|.+++....++++..+..++.|++.|+.+||+.|++|+|++|+||+++.++.++|+|||++......   ..
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            999999999999988788999999999999999999999999999999999999999999999999987644322   22


Q ss_pred             cccCcCCccCCcccc---CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC---CCCCCCHHHHHH
Q 038249          172 TMCGTLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP---PKPIVSSAAKDL  245 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l  245 (281)
                      ...+++.|+|||.+.   ...++.++|+||+|+++++|++|..||......+....+.......+   ....++.++.++
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF  244 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence            345778999999873   44467899999999999999999999865554433322222222211   122468899999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCc
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPW  268 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~  268 (281)
                      |++||+.+|++|||+++|++|+|
T Consensus       245 i~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         245 VKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHhhCChhhCcCHHHHhcCCC
Confidence            99999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-45  Score=300.57  Aligned_cols=256  Identities=29%  Similarity=0.506  Sum_probs=216.4

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||++.++.+++.+++|.+.....  ......+.+|++++++++||||+++++.+...+..++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            468899999999999999999999999999999865532  244567888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-ccc
Q 038249           96 EYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-RRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-~~~  172 (281)
                      ||+++++|.+++... .++++..+..++.+++.|+.+||+ .|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  158 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT  158 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence            999999999999876 778999999999999999999999 99999999999999999999999999987543221 122


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCC-----chHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE-----HSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      ..++..|+|||.+.+..++.++|+||||+++++|++|..||....     ..+..+..............++.++.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN  238 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence            557788999999988889999999999999999999999996542     122333333322212222237889999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +||..||++|||+.+++.||||+++.
T Consensus       239 ~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         239 LCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHcCCCchhCcCHHHHhhCchhhccc
Confidence            99999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.8e-44  Score=299.24  Aligned_cols=254  Identities=28%  Similarity=0.475  Sum_probs=214.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.|++.+.||.|++|.||+|++..++..+++|.+...   .......+.+|+.+++.++|+|++++++.+..++..++||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            6699999999999999999999999999999998543   3344566888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           96 EYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        96 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      ||+++++|...+.+ ...+++..++.++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+......   ..
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            99999999887754 456899999999999999999999999999999999999999999999999987543221   23


Q ss_pred             cccCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-cCCCCCCCCHHHHHH
Q 038249          172 TMCGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-KFPPKPIVSSAAKDL  245 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  245 (281)
                      ...+++.|+|||.+.     ...++.++|+||||+++|+|++|..||...+..+.......... .......++.++.++
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF  248 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence            345678899999874     34467789999999999999999999987766555544443322 222234578899999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCccccC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      |.+||..+|++||+++++++||||...
T Consensus       249 i~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         249 LKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             HHHHhcCCcccCcCHHHHhcCcccccc
Confidence            999999999999999999999999754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.3e-45  Score=300.77  Aligned_cols=261  Identities=27%  Similarity=0.445  Sum_probs=220.2

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|++|+||++.+..+++.+++|.+....  .......+.+|+++++.++||||+++++.+...+..++
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            4578999999999999999999999999999999886442  23445678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCccccc-CCcc
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTF-NRRR  171 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~-~~~~  171 (281)
                      |+||+++++|.+++...+++++..+..++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||++.... ....
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~  160 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD  160 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence            99999999999999887889999999999999999999997 699999999999999999999999999875432 2223


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-----------HHHHHHhhccccCCCCCCCCH
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-----------DTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~  240 (281)
                      ...++..|+|||.+.+..++.++|+||||++++++++|..||......           +....+............++.
T Consensus       161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd06620         161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE  240 (284)
T ss_pred             ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence            446788999999988888889999999999999999999999765442           222222222222222223778


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                      ++.+++.+||.+||++|||+.|+++|+||.+....+
T Consensus       241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~  276 (284)
T cd06620         241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS  276 (284)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence            999999999999999999999999999998875544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.8e-45  Score=301.24  Aligned_cols=254  Identities=27%  Similarity=0.479  Sum_probs=218.1

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      .+|++.+.||.|++|.||++.+..+++.+++|.+......   ....+.+|+..++.++|+|++++++.+...+..++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            5699999999999999999999999999999998654322   2456788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~  172 (281)
                      ||+++++|..++... .+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......   ...
T Consensus        96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            999999999988764 5899999999999999999999999999999999999999999999999987543222   123


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhh-ccccCCCCCCCCHHHHHHHHHhcc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-VDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ..++..|+|||.+.+..++.++|+||||+++++|++|..||...+.......+.. ..........++..+.++|.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE  254 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence            4577899999999888889999999999999999999999988776554443332 222223344688999999999999


Q ss_pred             cCCCCCCChhhhhcCCccccCC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .||++||++.+++.||||+...
T Consensus       255 ~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         255 MDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             cChhhCCCHHHHhhChHhhhcc
Confidence            9999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.8e-44  Score=295.16  Aligned_cols=255  Identities=25%  Similarity=0.461  Sum_probs=213.4

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--CE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL--QQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--KR   90 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~   90 (281)
                      +++|++.+.||+|++|.||.+.+..++..+++|.+.....  ......+.+.+|++++++++|+||+++++++.+.  ..
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence            3679999999999999999999999999999999854321  2233456788899999999999999999998763  56


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC--
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN--  168 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~--  168 (281)
                      +++++||+++++|.+++...+.+++..++.++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||.+.....  
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            889999999999999998877789999999999999999999999999999999999999999999999998754321  


Q ss_pred             ----CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHH
Q 038249          169 ----RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       169 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (281)
                          ......++..|+|||.+.+..++.++|+||||+++++|++|..||........................++..+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence                1222346788999999988888999999999999999999999998766555554443322222223357788999


Q ss_pred             HHHHhcccCCCCCCChhhhhcCCccc
Q 038249          245 LISQMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                      +|.+|+. +|++||++++++.|||+.
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-44  Score=295.26  Aligned_cols=254  Identities=34%  Similarity=0.510  Sum_probs=219.0

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+......  .....+.+|+..+++++|+|++++++++...+..++++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            4799999999999999999999999999999998665422  34567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc---
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR---  171 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~---  171 (281)
                      ||+++++|.+++....++++..++.++.+++.|+++||+ .|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999999999999887889999999999999999999999 9999999999999999999999999998754432221   


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCC---chHHHHHHhhccccCCCCCC-CCHHHHHHHH
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE---HSDTYRRIVQVDLKFPPKPI-VSSAAKDLIS  247 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~  247 (281)
                      ...++..|+|||.+....++.++|+||||+++++|++|..||....   ..+....+..... ...... ++..+.++|.
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  237 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP-PSLPAEEFSPEFRDFIS  237 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC-CCCCcccCCHHHHHHHH
Confidence            3356788999999988888999999999999999999999997774   3333434333222 222224 7899999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +||.++|++||+++++++||||++.
T Consensus       238 ~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         238 ACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHccCChhhCCCHHHHHhCHHHHhc
Confidence            9999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-44  Score=293.78  Aligned_cols=251  Identities=27%  Similarity=0.508  Sum_probs=217.4

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.+|.+.+..+++.+++|.+....... .....+.+|+.++++++|+||+++.+.+...+..++|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            5899999999999999999999999999999986554332 334578889999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           97 YAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      |+.+++|.+.+....  .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+......   ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            999999999887643  4789999999999999999999999999999999999999999999999987543222   12


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ...+++.|+|||.+.+...+.++|+||||+++++|++|..||...+..+.......+.... ....++.++.++|.+||+
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~  238 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP-VSSHYSYDLRNLVSQLFK  238 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC-CcccCCHHHHHHHHHHhh
Confidence            2346788999999988888899999999999999999999998877777766665543322 233688999999999999


Q ss_pred             cCCCCCCChhhhhcCCcc
Q 038249          252 KDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~  269 (281)
                      .+|++||++.++++||||
T Consensus       239 ~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         239 RNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CChhhCcCHHHHhhCcCC
Confidence            999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=294.87  Aligned_cols=250  Identities=29%  Similarity=0.491  Sum_probs=214.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+.....   ...+.+.+|++++++++|||++++++.+......++++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            579999999999999999999999999999999965432   24567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           96 EYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        96 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      ||+++++|.+++... .++++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......   ..
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            999999999998776 67999999999999999999999999999999999999999999999999987543322   23


Q ss_pred             cccCcCCccCCccccCC---CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC---CCCCCCCHHHHHH
Q 038249          172 TMCGTLDYLPPEMVESV---EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF---PPKPIVSSAAKDL  245 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l  245 (281)
                      ...++..|++||.+.+.   .++.++|+||||+++++|++|..||...+..+............   .....++.++.++
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF  239 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence            34567789999998766   78889999999999999999999998777665554443332211   1122467889999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCc
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPW  268 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~  268 (281)
                      +.+||..+|.+|||+.+++.|+|
T Consensus       240 i~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         240 IKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-44  Score=293.74  Aligned_cols=253  Identities=30%  Similarity=0.491  Sum_probs=215.6

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL--QQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +|+..+.||.|++|.||+|.+..+++.+++|.+.....  ...+..+.+.+|+.+++.++|+|++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            57888999999999999999998999999999865432  2234456788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--ccc
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRT  172 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~~  172 (281)
                      +||+++++|.+++...+++++..+..++.+|+.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......  ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            999999999999988878999999999999999999999999999999999999999999999999987543322  234


Q ss_pred             ccCcCCccCCccccCCC-CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          173 MCGTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ..++..|++||.+.... ++.++|+||||+++++|++|..||......+.................++.++.+++.+||+
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence            45788899999987666 88899999999999999999999987665444444333111222234578999999999999


Q ss_pred             cCCCCCCChhhhhcCCcc
Q 038249          252 KDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~  269 (281)
                      .+|++||++.+++.|||+
T Consensus       241 ~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         241 RDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCcccCcCHHHHhcCCCC
Confidence            999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-44  Score=296.56  Aligned_cols=254  Identities=30%  Similarity=0.527  Sum_probs=213.6

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccc---cchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL---QQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      +|+..+.||+|++|.||.+.+..+++.+++|++.....   ......+.+..|+..++.++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            58899999999999999999999999999999864332   122345778899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-cEEEeeecCcccccCC---
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWSVHTFNR---  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-~~~l~dfg~~~~~~~~---  169 (281)
                      |+||+.+++|.+++...+++++..++.++.||+.|+.+||++|++|+||+|.||+++.++ .++|+|||.+......   
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998776 5999999987543221   


Q ss_pred             ----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHh---hccccCCCCCCCCHHH
Q 038249          170 ----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV---QVDLKFPPKPIVSSAA  242 (281)
Q Consensus       170 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l  242 (281)
                          .....++..|+|||.+.+..++.++|+||||+++++|++|..||...........+.   ...........++.++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL  240 (268)
T ss_pred             CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence                122356788999999988888999999999999999999999997654433322221   1112222233578999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhcCCccc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                      .+++.+||..+|.+||++.++++||||+
T Consensus       241 ~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         241 RDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-44  Score=297.43  Aligned_cols=250  Identities=28%  Similarity=0.486  Sum_probs=208.4

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeC------
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQ------   88 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~------   88 (281)
                      +.|++.+.||.|++|.||+|.+..+++.+++|.+.....    ....+..|+.+++++ +|+|++++.+++...      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            568899999999999999999999999999999864431    234577888889888 799999999998752      


Q ss_pred             CEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           89 KRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      ..+++++||+.+++|.+++...  ..+++..+..++.|++.|+++||+++++|+|++|+||+++.++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4689999999999999998863  35899999999999999999999999999999999999999999999999997543


Q ss_pred             cC---CcccccCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCC
Q 038249          167 FN---RRRTMCGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV  238 (281)
Q Consensus       167 ~~---~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (281)
                      ..   ......+++.|+|||.+.     ...++.++|+||+|+++++|++|..||........................+
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCc
Confidence            22   223345788999999875     3357789999999999999999999997666554444333332222333457


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +.++.+++.+||..||.+|||+.++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.4e-44  Score=294.20  Aligned_cols=249  Identities=30%  Similarity=0.527  Sum_probs=213.8

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||++.+..++..+++|.+.....     ...+.+|++++++++|+|++++++.+......++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            579999999999999999999998899999999854321     567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           96 EYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        96 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      ||+++++|.+++.. ...+++..++.++.+++.|+.+||+.+++|+|++|.||+++.++.++|+|||++......   ..
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            99999999999875 456899999999999999999999999999999999999999999999999987544332   22


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc-ccCCCCCCCCHHHHHHHHHhc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD-LKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ...++..|+|||.+.+..++.++|+||||+++++|++|..||................ ........++.++.++|.+||
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL  237 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence            3346788999999988888999999999999999999999998766554443332211 112223357789999999999


Q ss_pred             ccCCCCCCChhhhhcCCcc
Q 038249          251 VKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       251 ~~~p~~Rps~~eil~~~~~  269 (281)
                      +.||++|||+.+++.||||
T Consensus       238 ~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         238 VKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hcChhhCcCHHHHhcCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.2e-44  Score=299.07  Aligned_cols=251  Identities=30%  Similarity=0.530  Sum_probs=205.2

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.++++++|||++++++++..++..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            589999999999999999999999999999998654322 2234567789999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---c
Q 038249           97 YAAKGELYKELQKC---KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---R  170 (281)
Q Consensus        97 ~~~~~~L~~~~~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~  170 (281)
                      |+++ +|.+++...   ..+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||++......   .
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            9975 888877543   45899999999999999999999999999999999999999999999999987533221   1


Q ss_pred             ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--------------------
Q 038249          171 RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--------------------  229 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------  229 (281)
                      ....+++.|+|||.+.+ ..++.++|+||||+++++|++|.+||...+............                    
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            22345788999998754 446889999999999999999999998665443322211100                    


Q ss_pred             -------ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          230 -------LKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       230 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                             ........++.++.++|.+||+.||++|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                   0000123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-45  Score=310.09  Aligned_cols=248  Identities=23%  Similarity=0.374  Sum_probs=199.7

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ...+|++.+.||.|++|.||+|++..+++.+|+|......         ...|+.++++++|+||+++++++...+..++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3457999999999999999999999999999999853321         2458889999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC--Cc
Q 038249           94 ILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN--RR  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~--~~  170 (281)
                      |++++.+ +|.+++.. ..++++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||.+.....  ..
T Consensus       135 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        135 VLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            9999965 77777754 46699999999999999999999999999999999999999999999999998854322  22


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCC-CCCCCCch---------HHHHHHhhc-c---ccCC---
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVP-PFEAKEHS---------DTYRRIVQV-D---LKFP---  233 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~-p~~~~~~~---------~~~~~~~~~-~---~~~~---  233 (281)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|+++.. +|......         ..+..+... .   ..++   
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  293 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP  293 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence            33468899999999988889999999999999999997544 44432211         001110000 0   0000   


Q ss_pred             -------------------------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          234 -------------------------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       234 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                                               ....++.++.++|.+||+.||++|||++|+|+||||++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                     01235677888999999999999999999999999986

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-44  Score=296.09  Aligned_cols=253  Identities=28%  Similarity=0.485  Sum_probs=211.0

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeeccccc-------chHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-------QSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      +|.+.+.||.|++|.||+|.+..+++.+++|.+......       .....+.+..|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            588999999999999999999989999999988543211       1122456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ..++|+||+.+++|.+.+...+.++...+..++.+|+.|+.+||+.|++|+||+|+||+++.++.++++|||++......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999987543321


Q ss_pred             -----cccccCcCCccCCccccCCC--CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccC--CCCCCC
Q 038249          170 -----RRTMCGTLDYLPPEMVESVE--HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKF--PPKPIV  238 (281)
Q Consensus       170 -----~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~--~~~~~~  238 (281)
                           .....++..|+|||.+....  ++.++|+||||++++++++|..||......+.........  ...  ...+.+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence                 12234678899999986654  7889999999999999999999997655544333322111  111  122357


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +.++.++|.+||+++|++|||++++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.9e-44  Score=292.82  Aligned_cols=252  Identities=28%  Similarity=0.551  Sum_probs=215.0

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||.+.+..++..+++|.+...... ....+.+.+|+++++.++|+||+++++++...+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            589999999999999999999989999999998766533 3456788999999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc-----
Q 038249           97 YAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR-----  171 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~-----  171 (281)
                      |+++++|.+++.....+++..++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........     
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            999999999998877789999999999999999999999999999999999999999999999998754332211     


Q ss_pred             --cccCcCCccCCccccCCC---CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHH-HHhh-ccccCCCCCCCCHHHHH
Q 038249          172 --TMCGTLDYLPPEMVESVE---HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR-RIVQ-VDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       172 --~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~l~~  244 (281)
                        ...+++.|++||.+.+..   .+.++|+||||++++++++|..||.......... .... .....+....++..+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence              234678999999987665   7889999999999999999999997654333222 2222 22233444456899999


Q ss_pred             HHHHhcccCCCCCCChhhhhcCCcc
Q 038249          245 LISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +|.+||+.+|++||++.+++.|||+
T Consensus       240 li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.2e-45  Score=299.56  Aligned_cols=252  Identities=37%  Similarity=0.674  Sum_probs=221.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ++|++.+.||.|++|.||++.+..+++.+++|++..+..........+.+|++++++++ |+||+++++.+...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            57999999999999999999999999999999997655545555677888999999998 99999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc----
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~----  170 (281)
                      ||++++++|.+++...+.++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||++.......    
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999875432221    


Q ss_pred             -------------------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc
Q 038249          171 -------------------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK  231 (281)
Q Consensus       171 -------------------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  231 (281)
                                         ....++..|++||.......+.++|+||||++++++++|..||...+.....+........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS  240 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence                               1224577899999988888889999999999999999999999988776666665544433


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCh----hhhhcCCcc
Q 038249          232 FPPKPIVSSAAKDLISQMLVKDSSQRLPL----HKLLEHPWI  269 (281)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~eil~~~~~  269 (281)
                      .+  ..++..+.++|.+||+.+|++||++    ++++.||||
T Consensus       241 ~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         241 FP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CC--CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            33  3679999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.6e-44  Score=299.44  Aligned_cols=257  Identities=28%  Similarity=0.451  Sum_probs=215.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ...|++.+.||.|++|+||+|++..+++.+++|.+........+....+.+|+.+++.++|||++++.+++...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            36699999999999999999999999999999998655444444456788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccc
Q 038249           95 LEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM  173 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~  173 (281)
                      +||+.+ ++.+.+.. ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus        94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-~~~~  171 (307)
T cd06607          94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-ANSF  171 (307)
T ss_pred             HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-CCCc
Confidence            999975 67666653 45689999999999999999999999999999999999999999999999998754332 2334


Q ss_pred             cCcCCccCCcccc---CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          174 CGTLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       174 ~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      .+++.|+|||.+.   ...++.++||||||+++|+|++|..||...+.......+............++.++.++|.+||
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  251 (307)
T cd06607         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCL  251 (307)
T ss_pred             cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh
Confidence            5678899999873   4567889999999999999999999998776655544443322222222347889999999999


Q ss_pred             ccCCCCCCChhhhhcCCccccCC
Q 038249          251 VKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       251 ~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +.+|++||++.+++.||||.+..
T Consensus       252 ~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         252 QKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             cCChhhCcCHHHHhcChhhcccC
Confidence            99999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.6e-44  Score=296.39  Aligned_cols=256  Identities=29%  Similarity=0.515  Sum_probs=218.1

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|+..+.||.|++|.||++.+..+++.+++|.+....   ......+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            4666789999999999999999999999999985432   2334567889999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cccc
Q 038249           97 YAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTM  173 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~~  173 (281)
                      |+.+++|.+.+.. ..++...+..++.+++.|+++||++|++|+||+|+||+++.++.++|+|||.+......   ....
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            9999999999887 56899999999999999999999999999999999999999999999999976433221   2234


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC-CCCCCCCHHHHHHHHHhccc
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF-PPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~  252 (281)
                      .+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.......+....... .....++..+.+++.+||+.
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR  255 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence            57889999999988888999999999999999999999998777666665555442212 12223788999999999999


Q ss_pred             CCCCCCChhhhhcCCccccCCCCC
Q 038249          253 DSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                      +|++||++.++++||||.++.++.
T Consensus       256 ~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         256 DPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             ChhhCcCHHHHccCcccccCCCcc
Confidence            999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-45  Score=312.64  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=207.6

Q ss_pred             cCCceecceecccCceEEEEEEEcc--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKR--SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      -.+|++++.||.|++|.||++....  ++..+++|.+....        ...+|++++++++|+||+++++.+......+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            3579999999999999999997653  45779999874321        2457999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--  170 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--  170 (281)
                      ++++++.+ +|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......  
T Consensus       163 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        163 MVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            99999964 888888777789999999999999999999999999999999999999999999999999875433221  


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch---HHHHHHhhc----c-----------
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS---DTYRRIVQV----D-----------  229 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~----~-----------  229 (281)
                         ....+++.|+|||.+.+..++.++|||||||++++|++|..||......   ..+..+...    .           
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  321 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL  321 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence               2346899999999999888999999999999999999999999654332   111111100    0           


Q ss_pred             ------------ccCCC-----CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCCCC
Q 038249          230 ------------LKFPP-----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGV  278 (281)
Q Consensus       230 ------------~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~~~  278 (281)
                                  .....     ...++.++.++|.+||..||++|||+.|+|.||||++.+.+...
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~~  387 (392)
T PHA03207        322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLLN  387 (392)
T ss_pred             HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhhc
Confidence                        00000     01356789999999999999999999999999999987554433

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-44  Score=293.83  Aligned_cols=250  Identities=34%  Similarity=0.615  Sum_probs=210.3

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-QSHLRHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      +.||.|++|.||+|.+..+++.+|+|.+.............+..|..+ ....+|+|++++++.+...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            679999999999999999999999999865443322223334444443 4455899999999999999999999999999


Q ss_pred             CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccccCcCCcc
Q 038249          101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL  180 (281)
Q Consensus       101 ~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  180 (281)
                      ++|.++++..+++++..+..++.|++.||.+||+.|++|+||+|.||+++.++.++|+|||++..... .....+++.|+
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~y~  160 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-NKKFVGTPDYL  160 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-cccCCCCcCcc
Confidence            99999999888899999999999999999999999999999999999999999999999998754332 23345778899


Q ss_pred             CCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCCCHHHHHHHHHhcccCCCCCC
Q 038249          181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIVSSAAKDLISQMLVKDSSQRL  258 (281)
Q Consensus       181 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp  258 (281)
                      +||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+  ....++.++.+++.+||+.+|++||
T Consensus       161 ~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  240 (260)
T cd05611         161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRL  240 (260)
T ss_pred             ChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHcc
Confidence            99999887788999999999999999999999988887777666655443333  2235789999999999999999999


Q ss_pred             C---hhhhhcCCccccC
Q 038249          259 P---LHKLLEHPWIIQN  272 (281)
Q Consensus       259 s---~~eil~~~~~~~~  272 (281)
                      +   ++|+++||||.+.
T Consensus       241 ~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         241 GANGYQEIKSHPFFKSI  257 (260)
T ss_pred             CCCcHHHHHcChHhhcC
Confidence            5   5799999999763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.6e-44  Score=300.39  Aligned_cols=259  Identities=29%  Similarity=0.507  Sum_probs=214.6

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ--QSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+......  .......+..|++.+++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588999999999999999999999999999999765433  133445677899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---c
Q 038249           95 LEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---R  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~  170 (281)
                      +||+ +++|.+++.... .+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||++......   .
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 889999998765 7999999999999999999999999999999999999999999999999987554332   1


Q ss_pred             ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc-----C------------
Q 038249          171 RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK-----F------------  232 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~------------  232 (281)
                      ....+++.|+|||.+.+ ..++.++|+||||+++++|++|.++|...+..+...........     +            
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            22335678999998754 45688999999999999999998888776665444333211000     0            


Q ss_pred             ---------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          233 ---------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       233 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                               ......+.++.++|.+||.+||++|||+.|++.||||.+++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence                     00123578899999999999999999999999999999986654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-46  Score=282.87  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=216.7

Q ss_pred             hhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249            8 KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus         8 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      ..+....-++|++.+.||.|+|+-||+++...+++.||+|++....   .+..+...+|++.-++++|||+++++++...
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~   89 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLR   89 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence            3444455589999999999999999999999999999999997765   3345678899999999999999999998765


Q ss_pred             CC-----EEEEEEeccCCCChhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCeEeCCCCcEE
Q 038249           88 QK-----RVYLILEYAAKGELYKELQKC----KYFSERRAATYVASLARALIYCHGKH--VIHRDIKPENLLIGAQGELK  156 (281)
Q Consensus        88 ~~-----~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~Ni~~~~~~~~~  156 (281)
                      +.     ..|++++|...|+|.+.++..    ..+++.+++.|+.+|++||++||+..  ++|+||||.||++..++.++
T Consensus        90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence            44     489999999999999998753    36999999999999999999999998  99999999999999999999


Q ss_pred             EeeecCcccccCCc------------ccccCcCCccCCcccc---CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc--h
Q 038249          157 IADFGWSVHTFNRR------------RTMCGTLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH--S  219 (281)
Q Consensus       157 l~dfg~~~~~~~~~------------~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~  219 (281)
                      +.|||.+....-.-            .....|..|.|||.+.   +...+.++|||||||++|.|+.|..||+....  .
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg  249 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG  249 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence            99999875432211            1234688999999984   44568899999999999999999999975322  3


Q ss_pred             HHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          220 DTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +..-.+..++..++....+++.+.++|++||++||.+||++.+++.+
T Consensus       250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            34445566678888888899999999999999999999999999864

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-44  Score=328.75  Aligned_cols=263  Identities=27%  Similarity=0.478  Sum_probs=216.5

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--   87 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--   87 (281)
                      ...+.+++|++++.||.|+||+||+|++..++..+++|.+....... .....+..|+.++++++||||+++++++..  
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            44566789999999999999999999999999999999986554333 335678889999999999999999998864  


Q ss_pred             CCEEEEEEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhc-------CceecCCCCCCeEeCC-----
Q 038249           88 QKRVYLILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGK-------HVIHRDIKPENLLIGA-----  151 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~-------~i~H~di~~~Ni~~~~-----  151 (281)
                      ...+++||||+++++|.+++..    ...+++..++.|+.||+.||.|||+.       +|+|+||+|+||+++.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            4578999999999999998875    25699999999999999999999984       4999999999999964     


Q ss_pred             ------------CCcEEEeeecCcccccCC--cccccCcCCccCCccccC--CCCCCcccHHhHHHHHHHHHhCCCCCCC
Q 038249          152 ------------QGELKIADFGWSVHTFNR--RRTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEA  215 (281)
Q Consensus       152 ------------~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~  215 (281)
                                  .+.++|+|||++......  .....+++.|+|||++.+  ..++.++|||||||++|+|++|..||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                        235899999998543222  233468999999999853  4578899999999999999999999986


Q ss_pred             CCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          216 KEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      .................+ ....+.++.+||..||+.+|.+||++.++|.|||+.....
T Consensus       246 ~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        246 ANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             CCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            665544433333322222 2357899999999999999999999999999999986543

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-44  Score=298.35  Aligned_cols=259  Identities=26%  Similarity=0.469  Sum_probs=215.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||++.+..++..+++|.+....  .......+.+|++++++++|+||+++++.+...+..++|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47999999999999999999999999999999985432  2233467888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCccccc-CCc
Q 038249           96 EYAAKGELYKELQKC---KYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTF-NRR  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~~---~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~-~~~  170 (281)
                      ||+++++|..++...   ..+++..+..++.+|+.|+.+||+ .|++|+||+|+||+++.++.++|+|||.+.... ...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA  158 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence            999999999888764   368999999999999999999996 599999999999999999999999999875432 223


Q ss_pred             ccccCcCCccCCccccCCC------CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHH---hhccccCCCCCCCCHH
Q 038249          171 RTMCGTLDYLPPEMVESVE------HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI---VQVDLKFPPKPIVSSA  241 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  241 (281)
                      ....+++.|+|||.+.+..      ++.++|+||||+++++|++|..||...........+   .... .....+.++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  237 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-PPTLPSGYSDD  237 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-CCCCCcccCHH
Confidence            3345778899999985443      477899999999999999999999765554443332   2221 11223358899


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhcCCccccCCCCCC
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSG  277 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~~  277 (281)
                      +.++|.+||+.+|++||++.+++.||||.+......
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~~  273 (286)
T cd06622         238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV  273 (286)
T ss_pred             HHHHHHHHcccCcccCCCHHHHhcChhhhhccCCcc
Confidence            999999999999999999999999999988765543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.9e-45  Score=300.91  Aligned_cols=251  Identities=29%  Similarity=0.528  Sum_probs=203.6

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||+|.++.+|+.+++|.+..... .......+.+|+.++++++|+|++++++++.+....++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            58999999999999999999999999999999865432 22233456789999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccc
Q 038249           97 YAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT  172 (281)
Q Consensus        97 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~  172 (281)
                      |+++ +|.+.+.. .+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++......   ...
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            9976 77777654 567999999999999999999999999999999999999999999999999987543221   122


Q ss_pred             ccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCC-CCCCchHHHHHHhhcc-----------------ccC-
Q 038249          173 MCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVD-----------------LKF-  232 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~-----------------~~~-  232 (281)
                      ..+++.|+|||.+.+. .++.++|+||||+++++|++|..|+ ...+..+....+....                 ... 
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            3467889999987654 4688999999999999999988875 3333333332221100                 000 


Q ss_pred             ---------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          233 ---------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       233 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                               ...+.++.++.++|.+||+.||.+|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                     0113478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-44  Score=295.19  Aligned_cols=248  Identities=36%  Similarity=0.671  Sum_probs=217.9

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCCh
Q 038249           24 LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGEL  103 (281)
Q Consensus        24 ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  103 (281)
                      ||.|++|.||++.+..+|+.+++|.+.............+.+|++++++++|+|++++++.+......++++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999999765544445567788999999999999999999999999999999999999999


Q ss_pred             hHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-----------ccc
Q 038249          104 YKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-----------RRT  172 (281)
Q Consensus       104 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-----------~~~  172 (281)
                      .+++...+.+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||++......           ...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            999988778999999999999999999999999999999999999999999999999987543222           122


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ..++..|++||.......+.++|+||||++++++++|..||......+............+.....+.++.+++.+||+.
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  240 (265)
T cd05579         161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP  240 (265)
T ss_pred             cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcC
Confidence            34677899999988888889999999999999999999999888887777777665555554434589999999999999


Q ss_pred             CCCCCCCh---hhhhcCCcccc
Q 038249          253 DSSQRLPL---HKLLEHPWIIQ  271 (281)
Q Consensus       253 ~p~~Rps~---~eil~~~~~~~  271 (281)
                      +|++|||+   .++++||||.+
T Consensus       241 ~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         241 DPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             CHhhcCCCccHHHHhcCccccC
Confidence            99999999   99999999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.6e-45  Score=300.74  Aligned_cols=258  Identities=30%  Similarity=0.523  Sum_probs=219.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.|+....||.|++|.||++.+..++..+++|.+....   ......+.+|+..++.++|+|++++++.+..++..++|+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            45667788999999999999999899999999985432   233456888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~  172 (281)
                      ||+++++|.+++.. ..+++..++.++.+|+.|+.+||++|++|+||+|+||+++.++.++|+|||++......   ...
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            99999999998865 45899999999999999999999999999999999999999999999999987533221   223


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-cccCCCCCCCCHHHHHHHHHhcc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-DLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ..++..|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+... .........++..+.+++.+||.
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  257 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV  257 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence            45788999999998888899999999999999999999999877666555444332 11222333578899999999999


Q ss_pred             cCCCCCCChhhhhcCCccccCCCCCC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQNADPSG  277 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~~~~~~  277 (281)
                      .||++|||+++++.||||.....+++
T Consensus       258 ~~P~~Rpt~~~il~~~~~~~~~~~~~  283 (292)
T cd06658         258 REPSQRATAQELLQHPFLKLAGPPSC  283 (292)
T ss_pred             CChhHCcCHHHHhhChhhhccCCccc
Confidence            99999999999999999998888776

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.4e-44  Score=290.23  Aligned_cols=251  Identities=29%  Similarity=0.476  Sum_probs=216.6

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||.+.+..+++.+++|.+....... .....+.+|+++++.++|+|++++++.+...+..++|+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            5899999999999999999999999999999997654333 345778899999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-cEEEeeecCcccccCC--cc
Q 038249           97 YAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWSVHTFNR--RR  171 (281)
Q Consensus        97 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-~~~l~dfg~~~~~~~~--~~  171 (281)
                      |+++++|.+++...  ..+++..++.++.+++.++.+||++|++|+||+|+||+++.++ .++++|||.+......  ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            99999999999764  3589999999999999999999999999999999999998654 5799999987654332  22


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ...++..|+|||.+.+..++.++|+||||+++++|++|..||...+.............. +....++.++.+++.+||+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~  238 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYSPDLRQLILSMLN  238 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-CCCCCcCHHHHHHHHHHcc
Confidence            345788999999998888899999999999999999999999887776666555443322 2233588999999999999


Q ss_pred             cCCCCCCChhhhhcCCcc
Q 038249          252 KDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~  269 (281)
                      ++|++|||++|++.||||
T Consensus       239 ~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         239 LDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CChhhCCCHHHHhhCCCC
Confidence            999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4e-44  Score=296.15  Aligned_cols=252  Identities=30%  Similarity=0.512  Sum_probs=211.0

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||+|.+..+|+.+++|.+...... ......+.+|+.++++++|+|++++++++......++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            589999999999999999999999999999998765432 2335668889999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC----cc
Q 038249           97 YAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR----RR  171 (281)
Q Consensus        97 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~----~~  171 (281)
                      |+ +++|.+++.. ..++++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++++|||.+......    ..
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 8899998864 456899999999999999999999999999999999999999999999999987554332    22


Q ss_pred             cccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-------------------c
Q 038249          172 TMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-------------------K  231 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~  231 (281)
                      ...++..|+|||.+.+. .++.++|+||+|+++++|++|.++|...........+.....                   .
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            34578899999997544 468899999999999999999888877665554443322100                   0


Q ss_pred             CC---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccc
Q 038249          232 FP---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       232 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                      .+         ..+..+.++.++|.+||.++|++||+++++++||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            00         0124678999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.3e-44  Score=292.60  Aligned_cols=251  Identities=29%  Similarity=0.479  Sum_probs=210.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||.|++|.||+|++..+++.+++|.+.............+.+|+++++.++|||++++++.+...+..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            36899999999999999999999999999999988654444455566788899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           95 LEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      +||+++++|.+++..    ...+++..++.++.+|+.|+.+||++|++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999988853    3458999999999999999999999999999999999999999999999999875433221


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc--hHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH--SDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                         ....+++.|+|||.+.+..++.++|+||+|+++++|++|..||.....  .+....+............++.++.++
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL  240 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence               234577889999999888888999999999999999999999865432  233333333222222223578899999


Q ss_pred             HHHhcccCCCCCCChhhhhc
Q 038249          246 ISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~  265 (281)
                      +.+||..+|++||++++++.
T Consensus       241 i~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         241 VSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHCCCCcccCcCHHHHHH
Confidence            99999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-44  Score=312.95  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=202.2

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +....|.+.+.||.|++|.||++.+..+++.|++|....         ....+|++++++++|+||+++++++...+..+
T Consensus       166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            344579999999999999999999999999999996422         22457999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           93 LILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      +|++++. ++|..++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......  
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            9999996 4888877653 56999999999999999999999999999999999999999999999999998543222  


Q ss_pred             ---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCC-CCC-------CchHHHHHHhhcccc---CC--
Q 038249          170 ---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPF-EAK-------EHSDTYRRIVQVDLK---FP--  233 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~-~~~-------~~~~~~~~~~~~~~~---~~--  233 (281)
                         .....+|..|+|||.+.+..++.++|||||||++|+|++|..++ ...       ...+..+.+......   ++  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence               12345899999999998888999999999999999999876543 221       112222222221110   00  


Q ss_pred             ------------------------CC---CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          234 ------------------------PK---PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       234 ------------------------~~---~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                                              .+   ..++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                    00   124568999999999999999999999999999975

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.6e-44  Score=295.94  Aligned_cols=252  Identities=29%  Similarity=0.476  Sum_probs=209.2

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe-----
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD-----   87 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-----   87 (281)
                      ..+.|++.+.||.|++|.||+|.+..+++.+++|.+....    .....+..|+.+++++ +|+|++++++.+..     
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            4478999999999999999999999999999999985432    2234577888888888 69999999999853     


Q ss_pred             -CCEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           88 -QKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        88 -~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                       ....+++|||+.+++|.+++...  ..+++..++.++.||+.|+.+||+.|++|+|++|+||+++.++.++|+|||++.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence             46789999999999999998753  347888899999999999999999999999999999999999999999999875


Q ss_pred             ccc---CCcccccCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCC
Q 038249          165 HTF---NRRRTMCGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP  236 (281)
Q Consensus       165 ~~~---~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (281)
                      ...   .......+++.|+|||.+.     ...++.++|+||||+++++|++|..||....+..................
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  249 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK  249 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence            432   2223445788999999874     34577889999999999999999999977665544443333322222334


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      .++.++.++|.+||+.||.+||++.||++||||
T Consensus       250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            588999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7e-44  Score=291.19  Aligned_cols=251  Identities=33%  Similarity=0.566  Sum_probs=215.4

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--CCEEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--QKRVYLI   94 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v   94 (281)
                      +|++.+.||.|++|.||++.+..++..+++|.+...... ....+.+.+|+++++.++|+|++++++.+..  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            589999999999999999999999999999998655433 3345678889999999999999999998763  4578999


Q ss_pred             EeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           95 LEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCH-----GKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh-----~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                      +||+++++|.+++..    ..++++..++.++.+|+.|+.+||     +.+++|+||+|+||+++.++.++++|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999875    356899999999999999999999     89999999999999999999999999998765


Q ss_pred             ccCCc---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHH
Q 038249          166 TFNRR---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       166 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                      .....   ....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.......+...... .....++.++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  238 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR-RIPYRYSSEL  238 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC-CCccccCHHH
Confidence            43322   2345788999999998888899999999999999999999999988766665555544332 2233688999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      .+++.+||+.+|++||++++|++|||+
T Consensus       239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         239 NEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-46  Score=290.20  Aligned_cols=255  Identities=36%  Similarity=0.601  Sum_probs=217.5

Q ss_pred             hcccccCCceec-ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCceeeeeeEEEe
Q 038249           10 KKRWTLNDFDIG-KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-QSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        10 ~~~~~~~~y~~~-~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~   87 (281)
                      +..-..++|++. ++||-|-.|.|..+.++.+++.+|+|++.-    +.    +.++|+++ +..-.|+|||.+++++.+
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----s~----KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----SP----KARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----CH----HHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            334456788874 689999999999999999999999999832    22    34556654 334479999999999975


Q ss_pred             ----CCEEEEEEeccCCCChhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC---CcEEEe
Q 038249           88 ----QKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIA  158 (281)
Q Consensus        88 ----~~~~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~---~~~~l~  158 (281)
                          ...+.+|||.++||.|.+.++.++.  +++.++..|+.||..|++|||+.+|.||||||+|++++..   ..+||+
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence                3467899999999999999998764  9999999999999999999999999999999999999754   469999


Q ss_pred             eecCccccc--CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc----hHHHHHHhhccccC
Q 038249          159 DFGWSVHTF--NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH----SDTYRRIVQVDLKF  232 (281)
Q Consensus       159 dfg~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~  232 (281)
                      |||++....  ......+.||.|.|||++....|+...|+||+|+++|-|++|.+||-....    ......+..+.+.+
T Consensus       207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            999997765  556677889999999999999999999999999999999999999965444    34456677776666


Q ss_pred             C--CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          233 P--PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       233 ~--~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +  .|..+|++.+++|+.+|..+|.+|.|+++++.|||+.+.
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            5  466799999999999999999999999999999999976

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.2e-44  Score=300.06  Aligned_cols=260  Identities=30%  Similarity=0.463  Sum_probs=213.2

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--CEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--KRV   91 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~   91 (281)
                      .+++|++.+.||.|++|.||+|.++.+|+.||+|.+....... .......+|+.++++++|+|++++++++...  +..
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            4678999999999999999999999999999999986543222 2223456799999999999999999998754  568


Q ss_pred             EEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           92 YLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      ++|+||+.+ +|.+++.. ...+++..++.++.||+.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999976 78888775 356899999999999999999999999999999999999999999999999987554322 


Q ss_pred             --cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc----------------
Q 038249          170 --RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL----------------  230 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  230 (281)
                        .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+..+....+.....                
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence              122234678999999754 4578899999999999999999999988877766655443110                


Q ss_pred             ---cCCC---------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          231 ---KFPP---------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       231 ---~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                         ....         ....+.++.++|.+||++||++|||+++++.||||++.+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence               0000         01257889999999999999999999999999999987554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.1e-44  Score=294.24  Aligned_cols=257  Identities=26%  Similarity=0.448  Sum_probs=206.9

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE-IQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ++|++.+.||.|+||.||++.++.+|+.||+|.+........  ...+..|+. .++..+|||++++++++..++..+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            479999999999999999999999999999999865432222  233444554 46677899999999999999999999


Q ss_pred             EeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           95 LEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      +||+++ +|.+++..    ...+++..++.++.||+.|+++||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999975 78777654    24589999999999999999999997 9999999999999999999999999987644322


Q ss_pred             --cccccCcCCccCCccccC----CCCCCcccHHhHHHHHHHHHhCCCCCCCCCc-hHHHHHHhhccccCCCCCCCCHHH
Q 038249          170 --RRTMCGTLDYLPPEMVES----VEHDANVDIWSLGVLCYEFLYGVPPFEAKEH-SDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                        .....++..|+|||.+.+    ..++.++|+||||+++++|++|..||..... .+.............+...+|.++
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF  237 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence              122456788999998754    4467899999999999999999999975332 233333333222222233588999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      .++|.+||..+|++||++.++++||||++....
T Consensus       238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         238 QDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            999999999999999999999999999987544

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.1e-44  Score=294.31  Aligned_cols=255  Identities=29%  Similarity=0.498  Sum_probs=217.3

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ..|+..+.||.|++|.||.|.+..+++.+++|.+.....  ......+.+|+.+++.+.|+|++++++.+.++...++|+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468899999999999999999998999999999865432  233567888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~  172 (281)
                      ||+++++|.+++.. ++++...+..++.+++.|+++||+.+++|+||+|+||+++.++.++++|||++......   ...
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99999999998876 45899999999999999999999999999999999999999999999999987443222   222


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ..++..|+|||.+.+...+.++|+||||+++++|++|..||................ .......++.++.+++.+||..
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGEFSKPFKEFIDACLNK  239 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC-CCCCchhhhHHHHHHHHHHccc
Confidence            346778999999988888999999999999999999999998776655544432221 1122235788999999999999


Q ss_pred             CCCCCCChhhhhcCCccccCCC
Q 038249          253 DSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      +|++||++.+++.||||.+...
T Consensus       240 ~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         240 DPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             CcccCcCHHHHHhChHhhhcch
Confidence            9999999999999999987644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.5e-44  Score=304.38  Aligned_cols=260  Identities=30%  Similarity=0.471  Sum_probs=211.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-----
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-----   88 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----   88 (281)
                      ..++|++.+.||.|++|.||+|.+..+++.+|+|.+..... .......+.+|+.+++.++|+||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            45889999999999999999999999999999999864432 223345677899999999999999999988643     


Q ss_pred             -CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           89 -KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        89 -~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                       ...++|+||+.+ +|.+.+...  ++...+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence             357999999966 888877654  8999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc--ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-----------------
Q 038249          168 NRR--RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------------  228 (281)
Q Consensus       168 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------  228 (281)
                      ...  ....++..|+|||.+.+..++.++|+||||+++++|++|..||...+.......+...                 
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            322  2234678899999998888999999999999999999999999876554433322110                 


Q ss_pred             -----cccC--------------C-----CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCCC
Q 038249          229 -----DLKF--------------P-----PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSG  277 (281)
Q Consensus       229 -----~~~~--------------~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~~  277 (281)
                           ....              +     .....+.+++++|.+||+.||++|||+.|+|.||||..+..++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~  322 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE  322 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence                 0000              0     01134667899999999999999999999999999987655443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.9e-44  Score=306.67  Aligned_cols=251  Identities=23%  Similarity=0.380  Sum_probs=206.0

Q ss_pred             ccCCceecceecccCceEEEEEEE-----ccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLARE-----KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~-----~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      ..++|++.+.||.|+||.||+|.+     ..++..||+|++.....  ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            346899999999999999999974     34567899999864432  22345688899999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC--------------------------------------------------------
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK--------------------------------------------------------  111 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~--------------------------------------------------------  111 (281)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999998886421                                                        


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc-
Q 038249          112 -------------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR-  171 (281)
Q Consensus       112 -------------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~-  171 (281)
                                         .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                               367888999999999999999999999999999999999999999999999754432211 


Q ss_pred             ----cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          172 ----TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       172 ----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                          ...++..|+|||.+.+..++.++|+||||+++++|++ |..||.........................+.++.+++
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  350 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM  350 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence                1223557999999988899999999999999999997 89999876655444444433332333345789999999


Q ss_pred             HHhcccCCCCCCChhhhhcC
Q 038249          247 SQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~  266 (281)
                      .+||+.||++|||+.++++.
T Consensus       351 ~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         351 KSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-44  Score=293.28  Aligned_cols=251  Identities=32%  Similarity=0.541  Sum_probs=208.5

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCC----
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQK----   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~----   89 (281)
                      .++|++.+.||.|++|.||+|+++.+++.+++|.+....    .....+.+|+.+++++ +|+|++++++++....    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            478999999999999999999999899999999986543    2235688999999998 7999999999997644    


Q ss_pred             --EEEEEEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           90 --RVYLILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        90 --~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                        ..++|+||+++++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence              58999999999999998865    346899999999999999999999999999999999999999999999999987


Q ss_pred             ccccC---CcccccCcCCccCCccccC-----CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-cCCC
Q 038249          164 VHTFN---RRRTMCGTLDYLPPEMVES-----VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-KFPP  234 (281)
Q Consensus       164 ~~~~~---~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~  234 (281)
                      .....   ......++..|+|||.+..     ..++.++|+||||+++++|++|..||...........+..... ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS  240 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence            54322   2233457888999998743     3457789999999999999999999987655555444433322 1222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          235 KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ...++.++.++|.+||..||++|||+.+++.|||+
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            22377899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.3e-43  Score=288.42  Aligned_cols=251  Identities=32%  Similarity=0.578  Sum_probs=219.2

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||++.+..++..+++|.+...... .+....+.+|++.++.++|+|++++.+.+...+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            589999999999999999999999999999999765432 3445678889999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---
Q 038249           97 YAAKGELYKELQKC----KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---  169 (281)
Q Consensus        97 ~~~~~~L~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---  169 (281)
                      ++++++|.+.+...    ..++...+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......   
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999998764    66999999999999999999999999999999999999999999999999987543322   


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM  249 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  249 (281)
                      .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+..+............ ....++.++.+++.+|
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~  238 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IPSQYSSELRNLVSSL  238 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHH
Confidence            223457788999999988888999999999999999999999998887777666665543322 2236889999999999


Q ss_pred             cccCCCCCCChhhhhcCCcc
Q 038249          250 LVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       250 l~~~p~~Rps~~eil~~~~~  269 (281)
                      |..+|++||++.++|+||||
T Consensus       239 l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         239 LQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             cCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.7e-44  Score=306.54  Aligned_cols=251  Identities=24%  Similarity=0.383  Sum_probs=206.9

Q ss_pred             cccCCceecceecccCceEEEEEEEccC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRS-----NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFY   86 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~   86 (281)
                      +..++|++.+.||+|+||.||+|++...     +..||+|.+.....  ......+.+|+++++.+ +|+||+++++.+.
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            3357899999999999999999986543     35799999965432  22345688899999999 8999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhC--------------------------------------------------------
Q 038249           87 DQKRVYLILEYAAKGELYKELQKC--------------------------------------------------------  110 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~--------------------------------------------------------  110 (281)
                      ..+..++||||+++++|.+++...                                                        
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999999999887532                                                        


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc-----
Q 038249          111 --------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR-----  171 (281)
Q Consensus       111 --------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~-----  171 (281)
                                    .++++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++........     
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                          2367888999999999999999999999999999999999999999999999754332211     


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ...++..|+|||.+.+..++.++||||||+++++|++ |..||.........................+.++.+++.+||
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  352 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW  352 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence            1223557999999988889999999999999999997 999998766655444444433333333457899999999999


Q ss_pred             ccCCCCCCChhhhhc
Q 038249          251 VKDSSQRLPLHKLLE  265 (281)
Q Consensus       251 ~~~p~~Rps~~eil~  265 (281)
                      +.||++|||+.++++
T Consensus       353 ~~dp~~RPs~~~l~~  367 (374)
T cd05106         353 NLEPTERPTFSQISQ  367 (374)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.4e-44  Score=295.03  Aligned_cols=251  Identities=25%  Similarity=0.433  Sum_probs=213.1

Q ss_pred             cccCCceecceecccCceEEEEEEEccCC-----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSN-----HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      +.+++|++.+.||.|++|.||+|.+...+     ..+++|.+....  .......+.+|+..+++++||||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            45678999999999999999999987655     679999986443  23345678899999999999999999999998


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           88 QKRVYLILEYAAKGELYKELQKC----------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                      .+..++++||+++++|.+++...                ..++...++.++.|++.||.+||++|++|+||+|+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            88999999999999999998754                34788899999999999999999999999999999999999


Q ss_pred             CCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038249          152 QGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRI  225 (281)
Q Consensus       152 ~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~  225 (281)
                      ++.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+....+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999987543222     122345678999999988889999999999999999997 99999888877776666


Q ss_pred             hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ..... ......++.++.+++.+||+.||++||++.||+++
T Consensus       240 ~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCCc-CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            54432 22334689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1e-43  Score=293.81  Aligned_cols=256  Identities=27%  Similarity=0.488  Sum_probs=219.2

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .+.|++.+.||.|++|.||.+.+..++..+++|++.....    ....+.+|++.++.++|+|++++++.+...+..+++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            3568999999999999999999998999999999965432    345678899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---c
Q 038249           95 LEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---R  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~  170 (281)
                      +||+++++|.+++...+ .++...++.++.+++.|+.+||+.|++|+|++|+||+++.++.++|+|||++......   .
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  173 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR  173 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence            99999999999999876 7999999999999999999999999999999999999999999999999986433221   1


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-cccCCCCCCCCHHHHHHHHHh
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-DLKFPPKPIVSSAAKDLISQM  249 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~  249 (281)
                      ....++..|++||.+.+..++.++|+||||+++++|++|..||............... .........++.++.++|.+|
T Consensus       174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  253 (286)
T cd06614         174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC  253 (286)
T ss_pred             ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHH
Confidence            2334678899999998888899999999999999999999999876665544443322 222223334789999999999


Q ss_pred             cccCCCCCCChhhhhcCCccccCCC
Q 038249          250 LVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       250 l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      |+.+|.+||++.++++||||.+.-.
T Consensus       254 l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         254 LVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             hccChhhCcCHHHHhhChHhhccCc
Confidence            9999999999999999999998533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.2e-44  Score=296.78  Aligned_cols=253  Identities=29%  Similarity=0.499  Sum_probs=209.6

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||+|.++.+++.+++|.+....... ...+.+.+|+++++.++||||+++++++...+..++|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47999999999999999999999899999999986543222 34456788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---cc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---RT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---~~  172 (281)
                      ||+++++|..+......+++..++.++.||+.|+++||+.|++|+|++|+||+++.++.++|+|||++.......   ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            999998888887766668999999999999999999999999999999999999999999999999875432221   22


Q ss_pred             ccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-------------------cC
Q 038249          173 MCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-------------------KF  232 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~  232 (281)
                      ..++..|+|||.+.+ ..++.++|+||||+++++|++|.+||......+....+.....                   ..
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            346778999998765 4467889999999999999999999976654443322221000                   00


Q ss_pred             ----------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          233 ----------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       233 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                                ...+.++..+.+++.+||..+|++||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                      0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-44  Score=294.73  Aligned_cols=253  Identities=32%  Similarity=0.512  Sum_probs=210.9

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|++++++++|+||+++++++...+..++++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            479999999999999999999999999999999865432 2334567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc----c
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----R  171 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~----~  171 (281)
                      ||++++.+..+......++...++.++.+|+.|+.+||+.|++|+|++|+||+++.++.++|+|||.+.......    .
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            999987777666666679999999999999999999999999999999999999999999999999875543322    2


Q ss_pred             cccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--------------c-----c
Q 038249          172 TMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--------------L-----K  231 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------~-----~  231 (281)
                      ...++..|+|||.+.+. .++.++|+||||+++++|++|..||......+....+....              .     .
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            33467789999998777 78899999999999999999999998665544333221100              0     0


Q ss_pred             C-----------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          232 F-----------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       232 ~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      .           .....++.++.++|.+||..+|++|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0           0011248899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-45  Score=301.95  Aligned_cols=258  Identities=37%  Similarity=0.637  Sum_probs=230.6

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ..-|++.+.||+|-|+.|-+|++..+|+.||||++++..++... ...+..|++-++.++|||||+++.+...+..+|+|
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            35699999999999999999999999999999999988776544 45577799999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC-CCCcEEEeeecCcccccCC--c
Q 038249           95 LEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNR--R  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~-~~~~~~l~dfg~~~~~~~~--~  170 (281)
                      .|.-++|+|.+++-+. ..+.++.+..++.||+.|+.|+|+..++|+|+||+||.+- .-|-+||.|||++-...+.  .
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL  175 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL  175 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence            9999999999998554 5599999999999999999999999999999999999875 4589999999998544333  3


Q ss_pred             ccccCcCCccCCccccCCCCC-CcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 038249          171 RTMCGTLDYLPPEMVESVEHD-ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM  249 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  249 (281)
                      ...||...|-|||++.+..|+ ++.||||||+++|.|.+|.+||+..+..+++..++.-++..|.  .++.++++||.+|
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs--hvS~eCrdLI~sM  253 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS--HVSKECRDLIQSM  253 (864)
T ss_pred             hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch--hhhHHHHHHHHHH
Confidence            567899999999999888876 5789999999999999999999999999999999888776665  6999999999999


Q ss_pred             cccCCCCCCChhhhhcCCccccCCCC
Q 038249          250 LVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       250 l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      |..||++|.+.+||..++|++-.-++
T Consensus       254 LvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  254 LVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             HhcCchhhccHHHHhccccccCCCCC
Confidence            99999999999999999999976444

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-45  Score=319.13  Aligned_cols=250  Identities=29%  Similarity=0.482  Sum_probs=215.6

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeee-EEEe---C--
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYG-YFYD---Q--   88 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~-~~~~---~--   88 (281)
                      .+++|.+.|.+|||+.||+|.+.+.+..||+|++...   ++...+.+.+||+++++|+ |+|||.++| ....   +  
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            6788999999999999999999988899999998544   5667889999999999996 999999999 3321   1  


Q ss_pred             -CEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           89 -KRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKH--VIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        89 -~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                       -.++++||||.|+.|.++++.+  ..|++.++++|+.++++|+++||...  |+|||||.+|||+..+|+.||||||.+
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence             2578999999999999999854  34999999999999999999999887  999999999999999999999999987


Q ss_pred             ccccCCc------------ccccCcCCccCCccc---cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc
Q 038249          164 VHTFNRR------------RTMCGTLDYLPPEMV---ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV  228 (281)
Q Consensus       164 ~~~~~~~------------~~~~~~~~~~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  228 (281)
                      .......            -....|+.|.+||.+   .+.+.+.++|||+|||+||.||..++||+.....    .++.+
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng  269 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNG  269 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEec
Confidence            5433322            112368999999975   6778999999999999999999999999866443    45778


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .+.+|..+.++..+.+||+.||++||.+||++-+++++-+...+
T Consensus       270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence            88999989999999999999999999999999999976554443

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-44  Score=292.77  Aligned_cols=255  Identities=29%  Similarity=0.498  Sum_probs=213.3

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCceeeeeeEEEeCCEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~~~~~~   93 (281)
                      .|++.+.||.|++|.||+|.+..+++.+++|.+.....  ......+.+|+.++++++   |||++++++.+......++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            58899999999999999999999999999999865422  223456778888888886   9999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---c
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---R  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~  170 (281)
                      |+||+++++|.++++.. ++++..++.++.+++.|+.+||+.|++|+||+|+||+++.++.++++|||.+......   .
T Consensus        80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            99999999999998764 6899999999999999999999999999999999999999999999999987544322   2


Q ss_pred             ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 038249          171 RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM  249 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  249 (281)
                      ....++..|+|||.+.+ ..++.++|+||||+++++|++|..||........................++.++.+++.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC  238 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence            23357788999998754 44688999999999999999999999877665544433322221112223788999999999


Q ss_pred             cccCCCCCCChhhhhcCCccccCCC
Q 038249          250 LVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       250 l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      |+.||++||++.++++||||++...
T Consensus       239 l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         239 LDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             cCCCcccCcCHHHHhhChHhhcccc
Confidence            9999999999999999999987653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-45  Score=303.93  Aligned_cols=262  Identities=26%  Similarity=0.446  Sum_probs=212.1

Q ss_pred             hhhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEE
Q 038249            7 AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYF   85 (281)
Q Consensus         7 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~   85 (281)
                      +-...+++-..|++++.||+|+.+.||++...+ .+.+|+|++.... .+......+.+|+..|.++ .|.+|++++|+-
T Consensus       352 ~~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE  429 (677)
T KOG0596|consen  352 ANEIIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE  429 (677)
T ss_pred             cCeeEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence            345667778999999999999999999998874 4557777765544 3445678899999999999 589999999999


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      ..++.+|+|||+-+- +|..++++... .+.-.++.+..|++.++.++|.+||+|.||||.|+++ -.|.+||+|||.+.
T Consensus       430 v~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~  507 (677)
T KOG0596|consen  430 VTDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIAN  507 (677)
T ss_pred             ccCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhc
Confidence            999999999998855 99999987654 4445899999999999999999999999999999999 78999999999986


Q ss_pred             cccCCc-----ccccCcCCccCCccccCCC-----------CCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhh
Q 038249          165 HTFNRR-----RTMCGTLDYLPPEMVESVE-----------HDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQ  227 (281)
Q Consensus       165 ~~~~~~-----~~~~~~~~~~aPE~~~~~~-----------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~  227 (281)
                      .....+     ...+||+.||+||.+....           .+.+||||||||++|+|+.|++||....+. .-+..+..
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~  587 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD  587 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence            655443     4467999999999983222           457899999999999999999999654432 22334444


Q ss_pred             ccccCCCCCC-CCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          228 VDLKFPPKPI-VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       228 ~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .....+.... -+.++.++++.||+.||++||++.|+|.|||++=-
T Consensus       588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            4332222212 23459999999999999999999999999999853

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.6e-44  Score=291.28  Aligned_cols=249  Identities=18%  Similarity=0.303  Sum_probs=210.2

Q ss_pred             ccCCceecceecccCceEEEEEEEc---cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ..++|++.+.||+|+||.||+|.++   ..+..+++|.+....  .......+.+|+..+++++||||+++++++..++.
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            4567999999999999999999875   346689999986543  22334568889999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           91 VYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .++||||+++++|.+++... ..+++..++.++.+|+.|+++||+.|++|+||+|+||+++.++.++++|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999998764 56899999999999999999999999999999999999999999999999976433211


Q ss_pred             c----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHH
Q 038249          170 R----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       170 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (281)
                      .    ....++..|+|||.+.+..++.++||||||++++++++ |..||......+....+... ...+....++..+.+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  239 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPAPRNCPNLLHQ  239 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCCCCCHHHHH
Confidence            1    11223568999999988889999999999999999774 99999888777766665443 233445578999999


Q ss_pred             HHHHhcccCCCCCCChhhhhc
Q 038249          245 LISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~  265 (281)
                      ++.+||+.+|.+||++++|++
T Consensus       240 li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         240 LMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.1e-43  Score=287.20  Aligned_cols=252  Identities=32%  Similarity=0.529  Sum_probs=216.6

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--CEEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--KRVYLI   94 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v   94 (281)
                      +|++.+.||+|++|.||.|.+..++..+++|.+...... ......+.+|+..+++++|+|++++++.+...  +..+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999999999999998665432 34467788999999999999999999999988  899999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-----
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-----  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-----  169 (281)
                      +|++++++|.+++...+.+++..++.++.+++.++.+||+.|++|+|++|+||+++.++.++|+|||.+......     
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            999999999999988878999999999999999999999999999999999999999999999999987554333     


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                      .....++..|.+||.......+.++|+||||+++++|++|..||...... .....+.............+.++.++|.+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  239 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK  239 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence            23345788999999998888899999999999999999999999877622 22222222122222334578999999999


Q ss_pred             hcccCCCCCCChhhhhcCCcc
Q 038249          249 MLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ||+.+|++||++.+++.||||
T Consensus       240 ~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         240 CLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             hCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=310.61  Aligned_cols=246  Identities=24%  Similarity=0.392  Sum_probs=207.6

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++..++..||+|+||+||+|+|..+   ||||++..+....+ ..++|++|+..+++.+|-||+-+.|++..++. .||
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             HHHhhccceeccccccceeecccccc---eEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            37888999999999999999999866   99999988775554 68899999999999999999999999998877 999


Q ss_pred             EeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc-----cC
Q 038249           95 LEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-----FN  168 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~-----~~  168 (281)
                      +.+|+|.+|+..+... -.++...++.|+.||+.|+.|||.++|+|+|++..||++.++++|+|+|||++...     ..
T Consensus       466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            9999999999999754 34899999999999999999999999999999999999999999999999997332     11


Q ss_pred             CcccccCcCCccCCccc---cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc---ccCCCCCCCCHHH
Q 038249          169 RRRTMCGTLDYLPPEMV---ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD---LKFPPKPIVSSAA  242 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l  242 (281)
                      ......+...|+|||+.   ...+|++.+||||||+++|||++|..||.....++++-.+-.+.   .........+.++
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~m  625 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAM  625 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHH
Confidence            22334567789999997   45568899999999999999999999999544444433222221   1122234688899


Q ss_pred             HHHHHHhcccCCCCCCChhhhhc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ++|+..||..++++||.+.+||.
T Consensus       626 k~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  626 KRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHhcCcccCccHHHHHH
Confidence            99999999999999999988887

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.5e-44  Score=291.37  Aligned_cols=251  Identities=29%  Similarity=0.492  Sum_probs=211.0

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++.+.||.|++|.||++.+..+++.+++|.+.............+.+|+.+++.++|+|++++++.+..++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            36799999999999999999999999999999988655444444556788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           95 LEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      +||+++++|.++++.    ...+++..++.++.+|+.|+.+||++|++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999998863    3458999999999999999999999999999999999999999999999999875432221


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch--HHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS--DTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                         ....++..|+|||.+.+..++.++|+||||+++++|++|..||......  +....+.............+.++.++
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL  240 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence               2345788999999998888899999999999999999999999654432  33333333222222334588899999


Q ss_pred             HHHhcccCCCCCCChhhhhc
Q 038249          246 ISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~  265 (281)
                      +.+||..||++|||+.+|++
T Consensus       241 i~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         241 VNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHhcCCCcccCCCHHHHHH
Confidence            99999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.1e-44  Score=295.72  Aligned_cols=257  Identities=27%  Similarity=0.465  Sum_probs=216.5

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ..+|++.+.||.|++|.||++.+..++..+++|.+....   ....+.+.+|+.++++++|||++++++.+...+..++|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            378999999999999999999999899999999985432   22345678899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      +||+++++|.+++... .++...+..++.+++.|+.+||++|++|+|++|+||+++.++.++|+|||++......   ..
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence            9999999999998764 4789999999999999999999999999999999999999999999999986433222   22


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHh-hccccCCCCCCCCHHHHHHHHHhc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-QVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ...+++.|++||.+....++.++|+||||++++++++|..||...+......... ...........++..+.++|.+||
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  253 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHc
Confidence            3357788999999988888999999999999999999999998765544433222 122223333457889999999999


Q ss_pred             ccCCCCCCChhhhhcCCccccCCCC
Q 038249          251 VKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       251 ~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      ..+|++||++++++.||||++..+-
T Consensus       254 ~~~p~~Rp~~~~il~h~~~~~~~~~  278 (293)
T cd06647         254 EMDVEKRGSAKELLQHPFLKIAKPL  278 (293)
T ss_pred             cCChhhCcCHHHHhcCHHHhcCccc
Confidence            9999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.6e-43  Score=292.12  Aligned_cols=253  Identities=29%  Similarity=0.503  Sum_probs=209.1

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeC----
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQ----   88 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~----   88 (281)
                      ..++|++.+.||.|++|.||++.+..+++.+++|.+....    .....+.+|+.+++++ +|||++++++++...    
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            3578999999999999999999999999999999985432    1234567788888888 899999999998753    


Q ss_pred             -CEEEEEEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           89 -KRVYLILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        89 -~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                       +..++|+||+++++|.++++.    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~  175 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS  175 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence             368999999999999998763    356899999999999999999999999999999999999999999999999987


Q ss_pred             ccccCC---cccccCcCCccCCccccCC-----CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-cCCC
Q 038249          164 VHTFNR---RRTMCGTLDYLPPEMVESV-----EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-KFPP  234 (281)
Q Consensus       164 ~~~~~~---~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~  234 (281)
                      ......   .....++..|+|||.+...     .++.++|+||||+++++|++|..||......+....+..... ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  255 (291)
T cd06639         176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH  255 (291)
T ss_pred             hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc
Confidence            543221   2334577889999987543     257899999999999999999999987766555544433221 1222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccc
Q 038249          235 KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                      ....+.++.++|.+||+.+|++||++.+++.||||+
T Consensus       256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            334678899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3e-43  Score=285.19  Aligned_cols=249  Identities=31%  Similarity=0.563  Sum_probs=215.3

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||++.+..++..+++|.+.....   .....+.+|++.++.++|++++++.+++...+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            58899999999999999999998999999999965442   345678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--ccc
Q 038249           97 YAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RTM  173 (281)
Q Consensus        97 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--~~~  173 (281)
                      |+++++|.+++... ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......  ...
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  157 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM  157 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence            99999999999876 578999999999999999999999999999999999999999999999999876554432  445


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-cccCCCCCCCCHHHHHHHHHhccc
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-DLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      .++..|++||.+.+...+.++|+||||+++++|++|..||...+..+........ ....+....++.++.++|.+||+.
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence            6788999999998888899999999999999999999999877555444433322 122222223489999999999999


Q ss_pred             CCCCCCChhhhhcCCc
Q 038249          253 DSSQRLPLHKLLEHPW  268 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~  268 (281)
                      ||++|||+.++++|||
T Consensus       238 ~p~~R~t~~~~l~~~~  253 (253)
T cd05122         238 NPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ChhhCCCHHHHhcCCC
Confidence            9999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.6e-43  Score=287.89  Aligned_cols=248  Identities=27%  Similarity=0.468  Sum_probs=213.1

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||.+.+..++..+++|.+.....  ....+.+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            58999999999999999999999999999999864432  2335667889999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           97 YAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        97 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      |+++++|.+.+...  ..+++..++.++.+|+.|+.+||++|++|+||+|+||+++.++.++++|||.+......   ..
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            99999999988643  45899999999999999999999999999999999999999999999999987543222   22


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ...+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.......+....... ....++.++.++|.+||+
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~  237 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFK  237 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC-CCcccCHHHHHHHHHHHh
Confidence            3457888999999988889999999999999999999999998877666666555543322 223588999999999999


Q ss_pred             cCCCCCCChhhhhcCC
Q 038249          252 KDSSQRLPLHKLLEHP  267 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~  267 (281)
                      .||++||++.+++.--
T Consensus       238 ~~P~~Rp~~~~il~~~  253 (255)
T cd08219         238 RNPRSRPSATTILSRG  253 (255)
T ss_pred             CCcccCCCHHHHhhcc
Confidence            9999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4e-43  Score=293.84  Aligned_cols=254  Identities=27%  Similarity=0.444  Sum_probs=215.1

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      .|...+.||.|++|+||+|++..++..+++|.+.............+.+|+++++.++|+|++++++++.+....++|+|
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            36777889999999999999999999999999876544444455678889999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccccC
Q 038249           97 YAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG  175 (281)
Q Consensus        97 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (281)
                      |+.+ ++.+.+.. ..++++..++.++.+|+.++.+||++|++|+||+|+||+++.++.++|+|||++.... ......+
T Consensus       102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-~~~~~~~  179 (313)
T cd06633         102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-PANSFVG  179 (313)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-CCCCccc
Confidence            9965 77776654 4568999999999999999999999999999999999999999999999999875432 2234467


Q ss_pred             cCCccCCcccc---CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          176 TLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       176 ~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      +..|+|||.+.   ...++.++|+||||+++++|++|..||...+....................++..+.+++.+||++
T Consensus       180 ~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  259 (313)
T cd06633         180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQK  259 (313)
T ss_pred             cccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccC
Confidence            88999999973   456788999999999999999999999877766655555443333333345788999999999999


Q ss_pred             CCCCCCChhhhhcCCccccC
Q 038249          253 DSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~  272 (281)
                      +|.+||++.+++.||||.+.
T Consensus       260 ~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         260 IPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             ChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.3e-44  Score=296.38  Aligned_cols=253  Identities=27%  Similarity=0.418  Sum_probs=209.2

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcE--EEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHI--VALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~--~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      ++..+++|++.+.||.|+||.||+|.++.++..  +++|.+...  ........+.+|+.++.++ +|+||+++++++..
T Consensus         2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~   79 (303)
T cd05088           2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   79 (303)
T ss_pred             CccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence            356788999999999999999999999877765  466665322  2334456788899999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                      .+..++|+||+++++|.+++...+                .+++..++.++.||+.|+++||++|++|+||+|+||+++.
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~  159 (303)
T cd05088          80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  159 (303)
T ss_pred             CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence            999999999999999999986432                4788999999999999999999999999999999999999


Q ss_pred             CCcEEEeeecCcccccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhc
Q 038249          152 QGELKIADFGWSVHTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQV  228 (281)
Q Consensus       152 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  228 (281)
                      ++.++|+|||++......  ......+..|+|||...+..++.++||||||+++++|++ |..||...+..+....+...
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  239 (303)
T cd05088         160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  239 (303)
T ss_pred             CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence            999999999987532211  111223567999999988888999999999999999998 99999877776666555433


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                       .........+.++.+++.+||+.+|++||++.+++..
T Consensus       240 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             1222233578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=310.16  Aligned_cols=254  Identities=28%  Similarity=0.463  Sum_probs=225.2

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      .|.-++.||.|+||.||-|.+..+.+.||||++..+.-.+.+-.+.+..|+..|+++.|||.+.+.++|....+.|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            36778999999999999999999999999999988887888888999999999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccccC
Q 038249           97 YAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG  175 (281)
Q Consensus        97 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (281)
                      ||-| +-.+++.- .+++-+.+|..|..+.+.||+|||+++.+|+|||..||++++.|.|||.|||.+... .+.+..+|
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~-~PAnsFvG  184 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM-APANSFVG  184 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc-CchhcccC
Confidence            9966 77787764 367999999999999999999999999999999999999999999999999987544 34456689


Q ss_pred             cCCccCCccc---cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          176 TLDYLPPEMV---ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       176 ~~~~~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ||.|||||++   .-+.|+.+.||||||+++.+|...++|+-+.+-...+..+-+.....-.....++.+++|+..||..
T Consensus       185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqK  264 (948)
T KOG0577|consen  185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQK  264 (948)
T ss_pred             CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhh
Confidence            9999999985   5678999999999999999999999997777766666555554433344557889999999999999


Q ss_pred             CCCCCCChhhhhcCCccccC
Q 038249          253 DSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~  272 (281)
                      -|.+|||++++|+|+|+.+.
T Consensus       265 ipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  265 IPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             CcccCCcHHHHhhcchhccC
Confidence            99999999999999999764

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-43  Score=285.39  Aligned_cols=251  Identities=34%  Similarity=0.586  Sum_probs=217.7

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|++++++++|+|++++++++...+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            589999999999999999999999999999999766533 2345678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---ccc
Q 038249           97 YAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---RTM  173 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---~~~  173 (281)
                      ++++++|.+++.....+++..++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            99999999999888889999999999999999999999999999999999999999999999999886543332   234


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD  253 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  253 (281)
                      .++..|++||...+...+.++|+|+||+++++|++|..||................ .......++.++.+++.+||..+
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~  238 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKD  238 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-CCCCCCCCCHHHHHHHHHHHhCC
Confidence            56788999999887778889999999999999999999998766544443333222 22233468899999999999999


Q ss_pred             CCCCCChhhhhcCCcc
Q 038249          254 SSQRLPLHKLLEHPWI  269 (281)
Q Consensus       254 p~~Rps~~eil~~~~~  269 (281)
                      |++|||+.+++.||||
T Consensus       239 p~~R~~~~~~l~~~~~  254 (254)
T cd06627         239 PNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hhhCcCHHHHhcCCCC
Confidence            9999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-43  Score=292.00  Aligned_cols=252  Identities=27%  Similarity=0.484  Sum_probs=206.8

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEE-----e
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFY-----D   87 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~-----~   87 (281)
                      ..++|++.+.||+|++|.||+|.+..+++.+++|.+....    .....+.+|+.+++++ +|+|++++++++.     .
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            5578999999999999999999999999999999875432    1224567788999998 7999999999874     3


Q ss_pred             CCEEEEEEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           88 QKRVYLILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      ++..++|+||+++++|.+++..    ...+++..++.++.+++.|+.+||+.+++|+|++|+||+++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            4578999999999999988752    345889999999999999999999999999999999999999999999999987


Q ss_pred             ccccCC---cccccCcCCccCCccccC-----CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc-ccCCC
Q 038249          164 VHTFNR---RRTMCGTLDYLPPEMVES-----VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD-LKFPP  234 (281)
Q Consensus       164 ~~~~~~---~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~  234 (281)
                      ......   .....+++.|+|||.+..     ..++.++|+||+|+++++|++|..||................ .....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence            543321   233457889999998743     446789999999999999999999998766544443332221 11222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          235 KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ...++.++.++|.+||+.||++|||+.|+++|+||
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            23467899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.7e-43  Score=290.21  Aligned_cols=249  Identities=27%  Similarity=0.442  Sum_probs=201.5

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHH---HHHhCCCCceeeeeeEEEeCCEEEEEEeccC
Q 038249           23 PLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE---IQSHLRHPNILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        23 ~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~---~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      .||+|+||.||++.+..+++.+|+|.+...............++..   ++...+|++++.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999987654332222222333333   3344579999999999999899999999999


Q ss_pred             CCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-CcccccCcCC
Q 038249          100 KGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLD  178 (281)
Q Consensus       100 ~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~  178 (281)
                      +++|.+++...+.+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++++|||++..... ......+++.
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  160 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG  160 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcC
Confidence            999999998888899999999999999999999999999999999999999999999999998754322 2233467899


Q ss_pred             ccCCcccc-CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH--HHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 038249          179 YLPPEMVE-SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD--TYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSS  255 (281)
Q Consensus       179 ~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  255 (281)
                      |+|||.+. +..++.++|+||+|+++++|++|..||.......  ....... .........++.++.++|.+||..||+
T Consensus       161 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~  239 (279)
T cd05633         161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TVNVELPDSFSPELKSLLEGLLQRDVS  239 (279)
T ss_pred             ccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-cCCcCCccccCHHHHHHHHHHhcCCHH
Confidence            99999975 4567889999999999999999999997544322  2222111 112222345889999999999999999


Q ss_pred             CCC-----ChhhhhcCCccccC
Q 038249          256 QRL-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       256 ~Rp-----s~~eil~~~~~~~~  272 (281)
                      +||     ++.++++||||+..
T Consensus       240 ~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         240 KRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             HhcCCCCCCHHHHHhCccccCC
Confidence            999     69999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.8e-44  Score=295.39  Aligned_cols=259  Identities=28%  Similarity=0.533  Sum_probs=218.9

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ..|+....||.|++|.||.+.+..+++.+++|.+.....   .....+.+|+..++.++|||++++++.+..++..++++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            346667789999999999999998999999999854332   22355778999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---Cccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~  172 (281)
                      ||+++++|...+.. ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.....   ....
T Consensus        98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            99999999987765 4589999999999999999999999999999999999999999999999998743322   1233


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-cCCCCCCCCHHHHHHHHHhcc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-KFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ..++..|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+..... .......++.++.++|.+||+
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~  256 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT  256 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence            4578899999999888889999999999999999999999987766655554433221 122233578899999999999


Q ss_pred             cCCCCCCChhhhhcCCccccCCCCCCC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQNADPSGV  278 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~~~~~~~  278 (281)
                      .+|++||++++++.||||.+...++|.
T Consensus       257 ~~P~~Rps~~~ll~~~~~~~~~~~~~~  283 (297)
T cd06659         257 REPQERATAQELLDHPFLLQTGLPECL  283 (297)
T ss_pred             CCcccCcCHHHHhhChhhccCCCcccc
Confidence            999999999999999999998766653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.8e-43  Score=293.40  Aligned_cols=255  Identities=27%  Similarity=0.458  Sum_probs=218.0

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.|+..+.||.|++|.||++++..++..+++|.+.............+.+|++.++.++|+|++++++++..+...++|+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            44889999999999999999999999999999987654444555667888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCccccc
Q 038249           96 EYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC  174 (281)
Q Consensus        96 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  174 (281)
                      ||+.+ ++.+.+.. ..++++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.... ......
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~  182 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS-PANSFV  182 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-Cccccc
Confidence            99976 77776654 4568999999999999999999999999999999999999999999999999875432 223345


Q ss_pred             CcCCccCCcccc---CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          175 GTLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       175 ~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      +++.|+|||.+.   ...++.++|+||||+++++|++|..||...........+............++..+.+++.+||+
T Consensus       183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  262 (317)
T cd06635         183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ  262 (317)
T ss_pred             CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHcc
Confidence            788899999873   45678899999999999999999999987776666666555444444444688899999999999


Q ss_pred             cCCCCCCChhhhhcCCccccC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .+|.+||++.++++|+|+...
T Consensus       263 ~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         263 KIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             CCcccCcCHHHHHhChhhhcc
Confidence            999999999999999999765

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.9e-43  Score=290.97  Aligned_cols=248  Identities=28%  Similarity=0.430  Sum_probs=206.6

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCCh
Q 038249           24 LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGEL  103 (281)
Q Consensus        24 ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  103 (281)
                      ||.|++|+||+|.+..+|+.+++|.+.............+..|+.+++.++|||++++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999998655433333445567899999999999999999999999999999999999999


Q ss_pred             hHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--cccccCcCCc
Q 038249          104 YKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRTMCGTLDY  179 (281)
Q Consensus       104 ~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~  179 (281)
                      .+.+...+  .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......  .....++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99987655  6899999999999999999999999999999999999999999999999987543221  2233467789


Q ss_pred             cCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       180 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      ++||.+.+..++.++|+||||+++++|++|..||...........+....  ........++.++.++|.+||+.||++|
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR  240 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence            99999888888999999999999999999999997765422222221111  1122233578999999999999999999


Q ss_pred             C-----ChhhhhcCCcccc
Q 038249          258 L-----PLHKLLEHPWIIQ  271 (281)
Q Consensus       258 p-----s~~eil~~~~~~~  271 (281)
                      |     ++.+++.||||.+
T Consensus       241 ~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         241 LGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             cCCCcccHHHHHhChhhhc
Confidence            9     8888999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.2e-44  Score=294.79  Aligned_cols=254  Identities=28%  Similarity=0.466  Sum_probs=214.6

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ..|+..+.||.|++|.||+|.+..++..+++|.+....  .......+.+|+.++++++|+||+++++.+..+...++|+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            35788899999999999999999889999999986443  2234567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---cc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---RT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---~~  172 (281)
                      ||+++++|.+.+.. ..+++..++.++.+++.|+.+||++|++|+||+|+||+++.++.++++|||++.......   ..
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence            99999999998875 458999999999999999999999999999999999999999999999999875433221   22


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ..++..|+|||.+.+..++.++|+||||+++++|++|..|+...........+..... ......++.++.++|.+||..
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-PTLEGQYSKPFKEFVEACLNK  239 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC-CCCCcccCHHHHHHHHHHccC
Confidence            3467789999999888889999999999999999999999976655554443322221 112235788999999999999


Q ss_pred             CCCCCCChhhhhcCCccccCC
Q 038249          253 DSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +|++||++.+++.||||.+..
T Consensus       240 ~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         240 DPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             CcccCcCHHHHHHhHHHHHHh
Confidence            999999999999999998653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.2e-43  Score=286.62  Aligned_cols=250  Identities=28%  Similarity=0.493  Sum_probs=210.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||.|++|.||+|.+..+|+.+++|.+.............+.+|++++++++|++++++++.+...+..++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999999999999999986544444444667889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           96 EYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        96 e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      ||+++++|..++..    ...++...++.++.+++.|+.+||+.|++|+||+|+||+++.++.++++|||++......  
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999998864    245899999999999999999999999999999999999999999999999987543222  


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc--hHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH--SDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                       .....+++.|.|||.+.+..++.++|+||||+++++|++|..||.....  .+....+........+...++.++.++|
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence             2234577889999999888889999999999999999999999865432  2333333333332222336788999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      .+||.++|++|||+.+|++
T Consensus       242 ~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         242 SRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHcCCCcccCCCHHHHHH
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.2e-43  Score=292.77  Aligned_cols=254  Identities=27%  Similarity=0.474  Sum_probs=209.1

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--CEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--KRV   91 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~   91 (281)
                      .+++|++.+.||.|++|.||+|.++.+++.+++|.+...... ......+.+|+.++++++||||+++++++...  ...
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            356899999999999999999999999999999999655432 22334566899999999999999999999877  899


Q ss_pred             EEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           92 YLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      ++|+||+.+ +|.+++.... .+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999999976 8988887643 5899999999999999999999999999999999999999999999999987543332 


Q ss_pred             --cccccCcCCccCCccccCCC-CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc---------------
Q 038249          170 --RRTMCGTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK---------------  231 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------  231 (281)
                        .....+++.|+|||.+.+.. ++.++|+||||+++++|++|..||...+..+....+......               
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence              12334678899999886544 578999999999999999999999877665554433221000               


Q ss_pred             -------------CCCCCC--CCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          232 -------------FPPKPI--VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       232 -------------~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                                   ....+.  ++..+.++|.+||+.+|++|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                         000011  47889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.5e-43  Score=292.49  Aligned_cols=251  Identities=31%  Similarity=0.521  Sum_probs=205.5

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||+|++..+++.+++|.+..... .......+.+|++++++++||||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            58999999999999999999999999999999865432 22234567889999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           97 YAAKGELYKELQK--CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        97 ~~~~~~L~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      |+. ++|.+++..  ...+++..++.++.+++.|++|||+.|++|+||+|+||+++.++.++++|||++......   ..
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 488888765  345899999999999999999999999999999999999999999999999987543221   12


Q ss_pred             cccCcCCccCCccccCCC-CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc------------------ccC
Q 038249          172 TMCGTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD------------------LKF  232 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~~~  232 (281)
                      ...+++.|+|||.+.+.. ++.++|+||||+++++|++|..||...+..+.........                  ..+
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            234577899999876544 5788999999999999999999997765544333222110                  000


Q ss_pred             C---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          233 P---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       233 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +         ..+.++.++.++|.+||+.||++||+++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0         012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-43  Score=288.78  Aligned_cols=254  Identities=28%  Similarity=0.485  Sum_probs=215.7

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      -|++.+.||.|++|.||++.+..++..+|+|.+.....  ......+.+|+..+++++|+|++++++.+..+...++|+|
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            47889999999999999999998999999999754432  2334678889999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cccc
Q 038249           97 YAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTM  173 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~~  173 (281)
                      |+++++|.+++... .++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++++|||++......   ....
T Consensus        83 ~~~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          83 YLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             eCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            99999999988754 5899999999999999999999999999999999999999999999999987443222   1223


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD  253 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  253 (281)
                      .++..|+|||.+.+...+.++|+||||+++++|++|..||...........+..... ......++.++.+++.+||..+
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~  240 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACLNKE  240 (277)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHccCC
Confidence            467789999999888888999999999999999999999987666555544433221 1122357899999999999999


Q ss_pred             CCCCCChhhhhcCCccccCCC
Q 038249          254 SSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       254 p~~Rps~~eil~~~~~~~~~~  274 (281)
                      |++||++.+++.||||.+..+
T Consensus       241 p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         241 PSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             hhhCcCHHHHHhCHHHhhhhh
Confidence            999999999999999987643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-43  Score=285.24  Aligned_cols=253  Identities=28%  Similarity=0.489  Sum_probs=214.0

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeeccc--ccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--CEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ--LQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--KRV   91 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~   91 (281)
                      ++|++.+.||.|++|.||++.+..++..+++|.+....  .........+.+|+.++++++|+||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57999999999999999999999999999999875332  11233456788999999999999999999998763  568


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      ++++||+++++|.+.+...+.+++..++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            899999999999999988777999999999999999999999999999999999999999999999999987543221  


Q ss_pred             ----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          170 ----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       170 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                          .....++..|+|||.+.+..++.++|+||||+++++|++|..||........................++.++.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  241 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF  241 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence                1223467889999999888889999999999999999999999987766655554443322233344688999999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCcc
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      |.+||. +|..||++.++++|||.
T Consensus       242 i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         242 LKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHhc-CcccCccHHHHhcCCCC
Confidence            999999 67999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.8e-43  Score=292.29  Aligned_cols=250  Identities=23%  Similarity=0.385  Sum_probs=202.9

Q ss_pred             cccCCceecceecccCceEEEEEEEcc----------------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKR----------------SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP   76 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~----------------~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~   76 (281)
                      +.-++|++.+.||+|+||.||+|.+..                ++..+|+|.+....  .......+.+|+.++++++||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence            345789999999999999999998643                23469999986542  233456788999999999999


Q ss_pred             ceeeeeeEEEeCCEEEEEEeccCCCChhHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCc
Q 038249           77 NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-------------------YFSERRAATYVASLARALIYCHGKHV  137 (281)
Q Consensus        77 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-------------------~l~~~~~~~i~~~i~~~l~~Lh~~~i  137 (281)
                      ||+++++++.+.+..++|+||+.+++|.+++....                   .+++..++.++.||+.||.+||+.|+
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999999999999999999999999999886531                   36778899999999999999999999


Q ss_pred             eecCCCCCCeEeCCCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh--CC
Q 038249          138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY--GV  210 (281)
Q Consensus       138 ~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~  210 (281)
                      +|+||+|+||+++.++.++|+|||++.......     ....++..|+|||.+....++.++|+||||+++++|++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            999999999999999999999999885432221     12234678999999988889999999999999999986  66


Q ss_pred             CCCCCCCchHHHHHHhhc------cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhh
Q 038249          211 PPFEAKEHSDTYRRIVQV------DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLL  264 (281)
Q Consensus       211 ~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil  264 (281)
                      .||......+........      .......+.++..+.+++.+||+.||++|||+.+|.
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            788776665554432211      111112235789999999999999999999999995

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.5e-43  Score=290.57  Aligned_cols=249  Identities=24%  Similarity=0.455  Sum_probs=211.8

Q ss_pred             ccCCceecceecccCceEEEEEEEcc-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ...+|.+.+.||+|++|.||+|.+..     ++..+++|.+....  ..+..+.+.+|+++++.++|+|++++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            35679999999999999999998753     35789999986443  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc
Q 038249           89 KRVYLILEYAAKGELYKELQKCK--------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE  154 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~  154 (281)
                      +..++++||+++++|.+++...+              .+++..+..++.+|+.|+.+||++|++|+||+|+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999987542              3788899999999999999999999999999999999999999


Q ss_pred             EEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhc
Q 038249          155 LKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQV  228 (281)
Q Consensus       155 ~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  228 (281)
                      ++|+|||++......     ......++.|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+..+
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            999999987543221     122234678999999998899999999999999999998 99999887777777766655


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ..... ...++.++.+++.+||+.||++||+++|+++
T Consensus       241 ~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         241 RLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CcCCC-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            44332 3368899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.5e-43  Score=291.34  Aligned_cols=256  Identities=28%  Similarity=0.496  Sum_probs=215.9

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEec
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEY   97 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   97 (281)
                      |+....||.|++|.||++.++.+++.+++|++...   .......+.+|+.+++.++|+|++++++.+..++..++++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            34457899999999999999999999999998432   223355688899999999999999999999999999999999


Q ss_pred             cCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccccc
Q 038249           98 AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTMC  174 (281)
Q Consensus        98 ~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~~~  174 (281)
                      +++++|.+++... .+++..++.++.|++.++++||+.|++|+||+|+||+++.++.++++|||++......   .....
T Consensus        99 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657          99 LEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence            9999999887654 5899999999999999999999999999999999999999999999999986443221   22345


Q ss_pred             CcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc-ccCCCCCCCCHHHHHHHHHhcccC
Q 038249          175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD-LKFPPKPIVSSAAKDLISQMLVKD  253 (281)
Q Consensus       175 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~  253 (281)
                      +++.|++||.+.+..++.++|+||+|+++++|++|..||......+....+.... ........++.++.+++.+||..+
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence            6788999999988888999999999999999999999998766655544443221 122223457899999999999999


Q ss_pred             CCCCCChhhhhcCCccccCCCCCC
Q 038249          254 SSQRLPLHKLLEHPWIIQNADPSG  277 (281)
Q Consensus       254 p~~Rps~~eil~~~~~~~~~~~~~  277 (281)
                      |.+||++.+++.||||.+...++|
T Consensus       258 P~~R~~~~~ll~~~~~~~~~~~~~  281 (292)
T cd06657         258 PAQRATAAELLKHPFLAKAGPPSC  281 (292)
T ss_pred             cccCcCHHHHhcChHHhccCCCcc
Confidence            999999999999999999977665

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.9e-43  Score=288.37  Aligned_cols=256  Identities=31%  Similarity=0.474  Sum_probs=209.6

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--CCEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--QKRVYL   93 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~   93 (281)
                      ++|+..+.||.|++|.||++.+..+++.+++|.+.....  ......+.+|+++++.++||||+++++++..  .+.+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            478999999999999999999999999999999865432  2345678889999999999999999998865  347899


Q ss_pred             EEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           94 ILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      |+||+++++|.+++..    ...++...+..++.+|+.||.+||+.|++|+||+|.||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999887653    345899999999999999999999999999999999999999999999999987543222


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc-----hHHHHHHhhccc-cCCC----CCCC
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH-----SDTYRRIVQVDL-KFPP----KPIV  238 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~-~~~~----~~~~  238 (281)
                       .....++..|++||.+.+..++.++|+||||+++++|++|..||.....     .+....+..... ..+.    ....
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd06621         159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW  238 (287)
T ss_pred             ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCch
Confidence             2233467789999999888899999999999999999999999976522     222222222111 1111    1134


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      ++++.++|.+||..+|.+|||+.|+++||||++..
T Consensus       239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             HHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence            67899999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.3e-43  Score=286.70  Aligned_cols=248  Identities=29%  Similarity=0.482  Sum_probs=203.3

Q ss_pred             cCCceeccee--cccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHH-hCCCCceeeeeeEEEeCCEE
Q 038249           15 LNDFDIGKPL--GRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS-HLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        15 ~~~y~~~~~i--g~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .++|++.+.+  |.|+||.||++.++.++..+++|.+........        |+.... ..+|+|++++++.+...+..
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            4677787777  999999999999999999999999865432211        111111 12799999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-cEEEeeecCcccccCCc
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWSVHTFNRR  170 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-~~~l~dfg~~~~~~~~~  170 (281)
                      ++|+||+++++|.++++...++++..++.++.||+.|+.+||+.|++|+||+|+||+++.++ .++++|||.+..... .
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~-~  163 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT-P  163 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-C
Confidence            99999999999999998887899999999999999999999999999999999999999998 999999998754432 2


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHH-HHHHhh-ccccCCCCCCCCHHHHHHHHH
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT-YRRIVQ-VDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~l~~li~~  248 (281)
                      ....++..|+|||.+.+..++.++|+||+|+++++|++|..||........ ...+.. ........+.++..+.++|.+
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  243 (267)
T PHA03390        164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQS  243 (267)
T ss_pred             ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHH
Confidence            334578899999999888899999999999999999999999975543321 111111 111223334689999999999


Q ss_pred             hcccCCCCCCC-hhhhhcCCcccc
Q 038249          249 MLVKDSSQRLP-LHKLLEHPWIIQ  271 (281)
Q Consensus       249 ~l~~~p~~Rps-~~eil~~~~~~~  271 (281)
                      ||+++|.+||+ ++++|+||||++
T Consensus       244 ~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        244 MLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HhccChhhCCchHHHHhcCCcccC
Confidence            99999999996 699999999974

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-47  Score=294.85  Aligned_cols=252  Identities=28%  Similarity=0.489  Sum_probs=220.2

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      -|+++++||+|+||.||+|.++.+|+.+|+|.+..+.     ..+.+..|+.++++++++++|++++.+.....+|+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            4889999999999999999999999999999985432     35678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---Cccc
Q 038249           97 YAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRT  172 (281)
Q Consensus        97 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~  172 (281)
                      ||..|++.+.++.+ ++++++++..++...++||+|||...-+|+||+..||+++.+|++||.|||.+.+..+   ..+.
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            99999999999754 6799999999999999999999999889999999999999999999999998855433   3455


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHH-hhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI-VQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ..|||-|+|||+...-.|+..+||||||++..+|..|++||.+..+...+--+ .+....+......++++.+++++||.
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi  268 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI  268 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence            67999999999999999999999999999999999999999877765433222 22222233334578899999999999


Q ss_pred             cCCCCCCChhhhhcCCccccCC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .+|++|.|+..+++|||+++.+
T Consensus       269 K~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  269 KKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             CCHHHHHHHHHHhhhhhhcCCC
Confidence            9999999999999999998764

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.7e-43  Score=293.39  Aligned_cols=256  Identities=27%  Similarity=0.440  Sum_probs=215.2

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.|+..+.||.|++|.||+|++..+++.+++|.+.............+.+|+++++.++|+|++++.+++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45888999999999999999999999999999986544344444566788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCccccc
Q 038249           96 EYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC  174 (281)
Q Consensus        96 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  174 (281)
                      ||+.+ ++.+.+.. ..++++..+..++.+++.|+.+||+.+++|+||+|.||+++.++.++++|||++..... .....
T Consensus        95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-~~~~~  172 (308)
T cd06634          95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANXFV  172 (308)
T ss_pred             EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-ccccc
Confidence            99975 77776653 45689999999999999999999999999999999999999999999999998754332 23345


Q ss_pred             CcCCccCCcccc---CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          175 GTLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       175 ~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      +++.|+|||.+.   ....+.++||||||+++++|++|..||...+..+.................++..+.++|.+||.
T Consensus       173 ~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  252 (308)
T cd06634         173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ  252 (308)
T ss_pred             CCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhh
Confidence            788999999873   34578899999999999999999999877666555544444333333334688999999999999


Q ss_pred             cCCCCCCChhhhhcCCccccCC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .+|++||+++++++|||+.+..
T Consensus       253 ~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         253 KIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             CCcccCCCHHHHhhCccccccC
Confidence            9999999999999999998763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.6e-43  Score=295.60  Aligned_cols=243  Identities=27%  Similarity=0.508  Sum_probs=189.4

Q ss_pred             cceecccCceEEEEEEEc--cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--CCEEEEEEe
Q 038249           21 GKPLGRGKFGHVYLAREK--RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--QKRVYLILE   96 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v~e   96 (281)
                      +++||+|+||+||+|+++  .+++.+|+|.+.....     ...+.+|++++++++||||+++++++..  +..+++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            468999999999999976  3678899999854431     2346689999999999999999999864  457899999


Q ss_pred             ccCCCChhHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe----CCCCcEEEeeecCc
Q 038249           97 YAAKGELYKELQKC---------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI----GAQGELKIADFGWS  163 (281)
Q Consensus        97 ~~~~~~L~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~----~~~~~~~l~dfg~~  163 (281)
                      |+.+ +|.+++...         ..+++..++.++.||+.||+|||+.|++|+||+|+||++    +.++.++|+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            9965 787777532         248999999999999999999999999999999999999    45678999999998


Q ss_pred             ccccCC------cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCch---------HHHHHHhh
Q 038249          164 VHTFNR------RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS---------DTYRRIVQ  227 (281)
Q Consensus       164 ~~~~~~------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~  227 (281)
                      ......      .....+++.|+|||.+.+ ..++.++|+||+||++++|++|.+||......         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            543221      123457889999999866 45788999999999999999999999653321         11111111


Q ss_pred             cc----------------------------ccC--------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          228 VD----------------------------LKF--------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       228 ~~----------------------------~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ..                            ...        ......+.++.++|.+||++||++|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00                            000        0001234678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-43  Score=284.65  Aligned_cols=244  Identities=41%  Similarity=0.694  Sum_probs=215.5

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCCh
Q 038249           24 LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGEL  103 (281)
Q Consensus        24 ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  103 (281)
                      ||.|++|.||.+.+..+++.+++|.+.............+.+|+.++++++|+|++++++.+..++..++++|++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            68999999999999988999999998766554444566788999999999999999999999999999999999999999


Q ss_pred             hHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cccccCcCCcc
Q 038249          104 YKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTMCGTLDYL  180 (281)
Q Consensus       104 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~  180 (281)
                      .+.+.....+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++++|||.+......   .....++..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            999998878999999999999999999999999999999999999999999999999987554332   33445678899


Q ss_pred             CCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCh
Q 038249          181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPL  260 (281)
Q Consensus       181 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  260 (281)
                      +||...+...+.++|+||||++++++++|..||...+..+....+.......  ....+.++.+++.+||..||++||++
T Consensus       161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~R~~~  238 (250)
T cd05123         161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF--PEFLSPEARDLISGLLQKDPTKRLGS  238 (250)
T ss_pred             ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCHHHHHHHHHHhcCCHhhCCCc
Confidence            9999988888899999999999999999999998877766666666544333  33579999999999999999999999


Q ss_pred             ---hhhhcCCcc
Q 038249          261 ---HKLLEHPWI  269 (281)
Q Consensus       261 ---~eil~~~~~  269 (281)
                         +++++||||
T Consensus       239 ~~~~~l~~~~~f  250 (250)
T cd05123         239 GGAEEIKAHPFF  250 (250)
T ss_pred             ccHHHHHhCCCC
Confidence               999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.2e-43  Score=285.48  Aligned_cols=253  Identities=28%  Similarity=0.459  Sum_probs=205.7

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..+.+.....||+|++|.||++.+..++..+++|.+....   ....+.+.+|+.+++.++|+||+++++++..++..++
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3445556678999999999999999999999999985443   2334578899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-CCcEEEeeecCcccccCC
Q 038249           94 ILEYAAKGELYKELQKC-KYF--SERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-QGELKIADFGWSVHTFNR  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~-~~l--~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-~~~~~l~dfg~~~~~~~~  169 (281)
                      ++||+++++|.+.+... .++  +...+..++.||+.|+++||+.|++|+||+|+||+++. ++.++|+|||.+......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            99999999999998764 445  88889999999999999999999999999999999986 679999999987543221


Q ss_pred             ---cccccCcCCccCCccccCCC--CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHH-HHhhccccCCCCCCCCHHHH
Q 038249          170 ---RRTMCGTLDYLPPEMVESVE--HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR-RIVQVDLKFPPKPIVSSAAK  243 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~  243 (281)
                         .....+++.|+|||.+....  ++.++|+||+|+++++|++|..||.......... ..............++.++.
T Consensus       163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (268)
T cd06624         163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK  242 (268)
T ss_pred             CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHH
Confidence               22234688999999985543  7789999999999999999999997654432221 11111111112235788999


Q ss_pred             HHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +++.+||+.+|++|||+.+++.||||
T Consensus       243 ~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         243 NFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-43  Score=290.45  Aligned_cols=253  Identities=29%  Similarity=0.539  Sum_probs=204.0

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .+++|++.+.||.|++|.||++.++.+++.|++|.+.......  ....+.+|++++++++|+||+++++++.+.+..++
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            4688999999999999999999999999999999986543221  12345679999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---
Q 038249           94 ILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---  169 (281)
                      |+||+.+ +|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......   
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            9999986 898888654 46899999999999999999999999999999999999999999999999987543211   


Q ss_pred             cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCc-hHHHHHHhhc-------------------
Q 038249          170 RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEH-SDTYRRIVQV-------------------  228 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~-------------------  228 (281)
                      .....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||..... .+....+...                   
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            122235778999998754 4578899999999999999999999976552 2222111100                   


Q ss_pred             cccC---------CCCCCCC--HHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          229 DLKF---------PPKPIVS--SAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       229 ~~~~---------~~~~~~~--~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ....         ...+..+  .++.+++.+||+++|++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000         0001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=327.27  Aligned_cols=262  Identities=35%  Similarity=0.575  Sum_probs=234.7

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      -..+...++|.+++.||+|+||.|.+++++.+++.||.|.+.+-.+.......-|+.|-.++..-+.+=|+.++-.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            34566779999999999999999999999999999999999775554444456688888888888899999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      .++|+||+|++||+|..++.+..+++++-++.++..|+.||..||+.|++||||||+||++|.+|+++|.|||.+..+..
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            99999999999999999999988999999999999999999999999999999999999999999999999998866542


Q ss_pred             C----cccccCcCCccCCcccc----C-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc--cccCCCCCC
Q 038249          169 R----RRTMCGTLDYLPPEMVE----S-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--DLKFPPKPI  237 (281)
Q Consensus       169 ~----~~~~~~~~~~~aPE~~~----~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~  237 (281)
                      .    ....+|||+|.+||++.    + +.|++..|.||+|+++|||+.|..||-..+-.+++..++..  .+.+|....
T Consensus       228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~  307 (1317)
T KOG0612|consen  228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETD  307 (1317)
T ss_pred             CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccc
Confidence            2    35568999999999982    3 56889999999999999999999999988889999998876  667776667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC---hhhhhcCCcccc
Q 038249          238 VSSAAKDLISQMLVKDSSQRLP---LHKLLEHPWIIQ  271 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps---~~eil~~~~~~~  271 (281)
                      +|.+.++||.+.++ +|+.|..   +++|..||||..
T Consensus       308 VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  308 VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence            99999999999997 8999998   999999999974

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.4e-43  Score=286.09  Aligned_cols=251  Identities=28%  Similarity=0.548  Sum_probs=214.4

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||++.++.++..+++|.+....... ...+.+.+|+++++.++|+|++++++.+...+..++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5899999999999999999999999999999986654322 234567889999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc-EEEeeecCcccccCCc---
Q 038249           97 YAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE-LKIADFGWSVHTFNRR---  170 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~-~~l~dfg~~~~~~~~~---  170 (281)
                      |+.+++|.+++....  .+++..+..++.+++.|+.+||+.+++|+|++|+||+++.++. ++++|||.+.......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999987543  4789999999999999999999999999999999999998864 6999999875443321   


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+.......... .+..+..+.++.++|.+||
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l  238 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPNFSRDLRSLISQLF  238 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-CCCCCCCCHHHHHHHHHHh
Confidence            223477889999999888889999999999999999999999987766666655544332 2223467899999999999


Q ss_pred             ccCCCCCCChhhhhcCCcc
Q 038249          251 VKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       251 ~~~p~~Rps~~eil~~~~~  269 (281)
                      ..+|++|||+.+++.||||
T Consensus       239 ~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         239 KVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ccChhhCcCHHHHhhCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=310.85  Aligned_cols=254  Identities=27%  Similarity=0.488  Sum_probs=222.9

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      -+.|+..||.|+||.||+|.++.++..-|.|++   ...+.+....+.-||++|..++||+|+++++.|...+.++++.|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI---etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI---ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhh---cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            467899999999999999999988888888988   44556667888899999999999999999999999999999999


Q ss_pred             ccCCCChhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc---cCCccc
Q 038249           97 YAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT---FNRRRT  172 (281)
Q Consensus        97 ~~~~~~L~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~---~~~~~~  172 (281)
                      ||.||.+...+- -+.++++.+|..++.+++.||.|||+.+|+|+|++..||+++.+|.++|.|||.+...   ......
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence            999998877664 4567999999999999999999999999999999999999999999999999987432   223345


Q ss_pred             ccCcCCccCCccc-----cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-cCCCCCCCCHHHHHHH
Q 038249          173 MCGTLDYLPPEMV-----ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-KFPPKPIVSSAAKDLI  246 (281)
Q Consensus       173 ~~~~~~~~aPE~~-----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li  246 (281)
                      ..|||.|||||+.     ...+|+.++||||||+++.+|..+.+|-...++...+-.+.++.. ....+...+..+.+|+
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfL  269 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFL  269 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHH
Confidence            6799999999975     677899999999999999999999999998888888777665433 3334456889999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccCC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      ++||..||..||++.++|+|||+++..
T Consensus       270 k~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  270 KRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHHhcCCccCCCHHHHhhCcccccCC
Confidence            999999999999999999999999653

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.8e-43  Score=284.79  Aligned_cols=246  Identities=24%  Similarity=0.418  Sum_probs=208.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||.|++|.||++.++ ++..+++|.+......    ...+.+|+.++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            3467999999999999999999886 4567999987544322    3457789999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--
Q 038249           94 ILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--  170 (281)
                      |+||+++++|.+.+... ..+++..++.++.+++.||.+||++|++|+||+|+||+++.++.++++|||.+.......  
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999999999998753 458999999999999999999999999999999999999999999999999876443221  


Q ss_pred             --ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          171 --RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       171 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                        ....++..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+...... ......+.++.+++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~  235 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-YRPKLASMTVYEVMY  235 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-CCCCCCCHHHHHHHH
Confidence              11223557999999988888999999999999999999 89999888877777766554322 223357889999999


Q ss_pred             HhcccCCCCCCChhhhhc
Q 038249          248 QMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~  265 (281)
                      +||+.+|++|||+.+++.
T Consensus       236 ~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         236 SCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHccCCcccCcCHHHHHH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.5e-43  Score=289.74  Aligned_cols=247  Identities=24%  Similarity=0.463  Sum_probs=208.9

Q ss_pred             cCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      -++|.+.+.||.|++|.||.+.+.     .++..+++|.+...   .......+.+|++++++++|+|++++++++...+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            467999999999999999999863     34566889988543   2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEE
Q 038249           90 RVYLILEYAAKGELYKELQKCK-------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELK  156 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~-------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~  156 (281)
                      ..++++||+++++|.+++...+             .+++..++.++.|++.||++||++|++|+||+|+||+++.++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            9999999999999999987543             389999999999999999999999999999999999999999999


Q ss_pred             EeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccc
Q 038249          157 IADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDL  230 (281)
Q Consensus       157 l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~  230 (281)
                      |+|||++.......     ....++..|+|||.+.+..++.++|+||||+++++|++ |..||......+....+..+..
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~  240 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV  240 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence            99999875433221     11223568999999988889999999999999999998 9999988877777776665543


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          231 KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      . .....++.++.+++.+||++||.+|||+.+++.
T Consensus       241 ~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         241 L-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2 223358899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.3e-44  Score=291.33  Aligned_cols=244  Identities=31%  Similarity=0.547  Sum_probs=202.3

Q ss_pred             eecceecccCceEEEEEEEc----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           19 DIGKPLGRGKFGHVYLAREK----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        19 ~~~~~ig~g~~~~v~~~~~~----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .+.+.||.|.||.||+|.+.    ..+..|+||.+...  ...+....+.+|++.+++++||||+++++++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            46789999999999999998    44677999999442  2334467889999999999999999999999988889999


Q ss_pred             EeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---
Q 038249           95 LEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---  169 (281)
                      +||+++++|.+++...  ..++...++.++.||+.||.|||+++++|++|++.||+++.++.+||+|||+.......   
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999886  66999999999999999999999999999999999999999999999999987654221   


Q ss_pred             --cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          170 --RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                        .........|+|||.+....++.++||||||++++++++ |..||...+..+....+..... .+....++..+.+++
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-LPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-TTSBTTSBHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ceeccchhHHHHHHH
Confidence              122345668999999988889999999999999999999 7899998888777777755433 334446899999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      .+||+.||++|||+.+|++
T Consensus       239 ~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  239 QQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHT-SSGGGS--HHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHh
Confidence            9999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-43  Score=298.70  Aligned_cols=257  Identities=31%  Similarity=0.484  Sum_probs=215.9

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-----EE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-----RV   91 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~   91 (281)
                      +|++.+.||.|++|.||+|++..+++.+++|.+.... ......+.+.+|+..++.++|+||+++.+++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            5899999999999999999999999999999986543 22334567888999999999999999999988765     78


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      +++++|+.+ +|...+....++++..++.++.+|+.||.+||+.|++|+||+|.||+++.++.++|+|||.+....... 
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            999999975 899998887789999999999999999999999999999999999999999999999999875543322 


Q ss_pred             -----ccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC-----------
Q 038249          171 -----RTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP-----------  233 (281)
Q Consensus       171 -----~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  233 (281)
                           ....++..|+|||.+.+. .++.++|+||||+++++|++|.+||...+..+....+.......+           
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence                 223467889999998777 788899999999999999999999987776555444332110000           


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          234 ------------------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       234 ------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                        ..+.++.++.++|.+||+.+|.+||++++++.||||++...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                              012367889999999999999999999999999999977554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6e-43  Score=288.54  Aligned_cols=248  Identities=30%  Similarity=0.509  Sum_probs=201.3

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeC--CEEEEE
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQ--KRVYLI   94 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~--~~~~~v   94 (281)
                      |++.+.||.|++|.||++.+..+++.+++|.+.........  ....+|+..++++. |+|++++++++.++  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh--hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            67899999999999999999999999999998654322221  23346788888885 99999999999987  899999


Q ss_pred             EeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--c
Q 038249           95 LEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--R  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--~  171 (281)
                      +||+++ ++.+.+.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++. +.++|+|||++.......  .
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            999976 77777765 356899999999999999999999999999999999999999 999999999885543222  2


Q ss_pred             cccCcCCccCCccc-cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc------------------ccC
Q 038249          172 TMCGTLDYLPPEMV-ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD------------------LKF  232 (281)
Q Consensus       172 ~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~~~  232 (281)
                      ...++..|+|||.+ .+..++.++|+||||+++++|++|..||...+..+.........                  ...
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            23467889999976 44556889999999999999999999998776655443332110                  001


Q ss_pred             CC---------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          233 PP---------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       233 ~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +.         .+.++.++.++|.+||+++|++||++++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            10         12468899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-43  Score=296.87  Aligned_cols=263  Identities=30%  Similarity=0.492  Sum_probs=215.0

Q ss_pred             ccc-ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           11 KRW-TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        11 ~~~-~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ..| ..++|++.+.||.|++|.||++.+..++..||+|.+.... ........+.+|+.++++++|+||+++++++..+.
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            344 3478999999999999999999999999999999985442 23334456788999999999999999999987543


Q ss_pred             ------EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           90 ------RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        90 ------~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                            .+++|++++ +++|..++.. ..+++..++.++.||+.|+++||+.|++|+||+|+||+++.++.++++|||.+
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence                  468999998 6688888775 45899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc-----------
Q 038249          164 VHTFNRRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK-----------  231 (281)
Q Consensus       164 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  231 (281)
                      ...........+++.|++||.+.+ ..++.++|+||||++++++++|..||...+..............           
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         166 RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             cccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            765544444567889999998765 45788999999999999999999999876654443332221100           


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          232 ------------------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       232 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                                        ....+.++.++.++|.+||+.||++|||+.+++.||||+...+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~  308 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE  308 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence                              001135778899999999999999999999999999999764443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-42  Score=288.45  Aligned_cols=252  Identities=29%  Similarity=0.477  Sum_probs=200.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ..+|++.+.||.|++|.||+|.+..+++.+++|.+.......  ....+.+|+.+++.++|+||+++++++..++..++|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            367999999999999999999999999999999986543222  223466899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---Cc
Q 038249           95 LEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RR  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~  170 (281)
                      +||+.+ ++.+.+.. ...++...+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.....   ..
T Consensus        82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             EecccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            999965 66666543 35578889999999999999999999999999999999999999999999998754221   12


Q ss_pred             ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhc----------------cc--
Q 038249          171 RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQV----------------DL--  230 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~----------------~~--  230 (281)
                      ....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...... +........                ..  
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            23346788999999765 44778899999999999999999999765432 111111000                00  


Q ss_pred             cC-----C-------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          231 KF-----P-------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       231 ~~-----~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ..     +       ..-..+.++.+++.+||..||++|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00     0       000135689999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.9e-43  Score=283.74  Aligned_cols=251  Identities=31%  Similarity=0.482  Sum_probs=216.8

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||++.+..+++.+++|.+....... .....+.+|+..++.++|+||+++.+++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999986654333 335667789999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-cc
Q 038249           97 YAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-RR  171 (281)
Q Consensus        97 ~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-~~  171 (281)
                      |+++++|.+++..    ...+++..++.++.+++.|+.+||+.|++|+||+|.||+++.++.++|+|||++...... ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  159 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK  159 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence            9999999998866    355899999999999999999999999999999999999999999999999987544332 23


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ...+++.|++||.+.+..++.++|+||||+++++|++|..||...+..+............ ....++.++.+++.+||+
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~  238 (256)
T cd08530         160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRSMLQ  238 (256)
T ss_pred             cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CchhhCHHHHHHHHHHcC
Confidence            3456789999999988888999999999999999999999998887766655554443322 223688999999999999


Q ss_pred             cCCCCCCChhhhhcCCcc
Q 038249          252 KDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~  269 (281)
                      .+|++||++.+++.||++
T Consensus       239 ~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         239 VKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CCcccCCCHHHHhcCCCC
Confidence            999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.6e-43  Score=317.52  Aligned_cols=250  Identities=27%  Similarity=0.442  Sum_probs=206.9

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++.+.||.|++|.||+|.+..+++.||+|++...........+.+.+|++++++++||||+++++++.+++..+++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            57899999999999999999999999999999999765444445566788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           95 LEYAAKGELYKELQKC-----------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      |||++|++|.+++...           ...+...++.++.||+.||++||+.|++|+||+|+||+++.++.++++|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988642           23556778999999999999999999999999999999999999999999987


Q ss_pred             ccccC---------------------CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHH
Q 038249          164 VHTFN---------------------RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY  222 (281)
Q Consensus       164 ~~~~~---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  222 (281)
                      .....                     ......||+.|+|||.+.+..++.++||||||+++++|++|..||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            54310                     011235899999999999888999999999999999999999999775443332


Q ss_pred             HH-HhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhh
Q 038249          223 RR-IVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLL  264 (281)
Q Consensus       223 ~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil  264 (281)
                      .. .............++..+.+++.+||+.||++||+..+.+
T Consensus       241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            21 1111112222346889999999999999999998755544

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-43  Score=298.59  Aligned_cols=259  Identities=29%  Similarity=0.463  Sum_probs=214.3

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE---
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR---   90 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~---   90 (281)
                      ..++|++.+.||.|++|.||+|++..+++.+++|++..... .......+.+|+.+++.++|+|++++.+++...+.   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34789999999999999999999999999999999865432 22334567789999999999999999998765544   


Q ss_pred             ---EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           91 ---VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        91 ---~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                         .++|+||+ +++|.+++.. ..+++..++.++.+|+.|+++||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence               89999999 5599988876 458999999999999999999999999999999999999999999999999986654


Q ss_pred             CCcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC--------------
Q 038249          168 NRRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--------------  232 (281)
Q Consensus       168 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  232 (281)
                      .......++..|+|||.+.+ ..++.++|+||||+++++|++|..||......+....+.......              
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  249 (343)
T cd07851         170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR  249 (343)
T ss_pred             ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence            44444567888999998754 357789999999999999999999998776665544433211000              


Q ss_pred             ---------------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          233 ---------------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       233 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                     .....++.++.++|.+||++||++|||+.+++.||||.+..++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                           0012368899999999999999999999999999999987554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.1e-43  Score=298.16  Aligned_cols=259  Identities=30%  Similarity=0.467  Sum_probs=211.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe----CCEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD----QKRV   91 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~   91 (281)
                      ++|++.+.||.|++|.||+|.++.+++.|++|.+..... .......+.+|+.++++++|+||+++++++..    ....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            689999999999999999999999999999999865432 22334567789999999999999999998753    3578


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      ++|+||+.+ +|.+.+.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            999999964 899998877779999999999999999999999999999999999999999999999999875432211 


Q ss_pred             ------ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--------------
Q 038249          171 ------RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--------------  229 (281)
Q Consensus       171 ------~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  229 (281)
                            ....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+....              
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence                  12357788999998755 457889999999999999999999997766544332211100              


Q ss_pred             --------cc-CCC------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          230 --------LK-FPP------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       230 --------~~-~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                              .. ...      .+..+.++.++|.+||+.+|++||++.+++.||||.+...+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                    00 000      134688999999999999999999999999999998775544

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.6e-43  Score=290.10  Aligned_cols=258  Identities=32%  Similarity=0.520  Sum_probs=209.0

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++.+.||.|++|+||+|.++.+|+.+++|.+...... ......+.+|++++++++|+|++++++++......++|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            47899999999999999999999999999999998654322 23345677899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-CCcEEEeeecCcccccCC--
Q 038249           95 LEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-QGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-~~~~~l~dfg~~~~~~~~--  169 (281)
                      +||+++ +|.+.+.....  +++..++.++.||+.||++||++|++|+||+|+||+++. ++.++++|||++......  
T Consensus        80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            999965 78777765433  578889999999999999999999999999999999985 457999999987543221  


Q ss_pred             -cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc------------------
Q 038249          170 -RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD------------------  229 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  229 (281)
                       .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+..+.........                  
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence             122345788999998755 457889999999999999999999998766654444322100                  


Q ss_pred             ---ccCC------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          230 ---LKFP------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       230 ---~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                         ....      ..+.++.++.+++.+||+.+|++||++.++++||||.+..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence               0000      12347888999999999999999999999999999987643

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.4e-43  Score=289.89  Aligned_cols=253  Identities=28%  Similarity=0.454  Sum_probs=204.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCE----
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKR----   90 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~----   90 (281)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+.... ........+.+|+.+++.+. |+|++++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            47999999999999999999999999999999985543 22222345778999999995 6999999999887655    


Q ss_pred             -EEEEEeccCCCChhHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-CCcEEEeeecCc
Q 038249           91 -VYLILEYAAKGELYKELQKC-----KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-QGELKIADFGWS  163 (281)
Q Consensus        91 -~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-~~~~~l~dfg~~  163 (281)
                       .++++||+++ +|.+++...     ..+++..++.++.||+.||.+||++|++|+||+|+||+++. ++.++|+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999986 788877542     35799999999999999999999999999999999999998 889999999987


Q ss_pred             ccccC---CcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-----c---
Q 038249          164 VHTFN---RRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-----K---  231 (281)
Q Consensus       164 ~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~---  231 (281)
                      .....   ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+..+....+.....     .   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            54322   1122345778999998754 4578899999999999999999999987666554433322100     0   


Q ss_pred             ---------CC---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccc
Q 038249          232 ---------FP---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       232 ---------~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                               .+         ..+.++.++.++|.+||.+||++||++.|++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                     00         0134788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-43  Score=289.05  Aligned_cols=250  Identities=32%  Similarity=0.512  Sum_probs=206.4

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEec
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEY   97 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   97 (281)
                      |++.+.||.|++|.||+|.++.+|..+++|++...... ......+.+|++.++.++|+|++++++++.+.+..++++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            67889999999999999999999999999998654322 22334577899999999999999999999999999999999


Q ss_pred             cCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccc
Q 038249           98 AAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT  172 (281)
Q Consensus        98 ~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~  172 (281)
                      ++ ++|.+++...+  .+++..++.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+......   ...
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            96 58999887765  6899999999999999999999999999999999999999999999999987543221   122


Q ss_pred             ccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc---------------------c
Q 038249          173 MCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD---------------------L  230 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~  230 (281)
                      ..+++.|+|||.+.+. .++.++|+||||+++++|++|..||...+.......+....                     .
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence            3457789999987553 56889999999999999999999998766544333221110                     0


Q ss_pred             ------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          231 ------KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       231 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                            .....+.++.++.++|.+||++||++||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                  001123577899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-43  Score=296.02  Aligned_cols=257  Identities=28%  Similarity=0.451  Sum_probs=207.1

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-----CE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-----KR   90 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~   90 (281)
                      ++|++.+.||.|++|.||+|.+..+|+.|++|.+....  .......+.+|+.++++++|+||+++++++...     ..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            68999999999999999999999999999999985322  223345677899999999999999999987643     35


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      .++++||+.+ +|...+.. ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          83 VYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            7999999975 78777755 458999999999999999999999999999999999999999999999999875432211


Q ss_pred             ------ccccCcCCccCCcccc-CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--------------
Q 038249          171 ------RTMCGTLDYLPPEMVE-SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--------------  229 (281)
Q Consensus       171 ------~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  229 (281)
                            ....+++.|+|||.+. ...++.++|+||||+++++|++|..||...+.......+....              
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence                  2235688899999864 4567889999999999999999999997655433222211100              


Q ss_pred             ----------ccCC-----CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          230 ----------LKFP-----PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       230 ----------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                                ....     ..+..+.++.+++.+||+.+|++|||+.++++||||.+..+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~  302 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS  302 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCC
Confidence                      0000     0124678899999999999999999999999999999886653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.2e-43  Score=283.91  Aligned_cols=247  Identities=25%  Similarity=0.440  Sum_probs=208.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||.|++|+||.+.+.. +..+++|.+......    ...+.+|+.++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            35679999999999999999998764 456999998654322    2457889999999999999999999998888999


Q ss_pred             EEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--
Q 038249           94 ILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--  170 (281)
                      ++||+.+++|.+++... ..+++..++.++.+|+.|+++||+.|++|+||+|.||+++.++.++|+|||.+.......  
T Consensus        77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999999999998764 468999999999999999999999999999999999999999999999999875432221  


Q ss_pred             --ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          171 --RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       171 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                        ....++..|++||...+..++.++|+||||+++++|++ |..||......+....+....... .....+..+.+++.
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~  235 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY-RPHLASEKVYAIMY  235 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHH
Confidence              11224567999999988888999999999999999998 999998877777666665543322 23357899999999


Q ss_pred             HhcccCCCCCCChhhhhcC
Q 038249          248 QMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~  266 (281)
                      +||+++|.+||++.+|+++
T Consensus       236 ~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         236 SCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHcCCCcccCCCHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.8e-43  Score=295.78  Aligned_cols=259  Identities=29%  Similarity=0.464  Sum_probs=211.4

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC------
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ------   88 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------   88 (281)
                      .++|++.+.||+|++|.||++.+..+++.||+|++.... ......+.+.+|++++++++|+||+++++++...      
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            488999999999999999999999999999999986543 2222345677899999999999999999988643      


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      ...+++++++ +++|.++++.. .+++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            3468888887 66898877654 589999999999999999999999999999999999999999999999999876554


Q ss_pred             CcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-----------------
Q 038249          169 RRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-----------------  230 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------  230 (281)
                      ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+.....                 
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (345)
T cd07877         173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  252 (345)
T ss_pred             cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence            4444567889999998755 5678899999999999999999999977665444333221100                 


Q ss_pred             ------cCCC------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          231 ------KFPP------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       231 ------~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                            ..+.      ....+.++.++|.+||+.||++||++.+++.||||++...+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence                  0000      113577899999999999999999999999999999875544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=283.33  Aligned_cols=242  Identities=26%  Similarity=0.488  Sum_probs=210.4

Q ss_pred             ceecccCceEEEEEEEccC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEecc
Q 038249           22 KPLGRGKFGHVYLAREKRS---NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYA   98 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   98 (281)
                      +.||.|++|.||+|.+...   +..+++|.+.......  ....+.+|+..++.++|+|++++++++......++++||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4799999999999999866   8889999986654322  4567889999999999999999999999999999999999


Q ss_pred             CCCChhHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           99 AKGELYKELQKC---------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        99 ~~~~L~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ++++|.++++..         ..+++..++.++.+++.|+.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         67999999999999999999999999999999999999999999999999988654432


Q ss_pred             -----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHH
Q 038249          170 -----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK  243 (281)
Q Consensus       170 -----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  243 (281)
                           .....+++.|+|||.+....++.++|+||||+++++|++ |..||......+....+.... .......++.++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  237 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-RLPKPEYCPDELY  237 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCccCChHHH
Confidence                 233446788999999988888999999999999999998 699999887777777666532 2333446789999


Q ss_pred             HHHHHhcccCCCCCCChhhhhcC
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +++.+||..+|++|||+.+++++
T Consensus       238 ~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         238 ELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-42  Score=281.96  Aligned_cols=245  Identities=22%  Similarity=0.418  Sum_probs=210.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||.|++|.||++.+.  |+.+++|.+.....    ..+.+.+|+.+++.++|+|++++++++......++
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            4678999999999999999999886  78899999965432    35668889999999999999999999998899999


Q ss_pred             EEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc
Q 038249           94 ILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR  171 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~  171 (281)
                      |+||+++++|.++++...  .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            999999999999998765  689999999999999999999999999999999999999999999999998866543333


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ....+..|.|||.+....++.++|+||||++++++++ |..||......+....+... ........++.++.++|.+||
T Consensus       158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l  236 (256)
T cd05039         158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKDCW  236 (256)
T ss_pred             cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCCCCccCCCHHHHHHHHHHh
Confidence            3344567999999988888899999999999999997 99999877666655544433 222233457899999999999


Q ss_pred             ccCCCCCCChhhhhc
Q 038249          251 VKDSSQRLPLHKLLE  265 (281)
Q Consensus       251 ~~~p~~Rps~~eil~  265 (281)
                      ..+|++|||+.|+++
T Consensus       237 ~~~p~~Rp~~~~l~~  251 (256)
T cd05039         237 ELDPAKRPTFKQLRE  251 (256)
T ss_pred             ccChhhCcCHHHHHH
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-42  Score=282.08  Aligned_cols=241  Identities=25%  Similarity=0.431  Sum_probs=202.3

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG  101 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~  101 (281)
                      +.||.|++|.||+|.++.+++.+++|.+....  .......+.+|+++++.++|+||+++++++...+..++|+||+.++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            47999999999999999999999999875432  2344567889999999999999999999999999999999999999


Q ss_pred             ChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc-----cccC
Q 038249          102 ELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR-----TMCG  175 (281)
Q Consensus       102 ~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~  175 (281)
                      +|.+++... ..+++..++.++.|++.||.+||++|++|+||+|.||+++.++.++|+|||.+........     ....
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            999998754 4589999999999999999999999999999999999999999999999998754322211     1112


Q ss_pred             cCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 038249          176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS  254 (281)
Q Consensus       176 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  254 (281)
                      +..|+|||.+.+..++.++|+||||+++++|++ |..||......+....+... ...+....++.++.+++.+||+++|
T Consensus       159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCcccCCHHHHHHHHHHcCCCh
Confidence            356999999988889999999999999999997 89999876665554444332 2223334678999999999999999


Q ss_pred             CCCCChhhhhc
Q 038249          255 SQRLPLHKLLE  265 (281)
Q Consensus       255 ~~Rps~~eil~  265 (281)
                      ++|||+.+++.
T Consensus       238 ~~Rps~~~~~~  248 (252)
T cd05084         238 GQRPSFSTVHQ  248 (252)
T ss_pred             hhCcCHHHHHH
Confidence            99999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-42  Score=283.48  Aligned_cols=246  Identities=24%  Similarity=0.409  Sum_probs=208.6

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||.|++|.||+|.+. ++..+++|.+.....    ..+.+.+|+.+++.++|+|++++++.+...+..++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            4578999999999999999999976 556799998754331    24568889999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           94 ILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      ++||+++++|.+++...  ..++...++.++.+++.|+++||+.+++|+||+|+||+++.++.++++|||++....... 
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999999998653  458899999999999999999999999999999999999999999999999986543221 


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                         ....++..|+|||.+.+..++.++|+||||+++++|++ |..||......+....+... ...+....++.++.+++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  237 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDELYDIM  237 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHH
Confidence               12234567999999988888999999999999999998 99999887776666655443 23344446889999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      .+||+.+|++||+++++++
T Consensus       238 ~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         238 KTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1e-42  Score=294.20  Aligned_cols=260  Identities=26%  Similarity=0.416  Sum_probs=211.5

Q ss_pred             cCCcee-cceecccCceEEEEEEEccCCcEEEEEEeecccccchH-----------HHHHHHHHHHHHHhCCCCceeeee
Q 038249           15 LNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ-----------VEHQLRREVEIQSHLRHPNILRLY   82 (281)
Q Consensus        15 ~~~y~~-~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~-----------~~~~~~~e~~~l~~~~h~~i~~~~   82 (281)
                      .++|.. .+.||.|++|+||+|.++.+++.+|+|.+.........           ....+.+|+++++.++|+|+++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356764 57799999999999999999999999998654322110           112467899999999999999999


Q ss_pred             eEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           83 GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        83 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      +++...+..++++||+.+ +|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        87 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence            999999999999999975 8999998877899999999999999999999999999999999999999999999999998


Q ss_pred             ccccc-----------------CCcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHH
Q 038249          163 SVHTF-----------------NRRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRR  224 (281)
Q Consensus       163 ~~~~~-----------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  224 (281)
                      +....                 .......+++.|+|||.+.+. .++.++|+||||+++++|++|.+||...+..+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            74432                 011122356789999988654 468899999999999999999999988776655543


Q ss_pred             Hhhcccc-----CC---------------------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          225 IVQVDLK-----FP---------------------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       225 ~~~~~~~-----~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      +......     ++                     .....+.++.++|.+||+.+|++|||++|++.||||+.....
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence            3221000     00                     012357889999999999999999999999999999987544

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-42  Score=283.35  Aligned_cols=247  Identities=23%  Similarity=0.400  Sum_probs=210.8

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ...+|++.+.||.|++|.||+|.++.+++.+++|.+..+.    .....+.+|++.++.++|+|++++++++...+..++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            4467999999999999999999999999999999985432    224567889999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc
Q 038249           94 ILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR  171 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~  171 (281)
                      ++||+++++|.+.+...  ..++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999998754  3588999999999999999999999999999999999999999999999998755433221


Q ss_pred             ----cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          172 ----TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       172 ----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                          ....+..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+... ........++.++.++|
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  238 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCPPKVYELM  238 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHH
Confidence                1223557999999988889999999999999999998 99999887776666665443 22333446889999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      .+||..||++||++.++++
T Consensus       239 ~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         239 RACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHccCCcccCCCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.1e-43  Score=294.85  Aligned_cols=252  Identities=24%  Similarity=0.441  Sum_probs=204.2

Q ss_pred             cccC--CceecceecccCceEEEEEEEcc-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeE
Q 038249           13 WTLN--DFDIGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGY   84 (281)
Q Consensus        13 ~~~~--~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~   84 (281)
                      |.+.  +|++.+.||.|+||.||+|.+..     +++.||+|.+....  .......+..|+++++++ +|+||++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            5554  89999999999999999997543     34789999986443  223345677899999999 79999999998


Q ss_pred             EEe-CCEEEEEEeccCCCChhHHHHhC-----------------------------------------------------
Q 038249           85 FYD-QKRVYLILEYAAKGELYKELQKC-----------------------------------------------------  110 (281)
Q Consensus        85 ~~~-~~~~~~v~e~~~~~~L~~~~~~~-----------------------------------------------------  110 (281)
                      +.. ...+++++||+++++|.+++...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            864 45788999999999999888532                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-----ccccCcC
Q 038249          111 --------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-----RTMCGTL  177 (281)
Q Consensus       111 --------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~  177 (281)
                              .++++..+..++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++.......     ....++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    257889999999999999999999999999999999999999999999999986532221     1223456


Q ss_pred             CccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 038249          178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ  256 (281)
Q Consensus       178 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  256 (281)
                      .|+|||.+.+..++.++|||||||++++|++ |..||......+..................+.++.+++.+||+.+|++
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            8999999999999999999999999999997 999998765544443333332222223357889999999999999999


Q ss_pred             CCChhhhhcC
Q 038249          257 RLPLHKLLEH  266 (281)
Q Consensus       257 Rps~~eil~~  266 (281)
                      ||++.|++++
T Consensus       320 RPs~~ell~~  329 (337)
T cd05054         320 RPTFSELVEI  329 (337)
T ss_pred             CcCHHHHHHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.9e-42  Score=285.07  Aligned_cols=248  Identities=27%  Similarity=0.450  Sum_probs=202.2

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHH---HHHHHhCCCCceeeeeeEEEeCCEEEEEEeccC
Q 038249           23 PLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE---VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        23 ~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e---~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      .||.|++|.||+|.+..+++.||+|.+................+   ...++...|++++++.+.+...+..++|+||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999999999999999876543322212222223   344555689999999999999999999999999


Q ss_pred             CCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-CcccccCcCC
Q 038249          100 KGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLD  178 (281)
Q Consensus       100 ~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~  178 (281)
                      |++|...+...+.+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||++..... ......++..
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  160 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG  160 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence            999999998878899999999999999999999999999999999999999999999999998754322 2233467889


Q ss_pred             ccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCch---HHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 038249          179 YLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHS---DTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS  254 (281)
Q Consensus       179 ~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  254 (281)
                      |+|||.+.+. .++.++|+||+|+++++|++|..||......   ............  ....++.++.+++.+||..+|
T Consensus       161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC--CCCcCCHHHHHHHHHHhhcCH
Confidence            9999998644 5788999999999999999999999766332   222222222222  223578999999999999999


Q ss_pred             CCCC-----ChhhhhcCCccccC
Q 038249          255 SQRL-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       255 ~~Rp-----s~~eil~~~~~~~~  272 (281)
                      .+||     ++.++++||||.+.
T Consensus       239 ~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         239 NRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             HhccCCCCCCHHHHHhCccccCC
Confidence            9999     99999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.2e-43  Score=295.59  Aligned_cols=259  Identities=29%  Similarity=0.465  Sum_probs=210.1

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-----C
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-----K   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~   89 (281)
                      .++|++.+.||.|++|+||.+++..++..|++|.+...... ......+.+|+.+++.++|+|++++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            36799999999999999999999999999999998654322 22234567899999999999999999987643     3


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ..++++||+. ++|.+.++..+.+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            5899999996 589999988888999999999999999999999999999999999999999999999999988654322


Q ss_pred             ---cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-----------------
Q 038249          170 ---RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------------  228 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------  228 (281)
                         .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+...                 
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence               122346788999998754 45888999999999999999999999766543322211110                 


Q ss_pred             ------cc--c----CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          229 ------DL--K----FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       229 ------~~--~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                            ..  .    ....+.++.++.++|.+||+++|++|||++++++||||....++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                  00  0    00123578899999999999999999999999999999865433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.7e-43  Score=291.37  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=203.3

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC---
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK---   89 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~---   89 (281)
                      -.+++|++.+.||.|++|.||+|.+..+++.+|+|.+...... ........+|++++++++||||+++++++...+   
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPY   87 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence            3457899999999999999999999999999999998654322 222334567999999999999999999987543   


Q ss_pred             -----EEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           90 -----RVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        90 -----~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                           ..++|+||+.+ +|...+... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++
T Consensus        88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence                 45999999975 788777654 36899999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCc-------ccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc----
Q 038249          164 VHTFNRR-------RTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK----  231 (281)
Q Consensus       164 ~~~~~~~-------~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----  231 (281)
                      .......       ....++..|+|||.+.+. .++.++|+||||+++++|++|..||...+.......+......    
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            5432211       123456789999987654 3678999999999999999999999876655443322221000    


Q ss_pred             ---------------CCC-----------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          232 ---------------FPP-----------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       232 ---------------~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                                     .+.           ....+..+.++|.+||..||.+|||+++++.||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                           000           01135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.7e-44  Score=312.72  Aligned_cols=254  Identities=24%  Similarity=0.438  Sum_probs=226.1

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEcc-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeee
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG   83 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~   83 (281)
                      ....+..++-+..+.||+|.||+||+|+-.+     +...||||.+....  +.+..++|++|++++..++|||||+++|
T Consensus       479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlG  556 (774)
T KOG1026|consen  479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLG  556 (774)
T ss_pred             ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence            3445566788899999999999999998653     34679999996554  3446788999999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChhHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe
Q 038249           84 YFYDQKRVYLILEYAAKGELYKELQKCK--------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI  149 (281)
Q Consensus        84 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~  149 (281)
                      +|.+++-+++|+||+..|+|.+++....              +++..+.+.|+.||+.|++||-++.++|+||.++|+++
T Consensus       557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV  636 (774)
T ss_pred             EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence            9999999999999999999999996432              27888999999999999999999999999999999999


Q ss_pred             CCCCcEEEeeecCcccccCCccccc-----CcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHH
Q 038249          150 GAQGELKIADFGWSVHTFNRRRTMC-----GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYR  223 (281)
Q Consensus       150 ~~~~~~~l~dfg~~~~~~~~~~~~~-----~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~  223 (281)
                      .++-.|||+|||+++..........     -+.+|||||.+....++..|||||+|+++||+++ |..||.+.++.+.++
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe  716 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE  716 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence            9999999999999987766654433     3679999999999999999999999999999995 999999999999999


Q ss_pred             HHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          224 RIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .+.+++. .+-+.++|.++.+|+..||+.+|++||++.||-.
T Consensus       717 ~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  717 CIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             HHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            9999988 6667799999999999999999999999999853

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.7e-42  Score=287.21  Aligned_cols=249  Identities=24%  Similarity=0.456  Sum_probs=209.4

Q ss_pred             cccCCceecceecccCceEEEEEEEcc-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      ++..+|.+.+.||.|++|.||.|++..     ++..+++|.+....   ......+.+|++.+++++|+||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            355789999999999999999998653     34568888875432   2334568889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                      .+..++|+||+++++|.+++...+                .+++..++.++.+|+.|+++||++|++|+||+|+||+++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            999999999999999999997543                3788999999999999999999999999999999999999


Q ss_pred             CCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038249          152 QGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRI  225 (281)
Q Consensus       152 ~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~  225 (281)
                      ++.++|+|||++.......     ....++..|+|||.+.+..++.++|+||||+++++|++ |..||......+....+
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999875433221     22334678999999988889999999999999999998 99999887777776666


Q ss_pred             hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ....... .....+.++.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         239 TQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            5543322 23357899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-42  Score=285.67  Aligned_cols=251  Identities=22%  Similarity=0.397  Sum_probs=208.3

Q ss_pred             cccCCceecceecccCceEEEEEEEc----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREK----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      +.+++|++.+.||+|+||.||+|.+.    .++..+++|.+....  .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            35678999999999999999999853    345789999986432  233446688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           89 KRVYLILEYAAKGELYKELQKC-----------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                      ...++++||+.+++|.+++...                 ..+++..++.++.+++.||.|||++|++|+||+|+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            9999999999999999998532                 23678889999999999999999999999999999999999


Q ss_pred             CCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038249          152 QGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRI  225 (281)
Q Consensus       152 ~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~  225 (281)
                      ++.++|+|||++......     .....++..|+|||.+.+..++.++|+||||+++++|++ |..||............
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999988543222     122234567999999988889999999999999999998 99999876665555544


Q ss_pred             hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .... ..+....++.++.+++.+||+.||++||++.+|+++
T Consensus       240 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         240 RKRQ-LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            4332 233344688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=302.20  Aligned_cols=239  Identities=27%  Similarity=0.463  Sum_probs=213.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.-.-++-||.|+.|.||+++.+  ++.||||++..          .-..+|..|++++|+||+.+.++|.+...+||||
T Consensus       124 e~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM  191 (904)
T KOG4721|consen  124 EEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM  191 (904)
T ss_pred             HHhhhhhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence            33445678999999999999988  78899999832          1235789999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc--CCcccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF--NRRRTM  173 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~--~~~~~~  173 (281)
                      |||..|.|.+.++.+.+++...+..|..+|+.|+.|||.+.|+|+|||.-||+++.++.+||+|||-+....  ...-..
T Consensus       192 EfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSF  271 (904)
T KOG4721|consen  192 EFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSF  271 (904)
T ss_pred             eccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhh
Confidence            999999999999999999999999999999999999999999999999999999999999999999875432  334456


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD  253 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  253 (281)
                      +||..|||||++.+.+.+.+.||||||++||||+||..||.+.+...++.-+-...+..+....+|+.+.=|+++||+..
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sK  351 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSK  351 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcC
Confidence            79999999999999999999999999999999999999999888877765555555566777789999999999999999


Q ss_pred             CCCCCChhhhhcC
Q 038249          254 SSQRLPLHKLLEH  266 (281)
Q Consensus       254 p~~Rps~~eil~~  266 (281)
                      |..|||+.+||.|
T Consensus       352 pRNRPSFrqil~H  364 (904)
T KOG4721|consen  352 PRNRPSFRQILLH  364 (904)
T ss_pred             CCCCccHHHHHHH
Confidence            9999999999987

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-43  Score=292.28  Aligned_cols=252  Identities=27%  Similarity=0.482  Sum_probs=201.4

Q ss_pred             CceecceecccCceEEEEEEEcc--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--CEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKR--SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--KRVY   92 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~   92 (281)
                      +|++.+.||.|++|.||+|.++.  ++..+|+|.+.............+.+|+.+++.++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48899999999999999999998  8899999999764322233345567899999999999999999999987  8899


Q ss_pred             EEEeccCCCChhHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC----CCcEEEeeecCc
Q 038249           93 LILEYAAKGELYKELQKC-----KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA----QGELKIADFGWS  163 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~----~~~~~l~dfg~~  163 (281)
                      +|+||+++ ++.+.+...     ..+++..++.++.||+.|+.+||+.+++|+||+|+||+++.    ++.++++|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999976 676666432     26899999999999999999999999999999999999999    899999999987


Q ss_pred             ccccCC------cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH---------HHHHHhh
Q 038249          164 VHTFNR------RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD---------TYRRIVQ  227 (281)
Q Consensus       164 ~~~~~~------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~  227 (281)
                      ......      .....+++.|+|||.+.+ ..++.++|+||||+++++|++|.+||.......         ....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            543221      123356788999998755 457889999999999999999999997654432         0000000


Q ss_pred             c-----------------------cccCCCC------------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          228 V-----------------------DLKFPPK------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       228 ~-----------------------~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      .                       .......            ...+.++.++|.+||++||++|||+.|++.||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            0                       0000001            1466789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3e-42  Score=282.17  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=210.6

Q ss_pred             cCCceecceecccCceEEEEEEEccC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRS---NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .++|++.+.||.|+||.||+|.++.+   ...+++|.+....  .......+.+|+..+++++|+||+++++.+...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            46899999999999999999998754   4578999885443  233456688899999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           92 YLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      ++++||+++++|.+++... +.++...++.++.+++.|+.+||++|++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999998764 468999999999999999999999999999999999999999999999999886543111


Q ss_pred             -----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHH
Q 038249          171 -----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       171 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (281)
                           ....++..|+|||.+.+..++.++|+||||+++++|++ |..||......+....+.... ..+....++.++.+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  239 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-RLPPPMDCPSALYQ  239 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence                 11223567999999988889999999999999999997 999998877776666655432 22334468999999


Q ss_pred             HHHHhcccCCCCCCChhhhhcC
Q 038249          245 LISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ++.+||+.+|++||++++++++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.9e-42  Score=284.94  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=208.6

Q ss_pred             cccCCceecceecccCceEEEEEEEcc-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      ...++|++.+.||+|++|.||+|.+..     ++..+++|.+....  .......+..|+..++.++|+||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            344779999999999999999999987     67889999875432  23334568889999999999999999999998


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC---cEEE
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK-------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---ELKI  157 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~---~~~l  157 (281)
                      .+..++|+||+++++|.+++...+       .+++..++.++.+|+.|+++||+++++|+||+|+||+++.++   .++|
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence            889999999999999999987643       488999999999999999999999999999999999998765   5999


Q ss_pred             eeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhcccc
Q 038249          158 ADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLK  231 (281)
Q Consensus       158 ~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  231 (281)
                      +|||++.......     .....+..|+|||.+.+..++.++||||||+++++|++ |..||......+....+... ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~  239 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR  239 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence            9999886542221     11123457999999988889999999999999999996 99999887776665554432 22


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          232 FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ......++.++.+++.+||+.+|++|||+.++++|
T Consensus       240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            23334688999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.1e-42  Score=287.49  Aligned_cols=248  Identities=25%  Similarity=0.402  Sum_probs=206.2

Q ss_pred             CCceecceecccCceEEEEEEEccCCc--EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNH--IVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~--~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~   92 (281)
                      ++|++.+.||.|++|.||+|.++.++.  .+++|.+...  ......+.+.+|+++++++ +||||+++++.+...+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999999987765  3678777532  2233346688899999999 7999999999999989999


Q ss_pred             EEEeccCCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEE
Q 038249           93 LILEYAAKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELK  156 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~  156 (281)
                      +++||+++++|.+++....                .+++..++.++.||+.|+++||++|++|+||+|+||+++.++.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999986532                478899999999999999999999999999999999999999999


Q ss_pred             EeeecCcccccCCc--ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCC
Q 038249          157 IADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFP  233 (281)
Q Consensus       157 l~dfg~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  233 (281)
                      |+|||++.......  .....+..|+|||...+..++.++||||||+++++|++ |..||......+......... ..+
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~-~~~  238 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RME  238 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCC
Confidence            99999875332211  11122456999999988889999999999999999997 999998887777666655432 222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ....++.++.+++.+||..+|.+|||+++++..
T Consensus       239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            334688999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-42  Score=285.62  Aligned_cols=250  Identities=30%  Similarity=0.540  Sum_probs=206.3

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      +|++.+.||.|++|.||+|.+..+|+.+++|.+......  .....+.+|+.++++++|+|++++++++...+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            589999999999999999999999999999998654322  123456679999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---c
Q 038249           97 YAAKGELYKELQKC---KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---R  170 (281)
Q Consensus        97 ~~~~~~L~~~~~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~  170 (281)
                      |+++ +|.+++...   ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++++|||++......   .
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            9986 888877653   35899999999999999999999999999999999999999999999999987533221   1


Q ss_pred             ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc------------------cc
Q 038249          171 RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD------------------LK  231 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~~  231 (281)
                      ....++..|++||.+.+ ..++.++|+||||+++++|++|..||...+..+....+....                  ..
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            23345788999998755 446889999999999999999999998777665544332110                  00


Q ss_pred             CC---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          232 FP---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       232 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      .+         ..+..+.++.++|.+||+.||.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            00         012357789999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-44  Score=281.30  Aligned_cols=252  Identities=35%  Similarity=0.569  Sum_probs=218.3

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEEEeccC
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      .+.||+|+++.|--++...++..||||++.+..   ......+.+|++++.++ .|+||++++++|+++..+|+|||.+.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            578999999999999999999999999996652   23456788999999999 59999999999999999999999999


Q ss_pred             CCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC---cEEEeeecCcccc----------
Q 038249          100 KGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---ELKIADFGWSVHT----------  166 (281)
Q Consensus       100 ~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~---~~~l~dfg~~~~~----------  166 (281)
                      ||+|...+.+++.+++.++.++..+|+.||.+||.+||.|+|+||+||+...-+   -+||+||++....          
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            999999999999999999999999999999999999999999999999997655   4899999985321          


Q ss_pred             cCCcccccCcCCccCCccc-----cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc---------------hHHHHHHh
Q 038249          167 FNRRRTMCGTLDYLPPEMV-----ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH---------------SDTYRRIV  226 (281)
Q Consensus       167 ~~~~~~~~~~~~~~aPE~~-----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------------~~~~~~~~  226 (281)
                      .+.....+|+..|||||+.     ....|+.+.|.||||+++|=|++|.+||.+...               ..++..++
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ  319 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ  319 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence            1112345677789999986     345589999999999999999999999965322               34567788


Q ss_pred             hccccCCC--CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          227 QVDLKFPP--KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       227 ~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      .+.+.+|.  |..++.+..++|+.+|..|+..|.++..++.|||++....+
T Consensus       320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            88888875  56799999999999999999999999999999999987554

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.7e-42  Score=290.49  Aligned_cols=259  Identities=31%  Similarity=0.504  Sum_probs=211.2

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-CCEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-QKRVY   92 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~   92 (281)
                      ..++|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+..|+.+++.++|||++++.+++.. .+..+
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45789999999999999999999999999999999865432 22334567789999999999999999999875 56789


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCccc
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT  172 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~  172 (281)
                      +++||+. ++|...++. .+++...+..++.||+.||.+||+.|++|+||+|.||+++.++.++|+|||.+.........
T Consensus        87 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  164 (328)
T cd07856          87 FVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG  164 (328)
T ss_pred             EEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCC
Confidence            9999984 588888775 35788999999999999999999999999999999999999999999999988654443344


Q ss_pred             ccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-----------------------
Q 038249          173 MCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------------------  228 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------------  228 (281)
                      ..++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+...                       
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (328)
T cd07856         165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS  244 (328)
T ss_pred             CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence            456788999998755 56888999999999999999999999776553322111100                       


Q ss_pred             -c--ccCC---CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          229 -D--LKFP---PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       229 -~--~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                       .  ...+   ..+.++.++.++|.+||+.+|++||++++++.||||.+...+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence             0  0000   113477899999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-42  Score=287.18  Aligned_cols=256  Identities=27%  Similarity=0.447  Sum_probs=206.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~   93 (281)
                      .++|+..+.||.|++|.||++.+..+++.+++|.+......  .....+.+|+..+.++. |+||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            45788899999999999999999999999999998654322  33456788999999996 9999999999998889999


Q ss_pred             EEeccCCCChhHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           94 ILEYAAKGELYKELQ-----KCKYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        94 v~e~~~~~~L~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      ++|++.. ++.++..     ....+++..+..++.+++.|+++||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9999865 5555432     235689999999999999999999975 99999999999999999999999999875432


Q ss_pred             CC--cccccCcCCccCCccccCC---CCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccc-cC--CCCCCC
Q 038249          168 NR--RRTMCGTLDYLPPEMVESV---EHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDL-KF--PPKPIV  238 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~--~~~~~~  238 (281)
                      ..  .....++..|+|||.+.+.   .++.++|+||+|+++++|++|..||...... +.......... ..  .....+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF  239 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence            22  2233578889999998765   6788999999999999999999999765421 12222221111 11  112247


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +.++.++|.+||+.+|++|||++++++||||.+..
T Consensus       240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            88999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=273.30  Aligned_cols=261  Identities=26%  Similarity=0.483  Sum_probs=215.6

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      .+....+++.+.+..||.|+.|+||++..+.+|...|||.+....  +.+....+...+.+.... +.|+||+.+|+|..
T Consensus        85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            445667788899999999999999999999999999999997654  333345566666655554 58999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           88 QKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                      +..+++.||.+.. .+..+++. .+++++..+-.+...++.||.||.. +||+|+|+||+||++|+.|++||+|||.+-.
T Consensus       163 n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  163 NTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             CchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence            9999999999855 66666654 3579999999999999999999995 6999999999999999999999999999865


Q ss_pred             ccCC--cccccCcCCccCCcccc---CCCCCCcccHHhHHHHHHHHHhCCCCCCCCC-chHHHHHHhhcccc-CCCCCCC
Q 038249          166 TFNR--RRTMCGTLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLYGVPPFEAKE-HSDTYRRIVQVDLK-FPPKPIV  238 (281)
Q Consensus       166 ~~~~--~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~  238 (281)
                      ....  .....|-+.|||||.+.   ...|+.++||||||++++||.||..||.+.. .-+....+++.... .+.....
T Consensus       242 lvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gF  321 (391)
T KOG0983|consen  242 LVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGF  321 (391)
T ss_pred             eecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCc
Confidence            5443  34456778999999984   4468889999999999999999999998744 44666666664332 2223348


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +.++.+++..||+.|+.+||.+.++|+|||+..+
T Consensus       322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             CHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            9999999999999999999999999999999876

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.1e-42  Score=283.67  Aligned_cols=250  Identities=18%  Similarity=0.341  Sum_probs=206.7

Q ss_pred             ccCCceecceecccCceEEEEEEEcc-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      .-++|++.+.||+|++|.||.|.++.     ++..+|+|.+....  .......+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            34789999999999999999998753     35679999985432  222345678899999999999999999999998


Q ss_pred             CEEEEEEeccCCCChhHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEe
Q 038249           89 KRVYLILEYAAKGELYKELQKCK----------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIA  158 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~  158 (281)
                      +..++|+||+++++|.+++....          .++...+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999999986532          25678899999999999999999999999999999999999999999


Q ss_pred             eecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccC
Q 038249          159 DFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKF  232 (281)
Q Consensus       159 dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~  232 (281)
                      |||++.......     ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+........... 
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-  240 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL-  240 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence            999875432221     11234668999999988889999999999999999998 78899887776666655544322 


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2233688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.5e-42  Score=286.71  Aligned_cols=253  Identities=23%  Similarity=0.417  Sum_probs=209.7

Q ss_pred             cccccCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGY   84 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~   84 (281)
                      ..+..++|.+.+.||.|++|.||++.+.     .++..+|+|.+....  .....+.+.+|+.+++++ +|+||+++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            3455578999999999999999999863     345679999886442  223346788999999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           85 FYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      +...+..++++||+.+++|.+++....  .+++..+..++.+++.|+++||+.+++|+||+|+||+++.++.++++|||+
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999999987543  389999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCC
Q 038249          163 SVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKP  236 (281)
Q Consensus       163 ~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (281)
                      +.......     ....++..|+|||.+.+..++.++|+||+|+++++|++ |..||......+................
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            75433221     12234668999999988889999999999999999998 9999987766655544444333333334


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ..+.++.+++.+||+++|++|||+.+++.
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            57899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.5e-42  Score=289.04  Aligned_cols=256  Identities=30%  Similarity=0.508  Sum_probs=208.1

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC--
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK--   89 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--   89 (281)
                      ....++|++.+.||.|++|.||+|.++.+++.+++|.+..... .......+.+|+++++.++|||++++++++....  
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            3456889999999999999999999999999999999865432 2222345678999999999999999999987654  


Q ss_pred             --------EEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeee
Q 038249           90 --------RVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADF  160 (281)
Q Consensus        90 --------~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~df  160 (281)
                              .+++|+||+++ ++...+... ..+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence                    78999999987 676766654 46899999999999999999999999999999999999999999999999


Q ss_pred             cCcccccCCc----ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC---
Q 038249          161 GWSVHTFNRR----RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF---  232 (281)
Q Consensus       161 g~~~~~~~~~----~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---  232 (281)
                      |.+.......    ....++..|++||.+.+ ..++.++|+||||+++++|++|.+||...+..+....+.......   
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            9875432221    12234678999998754 456889999999999999999999998766655554433311000   


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          233 -------------------------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       233 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                                               .....+|..+.+++.+||+.||++||++++++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                     0112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.7e-42  Score=280.23  Aligned_cols=241  Identities=25%  Similarity=0.365  Sum_probs=202.2

Q ss_pred             ceecccCceEEEEEEE--ccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccC
Q 038249           22 KPLGRGKFGHVYLARE--KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~--~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      +.||+|++|.||+|.+  ..++..+++|++.... ......+.+.+|+.+++.++|+||+++++++. .+..++|+||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence            3689999999999965  4567889999986443 33445677889999999999999999999875 456789999999


Q ss_pred             CCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc------ccc
Q 038249          100 KGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR------RTM  173 (281)
Q Consensus       100 ~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~------~~~  173 (281)
                      +++|.+++...+.+++..+..++.|++.|+++||++|++|+||+|.||+++.++.++|+|||++.......      ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence            99999999887789999999999999999999999999999999999999999999999999875432221      112


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      .++..|+|||.+....++.++|+||||+++++|++ |..||......+....+..+.. .+....++.++.++|.+||++
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~~~~  237 (257)
T cd05116         159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-MECPQRCPPEMYDLMKLCWTY  237 (257)
T ss_pred             CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHhcc
Confidence            23468999999988888899999999999999997 9999988777666666554432 233346899999999999999


Q ss_pred             CCCCCCChhhhhc
Q 038249          253 DSSQRLPLHKLLE  265 (281)
Q Consensus       253 ~p~~Rps~~eil~  265 (281)
                      ||++||++.+|..
T Consensus       238 ~p~~Rp~~~~i~~  250 (257)
T cd05116         238 GVDERPGFAVVEL  250 (257)
T ss_pred             CchhCcCHHHHHH
Confidence            9999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-42  Score=280.93  Aligned_cols=246  Identities=24%  Similarity=0.445  Sum_probs=206.7

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ..+|++.+.||.|++|.||++.++ ++..+++|.+......    ...+.+|+++++.++|+||+++++++...+..++|
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            356899999999999999999987 4667999998644322    23467799999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc--
Q 038249           95 LEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR--  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~--  171 (281)
                      +||+++++|.+++... ..+++..++.++.||+.|+++||+.|++|+||+|+||+++.++.++++|||.+........  
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999998753 4689999999999999999999999999999999999999999999999998754432211  


Q ss_pred             --cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          172 --TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       172 --~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                        ....+..|+|||.+.+..++.++|+||||++++++++ |..||...+..+....+... ........++.++.+++.+
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHH
Confidence              1122347999999988889999999999999999998 89999887776666555443 2223334689999999999


Q ss_pred             hcccCCCCCCChhhhhcC
Q 038249          249 MLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~  266 (281)
                      ||+.+|++|||+.++++.
T Consensus       237 cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         237 CWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HhcCChhhCcCHHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-42  Score=283.51  Aligned_cols=246  Identities=23%  Similarity=0.402  Sum_probs=210.9

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||.|++|.||+|.+.. +..+++|.+....   ......+.+|+++++.++|+|++++++++...+..++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            3579999999999999999999987 8889999986543   22345678899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--
Q 038249           95 LEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--  170 (281)
                      +||+++++|.+++...  ..++...++.++.+|+.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999999999753  458999999999999999999999999999999999999999999999999875443221  


Q ss_pred             -ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          171 -RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       171 -~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                       ....++..|++||......++.++|+||||+++++|++ |..||......+....+... ...+....++.++.+++.+
T Consensus       161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~  239 (261)
T cd05148         161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIMLE  239 (261)
T ss_pred             ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-CcCCCCCCCCHHHHHHHHH
Confidence             12234567999999988888999999999999999998 89999887777777666543 2334445789999999999


Q ss_pred             hcccCCCCCCChhhhhc
Q 038249          249 MLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~  265 (281)
                      ||..||++|||+.++++
T Consensus       240 ~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         240 CWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HcCCCchhCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-42  Score=294.50  Aligned_cols=254  Identities=31%  Similarity=0.490  Sum_probs=207.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC------C
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ------K   89 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~   89 (281)
                      ++|.+.+.||.|++|.||+|.+..+|+.+|+|.+..... .......+.+|+.+++.++|+||+++++++...      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            789999999999999999999999999999999865432 223345677899999999999999999998754      3


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .+++|++|+.. +|.....  ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            46999999865 6666543  35899999999999999999999999999999999999999999999999998655444


Q ss_pred             cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc-------------------
Q 038249          170 RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD-------------------  229 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------  229 (281)
                      .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...+.......+....                   
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (342)
T cd07879         171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY  250 (342)
T ss_pred             CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHH
Confidence            444456788999999765 457889999999999999999999998766554443322210                   


Q ss_pred             ----ccCC------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          230 ----LKFP------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       230 ----~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                          ...+      ..+..+.++.++|.+||+.||++||++.+++.||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                0000      0124678899999999999999999999999999999764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-42  Score=283.28  Aligned_cols=250  Identities=18%  Similarity=0.324  Sum_probs=209.5

Q ss_pred             cccCCceecceecccCceEEEEEEEccCC-----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSN-----HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      ...++|++.+.||.|++|.||++.++..+     ..+++|.+....  .......+.+|+++++.++|+|++++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            34578999999999999999999987543     789999985443  22334567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEE
Q 038249           88 QKRVYLILEYAAKGELYKELQKC----------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKI  157 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l  157 (281)
                      ....++|+||+++++|.+++...          ..+++..++.++.||+.|+.+||+.+++|+||+|+||+++.++.++|
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            99999999999999999998643          23678899999999999999999999999999999999999999999


Q ss_pred             eeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhcccc
Q 038249          158 ADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLK  231 (281)
Q Consensus       158 ~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  231 (281)
                      +|||++.......     ....++..|+|||.+.+..++.++|+||||++++++++ |..||...+..+......... .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~  239 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG-H  239 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC-C
Confidence            9999875432221     12234678999999988888999999999999999998 999998877777766665432 2


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          232 FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .......+.++.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            2233457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.7e-42  Score=296.43  Aligned_cols=252  Identities=23%  Similarity=0.394  Sum_probs=205.5

Q ss_pred             ccccCCceecceecccCceEEEEEEEccC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRS-----NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYF   85 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~   85 (281)
                      .+..++|++++.||.|+||.||+|.+...     +..||+|++....  .....+.+.+|+.+++++. ||||+++++++
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            34457889999999999999999987533     3469999985443  2333567889999999996 99999999999


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhC-------------------------------------------------------
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKC-------------------------------------------------------  110 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~-------------------------------------------------------  110 (281)
                      ...+..++||||+++++|.+++...                                                       
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            9999999999999999998887542                                                       


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe
Q 038249          111 -----------------------------------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI  149 (281)
Q Consensus       111 -----------------------------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~  149 (281)
                                                               ..+++..+..++.||+.|+.|||+.+++|+||+|+||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill  270 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence                                                     136778889999999999999999999999999999999


Q ss_pred             CCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHH
Q 038249          150 GAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYR  223 (281)
Q Consensus       150 ~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~  223 (281)
                      +.++.++|+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+...
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            99999999999987543221     122335678999999988889999999999999999996 999998765544443


Q ss_pred             HHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          224 RIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .........+....++.++.+++.+||+.||++||++.++.+
T Consensus       351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333332333334468899999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-42  Score=284.98  Aligned_cols=250  Identities=30%  Similarity=0.551  Sum_probs=208.1

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--CEEEEEE
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--KRVYLIL   95 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v~   95 (281)
                      |++.+.||.|++|.||+|.+..+++.+++|.+.... ........+.+|+++++.++|+|++++++++...  +..++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            788999999999999999999999999999997654 2333445678899999999999999999999987  8999999


Q ss_pred             eccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc----
Q 038249           96 EYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~----  170 (281)
                      ||+++ +|.+++... ..+++..++.++.+|+.|+++||+.|++|+||+|+||+++.++.++++|||.+.......    
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            99976 888888765 568999999999999999999999999999999999999999999999999875443321    


Q ss_pred             ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc-----CC-----------
Q 038249          171 RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK-----FP-----------  233 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~-----------  233 (281)
                      ....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+......     ++           
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            22345778999997654 45788999999999999999999999877765554443321000     00           


Q ss_pred             -------------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          234 -------------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       234 -------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                                   ....++.++.+++.+||+.+|.+||+++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                         001138899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.9e-42  Score=287.92  Aligned_cols=249  Identities=26%  Similarity=0.415  Sum_probs=206.5

Q ss_pred             cCCceecceecccCceEEEEEEEcc-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKR-------SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFY   86 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~   86 (281)
                      .++|.+.+.||+|+||.||.+.+..       +...+|+|.+....  .......+.+|+++++.+ +|+||+++++.+.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            3899999999999999999998753       23469999986542  223345678899999999 7999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC
Q 038249           87 DQKRVYLILEYAAKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG  150 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~  150 (281)
                      ..+..++|+||+++++|.+++...+                .++...++.++.|++.||++||++|++|+||+|+||+++
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence            9999999999999999999997642                378889999999999999999999999999999999999


Q ss_pred             CCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHH
Q 038249          151 AQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRR  224 (281)
Q Consensus       151 ~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~  224 (281)
                      .++.++|+|||.+.......     .....++.|+|||.+.+..++.++|+||||+++++|++ |..||......+....
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~  254 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  254 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            99999999999875432211     11123467999999988888999999999999999998 8899987666555555


Q ss_pred             HhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          225 IVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +.... ........+.++.+++.+||..+|++|||+.+++++
T Consensus       255 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         255 LKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHcCC-CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            54432 223334678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.1e-42  Score=285.58  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=208.9

Q ss_pred             cccCCceecceecccCceEEEEEEEccCC----------------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSN----------------HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP   76 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~----------------~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~   76 (281)
                      +...+|++++.||+|+||.||+|.+...+                ..+++|.+.....  ......+.+|++++++++|+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCC
Confidence            34578999999999999999999887544                4578999865432  23456788999999999999


Q ss_pred             ceeeeeeEEEeCCEEEEEEeccCCCChhHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 038249           77 NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-----------YFSERRAATYVASLARALIYCHGKHVIHRDIKPE  145 (281)
Q Consensus        77 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~  145 (281)
                      |++++++++..++..++++|++.+++|.+++....           .+++..++.++.|++.||.+||++|++|+||+|+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            99999999999999999999999999999987655           6899999999999999999999999999999999


Q ss_pred             CeEeCCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh--CCCCCCCCCc
Q 038249          146 NLLIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY--GVPPFEAKEH  218 (281)
Q Consensus       146 Ni~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~  218 (281)
                      ||+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|++  +..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            999999999999999987543222     122334668999999888889999999999999999987  7788887776


Q ss_pred             hHHHHHHhhc------cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          219 SDTYRRIVQV------DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       219 ~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .+.+......      ....+....++.++.+++.+||+.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            6665554322      1112223357899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-42  Score=290.01  Aligned_cols=251  Identities=20%  Similarity=0.346  Sum_probs=208.2

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcE----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHI----VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~----~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      .+...+|++.+.||+|+||.||+|.+..+++.    +|+|.+....  .....+.+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~   80 (316)
T cd05108           3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT   80 (316)
T ss_pred             ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence            34567899999999999999999998766654    8899985432  23345678889999999999999999999876


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      . ..+++++|+.+++|.+.+... ..++...++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence            5 567899999999999998864 45889999999999999999999999999999999999999999999999998654


Q ss_pred             cCCcc-----cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCH
Q 038249          167 FNRRR-----TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       167 ~~~~~-----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
                      .....     ....+..|++||.+.+..++.++|+||||+++|+|++ |..||......+..... ......+..+.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  238 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTI  238 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCH
Confidence            32211     1223567999999988889999999999999999987 99999876665544433 33333444456889


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ++.+++.+||..+|.+||++.+++.+
T Consensus       239 ~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         239 DVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.5e-42  Score=283.77  Aligned_cols=255  Identities=18%  Similarity=0.341  Sum_probs=208.7

Q ss_pred             ccCCceecceecccCceEEEEEEEcc-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ..++|++.+.||.|++|.||+|.++.     .+..+++|.+....  .......+.+|+..++.++|+||+++++++...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            34689999999999999999997652     34579999875443  222334577899999999999999999999998


Q ss_pred             CEEEEEEeccCCCChhHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEe
Q 038249           89 KRVYLILEYAAKGELYKELQKC----------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIA  158 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~  158 (281)
                      +..++||||+.+++|.+++...          ..++...+..++.+++.||.+||++|++|+||+|+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence            9999999999999999999752          235677889999999999999999999999999999999999999999


Q ss_pred             eecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccC
Q 038249          159 DFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKF  232 (281)
Q Consensus       159 dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~  232 (281)
                      |||++.......     ....++..|+|||.+.+..++.++|+||||+++++|++ |..||......+....+..... .
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~  240 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-L  240 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C
Confidence            999875432221     11233567999999988888999999999999999998 7889988777666665544322 2


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc------CCcccc
Q 038249          233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE------HPWIIQ  271 (281)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~------~~~~~~  271 (281)
                      ......+.++.+++.+||+.||++|||+.++++      ||||..
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            222356899999999999999999999999986      777754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.9e-42  Score=285.80  Aligned_cols=250  Identities=21%  Similarity=0.362  Sum_probs=209.8

Q ss_pred             cccCCceecceecccCceEEEEEEEccC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRS-----NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      +.+.+|++.+.||.|++|.||+|.+..+     +..+|+|++....  .......+.+|+.+++.++||||+++++++..
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   79 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK   79 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            4567899999999999999999987643     5779999986443  23345668889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           88 QKRVYLILEYAAKGELYKELQKC----------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                      .+..+++++|+.+++|.+++...                ..++...++.++.|++.||++||++|++|+||+|.||+++.
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence            89999999999999999998532                24788889999999999999999999999999999999999


Q ss_pred             CCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038249          152 QGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRI  225 (281)
Q Consensus       152 ~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~  225 (281)
                      ++.++|+|||++.......     ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+....+
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999875432221     22234678999999988888999999999999999997 88899887777776666


Q ss_pred             hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ...... +....++..+.+++.+||+.+|++||++.+|+.
T Consensus       240 ~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         240 RNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            555432 223468999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-42  Score=279.04  Aligned_cols=240  Identities=24%  Similarity=0.360  Sum_probs=202.3

Q ss_pred             ceecccCceEEEEEEEccCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEecc
Q 038249           22 KPLGRGKFGHVYLAREKRSN---HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYA   98 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   98 (281)
                      +.||+|++|.||+|++...+   ..+++|.+......  .....+.+|+++++.++|+|++++++++. .+..++|+||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            47999999999999887655   78999998765533  34567888999999999999999999876 45679999999


Q ss_pred             CCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCccc------
Q 038249           99 AKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT------  172 (281)
Q Consensus        99 ~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~------  172 (281)
                      ++++|.+++.....+++..++.++.|++.|+++||+.+++|+||+|+||+++.++.++|+|||.+.........      
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            99999999988778999999999999999999999999999999999999999999999999987544222211      


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ..++..|+|||.+.+..++.++|+||||++++++++ |..||...+..+....+.... ..+....++..+.++|.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-RLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhc
Confidence            112357999999988889999999999999999997 999998877766665554443 223344688999999999999


Q ss_pred             cCCCCCCChhhhhc
Q 038249          252 KDSSQRLPLHKLLE  265 (281)
Q Consensus       252 ~~p~~Rps~~eil~  265 (281)
                      ++|++||++.+++.
T Consensus       237 ~~p~~Rp~~~~l~~  250 (257)
T cd05060         237 YRPEDRPTFSELES  250 (257)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.3e-42  Score=280.31  Aligned_cols=244  Identities=23%  Similarity=0.426  Sum_probs=206.2

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE-eCCEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY-DQKRVY   92 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~   92 (281)
                      .+.+|++.+.||+|++|.||++...  +..+++|.+....     ....+.+|+.++++++|+|++++++++. ..+..+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            4578999999999999999999876  7789999984332     2356788999999999999999999764 456789


Q ss_pred             EEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           93 LILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      +++||+++++|.+++...+  .+++..++.++.+++.||++||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999999999999987643  37899999999999999999999999999999999999999999999999886544444


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM  249 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  249 (281)
                      .....+..|+|||.+.+..++.++|+||||+++++|++ |..||......+....+... ........++..+.+++.+|
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~  235 (256)
T cd05082         157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQC  235 (256)
T ss_pred             CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHH
Confidence            44445668999999988889999999999999999997 99999877666665555443 22233346889999999999


Q ss_pred             cccCCCCCCChhhhhc
Q 038249          250 LVKDSSQRLPLHKLLE  265 (281)
Q Consensus       250 l~~~p~~Rps~~eil~  265 (281)
                      |+.+|++|||+.++++
T Consensus       236 l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         236 WHLDAATRPSFLQLRE  251 (256)
T ss_pred             hcCChhhCcCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-42  Score=293.01  Aligned_cols=254  Identities=28%  Similarity=0.422  Sum_probs=205.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-------
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-------   88 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-------   88 (281)
                      .+|++.+.||.|++|.||+|.+..+++.+++|.+.....   ...+.+.+|+++++.++||||+++++.+...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            689999999999999999999999999999999865442   3345678899999999999999999876543       


Q ss_pred             -------CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-CCcEEEeee
Q 038249           89 -------KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-QGELKIADF  160 (281)
Q Consensus        89 -------~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-~~~~~l~df  160 (281)
                             ...++|+||+++ +|.+.+.. ..+++..++.++.||+.|+.+||+.|++|+||+|+||+++. ++.++++||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          82 VGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                   357899999975 88888765 35899999999999999999999999999999999999975 457899999


Q ss_pred             cCcccccCC------cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc---
Q 038249          161 GWSVHTFNR------RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL---  230 (281)
Q Consensus       161 g~~~~~~~~------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---  230 (281)
                      |.+......      .....++..|+|||.+.. ..++.++|+||||+++++|++|..||...+..+..........   
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            987543211      122346778999998643 5578899999999999999999999987665554443322100   


Q ss_pred             --------------------c--CC---CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          231 --------------------K--FP---PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       231 --------------------~--~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                                          .  .+   ..+.++.++.++|.+||++||++|||+.+++.||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence                                0  00   01247788999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-42  Score=279.51  Aligned_cols=246  Identities=23%  Similarity=0.378  Sum_probs=207.6

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||.|++|.||+|.+. +++.+++|.+......    .+.+.+|++++++++|+|++++++++...+..++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            3467999999999999999999976 4567999998654322    3457789999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           94 ILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      ++||+.+++|.+++....  .++...+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999999997654  68999999999999999999999999999999999999999999999999875433221 


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                         .....+..|+|||...+..++.++|+||||+++++|++ |..||...........+... ...+.....+.++.+++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  237 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKELYDIM  237 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHH
Confidence               11122357999999988889999999999999999998 99999887776666555433 22333446889999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      .+||+.+|++||++.+++.
T Consensus       238 ~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         238 LDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHhhcCcccCCCHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-43  Score=297.47  Aligned_cols=260  Identities=33%  Similarity=0.605  Sum_probs=236.5

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      ...+..|.+.+.||.|.|++|.++++..++..||+|.++++...... .+++.+|+++++.+.||||++++.+......+
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            34567899999999999999999999999999999999888765544 45589999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc--CC
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF--NR  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~--~~  169 (281)
                      ++||||+.++.+.+++.+.+...+..+..++.|+..|++|||+++|+|+||+++|++++.+-++||+|||++....  .-
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence            9999999999999999998888889999999999999999999999999999999999999999999999985543  33


Q ss_pred             cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                      ....+|++.|.|||++.+..+ ++..|+|++|+++|.|..|.+||++.+-.+.....+.+++..+.  .++.++.++|++
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~--~ms~dce~lLrk  288 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF--YMSCDCEDLLRK  288 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc--eeechhHHHHHH
Confidence            466789999999999988886 57899999999999999999999999998888888888777766  589999999999


Q ss_pred             hcccCCCCCCChhhhhcCCccccCCC
Q 038249          249 MLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      +|-.+|.+|++.++|++|.|+....+
T Consensus       289 ~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  289 FLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             hhccCccccCCHHHhhhhcccchhhh
Confidence            99999999999999999999986633

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.5e-42  Score=290.87  Aligned_cols=243  Identities=28%  Similarity=0.513  Sum_probs=188.0

Q ss_pred             cceecccCceEEEEEEEcc--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--CCEEEEEEe
Q 038249           21 GKPLGRGKFGHVYLAREKR--SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--QKRVYLILE   96 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v~e   96 (281)
                      +..||.|+||+||+|+++.  ++..+|+|.+.....     ...+.+|+.++++++||||+++++++..  +...++|+|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            4689999999999999764  567899998854321     2346789999999999999999999854  567899999


Q ss_pred             ccCCCChhHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe----CCCCcEEEeeecCc
Q 038249           97 YAAKGELYKELQKC---------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI----GAQGELKIADFGWS  163 (281)
Q Consensus        97 ~~~~~~L~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~----~~~~~~~l~dfg~~  163 (281)
                      |+++ +|.+.+...         ..+++..++.++.||+.||.+||+.|++|+||+|+||++    +.++.++|+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            9976 777776421         247899999999999999999999999999999999999    45678999999998


Q ss_pred             ccccCC------cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCch---------HHHHHHhh
Q 038249          164 VHTFNR------RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS---------DTYRRIVQ  227 (281)
Q Consensus       164 ~~~~~~------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~  227 (281)
                      ......      .....+++.|+|||.+.+ ..++.++||||||+++++|++|.+||......         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            543322      122356889999999865 45788999999999999999999999653321         00100000


Q ss_pred             c-----------------------cc---c----------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          228 V-----------------------DL---K----------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       228 ~-----------------------~~---~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      .                       ..   .          .......+..+.++|.+||..||++|||++|+|.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0                       00   0          00011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5e-42  Score=279.34  Aligned_cols=241  Identities=24%  Similarity=0.410  Sum_probs=204.6

Q ss_pred             ceecccCceEEEEEEEccC-Cc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEecc
Q 038249           22 KPLGRGKFGHVYLAREKRS-NH--IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYA   98 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~-~~--~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   98 (281)
                      +.||.|++|.||+|.+..+ +.  .+++|.+......  ...+.+.+|++.+++++|+||+++++.+.. ...++++||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            4689999999999998753 32  5899998665433  456778899999999999999999999988 8899999999


Q ss_pred             CCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC------c
Q 038249           99 AKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR------R  170 (281)
Q Consensus        99 ~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~------~  170 (281)
                      ++++|.+.+....  .+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++......      .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999997754  6899999999999999999999999999999999999999999999999987544221      1


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM  249 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  249 (281)
                      ....++..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+.............|.++.+++.+|
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  237 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC  237 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence            12335678999999988889999999999999999998 99999887777766665543333333446789999999999


Q ss_pred             cccCCCCCCChhhhhc
Q 038249          250 LVKDSSQRLPLHKLLE  265 (281)
Q Consensus       250 l~~~p~~Rps~~eil~  265 (281)
                      |+.+|++|||+.++++
T Consensus       238 l~~~p~~Rps~~~~~~  253 (257)
T cd05040         238 WAHNPADRPTFAALRE  253 (257)
T ss_pred             CCCCcccCCCHHHHHH
Confidence            9999999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.1e-42  Score=291.33  Aligned_cols=254  Identities=23%  Similarity=0.374  Sum_probs=204.4

Q ss_pred             cceeccc--CceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEecc
Q 038249           21 GKPLGRG--KFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYA   98 (281)
Q Consensus        21 ~~~ig~g--~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   98 (281)
                      ...||.|  ++++||.+++..+|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            3566767  88999999999999999999987654333 34577889999999999999999999999999999999999


Q ss_pred             CCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC--------
Q 038249           99 AKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN--------  168 (281)
Q Consensus        99 ~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~--------  168 (281)
                      .++++.+++...  ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++++||+.......        
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            999999998864  3489999999999999999999999999999999999999999999999975321111        


Q ss_pred             --CcccccCcCCccCCccccC--CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc--------------
Q 038249          169 --RRRTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL--------------  230 (281)
Q Consensus       169 --~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------  230 (281)
                        ......++..|++||.+.+  ..++.++|+||||+++++|++|..||......+..........              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence              0111224567999999865  3467899999999999999999999987665444333222110              


Q ss_pred             -------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          231 -------------------------------KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       231 -------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                                     ..+....++.++.+++++||+.||++|||+.++++||||.+..+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                                           011112356789999999999999999999999999999876543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.1e-42  Score=282.87  Aligned_cols=249  Identities=23%  Similarity=0.445  Sum_probs=209.0

Q ss_pred             cccCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      +...+|+..+.||+|++|.||++...     .++..+++|.+...   .......+.+|++.++.++|+||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            45678999999999999999999753     34667888887533   23345678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK---------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ  152 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~---------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~  152 (281)
                      .+..++++||+++++|.+++...+               .+++..++.++.||+.|+++||+.|++|+||+|+||+++.+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            999999999999999999987643               37889999999999999999999999999999999999999


Q ss_pred             CcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHh
Q 038249          153 GELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIV  226 (281)
Q Consensus       153 ~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~  226 (281)
                      +.++|+|||++.......     ....+++.|+|||.+.+..++.++|+||||+++++|++ |.+||......+......
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            999999999875432221     12224578999999988889999999999999999998 999998777777666665


Q ss_pred             hccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          227 QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .... ......++..+.+++.+||+.||++||+++|+++
T Consensus       239 ~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 QGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             cCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            5432 2233468899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-43  Score=296.22  Aligned_cols=256  Identities=28%  Similarity=0.483  Sum_probs=222.8

Q ss_pred             hccccc--CCceecceecccCceEEEEEEEccCCc---E-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeee
Q 038249           10 KKRWTL--NDFDIGKPLGRGKFGHVYLAREKRSNH---I-VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG   83 (281)
Q Consensus        10 ~~~~~~--~~y~~~~~ig~g~~~~v~~~~~~~~~~---~-~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~   83 (281)
                      +..|.+  ++-.+.+.||+|+||.||.|..+..+.   . ||+|....+..........+.+|++++++++||||++++|
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            445555  566678999999999999999875422   3 8999987644455667888999999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           84 YFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        84 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      +.....-+++|||+|.||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-.+|++++.++.+|++|||+
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            9999999999999999999999999876 499999999999999999999999999999999999999999999999999


Q ss_pred             ccccc--CCcc-cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCC
Q 038249          163 SVHTF--NRRR-TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIV  238 (281)
Q Consensus       163 ~~~~~--~~~~-~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (281)
                      +....  .... ...-+..|+|||.+....++.++||||+|+++||+++ |..||.+....+....+....+..+.+...
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~  388 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKT  388 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCC
Confidence            86543  1112 2234678999999999999999999999999999997 889999999999998886665666666689


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      |.++..++.+|+..+|++||++.++.+
T Consensus       389 p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  389 PKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHHHhccCChhhccCHHHHHH
Confidence            999999999999999999999988874

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.6e-42  Score=284.82  Aligned_cols=261  Identities=28%  Similarity=0.491  Sum_probs=209.9

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQ   88 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~   88 (281)
                      ...+..++|++.+.||.|++|+||+|.+..+++.+++|.+......  .....+..++..+.+. +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            3456779999999999999999999999988999999998654322  2234455566656555 599999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           89 KRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      ...++++||+.+ ++.+++.. ..++++..+..++.+|+.|+++||+ .|++|+||+|+||+++.++.++|+|||.+...
T Consensus        87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            999999999865 77777655 4568999999999999999999997 59999999999999999999999999987543


Q ss_pred             cCC--cccccCcCCccCCccccCCC----CCCcccHHhHHHHHHHHHhCCCCCCCCCc-hHHHHHHhhcc-ccCCCCCCC
Q 038249          167 FNR--RRTMCGTLDYLPPEMVESVE----HDANVDIWSLGVLCYEFLYGVPPFEAKEH-SDTYRRIVQVD-LKFPPKPIV  238 (281)
Q Consensus       167 ~~~--~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~-~~~~~~~~~  238 (281)
                      ...  .....++..|+|||.+.+..    ++.++|+||||+++++|++|..||..... .+......... ...+....+
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF  245 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCC
Confidence            222  22234677899999986543    77899999999999999999999976433 23333333332 222233357


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +.++.+++.+||+.||++||++++++.||||++..
T Consensus       246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            89999999999999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-42  Score=280.43  Aligned_cols=247  Identities=21%  Similarity=0.358  Sum_probs=205.5

Q ss_pred             ceecceecccCceEEEEEEEccC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE----
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRS---NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR----   90 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~----   90 (281)
                      |++++.||+|+||.||.|....+   +..+|+|.+...... ......+.+|+..++.++|+|++++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            67889999999999999998754   377999998654322 3335678889999999999999999998866443    


Q ss_pred             --EEEEEeccCCCChhHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           91 --VYLILEYAAKGELYKELQKC------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        91 --~~~v~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                        .++++||+++++|...+...      ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999999888532      2589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCC
Q 038249          163 SVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKP  236 (281)
Q Consensus       163 ~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (281)
                      +.......     .....+..|++||.+.+..++.++|+||||+++++|++ |..||......+....+..+.. .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~  238 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR-LKQPE  238 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCc
Confidence            75443221     11224567999999988889999999999999999998 9999988877777766655432 22334


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .++.++.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         239 DCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.4e-42  Score=284.49  Aligned_cols=252  Identities=25%  Similarity=0.423  Sum_probs=210.3

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCC-----cEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSN-----HIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYF   85 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~   85 (281)
                      .+.-++|++.+.||+|++|.||++.++..+     ..+++|.+....  .......+.+|+++++++ +|+||+++++++
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            445578999999999999999999987433     679999986542  223345688899999999 899999999999


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKC----------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI  149 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~  149 (281)
                      ..++..++++||+.+++|.++++..                ..+++..++.++.||+.|+.+||+.|++|+||+|+||++
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~  165 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV  165 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence            9999999999999999999998642                358899999999999999999999999999999999999


Q ss_pred             CCCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHH
Q 038249          150 GAQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYR  223 (281)
Q Consensus       150 ~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~  223 (281)
                      +.++.++|+|||.+.......     ....++..|+|||.+.+..++.++|+||||++++++++ |..||......+...
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            999999999999875433221     11223567999999988889999999999999999997 999998877766666


Q ss_pred             HHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          224 RIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .+.... ........+.++.+++.+||..||++|||+.|++++
T Consensus       246 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKEGY-RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            555443 223334678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-42  Score=284.21  Aligned_cols=250  Identities=33%  Similarity=0.531  Sum_probs=208.1

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEec
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEY   97 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   97 (281)
                      |++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|++++++++|+|++++++++..++..++++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            67889999999999999999999999999998655432 23456778899999999999999999999999999999999


Q ss_pred             cCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---ccc
Q 038249           98 AAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---RTM  173 (281)
Q Consensus        98 ~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---~~~  173 (281)
                      +++ ++.+.+.. ..++++..++.++.+|+.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            976 78777765 3578999999999999999999999999999999999999999999999999875443322   223


Q ss_pred             cCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-------------------cC-
Q 038249          174 CGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-------------------KF-  232 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~-  232 (281)
                      .++..|.|||.+.+. .++.++|+||||+++++|++|+.||...+..+..........                   .. 
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            467789999998766 688899999999999999999999987776554433221100                   00 


Q ss_pred             --------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          233 --------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       233 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                              ...+.++.++.++|.+||++||.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                    0112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.5e-42  Score=279.33  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=208.9

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ..++|++.+.||.|++|.||+|.++.++.   .+++|.+....  .......+.+|+..+++++||||+++++++..++.
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            35689999999999999999999875543   68999886543  22335678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           91 VYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .++|+||+++++|.+++... +.++...++.++.+++.|+++||+.|++|+||+|+||+++.++.++++|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999998764 46899999999999999999999999999999999999999999999999987543322


Q ss_pred             cc------cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHH
Q 038249          170 RR------TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       170 ~~------~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                      ..      ....+..|++||.+.+..++.++|+||||++++++++ |..||......+....+... ...+....++.++
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAAL  238 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHHH
Confidence            11      1112457999999988889999999999999999886 99999887776666655543 2333444688999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .+++.+||+.+|.+||++.++++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         239 HQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHcccCchhCCCHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-41  Score=280.31  Aligned_cols=250  Identities=18%  Similarity=0.306  Sum_probs=205.1

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      .+...+|++.+.||.|++|+||+|.+..+++    .+++|.+....  .......+..++..+++++||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~   80 (279)
T cd05111           3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG   80 (279)
T ss_pred             cCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence            3566889999999999999999999987776    36677764321  22334567788888999999999999998764


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                       ...++++||+++++|.+++... +.+++..+..++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence             4567899999999999999764 56899999999999999999999999999999999999999999999999988543


Q ss_pred             cCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCH
Q 038249          167 FNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       167 ~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
                      ....     ....++..|++||.+.+..++.++|+||||+++|++++ |..||...........+.... ..+....++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  238 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-RLAQPQICTI  238 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCCCCCCCCH
Confidence            2221     12335668999999988889999999999999999998 999998776665544444332 2233335788


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhc
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ++.+++.+||..||++|||+.|+++
T Consensus       239 ~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         239 DVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-43  Score=307.63  Aligned_cols=260  Identities=23%  Similarity=0.321  Sum_probs=195.0

Q ss_pred             cCCceecceecccCceEEEEEEEccCCc-EEEEE--------------EeecccccchHHHHHHHHHHHHHHhCCCCcee
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNH-IVALK--------------VLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL   79 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~-~~~lK--------------~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~   79 (281)
                      .++|++++.||+|+||+||++..+.... ..+.|              .+.............+.+|++++++++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4789999999999999999987653321 12222              11111111223455678999999999999999


Q ss_pred             eeeeEEEeCCEEEEEEeccCCCChhHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc
Q 038249           80 RLYGYFYDQKRVYLILEYAAKGELYKELQKC-----KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE  154 (281)
Q Consensus        80 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~  154 (281)
                      ++++++...+..+++++++.+ +|.+++...     .......++.++.||+.||.|||++||+|+||||+||+++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            999999999999999999965 676666432     22346678889999999999999999999999999999999999


Q ss_pred             EEEeeecCcccccCC----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCC-CCCCCc--hHHHHHHhh
Q 038249          155 LKIADFGWSVHTFNR----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPP-FEAKEH--SDTYRRIVQ  227 (281)
Q Consensus       155 ~~l~dfg~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p-~~~~~~--~~~~~~~~~  227 (281)
                      ++|+|||++......    .....++..|+|||.+.+..++.++|||||||++++|++|..+ +.....  ......+..
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~  385 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID  385 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence            999999998654322    1234689999999999988899999999999999999998754 433221  111111111


Q ss_pred             c----cccCC--------------------------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          228 V----DLKFP--------------------------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       228 ~----~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      .    ...++                          ....++.++.++|.+||+.||++|||+.|+|.||||....+.
T Consensus       386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~  463 (501)
T PHA03210        386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEE  463 (501)
T ss_pred             hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCch
Confidence            0    00000                          001356778889999999999999999999999999876443

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-41  Score=280.75  Aligned_cols=249  Identities=20%  Similarity=0.347  Sum_probs=207.1

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      +..++|++.+.||.|++|+||+|.+..+++    .||+|.+....  .......+.+|+.+++.+.|+|++++++++...
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence            456789999999999999999999887776    47899885433  233456788899999999999999999998754


Q ss_pred             CEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           89 KRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                       ..+++++|+++++|.+.+... +.+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence             567899999999999999764 468999999999999999999999999999999999999999999999999875443


Q ss_pred             CCcc-----cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          168 NRRR-----TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       168 ~~~~-----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                      ....     ...+++.|++||...+..++.++||||||+++++|++ |..||......+....+.... ..+....++.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  239 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLPQPPICTID  239 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCCCCccCCHH
Confidence            2211     1223567999999988889999999999999999998 999998776665555444332 23334568899


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhc
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +.+++.+||..||++||++.++++
T Consensus       240 ~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999994

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.7e-42  Score=287.68  Aligned_cols=253  Identities=31%  Similarity=0.504  Sum_probs=202.4

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC------
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ------   88 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------   88 (281)
                      +++|++.+.||.|++|.||+|.++.+++.+++|.+....... .......+|++.++.++|+||+++++++...      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            689999999999999999999999999999999986543222 1223467899999999999999999987543      


Q ss_pred             --CEEEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           89 --KRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        89 --~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                        ..+++|++|+.+ ++...+.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence              356999999976 67666654 45699999999999999999999999999999999999999999999999998754


Q ss_pred             ccCCcc--------------cccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc
Q 038249          166 TFNRRR--------------TMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL  230 (281)
Q Consensus       166 ~~~~~~--------------~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (281)
                      ......              ...+++.|+|||.+.+ ..++.++|+||||+++++|++|.+||...+.......+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            322111              1134677999998754 4578899999999999999999999987776655444322100


Q ss_pred             cC-----------------------C-----CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          231 KF-----------------------P-----PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       231 ~~-----------------------~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ..                       +     .....+.++.++|.+||+.||++|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            00                       0     001245678999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1e-41  Score=280.27  Aligned_cols=250  Identities=27%  Similarity=0.470  Sum_probs=211.9

Q ss_pred             cCCceecceecccCceEEEEEEEccC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRS-----NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      .++|++.+.||.|++|.||+|+.+.+     ...+++|.+....  .......+.+|++++++++|+|++++++++.+.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            46899999999999999999997643     4568899875432  2234567889999999999999999999999888


Q ss_pred             EEEEEEeccCCCChhHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeee
Q 038249           90 RVYLILEYAAKGELYKELQKCK---------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADF  160 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~df  160 (281)
                      ..++|+||+++++|.+++....         .+++..+..++.+++.||++||+.|++|+||+|+||+++.++.++++||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999998655         6899999999999999999999999999999999999999999999999


Q ss_pred             cCcccccCC----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCC
Q 038249          161 GWSVHTFNR----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPK  235 (281)
Q Consensus       161 g~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (281)
                      |++......    .....++..|++||.+.+...+.++|+||||++++++++ |..||...................+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            987543222    122234667999999888888899999999999999998 888998777766666665555555555


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ..++..+.+++.+||..+|++|||+.+++..
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            5789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-41  Score=276.77  Aligned_cols=245  Identities=27%  Similarity=0.463  Sum_probs=210.0

Q ss_pred             ceecceecccCceEEEEEEEccCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSN----HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~----~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      +++.+.||.|++|.||++++..++    ..+++|.+......  .....+..|+..++.++|+||+++++++...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            467899999999999999999766    88999999654322  245678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc
Q 038249           94 ILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR  171 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~  171 (281)
                      ++||+++++|.+.+.....  +++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999986554  89999999999999999999999999999999999999999999999998754433211


Q ss_pred             ----cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          172 ----TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       172 ----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                          ...+++.|++||......++.++|+||||+++++|++ |.+||...+..+..+........ .....++.++.+++
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i  237 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL-PKPENCPPEIYKLM  237 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-CCCCcCCHHHHHHH
Confidence                1225678999999988888999999999999999998 88999887777777766654432 23335899999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      .+||..||++|||+.++++
T Consensus       238 ~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      238 LQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHCcCChhhCcCHHHHHh
Confidence            9999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-41  Score=277.63  Aligned_cols=244  Identities=23%  Similarity=0.400  Sum_probs=204.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||.|++|.||+|..+ +++.+++|.+......    ...+.+|+.++++++|+|++++++++. .+..+++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            468999999999999999999876 5678999998654432    245778999999999999999999874 4578999


Q ss_pred             EeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--
Q 038249           95 LEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--  170 (281)
                      +||+.+++|.+.+...  ..++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++++|||.+.......  
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999999988653  458999999999999999999999999999999999999999999999999875433111  


Q ss_pred             --ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          171 --RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       171 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                        ....++..|+|||.+....++.++|+||||++++++++ |..||...+..+....+... ...+.....+.++.+++.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~  237 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPRPDNCPEELYELMR  237 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCHHHHHHHH
Confidence              12234568999999988888999999999999999998 99999887776666555433 223334468899999999


Q ss_pred             HhcccCCCCCCChhhhhc
Q 038249          248 QMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~  265 (281)
                      +||+.+|++||+++++++
T Consensus       238 ~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         238 LCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHccCChhhCCCHHHHHH
Confidence            999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=288.55  Aligned_cols=262  Identities=29%  Similarity=0.465  Sum_probs=229.9

Q ss_pred             hhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249            8 KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus         8 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      -+...++.+.|+.-++||+|+||.|+.+.-+.+|+.+|.|.+.+.++.......-..+|-++++++..+.||.+--.|+.
T Consensus       177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT  256 (591)
T KOG0986|consen  177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET  256 (591)
T ss_pred             HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence            34567888999999999999999999999999999999999988777766667778899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                      .+.+++|+..++||+|.-.+-+.+  .+++..+..++.+|+.||++||+.+|+.||+||+||++|..|+++|+|+|++..
T Consensus       257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence            999999999999999966664433  599999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCc--ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc----hHHHHHHhhccccCCCCCCCC
Q 038249          166 TFNRR--RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH----SDTYRRIVQVDLKFPPKPIVS  239 (281)
Q Consensus       166 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~  239 (281)
                      .....  ....||.+|||||++.+..|+...|.|||||++|+|+.|+.||.....    .+.-+.+......++  ...+
T Consensus       337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~--~kFS  414 (591)
T KOG0986|consen  337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS--DKFS  414 (591)
T ss_pred             cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--cccC
Confidence            65443  334799999999999999999999999999999999999999965333    244444555544454  4799


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----hhhhhcCCcccc
Q 038249          240 SAAKDLISQMLVKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      ++.+++.+.+|+.||.+|.-     +.++.+||||++
T Consensus       415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            99999999999999999984     679999999986

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.7e-41  Score=278.54  Aligned_cols=247  Identities=23%  Similarity=0.387  Sum_probs=203.2

Q ss_pred             ceecceecccCceEEEEEEEccCCc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC------C
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNH--IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ------K   89 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~--~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~   89 (281)
                      |.+++.||.|++|.||+|.+..++.  .+|+|.+.... ......+.+..|+..++.++|+||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            4578999999999999999987765  58999886543 2334456788899999999999999999987532      2


Q ss_pred             EEEEEEeccCCCChhHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           90 RVYLILEYAAKGELYKELQK------CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      ..++++||+.+++|.+.+..      ...+++..+..++.||+.|++|||++|++|+||+|+||+++.++.++|+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            46899999999999888742      134789999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCC
Q 038249          164 VHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPI  237 (281)
Q Consensus       164 ~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (281)
                      .......     .....++.|++||.+.+..++.++|+||||+++++|++ |..||......+....+..+.. .+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~  238 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-LKQPPD  238 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Confidence            6543221     12235668999999988889999999999999999998 8999988777666666555432 223346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          238 VSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ++..+.++|.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            88999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=281.27  Aligned_cols=250  Identities=28%  Similarity=0.493  Sum_probs=203.9

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeeeeeEEEeCCE----
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL---RHPNILRLYGYFYDQKR----   90 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~---~h~~i~~~~~~~~~~~~----   90 (281)
                      |++.+.||.|++|.||+|+++.+++.+++|.+...... ......+.+|+.+++++   +|+|++++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            78899999999999999999988999999999654332 22234455676666555   69999999999987766    


Q ss_pred             -EEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           91 -VYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        91 -~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                       .++++|++.+ +|.+++....  .+++..++.++.+++.||.+||+.+++|+|++|+||+++.++.++|+|||.+....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999976 7888887643  48999999999999999999999999999999999999999999999999875432


Q ss_pred             CC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-----cCC-------
Q 038249          168 NR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-----KFP-------  233 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~-------  233 (281)
                      ..  .....++..|+|||.+.+..++.++|+||||+++++|++|.+||......+....+.....     .++       
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            22  1223467789999999888899999999999999999999999988777666555433110     000       


Q ss_pred             ----C---------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          234 ----P---------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       234 ----~---------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                          .         .+..+..+.++|.+||+.||++||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                0         01345778999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.2e-41  Score=277.30  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=209.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ..++|+..+.||+|++|.||+|.++.++.   .+++|.+....  .....+.+..|++++++++|+|++++.+++...+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            45689999999999999999999886654   68899885442  22335668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           91 VYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .++|+||+++++|.+++... +.+++..+..++.+++.|+++||+.|++|+||+|+||+++.++.++++|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999998753 56899999999999999999999999999999999999999999999999987544322


Q ss_pred             ccc------ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHH
Q 038249          170 RRT------MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       170 ~~~------~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                      ...      ...+..|+|||.+.+..++.++|+||||++++++++ |..||...+..+....+... ...+.....+.++
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  239 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAPMDCPSAV  239 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCCCCCCCHHH
Confidence            111      112346999999988888999999999999999987 99999877776666666543 2333444688999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .+++.+||+.+|++||++.+++.
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=312.12  Aligned_cols=250  Identities=25%  Similarity=0.454  Sum_probs=218.7

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCc-----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNH-----IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~-----~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      +.-...+....||+|.||.||.|.......     .||+|.+.+.  .+.+....+.+|..++++++||||++++|++.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            444667888999999999999999775433     3888888654  355667889999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeee
Q 038249           88 QKRVYLILEYAAKGELYKELQKC-------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADF  160 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~df  160 (281)
                      .+..++++||++||+|..++++.       ..++..+++.++.+|++|+.||++++++|+||..+|+|++....+|+.||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999876       24899999999999999999999999999999999999999999999999


Q ss_pred             cCcccccCCccc-----ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCC
Q 038249          161 GWSVHTFNRRRT-----MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPP  234 (281)
Q Consensus       161 g~~~~~~~~~~~-----~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (281)
                      |+++........     ..-+..|||||.+..+.++.++||||||+++||+++ |..||...++.+.....+.+. ..++
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~  925 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDP  925 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCC
Confidence            999744333211     123568999999999999999999999999999996 999999999999988665554 5666


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          235 KPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +.++|+.+.+++.+||+.+|++||++.+|++
T Consensus       926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            6689999999999999999999999999997

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.7e-41  Score=278.14  Aligned_cols=249  Identities=23%  Similarity=0.392  Sum_probs=209.2

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ..++|++.+.||.|++|.||+|.++.++.   .+++|.+....  .......+..|+..++.++||||+++.+++..++.
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            45679999999999999999999987664   59999986432  23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           91 VYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .++|+||+++++|.+++... +.++...++.++.|++.|+.+||++|++|+||+|+||+++.++.++++|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999999998763 56899999999999999999999999999999999999999999999999987543221


Q ss_pred             ccc-----cc---CcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCH
Q 038249          170 RRT-----MC---GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       170 ~~~-----~~---~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
                      ...     ..   .+..|++||.+.+..++.++|+||||++++++++ |..||......+....+... ...+....++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~  238 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPPPMDCPT  238 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCcccCCH
Confidence            110     11   1346999999988889999999999999999885 99999887776666555332 33444456889


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhc
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ++.+++.+||..+|++||++++++.
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         239 ALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.4e-42  Score=288.47  Aligned_cols=256  Identities=30%  Similarity=0.508  Sum_probs=207.7

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeC--CE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQ--KR   90 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~   90 (281)
                      ..++|++.+.||.|++|.||+|.+..+++.+++|++...... ......+..|+.+++++ +|+||+++++++...  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            347899999999999999999999989999999998543222 22334567899999999 999999999998643  46


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      .++|+||+++ +|..++... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        84 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          84 IYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             EEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            8999999975 898888775 68899999999999999999999999999999999999999999999999875432221


Q ss_pred             --------ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-----------
Q 038249          171 --------RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-----------  230 (281)
Q Consensus       171 --------~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------  230 (281)
                              ....++..|+|||.+.+ ..++.++|+||||+++++|++|..||......+....+.....           
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence                    12346788999998744 4578899999999999999999999977655544332211100           


Q ss_pred             --------------c----CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          231 --------------K----FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       231 --------------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                                    .    ....+.++.++.++|.+||+.||++|||+.++++|||+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                          0    00112368899999999999999999999999999999866

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-41  Score=275.84  Aligned_cols=246  Identities=25%  Similarity=0.440  Sum_probs=208.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||.|++|.||+|.+. ++..+++|.+......    ...+.+|+..+++++|+|++++++++......++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            4578999999999999999999976 4577999998654322    3457889999999999999999999998889999


Q ss_pred             EEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           94 ILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      ++||+++++|.+++...  ..++...+..++.+++.|+.+||++|++|+||+|+||+++.++.++++|||.+......  
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999999999764  35899999999999999999999999999999999999999999999999987543321  


Q ss_pred             --cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          170 --RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                        ......+..|+|||.+.+...+.++|+||||++++++++ |..||...+.......+... ...+.....+.++.+++
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i  237 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPPNCPEELYDLM  237 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHH
Confidence              112223567999999988888999999999999999998 99999887776666665543 22333345789999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      .+||+.+|++||+++++++
T Consensus       238 ~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         238 LQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHcccCcccCCCHHHHHH
Confidence            9999999999999999873

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=282.06  Aligned_cols=249  Identities=22%  Similarity=0.396  Sum_probs=203.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCC--------------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceee
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSN--------------HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILR   80 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~--------------~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~   80 (281)
                      -++|++.+.||+|++|.||++.+..++              ..+++|.+....  .......+.+|++++++++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            468999999999999999999876432              358999986442  2334567889999999999999999


Q ss_pred             eeeEEEeCCEEEEEEeccCCCChhHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeE
Q 038249           81 LYGYFYDQKRVYLILEYAAKGELYKELQKCK------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLL  148 (281)
Q Consensus        81 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~  148 (281)
                      +++++...+..++||||+.+++|.+++....            .+++..++.++.+++.|+++||+.|++|+||+|+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999886432            3678899999999999999999999999999999999


Q ss_pred             eCCCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh--CCCCCCCCCchHH
Q 038249          149 IGAQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY--GVPPFEAKEHSDT  221 (281)
Q Consensus       149 ~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~  221 (281)
                      ++.++.++|+|||++.......     ....++..|+|||.+.+..++.++|+||||+++++|++  +..||......+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            9999999999999875432221     11223568999999888889999999999999999987  6778887766665


Q ss_pred             HHHHhhc-----c-ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          222 YRRIVQV-----D-LKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       222 ~~~~~~~-----~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .......     . ......+..+..+.+++.+||+.||++|||+++|+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            5443221     1 112223457899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-41  Score=277.18  Aligned_cols=244  Identities=23%  Similarity=0.422  Sum_probs=203.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||.|++|.||+|.+..+ ..+++|.+......    ...+.+|+++++.++|+|++++++.+.. ...++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv   78 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   78 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence            36899999999999999999998755 45999998653321    2457889999999999999999998754 567899


Q ss_pred             EeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--
Q 038249           95 LEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--  170 (281)
                      +||+++++|.+++...  ..+++..++.++.+++.||++||+.+++|+||+|.||+++.++.++|+|||.+.......  
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999999999753  357899999999999999999999999999999999999999999999999875432222  


Q ss_pred             --ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          171 --RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       171 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                        ....++..|+|||...+..++.++|+||||+++++|++ |..||......+....+.... ..+....++.++.+++.
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  237 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPESLHDLMC  237 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CCCCccccCHHHHHHHH
Confidence              12234567999999988889999999999999999999 888998777666665544332 22333468899999999


Q ss_pred             HhcccCCCCCCChhhhhc
Q 038249          248 QMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~  265 (281)
                      +||+.+|++||++.+++.
T Consensus       238 ~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         238 QCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHccCCcccCCCHHHHHH
Confidence            999999999999999885

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-41  Score=291.75  Aligned_cols=254  Identities=24%  Similarity=0.394  Sum_probs=207.7

Q ss_pred             cccccCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGY   84 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~   84 (281)
                      .....++|.+.+.||.|+||.||+|.+.     .++..||+|++.....  ....+.+.+|+.++.++. ||||+++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            3344577889999999999999999964     3456799999965432  233456889999999997 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChhHHHHhCC-----------------------------------------------------
Q 038249           85 FYDQKRVYLILEYAAKGELYKELQKCK-----------------------------------------------------  111 (281)
Q Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~~~-----------------------------------------------------  111 (281)
                      +...+..++|+||+++++|.+++...+                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999899999999999999999886421                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCC
Q 038249          112 ---------------------------------------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPEN  146 (281)
Q Consensus       112 ---------------------------------------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~N  146 (281)
                                                                   .++...++.++.+|+.||.|||+.+++|+||+|+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         25667788999999999999999999999999999


Q ss_pred             eEeCCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchH
Q 038249          147 LLIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSD  220 (281)
Q Consensus       147 i~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~  220 (281)
                      |+++.++.++|+|||++......     .....++..|+|||.+.+..++.++|+||||+++++|++ |..||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            99999999999999997543211     122345678999999988888999999999999999997 889998766655


Q ss_pred             HHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          221 TYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ............+....++.++.+++.+||+.+|.+||++.||++.
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5444443333333344678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.5e-41  Score=281.12  Aligned_cols=249  Identities=24%  Similarity=0.412  Sum_probs=208.2

Q ss_pred             ccCCceecceecccCceEEEEEEEcc-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      .-++|++.+.||.|++|.||+|.+..     ++..+++|.+....  .......+.+|+.++++++|||++++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            34689999999999999999999753     57789999986443  233446688899999999999999999999998


Q ss_pred             CEEEEEEeccCCCChhHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCC
Q 038249           89 KRVYLILEYAAKGELYKELQKCK----------------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPEN  146 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~----------------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~N  146 (281)
                      ...++++||+++++|.+++....                      .+++..++.++.+|+.||.+||+.|++|+||+|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            89999999999999999987432                      36788899999999999999999999999999999


Q ss_pred             eEeCCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchH
Q 038249          147 LLIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSD  220 (281)
Q Consensus       147 i~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~  220 (281)
                      |+++.++.++++|||++......     ......+..|+|||...+..++.++|+||||+++++|++ |..||......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999987543222     112234567999999988889999999999999999997 888998777777


Q ss_pred             HHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          221 TYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ....+...... +.....+.++.+++.+||+.+|++|||+.|++.
T Consensus       241 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         241 VIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            66665544332 223367899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-43  Score=297.64  Aligned_cols=253  Identities=25%  Similarity=0.464  Sum_probs=218.9

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeeccc-ccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC--EEEEE
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK--RVYLI   94 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~v   94 (281)
                      .+....||+|+|-+||+|.|..+|-.||=-.+.... ...++..+.+..|+.+|+.++|+||+++++.+.+..  .+.+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            355688999999999999999988877633332222 234445678999999999999999999999998754  58999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--CceecCCCCCCeEeCCC-CcEEEeeecCcccccCCcc
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK--HVIHRDIKPENLLIGAQ-GELKIADFGWSVHTFNRRR  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--~i~H~di~~~Ni~~~~~-~~~~l~dfg~~~~~~~~~~  171 (281)
                      +|.+..|+|..++++.+..+...+..|++||++||.|||++  .|+|||||.+||+++.+ |.+||+|+|++........
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            99999999999999999999999999999999999999988  59999999999999865 8999999999876555443


Q ss_pred             -cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCC-CCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 038249          172 -TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM  249 (281)
Q Consensus       172 -~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  249 (281)
                       ...|||.|||||.+. ..|+...|||||||.++||.|+..|| +..++.++++++..+.........-..++++||.+|
T Consensus       202 ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekC  280 (632)
T KOG0584|consen  202 KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKC  280 (632)
T ss_pred             ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHH
Confidence             357999999999988 68899999999999999999999998 467888889998888665554555678999999999


Q ss_pred             cccCCCCCCChhhhhcCCccccC
Q 038249          250 LVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       250 l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      |.. .++|+|+.|+|.||||...
T Consensus       281 l~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  281 LAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             hcC-chhccCHHHHhhChhhccc
Confidence            998 9999999999999999975

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-42  Score=282.01  Aligned_cols=250  Identities=32%  Similarity=0.558  Sum_probs=208.4

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEec
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEY   97 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   97 (281)
                      |++.+.||.|++|.||+|++..+++.+++|.+.... ........+..|+..++.++|+|++++++++...+..++|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            677899999999999999999999999999997653 2233345677899999999999999999999999999999999


Q ss_pred             cCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---ccc
Q 038249           98 AAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---RTM  173 (281)
Q Consensus        98 ~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---~~~  173 (281)
                      +++ +|.+++... ..+++..++.++.+++.|+++||+.|++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            975 899999876 579999999999999999999999999999999999999999999999999875433221   223


Q ss_pred             cCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc------------------ccC--
Q 038249          174 CGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD------------------LKF--  232 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~~~--  232 (281)
                      ..+..|+|||.+.+. .++.++|+||||++++++++|..||...+..+....+....                  ...  
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            346679999998665 78889999999999999999999998776655544332210                  000  


Q ss_pred             -------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          233 -------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       233 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                             ...+..+.++.++|.+||..||++||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                   0112357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.5e-41  Score=280.05  Aligned_cols=254  Identities=33%  Similarity=0.603  Sum_probs=209.3

Q ss_pred             CceecceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~-~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~   91 (281)
                      +|++.+.||.|++|.||.|.+.   .+|..+|+|++...... .......+.+|+++++.+ +|++|+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999985   47889999998654321 222345677899999999 589999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      ++|+||+++++|.+.+....++++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            999999999999999988888999999999999999999999999999999999999999999999999987543221  


Q ss_pred             --cccccCcCCccCCccccCC--CCCCcccHHhHHHHHHHHHhCCCCCCCCCch----HHHHHHhhccccCCCCCCCCHH
Q 038249          170 --RRTMCGTLDYLPPEMVESV--EHDANVDIWSLGVLCYEFLYGVPPFEAKEHS----DTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                        .....++..|++||.+...  .++.++|+||||+++++|++|..||......    ............  ....++..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  238 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSAL  238 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC--CCccCCHH
Confidence              1223467889999998643  4677899999999999999999999653332    222233222222  23358899


Q ss_pred             HHHHHHHhcccCCCCCC-----ChhhhhcCCccccC
Q 038249          242 AKDLISQMLVKDSSQRL-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rp-----s~~eil~~~~~~~~  272 (281)
                      +.+++.+||+.||++||     ++++++.||||++.
T Consensus       239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            99999999999999997     89999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.4e-41  Score=285.38  Aligned_cols=257  Identities=29%  Similarity=0.469  Sum_probs=206.0

Q ss_pred             CceecceecccCceEEEEEEEccC--CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe----CC
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRS--NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD----QK   89 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~--~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~----~~   89 (281)
                      +|++.+.||.|++|.||++.+..+  +..+|+|.+.... ........+.+|+.+++++ +|+||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            588999999999999999999988  8899999985432 2223345677899999999 59999999987543    24


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ..+++++++. ++|.+.+.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            6789999986 489999988788999999999999999999999999999999999999999999999999987543221


Q ss_pred             -------cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc------------
Q 038249          170 -------RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD------------  229 (281)
Q Consensus       170 -------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------  229 (281)
                             .....+++.|+|||.+.+ ..++.++|+||+|+++++|++|.+||...+.......+....            
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence                   122357888999998654 567889999999999999999999997655433322211100            


Q ss_pred             ----------------ccC-CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          230 ----------------LKF-PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       230 ----------------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                      ..+ ...+..+.++.+++.+||+.||++|||+.+++.||||.++.++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                            000 0123467899999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-41  Score=277.01  Aligned_cols=250  Identities=21%  Similarity=0.365  Sum_probs=210.2

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      .++..+|++.+.||.|++|+||+|.++.+|.    .+++|.+.....  ......+.+|+..+++++|+|++++++++..
T Consensus         3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T cd05057           3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS   80 (279)
T ss_pred             ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            4566889999999999999999999887665    588888755432  3345678889999999999999999999887


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                       ...++|+||+++++|.+.+... ..+++..+..++.||+.|+++||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence             7889999999999999998764 46899999999999999999999999999999999999999999999999987543


Q ss_pred             cCCcc-----cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCH
Q 038249          167 FNRRR-----TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       167 ~~~~~-----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
                      .....     ....+..|++||......++.++|+||||++++++++ |..||......+....+.... ..+.....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  238 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQPPICTI  238 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CCCCCCCCCH
Confidence            32211     1122457999999988888999999999999999998 999998877766666555432 2333446889


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhc
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ++.+++.+||..+|++||++.++++
T Consensus       239 ~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         239 DVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.7e-41  Score=282.13  Aligned_cols=248  Identities=25%  Similarity=0.409  Sum_probs=205.4

Q ss_pred             cCCceecceecccCceEEEEEEEcc-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKR-------SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFY   86 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~   86 (281)
                      ..+|++.+.||+|++|.||+|.+..       ....+++|.+....  .......+.+|+++++++ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            3789999999999999999998642       34568899875432  223355678899999999 6999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC
Q 038249           87 DQKRVYLILEYAAKGELYKELQKC----------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG  150 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~  150 (281)
                      ..+..++++||+++++|.+++...                ..++...+..++.||+.||.+||++|++|+||+|+||+++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence            889999999999999999998653                2378889999999999999999999999999999999999


Q ss_pred             CCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHH
Q 038249          151 AQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRR  224 (281)
Q Consensus       151 ~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~  224 (281)
                      .++.++|+|||.+.......     ....++..|+|||.+.+..++.++|+||||+++++|++ |..||......+....
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~  248 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL  248 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999986443211     11123457999999988889999999999999999998 8999988777666666


Q ss_pred             HhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          225 IVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +..... ......++.++.+++.+||..+|++|||+.++++
T Consensus       249 ~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         249 LREGHR-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            554322 2223467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2e-41  Score=286.98  Aligned_cols=249  Identities=24%  Similarity=0.433  Sum_probs=200.7

Q ss_pred             CCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe-C
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD-Q   88 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~   88 (281)
                      ++|++.+.||.|+||.||+|.+.     .+++.||+|.+....  .......+.+|+.++.++ +|+||+++++.+.. .
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            58999999999999999999853     457789999986543  223345688899999999 68999999998765 4


Q ss_pred             CEEEEEEeccCCCChhHHHHhC----------------------------------------------------------
Q 038249           89 KRVYLILEYAAKGELYKELQKC----------------------------------------------------------  110 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~----------------------------------------------------------  110 (281)
                      ...++++||+++++|.+++...                                                          
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            5678999999999999888642                                                          


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-----ccccCc
Q 038249          111 ---------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-----RTMCGT  176 (281)
Q Consensus       111 ---------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~  176 (281)
                               ..++...+..++.||+.||+|||++|++|+||+|+||+++.++.++++|||++.......     ....++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence                     136778889999999999999999999999999999999999999999999875432211     112345


Q ss_pred             CCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 038249          177 LDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSS  255 (281)
Q Consensus       177 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  255 (281)
                      ..|+|||.+.+..++.++|+||||+++++|++ |..||.........................+.++.+++.+||+.||+
T Consensus       245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~  324 (343)
T cd05103         245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS  324 (343)
T ss_pred             cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            67999999988889999999999999999996 99999776554433333322222222335778999999999999999


Q ss_pred             CCCChhhhhcC
Q 038249          256 QRLPLHKLLEH  266 (281)
Q Consensus       256 ~Rps~~eil~~  266 (281)
                      +|||+.||+++
T Consensus       325 ~Rps~~eil~~  335 (343)
T cd05103         325 QRPTFSELVEH  335 (343)
T ss_pred             hCcCHHHHHHH
Confidence            99999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=300.53  Aligned_cols=248  Identities=30%  Similarity=0.481  Sum_probs=211.5

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG  101 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~  101 (281)
                      -.||+|.||+||.|+|..+....|||.+....   .+..+-+.+||.+-++++|.|||+++|.+.+++.+-+.||.++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            36999999999999999999999999985432   334567889999999999999999999999999999999999999


Q ss_pred             ChhHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-CCcEEEeeecCccccc---CCccccc
Q 038249          102 ELYKELQKC-KYF--SERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-QGELKIADFGWSVHTF---NRRRTMC  174 (281)
Q Consensus       102 ~L~~~~~~~-~~l--~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-~~~~~l~dfg~~~~~~---~~~~~~~  174 (281)
                      +|.++++.. +|+  ++..+..+..||+.||.|||.+.|+|+|||-+||+++. .|.+||+|||-+.+..   +-+....
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            999999864 677  78889999999999999999999999999999999975 6899999999886643   3345567


Q ss_pred             CcCCccCCccccCCC--CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-cccCCCCCCCCHHHHHHHHHhcc
Q 038249          175 GTLDYLPPEMVESVE--HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-DLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       175 ~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ||..|||||+...++  |+.++|||||||++.||.||++||-....++....-... +...+.+..++.+.+.+|.+|+.
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            899999999986554  788999999999999999999999776666554332221 11222233577889999999999


Q ss_pred             cCCCCCCChhhhhcCCccccC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +||.+||++.++|.+||++.+
T Consensus       818 pd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  818 PDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCcccCccHHHhccCcccccC
Confidence            999999999999999999977

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.7e-41  Score=279.10  Aligned_cols=246  Identities=23%  Similarity=0.404  Sum_probs=204.1

Q ss_pred             CceecceecccCceEEEEEEEccC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRS-----NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      +|++.+.||+|+||.||+|.+...     ...+++|.+.....  ......+.+|+.+++.+.||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            588999999999999999987532     24588888754332  22346788899999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCe
Q 038249           92 YLILEYAAKGELYKELQKC------------------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENL  147 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni  147 (281)
                      ++++||+.+++|.+++...                        .+++...++.++.+++.|+.+||+.|++|+||+|+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999987642                        2478889999999999999999999999999999999


Q ss_pred             EeCCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHH
Q 038249          148 LIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDT  221 (281)
Q Consensus       148 ~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~  221 (281)
                      +++.++.++|+|||++......     .....++..|+|||...+..++.++|+||||+++++|++ |..||......+.
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            9999999999999987543221     122234568999999888888999999999999999998 9999987776666


Q ss_pred             HHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          222 YRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ....... ...+....++.++.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         239 FNLLKTG-YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHhCC-CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            5544432 233334468899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.3e-41  Score=275.05  Aligned_cols=244  Identities=24%  Similarity=0.412  Sum_probs=204.2

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||.|++|.||+|.+. ++..+++|.+......    ...+.+|+.++++++|++++++++++. .+..++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence            3468999999999999999999876 5567999998654432    245788999999999999999999875 456789


Q ss_pred             EEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           94 ILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      ++||+++++|.+++...  ..+++..++.++.+++.|+.+||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999999998753  358999999999999999999999999999999999999999999999999875432221 


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                         ....++..|+|||...+..++.++|+||||+++++|++ |..||...+..+....+... ...+.....+.++.+++
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  236 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHELM  236 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHH
Confidence               11223557999999988888999999999999999998 89999887776666655432 22333446889999999


Q ss_pred             HHhcccCCCCCCChhhhh
Q 038249          247 SQMLVKDSSQRLPLHKLL  264 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil  264 (281)
                      .+||.++|++|||+.+++
T Consensus       237 ~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         237 LQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             HHHcccCcccCcCHHHHH
Confidence            999999999999999987

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=278.61  Aligned_cols=249  Identities=35%  Similarity=0.539  Sum_probs=204.2

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEEEEEe
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      |++.+.||.|++|+||+|++..+++.+++|.+........  .....+|+..+++++ |+|++++++++..++..++|+|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            7889999999999999999998899999999865432211  223456888999998 9999999999999999999999


Q ss_pred             ccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--cc
Q 038249           97 YAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RT  172 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--~~  172 (281)
                      |+ +++|.+.+....  .+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            99 668988887654  68999999999999999999999999999999999999999999999999876543322  23


Q ss_pred             ccCcCCccCCcccc-CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-------------------cC
Q 038249          173 MCGTLDYLPPEMVE-SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-------------------KF  232 (281)
Q Consensus       173 ~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~  232 (281)
                      ..++..|+|||.+. ...++.++|+||||+++++|++|.+||......+..........                   ..
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            44677899999874 45578899999999999999999999987766554433221100                   00


Q ss_pred             C---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          233 P---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       233 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +         ..+..+.++.++|++||+.+|++||+++|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0         011246889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.1e-41  Score=275.23  Aligned_cols=243  Identities=23%  Similarity=0.412  Sum_probs=205.1

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .+.+|++.+.||.|++|.||.+..  +++.+++|.+..+.     ....+.+|+.++++++|+|++++++.+..+ ..++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            357899999999999999999865  57889999985432     234678899999999999999999998765 4689


Q ss_pred             EEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc
Q 038249           94 ILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR  171 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~  171 (281)
                      ++||+.+++|.+++....  .++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~  155 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD  155 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence            999999999999997643  478999999999999999999999999999999999999999999999998765433333


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ....+..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+........ ........++.++.+++.+||
T Consensus       156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l  234 (254)
T cd05083         156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCPADVYVLMTSCW  234 (254)
T ss_pred             CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHHHc
Confidence            3344567999999988888999999999999999997 99999887776665555443 233334568899999999999


Q ss_pred             ccCCCCCCChhhhhc
Q 038249          251 VKDSSQRLPLHKLLE  265 (281)
Q Consensus       251 ~~~p~~Rps~~eil~  265 (281)
                      +.+|++||++.+++.
T Consensus       235 ~~~p~~Rp~~~~l~~  249 (254)
T cd05083         235 ETEPKKRPSFHKLRE  249 (254)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.7e-41  Score=280.95  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=209.4

Q ss_pred             cccccCCceecceecccCceEEEEEEEc-------cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeee
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREK-------RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLY   82 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-------~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~   82 (281)
                      ..+...+|++.+.||.|++|.||.|.+.       .++..+++|.+....  .......+.+|+.+++.+ +||||++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            4566689999999999999999999753       234578999885432  223346788999999999 899999999


Q ss_pred             eEEEeCCEEEEEEeccCCCChhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCC
Q 038249           83 GYFYDQKRVYLILEYAAKGELYKELQKC----------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPEN  146 (281)
Q Consensus        83 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~N  146 (281)
                      +.+...+..++++||+.+++|.+++...                ..++...+..++.||+.||.|||++|++|+||+|+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            9999999999999999999999998753                236778899999999999999999999999999999


Q ss_pred             eEeCCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchH
Q 038249          147 LLIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSD  220 (281)
Q Consensus       147 i~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~  220 (281)
                      |+++.++.++|+|||.+......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            99999999999999987544321     112234567999999988889999999999999999998 888998877777


Q ss_pred             HHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          221 TYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ....+..... .......+.++.+++.+||..+|++|||+.|+++.
T Consensus       248 ~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         248 LFKLLKEGHR-MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            6666544432 22234688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.4e-41  Score=277.17  Aligned_cols=246  Identities=22%  Similarity=0.355  Sum_probs=197.4

Q ss_pred             Cc-eecceecccCceEEEEEE----EccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--CC
Q 038249           17 DF-DIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--QK   89 (281)
Q Consensus        17 ~y-~~~~~ig~g~~~~v~~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~   89 (281)
                      +| ++.+.||.|++|+||++.    ...++..+++|.+....  .......+.+|++.+++++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence            45 999999999999998765    33567889999986543  22334567889999999999999999998765  34


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ..+++|||+++++|.+++... .+++..++.++.+++.|+.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            689999999999999999775 4899999999999999999999999999999999999999999999999987544322


Q ss_pred             c------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH--------------HHHHHhhcc
Q 038249          170 R------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD--------------TYRRIVQVD  229 (281)
Q Consensus       170 ~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------~~~~~~~~~  229 (281)
                      .      ....++..|+|||.+.+...+.++|+||||+++++|++|..|+......-              .........
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            1      11234556999999988888999999999999999999999986433210              011111111


Q ss_pred             ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          230 LKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ...+....++.++.+++.+||+++|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            122223457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.3e-41  Score=277.43  Aligned_cols=251  Identities=29%  Similarity=0.484  Sum_probs=206.0

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ--QSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +|.+.+.||.|++|.||++++...+..+++|.+......  .......+..|+.+++.++|||++++++.+.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            589999999999999999999877776766665432221  111223456788999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           95 LEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      +||+++++|.+++..    ...+++..++.++.|++.|+.+||+.|++|+|++|+||+++. +.++++|||.+...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988753    356899999999999999999999999999999999999964 67999999987543222 


Q ss_pred             --cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          170 --RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                        .....+++.|++||.+.+..++.++|+||+|+++++|++|..||......+........... .....++.++.++|.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~  238 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP-SLPETYSRQLNSIMQ  238 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC-CCcchhcHHHHHHHH
Confidence              22334677899999988888888999999999999999999999876665555554433222 122368899999999


Q ss_pred             HhcccCCCCCCChhhhhcCCcc
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +||..+|++||++.++++||||
T Consensus       239 ~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         239 SMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-41  Score=271.69  Aligned_cols=240  Identities=25%  Similarity=0.429  Sum_probs=202.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG  101 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~  101 (281)
                      +.||.|++|.||++.+.. ++.+++|.+......  .....+.+|++++++++|+||+++++++...+..++|+||+.++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            479999999999999987 899999998655432  34567889999999999999999999999999999999999999


Q ss_pred             ChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-----ccccC
Q 038249          102 ELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-----RTMCG  175 (281)
Q Consensus       102 ~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~  175 (281)
                      +|.+++.. ...++...+..++.+++.++.+||+++++|+||+|+||+++.++.++|+|||.+.......     .....
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99999865 3468999999999999999999999999999999999999999999999999875433211     11223


Q ss_pred             cCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 038249          176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS  254 (281)
Q Consensus       176 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  254 (281)
                      +..|+|||.+.+..++.++|+||||+++++|++ |..||...........+... ...+.....+.++.+++.+||..+|
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p  236 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPAPQLCPEEIYRLMLQCWAYDP  236 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHhccCh
Confidence            456999999988889999999999999999998 88899877766555554433 2233344688999999999999999


Q ss_pred             CCCCChhhhhc
Q 038249          255 SQRLPLHKLLE  265 (281)
Q Consensus       255 ~~Rps~~eil~  265 (281)
                      ++||++.|++.
T Consensus       237 ~~Rp~~~ell~  247 (251)
T cd05041         237 ENRPSFSEIYN  247 (251)
T ss_pred             hhCcCHHHHHH
Confidence            99999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-41  Score=275.14  Aligned_cols=241  Identities=27%  Similarity=0.427  Sum_probs=198.9

Q ss_pred             ceecccCceEEEEEEEccCCcE--EEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEEEecc
Q 038249           22 KPLGRGKFGHVYLAREKRSNHI--VALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYA   98 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~--~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~   98 (281)
                      +.||.|++|.||+|+++.++..  +++|.+...  ........+.+|+++++++ +||||+++++++...+..++++||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            4689999999999999887754  577877532  2233445788899999999 7999999999999999999999999


Q ss_pred             CCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           99 AKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        99 ~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      ++++|.+++....                .+++..++.++.+++.|+++||+.|++|+||+|+||+++.++.++++|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999987532                378899999999999999999999999999999999999999999999998


Q ss_pred             cccccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCC
Q 038249          163 SVHTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS  239 (281)
Q Consensus       163 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (281)
                      +......  ......+..|+|||.+....++.++|+||||+++++|++ |..||...+..+....+.... ........+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~  237 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKPLNCD  237 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CCCCCCcCC
Confidence            7432211  111223557999999988889999999999999999996 999998777766666554432 222333578


Q ss_pred             HHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          240 SAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .++.+++.+||..||.+|||+.+++.
T Consensus       238 ~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         238 DEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHHH
Confidence            89999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6e-41  Score=272.84  Aligned_cols=246  Identities=23%  Similarity=0.424  Sum_probs=207.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ..+|++.+.||.|++|.||++.+. ++..+++|.+......    ...+.+|++++++++||+++++++++......+++
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            468999999999999999999886 4678999988644322    23577899999999999999999999998999999


Q ss_pred             EeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---
Q 038249           95 LEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---  170 (281)
                      +||+.+++|.+++... .++++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.......   
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999998764 468999999999999999999999999999999999999999999999999875432221   


Q ss_pred             -ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          171 -RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       171 -~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                       .....+..|+|||.+.+..++.++|+||||+++++|++ |..||...........+...... ......+.++.+++.+
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~  236 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL-YKPRLASQSVYELMQH  236 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC-CCCCCCCHHHHHHHHH
Confidence             12223568999999988888999999999999999998 99999887776666665543222 2233578999999999


Q ss_pred             hcccCCCCCCChhhhhcC
Q 038249          249 MLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~  266 (281)
                      ||+.+|++|||+.++++.
T Consensus       237 ~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         237 CWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HcccChhhCCCHHHHHHh
Confidence            999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.6e-41  Score=273.14  Aligned_cols=229  Identities=25%  Similarity=0.371  Sum_probs=191.1

Q ss_pred             cCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCChhHH
Q 038249           27 GKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKE  106 (281)
Q Consensus        27 g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~  106 (281)
                      |.++.||+++++.+++.+|+|.+.....        ...+...+....|||++++++++.+.+..++++||+++++|.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            8999999999999999999999865421        12234444556799999999999999999999999999999999


Q ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccccCcCCccCCcccc
Q 038249          107 LQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVE  186 (281)
Q Consensus       107 ~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~  186 (281)
                      +.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+............+..|+|||...
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG  155 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence            98877799999999999999999999999999999999999999999999999997655444434445567899999998


Q ss_pred             CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCh-----h
Q 038249          187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPL-----H  261 (281)
Q Consensus       187 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~  261 (281)
                      +..++.++|+||+|+++++|++|..|+......  .    ...........++.++.++|.+||+.||++||++     +
T Consensus       156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~  229 (237)
T cd05576         156 ISEETEACDWWSLGAILFELLTGKTLVECHPSG--I----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE  229 (237)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--c----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence            888899999999999999999999887543211  0    0011112223578999999999999999999986     9


Q ss_pred             hhhcCCcc
Q 038249          262 KLLEHPWI  269 (281)
Q Consensus       262 eil~~~~~  269 (281)
                      +++.||||
T Consensus       230 ~~~~h~~~  237 (237)
T cd05576         230 DIKSHPFF  237 (237)
T ss_pred             HHHcCCCC
Confidence            99999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.4e-41  Score=283.29  Aligned_cols=245  Identities=24%  Similarity=0.366  Sum_probs=196.1

Q ss_pred             CceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCChhHHH
Q 038249           28 KFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL  107 (281)
Q Consensus        28 ~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~  107 (281)
                      +++.||.+++..+++.+|+|++....... .....+.+|++.++.++|+||+++++++...+..++++||+++++|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            44566777777789999999997653333 34567899999999999999999999999999999999999999999998


Q ss_pred             HhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC----------cccccC
Q 038249          108 QKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR----------RRTMCG  175 (281)
Q Consensus       108 ~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~----------~~~~~~  175 (281)
                      ...  ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++++||+.+......          .....+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence            763  45899999999999999999999999999999999999999999999999976433211          122235


Q ss_pred             cCCccCCccccC--CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-----------------------
Q 038249          176 TLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-----------------------  230 (281)
Q Consensus       176 ~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------------  230 (281)
                      +..|+|||.+..  ..++.++|+||+|+++++|++|..||..............+..                       
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN  250 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence            668999999865  3578899999999999999999999987654433221111100                       


Q ss_pred             ---------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          231 ---------KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       231 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                               .......++.++.+++.+||+.||++|||++++|+||||++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                     0000112346788999999999999999999999999998763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-40  Score=270.39  Aligned_cols=240  Identities=22%  Similarity=0.394  Sum_probs=201.3

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG  101 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~  101 (281)
                      +.||.|++|.||++... ++..+++|.+....  .......+.+|+++++.++|||++++++++...+..++|+||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            47899999999999865 67889999986543  2333456888999999999999999999999999999999999999


Q ss_pred             ChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc----ccccCc
Q 038249          102 ELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----RTMCGT  176 (281)
Q Consensus       102 ~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~  176 (281)
                      +|.+++... ..+++..++.++.+++.++.+||++|++|+||+|+||+++.++.++|+|||++.......    .....+
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            999988754 457999999999999999999999999999999999999999999999999875432221    112335


Q ss_pred             CCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 038249          177 LDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSS  255 (281)
Q Consensus       177 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  255 (281)
                      ..|+|||.+.+..++.++|+||||++++++++ |..||...........+.... .......++.++.+++.+||+.+|+
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~  236 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-RMSCPQKCPDDVYKVMQRCWDYKPE  236 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcccCcc
Confidence            67999999988888999999999999999998 999998777666555554332 2223345889999999999999999


Q ss_pred             CCCChhhhhc
Q 038249          256 QRLPLHKLLE  265 (281)
Q Consensus       256 ~Rps~~eil~  265 (281)
                      +||++.|+++
T Consensus       237 ~Rp~~~~l~~  246 (250)
T cd05085         237 NRPKFSELQK  246 (250)
T ss_pred             cCCCHHHHHH
Confidence            9999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.2e-40  Score=271.35  Aligned_cols=239  Identities=25%  Similarity=0.358  Sum_probs=197.7

Q ss_pred             eecccCceEEEEEEEc--cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           23 PLGRGKFGHVYLAREK--RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        23 ~ig~g~~~~v~~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      .||.|++|.||+|.+.  ..+..+|+|.+....  .....+.+.+|+.++++++|+||+++++++. ....++|+||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            4899999999999876  345568999885442  2334566889999999999999999999875 4577999999999


Q ss_pred             CChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc------ccc
Q 038249          101 GELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR------RTM  173 (281)
Q Consensus       101 ~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~------~~~  173 (281)
                      ++|.+++.. ...+++..++.++.+|+.|+.+||++|++|+||+|+||+++.++.++|+|||.+.......      ...
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999999875 4568999999999999999999999999999999999999999999999999875332211      111


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      .++..|+|||.+....++.++|+||||++++++++ |..||......+....+.++.. .......+.++.+++.+||..
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-LDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHcCC
Confidence            22467999999988888999999999999999996 9999988877776665555432 222346789999999999999


Q ss_pred             CCCCCCChhhhhc
Q 038249          253 DSSQRLPLHKLLE  265 (281)
Q Consensus       253 ~p~~Rps~~eil~  265 (281)
                      +|++||++.+|++
T Consensus       238 ~~~~Rp~~~~i~~  250 (257)
T cd05115         238 KWEDRPNFAKVEE  250 (257)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8e-41  Score=272.81  Aligned_cols=244  Identities=23%  Similarity=0.414  Sum_probs=202.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||.|++|.||++.+..+ ..+++|.+.....    ..+.+.+|+++++.++|+|++++++++.. +..+++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV   78 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence            36799999999999999999998754 4589998754432    23457789999999999999999998754 567899


Q ss_pred             EeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc--
Q 038249           95 LEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~--  170 (281)
                      |||+.+++|.+++...  ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999999999754  347899999999999999999999999999999999999999999999999875432221  


Q ss_pred             --ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          171 --RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       171 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                        ....++..|+|||...+...+.++|+||||+++++|++ |..||......+....+... ...+.....+..+.+++.
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~  237 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPCPQGCPESLHELMK  237 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHHHH
Confidence              12234567999999988889999999999999999998 99999887776666555433 223333468899999999


Q ss_pred             HhcccCCCCCCChhhhhc
Q 038249          248 QMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~  265 (281)
                      +||+.||++||+++++++
T Consensus       238 ~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         238 LCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHccCCcccCcCHHHHHH
Confidence            999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.7e-41  Score=276.37  Aligned_cols=249  Identities=23%  Similarity=0.389  Sum_probs=199.3

Q ss_pred             CCceecceecccCceEEEEEEE----ccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--C
Q 038249           16 NDFDIGKPLGRGKFGHVYLARE----KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--K   89 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~----~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~   89 (281)
                      .-|++.+.||+|++|.||.++.    ..++..+++|.+....  .......+.+|+++++.++|+|++++.+++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            4578999999999999999984    4568889999985442  233456788999999999999999999998765  5


Q ss_pred             EEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           90 RVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      ..++|+||+++++|.+++... ..+++..++.++.+|+.||++||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            789999999999999998764 3589999999999999999999999999999999999999999999999998754322


Q ss_pred             Cc------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc--------------hHHHHHHhhc
Q 038249          169 RR------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH--------------SDTYRRIVQV  228 (281)
Q Consensus       169 ~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------------~~~~~~~~~~  228 (281)
                      ..      ....++..|+|||.+.+..++.++|+||||+++++|+++..|......              ..........
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            21      123355679999998888889999999999999999997665422110              0111111111


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ....+....++.++.+++.+||+.+|++|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            22233344688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7.1e-41  Score=304.34  Aligned_cols=150  Identities=37%  Similarity=0.678  Sum_probs=139.3

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .+++|++.+.||.|+||.||+|.+..+++.||+|++.............+..|+.+++.++|+||+++++.+...+.+++
T Consensus         2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            36889999999999999999999999999999999976655555556778899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      ||||+.+++|.+++...+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls  151 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS  151 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence            9999999999999988788999999999999999999999999999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-40  Score=275.21  Aligned_cols=248  Identities=25%  Similarity=0.430  Sum_probs=198.8

Q ss_pred             cCCceecceecccCceEEEEEE----EccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--C
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--Q   88 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~   88 (281)
                      -++|++.+.||.|++|.||.+.    +..++..+++|.+....   ....+.+.+|+++++.++||||+++.+++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            3579999999999999999987    44578899999985432   3345678899999999999999999998754  3


Q ss_pred             CEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           89 KRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      ...++|+||+++++|.+++... ..+++..++.++.+++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            4689999999999999998754 458999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcc------cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH---------------HHHHHh
Q 038249          168 NRRR------TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD---------------TYRRIV  226 (281)
Q Consensus       168 ~~~~------~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------~~~~~~  226 (281)
                      ....      ...++..|+|||.+.+..++.++|+||||+++++|++|..++.......               ......
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            2211      1122345899999988888999999999999999999876653322110               011112


Q ss_pred             hccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          227 QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ......+....++.++.+++.+||.++|++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            222233344568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.9e-41  Score=277.91  Aligned_cols=248  Identities=21%  Similarity=0.392  Sum_probs=201.7

Q ss_pred             CCceecceecccCceEEEEEEEcc----------------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCcee
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKR----------------SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL   79 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~----------------~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~   79 (281)
                      ++|++.+.||.|++|.||++.+..                ++..+++|.+....  .......+.+|+..++.++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            579999999999999999986542                34468999986442  233456788999999999999999


Q ss_pred             eeeeEEEeCCEEEEEEeccCCCChhHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeE
Q 038249           80 RLYGYFYDQKRVYLILEYAAKGELYKELQKCK-----------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLL  148 (281)
Q Consensus        80 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~  148 (281)
                      ++++++...+..++++||+.+++|.+++....           .+++..++.++.+|+.|+++||+.|++|+||+|+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999987642           2567789999999999999999999999999999999


Q ss_pred             eCCCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh--CCCCCCCCCchHH
Q 038249          149 IGAQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY--GVPPFEAKEHSDT  221 (281)
Q Consensus       149 ~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~  221 (281)
                      ++.++.++|+|||++.......     .....+..|++||...+..++.++|+||||+++++|++  |..||...+..+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            9999999999999975432221     11223567999998887889999999999999999997  7789877666554


Q ss_pred             HHHHhh------ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          222 YRRIVQ------VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       222 ~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ......      .....+....++..+.+++.+||+.||++||++.+|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            433211      11112333457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7e-41  Score=277.14  Aligned_cols=254  Identities=33%  Similarity=0.600  Sum_probs=207.9

Q ss_pred             CceecceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~-~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~   91 (281)
                      +|++.+.||.|++|.||++++.   .++..+++|.+...... .......+.+|+.+++++ +|++++++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   35788999998654322 223345577899999999 599999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      ++|+||+.+++|.+.+.....+++..+..++.|++.+|.+||+.|++|+||+|.||+++.++.++++|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            9999999999999998877779999999999999999999999999999999999999999999999999875432221 


Q ss_pred             ---ccccCcCCccCCccccCCC--CCCcccHHhHHHHHHHHHhCCCCCCCCCch----HHHHHHhhccccCCCCCCCCHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVE--HDANVDIWSLGVLCYEFLYGVPPFEAKEHS----DTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                         ....++..|++||.+.+..  .+.++|+||||+++++|++|..||......    +..+......  .+....++.+
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  238 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTMSAE  238 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--CCCCcccCHH
Confidence               2234688999999986654  678999999999999999999999643322    2222222222  2333458899


Q ss_pred             HHHHHHHhcccCCCCCCC---hhhhhcCCccccC
Q 038249          242 AKDLISQMLVKDSSQRLP---LHKLLEHPWIIQN  272 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps---~~eil~~~~~~~~  272 (281)
                      +.++|.+||+.||++|||   +.++|+||||+..
T Consensus       239 l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            999999999999999998   5677999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-42  Score=272.19  Aligned_cols=258  Identities=27%  Similarity=0.505  Sum_probs=205.3

Q ss_pred             CCceecceecccCceEEEEEEEccCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-CCE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-QKR   90 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   90 (281)
                      ..|++.+.||+|.+|.||+|..++++.    .+|+|.+..+. +......+.-+|+.+++.++|+|++.+..++.. +..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~k-d~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEK-DGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccC-CCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            679999999999999999997776543    68999986542 122233456789999999999999999999987 789


Q ss_pred             EEEEEeccCCCChhHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC----CcEEEeeec
Q 038249           91 VYLILEYAAKGELYKELQK-----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ----GELKIADFG  161 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~----~~~~l~dfg  161 (281)
                      +++++||.+. +|++.++-     .+.++...+.+|++||+.|+.|||++=|.|||+||.|||+..+    |.+||.|+|
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999999988 89998863     2458999999999999999999999999999999999999988    899999999


Q ss_pred             CcccccCCc------ccccCcCCccCCccccCCC-CCCcccHHhHHHHHHHHHhCCCCCCCCCc---------hHHHHHH
Q 038249          162 WSVHTFNRR------RTMCGTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEH---------SDTYRRI  225 (281)
Q Consensus       162 ~~~~~~~~~------~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~~~~~~  225 (281)
                      +++...+..      ...+-|.+|.|||.+.+.. |+++.|+|++||++.||++-.+.|.+.+.         .++...+
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            986543332      2334688999999976655 78999999999999999998888854221         1222222


Q ss_pred             hh--cccc---CCCC------------------------------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccc
Q 038249          226 VQ--VDLK---FPPK------------------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       226 ~~--~~~~---~~~~------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                      ..  +...   ++..                              ..-+....+|+.+||++||.+|.|++++|+|+||.
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~  341 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT  341 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence            22  1111   1110                              11333477999999999999999999999999999


Q ss_pred             cCCCC
Q 038249          271 QNADP  275 (281)
Q Consensus       271 ~~~~~  275 (281)
                      +.+.|
T Consensus       342 ~d~lp  346 (438)
T KOG0666|consen  342 EDPLP  346 (438)
T ss_pred             cCCCC
Confidence            98766

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.3e-40  Score=273.12  Aligned_cols=250  Identities=27%  Similarity=0.441  Sum_probs=206.2

Q ss_pred             cccCCceecceecccCceEEEEEEEccC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRS---NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      +.-++|++.+.||.|++|.||+|.+...   ...+++|......  .....+.+.+|+++++.++|+|++++++++.+ +
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            3456799999999999999999997644   3468899885432  13345678899999999999999999998875 4


Q ss_pred             EEEEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           90 RVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      ..++|+||+++++|.+++.... .++...++.++.+++.|+.+||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            5689999999999999997643 589999999999999999999999999999999999999999999999998754332


Q ss_pred             Ccc----cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHH
Q 038249          169 RRR----TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK  243 (281)
Q Consensus       169 ~~~----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  243 (281)
                      ...    ...++..|+|||.+....++.++|+||||++++++++ |..||......+....+..... .+....++.++.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER-LPMPPNCPPTLY  238 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc-CCCCCCCCHHHH
Confidence            211    1123457999999888888999999999999999885 9999988877766655544322 233346889999


Q ss_pred             HHHHHhcccCCCCCCChhhhhcC
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +++.+|+.++|++|||+.++++.
T Consensus       239 ~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         239 SLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999998853

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-42  Score=249.36  Aligned_cols=257  Identities=29%  Similarity=0.509  Sum_probs=214.6

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +.+|+-.++||+|.+|+||+++++++++.||+|.+..+.- .+....+..+||-+++.++|.||++++++...+..+.+|
T Consensus         1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            3568889999999999999999999999999999976652 333345677899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---c
Q 038249           95 LEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---R  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~  170 (281)
                      +|||+. +|..+..+. +.++.+.+++++.|+++|+.++|++++.|+|++|.|.+++.+|.+|+.|||+++-..-.   .
T Consensus        80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            999977 888887653 56899999999999999999999999999999999999999999999999997432111   1


Q ss_pred             ccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHH-hCCCCCCCCCchHHHHHHhhc--cccCCCC-----------
Q 038249          171 RTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQV--DLKFPPK-----------  235 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~--~~~~~~~-----------  235 (281)
                      .-..-|.+|.+|.++.+. -|+...|+||-||++.|+. .|.+.|.+.+..++...+...  ......|           
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            223468899999997554 4788999999999999998 588899999988887765432  1111111           


Q ss_pred             --------------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          236 --------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       236 --------------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                                    +.++..-+++++++|.-+|..|+++++++.||||.+..
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence                          23555678999999999999999999999999998653

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.5e-40  Score=272.50  Aligned_cols=249  Identities=27%  Similarity=0.508  Sum_probs=207.8

Q ss_pred             CceecceecccCceEEEEEEEcc-CCcEEEEEEeecccc-------cchHHHHHHHHHHHHHHh-CCCCceeeeeeEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKR-SNHIVALKVLFKSQL-------QQSQVEHQLRREVEIQSH-LRHPNILRLYGYFYD   87 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~-~~~~~~lK~~~~~~~-------~~~~~~~~~~~e~~~l~~-~~h~~i~~~~~~~~~   87 (281)
                      .|++.+.||.|++|.||.+.+.. +++.+++|.+.....       ........+..|+.++.+ ++|+|++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 678899998854321       122334556678887765 799999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           88 QKRVYLILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      ++..++++||+++++|.+++..    ...+++..++.++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999888743    3458999999999999999999996 6899999999999999999999999998


Q ss_pred             cccccCCc--ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCH
Q 038249          163 SVHTFNRR--RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       163 ~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
                      +.......  ....++..|++||.+.+..++.++|+||||+++|+|++|..||........................++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE  240 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence            75543332  2345678899999998888899999999999999999999999877766666665554443333336789


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhc
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ++.+++.+||+.||++||++.|+..
T Consensus       241 ~l~~li~~cl~~~p~~Rp~~~e~~~  265 (269)
T cd08528         241 DVTDVITSCLTPDAEARPDIIQVSA  265 (269)
T ss_pred             HHHHHHHHHCCCCCccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-40  Score=274.69  Aligned_cols=250  Identities=20%  Similarity=0.302  Sum_probs=207.6

Q ss_pred             cccCCceecceecccCceEEEEEEEcc----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKR----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-   87 (281)
                      ..-++|++.+.||+|++|.||.|.+..    ++..+++|.+...  ........+.+|+.+++.++|+|++++++++.. 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            445789999999999999999999886    2577889887533  233445678889999999999999999998766 


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEee
Q 038249           88 QKRVYLILEYAAKGELYKELQKC--------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIAD  159 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~d  159 (281)
                      +...+++++|+.+++|.+++...        ..+++..++.++.+++.||+|||+++++|+||+|+||+++.++.++++|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            46789999999999999998653        3488999999999999999999999999999999999999999999999


Q ss_pred             ecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCC
Q 038249          160 FGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFP  233 (281)
Q Consensus       160 fg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  233 (281)
                      ||++.......     ....++..|+|||.+.+..++.++||||||++++++++ |..||...+..+....+... ....
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~  239 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRLA  239 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCCC
Confidence            99986443221     11234567999999988889999999999999999998 99999877666655544433 2333


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ....++.++.+++.+||..||++|||+.++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            34457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-40  Score=281.37  Aligned_cols=248  Identities=25%  Similarity=0.421  Sum_probs=205.3

Q ss_pred             CCceecceecccCceEEEEEEEccC-------CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRS-------NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~-------~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      .+|++++.||+|+||.||.|.+...       +..+++|.+....  .....+.+.+|+++++++ +|+||+++++.+..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            5799999999999999999986532       2368999875432  233456788899999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                      .+..++++||+++++|.+++....                .++...+..++.||+.||.+||++|++|+||+|+||+++.
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~  169 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence            999999999999999999987532                3678889999999999999999999999999999999999


Q ss_pred             CCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038249          152 QGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRI  225 (281)
Q Consensus       152 ~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~  225 (281)
                      ++.++|+|||++.......     ....++..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  249 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL  249 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            9999999999875433221     11223457999999988889999999999999999998 88999887776666655


Q ss_pred             hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .... .......++.++.+++.+||+.+|++|||+.+++++
T Consensus       250 ~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         250 KEGH-RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            4432 222334678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=289.71  Aligned_cols=251  Identities=33%  Similarity=0.569  Sum_probs=219.0

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      .+.||.|-||+||-++++++|+.||||++.+.++.... ...+++|+.+|+++.||.||.+--.++..+.+++|||.+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            57899999999999999999999999999988877655 47799999999999999999999999999999999999966


Q ss_pred             CChhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC---cEEEeeecCcccccCC--cccc
Q 038249          101 GELYKELQK--CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---ELKIADFGWSVHTFNR--RRTM  173 (281)
Q Consensus       101 ~~L~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~---~~~l~dfg~~~~~~~~--~~~~  173 (281)
                       ++.+++-.  .+.+++.....++.||+.||.|||-+||+|+|+||+||++....   .+||+|||+++.....  ....
T Consensus       648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV  726 (888)
T KOG4236|consen  648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV  726 (888)
T ss_pred             -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence             77777643  35699999999999999999999999999999999999997654   6999999999765444  3456


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCCCHHHHHHHHHhcc
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~  251 (281)
                      .|||.|+|||++.+..|+..-|+||+|+++|--++|+.||+.  ..++..+++...+.++  +|..++.+..++|+.+|+
T Consensus       727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLq  804 (888)
T KOG4236|consen  727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQ  804 (888)
T ss_pred             cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHHHHHHH
Confidence            799999999999999999999999999999999999999954  3344444555555554  456699999999999999


Q ss_pred             cCCCCCCChhhhhcCCccccCCCC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      ..-.+|.|.+..|.|||++++..|
T Consensus       805 Vkm~kRysvdk~lsh~Wlq~yq~w  828 (888)
T KOG4236|consen  805 VKMRKRYSVDKSLSHPWLQDYQTW  828 (888)
T ss_pred             HHHHHhcchHhhccchhhhcchHH
Confidence            999999999999999999987654

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.6e-40  Score=268.95  Aligned_cols=245  Identities=21%  Similarity=0.373  Sum_probs=204.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ...+|++.+.||+|++|.||++.+. .+..+++|.+....    .....+.+|+++++.++|+|++++++.+.. ...++
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            4578999999999999999999865 45669999875432    234567889999999999999999999887 77899


Q ss_pred             EEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           94 ILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      ++||+++++|.+++...  ..++...++.++.+|+.|+.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            99999999999999763  357888999999999999999999999999999999999999999999999875432211 


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                         ....++..|+|||.+....++.++|+||||++++++++ |..||...+..+....+... ...+.....+.++.+++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i  236 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELYNIM  236 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCCCcccCCHHHHHHH
Confidence               12233567999999988888999999999999999998 99999887766666554433 23333446889999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      .+||+++|++||++.++++
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         237 MRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHcccCcccCcCHHHHHH
Confidence            9999999999999998874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=282.25  Aligned_cols=247  Identities=28%  Similarity=0.430  Sum_probs=199.0

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-EEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-RVYL   93 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~   93 (281)
                      .++|.....||+|+||.||+|.-.+ +..+|||++.......   ..++.+|+.++.+++|||+++++|+|.+.+ ..++
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L  149 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL  149 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence            3778888999999999999999884 4889999886554322   345999999999999999999999999988 5999


Q ss_pred             EEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC---ceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           94 ILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKH---VIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~---i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      |+||+++|+|.+.+....  +++|....+|+.+++.||+|||...   |+|+|||+.||++|++.++||+|||++.....
T Consensus       150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE  229 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence            999999999999998664  8999999999999999999999753   99999999999999999999999999965543


Q ss_pred             -Ccccc---cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCC---ch---HHHHH-Hhhcccc-CCC--
Q 038249          169 -RRRTM---CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE---HS---DTYRR-IVQVDLK-FPP--  234 (281)
Q Consensus       169 -~~~~~---~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~---~~~~~-~~~~~~~-~~~--  234 (281)
                       .....   .||.+|++||....+..+.++||||||++++|+++|+.+.+...   ..   +.... +..+... ..+  
T Consensus       230 ~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~  309 (361)
T KOG1187|consen  230 GDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR  309 (361)
T ss_pred             cccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence             22222   78999999999988899999999999999999999998876532   11   11111 1111110 000  


Q ss_pred             -C-CCCC--H---HHHHHHHHhcccCCCCCCChhhhhc
Q 038249          235 -K-PIVS--S---AAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       235 -~-~~~~--~---~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                       . ..++  .   .+..+..+|++.+|++||+..++++
T Consensus       310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence             0 1233  2   3668889999999999999998754

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-40  Score=273.58  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=204.1

Q ss_pred             ccCCceecceecccCceEEEEEEEcc----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKR----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--   87 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--   87 (281)
                      ...+|++.+.||.|++|.||++.+..    ++..+|+|.+......  .....+.+|++.++.++|+|++++++++..  
T Consensus         2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            34678999999999999999998653    4788999998655432  345678899999999999999999999877  


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      ....++++||+++++|.+++.... .++...++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            557899999999999999997654 5899999999999999999999999999999999999999999999999987654


Q ss_pred             cCCcc------cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH--------------HHHHHh
Q 038249          167 FNRRR------TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD--------------TYRRIV  226 (281)
Q Consensus       167 ~~~~~------~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------~~~~~~  226 (281)
                      .....      ....+..|++||......++.++|+||||+++++|++|..|+.......              ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            32211      1223456999999888888999999999999999999999875432211              112222


Q ss_pred             hccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          227 QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ......+....++.++.+++.+||.++|++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            223333434467899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=287.90  Aligned_cols=247  Identities=32%  Similarity=0.523  Sum_probs=211.9

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~   92 (281)
                      ..+.|.+...+|.|+|+.+-.+.+..+++..++|.+.....+       ..+|+.++... +|+|+++..+.+.++...+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceee
Confidence            457899999999999999999999999999999999665222       23455444444 7999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe-CCCCcEEEeeecCcccccCCcc
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI-GAQGELKIADFGWSVHTFNRRR  171 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~-~~~~~~~l~dfg~~~~~~~~~~  171 (281)
                      +|||.+.|+-+.+.+...+.+. .++..|+.+|+.|+.+||++|++|||++|+||++ +..++++|+|||..........
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~  471 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD  471 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence            9999999998887777655444 7888899999999999999999999999999999 5889999999999877766655


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ..+-|..|.|||++....+++++|+||||++||+|++|..||...... ++...+..+.+.    ..+|++.++||+.||
T Consensus       472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~vS~~AKdLl~~LL  547 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----ECVSDEAKDLLQQLL  547 (612)
T ss_pred             ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cccCHHHHHHHHHhc
Confidence            556788999999999999999999999999999999999999887776 444444444333    479999999999999


Q ss_pred             ccCCCCCCChhhhhcCCcc-ccC
Q 038249          251 VKDSSQRLPLHKLLEHPWI-IQN  272 (281)
Q Consensus       251 ~~~p~~Rps~~eil~~~~~-~~~  272 (281)
                      +.||.+|+++.+++.|||| .+.
T Consensus       548 ~~dP~~Rl~~~~i~~h~w~~~~~  570 (612)
T KOG0603|consen  548 QVDPALRLGADEIGAHPWFLSHP  570 (612)
T ss_pred             cCChhhCcChhhhccCcchhcCC
Confidence            9999999999999999999 443

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.7e-40  Score=269.16  Aligned_cols=238  Identities=22%  Similarity=0.339  Sum_probs=190.6

Q ss_pred             ceecccCceEEEEEEEccC------------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           22 KPLGRGKFGHVYLAREKRS------------NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~------------~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      +.||.|++|.||+++....            ...+++|.+....   ......+.+++.+++.++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            4689999999999985422            2358888875432   333456788899999999999999999999988


Q ss_pred             EEEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc-------EEEeeec
Q 038249           90 RVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE-------LKIADFG  161 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~-------~~l~dfg  161 (281)
                      ..++++||+++++|..++.. ..++++..++.++.||+.|++|||++|++|+||+|+||+++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999999888875 356899999999999999999999999999999999999987664       8999999


Q ss_pred             CcccccCCcccccCcCCccCCcccc-CCCCCCcccHHhHHHHHHHHH-hCCCCCCCCCchHHHHHHhhccccCCCCCCCC
Q 038249          162 WSVHTFNRRRTMCGTLDYLPPEMVE-SVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS  239 (281)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (281)
                      ++..... .....++..|+|||.+. +..++.++||||||+++|+|+ .|..|+......+.... .....  ......+
T Consensus       158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-~~~~~--~~~~~~~  233 (262)
T cd05077         158 IPITVLS-RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-YEGQC--MLVTPSC  233 (262)
T ss_pred             CCccccC-cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-HhcCc--cCCCCCh
Confidence            8754322 22344678899999876 566888999999999999997 58888876554443322 22211  1222356


Q ss_pred             HHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          240 SAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .++.+++.+||+.||++||++.+|+++
T Consensus       234 ~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         234 KELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-43  Score=289.35  Aligned_cols=262  Identities=35%  Similarity=0.571  Sum_probs=240.8

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      +-..+.+++++++..||.|+||.|-++..+.....+|+|.+.+..+......+.+..|-+++..+++|.||+++--|.++
T Consensus       413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~  492 (732)
T KOG0614|consen  413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS  492 (732)
T ss_pred             hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence            44567789999999999999999999998876667899998777766666667788899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      ..+|++||-|-||.++..+..++.+++..++.++..++.|++|||++||+.+|+||+|.|++.+|-+||.|||++.....
T Consensus       493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999977655


Q ss_pred             Cc--ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          169 RR--RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       169 ~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                      ..  -..||||.|.|||+..+..++.+.|.||||++++||++|.+||.+.++..+++.++++-.....+..++....++|
T Consensus       573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li  652 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI  652 (732)
T ss_pred             CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence            44  4468999999999999999999999999999999999999999999999999999998766666678999999999


Q ss_pred             HHhcccCCCCCCC-----hhhhhcCCccc
Q 038249          247 SQMLVKDSSQRLP-----LHKLLEHPWII  270 (281)
Q Consensus       247 ~~~l~~~p~~Rps-----~~eil~~~~~~  270 (281)
                      +++...+|.+|.-     +.||-+|.||.
T Consensus       653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  653 KKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             HHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence            9999999999995     89999999997

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4e-40  Score=274.55  Aligned_cols=251  Identities=20%  Similarity=0.368  Sum_probs=205.6

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      .++-++|++.+.||.|++|.||+|.+..++.    .+++|.+....  .......+.+|+.+++.++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            3456789999999999999999999987776    46888875433  22334467889999999999999999999875


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      . ..+++++|+++++|.+.+.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence            4 4678999999999999987653 5899999999999999999999999999999999999999999999999988643


Q ss_pred             cCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCH
Q 038249          167 FNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       167 ~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
                      ....     ....++..|++||.+.+..++.++||||||+++++|++ |..||......+....+ ......+..+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  238 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLPQPPICTI  238 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCCH
Confidence            3221     12234668999999988889999999999999999987 89999776554444333 33333444456889


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ++.+++.+||..+|++||++.+++..
T Consensus       239 ~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         239 DVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.7e-40  Score=270.84  Aligned_cols=238  Identities=24%  Similarity=0.335  Sum_probs=190.7

Q ss_pred             ceecccCceEEEEEEEccC------------------------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc
Q 038249           22 KPLGRGKFGHVYLAREKRS------------------------NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN   77 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~------------------------~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~   77 (281)
                      ..||+|+||.||++....+                        ...+++|.+....   ......+.+++.+++.++|||
T Consensus         1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCC
Confidence            3699999999999875321                        2357888874432   233456788899999999999


Q ss_pred             eeeeeeEEEeCCEEEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC---
Q 038249           78 ILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---  153 (281)
Q Consensus        78 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~---  153 (281)
                      |+++++++......++||||+++++|..++.. .+.+++..+..++.||+.||+|||++|++|+||+|+||+++..+   
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999998865 45689999999999999999999999999999999999997654   


Q ss_pred             ----cEEEeeecCcccccCCcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHH-hCCCCCCCCCchHHHHHHhh
Q 038249          154 ----ELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQ  227 (281)
Q Consensus       154 ----~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~  227 (281)
                          .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++++++ +|..||......+.......
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  236 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK  236 (274)
T ss_pred             CccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh
Confidence                3799999987443222 22346778999998754 55788999999999999985 79999987766554333222


Q ss_pred             ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          228 VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                       ....+  ...+.++.++|.+||+.+|++|||+.+++++
T Consensus       237 -~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         237 -KHRLP--EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -ccCCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             12222  2356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.3e-40  Score=268.87  Aligned_cols=235  Identities=23%  Similarity=0.353  Sum_probs=192.6

Q ss_pred             ceecccCceEEEEEEEccCC----------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           22 KPLGRGKFGHVYLAREKRSN----------HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~----------~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      +.||+|++|.||++.++.++          ..+++|.+.....    ....+.+|+.+++.++|+|++++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46899999999999998776          3477787644321    14677889999999999999999999888 778


Q ss_pred             EEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-------cEEEeeecCc
Q 038249           92 YLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-------ELKIADFGWS  163 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-------~~~l~dfg~~  163 (281)
                      ++|+||+++++|.+++...+ .++...+..++.||+.||++||+.|++|+||+|+||+++.++       .++++|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998765 789999999999999999999999999999999999999888       7999999988


Q ss_pred             ccccCCcccccCcCCccCCccccCC--CCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCH
Q 038249          164 VHTFNRRRTMCGTLDYLPPEMVESV--EHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       164 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
                      ..... .....++..|+|||.+.+.  .++.++|+||||+++++|++ |..||......+........ ...+.  ....
T Consensus       156 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~  231 (259)
T cd05037         156 ITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLPM--PDCA  231 (259)
T ss_pred             ccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCCC--CCch
Confidence            65433 3334466789999998766  68889999999999999998 57888776544433332211 11111  2347


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhc
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ++.+++.+||+.+|++|||+.++++
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         232 ELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            8999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-40  Score=271.29  Aligned_cols=238  Identities=22%  Similarity=0.367  Sum_probs=192.3

Q ss_pred             ceecccCceEEEEEEEccCCcE-------EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           22 KPLGRGKFGHVYLAREKRSNHI-------VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~-------~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +.||.|+||.||+|.++..+..       +++|.+....   ....+.+.+|+.+++.++|||++++++.+..++..++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            4699999999999998765443       7788874332   33345678899999999999999999999998899999


Q ss_pred             EeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc--------EEEeeecCccc
Q 038249           95 LEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE--------LKIADFGWSVH  165 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~--------~~l~dfg~~~~  165 (281)
                      |||+++++|..++...+ .+++..++.++.||+.|+.+||+.|++|+||+|+||+++.++.        ++++|||.+..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997654 5899999999999999999999999999999999999987765        69999998754


Q ss_pred             ccCCcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhC-CCCCCCCCchHHHHHHhhccccCCCCCCCCHHHH
Q 038249          166 TFNRRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYG-VPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK  243 (281)
Q Consensus       166 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  243 (281)
                      ... .....++..|+|||.+.+ ..++.++|+||||+++++|++| ..|+...+...... ........+.  ..+.++.
T Consensus       158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~  233 (258)
T cd05078         158 VLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPA--PKWTELA  233 (258)
T ss_pred             cCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCC--CCcHHHH
Confidence            433 223456788999999876 4578899999999999999998 46666555444332 2222222222  4668899


Q ss_pred             HHHHHhcccCCCCCCChhhhhcC
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +++.+||+.||++|||+++|++.
T Consensus       234 ~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         234 NLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHhccChhhCCCHHHHHHh
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3e-40  Score=270.70  Aligned_cols=241  Identities=25%  Similarity=0.442  Sum_probs=198.7

Q ss_pred             ceecccCceEEEEEEEccCC------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           22 KPLGRGKFGHVYLAREKRSN------HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~------~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.||.|++|.||+++++..+      ..+++|.+.....  ......+.+|++.++.++||||+++++++...+..++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36899999999999987543      6789998754321  223456788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-----cEEEeeecCc
Q 038249           96 EYAAKGELYKELQKC-------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-----ELKIADFGWS  163 (281)
Q Consensus        96 e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-----~~~l~dfg~~  163 (281)
                      ||+++++|.+++...       ..+++..++.++.+++.|+.+||+.+++|+||+|+||+++.++     .++++|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998642       3378899999999999999999999999999999999999887     8999999987


Q ss_pred             ccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCC
Q 038249          164 VHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPI  237 (281)
Q Consensus       164 ~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (281)
                      .......     .....+..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+... ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~  237 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKPEN  237 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCccc
Confidence            5432221     12234678999999988889999999999999999998 99999877666655544332 22233346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          238 VSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +|.++.++|.+||.++|++||++.++++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.1e-40  Score=267.10  Aligned_cols=241  Identities=20%  Similarity=0.369  Sum_probs=194.4

Q ss_pred             ceecccCceEEEEEEEcc---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE-eCCEEEEEEec
Q 038249           22 KPLGRGKFGHVYLAREKR---SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY-DQKRVYLILEY   97 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~---~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~~v~e~   97 (281)
                      +.||+|++|.||+|.+..   ++..+++|.+...  ........+.+|+.+++.++|||++++++++. .++..++++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998753   3456999987432  22333566788999999999999999999775 45568899999


Q ss_pred             cCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-------
Q 038249           98 AAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-------  169 (281)
Q Consensus        98 ~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-------  169 (281)
                      +.+++|.+++... ..++...+..++.+|+.|+.+||+.+++|+||+|+||+++.++.++|+|||++......       
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999998764 34677888999999999999999999999999999999999999999999987543221       


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                      .....++..|+|||.+.+..++.++||||||+++++|++ |.+||...+..+....+..... .......+..+.+++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~  237 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR-LLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-CCCCCcCCHHHHHHHHH
Confidence            112234668999999988889999999999999999998 5667776666565555544322 22223578999999999


Q ss_pred             hcccCCCCCCChhhhhc
Q 038249          249 MLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~  265 (281)
                      ||.++|++||++.+++.
T Consensus       238 cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         238 CWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HcCCChhhCCCHHHHHH
Confidence            99999999999999985

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-43  Score=316.32  Aligned_cols=260  Identities=29%  Similarity=0.498  Sum_probs=224.0

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      -+++-...||.|.||.||.|.+..+|+..|+|-+.-.... ......+.+|..++..++|||+|+++++-.+.+..+|.|
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            4577889999999999999999999999999998544433 344566889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-----
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-----  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-----  170 (281)
                      |||++|+|.++++.++..++.-...+..|++.|+.+||++||+|+||||+||+++.+|.+|++|||.+....+..     
T Consensus      1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence            999999999999998878888888899999999999999999999999999999999999999999986554432     


Q ss_pred             --ccccCcCCccCCccccCCC---CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhh--ccccCCCCCCCCHHHH
Q 038249          171 --RTMCGTLDYLPPEMVESVE---HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ--VDLKFPPKPIVSSAAK  243 (281)
Q Consensus       171 --~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~  243 (281)
                        ....||+.|||||++.+..   ...+.|||||||++.||+||+.||...++.-.+..-..  ...+.|.  .++.+-+
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~--~ls~~g~ 1471 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE--RLSSEGR 1471 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch--hhhHhHH
Confidence              3456999999999986544   56689999999999999999999998887765543222  2333333  4999999


Q ss_pred             HHHHHhcccCCCCCCChhhhhcCCccccCCCCCCC
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGV  278 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~~~  278 (281)
                      +||..||..||++|.++.+|++|-|-+...++..+
T Consensus      1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~s~ 1506 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGKSCTDEDSS 1506 (1509)
T ss_pred             HHHHHHHhcCchhhhHHHHHHHhhccccccccchh
Confidence            99999999999999999999999999887665543

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-39  Score=267.00  Aligned_cols=242  Identities=24%  Similarity=0.410  Sum_probs=191.3

Q ss_pred             ceecccCceEEEEEEEcc--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccC
Q 038249           22 KPLGRGKFGHVYLAREKR--SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      +.||+|+||.||+|....  ....+++|.+....  .......+.+|+..++.++|+||+++++.+...+..++||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            468999999999996543  34568888775432  23334567889999999999999999999999999999999999


Q ss_pred             CCChhHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-----
Q 038249          100 KGELYKELQKCK-----YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-----  169 (281)
Q Consensus       100 ~~~L~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-----  169 (281)
                      +++|.+++....     ..++..++.++.||+.|++|||++|++|+||+|+||+++.++.++++|||++......     
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999987643     2467788999999999999999999999999999999999999999999987543221     


Q ss_pred             cccccCcCCccCCcccc-------CCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhcc-ccCCC---CCC
Q 038249          170 RRTMCGTLDYLPPEMVE-------SVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVD-LKFPP---KPI  237 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~---~~~  237 (281)
                      .....+++.|+|||.+.       ...++.++|+||||+++++|++ |..||....+.+......... ...+.   ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            12233466799999863       2345779999999999999998 788998777666555443322 11111   225


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          238 VSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ++..+.+++..|+ .||++|||++++++.
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence            7888999999998 599999999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=275.63  Aligned_cols=258  Identities=31%  Similarity=0.580  Sum_probs=229.6

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKR   90 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~   90 (281)
                      ..+..+|-.+..||.|+||.|.++..+.+.+.+|||++.++-+-+....+--..|-++|... +-|.+++++..|..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            56678899999999999999999999999999999999877665444333334455555554 46889999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc---cc
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TF  167 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~---~~  167 (281)
                      +|+||||+.||+|-..+++-+.+.+..+..++.+|+.||-+||++||+.+|++.+|||++..|++||.|||++..   ..
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            999999999999999999888899999999999999999999999999999999999999999999999999854   33


Q ss_pred             CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          168 NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      ..+...+|||.|+|||+...++|+.+.|.||+|+++|||+.|++||++.+..++++.++.....++.  .++.+..++.+
T Consensus       505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK--slSkEAv~ick  582 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK--SLSKEAVAICK  582 (683)
T ss_pred             cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc--cccHHHHHHHH
Confidence            4567789999999999999999999999999999999999999999999999999999988777766  49999999999


Q ss_pred             HhcccCCCCCCC-----hhhhhcCCcccc
Q 038249          248 QMLVKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       248 ~~l~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      ..|...|.+|..     -++|-+||||..
T Consensus       583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  583 GLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HHhhcCCccccCCCCccccchhhCcchhh
Confidence            999999999985     478899999974

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=273.04  Aligned_cols=254  Identities=23%  Similarity=0.430  Sum_probs=210.2

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--C----ceeeeeeEEEeC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH--P----NILRLYGYFYDQ   88 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h--~----~i~~~~~~~~~~   88 (281)
                      -++|.+.+.+|+|.||.|-.+.+..++..+|||++..-    ....++.+-|++.++++.+  |    -++.+.++|.-.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            58899999999999999999999999999999998432    2334556678999999932  2    377888889989


Q ss_pred             CEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC---------------
Q 038249           89 KRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA---------------  151 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~---------------  151 (281)
                      +++|+|+|.+ |.|+.+.+..++  +++...++.+..|++.++.+||+.+++|.|+||+||++..               
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999998 559999998754  5899999999999999999999999999999999999842               


Q ss_pred             -----CCcEEEeeecCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHH---
Q 038249          152 -----QGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR---  223 (281)
Q Consensus       152 -----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---  223 (281)
                           +-.++++|||.+..........+.|..|.|||++.+..++.++||||+||||.|+++|...|...++.+-+.   
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe  322 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME  322 (415)
T ss_pred             eccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence                 235899999999887777777888999999999999999999999999999999999999998877666431   


Q ss_pred             HHhhc------------------cccCCCC-----------------------CCCCHHHHHHHHHhcccCCCCCCChhh
Q 038249          224 RIVQV------------------DLKFPPK-----------------------PIVSSAAKDLISQMLVKDSSQRLPLHK  262 (281)
Q Consensus       224 ~~~~~------------------~~~~~~~-----------------------~~~~~~l~~li~~~l~~~p~~Rps~~e  262 (281)
                      .+++.                  ...++..                       ...-.+|.+||++||..||.+|+|+.|
T Consensus       323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E  402 (415)
T KOG0671|consen  323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE  402 (415)
T ss_pred             HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence            11111                  0011100                       012235889999999999999999999


Q ss_pred             hhcCCccccCC
Q 038249          263 LLEHPWIIQNA  273 (281)
Q Consensus       263 il~~~~~~~~~  273 (281)
                      +|.||||....
T Consensus       403 AL~HpFF~~~~  413 (415)
T KOG0671|consen  403 ALSHPFFARLT  413 (415)
T ss_pred             HhcCHHhhcCC
Confidence            99999998753

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.8e-39  Score=265.04  Aligned_cols=241  Identities=24%  Similarity=0.397  Sum_probs=190.8

Q ss_pred             ceecccCceEEEEEEEcc--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccC
Q 038249           22 KPLGRGKFGHVYLAREKR--SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      +.||+|+||.||+|.+..  ++..+++|.+.....  ......+.+|+.++++++||||+++++.+.+....++|+||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            468999999999998653  456789998865432  2233467889999999999999999999998889999999999


Q ss_pred             CCChhHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-----
Q 038249          100 KGELYKELQKCK-----YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-----  169 (281)
Q Consensus       100 ~~~L~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-----  169 (281)
                      +++|.+++....     ..+...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......     
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999987532     3567778899999999999999999999999999999999999999999987543222     


Q ss_pred             cccccCcCCccCCccccCC-------CCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhc-cccCCC---CCC
Q 038249          170 RRTMCGTLDYLPPEMVESV-------EHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQV-DLKFPP---KPI  237 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~-------~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~---~~~  237 (281)
                      .....++..|+|||.+.+.       .++.++|+||||+++++|++ |..||......+........ ....+.   ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            1223456789999987532       35778999999999999996 99999877666554332222 111111   124


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          238 VSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .+..+.+++.+|+ .+|++|||++||+.
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            6788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=8.3e-41  Score=251.92  Aligned_cols=249  Identities=27%  Similarity=0.524  Sum_probs=203.6

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeC--CEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQ--KRV   91 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~--~~~   91 (281)
                      .++|++.+++|+|.+++||.|....+++.+++|.+.+-.      .+++.+|+.+|+.+. +|||++++++..++  ...
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            478999999999999999999999999999999985432      567899999999996 99999999999764  467


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC-CcEEEeeecCcccccCCc
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-GELKIADFGWSVHTFNRR  170 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~-~~~~l~dfg~~~~~~~~~  170 (281)
                      .+++||+++.+...+...   ++...++..+.+++.||.|+|++||+|+|++|+|+|+|.. ..++|+|+|++...-+..
T Consensus       111 aLiFE~v~n~Dfk~ly~t---l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYPT---LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhHhhhhccccHHHHhhh---hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            899999998766665554   8899999999999999999999999999999999999976 469999999997665554


Q ss_pred             ccc--cCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCC-CCCCchHHHHHHhhc-------------ccc--
Q 038249          171 RTM--CGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQV-------------DLK--  231 (281)
Q Consensus       171 ~~~--~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~-------------~~~--  231 (281)
                      ...  ..+..|--||.+... .++..-|+|||||++..|++.+.|| .+.++.+++-.+-+.             ...  
T Consensus       188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld  267 (338)
T KOG0668|consen  188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD  267 (338)
T ss_pred             eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence            443  345567899997544 4788999999999999999888775 555555544332211             000  


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          232 --------------------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       232 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                                          .......+.+..+++.++|.+|.++|+|+.|++.||||...
T Consensus       268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                                01112367899999999999999999999999999999854

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.9e-39  Score=265.36  Aligned_cols=246  Identities=24%  Similarity=0.401  Sum_probs=200.1

Q ss_pred             ceecceecccCceEEEEEEEcc---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-----
Q 038249           18 FDIGKPLGRGKFGHVYLAREKR---SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-----   89 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~---~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----   89 (281)
                      |++.+.||+|++|.||+|.+..   ++..+|+|.+..... .....+.+.+|++.++.++|||++++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            6788999999999999998653   468899999865432 3334566788999999999999999999886532     


Q ss_pred             -EEEEEEeccCCCChhHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           90 -RVYLILEYAAKGELYKELQKC------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        90 -~~~~v~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                       ..+++++|+.+++|..++...      ..++...++.++.||+.|+++||+.|++|+||+|+||+++.++.++++|||.
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             347889999999998876432      1478899999999999999999999999999999999999999999999998


Q ss_pred             cccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCC
Q 038249          163 SVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKP  236 (281)
Q Consensus       163 ~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (281)
                      +.......     ....+++.|++||.+.+..++.++|+||||+++++|++ |.+||...+..+....+..... .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~  238 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-LKQPP  238 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-CCCCC
Confidence            76442221     12234567999999988888999999999999999998 8899987776666555544322 22234


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ..+.++.+++.+||+.+|++|||+.+++.
T Consensus       239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         239 DCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            57899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-42  Score=263.65  Aligned_cols=262  Identities=26%  Similarity=0.426  Sum_probs=213.0

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe------
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD------   87 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------   87 (281)
                      ..+.|.-...||+|.||.||+|+.+++|+.|++|++..+. ..+.......+|+.+++.++|+|++.++.+|..      
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            3477888999999999999999999999999999875432 122233446679999999999999999988753      


Q ss_pred             --CCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           88 --QKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        88 --~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                        ...+++||++|+. +|..++... -.++..++..++.+++.||.|+|++.|+|+|++++|++++.+|.++|.|||+++
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence              3468999999988 899888876 458999999999999999999999999999999999999999999999999974


Q ss_pred             cccCC-------cccccCcCCccCCcccc-CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhh--ccccCCC
Q 038249          165 HTFNR-------RRTMCGTLDYLPPEMVE-SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ--VDLKFPP  234 (281)
Q Consensus       165 ~~~~~-------~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~  234 (281)
                      .....       ..+..-|.+|.+||.+. ...++++.|+|+-||++.+|+++.+.+.+++..+++..+.+  +......
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            32111       12233488999999864 45689999999999999999999999999888877665433  3222222


Q ss_pred             CCC-------------------------------CCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCCC
Q 038249          235 KPI-------------------------------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSG  277 (281)
Q Consensus       235 ~~~-------------------------------~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~~  277 (281)
                      |++                               -.++..+++.+||..||++|+++.+++.|.||.+.+.|.+
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqa  326 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQA  326 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchh
Confidence            211                               2236779999999999999999999999999999887743

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=263.76  Aligned_cols=260  Identities=28%  Similarity=0.546  Sum_probs=226.2

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      ....+.+++|++++.||+|+++.|.++..+++.+.+|+|++.+.-+..++.+..+..|-....+- +||.+|.++.+|..
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            33455679999999999999999999999999999999999887777766667777777766555 79999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc--
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH--  165 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~--  165 (281)
                      ...+++|.||++||+|--.++.++.++++.++.+...|+.||.|||++||+.+|+|.+||++|..|++||.|+|+...  
T Consensus       323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999999999988888888899999999999999999999999999999999999999999999999999754  


Q ss_pred             -ccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCC--------CCchHHHHHHhhccccCCCCC
Q 038249          166 -TFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEA--------KEHSDTYRRIVQVDLKFPPKP  236 (281)
Q Consensus       166 -~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~~~~~  236 (281)
                       ....+...+|||+|.|||++.+..|+...|.|+||+++++|+.|..||+-        ++.+-+++.++......|.  
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--  480 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--  480 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--
Confidence             34456778999999999999999999999999999999999999999953        2222344555555554544  


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC------hhhhhcCCccc
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLP------LHKLLEHPWII  270 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps------~~eil~~~~~~  270 (281)
                      .++-....+++..|+.||++|..      +.++..|+||.
T Consensus       481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr  520 (593)
T KOG0695|consen  481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR  520 (593)
T ss_pred             eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence            47778889999999999999974      78999999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.9e-39  Score=259.42  Aligned_cols=240  Identities=40%  Similarity=0.744  Sum_probs=206.0

Q ss_pred             CceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCChhHHH
Q 038249           28 KFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL  107 (281)
Q Consensus        28 ~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~  107 (281)
                      ++|.||++++..+++.+++|++........  ...+.+|++.+++++|+|++++++.+......++++|++++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            578999999998899999999965543221  467889999999999999999999999999999999999999999999


Q ss_pred             HhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--cccccCcCCccCCccc
Q 038249          108 QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRTMCGTLDYLPPEMV  185 (281)
Q Consensus       108 ~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~aPE~~  185 (281)
                      .....++...++.++.+++.++.+||+.+++|+||+|.||+++.++.++++|||.+......  .....++..|++||.+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            88766899999999999999999999999999999999999999999999999998655442  3445578899999999


Q ss_pred             cCCCCCCcccHHhHHHHHHHHHhCCCCCCC-CCchHHHHHHhhccccCCCCCC-CCHHHHHHHHHhcccCCCCCCChhhh
Q 038249          186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEA-KEHSDTYRRIVQVDLKFPPKPI-VSSAAKDLISQMLVKDSSQRLPLHKL  263 (281)
Q Consensus       186 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~ei  263 (281)
                      .+...+.++|+|+||++++++++|..||.. .........+............ ++.++.+++.+||..+|++||++.++
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA  238 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence            888888999999999999999999999987 4444444444444333322212 88999999999999999999999999


Q ss_pred             hcCCcc
Q 038249          264 LEHPWI  269 (281)
Q Consensus       264 l~~~~~  269 (281)
                      ++||||
T Consensus       239 ~~~~~~  244 (244)
T smart00220      239 LQHPFF  244 (244)
T ss_pred             hhCCCC
Confidence            999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.5e-39  Score=266.08  Aligned_cols=247  Identities=18%  Similarity=0.233  Sum_probs=188.8

Q ss_pred             cCCceecceecccCceEEEEEEEccC---CcEEEEEEeeccccc--chHH------HHHHHHHHHHHHhCCCCceeeeee
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRS---NHIVALKVLFKSQLQ--QSQV------EHQLRREVEIQSHLRHPNILRLYG   83 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~---~~~~~lK~~~~~~~~--~~~~------~~~~~~e~~~l~~~~h~~i~~~~~   83 (281)
                      -++|++.+.||+|+||.||+|.+..+   +..+++|........  .+..      ......+...++.++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999999877   566777764322211  0000      011122334456678999999998


Q ss_pred             EEEeCC----EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEee
Q 038249           84 YFYDQK----RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIAD  159 (281)
Q Consensus        84 ~~~~~~----~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~d  159 (281)
                      .+....    ..++++++... ++.+.++.....++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D  169 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID  169 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence            765433    44777887744 6777777666678889999999999999999999999999999999999999999999


Q ss_pred             ecCcccccC----------CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHH------
Q 038249          160 FGWSVHTFN----------RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTY------  222 (281)
Q Consensus       160 fg~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~------  222 (281)
                      ||++.....          ......+|+.|+|||.+.+..++.++||||||+++++|++|..||...... ...      
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~  249 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD  249 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence            999754321          112345899999999999999999999999999999999999999877432 221      


Q ss_pred             --HHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          223 --RRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       223 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                        ..+.....   ..+..+.++.++++.|+..+|++||++.+|++
T Consensus       250 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        250 FIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              22222221   22356899999999999999999999999875

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.6e-38  Score=259.14  Aligned_cols=241  Identities=20%  Similarity=0.335  Sum_probs=190.1

Q ss_pred             ceecccCceEEEEEEEccCC--cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccC
Q 038249           22 KPLGRGKFGHVYLAREKRSN--HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~--~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      +.||+|+||.||++.....+  ..+++|.+....  .......+.+|+..++.++||||+++++.+......++|+||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            46999999999999765332  346677664432  22335678889999999999999999999999899999999999


Q ss_pred             CCChhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-----Cc
Q 038249          100 KGELYKELQKC----KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RR  170 (281)
Q Consensus       100 ~~~L~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-----~~  170 (281)
                      +++|.+++...    ...+...++.++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++.....     ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999998753    2356778889999999999999999999999999999999999999999998743221     12


Q ss_pred             ccccCcCCccCCccccC-------CCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccc-c---CCCCCCC
Q 038249          171 RTMCGTLDYLPPEMVES-------VEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDL-K---FPPKPIV  238 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~---~~~~~~~  238 (281)
                      ....++..|+|||.+..       ..++.++|+||||+++++|++ +..||...+..+.......... .   ......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            23456788999998742       234678999999999999986 5778877776666655443321 1   1112347


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +..+.+++..|+ .+|++||++.++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            889999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.4e-40  Score=294.90  Aligned_cols=251  Identities=27%  Similarity=0.467  Sum_probs=203.0

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-------
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-------   87 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------   87 (281)
                      .++|+.++.||+|+||.||+++++-+|..||||++....  +......+.+|+..+.+++|||||+++..+.+       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            477899999999999999999999999999999997654  45567789999999999999999998643210       


Q ss_pred             -----------------------------------------------------------------------C--------
Q 038249           88 -----------------------------------------------------------------------Q--------   88 (281)
Q Consensus        88 -----------------------------------------------------------------------~--------   88 (281)
                                                                                             .        
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                   0        


Q ss_pred             ---------------------------------CEEEEEEeccCCCChhHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHh
Q 038249           89 ---------------------------------KRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHG  134 (281)
Q Consensus        89 ---------------------------------~~~~~v~e~~~~~~L~~~~~~~~~l-~~~~~~~i~~~i~~~l~~Lh~  134 (281)
                                                       -.+||-||||+..++++++..+... ..+.+|+++.+|+.||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                             1368889999887777777665433 478899999999999999999


Q ss_pred             cCceecCCCCCCeEeCCCCcEEEeeecCccccc---------------------CCcccccCcCCccCCccccCCC---C
Q 038249          135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---------------------NRRRTMCGTLDYLPPEMVESVE---H  190 (281)
Q Consensus       135 ~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---------------------~~~~~~~~~~~~~aPE~~~~~~---~  190 (281)
                      .|++||||||.||+++.++.|||+|||++....                     +......||.-|+|||++.+..   |
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999999999999999999975410                     0112346888999999986554   8


Q ss_pred             CCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC---CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCC
Q 038249          191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP---PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHP  267 (281)
Q Consensus       191 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~  267 (281)
                      +.++|+||||++++||+..  .-..++....+..+..+....+   ..+ .-..-..+|++||+.||.+|||+.|+|.+.
T Consensus       796 n~KiDmYSLGIVlFEM~yP--F~TsMERa~iL~~LR~g~iP~~~~f~~~-~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~  872 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLYP--FGTSMERASILTNLRKGSIPEPADFFDP-EHPEEASLIRWLLSHDPSKRPTATELLNSE  872 (1351)
T ss_pred             cchhhhHHHHHHHHHHhcc--CCchHHHHHHHHhcccCCCCCCcccccc-cchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence            9999999999999999853  2234566666677766655555   211 223467899999999999999999999999


Q ss_pred             ccc
Q 038249          268 WII  270 (281)
Q Consensus       268 ~~~  270 (281)
                      ||-
T Consensus       873 llp  875 (1351)
T KOG1035|consen  873 LLP  875 (1351)
T ss_pred             CCC
Confidence            986

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-39  Score=273.66  Aligned_cols=254  Identities=30%  Similarity=0.521  Sum_probs=222.0

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +-|..++.||-|+||+|.++....++..||.|.+.+...........++.|-.+|..-+++-||+++-.|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            56888999999999999999999999999999997776655555677888999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc---------c
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---------T  166 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~---------~  166 (281)
                      +|++||++-.++-+.+-+.++.++.++.++..|++++|+.|++|+||||+||++|.+|++||.|||++..         .
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence            9999999999999888999999999999999999999999999999999999999999999999998621         0


Q ss_pred             cCC--c----------------------------------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCC
Q 038249          167 FNR--R----------------------------------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGV  210 (281)
Q Consensus       167 ~~~--~----------------------------------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  210 (281)
                      ...  .                                  -..+||++|+|||++....++...|.||.|++|++|+.|.
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence            000  0                                  0135899999999999999999999999999999999999


Q ss_pred             CCCCCCCchHHHHHHhhc--cccCCCCCCCCHHHHHHHHHhcccCCCCCCC---hhhhhcCCccc
Q 038249          211 PPFEAKEHSDTYRRIVQV--DLKFPPKPIVSSAAKDLISQMLVKDSSQRLP---LHKLLEHPWII  270 (281)
Q Consensus       211 ~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~~~~~~  270 (281)
                      +||...++.++...+...  .+.++....++.+..++|.+++. +++.|.-   ++++..||||+
T Consensus       869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFk  932 (1034)
T KOG0608|consen  869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFK  932 (1034)
T ss_pred             CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccc
Confidence            999988888776555442  33455556799999999999886 8888884   77899999997

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=278.17  Aligned_cols=254  Identities=30%  Similarity=0.511  Sum_probs=216.6

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe-----CC
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD-----QK   89 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-----~~   89 (281)
                      ..|++...||.|.+|.||+++.+.+++..|+|+.+.+.-.    ..++..|+++++.. .|||++.+++++..     ++
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            5588999999999999999999999999999998766422    34567788888888 69999999999863     57


Q ss_pred             EEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           90 RVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      .+|+|||||.|||..++++.-  ..+.++.+..|+..++.|+++||++.++|+||+-.||+++.++.+||+|||.+.+..
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            899999999999999999863  458899999999999999999999999999999999999999999999999986643


Q ss_pred             ---CCcccccCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHH-hhccccCCCCCCC
Q 038249          168 ---NRRRTMCGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI-VQVDLKFPPKPIV  238 (281)
Q Consensus       168 ---~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (281)
                         ...+...|||.|||||+..     ...|+..+|+||||++..||..|.+|+.+..+...+-.+ .........+...
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kW  254 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKW  254 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhH
Confidence               3456678999999999873     334677899999999999999999999888776554332 3333333344567


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +.++.++|..||..|..+||+..++|+|||+.+..
T Consensus       255 s~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  255 SKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             HHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence            88999999999999999999999999999998543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=280.15  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=227.9

Q ss_pred             ccchhhhcccccCCceecceecccCceEEEEEEEccCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceee
Q 038249            4 EVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSN---HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILR   80 (281)
Q Consensus         4 ~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~   80 (281)
                      |.--++.+.+..+.-+|.+.||.|.||.|+++..+..|   ..||||.+....  .+.....|+.|+.++-+++||||++
T Consensus       617 qAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIr  694 (996)
T KOG0196|consen  617 QAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIR  694 (996)
T ss_pred             HHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEE
Confidence            34455667777888999999999999999999988666   459999996553  4455788999999999999999999


Q ss_pred             eeeEEEeCCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEee
Q 038249           81 LYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIAD  159 (281)
Q Consensus        81 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~d  159 (281)
                      +.|+.....-+.||+||+++|+|..+++.+ +.++..++.-+++.|+.|+.||.++|++||||...||+++.+-..|++|
T Consensus       695 LEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsD  774 (996)
T KOG0196|consen  695 LEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSD  774 (996)
T ss_pred             EEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecc
Confidence            999999999999999999999999999865 5699999999999999999999999999999999999999999999999


Q ss_pred             ecCcccccCCcccc----cC--cCCccCCccccCCCCCCcccHHhHHHHHHHHH-hCCCCCCCCCchHHHHHHhhccccC
Q 038249          160 FGWSVHTFNRRRTM----CG--TLDYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKF  232 (281)
Q Consensus       160 fg~~~~~~~~~~~~----~~--~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~  232 (281)
                      ||+++...+.....    .|  +.+|+|||.+.-..++.+|||||+|++|||.+ .|..||.+.++.+.+..+.++- ..
T Consensus       775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy-RL  853 (996)
T KOG0196|consen  775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY-RL  853 (996)
T ss_pred             ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc-CC
Confidence            99997554433211    11  45899999999999999999999999999977 6999999999999999988864 45


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      |++..+|..|.+|+..||++|-.+||.+.+|+.
T Consensus       854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            555589999999999999999999999999986

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-40  Score=252.65  Aligned_cols=263  Identities=24%  Similarity=0.391  Sum_probs=211.6

Q ss_pred             hhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHH-hCCCCceeeeeeEEE
Q 038249            8 KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS-HLRHPNILRLYGYFY   86 (281)
Q Consensus         8 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~   86 (281)
                      ....+|.-.+.+-+..||.|+||+|++-.++.+|+..|||.+.......+  ...+..|.+... .-+.||||+++|...
T Consensus        56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke--q~rll~e~d~~mks~~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE--QKRLLMEHDTVMKSSNCPNIVKFYGALF  133 (361)
T ss_pred             ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH--HHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence            34455666778889999999999999999999999999999976654222  344555665444 447899999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeee
Q 038249           87 DQKRVYLILEYAAKGELYKELQ-----KCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADF  160 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~df  160 (281)
                      ..+..|+.||.++- ||..+.+     ....+++..+-.|....+.||.||.. .+|+|||+||+||+++..|.+||+||
T Consensus       134 ~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  134 SEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             cCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence            99999999999966 7766554     23458999999999999999999995 49999999999999999999999999


Q ss_pred             cCcccccCC--cccccCcCCccCCccccC--CCCCCcccHHhHHHHHHHHHhCCCCCCCCCc-hHHHHHHhhccccCCC-
Q 038249          161 GWSVHTFNR--RRTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEAKEH-SDTYRRIVQVDLKFPP-  234 (281)
Q Consensus       161 g~~~~~~~~--~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~-  234 (281)
                      |.+-+..++  .....|-..|+|||.+..  ..|+.+||+||||++++|+.||..|+...+. .+++..+..+....-. 
T Consensus       213 GIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  213 GICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             cchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence            998655443  233456678999999843  3488899999999999999999999977554 3455555554432221 


Q ss_pred             C---CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          235 K---PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       235 ~---~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .   -.++..+.++|..||..|-..||.+.+++++||+..++
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence            1   23888999999999999999999999999999998774

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-39  Score=263.13  Aligned_cols=256  Identities=33%  Similarity=0.573  Sum_probs=215.6

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHH----HHHHHHHHHHHhCCCCceeeeeeEEE-eCCE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE----HQLRREVEIQSHLRHPNILRLYGYFY-DQKR   90 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~----~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~   90 (281)
                      .+|.++..||+|+|+.||+|.|...+..||+|+-.....+.++-.    +..-+|.++-+.++||.||++++++. +...
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            679999999999999999999999999999999866555544332    23457899999999999999999996 4567


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--CceecCCCCCCeEeCC---CCcEEEeeecCccc
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK--HVIHRDIKPENLLIGA---QGELKIADFGWSVH  165 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--~i~H~di~~~Ni~~~~---~~~~~l~dfg~~~~  165 (281)
                      +|-|.|||+|.+|.-+++..+.+++.+++.|+.||+.||.||...  .|+|.|++|.||++-.   -|.+||.|||++..
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            899999999999999999999999999999999999999999965  6999999999999943   36799999999977


Q ss_pred             ccCCccc----------ccCcCCccCCcccc----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHH---Hhh
Q 038249          166 TFNRRRT----------MCGTLDYLPPEMVE----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRR---IVQ  227 (281)
Q Consensus       166 ~~~~~~~----------~~~~~~~~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~---~~~  227 (281)
                      +.+....          ..||-+|++||.+.    ....+.+.||||+|+++|.++.|+.||...... ++++.   +..
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA  702 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA  702 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence            6554322          35788999999872    334677999999999999999999999654333 33321   233


Q ss_pred             ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          228 VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      ....+|..+.++.+..+||++||++-.++|....++..||||--
T Consensus       703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            45678888899999999999999999999999999999999974

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=268.99  Aligned_cols=249  Identities=24%  Similarity=0.428  Sum_probs=217.4

Q ss_pred             cccccCCcee--cceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           11 KRWTLNDFDI--GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        11 ~~~~~~~y~~--~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      -+|.|++-+|  ..+||.|-||.||.+.|++-.-.||||.+..+.+.    .+++..|+.+++.++|||+|+++++|...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            3567755444  68899999999999999998888999999777654    35688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           89 KRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      --+|||+||+..|+|.+++.+..  .++---++.++.||..|+.||.+++++|+|+...|.++.++..+|+.|||+++.+
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            99999999999999999998764  3677778999999999999999999999999999999999999999999999877


Q ss_pred             cCCcccc----cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          167 FNRRRTM----CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       167 ~~~~~~~----~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                      .+.+...    --+..|+|||.+.-..++.++|||+||++|||+.| |..||.+.+..+.+..+.++ +.......+|..
T Consensus       416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM~~PeGCPpk  494 (1157)
T KOG4278|consen  416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRMDGPEGCPPK  494 (1157)
T ss_pred             cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-ccccCCCCCCHH
Confidence            6665432    23568999999999999999999999999999986 89999999888887776665 344445589999


Q ss_pred             HHHHHHHhcccCCCCCCChhhhh
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLL  264 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil  264 (281)
                      ..+|+++||+++|.+||++.||-
T Consensus       495 VYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  495 VYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHHHHhcCCcccCccHHHHH
Confidence            99999999999999999998874

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=8.9e-38  Score=277.86  Aligned_cols=254  Identities=20%  Similarity=0.288  Sum_probs=175.9

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccC----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeE-
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRS----NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGY-   84 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~----~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-   84 (281)
                      ...+..++|++.+.||+|+||.||+|.+..+    +..+|+|.+.......     ...++  .++...+.++..+... 
T Consensus       126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~  198 (566)
T PLN03225        126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGF  198 (566)
T ss_pred             CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhh
Confidence            5567889999999999999999999999988    8999999875322111     01111  1111112222221111 


Q ss_pred             -----EEeCCEEEEEEeccCCCChhHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCcee
Q 038249           85 -----FYDQKRVYLILEYAAKGELYKELQKCKY--------------------FSERRAATYVASLARALIYCHGKHVIH  139 (281)
Q Consensus        85 -----~~~~~~~~~v~e~~~~~~L~~~~~~~~~--------------------l~~~~~~~i~~~i~~~l~~Lh~~~i~H  139 (281)
                           .......++|+||+++++|.+++.....                    .....+..++.||+.||.|||++||+|
T Consensus       199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH  278 (566)
T PLN03225        199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH  278 (566)
T ss_pred             hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence                 2345678999999999999998875421                    123346789999999999999999999


Q ss_pred             cCCCCCCeEeCC-CCcEEEeeecCcccccCC----cccccCcCCccCCccccCCC----------------------CCC
Q 038249          140 RDIKPENLLIGA-QGELKIADFGWSVHTFNR----RRTMCGTLDYLPPEMVESVE----------------------HDA  192 (281)
Q Consensus       140 ~di~~~Ni~~~~-~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~aPE~~~~~~----------------------~~~  192 (281)
                      +||||+||+++. ++.+||+|||++......    .....+++.|+|||.+....                      ++.
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            999999999986 579999999998643221    23446788999999653221                      234


Q ss_pred             cccHHhHHHHHHHHHhCCCCCCCCCchHHHHH-Hhhcccc-------------------CCCCCCCCHHHHHHHHHhccc
Q 038249          193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRR-IVQVDLK-------------------FPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       193 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ++|||||||++++|+++..++..  ....+.. +......                   +......+.+..+||.+||+.
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            56999999999999987665432  1111111 1110000                   000011233456899999999


Q ss_pred             CCCCCCChhhhhcCCccccC
Q 038249          253 DSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~  272 (281)
                      ||++|||+.++|+||||...
T Consensus       437 dP~kR~ta~e~L~Hpff~~~  456 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDRE  456 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCC
Confidence            99999999999999999865

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=268.49  Aligned_cols=246  Identities=26%  Similarity=0.432  Sum_probs=211.1

Q ss_pred             CCceecceecccCceEEEEEEEccC----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRS----NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~----~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      +.-++.+.||.|-||.||.|.+..-    +-.||||....+...  +..+.+..|..++++++||||++++|++.+ .-.
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            3344578999999999999986532    335889998765422  236789999999999999999999999986 467


Q ss_pred             EEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           92 YLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      |+|||.++.|.|+++++.++ .++...+..++.||+.||.|||+.+++||||...||++.....+||.|||+++......
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            99999999999999998764 58999999999999999999999999999999999999999999999999998766654


Q ss_pred             cccc----CcCCccCCccccCCCCCCcccHHhHHHHHHHHH-hCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          171 RTMC----GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       171 ~~~~----~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                      ....    -+..|+|||..+-..++.+||||-||+.+||++ .|..||.+..+.+.+-.+.++.. .|-++++|..|..+
T Consensus       546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-lP~P~nCPp~LYsl  624 (974)
T KOG4257|consen  546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-LPCPPNCPPALYSL  624 (974)
T ss_pred             hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-CCCCCCCChHHHHH
Confidence            3332    356899999999999999999999999999987 69999999999999888877653 44455899999999


Q ss_pred             HHHhcccCCCCCCChhhhhc
Q 038249          246 ISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~  265 (281)
                      ..+||+++|.+||.+.+|..
T Consensus       625 mskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  625 MSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHhccCcccCCcHHHHHH
Confidence            99999999999999877653

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=265.16  Aligned_cols=247  Identities=21%  Similarity=0.371  Sum_probs=211.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      -+...+.++||+|-||.|.++.-.. +..||+|.+..+...  ...+++.+|+.+|.+++||||+.++++|..++-++++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            3567889999999999999998763 688999999877543  3468899999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCccc
Q 038249           95 LEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT  172 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~  172 (281)
                      +||++.|+|..++...  +.+.-....+++.||+.|++||.+.+++|||+.+.|++++.+.++|++|||+++........
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999999999876  33456677889999999999999999999999999999999999999999998755544433


Q ss_pred             -----ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHH--hCCCCCCCCCchHHHHHHhhcc------ccCCCCCCCC
Q 038249          173 -----MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL--YGVPPFEAKEHSDTYRRIVQVD------LKFPPKPIVS  239 (281)
Q Consensus       173 -----~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~  239 (281)
                           ..-+.+|+|||.+..+.++.+||+|++|+++||++  +...||...++.+..+......      .....++.+|
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp  773 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP  773 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence                 23467999999999999999999999999999976  6889999988888776654321      1122345699


Q ss_pred             HHHHHHHHHhcccCCCCCCChhhhh
Q 038249          240 SAAKDLISQMLVKDSSQRLPLHKLL  264 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps~~eil  264 (281)
                      ..+.+++-+|+..|.++|||++++-
T Consensus       774 ~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  774 QGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             HHHHHHHHHHhchhhhcCCCHHHHH
Confidence            9999999999999999999999985

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.8e-37  Score=265.87  Aligned_cols=262  Identities=22%  Similarity=0.319  Sum_probs=190.8

Q ss_pred             hcccccCCceecceecccCceEEEEEEEc----------------cCCcEEEEEEeecccccch-H----------HHHH
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREK----------------RSNHIVALKVLFKSQLQQS-Q----------VEHQ   62 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~----------------~~~~~~~lK~~~~~~~~~~-~----------~~~~   62 (281)
                      ..+|..++|++.++||+|+||+||+|.+.                ..+..||||++........ +          ..+.
T Consensus       139 ~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~  218 (507)
T PLN03224        139 NSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAET  218 (507)
T ss_pred             CCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccch
Confidence            45788999999999999999999999752                2346799999854331110 0          0112


Q ss_pred             HHHHHHHHHhCCCCce-----eeeeeEEEe--------CCEEEEEEeccCCCChhHHHHhC-------------------
Q 038249           63 LRREVEIQSHLRHPNI-----LRLYGYFYD--------QKRVYLILEYAAKGELYKELQKC-------------------  110 (281)
Q Consensus        63 ~~~e~~~l~~~~h~~i-----~~~~~~~~~--------~~~~~~v~e~~~~~~L~~~~~~~-------------------  110 (281)
                      ...|+.++.+++|.++     +++++++..        .+..++|+||+++++|.+++...                   
T Consensus       219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~  298 (507)
T PLN03224        219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP  298 (507)
T ss_pred             hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence            2345666677766543     566666642        35679999999999998888632                   


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc----ccccCcCCccC
Q 038249          111 -----KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----RTMCGTLDYLP  181 (281)
Q Consensus       111 -----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~a  181 (281)
                           ..+++..++.++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||++.......    .....++.|++
T Consensus       299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence                 123567788999999999999999999999999999999999999999999985432221    11234789999


Q ss_pred             CccccCCC--------------------CC--CcccHHhHHHHHHHHHhCCC-CCCCCC-----------chHHHHHHhh
Q 038249          182 PEMVESVE--------------------HD--ANVDIWSLGVLCYEFLYGVP-PFEAKE-----------HSDTYRRIVQ  227 (281)
Q Consensus       182 PE~~~~~~--------------------~~--~~~Di~slG~~l~~l~~g~~-p~~~~~-----------~~~~~~~~~~  227 (281)
                      ||.+....                    ++  ...|+||+||++++|+++.. |+....           ....++....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99874322                    11  24699999999999999875 664321           1111222333


Q ss_pred             ccccCCCCCCCCHHHHHHHHHhcccCC---CCCCChhhhhcCCcccc
Q 038249          228 VDLKFPPKPIVSSAAKDLISQMLVKDS---SQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~eil~~~~~~~  271 (281)
                      ....++.....+.+..+++.+||..+|   .+|+|+.|+|+||||..
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            344555556688999999999999765   78999999999999964

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=255.13  Aligned_cols=134  Identities=24%  Similarity=0.410  Sum_probs=116.2

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----C---Cceeeeee
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-----H---PNILRLYG   83 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----h---~~i~~~~~   83 (281)
                      .|.-.+|.+.++||.|-|++||++.|.++.+.||+|+.....    ...++...||.+|+++.     |   .+||++++
T Consensus        74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            455689999999999999999999999999999999985443    34566788999999983     2   57999999


Q ss_pred             EEEe----CCEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeC
Q 038249           84 YFYD----QKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIG  150 (281)
Q Consensus        84 ~~~~----~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~  150 (281)
                      .|..    +.++|+|+|+. |.+|..+++..  +.++...+..|+.|++.||.|||+. ||+|.||||+||++.
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            9974    56999999999 66899998865  4599999999999999999999965 999999999999983

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.5e-38  Score=264.43  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=214.1

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC------CCceeeeeeEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR------HPNILRLYGYFY   86 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~   86 (281)
                      +-..+|.+....|+|-||+|..|.+..-|..||||++.......    ..=+.|+++|+++.      -.|+++++-.|.
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            34578999999999999999999999999999999996655433    34567999999995      358999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-cEEEeeecC
Q 038249           87 DQKRVYLILEYAAKGELYKELQKCKY---FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGW  162 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-~~~l~dfg~  162 (281)
                      ..+++|+|||.... +|.+.+++.+.   |....+..++.|++.||..|.+.||+|.||+|+||+++++. .+||||||.
T Consensus       505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence            99999999999966 89999997653   88889999999999999999999999999999999999875 579999999


Q ss_pred             cccccCCcccc-cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCC------
Q 038249          163 SVHTFNRRRTM-CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK------  235 (281)
Q Consensus       163 ~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------  235 (281)
                      +.........+ .-.--|.|||++.+.+|+...|+||+||+||||+||+..|.+.++.+.+...+.....+|..      
T Consensus       584 A~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq  663 (752)
T KOG0670|consen  584 ASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ  663 (752)
T ss_pred             ccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence            86554433221 22445899999999999999999999999999999999999999999887766543333321      


Q ss_pred             ---------------------------------------------CCCCH-------HHHHHHHHhcccCCCCCCChhhh
Q 038249          236 ---------------------------------------------PIVSS-------AAKDLISQMLVKDSSQRLPLHKL  263 (281)
Q Consensus       236 ---------------------------------------------~~~~~-------~l~~li~~~l~~~p~~Rps~~ei  263 (281)
                                                                   +.++.       +|++||.+||..||++|.|++++
T Consensus       664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA  743 (752)
T KOG0670|consen  664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA  743 (752)
T ss_pred             hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence                                                         11332       48899999999999999999999


Q ss_pred             hcCCcccc
Q 038249          264 LEHPWIIQ  271 (281)
Q Consensus       264 l~~~~~~~  271 (281)
                      |.||||+.
T Consensus       744 L~HpFi~~  751 (752)
T KOG0670|consen  744 LKHPFITE  751 (752)
T ss_pred             hcCCcccC
Confidence            99999974

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=266.82  Aligned_cols=252  Identities=23%  Similarity=0.390  Sum_probs=214.4

Q ss_pred             CCceecceecccCceEEEEEEEccCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSN---HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      ++.++.+.||+|.||.|++|.|..-+   ..||||.+..+....  ....|.+|+.++.+++|+|+++++|++.+ .-..
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            55677899999999999999998643   358999996654332  46789999999999999999999999987 6778


Q ss_pred             EEEeccCCCChhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           93 LILEYAAKGELYKELQK--CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      +|+|.++.|+|.+.+.+  ...|-...+-.++.||+.|+.||.+++++|+|+...|+++-.-..+||+|||+.+-.....
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999999987  3457788888999999999999999999999999999999999999999999975543332


Q ss_pred             ccc------cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHH
Q 038249          171 RTM------CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK  243 (281)
Q Consensus       171 ~~~------~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  243 (281)
                      ...      .-...|+|||.+....++.+||+|++|+++|||++ |..||.+....++++.+-.+ -..+-.+.+++++.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-erLpRPk~csedIY  345 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-ERLPRPKYCSEDIY  345 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-ccCCCCCCChHHHH
Confidence            221      12557999999999999999999999999999996 88999999999998888743 34455558999999


Q ss_pred             HHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      +++..||+.+|++||++..|.+.-++.+
T Consensus       346 ~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  346 QIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             HHHHHhccCCccccccHHHHHHhHHHHh
Confidence            9999999999999999999976555543

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=264.52  Aligned_cols=239  Identities=29%  Similarity=0.475  Sum_probs=190.9

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC------EE
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK------RV   91 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------~~   91 (281)
                      +...+.||+|+||.||+++++.+|+.+|||.+......  ...+..-+|++++++++|+|||++.++-+...      ..
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            34458999999999999999999999999999765432  23456778999999999999999999865433      46


Q ss_pred             EEEEeccCCCChhHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC--CC--cEEEeeecCcc
Q 038249           92 YLILEYAAKGELYKELQKC---KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA--QG--ELKIADFGWSV  164 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~--~~--~~~l~dfg~~~  164 (281)
                      .++||||.||+|+..+++-   ..+++.+++.++.++..||.+||++||+||||||.||++-.  +|  ..||+|||.++
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            8999999999999999753   45999999999999999999999999999999999999843  23  47999999997


Q ss_pred             cccCCc--ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH-----HHHHHhhc--------
Q 038249          165 HTFNRR--RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD-----TYRRIVQV--------  228 (281)
Q Consensus       165 ~~~~~~--~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~--------  228 (281)
                      ......  ....||..|++||.+.. ..++...|.||||+++|+++||..||.....+.     .+..+.+.        
T Consensus       173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~  252 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA  252 (732)
T ss_pred             cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence            765554  44579999999999984 788899999999999999999999997655552     22222211        


Q ss_pred             ----------cccCCCCCCCCH----HHHHHHHHhcccCCCCCC
Q 038249          229 ----------DLKFPPKPIVSS----AAKDLISQMLVKDSSQRL  258 (281)
Q Consensus       229 ----------~~~~~~~~~~~~----~l~~li~~~l~~~p~~Rp  258 (281)
                                ....|....++.    .+...+..||..+|++|-
T Consensus       253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                      111222222333    356778888899999998

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=282.45  Aligned_cols=239  Identities=21%  Similarity=0.298  Sum_probs=186.8

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ..|+..+.||+|++|.||+|+++.++..||+|.+......       ...+++.+++++||||+++++++.+.+..++||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            4567778999999999999999989999999998543211       123578889999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH---GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh---~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~  172 (281)
                      ||+++++|.++++.   +++..+..++.+|+.|++|||   +.+++|+|++|+||+++.++..++. ++....... ...
T Consensus       763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-~~~  837 (968)
T PLN00113        763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-DTK  837 (968)
T ss_pred             eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-CCC
Confidence            99999999999974   789999999999999999999   6699999999999999998887765 554422211 122


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch--HHHH---HHhh---------ccccC--CCCC
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS--DTYR---RIVQ---------VDLKF--PPKP  236 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~---~~~~---------~~~~~--~~~~  236 (281)
                      ..+++.|+|||.+.+..++.++||||+|+++|||++|+.||......  ....   ....         .....  +...
T Consensus       838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence            35678999999999888999999999999999999999998542211  1111   0000         00000  0000


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ....++.+++.+||+.||++||++.|+++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            122357789999999999999999999864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=265.46  Aligned_cols=244  Identities=30%  Similarity=0.444  Sum_probs=193.3

Q ss_pred             ceecceecccCceE-EEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEEE
Q 038249           18 FDIGKPLGRGKFGH-VYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        18 y~~~~~ig~g~~~~-v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      |...+++|.|+.|+ ||+|...  |+.||||++..+.      ..-..+|+..++.. +||||+++++.-.+....|+..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            45567889999875 5999886  8899999985543      33467899999988 6999999999988889999999


Q ss_pred             eccCCCChhHHHHhCC-C---CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC---CC--cEEEeeecCcccc
Q 038249           96 EYAAKGELYKELQKCK-Y---FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA---QG--ELKIADFGWSVHT  166 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~-~---l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~---~~--~~~l~dfg~~~~~  166 (281)
                      |.|.. +|.++++... .   ......+.++.|++.||++||+.+|+|||++|+||+++.   ++  +++|+|||+++..
T Consensus       583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            99965 9999998741 1   122456889999999999999999999999999999976   33  6899999998765


Q ss_pred             cCCc------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhC-CCCCCCCCchHHHHHHhhccccCCCC-CCC
Q 038249          167 FNRR------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYG-VPPFEAKEHSDTYRRIVQVDLKFPPK-PIV  238 (281)
Q Consensus       167 ~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~  238 (281)
                      ....      ....||-+|+|||++....-+.+.||+||||++|+.++| .+||...-..+  .+++.+....... +..
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~  739 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLP  739 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCc
Confidence            4443      345689999999999888888899999999999998874 99996543322  2233332222111 111


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ..+..+||.+|++++|..||++.++|.||+|=..
T Consensus       740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            1288999999999999999999999999999543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=237.15  Aligned_cols=254  Identities=29%  Similarity=0.431  Sum_probs=207.7

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC--
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK--   89 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--   89 (281)
                      +....+|.-++.+|.|.. .|..|.|.-+++++++|++..+. ......+...+|...+..+.|+|+++++.++....  
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence            334578999999999999 88889999999999999997774 33344566778999999999999999999986543  


Q ss_pred             ----EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           90 ----RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        90 ----~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                          ..|+|||+++. +|...+..  .++=+.+..++.|++.|+++||+.||+|||++|+||++..++.+|+.|||++..
T Consensus        91 ~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   91 EEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence                57999999976 78777773  367788999999999999999999999999999999999999999999999876


Q ss_pred             ccCCc--ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-------------
Q 038249          166 TFNRR--RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-------------  230 (281)
Q Consensus       166 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------  230 (281)
                      .....  .....+-.|.|||+.-+..+....||||+||++.+|++|+..|.+.+.-+++.++...-.             
T Consensus       168 e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  168 EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence            55541  223457789999998777799999999999999999999999988776665544322100             


Q ss_pred             ------------------cCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccc
Q 038249          231 ------------------KFP---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       231 ------------------~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                                        .++         ..+.-+..+++++.+||-.||++|.|++++|+|||++
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                              000         0122445689999999999999999999999999997

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-37  Score=236.90  Aligned_cols=255  Identities=29%  Similarity=0.463  Sum_probs=205.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-----E
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-----R   90 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~   90 (281)
                      .+.+..+.||-|+||.||.+.|..+|+.+++|++..- +++-...+.+.+|+.++...+|.|++..+++.....     .
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            3456778999999999999999999999999998433 344455677889999999999999999999875432     4


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      +|+++|.+.. +|...+-+-.+++.+.+.-.+.||++||.|||+.||.|+||||.|.+++.|..+||+|||+++......
T Consensus       132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            5777887744 777777776779999999999999999999999999999999999999999999999999987654443


Q ss_pred             cc----ccCcCCccCCccccCCC-CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-----------------
Q 038249          171 RT----MCGTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------------  228 (281)
Q Consensus       171 ~~----~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------  228 (281)
                      ..    ..-|..|.|||++.+.. |+...||||+||++.||+..+..|...++-++++.+..-                 
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            32    23588999999986554 788999999999999999988888877776655443221                 


Q ss_pred             ------cccCCCC---------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          229 ------DLKFPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       229 ------~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                            ....+..         ..-..+...++.+||.+||++|.+.++.+.|+++.+.
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                  1111110         1233467889999999999999999999999998764

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=257.89  Aligned_cols=247  Identities=25%  Similarity=0.435  Sum_probs=206.6

Q ss_pred             CCceecceecccCceEEEEEEEcc-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKR-------SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      ++.++.+.||.|.||.|++|.-..       ....||||.+......  ...+.+..|+++++.+ +|+|++.+++.+..
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            444678899999999999987441       1456999998766533  4467899999999999 59999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                      .+..++|.||+..|+|.++++..+                .++...+..++.||+.|++||++.+++|||+...||+++.
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK  453 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence            999999999999999999998765                4889999999999999999999999999999999999999


Q ss_pred             CCcEEEeeecCcccccCCcccc----c--CcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCC-chHHHH
Q 038249          152 QGELKIADFGWSVHTFNRRRTM----C--GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKE-HSDTYR  223 (281)
Q Consensus       152 ~~~~~l~dfg~~~~~~~~~~~~----~--~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~-~~~~~~  223 (281)
                      +..+|++|||+++.........    .  -+..|+|||.+....++.+|||||+|+++||+++ |..||.+.. ..+..+
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~  533 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE  533 (609)
T ss_pred             CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence            9999999999997543332221    1  2446999999999999999999999999999986 899998866 555555


Q ss_pred             HHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          224 RIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .+..+. ....+..++.++.++++.||+.+|++||++.++.+
T Consensus       534 ~l~~G~-r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  534 FLKEGN-RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHhcCC-CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            444443 33344467999999999999999999999988873

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-35  Score=253.37  Aligned_cols=245  Identities=22%  Similarity=0.369  Sum_probs=210.5

Q ss_pred             CceecceecccCceEEEEEEEccCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      ..+..+.||+|+||+||++.+-..|+    +||+|++....  ..+...++.+|+-.+.+++|||++++++++..+. .-
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            35567899999999999999876665    57788875543  3334567899999999999999999999998765 78


Q ss_pred             EEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc
Q 038249           93 LILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR  171 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~  171 (281)
                      +|++|+++|+|.++++.. .++.....+.|..||++|+.|||.+.++||||-++||++..-+.+|+.|||++........
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999864 5689999999999999999999999999999999999999999999999999865433322


Q ss_pred             c-----ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          172 T-----MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       172 ~-----~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                      .     ..-.+.|+|-|......++.++||||+|+++||++| |..|+.+....++...+..+.. .+..+.++.++..+
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqPpiCtiDVy~~  932 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQPPICTIDVYMV  932 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCCCCccHHHHHH
Confidence            1     123557888899999999999999999999999985 9999999998888888877765 77778999999999


Q ss_pred             HHHhcccCCCCCCChhhhhc
Q 038249          246 ISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~  265 (281)
                      +.+||..|+..||+++++..
T Consensus       933 mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  933 MVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHhccCcccCccHHHHHH
Confidence            99999999999999988764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=4.8e-33  Score=219.00  Aligned_cols=209  Identities=41%  Similarity=0.699  Sum_probs=186.0

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCCh
Q 038249           24 LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGEL  103 (281)
Q Consensus        24 ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  103 (281)
                      ||.|.+|.||++.+..+++.+++|.+.......  ....+.+|++.++.++|++++++++++......++++|++.+++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999999889999999996554322  346788999999999999999999999998999999999998999


Q ss_pred             hHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-CCcEEEeeecCcccccCC---cccccCcCC
Q 038249          104 YKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-QGELKIADFGWSVHTFNR---RRTMCGTLD  178 (281)
Q Consensus       104 ~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-~~~~~l~dfg~~~~~~~~---~~~~~~~~~  178 (281)
                      .+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++++|||.+......   .....+...
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            9999876 46899999999999999999999999999999999999999 899999999987554433   334456788


Q ss_pred             ccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          179 YLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       179 ~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      |++||..... ..+.++|+|++|++++++                                 .++.+++.+|++.+|++|
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R  205 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKR  205 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccC
Confidence            9999998776 778899999999999998                                 679999999999999999


Q ss_pred             CChhhhhcCC
Q 038249          258 LPLHKLLEHP  267 (281)
Q Consensus       258 ps~~eil~~~  267 (281)
                      |++.++++++
T Consensus       206 ~~~~~l~~~~  215 (215)
T cd00180         206 PSAKEILEHL  215 (215)
T ss_pred             cCHHHHhhCC
Confidence            9999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-36  Score=254.51  Aligned_cols=254  Identities=28%  Similarity=0.485  Sum_probs=223.2

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      .+|..+..+|.|.+|.||+++++.+++..|+|+++...-+.   ..-+..|+-+++.++||||+.+++.+......++.|
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            67999999999999999999999999999999997654332   345778999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~~~  172 (281)
                      |||.+|+|.+...--+++++.++....+..+.|+.|||+.|-+|||||-.||+++..|.+++.|||.+.+..   .....
T Consensus        92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks  171 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS  171 (829)
T ss_pred             EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence            999999999999888899999999999999999999999999999999999999999999999999875432   23455


Q ss_pred             ccCcCCccCCccc---cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC---CCCCCHHHHHHH
Q 038249          173 MCGTLDYLPPEMV---ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP---KPIVSSAAKDLI  246 (281)
Q Consensus       173 ~~~~~~~~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li  246 (281)
                      ..||+.|+|||+.   ..+.|...+|+|++|++..++-.-++|.....+......+.++.++.+-   ....+..+.+|+
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fv  251 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFV  251 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHH
Confidence            6799999999985   5667888999999999999998888887777777776666666554442   334778899999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +.+|..+|++||+++.+|.|||+.+.
T Consensus       252 K~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  252 KGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHhcCCCccCCChhhheeceeeccc
Confidence            99999999999999999999999865

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=231.59  Aligned_cols=243  Identities=24%  Similarity=0.398  Sum_probs=185.4

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC--CCCceeeeeeEEEeCC-
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL--RHPNILRLYGYFYDQK-   89 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~--~h~~i~~~~~~~~~~~-   89 (281)
                      -.-.+-++.+.||+|.||+||+|+++  |+.||||+|...+      +++..+|.++.+..  +|+||+.+++.-..++ 
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG  279 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence            34467889999999999999999999  8899999994332      24556666666654  9999999998765433 


Q ss_pred             ---EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------cCceecCCCCCCeEeCCCCcEEEe
Q 038249           90 ---RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG--------KHVIHRDIKPENLLIGAQGELKIA  158 (281)
Q Consensus        90 ---~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~--------~~i~H~di~~~Ni~~~~~~~~~l~  158 (281)
                         .+++|++|.+.|||.++++. ..++.+..++++..++.||++||.        -.|+|||||..||++..++...|.
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence               68999999999999999998 568999999999999999999994        259999999999999999999999


Q ss_pred             eecCcccccCC-------cccccCcCCccCCccccCCCC------CCcccHHhHHHHHHHHHhC----------CCCCCC
Q 038249          159 DFGWSVHTFNR-------RRTMCGTLDYLPPEMVESVEH------DANVDIWSLGVLCYEFLYG----------VPPFEA  215 (281)
Q Consensus       159 dfg~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~------~~~~Di~slG~~l~~l~~g----------~~p~~~  215 (281)
                      |+|++......       .+..+||.+|||||++...-.      -..+||||||.++||++..          .+||.+
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99998543332       345679999999999854432      1358999999999998742          566644


Q ss_pred             CCch-HHHHHHhhc---cccCCCCCC--CC----HHHHHHHHHhcccCCCCCCChhhhh
Q 038249          216 KEHS-DTYRRIVQV---DLKFPPKPI--VS----SAAKDLISQMLVKDSSQRLPLHKLL  264 (281)
Q Consensus       216 ~~~~-~~~~~~~~~---~~~~~~~~~--~~----~~l~~li~~~l~~~p~~Rps~~eil  264 (281)
                      .-+. ..+..+.+.   +...|..++  -+    ..+..+++-||..||..|.|+--|-
T Consensus       439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence            3222 222333222   111221111  11    2467889999999999999986664

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=235.31  Aligned_cols=238  Identities=26%  Similarity=0.404  Sum_probs=182.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCceeeeeeEEEeCC---
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH--LRHPNILRLYGYFYDQK---   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~--~~h~~i~~~~~~~~~~~---   89 (281)
                      ....+..+.||+|.||.||+|...  ++.||||++..      +..+.+.+|-++.+.  ++|+||+++++.-....   
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            456778899999999999999887  68999999943      335567777766654  48999999999866544   


Q ss_pred             -EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------cCceecCCCCCCeEeCCCCcEEEee
Q 038249           90 -RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG---------KHVIHRDIKPENLLIGAQGELKIAD  159 (281)
Q Consensus        90 -~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------~~i~H~di~~~Ni~~~~~~~~~l~d  159 (281)
                       .+++|++|.+.|+|.++++.. .+++.++.+++..+++||+|||+         ..|+|||||..||++..|++..|+|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence             789999999999999999985 48999999999999999999995         3699999999999999999999999


Q ss_pred             ecCcccccCC-----cccccCcCCccCCccccCCCC-C-----CcccHHhHHHHHHHHHhCCCC------------CCC-
Q 038249          160 FGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEH-D-----ANVDIWSLGVLCYEFLYGVPP------------FEA-  215 (281)
Q Consensus       160 fg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~-~-----~~~Di~slG~~l~~l~~g~~p------------~~~-  215 (281)
                      ||++......     .-..+||.+|||||++.+... .     .+.||||+|.++||+++.-..            |+. 
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9998654432     334679999999999966432 1     368999999999999875332            220 


Q ss_pred             --CCc-hHHHHHHhhccccCCCC------CCCCHHHHHHHHHhcccCCCCCCChh
Q 038249          216 --KEH-SDTYRRIVQVDLKFPPK------PIVSSAAKDLISQMLVKDSSQRLPLH  261 (281)
Q Consensus       216 --~~~-~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~  261 (281)
                        ..+ .+..+.+...+...|..      .....-+.+.+..||..||+.|.|+.
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence              111 11222222222222221      12345689999999999999999964

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-34  Score=211.54  Aligned_cols=209  Identities=29%  Similarity=0.432  Sum_probs=171.8

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ++...+..||+|++|.|-+.++..+|...|+|.+...-.  .+.-+.+.+++.+..+. ..|.+|.+++.....+.+++.
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            455667899999999999999999999999999965532  23345566777776665 789999999999999999999


Q ss_pred             EeccCCCChhHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           95 LEYAAKGELYKEL----QKCKYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ||.++. ||..+.    +.++.+++.-+-+|+..++.||.+||++ .++|||+||.||+++.+|.+|++|||.+-...++
T Consensus       124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            999976 775554    4567799999999999999999999975 9999999999999999999999999998665444


Q ss_pred             c--ccccCcCCccCCcccc----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCC-chHHHHHHhh
Q 038249          170 R--RTMCGTLDYLPPEMVE----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKE-HSDTYRRIVQ  227 (281)
Q Consensus       170 ~--~~~~~~~~~~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~  227 (281)
                      -  ....|-..|+|||...    ...|+.+|||||||+++.||.+++.||+... +-+++.++..
T Consensus       203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            2  2245667899999873    3468899999999999999999999997644 3455555443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=240.89  Aligned_cols=205  Identities=30%  Similarity=0.505  Sum_probs=178.6

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCC---CCceeee
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS-----QVEHQLRREVEIQSHLR---HPNILRL   81 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~-----~~~~~~~~e~~~l~~~~---h~~i~~~   81 (281)
                      +-..++.+|..++.+|.|+||.|++|.++.++..|+||.+.++++--+     .-.-.+-.||+++..++   |+||+++
T Consensus       555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            344567889999999999999999999999999999999977665322     12234567999999997   9999999


Q ss_pred             eeEEEeCCEEEEEEecc-CCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeee
Q 038249           82 YGYFYDQKRVYLILEYA-AKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADF  160 (281)
Q Consensus        82 ~~~~~~~~~~~~v~e~~-~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~df  160 (281)
                      +++|++++.+++++|.. +|.+|.++++-.+.+++.++..|+.|+..|+++||+.||+|||||-+||.++.+|-+||+||
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence            99999999999999976 45589999998888999999999999999999999999999999999999999999999999


Q ss_pred             cCcccccCC-cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCC
Q 038249          161 GWSVHTFNR-RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFE  214 (281)
Q Consensus       161 g~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~  214 (281)
                      |.+....+. -....||.+|.|||++.+..| +...|||+||+++|-+.....||-
T Consensus       715 gsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            998665444 455679999999999999887 567899999999998887777763

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-31  Score=213.71  Aligned_cols=210  Identities=40%  Similarity=0.701  Sum_probs=181.4

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEec
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEY   97 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   97 (281)
                      |++.+.||.|+++.||++.+..+++.+++|.+......  ...+.+.+|++.+++++|+|++++++.+......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999988999999999765432  2456788899999999999999999999988999999999


Q ss_pred             cCCCChhHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc----cc
Q 038249           98 AAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----RT  172 (281)
Q Consensus        98 ~~~~~L~~~~~~~~~-l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~----~~  172 (281)
                      +++++|.+++..... +++..++.++.+++.++.+||+.+++|+|++|.||+++.++.++++|||.+.......    ..
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999999988766 8999999999999999999999999999999999999999999999999876554432    44


Q ss_pred             ccCcCCccCCccc-cCCCCCCcccHHhHHHHHHHHHhCCCCCCC-CCch-HHHHHHhhcc
Q 038249          173 MCGTLDYLPPEMV-ESVEHDANVDIWSLGVLCYEFLYGVPPFEA-KEHS-DTYRRIVQVD  229 (281)
Q Consensus       173 ~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~-~~~~~~~~~~  229 (281)
                      ..++..|++||.+ ....++.++|+|+||+++++|++|..||.. ..+. ...+.+..+.
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            4567789999998 666777899999999999999999999977 3443 5555555543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=4.1e-33  Score=226.92  Aligned_cols=254  Identities=24%  Similarity=0.415  Sum_probs=200.8

Q ss_pred             cccccCCceecceecccCceEEEEEEEcc---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKR---SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFY   86 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~   86 (281)
                      .+...+.|+.+.+||.|.|++||++.+..   ..+.||+|.+.......     .+.+|++++..+ .+.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~-----ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS-----RILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch-----HHHHHHHHHHHhccchhhhcchhhhc
Confidence            44556889999999999999999999887   67889999996654332     378899999999 5899999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-CCcEEEeeecCccc
Q 038249           87 DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-QGELKIADFGWSVH  165 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-~~~~~l~dfg~~~~  165 (281)
                      .++...+|+||.+.....++...   ++..++..+++.++.||.++|+.||+|+||||.|++++. .+.-.|+|||++..
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence            99999999999999988888887   778999999999999999999999999999999999975 47789999998740


Q ss_pred             c-----------------cC---C------------c---------------ccccCcCCccCCccccCCC-CCCcccHH
Q 038249          166 T-----------------FN---R------------R---------------RTMCGTLDYLPPEMVESVE-HDANVDIW  197 (281)
Q Consensus       166 ~-----------------~~---~------------~---------------~~~~~~~~~~aPE~~~~~~-~~~~~Di~  197 (281)
                      .                 ..   .            +               ....||++|.|||++...+ -+++.|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            0                 00   0            0               0124799999999986544 57789999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCc-hHHHHH--------------Hhhcc---------------------c-----------
Q 038249          198 SLGVLCYEFLYGVPPFEAKEH-SDTYRR--------------IVQVD---------------------L-----------  230 (281)
Q Consensus       198 slG~~l~~l~~g~~p~~~~~~-~~~~~~--------------~~~~~---------------------~-----------  230 (281)
                      |.|++++.++++..||-.... .+.+..              ..-+.                     .           
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            999999999999998732111 111000              00000                     0           


Q ss_pred             --c-CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          231 --K-FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       231 --~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                        . .......+..+.+++++||..||.+|.|++|+|+||||.+.
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence              0 00012255578999999999999999999999999999854

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-32  Score=210.20  Aligned_cols=250  Identities=24%  Similarity=0.411  Sum_probs=193.6

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeE-EEeCCEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGY-FYDQKRVYL   93 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~-~~~~~~~~~   93 (281)
                      +.|.+.+.+|+|.||.+-++.++.+++.+++|.+..+...    .+.+.+|...--.+ .|.||+..+++ |...+.+.+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            6799999999999999999999999999999999776543    34566666654444 58999988775 455678899


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC--CcEEEeeecCcccccCCcc
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ--GELKIADFGWSVHTFNRRR  171 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~--~~~~l~dfg~~~~~~~~~~  171 (281)
                      ++||++.|+|.+-+...+ +.+.....++.|++.|+.|+|+.+++|||||.+||++-..  -++||+|||.+......-.
T Consensus       100 ~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             eeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            999999999999888755 7899999999999999999999999999999999998543  3799999999876655555


Q ss_pred             cccCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH-H---HHHHhhccccCC--CCCCCCH
Q 038249          172 TMCGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD-T---YRRIVQVDLKFP--PKPIVSS  240 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~---~~~~~~~~~~~~--~~~~~~~  240 (281)
                      .......|.+||...     ....++.+|+|.||++++.+++|.+||......+ .   +...+++.....  ....+++
T Consensus       179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~  258 (378)
T KOG1345|consen  179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSE  258 (378)
T ss_pred             hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCH
Confidence            445567889998752     3335788999999999999999999997433221 1   222233222111  1124788


Q ss_pred             HHHHHHHHhcccCCCCCC---ChhhhhcCCccc
Q 038249          241 AAKDLISQMLVKDSSQRL---PLHKLLEHPWII  270 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rp---s~~eil~~~~~~  270 (281)
                      .+.++.++-|+++|++|.   ++......-|..
T Consensus       259 ~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  259 KALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             HHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            899999999999999994   444444445544

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=5e-31  Score=213.12  Aligned_cols=247  Identities=19%  Similarity=0.275  Sum_probs=204.8

Q ss_pred             CCceecceecccCceEEEEEEEccCCc-----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-C
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNH-----IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-K   89 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~-----~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~   89 (281)
                      .+++....+-+|.||+||.|+++.+..     .+.+|.+....  +.-....+..|.-++....|||+..+.++..+. .
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            567888899999999999998885433     34556553322  222345577788888899999999999988654 5


Q ss_pred             EEEEEEeccCCCChhHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeec
Q 038249           90 RVYLILEYAAKGELYKELQKC--------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFG  161 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg  161 (281)
                      ..++++.+..-++|..++...        ..++..++..++.|++.|+++||++|++|.||...|..+++.-.+||+|=.
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence            668888999888999988732        236777888999999999999999999999999999999999999999999


Q ss_pred             CcccccCCccccc-----CcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCC
Q 038249          162 WSVHTFNRRRTMC-----GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPK  235 (281)
Q Consensus       162 ~~~~~~~~~~~~~-----~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (281)
                      +++..++......     .+..|++||.+.+..++..+|+||||+++|||+| |+.|+...++.+...-+..+. ...++
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-RlaQP  520 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-RLAQP  520 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-eecCC
Confidence            9887776654433     4567999999999999999999999999999996 999999999988887776664 44445


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .++|+++..++--||+..|++||+++++..
T Consensus       521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  521 FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            589999999999999999999999998863

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=8e-31  Score=243.86  Aligned_cols=193  Identities=17%  Similarity=0.206  Sum_probs=141.9

Q ss_pred             CceeeeeeEE-------EeCCEEEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCe
Q 038249           76 PNILRLYGYF-------YDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENL  147 (281)
Q Consensus        76 ~~i~~~~~~~-------~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni  147 (281)
                      .||.++++.+       ...+.+..++|+.+ ++|.+++.. ...+++.+++.++.||+.||.|||++||+|+||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            4666666665       23346778888874 499999975 35689999999999999999999999999999999999


Q ss_pred             EeCCCCc-------------------EEEeeecCcccccCC-------------------cccccCcCCccCCccccCCC
Q 038249          148 LIGAQGE-------------------LKIADFGWSVHTFNR-------------------RRTMCGTLDYLPPEMVESVE  189 (281)
Q Consensus       148 ~~~~~~~-------------------~~l~dfg~~~~~~~~-------------------~~~~~~~~~~~aPE~~~~~~  189 (281)
                      +++..+.                   +|++|||++......                   .....+|+.|+|||.+.+..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            9965444                   455555554321100                   00124678899999998889


Q ss_pred             CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       190 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ++.++|||||||+++||++|.+|+....  .....+...... +.......+..+++.+||+++|.+||++.|++.||||
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~  268 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLP-PQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI  268 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcC-hhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence            9999999999999999999888765322  122222111111 1111124556789999999999999999999999999


Q ss_pred             ccC
Q 038249          270 IQN  272 (281)
Q Consensus       270 ~~~  272 (281)
                      .+.
T Consensus       269 ~~~  271 (793)
T PLN00181        269 NEP  271 (793)
T ss_pred             hhh
Confidence            864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=7.7e-30  Score=195.92  Aligned_cols=162  Identities=19%  Similarity=0.174  Sum_probs=129.6

Q ss_pred             CChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccccCcCCc
Q 038249          101 GELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY  179 (281)
Q Consensus       101 ~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (281)
                      |+|.+++.. ..++++..++.++.||+.||.|||+.+      +|+||+++.++.+++  ||.+.......  ..+++.|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--~~g~~~y   70 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--SRVDPYF   70 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc--CCCcccc
Confidence            588999986 456999999999999999999999998      999999999999999  99875443322  2578999


Q ss_pred             cCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccccCC-----CCCCCCH--HHHHHHHHhcc
Q 038249          180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLKFP-----PKPIVSS--AAKDLISQMLV  251 (281)
Q Consensus       180 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~~--~l~~li~~~l~  251 (281)
                      +|||.+.+..++.++||||||+++|+|++|..||...... .....+........     .....+.  ++.+++.+||.
T Consensus        71 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~  150 (176)
T smart00750       71 MAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCAS  150 (176)
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHh
Confidence            9999999999999999999999999999999999765442 33333332211111     1112333  69999999999


Q ss_pred             cCCCCCCChhhhhcCCccccC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .+|++||++.++++|+|+...
T Consensus       151 ~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      151 RLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             cccccccCHHHHHHHHHHHHH
Confidence            999999999999999998643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2e-29  Score=224.07  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=202.0

Q ss_pred             eecceecccCceEEEEEEEccCCcEEEEEEeec---ccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           19 DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFK---SQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        19 ~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~---~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      .....+|.|++|.|+.+......+.+..|.+..   ...........+..|+-+-..+.|+|++.....+.+.......|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            567899999999888888887777777776642   11122222333677777888889999999888887776666669


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC------
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR------  169 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~------  169 (281)
                      ||+++ +|..++.....++..++-.++.|++.|++|+|+.|+.|+|++++|++++.+|.+|++|||.+......      
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99999 99999998878999999999999999999999999999999999999999999999999986332111      


Q ss_pred             -cccccCcCCccCCccccCCCCCC-cccHHhHHHHHHHHHhCCCCCCCCCchHHH--HHHhhccc-----cCCCCCCCCH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDA-NVDIWSLGVLCYEFLYGVPPFEAKEHSDTY--RRIVQVDL-----KFPPKPIVSS  240 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~  240 (281)
                       ....+|...|+|||.+.+..|++ ..||||.|+++..|.+|+.||......+..  ...-....     .......+|.
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~  559 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR  559 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence             23456788999999999999876 589999999999999999999765555432  11111111     1111234888


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +.+.+|.+||++||.+|.|+++|++++||++.
T Consensus       560 ~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  560 ETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             hHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            99999999999999999999999999999975

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-26  Score=192.50  Aligned_cols=246  Identities=24%  Similarity=0.310  Sum_probs=192.9

Q ss_pred             CceecceecccCceEEEEEEEccCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCC----CCceeeeeeEE-EeCCE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSN-HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR----HPNILRLYGYF-YDQKR   90 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~-~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~----h~~i~~~~~~~-~~~~~   90 (281)
                      +|++.+.||.|+||.||.|.+..++ ..+|+|..........   ..+..|..++..+.    .+++..+++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999998775 5688888755432211   13566777777775    36899999999 47778


Q ss_pred             EEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC-----CcEEEeeecCc
Q 038249           91 VYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-----GELKIADFGWS  163 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~-----~~~~l~dfg~~  163 (281)
                      -++||+.. |.+|.++.+..  +.++...+..++.|++.+|.++|+.|++||||+|.|+++...     ..+.++|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            89999988 66999988654  469999999999999999999999999999999999999865     35999999999


Q ss_pred             c--cccCC-----------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc
Q 038249          164 V--HTFNR-----------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL  230 (281)
Q Consensus       164 ~--~~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (281)
                      .  .....           .....||..|.++.++.+...+.+.|+||++.++.++..|..||...........+.+...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            7  31111           1123489999999999999999999999999999999999999977665433333322211


Q ss_pred             cCC---CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          231 KFP---PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       231 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ...   .....+.++.++...+-..+...+|....+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            111   223466888888888888999999998777543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=1.3e-24  Score=182.61  Aligned_cols=252  Identities=39%  Similarity=0.653  Sum_probs=206.5

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC-ceeeeeeEEEeCCEEEEEEe
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP-NILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~-~i~~~~~~~~~~~~~~~v~e   96 (281)
                      |.+.+.||.|+++.||.+.+.   ..+++|.+.............+.+|+..++.+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999998   66899998766544433567788999999999988 79999999987778899999


Q ss_pred             ccCCCChhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-cEEEeeecCcccccC----
Q 038249           97 YAAKGELYKELQKCK---YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWSVHTFN----  168 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~---~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-~~~l~dfg~~~~~~~----  168 (281)
                      ++.++++.+.+....   .++......++.+++.++.++|+.+++|+|++|+||+++..+ .++++|||.+.....    
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997777764   689999999999999999999999999999999999999998 799999998753322    


Q ss_pred             -----CcccccCcCCccCCccccC---CCCCCcccHHhHHHHHHHHHhCCCCCCCCCc----hHHHHHHhhcccc-CCCC
Q 038249          169 -----RRRTMCGTLDYLPPEMVES---VEHDANVDIWSLGVLCYEFLYGVPPFEAKEH----SDTYRRIVQVDLK-FPPK  235 (281)
Q Consensus       169 -----~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~-~~~~  235 (281)
                           ......++..|.+||...+   .......|+|++|++++++++|..||.....    ......+...... ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 2345578999999999877   5778899999999999999999999877664    3333333333222 1111


Q ss_pred             --CCC----CHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          236 --PIV----SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       236 --~~~----~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                        ...    ...+.+++..++..+|..|.+..+...+++....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence              111    2579999999999999999999998888666544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=5.9e-26  Score=190.20  Aligned_cols=167  Identities=19%  Similarity=0.209  Sum_probs=129.8

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEcc-CCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCceee-eeeE
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKR-SNHIVALKVLFKSQL--QQSQVEHQLRREVEIQSHLRHPNILR-LYGY   84 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~~~~lK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~-~~~~   84 (281)
                      +..+...++|++.+.||+|+||+||+|.++. +++.+|+|++.....  ........+.+|++++++++|+|++. +++ 
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            4456677899999999999999999999886 677789998753211  12334567899999999999999985 433 


Q ss_pred             EEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCC-CCCCeEeCCCCcEEEeeecCc
Q 038249           85 FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI-KPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di-~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                         .+..++||||++|++|.. ...   ..   ...++.+++.+|.+||++||+|+|| ||+||+++.++.++|+|||++
T Consensus        90 ---~~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         90 ---TGKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             ---cCCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence               246799999999988863 221   11   1467889999999999999999999 999999999999999999998


Q ss_pred             ccccCCc-----------ccccCcCCccCCcccc
Q 038249          164 VHTFNRR-----------RTMCGTLDYLPPEMVE  186 (281)
Q Consensus       164 ~~~~~~~-----------~~~~~~~~~~aPE~~~  186 (281)
                      .......           ....+++.|++||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            5432221           1234677899999874

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.94  E-value=4.5e-28  Score=217.56  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=189.6

Q ss_pred             cccchhhhcccccC-CceecceecccCceEEEEEEEccCCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCcee
Q 038249            3 SEVSAKEKKRWTLN-DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL--QQSQVEHQLRREVEIQSHLRHPNIL   79 (281)
Q Consensus         3 ~~~~~~~~~~~~~~-~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~   79 (281)
                      +|++..+...-... ++...+-||.+.|=.|.++++. +|. +++|++.....  .-+...+ ...+++ ....++||++
T Consensus         9 sQi~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~q-rL~~ik-~~l~~~pn~l   84 (1431)
T KOG1240|consen    9 SQISPVEVYFSDLSVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQ-RLEEIK-FALMKAPNCL   84 (1431)
T ss_pred             cccchHHHHhhcCccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHH-HHHHHH-HHhhcCCccc
Confidence            45555665555554 7999999999999999999988 344 99999976541  1222222 223444 5666899999


Q ss_pred             eeeeEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEee
Q 038249           80 RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIAD  159 (281)
Q Consensus        80 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~d  159 (281)
                      .+.-....+...|+|.+|... +|++.+..++.+..-+.+.|+.||+.|+..+|+.||+|||||.+|||++.-+.+.|.|
T Consensus        85 Pfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtD  163 (1431)
T KOG1240|consen   85 PFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTD  163 (1431)
T ss_pred             chHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhc
Confidence            999988888888999999966 9999999999999999999999999999999999999999999999999999999999


Q ss_pred             ecCcccccCCccc----------ccCcCCccCCccccCC-----------CCCCcccHHhHHHHHHHHHh-CCCCCCCC-
Q 038249          160 FGWSVHTFNRRRT----------MCGTLDYLPPEMVESV-----------EHDANVDIWSLGVLCYEFLY-GVPPFEAK-  216 (281)
Q Consensus       160 fg~~~~~~~~~~~----------~~~~~~~~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~~-g~~p~~~~-  216 (281)
                      |..-+...-...+          ...-..|.|||.+...           ..+++.||||+||+++||++ |.++|+.. 
T Consensus       164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ  243 (1431)
T KOG1240|consen  164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ  243 (1431)
T ss_pred             ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH
Confidence            9864322111111          1234479999987331           14568999999999999985 78888521 


Q ss_pred             -----Cc-hHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          217 -----EH-SDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       217 -----~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                           .. ....+..+        ....+..++.+|..|++.||.+|.|+++.|..
T Consensus       244 L~aYr~~~~~~~e~~L--------e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  244 LLAYRSGNADDPEQLL--------EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhHhccCccCHHHHH--------HhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                 11 00111111        11234579999999999999999999999975

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.94  E-value=1.2e-26  Score=186.63  Aligned_cols=234  Identities=21%  Similarity=0.302  Sum_probs=154.8

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC----------CCceeeeeeEEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR----------HPNILRLYGYFY   86 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~----------h~~i~~~~~~~~   86 (281)
                      ....++.||.|+++.||.+.+..+|+.+++|++...........+++++|......+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4577899999999999999999999999999997766545545667777765555532          234555555443


Q ss_pred             eC------------CE-----EEEEEeccCCCChhHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhcCceecCC
Q 038249           87 DQ------------KR-----VYLILEYAAKGELYKELQK---CKY----FSERRAATYVASLARALIYCHGKHVIHRDI  142 (281)
Q Consensus        87 ~~------------~~-----~~~v~e~~~~~~L~~~~~~---~~~----l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di  142 (281)
                      -.            +.     .+++++-..+ +|..++..   ...    +.....+.+..|+++.+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            11            12     3677887744 78777542   221    223333456689999999999999999999


Q ss_pred             CCCCeEeCCCCcEEEeeecCcccccCCcccccCcCCccCCccccC--------CCCCCcccHHhHHHHHHHHHhCCCCCC
Q 038249          143 KPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES--------VEHDANVDIWSLGVLCYEFLYGVPPFE  214 (281)
Q Consensus       143 ~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~  214 (281)
                      +|+|++++.+|.+.|+||+..............+..|.+||....        ..++.+.|.|+||+++|.++++..||.
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~  251 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG  251 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence            999999999999999999876443333222334567889987633        246778999999999999999999998


Q ss_pred             CCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 038249          215 AKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      ..........      .+..-..+|+.+++||..+|++||.+|
T Consensus       252 ~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  252 LSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            6544322211      222223789999999999999999988

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=7.4e-25  Score=167.04  Aligned_cols=243  Identities=20%  Similarity=0.295  Sum_probs=188.8

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeeeeeEEEeCCE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH-PNILRLYGYFYDQKR   90 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~   90 (281)
                      .+....|++++.||.|+||.+|.+.+..+|+.||||+-.... ..+    .+..|..+...+++ ..|..+..+..+..+
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCc----chhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            345688999999999999999999999999999999974332 222    35566666666654 567777777777788


Q ss_pred             EEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC---CcEEEeeecCcccc
Q 038249           91 VYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHT  166 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~---~~~~l~dfg~~~~~  166 (281)
                      -.+||+.. |.+|.++.+-. +.++...++-++-|++.-++|+|.++++|+||||+|+++.-+   ..+.++|||++...
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            89999988 77999998854 458999999999999999999999999999999999999754   46899999998654


Q ss_pred             cCC----------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHH---HHHhhccccCC
Q 038249          167 FNR----------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY---RRIVQVDLKFP  233 (281)
Q Consensus       167 ~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~  233 (281)
                      .+.          .....||.+|.+--.+-+..-+...|+-|+|.++.++-.|.+||.+.....-.   +.+...+...+
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            332          23445788888877776666778899999999999999999999886554333   33333322222


Q ss_pred             C---CCCCCHHHHHHHHHhcccCCCCCCCh
Q 038249          234 P---KPIVSSAAKDLISQMLVKDSSQRLPL  260 (281)
Q Consensus       234 ~---~~~~~~~l~~li~~~l~~~p~~Rps~  260 (281)
                      .   -..+|.++.-.+.-|-..--++-|+.
T Consensus       245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             HHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            1   24578888888888887777777764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.4e-26  Score=176.83  Aligned_cols=245  Identities=18%  Similarity=0.327  Sum_probs=199.0

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +.+.+..+..+|.....|+.|++++.  |..++.|++..... ..+..+.+.+|.-.++-+.||||+.+++.+.......
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            44566677889999999999999998  55677888765443 3344567888888888899999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCeEeCCCCcEEEe--eecCcccc
Q 038249           93 LILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCHGKH--VIHRDIKPENLLIGAQGELKIA--DFGWSVHT  166 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~Ni~~~~~~~~~l~--dfg~~~~~  166 (281)
                      ++..|++.++|+..+..+..  .+..++.+++.++++|++|||+..  |.-.-++...||+|++-+++++  |--++.+.
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe  343 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE  343 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence            99999999999999987643  577789999999999999999874  3344688999999998876653  32233222


Q ss_pred             cCCcccccCcCCccCCccccCCCCC---CcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHH
Q 038249          167 FNRRRTMCGTLDYLPPEMVESVEHD---ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK  243 (281)
Q Consensus       167 ~~~~~~~~~~~~~~aPE~~~~~~~~---~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  243 (281)
                      .+    ..-.|.|++||.+...+.+   ..+|+|||++++|||-|...||....+.+--.++-........++.++..+.
T Consensus       344 ~g----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~  419 (448)
T KOG0195|consen  344 VG----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN  419 (448)
T ss_pred             cc----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence            22    2346899999999777754   3689999999999999999999999998877666555555566668999999


Q ss_pred             HHHHHhcccCCCCCCChhhhh
Q 038249          244 DLISQMLVKDSSQRLPLHKLL  264 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil  264 (281)
                      .+++-|++.||.+||.+..|+
T Consensus       420 klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  420 KLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999988765

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-24  Score=172.90  Aligned_cols=241  Identities=24%  Similarity=0.340  Sum_probs=189.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~   93 (281)
                      --.|+++++||+|+||.++.+++.-++++||||.-....     ....+..|.+..+.+ ..++|...+-+..++-+=.+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            356999999999999999999999999999999863221     134577788887777 46888888888777777789


Q ss_pred             EEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-----cEEEeeecCccccc
Q 038249           94 ILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-----ELKIADFGWSVHTF  167 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-----~~~l~dfg~~~~~~  167 (281)
                      |+|.. |.||+++..-++ .++...+..++.|++.-++++|++.++.+||||+|+++..-+     .+.++|||++....
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            99988 779999998764 599999999999999999999999999999999999997543     58999999996654


Q ss_pred             CC----------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHH---HHhhccccCC-
Q 038249          168 NR----------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR---RIVQVDLKFP-  233 (281)
Q Consensus       168 ~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~-  233 (281)
                      +.          .....||.+||+--.+.+..-+.+.|+-|||-++++++-|.+||.+..-+...+   .+-..+..-+ 
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i  260 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI  260 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence            43          244568999999988888888889999999999999999999998755443333   2221111111 


Q ss_pred             --CCCCCCHHHHHHHHHhcccCCCCCCChh
Q 038249          234 --PKPIVSSAAKDLISQMLVKDSSQRLPLH  261 (281)
Q Consensus       234 --~~~~~~~~l~~li~~~l~~~p~~Rps~~  261 (281)
                        ....+|.++..-++-.-..+-.+-|..+
T Consensus       261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  261 EVLCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             HHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence              1134777777777777777777777653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.8e-26  Score=196.15  Aligned_cols=239  Identities=33%  Similarity=0.604  Sum_probs=199.7

Q ss_pred             eecccCceEEEEEEEc---cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEEEEEecc
Q 038249           23 PLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVYLILEYA   98 (281)
Q Consensus        23 ~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~e~~   98 (281)
                      .+|.|++|.|+++...   ..+..+++|+............ .-..|..++..++ ||.+++++..+..++..+++.++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            3689999999976533   3467788888765543322211 3345666677776 999999999999999999999999


Q ss_pred             CCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccccCcCC
Q 038249           99 AKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD  178 (281)
Q Consensus        99 ~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  178 (281)
                      .|+.|...+.....+++.........++.+++++|+.+++++|+|++||+++.+|++++.|||++......... ||+..
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-cgt~e  158 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-CGTYE  158 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-ccchh
Confidence            99999988888888899999999999999999999999999999999999999999999999998665444444 89999


Q ss_pred             ccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 038249          179 YLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL  258 (281)
Q Consensus       179 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  258 (281)
                      |+|||+.+  ......|.||+|+++++|++|..||..    +....++......+.  .++...++++..++..+|.+|.
T Consensus       159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~~r~p~nrL  230 (612)
T KOG0603|consen  159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR--ELSAEARSLFRQLFKRNPENRL  230 (612)
T ss_pred             hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch--hhhHHHHHHHHHHHhhCHHHHh
Confidence            99999988  566789999999999999999999987    666666665554444  5888999999999999999998


Q ss_pred             C-----hhhhhcCCcccc
Q 038249          259 P-----LHKLLEHPWIIQ  271 (281)
Q Consensus       259 s-----~~eil~~~~~~~  271 (281)
                      -     +.||++|+||+.
T Consensus       231 g~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  231 GAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             ccCcchhHHHhccchhee
Confidence            5     579999999984

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=1.1e-24  Score=170.41  Aligned_cols=173  Identities=16%  Similarity=0.157  Sum_probs=133.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHH------HHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ------LRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~------~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      -++|++.+.+|.|++|.||++.+  ++..+|+|.+.......+.....      +.+|++.+.++.|++|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            47899999999999999999765  36689999997665544444334      57899999999999999999986643


Q ss_pred             --------CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeee
Q 038249           89 --------KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADF  160 (281)
Q Consensus        89 --------~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~df  160 (281)
                              +..+++|||++|.+|.+...    +++    ....++..++..+|+.|++|+|++|.||+++.+| ++++||
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence                    35789999999999977632    233    2456899999999999999999999999999988 999999


Q ss_pred             cCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHH
Q 038249          161 GWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL  207 (281)
Q Consensus       161 g~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~  207 (281)
                      |...........         ........++.++|+|+||+++..+.
T Consensus       179 g~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence            976433211111         00222334557899999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=7.1e-24  Score=163.82  Aligned_cols=141  Identities=21%  Similarity=0.204  Sum_probs=110.5

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeecccccchH-----------------------HHHHHHHHHHHHHhCCCCc
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ-----------------------VEHQLRREVEIQSHLRHPN   77 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~~~h~~   77 (281)
                      ...||+|++|.||+|.+. +|+.||+|++.........                       .......|++.++++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            578999999999999997 8999999999765321110                       0122345889999998777


Q ss_pred             eeeeeeEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhcCceecCCCCCCeEeCCCCcEE
Q 038249           78 ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC-HGKHVIHRDIKPENLLIGAQGELK  156 (281)
Q Consensus        78 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~i~H~di~~~Ni~~~~~~~~~  156 (281)
                      +.....+... + .++||||++|+++........+++...+..++.|++.+|.++ |+.|++|+||||+||+++ ++.++
T Consensus        81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            6544433222 2 379999999877765544446789999999999999999999 799999999999999998 57899


Q ss_pred             EeeecCccc
Q 038249          157 IADFGWSVH  165 (281)
Q Consensus       157 l~dfg~~~~  165 (281)
                      |+|||++..
T Consensus       158 LiDFG~a~~  166 (190)
T cd05147         158 IIDVSQSVE  166 (190)
T ss_pred             EEEcccccc
Confidence            999999854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=1.2e-22  Score=157.45  Aligned_cols=143  Identities=19%  Similarity=0.169  Sum_probs=112.3

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccccch-----------------------HHHHHHHHHHHHHHhCCCC
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS-----------------------QVEHQLRREVEIQSHLRHP   76 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~-----------------------~~~~~~~~e~~~l~~~~h~   76 (281)
                      +.+.||+|++|.||+|.+. +|+.||+|++........                       ........|++.+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4578999999999999988 899999999976532100                       0012245788899999888


Q ss_pred             ceeeeeeEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcE
Q 038249           77 NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGEL  155 (281)
Q Consensus        77 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~  155 (281)
                      ++.....+....  .++||||++|+++.........++...+..++.+++.++.++|+ .|++|+||+|+||+++ ++.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            876555544332  37999999987554432233557888999999999999999999 9999999999999998 8999


Q ss_pred             EEeeecCcccc
Q 038249          156 KIADFGWSVHT  166 (281)
Q Consensus       156 ~l~dfg~~~~~  166 (281)
                      +|+|||++...
T Consensus       157 ~liDFG~a~~~  167 (190)
T cd05145         157 YIIDVSQAVEL  167 (190)
T ss_pred             EEEEcccceec
Confidence            99999988543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.90  E-value=8.9e-24  Score=189.75  Aligned_cols=221  Identities=29%  Similarity=0.551  Sum_probs=177.2

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ..-.-++|..++.|.-|++|.||.++|+.+.+++|. ++......       +++   ++....+|.+|           
T Consensus        78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-------lRn---ilt~a~npfvv-----------  135 (1205)
T KOG0606|consen   78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-------LRN---ILTFAGNPFVV-----------  135 (1205)
T ss_pred             cCCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchh-------hhc---cccccCCccee-----------
Confidence            334458899999999999999999999999999999 54322210       111   33334455554           


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC--
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN--  168 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~--  168 (281)
                                |+=...++.-++++.+.        +.+++|||+.||+|+|++|+|.+++.-|++|+.|||++....-  
T Consensus       136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                      34455666656666554        7789999999999999999999999999999999998632100  


Q ss_pred             ----------------CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC
Q 038249          169 ----------------RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF  232 (281)
Q Consensus       169 ----------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  232 (281)
                                      ..+..++||.|.|||+...+.|+...|.|++|+++|+++-|..||.+.++.+++..+......+
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence                            1133478999999999999999999999999999999999999999999999999888776666


Q ss_pred             CCC-CCCCHHHHHHHHHhcccCCCCCC---ChhhhhcCCcccc
Q 038249          233 PPK-PIVSSAAKDLISQMLVKDSSQRL---PLHKLLEHPWIIQ  271 (281)
Q Consensus       233 ~~~-~~~~~~l~~li~~~l~~~p~~Rp---s~~eil~~~~~~~  271 (281)
                      +.. ..++.+.+++|.++|..+|..|.   .+-++..|+||+.
T Consensus       278 pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  278 PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence            543 35889999999999999999997   4778889999984

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5.1e-23  Score=167.53  Aligned_cols=255  Identities=25%  Similarity=0.419  Sum_probs=173.7

Q ss_pred             cchhhhcccccCCceecceecccCceEEEEEEEccCCc-----------------------------------EEEEEEe
Q 038249            5 VSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNH-----------------------------------IVALKVL   49 (281)
Q Consensus         5 ~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~-----------------------------------~~~lK~~   49 (281)
                      .++....++++++|+++..||+|..+.||.+.-+.+|.                                   +.|||.+
T Consensus       146 i~~r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmM  225 (598)
T KOG4158|consen  146 IPNRIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMM  225 (598)
T ss_pred             CcchhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHh
Confidence            35556678899999999999999999999987665321                                   2344543


Q ss_pred             eccccc--chHHHHHHHHHHH--------------HHHh--------CCCCceeeeeeEEE-------------------
Q 038249           50 FKSQLQ--QSQVEHQLRREVE--------------IQSH--------LRHPNILRLYGYFY-------------------   86 (281)
Q Consensus        50 ~~~~~~--~~~~~~~~~~e~~--------------~l~~--------~~h~~i~~~~~~~~-------------------   86 (281)
                      ..-..+  .....+..-+|.-              ..+.        -+||||+++.+.|.                   
T Consensus       226 fN~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~  305 (598)
T KOG4158|consen  226 FNFEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPA  305 (598)
T ss_pred             cccccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccc
Confidence            221111  1112222222210              0111        25999999987663                   


Q ss_pred             --------eCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC--CCC--c
Q 038249           87 --------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG--AQG--E  154 (281)
Q Consensus        87 --------~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~--~~~--~  154 (281)
                              .+.++|+||..++. +|.+++-.+. .+.....-++.|+++|+.|||++|+.|+|+|.+||++.  .|+  .
T Consensus       306 R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~  383 (598)
T KOG4158|consen  306 RWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQ  383 (598)
T ss_pred             eecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcE
Confidence                    23378999999977 9999998765 46666777889999999999999999999999999984  333  5


Q ss_pred             EEEeeecCcccccC---------CcccccCcCCccCCccccCCC------CCCcccHHhHHHHHHHHHhCCCCCCCCCch
Q 038249          155 LKIADFGWSVHTFN---------RRRTMCGTLDYLPPEMVESVE------HDANVDIWSLGVLCYEFLYGVPPFEAKEHS  219 (281)
Q Consensus       155 ~~l~dfg~~~~~~~---------~~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  219 (281)
                      +.+.|||-+.-...         ..-...|....+|||+....+      .-.++|.|+.|.+.||++....||-.....
T Consensus       384 LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem  463 (598)
T KOG4158|consen  384 LVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM  463 (598)
T ss_pred             EEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh
Confidence            78899996522111         112223566789999974332      124799999999999999999999663332


Q ss_pred             HHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChh
Q 038249          220 DTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLH  261 (281)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  261 (281)
                      .+-...-+.......+..+|..+++++..+|+.||.+|+|.+
T Consensus       464 ~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  464 LLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            221111111111222346889999999999999999999943

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=4.4e-23  Score=187.85  Aligned_cols=195  Identities=25%  Similarity=0.308  Sum_probs=164.2

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .-..|.|.+.||.|++|.||.|.+.+ |+.||||+-.++..+.-.....+...+. .+  --+.|+.+...+...+..++
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccCCccee
Confidence            34779999999999999999999997 9999999998887776666655555554 11  13466677777777788899


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-------CCcEEEeeecCcccc
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-------QGELKIADFGWSVHT  166 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-------~~~~~l~dfg~~~~~  166 (281)
                      |++|.+.|+|.++++..+..++..+..+..|++..++.||..+|+||||||+|+|+..       +--++|+|||.+..+
T Consensus       772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            9999999999999998888999999999999999999999999999999999999942       235899999988554


Q ss_pred             cCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCC
Q 038249          167 FNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPP  212 (281)
Q Consensus       167 ~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  212 (281)
                      ..-     -...++|..+-.+|...+.+++...|.|+|+.+++.|++|+..
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            322     2345678899999999999999999999999999999998653

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=9.4e-21  Score=145.31  Aligned_cols=185  Identities=22%  Similarity=0.229  Sum_probs=135.2

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHH-HHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEEEEE
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV-EHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~-~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.+...|++|+||+|+.+..  .+.+++.+.+.......... ...+.+|+++++++. ++++.+++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            45678999999999997766  47788878775544322211 224788999999995 4788888886    3468999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCC-CCCCeEeCCCCcEEEeeecCcccccCCcc---
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI-KPENLLIGAQGELKIADFGWSVHTFNRRR---  171 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di-~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~---  171 (281)
                      +|+.|.+|......       ....++.++..++.++|+.||+|+|| +|+||+++.++.++|+|||++........   
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999888654322       12357789999999999999999999 79999999999999999999864332221   


Q ss_pred             -------------cccCcCCccCCccccCC-CCC-CcccHHhHHHHHHHHHhCCCCCCC
Q 038249          172 -------------TMCGTLDYLPPEMVESV-EHD-ANVDIWSLGVLCYEFLYGVPPFEA  215 (281)
Q Consensus       172 -------------~~~~~~~~~aPE~~~~~-~~~-~~~Di~slG~~l~~l~~g~~p~~~  215 (281)
                                   ....++.++.|+...-. ..+ ...+.++.|+-+|.++|+..+...
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                         01135555666543211 222 457888999999999998887543

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=1.1e-20  Score=150.93  Aligned_cols=144  Identities=20%  Similarity=0.196  Sum_probs=112.7

Q ss_pred             CceecceecccCceEEEEEE-EccCCcEEEEEEeecccccc---------------------hHHHHHHHHHHHHHHhCC
Q 038249           17 DFDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQLQQ---------------------SQVEHQLRREVEIQSHLR   74 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~-~~~~~~~~~lK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~~~   74 (281)
                      -|++.+.||.|++|.||+|. +..+|+.||+|.+.......                     ......+..|+..++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999999 66789999999987543210                     011234568999999986


Q ss_pred             CCc--eeeeeeEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC-ceecCCCCCCeEeCC
Q 038249           75 HPN--ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH-VIHRDIKPENLLIGA  151 (281)
Q Consensus        75 h~~--i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-i~H~di~~~Ni~~~~  151 (281)
                      +.+  +.++++.   . ..++||||++|.++.........+....+..++.+|+.++.+||+.| ++|+|++|+||+++ 
T Consensus       109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            532  3333332   2 34799999999888766544455677778899999999999999999 99999999999998 


Q ss_pred             CCcEEEeeecCccc
Q 038249          152 QGELKIADFGWSVH  165 (281)
Q Consensus       152 ~~~~~l~dfg~~~~  165 (281)
                      ++.++|+|||.+..
T Consensus       184 ~~~i~LiDFg~a~~  197 (237)
T smart00090      184 DGKVVIIDVSQSVE  197 (237)
T ss_pred             CCCEEEEEChhhhc
Confidence            88999999998743

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=3.1e-20  Score=144.88  Aligned_cols=136  Identities=20%  Similarity=0.333  Sum_probs=107.8

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-----CCCceeeeeeEEEeCC---
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-----RHPNILRLYGYFYDQK---   89 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~---   89 (281)
                      +.-.+.||+|+++.||.  ++.++.. +||++.....   ...+.+.+|+.+++.+     +||||+++++++.++.   
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            44568999999999995  7777666 6998865432   2245688999999999     6799999999998863   


Q ss_pred             E-EEEEEec--cCCCChhHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhcCceecCCCCCCeEeCCC----CcEEEeeec
Q 038249           90 R-VYLILEY--AAKGELYKELQKCKYFSERRAATYVASLARAL-IYCHGKHVIHRDIKPENLLIGAQ----GELKIADFG  161 (281)
Q Consensus        90 ~-~~~v~e~--~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l-~~Lh~~~i~H~di~~~Ni~~~~~----~~~~l~dfg  161 (281)
                      . +.+|+||  +.+++|.++++.. .+++.  ..++.+++.++ +|||+++|+|+||+|+||+++..    +.++|+|++
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            4 3478999  4578999999874 35555  35678888777 99999999999999999999743    379999954


Q ss_pred             C
Q 038249          162 W  162 (281)
Q Consensus       162 ~  162 (281)
                      .
T Consensus       155 G  155 (210)
T PRK10345        155 G  155 (210)
T ss_pred             C
Confidence            3

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.6e-19  Score=141.44  Aligned_cols=138  Identities=20%  Similarity=0.310  Sum_probs=114.8

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS-----QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++.||+|++|.||+|.+  .|..+++|..........     .....+.+|+.++..+.|+++..+..++...+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999987  477899998654332211     12245778999999999999888888877778889999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                      ||++|++|.+.+.....    ....++.+++.++.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999999876432    7889999999999999999999999999999998 88999999998643

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.8e-19  Score=154.26  Aligned_cols=195  Identities=21%  Similarity=0.364  Sum_probs=152.6

Q ss_pred             HhCCCCceeeeeeEEEeCCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCc-eecCCCCCCeE
Q 038249           71 SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHV-IHRDIKPENLL  148 (281)
Q Consensus        71 ~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i-~H~di~~~Ni~  148 (281)
                      +.+.|.|+.++++.+.++...++|.+||.-|+|.+.+... -.++......++.+|+.|++|||+..| +|+.++..|.+
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl   81 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL   81 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence            5678999999999999999999999999999999999874 358888999999999999999998765 99999999999


Q ss_pred             eCCCCcEEEeeecCcccccC-----CcccccCcCCccCCccccCCC-------CCCcccHHhHHHHHHHHHhCCCCCCCC
Q 038249          149 IGAQGELKIADFGWSVHTFN-----RRRTMCGTLDYLPPEMVESVE-------HDANVDIWSLGVLCYEFLYGVPPFEAK  216 (281)
Q Consensus       149 ~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~g~~p~~~~  216 (281)
                      ++..-.+|+.|||+......     .........-|.|||.+....       .+.+.|+||+|++++++++...||...
T Consensus        82 vd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~  161 (484)
T KOG1023|consen   82 VDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLR  161 (484)
T ss_pred             eeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccc
Confidence            99999999999998644321     111112344689999986532       355799999999999999999999763


Q ss_pred             Cc----hHHHHHHhh-ccccCCCC----CCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          217 EH----SDTYRRIVQ-VDLKFPPK----PIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       217 ~~----~~~~~~~~~-~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ..    .+....+.. +...+.+.    ...++++..++..||..+|.+||+++.+-.
T Consensus       162 ~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  162 NLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            22    234444433 11111111    134557999999999999999999887753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=9.9e-19  Score=136.81  Aligned_cols=133  Identities=17%  Similarity=0.254  Sum_probs=107.6

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeecccccc-----hHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEec
Q 038249           23 PLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-----SQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEY   97 (281)
Q Consensus        23 ~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   97 (281)
                      .||+|++|.||++.+.  +..+++|.........     ......+.+|+++++.+.++++.....++...+..+++|||
T Consensus         1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            4899999999999854  7789999865432221     11235567899999999888766666666666777899999


Q ss_pred             cCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           98 AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        98 ~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                      ++|++|.+.+.....       .++.+++.++.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988766321       7889999999999999999999999999998 88999999998743

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.2e-18  Score=136.14  Aligned_cols=137  Identities=20%  Similarity=0.268  Sum_probs=106.8

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccch-------------------HHHHHHHHHHHHHHhCCCCc-
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS-------------------QVEHQLRREVEIQSHLRHPN-   77 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~-------------------~~~~~~~~e~~~l~~~~h~~-   77 (281)
                      |.+.+.||.|++|.||++.+. +|+.+++|++..+.....                   ........|+..+..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999886 799999999764331100                   11223567888888887763 


Q ss_pred             -eeeeeeEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEE
Q 038249           78 -ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELK  156 (281)
Q Consensus        78 -i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~  156 (281)
                       +...++    ....++||||++|++|......      .....++.+|+.++.++|+.|++|+||+|+||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             333333    2345899999999888765431      34567889999999999999999999999999999999999


Q ss_pred             EeeecCccc
Q 038249          157 IADFGWSVH  165 (281)
Q Consensus       157 l~dfg~~~~  165 (281)
                      |+|||.+..
T Consensus       166 liDfg~~~~  174 (198)
T cd05144         166 IIDWPQMVS  174 (198)
T ss_pred             EEECCcccc
Confidence            999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=1.3e-20  Score=167.98  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=204.7

Q ss_pred             cCCceecceecccCceEEEEEEEccCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSN-HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~-~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~   92 (281)
                      ...|.+.+.||.|+++.|-.+....+. ..++.|.+.... ...........|..+-+.+. |+|++..++...+.+..+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            678999999999999999888775443 345666654433 22233344555666666675 999999999999999999


Q ss_pred             EEEeccCCCChhHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCCeEeCCCC-cEEEeeecCcccccC
Q 038249           93 LILEYAAKGELYKEL-QKCK-YFSERRAATYVASLARALIYCH-GKHVIHRDIKPENLLIGAQG-ELKIADFGWSVHTFN  168 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~-~~~~-~l~~~~~~~i~~~i~~~l~~Lh-~~~i~H~di~~~Ni~~~~~~-~~~l~dfg~~~~~~~  168 (281)
                      +..++..|+++.+.+ .... ..+...+...+.|+..++.|+| ..++.|+|++|+|.+++.++ .+++.|||++.....
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999998888 4443 5677888899999999999999 99999999999999999999 999999999855433


Q ss_pred             --C----cccccC-cCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHH-Hhh--ccccCCCCCC
Q 038249          169 --R----RRTMCG-TLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRR-IVQ--VDLKFPPKPI  237 (281)
Q Consensus       169 --~----~~~~~~-~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~--~~~~~~~~~~  237 (281)
                        .    ....++ ++.|.|||...+. -..+..|+||.|+++..+++|..||........... ...  .......+..
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence              1    123456 8999999998774 446789999999999999999999977665543322 111  1223455667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          238 VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      .+....+++.+++..+|..|.+.+++-.+||+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            8899999999999999999999999999999998

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=4.2e-18  Score=152.10  Aligned_cols=138  Identities=16%  Similarity=0.218  Sum_probs=111.3

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-----QSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .|...+.||+|++|+||++.+..  ..+++|+.......     .......+.+|+++++.++|++++.+..+.......
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34668899999999999998763  34555543322111     112235678899999999999998888777777778


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                      ++||||++|++|.+.+.        ....++.+++.++.+||+.|++|+|++|+||++ .++.++++|||++..
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            89999999999998876        356789999999999999999999999999999 678999999998744

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=9.8e-20  Score=153.48  Aligned_cols=174  Identities=25%  Similarity=0.344  Sum_probs=134.6

Q ss_pred             EEEEEEeccCCCChhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           90 RVYLILEYAAKGELYKELQKCK---YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      +.++.|++|...+|.+++..++   ..+....+.++.|+..|+.|   +|.+|+|++|.||+...++.++|+|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            5789999999999999997553   36777889999999999999   99999999999999999999999999997554


Q ss_pred             cCCc---------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCC
Q 038249          167 FNRR---------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKP  236 (281)
Q Consensus       167 ~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (281)
                      ....         ....+|..|++||.+.+..|+.++|||+||++++|++. =...+   ........+..+.+......
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~~~~~  483 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIPPEFLQ  483 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCChHHhh
Confidence            3332         34568999999999999999999999999999999986 12222   12222223333322211222


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhhhhcCCccc
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                      .+| +-..|+.+||.+.|.+||++.+.-.|+|.+
T Consensus       484 d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  484 DYP-EEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             cCc-HHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            222 345899999999999999888887787764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=1.8e-17  Score=128.34  Aligned_cols=139  Identities=19%  Similarity=0.292  Sum_probs=97.8

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHH---------------------HHHHHHHHHhCCCCc-
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ---------------------LRREVEIQSHLRHPN-   77 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~---------------------~~~e~~~l~~~~h~~-   77 (281)
                      +.+.||+|++|+||.|.+. +++.||+|++.............                     ...|.+.+..+.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999987 78999999986543221111111                     134555555554332 


Q ss_pred             -eeeeeeEEEeCCEEEEEEeccCCCChh-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCc
Q 038249           78 -ILRLYGYFYDQKRVYLILEYAAKGELY-KELQKCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGE  154 (281)
Q Consensus        78 -i~~~~~~~~~~~~~~~v~e~~~~~~L~-~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~  154 (281)
                       +.++++.    ...++|+||++++.+. ..+....  ....+..++.+++.++.++|. .|++|+|++|+||+++ ++.
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence             3333332    2358999999985432 1222211  116688899999999999999 9999999999999999 899


Q ss_pred             EEEeeecCcccc
Q 038249          155 LKIADFGWSVHT  166 (281)
Q Consensus       155 ~~l~dfg~~~~~  166 (281)
                      ++++|||.+...
T Consensus       153 ~~liDfg~a~~~  164 (187)
T cd05119         153 VYIIDVPQAVEI  164 (187)
T ss_pred             EEEEECcccccc
Confidence            999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=2.2e-16  Score=126.35  Aligned_cols=137  Identities=17%  Similarity=0.226  Sum_probs=103.8

Q ss_pred             ceec-ccCceEEEEEEEccCCcEEEEEEeecccc----------cchHHHHHHHHHHHHHHhCCCCce--eeeeeEEEeC
Q 038249           22 KPLG-RGKFGHVYLAREKRSNHIVALKVLFKSQL----------QQSQVEHQLRREVEIQSHLRHPNI--LRLYGYFYDQ   88 (281)
Q Consensus        22 ~~ig-~g~~~~v~~~~~~~~~~~~~lK~~~~~~~----------~~~~~~~~~~~e~~~l~~~~h~~i--~~~~~~~~~~   88 (281)
                      ..|| .|+.|+||.+...  +..++||.+.....          ........+.+|++++..+.|+++  +.++++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 8888889988775  77899998854321          011223457789999999988775  6666664332


Q ss_pred             -C---EEEEEEeccCC-CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           89 -K---RVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        89 -~---~~~~v~e~~~~-~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                       .   ..++|+|+++| .+|.+++... +++...    +.+|+.++.+||+.||+|+||+|.||+++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence             2   23599999997 6888888763 455543    568999999999999999999999999999999999999977


Q ss_pred             cc
Q 038249          164 VH  165 (281)
Q Consensus       164 ~~  165 (281)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            43

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=7.3e-16  Score=114.89  Aligned_cols=131  Identities=24%  Similarity=0.258  Sum_probs=109.1

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CceeeeeeEEEeCCEEEEEEec
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH--PNILRLYGYFYDQKRVYLILEY   97 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~~v~e~   97 (281)
                      +++.||.|.++.||++...  +..+++|.......     ...+.+|+..++.+.+  .++.+++......+..++++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            4678999999999999986  36799999854432     3457788888888866  5888888888877889999999


Q ss_pred             cCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---CceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           98 AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK---HVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        98 ~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      +++.++...       +......++.+++.++..+|..   +++|+|++|.||+++..+.++++||+.+.
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            998777654       5556677889999999999985   79999999999999998999999999764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.65  E-value=6.6e-15  Score=128.05  Aligned_cols=183  Identities=20%  Similarity=0.292  Sum_probs=138.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      --|++ ....-++.+..-.|..+.++.++.+.+.....-   .......+-+..++.++||||+++++.++..+++|+|+
T Consensus        13 fpY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvT   88 (690)
T KOG1243|consen   13 FPYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVT   88 (690)
T ss_pred             CCccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEe
Confidence            34555 444444444322577778899999998865542   33455777889999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc---c
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH-GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR---R  171 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~---~  171 (281)
                      |.+.  .|..++++   ++...+-..+.||+.||.+|| +.+++|++|+...|+++..|.++|++|.+.....+..   .
T Consensus        89 ErV~--Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~  163 (690)
T KOG1243|consen   89 ERVR--PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK  163 (690)
T ss_pred             eccc--cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc
Confidence            9983  57778877   446777788899999999998 5699999999999999999999999999864433332   1


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhC
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYG  209 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g  209 (281)
                      .......|..|+......  -..|.|.||+++++++.|
T Consensus       164 ~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  164 SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            222233455666544433  236999999999999988

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=3.4e-16  Score=134.43  Aligned_cols=255  Identities=21%  Similarity=0.221  Sum_probs=190.5

Q ss_pred             cccCCceecceecc--cCceEEEEEEE--ccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249           13 WTLNDFDIGKPLGR--GKFGHVYLARE--KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~--g~~~~v~~~~~--~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      |.-..+.+.+.+|.  |.+|.+|.+.-  ..++..+|+|.-........... .-.+++...+.+ .|++.++.+..+..
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~-~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSK-RKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccc-cccchhhcccccCccccccccCccccc
Confidence            33466788899999  99999999888  78889999998433322111111 122345444455 48999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHH----HHHHHHhcCceecCCCCCCeEeCCC-CcEEEeeec
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLAR----ALIYCHGKHVIHRDIKPENLLIGAQ-GELKIADFG  161 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~----~l~~Lh~~~i~H~di~~~Ni~~~~~-~~~~l~dfg  161 (281)
                      .+..++-+|.+. .+|..+...-. .++...++..+.+...    |+.++|+.+++|.|++|.||+...+ ...+++|||
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence            999999999996 57777776544 4899999999999999    9999999999999999999999999 789999999


Q ss_pred             CcccccCCc--------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC
Q 038249          162 WSVHTFNRR--------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP  233 (281)
Q Consensus       162 ~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  233 (281)
                      +........        ....+...|++||...+ .++..+|++++|.++.+-.++........... +..+.++....+
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~~ip~e  346 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQGYIPLE  346 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-ccccccccCchh
Confidence            865433322        22256778999999766 55778999999999999887766544331111 111111112222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      .....+.++...+..|+..+|..|+++++++.++++.+
T Consensus       347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            23346678888999999999999999999999999874

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=8.7e-16  Score=122.86  Aligned_cols=201  Identities=19%  Similarity=0.301  Sum_probs=145.4

Q ss_pred             HHHHHhCCCCceeeeeeEEEeC-----CEEEEEEeccCCCChhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhc--
Q 038249           67 VEIQSHLRHPNILRLYGYFYDQ-----KRVYLILEYAAKGELYKELQKC----KYFSERRAATYVASLARALIYCHGK--  135 (281)
Q Consensus        67 ~~~l~~~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~--  135 (281)
                      ...+-++.|.||++++.++.+.     ....+++||++.+++..++++-    ..+......+|+.||+.||.|||+.  
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            3344555799999999998653     3578899999999999988753    3488888999999999999999986  


Q ss_pred             CceecCCCCCCeEeCCCCcEEEeeecCcccc-------cCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh
Q 038249          136 HVIHRDIKPENLLIGAQGELKIADFGWSVHT-------FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY  208 (281)
Q Consensus       136 ~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~  208 (281)
                      -++|+++..+.|++..+|-+|+.--.....-       ...+....+.++|.+||.-.....+.++|||++|+...+|.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            5999999999999999998887543321110       011223345788999998766667778999999999999976


Q ss_pred             CCCC-CCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          209 GVPP-FEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       209 g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +..- -+..+....-..+.......     .+.--+.++.+|++..|..||++++++.||-+.+.
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~~l-----en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVIIGL-----ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             heeccCCCcceeehhhhhhhheeec-----cCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            5432 22222211111111111111     22335679999999999999999999999987754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=2.8e-16  Score=142.19  Aligned_cols=262  Identities=28%  Similarity=0.443  Sum_probs=206.4

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      .+..+..+.+.+-+..|+++.++.+.-..+|...+.|+......-.....+....+-+++-...+|-++...--+....-
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            56778899999999999999999998888887777776533322111111222222222222234666655544555667


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc----
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT----  166 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~----  166 (281)
                      .++++++..+++|...+...++.+.+-++..+..+..+.++||+..+.|+|++|.|.+...+++..+.+|+.....    
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            8999999999999999999888888888889999999999999999999999999999999999999998732000    


Q ss_pred             ----c-------------------CC-------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCC
Q 038249          167 ----F-------------------NR-------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAK  216 (281)
Q Consensus       167 ----~-------------------~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  216 (281)
                          .                   ..       .....+|+.|.+||...+......+|.|+.|+++++.++|.+||+..
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                0                   00       01124789999999999999999999999999999999999999999


Q ss_pred             CchHHHHHHhhccccCCCCC-CCCHHHHHHHHHhcccCCCCCCChh---hhhcCCccccC
Q 038249          217 EHSDTYRRIVQVDLKFPPKP-IVSSAAKDLISQMLVKDSSQRLPLH---KLLEHPWIIQN  272 (281)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~---eil~~~~~~~~  272 (281)
                      .+.+.++.+..+...++..+ ..+.+.++++...|..+|.+|..+.   +.-.|+||+..
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            99999999998877777543 4788999999999999999999988   88899999965

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.55  E-value=1.3e-13  Score=105.87  Aligned_cols=140  Identities=14%  Similarity=0.150  Sum_probs=100.0

Q ss_pred             cceecccCceEEEEEEEcc------CCcEEEEEEeeccccc----------c---------hHHHHH----HHHHHHHHH
Q 038249           21 GKPLGRGKFGHVYLAREKR------SNHIVALKVLFKSQLQ----------Q---------SQVEHQ----LRREVEIQS   71 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~------~~~~~~lK~~~~~~~~----------~---------~~~~~~----~~~e~~~l~   71 (281)
                      ...||.|..+.||.|....      ++..+|||++......          .         ......    ..+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4689999999999998764      3578999998433210          0         001122    337888888


Q ss_pred             hCCC--CceeeeeeEEEeCCEEEEEEeccCCCChh-HHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhcCceecCCCCCCe
Q 038249           72 HLRH--PNILRLYGYFYDQKRVYLILEYAAKGELY-KELQKCKYFSERRAATYVASLARALIYC-HGKHVIHRDIKPENL  147 (281)
Q Consensus        72 ~~~h--~~i~~~~~~~~~~~~~~~v~e~~~~~~L~-~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~i~H~di~~~Ni  147 (281)
                      ++..  -++.+++++    ..-++||||+.+..+. ..++. ..++...+..+..+++.++..+ |+.|++|||+++.||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            8854  345555554    3457899999764332 22333 2356667778889999999988 899999999999999


Q ss_pred             EeCCCCcEEEeeecCcccc
Q 038249          148 LIGAQGELKIADFGWSVHT  166 (281)
Q Consensus       148 ~~~~~~~~~l~dfg~~~~~  166 (281)
                      +++ ++.+.++|||.+...
T Consensus       157 L~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         157 LWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             EEE-CCcEEEEECCCceeC
Confidence            996 578999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.54  E-value=1.9e-14  Score=126.44  Aligned_cols=148  Identities=22%  Similarity=0.315  Sum_probs=94.1

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccc-------------------------------hHHHHHH
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-------------------------------SQVEHQL   63 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~-------------------------------~~~~~~~   63 (281)
                      +.+|+. +.||.|+.|+||.|+.+.+|+.||||+..+.-...                               ++..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            566787 89999999999999999889999999996442000                               0112223


Q ss_pred             HHHHHH------HHhC----CCCceeeeeeEEEe-CCEEEEEEeccCCCChhHH--HHhCCCCCHHHHHHHHHHHHHHHH
Q 038249           64 RREVEI------QSHL----RHPNILRLYGYFYD-QKRVYLILEYAAKGELYKE--LQKCKYFSERRAATYVASLARALI  130 (281)
Q Consensus        64 ~~e~~~------l~~~----~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~--~~~~~~l~~~~~~~i~~~i~~~l~  130 (281)
                      .+|+..      +.++    .+...+.+-.++.+ ....++||||++|+++.+.  +...+ .+...+.....+  ..+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~--~~~~  274 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVE--VFFT  274 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHH--HHHH
Confidence            333332      2222    23333333333322 4566799999999999764  23322 222222221111  1133


Q ss_pred             HHHhcCceecCCCCCCeEeCCCC----cEEEeeecCcccc
Q 038249          131 YCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWSVHT  166 (281)
Q Consensus       131 ~Lh~~~i~H~di~~~Ni~~~~~~----~~~l~dfg~~~~~  166 (281)
                      .+...|++|+|++|.||+++.+|    .++++|||+....
T Consensus       275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            44569999999999999999988    9999999987544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=1.5e-13  Score=119.27  Aligned_cols=143  Identities=24%  Similarity=0.263  Sum_probs=96.5

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeecccccch-------------------------------HHHH------HH
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS-------------------------------QVEH------QL   63 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~-------------------------------~~~~------~~   63 (281)
                      .+.||.|+.|.||+|+.+ +|+.||||+..+.-...-                               +...      .+
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            368999999999999986 789999999854321000                               0000      12


Q ss_pred             HHHHHHHHhC----C-CCceeeeeeEEEeCCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 038249           64 RREVEIQSHL----R-HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLAR-ALIYCHGKH  136 (281)
Q Consensus        64 ~~e~~~l~~~----~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~-~l~~Lh~~~  136 (281)
                      .+|.+.+.++    + ++++.-..-+....+..++||||++|.+|.+..... ...+   ...++..++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            3344433333    2 344333332333345678999999999998876532 1122   2345555555 478899999


Q ss_pred             ceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249          137 VIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus       137 i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      ++|+|++|.||+++.++.++++|||++....
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999875543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=2.9e-13  Score=100.67  Aligned_cols=133  Identities=17%  Similarity=0.282  Sum_probs=102.9

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHH-----HHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV-----EHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~-----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      ..+.+|+.+.++.+.+.  |.++++|.=.+...-.++.     ...-.+|+.++.+++--.|..+.-+..+.....++||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            46789999999999775  5557777633322222222     3344678888888877677777777777788889999


Q ss_pred             ccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           97 YAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      |++|..|.+.+...       ...++..+-.-+.-||+.||+|||+.++||++..++ +.++|||++.
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            99999999888875       245677788888999999999999999999995554 9999999974

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.49  E-value=2e-12  Score=109.78  Aligned_cols=211  Identities=17%  Similarity=0.211  Sum_probs=156.0

Q ss_pred             ceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE----eCCEEEEEEeccCCC-Ch
Q 038249           29 FGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY----DQKRVYLILEYAAKG-EL  103 (281)
Q Consensus        29 ~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~----~~~~~~~v~e~~~~~-~L  103 (281)
                      ..+.|++....+|..|++|+++-.+..+.   .+...-+++++++.|+|+|++.+++.    .+..+++|++|.++. +|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            35789999999999999999954443332   23445688999999999999999887    356889999999764 66


Q ss_pred             hHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249          104 YKELQK---------------CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus       104 ~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      .++.-.               +...++..+|.++.|+..||.++|+.|+.-+-+.+.+|+++.+.+++++..|.......
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            665421               12368899999999999999999999999999999999999999999998886533322


Q ss_pred             CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc-hHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH-SDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      .+         .  +.+..   -.+-|.-.||.+++.|.+|..--...+. .+......        ...++.+++++|.
T Consensus       446 d~---------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I--------~~~yS~D~rn~v~  503 (655)
T KOG3741|consen  446 DP---------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI--------TTTYSTDLRNVVE  503 (655)
T ss_pred             CC---------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh--------hhhhhHHHHHHHH
Confidence            22         0  11111   1256888899999999998654222221 12211111        2258899999999


Q ss_pred             HhcccCCCCCCChhhhhc
Q 038249          248 QMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~  265 (281)
                      -+...++++ -++++++-
T Consensus       504 yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  504 YLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             HHHhcCccc-ccHHHHHH
Confidence            999988887 67777774

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.49  E-value=7.9e-13  Score=98.05  Aligned_cols=144  Identities=17%  Similarity=0.196  Sum_probs=109.5

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeeccc-----ccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-----LQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .+..|-+|+.+.|+.+.+.  |+.++||.=....     .+..-..+...+|++.+.++.--.|.-..-++.+.+.-.+.
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            6788999999999999887  8888888632222     23333345567888888888766666666677777777899


Q ss_pred             EeccCCC-ChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC---cEEEeeecCccc
Q 038249           95 LEYAAKG-ELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---ELKIADFGWSVH  165 (281)
Q Consensus        95 ~e~~~~~-~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~---~~~l~dfg~~~~  165 (281)
                      |||.+|. ++.+++...  .+...+....++..|-..+.-||..+++|||+.++||++..++   .+.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999883 667776543  2233444478899999999999999999999999999997766   358999998743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=3.9e-14  Score=121.91  Aligned_cols=254  Identities=22%  Similarity=0.253  Sum_probs=185.2

Q ss_pred             cccCCceecceecccCceEEEEEEEc-cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREK-RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKR   90 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~   90 (281)
                      ...-+|..+..||.|.++.|+.+... .++..|++|............+.. ..|+.+...+ .|.+++.....+...+.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccccc
Confidence            34467889999999999999987755 567789999876554433332222 2344444444 58888888888888888


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC-CcEEEeeecCcccccCC
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-GELKIADFGWSVHTFNR  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~-~~~~l~dfg~~~~~~~~  169 (281)
                      .++--||++++++.........+++...+++..+++.++.++|+..++|.|++|.||++..+ +.-++.||+......-.
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            88999999998877766544558888999999999999999999999999999999999886 67788888876432111


Q ss_pred             cccccCcCCcc--CCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          170 RRTMCGTLDYL--PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       170 ~~~~~~~~~~~--aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      ........++.  ++.......+..+.|+++||..+.+..++...-+...   ....+..+.  .+..+....+++.+.+
T Consensus       421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~--~p~~~~~~~~~q~~~k  495 (524)
T KOG0601|consen  421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGD--TPNLPGLKLQLQVLLK  495 (524)
T ss_pred             cccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeeccc--ccCCCchHHhhhhhhh
Confidence            11122233444  4555677778889999999999999988765433222   222222222  2333345588999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .|+.+++..||++.++..|.-|.+.
T Consensus       496 v~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  496 VMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             hhcCCccccchhhhhhcccchhhhh
Confidence            9999999999999999888766543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=4.7e-13  Score=101.87  Aligned_cols=126  Identities=21%  Similarity=0.283  Sum_probs=92.0

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eeeeeEEEeCCEEEEEEeccC
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI-LRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      .+.|+.|..+.||++...  +..+++|.......    .......|+..++.+.+.++ .+++...  ....++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence            467899999999999876  77899999754421    11234567777777754443 3444433  233479999999


Q ss_pred             CCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCc-----eecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          100 KGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV-----IHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       100 ~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i-----~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      |.++... .       .....++.+++.+++.||+.++     +|+|++|.||+++ ++.++++||+.+
T Consensus        75 G~~l~~~-~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a  134 (170)
T cd05151          75 GSELLTE-D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA  134 (170)
T ss_pred             CCccccc-c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence            9887653 0       1123456789999999999885     9999999999998 678999999976

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=1.6e-13  Score=119.99  Aligned_cols=154  Identities=25%  Similarity=0.383  Sum_probs=118.7

Q ss_pred             HHHHHHHHhc-CceecCCCCCCeEeCCCCcEEEeeecCcccccCCccc------------ccCcCCccCCccccCCCCCC
Q 038249          126 ARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT------------MCGTLDYLPPEMVESVEHDA  192 (281)
Q Consensus       126 ~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~aPE~~~~~~~~~  192 (281)
                      ..|+.++|.. +++|++|.|++|.++.++.+|+.+|+++....+....            ......|.|||.+.....+.
T Consensus       109 ~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~  188 (700)
T KOG2137|consen  109 ADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTP  188 (700)
T ss_pred             cchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccccc
Confidence            3899999965 9999999999999999999999999987544432211            12356799999998888889


Q ss_pred             cccHHhHHHHHHHHH-hCCCCCCCCCchHHHHHH--hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          193 NVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRI--VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       193 ~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      ++|++|+|+.++.+. .|+..+............  ...-..+.....+|.++++=+.+++..++..||++..++..|||
T Consensus       189 ~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff  268 (700)
T KOG2137|consen  189 ASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFF  268 (700)
T ss_pred             cccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccccc
Confidence            999999999999988 566666655544433221  11112223335799999999999999999999999999999999


Q ss_pred             ccCCCCCCCC
Q 038249          270 IQNADPSGVY  279 (281)
Q Consensus       270 ~~~~~~~~~~  279 (281)
                      .+..-...+|
T Consensus       269 ~D~~~~aLrf  278 (700)
T KOG2137|consen  269 SDPGLKALRF  278 (700)
T ss_pred             CCchhhhhhh
Confidence            9876554443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.36  E-value=7.1e-11  Score=98.35  Aligned_cols=237  Identities=17%  Similarity=0.227  Sum_probs=154.5

Q ss_pred             eecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceee----eeeEE--Ee-CCE
Q 038249           19 DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILR----LYGYF--YD-QKR   90 (281)
Q Consensus        19 ~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~----~~~~~--~~-~~~   90 (281)
                      ..+..||+|+.+.+|..-...+   .+.|+++.+.....      ......+... +||-+-.    .....  .+ +..
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchhhc---hhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            3568899999999997644322   56788876543221      1123333333 4543322    11111  11 223


Q ss_pred             EEEEEeccCCCC-hhHHH------HhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           91 VYLILEYAAKGE-LYKEL------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        91 ~~~v~e~~~~~~-L~~~~------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      +.++|+.+.|.. ...+.      +..+..+++.+++.+..++.+.+.||..|..-||++++|+|+..++.+.|+|-+.-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            788898887752 22222      23345889999999999999999999999999999999999999999999886643


Q ss_pred             ccccCC--cccccCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhC-CCCCCCCCc----hHHHH-HHhhcc-
Q 038249          164 VHTFNR--RRTMCGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYG-VPPFEAKEH----SDTYR-RIVQVD-  229 (281)
Q Consensus       164 ~~~~~~--~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~----~~~~~-~~~~~~-  229 (281)
                      ..-.+.  ..-..+...|++||.-+     +..-+..+|.|.||+++++++.| .+||.+...    ....+ .+-.+. 
T Consensus       165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            211122  12345788999999753     33346679999999999999875 999965211    11111 111111 


Q ss_pred             -------------ccCCCCCCCCHHHHHHHHHhccc--CCCCCCChhhhh
Q 038249          230 -------------LKFPPKPIVSSAAKDLISQMLVK--DSSQRLPLHKLL  264 (281)
Q Consensus       230 -------------~~~~~~~~~~~~l~~li~~~l~~--~p~~Rps~~eil  264 (281)
                                   ....++..++.+++.++.+|++.  ++.-|||++..+
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~  294 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV  294 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence                         11122345889999999999974  467899976543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.32  E-value=2e-11  Score=96.32  Aligned_cols=136  Identities=20%  Similarity=0.291  Sum_probs=102.5

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccc-------------------cchHHHHHHHHHHHHHHhCCCC--
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-------------------QQSQVEHQLRREVEIQSHLRHP--   76 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~-------------------~~~~~~~~~~~e~~~l~~~~h~--   76 (281)
                      +.++..||.|..|.||.|.+. .|.++++|.-.....                   +-.-...+..+|.+.|+.+...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            346789999999999999998 688899997532211                   1112245567889999888655  


Q ss_pred             ceeeeeeEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEE
Q 038249           77 NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELK  156 (281)
Q Consensus        77 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~  156 (281)
                      .+.+.+++    +...+|||+++|..|...-     ++.+.+..++..|+..+..+-..|++|||+++-||+++++|.+.
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            66666665    5668999999997666533     13444556666777777777789999999999999999999999


Q ss_pred             EeeecCc
Q 038249          157 IADFGWS  163 (281)
Q Consensus       157 l~dfg~~  163 (281)
                      ++||--+
T Consensus       243 vIDwPQ~  249 (304)
T COG0478         243 VIDWPQA  249 (304)
T ss_pred             EEeCccc
Confidence            9999654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=6.2e-11  Score=94.13  Aligned_cols=139  Identities=17%  Similarity=0.242  Sum_probs=99.9

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeeeeeEEEeC---CEEEEEEe
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN--ILRLYGYFYDQ---KRVYLILE   96 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~--i~~~~~~~~~~---~~~~~v~e   96 (281)
                      +.|+.|..+.+|++...+ |..+++|........  .....+..|+..++.+.+.+  +.+++.+....   +..++|+|
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            678999999999998763 578999997554321  12345778888888886533  45666665543   36689999


Q ss_pred             ccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 038249           97 YAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG------------------------------------------  134 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~------------------------------------------  134 (281)
                      |++|.++.+.+.. ..++......++.+++.++..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888765432 235555666666666666666663                                          


Q ss_pred             --------------cCceecCCCCCCeEeCC--CCcEEEeeecCcc
Q 038249          135 --------------KHVIHRDIKPENLLIGA--QGELKIADFGWSV  164 (281)
Q Consensus       135 --------------~~i~H~di~~~Ni~~~~--~~~~~l~dfg~~~  164 (281)
                                    ..++|+|+++.||+++.  ++.+.++||+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                          34699999999999998  5678999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.25  E-value=4e-10  Score=91.40  Aligned_cols=141  Identities=13%  Similarity=0.011  Sum_probs=96.3

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccc---h-----HHHHHHHHHHHHHHhCCCCceee--eeeEEEe----
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ---S-----QVEHQLRREVEIQSHLRHPNILR--LYGYFYD----   87 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~---~-----~~~~~~~~e~~~l~~~~h~~i~~--~~~~~~~----   87 (281)
                      +.+..-....|..+..  .|+.+.||.........   .     .......+|.+.+..+...+|..  ++++...    
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            3444444445666654  47789999773322110   0     00113567787777774433333  3444432    


Q ss_pred             -CCEEEEEEeccCCC-ChhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-------CCcEE
Q 038249           88 -QKRVYLILEYAAKG-ELYKELQK--CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-------QGELK  156 (281)
Q Consensus        88 -~~~~~~v~e~~~~~-~L~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-------~~~~~  156 (281)
                       ....++|+|++++. +|.+++..  ..+.+......++.++...+..||..|++|+|+++.||+++.       +..+.
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence             23568999999886 78888864  234567778899999999999999999999999999999975       45799


Q ss_pred             EeeecCcc
Q 038249          157 IADFGWSV  164 (281)
Q Consensus       157 l~dfg~~~  164 (281)
                      ++||+.+.
T Consensus       186 LIDl~r~~  193 (268)
T PRK15123        186 VIDLHRAQ  193 (268)
T ss_pred             EEECCccc
Confidence            99999763

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.23  E-value=2.3e-10  Score=87.60  Aligned_cols=128  Identities=20%  Similarity=0.310  Sum_probs=83.0

Q ss_pred             EEEEEEEccCCcEEEEEEeecccc-----------------------cchHHHHHHHHHHHHHHhCCCC--ceeeeeeEE
Q 038249           31 HVYLAREKRSNHIVALKVLFKSQL-----------------------QQSQVEHQLRREVEIQSHLRHP--NILRLYGYF   85 (281)
Q Consensus        31 ~v~~~~~~~~~~~~~lK~~~~~~~-----------------------~~~~~~~~~~~e~~~l~~~~h~--~i~~~~~~~   85 (281)
                      .||.|... +|..+|+|.......                       ...-......+|.+.|+++..-  ++.+++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38888886 577899999843321                       1122235567899999999766  455665442


Q ss_pred             EeCCEEEEEEeccC--CCChhHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhcCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           86 YDQKRVYLILEYAA--KGELYKELQKCKYFSERRAATYVASLARALIY-CHGKHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        86 ~~~~~~~~v~e~~~--~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~-Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                          .-.+||||++  |..+..+....  ++.+....++.+++..+.. +|+.|++|||+++.||+++.+ .+.++|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                2359999998  65555544432  1244566777888885444 679999999999999999777 999999997


Q ss_pred             cccc
Q 038249          163 SVHT  166 (281)
Q Consensus       163 ~~~~  166 (281)
                      +...
T Consensus       153 av~~  156 (188)
T PF01163_consen  153 AVDS  156 (188)
T ss_dssp             EEET
T ss_pred             ceec
Confidence            7543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=99.07  E-value=3.9e-09  Score=81.48  Aligned_cols=136  Identities=14%  Similarity=0.113  Sum_probs=97.1

Q ss_pred             cccCceEEEEEEEccCCcEEEEEEeeccc--c-cchHHHHHHHHHHHHHHhCCCCc--eeeeeeEEE---e--CCEEEEE
Q 038249           25 GRGKFGHVYLAREKRSNHIVALKVLFKSQ--L-QQSQVEHQLRREVEIQSHLRHPN--ILRLYGYFY---D--QKRVYLI   94 (281)
Q Consensus        25 g~g~~~~v~~~~~~~~~~~~~lK~~~~~~--~-~~~~~~~~~~~e~~~l~~~~h~~--i~~~~~~~~---~--~~~~~~v   94 (281)
                      |+|+.|.|+.....  |..+-+|.-....  . -..-....+.+|+..++++...+  +.++. ++.   .  ....++|
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            45888999987665  5568888752100  0 00223567888998888885322  33433 222   1  2246889


Q ss_pred             EeccCC-CChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc--EEEeeecCc
Q 038249           95 LEYAAK-GELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE--LKIADFGWS  163 (281)
Q Consensus        95 ~e~~~~-~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~--~~l~dfg~~  163 (281)
                      +|-+++ .+|.+++...  .+.+......++.++...+..||+.|+.|+|+.+.||+++.+|.  ++++||.-+
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            997754 4888887663  34577777899999999999999999999999999999987777  999999754

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.04  E-value=5.7e-09  Score=80.86  Aligned_cols=141  Identities=18%  Similarity=0.162  Sum_probs=91.5

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHH------HHHHHHHHhCCC---Cceeeee
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQL------RREVEIQSHLRH---PNILRLY   82 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~------~~e~~~l~~~~h---~~i~~~~   82 (281)
                      .+.-.+|.+.+.+......-|.+....  |..+++|.........++...++      .+.+....++..   .....++
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y  104 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY  104 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence            344578888899888887777766554  88899999865443222222211      233333333322   2222222


Q ss_pred             eEEE-----eCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEE
Q 038249           83 GYFY-----DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKI  157 (281)
Q Consensus        83 ~~~~-----~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l  157 (281)
                      .+..     -....++++||++|..|.+...    +++    .+...+..++..+|+.|++|||.+|.|++++.+ .+++
T Consensus       105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~i  175 (229)
T PF06176_consen  105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRI  175 (229)
T ss_pred             eeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEE
Confidence            2222     2245678999999988776543    222    244567788999999999999999999999754 5999


Q ss_pred             eeecCc
Q 038249          158 ADFGWS  163 (281)
Q Consensus       158 ~dfg~~  163 (281)
                      +|++..
T Consensus       176 ID~~~k  181 (229)
T PF06176_consen  176 IDTQGK  181 (229)
T ss_pred             EECccc
Confidence            999754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=7.3e-09  Score=81.28  Aligned_cols=103  Identities=22%  Similarity=0.312  Sum_probs=79.5

Q ss_pred             HHHHHHHHHHhCCCCc--eeeeeeEEEeC----CEEEEEEeccCCC-ChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 038249           62 QLRREVEIQSHLRHPN--ILRLYGYFYDQ----KRVYLILEYAAKG-ELYKELQKCKYFSERRAATYVASLARALIYCHG  134 (281)
Q Consensus        62 ~~~~e~~~l~~~~h~~--i~~~~~~~~~~----~~~~~v~e~~~~~-~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~  134 (281)
                      ...+|.+.+..+...+  ..+++++....    ...++|+|++++. +|.+++......+......++.++...+..||.
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence            3556666666664322  33444454431    2458999999885 799998875556777888999999999999999


Q ss_pred             cCceecCCCCCCeEeCCCC---cEEEeeecCcc
Q 038249          135 KHVIHRDIKPENLLIGAQG---ELKIADFGWSV  164 (281)
Q Consensus       135 ~~i~H~di~~~Ni~~~~~~---~~~l~dfg~~~  164 (281)
                      .|++|+|+++.||+++.++   .+.++||+.+.
T Consensus       137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             CcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            9999999999999999887   89999998653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.80  E-value=7.2e-08  Score=84.82  Aligned_cols=141  Identities=21%  Similarity=0.269  Sum_probs=94.6

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccc-------------------------------hHHHHHH------H
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-------------------------------SQVEHQL------R   64 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~-------------------------------~~~~~~~------~   64 (281)
                      +.|+.++-|+||.|+.+ +|+.||||+..+.-...                               ++..+.+      .
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            78899999999999998 49999999984432100                               1111112      2


Q ss_pred             HHHHHHHhC-----CCCceeeeeeEEEeCCEEEEEEeccCCCChhHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 038249           65 REVEIQSHL-----RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHV  137 (281)
Q Consensus        65 ~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i  137 (281)
                      .|...+.++     +.+.+.-..-+++-.+.-.++|||++|..+.+..  +. ...+...+.....++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            233222222     2345544444545456778999999999988874  44 3356555444443332  344445899


Q ss_pred             eecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249          138 IHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus       138 ~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      +|+|.+|.||+++.+|++.+.|||+....
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecC
Confidence            99999999999999999999999986443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.77  E-value=1.8e-07  Score=73.49  Aligned_cols=139  Identities=19%  Similarity=0.194  Sum_probs=92.1

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeecccccchH---------------------HHHHHHHHHHHHHhCCC--Cc
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---------------------VEHQLRREVEIQSHLRH--PN   77 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~---------------------~~~~~~~e~~~l~~~~h--~~   77 (281)
                      ...|+.|..+.||+|... ++..+|+|++......-..                     .......|+..|+++..  =.
T Consensus        53 ~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            447788888999998874 5788999998554432111                     01123455656666533  33


Q ss_pred             eeeeeeEEEeCCEEEEEEeccCCCC-hhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcE
Q 038249           78 ILRLYGYFYDQKRVYLILEYAAKGE-LYKELQKCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGEL  155 (281)
Q Consensus        78 i~~~~~~~~~~~~~~~v~e~~~~~~-L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~  155 (281)
                      +.+.+++.    .-.+||||+.... -.-.++.- ++..+++..+..++++.+.-|-. .+++|+|++.-||++. ++.+
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            44444443    2258999995531 11112221 13344677888888888888877 8999999999999998 8899


Q ss_pred             EEeeecCcccc
Q 038249          156 KIADFGWSVHT  166 (281)
Q Consensus       156 ~l~dfg~~~~~  166 (281)
                      .++|++-+...
T Consensus       206 ~iID~~QaV~~  216 (268)
T COG1718         206 YIIDVSQAVTI  216 (268)
T ss_pred             EEEECcccccc
Confidence            99999977543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.74  E-value=2.2e-07  Score=86.71  Aligned_cols=202  Identities=21%  Similarity=0.217  Sum_probs=142.5

Q ss_pred             HHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE----EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 038249           60 EHQLRREVEIQSHLRHPNILRLYGYFYDQKRV----YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK  135 (281)
Q Consensus        60 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~----~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~  135 (281)
                      ......|...+.+..|+|++.++.+..+....    .+..+++...++...++.-...+...++.+..++..|+.++|+.
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            44455677778888999999999998765433    34567888888999999888899999999999999999999998


Q ss_pred             CceecCCCCC---CeEeCCCCcEEEe--eecCcccccCCc--ccccCcCCccCCccccCCCCCC--cccHHhHHHHHHHH
Q 038249          136 HVIHRDIKPE---NLLIGAQGELKIA--DFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEHDA--NVDIWSLGVLCYEF  206 (281)
Q Consensus       136 ~i~H~di~~~---Ni~~~~~~~~~l~--dfg~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~--~~Di~slG~~l~~l  206 (281)
                      ..-|.-+...   +.-.+..+.+..+  ||+.+.......  .....+..+.++|.......+.  ..|+|.+|.....+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            6655555444   4444555556655  777654433322  2223344566777765555444  47999999999999


Q ss_pred             HhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          207 LYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       207 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ..|..+-........   ++..        .....+.+.+.+|+.-++++|+++.+++.|||..-+
T Consensus       386 ~~~~~i~~~~~~~~~---~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  386 SQGEDISEKSAVPVS---LLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             hhcCcccccccchhh---hhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence            887654322211111   1110        112268899999999999999999999999999855

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.72  E-value=3e-07  Score=73.13  Aligned_cols=132  Identities=15%  Similarity=0.150  Sum_probs=81.1

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeeeeeEEEeCCEEEEEEeccC
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN--ILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~--i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      ..|+.|..+.||+.    .+..+++|......     ....+.+|.+.++.+..-.  +.+++++...++...+||++++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            67899999999974    24567889875422     1234677888888875433  4667777777778889999999


Q ss_pred             CCC-hhHHH--------------H-------hC--CCCCHHHHHH-HHHH----------HHHH-HHHHH----hcCcee
Q 038249          100 KGE-LYKEL--------------Q-------KC--KYFSERRAAT-YVAS----------LARA-LIYCH----GKHVIH  139 (281)
Q Consensus       100 ~~~-L~~~~--------------~-------~~--~~l~~~~~~~-i~~~----------i~~~-l~~Lh----~~~i~H  139 (281)
                      |.+ +...+              .       .-  ...+...... +-.+          +... ..+|.    ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            963 11111              1       00  0111111000 0000          0111 12222    124689


Q ss_pred             cCCCCCCeEeCCCCcEEEeeecCc
Q 038249          140 RDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       140 ~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      +|++|.||+++.++ +.++||+.+
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a  180 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDF  180 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhc
Confidence            99999999999888 999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.50  E-value=1.7e-07  Score=76.30  Aligned_cols=135  Identities=16%  Similarity=0.208  Sum_probs=95.1

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeeccccc--c--------------hH---HHHHHHHHHHHHHhCCC--C
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ--Q--------------SQ---VEHQLRREVEIQSHLRH--P   76 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~--~--------------~~---~~~~~~~e~~~l~~~~h--~   76 (281)
                      +.++..||-|..+.+|.+-+. +|++.++|.-...+..  +              .+   ..-+..+|...++.+..  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            567889999999999999887 6888899875322210  0              00   01223455666666533  2


Q ss_pred             ceeeeeeEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEE
Q 038249           77 NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELK  156 (281)
Q Consensus        77 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~  156 (281)
                      -+.+.+++    +..++||+++.|.+|...-+-..      +..+...++..+--|.++|++|||++--|||++.++.++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d------~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVED------PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeecCC------hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            34444444    46689999999988876543322      345556677777888899999999999999999999999


Q ss_pred             EeeecCc
Q 038249          157 IADFGWS  163 (281)
Q Consensus       157 l~dfg~~  163 (281)
                      ++||--.
T Consensus       243 vIDFPQm  249 (465)
T KOG2268|consen  243 VIDFPQM  249 (465)
T ss_pred             EeechHh
Confidence            9999743

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.48  E-value=5.5e-06  Score=66.12  Aligned_cols=136  Identities=24%  Similarity=0.346  Sum_probs=78.5

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--ceeeeeeEE---EeCCEEEEEE
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP--NILRLYGYF---YDQKRVYLIL   95 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~--~i~~~~~~~---~~~~~~~~v~   95 (281)
                      ++.|+.|..+.||.+...+  ..+++|.....     .....+..|...++.+...  .+.+++...   ......+.++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            4678999999999999884  58999997443     2334566677666666322  344555533   3345679999


Q ss_pred             eccCCCChhH----------------HHH---hC----CCCCHHH---------HHHH------------HHHHHH-HHH
Q 038249           96 EYAAKGELYK----------------ELQ---KC----KYFSERR---------AATY------------VASLAR-ALI  130 (281)
Q Consensus        96 e~~~~~~L~~----------------~~~---~~----~~l~~~~---------~~~i------------~~~i~~-~l~  130 (281)
                      ++++|.++..                .+.   ..    .++....         ....            ...+.. .++
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987776                111   11    0100000         0000            111222 333


Q ss_pred             HHH-------hcCceecCCCCCCeEeC-CCCcEEEeeecCc
Q 038249          131 YCH-------GKHVIHRDIKPENLLIG-AQGELKIADFGWS  163 (281)
Q Consensus       131 ~Lh-------~~~i~H~di~~~Ni~~~-~~~~~~l~dfg~~  163 (281)
                      .++       ...++|+|+.|.||+++ .++.+.++||+.+
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence            333       24699999999999999 5666789999865

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.48  E-value=2e-08  Score=88.05  Aligned_cols=241  Identities=17%  Similarity=0.151  Sum_probs=157.9

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeeeeeEEEeCCEEEEEEe
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN-ILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~~~~~v~e   96 (281)
                      +....-+++++++.+++.+...+.... .+.+...        ....-++++|.+++||| .+..++-+..+...+++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            344566788899999988776655544 5554222        23455789999999999 6566666566678899999


Q ss_pred             ccCCC-ChhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--ccc
Q 038249           97 YAAKG-ELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRT  172 (281)
Q Consensus        97 ~~~~~-~L~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~~  172 (281)
                      ++.++ +...... ..-.+...+...+...=.++++++|+.-=+|+|    ||+.. ++..+..+|+........  .+.
T Consensus       315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t  389 (829)
T KOG0576|consen  315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRT  389 (829)
T ss_pred             hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccccccc
Confidence            99877 2222111 111134444555666667889999987557777    77664 467889999887554444  566


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc--cccCCC-CCCCCHHHHHHHHHh
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--DLKFPP-KPIVSSAAKDLISQM  249 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~l~~li~~~  249 (281)
                      ..+++.+++||......++...|.|++|.--.++.-|.+|-...-.  ....+-.+  ...... ...-+..-+++...|
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~  467 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPC  467 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcCcccccCCcccc
Confidence            6789999999999888999999999999877777777766533000  00000000  000000 000011112477889


Q ss_pred             cccCCCCCCChhhhhcCCccccCCC
Q 038249          250 LVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       250 l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      +...|..|+....++.+.+|..++.
T Consensus       468 ~~g~P~~pkv~mgacfsKvfngCpl  492 (829)
T KOG0576|consen  468 LNGLPPTPKVHMGACFSKVFNGCPL  492 (829)
T ss_pred             cCCCCCCCcchhhHHHHHHhccCcc
Confidence            9999999999999999999987753

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.46  E-value=3.1e-06  Score=68.27  Aligned_cols=133  Identities=20%  Similarity=0.150  Sum_probs=78.8

Q ss_pred             eecccCc-eEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEEEEEeccCC
Q 038249           23 PLGRGKF-GHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVYLILEYAAK  100 (281)
Q Consensus        23 ~ig~g~~-~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~e~~~~  100 (281)
                      .|..|.. +.||++...  +..+++|......      ...+..|+..++.+. +--+.+++++....+..++||++++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            3444555 789998654  4678888874332      123556777766663 23455667776666677899999999


Q ss_pred             CChhHHHH-------------------hCC----CCCHH--HHHHHHH--------------------HHHHHHHHHH--
Q 038249          101 GELYKELQ-------------------KCK----YFSER--RAATYVA--------------------SLARALIYCH--  133 (281)
Q Consensus       101 ~~L~~~~~-------------------~~~----~l~~~--~~~~i~~--------------------~i~~~l~~Lh--  133 (281)
                      .++.....                   .-+    ++...  .......                    .+...+..|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            87764320                   000    11100  0000000                    0111122221  


Q ss_pred             -----hcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          134 -----GKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       134 -----~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                           ...++|+|+.|.||++++++.+.|+||+.+
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a  191 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRL  191 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence                 234899999999999999877889999865

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=5.2e-06  Score=61.96  Aligned_cols=128  Identities=20%  Similarity=0.234  Sum_probs=90.3

Q ss_pred             eecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceee-eeeEEEeCCEEEEEEec
Q 038249           19 DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILR-LYGYFYDQKRVYLILEY   97 (281)
Q Consensus        19 ~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~-~~~~~~~~~~~~~v~e~   97 (281)
                      .+.+.|+.|..|.||++.+.  |..+|+|+=..+.     ...++..|++++..+.-.++.+ ++.+.    ..++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhh
Confidence            45788999999999999998  6788999864432     2456888999888887655443 33332    22455999


Q ss_pred             cCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCC-CCCeEeCCCCcEEEeeecCcc
Q 038249           98 AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK-PENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        98 ~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~-~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      .+|.+|.+.....   +...+    ..++....-|-..||-|+.++ |....+-.++.+.|+||..+.
T Consensus        94 i~G~~L~~~~~~~---~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          94 IDGRPLGKLEIGG---DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hcCcchhhhhhcc---cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            9998887766542   33333    445566666778899999986 444444466699999999764

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.24  E-value=5.2e-05  Score=58.75  Aligned_cols=131  Identities=21%  Similarity=0.319  Sum_probs=88.7

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeeccccc-------------chHHHHHHHHHHHHHHhC------CCCceeee
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-------------QSQVEHQLRREVEIQSHL------RHPNILRL   81 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~-------------~~~~~~~~~~e~~~l~~~------~h~~i~~~   81 (281)
                      ...||.|+.=.+|  .++.+ ...+||+.......             .....+...+|+.....+      .+.+|.++
T Consensus         6 ~~~i~~G~~R~cy--~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCY--QHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEE--ECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4678999999888  45543 33679998766500             001123334444443333      37899999


Q ss_pred             eeEEEeCCEEEEEEeccC------CCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC--
Q 038249           82 YGYFYDQKRVYLILEYAA------KGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG--  153 (281)
Q Consensus        82 ~~~~~~~~~~~~v~e~~~------~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~--  153 (281)
                      +|+.+.+-...+|+|.+.      ..+|.++++... ++. .+...   +-....+|-+++|+.+|++|.||++...+  
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            999999999999999763      236888886643 555 43333   44556677889999999999999997543  


Q ss_pred             --cEEEee
Q 038249          154 --ELKIAD  159 (281)
Q Consensus       154 --~~~l~d  159 (281)
                        .+.++|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.20  E-value=4.2e-05  Score=72.36  Aligned_cols=82  Identities=20%  Similarity=0.311  Sum_probs=56.5

Q ss_pred             ecceecccCceEEEEEEEccCC--cEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCce--eeeeeEEEeC---CEE
Q 038249           20 IGKPLGRGKFGHVYLAREKRSN--HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNI--LRLYGYFYDQ---KRV   91 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~--~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i--~~~~~~~~~~---~~~   91 (281)
                      .++.++.|.+..+|+......+  ..+++|+........  ....+.+|+++++.+. |.++  .+++.++.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            3677899999999998776432  467888864332111  1245778999998885 5654  6666666553   467


Q ss_pred             EEEEeccCCCCh
Q 038249           92 YLILEYAAKGEL  103 (281)
Q Consensus        92 ~~v~e~~~~~~L  103 (281)
                      ++||||++|..+
T Consensus       120 flVME~v~G~~~  131 (822)
T PLN02876        120 FYIMEYLEGRIF  131 (822)
T ss_pred             eEEEEecCCccc
Confidence            899999998653

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.17  E-value=5.3e-05  Score=66.94  Aligned_cols=141  Identities=17%  Similarity=0.199  Sum_probs=86.6

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeeccccc----------------------------chHHHHHHH------HHH
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ----------------------------QSQVEHQLR------REV   67 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~----------------------------~~~~~~~~~------~e~   67 (281)
                      +.|+..+.+.|++|+-++ |+.||||+=++.--.                            -++....+.      +|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            689999999999999995 999999986332210                            011111222      222


Q ss_pred             HHH----HhCCCCc---eeeeeeEE-EeCCEEEEEEeccCCCChhHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 038249           68 EIQ----SHLRHPN---ILRLYGYF-YDQKRVYLILEYAAKGELYKE--LQKCKYFSERRAATYVASLARALIYCHGKHV  137 (281)
Q Consensus        68 ~~l----~~~~h~~---i~~~~~~~-~~~~~~~~v~e~~~~~~L~~~--~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i  137 (281)
                      +-.    +.+.|-+   -+.+=.++ .-.....++|||++|..+.+.  +.+.+ ++...+..-+.+...  ..+=..|+
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~qIf~~Gf  322 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--EQIFKTGF  322 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--HHHHhcCC
Confidence            211    1222323   11122222 224467899999999977555  44444 566554444433332  33346789


Q ss_pred             eecCCCCCCeEeCC----CCcEEEeeecCcccc
Q 038249          138 IHRDIKPENLLIGA----QGELKIADFGWSVHT  166 (281)
Q Consensus       138 ~H~di~~~Ni~~~~----~~~~~l~dfg~~~~~  166 (281)
                      +|+|-+|.||++..    ++.+.+.|||+....
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            99999999999984    568999999986443

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.07  E-value=3.4e-05  Score=61.90  Aligned_cols=74  Identities=9%  Similarity=0.065  Sum_probs=43.5

Q ss_pred             cceecccCce-EEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---ceeeeeeEEEeC---CEEEE
Q 038249           21 GKPLGRGKFG-HVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP---NILRLYGYFYDQ---KRVYL   93 (281)
Q Consensus        21 ~~~ig~g~~~-~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~---~i~~~~~~~~~~---~~~~~   93 (281)
                      ++.|+.|+.. .||.+     +..+++|......     ....+..|...++.+...   .+.++++.....   +..++
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            3567766665 58876     2347788754321     234577788888776432   233333332221   23478


Q ss_pred             EEeccCCCChh
Q 038249           94 ILEYAAKGELY  104 (281)
Q Consensus        94 v~e~~~~~~L~  104 (281)
                      +|++++|.++.
T Consensus        72 l~~~i~G~~l~   82 (235)
T cd05155          72 VYRWLEGETAT   82 (235)
T ss_pred             EEEeecCCCCC
Confidence            99999997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.07  E-value=7.4e-05  Score=59.87  Aligned_cols=75  Identities=23%  Similarity=0.250  Sum_probs=45.7

Q ss_pred             cceecccCceEEEEEEEcc-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eeeeeEEEeCCEEEEEEecc
Q 038249           21 GKPLGRGKFGHVYLAREKR-SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI-LRLYGYFYDQKRVYLILEYA   98 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~-~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-~~~~~~~~~~~~~~~v~e~~   98 (281)
                      ++.|..|-...+|++.... .+..+++|........    .-...+|+.+++.+...++ .+++...  .+  .+++||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATF--QN--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEe--CC--cEEEEee
Confidence            4678889999999997653 3567889976432211    1122356767776643333 3333332  22  3799999


Q ss_pred             CCCCh
Q 038249           99 AKGEL  103 (281)
Q Consensus        99 ~~~~L  103 (281)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            99776

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.02  E-value=0.00017  Score=55.62  Aligned_cols=128  Identities=20%  Similarity=0.300  Sum_probs=86.8

Q ss_pred             CCceecceecccCc-eEEEEEEEccCCcEEEEEEeec---ccc-------cc-h-------HHHHHHHHHHHHHHhC---
Q 038249           16 NDFDIGKPLGRGKF-GHVYLAREKRSNHIVALKVLFK---SQL-------QQ-S-------QVEHQLRREVEIQSHL---   73 (281)
Q Consensus        16 ~~y~~~~~ig~g~~-~~v~~~~~~~~~~~~~lK~~~~---~~~-------~~-~-------~~~~~~~~e~~~l~~~---   73 (281)
                      .+++.++.||.|.. |.||+++..  |+.+|||++..   ...       .. +       .....+..|-+..-++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 999999887  88999999321   110       00 0       1122345555544444   


Q ss_pred             CCCce--eeeeeEEEeC------------------CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 038249           74 RHPNI--LRLYGYFYDQ------------------KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH  133 (281)
Q Consensus        74 ~h~~i--~~~~~~~~~~------------------~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh  133 (281)
                      .+.++  ++++|+..-.                  ....||.||.+...         .++.    .-+.+|.+-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence            45566  8999887421                  13467777776533         1233    33456777788999


Q ss_pred             hcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          134 GKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       134 ~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      +.||+-+|+++.|..   +  -+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc---C--CEEEecccC
Confidence            999999999999985   3  378898854

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.02  E-value=0.00012  Score=61.20  Aligned_cols=142  Identities=22%  Similarity=0.261  Sum_probs=95.8

Q ss_pred             eecceecccCceEEEEEEEccCCcEEEEEEeeccccc----------------------chHH-HHHHHHHHHHHHhCCC
Q 038249           19 DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ----------------------QSQV-EHQLRREVEIQSHLRH   75 (281)
Q Consensus        19 ~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~----------------------~~~~-~~~~~~e~~~l~~~~h   75 (281)
                      .+...|+.|..+.||.|... +|..+|||++..+-+.                      +... .-....|++-|+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            35578899999999998776 6777999988433210                      1111 1123467777777766


Q ss_pred             CceeeeeeEEEeCCEEEEEEeccCCCCh-hHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCCeEeCCCC
Q 038249           76 PNILRLYGYFYDQKRVYLILEYAAKGEL-YKELQKCKYFSERRAATYVASLARALIYCH-GKHVIHRDIKPENLLIGAQG  153 (281)
Q Consensus        76 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L-~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~i~H~di~~~Ni~~~~~~  153 (281)
                      ..|.-.--+...  ...+||+|+..... .-.++. ..++...+..+-.+++.-+.-|- ..+++|.||+--|+++ .+|
T Consensus       226 aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd-~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG  301 (520)
T KOG2270|consen  226 AGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKD-ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDG  301 (520)
T ss_pred             cCCCCCCceeee--cceEeeeeccCCCCcCccccc-ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECC
Confidence            555433333332  33689999953221 111222 34777788888888888877776 4599999999999999 888


Q ss_pred             cEEEeeecCccc
Q 038249          154 ELKIADFGWSVH  165 (281)
Q Consensus       154 ~~~l~dfg~~~~  165 (281)
                      .+.++|.+-+..
T Consensus       302 ~lyiIDVSQSVE  313 (520)
T KOG2270|consen  302 KLYIIDVSQSVE  313 (520)
T ss_pred             EEEEEEcccccc
Confidence            999999987643

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.98  E-value=3.4e-05  Score=66.90  Aligned_cols=163  Identities=14%  Similarity=0.159  Sum_probs=108.1

Q ss_pred             HHHHHHHHHHHhCCCCceeeeeeEEEe-CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcee
Q 038249           61 HQLRREVEIQSHLRHPNILRLYGYFYD-QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIH  139 (281)
Q Consensus        61 ~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H  139 (281)
                      .++.-..++++.+.|+|+...+++-.. .....+|+|++.. +|++.+..+. +-.....              .+|+  
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~s~~--------------~~~~--   88 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-LKDESLL--------------AHGV--   88 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-cchhhhc--------------cccc--
Confidence            346677899999999999999998764 3467899999955 9999888765 3222211              1222  


Q ss_pred             cCCCCCCeEeCCCCcEEEeeecCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch
Q 038249          140 RDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS  219 (281)
Q Consensus       140 ~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  219 (281)
                         .+.|+....+        .+....                    ..+..+++|||++|.++.++..|...+......
T Consensus        89 ---~~~~~~~~td--------~~~t~~--------------------~~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s  137 (725)
T KOG1093|consen   89 ---LHLNIIYITD--------HFLTKY--------------------PSPIGPKSDVWSLGFIILELYLGISLEAELTES  137 (725)
T ss_pred             ---ceehhhhccc--------cccccC--------------------CCCCCcchhhhhHHHHHHHHHHhhHHHHHHHHH
Confidence               2233333222        011000                    011124899999999999999998888776666


Q ss_pred             HHHHHHhhccccCCCC----------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          220 DTYRRIVQVDLKFPPK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       220 ~~~~~~~~~~~~~~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +....+.+........          -.++..+.+++.+|+...|..||...+..+++-|.+.
T Consensus       138 ~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  138 EYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            6665555432211110          1255667899999999999999999999988877643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.98  E-value=3.7e-05  Score=59.19  Aligned_cols=96  Identities=22%  Similarity=0.281  Sum_probs=76.1

Q ss_pred             HHHHHHHHhCCC-CceeeeeeEEEeCCEEEEEEeccCCCChhHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC
Q 038249           64 RREVEIQSHLRH-PNILRLYGYFYDQKRVYLILEYAAKGELYKE---LQKCKYFSERRAATYVASLARALIYCHG---KH  136 (281)
Q Consensus        64 ~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~---~~~~~~l~~~~~~~i~~~i~~~l~~Lh~---~~  136 (281)
                      .+|.-+++.+++ +++.+++|.|   +. +++.|+...+++.+.   +......++..+..++.+++..+.+|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C---G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC---GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC---CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            347778888866 6999999998   33 567788876655421   1222235899999999999999999997   45


Q ss_pred             ceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          137 VIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       137 i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      +.-.|++++|+-++.+++++++|.+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v  109 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDV  109 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhc
Confidence            788999999999999999999999875

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.85  E-value=0.00051  Score=57.05  Aligned_cols=136  Identities=18%  Similarity=0.160  Sum_probs=78.8

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeeeee------EEEeCCEE
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN--ILRLYG------YFYDQKRV   91 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~--i~~~~~------~~~~~~~~   91 (281)
                      -.+.|..|....+|++...  +..+++|.+..   ..   ...+..|++++..+...+  +.+++.      +....+..
T Consensus        18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEK---VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             heecccCccccceEEEEeC--CCcEEEEEcCC---CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            3667888888999998654  45789998743   11   123445566555553222  333332      22334567


Q ss_pred             EEEEeccCCCChhH----HHH----------h---C-C-C------CCHHHH----------HHHHHHHHHHHHHHHh--
Q 038249           92 YLILEYAAKGELYK----ELQ----------K---C-K-Y------FSERRA----------ATYVASLARALIYCHG--  134 (281)
Q Consensus        92 ~~v~e~~~~~~L~~----~~~----------~---~-~-~------l~~~~~----------~~i~~~i~~~l~~Lh~--  134 (281)
                      ++++++++|.++..    ...          .   . . .      ..+...          ......+..++..+.+  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            89999999876532    110          0   0 0 0      000000          0011112233444442  


Q ss_pred             -----cCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          135 -----KHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       135 -----~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                           .+++|+|+.|.||+++.++.+.|+||+.+
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a  203 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA  203 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence                 47999999999999998777789999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.84  E-value=9.9e-05  Score=60.01  Aligned_cols=132  Identities=17%  Similarity=0.217  Sum_probs=73.5

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eeeeeEEEeCCEEEEEEeccCCC
Q 038249           23 PLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI-LRLYGYFYDQKRVYLILEYAAKG  101 (281)
Q Consensus        23 ~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-~~~~~~~~~~~~~~~v~e~~~~~  101 (281)
                      .+..|..+.+|++..  ++..+++|.......   ...-...+|..+++.+....+ .+++..  ..+  ++|++|++|.
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~~--~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILV--NEH--WLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEE--eCC--EEEEEeccCc
Confidence            456788889998873  467788987643211   100123557777777754333 223333  222  5899999987


Q ss_pred             ChhHH-------H-------H---hC----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------cCceecCC
Q 038249          102 ELYKE-------L-------Q---KC----KYFSER-RAATYVASL---------ARALIYCHG--------KHVIHRDI  142 (281)
Q Consensus       102 ~L~~~-------~-------~---~~----~~l~~~-~~~~i~~~i---------~~~l~~Lh~--------~~i~H~di  142 (281)
                      ++...       .       .   ..    .+++.. .+..+..++         ...+..+-+        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            65321       1       1   11    112211 111211111         111222221        25899999


Q ss_pred             CCCCeEeCCCCcEEEeeecCcc
Q 038249          143 KPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus       143 ~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      .|.||+++.++ +.++||..+.
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccC
Confidence            99999998877 7899998763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.81  E-value=0.0012  Score=55.46  Aligned_cols=30  Identities=27%  Similarity=0.411  Sum_probs=25.7

Q ss_pred             cCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249          135 KHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus       135 ~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      .+++|+|+.|.||+++.+...-++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            489999999999999866666899999763

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.80  E-value=0.00062  Score=56.92  Aligned_cols=140  Identities=18%  Similarity=0.163  Sum_probs=78.2

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeeeee------EEEeC
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN--ILRLYG------YFYDQ   88 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~--i~~~~~------~~~~~   88 (281)
                      .....+.++.|....+|.+...  +..+++|......  +.   ..+..+.+++..+....  +.+++.      +....
T Consensus        23 ~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        23 ELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             CceeccccCCccccceEEEEeC--CCcEEEEEecCCC--CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            3444677788888899988654  4468899874421  11   12334455554442211  233322      11224


Q ss_pred             CEEEEEEeccCCCChh----HHH-------H---h-CCCC--C-----HHHHHH----------------HHHHHHHHHH
Q 038249           89 KRVYLILEYAAKGELY----KEL-------Q---K-CKYF--S-----ERRAAT----------------YVASLARALI  130 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~----~~~-------~---~-~~~l--~-----~~~~~~----------------i~~~i~~~l~  130 (281)
                      +..+++++|++|.++.    ...       .   . ...+  +     ....+.                ....+...++
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            5678999999886532    111       0   0 0000  0     001000                0111223444


Q ss_pred             HHH-------hcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          131 YCH-------GKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       131 ~Lh-------~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      ++.       ..+++|+|+++.||+++.++...++||+.+
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence            443       268999999999999998887789999976

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.74  E-value=0.00041  Score=57.87  Aligned_cols=76  Identities=24%  Similarity=0.235  Sum_probs=46.0

Q ss_pred             cceecccCceEEEEEEEcc------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eeeeeEEEeCCEEEE
Q 038249           21 GKPLGRGKFGHVYLAREKR------SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI-LRLYGYFYDQKRVYL   93 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~------~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-~~~~~~~~~~~~~~~   93 (281)
                      ++.+..|-...+|++....      +++.+++|.......    ......+|..+++.+....+ .+++..+. +   ..
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFP-N---GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence            4567788888999987653      257899999754321    11234556666666643333 33444433 2   25


Q ss_pred             EEeccCCCChh
Q 038249           94 ILEYAAKGELY  104 (281)
Q Consensus        94 v~e~~~~~~L~  104 (281)
                      |++|++|.++.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            88998887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.63  E-value=0.00091  Score=55.58  Aligned_cols=146  Identities=14%  Similarity=0.251  Sum_probs=84.8

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeeeeeEEEeCC--EEE
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN--ILRLYGYFYDQK--RVY   92 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~--i~~~~~~~~~~~--~~~   92 (281)
                      ...+++.+..|-...+|...+.  ++.++++ . ++............+|+..++.+.--.  +...++++.++.  ..+
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~-P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf  101 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-K-PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF  101 (321)
T ss_pred             CCceeeeccCCcccceEEEecC--CceEEEe-c-CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence            3455666666666677777666  7889999 2 222223334566777888888774322  334445554443  669


Q ss_pred             EEEeccCCCChhHHHHhC--------------------------CC------CCHHHHHHHHHHH--------------H
Q 038249           93 LILEYAAKGELYKELQKC--------------------------KY------FSERRAATYVASL--------------A  126 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~--------------------------~~------l~~~~~~~i~~~i--------------~  126 (281)
                      .||+|++|..+.......                          ..      ....++..+..+.              .
T Consensus       102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~  181 (321)
T COG3173         102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD  181 (321)
T ss_pred             EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence            999999884221111000                          00      0011111111111              1


Q ss_pred             HHHHHHHh--------cCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249          127 RALIYCHG--------KHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus       127 ~~l~~Lh~--------~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      ....+|+.        ..++|||+.+.|++++.++-+-++||+++...
T Consensus       182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            22333332        24899999999999999998999999987543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.54  E-value=6.8e-06  Score=79.26  Aligned_cols=256  Identities=10%  Similarity=-0.034  Sum_probs=167.0

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCc-EEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNH-IVALKVLFKSQLQ--QSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~-~~~lK~~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      .++.|.+..+++.=-++.+.++   ++.+-.... -+.+++......+  .+...+-...|..-++...|+++.....-.
T Consensus      1222 skM~s~~e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI 1298 (2724)
T KOG1826|consen 1222 SKMFSAMEHSEVNLGISNHFHF---RNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRI 1298 (2724)
T ss_pred             HHHHHHhhhhheeeecccceee---ccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccC
Confidence            4567888888887777777765   333332211 1455555333322  223334444555555666788877665544


Q ss_pred             Ee--CCEEEEEEeccCCCChhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhc-C----ceecCCCCCCeEeCCCCc
Q 038249           86 YD--QKRVYLILEYAAKGELYKELQKC----KYFSERRAATYVASLARALIYCHGK-H----VIHRDIKPENLLIGAQGE  154 (281)
Q Consensus        86 ~~--~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~-~----i~H~di~~~Ni~~~~~~~  154 (281)
                      ..  +...+.+++++.+|.+.+.+-++    ++++..-+.....+.+....-.|+. |    .+|.++++.|.++..+-+
T Consensus      1299 ~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~ 1378 (2724)
T KOG1826|consen 1299 PPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYN 1378 (2724)
T ss_pred             CCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCc
Confidence            43  23457889999999998888543    3455555555555545555555532 2    578899999999999999


Q ss_pred             EEEeeecCcccccCCc---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-
Q 038249          155 LKIADFGWSVHTFNRR---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-  230 (281)
Q Consensus       155 ~~l~dfg~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-  230 (281)
                      +++.++|+.+...+..   ....+++-|+.|++.+.-.++.++|+|..|+.++....|..+|-     ...+..+++.. 
T Consensus      1379 v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi-----~flq~~Lkgiid 1453 (2724)
T KOG1826|consen 1379 VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI-----FFLQPALKGIID 1453 (2724)
T ss_pred             ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH-----HHHHHHHcCccc
Confidence            9999999987332221   23456777888888888888888999999999999888877663     22222333211 


Q ss_pred             ---cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          231 ---KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       231 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                         ........|.+.......+|-..-..||.-..++..+.+--.
T Consensus      1454 n~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1454 NHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred             ccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence               222233456777777777777788899999888888776533

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.45  E-value=0.0012  Score=55.31  Aligned_cols=120  Identities=16%  Similarity=0.169  Sum_probs=75.9

Q ss_pred             CCceeeeeeEE-EeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCC
Q 038249           75 HPNILRLYGYF-YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQ  152 (281)
Q Consensus        75 h~~i~~~~~~~-~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~  152 (281)
                      .++..+..-+- .+..+.+++|++. |+++.. ++.   -..+++..++++.+..++-+.+. .+-|+++.-.||+++ .
T Consensus       284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-ik~---~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~  357 (488)
T COG5072         284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI-IKA---DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E  357 (488)
T ss_pred             chhhhcceEEecCCceEEEEEEecC-Cceeee-eec---ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence            33433333333 2334567777776 434432 222   36778889999998888888865 889999999999998 9


Q ss_pred             CcEEEeeecCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHH
Q 038249          153 GELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLC  203 (281)
Q Consensus       153 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l  203 (281)
                      |++.|+||-+++...+..  .......--|-.+. +..+.+-+||-+.-.+
T Consensus       358 GnvtLIDfklsRl~~~q~--~isy~rldhp~lF~-G~dd~QFeIYrlMr~l  405 (488)
T COG5072         358 GNVTLIDFKLSRLSYSQG--IISYNRLDHPDLFN-GVDDYQFEIYRLMRRL  405 (488)
T ss_pred             CceEEEEeeeeecccCCc--eeeccccCchhhhc-CccceeeeHHHHHHHH
Confidence            999999999876332221  11122233344444 3446777888754443

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.33  E-value=0.0081  Score=51.82  Aligned_cols=81  Identities=15%  Similarity=0.223  Sum_probs=50.3

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccc--cc--hHHHHHHHHHHHHHHhCC---CCceeeeeeEEEeCCEEE
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL--QQ--SQVEHQLRREVEIQSHLR---HPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~--~~--~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~~~~~   92 (281)
                      -.+.||.|....||++.+...++.++||.-.+...  ..  .-.......|.+.|+.+.   ..++.+++.+  +.+..+
T Consensus        30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~  107 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV  107 (401)
T ss_pred             eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence            34689999999999999874335799998531110  00  011233445666666652   2356666665  345578


Q ss_pred             EEEeccCCCC
Q 038249           93 LILEYAAKGE  102 (281)
Q Consensus        93 ~v~e~~~~~~  102 (281)
                      +|||++++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999987643

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.28  E-value=0.0079  Score=49.45  Aligned_cols=28  Identities=21%  Similarity=0.481  Sum_probs=23.7

Q ss_pred             CceecCCCCCCeEeCCCCc-EEEeeecCc
Q 038249          136 HVIHRDIKPENLLIGAQGE-LKIADFGWS  163 (281)
Q Consensus       136 ~i~H~di~~~Ni~~~~~~~-~~l~dfg~~  163 (281)
                      .++|+|+++.||+++.++. .-|+||+.+
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a  214 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEA  214 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhc
Confidence            4899999999999987555 469999976

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.20  E-value=0.0035  Score=52.97  Aligned_cols=136  Identities=14%  Similarity=0.171  Sum_probs=74.3

Q ss_pred             cceecccCceEEEEEEEccC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCcee-eeeeEEEeCCEEEEEEe
Q 038249           21 GKPLGRGKFGHVYLAREKRS---NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL-RLYGYFYDQKRVYLILE   96 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~-~~~~~~~~~~~~~~v~e   96 (281)
                      .+.|..|-...+|++.....   +..+++|.......   . .-.-.+|..+++.+...++. ++++++ .++   +|.+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~   90 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQS   90 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEe-CCc---Eeeh
Confidence            45556688889999875532   23788998754321   1 11123466666666443433 444444 222   4889


Q ss_pred             ccCCCChhHH-------H-------H---hCC-C----C-CHHHHHHHHHHH----------------------HHHHHH
Q 038249           97 YAAKGELYKE-------L-------Q---KCK-Y----F-SERRAATYVASL----------------------ARALIY  131 (281)
Q Consensus        97 ~~~~~~L~~~-------~-------~---~~~-~----l-~~~~~~~i~~~i----------------------~~~l~~  131 (281)
                      |++|.++...       +       +   ..+ +    . -...+..+..++                      ..-+..
T Consensus        91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  170 (330)
T PLN02421         91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE  170 (330)
T ss_pred             hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence            9887765221       1       0   111 0    1 122222222221                      111222


Q ss_pred             HH----hc----CceecCCCCCCeEeCC-CCcEEEeeecCcc
Q 038249          132 CH----GK----HVIHRDIKPENLLIGA-QGELKIADFGWSV  164 (281)
Q Consensus       132 Lh----~~----~i~H~di~~~Ni~~~~-~~~~~l~dfg~~~  164 (281)
                      +.    +.    -+.|+|+.+.||++++ ++.++++||..+.
T Consensus       171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            21    11    2799999999999975 4789999999863

>PLN02236 choline kinase

Probab=97.15  E-value=0.0064  Score=51.69  Aligned_cols=139  Identities=13%  Similarity=0.136  Sum_probs=78.2

Q ss_pred             ceecceecccCceEEEEEEEcc----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCcee-eeeeEEEeCCEEE
Q 038249           18 FDIGKPLGRGKFGHVYLAREKR----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL-RLYGYFYDQKRVY   92 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~-~~~~~~~~~~~~~   92 (281)
                      ..-.+.+..|-...+|++....    .++.+++|......   +... ...+|..+++.+...++. ++++.+.. +   
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---  109 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---  109 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceee-chHHHHHHHHHHHHcCCCCceEEEECC-c---
Confidence            3345566678899999987542    24678999875432   1111 124566666666443333 34455432 2   


Q ss_pred             EEEeccCCCChhHH----------H----H---hCC------CCCHHHHHHHHHHH-----------------HHHHHHH
Q 038249           93 LILEYAAKGELYKE----------L----Q---KCK------YFSERRAATYVASL-----------------ARALIYC  132 (281)
Q Consensus        93 ~v~e~~~~~~L~~~----------~----~---~~~------~l~~~~~~~i~~~i-----------------~~~l~~L  132 (281)
                      .|.+|+++.++...          +    +   ...      +...+.+..++.++                 ...+..|
T Consensus       110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L  189 (344)
T PLN02236        110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL  189 (344)
T ss_pred             eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence            47889887766321          1    0   001      11122333333221                 1111122


Q ss_pred             ----H----hcCceecCCCCCCeEeCC-CCcEEEeeecCcc
Q 038249          133 ----H----GKHVIHRDIKPENLLIGA-QGELKIADFGWSV  164 (281)
Q Consensus       133 ----h----~~~i~H~di~~~Ni~~~~-~~~~~l~dfg~~~  164 (281)
                          .    ...++|+|+++.||++++ ++.+.++||..+.
T Consensus       190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence                1    235899999999999986 4689999998763

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=97.13  E-value=0.0034  Score=49.06  Aligned_cols=115  Identities=19%  Similarity=0.234  Sum_probs=72.5

Q ss_pred             cCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCChhHH
Q 038249           27 GKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKE  106 (281)
Q Consensus        27 g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~  106 (281)
                      ++-++.-.++.+-  .+.++|++......-.  ...+.++.+++.++.  .|+++..=  +...+.++.|+|....    
T Consensus        73 ~gNsTl~~~kt~i--G~L~lKKi~slp~~~~--~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~----  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKI--GPLFLKKIRSLPCCIN--DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK----  140 (308)
T ss_pred             CCceEEEEecccc--chhhhhhccCCCcccc--hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc----
Confidence            4445555444432  3466777754443311  234567788887765  66776622  4456788999885421    


Q ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHh--cCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249          107 LQKCKYFSERRAATYVASLARALIYCHG--KHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus       107 ~~~~~~l~~~~~~~i~~~i~~~l~~Lh~--~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                              ....- ++..=+.+|.-.|+  .+..|||..|+|||.|..|.+||.|-+.
T Consensus       141 --------i~~~N-~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  141 --------INFSN-FITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             --------cchhH-HHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence                    11111 11222456778884  3789999999999999999999999764

The function of this family is unknown.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.08  E-value=0.028  Score=47.03  Aligned_cols=29  Identities=10%  Similarity=0.148  Sum_probs=26.7

Q ss_pred             CceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249          136 HVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus       136 ~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      +++|+|+.++|++++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.90  E-value=0.073  Score=44.48  Aligned_cols=28  Identities=25%  Similarity=0.509  Sum_probs=24.7

Q ss_pred             cCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          135 KHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       135 ~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      .+++|||+.+.||+++. +.+.++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            57899999999999987 67899999865

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PTZ00384 choline kinase; Provisional

Probab=96.76  E-value=0.014  Score=50.26  Aligned_cols=28  Identities=21%  Similarity=0.239  Sum_probs=23.8

Q ss_pred             cCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          135 KHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       135 ~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      ..+.|+|+.+.||+.+ ++.+.++||..+
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA  254 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFA  254 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEeccc
Confidence            4679999999999975 456999999876

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.60  E-value=0.07  Score=46.12  Aligned_cols=77  Identities=12%  Similarity=0.124  Sum_probs=47.0

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccc-cch---HHHHHHHHHHHHHHhCC---CCceeeeeeEEEeCCEEE
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQS---QVEHQLRREVEIQSHLR---HPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~-~~~---~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~~~~~   92 (281)
                      ..+.||.|....||++.+.  +..++||.-..... ...   -.......|.+.|+.+.   ..++.+++.++.  +...
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            4678899999999999874  45689998641111 000   01112223355555442   246777777765  4456


Q ss_pred             EEEeccCC
Q 038249           93 LILEYAAK  100 (281)
Q Consensus        93 ~v~e~~~~  100 (281)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            78999976

>PRK10593 hypothetical protein; Provisional

Probab=96.49  E-value=0.031  Score=46.52  Aligned_cols=105  Identities=10%  Similarity=0.020  Sum_probs=70.5

Q ss_pred             eecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC---CceeeeeeEEEe---CCEEE
Q 038249           19 DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH---PNILRLYGYFYD---QKRVY   92 (281)
Q Consensus        19 ~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h---~~i~~~~~~~~~---~~~~~   92 (281)
                      .-.+.||.|..+.||.....  +..+++|...... .    ...+..|...++.+..   -.+.++++++..   .+..+
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~-~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~   89 (297)
T PRK10593         17 SRVECISEQPYAALWALYDS--QGNPMPLMARSFS-T----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV   89 (297)
T ss_pred             heeeecCCccceeEEEEEcC--CCCEEEEEecccc-c----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence            34568999999999998655  2346677753211 1    1356778888877743   356777776653   36689


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK  135 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~  135 (281)
                      +|||+++|.++.+.     ..+......+..+++.+++.||+.
T Consensus        90 LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         90 LLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999877651     123334455667777888888874

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.48  E-value=0.038  Score=45.62  Aligned_cols=75  Identities=17%  Similarity=0.210  Sum_probs=44.7

Q ss_pred             eecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeeeeeEEEeCCEEEEEE
Q 038249           19 DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL---RHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        19 ~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~---~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +-.+.++.|.-+.+|.+.  .+++.+.+|.-....      ...+..|..-|+.+   .--.+.+++++....+..++++
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            345678889999999887  568889999975222      12355566666665   3456778888887777779999


Q ss_pred             eccCCC
Q 038249           96 EYAAKG  101 (281)
Q Consensus        96 e~~~~~  101 (281)
                      ||.+.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            998876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.93  E-value=0.87  Score=38.45  Aligned_cols=27  Identities=22%  Similarity=0.283  Sum_probs=23.1

Q ss_pred             cCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          135 KHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       135 ~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      .+++|+|+.+.||+++ + .+.++||+.+
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~  222 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDA  222 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCC
Confidence            4689999999999995 4 5789999976

>PRK06148 hypothetical protein; Provisional

Probab=95.92  E-value=0.34  Score=47.44  Aligned_cols=31  Identities=39%  Similarity=0.666  Sum_probs=26.0

Q ss_pred             cCceecCCCCCCeEeCCCC--cEE-EeeecCccc
Q 038249          135 KHVIHRDIKPENLLIGAQG--ELK-IADFGWSVH  165 (281)
Q Consensus       135 ~~i~H~di~~~Ni~~~~~~--~~~-l~dfg~~~~  165 (281)
                      .+++|+|+++.||+++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999875  555 999997643

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.89  E-value=0.21  Score=42.47  Aligned_cols=76  Identities=13%  Similarity=0.208  Sum_probs=43.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccc-----cchHHHHHHHHHHHHHHhCC--CC-ceeeeeeEEEeCCEEEE
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQSHLR--HP-NILRLYGYFYDQKRVYL   93 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~--h~-~i~~~~~~~~~~~~~~~   93 (281)
                      +.||.|...-||++.+...++.++||.-.+--.     .... ......|.+.|+...  -| ++.+++.+  +.+...+
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~-~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~   77 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLT-LDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVT   77 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCC-ccHHHHHHHHHHHhhccCccccCeEEEE--cccccee
Confidence            357999999999999864336799997421110     0111 122334555555542  23 34444433  4456668


Q ss_pred             EEeccCC
Q 038249           94 ILEYAAK  100 (281)
Q Consensus        94 v~e~~~~  100 (281)
                      |||+.+.
T Consensus        78 vMEdL~~   84 (370)
T TIGR01767        78 VMEDLSH   84 (370)
T ss_pred             hHhhCcc
Confidence            9998754

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PTZ00296 choline kinase; Provisional

Probab=95.74  E-value=0.16  Score=44.69  Aligned_cols=76  Identities=16%  Similarity=0.117  Sum_probs=43.5

Q ss_pred             ecceecccCceEEEEEEEccC--------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCcee-eeeeEEEeCCE
Q 038249           20 IGKPLGRGKFGHVYLAREKRS--------NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL-RLYGYFYDQKR   90 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~--------~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~-~~~~~~~~~~~   90 (281)
                      -.+.|..|-...+|++.....        ++.|++|+.-...   +... .-..|..+++.+...++. ++++.+. +  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~-g--  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS-G--  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC-C--
Confidence            567788888899999875522        4578888874332   1111 123355555555333332 3444442 2  


Q ss_pred             EEEEEeccCCCCh
Q 038249           91 VYLILEYAAKGEL  103 (281)
Q Consensus        91 ~~~v~e~~~~~~L  103 (281)
                       +.+.+|++|.+|
T Consensus       182 -g~I~efi~g~~l  193 (442)
T PTZ00296        182 -GRIEEWLYGDPL  193 (442)
T ss_pred             -CEEEEeeCCccC
Confidence             247899888644

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.62  E-value=0.18  Score=39.91  Aligned_cols=75  Identities=16%  Similarity=0.209  Sum_probs=49.9

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeeeeeEEEeCCEEEEEEecc
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL---RHPNILRLYGYFYDQKRVYLILEYA   98 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~---~h~~i~~~~~~~~~~~~~~~v~e~~   98 (281)
                      +.+..|---..|.+.+.  ..++.+|+=.      .+....+..|+.-|..+   +.-.+.+.+.+....++.++|++|.
T Consensus        22 ~~v~gG~inea~~v~dg--~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L   93 (286)
T COG3001          22 EEVSGGDINEAWRLRDG--TDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL   93 (286)
T ss_pred             cccCCccccceeEeecC--CcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence            44555555556665554  4568888742      22344566666655555   4456778888888889999999999


Q ss_pred             CCCChh
Q 038249           99 AKGELY  104 (281)
Q Consensus        99 ~~~~L~  104 (281)
                      +.+.+.
T Consensus        94 ~~~~~d   99 (286)
T COG3001          94 PTGPLD   99 (286)
T ss_pred             cCCCCC
Confidence            887664

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.19  E-value=0.1  Score=43.53  Aligned_cols=137  Identities=18%  Similarity=0.201  Sum_probs=84.2

Q ss_pred             eecceecccCceEEEEEEEcc----------CCcEEEEEEeecccc---------------------cchHHHHHH--HH
Q 038249           19 DIGKPLGRGKFGHVYLAREKR----------SNHIVALKVLFKSQL---------------------QQSQVEHQL--RR   65 (281)
Q Consensus        19 ~~~~~ig~g~~~~v~~~~~~~----------~~~~~~lK~~~~~~~---------------------~~~~~~~~~--~~   65 (281)
                      +|..+|+.|..+.|+.|.-..          .-+.+|||++...-.                     ...+.+..+  ..
T Consensus       255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk  334 (531)
T KOG2269|consen  255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK  334 (531)
T ss_pred             hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence            356789999999998884311          123478887622110                     011111112  22


Q ss_pred             HHHHHHhC-----CCCceeeeeeEEEeCCEEEEEEeccCCCCh-hHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hcCce
Q 038249           66 EVEIQSHL-----RHPNILRLYGYFYDQKRVYLILEYAAKGEL-YKELQKCKYFSERRAATYVASLARALIYCH-GKHVI  138 (281)
Q Consensus        66 e~~~l~~~-----~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L-~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~i~  138 (281)
                      |+--|.++     ..|-+|.+..       ..+||.|+...-+ .-.++. -.++.++....-.|+..++..|- ..-++
T Consensus       335 EmhNL~RMq~~GlpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~-v~l~d~E~~~aY~q~~~~M~~lY~Ec~LV  406 (531)
T KOG2269|consen  335 EMHNLSRMQKHGLPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKN-VELTDDERRNAYDQVQSIMCRLYKECLLV  406 (531)
T ss_pred             HHHHHHHHHhcCCCCCceeeeec-------ceEEEEeecCCCCCCccccc-cccChHHHHHHHHHHHHHHHHHHHhhhee
Confidence            33333333     2455555443       3578888854322 222232 23888888888888888877765 45799


Q ss_pred             ecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249          139 HRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus       139 H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      |.|++--|+++..+ .+.++|..-+.
T Consensus       407 HADlSEyN~Lw~~g-Kvw~IDVsQsv  431 (531)
T KOG2269|consen  407 HADLSEYNLLWTPG-KVWVIDVSQSV  431 (531)
T ss_pred             ecchhhhhheecCC-ceEEEechhcc
Confidence            99999999999766 88999987654

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.33  E-value=0.62  Score=40.27  Aligned_cols=76  Identities=17%  Similarity=0.243  Sum_probs=44.4

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeeccc----ccchHHHHHHHHHHHHHHhCC--CC-ceeeeeeEEEeCCEEEE
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ----LQQSQVEHQLRREVEIQSHLR--HP-NILRLYGYFYDQKRVYL   93 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~~~~~e~~~l~~~~--h~-~i~~~~~~~~~~~~~~~   93 (281)
                      .+.||.|...-||++.+...++.++||--.+--    ...-. ......|.+.|+...  -| ++.+++.+  +.+...+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~-~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~  110 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLS-TNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCC  110 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCC-hHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhH
Confidence            678999999999999985445679998742111    11111 122344555555542  23 44445443  3445567


Q ss_pred             EEeccC
Q 038249           94 ILEYAA   99 (281)
Q Consensus        94 v~e~~~   99 (281)
                      |||+.+
T Consensus       111 vMEdL~  116 (409)
T PRK12396        111 VMEDLS  116 (409)
T ss_pred             HHHhCc
Confidence            888764

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.32  E-value=0.23  Score=42.87  Aligned_cols=62  Identities=18%  Similarity=0.176  Sum_probs=43.4

Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCCeEeCCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH-GKHVIHRDIKPENLLIGAQ  152 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~i~H~di~~~Ni~~~~~  152 (281)
                      ...++-+|..|.++...++..+ .+++....++.-...|+..+- --+++|.|++|.||++--+
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            3467778888888888888754 355455555555555544433 4589999999999999544

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	281
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-105
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-105
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-104
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-103
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-103
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-103
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-103
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-103
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-103
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-103
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-103
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-103
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-103
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-103
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-103
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-103
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-103
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-103
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-102
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-102
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-102
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-102
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-102
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-102
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-102
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-102
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-102
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-102
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-102
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-102
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-102
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-102
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-101
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-101
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-101
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-98
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-47
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-45
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-42
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-42
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-42
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-42
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-41
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-41
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-41
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-41
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-41
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-41
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-41
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-41
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-41
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-41
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-41
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-41
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-41
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-41
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-41
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-41
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-41
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-41
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-41
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-41
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-41
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-41
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-41
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-41
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-41
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-41
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-41
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-40
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-40
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-40
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-40
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-40
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-40
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-40
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-40
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-40
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-40
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-40
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-40
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-40
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-40
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-40
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-40
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-40
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-40
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-40
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-40
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-40
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-40
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-40
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-40
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-40
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-40
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-40
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-39
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-39
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-39
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-39
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-39
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-39
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-39
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-39
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-39
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-39
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-39
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-39
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-39
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-39
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-39
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-39
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-39
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-39
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-39
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-39
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-39
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-39
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-39
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-39
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-39
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-39
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-39
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-39
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-39
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-39
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-39
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-39
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-39
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-39
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-39
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-39
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-39
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-39
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-39
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-39
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-39
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-39
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-38
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-38
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-38
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-38
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-38
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-38
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-38
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-38
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-37
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-37
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-37
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-37
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-37
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-37
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-37
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-37
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-37
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-37
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-37
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-36
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-36
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-36
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-36
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-36
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-36
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-36
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-35
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-35
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-35
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-35
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-35
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-35
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-35
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-35
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-35
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-34
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-34
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-34
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-34
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-34
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-34
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-34
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-34
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-34
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-34
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-34
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-34
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-34
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-34
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-34
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-34
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-34
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-34
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-34
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-34
3soa_A	444	Full-Length Human Camkii Length = 444		7e-34
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-34
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-34
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-34
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-34
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-34
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-34
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-34
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-34
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-34
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-33
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-33
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-33
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-33
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-33
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-33
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-33
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-33
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-33
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-33
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-33
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-33
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-33
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-33
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-33
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-33
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-33
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-33
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-33
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-33
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-33
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-33
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-32
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-32
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-32
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-32
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-32
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-32
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-32
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-32
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-32
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-32
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-32
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-32
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-32
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-32
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-32
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-32
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-32
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-31
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-31
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-31
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-31
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-31
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-31
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-31
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-31
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-31
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-31
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-31
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-31
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-31
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-31
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-31
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-31
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-31
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-31
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-31
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-31
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-31
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-31
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-31
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-31
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-30
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-30
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-30
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-30
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-30
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-30
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-30
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-30
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-30
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-30
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-30
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-30
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-29
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-29
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-29
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-29
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-29
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-29
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-29
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-28
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-28
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-28
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-28
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-28
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-28
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-28
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-28
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-28
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-28
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-28
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-28
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-28
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-28
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-28
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-28
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-28
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-28
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-28
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-27
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-27
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-27
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-27
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-27
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-27
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-27
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-26
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-26
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-26
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-26
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-26
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-26
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-26
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-26
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-26
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-26
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-26
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-26
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-26
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-25
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-25
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-25
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-25
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-25
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-25
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-25
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-25
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-25
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-25
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-25
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-25
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-25
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-25
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-25
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-25
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-24
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-24
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-24
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-24
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-24
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-24
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-24
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-24
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-24
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-24
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-24
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-24
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-24
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-24
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-24
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-24
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-24
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-24
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-24
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-24
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-24
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-24
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-24
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-24
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-24
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-24
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-24
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-24
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-24
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-24
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-24
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-24
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-24
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-24
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-24
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-24
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-24
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-24
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-24
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-24
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-24
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-24
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-24
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-24
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-24
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-24
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-24
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-24
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-24
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-24
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-24
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-24
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-24
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-24
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-24
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-24
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-24
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-24
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-24
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-24
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-23
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-23
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-23
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-23
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-23
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-23
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-23
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-23
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-23
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-23
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-23
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-23
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-23
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-23
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-23
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-23
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-23
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-23
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-23
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-23
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-23
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-23
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-23
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-23
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-23
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-23
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-23
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-23
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-23
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-23
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-23
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-23
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-23
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-23
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-23
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-23
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-23
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-23
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-23
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-23
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-23
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-23
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-23
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-23
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-23
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-23
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-23
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-23
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-23
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-23
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-23
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-23
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-23
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-23
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-23
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-23
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-23
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-23
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-23
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-23
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-22
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-22
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-22
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-22
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-22
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-22
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-22
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-22
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-22
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-22
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-22
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-22
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-22
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-22
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-21
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-21
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-21
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-21
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-21
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-21
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-21
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-21
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-21
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-21
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-21
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-20
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-20
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-20
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-20
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-20
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-20
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-20
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-20
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-20
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-20
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-20
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-20
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-20
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-20
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-20
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-20
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-20
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-19
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-19
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-19
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-19
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-19
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-19
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-19
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-19
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-19
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-19
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-19
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-19
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-19
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-19
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-19
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-19
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-19
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-19
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-19
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-19
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-19
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-19
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-19
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-19
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-19
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-19
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-19
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-19
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-19
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-19
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-19
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-19
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-19
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-19
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-19
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-18
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-18
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-18
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-18
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-18
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-18
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-18
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-18
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-18
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-18
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-18
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-18
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-18
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-18
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-18
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-18
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-18
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-18
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-18
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-18
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-18
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-18
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-18
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-18
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-18
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-18
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-18
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-18
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-18
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-18
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-18
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-18
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-18
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-18
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-18
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-18
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-18
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-18
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-18
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-18
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-18
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-18
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-17
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-17
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-17
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-17
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-17
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-17
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-17
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-17
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-17
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-17
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-17
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-17
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-17
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-17
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-17
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-17
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-17
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-17
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-17
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-17
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-17
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-17
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-17
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-17
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-17
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-17
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-17
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-17
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-17
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-17
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-17
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-17
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-17
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-17
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-17
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-17
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-17
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-17
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-17
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-17
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-17
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-17
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-17
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-17
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-17
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-17
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-17
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-16
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-16
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-16
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-16
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-16
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-16
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-16
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-15
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-15
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-15
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-15
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-15
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-15
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-15
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-15
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-14
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-14
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-14
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-14
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-14
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-14
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-13
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-13
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-13
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-13
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-13
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-13
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-12
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-12
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-12
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-11
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-10
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-10
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-10
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-10
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-10
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-10
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-10
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-10
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-10
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-10
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		8e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		8e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-09
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-09
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-09
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		2e-09
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-09
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-09
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-09
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-09
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-09
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-09
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-09
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		2e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-09
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-09
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-09
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-09
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-09
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		4e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-09

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  378 bits (971), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 179/266 (67%), Positives = 216/266 (81%), Gaps = 3/266 (1%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           K++WTL DFDIG+PLG+GKFG+VYLARE++S  I+ALKVLFK+QL+++ VEHQLRREVEI
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
           QSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVESV 188
            YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E  
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            HD  VD+WSLGVLCYEFL G+PPFEA  + +TYRRI +V+  FP    V+  A+DLIS+
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP--DFVTEGARDLISR 243
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNAD 274
           +L  ++SQRL L ++LEHPWI  N+ 
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKANSS 269

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  377 bits (969), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 179/265 (67%), Positives = 216/265 (81%), Gaps = 3/265 (1%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           K++WTL DFDIG+PLG+GKFG+VYLARE++S  I+ALKVLFK+QL+++ VEHQLRREVEI
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
           QSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVESV 188
            YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E  
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            HD  VD+WSLGVLCYEFL G+PPFEA  + +TYRRI +V+  FP    V+  A+DLIS+
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP--DFVTEGARDLISR 243
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNA 273
           +L  ++SQRL L ++LEHPWI  N+
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKANS 268

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  375 bits (964), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 178/267 (66%), Positives = 215/267 (80%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA +GE+YKELQK   F E+R ATY+  LA A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 243
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANSS 270

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  372 bits (955), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 174/272 (63%), Positives = 222/272 (81%), Gaps = 3/272 (1%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           + ++   K+++T++DFDIG+PLG+GKFG+VYLAREK++  I+ALKVLFKSQL++  VEHQ
Sbjct: 2   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 61
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           LRRE+EIQSHLRHPNILR+Y YF+D+KR+YL+LE+A +GELYKELQK   F E+R+AT++
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 121
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLDYLP 181
             LA AL YCH + VIHRDIKPENLL+G +GELKIADFGWSVH  + RRR MCGTLDYLP
Sbjct: 122 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLP 181
Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           PEM+E   HD  VD+W  GVLCYEFL G+PPF++  H++T+RRIV VDLKFP  P +S  
Sbjct: 182 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDG 239
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +KDLIS++L     QRLPL  ++EHPW+  N+
Sbjct: 240 SKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 271

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  372 bits (954), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/266 (66%), Positives = 213/266 (80%), Gaps = 3/266 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 18  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 77
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 78  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 137
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 138 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 197
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 198 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 255
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNA 273
           ++L  + SQR  L ++LEHPWI  N+
Sbjct: 256 RLLKHNPSQRPMLREVLEHPWITANS 281

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  372 bits (954), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/267 (65%), Positives = 213/267 (79%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 146
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 147 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 206
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 264
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 265 RLLKHNPSQRPMLREVLEHPWITANSS 291

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  371 bits (953), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/267 (65%), Positives = 213/267 (79%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 243
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANSS 270

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  371 bits (953), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/267 (65%), Positives = 213/267 (79%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 241
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  370 bits (951), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/266 (66%), Positives = 213/266 (80%), Gaps = 3/266 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEG 181
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 239
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNA 273
           ++L  + SQR  L ++LEHPWI  N+
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANS 265

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  370 bits (950), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/266 (66%), Positives = 212/266 (79%), Gaps = 3/266 (1%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVEI
Sbjct: 6   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 65
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
           QSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 125
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVESV 188
            YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E  
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS+
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISR 243
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNAD 274
           +L  + SQR  L ++LEHPWI  N+ 
Sbjct: 244 LLKHNPSQRPMLREVLEHPWITANSS 269

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  370 bits (950), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/266 (66%), Positives = 213/266 (80%), Gaps = 3/266 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH  + RRT +CGTLDYLPPEM+E 
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 239
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNA 273
           ++L  + SQR  L ++LEHPWI  N+
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANS 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  370 bits (949), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/265 (66%), Positives = 212/265 (80%), Gaps = 3/265 (1%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVEI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
           QSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVESV 188
            YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH  + RRT +CGTLDYLPPEM+E  
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS+
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISR 239
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNA 273
           +L  + SQR  L ++LEHPWI  N+
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANS 264

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  370 bits (949), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/266 (66%), Positives = 213/266 (80%), Gaps = 3/266 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH  + RRT +CGTLDYLPPEM+E 
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEG 185
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 243
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNA 273
           ++L  + SQR  L ++LEHPWI  N+
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANS 269

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  370 bits (949), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/267 (65%), Positives = 213/267 (79%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 241
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  370 bits (949), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/266 (66%), Positives = 212/266 (79%), Gaps = 3/266 (1%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVEI
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 60
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
           QSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL
Sbjct: 61  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 120
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVESV 188
            YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E  
Sbjct: 121 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS+
Sbjct: 181 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISR 238
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNAD 274
           +L  + SQR  L ++LEHPWI  N+ 
Sbjct: 239 LLKHNPSQRPMLREVLEHPWITANSS 264

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  369 bits (948), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/267 (65%), Positives = 213/267 (79%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA +GE+YKELQK   F E+R ATY+  LA A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR  + GTLDYLPPEM+E 
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMIEG 185
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 243
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANSS 270

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  369 bits (948), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/266 (66%), Positives = 213/266 (80%), Gaps = 3/266 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH  + RRT +CGTLDYLPPEM+E 
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 238
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNA 273
           ++L  + SQR  L ++LEHPWI  N+
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANS 264

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  369 bits (947), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/267 (65%), Positives = 213/267 (79%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIA+FGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 182
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 240
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 241 RLLKHNPSQRPMLREVLEHPWITANSS 267

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  369 bits (947), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 176/266 (66%), Positives = 212/266 (79%), Gaps = 3/266 (1%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVEI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
           QSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVESV 188
            YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH  + RRT +CGTLDYLPPEM+E  
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS+
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISR 239
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNAD 274
           +L  + SQR  L ++LEHPWI  N+ 
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSS 265

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  369 bits (947), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 176/265 (66%), Positives = 210/265 (79%), Gaps = 3/265 (1%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           K++W L DF+IG+PLG+GKFG+VYLAREK S  I+ALKVLFK+QL+++ VEHQLRREVEI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
           QSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVESV 188
            YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR  +CGTLDYLPPEM+E  
Sbjct: 122 SYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            HD  VD+WSLGVLCYEFL G PPFEA  + DTY+RI +V+  FP    V+  A+DLIS+
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFP--DFVTEGARDLISR 239
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNA 273
           +L  + SQR  L ++LEHPWI  N+
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANS 264

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  369 bits (946), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/267 (65%), Positives = 213/267 (79%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIA+FGWSVH   +RR T+CGTLDYLPPEM+E 
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 241
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  369 bits (946), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/266 (65%), Positives = 212/266 (79%), Gaps = 3/266 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 146
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR  +CGTLDYLPPEM+E 
Sbjct: 147 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEG 206
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 264
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNA 273
           ++L  + SQR  L ++LEHPWI  N+
Sbjct: 265 RLLKHNPSQRPMLREVLEHPWITANS 290

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  369 bits (946), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/265 (66%), Positives = 211/265 (79%), Gaps = 3/265 (1%)
Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           ++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVEIQ
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           SHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVESVE 189
           YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E   
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS++
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISRL 240
Query: 250 LVKDSSQRLPLHKLLEHPWIIQNAD 274
           L  + SQR  L ++LEHPWI  N+ 
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSS 265

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  369 bits (946), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/267 (65%), Positives = 212/267 (79%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPE +E 
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXIEG 185
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 186 RXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 243
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 244 RLLKHNPSQRPXLREVLEHPWITANSS 270

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  368 bits (945), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/267 (65%), Positives = 212/267 (79%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR  +CGTLDYLPPEM+E 
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEG 182
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 240
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 241 RLLKHNPSQRPMLREVLEHPWITANSS 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  368 bits (945), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 173/272 (63%), Positives = 221/272 (81%), Gaps = 3/272 (1%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           + ++   K+++T++DFDI +PLG+GKFG+VYLAREK++  I+ALKVLFKSQL++  VEHQ
Sbjct: 1   TALAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           LRRE+EIQSHLRHPNILR+Y YF+D+KR+YL+LE+A +GELYKELQK   F E+R+AT++
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLDYLP 181
             LA AL YCH + VIHRDIKPENLL+G +GELKIADFGWSVH  + RRR MCGTLDYLP
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLP 180
Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           PEM+E   HD  VD+W  GVLCYEFL G+PPF++  H++T+RRIV VDLKFP  P +S  
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDG 238
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +KDLIS++L     QRLPL  ++EHPW+  N+
Sbjct: 239 SKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  368 bits (945), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/265 (66%), Positives = 211/265 (79%), Gaps = 3/265 (1%)
Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           ++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVEIQ
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           SHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVESVE 189
           YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH  + RRT +CGTLDYLPPEM+E   
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRM 182
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS++
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISRL 240
Query: 250 LVKDSSQRLPLHKLLEHPWIIQNAD 274
           L  + SQR  L ++LEHPWI  N+ 
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSS 265

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  368 bits (944), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/267 (65%), Positives = 212/267 (79%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR  +CGTLDYLPPEM+E 
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEG 183
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 241
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  367 bits (943), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/266 (65%), Positives = 211/266 (79%), Gaps = 3/266 (1%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVEI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
           QSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVESV 188
            YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR  +CGTLDYLPPEM+E  
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS+
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISR 239
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNAD 274
           +L  + SQR  L ++LEHPWI  N+ 
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSS 265

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  367 bits (943), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/266 (65%), Positives = 211/266 (79%), Gaps = 3/266 (1%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVEI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
           QSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVESV 188
            YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR  +CGTLDYLPPEM+E  
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS+
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISR 239
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNAD 274
           +L  + SQR  L ++LEHPWI  N+ 
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSS 265

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  367 bits (942), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/270 (64%), Positives = 211/270 (78%), Gaps = 3/270 (1%)
Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
            A   ++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRR
Sbjct: 1   GAMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
           EVEIQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEM 184
           A AL YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR  +CGTLDYLPPEM
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEM 180
Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
           +E   HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+D
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARD 238
Query: 245 LISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           LIS++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  365 bits (938), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 174/267 (65%), Positives = 211/267 (79%), Gaps = 3/267 (1%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWS H   +RR T+ GTLDYLPPEM+E 
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIEG 181
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 239
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ++L  + SQR  L ++LEHPWI  N+ 
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSS 266

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  365 bits (936), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 174/264 (65%), Positives = 209/264 (79%), Gaps = 3/264 (1%)
Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           +W L DF+IG+PLG+GKFG+VYLAREK+   I+ALKVLFK+QL+++ VEHQLRREVEIQS
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
           HLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL Y
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 120
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVESVEH 190
           CH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR T+CGTLDYLPPEM+E   H
Sbjct: 121 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           D  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS++L
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISRLL 238
Query: 251 VKDSSQRLPLHKLLEHPWIIQNAD 274
             + SQR  L ++LEHPWI  N+ 
Sbjct: 239 KHNPSQRPMLREVLEHPWITANSS 262

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  364 bits (935), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 174/264 (65%), Positives = 210/264 (79%), Gaps = 3/264 (1%)
Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           ++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVEIQ
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           SHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVESVE 189
           YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR  +CGTLDYLPPEM+E   
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS++
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISRL 243
Query: 250 LVKDSSQRLPLHKLLEHPWIIQNA 273
           L  + SQR  L ++LEHPWI  N+
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANS 267

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  353 bits (906), Expect = 6e-98,   Method: Compositional matrix adjust.
 Identities = 174/264 (65%), Positives = 218/264 (82%), Gaps = 3/264 (1%)
Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           + +T++DF+IG+PLG+GKFG+VYLAREK+S+ IVALKVLFKSQ+++  VEHQLRRE+EIQ
Sbjct: 18  RHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQ 77
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           +HL HPNILRLY YFYD++R+YLILEYA +GELYKELQK   F E+R AT +  LA AL+
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALM 137
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLDYLPPEMVESVE 189
           YCHGK VIHRDIKPENLL+G +GELKIADFGWSVH  + RR+TMCGTLDYLPPEM+E   
Sbjct: 138 YCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRM 197
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           H+  VD+W +GVLCYE L G PPFE+  H++TYRRIV+VDLKFP    V + A+DLIS++
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPAS--VPTGAQDLISKL 255
Query: 250 LVKDSSQRLPLHKLLEHPWIIQNA 273
           L  + S+RLPL ++  HPW+  N+
Sbjct: 256 LRHNPSERLPLAQVSAHPWVRANS 279

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 154/264 (58%), Gaps = 9/264 (3%)
Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKS-QLQQSQVEHQLRREVEIQ 70
           +++L DF I + LG G FG V+L R + +    A+KVL K   ++  QVEH    E  + 
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLML 60
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           S + HP I+R++G F D +++++I++Y   GEL+  L+K + F    A  Y A +  AL 
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEH 190
           Y H K +I+RD+KPEN+L+   G +KI DFG++ +  +    +CGT DY+ PE+V +  +
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPY 180
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           + ++D WS G+L YE L G  PF       TY +I+  +L+FP  P  +   KDL+S+++
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLSRLI 238
Query: 251 VKDSSQRL-----PLHKLLEHPWI 269
            +D SQRL         +  HPW 
Sbjct: 239 TRDLSQRLGNLQNGTEDVKNHPWF 262

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 148/263 (56%), Gaps = 6/263 (2%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + DF +G  LG+G F  VY A    +   VA+K++ K  + ++ +  +++ EV+I   L+
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCH 133
           HP+IL LY YF D   VYL+LE    GE+ + L+ + K FSE  A  ++  +   ++Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMVESVEH 190
              ++HRD+   NLL+     +KIADFG +        +  T+CGT +Y+ PE+     H
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
               D+WSLG + Y  L G PPF+     +T  ++V  D + P    +S  AKDLI Q+L
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP--SFLSIEAKDLIHQLL 247
Query: 251 VKDSSQRLPLHKLLEHPWIIQNA 273
            ++ + RL L  +L+HP++ +N+
Sbjct: 248 RRNPADRLSLSSVLDHPFMSRNS 270

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 145/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  + LG G FG V L + K + +  A+K+L K ++ +  Q+EH L  E  IQ  +
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRIQQAV 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y++LEYA  GE++  L++   FSE  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +K+ADFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  167 bits (423), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 145/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A E    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  167 bits (422), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 94/254 (37%), Positives = 138/254 (54%), Gaps = 10/254 (3%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V L ++K +    A+KV+ K Q++Q   +  L REV++   L HPNI++LY 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
           +F D+   YL+ E    GEL+ E+   K FSE  AA  +  +   + Y H   ++HRD+K
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153
Query: 144 PENLLIGAQ---GELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVEHDANVDIW 197
           PENLL+ ++     ++I DFG S H F   + M    GT  Y+ PE++    +D   D+W
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTH-FEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVW 211
Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQMLVKDSS 255
           S GV+ Y  L G PPF      D  +++ +    F  P    VS +AKDLI +ML    S
Sbjct: 212 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPS 271
Query: 256 QRLPLHKLLEHPWI 269
            R+     L+H WI
Sbjct: 272 MRISARDALDHEWI 285

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  167 bits (422), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 94/254 (37%), Positives = 138/254 (54%), Gaps = 10/254 (3%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V L ++K +    A+KV+ K Q++Q   +  L REV++   L HPNI++LY 
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
           +F D+   YL+ E    GEL+ E+   K FSE  AA  +  +   + Y H   ++HRD+K
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 177
Query: 144 PENLLIGAQ---GELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVEHDANVDIW 197
           PENLL+ ++     ++I DFG S H F   + M    GT  Y+ PE++    +D   D+W
Sbjct: 178 PENLLLESKSKDANIRIIDFGLSTH-FEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVW 235
Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQMLVKDSS 255
           S GV+ Y  L G PPF      D  +++ +    F  P    VS +AKDLI +ML    S
Sbjct: 236 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPS 295
Query: 256 QRLPLHKLLEHPWI 269
            R+     L+H WI
Sbjct: 296 MRISARDALDHEWI 309

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 147/261 (56%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQR---LP--LHKLLEHPWI 269
            ++R   LP  ++ +  H W 
Sbjct: 277 LTKRFGNLPNGVNDIKNHKWF 297

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 94/254 (37%), Positives = 138/254 (54%), Gaps = 10/254 (3%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V L ++K +    A+KV+ K Q++Q   +  L REV++   L HPNI++LY 
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
           +F D+   YL+ E    GEL+ E+   K FSE  AA  +  +   + Y H   ++HRD+K
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 176
Query: 144 PENLLIGAQ---GELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVEHDANVDIW 197
           PENLL+ ++     ++I DFG S H F   + M    GT  Y+ PE++    +D   D+W
Sbjct: 177 PENLLLESKSKDANIRIIDFGLSTH-FEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVW 234
Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQMLVKDSS 255
           S GV+ Y  L G PPF      D  +++ +    F  P    VS +AKDLI +ML    S
Sbjct: 235 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPS 294
Query: 256 QRLPLHKLLEHPWI 269
            R+     L+H WI
Sbjct: 295 MRISARDALDHEWI 308

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 145/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 145/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 145/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 92/245 (37%), Positives = 140/245 (57%), Gaps = 4/245 (1%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 85
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 86  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 206 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 263
Query: 254 SSQRL 258
            ++R 
Sbjct: 264 LTKRF 268

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 145/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 119
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++        T+CGT +YL PE++ S  ++  
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIILSKGYNKA 239
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 297
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWF 318

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  165 bits (418), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 94/254 (37%), Positives = 139/254 (54%), Gaps = 10/254 (3%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V L ++K +    A+KV+ K Q++Q   +  L REV++   L HPNI++LY 
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
           +F D+   YL+ E    GEL+ E+   K FSE  AA  +  +   + Y H   ++HRD+K
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 159
Query: 144 PENLLIGAQGE---LKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVEHDANVDIW 197
           PENLL+ ++ +   ++I DFG S H F   + M    GT  Y+ PE++    +D   D+W
Sbjct: 160 PENLLLESKSKDANIRIIDFGLSTH-FEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVW 217
Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQMLVKDSS 255
           S GV+ Y  L G PPF      D  +++ +    F  P    VS +AKDLI +ML    S
Sbjct: 218 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPS 277
Query: 256 QRLPLHKLLEHPWI 269
            R+     L+H WI
Sbjct: 278 MRISARDALDHEWI 291

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 145/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENL+I  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIISKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 145/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   F+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 88/247 (35%), Positives = 146/247 (59%), Gaps = 6/247 (2%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLR 74
           +DF   K +G+G FG V LAR K      A+KVL K   L++ + +H +     +  +++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HP ++ L+  F    ++Y +L+Y   GEL+  LQ+ + F E RA  Y A +A AL Y H 
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 157
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEHD 191
            ++++RD+KPEN+L+ +QG + + DFG    ++   +   T CGT +YL PE++    +D
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
             VD W LG + YE LYG+PPF ++  ++ Y  I+   L+   KP ++++A+ L+  +L 
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL--KPNITNSARHLLEGLLQ 275
Query: 252 KDSSQRL 258
           KD ++RL
Sbjct: 276 KDRTKRL 282

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 145/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL Y+   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 94/253 (37%), Positives = 142/253 (56%), Gaps = 7/253 (2%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVE 68
           + + T+NDFD  K LG+G FG V L REK +    A+K+L K  +  + +V H +  E  
Sbjct: 2   RAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESR 60
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           +  + RHP +  L   F    R+  ++EYA  GEL+  L + + F+E RA  Y A +  A
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 120
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMV 185
           L Y H + V++RDIK ENL++   G +KI DFG     +      +T CGT +YL PE++
Sbjct: 121 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 180
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
           E  ++   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSL 238
Query: 246 ISQMLVKDSSQRL 258
           ++ +L KD  QRL
Sbjct: 239 LAGLLKKDPKQRL 251

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   F E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   F E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 119
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   F E  A  Y A +     Y H
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 179
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 239
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 297
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWF 318

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   F E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  164 bits (414), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 94/249 (37%), Positives = 140/249 (56%), Gaps = 7/249 (2%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSH 72
           T+NDFD  K LG+G FG V L REK +    A+K+L K  +  + +V H +  E  +  +
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQN 61
Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
            RHP +  L   F    R+  ++EYA  GEL+  L + + F+E RA  Y A +  AL Y 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVE 189
           H + V++RDIK ENL++   G +KI DFG     +      +T CGT +YL PE++E  +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           +   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L++ +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGL 239
Query: 250 LVKDSSQRL 258
           L KD  QRL
Sbjct: 240 LKKDPKQRL 248

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 94/249 (37%), Positives = 140/249 (56%), Gaps = 7/249 (2%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSH 72
           T+NDFD  K LG+G FG V L REK +    A+K+L K  +  + +V H +  E  +  +
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQN 61
Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
            RHP +  L   F    R+  ++EYA  GEL+  L + + F+E RA  Y A +  AL Y 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVE 189
           H + V++RDIK ENL++   G +KI DFG     +      +T CGT +YL PE++E  +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           +   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L++ +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGL 239
Query: 250 LVKDSSQRL 258
           L KD  QRL
Sbjct: 240 LKKDPKQRL 248

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 93
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   F E  A  Y A +     Y H
Sbjct: 94  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 213
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 214 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 271
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 272 LTKRFGNLKNGVNDIKNHKWF 292

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 95/249 (38%), Positives = 140/249 (56%), Gaps = 7/249 (2%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSH 72
           T+NDFD  K LG+G FG V L REK +    A+K+L K  +  + +V H +  E  +  +
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQN 66
Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
            RHP +  L   F    R+  ++EYA  GEL+  L + + F+E RA  Y A +  AL Y 
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVE 189
           H + V++RDIK ENL++   G +KI DFG      +   TM   CGT +YL PE++E  +
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           +   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L++ +
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGL 244
Query: 250 LVKDSSQRL 258
           L KD  QRL
Sbjct: 245 LKKDPKQRL 253

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 95/249 (38%), Positives = 140/249 (56%), Gaps = 7/249 (2%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSH 72
           T+NDFD  K LG+G FG V L REK +    A+K+L K  +  + +V H +  E  +  +
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQN 61
Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
            RHP +  L   F    R+  ++EYA  GEL+  L + + F+E RA  Y A +  AL Y 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVE 189
           H + V++RDIK ENL++   G +KI DFG      +   TM   CGT +YL PE++E  +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           +   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L++ +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGL 239
Query: 250 LVKDSSQRL 258
           L KD  QRL
Sbjct: 240 LKKDPKQRL 248

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 95/249 (38%), Positives = 140/249 (56%), Gaps = 7/249 (2%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSH 72
           T+NDFD  K LG+G FG V L REK +    A+K+L K  +  + +V H +  E  +  +
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQN 61
Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
            RHP +  L   F    R+  ++EYA  GEL+  L + + F+E RA  Y A +  AL Y 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVE 189
           H + V++RDIK ENL++   G +KI DFG      +   TM   CGT +YL PE++E  +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           +   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L++ +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGL 239
Query: 250 LVKDSSQRL 258
           L KD  QRL
Sbjct: 240 LKKDPKQRL 248

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL P ++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPAIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 95/249 (38%), Positives = 140/249 (56%), Gaps = 7/249 (2%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSH 72
           T+NDFD  K LG+G FG V L REK +    A+K+L K  +  + +V H +  E  +  +
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQN 61
Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
            RHP +  L   F    R+  ++EYA  GEL+  L + + F+E RA  Y A +  AL Y 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVE 189
           H + V++RDIK ENL++   G +KI DFG      +   TM   CGT +YL PE++E  +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           +   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L++ +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGL 239
Query: 250 LVKDSSQRL 258
           L KD  QRL
Sbjct: 240 LKKDPKQRL 248

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  163 bits (413), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++        ++ +  H W 
Sbjct: 277 LTKAFGNLKNGVNDIKNHKWF 297

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  163 bits (413), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 145/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L + K + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EYA  GE++  L++   FSE  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENL+I  QG +K+ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 93/256 (36%), Positives = 145/256 (56%), Gaps = 11/256 (4%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G +G V L R+K ++   A+K++ K+ +  S    +L  EV +   L HPNI++L
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKL 101
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
           Y +F D++  YL++E    GEL+ E+     F+E  AA  +  +   + Y H  +++HRD
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 142 IKPENLLIGAQGE---LKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVEHDANVD 195
           +KPENLL+ ++ +   +KI DFG S   F  ++ M    GT  Y+ PE++   ++D   D
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSA-VFENQKKMKERLGTAYYIAPEVLRK-KYDEKCD 219
Query: 196 IWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQMLVKD 253
           +WS+GV+ +  L G PPF  +   +  R++ +    F  P    VS  AKDLI QML  D
Sbjct: 220 VWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFD 279
Query: 254 SSQRLPLHKLLEHPWI 269
           S +R+   + LEHPWI
Sbjct: 280 SQRRISAQQALEHPWI 295

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT + L PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEALAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   + GT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 135/253 (53%), Gaps = 8/253 (3%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V L ++K +    A+KV+ K Q++Q   +  L REV++   L HPNI +LY 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
           +F D+   YL+ E    GEL+ E+   K FSE  AA  +  +   + Y H   ++HRD+K
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLK 153
Query: 144 PENLLIGAQ---GELKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVEHDANVDIWS 198
           PENLL+ ++     ++I DFG S H     + +   GT  Y+ PE++    +D   D+WS
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YDEKCDVWS 212
Query: 199 LGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQMLVKDSSQ 256
            GV+ Y  L G PPF      D  +++ +    F  P    VS +AKDLI + L    S 
Sbjct: 213 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXLTYVPSX 272
Query: 257 RLPLHKLLEHPWI 269
           R+     L+H WI
Sbjct: 273 RISARDALDHEWI 285

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 86/248 (34%), Positives = 145/248 (58%), Gaps = 9/248 (3%)
Query: 18  FDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSHL 73
           F++ + LG+G +G V+  R+     +  I A+KVL K+ + + ++     + E  I   +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           +HP I+ L   F    ++YLILEY + GEL+ +L++   F E  A  Y+A ++ AL + H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEH 190
            K +I+RD+KPEN+++  QG +K+ DFG    S+H      T CGT++Y+ PE++    H
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           +  VD WSLG L Y+ L G PPF  +    T  +I++  L  P  P ++  A+DL+ ++L
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PYLTQEARDLLKKLL 256
Query: 251 VKDSSQRL 258
            ++++ RL
Sbjct: 257 KRNAASRL 264

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L + K + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIXNHKWF 298

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 88/258 (34%), Positives = 152/258 (58%), Gaps = 6/258 (2%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + ++ + K +G+G F  V LAR   +   VA+K++ K+QL  S ++ +L REV I   L 
Sbjct: 6   IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIMKVLN 64
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI++L+     +K +YL++EYA+ GE++  L    +  E+ A      +  A+ YCH 
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVH-TF-NRRRTMCGTLDYLPPEMVESVEHDA 192
           K ++HRD+K ENLL+ A   +KIADFG+S   TF N+  T CG+  Y  PE+ +  ++D 
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 193 -NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
             VD+WSLGV+ Y  + G  PF+ +   +   R+++   + P    +S+  ++L+ + L+
Sbjct: 185 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMSTDCENLLKKFLI 242
Query: 252 KDSSQRLPLHKLLEHPWI 269
            + S+R  L ++++  W+
Sbjct: 243 LNPSKRGTLEQIMKDRWM 260

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ FD  K LG G FG V L + K S +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   + GT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R  T+CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  161 bits (407), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L + K + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  161 bits (407), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L + K + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  161 bits (407), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EYA  GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENL+I  QG +K+ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L + K + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 89/245 (36%), Positives = 139/245 (56%), Gaps = 4/245 (1%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L + K + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 119
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 239
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 297
Query: 254 SSQRL 258
            ++R 
Sbjct: 298 LTKRF 302

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L + K + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L + K + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 147/261 (56%), Gaps = 9/261 (3%)
Query: 4   EVS-AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEH 61
           EVS AK K R T+N+F+  K LG+G FG V L +EK +    A+K+L K  +  + +V H
Sbjct: 138 EVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH 197
Query: 62  QLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATY 121
            L     +Q+  RHP +  L   F    R+  ++EYA  GEL+  L + + FSE RA  Y
Sbjct: 198 TLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 256
Query: 122 VASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTL 177
            A +  AL Y H  K+V++RD+K ENL++   G +KI DFG     +      +T CGT 
Sbjct: 257 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI 237
           +YL PE++E  ++   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RT 374
Query: 238 VSSAAKDLISQMLVKDSSQRL 258
           +   AK L+S +L KD  QRL
Sbjct: 375 LGPEAKSLLSGLLKKDPKQRL 395

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 92/270 (34%), Positives = 156/270 (57%), Gaps = 8/270 (2%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           S  SA E+    + ++ + K +G+G F  V LAR   +   VA+K++ K+QL  S ++ +
Sbjct: 3   SATSADEQPH--IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-K 59
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           L REV I   L HPNI++L+     +K +YL++EYA+ GE++  L       E+ A    
Sbjct: 60  LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF 119
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-TF-NRRRTMCGTLDYL 180
             +  A+ YCH K ++HRD+K ENLL+ A   +KIADFG+S   TF N+  T CG+  Y 
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 181 PPEMVESVEHDA-NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
            PE+ +  ++D   VD+WSLGV+ Y  + G  PF+ +   +   R+++   + P    +S
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMS 237
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +  ++L+ + L+ + S+R  L ++++  W+
Sbjct: 238 TDCENLLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 89/245 (36%), Positives = 139/245 (56%), Gaps = 4/245 (1%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L + K + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 91
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 151
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 211
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 269
Query: 254 SSQRL 258
            ++R 
Sbjct: 270 LTKRF 274

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 147/261 (56%), Gaps = 9/261 (3%)
Query: 4   EVS-AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEH 61
           EVS AK K R T+N+F+  K LG+G FG V L +EK +    A+K+L K  +  + +V H
Sbjct: 135 EVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH 194
Query: 62  QLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATY 121
            L     +Q+  RHP +  L   F    R+  ++EYA  GEL+  L + + FSE RA  Y
Sbjct: 195 TLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 253
Query: 122 VASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTL 177
            A +  AL Y H  K+V++RD+K ENL++   G +KI DFG     +      +T CGT 
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI 237
           +YL PE++E  ++   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RT 371
Query: 238 VSSAAKDLISQMLVKDSSQRL 258
           +   AK L+S +L KD  QRL
Sbjct: 372 LGPEAKSLLSGLLKKDPKQRL 392

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 89/245 (36%), Positives = 139/245 (56%), Gaps = 4/245 (1%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 84
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 85  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 144
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R  T+CGT +YL PE++ S  ++  
Sbjct: 145 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKA 204
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 205 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 262
Query: 254 SSQRL 258
            ++R 
Sbjct: 263 LTKRF 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 92/270 (34%), Positives = 156/270 (57%), Gaps = 8/270 (2%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           S  SA E+    + ++ + K +G+G F  V LAR   +   VA+K++ K+QL  S ++ +
Sbjct: 3   SATSADEQPH--IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-K 59
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           L REV I   L HPNI++L+     +K +YL++EYA+ GE++  L       E+ A    
Sbjct: 60  LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF 119
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-TF-NRRRTMCGTLDYL 180
             +  A+ YCH K ++HRD+K ENLL+ A   +KIADFG+S   TF N+  T CG+  Y 
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 181 PPEMVESVEHDA-NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
            PE+ +  ++D   VD+WSLGV+ Y  + G  PF+ +   +   R+++   + P    +S
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMS 237
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +  ++L+ + L+ + S+R  L ++++  W+
Sbjct: 238 TDCENLLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K +G G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +K+ADFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  160 bits (405), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 143/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P + +L   F D   +Y+++EYA  GE++  L++   FSE  A  Y A +     Y H
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENL+I  QG +K+ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  160 bits (405), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 143/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P + +L   F D   +Y+++EYA  GE++  L++   FSE  A  Y A +     Y H
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENL+I  QG +K+ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  160 bits (404), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 88/257 (34%), Positives = 139/257 (54%), Gaps = 8/257 (3%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G +G V L ++K +    A+K++ KS +  +     L  EV +   L HPNI++L
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
           Y +F D++  YL++E    GEL+ E+   + FSE  AA  +  +     Y H  +++HRD
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 129
Query: 142 IKPENLLIGAQGE---LKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVEHDANVDI 196
           +KPENLL+ ++     +KI DFG S H     + +   GT  Y+ PE++   ++D   D+
Sbjct: 130 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK-KYDEKCDV 188
Query: 197 WSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLISQMLVKDS 254
           WS GV+ Y  L G PPF  +   +  +R+ +    F P     VS  AK L+  ML  + 
Sbjct: 189 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEP 248
Query: 255 SQRLPLHKLLEHPWIIQ 271
           S+R+   + L HPWI++
Sbjct: 249 SKRISAEEALNHPWIVK 265

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 134/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      + +I++++  FP K      A+DL+ ++LV
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEK--FFPKARDLVEKLLV 270
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 271 LDATKRL 277

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 91/270 (33%), Positives = 156/270 (57%), Gaps = 8/270 (2%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           S  SA E+    + ++ + K +G+G F  V LAR   +   VA++++ K+QL  S ++ +
Sbjct: 3   SATSADEQPH--IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ-K 59
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           L REV I   L HPNI++L+     +K +YL++EYA+ GE++  L       E+ A    
Sbjct: 60  LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF 119
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-TF-NRRRTMCGTLDYL 180
             +  A+ YCH K ++HRD+K ENLL+ A   +KIADFG+S   TF N+  T CG+  Y 
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 181 PPEMVESVEHDA-NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
            PE+ +  ++D   VD+WSLGV+ Y  + G  PF+ +   +   R+++   + P    +S
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMS 237
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +  ++L+ + L+ + S+R  L ++++  W+
Sbjct: 238 TDCENLLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 136/247 (55%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R  +  GT  Y+ PE++      
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 271
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 272 LDATKRL 278

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EYA  GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENL+I  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 136/247 (55%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R  +  GT  Y+ PE++      
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 267
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 268 LDATKRL 274

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 85/248 (34%), Positives = 144/248 (58%), Gaps = 9/248 (3%)
Query: 18  FDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQSHL 73
           F++ + LG+G +G V+  R+     +  I A+KVL K+ + + ++     + E  I   +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           +HP I+ L   F    ++YLILEY + GEL+ +L++   F E  A  Y+A ++ AL + H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEH 190
            K +I+RD+KPEN+++  QG +K+ DFG    S+H        CGT++Y+ PE++    H
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           +  VD WSLG L Y+ L G PPF  +    T  +I++  L  P  P ++  A+DL+ ++L
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PYLTQEARDLLKKLL 256
Query: 251 VKDSSQRL 258
            ++++ RL
Sbjct: 257 KRNAASRL 264

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 88/257 (34%), Positives = 139/257 (54%), Gaps = 8/257 (3%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G +G V L ++K +    A+K++ KS +  +     L  EV +   L HPNI++L
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
           Y +F D++  YL++E    GEL+ E+   + FSE  AA  +  +     Y H  +++HRD
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 146
Query: 142 IKPENLLIGAQGE---LKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVEHDANVDI 196
           +KPENLL+ ++     +KI DFG S H     + +   GT  Y+ PE++   ++D   D+
Sbjct: 147 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK-KYDEKCDV 205
Query: 197 WSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLISQMLVKDS 254
           WS GV+ Y  L G PPF  +   +  +R+ +    F P     VS  AK L+  ML  + 
Sbjct: 206 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEP 265
Query: 255 SQRLPLHKLLEHPWIIQ 271
           S+R+   + L HPWI++
Sbjct: 266 SKRISAEEALNHPWIVK 282

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 88/245 (35%), Positives = 138/245 (56%), Gaps = 4/245 (1%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L + K + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 91
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   F E  A  Y A +     Y H
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 151
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 211
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 269
Query: 254 SSQRL 258
            ++R 
Sbjct: 270 LTKRF 274

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 143/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EYA  GE++  L++   F E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENL+I  QG +K+ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 270
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 271 LDATKRL 277

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K +G G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   G+++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +K+ADFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 268
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 269 LDATKRL 275

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 144/261 (55%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K +G G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   G+++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +K+ADFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 268
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 269 LDATKRL 275

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 134/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      + +I++++  FP K      A+DL+ ++LV
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEK--FFPKARDLVEKLLV 270
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 271 LDATKRL 277

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 268
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 269 LDATKRL 275

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 270
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 271 LDATKRL 277

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 270
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 271 LDATKRL 277

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 271
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 272 LDATKRL 278

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 143/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 129
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 189
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 190 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 247
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 248 LDATKRL 254

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 252
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 253 LDATKRL 259

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 127
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 187
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 188 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 245
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 246 LDATKRL 252

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 188
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 246
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 247 LDATKRL 253

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 143/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 143/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 267
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 268 LDATKRL 274

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 143/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  ++EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EYA  GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENL+I  QG +K+ DFG +     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 218 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 275
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 276 LDATKRL 282

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 143/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   FSE  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 142/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P + +L   F D   +Y+++EYA  GE++  L++   F E  A  Y A +     Y H
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENL+I  QG +K+ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 130
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 190
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 191 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 248
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 249 LDATKRL 255

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 91/270 (33%), Positives = 154/270 (57%), Gaps = 8/270 (2%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           S  SA E+    + ++ + K +G+G F  V LAR   +   VA+K++ K+QL  S ++ +
Sbjct: 3   SATSADEQPH--IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-K 59
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           L REV I   L HPNI++L+     +K +YL++EYA+ GE++  L       E+ A    
Sbjct: 60  LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF 119
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-TF-NRRRTMCGTLDYL 180
             +  A+ YCH K ++HRD+K ENLL+ A   +KIADFG+S   TF N+    CG   Y 
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 181 PPEMVESVEHDA-NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
            PE+ +  ++D   VD+WSLGV+ Y  + G  PF+ +   +   R+++   + P    +S
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMS 237
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +  ++L+ + L+ + S+R  L ++++  W+
Sbjct: 238 TDCENLLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 86/247 (34%), Positives = 135/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  G L K ++K   F E     Y A +  AL Y HGK 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R  +  GT  Y+ PE++      
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 270
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 271 LDATKRL 277

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 86/247 (34%), Positives = 134/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F    LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL+ ++LV
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLV 268
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 269 LDATKRL 275

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 155/270 (57%), Gaps = 8/270 (2%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           S  SA E+    + ++ + K +G+G F  V LAR   +   VA++++ K+QL  S ++ +
Sbjct: 3   SATSADEQPH--IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ-K 59
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           L REV I   L HPNI++L+     +K +YL++EYA+ GE++  L       E+ A    
Sbjct: 60  LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF 119
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-TF-NRRRTMCGTLDYL 180
             +  A+ YCH K ++HRD+K ENLL+ A   +KIADFG+S   TF N+    CG+  Y 
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYA 179
Query: 181 PPEMVESVEHDA-NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
            PE+ +  ++D   VD+WSLGV+ Y  + G  PF+ +   +   R+++   + P    +S
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMS 237
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +  ++L+ + L+ + S+R  L ++++  W+
Sbjct: 238 TDCENLLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 89/261 (34%), Positives = 143/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  ++EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EYA  GE++  L++   FSE  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENL+I  QG +++ DFG +     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 86/247 (34%), Positives = 134/247 (54%), Gaps = 7/247 (2%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ S L HP
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL Y HGK 
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           +IHRD+KPEN+L+     ++I DFG +          R     GT  Y+ PE++      
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
            + D+W+LG + Y+ + G+PPF A      +++I++++  FP        A+DL+ ++LV
Sbjct: 216 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAA--FFPKARDLVEKLLV 273
Query: 252 KDSSQRL 258
            D+++RL
Sbjct: 274 LDATKRL 280

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 89/261 (34%), Positives = 142/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   F E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  157 bits (396), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 89/261 (34%), Positives = 142/261 (54%), Gaps = 9/261 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   F E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 277
Query: 254 SSQRL-----PLHKLLEHPWI 269
            ++R       ++ +  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  157 bits (396), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 140/252 (55%), Gaps = 8/252 (3%)
Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQ 70
           R T+N+F+  K LG+G FG V L +EK +    A+K+L K  +  + +V H L     +Q
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           +  RHP +  L   F    R+  ++EYA  GEL+  L + + FSE RA  Y A +  AL 
Sbjct: 64  NS-RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 122
Query: 131 YCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVE 186
           Y H  K+V++RD+K ENL++   G +KI DFG          TM   CGT +YL PE++E
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 182
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
             ++   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +   AK L+
Sbjct: 183 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLGPEAKSLL 240
Query: 247 SQMLVKDSSQRL 258
           S +L KD  QRL
Sbjct: 241 SGLLKKDPKQRL 252

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  156 bits (395), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 87/245 (35%), Positives = 137/245 (55%), Gaps = 4/245 (1%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           L+ F+  K LG G FG V L +   + +  A+K+L K ++ +  Q+EH L  +  +Q+ +
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-V 98
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
             P +++L   F D   +Y+++EY   GE++  L++   F E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +I+RD+KPENLLI  QG +++ DFG++     R   +CGT +YL PE++ S  ++  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
           VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+  +L  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVD 276
Query: 254 SSQRL 258
            ++R 
Sbjct: 277 LTKRF 281

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 140/252 (55%), Gaps = 8/252 (3%)
Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQ 70
           R T+N+F+  K LG+G FG V L +EK +    A+K+L K  +  + +V H L     +Q
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           +  RHP +  L   F    R+  ++EYA  GEL+  L + + FSE RA  Y A +  AL 
Sbjct: 65  NS-RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 123
Query: 131 YCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVE 186
           Y H  K+V++RD+K ENL++   G +KI DFG          TM   CGT +YL PE++E
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 183
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
             ++   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +   AK L+
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLGPEAKSLL 241
Query: 247 SQMLVKDSSQRL 258
           S +L KD  QRL
Sbjct: 242 SGLLKKDPKQRL 253

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 140/252 (55%), Gaps = 8/252 (3%)
Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREVEIQ 70
           R T+N+F+  K LG+G FG V L +EK +    A+K+L K  +  + +V H L     +Q
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           +  RHP +  L   F    R+  ++EYA  GEL+  L + + FSE RA  Y A +  AL 
Sbjct: 66  NS-RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 124
Query: 131 YCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVE 186
           Y H  K+V++RD+K ENL++   G +KI DFG          TM   CGT +YL PE++E
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 184
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
             ++   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +   AK L+
Sbjct: 185 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLGPEAKSLL 242
Query: 247 SQMLVKDSSQRL 258
           S +L KD  QRL
Sbjct: 243 SGLLKKDPKQRL 254

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/258 (33%), Positives = 148/258 (57%), Gaps = 6/258 (2%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + ++ + K +G+G F  V LAR   +   VA+K++ K+QL  + ++ +L REV I   L 
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ-KLFREVRIMKILN 69
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI++L+     +K +YLI+EYA+ GE++  L       E+ A +    +  A+ YCH 
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESVEHDA 192
           K ++HRD+K ENLL+ A   +KIADFG+S       +  T CG+  Y  PE+ +  ++D 
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDG 189
Query: 193 -NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
             VD+WSLGV+ Y  + G  PF+ +   +   R+++   + P    +S+  ++L+ + LV
Sbjct: 190 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMSTDCENLLKRFLV 247
Query: 252 KDSSQRLPLHKLLEHPWI 269
            +  +R  L ++++  WI
Sbjct: 248 LNPIKRGTLEQIMKDRWI 265

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  154 bits (388), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 91/254 (35%), Positives = 134/254 (52%), Gaps = 11/254 (4%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V   +++ +    A+KV+ K+  +       LR EVE+   L HPNI++L+ 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFE 88
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
              D    Y++ E    GEL+ E+ K K FSE  AA  +  +   + Y H  +++HRD+K
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 144 PENLLIGAQG---ELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVEHDANVDIW 197
           PEN+L+ ++    ++KI DFG S   F +   M    GT  Y+ PE++    +D   D+W
Sbjct: 149 PENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVW 206
Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQMLVKDSS 255
           S GV+ Y  L G PPF  K   D  +R+      F  P    +S  AKDLI +ML    S
Sbjct: 207 SAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPS 266
Query: 256 QRLPLHKLLEHPWI 269
            R+   + LEHPWI
Sbjct: 267 LRITATQCLEHPWI 280

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  154 bits (388), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 146/258 (56%), Gaps = 6/258 (2%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + ++ + K +G+G F  V LAR   +   VA+K++ K+QL  + ++ +L REV I   L 
Sbjct: 14  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ-KLFREVRIMKILN 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI++L+     +K +YLI+EYA+ GE++  L       E+ A +    +  A+ YCH 
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESVEHDA 192
           K ++HRD+K ENLL+ A   +KIADFG+S       +    CG   Y  PE+ +  ++D 
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 193 -NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
             VD+WSLGV+ Y  + G  PF+ +   +   R+++   + P    +S+  ++L+ + LV
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMSTDCENLLKRFLV 250
Query: 252 KDSSQRLPLHKLLEHPWI 269
            +  +R  L ++++  WI
Sbjct: 251 LNPIKRGTLEQIMKDRWI 268

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  153 bits (387), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 92/260 (35%), Positives = 137/260 (52%), Gaps = 11/260 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           ++I   LG+G FG V   +++ +    A+KV+ K+  +       LR EVE+   L HPN
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPN 82
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I++L+    D    Y++ E    GEL+ E+ K K FSE  AA  +  +   + Y H  ++
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 138 IHRDIKPENLLIGAQ---GELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVEHD 191
           +HRD+KPEN+L+ ++    ++KI DFG S   F +   M    GT  Y+ PE++    +D
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRIGTAYYIAPEVLRGT-YD 200
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQM 249
              D+WS GV+ Y  L G PPF  K   D  +R+      F  P    +S  AKDLI +M
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260
Query: 250 LVKDSSQRLPLHKLLEHPWI 269
           L    S R+   + LEHPWI
Sbjct: 261 LTFHPSLRITATQCLEHPWI 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  153 bits (387), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 92/260 (35%), Positives = 137/260 (52%), Gaps = 11/260 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           ++I   LG+G FG V   +++ +    A+KV+ K+  +       LR EVE+   L HPN
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPN 82
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I++L+    D    Y++ E    GEL+ E+ K K FSE  AA  +  +   + Y H  ++
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 138 IHRDIKPENLLIGAQ---GELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESVEHD 191
           +HRD+KPEN+L+ ++    ++KI DFG S   F +   M    GT  Y+ PE++    +D
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRIGTAYYIAPEVLRGT-YD 200
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQM 249
              D+WS GV+ Y  L G PPF  K   D  +R+      F  P    +S  AKDLI +M
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260
Query: 250 LVKDSSQRLPLHKLLEHPWI 269
           L    S R+   + LEHPWI
Sbjct: 261 LTFHPSLRITATQCLEHPWI 280

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  153 bits (387), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 150/269 (55%), Gaps = 8/269 (2%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           S  SA E+    + ++ + K +G+G F  V LAR   +   VA+K++ K+QL  S ++ +
Sbjct: 3   SATSADEQPH--IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-K 59
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           L REV I   L HPNI++L+     +K +YL+ EYA+ GE++  L       E+ A    
Sbjct: 60  LFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF 119
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-TF-NRRRTMCGTLDYL 180
             +  A+ YCH K ++HRD+K ENLL+ A   +KIADFG+S   TF N+    CG   Y 
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 181 PPEMVESVEHDA-NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
            PE+ +  ++D   VD+WSLGV+ Y  + G  PF+ +   +   R+++   + P     S
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYXS 237
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
           +  ++L+ + L+ + S+R  L ++ +  W
Sbjct: 238 TDCENLLKKFLILNPSKRGTLEQIXKDRW 266

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 144/272 (52%), Gaps = 14/272 (5%)
Query: 11  KRWTLNDF-DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
            R  L+DF ++   LGRG    VY  ++K +    ALKVL K+  ++      +R E+ +
Sbjct: 47  NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-----VRTEIGV 101
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
              L HPNI++L   F     + L+LE    GEL+  + +  Y+SER AA  V  +  A+
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAV 161
Query: 130 IYCHGKHVIHRDIKPENLLIGA---QGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEM 184
            Y H   ++HRD+KPENLL         LKIADFG S  V      +T+CGT  Y  PE+
Sbjct: 162 AYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI 221
Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKF--PPKPIVSSA 241
           +    +   VD+WS+G++ Y  L G  PF + +     +RRI+  +  F  P    VS  
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           AKDL+ +++V D  +RL   + L+HPW+   A
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 144/275 (52%), Gaps = 12/275 (4%)
Query: 5   VSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQL 63
           +      R  +++F+  + LG+G FG V LAR K +  + A+KVL K   LQ   VE  +
Sbjct: 12  IGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM 71
Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA 123
             +  +     HP + +L+  F    R++ ++E+   G+L   +QK + F E RA  Y A
Sbjct: 72  TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA 131
Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYL 180
            +  AL++ H K +I+RD+K +N+L+  +G  K+ADFG     +       T CGT DY+
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYI 191
Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
            PE+++ + +   VD W++GVL YE L G  PFEA+   D +  I+  ++ +P    +  
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLHE 249
Query: 241 AAKDLISQMLVKDSSQRLPL------HKLLEHPWI 269
            A  ++   + K+ + RL        H +L HP+ 
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 146/277 (52%), Gaps = 14/277 (5%)
Query: 5   VSAKEKKRWTLND-----FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV 59
           + A E  RW   +     +D    LG G F  V LA +KR+  +VA+K + K  L+    
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-- 59
Query: 60  EHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA 119
           E  +  E+ +   ++HPNI+ L   +     +YLI++  + GEL+  + +  +++ER A+
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLL---IGAQGELKIADFGWS--VHTFNRRRTMC 174
             +  +  A+ Y H   ++HRD+KPENLL   +    ++ I+DFG S      +   T C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF-- 232
           GT  Y+ PE++    +   VD WS+GV+ Y  L G PPF  +  +  + +I++ + +F  
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 239
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P    +S +AKD I  ++ KD  +R    + L+HPWI
Sbjct: 240 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 146/277 (52%), Gaps = 14/277 (5%)
Query: 5   VSAKEKKRWTLND-----FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV 59
           + A E  RW   +     +D    LG G F  V LA +KR+  +VA+K + K  L+    
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-- 59
Query: 60  EHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA 119
           E  +  E+ +   ++HPNI+ L   +     +YLI++  + GEL+  + +  +++ER A+
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLL---IGAQGELKIADFGWS--VHTFNRRRTMC 174
             +  +  A+ Y H   ++HRD+KPENLL   +    ++ I+DFG S      +   T C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF-- 232
           GT  Y+ PE++    +   VD WS+GV+ Y  L G PPF  +  +  + +I++ + +F  
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 239
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P    +S +AKD I  ++ KD  +R    + L+HPWI
Sbjct: 240 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 84/248 (33%), Positives = 144/248 (58%), Gaps = 11/248 (4%)
Query: 18  FDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHL 73
           F++ K LG+G FG V+L R+     S H+ A+KVL K+ L+ + +V  ++ R+  I + +
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD--ILADV 87
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            HP +++L+  F  + ++YLIL++   G+L+  L K   F+E     Y+A LA  L + H
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR---TMCGTLDYLPPEMVESVEH 190
              +I+RD+KPEN+L+  +G +K+ DFG S    +  +   + CGT++Y+ PE+V    H
Sbjct: 148 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGH 207
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
             + D WS GVL +E L G  PF+ K+  +T   I++  L  P    +S+ A+ L+  + 
Sbjct: 208 SHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP--QFLSTEAQSLLRALF 265
Query: 251 VKDSSQRL 258
            ++ + RL
Sbjct: 266 KRNPANRL 273

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 146/277 (52%), Gaps = 14/277 (5%)
Query: 5   VSAKEKKRWTLND-----FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV 59
           + A E  RW   +     +D    LG G F  V LA +KR+  +VA+K + K  L+    
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-- 59
Query: 60  EHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA 119
           E  +  E+ +   ++HPNI+ L   +     +YLI++  + GEL+  + +  +++ER A+
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLL---IGAQGELKIADFGWS--VHTFNRRRTMC 174
             +  +  A+ Y H   ++HRD+KPENLL   +    ++ I+DFG S      +   T C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF-- 232
           GT  Y+ PE++    +   VD WS+GV+ Y  L G PPF  +  +  + +I++ + +F  
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 239
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P    +S +AKD I  ++ KD  +R    + L+HPWI
Sbjct: 240 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 82/250 (32%), Positives = 146/250 (58%), Gaps = 11/250 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQS 71
           + F++ K LG+G FG V+L ++     +  + A+KVL K+ L+ + +V  ++ R++ ++ 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE- 82
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
            + HP I++L+  F  + ++YLIL++   G+L+  L K   F+E     Y+A LA AL +
Sbjct: 83  -VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR---TMCGTLDYLPPEMVESV 188
            H   +I+RD+KPEN+L+  +G +K+ DFG S  + +  +   + CGT++Y+ PE+V   
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            H  + D WS GVL +E L G  PF+ K+  +T   I++  L  P    +S  A+ L+  
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP--QFLSPEAQSLLRM 259
Query: 249 MLVKDSSQRL 258
           +  ++ + RL
Sbjct: 260 LFKRNPANRL 269

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 82/250 (32%), Positives = 146/250 (58%), Gaps = 11/250 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQS 71
           + F++ K LG+G FG V+L ++     +  + A+KVL K+ L+ + +V  ++ R++ ++ 
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE- 83
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
            + HP I++L+  F  + ++YLIL++   G+L+  L K   F+E     Y+A LA AL +
Sbjct: 84  -VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 142
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR---TMCGTLDYLPPEMVESV 188
            H   +I+RD+KPEN+L+  +G +K+ DFG S  + +  +   + CGT++Y+ PE+V   
Sbjct: 143 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 202
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            H  + D WS GVL +E L G  PF+ K+  +T   I++  L  P    +S  A+ L+  
Sbjct: 203 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP--QFLSPEAQSLLRM 260
Query: 249 MLVKDSSQRL 258
           +  ++ + RL
Sbjct: 261 LFKRNPANRL 270

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 82/250 (32%), Positives = 146/250 (58%), Gaps = 11/250 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQS 71
           + F++ K LG+G FG V+L ++     +  + A+KVL K+ L+ + +V  ++ R++ ++ 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE- 82
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
            + HP I++L+  F  + ++YLIL++   G+L+  L K   F+E     Y+A LA AL +
Sbjct: 83  -VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR---TMCGTLDYLPPEMVESV 188
            H   +I+RD+KPEN+L+  +G +K+ DFG S  + +  +   + CGT++Y+ PE+V   
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
            H  + D WS GVL +E L G  PF+ K+  +T   I++  L  P    +S  A+ L+  
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP--QFLSPEAQSLLRM 259
Query: 249 MLVKDSSQRL 258
           +  ++ + RL
Sbjct: 260 LFKRNPANRL 269

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 145/276 (52%), Gaps = 14/276 (5%)
Query: 6   SAKEKKRWTLND-----FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
            A E  RW   +     +D    LG G F  V LA +KR+  +VA+K + K  L+    E
Sbjct: 3   GAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--E 60
Query: 61  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
             +  E+ +   ++HPNI+ L   +     +YLI++  + GEL+  + +  +++ER A+ 
Sbjct: 61  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 121 YVASLARALIYCHGKHVIHRDIKPENLL---IGAQGELKIADFGWSV--HTFNRRRTMCG 175
            +  +  A+ Y H   ++HRD+KPENLL   +    ++ I+DFG S      +   T CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--P 233
           T  Y+ PE++    +   VD WS+GV+ Y  L G PPF  +  +  + +I++ + +F  P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
               +S +AKD I  ++ KD  +R    + L+HPWI
Sbjct: 241 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  150 bits (380), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 86/264 (32%), Positives = 141/264 (53%), Gaps = 13/264 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++ K +G G FG   L R+K+SN +VA+K + + +    +++  ++RE+     LRHPN
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 75
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+R          + +++EYA+ GEL++ +     FSE  A  +   L   + YCH   V
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 138 IHRDIKPENLLIGAQ--GELKIADFGWSVHTF--NRRRTMCGTLDYLPPEMVESVEHDAN 193
            HRD+K EN L+       LKI DFG+S  +   ++ ++  GT  Y+ PE++   E+D  
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 194 V-DIWSLGVLCYEFLYGVPPFEAKEHSDTYR----RIVQVDLKFPPKPIVSSAAKDLISQ 248
           V D+WS GV  Y  L G  PFE  E    +R    RI+ V    P    +S   + LIS+
Sbjct: 196 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 255
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQN 272
           + V D ++R+ + ++  H W ++N
Sbjct: 256 IFVADPAKRISIPEIRNHEWFLKN 279

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 86/264 (32%), Positives = 140/264 (53%), Gaps = 13/264 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++ K +G G FG   L R+K+SN +VA+K + + +    ++   ++RE+     LRHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIAANVKREIINHRSLRHPN 76
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+R          + +++EYA+ GEL++ +     FSE  A  +   L   + YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 138 IHRDIKPENLLIGAQ--GELKIADFGWSVHTF--NRRRTMCGTLDYLPPEMVESVEHDAN 193
            HRD+K EN L+       LKI DFG+S  +   ++ ++  GT  Y+ PE++   E+D  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 194 V-DIWSLGVLCYEFLYGVPPFEAKEHSDTYR----RIVQVDLKFPPKPIVSSAAKDLISQ 248
           V D+WS GV  Y  L G  PFE  E    +R    RI+ V    P    +S   + LIS+
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQN 272
           + V D ++R+ + ++  H W ++N
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 92/260 (35%), Positives = 148/260 (56%), Gaps = 19/260 (7%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQL-QQSQVEHQLRREVEI 69
           + +F++ K LG G +G V+L R K S H    + A+KVL K+ + Q+++     R E ++
Sbjct: 53  IENFELLKVLGTGAYGKVFLVR-KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 70  QSHLRH-PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
             H+R  P ++ L+  F  + +++LIL+Y   GEL+  L + + F+E     YV  +  A
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS----VHTFNRRRTMCGTLDYLPPEM 184
           L + H   +I+RDIK EN+L+ + G + + DFG S         R    CGT++Y+ P++
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 185 VESVE--HDANVDIWSLGVLCYEFLYGVPPF----EAKEHSDTYRRIVQVDLKFPPKPIV 238
           V   +  HD  VD WSLGVL YE L G  PF    E    ++  RRI++ +  +P +  +
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--M 289
Query: 239 SSAAKDLISQMLVKDSSQRL 258
           S+ AKDLI ++L+KD  +RL
Sbjct: 290 SALAKDLIQRLLMKDPKKRL 309

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 77/234 (32%), Positives = 134/234 (57%), Gaps = 4/234 (1%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           + +++   ++  + ++ + K +G+G F  V LAR   +   VA+K++ K+QL  + ++ +
Sbjct: 2   NSITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQ-K 60
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           L REV I   L HPNI++L+     +K +YL++EYA+ GE++  L       E+ A    
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF 120
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYL 180
             +  A+ YCH K+++HRD+K ENLL+     +KIADFG+S      N+  T CG+  Y 
Sbjct: 121 RQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYA 180
Query: 181 PPEMVESVEHDA-NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
            PE+ +  ++D   VD+WSLGV+ Y  + G  PF+ +   +   R+++   + P
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 234

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  147 bits (372), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 139/259 (53%), Gaps = 9/259 (3%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           F+  + LG G F  V LA EK +  + A+K + K  L+    E  +  E+ +   ++H N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGK--ESSIENEIAVLRKIKHEN 81
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+ L   +     +YL+++  + GEL+  + +  +++E+ A+T +  +  A+ Y H   +
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 138 IHRDIKPENLLIGAQGE---LKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVEHDA 192
           +HRD+KPENLL  +Q E   + I+DFG S      +   T CGT  Y+ PE++    +  
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSK 201
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQML 250
            VD WS+GV+ Y  L G PPF  +  S  + +I++ + +F  P    +S +AKD I  ++
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLM 261
Query: 251 VKDSSQRLPLHKLLEHPWI 269
            KD ++R    +   HPWI
Sbjct: 262 EKDPNKRYTCEQAARHPWI 280

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  147 bits (372), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 140/264 (53%), Gaps = 13/264 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++ K +G G FG   L R+K+SN +VA+K + + +    +++  ++RE+     LRHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+R          + +++EYA+ GEL++ +     FSE  A  +   L   + YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 138 IHRDIKPENLLIGAQ--GELKIADFGWSVHTF--NRRRTMCGTLDYLPPEMVESVEHDAN 193
            HRD+K EN L+       LKI  FG+S  +   ++ ++  GT  Y+ PE++   E+D  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 194 V-DIWSLGVLCYEFLYGVPPFEAKEHSDTYR----RIVQVDLKFPPKPIVSSAAKDLISQ 248
           V D+WS GV  Y  L G  PFE  E    +R    RI+ V    P    +S   + LIS+
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQN 272
           + V D ++R+ + ++  H W ++N
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  147 bits (371), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 148/267 (55%), Gaps = 11/267 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQSHLR 74
           +++ + + +G+G F  V    +  + H  A K++   +L  S  +HQ L RE  I   L+
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKL--SARDHQKLEREARICRLLK 61
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H NI+RL+    ++   YL+ +    GEL++++   +Y+SE  A+  +  +  A+++CH 
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 135 KHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTFNRRRT---MCGTLDYLPPEMVESV 188
             V+HRD+KPENLL+ ++     +K+ADFG ++     ++      GT  YL PE++   
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKE 181
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLI 246
            +   VDIW+ GV+ Y  L G PPF  ++    Y++I      FP      V+  AK+LI
Sbjct: 182 AYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLI 241
Query: 247 SQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +QML  + ++R+  H+ L+HPW+ Q +
Sbjct: 242 NQMLTINPAKRITAHEALKHPWVCQRS 268

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  147 bits (370), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 139/258 (53%), Gaps = 7/258 (2%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHL 73
           + DF++ K LG+G FG V+LA  K++N   A+K L K   L    VE  +  +  +    
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            HP +  ++  F  ++ ++ ++EY   G+L   +Q C  F   RA  Y A +   L + H
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEH 190
            K +++RD+K +N+L+   G +KIADFG          +    CGT DY+ PE++   ++
Sbjct: 137 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKY 196
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           + +VD WS GVL YE L G  PF  ++  + +  I ++D  F P+  +   AKDL+ ++ 
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMDNPFYPR-WLEKEAKDLLVKLF 254
Query: 251 VKDSSQRLPLH-KLLEHP 267
           V++  +RL +   + +HP
Sbjct: 255 VREPEKRLGVRGDIRQHP 272

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 141/264 (53%), Gaps = 13/264 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++ K +G G FG   L R+K++N +VA+K + + +    +++  ++RE+     LRHPN
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+R          + +++EYA+ GEL++ +     FSE  A  +   L   + Y H   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQV 136
Query: 138 IHRDIKPENLLIGAQ--GELKIADFGWSVHTF--NRRRTMCGTLDYLPPEMVESVEHDAN 193
            HRD+K EN L+       LKIADFG+S  +   ++ ++  GT  Y+ PE++   E+D  
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGK 196
Query: 194 V-DIWSLGVLCYEFLYGVPPFEAKEHSDTYR----RIVQVDLKFPPKPIVSSAAKDLISQ 248
           V D+WS GV  Y  L G  PFE  E    +R    RI+ V    P    +S   + LIS+
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQN 272
           + V D ++R+ + ++  H W ++N
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 139/264 (52%), Gaps = 13/264 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++ K +G G FG   L R+K+SN +VA+K + + +    +++  ++RE+     LRHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+R          + +++EYA+ GEL++ +     FSE  A  +   L   + YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 138 IHRDIKPENLLIGAQ--GELKIADFGWSVHTF--NRRRTMCGTLDYLPPEMVESVEHDAN 193
            HRD+K EN L+       LKI  FG+S  +   ++ +   GT  Y+ PE++   E+D  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 194 V-DIWSLGVLCYEFLYGVPPFEAKEHSDTYR----RIVQVDLKFPPKPIVSSAAKDLISQ 248
           V D+WS GV  Y  L G  PFE  E    +R    RI+ V    P    +S   + LIS+
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQN 272
           + V D ++R+ + ++  H W ++N
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 138/258 (53%), Gaps = 7/258 (2%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHL 73
           + DF + K LG+G FG V+LA  K++N   A+K L K   L    VE  +  +  +    
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            HP +  ++  F  ++ ++ ++EY   G+L   +Q C  F   RA  Y A +   L + H
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEH 190
            K +++RD+K +N+L+   G +KIADFG          +    CGT DY+ PE++   ++
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKY 195
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           + +VD WS GVL YE L G  PF  ++  + +  I ++D  F P+  +   AKDL+ ++ 
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMDNPFYPR-WLEKEAKDLLVKLF 253
Query: 251 VKDSSQRLPLH-KLLEHP 267
           V++  +RL +   + +HP
Sbjct: 254 VREPEKRLGVRGDIRQHP 271

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/264 (32%), Positives = 135/264 (51%), Gaps = 13/264 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +D  K +G G FG   L R+K +  +VA+K + +     + ++  ++RE+     LRHPN
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG----AAIDENVQREIINHRSLRHPN 77
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+R          + +I+EYA+ GELY+ +     FSE  A  +   L   + YCH   +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 138 IHRDIKPENLLIGAQ--GELKIADFGWSVHTF--NRRRTMCGTLDYLPPEMVESVEHDAN 193
            HRD+K EN L+       LKI DFG+S  +   ++ ++  GT  Y+ PE++   E+D  
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197
Query: 194 V-DIWSLGVLCYEFLYGVPPFEAKEHSDTYR----RIVQVDLKFPPKPIVSSAAKDLISQ 248
           + D+WS GV  Y  L G  PFE  E    YR    RI+ V    P    +S     LIS+
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257
Query: 249 MLVKDSSQRLPLHKLLEHPWIIQN 272
           + V D + R+ + ++  H W ++N
Sbjct: 258 IFVADPATRISIPEIKTHSWFLKN 281

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 137/269 (50%), Gaps = 10/269 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           L+ +DI + LG G FG V+   E+ + +  A K +        +    +R+E++  S LR
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET---VRKEIQTMSVLR 212
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCH 133
           HP ++ L+  F D   + +I E+ + GEL++++  +    SE  A  Y+  + + L + H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 134 GKHVIHRDIKPENLLIGAQ--GELKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVE 189
             + +H D+KPEN++   +   ELK+ DFG + H   ++  +   GT ++  PE+ E   
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLIS 247
                D+WS+GVL Y  L G+ PF  +   +T R +   D          +S   KD I 
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           ++L+ D + R+ +H+ LEHPW+     P 
Sbjct: 393 KLLLADPNTRMTIHQALEHPWLTPGNAPG 421

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 137/269 (50%), Gaps = 10/269 (3%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           L+ +DI + LG G FG V+   E+ + +  A K +        +    +R+E++  S LR
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET---VRKEIQTMSVLR 106
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCH 133
           HP ++ L+  F D   + +I E+ + GEL++++  +    SE  A  Y+  + + L + H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 134 GKHVIHRDIKPENLLIGAQ--GELKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVE 189
             + +H D+KPEN++   +   ELK+ DFG + H   ++  +   GT ++  PE+ E   
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 226
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLIS 247
                D+WS+GVL Y  L G+ PF  +   +T R +   D          +S   KD I 
Sbjct: 227 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 286
Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           ++L+ D + R+ +H+ LEHPW+     P 
Sbjct: 287 KLLLADPNTRMTIHQALEHPWLTPGNAPG 315

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  144 bits (363), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 86/270 (31%), Positives = 140/270 (51%), Gaps = 5/270 (1%)
Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
            +K   R  +  + +G  LG G FG V +   + + H VA+K+L + +++   V  +++R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
           E++     RHP+I++LY         ++++EY + GEL+  + K     E  A      +
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RTMCGTLDYLPPE 183
             A+ YCH   V+HRD+KPEN+L+ A    KIADFG S    +    RT CG+ +Y  PE
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPE 180
Query: 184 MVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
           ++   +     VDIWS GV+ Y  L G  PF+  EH  T  + ++  + + P+ +  S A
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQN 272
             L+  ML  D  +R  +  + EH W  Q+
Sbjct: 240 T-LLMHMLQVDPLKRATIKDIREHEWFKQD 268

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  144 bits (362), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 82/256 (32%), Positives = 137/256 (53%), Gaps = 6/256 (2%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           I + LG G FG V LA   ++   VALK + +  L++S +  ++ RE+     LRHP+I+
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIH 139
           +LY        + +++EYA  GEL+  + + K  +E     +   +  A+ YCH   ++H
Sbjct: 73  KLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH 131
Query: 140 RDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVES-VEHDANVDI 196
           RD+KPENLL+     +KIADFG S  +   N  +T CG+ +Y  PE++   +     VD+
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDV 191
Query: 197 WSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           WS G++ Y  L G  PF+ +   + ++++       P    +S  A+ LI +M+V D  Q
Sbjct: 192 WSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--DFLSPGAQSLIRRMIVADPMQ 249
Query: 257 RLPLHKLLEHPWIIQN 272
           R+ + ++   PW   N
Sbjct: 250 RITIQEIRRDPWFNVN 265

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  143 bits (361), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 143/261 (54%), Gaps = 11/261 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQSHLRHP 76
           + + + LG+G F  V    +  +    A K++   +L  S  +HQ L RE  I   L+HP
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL--SARDHQKLEREARICRLLKHP 81
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
           NI+RL+    ++   YLI +    GEL++++   +Y+SE  A+  +  +  A+++CH   
Sbjct: 82  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 141
Query: 137 VIHRDIKPENLLIGAQ---GELKIADFGWSVHTFNRRRT---MCGTLDYLPPEMVESVEH 190
           V+HRD+KPENLL+ ++     +K+ADFG ++     ++      GT  YL PE++    +
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQ 248
              VD+W+ GV+ Y  L G PPF  ++    Y++I      FP      V+  AKDLI++
Sbjct: 202 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 261
Query: 249 MLVKDSSQRLPLHKLLEHPWI 269
           ML  + S+R+   + L+HPWI
Sbjct: 262 MLTINPSKRITAAEALKHPWI 282

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 137/257 (53%), Gaps = 6/257 (2%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + ++ I K LG G FG V LA    +   VALK++ K  L +S ++ ++ RE+     LR
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HP+I++LY     +  + +++EYA   EL+  + +    SE+ A  +   +  A+ YCH 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVES-VEHD 191
             ++HRD+KPENLL+     +KIADFG S  +   N  +T CG+ +Y  PE++   +   
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
             VD+WS GV+ Y  L    PF+ +     ++ I       P    +S  A  LI +ML+
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP--KFLSPGAAGLIKRMLI 248
Query: 252 KDSSQRLPLHKLLEHPW 268
            +   R+ +H++++  W
Sbjct: 249 VNPLNRISIHEIMQDDW 265

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 137/257 (53%), Gaps = 6/257 (2%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + ++ I K LG G FG V LA    +   VALK++ K  L +S ++ ++ RE+     LR
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HP+I++LY     +  + +++EYA   EL+  + +    SE+ A  +   +  A+ YCH 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 131
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVES-VEHD 191
             ++HRD+KPENLL+     +KIADFG S  +   N  +T CG+ +Y  PE++   +   
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
             VD+WS GV+ Y  L    PF+ +     ++ I       P    +S  A  LI +ML+
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP--KFLSPGAAGLIKRMLI 249
Query: 252 KDSSQRLPLHKLLEHPW 268
            +   R+ +H++++  W
Sbjct: 250 VNPLNRISIHEIMQDDW 266

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 137/257 (53%), Gaps = 6/257 (2%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + ++ I K LG G FG V LA    +   VALK++ K  L +S ++ ++ RE+     LR
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HP+I++LY     +  + +++EYA   EL+  + +    SE+ A  +   +  A+ YCH 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVES-VEHD 191
             ++HRD+KPENLL+     +KIADFG S  +   N  +T CG+ +Y  PE++   +   
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
             VD+WS GV+ Y  L    PF+ +     ++ I       P    +S  A  LI +ML+
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP--KFLSPGAAGLIKRMLI 243
Query: 252 KDSSQRLPLHKLLEHPW 268
            +   R+ +H++++  W
Sbjct: 244 VNPLNRISIHEIMQDDW 260

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 137/257 (53%), Gaps = 6/257 (2%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + ++ I K LG G FG V LA    +   VALK++ K  L +S ++ ++ RE+     LR
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HP+I++LY     +  + +++EYA   EL+  + +    SE+ A  +   +  A+ YCH 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVES-VEHD 191
             ++HRD+KPENLL+     +KIADFG S  +   N  +T CG+ +Y  PE++   +   
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV 251
             VD+WS GV+ Y  L    PF+ +     ++ I       P    +S  A  LI +ML+
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP--KFLSPGAAGLIKRMLI 239
Query: 252 KDSSQRLPLHKLLEHPW 268
            +   R+ +H++++  W
Sbjct: 240 VNPLNRISIHEIMQDDW 256

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 139/270 (51%), Gaps = 5/270 (1%)
Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
            +K   R  +  + +G  LG G FG V +   + + H VA+K+L + +++   V  +++R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
           E++     RHP+I++LY         ++++EY + GEL+  + K     E  A      +
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RTMCGTLDYLPPE 183
             A+ YCH   V+HRD+KPEN+L+ A    KIADFG S    +    R  CG+ +Y  PE
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPE 180
Query: 184 MVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
           ++   +     VDIWS GV+ Y  L G  PF+  EH  T  + ++  + + P+ +  S A
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQN 272
             L+  ML  D  +R  +  + EH W  Q+
Sbjct: 240 T-LLMHMLQVDPLKRATIKDIREHEWFKQD 268

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 145/267 (54%), Gaps = 11/267 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQSHLR 74
           +D+ + + LG+G F  V    +K      A K++   +L  S  +HQ L RE  I   L+
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL--SARDHQKLEREARICRLLK 88
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+RL+    ++   YL+ +    GEL++++   +Y+SE  A+  +  +  ++ + H 
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 135 KHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTFNRRRT---MCGTLDYLPPEMVESV 188
             ++HRD+KPENLL+ ++     +K+ADFG ++     ++      GT  YL PE++   
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKD 208
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLI 246
            +   VDIW+ GV+ Y  L G PPF  ++    Y++I      FP      V+  AK+LI
Sbjct: 209 PYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLI 268
Query: 247 SQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +QML  + ++R+   + L+HPW+ Q +
Sbjct: 269 NQMLTINPAKRITADQALKHPWVCQRS 295

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 147/267 (55%), Gaps = 11/267 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQSHLR 74
           +++ + + LG+G F  V    +  +    A K++   +L  S  +HQ L RE  I   L+
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL--SARDHQKLEREARICRLLK 61
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+RL+    ++   YL+ +    GEL++++   +Y+SE  A+  +  +  ++ +CH 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 135 KHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRRRT---MCGTLDYLPPEMVESV 188
             ++HRD+KPENLL+ ++ +   +K+ADFG ++     ++      GT  YL PE++   
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD 181
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLI 246
            +   VD+W+ GV+ Y  L G PPF  ++    Y++I      FP      V+  AKDLI
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 241
Query: 247 SQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           ++ML  + ++R+   + L+HPWI Q +
Sbjct: 242 NKMLTINPAKRITASEALKHPWICQRS 268

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 140/269 (52%), Gaps = 21/269 (7%)
Query: 17  DFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           D D+  KPLG G F        K+SN   A+K++ K     +Q E    +  E      H
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE-----GH 65
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI++L+  F+DQ   +L++E    GEL++ ++K K+FSE  A+  +  L  A+ + H  
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125
Query: 136 HVIHRDIKPENLLIGAQG---ELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVE 189
            V+HRD+KPENLL   +    E+KI DFG++          +T C TL Y  PE++    
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------DLKFPPKP--IVSS 240
           +D + D+WSLGV+ Y  L G  PF++ + S T    V++       D  F  +    VS 
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245
Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            AKDLI  +L  D ++RL +  L  + W+
Sbjct: 246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +++G+ LG G+F  V   R+K +    A K + K +L  S+      ++ REV I   +R
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+ L+  F ++  V LILE  + GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
           K + H D+KPEN+++  +      +K+ DFG +  +   N  + + GT +++ PE+V   
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF  +   +T   I  V+  F  +     S  AKD I
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 246
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ + + LEH WI
Sbjct: 247 RRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 147/267 (55%), Gaps = 11/267 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQSHLR 74
           +++ + + LG+G F  V    +  +    A K++   +L  S  +HQ L RE  I   L+
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL--SARDHQKLEREARICRLLK 61
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+RL+    ++   YL+ +    GEL++++   +Y+SE  A+  +  +  ++ +CH 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 135 KHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRRRT---MCGTLDYLPPEMVESV 188
             ++HRD+KPENLL+ ++ +   +K+ADFG ++     ++      GT  YL PE++   
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD 181
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLI 246
            +   VD+W+ GV+ Y  L G PPF  ++    Y++I      FP      V+  AKDLI
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 241
Query: 247 SQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           ++ML  + ++R+   + L+HPWI Q +
Sbjct: 242 NKMLTINPAKRITASEALKHPWICQRS 268

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG GKF  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 140/271 (51%), Gaps = 12/271 (4%)
Query: 11  KRWTLNDF-DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRRE 66
           K+  + DF DIG+ LG G+F  V   REK +    A K + K Q + S+      ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
           V I   + HPNI+ L+  + ++  V LILE  + GEL+  L + +  SE  A +++  + 
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYL 180
             + Y H K + H D+KPEN+++  +      +K+ DFG +  +      + + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--V 238
            PE+V         D+WS+GV+ Y  L G  PF      +T   I  V   F  +     
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           S  AKD I ++LVK++ +RL + + L HPWI
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 145/275 (52%), Gaps = 18/275 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQ 70
           +++ + K LG G  G V LA E+++   VA+K++ K +      +++     +  E+EI 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
             L HP I+++  +F D +  Y++LE    GEL+ ++   K   E     Y   +  A+ 
Sbjct: 70  KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 131 YCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWS--VHTFNRRRTMCGTLDYLPPEMV 185
           Y H   +IHRD+KPEN+L+ +Q E   +KI DFG S  +   +  RT+CGT  YL PE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 186 ESV---EHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPK--PIVS 239
            SV    ++  VD WSLGV+ +  L G PPF E +       +I      F P+    VS
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
             A DL+ ++LV D   R    + L HPW +Q+ D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPW-LQDED 282

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 136/268 (50%), Gaps = 5/268 (1%)
Query: 8   KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           K   R  +  + +G  LG G FG V + + + + H VA+K+L + +++   V  ++RRE+
Sbjct: 8   KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
           +     RHP+I++LY        +++++EY + GEL+  + K     E+ +      +  
Sbjct: 68  QNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RTMCGTLDYLPPEMV 185
            + YCH   V+HRD+KPEN+L+ A    KIADFG S    +    R  CG+ +Y  PE++
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVI 187
Query: 186 ES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
              +     VDIWS GV+ Y  L G  PF+       +++I   D  F     ++ +   
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVIS 245
Query: 245 LISQMLVKDSSQRLPLHKLLEHPWIIQN 272
           L+  ML  D  +R  +  + EH W  Q+
Sbjct: 246 LLKHMLQVDPMKRATIKDIREHEWFKQD 273

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 145/275 (52%), Gaps = 18/275 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQ 70
           +++ + K LG G  G V LA E+++   VA+K++ K +      +++     +  E+EI 
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
             L HP I+++  +F D +  Y++LE    GEL+ ++   K   E     Y   +  A+ 
Sbjct: 69  KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 131 YCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWS--VHTFNRRRTMCGTLDYLPPEMV 185
           Y H   +IHRD+KPEN+L+ +Q E   +KI DFG S  +   +  RT+CGT  YL PE++
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 187
Query: 186 ESV---EHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPK--PIVS 239
            SV    ++  VD WSLGV+ +  L G PPF E +       +I      F P+    VS
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 247
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
             A DL+ ++LV D   R    + L HPW +Q+ D
Sbjct: 248 EKALDLVKKLLVVDPKARFTTEEALRHPW-LQDED 281

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 145/275 (52%), Gaps = 18/275 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQ 70
           +++ + K LG G  G V LA E+++   VA+K++ K +      +++     +  E+EI 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
             L HP I+++  +F D +  Y++LE    GEL+ ++   K   E     Y   +  A+ 
Sbjct: 70  KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 131 YCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWS--VHTFNRRRTMCGTLDYLPPEMV 185
           Y H   +IHRD+KPEN+L+ +Q E   +KI DFG S  +   +  RT+CGT  YL PE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 186 ESV---EHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPK--PIVS 239
            SV    ++  VD WSLGV+ +  L G PPF E +       +I      F P+    VS
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
             A DL+ ++LV D   R    + L HPW +Q+ D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPW-LQDED 282

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 145/275 (52%), Gaps = 18/275 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQ 70
           +++ + K LG G  G V LA E+++   VA+K++ K +      +++     +  E+EI 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
             L HP I+++  +F D +  Y++LE    GEL+ ++   K   E     Y   +  A+ 
Sbjct: 70  KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 131 YCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWS--VHTFNRRRTMCGTLDYLPPEMV 185
           Y H   +IHRD+KPEN+L+ +Q E   +KI DFG S  +   +  RT+CGT  YL PE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 186 ESV---EHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPK--PIVS 239
            SV    ++  VD WSLGV+ +  L G PPF E +       +I      F P+    VS
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
             A DL+ ++LV D   R    + L HPW +Q+ D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPW-LQDED 282

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +++G+ LG G+F  V   R+K +    A K + K +L  S+      ++ REV I   +R
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+ L+  F ++  V LILE  + GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
           K + H D+KPEN+++  +      +K+ DFG +  +   N  + + GT +++ PE+V   
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 193
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF  +   +T   I  V+  F  +     S  AKD I
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 253
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ + + LEH WI
Sbjct: 254 RRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +++G+ LG G+F  V   R+K +    A K + K +L  S+      ++ REV I   +R
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+ L+  F ++  V LILE  + GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
           K + H D+KPEN+++  +      +K+ DFG +  +   N  + + GT +++ PE+V   
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 207
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF  +   +T   I  V+  F  +     S  AKD I
Sbjct: 208 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 267
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ + + LEH WI
Sbjct: 268 RRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 145/275 (52%), Gaps = 18/275 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQ 70
           +++ + K LG G  G V LA E+++   VA+K++ K +      +++     +  E+EI 
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
             L HP I+++  +F D +  Y++LE    GEL+ ++   K   E     Y   +  A+ 
Sbjct: 76  KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 131 YCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWS--VHTFNRRRTMCGTLDYLPPEMV 185
           Y H   +IHRD+KPEN+L+ +Q E   +KI DFG S  +   +  RT+CGT  YL PE++
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 194
Query: 186 ESV---EHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPK--PIVS 239
            SV    ++  VD WSLGV+ +  L G PPF E +       +I      F P+    VS
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 254
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
             A DL+ ++LV D   R    + L HPW +Q+ D
Sbjct: 255 EKALDLVKKLLVVDPKARFTTEEALRHPW-LQDED 288

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  140 bits (353), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 145/267 (54%), Gaps = 21/267 (7%)
Query: 17  DFDIGKPLGRGKFGHV-----YLAREKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQ 70
           ++ + + LG+G F  V      LA ++ +  I+  K L       S  +HQ L RE  I 
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-------SARDHQKLEREARIC 64
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
             L+HPNI+RL+    ++   YLI +    GEL++++   +Y+SE  A+  +  +  A++
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 124
Query: 131 YCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTFNRRRT---MCGTLDYLPPEM 184
           +CH   V+HR++KPENLL+ ++     +K+ADFG ++     ++      GT  YL PE+
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAA 242
           +    +   VD+W+ GV+ Y  L G PPF  ++    Y++I      FP      V+  A
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244
Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWI 269
           KDLI++ML  + S+R+   + L+HPWI
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  140 bits (353), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  140 bits (353), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  140 bits (353), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  140 bits (353), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 137/251 (54%), Gaps = 6/251 (2%)
Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQ 70
           R  L DF+    LG+G FG V LA  K +  + A+K+L K   +Q   VE  +  +  + 
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLA 74
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
              + P + +L+  F    R+Y ++EY   G+L   +Q+   F E +A  Y A ++  L 
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLF 134
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-HTFN--RRRTMCGTLDYLPPEMVES 187
           + H + +I+RD+K +N+++ ++G +KIADFG    H  +    R  CGT DY+ PE++  
Sbjct: 135 FLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAY 194
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             +  +VD W+ GVL YE L G PPF+ ++  + ++ I++ ++ +P    +S  A  +  
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS--LSKEAVSICK 252
Query: 248 QMLVKDSSQRL 258
            ++ K  ++RL
Sbjct: 253 GLMTKHPAKRL 263

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 252 RRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 252 RRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/275 (33%), Positives = 145/275 (52%), Gaps = 18/275 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQ 70
           +++ + K LG G  G V LA E+++   VA++++ K +      +++     +  E+EI 
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
             L HP I+++  +F D +  Y++LE    GEL+ ++   K   E     Y   +  A+ 
Sbjct: 209 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 131 YCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWS--VHTFNRRRTMCGTLDYLPPEMV 185
           Y H   +IHRD+KPEN+L+ +Q E   +KI DFG S  +   +  RT+CGT  YL PE++
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327
Query: 186 ESV---EHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPK--PIVS 239
            SV    ++  VD WSLGV+ +  L G PPF E +       +I      F P+    VS
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 387
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
             A DL+ ++LV D   R    + L HPW +Q+ D
Sbjct: 388 EKALDLVKKLLVVDPKARFTTEEALRHPW-LQDED 421

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/275 (33%), Positives = 145/275 (52%), Gaps = 18/275 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQ 70
           +++ + K LG G  G V LA E+++   VA++++ K +      +++     +  E+EI 
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
             L HP I+++  +F D +  Y++LE    GEL+ ++   K   E     Y   +  A+ 
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 131 YCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWS--VHTFNRRRTMCGTLDYLPPEMV 185
           Y H   +IHRD+KPEN+L+ +Q E   +KI DFG S  +   +  RT+CGT  YL PE++
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 186 ESV---EHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPK--PIVS 239
            SV    ++  VD WSLGV+ +  L G PPF E +       +I      F P+    VS
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
             A DL+ ++LV D   R    + L HPW +Q+ D
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALRHPW-LQDED 407

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 135/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT  ++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 131/259 (50%), Gaps = 11/259 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           + +   +GRG +G V +A +K +    A K + K  ++      + ++E+EI   L HPN
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---RFKQEIEIMKSLDHPN 84
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+RLY  F D   +YL++E    GEL++ +   + F E  AA  +  +  A+ YCH  +V
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 144
Query: 138 IHRDIKPENLLI---GAQGELKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVEHDA 192
            HRD+KPEN L         LK+ DFG +         RT  GT  Y+ P+++E + +  
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGP 203
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLISQML 250
             D WS GV+ Y  L G PPF A    +   +I +    FP K    VS  A+ LI ++L
Sbjct: 204 ECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLL 263
Query: 251 VKDSSQRLPLHKLLEHPWI 269
            K   QR+   + LEH W 
Sbjct: 264 TKSPKQRITSLQALEHEWF 282

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 138/261 (52%), Gaps = 8/261 (3%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +++D+ + LG+G F  V     K +    A K++   +L     + +L RE  I   L+H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQH 87
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI+RL+    ++   YL+ +    GEL++++   +++SE  A+  +  +  ++ YCH  
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 136 HVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEH 190
            ++HR++KPENLL+ ++ +   +K+ADFG ++   +        GT  YL PE+++   +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSAAKDLISQ 248
              VDIW+ GV+ Y  L G PPF  ++    Y +I     D   P    V+  AK LI  
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267
Query: 249 MLVKDSSQRLPLHKLLEHPWI 269
           ML  +  +R+   + L+ PWI
Sbjct: 268 MLTVNPKKRITADQALKVPWI 288

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 138/261 (52%), Gaps = 8/261 (3%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +++D+ + LG+G F  V     K +    A K++   +L     + +L RE  I   L+H
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQH 63
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI+RL+    ++   YL+ +    GEL++++   +++SE  A+  +  +  ++ YCH  
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 123
Query: 136 HVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEH 190
            ++HR++KPENLL+ ++ +   +K+ADFG ++   +        GT  YL PE+++   +
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 183
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSAAKDLISQ 248
              VDIW+ GV+ Y  L G PPF  ++    Y +I     D   P    V+  AK LI  
Sbjct: 184 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 243
Query: 249 MLVKDSSQRLPLHKLLEHPWI 269
           ML  +  +R+   + L+ PWI
Sbjct: 244 MLTVNPKKRITADQALKVPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 138/261 (52%), Gaps = 8/261 (3%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +++D+ + LG+G F  V     K +    A K++   +L     + +L RE  I   L+H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQH 64
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI+RL+    ++   YL+ +    GEL++++   +++SE  A+  +  +  ++ YCH  
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 136 HVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEH 190
            ++HR++KPENLL+ ++ +   +K+ADFG ++   +        GT  YL PE+++   +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSAAKDLISQ 248
              VDIW+ GV+ Y  L G PPF  ++    Y +I     D   P    V+  AK LI  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 249 MLVKDSSQRLPLHKLLEHPWI 269
           ML  +  +R+   + L+ PWI
Sbjct: 245 MLTVNPKKRITADQALKVPWI 265

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 131/259 (50%), Gaps = 11/259 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           + +   +GRG +G V +A +K +    A K + K  ++      + ++E+EI   L HPN
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---RFKQEIEIMKSLDHPN 67
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+RLY  F D   +YL++E    GEL++ +   + F E  AA  +  +  A+ YCH  +V
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 138 IHRDIKPENLLI---GAQGELKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVEHDA 192
            HRD+KPEN L         LK+ DFG +         RT  GT  Y+ P+++E + +  
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGP 186
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLISQML 250
             D WS GV+ Y  L G PPF A    +   +I +    FP K    VS  A+ LI ++L
Sbjct: 187 ECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLL 246
Query: 251 VKDSSQRLPLHKLLEHPWI 269
            K   QR+   + LEH W 
Sbjct: 247 TKSPKQRITSLQALEHEWF 265

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 138/261 (52%), Gaps = 8/261 (3%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +++D+ + LG+G F  V     K +    A K++   +L     + +L RE  I   L+H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQH 64
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI+RL+    ++   YL+ +    GEL++++   +++SE  A+  +  +  ++ YCH  
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 136 HVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEH 190
            ++HR++KPENLL+ ++ +   +K+ADFG ++   +        GT  YL PE+++   +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSAAKDLISQ 248
              VDIW+ GV+ Y  L G PPF  ++    Y +I     D   P    V+  AK LI  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 249 MLVKDSSQRLPLHKLLEHPWI 269
           ML  +  +R+   + L+ PWI
Sbjct: 245 MLTVNPKKRITADQALKVPWI 265

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 135/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/256 (32%), Positives = 131/256 (51%), Gaps = 9/256 (3%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G F  V+L +++ +  + ALK + KS   +   +  L  E+ +   ++H NI+ L  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLED 73
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +      YL+++  + GEL+  + +   ++E+ A+  +  +  A+ Y H   ++HRD+K
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133
Query: 144 PENLLIGAQGE---LKIADFGWSVHTFNR-RRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           PENLL     E   + I DFG S    N    T CGT  Y+ PE++    +   VD WS+
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSI 193
Query: 200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQMLVKDSSQR 257
           GV+ Y  L G PPF  +  S  + +I +   +F  P    +S +AKD I  +L KD ++R
Sbjct: 194 GVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNER 253
Query: 258 LPLHKLLEHPWIIQNA 273
               K L HPWI  N 
Sbjct: 254 YTCEKALSHPWIDGNT 269

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 139/271 (51%), Gaps = 20/271 (7%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS----------QVEHQLRREVEIQS 71
           + LG G +G V L +EK  +   A+KV+ KSQ  +           +   ++  E+ +  
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
            L HPNI++L+  F D+K  YL+ E+   GEL++++     F E  AA  +  +   + Y
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICY 161
Query: 132 CHGKHVIHRDIKPENLLIGAQGEL---KIADFGWSVHTFNRR---RTMCGTLDYLPPEMV 185
            H  +++HRDIKPEN+L+  +  L   KI DFG S   F++    R   GT  Y+ PE++
Sbjct: 162 LHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-FSKDYKLRDRLGTAYYIAPEVL 220
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPIVSSAAK 243
           +  +++   D+WS GV+ Y  L G PPF  +   D  +++ +      F     +S  AK
Sbjct: 221 KK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAK 279
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           +LI  ML  D ++R    + L   WI + A+
Sbjct: 280 ELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  138 bits (347), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 135/256 (52%), Gaps = 12/256 (4%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVE 68
           + R  L DF+    LG+G FG V L+  K ++ + A+K+L K   +Q   VE  +  +  
Sbjct: 14  RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV 73
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           +    + P + +L+  F    R+Y ++EY   G+L   +Q+   F E  A  Y A +A  
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 133
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFG------WSVHTFNRRRTMCGTLDYLPP 182
           L +   K +I+RD+K +N+++ ++G +KIADFG      W   T    +  CGT DY+ P
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKXFCGTPDYIAP 190
Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
           E++    +  +VD W+ GVL YE L G  PFE ++  + ++ I++ ++ +P    +S  A
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS--MSKEA 248
Query: 243 KDLISQMLVKDSSQRL 258
             +   ++ K   +RL
Sbjct: 249 VAICKGLMTKHPGKRL 264

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 91/270 (33%), Positives = 142/270 (52%), Gaps = 22/270 (8%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ-SHLR 74
           + + + + +G G +        K +N   A+KV+ KS+   S+       E+EI   + +
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE-------EIEILLRYGQ 79
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+ L   + D K VYL+ E    GEL  ++ + K+FSER A+  + ++ + + Y H 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 135 KHVIHRDIKPENLL-IGAQGE---LKIADFGWSVHTFNRR---RTMCGTLDYLPPEMVES 187
           + V+HRD+KP N+L +   G    L+I DFG++           T C T +++ PE+++ 
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKR 199
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV------QVDLKFPPKPIVSSA 241
             +D   DIWSLG+L Y  L G  PF A   SDT   I+      +  L       VS  
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGSGKFTLSGGNWNTVSET 258
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
           AKDL+S+ML  D  QRL   ++L+HPW+ Q
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 91/270 (33%), Positives = 142/270 (52%), Gaps = 22/270 (8%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ-SHLR 74
           + + + + +G G +        K +N   A+KV+ KS+   S+       E+EI   + +
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE-------EIEILLRYGQ 79
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+ L   + D K VYL+ E    GEL  ++ + K+FSER A+  + ++ + + Y H 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 135 KHVIHRDIKPENLL-IGAQGE---LKIADFGWSVHTFNRR---RTMCGTLDYLPPEMVES 187
           + V+HRD+KP N+L +   G    L+I DFG++           T C T +++ PE+++ 
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKR 199
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV------QVDLKFPPKPIVSSA 241
             +D   DIWSLG+L Y  L G  PF A   SDT   I+      +  L       VS  
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGSGKFTLSGGNWNTVSET 258
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
           AKDL+S+ML  D  QRL   ++L+HPW+ Q
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 144/290 (49%), Gaps = 39/290 (13%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLY 82
           LG G +  V  A   ++    A+K++ K   Q      ++ REVE     + + NIL L 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEK---QAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            +F D  R YL+ E    G +   +QK K+F+ER A+  V  +A AL + H K + HRD+
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 143 KPENLLIGAQ---GELKIADF----GWSVH------TFNRRRTMCGTLDYLPPEMVE--- 186
           KPEN+L  +      +KI DF    G  ++      T     T CG+ +Y+ PE+VE   
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFT 197
Query: 187 --SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT---------------YRRIVQVD 229
             +  +D   D+WSLGV+ Y  L G PPF     +D                +  I +  
Sbjct: 198 DQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 257
Query: 230 LKFPPKPI--VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSG 277
            +FP K    +SS AKDLIS++LV+D+ QRL   ++L+HPW+   A   G
Sbjct: 258 YEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKG 307

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 135/256 (52%), Gaps = 12/256 (4%)
Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVE 68
           + R  L DF+    LG+G FG V L+  K ++ + A+K+L K   +Q   VE  +  +  
Sbjct: 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV 394
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           +    + P + +L+  F    R+Y ++EY   G+L   +Q+   F E  A  Y A +A  
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 454
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFG------WSVHTFNRRRTMCGTLDYLPP 182
           L +   K +I+RD+K +N+++ ++G +KIADFG      W   T    +  CGT DY+ P
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKXFCGTPDYIAP 511
Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
           E++    +  +VD W+ GVL YE L G  PFE ++  + ++ I++ ++ +P    +S  A
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS--MSKEA 569
Query: 243 KDLISQMLVKDSSQRL 258
             +   ++ K   +RL
Sbjct: 570 VAICKGLMTKHPGKRL 585

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  137 bits (345), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 135/263 (51%), Gaps = 11/263 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LI E  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 135 KHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ +   L+HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  137 bits (344), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 139/271 (51%), Gaps = 12/271 (4%)
Query: 11  KRWTLNDF-DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRRE 66
           K+  + DF DIG+ LG G+F  V   REK +    A K + K Q + S+      ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
           V I   + H N++ L+  + ++  V LILE  + GEL+  L + +  SE  A +++  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYL 180
             + Y H K + H D+KPEN+++  +      +K+ DFG +  +      + + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--V 238
            PE+V         D+WS+GV+ Y  L G  PF      +T   I  V   F  +     
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           S  AKD I ++LVK++ +RL + + L HPWI
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  137 bits (344), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 139/271 (51%), Gaps = 12/271 (4%)
Query: 11  KRWTLNDF-DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRRE 66
           K+  + DF DIG+ LG G+F  V   REK +    A K + K Q + S+      ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
           V I   + H N++ L+  + ++  V LILE  + GEL+  L + +  SE  A +++  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYL 180
             + Y H K + H D+KPEN+++  +      +K+ DFG +  +      + + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--V 238
            PE+V         D+WS+GV+ Y  L G  PF      +T   I  V   F  +     
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           S  AKD I ++LVK++ +RL + + L HPWI
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 139/271 (51%), Gaps = 12/271 (4%)
Query: 11  KRWTLNDF-DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRRE 66
           K+  + DF DIG+ LG G+F  V   REK +    A K + K Q + S+      ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
           V I   + H N++ L+  + ++  V LILE  + GEL+  L + +  SE  A +++  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYL 180
             + Y H K + H D+KPEN+++  +      +K+ DFG +  +      + + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--V 238
            PE+V         D+WS+GV+ Y  L G  PF      +T   I  V   F  +     
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           S  AKD I ++LVK++ +RL + + L HPWI
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 139/271 (51%), Gaps = 12/271 (4%)
Query: 11  KRWTLNDF-DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRRE 66
           K+  + DF DIG+ LG G+F  V   REK +    A K + K Q + S+      ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
           V I   + H N++ L+  + ++  V LILE  + GEL+  L + +  SE  A +++  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYL 180
             + Y H K + H D+KPEN+++  +      +K+ DFG +  +      + + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--V 238
            PE+V         D+WS+GV+ Y  L G  PF      +T   I  V   F  +     
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           S  AKD I ++LVK++ +RL + + L HPWI
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 136/265 (51%), Gaps = 5/265 (1%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           T+  +  G+ LG+G F   Y   +  +  + A KV+ KS L +   + ++  E+ I   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            +P+++  +G+F D   VY++LE   +  L +  ++ K  +E  A  ++    + + Y H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FN--RRRTMCGTLDYLPPEMVESVEH 190
              VIHRD+K  NL +    ++KI DFG +    F+  R++T+CGT +Y+ PE++    H
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
              VDIWSLG + Y  L G PPFE     +TY RI + +   P    ++  A  LI +ML
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH--INPVASALIRRML 277
Query: 251 VKDSSQRLPLHKLLEHPWIIQNADP 275
             D + R  + +LL   +      P
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 139/271 (51%), Gaps = 12/271 (4%)
Query: 11  KRWTLNDF-DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRRE 66
           K+  + DF DIG+ LG G+F  V   REK +    A K + K Q + S+      ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
           V I   + H N++ L+  + ++  V LILE  + GEL+  L + +  SE  A +++  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWS--VHTFNRRRTMCGTLDYL 180
             + Y H K + H D+KPEN+++  +      +K+ DFG +  +      + + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--V 238
            PE+V         D+WS+GV+ Y  L G  PF      +T   I  V   F  +     
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           S  AKD I ++LVK++ +RL + + L HPWI
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 129/256 (50%), Gaps = 5/256 (1%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G F   +   +  +  + A K++ KS L +     ++  E+ I   L H +++  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
           +F D   V+++LE   +  L +  ++ K  +E  A  Y+  +     Y H   VIHRD+K
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 144 PENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             NL +    E+KI DFG +    +   R++T+CGT +Y+ PE++    H   VD+WS+G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPL 260
            + Y  L G PPFE     +TY RI + +   P    ++  A  LI +ML  D + R  +
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKMLQTDPTARPTI 262
Query: 261 HKLLEHPWIIQNADPS 276
           ++LL   +      P+
Sbjct: 263 NELLNDEFFTSGYIPA 278

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 140/269 (52%), Gaps = 22/269 (8%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ-SHLR 74
           + +++ + +G G +        K +N   A+K++ KS+   ++       E+EI   + +
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-------EIEILLRYGQ 74
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+ L   + D K VY++ E    GEL  ++ + K+FSER A+  + ++ + + Y H 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 135 KHVIHRDIKPENLLI----GAQGELKIADFGWSVHTFNRR---RTMCGTLDYLPPEMVES 187
           + V+HRD+KP N+L     G    ++I DFG++           T C T +++ PE++E 
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV------QVDLKFPPKPIVSSA 241
             +DA  DIWSLGVL Y  L G  PF A    DT   I+      +  L       VS  
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWII 270
           AKDL+S+ML  D  QRL    +L HPWI+
Sbjct: 254 AKDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 134/266 (50%), Gaps = 15/266 (5%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D+D+ K +GRG FG V L R K S  + A+K+L K ++ +         E +I +    P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
            +++L+  F D K +Y+++EY   G+L   L       E+ A  Y A +  AL   H   
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 194
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC----GTLDYLPPEMVESVEHDA 192
           +IHRD+KP+N+L+   G LK+ADFG  +         C    GT DY+ PE+++S   D 
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDG 254
Query: 193 ----NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSAAKDLI 246
                 D WS+GV  +E L G  PF A     TY +I+  +  L FP    +S  AK+LI
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLI 314
Query: 247 SQMLVKDSSQRL---PLHKLLEHPWI 269
              L  D   RL    + ++ +HP+ 
Sbjct: 315 CAFLT-DREVRLGRNGVEEIKQHPFF 339

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 129/256 (50%), Gaps = 5/256 (1%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G F   +   +  +  + A K++ KS L +     ++  E+ I   L H +++  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
           +F D   V+++LE   +  L +  ++ K  +E  A  Y+  +     Y H   VIHRD+K
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 144 PENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             NL +    E+KI DFG +    +   R++T+CGT +Y+ PE++    H   VD+WS+G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPL 260
            + Y  L G PPFE     +TY RI + +   P    ++  A  LI +ML  D + R  +
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKMLQTDPTARPTI 262
Query: 261 HKLLEHPWIIQNADPS 276
           ++LL   +      P+
Sbjct: 263 NELLNDEFFTSGYIPA 278

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 129/256 (50%), Gaps = 5/256 (1%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G F   +   +  +  + A K++ KS L +     ++  E+ I   L H +++  +G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
           +F D   V+++LE   +  L +  ++ K  +E  A  Y+  +     Y H   VIHRD+K
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 144 PENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             NL +    E+KI DFG +    +   R++T+CGT +Y+ PE++    H   VD+WS+G
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 208
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPL 260
            + Y  L G PPFE     +TY RI + +   P    ++  A  LI +ML  D + R  +
Sbjct: 209 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKMLQTDPTARPTI 266
Query: 261 HKLLEHPWIIQNADPS 276
           ++LL   +      P+
Sbjct: 267 NELLNDEFFTSGYIPA 282

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  134 bits (336), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 135/265 (50%), Gaps = 5/265 (1%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           T+  +  G+ LG+G F   Y   +  +  + A KV+ KS L +   + ++  E+ I   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            +P+++  +G+F D   VY++LE   +  L +  ++ K  +E  A  ++    + + Y H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FN--RRRTMCGTLDYLPPEMVESVEH 190
              VIHRD+K  NL +    ++KI DFG +    F+  R++ +CGT +Y+ PE++    H
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
              VDIWSLG + Y  L G PPFE     +TY RI + +   P    ++  A  LI +ML
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH--INPVASALIRRML 277
Query: 251 VKDSSQRLPLHKLLEHPWIIQNADP 275
             D + R  + +LL   +      P
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  134 bits (336), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 135/265 (50%), Gaps = 5/265 (1%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           T+  +  G+ LG+G F   Y   +  +  + A KV+ KS L +   + ++  E+ I   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            +P+++  +G+F D   VY++LE   +  L +  ++ K  +E  A  ++    + + Y H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FN--RRRTMCGTLDYLPPEMVESVEH 190
              VIHRD+K  NL +    ++KI DFG +    F+  R++ +CGT +Y+ PE++    H
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
              VDIWSLG + Y  L G PPFE     +TY RI + +   P    ++  A  LI +ML
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH--INPVASALIRRML 277
Query: 251 VKDSSQRLPLHKLLEHPWIIQNADP 275
             D + R  + +LL   +      P
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  134 bits (336), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 135/261 (51%), Gaps = 18/261 (6%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           FD+ + LG G +G VY A  K +  IVA+K V  +S LQ+      + +E+ I      P
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE------IIKEISIMQQCDSP 84
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGK 135
           ++++ YG ++    +++++EY   G +   ++ + K  +E   AT + S  + L Y H  
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDA 192
             IHRDIK  N+L+  +G  K+ADFG +        +R  + GT  ++ PE+++ + ++ 
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNC 204
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP---KP-IVSSAAKDLISQ 248
             DIWSLG+   E   G PP+ A  H    R I  +    PP   KP + S    D + Q
Sbjct: 205 VADIWSLGITAIEMAEGKPPY-ADIHP--MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261
Query: 249 MLVKDSSQRLPLHKLLEHPWI 269
            LVK   QR    +LL+HP++
Sbjct: 262 CLVKSPEQRATATQLLQHPFV 282

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  134 bits (336), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 135/265 (50%), Gaps = 5/265 (1%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           T+  +  G+ LG+G F   Y   +  +  + A KV+ KS L +   + ++  E+ I   L
Sbjct: 24  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 83
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            +P+++  +G+F D   VY++LE   +  L +  ++ K  +E  A  ++    + + Y H
Sbjct: 84  DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 143
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FN--RRRTMCGTLDYLPPEMVESVEH 190
              VIHRD+K  NL +    ++KI DFG +    F+  R++ +CGT +Y+ PE++    H
Sbjct: 144 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
              VDIWSLG + Y  L G PPFE     +TY RI + +   P    ++  A  LI +ML
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH--INPVASALIRRML 261
Query: 251 VKDSSQRLPLHKLLEHPWIIQNADP 275
             D + R  + +LL   +      P
Sbjct: 262 HADPTLRPSVAELLTDEFFTSGYAP 286

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  134 bits (336), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  133 bits (335), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 128/256 (50%), Gaps = 5/256 (1%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G F   +   +  +  + A K++ KS L +     ++  E+ I   L H +++  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
           +F D   V+++LE   +  L +  ++ K  +E  A  Y+  +     Y H   VIHRD+K
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 144 PENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             NL +    E+KI DFG +    +   R++ +CGT +Y+ PE++    H   VD+WS+G
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPL 260
            + Y  L G PPFE     +TY RI + +   P    ++  A  LI +ML  D + R  +
Sbjct: 203 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKMLQTDPTARPTI 260
Query: 261 HKLLEHPWIIQNADPS 276
           ++LL   +      P+
Sbjct: 261 NELLNDEFFTSGYIPA 276

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  133 bits (335), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 128/256 (50%), Gaps = 5/256 (1%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G F   +   +  +  + A K++ KS L +     ++  E+ I   L H +++  +G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
           +F D   V+++LE   +  L +  ++ K  +E  A  Y+  +     Y H   VIHRD+K
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 144 PENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             NL +    E+KI DFG +    +   R++ +CGT +Y+ PE++    H   VD+WS+G
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 226
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPL 260
            + Y  L G PPFE     +TY RI + +   P    ++  A  LI +ML  D + R  +
Sbjct: 227 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKMLQTDPTARPTI 284
Query: 261 HKLLEHPWIIQNADPS 276
           ++LL   +      P+
Sbjct: 285 NELLNDEFFTSGYIPA 300

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 140/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I + L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINAMLN 63
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 239
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRW 264

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 125/250 (50%), Gaps = 11/250 (4%)
Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           R    D+++ K +GRG FG V L R K +  + A+K+L K ++ +         E +I +
Sbjct: 65  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
               P +++L+  F D + +Y+++EY   G+L   +       E+ A  Y A +  AL  
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDA 183
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVES 187
            H    IHRD+KP+N+L+   G LK+ADFG  +        R  T  GT DY+ PE+++S
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 188 VEHDA----NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSA 241
              D       D WS+GV  YE L G  PF A     TY +I+  +  L FP    +S  
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303
Query: 242 AKDLISQMLV 251
           AK+LI   L 
Sbjct: 304 AKNLICAFLT 313

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 125/250 (50%), Gaps = 11/250 (4%)
Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           R    D+++ K +GRG FG V L R K +  + A+K+L K ++ +         E +I +
Sbjct: 70  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
               P +++L+  F D + +Y+++EY   G+L   +       E+ A  Y A +  AL  
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDA 188
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVES 187
            H    IHRD+KP+N+L+   G LK+ADFG  +        R  T  GT DY+ PE+++S
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 188 VEHDA----NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSA 241
              D       D WS+GV  YE L G  PF A     TY +I+  +  L FP    +S  
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 308
Query: 242 AKDLISQMLV 251
           AK+LI   L 
Sbjct: 309 AKNLICAFLT 318

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 125/250 (50%), Gaps = 11/250 (4%)
Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           R    D+++ K +GRG FG V L R K +  + A+K+L K ++ +         E +I +
Sbjct: 70  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
               P +++L+  F D + +Y+++EY   G+L   +       E+ A  Y A +  AL  
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDA 188
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVES 187
            H    IHRD+KP+N+L+   G LK+ADFG  +        R  T  GT DY+ PE+++S
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 188 VEHDA----NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSA 241
              D       D WS+GV  YE L G  PF A     TY +I+  +  L FP    +S  
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 308
Query: 242 AKDLISQMLV 251
           AK+LI   L 
Sbjct: 309 AKNLICAFLT 318

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 128/256 (50%), Gaps = 5/256 (1%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G F   +   +  +  + A K++ KS L +     ++  E+ I   L H +++  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
           +F D   V+++LE   +  L +  ++ K  +E  A  Y+  +     Y H   VIHRD+K
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 144 PENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             NL +    E+KI DFG +    +   R++ +CGT +Y+ PE++    H   VD+WS+G
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPL 260
            + Y  L G PPFE     +TY RI + +   P    ++  A  LI +ML  D + R  +
Sbjct: 229 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKMLQTDPTARPTI 286
Query: 261 HKLLEHPWIIQNADPS 276
           ++LL   +      P+
Sbjct: 287 NELLNDEFFTSGYIPA 302

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 139/261 (53%), Gaps = 18/261 (6%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G  G V LAREK S   VA+K++    L++ Q    L  EV I    +H N++ +Y 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +   + +++++E+   G L   + + +  +E + AT   ++ +AL Y H + VIHRDIK
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 144 PENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +++L+   G +K++DFG+         +R+ + GT  ++ PE++    +   VDIWSLG
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLG 228
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP------IVSSAAKDLISQMLVKDS 254
           ++  E + G PP+ +       +R     L+  P P       VS   +D + +MLV+D 
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKR-----LRDSPPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 255 SQRLPLHKLLEHPWIIQNADP 275
            +R    +LL+HP+++Q   P
Sbjct: 284 QERATAQELLDHPFLLQTGLP 304

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 239
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRW 264

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 239
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 239
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 239
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRW 264

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 239
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRW 264

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 61
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 237
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRW 262

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 239
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRW 264

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 139/269 (51%), Gaps = 22/269 (8%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ-SHLR 74
           + +++ + +G G +        K +N   A+K++ KS+   ++       E+EI   + +
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE-------EIEILLRYGQ 74
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+ L   + D K VY++ E    GEL  ++ + K+FSER A+  + ++ + + Y H 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 135 KHVIHRDIKPENLLI----GAQGELKIADFGWSVHTFNRR---RTMCGTLDYLPPEMVES 187
           + V+HRD+KP N+L     G    ++I DFG++           T C T +++ PE++E 
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLER 194
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV------QVDLKFPPKPIVSSA 241
             +DA  DIWSLGVL Y  L G  PF A    DT   I+      +  L       VS  
Sbjct: 195 QGYDAACDIWSLGVLLYTXLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWII 270
           AKDL+S+ L  D  QRL    +L HPWI+
Sbjct: 254 AKDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 141/269 (52%), Gaps = 15/269 (5%)
Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
           S K      L DFD+ + +GRG +  V L R K+++ I A++V+ K  +   +    ++ 
Sbjct: 42  SGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT 101
Query: 66  EVEI-QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS 124
           E  + +    HP ++ L+  F  + R++ ++EY   G+L   +Q+ +   E  A  Y A 
Sbjct: 102 EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE 161
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLP 181
           ++ AL Y H + +I+RD+K +N+L+ ++G +K+ D+G     +   +   T CGT +Y+ 
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT---------YRRIVQVDLKF 232
           PE++   ++  +VD W+LGVL +E + G  PF+    SD          ++ I++  ++ 
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLH 261
           P    +S  A  ++   L KD  +RL  H
Sbjct: 282 PRS--LSVKAASVLKSFLNKDPKERLGCH 308

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  131 bits (329), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G  G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      MCGTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  130 bits (328), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 140/287 (48%), Gaps = 34/287 (11%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-------------------- 54
           LN + +   +G+G +G V LA  +  N   A+KVL K +L                    
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 55  ---QQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--QKRVYLILEYAAKGELYKELQK 109
              Q      Q+ +E+ I   L HPN+++L     D  +  +Y++ E   +G +  E+  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM-EVPT 130
Query: 110 CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR 169
            K  SE +A  Y   L + + Y H + +IHRDIKP NLL+G  G +KIADFG S + F  
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFKG 189
Query: 170 RRTM----CGTLDYLPPEMVESVE---HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY 222
              +     GT  ++ PE +           +D+W++GV  Y F++G  PF  +     +
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 223 RRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +I    L+FP +P ++   KDLI++ML K+   R+ + ++  HPW+
Sbjct: 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  130 bits (328), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 135/262 (51%), Gaps = 14/262 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G  G V +A EK +   VA+K   K  L++ Q    L  EV I     H N++ +Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++E+   G L   +   +  +E + AT   S+ RAL Y H + VIHRDIK
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 144 PENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +++L+ + G +K++DFG+         +R+ + GT  ++ PE++  + +   VDIWSLG
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLG 228
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP----IVSSAAKDLISQMLVKDSSQ 256
           ++  E + G PP+  +      RRI       PP+      VSS  +  +  MLV++ SQ
Sbjct: 229 IMVIEMIDGEPPYFNEPPLQAMRRIRD---SLPPRVKDLHKVSSVLRGFLDLMLVREPSQ 285
Query: 257 RLPLHKLLEHPWIIQNADPSGV 278
           R    +LL HP++     PS +
Sbjct: 286 RATAQELLGHPFLKLAGPPSCI 307

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 132/247 (53%), Gaps = 13/247 (5%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF+I K +GRG FG V + + K ++ + A+K+L K ++ +       R E ++  +    
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGK 135
            I  L+  F D   +YL+++Y   G+L   L K +    E  A  Y+A +  A+   H  
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFN----RRRTMCGTLDYLPPEMVESVE-- 189
           H +HRDIKP+N+L+   G +++ADFG  +        +     GT DY+ PE+++++E  
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 190 ---HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPI-VSSAAK 243
              +    D WSLGV  YE LYG  PF A+   +TY +I+  +   +FP +   VS  AK
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 244 DLISQML 250
           DLI +++
Sbjct: 315 DLIRRLI 321

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/248 (33%), Positives = 132/248 (53%), Gaps = 15/248 (6%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF+I K +GRG FG V + + K +  I A+K+L K ++ +       R E ++  +    
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGK 135
            I  L+  F D+  +YL+++Y   G+L   L K +    E  A  Y+  +  A+   H  
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 210
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM-----CGTLDYLPPEMVESVE- 189
           H +HRDIKP+N+L+   G +++ADFG S    N   T+      GT DY+ PE+++++E 
Sbjct: 211 HYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 190 ----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPI-VSSAA 242
               +    D WSLGV  YE LYG  PF A+   +TY +I+  +   +FP     VS  A
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 329
Query: 243 KDLISQML 250
           KDLI +++
Sbjct: 330 KDLIQRLI 337

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/248 (33%), Positives = 132/248 (53%), Gaps = 15/248 (6%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           DF+I K +GRG FG V + + K +  I A+K+L K ++ +       R E ++  +    
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGK 135
            I  L+  F D+  +YL+++Y   G+L   L K +    E  A  Y+  +  A+   H  
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 194
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM-----CGTLDYLPPEMVESVE- 189
           H +HRDIKP+N+L+   G +++ADFG S    N   T+      GT DY+ PE+++++E 
Sbjct: 195 HYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 190 ----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPI-VSSAA 242
               +    D WSLGV  YE LYG  PF A+   +TY +I+  +   +FP     VS  A
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 313
Query: 243 KDLISQML 250
           KDLI +++
Sbjct: 314 KDLIQRLI 321

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 140/266 (52%), Gaps = 15/266 (5%)
Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
           S K      L DFD+ + +GRG +  V L R K+++ I A+KV+ K  +   +    ++ 
Sbjct: 10  SGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 69
Query: 66  EVEI-QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS 124
           E  + +    HP ++ L+  F  + R++ ++EY   G+L   +Q+ +   E  A  Y A 
Sbjct: 70  EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE 129
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLP 181
           ++ AL Y H + +I+RD+K +N+L+ ++G +K+ D+G     +   +     CGT +Y+ 
Sbjct: 130 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 189
Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT---------YRRIVQVDLKF 232
           PE++   ++  +VD W+LGVL +E + G  PF+    SD          ++ I++  ++ 
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 249
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRL 258
           P    V +A+  ++   L KD  +RL
Sbjct: 250 PRSMSVKAAS--VLKSFLNKDPKERL 273

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKMLN 63
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      M GTL Y+ PE+++  E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 239
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRW 264

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      M GTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 138/260 (53%), Gaps = 15/260 (5%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-QSHL 73
           L DFD+ + +GRG +  V L R K+++ I A+KV+ K  +   +    ++ E  + +   
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            HP ++ L+  F  + R++ ++EY   G+L   +Q+ +   E  A  Y A ++ AL Y H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEH 190
            + +I+RD+K +N+L+ ++G +K+ D+G     +   +     CGT +Y+ PE++   ++
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 183
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDT---------YRRIVQVDLKFPPKPIVSSA 241
             +VD W+LGVL +E + G  PF+    SD          ++ I++  ++ P    +S  
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVK 241
Query: 242 AKDLISQMLVKDSSQRLPLH 261
           A  ++   L KD  +RL  H
Sbjct: 242 AASVLKSFLNKDPKERLGCH 261

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 138/260 (53%), Gaps = 15/260 (5%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-QSHL 73
           L DFD+ + +GRG +  V L R K+++ I A+KV+ K  +   +    ++ E  + +   
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            HP ++ L+  F  + R++ ++EY   G+L   +Q+ +   E  A  Y A ++ AL Y H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGW---SVHTFNRRRTMCGTLDYLPPEMVESVEH 190
            + +I+RD+K +N+L+ ++G +K+ D+G     +   +     CGT +Y+ PE++   ++
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 187
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDT---------YRRIVQVDLKFPPKPIVSSA 241
             +VD W+LGVL +E + G  PF+    SD          ++ I++  ++ P    +S  
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVK 245
Query: 242 AKDLISQMLVKDSSQRLPLH 261
           A  ++   L KD  +RL  H
Sbjct: 246 AASVLKSFLNKDPKERLGCH 265

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      M GTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      M GTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 17/265 (6%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++     +       +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW-SVHTFNRR----RTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG  +V  +N R      M GTL Y+ PE+++  E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 190 -HDANVDIWSLGVLCYEFLYGVPPFE-----AKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            H   VD+WS G++    L G  P++      +E+SD   +   ++    P   + SA  
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLN----PWKKIDSAPL 238
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPW 268
            L+ ++LV++ S R+ +  + +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  127 bits (319), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 10/259 (3%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +DI + LG G FG V+   EK +  +   K +          ++ ++ E+ I + L HP 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFI---NTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKH 136
           ++ L+  F D+  + LILE+ + GEL+  +    Y  SE     Y+      L + H   
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 137 VIHRDIKPENLLIGAQ--GELKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEHDA 192
           ++H DIKPEN++   +    +KI DFG +         +    T ++  PE+V+      
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLISQML 250
             D+W++GVL Y  L G+ PF  ++  +T + + + D +F       VS  AKD I  +L
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 289
Query: 251 VKDSSQRLPLHKLLEHPWI 269
            K+  +RL +H  LEHPW+
Sbjct: 290 QKEPRKRLTVHDALEHPWL 308

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/282 (32%), Positives = 143/282 (50%), Gaps = 39/282 (13%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLY 82
           LG G    V       ++   A+K++ K   Q   +  ++ REVE+    + H N+L L 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEK---QPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            +F ++ R YL+ E    G +   + K ++F+E  A+  V  +A AL + H K + HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 143 KPENLLIGAQGE---LKIADFG----------WSVHTFNRRRTMCGTLDYLPPEMVESVE 189
           KPEN+L     +   +KI DFG           S  +     T CG+ +Y+ PE+VE+  
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 190 HDANV-----DIWSLGVLCYEFLYGVPPFEAKEHSDT---------------YRRIVQVD 229
            +A++     D+WSLGV+ Y  L G PPF  +  SD                +  I +  
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 230 LKFPPKPI--VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +FP K    +S AAKDLIS++LV+D+ QRL   ++L+HPW+
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 135/257 (52%), Gaps = 15/257 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G FG V+   + R+  +VA+K++   + +    + Q  +E+ + S      + + YG
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSSYVTKYYG 88
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +    ++++I+EY   G    +L +   F E + AT +  + + L Y H +  IHRDIK
Sbjct: 89  SYLKGSKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 144 PENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             N+L+  QG++K+ADFG +     T  +R T  GT  ++ PE+++   +D+  DIWSLG
Sbjct: 148 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG 207
Query: 201 VLCYEFLYGVPPFEAKEHSDTY--RRIVQVDLKFPPKPI--VSSAAKDLISQMLVKDSSQ 256
           +   E   G PP     +SD +  R +  +    PP  +   + + K+ I   L KD S 
Sbjct: 208 ITAIELAKGEPP-----NSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSF 262
Query: 257 RLPLHKLLEHPWIIQNA 273
           R    +LL+H +I++N+
Sbjct: 263 RPTAKELLKHKFIVKNS 279

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 16/268 (5%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFK-----SQLQQSQVEHQLRREVEIQSH 72
           +D    +GRG    V     + + H  A+K++       S  Q  +V    RRE  I   
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 73  LR-HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
           +  HP+I+ L   +     ++L+ +   KGEL+  L +    SE+   + + SL  A+ +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVE 189
            H  +++HRD+KPEN+L+    +++++DFG+S H     + R +CGT  YL PE+++   
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSM 275
Query: 190 HDAN------VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSA 241
            + +      VD+W+ GV+ +  L G PPF  +      R I++   +F  P     SS 
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSST 335
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            KDLIS++L  D   RL   + L+HP+ 
Sbjct: 336 VKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 145/277 (52%), Gaps = 18/277 (6%)
Query: 10  KKRWTLNDFDIGKP-LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK    +D+ + K  LG G  G V     +R+    ALK+L+ S   + +V+H    +  
Sbjct: 22  KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW--QAS 79
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAATYVASL 125
              H+    IL +Y   +  KR  LI +E    GEL+  +Q+   + F+ER AA  +  +
Sbjct: 80  GGPHIV--CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTF-NRRRTMCGTLDYLP 181
             A+ + H  ++ HRD+KPENLL  ++ +   LK+ DFG++  T  N  +T C T  Y+ 
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVA 197
Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPF---EAKEHSDTYRRIVQVDLKFPPKP-- 236
           PE++   ++D + D+WSLGV+ Y  L G PPF     +  S   +R +++     P P  
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257
Query: 237 -IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN 272
             VS  AK LI  +L  D ++RL + + + HPWI Q+
Sbjct: 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 145/277 (52%), Gaps = 18/277 (6%)
Query: 10  KKRWTLNDFDIGKP-LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK    +D+ + K  LG G  G V     +R+    ALK+L+ S   + +V+H    +  
Sbjct: 3   KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW--QAS 60
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAATYVASL 125
              H+    IL +Y   +  KR  LI +E    GEL+  +Q+   + F+ER AA  +  +
Sbjct: 61  GGPHIV--CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 118
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTF-NRRRTMCGTLDYLP 181
             A+ + H  ++ HRD+KPENLL  ++ +   LK+ DFG++  T  N  +T C T  Y+ 
Sbjct: 119 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVA 178
Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPF---EAKEHSDTYRRIVQVDLKFPPKP-- 236
           PE++   ++D + D+WSLGV+ Y  L G PPF     +  S   +R +++     P P  
Sbjct: 179 PEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 238
Query: 237 -IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN 272
             VS  AK LI  +L  D ++RL + + + HPWI Q+
Sbjct: 239 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 275

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  123 bits (309), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 145/285 (50%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 17  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 68
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 69  L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 126
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C
Sbjct: 127 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 186
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           T  R+ Q 
Sbjct: 187 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 246
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 247 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 291

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  123 bits (309), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 145/285 (50%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 25  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 76
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 77  L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 134
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C
Sbjct: 135 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 194
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           T  R+ Q 
Sbjct: 195 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 254
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 255 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 299

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 145/285 (50%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 16  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 67
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 68  L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 125
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C
Sbjct: 126 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 185
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           T  R+ Q 
Sbjct: 186 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 245
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 246 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 290

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 145/285 (50%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 61  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 112
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 113 L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 170
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C
Sbjct: 171 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 230
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           T  R+ Q 
Sbjct: 231 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 290
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 291 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 335

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 142/282 (50%), Gaps = 39/282 (13%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLY 82
           LG G    V       ++   A+K++ K   Q   +  ++ REVE+    + H N+L L 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEK---QPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            +F ++ R YL+ E    G +   + K ++F+E  A+  V  +A AL + H K + HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 143 KPENLLIGAQGE---LKIADF----------GWSVHTFNRRRTMCGTLDYLPPEMVESVE 189
           KPEN+L     +   +KI DF            S  +     T CG+ +Y+ PE+VE+  
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 190 HDANV-----DIWSLGVLCYEFLYGVPPFEAKEHSDT---------------YRRIVQVD 229
            +A++     D+WSLGV+ Y  L G PPF  +  SD                +  I +  
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 230 LKFPPKPI--VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +FP K    +S AAKDLIS++LV+D+ QRL   ++L+HPW+
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 145/285 (50%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 63  L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 180
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           T  R+ Q 
Sbjct: 181 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 240
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 241 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 285

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 145/285 (50%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 15  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 66
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 67  L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 124
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C
Sbjct: 125 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 184
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           T  R+ Q 
Sbjct: 185 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 244
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 245 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 289

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 145/285 (50%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 106
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 107 L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           T  R+ Q 
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 145/285 (50%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 10  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 61
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 62  L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 119
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C
Sbjct: 120 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 179
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           T  R+ Q 
Sbjct: 180 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 239
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 240 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 284

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 145/285 (50%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 60
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 61  L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 118
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C
Sbjct: 119 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 178
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           T  R+ Q 
Sbjct: 179 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 238
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 239 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 283

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 136/262 (51%), Gaps = 14/262 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G  G V +A  + S  +VA+K   K  L++ Q    L  EV I    +H N++ +Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++E+   G L   +   +   E+ AA  +A L +AL   H + VIHRDIK
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL-QALSVLHAQGVIHRDIK 147
Query: 144 PENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +++L+   G +K++DFG+         RR+ + GT  ++ PE++  + +   VDIWSLG
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 207
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP----IVSSAAKDLISQMLVKDSSQ 256
           ++  E + G PP+  +      + I       PP+      VS + K  + ++LV+D +Q
Sbjct: 208 IMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 264
Query: 257 RLPLHKLLEHPWIIQNADPSGV 278
           R    +LL+HP++ +   P+ +
Sbjct: 265 RATAAELLKHPFLAKAGPPASI 286

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 145/285 (50%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 63  L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 180
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           T  R+ Q 
Sbjct: 181 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 240
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 241 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 285

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 136/262 (51%), Gaps = 14/262 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G  G V +A  + S  +VA+K   K  L++ Q    L  EV I    +H N++ +Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++E+   G L   +   +   E+ AA  +A L +AL   H + VIHRDIK
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL-QALSVLHAQGVIHRDIK 143
Query: 144 PENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +++L+   G +K++DFG+         RR+ + GT  ++ PE++  + +   VDIWSLG
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP----IVSSAAKDLISQMLVKDSSQ 256
           ++  E + G PP+  +      + I       PP+      VS + K  + ++LV+D +Q
Sbjct: 204 IMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 260
Query: 257 RLPLHKLLEHPWIIQNADPSGV 278
           R    +LL+HP++ +   P+ +
Sbjct: 261 RATAAELLKHPFLAKAGPPASI 282

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 136/262 (51%), Gaps = 14/262 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G  G V +A  + S  +VA+K   K  L++ Q    L  EV I    +H N++ +Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++E+   G L   +   +   E+ AA  +A L +AL   H + VIHRDIK
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL-QALSVLHAQGVIHRDIK 154
Query: 144 PENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +++L+   G +K++DFG+         RR+ + GT  ++ PE++  + +   VDIWSLG
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 214
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP----IVSSAAKDLISQMLVKDSSQ 256
           ++  E + G PP+  +      + I       PP+      VS + K  + ++LV+D +Q
Sbjct: 215 IMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 271
Query: 257 RLPLHKLLEHPWIIQNADPSGV 278
           R    +LL+HP++ +   P+ +
Sbjct: 272 RATAAELLKHPFLAKAGPPASI 293

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 136/262 (51%), Gaps = 14/262 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G  G V +A  + S  +VA+K   K  L++ Q    L  EV I    +H N++ +Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++E+   G L   +   +   E+ AA  +A L +AL   H + VIHRDIK
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL-QALSVLHAQGVIHRDIK 152
Query: 144 PENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +++L+   G +K++DFG+         RR+ + GT  ++ PE++  + +   VDIWSLG
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 212
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP----IVSSAAKDLISQMLVKDSSQ 256
           ++  E + G PP+  +      + I       PP+      VS + K  + ++LV+D +Q
Sbjct: 213 IMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 269
Query: 257 RLPLHKLLEHPWIIQNADPSGV 278
           R    +LL+HP++ +   P+ +
Sbjct: 270 RATAAELLKHPFLAKAGPPASI 291

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 16/270 (5%)
Query: 14  TLND-FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           T++D F   + LG G FG V+L  E+ S     +K + K + Q      Q+  E+E+   
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKS 76
Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL----QKCKYFSERRAATYVASLARA 128
           L HPNI++++  F D   +Y+++E    GEL + +     + K  SE   A  +  +  A
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 129 LIYCHGKHVIHRDIKPENLLI---GAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPE 183
           L Y H +HV+H+D+KPEN+L         +KI DFG +    +        GT  Y+ PE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLKFPPKPIVSSA 241
           + +  +     DIWS GV+ Y  L G  PF      +  ++    + +     +P+   A
Sbjct: 197 VFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
             DL+ QML KD  +R    ++L H W  Q
Sbjct: 256 V-DLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 136/262 (51%), Gaps = 14/262 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G  G V +A  + S  +VA+K   K  L++ Q    L  EV I    +H N++ +Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++E+   G L   +   +   E+ AA  +A L +AL   H + VIHRDIK
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL-QALSVLHAQGVIHRDIK 197
Query: 144 PENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +++L+   G +K++DFG+         RR+ + GT  ++ PE++  + +   VDIWSLG
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 257
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP----IVSSAAKDLISQMLVKDSSQ 256
           ++  E + G PP+  +      + I       PP+      VS + K  + ++LV+D +Q
Sbjct: 258 IMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 314
Query: 257 RLPLHKLLEHPWIIQNADPSGV 278
           R    +LL+HP++ +   P+ +
Sbjct: 315 RATAAELLKHPFLAKAGPPASI 336

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 137/262 (52%), Gaps = 14/262 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G  G V +A  + S  +VA+K   K  L++ Q    L  EV I    +H N++ +Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++E+   G L   +   +   E+ AA  +A L +AL   H + VIHRDIK
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL-QALSVLHAQGVIHRDIK 274
Query: 144 PENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +++L+   G +K++DFG+         RR+ + GT  ++ PE++  + +   VDIWSLG
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 334
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP----IVSSAAKDLISQMLVKDSSQ 256
           ++  E + G PP+    +    + +  +    PP+      VS + K  + ++LV+D +Q
Sbjct: 335 IMVIEMVDGEPPY---FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 391
Query: 257 RLPLHKLLEHPWIIQNADPSGV 278
           R    +LL+HP++ +   P+ +
Sbjct: 392 RATAAELLKHPFLAKAGPPASI 413

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 132/253 (52%), Gaps = 10/253 (3%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G+FG V+   E  +   +A K++    ++  +   +++ E+ + + L H N+++LY 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE---EVKNEISVMNQLDHANLIQLYD 153
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVIHRDI 142
            F  +  + L++EY   GEL+  +    Y  +E     ++  +   + + H  +++H D+
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDL 213
Query: 143 KPENLLIGAQG--ELKIADFGWSVHTFNRRRTMC--GTLDYLPPEMVESVEHDANVDIWS 198
           KPEN+L   +   ++KI DFG +     R +     GT ++L PE+V         D+WS
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWS 273
Query: 199 LGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--DLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           +GV+ Y  L G+ PF     ++T   I+    DL+      +S  AK+ IS++L+K+ S 
Sbjct: 274 VGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSW 333
Query: 257 RLPLHKLLEHPWI 269
           R+   + L+HPW+
Sbjct: 334 RISASEALKHPWL 346

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  120 bits (302), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 93/285 (32%), Positives = 144/285 (50%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 60
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 61  L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 118
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N     C
Sbjct: 119 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPC 178
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           T  R+ Q 
Sbjct: 179 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 238
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 239 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 283

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  120 bits (301), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 137/266 (51%), Gaps = 15/266 (5%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSHLRH 75
           +++ + +G+G F  V     + +    A+K++  ++   S       L+RE  I   L+H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARALIY 131
           P+I+ L   +     +Y++ E+    +L  E+ K       +SE  A+ Y+  +  AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 132 CHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMV 185
           CH  ++IHRD+KPEN+L+ ++     +K+ DFG ++             GT  ++ PE+V
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAK 243
           +   +   VD+W  GV+ +  L G  PF   +    +  I++   K  P+    +S +AK
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISESAK 264
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPWI 269
           DL+ +ML+ D ++R+ +++ L HPW+
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 132/257 (51%), Gaps = 15/257 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G FG V+   + R+  +VA+K++   + +    + Q  +E+ + S    P + + YG
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 92
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +    ++++I+EY   G     L+      E + AT +  + + L Y H +  IHRDIK
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 144 PENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             N+L+   GE+K+ADFG +     T  +R T  GT  ++ PE+++   +D+  DIWSLG
Sbjct: 152 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 211
Query: 201 VLCYEFLYGVPPFEAKEHSDTY--RRIVQVDLKFPP--KPIVSSAAKDLISQMLVKDSSQ 256
           +   E   G PP     HS+ +  + +  +    PP  +   S   K+ +   L K+ S 
Sbjct: 212 ITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 266
Query: 257 RLPLHKLLEHPWIIQNA 273
           R    +LL+H +I++NA
Sbjct: 267 RPTAKELLKHKFILRNA 283

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 132/257 (51%), Gaps = 15/257 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G FG V+   + R+  +VA+K++   + +    + Q  +E+ + S    P + + YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +    ++++I+EY   G     L+      E + AT +  + + L Y H +  IHRDIK
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 144 PENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             N+L+   GE+K+ADFG +     T  +R T  GT  ++ PE+++   +D+  DIWSLG
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 191
Query: 201 VLCYEFLYGVPPFEAKEHSDTY--RRIVQVDLKFPP--KPIVSSAAKDLISQMLVKDSSQ 256
           +   E   G PP     HS+ +  + +  +    PP  +   S   K+ +   L K+ S 
Sbjct: 192 ITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 246
Query: 257 RLPLHKLLEHPWIIQNA 273
           R    +LL+H +I++NA
Sbjct: 247 RPTAKELLKHKFILRNA 263

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 137/268 (51%), Gaps = 18/268 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V+    K S  ++A K++    L+ +  + +Q+ RE+++     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHECN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y   
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 193 NVDIWSLGVLCYEFLYG---VPPFEAKEHSDTYRRIVQVDLKF-----PPK---PIVSSA 241
             DIWS+G+   E   G   +PP +AKE S     I ++ L +     PPK    + S  
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFEL-LDYIVNEPPPKLPSGVFSLE 241
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +D +++ L+K+ ++R  L +L+ H +I
Sbjct: 242 FQDFVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 128/270 (47%), Gaps = 13/270 (4%)
Query: 14  TLNDFDI--GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
             N+F I   K LGRGKF  V     K +    A K L K +  Q      L     ++ 
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARAL 129
               P ++ L+  + +   + LILEYAA GE++     +  +  SE      +  +   +
Sbjct: 85  AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 130 IYCHGKHVIHRDIKPENLLIGA---QGELKIADFGWS---VHTFNRRRTMCGTLDYLPPE 183
            Y H  +++H D+KP+N+L+ +    G++KI DFG S    H    R  M GT +YL PE
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-GTPEYLAPE 203
Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSA 241
           ++         D+W++G++ Y  L    PF  +++ +TY  I QV++ +  +    VS  
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
           A D I  +LVK+  +R      L H W+ Q
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 140/306 (45%), Gaps = 55/306 (17%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE--HQLRREVEIQSHLRHPNILRL 81
           +G+G +G V +A E ++  I A+K++ K++++Q   +   +++ EV +   L HPNI RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQ--------KCKY--------------------- 112
           Y  + D++ + L++E    G L  +L         KC                       
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 113 ---------FSERRA--ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG--ELKIAD 159
                    F +R    +  +  +  AL Y H + + HRDIKPEN L       E+K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 160 FGWSVHTFNRRR-------TMCGTLDYLPPEMVESVE--HDANVDIWSLGVLCYEFLYGV 210
           FG S   +           T  GT  ++ PE++ +    +    D WS GVL +  L G 
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 211 PPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
            PF     +DT  +++   L F  P   ++S  A+DL+S +L ++  +R    + L+HPW
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333
Query: 269 IIQNAD 274
           I Q +D
Sbjct: 334 ISQFSD 339

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 131/257 (50%), Gaps = 15/257 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G FG V+   + R+  +VA+K++   + +    + Q  +E+ + S    P + + YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +    ++++I+EY   G     L+      E + AT +  + + L Y H +  IHRDIK
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 144 PENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             N+L+   GE+K+ADFG +     T  +R    GT  ++ PE+++   +D+  DIWSLG
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLG 191
Query: 201 VLCYEFLYGVPPFEAKEHSDTY--RRIVQVDLKFPP--KPIVSSAAKDLISQMLVKDSSQ 256
           +   E   G PP     HS+ +  + +  +    PP  +   S   K+ +   L K+ S 
Sbjct: 192 ITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 246
Query: 257 RLPLHKLLEHPWIIQNA 273
           R    +LL+H +I++NA
Sbjct: 247 RPTAKELLKHKFILRNA 263

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 131/257 (50%), Gaps = 15/257 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G FG V+   + R+  +VA+K++   + +    + Q  +E+ + S    P + + YG
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 87
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +    ++++I+EY   G     L+      E + AT +  + + L Y H +  IHRDIK
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 144 PENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             N+L+   GE+K+ADFG +     T  +R    GT  ++ PE+++   +D+  DIWSLG
Sbjct: 147 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLG 206
Query: 201 VLCYEFLYGVPPFEAKEHSDTY--RRIVQVDLKFPP--KPIVSSAAKDLISQMLVKDSSQ 256
           +   E   G PP     HS+ +  + +  +    PP  +   S   K+ +   L K+ S 
Sbjct: 207 ITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 261
Query: 257 RLPLHKLLEHPWIIQNA 273
           R    +LL+H +I++NA
Sbjct: 262 RPTAKELLKHKFILRNA 278

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 126/252 (50%), Gaps = 9/252 (3%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G FG   L +         +K +  S++   + E   RREV + ++++HPNI++   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-RREVAVLANMKHPNIVQYRE 90
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
            F +   +Y++++Y   G+L+K +  QK   F E +   +   +  AL + H + ++HRD
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRD 150
Query: 142 IKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWS 198
           IK +N+ +   G +++ DFG +     T    R   GT  YL PE+ E+  ++   DIW+
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWA 210
Query: 199 LGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI-VSSAAKDLISQMLVKDSSQR 257
           LG + YE       FEA    +   +I+     FPP  +  S   + L+SQ+  ++   R
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGS--FPPVSLHYSYDLRSLVSQLFKRNPRDR 268
Query: 258 LPLHKLLEHPWI 269
             ++ +LE  +I
Sbjct: 269 PSVNSILEKGFI 280

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 138/285 (48%), Gaps = 31/285 (10%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK L        Q   + RREVE
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL--------QDCPKARREVE 106
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLIL-EYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI+ E    GEL+  +Q    + F+ER A+
Sbjct: 107 L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTF--NRRRTMC 174
               S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C
Sbjct: 165 EIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQV 228
            T  Y+ PE++   ++D + D WSLGV+ Y  L G PPF +           T  R  Q 
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQY 284
Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +   P    VS   K LI  +L  + +QR  + +   HPWI Q+ 
Sbjct: 285 EFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQST 329

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 131/266 (49%), Gaps = 19/266 (7%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVL-------FKSQLQQSQVEHQLRREVEIQSHLR-H 75
           LGRG    V     K +    A+K++       F ++  Q   E  L+ EV+I   +  H
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK-EVDILRKVSGH 83
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI++L   +      +L+ +   KGEL+  L +    SE+     + +L   +   H  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
           +++HRD+KPEN+L+     +K+ DFG+S  +    + R++CGT  YL PE++E   +D +
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNH 203
Query: 194 ------VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDL 245
                 VD+WS GV+ Y  L G PPF  ++     R I+  + +F  P     S   KDL
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 263
Query: 246 ISQMLVKDSSQRLPLHKLLEHPWIIQ 271
           +S+ LV    +R    + L HP+  Q
Sbjct: 264 VSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 130/266 (48%), Gaps = 19/266 (7%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVL-------FKSQLQQSQVEHQLRREVEIQSHLR-H 75
           LGRG    V     K +    A+K++       F ++  Q   E  L+ EV+I   +  H
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK-EVDILRKVSGH 70
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI++L   +      +L+ +   KGEL+  L +    SE+     + +L   +   H  
Sbjct: 71  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 130
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
           +++HRD+KPEN+L+     +K+ DFG+S  +    + R +CGT  YL PE++E   +D +
Sbjct: 131 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 190
Query: 194 ------VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDL 245
                 VD+WS GV+ Y  L G PPF  ++     R I+  + +F  P     S   KDL
Sbjct: 191 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 250
Query: 246 ISQMLVKDSSQRLPLHKLLEHPWIIQ 271
           +S+ LV    +R    + L HP+  Q
Sbjct: 251 VSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/253 (31%), Positives = 125/253 (49%), Gaps = 21/253 (8%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +DF+I K +GRG F  V + + K++  + A+K++ K  + +       R E ++  +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT----YVASLARALIY 131
             I +L+  F D+  +YL++EY   G+L   L K   F ER  A     Y+A +  A+  
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDS 177
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVES 187
            H    +HRDIKP+N+L+   G +++ADFG  +        R     GT DYL PE++++
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 188 VEHDA-------NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFP-PKPI 237
           V             D W+LGV  YE  YG  PF A   ++TY +IV     L  P     
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297
Query: 238 VSSAAKDLISQML 250
           V   A+D I ++L
Sbjct: 298 VPEEARDFIQRLL 310

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 112/218 (51%), Gaps = 5/218 (2%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           E +    + F+I + +G+G FG V + ++  +  + A+K + K +  +      + +E++
Sbjct: 8   ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           I   L HP ++ L+  F D++ ++++++    G+L   LQ+  +F E     ++  L  A
Sbjct: 68  IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR--TMCGTLDYLPPEMVE 186
           L Y   + +IHRD+KP+N+L+   G + I DF  +       +  TM GT  Y+ PEM  
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187
Query: 187 S---VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT 221
           S     +   VD WSLGV  YE L G  P+  +  + +
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 129/269 (47%), Gaps = 16/269 (5%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D+++   +G G +G     R K    I+  K L    + +++ +  L  EV +   L+HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHP 65
Query: 77  NILRLYGYFYDQKR--VYLILEYAAKGELYKELQKC----KYFSERRAATYVASLARALI 130
           NI+R Y    D+    +Y+++EY   G+L   + K     +Y  E      +  L  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 131 YCH-----GKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPP 182
            CH     G  V+HRD+KP N+ +  +  +K+ DFG +    H  +  +T  GT  Y+ P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
           E +  + ++   DIWSLG L YE    +PPF A    +   +I +   +  P    S   
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-YSDEL 244
Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
            ++I++ML      R  + ++LE+P I++
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 123/256 (48%), Gaps = 15/256 (5%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           TL +F I K +GRG+F  VY A        VALK +    L  ++      +E+++   L
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARAL 129
            HPN+++ Y  F +   + ++LE A  G+L + ++  K       ER    Y   L  AL
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT----MCGTLDYLPPEMV 185
            + H + V+HRDIKP N+ I A G +K+ D G     F+ + T    + GT  Y+ PE +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS--DTYRRIVQVDLKFPPKPI--VSSA 241
               ++   DIWSLG L YE      PF   + +     ++I Q D  +PP P    S  
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEE 266
Query: 242 AKDLISQMLVKDSSQR 257
            + L++  +  D  +R
Sbjct: 267 LRQLVNMCINPDPEKR 282

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 130/266 (48%), Gaps = 19/266 (7%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVL-------FKSQLQQSQVEHQLRREVEIQSHLR-H 75
           LGRG    V     K +    A+K++       F ++  Q   E  L+ EV+I   +  H
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK-EVDILRKVSGH 83
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI++L   +      +L+ +   KGEL+  L +    SE+     + +L   +   H  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
           +++HRD+KPEN+L+     +K+ DFG+S  +    + R +CGT  YL PE++E   +D +
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 203
Query: 194 ------VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAAKDL 245
                 VD+WS GV+ Y  L G PPF  ++     R I+  + +F  P     S   KDL
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 263
Query: 246 ISQMLVKDSSQRLPLHKLLEHPWIIQ 271
           +S+ LV    +R    + L HP+  Q
Sbjct: 264 VSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 137/282 (48%), Gaps = 37/282 (13%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G VY A+          K+  + + +   +     RE+ I   L+H NI++LY 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI--RLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSER-RAATYVASLARALIYCHGKHVIHRDI 142
             + +KR+ L+ E+  + +L K L  C+   E   A +++  L   + YCH + V+HRD+
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 143 KPENLLIGAQGELKIADFGWSVHTFN---RRRT-MCGTLDYLPPE-MVESVEHDANVDIW 197
           KP+NLLI  +GELKIADFG +   F    R+ T    TL Y  P+ ++ S ++   +DIW
Sbjct: 127 KPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------------------DLKFP---PKP 236
           S+G +  E + G P F     +D   RI ++                  D  F    P P
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245
Query: 237 IVS------SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN 272
             S       +  DL+S+ML  D +QR+   + LEH +  +N
Sbjct: 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 137/282 (48%), Gaps = 37/282 (13%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G VY A+          K+  + + +   +     RE+ I   L+H NI++LY 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI--RLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSER-RAATYVASLARALIYCHGKHVIHRDI 142
             + +KR+ L+ E+  + +L K L  C+   E   A +++  L   + YCH + V+HRD+
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 143 KPENLLIGAQGELKIADFGWSVHTFN---RRRT-MCGTLDYLPPE-MVESVEHDANVDIW 197
           KP+NLLI  +GELKIADFG +   F    R+ T    TL Y  P+ ++ S ++   +DIW
Sbjct: 127 KPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------------------DLKFP---PKP 236
           S+G +  E + G P F     +D   RI ++                  D  F    P P
Sbjct: 186 SVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245
Query: 237 IVS------SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN 272
             S       +  DL+S+ML  D +QR+   + LEH +  +N
Sbjct: 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 137/282 (48%), Gaps = 37/282 (13%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G VY A+          K+  + + +   +     RE+ I   L+H NI++LY 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI--RLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSER-RAATYVASLARALIYCHGKHVIHRDI 142
             + +KR+ L+ E+  + +L K L  C+   E   A +++  L   + YCH + V+HRD+
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 143 KPENLLIGAQGELKIADFGWSVHTFN---RRRT-MCGTLDYLPPE-MVESVEHDANVDIW 197
           KP+NLLI  +GELKIADFG +   F    R+ T    TL Y  P+ ++ S ++   +DIW
Sbjct: 127 KPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------------------DLKFP---PKP 236
           S+G +  E + G P F     +D   RI ++                  D  F    P P
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245
Query: 237 IVS------SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN 272
             S       +  DL+S+ML  D +QR+   + LEH +  +N
Sbjct: 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 129/261 (49%), Gaps = 10/261 (3%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V+    K S  ++A K++    L+ +  + +Q+ RE+++     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHECN 81
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y   
Sbjct: 82  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +  
Sbjct: 142 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 201
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP----PKPIVSSAAKDLISQ 248
             DIWS+G+   E   G  P  +   S     ++   +  P    P  + S   +D +++
Sbjct: 202 QSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 261
Query: 249 MLVKDSSQRLPLHKLLEHPWI 269
            L+K+ ++R  L +L+ H +I
Sbjct: 262 CLIKNPAERADLKQLMVHAFI 282

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 16/269 (5%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D+++   +G G +G     R K    I+  K L    + +++ +  L  EV +   L+HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHP 65
Query: 77  NILRLYGYFYDQKR--VYLILEYAAKGELYKELQKC----KYFSERRAATYVASLARALI 130
           NI+R Y    D+    +Y+++EY   G+L   + K     +Y  E      +  L  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 131 YCH-----GKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPP 182
            CH     G  V+HRD+KP N+ +  +  +K+ DFG +    H  +  +   GT  Y+ P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 185
Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
           E +  + ++   DIWSLG L YE    +PPF A    +   +I +   +  P    S   
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-YSDEL 244
Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
            ++I++ML      R  + ++LE+P I++
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++G+ LG G    V+LAR+ R +  VA+KVL     +      + RRE +  + L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 78  ILRLYGYFYDQKRV----YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           I+ +Y     +       Y+++EY     L   +      + +RA   +A   +AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGW------SVHTFNRRRTMCGTLDYLPPEMVES 187
              +IHRD+KP N+LI A   +K+ DFG       S ++  +   + GT  YL PE    
Sbjct: 134 QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPF 213
              DA  D++SLG + YE L G PPF
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 16/269 (5%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D+++   +G G +G     R K    I+  K L    + +++ +  L  EV +   L+HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHP 65
Query: 77  NILRLYGYFYDQKR--VYLILEYAAKGELYKELQKC----KYFSERRAATYVASLARALI 130
           NI+R Y    D+    +Y+++EY   G+L   + K     +Y  E      +  L  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 131 YCH-----GKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPP 182
            CH     G  V+HRD+KP N+ +  +  +K+ DFG +    H  +  +   GT  Y+ P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSP 185
Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
           E +  + ++   DIWSLG L YE    +PPF A    +   +I +   +  P    S   
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-YSDEL 244
Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
            ++I++ML      R  + ++LE+P I++
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 133/274 (48%), Gaps = 27/274 (9%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQSHLR 74
           ++I   LG G FG VY A+ K ++ + A KV+       ++ E +L     E++I +   
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI------DTKSEEELEDYMVEIDILASCD 92
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYK-ELQKCKYFSERRAATYVASLARALIYCH 133
           HPNI++L   FY +  +++++E+ A G +    L+  +  +E +          AL Y H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV----- 185
              +IHRD+K  N+L    G++K+ADFG S     T  RR +  GT  ++ PE+V     
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV-----SS 240
           +   +D   D+WSLG+   E     PP     H     R++    K  P  +      SS
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPP----HHELNPMRVLLKIAKSEPPTLAQPSRWSS 268
Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
             KD + + L K+   R    +LL+HP++  +++
Sbjct: 269 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++G+ LG G    V+LAR+ R +  VA+KVL     +      + RRE +  + L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 78  ILRLYGYFYDQKRV----YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           I+ +Y     +       Y+++EY     L   +      + +RA   +A   +AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGW------SVHTFNRRRTMCGTLDYLPPEMVES 187
              +IHRD+KP N++I A   +K+ DFG       S ++  +   + GT  YL PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPF 213
              DA  D++SLG + YE L G PPF
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++G+ LG G    V+LAR+ R +  VA+KVL     +      + RRE +  + L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 78  ILRLYGYFYDQKRV----YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           I+ +Y     +       Y+++EY     L   +      + +RA   +A   +AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGW------SVHTFNRRRTMCGTLDYLPPEMVES 187
              +IHRD+KP N++I A   +K+ DFG       S ++  +   + GT  YL PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPF 213
              DA  D++SLG + YE L G PPF
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 134/266 (50%), Gaps = 15/266 (5%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSHLRH 75
           +++ + +G+G F  V     + +    A+K++  ++   S       L+RE  I   L+H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARALIY 131
           P+I+ L   +     +Y++ E+    +L  E+ K       +SE  A+ Y+  +  AL Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 132 CHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMV 185
           CH  ++IHRD+KP  +L+ ++     +K+  FG ++             GT  ++ PE+V
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAK 243
           +   +   VD+W  GV+ +  L G  PF   +    +  I++   K  P+    +S +AK
Sbjct: 208 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISESAK 266
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPWI 269
           DL+ +ML+ D ++R+ +++ L HPW+
Sbjct: 267 DLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 134/266 (50%), Gaps = 15/266 (5%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSHLRH 75
           +++ + +G+G F  V     + +    A+K++  ++   S       L+RE  I   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARALIY 131
           P+I+ L   +     +Y++ E+    +L  E+ K       +SE  A+ Y+  +  AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 132 CHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMV 185
           CH  ++IHRD+KP  +L+ ++     +K+  FG ++             GT  ++ PE+V
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAK 243
           +   +   VD+W  GV+ +  L G  PF   +    +  I++   K  P+    +S +AK
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISESAK 264
Query: 244 DLISQMLVKDSSQRLPLHKLLEHPWI 269
           DL+ +ML+ D ++R+ +++ L HPW+
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++G+ LG G    V+LAR+ R +  VA+KVL     +      + RRE +  + L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 78  ILRLYGYFYDQKRV----YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           I+ +Y     +       Y+++EY     L   +      + +RA   +A   +AL + H
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGW------SVHTFNRRRTMCGTLDYLPPEMVES 187
              +IHRD+KP N++I A   +K+ DFG       S ++  +   + GT  YL PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPF 213
              DA  D++SLG + YE L G PPF
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 132/268 (49%), Gaps = 25/268 (9%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQSHLR 74
           ++I   LG G FG VY A+ K +  + A KV+      +++ E +L     E+EI +   
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVI------ETKSEEELEDYIVEIEILATCD 66
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYK-ELQKCKYFSERRAATYVASLARALIYCH 133
           HP I++L G +Y   ++++++E+   G +    L+  +  +E +       +  AL + H
Sbjct: 67  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 126
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV----- 185
            K +IHRD+K  N+L+  +G++++ADFG S   + T  +R +  GT  ++ PE+V     
Sbjct: 127 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS----A 241
           +   +D   DIWSLG+   E     PP           +I + D   PP  +  S     
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---PPTLLTPSKWSVE 243
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +D +   L K+   R    +LLEHP++
Sbjct: 244 FRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 125/257 (48%), Gaps = 6/257 (2%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V+    K S  ++A K++    L+ +  + +Q+ RE+++     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHECN 65
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y   
Sbjct: 66  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +       GT  Y+ PE ++   +  
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHYSV 185
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
             DIWS+G+   E   G  P       +    IV       P  + S   +D +++ L+K
Sbjct: 186 QSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIK 245
Query: 253 DSSQRLPLHKLLEHPWI 269
           + ++R  L +L+ H +I
Sbjct: 246 NPAERADLKQLMVHAFI 262

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 132/268 (49%), Gaps = 25/268 (9%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQSHLR 74
           ++I   LG G FG VY A+ K +  + A KV+      +++ E +L     E+EI +   
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVI------ETKSEEELEDYIVEIEILATCD 74
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYK-ELQKCKYFSERRAATYVASLARALIYCH 133
           HP I++L G +Y   ++++++E+   G +    L+  +  +E +       +  AL + H
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV----- 185
            K +IHRD+K  N+L+  +G++++ADFG S   + T  +R +  GT  ++ PE+V     
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS----A 241
           +   +D   DIWSLG+   E     PP           +I + D   PP  +  S     
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---PPTLLTPSKWSVE 251
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +D +   L K+   R    +LLEHP++
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++G+ LG G    V+LAR+ R +  VA+KVL     +      + RRE +  + L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 78  ILRLYGYFYDQKRV----YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           I+ +Y     +       Y+++EY     L   +      + +RA   +A   +AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGW------SVHTFNRRRTMCGTLDYLPPEMVES 187
              +IHRD+KP N++I A   +K+ DFG       S ++  +   + GT  YL PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPF 213
              DA  D++SLG + YE L G PPF
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 127/255 (49%), Gaps = 15/255 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G FG VY   +  +  +VA+K++   + +    + Q  +E+ + S    P I R +G
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYITRYFG 84
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +    ++++I+EY   G    +L K     E   AT +  + + L Y H +  IHRDIK
Sbjct: 85  SYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 144 PENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
             N+L+  QG++K+ADFG +     T  +R    GT  ++ PE+++   +D   DIWSLG
Sbjct: 144 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLG 203
Query: 201 VLCYEFLYGVPPFEAKEHSDTY-RRIVQVDLKFPPKPIV---SSAAKDLISQMLVKDSSQ 256
           +   E   G PP     +SD +  R++ +  K  P  +    S   K+ +   L KD   
Sbjct: 204 ITAIELAKGEPP-----NSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRF 258
Query: 257 RLPLHKLLEHPWIIQ 271
           R    +LL+H +I +
Sbjct: 259 RPTAKELLKHKFITR 273

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 126/252 (50%), Gaps = 12/252 (4%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G  G VY A +  +   VA++ +    LQQ   +  +  E+ +    ++PNI+    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++EY A G L   + +     E + A       +AL + H   VIHRDIK
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 144 PENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +N+L+G  G +K+ DFG+        ++R TM GT  ++ PE+V    +   VDIWSLG
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIV---QVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
           ++  E + G PP+  +        I      +L+ P K  +S+  +D +++ L  D  +R
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK--LSAIFRDFLNRCLDMDVEKR 261
Query: 258 LPLHKLLEHPWI 269
               +LL+H ++
Sbjct: 262 GSAKELLQHQFL 273

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  110 bits (275), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 127/262 (48%), Gaps = 11/262 (4%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           I + LGRG+FG V+   E  S      K +      Q  V    ++E+ I +  RH NIL
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV----KKEISILNIARHRNIL 64
Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVI 138
            L+  F   + + +I E+ +  ++++ +    +  +ER   +YV  +  AL + H  ++ 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 139 HRDIKPENLLIGAQ--GELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
           H DI+PEN++   +    +KI +FG +  +   +  R +    +Y  PE+ +        
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLISQMLVK 252
           D+WSLG L Y  L G+ PF A+ +      I+  +  F  +    +S  A D + ++LVK
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244
Query: 253 DSSQRLPLHKLLEHPWIIQNAD 274
           +   R+   + L+HPW+ Q  +
Sbjct: 245 ERKSRMTASEALQHPWLKQKIE 266

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  110 bits (275), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +++G+ LG G    V+LAR+ R +  VA+KVL     +      + RRE +  + L HP 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 78  ILRLYGYFYDQKRV----YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           I+ +Y     +       Y+++EY     L   +      + +RA   +A   +AL + H
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 150
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGW------SVHTFNRRRTMCGTLDYLPPEMVES 187
              +IHRD+KP N++I A   +K+ DFG       S ++  +   + GT  YL PE    
Sbjct: 151 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPF 213
              DA  D++SLG + YE L G PPF
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 132/274 (48%), Gaps = 27/274 (9%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQSHLR 74
           ++I   LG G FG VY A+ K ++ + A KV+       ++ E +L     E++I +   
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI------DTKSEEELEDYMVEIDILASCD 92
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYK-ELQKCKYFSERRAATYVASLARALIYCH 133
           HPNI++L   FY +  +++++E+ A G +    L+  +  +E +          AL Y H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMV----- 185
              +IHRD+K  N+L    G++K+ADFG S        RR +  GT  ++ PE+V     
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV-----SS 240
           +   +D   D+WSLG+   E     PP     H     R++    K  P  +      SS
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPP----HHELNPMRVLLKIAKSEPPTLAQPSRWSS 268
Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
             KD + + L K+   R    +LL+HP++  +++
Sbjct: 269 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KPENLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 233 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 274 DP 275
            P
Sbjct: 293 KP 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 113
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KPENLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 234 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293
Query: 274 DP 275
            P
Sbjct: 294 KP 295

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 125/259 (48%), Gaps = 19/259 (7%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEH----QLRREVEIQSHLRHPN 77
           PLG G FG V+ A +K  N  V +K + K + L+   +E     ++  E+ I S + H N
Sbjct: 31  PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 78  ILRLYGYFYDQKRVYLILEYAAKG-ELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
           I+++   F +Q    L++E    G +L+  + +     E  A+     L  A+ Y   K 
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR---TMCGTLDYLPPEMVESVEHDA- 192
           +IHRDIK EN++I     +K+ DFG S     R +   T CGT++Y  PE++    +   
Sbjct: 151 IIHRDIKDENIVIAEDFTIKLIDFG-SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGP 209
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
            +++WSLGV  Y  ++   PF   E +        V+    P  +VS     L+S +L  
Sbjct: 210 ELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPPYLVSKELMSLVSGLLQP 261
Query: 253 DSSQRLPLHKLLEHPWIIQ 271
              +R  L KL+  PW+ Q
Sbjct: 262 VPERRTTLEKLVTDPWVTQ 280

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQSHLR 74
           ++I   LG G FG VY A+ K ++ + A KV+       ++ E +L     E++I +   
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI------DTKSEEELEDYMVEIDILASCD 92
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYK-ELQKCKYFSERRAATYVASLARALIYCH 133
           HPNI++L   FY +  +++++E+ A G +    L+  +  +E +          AL Y H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHT---FNRRRTMCGTLDYLPPEMV----- 185
              +IHRD+K  N+L    G++K+ADFG S        RR    GT  ++ PE+V     
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETS 212
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV-----SS 240
           +   +D   D+WSLG+   E     PP     H     R++    K  P  +      SS
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPP----HHELNPMRVLLKIAKSEPPTLAQPSRWSS 268
Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
             KD + + L K+   R    +LL+HP++  +++
Sbjct: 269 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 140/305 (45%), Gaps = 55/305 (18%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLD 178
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL 
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLW 169
Query: 179 YLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKF 232
           Y  PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 229
Query: 233 P------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII 270
           P            PK          P +    + L+SQML  D ++R+     L HP+  
Sbjct: 230 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289
Query: 271 QNADP 275
               P
Sbjct: 290 DVTKP 294

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 128/292 (43%), Gaps = 43/292 (14%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSHLRHPNIL 79
           +P+G G +G V  A + R    VA+K L  S+  QS + H  R  RE+ +  HL+H N++
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKL--SRPFQSLI-HARRTYRELRLLKHLKHENVI 90
Query: 80  RLYGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F       D   VYL+      G     + KC+  S+      V  L R L Y H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVT--TLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP N+ +    EL+I DFG +            T  Y  PE M+  + ++ 
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--------------------DLKF 232
            VDIWS+G +  E L G   F   ++ D  +RI++V                        
Sbjct: 209 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSL 268
Query: 233 PPKP------IVSSA---AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           PP P      I   A   A DL+ +MLV DS QR+   + L H +  Q  DP
Sbjct: 269 PPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 320

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 129/256 (50%), Gaps = 20/256 (7%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G  G VY A +  +   VA++   +  LQQ   +  +  E+ +    ++PNI+    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 84  YFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            +     +++++EY A G L   + + C    E + A       +AL + H   VIHRDI
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 143 KPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K +N+L+G  G +K+ DFG+        ++R  M GT  ++ PE+V    +   VDIWSL
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQV------DLKFPPKPIVSSAAKDLISQMLVKD 253
           G++  E + G PP+    + +  R +  +      +L+ P K  +S+  +D +++ L  D
Sbjct: 203 GIMAIEMIEGEPPY---LNENPLRALYLIATNGTPELQNPEK--LSAIFRDFLNRCLEMD 257
Query: 254 SSQRLPLHKLLEHPWI 269
             +R    +LL+H ++
Sbjct: 258 VEKRGSAKELLQHQFL 273

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 274 DP 275
            P
Sbjct: 292 KP 293

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 47/294 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 49  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 104
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 162
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATRWYRAPEIMLNWMHYNQ 222
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 281
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                                DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 282 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 274 DP 275
            P
Sbjct: 292 KP 293

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 274 DP 275
            P
Sbjct: 292 KP 293

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 47/294 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 261
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                                DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 262 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDY 179
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWY 169
Query: 180 LPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP 233
             PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 234 ------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       PK          P +    + L+SQML  D ++R+     L HP+   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 272 NADP 275
              P
Sbjct: 290 VTKP 293

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 4/203 (1%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           + I   LG G    VYLA +   N  VA+K +F    ++ +   +  REV   S L H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+ +     +    YL++EY     L + ++     S   A  +   +   + + H   +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 138 IHRDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
           +HRDIKP+N+LI +   LKI DFG     S  +  +   + GT+ Y  PE  +    D  
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 194 VDIWSLGVLCYEFLYGVPPFEAK 216
            DI+S+G++ YE L G PPF  +
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGE 215

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDY 179
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWY 168
Query: 180 LPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP 233
             PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 234 ------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       PK          P +    + L+SQML  D ++R+     L HP+   
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 272 NADP 275
              P
Sbjct: 289 VTKP 292

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 113
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 234 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293
Query: 274 DP 275
            P
Sbjct: 294 KP 295

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 138/296 (46%), Gaps = 49/296 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                     PK          P +    + L+SQML  D ++R+     L HP+ 
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 63
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 115
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 116 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 175
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 235
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 236 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 295
Query: 274 DP 275
            P
Sbjct: 296 KP 297

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 114
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 274 DP 275
            P
Sbjct: 295 KP 296

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDY 179
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWY 169
Query: 180 LPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP 233
             PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 234 ------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       PK          P +    + L+SQML  D ++R+     L HP+   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 272 NADP 275
              P
Sbjct: 290 VTKP 293

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 233 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 274 DP 275
            P
Sbjct: 293 KP 294

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 47/294 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 25  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 80
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQ 198
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 257
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                                DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 258 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           F++ + +G G +G VY  R  ++  + A+KV+  +  ++ +++ ++     ++ +  H N
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM---LKKYSHHRN 82
Query: 78  ILRLYGYFYDQK------RVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARAL 129
           I   YG F  +       +++L++E+   G +   ++  K     E   A     + R L
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPPEMVE 186
            + H   VIHRDIK +N+L+    E+K+ DFG S     T  RR T  GT  ++ PE++ 
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 187 SVE-----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
             E     +D   D+WSLG+   E   G PP       D +       +   P P + S 
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPL-----CDMHPMRALFLIPRNPAPRLKSK 257
Query: 242 A-----KDLISQMLVKDSSQRLPLHKLLEHPWI 269
                 +  I   LVK+ SQR    +L++HP+I
Sbjct: 258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 27/277 (9%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G F +V L       H  ALK +   + QQ + E Q  RE ++     HPNILRL  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQ--READMHRLFNHPNILRLVA 93
Query: 84  YFYDQK----RVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARALIYCHGK 135
           Y   ++      +L+L +  +G L+ E+++ K    + +E +    +  + R L   H K
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 136 HVIHRDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTMC--------GTLDYLPPE 183
              HRD+KP N+L+G +G+  + D G      +H    R+ +          T+ Y  PE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 184 MVESVEH---DANVDIWSLGVLCYEFLYGVPPFEAK-EHSDTYRRIVQVDLKFPPKPIVS 239
           +     H   D   D+WSLG + Y  ++G  P++   +  D+    VQ  L  P  P  S
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS 273
Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           SA   L++ M+  D  QR  +  LL     +Q   P 
Sbjct: 274 SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 135/283 (47%), Gaps = 48/283 (16%)
Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L        Q   + RREVE
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 69  IQSHLRH---PNILRL---YGYFYDQKRVYLI-LEYAAKGELYKELQK--CKYFSERRAA 119
           +  H R    P+I+R+   Y   Y  ++  LI +E    GEL+  +Q    + F+ER A+
Sbjct: 63  L--HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTFNRRRTMCGT 176
             + S+  A+ Y H  ++ HRD+KPENLL  ++     LK+ DFG++  T   +      
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK------ 174
Query: 177 LDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE------HSDTYRRIVQVDL 230
                        +D + D+WSLGV+ Y  L G PPF +           T  R+ Q + 
Sbjct: 175 -------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221
Query: 231 KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
             P    VS   K LI  +L  + +QR+ + + + HPWI+Q+ 
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 114
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 274 DP 275
            P
Sbjct: 295 KP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQ 113
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 234 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293
Query: 274 DP 275
            P
Sbjct: 294 KP 295

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 129/256 (50%), Gaps = 20/256 (7%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G  G VY A +  +   VA++ +    LQQ   +  +  E+ +    ++PNI+    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 84  YFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            +     +++++EY A G L   + + C    E + A       +AL + H   VIHRDI
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 143 KPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K +N+L+G  G +K+ DFG+        ++R  M GT  ++ PE+V    +   VDIWSL
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQV------DLKFPPKPIVSSAAKDLISQMLVKD 253
           G++  E + G PP+    + +  R +  +      +L+ P K  +S+  +D +++ L  D
Sbjct: 203 GIMAIEMIEGEPPY---LNENPLRALYLIATNGTPELQNPEK--LSAIFRDFLNRCLDMD 257
Query: 254 SSQRLPLHKLLEHPWI 269
             +R    +LL+H ++
Sbjct: 258 VEKRGSAKELLQHQFL 273

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+          Q  K F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKDFMDASALTGIPLPLIKSYLFQ 111
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KPENLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 274 DP 275
            P
Sbjct: 292 KP 293

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDY 179
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE---VVTLWY 169
Query: 180 LPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP 233
             PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P
Sbjct: 170 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 234 ------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       PK          P +    + L+SQML  D ++R+     L HP+   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 272 NADP 275
              P
Sbjct: 290 VTKP 293

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 67
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 119
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDY 179
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y
Sbjct: 120 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWY 176
Query: 180 LPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP 233
             PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P
Sbjct: 177 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 236
Query: 234 ------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       PK          P +    + L+SQML  D ++R+     L HP+   
Sbjct: 237 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296
Query: 272 NADP 275
              P
Sbjct: 297 VTKP 300

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 47/294 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 49  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 104
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 162
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 222
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 281
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                                DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 282 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 129/255 (50%), Gaps = 18/255 (7%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G  G VY A +  +   VA++   +  LQQ   +  +  E+ +    ++PNI+    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
            +     +++++EY A G L   + +     E + A       +AL + H   VIHR+IK
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRNIK 144
Query: 144 PENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG 200
            +N+L+G  G +K+ DFG+        ++R TM GT  ++ PE+V    +   VDIWSLG
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 204
Query: 201 VLCYEFLYGVPPFEAKEHSDTYRRIVQV------DLKFPPKPIVSSAAKDLISQMLVKDS 254
           ++  E + G PP+    + +  R +  +      +L+ P K  +S+  +D +++ L  D 
Sbjct: 205 IMAIEMIEGEPPY---LNENPLRALYLIATNGTPELQNPEK--LSAIFRDFLNRCLEMDV 259
Query: 255 SQRLPLHKLLEHPWI 269
            +R    +L++H ++
Sbjct: 260 EKRGSAKELIQHQFL 274

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 64
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 116
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDY 179
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y
Sbjct: 117 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWY 173
Query: 180 LPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP 233
             PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 233
Query: 234 ------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       PK          P +    + L+SQML  D ++R+     L HP+   
Sbjct: 234 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293
Query: 272 NADP 275
              P
Sbjct: 294 VTKP 297

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 137/302 (45%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L  +L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KPENLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 233 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 274 DP 275
            P
Sbjct: 293 KP 294

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 47/294 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 35  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 90
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 267
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                                DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 268 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 47/294 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 48  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 103
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 104 GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 161
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 162 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 221
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 222 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 280
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                                DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 281 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 67
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 119
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDY 179
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y
Sbjct: 120 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWY 176
Query: 180 LPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP 233
             PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P
Sbjct: 177 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 236
Query: 234 ------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       PK          P +    + L+SQML  D ++R+     L HP+   
Sbjct: 237 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296
Query: 272 NADP 275
              P
Sbjct: 297 VTKP 300

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 47/294 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 25  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 80
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 257
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                                DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 258 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 47/294 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 261
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                                DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 262 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 138/301 (45%), Gaps = 49/301 (16%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPP 182
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  P
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 171
Query: 183 EMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP--- 233
           E++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P   
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 234 ---------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
                    PK          P +    + L+SQML  D ++R+     L HP+      
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
Query: 275 P 275
           P
Sbjct: 292 P 292

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 137/302 (45%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+     L  +L+K   F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKK---FMDASALTGIPLPLIKSYLFQ 114
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KPENLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 274 DP 275
            P
Sbjct: 295 KP 296

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 138/301 (45%), Gaps = 49/301 (16%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPP 182
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  P
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 171
Query: 183 EMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP--- 233
           E++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P   
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 234 ---------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
                    PK          P +    + L+SQML  D ++R+     L HP+      
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
Query: 275 P 275
           P
Sbjct: 292 P 292

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 138/301 (45%), Gaps = 49/301 (16%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 113
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPP 182
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  P
Sbjct: 114 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 173
Query: 183 EMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP--- 233
           E++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P   
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 233
Query: 234 ---------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
                    PK          P +    + L+SQML  D ++R+     L HP+      
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293
Query: 275 P 275
           P
Sbjct: 294 P 294

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 47/294 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 39  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 94
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 95  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 152
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 153 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 212
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 213 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 271
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                                DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 272 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 325

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDY 179
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y
Sbjct: 113 LQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWY 169
Query: 180 LPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP 233
             PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 234 ------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       PK          P +    + L+SQML  D ++R+     L HP+   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 272 NADP 275
              P
Sbjct: 290 VTKP 293

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 128/292 (43%), Gaps = 43/292 (14%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSHLRHPNIL 79
           +P+G G +G V  A + R    VA+K L  S+  QS + H  R  RE+ +  HL+H N++
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKL--SRPFQSLI-HARRTYRELRLLKHLKHENVI 82
Query: 80  RLYGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F       D   VYL+      G     + KC+  S+      V  L R L Y H
Sbjct: 83  GLLDVFTPATSIEDFSEVYLVT--TLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP N+ +    EL+I DFG +            T  Y  PE M+  + ++ 
Sbjct: 141 SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQ 200
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--------------------DLKF 232
            VDIWS+G +  E L G   F   ++ D  +RI++V                        
Sbjct: 201 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSL 260
Query: 233 PPKP------IVSSA---AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           PP P      I   A   A DL+ +MLV DS QR+   + L H +  Q  DP
Sbjct: 261 PPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 312

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 56/290 (19%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ------LRREVEIQSHLRHPN 77
           LG G +  VY  + K ++++VALK        + ++EH+        REV +   L+H N
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALK--------EIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKH 136
           I+ L+   + +K + L+ EY  K +L + L  C    +      ++  L R L YCH + 
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPE-MVESVE 189
           V+HRD+KP+NLLI  +GELK+ADFG +        T++       TL Y PP+ ++ S +
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---TLWYRPPDILLGSTD 177
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP---------------- 233
           +   +D+W +G + YE   G P F      +    I ++ L  P                
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI-LGTPTEETWPGILSNEEFKT 236
Query: 234 ---PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII 270
              PK          P + S   DL++++L  +   R+     ++HP+ +
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 135/295 (45%), Gaps = 55/295 (18%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L HPNI++L  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASLARALIYCHG 134
             + + ++YL+ E+     L+++L+K   F +  A T         Y+  L + L +CH 
Sbjct: 69  VIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
             V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y  PE++   
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEILLGC 177
Query: 189 E-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP--------- 233
           + +   VDIWSLG +  E +     F      D   RI +      ++ +P         
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 234 ---PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
              PK          P +    + L+SQML  D ++R+     L HP+      P
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 129/256 (50%), Gaps = 20/256 (7%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G+G  G VY A +  +   VA++   +  LQQ   +  +  E+ +    ++PNI+    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 84  YFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
            +     +++++EY A G L   + + C    E + A       +AL + H   VIHRDI
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHRDI 143
Query: 143 KPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
           K +N+L+G  G +K+ DFG+        ++R  M GT  ++ PE+V    +   VDIWSL
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSL 203
Query: 200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQV------DLKFPPKPIVSSAAKDLISQMLVKD 253
           G++  E + G PP+    + +  R +  +      +L+ P K  +S+  +D +++ L  D
Sbjct: 204 GIMAIEMIEGEPPY---LNENPLRALYLIATNGTPELQNPEK--LSAIFRDFLNRCLEMD 258
Query: 254 SSQRLPLHKLLEHPWI 269
             +R    +L++H ++
Sbjct: 259 VEKRGSAKELIQHQFL 274

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 134/302 (44%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+          Q  K F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 274 DP 275
            P
Sbjct: 295 KP 296

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 130/294 (44%), Gaps = 47/294 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 25  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 80
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC   ++      +  + R L Y H
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH 138
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 257
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                                DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 258 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 134/304 (44%), Gaps = 55/304 (18%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+          Q  K F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVH--------QDLKTFMDASALTGIPLPLIKSYLFQL 111
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDY 179
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWY 168
Query: 180 LPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP 233
             PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 234 ------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       PK          P +    + L+SQML  D ++R+     L HP+   
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 272 NADP 275
              P
Sbjct: 289 VTKP 292

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 133/254 (52%), Gaps = 12/254 (4%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE---VEIQ 70
           T+NDF + + +GRG FG VY  R+  +  + A+K L K +++  Q E     E   + + 
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           S    P I+ +   F+   ++  IL+    G+L+  L +   FSE     Y A +   L 
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR--TMCGTLDYLPPEMVE-S 187
           + H + V++RD+KP N+L+   G ++I+D G +   F++++     GT  Y+ PE+++  
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPF---EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
           V +D++ D +SLG + ++ L G  PF   + K+  +  R  + + ++ P     S   + 
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPELRS 423
Query: 245 LISQMLVKDSSQRL 258
           L+  +L +D ++RL
Sbjct: 424 LLEGLLQRDVNRRL 437

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 133/254 (52%), Gaps = 12/254 (4%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE---VEIQ 70
           T+NDF + + +GRG FG VY  R+  +  + A+K L K +++  Q E     E   + + 
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 245
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           S    P I+ +   F+   ++  IL+    G+L+  L +   FSE     Y A +   L 
Sbjct: 246 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 305
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR--TMCGTLDYLPPEMVE-S 187
           + H + V++RD+KP N+L+   G ++I+D G +   F++++     GT  Y+ PE+++  
Sbjct: 306 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKG 364
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPF---EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
           V +D++ D +SLG + ++ L G  PF   + K+  +  R  + + ++ P     S   + 
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPELRS 422
Query: 245 LISQMLVKDSSQRL 258
           L+  +L +D ++RL
Sbjct: 423 LLEGLLQRDVNRRL 436

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 133/254 (52%), Gaps = 12/254 (4%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE---VEIQ 70
           T+NDF + + +GRG FG VY  R+  +  + A+K L K +++  Q E     E   + + 
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           S    P I+ +   F+   ++  IL+    G+L+  L +   FSE     Y A +   L 
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR--TMCGTLDYLPPEMVE-S 187
           + H + V++RD+KP N+L+   G ++I+D G +   F++++     GT  Y+ PE+++  
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPF---EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
           V +D++ D +SLG + ++ L G  PF   + K+  +  R  + + ++ P     S   + 
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPELRS 423
Query: 245 LISQMLVKDSSQRL 258
           L+  +L +D ++RL
Sbjct: 424 LLEGLLQRDVNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 133/254 (52%), Gaps = 12/254 (4%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE---VEIQ 70
           T+NDF + + +GRG FG VY  R+  +  + A+K L K +++  Q E     E   + + 
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           S    P I+ +   F+   ++  IL+    G+L+  L +   FSE     Y A +   L 
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR--TMCGTLDYLPPEMVE-S 187
           + H + V++RD+KP N+L+   G ++I+D G +   F++++     GT  Y+ PE+++  
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPF---EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
           V +D++ D +SLG + ++ L G  PF   + K+  +  R  + + ++ P     S   + 
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPELRS 423
Query: 245 LISQMLVKDSSQRL 258
           L+  +L +D ++RL
Sbjct: 424 LLEGLLQRDVNRRL 437

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 134/302 (44%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+          Q  K F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVD--------QDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 274 DP 275
            P
Sbjct: 295 KP 296

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 138/299 (46%), Gaps = 48/299 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V+    K S  ++A K++    L+ +  + +Q+ RE+++     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHECN 124
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y   
Sbjct: 125 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +  
Sbjct: 185 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 244
Query: 193 NVDIWSLGVLCYEFLYG---VPPFEAKEHSDTYRRIVQ---------------------V 228
             DIWS+G+   E   G   +PP +AKE    +   V+                     +
Sbjct: 245 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 304
Query: 229 DLKFP-------------PKPIVSSAA-----KDLISQMLVKDSSQRLPLHKLLEHPWI 269
           D + P             P P + SA      +D +++ L+K+ ++R  L +L+ H +I
Sbjct: 305 DSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 363

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 9/217 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V   + + S  I+A K++    L+ +  + +Q+ RE+++     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLI---HLEIKPAIRNQIIRELQVLHECN 72
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L++ K   E        ++ R L Y   
Sbjct: 73  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 132
Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +  
Sbjct: 133 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTHYSV 192
Query: 193 NVDIWSLGVLCYEFLYG---VPPFEAKEHSDTYRRIV 226
             DIWS+G+   E   G   +PP +AKE    + R V
Sbjct: 193 QSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPV 229

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 137/299 (45%), Gaps = 48/299 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V+    K S  ++A K++    L+ +  + +Q+ RE+++     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHECN 89
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y   
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +  
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 209
Query: 193 NVDIWSLGVLCYEFLYG---VPPFEAKEHSDTYRRIVQVDL---------------KF-- 232
             DIWS+G+   E   G   +PP +AKE    +   V+ D                KF  
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269
Query: 233 -------------------PPK---PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                              PPK    + S   +D +++ L+K+ ++R  L +L+ H +I
Sbjct: 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 138/304 (45%), Gaps = 55/304 (18%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VAL  + +   +   V     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDY 179
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWY 169
Query: 180 LPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP 233
             PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 234 ------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       PK          P +    + L+SQML  D ++R+     L HP+   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 272 NADP 275
              P
Sbjct: 290 VTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 138/304 (45%), Gaps = 55/304 (18%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VAL  + +   +   V     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVASL 125
           HPNI++L    + + ++YL+ E+     L+++L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDY 179
            + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +      V T+        TL Y
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWY 168
Query: 180 LPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP 233
             PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 234 ------------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       PK          P +    + L+SQML  D ++R+     L HP+   
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 272 NADP 275
              P
Sbjct: 289 VTKP 292

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 134/302 (44%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+ +           K F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLS--------MDLKDFMDASALTGIPLPLIKSYLFQ 114
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 274 DP 275
            P
Sbjct: 295 KP 296

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 134/302 (44%), Gaps = 49/302 (16%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++ +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---------YVAS 124
            HPNI++L    + + ++YL+ E+ +           K F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLS--------MDLKDFMDASALTGIPLPLIKSYLFQ 113
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLP 181
           L + L +CH   V+HRD+KP+NLLI  +G +K+ADFG +       RT      TL Y  
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 182 PEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----DLKFP-- 233
           PE++   + +   VDIWSLG +  E +     F      D   RI +      ++ +P  
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 234 ----------PK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                     PK          P +    + L+SQML  D ++R+     L HP+     
Sbjct: 234 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293
Query: 274 DP 275
            P
Sbjct: 294 KP 295

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 47/293 (16%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  + + +S   +A+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 58  PVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 113
Query: 80  RLYGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F       +   VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 114 GLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 171
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 172 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNM 231
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA----------- 241
            VDIWS+G +  E L G   F   +H +  ++I+++    PP  ++S             
Sbjct: 232 TVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRL-TGTPPASVISRMPSHEARNYINS 290
Query: 242 -------------------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
                              A DL+ +MLV D+ +R+   + L HP+  Q  DP
Sbjct: 291 LPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDP 343

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 6/259 (2%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           + +G G FG VY AR+ R++ +VA+K +  S  Q ++    + +EV     LRHPN ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 82  YGYFYDQKRVYLILEYA-AKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
            G +  +   +L++EY         E+ K K   E   A       + L Y H  ++IHR
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE---HDANVDIW 197
           D+K  N+L+   G +K+ DFG S           GT  ++ PE++ +++   +D  VD+W
Sbjct: 179 DVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVW 237
Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
           SLG+ C E     PP            I Q +         S   ++ +   L K    R
Sbjct: 238 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 297
Query: 258 LPLHKLLEHPWIIQNADPS 276
                LL+H ++++   P+
Sbjct: 298 PTSEVLLKHRFVLRERPPT 316

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 120/261 (45%), Gaps = 6/261 (2%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           + +G G FG VY AR+ R++ +VA+K +  S  Q ++    + +EV     LRHPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 82  YGYFYDQKRVYLILEYA-AKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHR 140
            G +  +   +L++EY         E+ K K   E   A       + L Y H  ++IHR
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE---HDANVDIW 197
           D+K  N+L+   G +K+ DFG S           GT  ++ PE++ +++   +D  VD+W
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVW 198
Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQR 257
           SLG+ C E     PP            I Q +         S   ++ +   L K    R
Sbjct: 199 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
Query: 258 LPLHKLLEHPWIIQNADPSGV 278
                LL+H ++++   P+ +
Sbjct: 259 PTSEVLLKHRFVLRERPPTVI 279

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 9/208 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V+    K S  ++A K++    L+ +  + +Q+ RE+++     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHECN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y   
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 193 NVDIWSLGVLCYEFLYG---VPPFEAKE 217
             DIWS+G+   E   G   +PP +AKE
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+ ++ ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNAMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 9/208 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V+    K S  ++A K++    L+ +  + +Q+ RE+++     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHECN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y   
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 193 NVDIWSLGVLCYEFLYG---VPPFEAKE 217
             DIWS+G+   E   G   +PP +AKE
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 133/285 (46%), Gaps = 35/285 (12%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G V+ A+ + ++ IVALK + +       V     RE+ +   L+H NI+RL+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVIHRDI 142
             +  K++ L+ E+  + +L K    C          +++  L + L +CH ++V+HRD+
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 143 KPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---TLDYLPPEMVESVE-HDANVDIWS 198
           KP+NLLI   GELK+ADFG +       R       TL Y PP+++   + +  ++D+WS
Sbjct: 128 KPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 199 LGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV----------------DLKFPPK------ 235
            G +  E      P F   +  D  +RI ++                D K  P       
Sbjct: 188 AGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247
Query: 236 -----PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
                P +++  +DL+  +L  +  QR+   + L+HP+      P
Sbjct: 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 9/208 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V+    K S  ++A K++    L+ +  + +Q+ RE+++     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHECN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y   
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 193 NVDIWSLGVLCYEFLYG---VPPFEAKE 217
             DIWS+G+   E   G   +PP +AKE
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 9/208 (4%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLR 74
           +DF+    LG G  G V+    K S  ++A K++    L+ +  + +Q+ RE+++     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHECN 62
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
            P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y   
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 193 NVDIWSLGVLCYEFLYG---VPPFEAKE 217
             DIWS+G+   E   G   +PP +AKE
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 126/289 (43%), Gaps = 39/289 (13%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLY 82
           P+G G +G V  A + ++   VA+K L K   Q      +  RE+ +  H++H N++ L 
Sbjct: 41  PVGSGAYGSVCAAFDTKTGLRVAVKKLSKP-FQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 83  GYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
             F   +       VYL+      G     + KC+  ++      +  + R L Y H   
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDANVD 195
           +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++  VD
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVD 217
Query: 196 IWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DLKFP 233
           IWS+G +  E L G   F   +H D  + I+++                       L   
Sbjct: 218 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 277
Query: 234 PKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP
Sbjct: 278 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 326

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 35/285 (12%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G V+ A+ + ++ IVALK + +       V     RE+ +   L+H NI+RL+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVIHRDI 142
             +  K++ L+ E+  + +L K    C          +++  L + L +CH ++V+HRD+
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 143 KPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---TLDYLPPEMVESVE-HDANVDIWS 198
           KP+NLLI   GELK+A+FG +       R       TL Y PP+++   + +  ++D+WS
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 199 LGVLCYEFL-YGVPPFEAKEHSDTYRRIVQV----------------DLKFPPK------ 235
            G +  E    G P F   +  D  +RI ++                D K  P       
Sbjct: 188 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247
Query: 236 -----PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
                P +++  +DL+  +L  +  QR+   + L+HP+      P
Sbjct: 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 45/292 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 35  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 90
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 149 SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 268
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP
Sbjct: 269 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 320

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 45/292 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 31  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 86
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 144
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 145 SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 264
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP
Sbjct: 265 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 316

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 36  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 91
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 127/292 (43%), Gaps = 43/292 (14%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSHLRHPNIL 79
           +P+G G +G V  A + R    VA+K L  S+  QS + H  R  RE+ +  HL+H N++
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKL--SRPFQSLI-HARRTYRELRLLKHLKHENVI 90
Query: 80  RLYGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F       D   VYL+      G     + K +  S+      V  L R L Y H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVT--TLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP N+ +    EL+I DFG +            T  Y  PE M+  + ++ 
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--------------------DLKF 232
            VDIWS+G +  E L G   F   ++ D  +RI++V                        
Sbjct: 209 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSL 268
Query: 233 PPKP------IVSSA---AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           PP P      I   A   A DL+ +MLV DS QR+   + L H +  Q  DP
Sbjct: 269 PPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 320

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 36  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 91
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 45/292 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 36  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 91
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP
Sbjct: 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 34  PIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 89
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 147
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 148 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 267
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 268 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 130/294 (44%), Gaps = 47/294 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 40  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 95
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 96  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 153
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 154 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 213
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 214 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 272
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                                DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 273 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 40  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 95
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 96  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 153
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 154 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 213
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 214 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 273
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 274 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 49  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 104
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 162
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 222
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 282
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 283 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 130/293 (44%), Gaps = 47/293 (16%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 41  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 96
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 154
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 214
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 215 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 273
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
                                DL+ +MLV DS +R+   + L H +  Q  DP
Sbjct: 274 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 326

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 130/293 (44%), Gaps = 47/293 (16%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 41  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 96
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 154
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 214
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAAK----- 243
            VDIWS+G +  E L G   F   +H D  + I+++ +  P     K I S +A+     
Sbjct: 215 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQS 273
Query: 244 ---------------------DLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
                                DL+ +MLV DS +R+   + L H +  Q  DP
Sbjct: 274 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 326

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 34  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 89
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 147
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 148 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 267
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 268 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 45/292 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 52  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 107
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 108 GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 165
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 166 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATRWYRAPEIMLNWMHYNQ 225
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 226 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 285
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP
Sbjct: 286 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 337

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 36  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 91
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 34  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 89
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 147
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 148 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 267
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 268 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 31  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 86
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 144
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 264
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 265 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 35  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 90
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 268
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 269 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++ H VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DF  + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 26  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 81
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 82  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 139
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 140 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 199
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 200 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 259
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 260 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 48  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 103
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 104 GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 161
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 162 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 221
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 222 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 281
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 282 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 34  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 89
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 147
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 148 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 267
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 268 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 28  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 83
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 84  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 141
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 142 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 201
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 202 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 261
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 262 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 314

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 52  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 107
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 108 GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 165
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 166 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 225
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 226 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 285
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 286 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 31  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 86
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 144
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 264
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 265 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 26  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 81
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 82  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 139
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 140 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 199
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 200 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 259
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 260 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 27  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 82
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 83  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 140
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 141 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 200
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 201 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 260
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 261 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 313

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 80
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 259 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 35  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 90
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 268
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 269 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 31  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 86
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 144
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 264
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 265 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D +I + +G G FG V+ A    S+  VA+K+L +      +V ++  REV I   LRHP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERV-NEFLREVAIMKRLRHP 94
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKC---KYFSERRAATYVASLARALIYCH 133
           NI+   G       + ++ EY ++G LY+ L K    +   ERR  +    +A+ + Y H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 134 GKH--VIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESV 188
            ++  ++HR++K  NLL+  +  +K+ DFG S     TF   ++  GT +++ PE++   
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 189 EHDANVDIWSLGVLCYEF 206
             +   D++S GV+ +E 
Sbjct: 215 PSNEKSDVYSFGVILWEL 232

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 125/285 (43%), Gaps = 41/285 (14%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           +P+G G +G V  A + R+   VA+K L++   Q      +  RE+ +  H+RH N++ L
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F       D    YL++ +   G    +L K +   E R    V  + + L Y H  
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES-VEHDANV 194
            +IHRD+KP NL +    ELKI DFG +    +       T  Y  PE++ + + +   V
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWMRYTQTV 207
Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV---------------- 238
           DIWS+G +  E + G   F+  +H D  + I++V    PP   V                
Sbjct: 208 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV-TGTPPAEFVQRLQSDEAKNYMKGLP 266
Query: 239 --------------SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                         S  A +L+ +MLV D+ QR+   + L HP+ 
Sbjct: 267 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 130/293 (44%), Gaps = 55/293 (18%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           IGK +G G +G V+  R + +  IVA+K   +S+     ++    RE+ +   L+HPN++
Sbjct: 8   IGK-IGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLV 65
Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIH 139
            L   F  ++R++L+ EY     L++  +  +   E    +      +A+ +CH  + IH
Sbjct: 66  NLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIH 125
Query: 140 RDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL-----------PPEMVESV 188
           RD+KPEN+LI     +K+ DFG++       R + G  DY            P  +V   
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFA-------RLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ--------------------- 227
           ++   VD+W++G +  E L GVP +  K   D    I +                     
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 228 -----------VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                      ++LKFP    +S  A  L+   L  D ++RL   +LL HP+ 
Sbjct: 239 VKIPDPEDMEPLELKFPN---ISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 135/288 (46%), Gaps = 43/288 (14%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G VY A++ +   IVALK + +   +   +     RE+ +   L HPNI+ L  
Sbjct: 29  VGEGTYGVVYKAKDSQG-RIVALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVIHRDI 142
             + ++ + L+ E+  K +L K L + K    + +   Y+  L R + +CH   ++HRD+
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDL 145
Query: 143 KPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPE-MVESVEHDANVD 195
           KP+NLLI + G LK+ADFG +      V ++        TL Y  P+ ++ S ++  +VD
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV---TLWYRAPDVLMGSKKYSTSVD 202
Query: 196 IWSLGVLCYEFLYGVPPFEAKEHSDTY-------------------------RRIVQVDL 230
           IWS+G +  E + G P F      D                           +R  QV  
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFE 262
Query: 231 KFPPKPIVSSAAK---DLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           K P   I+    +   DL+S ML  D ++R+     + HP+  ++ DP
Sbjct: 263 KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY-FKDLDP 309

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 135/288 (46%), Gaps = 43/288 (14%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G VY A++ +   IVALK + +   +   +     RE+ +   L HPNI+ L  
Sbjct: 29  VGEGTYGVVYKAKDSQG-RIVALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVIHRDI 142
             + ++ + L+ E+  K +L K L + K    + +   Y+  L R + +CH   ++HRD+
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDL 145
Query: 143 KPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPE-MVESVEHDANVD 195
           KP+NLLI + G LK+ADFG +      V ++        TL Y  P+ ++ S ++  +VD
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV---TLWYRAPDVLMGSKKYSTSVD 202
Query: 196 IWSLGVLCYEFLYGVPPFEAKEHSDTY-------------------------RRIVQVDL 230
           IWS+G +  E + G P F      D                           +R  QV  
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFE 262
Query: 231 KFPPKPIVSSAAK---DLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           K P   I+    +   DL+S ML  D ++R+     + HP+  ++ DP
Sbjct: 263 KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY-FKDLDP 309

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI D+G + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D +I + +G G FG V+ A    S+  VA+K+L +      +V ++  REV I   LRHP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERV-NEFLREVAIMKRLRHP 94
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKC---KYFSERRAATYVASLARALIYCH 133
           NI+   G       + ++ EY ++G LY+ L K    +   ERR  +    +A+ + Y H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 134 GKH--VIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESV 188
            ++  ++HRD+K  NLL+  +  +K+ DFG S      F   +   GT +++ PE++   
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 189 EHDANVDIWSLGVLCYEF 206
             +   D++S GV+ +E 
Sbjct: 215 PSNEKSDVYSFGVILWEL 232

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 127/290 (43%), Gaps = 44/290 (15%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G V  A +KRS   VA+K L +   Q      +  RE+ +  H++H N++ L  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQHENVIGLLD 108
Query: 84  YFYDQKRV------YLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGK 135
            F     +      YL++ +     +  +LQK     FSE +    V  + + L Y H  
Sbjct: 109 VFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA 163
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEH-DANV 194
            V+HRD+KP NL +    ELKI DFG + H          T  Y  PE++ S  H +  V
Sbjct: 164 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTV 223
Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DLKF 232
           DIWS+G +  E L G   F+ K++ D   +I++V                       L  
Sbjct: 224 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ 283
Query: 233 PPK-------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
            P+       P  S  A DL+ +ML  D  +RL   + L HP+     DP
Sbjct: 284 TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 127/290 (43%), Gaps = 44/290 (15%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G V  A +KRS   VA+K L +   Q      +  RE+ +  H++H N++ L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 84  YFYDQKRV------YLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGK 135
            F     +      YL++ +     +  +LQK     FSE +    V  + + L Y H  
Sbjct: 91  VFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEH-DANV 194
            V+HRD+KP NL +    ELKI DFG + H          T  Y  PE++ S  H +  V
Sbjct: 146 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTV 205
Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DLKF 232
           DIWS+G +  E L G   F+ K++ D   +I++V                       L  
Sbjct: 206 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ 265
Query: 233 PPK-------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
            P+       P  S  A DL+ +ML  D  +RL   + L HP+     DP
Sbjct: 266 TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI  FG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           +ND +    +G G  G V+  R +++ H++A+K + +S  ++      +  +V ++SH  
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-D 82
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKG--ELYKELQKCKYFSERRAATYVASLARALIYC 132
            P I++ +G F     V++ +E       +L K +Q      ER       ++ +AL Y 
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYL 140
Query: 133 HGKH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT--MCGTLDYLPPEMVE--- 186
             KH VIHRD+KP N+L+  +G++K+ DFG S    + +      G   Y+ PE ++   
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 187 --SVEHDANVDIWSLGVLCYEFLYGVPPFE-AKEHSDTYRRIVQVDLKFPPKPI-VSSAA 242
               ++D   D+WSLG+   E   G  P++  K   +   +++Q +    P  +  S   
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF 260
Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +  +   L KD  +R   +KLLEH +I
Sbjct: 261 QSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 116/260 (44%), Gaps = 12/260 (4%)
Query: 7   AKEKKRWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR 64
           A  K +W LN  D  +G+ +GRG FG V+  R +  N +VA+K   ++      ++ +  
Sbjct: 103 AVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFL 160
Query: 65  REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVA 123
           +E  I     HPNI+RL G    ++ +Y+++E    G+    L+ +      +     V 
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP-- 181
             A  + Y   K  IHRD+   N L+  +  LKI+DFG S    +      G L  +P  
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK 280
Query: 182 ---PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI 237
              PE +    + +  D+WS G+L +E F  G  P+    +  T R  V+   + P   +
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-REFVEKGGRLPCPEL 339
Query: 238 VSSAAKDLISQMLVKDSSQR 257
              A   L+ Q    +  QR
Sbjct: 340 CPDAVFRLMEQCWAYEPGQR 359

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI D G + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 116/260 (44%), Gaps = 12/260 (4%)
Query: 7   AKEKKRWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR 64
           A  K +W LN  D  +G+ +GRG FG V+  R +  N +VA+K   ++      ++ +  
Sbjct: 103 AVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFL 160
Query: 65  REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVA 123
           +E  I     HPNI+RL G    ++ +Y+++E    G+    L+ +      +     V 
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP-- 181
             A  + Y   K  IHRD+   N L+  +  LKI+DFG S    +      G L  +P  
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 182 ---PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI 237
              PE +    + +  D+WS G+L +E F  G  P+    +  T R  V+   + P   +
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-REFVEKGGRLPCPEL 339
Query: 238 VSSAAKDLISQMLVKDSSQR 257
              A   L+ Q    +  QR
Sbjct: 340 CPDAVFRLMEQCWAYEPGQR 359

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI D G + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + KC+  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI D G + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 129/286 (45%), Gaps = 39/286 (13%)
Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W++N  D+++ + +G G    V  A        VA+K +   + Q S  E  L +E++  
Sbjct: 10  WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE--LLKEIQAM 67
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELY--------KELQKCKYFSERRAATYV 122
           S   HPNI+  Y  F  +  ++L+++  + G +         K   K     E   AT +
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-------TFNR-RRTMC 174
             +   L Y H    IHRD+K  N+L+G  G ++IADFG S         T N+ R+T  
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  ++ PE++E V  +D   DIWS G+   E   G  P+    H     +++ + L+  
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY----HKYPPMKVLMLTLQND 243
Query: 234 PKPIVSSAAKD-------------LISQMLVKDSSQRLPLHKLLEH 266
           P P + +  +D             +IS  L KD  +R    +LL H
Sbjct: 244 P-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 126/292 (43%), Gaps = 45/292 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + K +  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG   HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 129/286 (45%), Gaps = 39/286 (13%)
Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W++N  D+++ + +G G    V  A        VA+K +   + Q S  E  L +E++  
Sbjct: 5   WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE--LLKEIQAM 62
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELY--------KELQKCKYFSERRAATYV 122
           S   HPNI+  Y  F  +  ++L+++  + G +         K   K     E   AT +
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-------TFNR-RRTMC 174
             +   L Y H    IHRD+K  N+L+G  G ++IADFG S         T N+ R+T  
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  ++ PE++E V  +D   DIWS G+   E   G  P+    H     +++ + L+  
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY----HKYPPMKVLMLTLQND 238
Query: 234 PKPIVSSAAKD-------------LISQMLVKDSSQRLPLHKLLEH 266
           P P + +  +D             +IS  L KD  +R    +LL H
Sbjct: 239 P-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 283

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 130/275 (47%), Gaps = 17/275 (6%)
Query: 15  LNDFDIGKPLGRGKFGHV--YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           +  + +G  LG G +G V   L  E      V +    K +   +  E  +++E+++   
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNG-EANVKKEIQLLRR 62
Query: 73  LRHPNILRLYGYFYDQ--KRVYLILEYAAKG--ELYKELQKCKYFSERRAATYVASLARA 128
           LRH N+++L    Y++  +++Y+++EY   G  E+   + + K F   +A  Y   L   
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDG 121
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW--SVHTF---NRRRTMCGTLDYLPPE 183
           L Y H + ++H+DIKP NLL+   G LKI+  G   ++H F   +  RT  G+  + PPE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 184 MVESVEHDAN--VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           +   ++  +   VDIWS GV  Y    G+ PFE       +  I +     P        
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD--CGPP 239
Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
             DL+  ML  + ++R  + ++ +H W  +   P+
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + K +  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 23  PLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           P+G G +G V  A + ++   VA+K L   F+S +   +      RE+ +  H++H N++
Sbjct: 29  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLKHMKHENVI 84
Query: 80  RLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            L   F   +       VYL+      G     + K +  ++      +  + R L Y H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH 142
Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEHDA 192
              +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + ++ 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------------DL 230
            VDIWS+G +  E L G   F   +H D  + I+++                       L
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 231 KFPPKPIVSSA-------AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              PK   ++        A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 17/217 (7%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G +G VY A +  +N  VA+K + + + ++  V     REV +   L+H NI+ L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
             +   R++LI EYA + +L K + K    S R   +++  L   + +CH +  +HRD+K
Sbjct: 101 VIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK 159
Query: 144 PENLLIGAQGE-----LKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESVEH-D 191
           P+NLL+          LKI DFG +      +  F        TL Y PPE++    H  
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE---IITLWYRPPEILLGSRHYS 216
Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV 228
            +VDIWS+  +  E L   P F      D   +I +V
Sbjct: 217 TSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 139/308 (45%), Gaps = 49/308 (15%)
Query: 7   AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ-------- 58
            KEK ++ +ND+ I + L +GKF  + L   ++ N   ALK   KS L++ +        
Sbjct: 23  VKEKDKY-INDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 59  ------VEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY 112
                      + E++I + +++   L   G   +   VY+I EY     + K   +  +
Sbjct: 80  KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK-FDEYFF 138
Query: 113 FSERRAATYV---------ASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGW 162
             ++    ++          S+  +  Y H  K++ HRD+KP N+L+   G +K++DFG 
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 163 SVHTFNRR-RTMCGTLDYLPPEMV--ESVEHDANVDIWSLGVLCYEFLYGVPPFEAK-EH 218
           S +  +++ +   GT +++PPE    ES  + A VDIWSLG+  Y   Y V PF  K   
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 219 SDTYRRIVQVDLKFP-----------------PKPIVSSAAKDLISQMLVKDSSQRLPLH 261
            + +  I   ++++P                     +S+   D +   L K+ ++R+   
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318
Query: 262 KLLEHPWI 269
             L+H W+
Sbjct: 319 DALKHEWL 326

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 131/257 (50%), Gaps = 17/257 (6%)
Query: 13  WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           W L DF +   LGRG FG V+  + K +  + A K L K +L++ +       E +I + 
Sbjct: 186 WFL-DFRV---LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGEL----YKELQKCKYFSERRAATYVASLARA 128
           +    I+ L   F  +  + L++     G++    Y   +    F E RA  Y A +   
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPPEMV 185
           L + H +++I+RD+KPEN+L+   G ++I+D G +V       + +   GT  ++ PE++
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAK----EHSDTYRRIVQVDLKFPPKPIVSSA 241
              E+D +VD ++LGV  YE +    PF A+    E+ +  +R+++  + +P K   S A
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPA 419
Query: 242 AKDLISQMLVKDSSQRL 258
           +KD    +L KD  +RL
Sbjct: 420 SKDFCEALLQKDPEKRL 436

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 131/257 (50%), Gaps = 17/257 (6%)
Query: 13  WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           W L DF +   LGRG FG V+  + K +  + A K L K +L++ +       E +I + 
Sbjct: 186 WFL-DFRV---LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGEL----YKELQKCKYFSERRAATYVASLARA 128
           +    I+ L   F  +  + L++     G++    Y   +    F E RA  Y A +   
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPPEMV 185
           L + H +++I+RD+KPEN+L+   G ++I+D G +V       + +   GT  ++ PE++
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAK----EHSDTYRRIVQVDLKFPPKPIVSSA 241
              E+D +VD ++LGV  YE +    PF A+    E+ +  +R+++  + +P K   S A
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPA 419
Query: 242 AKDLISQMLVKDSSQRL 258
           +KD    +L KD  +RL
Sbjct: 420 SKDFCEALLQKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 131/257 (50%), Gaps = 17/257 (6%)
Query: 13  WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           W L DF +   LGRG FG V+  + K +  + A K L K +L++ +       E +I + 
Sbjct: 186 WFL-DFRV---LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGEL----YKELQKCKYFSERRAATYVASLARA 128
           +    I+ L   F  +  + L++     G++    Y   +    F E RA  Y A +   
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPPEMV 185
           L + H +++I+RD+KPEN+L+   G ++I+D G +V       + +   GT  ++ PE++
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAK----EHSDTYRRIVQVDLKFPPKPIVSSA 241
              E+D +VD ++LGV  YE +    PF A+    E+ +  +R+++  + +P K   S A
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPA 419
Query: 242 AKDLISQMLVKDSSQRL 258
           +KD    +L KD  +RL
Sbjct: 420 SKDFCEALLQKDPEKRL 436

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 131/257 (50%), Gaps = 17/257 (6%)
Query: 13  WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           W L DF +   LGRG FG V+  + K +  + A K L K +L++ +       E +I + 
Sbjct: 186 WFL-DFRV---LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGEL----YKELQKCKYFSERRAATYVASLARA 128
           +    I+ L   F  +  + L++     G++    Y   +    F E RA  Y A +   
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPPEMV 185
           L + H +++I+RD+KPEN+L+   G ++I+D G +V       + +   GT  ++ PE++
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAK----EHSDTYRRIVQVDLKFPPKPIVSSA 241
              E+D +VD ++LGV  YE +    PF A+    E+ +  +R+++  + +P K   S A
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPA 419
Query: 242 AKDLISQMLVKDSSQRL 258
           +KD    +L KD  +RL
Sbjct: 420 SKDFCEALLQKDPEKRL 436

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 127/269 (47%), Gaps = 19/269 (7%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLR- 74
           ++ +G  LG+G FG V+          VA+KV+ +++ L  S +   +   +E+    + 
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 75  -----HPNILRLYGYFYDQKRVYLILEYAAKG-ELYKELQKCKYFSERRAATYVASLARA 128
                HP ++RL  +F  Q+   L+LE      +L+  + +     E  +  +   +  A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 129 LIYCHGKHVIHRDIKPENLLIGA-QGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVE 186
           + +CH + V+HRDIK EN+LI   +G  K+ DFG      +   T   GT  Y PPE + 
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWIS 211
Query: 187 SVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
             + H     +WSLG+L Y+ + G  PFE  +       I++ +L FP    VS     L
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPAH--VSPDCCAL 263
Query: 246 ISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           I + L    S R  L ++L  PW+   A+
Sbjct: 264 IRRCLAPKPSSRPSLEEILLDPWMQTPAE 292

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 118/252 (46%), Gaps = 15/252 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G +G VY  R+  +   +A+K + +   + SQ  H+   E+ +  HL+H NI++  G
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE---EIALHKHLKHKNIVQYLG 72
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYF----SERRAATYVASLARALIYCHGKHVIH 139
            F +   + + +E    G L   L + K+     +E+    Y   +   L Y H   ++H
Sbjct: 73  SFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 131
Query: 140 RDIKPENLLIGA-QGELKIADFGWS--VHTFNR-RRTMCGTLDYLPPEMVESVE--HDAN 193
           RDIK +N+LI    G LKI+DFG S  +   N    T  GTL Y+ PE+++     +   
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 191
Query: 194 VDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
            DIWSLG    E   G PPF E  E      ++    +       +S+ AK  I +    
Sbjct: 192 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 251
Query: 253 DSSQRLPLHKLL 264
           D  +R   + LL
Sbjct: 252 DPDKRACANDLL 263

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G +G VY  R+  +   +A+K + +   + SQ  H+   E+ +  HL+H NI++  G
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE---EIALHKHLKHKNIVQYLG 86
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYF----SERRAATYVASLARALIYCHGKHVIH 139
            F +   + + +E    G L   L + K+     +E+    Y   +   L Y H   ++H
Sbjct: 87  SFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 140 RDIKPENLLIGA-QGELKIADFGWS--VHTFNR-RRTMCGTLDYLPPEMVESVE--HDAN 193
           RDIK +N+LI    G LKI+DFG S  +   N    T  GTL Y+ PE+++     +   
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 194 VDIWSLGVLCYEFLYGVPPF 213
            DIWSLG    E   G PPF
Sbjct: 206 ADIWSLGCTIIEMATGKPPF 225

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/315 (26%), Positives = 138/315 (43%), Gaps = 53/315 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +DF +   LG G +G V  A  K +  IVA+K +      +     +  RE++I  H +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKH 68
Query: 76  PNILRLYGY-----FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
            NI+ ++       F +   VY+I E   + +L++ +   +  S+     ++    RA+ 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIS-TQMLSDDHIQYFIYQTLRAVK 126
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-----VHTFNRRRT--MCGTLDYL--- 180
             HG +VIHRD+KP NLLI +  +LK+ DFG +         N   T    G  +Y+   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 181 ----PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE---------------HSDT 221
               P  M+ S ++   +D+WS G +  E     P F  ++               HSD 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 222 YRRIVQVDLK---------FPPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
             R ++             +P  P+      V+    DL+ +MLV D ++R+   + LEH
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 267 PWIIQNADPSGVYRG 281
           P++    DP+    G
Sbjct: 307 PYLQTYHDPNDEPEG 321

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 23  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 80
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L KC++ S      ++  + R
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKCQHLSNDHICYFLYQILR 139
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 272 NADPS 276
             DPS
Sbjct: 320 YYDPS 324

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 139/315 (44%), Gaps = 53/315 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +DF +   LG G +G V  A  K +  IVA+K +      +     +  RE++I  H +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKH 68
Query: 76  PNILRLYGY-----FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
            NI+ ++       F +   VY+I E   + +L++ +   +  S+     ++    RA+ 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIS-TQMLSDDHIQYFIYQTLRAVK 126
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-----VHTFNRRRT--MCGTLDYL--- 180
             HG +VIHRD+KP NLLI +  +LK+ DFG +         N   T    G ++++   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 181 ----PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE---------------HSDT 221
               P  M+ S ++   +D+WS G +  E     P F  ++               HSD 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 222 YRRIVQVDLK---------FPPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
             R ++             +P  P+      V+    DL+ +MLV D ++R+   + LEH
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 267 PWIIQNADPSGVYRG 281
           P++    DP+    G
Sbjct: 307 PYLQTYHDPNDEPEG 321

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 29/263 (11%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           + ++ + +GRG FG V  A+ +  +  VA+K     Q++          E+   S + HP
Sbjct: 10  EIEVEEVVGRGAFGVVCKAKWRAKD--VAIK-----QIESESERKAFIVELRQLSRVNHP 62
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK---YFSERRAATYVASLARALIYCH 133
           NI++LYG   +   V L++EYA  G LY  L   +   Y++   A ++    ++ + Y H
Sbjct: 63  NIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 134 G---KHVIHRDIKPENLLIGAQGE-LKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE 189
               K +IHRD+KP NLL+ A G  LKI DFG +           G+  ++ PE+ E   
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSN 180
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD-------LKFPPKPIVSSAA 242
           +    D++S G++ +E +    PF+ +     +R +  V        +K  PKPI S   
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHNGTRPPLIKNLPKPIES--- 236
Query: 243 KDLISQMLVKDSSQRLPLHKLLE 265
             L+++   KD SQR  + ++++
Sbjct: 237 --LMTRCWSKDPSQRPSMEEIVK 257

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 137/315 (43%), Gaps = 53/315 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +DF +   LG G +G V  A  K +  IVA+K +      +     +  RE++I  H +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKH 68
Query: 76  PNILRLYGY-----FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
            NI+ ++       F +   VY+I E   + +L++ +   +  S+     ++    RA+ 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIS-TQMLSDDHIQYFIYQTLRAVK 126
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-----VHTFNRRRT--------MCGTL 177
             HG +VIHRD+KP NLLI +  +LK+ DFG +         N   T           T 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 178 DYLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE---------------HSDT 221
            Y  PE M+ S ++   +D+WS G +  E     P F  ++               HSD 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 222 YRRIVQVDLK---------FPPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
             R ++             +P  P+      V+    DL+ +MLV D ++R+   + LEH
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 267 PWIIQNADPSGVYRG 281
           P++    DP+    G
Sbjct: 307 PYLQTYHDPNDEPEG 321

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 133/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMSYLLYQMLVGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+GV+  E + G   F   +H D + ++++                          
Sbjct: 206 VDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 131/260 (50%), Gaps = 14/260 (5%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           E++  T N F   + LG+G FG V   + + +  + A K L K ++++ + E     E +
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGEL----YKELQKCKYFSERRAATYVAS 124
           I   +    ++ L   +  +  + L+L     G+L    Y   Q    F E RA  Y A 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA--GFPEARAVFYAAE 294
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RTMCGTLDYLPP 182
           +   L   H + +++RD+KPEN+L+   G ++I+D G +VH    +  +   GT+ Y+ P
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAK----EHSDTYRRIVQVDLKFPPKPIV 238
           E+V++  +  + D W+LG L YE + G  PF+ +    +  +  R + +V  ++  +   
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--F 412
Query: 239 SSAAKDLISQMLVKDSSQRL 258
           S  A+ L SQ+L KD ++RL
Sbjct: 413 SPQARSLCSQLLCKDPAERL 432

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 29/263 (11%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           + ++ + +GRG FG V  A+ +  +  VA+K     Q++          E+   S + HP
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKWRAKD--VAIK-----QIESESERKAFIVELRQLSRVNHP 61
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK---YFSERRAATYVASLARALIYCH 133
           NI++LYG   +   V L++EYA  G LY  L   +   Y++   A ++    ++ + Y H
Sbjct: 62  NIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 134 G---KHVIHRDIKPENLLIGAQGE-LKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE 189
               K +IHRD+KP NLL+ A G  LKI DFG +           G+  ++ PE+ E   
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD-------LKFPPKPIVSSAA 242
           +    D++S G++ +E +    PF+ +     +R +  V        +K  PKPI S   
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHNGTRPPLIKNLPKPIES--- 235
Query: 243 KDLISQMLVKDSSQRLPLHKLLE 265
             L+++   KD SQR  + ++++
Sbjct: 236 --LMTRCWSKDPSQRPSMEEIVK 256

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 113/223 (50%), Gaps = 13/223 (5%)
Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W ++  D    K LG G+FG V   +  R  + VA+K++     + S  E +   E ++ 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI----KEGSMSEDEFIEEAKVM 73
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
            +L H  +++LYG    Q+ +++I EY A G L   L++ ++ F  ++       +  A+
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEMV 185
            Y   K  +HRD+   N L+  QG +K++DFG S +  +   T   G+   + + PPE++
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVL 193
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
              +  +  DIW+ GVL +E +  G  P+E   +S+T   I Q
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 130/258 (50%), Gaps = 10/258 (3%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           E++  T N F   + LG+G FG V   + + +  + A K L K ++++ + E     E +
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLA 126
           I   +    ++ L   +  +  + L+L     G+L   +       F E RA  Y A + 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RTMCGTLDYLPPEM 184
             L   H + +++RD+KPEN+L+   G ++I+D G +VH    +  +   GT+ Y+ PE+
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPFEAK----EHSDTYRRIVQVDLKFPPKPIVSS 240
           V++  +  + D W+LG L YE + G  PF+ +    +  +  R + +V  ++  +   S 
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSP 414
Query: 241 AAKDLISQMLVKDSSQRL 258
            A+ L SQ+L KD ++RL
Sbjct: 415 QARSLCSQLLCKDPAERL 432

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 133/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM--ELDHERMSYLLYQMLVGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+GV+  E + G   F   +H D + ++++                          
Sbjct: 206 VDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 113/223 (50%), Gaps = 13/223 (5%)
Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W ++  D    K LG G+FG V   +  R  + VA+K++     + S  E +   E ++ 
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI----KEGSMSEDEFIEEAKVM 57
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
            +L H  +++LYG    Q+ +++I EY A G L   L++ ++ F  ++       +  A+
Sbjct: 58  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 117
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEMV 185
            Y   K  +HRD+   N L+  QG +K++DFG S +  +   T   G+   + + PPE++
Sbjct: 118 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 177
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
              +  +  DIW+ GVL +E +  G  P+E   +S+T   I Q
Sbjct: 178 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 220

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 113/223 (50%), Gaps = 13/223 (5%)
Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W ++  D    K LG G+FG V   +  R  + VA+K++     + S  E +   E ++ 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI----KEGSMSEDEFIEEAKVM 73
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
            +L H  +++LYG    Q+ +++I EY A G L   L++ ++ F  ++       +  A+
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEMV 185
            Y   K  +HRD+   N L+  QG +K++DFG S +  +   T   G+   + + PPE++
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 193
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
              +  +  DIW+ GVL +E +  G  P+E   +S+T   I Q
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 11/217 (5%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D    K LG G+FG V   +  R  + VA+K++     + S  E +   E ++  +L H 
Sbjct: 10  DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI----KEGSMSEDEFIEEAKVMMNLSHE 64
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGK 135
            +++LYG    Q+ +++I EY A G L   L++ ++ F  ++       +  A+ Y   K
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEMVESVEHD 191
             +HRD+   N L+  QG +K++DFG S +  +   T   G+   + + PPE++   +  
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 192 ANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           +  DIW+ GVL +E +  G  P+E   +S+T   I Q
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 221

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 11/217 (5%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D    K LG G+FG V   +  R  + VA+K++     + S  E +   E ++  +L H 
Sbjct: 5   DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI----KEGSMSEDEFIEEAKVMMNLSHE 59
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGK 135
            +++LYG    Q+ +++I EY A G L   L++ ++ F  ++       +  A+ Y   K
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEMVESVEHD 191
             +HRD+   N L+  QG +K++DFG S +  +   T   G+   + + PPE++   +  
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 192 ANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           +  DIW+ GVL +E +  G  P+E   +S+T   I Q
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 113/223 (50%), Gaps = 13/223 (5%)
Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W ++  D    K LG G+FG V   +  R  + VA+K++     + S  E +   E ++ 
Sbjct: 10  WEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI----KEGSMSEDEFIEEAKVM 64
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
            +L H  +++LYG    Q+ +++I EY A G L   L++ ++ F  ++       +  A+
Sbjct: 65  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 124
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEMV 185
            Y   K  +HRD+   N L+  QG +K++DFG S +  +   T   G+   + + PPE++
Sbjct: 125 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 184
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
              +  +  DIW+ GVL +E +  G  P+E   +S+T   I Q
Sbjct: 185 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 227

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 113/223 (50%), Gaps = 13/223 (5%)
Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W ++  D    K LG G+FG V   +  R  + VA+K++     + S  E +   E ++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI----KEGSMSEDEFIEEAKVM 58
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
            +L H  +++LYG    Q+ +++I EY A G L   L++ ++ F  ++       +  A+
Sbjct: 59  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 118
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC-GT---LDYLPPEMV 185
            Y   K  +HRD+   N L+  QG +K++DFG S +  +   T   G+   + + PPE++
Sbjct: 119 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVL 178
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
              +  +  DIW+ GVL +E +  G  P+E   +S+T   I Q
Sbjct: 179 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 221

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIG------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 21  FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 78
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 137
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCG 257
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317
Query: 272 NADPS 276
             DPS
Sbjct: 318 YYDPS 322

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 132/313 (42%), Gaps = 72/313 (23%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R  V ++  + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC-VNHKNIISL 88
Query: 82  YGYFYDQKR------VYLILEYAAKG---ELYKELQKCKYFSERRAATYVASLARALIYC 132
              F  QK       VYL++E         ++ EL         R +  +  +   + + 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMEL------DHERMSYLLYQMLCGIKHL 142
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP---------PE 183
           H   +IHRD+KP N+++ +   LKI DFG +       RT C      P         PE
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------RTACTNFMMTPYVVTRYYRAPE 195
Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ---------------- 227
           ++  + + ANVDIWS+G +  E + G   F+  +H D + ++++                
Sbjct: 196 VILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPT 255
Query: 228 --------------------VDLKFPPKP----IVSSAAKDLISQMLVKDSSQRLPLHKL 263
                                D  FP +     I +S A+DL+S+MLV D  +R+ + + 
Sbjct: 256 VRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 315
Query: 264 LEHPWIIQNADPS 276
           L HP+I    DP+
Sbjct: 316 LRHPYITVWYDPA 328

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 23  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYXQRTLREIKILL 80
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 139
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 272 NADPS 276
             DPS
Sbjct: 320 YYDPS 324

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM--ELDHERMSYLLYQMLVGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E + G   F   +H D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIG------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 21  FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 78
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 137
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317
Query: 272 NADPS 276
             DPS
Sbjct: 318 YYDPS 322

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 23  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 80
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 139
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 272 NADPS 276
             DPS
Sbjct: 320 YYDPS 324

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 24  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 81
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 140
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 272 NADPS 276
             DPS
Sbjct: 321 YYDPS 325

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E + G   F   +H D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/306 (28%), Positives = 133/306 (43%), Gaps = 51/306 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 39  FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 96
Query: 72  HLRHPNILRLYGYFY-----DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
             RH NI+ +            K VYL+  +    +LYK L K ++ S      ++  + 
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYK-LLKTQHLSNDHICYFLYQIL 154
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYL 180
           R L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y 
Sbjct: 155 RGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 181 PPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK- 231
            PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL  
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 232 ------------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII 270
                        P K         P   S A DL+ +ML  +  +R+ + + L HP++ 
Sbjct: 275 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334
Query: 271 QNADPS 276
           Q  DPS
Sbjct: 335 QYYDPS 340

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIG------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 23  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 80
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 139
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 272 NADPS 276
             DPS
Sbjct: 320 YYDPS 324

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E + G   F   +H D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 24  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 81
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 140
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 272 NADPS 276
             DPS
Sbjct: 321 YYDPS 325

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 120/267 (44%), Gaps = 32/267 (11%)
Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           R  L  +++ K LG+G +G V+ + ++R+  +VA+K +F +  Q S    +  RE+ I +
Sbjct: 5   RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILT 63
Query: 72  HLR-HPNILRLYGYFY--DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
            L  H NI+ L       + + VYL+ +Y  + +L+  + +            V  L + 
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI-RANILEPVHKQYVVYQLIKV 121
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------------ 176
           + Y H   ++HRD+KP N+L+ A+  +K+ADFG S    N RR                 
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 177 ------LDYL-------PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR 223
                  DY+       P  ++ S ++   +D+WSLG +  E L G P F      +   
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 224 RIVQVDLKFPPKPIVSSAAKDLISQML 250
           RI+ V + FP    V S        M+
Sbjct: 242 RIIGV-IDFPSNEDVESIQSPFAKTMI 267

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 25  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 82
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 83  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 141
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 261
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 262 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 321
Query: 272 NADPS 276
             DPS
Sbjct: 322 YYDPS 326

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 16  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 73
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 74  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 132
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 252
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 253 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 312
Query: 272 NADPS 276
             DPS
Sbjct: 313 YYDPS 317

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 23  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 80
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 139
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 272 NADPS 276
             DPS
Sbjct: 320 YYDPS 324

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 17  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 74
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 133
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCI 253
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313
Query: 272 NADPS 276
             DPS
Sbjct: 314 YYDPS 318

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 17  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 74
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 133
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 253
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313
Query: 272 NADPS 276
             DPS
Sbjct: 314 YYDPS 318

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIG------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 27  FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 84
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 85  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 143
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 263
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 264 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 323
Query: 272 NADPS 276
             DPS
Sbjct: 324 YYDPS 328

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIG------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 19  FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 76
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 135
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 272 NADPS 276
             DPS
Sbjct: 316 YYDPS 320

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 19  FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 76
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 135
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 272 NADPS 276
             DPS
Sbjct: 316 YYDPS 320

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 39  FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 96
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 155
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 276 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335
Query: 272 NADPS 276
             DPS
Sbjct: 336 YYDPS 340

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIG------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 19  FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 76
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 135
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 272 NADPS 276
             DPS
Sbjct: 316 YYDPS 320

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G +G V   R K +  IVA+K   +S      V+    RE+++   LRH N++ L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
               +KR YL+ E+     L            +    Y+  +   + +CH  ++IHRDIK
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIK 151
Query: 144 PENLLIGAQGELKIADFGWSVHTFNRRRTMC----------GTLDYLPPE-MVESVEHDA 192
           PEN+L+   G +K+ DFG++       RT+            T  Y  PE +V  V++  
Sbjct: 152 PENILVSQSGVVKLCDFGFA-------RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV 226
            VD+W++G L  E   G P F      D    I+
Sbjct: 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIG------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 21  FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 78
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 79  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 137
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 317
Query: 272 NADPS 276
             DPS
Sbjct: 318 YYDPS 322

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 19  FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 76
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 135
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 272 NADPS 276
             DPS
Sbjct: 316 YYDPS 320

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 35/226 (15%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G +  VY    K +   VALK + K   ++      +R E+ +   L+H NI+RLY 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIR-EISLMKELKHENIVRLYD 70
Query: 84  YFYDQKRVYLILEYAAKGELYK--------------ELQKCKYFSERRAATYVASLARAL 129
             + + ++ L+ E+    +L K              EL   KYF  +        L + L
Sbjct: 71  VIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ--------LLQGL 121
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPE 183
            +CH   ++HRD+KP+NLLI  +G+LK+ DFG +      V+TF+       TL Y  P+
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV---TLWYRAPD 178
Query: 184 -MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV 228
            ++ S  +  ++DIWS G +  E + G P F      +  + I  +
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E + G   F   +H D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 265
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 146
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E + G   F   +H D + ++++                          
Sbjct: 207 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 266
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 267 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326
Query: 274 DPS 276
           DPS
Sbjct: 327 DPS 329

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 32  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 90
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 147
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 148 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKEN 207
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E + G   F   +H D + ++++                          
Sbjct: 208 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 267
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 268 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 327
Query: 274 DPS 276
           DPS
Sbjct: 328 DPS 330

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E + G   F   +H D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 265
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E + G   F   +H D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E + G   F   +H D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA+K +  S  +      +  RE++I  
Sbjct: 19  FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILL 76
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 135
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 272 NADPS 276
             DPS
Sbjct: 316 YYDPS 320

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18  FDIGKP------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G        +G G +G V  A +  +   VA++ +  S  +      +  RE++I  
Sbjct: 23  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKI--SPFEHQTYCQRTLREIKILL 80
Query: 72  HLRHPNILRLYGYF----YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH NI+ +         +Q +   I++   + +LYK L K ++ S      ++  + R
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILR 139
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-----MCGTLDYLP 181
            L Y H  +V+HRD+KP NLL+    +LKI DFG + V   +   T        T  Y  
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 182 PE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           PE M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  +  +R+ + + L HP++ Q
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 272 NADPS 276
             DPS
Sbjct: 320 YYDPS 324

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 130/305 (42%), Gaps = 49/305 (16%)
Query: 18  FDIG------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           FD+G      + +G G +G V  A +      VA+K +  S  +      +  RE++I  
Sbjct: 39  FDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKI--SPFEHQTYCQRTLREIQILL 96
Query: 72  HLRHPNILR----LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
             RH N++     L     +  R   I++   + +LYK L K +  S      ++  + R
Sbjct: 97  RFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK-LLKSQQLSNDHICYFLYQILR 155
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-------HTFNRRRTMCGTLDYL 180
            L Y H  +V+HRD+KP NLLI    +LKI DFG +        HT      +       
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRA 215
Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV-------QVDLK-- 231
           P  M+ S  +  ++DIWS+G +  E L   P F  K + D    I+       Q DL   
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 232 -----------FPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                       P K         P   S A DL+ +ML  + ++R+ + + L HP++ Q
Sbjct: 276 INMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 272 NADPS 276
             DP+
Sbjct: 336 YYDPT 340

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 110/244 (45%), Gaps = 32/244 (13%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKV-LFKS 52
             SE    E  RW L  +   +GKPLG G FG V LA      + + N +  + V + KS
Sbjct: 11  GVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 70
Query: 53  QLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK 111
              +  +   L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + LQ  +
Sbjct: 71  DATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
Query: 112 ----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
                             S +   +    +AR + Y   K  IHRD+   N+L+     +
Sbjct: 130 PPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 189
Query: 156 KIADFGWSV---HTFNRRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYG 209
           KIADFG +    H    ++T  G L   ++ PE +    +    D+WS GVL +E F  G
Sbjct: 190 KIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 249
Query: 210 VPPF 213
             P+
Sbjct: 250 GSPY 253

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 11/224 (4%)
Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVE 68
           KR+   DF     LG G+F  VY AR+K +N IVA+K +      +++  +     RE++
Sbjct: 10  KRYEKLDF-----LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           +   L HPNI+ L   F  +  + L+ ++                +      Y+    + 
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT---MCGTLDYLPPEMV 185
           L Y H   ++HRD+KP NLL+   G LK+ADFG +    +  R       T  Y  PE++
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELL 184
Query: 186 ESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV 228
                +   VD+W++G +  E L  VP        D   RI + 
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 131/292 (44%), Gaps = 58/292 (19%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG V+ A+   S+ +   KVL   + +         RE++I   ++HPN++ L
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN--------RELQIMRIVKHPNVVDL 97
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAAT-------YVASLARA 128
             +FY      D+  + L+LEY  +  +Y+     +++++ +          Y+  L R+
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPE-TVYR---ASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 129 LIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEM 184
           L Y H   + HRDIKP+NLL+    G LK+ DFG +   +        +C    Y  PE+
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-YRAPEL 212
Query: 185 V-ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--------------- 228
           +  +  +  N+DIWS G +  E + G P F  +   D    I++V               
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272
Query: 229 --DLKFPP----------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
             + KFP           +P     A DLIS++L    S RL   + L HP+
Sbjct: 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 40/284 (14%)
Query: 24  LGRGKFGHVYLARE-KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNIL 79
           +G G +G V+ AR+ K     VALK + + Q  +  +     REV +  HL    HPN++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 80  RLYGYFY-----DQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYC 132
           RL+          + ++ L+ E+  + +L   L K              +  L R L + 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-MCGTLDYLPPEMVESVEH 190
           H   V+HRD+KP+N+L+ + G++K+ADFG + +++F    T +  TL Y  PE++    +
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY 196
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------DLKFP------ 233
              VD+WS+G +  E     P F      D   +I+ V           D+  P      
Sbjct: 197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 256
Query: 234 --PKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
              +PI      +    KDL+ + L  + ++R+  +  L HP+ 
Sbjct: 257 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 40/284 (14%)
Query: 24  LGRGKFGHVYLARE-KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNIL 79
           +G G +G V+ AR+ K     VALK + + Q  +  +     REV +  HL    HPN++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 80  RLYGYFY-----DQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYC 132
           RL+          + ++ L+ E+  + +L   L K              +  L R L + 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-MCGTLDYLPPEMVESVEH 190
           H   V+HRD+KP+N+L+ + G++K+ADFG + +++F    T +  TL Y  PE++    +
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY 196
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------DLKFP------ 233
              VD+WS+G +  E     P F      D   +I+ V           D+  P      
Sbjct: 197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 256
Query: 234 --PKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
              +PI      +    KDL+ + L  + ++R+  +  L HP+ 
Sbjct: 257 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 40/284 (14%)
Query: 24  LGRGKFGHVYLARE-KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNIL 79
           +G G +G V+ AR+ K     VALK + + Q  +  +     REV +  HL    HPN++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 80  RLYGYFY-----DQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYC 132
           RL+          + ++ L+ E+  + +L   L K              +  L R L + 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-MCGTLDYLPPEMVESVEH 190
           H   V+HRD+KP+N+L+ + G++K+ADFG + +++F    T +  TL Y  PE++    +
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY 196
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------DLKFP------ 233
              VD+WS+G +  E     P F      D   +I+ V           D+  P      
Sbjct: 197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 256
Query: 234 --PKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
              +PI      +    KDL+ + L  + ++R+  +  L HP+ 
Sbjct: 257 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 113/244 (46%), Gaps = 32/244 (13%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKV-LFKS 52
             SE    E  RW L  +   +GKPLG G FG V LA      + + N +  + V + KS
Sbjct: 11  GVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 70
Query: 53  QLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-- 109
              +  +   L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + LQ   
Sbjct: 71  DATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
Query: 110 ------C--------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
                 C        +  S +   +    +AR + Y   K  IHRD+   N+L+     +
Sbjct: 130 PPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 189
Query: 156 KIADFGWS--VHTFN-RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYG 209
           KIADFG +  +H  +  ++T  G L   ++ PE +    +    D+WS GVL +E F  G
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 249
Query: 210 VPPF 213
             P+
Sbjct: 250 GSPY 253

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 15/250 (6%)
Query: 18  FDIGKPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            ++G+ +G G+FG V    Y++ E   N  +A+ +          V  +  +E       
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPE---NPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT-YVASLARALIYC 132
            HP+I++L G   +   V++I+E    GEL   LQ  KY  +  +   Y   L+ AL Y 
Sbjct: 69  DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 127
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVESV 188
             K  +HRDI   N+L+ +   +K+ DFG S +    T+ +       + ++ PE +   
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 189 EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
              +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L++
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMT 246
Query: 248 QMLVKDSSQR 257
           +    D S+R
Sbjct: 247 KCWAYDPSRR 256

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 15/250 (6%)
Query: 18  FDIGKPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            ++G+ +G G+FG V    Y++ E   N  +A+ +          V  +  +E       
Sbjct: 17  IELGRCIGEGQFGDVHQGIYMSPE---NPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 73
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT-YVASLARALIYC 132
            HP+I++L G   +   V++I+E    GEL   LQ  KY  +  +   Y   L+ AL Y 
Sbjct: 74  DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVESV 188
             K  +HRDI   N+L+ +   +K+ DFG S +    T+ +       + ++ PE +   
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 189 EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
              +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L++
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMT 251
Query: 248 QMLVKDSSQR 257
           +    D S+R
Sbjct: 252 KCWAYDPSRR 261

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 15/250 (6%)
Query: 18  FDIGKPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            ++G+ +G G+FG V    Y++ E   N  +A+ +          V  +  +E       
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPE---NPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 65
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT-YVASLARALIYC 132
            HP+I++L G   +   V++I+E    GEL   LQ  KY  +  +   Y   L+ AL Y 
Sbjct: 66  DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVESV 188
             K  +HRDI   N+L+ +   +K+ DFG S +    T+ +       + ++ PE +   
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 189 EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
              +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L++
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMT 243
Query: 248 QMLVKDSSQR 257
           +    D S+R
Sbjct: 244 KCWAYDPSRR 253

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKV-LFKS 52
             SE    E  RW L  +   +GKPLG G FG V LA      + + N +  + V + KS
Sbjct: 4   GVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 63
Query: 53  QLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK 111
              +  +   L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + LQ  +
Sbjct: 64  DATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 122
Query: 112 ----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
                             S +   +    +AR + Y   K  IHRD+   N+L+     +
Sbjct: 123 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 182
Query: 156 KIADFGWS--VHTFN-RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYG 209
           KIADFG +  +H  +  ++T  G L   ++ PE +    +    D+WS GVL +E F  G
Sbjct: 183 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 242
Query: 210 VPPF 213
             P+
Sbjct: 243 GSPY 246

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 15/250 (6%)
Query: 18  FDIGKPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            ++G+ +G G+FG V    Y++ E   N  +A+ +          V  +  +E       
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPE---NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT-YVASLARALIYC 132
            HP+I++L G   +   V++I+E    GEL   LQ  KY  +  +   Y   L+ AL Y 
Sbjct: 69  DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 127
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVESV 188
             K  +HRDI   N+L+ +   +K+ DFG S +    T+ +       + ++ PE +   
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 189 EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
              +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L++
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMT 246
Query: 248 QMLVKDSSQR 257
           +    D S+R
Sbjct: 247 KCWAYDPSRR 256

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 15/250 (6%)
Query: 18  FDIGKPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            ++G+ +G G+FG V    Y++ E   N  +A+ +          V  +  +E       
Sbjct: 15  IELGRCIGEGQFGDVHQGIYMSPE---NPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 71
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT-YVASLARALIYC 132
            HP+I++L G   +   V++I+E    GEL   LQ  KY  +  +   Y   L+ AL Y 
Sbjct: 72  DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 130
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVESV 188
             K  +HRDI   N+L+ +   +K+ DFG S +    T+ +       + ++ PE +   
Sbjct: 131 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 190
Query: 189 EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
              +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L++
Sbjct: 191 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMT 249
Query: 248 QMLVKDSSQR 257
           +    D S+R
Sbjct: 250 KCWAYDPSRR 259

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/325 (25%), Positives = 148/325 (45%), Gaps = 60/325 (18%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           +  +A E+ R  ++ F + +  G+G FG V L +EK +   VA+K + +    +++ E Q
Sbjct: 10  AAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-ELQ 68
Query: 63  LRREVEIQSHLRHPNILRLYGYFY-----DQKRVYL--ILEYAAKGELYKELQKCKYFSE 115
           + +++ +   L HPNI++L  YFY     D++ +YL  ++EY     L++    C+ +  
Sbjct: 69  IMQDLAV---LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR---CCRNYYR 121
Query: 116 RRAA-------TYVASLARALIYCH--GKHVIHRDIKPENLLIG-AQGELKIADFGWSVH 165
           R+ A        ++  L R++   H    +V HRDIKP N+L+  A G LK+ DFG +  
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 166 TFNRRRTMCGTLD--YLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY 222
                  +       Y  PE++   +H    VDIWS+G +  E + G P F     +   
Sbjct: 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241
Query: 223 RRIVQVDLKFPPKPIV-------------------------------SSAAKDLISQMLV 251
             IV+V L  P + ++                               +  A DL+S +L 
Sbjct: 242 HEIVRV-LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300
Query: 252 KDSSQRLPLHKLLEHPWIIQNADPS 276
               +R+  ++ L HP+  +  DP+
Sbjct: 301 YLPEERMKPYEALCHPYFDELHDPA 325

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKV-LFKS 52
             SE    E  RW L  +   +GKPLG G FG V LA      + + N +  + V + KS
Sbjct: 11  GVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 70
Query: 53  QLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK 111
              +  +   L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + LQ  +
Sbjct: 71  DATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
Query: 112 ----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
                             S +   +    +AR + Y   K  IHRD+   N+L+     +
Sbjct: 130 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 189
Query: 156 KIADFGWS--VHTFN-RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYG 209
           KIADFG +  +H  +  ++T  G L   ++ PE +    +    D+WS GVL +E F  G
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 249
Query: 210 VPPF 213
             P+
Sbjct: 250 GSPY 253

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 15/221 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G+FG VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 5   KWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 60
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 119
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 179
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTY 222
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVY 220

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 15/250 (6%)
Query: 18  FDIGKPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            ++G+ +G G+FG V    Y++ E   N  +A+ +          V  +  +E       
Sbjct: 40  IELGRCIGEGQFGDVHQGIYMSPE---NPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 96
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT-YVASLARALIYC 132
            HP+I++L G   +   V++I+E    GEL   LQ  KY  +  +   Y   L+ AL Y 
Sbjct: 97  DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 155
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVESV 188
             K  +HRDI   N+L+ +   +K+ DFG S +    T+ +       + ++ PE +   
Sbjct: 156 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 215
Query: 189 EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
              +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L++
Sbjct: 216 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMT 274
Query: 248 QMLVKDSSQR 257
           +    D S+R
Sbjct: 275 KCWAYDPSRR 284

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 15/250 (6%)
Query: 18  FDIGKPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            ++G+ +G G+FG V    Y++ E   N  +A+ +          V  +  +E       
Sbjct: 14  IELGRCIGEGQFGDVHQGIYMSPE---NPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 70
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT-YVASLARALIYC 132
            HP+I++L G   +   V++I+E    GEL   LQ  KY  +  +   Y   L+ AL Y 
Sbjct: 71  DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 129
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVESV 188
             K  +HRDI   N+L+ +   +K+ DFG S +    T+ +       + ++ PE +   
Sbjct: 130 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 189
Query: 189 EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
              +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L++
Sbjct: 190 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMT 248
Query: 248 QMLVKDSSQR 257
           +    D S+R
Sbjct: 249 KCWAYDPSRR 258

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKV-LFKS 52
             SE    E  RW L  +   +GKPLG G FG V LA      + + N +  + V + KS
Sbjct: 3   GVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 62
Query: 53  QLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK 111
              +  +   L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + LQ  +
Sbjct: 63  DATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 121
Query: 112 ----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
                             S +   +    +AR + Y   K  IHRD+   N+L+     +
Sbjct: 122 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 181
Query: 156 KIADFGWS--VHTFN-RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYG 209
           KIADFG +  +H  +  ++T  G L   ++ PE +    +    D+WS GVL +E F  G
Sbjct: 182 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 241
Query: 210 VPPF 213
             P+
Sbjct: 242 GSPY 245

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 129/307 (42%), Gaps = 60/307 (19%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R  V ++  + H NI+ L
Sbjct: 28  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC-VNHKNIISL 86
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKY----FSERRAATYVASLARALIY 131
              F  QK       VYL++E         +   C+         R +  +  +   + +
Sbjct: 87  LNVFTPQKTLEEFQDVYLVMELM-------DANLCQVIHMELDHERMSYLLYQMLCGIKH 139
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVE 189
            H   +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + 
Sbjct: 140 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG 199
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ---------------------- 227
           +  NVDIWS+G +  E + G   F+  +H D + ++++                      
Sbjct: 200 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 228 --------------VDLKFPPKP----IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                          D  FP +     I +S A+DL+S+MLV D  +R+ + + L HP+I
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319
Query: 270 IQNADPS 276
               DP+
Sbjct: 320 TVWYDPA 326

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 112/242 (46%), Gaps = 32/242 (13%)
Query: 3   SEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKV-LFKSQL 54
           SE    E  RW L  +   +GKPLG G FG V LA      + + N +  + V + KS  
Sbjct: 2   SEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA 61
Query: 55  QQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-- 111
            +  +   L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + LQ  +  
Sbjct: 62  TEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 120
Query: 112 --------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKI 157
                           S +   +    +AR + Y   K  IHRD+   N+L+     +KI
Sbjct: 121 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 180
Query: 158 ADFGWS--VHTFN-RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVP 211
           ADFG +  +H  +  ++T  G L   ++ PE +    +    D+WS GVL +E F  G  
Sbjct: 181 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 240
Query: 212 PF 213
           P+
Sbjct: 241 PY 242

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKV-LFKS 52
             SE    E  RW L  +   +GKPLG G FG V LA      + + N +  + V + KS
Sbjct: 52  GVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 111
Query: 53  QLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK 111
              +  +   L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + LQ  +
Sbjct: 112 DATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 170
Query: 112 ----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
                             S +   +    +AR + Y   K  IHRD+   N+L+     +
Sbjct: 171 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 230
Query: 156 KIADFGWS--VHTFN-RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYG 209
           KIADFG +  +H  +  ++T  G L   ++ PE +    +    D+WS GVL +E F  G
Sbjct: 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290
Query: 210 VPPF 213
             P+
Sbjct: 291 GSPY 294

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 17/251 (6%)
Query: 18  FDIGKPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            ++G+ +G G+FG V    Y++ E   N  +A+ +          V  +  +E       
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPE---NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVASLARALIY 131
            HP+I++L G   +   V++I+E    GEL   LQ  + FS   A+   Y   L+ AL Y
Sbjct: 69  DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAY 126
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVES 187
              K  +HRDI   N+L+ A   +K+ DFG S +    T+ +       + ++ PE +  
Sbjct: 127 LESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 188 VEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
               +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L+
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLM 245
Query: 247 SQMLVKDSSQR 257
           ++    D S+R
Sbjct: 246 TKCWAYDPSRR 256

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 15/222 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 60
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I+E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 119
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 179
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKV-LFKS 52
             SE    E  RW L  +   +GKPLG G FG V LA      + + N +  + V + KS
Sbjct: 11  GVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 70
Query: 53  QLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-- 109
              +  +   L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + LQ   
Sbjct: 71  DATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARE 129
Query: 110 --------------CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
                          +  S +   +    +AR + Y   K  IHRD+   N+L+     +
Sbjct: 130 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 189
Query: 156 KIADFGWS--VHTFN-RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYG 209
           KIADFG +  +H  +  ++T  G L   ++ PE +    +    D+WS GVL +E F  G
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 249
Query: 210 VPPF 213
             P+
Sbjct: 250 GSPY 253

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 15/222 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 63
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I+E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 122
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 182
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 224

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 112/228 (49%), Gaps = 15/228 (6%)
Query: 6   SAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQL 63
           S+    +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL 62
Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--Y 121
           + E  +   ++HPN+++L G    +   Y+I+E+   G L   L++C    E  A    Y
Sbjct: 63  K-EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLY 120
Query: 122 VAS-LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT--- 176
           +A+ ++ A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 177 LDYLPPEMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           + +  PE +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 17/276 (6%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEH 61
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ +
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 62  QLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSER 116
             R  +E+    +       ++RL  +F       LILE      +L+  + +     E 
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 130
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   
Sbjct: 131 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 190
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I++  + F 
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR 244
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +  VSS  + LI   L    S R    ++  HPW+
Sbjct: 245 QR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 17/276 (6%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEH 61
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ +
Sbjct: 30  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 89
Query: 62  QLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSER 116
             R  +E+    +       ++RL  +F       LILE      +L+  + +     E 
Sbjct: 90  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 149
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   
Sbjct: 150 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 209
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I++  + F 
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR 263
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +  VSS  + LI   L    S R    ++  HPW+
Sbjct: 264 QR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 17/222 (7%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY+   K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 26  KWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 81
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT---YVAS-L 125
              ++HPN+++L G    +   Y++ EY   G L   L++C    E   A    Y+A+ +
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECN--REEVTAVVLLYMATQI 139
Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLP 181
           + A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  
Sbjct: 140 SSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 199
Query: 182 PEMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTY 222
           PE +         D+W+ GVL +E   YG+ P+   + S  Y
Sbjct: 200 PESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 241

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 17/276 (6%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEH 61
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ +
Sbjct: 10  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 69
Query: 62  QLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSER 116
             R  +E+    +       ++RL  +F       LILE      +L+  + +     E 
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 129
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   
Sbjct: 130 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 189
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I++  + F 
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR 243
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +  VSS  + LI   L    S R    ++  HPW+
Sbjct: 244 QR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 128/277 (46%), Gaps = 17/277 (6%)
Query: 2   CSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVE 60
            ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ 
Sbjct: 37  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 96
Query: 61  HQLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSE 115
           +  R  +E+    +       ++RL  +F       LILE      +L+  + +     E
Sbjct: 97  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 156
Query: 116 RRAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-M 173
             A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T  
Sbjct: 157 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 216
Query: 174 CGTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF 232
            GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I++  + F
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF 270
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
             +  VSS  + LI   L    S R    ++  HPW+
Sbjct: 271 RQR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILE-YAAKGELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 187
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VSS  + LI
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR--VSSECQHLI 239
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 240 RWCLALRPSDRPTFEEIQNHPWM 262

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 126
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 127 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 186
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VSS  + LI
Sbjct: 187 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR--VSSECQHLI 238
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 239 RWCLALRPSDRPTFEEIQNHPWM 261

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VSS  + LI
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR--VSSECQHLI 240
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 241 RWCLALRPSDRPTFEEIQNHPWM 263

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 155
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VSS  + LI
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR--VSSECQHLI 267
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VSS  + LI
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR--VSSECQHLI 240
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 241 RWCLALRPSDRPTFEEIQNHPWM 263

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 187
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VSS  + LI
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR--VSSECQHLI 239
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 240 RWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VSS  + LI
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR--VSSECQHLI 240
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 241 RWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VSS  + LI
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR--VSSECQHLI 235
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWM 258

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 108/213 (50%), Gaps = 16/213 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALK--VLFKSQLQQSQVE--HQLRREVEIQS 71
           N+ +  K +G+G FG V+  R  +   +VA+K  +L  S+ +   +E   + +REV I S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELY-KELQKCKYFSERRAATYVASLARALI 130
           +L HPNI++LYG  ++  R  +++E+   G+LY + L K            +  +A  + 
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 131 YCHGKH--VIHRDIKPENLLIGAQGE-----LKIADFGWSVHTFNRRRTMCGTLDYLPPE 183
           Y   ++  ++HRD++  N+ + +  E      K+ADFG S  + +    + G   ++ PE
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPE 196
Query: 184 MVESVE--HDANVDIWSLGVLCYEFLYGVPPFE 214
            + + E  +    D +S  ++ Y  L G  PF+
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 15/221 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 62
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I+E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTY 222
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 15/228 (6%)
Query: 6   SAKEKKRWTLNDFDIGKP--LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQL 63
           S+    +W +   DI     LG G++G VY    K+ +  VA+K L +  ++   VE  L
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL 62
Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--Y 121
           + E  +   ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y
Sbjct: 63  K-EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLY 120
Query: 122 VAS-LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT--- 176
           +A+ ++ A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 180
Query: 177 LDYLPPEMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           + +  PE +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 15/222 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 62
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I+E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 15/221 (6%)
Query: 12  RWTLNDFDIGKP--LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   DI     LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 60
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 119
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS----VHTFNRRRTMCGTLDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S      TF         + +  P
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAP 179
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTY 222
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVY 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 17/251 (6%)
Query: 18  FDIGKPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            ++G+ +G G+FG V    Y++ E   N  +A+ +          V  +  +E       
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPE---NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 448
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVASLARALIY 131
            HP+I++L G   +   V++I+E    GEL   LQ  + FS   A+   Y   L+ AL Y
Sbjct: 449 DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAY 506
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVES 187
              K  +HRDI   N+L+ A   +K+ DFG S +    T+ +       + ++ PE +  
Sbjct: 507 LESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 188 VEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
               +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L+
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLM 625
Query: 247 SQMLVKDSSQR 257
           ++    D S+R
Sbjct: 626 TKCWAYDPSRR 636

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 107/213 (50%), Gaps = 16/213 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALK--VLFKSQLQQSQVE--HQLRREVEIQS 71
           N+ +  K +G+G FG V+  R  +   +VA+K  +L  S+ +   +E   + +REV I S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELY-KELQKCKYFSERRAATYVASLARALI 130
           +L HPNI++LYG  ++  R  +++E+   G+LY + L K            +  +A  + 
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 131 YCHGKH--VIHRDIKPENLLIGAQGE-----LKIADFGWSVHTFNRRRTMCGTLDYLPPE 183
           Y   ++  ++HRD++  N+ + +  E      K+ADFG S  + +    + G   ++ PE
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQWMAPE 196
Query: 184 MV--ESVEHDANVDIWSLGVLCYEFLYGVPPFE 214
            +  E   +    D +S  ++ Y  L G  PF+
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 124/274 (45%), Gaps = 31/274 (11%)
Query: 17  DFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           D  + + LG G FG V+LA        +   +VA+K L    L   +     +RE E+ +
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLT 72
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQ---------------KCKYFSER 116
           +L+H +I++ YG   D   + ++ EY   G+L K L+               + K     
Sbjct: 73  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 117 RAATYVAS-LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG 175
               ++AS +A  ++Y   +H +HRD+   N L+GA   +KI DFG S   ++      G
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 176 T-----LDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVD 229
                 + ++PPE +   +     D+WS GV+ +E F YG  P+    +++    I Q  
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 230 LKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKL 263
           +   P+ +      D++     ++  QRL + ++
Sbjct: 253 VLERPR-VCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 15/228 (6%)
Query: 6   SAKEKKRWTLNDFDIGKP--LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQL 63
           S+    +W +   DI     LG G++G VY    K+ +  VA+K L +  ++   VE  L
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL 62
Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--Y 121
           + E  +   ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y
Sbjct: 63  K-EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLY 120
Query: 122 VAS-LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT--- 176
           +A+ ++ A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 177 LDYLPPEMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           + +  PE +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 132/305 (43%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQM--ELDHERMSYLLYQMLXGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 228 -VDLKFP---PKPIV----------SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP   P  +           +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 274 DPSGV 278
           DP+ V
Sbjct: 326 DPAEV 330

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 9   EKKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKV-LFKSQLQQSQVE 60
           E  RW L  +   +GKPLG G FG V LA      + + N +  + V + KS   +  + 
Sbjct: 4   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 63
Query: 61  HQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK--------C- 110
             L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + LQ         C 
Sbjct: 64  -DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCY 122
Query: 111 -------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS 163
                  +  S +   +    +AR + Y   K  IHRD+   N+L+     +KIADFG +
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 164 --VHTFN-RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
             +H  +  ++T  G L   ++ PE +    +    D+WS GVL +E F  G  P+
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 127/276 (46%), Gaps = 17/276 (6%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEH 61
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ +
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 62  QLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSER 116
             R  +E+    +       ++RL  +F       LILE      +L+  + +     E 
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 143
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   
Sbjct: 144 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 203
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I+   + F 
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIGGQVFFR 257
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +  VSS  + LI   L    S R    ++  HPW+
Sbjct: 258 QR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 114/251 (45%), Gaps = 17/251 (6%)
Query: 18  FDIGKPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            ++G+ +G G+FG V    Y++ E   N  +A+ +          V  +  +E       
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPE---NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVASLARALIY 131
            HP+I++L G   +   V++I+E    GEL   LQ  + FS   A+   Y   L+ AL Y
Sbjct: 69  DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAY 126
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT----LDYLPPEMVES 187
              K  +HRDI   N+L+ +   +K+ DFG S +  +            + ++ PE +  
Sbjct: 127 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINF 186
Query: 188 VEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
               +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L+
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLM 245
Query: 247 SQMLVKDSSQR 257
           ++    D S+R
Sbjct: 246 TKCWAYDPSRR 256

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 15/228 (6%)
Query: 6   SAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQL 63
           S+    +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL 62
Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--Y 121
           + E  +   ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y
Sbjct: 63  K-EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLY 120
Query: 122 VAS-LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT--- 176
           +A+ ++ A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 177 LDYLPPEMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           + +  PE +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 155
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I+   + F  +  VSS  + LI
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIGGQVFFRQR--VSSECQHLI 267
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 156
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I+   + F  +  VSS  + LI
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIGGQVFFRQR--VSSECQHLI 268
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 127/276 (46%), Gaps = 17/276 (6%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEH 61
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ +
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 62  QLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSER 116
             R  +E+    +       ++RL  +F       LILE      +L+  + +     E 
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 142
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   
Sbjct: 143 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 202
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I+   + F 
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIGGQVFFR 256
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +  VSS  + LI   L    S R    ++  HPW+
Sbjct: 257 QR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I+   + F  +  VSS  + LI
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIGGQVFFRQR--VSSECQHLI 235
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 15/222 (6%)
Query: 12  RWTLNDFDIGKP--LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   DI     LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 63
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 122
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP 182
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 224

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 135/303 (44%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLG-----VLCYEFLY----------------GVP-PFEAKEHSDTYRRIVQ---- 227
           VDIWS+G     ++C++ L+                G P P   K+   T R  V+    
Sbjct: 206 VDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVENRPK 265
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D   G+ LG+G FG       + +  ++ +K L +      + +    +EV++   L H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEH 66
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGEL---YKELQKCKYFSERRAATYVASLARALIYC 132
           PN+L+  G  Y  KR+  I EY   G L    K +     +S+R   ++   +A  + Y 
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQR--VSFAKDIASGMAYL 124
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----------------RRRTMCG 175
           H  ++IHRD+   N L+     + +ADFG +    +                 +R T+ G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFL 207
              ++ PEM+    +D  VD++S G++  E +
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 15/228 (6%)
Query: 6   SAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQL 63
           S+    +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL 62
Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--Y 121
           + E  +   ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y
Sbjct: 63  K-EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLY 120
Query: 122 VAS-LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT--- 176
           +A+ ++ A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 177 LDYLPPEMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           + +  PE +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 118/242 (48%), Gaps = 18/242 (7%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP- 76
           +++ K +G+G FG V  A + + +  VALK++      + +   Q   E+ I  HLR   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQD 154
Query: 77  -----NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARAL 129
                N++ +   F  +  + +  E  +   LY+ ++K K+  FS      +  S+ + L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGE--LKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES 187
              H   +IH D+KPEN+L+  QG   +K+ DFG S +   R  T   +  Y  PE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILG 273
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA--AKDL 245
             +   +D+WSLG +  E L G P    ++  D    ++++ L  P + ++ ++  AK+ 
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL-LGMPSQKLLDASKRAKNF 332
Query: 246 IS 247
           +S
Sbjct: 333 VS 334

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 15/222 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 20  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 75
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 134
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 135 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 194
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 195 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 236

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 15/222 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 62
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 121
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 15/222 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 66
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 125
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 15/222 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 64
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 123
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP 183
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 118/242 (48%), Gaps = 18/242 (7%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP- 76
           +++ K +G+G FG V  A + + +  VALK++      + +   Q   E+ I  HLR   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQD 154
Query: 77  -----NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARAL 129
                N++ +   F  +  + +  E  +   LY+ ++K K+  FS      +  S+ + L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGE--LKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES 187
              H   +IH D+KPEN+L+  QG   +K+ DFG S +   R  T   +  Y  PE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILG 273
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA--AKDL 245
             +   +D+WSLG +  E L G P    ++  D    ++++ L  P + ++ ++  AK+ 
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL-LGMPSQKLLDASKRAKNF 332
Query: 246 IS 247
           +S
Sbjct: 333 VS 334

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 15/222 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 64
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 123
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 183
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 15/221 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 62
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 121
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTY 222
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQM--ELDHERMSYLLYQMLXGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP                + +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 274 DPSGV 278
           DP+ V
Sbjct: 326 DPAEV 330

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 15/221 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 62
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTY 222
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 15/222 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 64
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 123
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 183
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 132/305 (43%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQM--ELDHERMSYLLYQMLXGIKHLHSA 138
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 139 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258
Query: 228 -VDLKFP---PKPIV----------SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP   P  +           +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318
Query: 274 DPSGV 278
           DP+ V
Sbjct: 319 DPAEV 323

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 116/251 (46%), Gaps = 17/251 (6%)
Query: 18  FDIGKPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
            ++G+ +G G+FG V    Y++ E   N  +A+ +          V  +  +E       
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPE---NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 448
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVASLARALIY 131
            HP+I++L G   +   V++I+E    GEL   LQ  + FS   A+   Y   L+ AL Y
Sbjct: 449 DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAY 506
Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVES 187
              K  +HRDI   N+L+ +   +K+ DFG S +    T+ +       + ++ PE +  
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 188 VEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
               +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L+
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLM 625
Query: 247 SQMLVKDSSQR 257
           ++    D S+R
Sbjct: 626 TKCWAYDPSRR 636

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 120/263 (45%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 124 RHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VS   + LI
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR--VSXECQHLI 235
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 15/222 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 62
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHRD+   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTYR 223
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y 
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 116/251 (46%), Gaps = 38/251 (15%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           L DF+  + LGRG FG V+ A+ K  +   A+K +     + ++   ++ REV+  + L 
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 61
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFS--------------ERRAAT 120
           HP I+R +  + ++     +   + K  LY ++Q C+  +              ER    
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 121 YV-ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW---------------SV 164
           ++   +A A+ + H K ++HRD+KP N+       +K+ DFG                 +
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 165 HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRR 224
             + R     GT  Y+ PE +    +   VDI+SLG++ +E LY   PF  +   +  R 
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236
Query: 225 IVQV-DLKFPP 234
           +  V +LKFPP
Sbjct: 237 LTDVRNLKFPP 247

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 132/305 (43%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 183
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 243
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 303
Query: 228 -VDLKFP---PKPIV----------SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP   P  +           +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363
Query: 274 DPSGV 278
           DP+ V
Sbjct: 364 DPAEV 368

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 17/276 (6%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEH 61
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ +
Sbjct: 10  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 69
Query: 62  QLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSER 116
             R  +E+    +       ++RL  +F       LILE      +L+  + +     E 
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 129
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   
Sbjct: 130 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 189
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I++  + F 
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR 243
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +  VS   + LI   L    S R    ++  HPW+
Sbjct: 244 QR--VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 17/276 (6%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEH 61
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ +
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 62  QLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSER 116
             R  +E+    +       ++RL  +F       LILE      +L+  + +     E 
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 130
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   
Sbjct: 131 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 190
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I++  + F 
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR 244
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +  VS   + LI   L    S R    ++  HPW+
Sbjct: 245 QR--VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 17/277 (6%)
Query: 2   CSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVE 60
            ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ 
Sbjct: 42  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 101
Query: 61  HQLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSE 115
           +  R  +E+    +       ++RL  +F       LILE      +L+  + +     E
Sbjct: 102 NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 161
Query: 116 RRAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-M 173
             A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T  
Sbjct: 162 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 221
Query: 174 CGTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF 232
            GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I++  + F
Sbjct: 222 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF 275
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
             +  VS   + LI   L    S R    ++  HPW+
Sbjct: 276 RQR--VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 130/303 (42%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP                + +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 274 DPS 276
           DP+
Sbjct: 326 DPA 328

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 17/276 (6%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEH 61
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ +
Sbjct: 38  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 97
Query: 62  QLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSER 116
             R  +E+    +       ++RL  +F       LILE      +L+  + +     E 
Sbjct: 98  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 157
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   
Sbjct: 158 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 217
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I++  + F 
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR 271
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +  VS   + LI   L    S R    ++  HPW+
Sbjct: 272 QR--VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 132/305 (43%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  + +  RE+ +   + H NI+ L
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAYRELVLMKCVNHKNIISL 126
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 183
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 243
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 303
Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP                + +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363
Query: 274 DPSGV 278
           DP+ V
Sbjct: 364 DPAEV 368

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 146
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 207 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 266
Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP                + +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 267 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 326
Query: 274 DPSGV 278
           DP+ V
Sbjct: 327 DPAEV 331

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP                + +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 274 DPSGV 278
           DP+ V
Sbjct: 326 DPAEV 330

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 146
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 207 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 266
Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP                + +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 267 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 326
Query: 274 DPSGV 278
           DP+ V
Sbjct: 327 DPAEV 331

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP                + +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 274 DPSGV 278
           DP+ V
Sbjct: 326 DPAEV 330

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 138
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258
Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP                + +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318
Query: 274 DPSGV 278
           DP+ V
Sbjct: 319 DPAEV 323

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 120/263 (45%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 31  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 90
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 91  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 150
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 151 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 210
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VS   + LI
Sbjct: 211 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR--VSXECQHLI 262
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 263 RWCLALRPSDRPTFEEIQNHPWM 285

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 29  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 87
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 144
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 145 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 204
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 205 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 264
Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP                + +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 265 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 324
Query: 274 DPSGV 278
           DP+ V
Sbjct: 325 DPAEV 329

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 139
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 140 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 200 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 259
Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP                + +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 260 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 319
Query: 274 DPSGV 278
           DP+ V
Sbjct: 320 DPAEV 324

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 132/305 (43%), Gaps = 52/305 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 139
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 140 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 200 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 259
Query: 228 -VDLKFP---PKPIV----------SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
              L FP   P  +           +S A+DL+S+MLV D ++R+ +   L+HP+I    
Sbjct: 260 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 319
Query: 274 DPSGV 278
           DP+ V
Sbjct: 320 DPAEV 324

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 121/256 (47%), Gaps = 12/256 (4%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LGRG +G V   R   S  I+A+K +  +   Q Q    +  ++ +++ +  P  +  YG
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT-VDCPFTVTFYG 117
Query: 84  YFYDQKRVYLILEY--AAKGELYKE-LQKCKYFSERRAATYVASLARALIYCHGK-HVIH 139
             + +  V++ +E    +  + YK+ + K +   E        S+ +AL + H K  VIH
Sbjct: 118 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 177
Query: 140 RDIKPENLLIGAQGELKIADFGWSVHTFNR--RRTMCGTLDYLPPEMV----ESVEHDAN 193
           RD+KP N+LI A G++K+ DFG S +  +   +    G   Y+ PE +        +   
Sbjct: 178 RDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVK 237
Query: 194 VDIWSLGVLCYEFLYGVPPFEA-KEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
            DIWSLG+   E      P+++        +++V+      P    S+   D  SQ L K
Sbjct: 238 SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKK 297
Query: 253 DSSQRLPLHKLLEHPW 268
           +S +R    +L++HP+
Sbjct: 298 NSKERPTYPELMQHPF 313

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 35  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 93
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 150
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 151 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 210
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VD+WS+G +  E +     F  +++ D + ++++                          
Sbjct: 211 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 270
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 271 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 330
Query: 274 DPS 276
           DPS
Sbjct: 331 DPS 333

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQ 70
           T   +++ + LG G FG+V     + +   VA+K     Q +Q        R   E++I 
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIK-----QCRQELSPKNRERWCLEIQIM 66
Query: 71  SHLRHPNILRLYGYFYDQKRV------YLILEYAAKGELYK---ELQKCKYFSERRAATY 121
             L HPN++         +++       L +EY   G+L K   + + C    E    T 
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 122 VASLARALIYCHGKHVIHRDIKPENLLI--GAQGEL-KIADFGWSVHTFNRRRTMC---- 174
           ++ ++ AL Y H   +IHRD+KPEN+++  G Q  + KI D G++      +  +C    
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFV 184
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPF 213
           GTL YL PE++E  ++   VD WS G L +E + G  PF
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQ 70
           T   +++ + LG G FG+V     + +   VA+K     Q +Q        R   E++I 
Sbjct: 13  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIK-----QCRQELSPKNRERWCLEIQIM 67
Query: 71  SHLRHPNILRLYGYFYDQKRV------YLILEYAAKGELYK---ELQKCKYFSERRAATY 121
             L HPN++         +++       L +EY   G+L K   + + C    E    T 
Sbjct: 68  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 127
Query: 122 VASLARALIYCHGKHVIHRDIKPENLLI--GAQGEL-KIADFGWSVHTFNRRRTMC---- 174
           ++ ++ AL Y H   +IHRD+KPEN+++  G Q  + KI D G++      +  +C    
Sbjct: 128 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFV 185
Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPF 213
           GTL YL PE++E  ++   VD WS G L +E + G  PF
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 24  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 82
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 139
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 140 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VD+WS+G +  E +     F  +++ D + ++++                          
Sbjct: 200 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 259
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 260 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 319
Query: 274 DPS 276
           DPS
Sbjct: 320 DPS 322

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 17/276 (6%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEH 61
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ +
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 62  QLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSER 116
             R  +E+    +       ++RL  +F       LILE      +L+  + +     E 
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 142
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   
Sbjct: 143 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 202
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I+   + F 
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIGGQVFFR 256
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +  VS   + LI   L    S R    ++  HPW+
Sbjct: 257 QR--VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 112
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFG 230
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 281
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 282 REMNPNYTEFKFP--QIKAHPW 301

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 90
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 150 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFG 208
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 259
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 260 REMNPNYTEFKFP--QIKAHPW 279

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 119/263 (45%), Gaps = 17/263 (6%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEI----Q 70
           + + +G  LG G FG VY       N  VA+K + K ++    ++ +  R  +E+    +
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARAL 129
                  ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 156
Query: 130 IYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +  
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I+   + F  +  VS   + LI
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIGGQVFFRQR--VSXECQHLI 268
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              L    S R    ++  HPW+
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPWM 291

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALK--VLFKSQLQQSQVE--HQLRREVEIQS 71
           N+ +  K +G+G FG V+  R  +   +VA+K  +L  S+ +   +E   + +REV I S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELY-KELQKCKYFSERRAATYVASLARALI 130
           +L HPNI++LYG  ++  R  +++E+   G+LY + L K            +  +A  + 
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 131 YCHGKH--VIHRDIKPENLLIGAQGE-----LKIADFGWSVHTFNRRRTMCGTLDYLPPE 183
           Y   ++  ++HRD++  N+ + +  E      K+ADF  S  + +    + G   ++ PE
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQWMAPE 196
Query: 184 MV--ESVEHDANVDIWSLGVLCYEFLYGVPPFE 214
            +  E   +    D +S  ++ Y  L G  PF+
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 17/276 (6%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEH 61
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ +
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 62  QLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSER 116
             R  +E+    +       ++RL  +F       LILE      +L+  + +     E 
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 143
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   
Sbjct: 144 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 203
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I+   + F 
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIGGQVFFR 257
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +  VS   + LI   L    S R    ++  HPW+
Sbjct: 258 QR--VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +      VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VY+++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VD+WS+G +  E +     F  +++ D + ++++                          
Sbjct: 206 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 265
Query: 228 ----------VDLKFPP----KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
                      D+ FP       + +S A+DL+S+MLV D+S+R+ + + L+HP+I    
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 274 DPS 276
           DPS
Sbjct: 326 DPS 328

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 86
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 146 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFG 204
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 205 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 255
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 256 REMNPNYTEFKFP--QIKAHPW 275

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 90
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 150 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFG 208
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 259
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 260 REMNPNYTEFKFP--QIKAHPW 279

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 82
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 142 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFG 200
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 201 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 251
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 252 REMNPNYTEFKFP--QIKAHPW 271

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 97
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 157 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFG 215
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 216 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 266
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 267 REMNPNYTEFKFP--QIKAHPW 286

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 79
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 139 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFG 197
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 198 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 248
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 249 REMNPNYTEFKFP--QIKAHPW 268

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 120/261 (45%), Gaps = 33/261 (12%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVES 187
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C      P  +  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
            ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQIR 248
Query: 248 QMLVKDSSQRLPLHKLLEHPW 268
           +M    +  + P  ++  HPW
Sbjct: 249 EMNPNYTEFKFP--QIKAHPW 267

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 18  GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L   
Sbjct: 78  DATEKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 136 RPPGMEXSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTEN 193
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             +KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 194 NVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 254 TLGGSPY 260

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFG 196
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 247
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 248 REMNPNYTEFKFP--QIKAHPW 267

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 134/313 (42%), Gaps = 65/313 (20%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           ++++I + +G G +G V  AR + +   VA+K +  +    +  +  LR E++I  H +H
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 112
Query: 76  PNILRL---------YGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
            NI+ +         YG F   K VY++L+   + +L++ +   +  +      ++  L 
Sbjct: 113 DNIIAIKDILRPTVPYGEF---KSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLL 168
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC------------ 174
           R L Y H   VIHRD+KP NLL+    ELKI DFG +       R +C            
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA-------RGLCTSPAEHQYFMTE 221
Query: 175 --GTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--- 228
              T  Y  PE++ S+ E+   +D+WS+G +  E L     F  K +    + I+ V   
Sbjct: 222 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281
Query: 229 -----------------DLKFPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHK 262
                                PP+         P     A  L+ +ML  + S R+    
Sbjct: 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 341
Query: 263 LLEHPWIIQNADP 275
            L HP++ +  DP
Sbjct: 342 ALRHPFLAKYHDP 354

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 18  GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L   
Sbjct: 78  DATEKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTEN 193
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             +KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 194 NVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 254 TLGGSPY 260

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 106
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 166 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFG 224
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 225 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 275
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 276 REMNPNYTEFKFP--QIKAHPW 295

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 136/286 (47%), Gaps = 24/286 (8%)
Query: 4   EVSAKEKKRWTLNDF-DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           ++S ++   +T  D  D+G+ +GRG +G V     K S  I+A+K +  +  ++ Q +  
Sbjct: 10  KISPEQHWDFTAEDLKDLGE-IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG--ELYKELQKC--KYFSERRA 118
           +  +V ++S    P I++ YG  + +   ++ +E  +    + YK +         E   
Sbjct: 69  MDLDVVMRSS-DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL 127
Query: 119 ATYVASLARALIYC-HGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMC 174
                +  +AL +      +IHRDIKP N+L+   G +K+ DFG S   V +  + R   
Sbjct: 128 GKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-A 186
Query: 175 GTLDYLPPEMVESVE----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL 230
           G   Y+ PE ++       +D   D+WSLG+  YE   G  P+   + +  + ++ QV  
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVK 244
Query: 231 KFPPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII 270
             PP+         S +  + ++  L KD S+R    +LL+HP+I+
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 121/256 (47%), Gaps = 12/256 (4%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LGRG +G V   R   S  I+A+K +  +   Q Q    +  ++ +++ +  P  +  YG
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT-VDCPFTVTFYG 73
Query: 84  YFYDQKRVYLILEY--AAKGELYKE-LQKCKYFSERRAATYVASLARALIYCHGK-HVIH 139
             + +  V++ +E    +  + YK+ + K +   E        S+ +AL + H K  VIH
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 133
Query: 140 RDIKPENLLIGAQGELKIADFGWSVHTFN--RRRTMCGTLDYLPPEMV----ESVEHDAN 193
           RD+KP N+LI A G++K+ DFG S +  +   +    G   Y+ PE +        +   
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVK 193
Query: 194 VDIWSLGVLCYEFLYGVPPFEA-KEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
            DIWSLG+   E      P+++        +++V+      P    S+   D  SQ L K
Sbjct: 194 SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKK 253
Query: 253 DSSQRLPLHKLLEHPW 268
           +S +R    +L++HP+
Sbjct: 254 NSKERPTYPELMQHPF 269

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 33/261 (12%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K + + +  ++       RE++I   L H NI+RL
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKLDHCNIVRL 78
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVES 187
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C      P  +  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
            ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQIR 248
Query: 248 QMLVKDSSQRLPLHKLLEHPW 268
           +M    +  + P  ++  HPW
Sbjct: 249 EMNPNYTEFKFP--QIKAHPW 267

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 83
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 143 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFG 201
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 202 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 252
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 253 REMNPNYTEFKFP--QIKAHPW 272

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 15/221 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 269
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 328
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHR++   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTY 222
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 112
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFG 230
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 281
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 282 REMNPNYTEFKFP--QIKAHPW 301

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 91
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 151 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFG 209
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 210 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 260
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 261 REMNPNYTEFKFP--QIKAHPW 280

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 18  GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L   
Sbjct: 78  DATEEDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTEN 193
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             +KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 254 TLGGSPY 260

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 157
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 217 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFG 275
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 276 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 326
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 327 REMNPNYTEFKFP--QIKAHPW 346

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 114
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 174 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFG 232
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 233 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 283
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 284 REMNPNYTEFKFP--QIKAHPW 303

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 116
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 176 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFG 234
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 235 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 285
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 286 REMNPNYTEFKFP--QIKAHPW 305

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFG 196
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 247
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 248 REMNPNYTEFKFP--QIKAHPW 267

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 127/296 (42%), Gaps = 52/296 (17%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           KP+G G  G V  A +   +  VA+K L +    Q+  +   R E+ +   + H NI+ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 82  YGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
              F  QK       VYL++E      L + +Q        R +  +  +   + + H  
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
            +IHRD+KP N+++ +   LKI DFG   +  T         T  Y  PE++  + +  N
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-------------------------- 227
           VDIWS+G +  E +     F  +++ D + ++++                          
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 228 -VDLKFPP-------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
              L FP                + +S A+DL+S+MLV D ++R+ +   L+HP+I
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 126/276 (45%), Gaps = 17/276 (6%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEH 61
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++    ++ +
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 62  QLRREVEI----QSHLRHPNILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSER 116
             R  +E+    +       ++RL  +F       LILE      +L+  + +     E 
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 130
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +   T   
Sbjct: 131 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 190
Query: 175 GTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +     H  +  +WSLG+L Y+ + G  PFE  E       I++  + F 
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR 244
Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            +  VS   + LI   L      R    ++  HPW+
Sbjct: 245 QR--VSXECQHLIRWCLALRPXDRPTFEEIQNHPWM 278

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 15/221 (6%)
Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++   VE  L+ E  +
Sbjct: 253 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLK-EAAV 308
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT--YVAS-LA 126
              ++HPN+++L G    +   Y+I E+   G L   L++C    E  A    Y+A+ ++
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 367
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGT---LDYLPP 182
            A+ Y   K+ IHR++   N L+G    +K+ADFG S + T +      G    + +  P
Sbjct: 368 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 427
Query: 183 EMVESVEHDANVDIWSLGVLCYEF-LYGVPPFEAKEHSDTY 222
           E +   +     D+W+ GVL +E   YG+ P+   + S  Y
Sbjct: 428 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 468

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 134/313 (42%), Gaps = 65/313 (20%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           ++++I + +G G +G V  AR + +   VA+K +  +    +  +  LR E++I  H +H
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 113
Query: 76  PNILRL---------YGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
            NI+ +         YG F   K VY++L+   + +L++ +   +  +      ++  L 
Sbjct: 114 DNIIAIKDILRPTVPYGEF---KSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLL 169
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC------------ 174
           R L Y H   VIHRD+KP NLL+    ELKI DFG +       R +C            
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA-------RGLCTSPAEHQYFMTE 222
Query: 175 --GTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--- 228
              T  Y  PE++ S+ E+   +D+WS+G +  E L     F  K +    + I+ V   
Sbjct: 223 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 282
Query: 229 -----------------DLKFPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHK 262
                                PP+         P     A  L+ +ML  + S R+    
Sbjct: 283 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 342
Query: 263 LLEHPWIIQNADP 275
            L HP++ +  DP
Sbjct: 343 ALRHPFLAKYHDP 355

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 117/242 (48%), Gaps = 18/242 (7%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP- 76
           +++ K +G+G FG V  A + + +  VALK++      + +   Q   E+ I  HLR   
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQD 154
Query: 77  -----NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARAL 129
                N++ +   F  +  + +  E  +   LY+ ++K K+  FS      +  S+ + L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGE--LKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES 187
              H   +IH D+KPEN+L+  QG   +K+ DFG S +   R      +  Y  PE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYRAPEVILG 273
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA--AKDL 245
             +   +D+WSLG +  E L G P    ++  D    ++++ L  P + ++ ++  AK+ 
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL-LGMPXQKLLDASKRAKNF 332
Query: 246 IS 247
           +S
Sbjct: 333 VS 334

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 18  GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L   
Sbjct: 78  DATEKDLSD--LVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTEN 193
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             +KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 254 TLGGSPY 260

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 33/261 (12%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K + + +  ++       RE++I   L H NI+RL
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKLDHCNIVRL 78
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y     +Y+  +      +     YV      L R+L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVES 187
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C      P  +  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
            ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQIR 248
Query: 248 QMLVKDSSQRLPLHKLLEHPW 268
           +M    +    P  ++  HPW
Sbjct: 249 EMNPNYTEFAFP--QIKAHPW 267

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 18  GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L   
Sbjct: 78  DATEKDLSD--LVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTEN 193
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             +KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 254 TLGGSPY 260

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 122/262 (46%), Gaps = 35/262 (13%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K +    LQ  + ++   RE++I   L H NI+RL
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D   + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-E 186
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C    Y  PE++  
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFG 196
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           + ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQI 247
Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
            +M    +  + P  ++  HPW
Sbjct: 248 REMNPNYTEFKFP--QIKAHPW 267

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 110/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 18  GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L   
Sbjct: 78  DATEKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTEN 193
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             +KIADFG +    N    + T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 194 NVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 254 TLGGSPY 260

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 64  GVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 123
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L   
Sbjct: 124 DATEKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 181
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 182 RPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTEN 239
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             +KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 300 TLGGSPY 306

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 36/246 (14%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLA------REKRSNHIVALKVLFKS 52
             SE    E  +W    +   +GKPLG G FG V +A      ++K    +     + K 
Sbjct: 10  GVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 69
Query: 53  QLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL---- 107
              +  +   L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L    
Sbjct: 70  DATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 128
Query: 108 --------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG 153
                         ++   F +  + TY   LAR + Y   +  IHRD+   N+L+    
Sbjct: 129 PPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENN 186
Query: 154 ELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-FL 207
            +KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F 
Sbjct: 187 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246
Query: 208 YGVPPF 213
            G  P+
Sbjct: 247 LGGSPY 252

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 5   GVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 64
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L   
Sbjct: 65  DATEKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 122
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 123 RPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLTARNVLVTEN 180
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             +KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 181 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 240
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 241 TLGGSPY 247

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 7   GVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 66
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L   
Sbjct: 67  DATEKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 124
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 125 RPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTEN 182
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             +KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 183 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 242
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 243 TLGGSPY 249

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 118/261 (45%), Gaps = 33/261 (12%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG VY A+   S  +VA+K + + +  ++       RE++I   L H NI+RL
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKLDHCNIVRL 78
Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA----SLARALIY 131
             +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R+L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 132 CHGKHVIHRDIKPENLLIGAQGE-LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVES 187
            H   + HRDIKP+NLL+      LK+ DFG +   V        +C      P  +  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
            ++ +++D+WS G +  E L G P F      D    I++V         + +  ++ I 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV---------LGTPTREQIR 248
Query: 248 QMLVKDSSQRLPLHKLLEHPW 268
           +M    +    P  ++  HPW
Sbjct: 249 EMNPNYTEFAFP--QIKAHPW 267

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 111/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 18  GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L   
Sbjct: 78  DATEKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTEN 193
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             ++IADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 194 NVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 254 TLGGSPY 260

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 114/266 (42%), Gaps = 39/266 (14%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHLRHPNILRLY 82
           +G G FG VY  R       VA+K       +  SQ    +R+E ++ + L+HPNI+ L 
Sbjct: 15  IGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH---VIH 139
           G    +  + L++E+A  G L + L   K         +   +AR + Y H +    +IH
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 140 RDIKPENLLIGAQGE--------LKIADFGWSVHTFNRRRTM--CGTLDYLPPEMVESVE 189
           RD+K  N+LI  + E        LKI DFG +   ++R   M   G   ++ PE++ +  
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTKMSAAGAYAWMAPEVIRASM 190
Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
                D+WS GVL +E L G  PF   +       +    L     PI S+  +      
Sbjct: 191 FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL---PIPSTCPE------ 241
Query: 250 LVKDSSQRLPLHKLLEHPWIIQNADP 275
                    P  KL+E  W   N DP
Sbjct: 242 ---------PFAKLMEDCW---NPDP 255

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 27/230 (11%)
Query: 22  KPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           + LG G FG V+LA       ++   +VA+K L  +            RE E+ ++L+H 
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHE 75
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQ----KCKYFSERRAATYVAS-------- 124
           +I++ YG   +   + ++ EY   G+L K L+         +E    T +          
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 125 -LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT-----LD 178
            +A  ++Y   +H +HRD+   N L+G    +KI DFG S   ++      G      + 
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 179 YLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           ++PPE +   +     D+WSLGV+ +E F YG  P+    +++    I Q
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 21/250 (8%)
Query: 7   AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLF--KSQLQQSQVEHQL- 63
            K  ++W ++ ++I   +G+G FG V  A ++     VA+K++   K+ L Q+Q+E +L 
Sbjct: 46  VKNGEKW-MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLL 104
Query: 64  ----RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERR 117
               + + E++ ++ H     L  +F  +  + L+ E  +   LY  L+   +   S   
Sbjct: 105 ELMNKHDTEMKYYIVH-----LKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNL 158
Query: 118 AATYVASLARALIYCHGKH--VIHRDIKPENLLIG--AQGELKIADFGWSVHTFNRRRTM 173
              +   +  AL++       +IH D+KPEN+L+    +  +KI DFG S     R    
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX 218
Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
             +  Y  PE++  + +D  +D+WSLG +  E   G P F      D   +IV+V L  P
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LGIP 277
Query: 234 PKPIVSSAAK 243
           P  I+  A K
Sbjct: 278 PAHILDQAPK 287

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 21/250 (8%)
Query: 7   AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLF--KSQLQQSQVEHQL- 63
            K  ++W ++ ++I   +G+G FG V  A ++     VA+K++   K+ L Q+Q+E +L 
Sbjct: 27  VKNGEKW-MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLL 85
Query: 64  ----RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERR 117
               + + E++ ++ H     L  +F  +  + L+ E  +   LY  L+   +   S   
Sbjct: 86  ELMNKHDTEMKYYIVH-----LKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNL 139
Query: 118 AATYVASLARALIYCHGKH--VIHRDIKPENLLIG--AQGELKIADFGWSVHTFNRRRTM 173
              +   +  AL++       +IH D+KPEN+L+    +  +KI DFG S     R    
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX 199
Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
             +  Y  PE++  + +D  +D+WSLG +  E   G P F      D   +IV+V L  P
Sbjct: 200 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LGIP 258
Query: 234 PKPIVSSAAK 243
           P  I+  A K
Sbjct: 259 PAHILDQAPK 268

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           + +G G+FG V+L      +     KV  K+  + S  E     E E+   L HP +++L
Sbjct: 33  QEIGSGQFGLVHLGYWLNKD-----KVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQL 87
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHR 140
           YG   +Q  + L+ E+   G L   L+  +  F+          +   + Y     VIHR
Sbjct: 88  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 147
Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEMVESVEHDANVDI 196
           D+   N L+G    +K++DFG +    + + T   GT   + +  PE+     + +  D+
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 207
Query: 197 WSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           WS GVL +E F  G  P+E + +S+    I
Sbjct: 208 WSFGVLMWEVFSEGKIPYENRSNSEVVEDI 237

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 31/231 (13%)
Query: 24  LGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           LG G FG V+LA       ++   +VA+K L ++     Q     +RE E+ + L+H +I
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ---DFQREAELLTMLQHQHI 82
Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA---------------TYVA 123
           +R +G   + + + ++ EY   G+L + L+     ++  A                   +
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR------RTMCGTL 177
            +A  ++Y  G H +HRD+   N L+G    +KI DFG S   ++        RTM   +
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-PI 201
Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
            ++PPE +   +     D+WS GV+ +E F YG  P+    +++    I Q
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 252

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           + +G G+FG V+L      +     KV  K+  + +  E     E E+   L HP +++L
Sbjct: 13  QEIGSGQFGLVHLGYWLNKD-----KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHR 140
           YG   +Q  + L+ E+   G L   L+  +  F+          +   + Y     VIHR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHR 127
Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEMVESVEHDANVDI 196
           D+   N L+G    +K++DFG +    + + T   GT   + +  PE+     + +  D+
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 197 WSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           WS GVL +E F  G  P+E + +S+    I
Sbjct: 188 WSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 31/231 (13%)
Query: 24  LGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           LG G FG V+LA       ++   +VA+K L ++     Q     +RE E+ + L+H +I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ---DFQREAELLTMLQHQHI 105
Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA---------------TYVA 123
           +R +G   + + + ++ EY   G+L + L+     ++  A                   +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR------RTMCGTL 177
            +A  ++Y  G H +HRD+   N L+G    +KI DFG S   ++        RTM   +
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-PI 224
Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
            ++PPE +   +     D+WS GV+ +E F YG  P+    +++    I Q
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 38/284 (13%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSHLR---HPNI 78
           +G G +G VY AR+  S H VALK +             +   REV +   L    HPN+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 79  LRLYGYFYDQK-----RVYLILEYAAKG-ELYKELQKCKYFSERRAATYVASLARALIYC 132
           +RL       +     +V L+ E+  +    Y +               +    R L + 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRT-MCGTLDYLPPEMVESVEH 190
           H   ++HRD+KPEN+L+ + G +K+ADFG + ++++    T +  TL Y  PE++    +
Sbjct: 137 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTY 196
Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------DLKFP------ 233
              VD+WS+G +  E     P F     +D   +I  +           D+  P      
Sbjct: 197 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPP 256
Query: 234 --PKPIVS------SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
             P+P+ S       +   L+ +ML  +  +R+   + L+H ++
Sbjct: 257 RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 31/231 (13%)
Query: 24  LGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           LG G FG V+LA       ++   +VA+K L ++     Q     +RE E+ + L+H +I
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ---DFQREAELLTMLQHQHI 76
Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA---------------TYVA 123
           +R +G   + + + ++ EY   G+L + L+     ++  A                   +
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR------RTMCGTL 177
            +A  ++Y  G H +HRD+   N L+G    +KI DFG S   ++        RTM   +
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-PI 195
Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
            ++PPE +   +     D+WS GV+ +E F YG  P+    +++    I Q
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 246

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 18  GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+ YA+KG L + L   
Sbjct: 78  DATEKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRAR 135
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTEN 193
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             +KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 254 TLGGSPY 260

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 13/222 (5%)
Query: 12  RWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W ++  +    + +G G+FG V+L      +     KV  K+  + +  E     E E+
Sbjct: 4   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKD-----KVAIKTIREGAMSEEDFIEEAEV 58
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARA 128
              L HP +++LYG   +Q  + L+ E+   G L   L+  +  F+          +   
Sbjct: 59  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 118
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEM 184
           + Y     VIHRD+   N L+G    +K++DFG +    + + T   GT   + +  PE+
Sbjct: 119 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 178
Query: 185 VESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
                + +  D+WS GVL +E F  G  P+E + +S+    I
Sbjct: 179 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 103/243 (42%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +         F  +      + +  PE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 193 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 235
Query: 249 MLV 251
           M+V
Sbjct: 236 MIV 238

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 125/274 (45%), Gaps = 29/274 (10%)
Query: 18  FDIGKPLGRGKFGHVY-LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH- 75
           + I K +G G    V+ +  EK+   I A+K +   +   +Q     R E+   + L+  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 70
Query: 76  -PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
              I+RLY Y    + +Y+++E     +L   L+K K        +Y  ++  A+   H 
Sbjct: 71  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLDYLPPEMVESVE 189
             ++H D+KP N LI   G LK+ DFG +       T   + +  GT++Y+PPE ++ + 
Sbjct: 130 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 190 HD-----------ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV---QVDLKFPPK 235
                           D+WSLG + Y   YG  PF+   +  +    +     +++FP  
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 248
Query: 236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P      +D++   L +D  QR+ + +LL HP++
Sbjct: 249 P--EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G+FG V++     S   VA+K L    +           E  +   L+H  ++RL
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSV----QAFLEEANLMKTLQHDKLVRL 73
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQ--KCKYFSERRAATYVASLARALIYCHGKHVIH 139
           Y     ++ +Y+I EY AKG L   L+  +       +   + A +A  + Y   K+ IH
Sbjct: 74  YAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 133
Query: 140 RDIKPENLLIGAQGELKIADFGWS----VHTFNRRRTMCGTLDYLPPEMVESVEHDANVD 195
           RD++  N+L+      KIADFG +     + +  R      + +  PE +         D
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 196 IWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQ 227
           +WS G+L YE + YG  P+  + ++D    + Q
Sbjct: 194 VWSFGILLYEIVTYGKIPYPGRTNADVMTALSQ 226

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 21/250 (8%)
Query: 7   AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLF--KSQLQQSQVEHQL- 63
            K  ++W ++ ++I   +G+G FG V  A ++     VA+K++   K+ L Q+Q+E +L 
Sbjct: 46  VKNGEKW-MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLL 104
Query: 64  ----RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERR 117
               + + E++ ++ H     L  +F  +  + L+ E  +   LY  L+   +   S   
Sbjct: 105 ELMNKHDTEMKYYIVH-----LKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNL 158
Query: 118 AATYVASLARALIYCHGKH--VIHRDIKPENLLIG--AQGELKIADFGWSVHTFNRRRTM 173
              +   +  AL++       +IH D+KPEN+L+    +  +KI DFG S     R    
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQX 218
Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
             +  Y  PE++  + +D  +D+WSLG +  E   G P F      D   +IV+V L  P
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LGIP 277
Query: 234 PKPIVSSAAK 243
           P  I+  A K
Sbjct: 278 PAHILDQAPK 287

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 125/274 (45%), Gaps = 29/274 (10%)
Query: 18  FDIGKPLGRGKFGHVY-LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH- 75
           + I K +G G    V+ +  EK+   I A+K +   +   +Q     R E+   + L+  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 67
Query: 76  -PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
              I+RLY Y    + +Y+++E     +L   L+K K        +Y  ++  A+   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLDYLPPEMVESVE 189
             ++H D+KP N LI   G LK+ DFG +       T   + +  GT++Y+PPE ++ + 
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 190 HD-----------ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV---QVDLKFPPK 235
                           D+WSLG + Y   YG  PF+   +  +    +     +++FP  
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P      +D++   L +D  QR+ + +LL HP++
Sbjct: 246 P--EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 125/274 (45%), Gaps = 29/274 (10%)
Query: 18  FDIGKPLGRGKFGHVY-LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH- 75
           + I K +G G    V+ +  EK+   I A+K +   +   +Q     R E+   + L+  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 86
Query: 76  -PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
              I+RLY Y    + +Y+++E     +L   L+K K        +Y  ++  A+   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLDYLPPEMVESVE 189
             ++H D+KP N LI   G LK+ DFG +       T   + +  GT++Y+PPE ++ + 
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 190 HD-----------ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV---QVDLKFPPK 235
                           D+WSLG + Y   YG  PF+   +  +    +     +++FP  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P      +D++   L +D  QR+ + +LL HP++
Sbjct: 265 P--EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 125/274 (45%), Gaps = 29/274 (10%)
Query: 18  FDIGKPLGRGKFGHVY-LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH- 75
           + I K +G G    V+ +  EK+   I A+K +   +   +Q     R E+   + L+  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 66
Query: 76  -PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
              I+RLY Y    + +Y+++E     +L   L+K K        +Y  ++  A+   H 
Sbjct: 67  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLDYLPPEMVESVE 189
             ++H D+KP N LI   G LK+ DFG +       T   + +  GT++Y+PPE ++ + 
Sbjct: 126 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 190 HD-----------ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV---QVDLKFPPK 235
                           D+WSLG + Y   YG  PF+   +  +    +     +++FP  
Sbjct: 185 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 244
Query: 236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P      +D++   L +D  QR+ + +LL HP++
Sbjct: 245 P--EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 125/274 (45%), Gaps = 29/274 (10%)
Query: 18  FDIGKPLGRGKFGHVY-LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH- 75
           + I K +G G    V+ +  EK+   I A+K +   +   +Q     R E+   + L+  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQH 114
Query: 76  -PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
              I+RLY Y    + +Y+++E     +L   L+K K        +Y  ++  A+   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLDYLPPEMVESVE 189
             ++H D+KP N LI   G LK+ DFG +       T   + +  GT++Y+PPE ++ + 
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 190 HD-----------ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV---QVDLKFPPK 235
                           D+WSLG + Y   YG  PF+   +  +    +     +++FP  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P      +D++   L +D  QR+ + +LL HP++
Sbjct: 293 P--EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 38/247 (15%)
Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 18  GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL--- 107
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+ YA+KG L + L   
Sbjct: 78  DATEKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRAR 135
Query: 108 ---------------QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ 152
                          ++   F +  + TY   LAR + Y   +  IHRD+   N+L+   
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTEN 193
Query: 153 GELKIADFGWSVHTFN---RRRTMCGTL--DYLPPEMVESVEHDANVDIWSLGVLCYE-F 206
             +KIADFG +    N    ++T  G L   ++ PE +    +    D+WS GVL +E F
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 207 LYGVPPF 213
             G  P+
Sbjct: 254 TLGGSPY 260

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           + +G G+FG V+L      +     KV  K+  + +  E     E E+   L HP +++L
Sbjct: 11  QEIGSGQFGLVHLGYWLNKD-----KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHR 140
           YG   +Q  + L+ E+   G L   L+  +  F+          +   + Y     VIHR
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEMVESVEHDANVDI 196
           D+   N L+G    +K++DFG +    + + T   GT   + +  PE+     + +  D+
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 197 WSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           WS GVL +E F  G  P+E + +S+    I
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           + +G G+FG V+L      +     KV  K+  + +  E     E E+   L HP +++L
Sbjct: 13  QEIGSGQFGLVHLGYWLNKD-----KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHR 140
           YG   +Q  + L+ E+   G L   L+  +  F+          +   + Y     VIHR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 127
Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEMVESVEHDANVDI 196
           D+   N L+G    +K++DFG +    + + T   GT   + +  PE+     + +  D+
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 197 WSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           WS GVL +E F  G  P+E + +S+    I
Sbjct: 188 WSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNILR 80
           +G G +G VY AR+  S H VALK + +    +  +     REV +   L    HPN++R
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV-RVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 81  LYGYFYDQK-----RVYLILEYAAKG-ELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           L       +     +V L+ E+  +    Y +               +    R L + H 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
             ++HRD+KPEN+L+ + G +K+ADFG + ++++      +  TL Y  PE++    +  
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTYAT 190
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------DLKFP-------- 233
            VD+WS+G +  E     P F     +D   +I  +           D+  P        
Sbjct: 191 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRG 250
Query: 234 PKPIVS------SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P+P+ S       +   L+ +ML  +  +R+   + L+H ++
Sbjct: 251 PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 108/228 (47%), Gaps = 22/228 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 7   WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 62
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY   + ++ ++ ++     LY  L   +  F  ++        AR +
Sbjct: 63  RKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 121
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 122 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQ---LSGSILWMA 178
Query: 182 PEMV---ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV 226
           PE++   +S  +    D+++ G++ YE + G  P+    + D    +V
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNILR 80
           +G G +G VY AR+  S H VALK + +    +  +     REV +   L    HPN++R
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV-RVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 81  LYGYFYDQK-----RVYLILEYAAKG-ELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           L       +     +V L+ E+  +    Y +               +    R L + H 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
             ++HRD+KPEN+L+ + G +K+ADFG + ++++      +  TL Y  PE++    +  
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTYAT 190
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------DLKFP-------- 233
            VD+WS+G +  E     P F     +D   +I  +           D+  P        
Sbjct: 191 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRG 250
Query: 234 PKPIVS------SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P+P+ S       +   L+ +ML  +  +R+   + L+H ++
Sbjct: 251 PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +DF+    LG+G FG V  AR    +   A+K +  ++ + S +      EV + + L H
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI----LSEVMLLASLNH 61
Query: 76  PNILRLYGYFYDQKR-------------VYLILEYAAKGELYKELQKCKYFSERRAATY- 121
             ++R Y  + +++              +++ +EY   G LY +L   +  +++R   + 
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLY-DLIHSENLNQQRDEYWR 120
Query: 122 -VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VH------------- 165
               +  AL Y H + +IHRD+KP N+ I     +KI DFG +  VH             
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 166 --TFNRRRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY 222
             + +   +  GT  Y+  E+++   H +  +D++SLG++ +E +Y  P     E  +  
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238
Query: 223 RRIVQVDLKFPP--KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +++  V ++FPP          K +I  ++  D ++R     LL   W+
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 13/222 (5%)
Query: 12  RWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W ++  +    + +G G+FG V+L      +     KV  K+  + +  E     E E+
Sbjct: 2   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKD-----KVAIKTIREGAMSEEDFIEEAEV 56
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARA 128
              L HP +++LYG   +Q  + L+ E+   G L   L+  +  F+          +   
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-MCGT---LDYLPPEM 184
           + Y     VIHRD+   N L+G    +K++DFG +    + + T   GT   + +  PE+
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 185 VESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
                + +  D+WS GVL +E F  G  P+E + +S+    I
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 17/263 (6%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           FDI   +GRG F  VY   +  +   VA   L   +L +S+   + + E E    L+HPN
Sbjct: 30  FDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEXLKGLQHPN 86
Query: 78  ILRLYGYFYD----QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           I+R Y  +      +K + L+ E    G L   L++ K    +   ++   + + L + H
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLH 146
Query: 134 GKH--VIHRDIKPENLLI-GAQGELKIADFGWSVHTFNR---RRTMCGTLDYLPPEMVES 187
            +   +IHRD+K +N+ I G  G +KI D G +  T  R    + + GT ++  PE  E 
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA--TLKRASFAKAVIGTPEFXAPEXYEE 204
Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
            ++D +VD+++ G    E      P+ E +  +  YRR+           +     K++I
Sbjct: 205 -KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263
Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
              + ++  +R  +  LL H + 
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFF 286

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 125/274 (45%), Gaps = 29/274 (10%)
Query: 18  FDIGKPLGRGKFGHVY-LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH- 75
           + I K +G G    V+ +  EK+   I A+K +   +   +Q     R E+   + L+  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQH 114
Query: 76  -PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
              I+RLY Y    + +Y+++E     +L   L+K K        +Y  ++  A+   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLDYLPPEMVESVE 189
             ++H D+KP N LI   G LK+ DFG +       T   + +  GT++Y+PPE ++ + 
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 190 HD-----------ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV---QVDLKFPPK 235
                           D+WSLG + Y   YG  PF+   +  +    +     +++FP  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P      +D++   L +D  QR+ + +LL HP++
Sbjct: 293 P--EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 108/228 (47%), Gaps = 22/228 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 19  WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 74
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY   + ++ ++ ++     LY  L   +  F  ++        AR +
Sbjct: 75  RKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ---LSGSILWMA 190
Query: 182 PEMV---ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV 226
           PE++   +S  +    D+++ G++ YE + G  P+    + D    +V
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNILR 80
           +G G +G VY AR+  S H VALK + +    +  +     REV +   L    HPN++R
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV-RVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 81  LYGYFYDQK-----RVYLILEYAAKG-ELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           L       +     +V L+ E+  +    Y +               +    R L + H 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRR-TMCGTLDYLPPEMVESVEHDA 192
             ++HRD+KPEN+L+ + G +K+ADFG + ++++      +  TL Y  PE++    +  
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTYAT 190
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-----------DLKFP-------- 233
            VD+WS+G +  E     P F     +D   +I  +           D+  P        
Sbjct: 191 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRG 250
Query: 234 PKPIVS------SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P+P+ S       +   L+ +ML  +  +R+   + L+H ++
Sbjct: 251 PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 27/268 (10%)
Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W LN  +  + + +G+G+FG V L  + R N  VA+K +      Q+        E  + 
Sbjct: 188 WALNMKELKLLQTIGKGEFGDVMLG-DYRGNK-VAVKCIKNDATAQA-----FLAEASVM 240
Query: 71  SHLRHPNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCKYFSERRAA-------TYV 122
           + LRH N+++L G   ++K  +Y++ EY AKG L   L+     S  R+         + 
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKFS 295
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPP 182
             +  A+ Y  G + +HRD+   N+L+      K++DFG +    + + T    + +  P
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 355
Query: 183 EMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +     D+WS G+L +E + +G  P+      D   R V+   K         A
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPA 414
Query: 242 AKDLISQMLVKDSSQR---LPLHKLLEH 266
             D++      D++ R   L L + LEH
Sbjct: 415 VYDVMKNCWHLDAATRPTFLQLREQLEH 442

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 19  WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 74
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY     ++ ++ ++     LY  L   +  F  ++        AR +
Sbjct: 75  RKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ---LSGSILWMA 190
Query: 182 PEMV---ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           PE++   +S  +    D+++ G++ YE + G  P+    + D    +V      P    V
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 239 SSAA----KDLISQMLVKDSSQRLPLHKLL 264
            S      K L+++ L K   +R    ++L
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W LN  +  + + +G+G+FG V L  + R N  VA+K +      Q+        E  + 
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLG-DYRGNK-VAVKCIKNDATAQA-----FLAEASVM 59
Query: 71  SHLRHPNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCKYFSERRAA-------TYV 122
           + LRH N+++L G   ++K  +Y++ EY AKG L   L+     S  R+         + 
Sbjct: 60  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKFS 114
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPP 182
             +  A+ Y  G + +HRD+   N+L+      K++DFG +    + + T    + +  P
Sbjct: 115 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 174
Query: 183 EMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           E +         D+WS G+L +E + +G  P+      D   R+
Sbjct: 175 EALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 218

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G+FG V++     S   VA+K L    +           E  +   L+H  ++RL
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSV----QAFLEEANLMKTLQHDKLVRL 72
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQ--KCKYFSERRAATYVASLARALIYCHGKHVIH 139
           Y     ++ +Y+I E+ AKG L   L+  +       +   + A +A  + Y   K+ IH
Sbjct: 73  YAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 132
Query: 140 RDIKPENLLIGAQGELKIADFGWS----VHTFNRRRTMCGTLDYLPPEMVESVEHDANVD 195
           RD++  N+L+      KIADFG +     + +  R      + +  PE +         +
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 196 IWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQ 227
           +WS G+L YE + YG  P+  + ++D    + Q
Sbjct: 193 VWSFGILLYEIVTYGKIPYPGRTNADVMSALSQ 225

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W LN  +  + + +G+G+FG V L  + R N  VA+K +      Q+        E  + 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLG-DYRGNK-VAVKCIKNDATAQA-----FLAEASVM 53
Query: 71  SHLRHPNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCKYFSERRAA-------TYV 122
           + LRH N+++L G   ++K  +Y++ EY AKG L   L+     S  R+         + 
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKFS 108
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPP 182
             +  A+ Y  G + +HRD+   N+L+      K++DFG +    + + T    + +  P
Sbjct: 109 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 168
Query: 183 EMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           E +   +     D+WS G+L +E + +G  P+      D   R+
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 212

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W LN  +  + + +G+G+FG V L  + R N  VA+K +      Q+        E  + 
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLG-DYRGNK-VAVKCIKNDATAQA-----FLAEASVM 68
Query: 71  SHLRHPNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCKYFSERRAA-------TYV 122
           + LRH N+++L G   ++K  +Y++ EY AKG L   L+     S  R+         + 
Sbjct: 69  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKFS 123
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPP 182
             +  A+ Y  G + +HRD+   N+L+      K++DFG +    + + T    + +  P
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 183
Query: 183 EMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           E +   +     D+WS G+L +E + +G  P+      D   R+
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 18  FDIGKPLGRGKFGHVY-LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH- 75
           + I K +G G    V+ +  EK+   I A+K +   +   +Q     R E+   + L+  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 86
Query: 76  -PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
              I+RLY Y    + +Y+++E     +L   L+K K        +Y  ++  A+   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHT-----FNRRRTMCGTLDYLPPEMVESVE 189
             ++H D+KP N LI   G LK+ DFG +           + +  GT++Y+PPE ++ + 
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMS 204
Query: 190 HD-----------ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV---QVDLKFPPK 235
                           D+WSLG + Y   YG  PF+   +  +    +     +++FP  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P      +D++   L +D  QR+ + +LL HP++
Sbjct: 265 P--EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 193 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 235
Query: 249 MLV 251
           M+V
Sbjct: 236 MIV 238

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 70
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 191 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 233
Query: 249 MLV 251
           M+V
Sbjct: 234 MIV 236

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 79
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 200 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 242
Query: 249 MLV 251
           M+V
Sbjct: 243 MIV 245

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 77
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 198 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 240
Query: 249 MLV 251
           M+V
Sbjct: 241 MIV 243

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 193 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 235
Query: 249 MLV 251
           M+V
Sbjct: 236 MIV 238

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 224 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 266
Query: 249 MLV 251
           M+V
Sbjct: 267 MIV 269

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 78
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 199 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 241
Query: 249 MLV 251
           M+V
Sbjct: 242 MIV 244

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 211 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 253
Query: 249 MLV 251
           M+V
Sbjct: 254 MIV 256

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 196 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 238
Query: 249 MLV 251
           M+V
Sbjct: 239 MIV 241

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 192 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 234
Query: 249 MLV 251
           M+V
Sbjct: 235 MIV 237

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 76
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 197 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 239
Query: 249 MLV 251
           M+V
Sbjct: 240 MIV 242

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 211 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 253
Query: 249 MLV 251
           M+V
Sbjct: 254 MIV 256

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 18  FDIGKPLGRGKFGHVY-LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH- 75
           + I K +G G    V+ +  EK+   I A+K +   +   +Q     R E+   + L+  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQH 114
Query: 76  -PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
              I+RLY Y    + +Y+++E     +L   L+K K        +Y  ++  A+   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLDYLPPEMVESVE 189
             ++H D+KP N LI   G LK+ DFG +       T   + +  G ++Y+PPE ++ + 
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 190 HD-----------ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV---QVDLKFPPK 235
                           D+WSLG + Y   YG  PF+   +  +    +     +++FP  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           P      +D++   L +D  QR+ + +LL HP++
Sbjct: 293 P--EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 20/232 (8%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-R 74
           ND      +G G FG V  AR K+    +   +    +            E+E+   L  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYF----------------SERRA 118
           HPNI+ L G    +  +YL +EYA  G L   L+K +                  S ++ 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD 178
             + A +AR + Y   K  IHRD+   N+L+G     KIADFG S       +   G L 
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 179 --YLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQ 227
             ++  E +    +  N D+WS GVL +E +  G  P+     ++ Y ++ Q
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 104/245 (42%), Gaps = 37/245 (15%)
Query: 22  KPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRH 75
           + LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQH 73
Query: 76  PNILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            NI++  G  Y   R  + LI+E+   G L + LQK K      +   Y + + + + Y 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVE 186
             K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE + 
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
             +     D+WS GV+ YE       F   E S           K PP   +     D  
Sbjct: 194 ESKFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQ 236
Query: 247 SQMLV 251
            QM+V
Sbjct: 237 GQMIV 241

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 14/274 (5%)
Query: 7   AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE 66
           A E      +D +    LGRG +G V   R   S  I A+K +  +    SQ + +L  +
Sbjct: 25  AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATV--NSQEQKRLLXD 82
Query: 67  VEIQSH-LRHPNILRLYGYFYDQKRVYLILEY--AAKGELYKE-LQKCKYFSERRAATYV 122
           ++I    +  P  +  YG  + +  V++  E    +  + YK+ + K +   E       
Sbjct: 83  LDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIA 142
Query: 123 ASLARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRTMCGTLDY 179
            S+ +AL + H K  VIHRD+KP N+LI A G++K  DFG S +  +   +    G   Y
Sbjct: 143 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPY 202
Query: 180 LPPEMV----ESVEHDANVDIWSLGVLCYEFLYGVPPFEA-KEHSDTYRRIVQVDLKFPP 234
             PE +        +    DIWSLG+   E      P+++        +++V+      P
Sbjct: 203 XAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP 262
Query: 235 KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
               S+   D  SQ L K+S +R    +L +HP+
Sbjct: 263 ADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPF 296

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 103/243 (42%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 73
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQK K      +   Y + + + + Y   
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHR++   N+L+  +  +KI DFG +         +  +      + +  PE +   
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 193
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 194 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 236
Query: 249 MLV 251
           M+V
Sbjct: 237 MIV 239

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 20/232 (8%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-R 74
           ND      +G G FG V  AR K+    +   +    +            E+E+   L  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYF----------------SERRA 118
           HPNI+ L G    +  +YL +EYA  G L   L+K +                  S ++ 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD 178
             + A +AR + Y   K  IHRD+   N+L+G     KIADFG S       +   G L 
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 179 --YLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQ 227
             ++  E +    +  N D+WS GVL +E +  G  P+     ++ Y ++ Q
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 246

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 110/257 (42%), Gaps = 54/257 (21%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           + +GK LG G FG V    +  S    ALK +    LQ  + ++   RE++I   L H N
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKN---RELDIMKVLDHVN 61
Query: 78  ILRLYGYFY--------------------------------------DQKRVYLILEYAA 99
           I++L  YFY                                        K + +I+EY  
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 100 KGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-GE 154
              L+K L+      +       + Y+  L RA+ + H   + HRDIKP+NLL+ ++   
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 155 LKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVP 211
           LK+ DFG +   + +      +C      P  M+ + E+  ++D+WS+G +  E + G P
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 212 PFEAKEHSDTYRRIVQV 228
            F  +   D   RI+Q+
Sbjct: 241 LFSGETSIDQLVRIIQI 257

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 130/289 (44%), Gaps = 42/289 (14%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +DF+    LG+G FG V  AR    +   A+K +  ++ + S +      EV + + L H
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI----LSEVMLLASLNH 61
Query: 76  PNILRLYGYFYDQKR-------------VYLILEYAAKGELYKELQKCKYFSERRAATY- 121
             ++R Y  + +++              +++ +EY     LY +L   +  +++R   + 
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLY-DLIHSENLNQQRDEYWR 120
Query: 122 -VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VH------------- 165
               +  AL Y H + +IHRD+KP N+ I     +KI DFG +  VH             
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 166 --TFNRRRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY 222
             + +   +  GT  Y+  E+++   H +  +D++SLG++ +E +Y  P     E  +  
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238
Query: 223 RRIVQVDLKFPP--KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +++  V ++FPP          K +I  ++  D ++R     LL   W+
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 106/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y+++EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 81  VVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   KD  +
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKDPEE 258
Query: 257 R 257
           R
Sbjct: 259 R 259

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 25/251 (9%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LGRG FG V+   +K++    A+K   K +L+  + E     E+   + L  P I+ LYG
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVK---KVRLEVFRAE-----ELMACAGLTSPRIVPLYG 152
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
              +   V + +E    G L + +++     E RA  Y+      L Y H + ++H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 144 PENLLIGAQGE-LKIADFGWSV--------HTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
            +N+L+ + G    + DFG +V         +      + GT  ++ PE+V     DA V
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV 272
Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLISQMLVK 252
           D+WS   +    L G  P+     +  +R  + + +   P P+  +  +   L +Q  ++
Sbjct: 273 DVWSSCCMMLHMLNGCHPW-----TQFFRGPLCLKIASEPPPVREIPPSCAPLTAQA-IQ 326
Query: 253 DSSQRLPLHKL 263
           +  ++ P+H++
Sbjct: 327 EGLRKEPIHRV 337

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 134/297 (45%), Gaps = 52/297 (17%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N  V +K+L      +   +++++RE++I  +LR 
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL------KPVKKNKIKREIKILENLRG 90
Query: 76  -PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
            PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YC
Sbjct: 91  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYC 147
Query: 133 HGKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESV 188
           H   ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 189 EHDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP 234
            +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 235 K----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +                       +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 101/243 (41%), Gaps = 37/243 (15%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPN 77
           LG+G FG V + R    +  +  +VA+K     +LQ S  EH     RE+EI   L+H N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + LI+EY   G L   LQ   +     +   Y + + + + Y   
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           K  IHRD+   N+L+  +  +KI DFG +            +      + +  PE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +     D+WS GV+ YE       F   E S           K PP   +     D   Q
Sbjct: 196 KFSVASDVWSFGVVLYEL------FTYIEKS-----------KSPPAEFMRMIGNDKQGQ 238
Query: 249 MLV 251
           M+V
Sbjct: 239 MIV 241

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LGRG FG V+  ++K++    A+K   K +L+  +VE     E+   + L  P I+ LYG
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE-----ELVACAGLSSPRIVPLYG 131
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
              +   V + +E    G L + +++     E RA  Y+      L Y H + ++H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 144 PENLLIGAQGE-LKIADFGWSVHTFNRRRTMCG----TLDYLP-------PEMVESVEHD 191
            +N+L+ + G    + DFG   H    +    G    T DY+P       PE+V     D
Sbjct: 192 ADNVLLSSDGSRAALCDFG---HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 192 ANVDIWSLGVLCYEFLYGVPPF 213
           A VDIWS   +    L G  P+
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHPW 270

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 77  NILRLYGYFYDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
            ++RL  +F       LILE      +L+  + +     E  A ++   +  A+ +CH  
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 136 HVIHRDIKPENLLIG-AQGELKIADFGWSVHTFNRRRT-MCGTLDYLPPEMVESVE-HDA 192
            V+HRDIK EN+LI   +GELK+ DFG      +   T   GT  Y PPE +     H  
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 236
Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
           +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VSS  + LI   L  
Sbjct: 237 SAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR--VSSECQHLIRWCLAL 288
Query: 253 DSSQRLPLHKLLEHPWI 269
             S R    ++  HPW+
Sbjct: 289 RPSDRPTFEEIQNHPWM 305

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALKVLFKS-QLQQSQVEHQLRREVEIQSHLRHPNIL 79
           G  +G G FG VY  +   +N  VA+K L     +   +++ Q  +E+++ +  +H N++
Sbjct: 36  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQ---KCKYFSERRAATYVASLARALIYCHGKH 136
            L G+  D   + L+  Y   G L   L         S           A  + + H  H
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-----MCGTLDYLPPEMVESVEHD 191
            IHRDIK  N+L+      KI+DFG +  +    +T     + GT  Y+ PE +   E  
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG-EIT 212
Query: 192 ANVDIWSLGVLCYEFLYGVPPFE 214
              DI+S GV+  E + G+P  +
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALKVLFKS-QLQQSQVEHQLRREVEIQSHLRHPNIL 79
           G  +G G FG VY  +   +N  VA+K L     +   +++ Q  +E+++ +  +H N++
Sbjct: 36  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQ---KCKYFSERRAATYVASLARALIYCHGKH 136
            L G+  D   + L+  Y   G L   L         S           A  + + H  H
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-----MCGTLDYLPPEMVESVEHD 191
            IHRDIK  N+L+      KI+DFG +  +    +T     + GT  Y+ PE +   E  
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRG-EIT 212
Query: 192 ANVDIWSLGVLCYEFLYGVPPFE 214
              DI+S GV+  E + G+P  +
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 134/312 (42%), Gaps = 61/312 (19%)
Query: 14  TLNDFDIG------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
            ++ FD+G      KPLG G  G V+ A +   +  VA+K +  +  Q   V+H LR E+
Sbjct: 3   NIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS--VKHALR-EI 59
Query: 68  EIQSHLRHPNILRLY--------------GYFYDQKRVYLILEYAAKGELYKELQKCKYF 113
           +I   L H NI++++              G   +   VY++ EY  + +L   L++    
Sbjct: 60  KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLL 118
Query: 114 SERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWS----VHTFN 168
            E  A  ++  L R L Y H  +V+HRD+KP NL I  +   LKI DFG +     H  +
Sbjct: 119 -EEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 169 RRRTMCGTLD--YLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKE-------- 217
           +     G +   Y  P ++ S   +   +D+W+ G +  E L G   F            
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
Query: 218 -------HSDTYRRIVQV-------DLKFPPKPI------VSSAAKDLISQMLVKDSSQR 257
                  H +  + ++ V       D+  P KP+      +S  A D + Q+L      R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297
Query: 258 LPLHKLLEHPWI 269
           L   + L HP++
Sbjct: 298 LTAEEALSHPYM 309

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 20/232 (8%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-R 74
           ND      +G G FG V  AR K+    +   +    +            E+E+   L  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYF----------------SERRA 118
           HPNI+ L G    +  +YL +EYA  G L   L+K +                  S ++ 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD 178
             + A +AR + Y   K  IHR++   N+L+G     KIADFG S       +   G L 
Sbjct: 142 LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 201
Query: 179 --YLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQ 227
             ++  E +    +  N D+WS GVL +E +  G  P+     ++ Y ++ Q
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 253

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 115/251 (45%), Gaps = 25/251 (9%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LGRG FG V+   +K++    A+K   K +L+  + E     E+   + L  P I+ LYG
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVK---KVRLEVFRAE-----ELMACAGLTSPRIVPLYG 133
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
              +   V + +E    G L + +++     E RA  Y+      L Y H + ++H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 144 PENLLIGAQGE-LKIADFGWSV--------HTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
            +N+L+ + G    + DFG +V                + GT  ++ PE+V     DA V
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV 253
Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLISQMLVK 252
           D+WS   +    L G  P+     +  +R  + + +   P P+  +  +   L +Q  ++
Sbjct: 254 DVWSSCCMMLHMLNGCHPW-----TQFFRGPLCLKIASEPPPVREIPPSCAPLTAQA-IQ 307
Query: 253 DSSQRLPLHKL 263
           +  ++ P+H++
Sbjct: 308 EGLRKEPIHRV 318

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 106/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y+++EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 81  VVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   KD  +
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKDPEE 258
Query: 257 R 257
           R
Sbjct: 259 R 259

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 81  VVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   KD  +
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKDPEE 258
Query: 257 R 257
           R
Sbjct: 259 R 259

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 15  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 69
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 70  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   KD  +
Sbjct: 189 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKDPEE 247
Query: 257 R 257
           R
Sbjct: 248 R 248

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 17  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 71
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 72  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   KD  +
Sbjct: 191 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKDPEE 249
Query: 257 R 257
           R
Sbjct: 250 R 250

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 29/266 (10%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQQSQV 59
           +++   EK  +  N+   GK LG G FG V  A      + + ++ + V        +  
Sbjct: 33  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 92
Query: 60  EHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRA 118
           +  L  E++I SHL +H NI+ L G       V +I EY   G+L   L++     E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 119 ATYVAS--------------LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV 164
           A  +A+              +A+ + +   K+ IHRD+   N+L+      KI DFG + 
Sbjct: 153 AFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 165 HTFNRRRTMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEH 218
              N    +      LP     PE +    +    D+WS G+L +E F  G+ P+     
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272
Query: 219 SDTYRRIVQ-----VDLKFPPKPIVS 239
           +  + ++V+         F PK I S
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPKNIYS 298

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 29/266 (10%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQQSQV 59
           +++   EK  +  N+   GK LG G FG V  A      + + ++ + V        +  
Sbjct: 33  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 92
Query: 60  EHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRA 118
           +  L  E++I SHL +H NI+ L G       V +I EY   G+L   L++     E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 119 ATYVAS--------------LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV 164
           A  +A+              +A+ + +   K+ IHRD+   N+L+      KI DFG + 
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 165 HTFNRRRTMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEH 218
              N    +      LP     PE +    +    D+WS G+L +E F  G+ P+     
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272
Query: 219 SDTYRRIVQ-----VDLKFPPKPIVS 239
           +  + ++V+         F PK I S
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPKNIYS 298

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 81  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   KD  +
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKDPEE 258
Query: 257 R 257
           R
Sbjct: 259 R 259

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +GRG FG V+  ++K++    A+K   K +L+  +VE     E+   + L  P I+ LYG
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE-----ELVACAGLSSPRIVPLYG 117
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
              +   V + +E    G L + +++     E RA  Y+      L Y H + ++H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 144 PENLLIGAQGE-LKIADFGWSVHTFNRRRTMCG----TLDYLP-------PEMVESVEHD 191
            +N+L+ + G    + DFG   H    +    G    T DY+P       PE+V     D
Sbjct: 178 ADNVLLSSDGSRAALCDFG---HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 192 ANVDIWSLGVLCYEFLYGVPPF 213
           A VDIWS   +    L G  P+
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPW 256

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y+++EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 81  VVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     +    R+     + +  PE           D+W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   KD  +
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKDPEE 258
Query: 257 R 257
           R
Sbjct: 259 R 259

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +GRG FG V+  ++K++    A+K   K +L+  +VE     E+   + L  P I+ LYG
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE-----ELVACAGLSSPRIVPLYG 133
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIK 143
              +   V + +E    G L + +++     E RA  Y+      L Y H + ++H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 144 PENLLIGAQGE-LKIADFGWSVHTFNRRRTMCG----TLDYLP-------PEMVESVEHD 191
            +N+L+ + G    + DFG   H    +    G    T DY+P       PE+V     D
Sbjct: 194 ADNVLLSSDGSRAALCDFG---HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 192 ANVDIWSLGVLCYEFLYGVPPF 213
           A VDIWS   +    L G  P+
Sbjct: 251 AKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMS----PEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 248 VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG       + +  R+     + +  PE           D+W
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   KD  +
Sbjct: 367 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKDPEE 425
Query: 257 R 257
           R
Sbjct: 426 R 426

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/328 (25%), Positives = 133/328 (40%), Gaps = 67/328 (20%)
Query: 2   CSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVE 60
           C EVS  EK         + K +G+G FG V+ AR +++   VALK VL +++ +   + 
Sbjct: 14  CDEVSKYEK---------LAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 63
Query: 61  HQLRREVEIQSHLRHPNILRLY--------GYFYDQKRVYLILEYAA---KGELYKELQK 109
               RE++I   L+H N++ L          Y   +  +YL+ ++      G L   L K
Sbjct: 64  AL--REIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK 121
Query: 110 CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF-- 167
              F+       +  L   L Y H   ++HRD+K  N+LI   G LK+ADFG +   F  
Sbjct: 122 ---FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA-RAFSL 177
Query: 168 ------NRRRTMCGTLDYLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD 220
                 NR      TL Y PPE ++   ++   +D+W  G +  E     P  +      
Sbjct: 178 AKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 237
Query: 221 TYRRIVQVDLKFPPK--PIVSS----------------------------AAKDLISQML 250
               I Q+     P+  P V +                             A DLI ++L
Sbjct: 238 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 297
Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPSGV 278
           V D +QR+     L H +   +  PS +
Sbjct: 298 VLDPAQRIDSDDALNHDFFWSDPMPSDL 325

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   +RH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKIRHEKLVQLYA 80
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 81  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   KD  +
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKDPEE 258
Query: 257 R 257
           R
Sbjct: 259 R 259

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 111/248 (44%), Gaps = 44/248 (17%)
Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILR 80
           G  +GRG +GHVY A+ K         +    Q++ + +     RE+ +   L+HPN++ 
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYAL---KQIEGTGISMSACREIALLRELKHPNVIS 82
Query: 81  LYGYF--YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI-------- 130
           L   F  +  ++V+L+ +YA + +L+  +   K+    +A      L R ++        
Sbjct: 83  LQKVFLSHADRKVWLLFDYA-EHDLWHII---KFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 131 ----YCHGKHVIHRDIKPENLLIGAQ----GELKIADFGWSVHTFNRRRTMCGTLD---- 178
               Y H   V+HRD+KP N+L+  +    G +KIAD G++   FN        LD    
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDPVVV 197
Query: 179 ---YLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKE---------HSDTYRRI 225
              Y  PE++    H    +DIW++G +  E L   P F  ++         H D   RI
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257
Query: 226 VQVDLKFP 233
             V + FP
Sbjct: 258 FNV-MGFP 264

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 110/262 (41%), Gaps = 25/262 (9%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQQSQV 59
           +++   EK  +  N+   GK LG G FG V  A      + + ++ + V        +  
Sbjct: 25  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 84
Query: 60  EHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK--------- 109
           +  L  E++I SHL +H NI+ L G       V +I EY   G+L   L++         
Sbjct: 85  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 144
Query: 110 -CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN 168
             +    R    + + +A+ + +   K+ IHRD+   N+L+      KI DFG +    N
Sbjct: 145 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 204
Query: 169 RRRTMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTY 222
               +      LP     PE +    +    D+WS G+L +E F  G+ P+     +  +
Sbjct: 205 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 264
Query: 223 RRIVQ-----VDLKFPPKPIVS 239
            ++V+         F PK I S
Sbjct: 265 YKLVKDGYQMAQPAFAPKNIYS 286

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 85/328 (25%), Positives = 133/328 (40%), Gaps = 67/328 (20%)
Query: 2   CSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVE 60
           C EVS  EK         + K +G+G FG V+ AR +++   VALK VL +++ +   + 
Sbjct: 14  CDEVSKYEK---------LAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 63
Query: 61  HQLRREVEIQSHLRHPNILRLY--------GYFYDQKRVYLILEYAA---KGELYKELQK 109
               RE++I   L+H N++ L          Y   +  +YL+ ++      G L   L K
Sbjct: 64  AL--REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK 121
Query: 110 CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF-- 167
              F+       +  L   L Y H   ++HRD+K  N+LI   G LK+ADFG +   F  
Sbjct: 122 ---FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA-RAFSL 177
Query: 168 ------NRRRTMCGTLDYLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD 220
                 NR      TL Y PPE ++   ++   +D+W  G +  E     P  +      
Sbjct: 178 AKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 237
Query: 221 TYRRIVQVDLKFPPK--PIVSS----------------------------AAKDLISQML 250
               I Q+     P+  P V +                             A DLI ++L
Sbjct: 238 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 297
Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPSGV 278
           V D +QR+     L H +   +  PS +
Sbjct: 298 VLDPAQRIDSDDALNHDFFWSDPMPSDL 325

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 111/268 (41%), Gaps = 31/268 (11%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQQSQV 59
           +++   EK  +  N+   GK LG G FG V  A      + + ++ + V        +  
Sbjct: 33  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 92
Query: 60  EHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK------- 111
           +  L  E++I SHL +H NI+ L G       V +I EY   G+L   L++ +       
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYS 152
Query: 112 ---------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW 162
                      S R    + + +A+ + +   K+ IHRD+   N+L+      KI DFG 
Sbjct: 153 YNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 212
Query: 163 SVHTFNRRRTMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAK 216
           +    N    +      LP     PE +    +    D+WS G+L +E F  G+ P+   
Sbjct: 213 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 272
Query: 217 EHSDTYRRIVQ-----VDLKFPPKPIVS 239
             +  + ++V+         F PK I S
Sbjct: 273 LVNSKFYKLVKDGYQMAQPAFAPKNIYS 300

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 81  VVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   KD  +
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKDPEE 258
Query: 257 R 257
           R
Sbjct: 259 R 259

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 128/289 (44%), Gaps = 42/289 (14%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +DF+    LG+G FG V  AR    +   A+K +  ++ + S +      EV + + L H
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI----LSEVXLLASLNH 61
Query: 76  PNILRLYGYFYDQKR-------------VYLILEYAAKGELYKELQKCKYFSERRAATY- 121
             ++R Y  + +++              +++  EY     LY +L   +  +++R   + 
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLY-DLIHSENLNQQRDEYWR 120
Query: 122 -VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VH------------- 165
               +  AL Y H + +IHR++KP N+ I     +KI DFG +  VH             
Sbjct: 121 LFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 166 --TFNRRRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY 222
             + +   +  GT  Y+  E+++   H +  +D +SLG++ +E +Y  P     E  +  
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY--PFSTGXERVNIL 238
Query: 223 RRIVQVDLKFPP--KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +++  V ++FPP          K +I  ++  D ++R     LL   W+
Sbjct: 239 KKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 81  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           +   N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   KD  +
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKDPEE 258
Query: 257 R 257
           R
Sbjct: 259 R 259

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 5   VSAKEKKRWTLNDFDIG-------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS 57
           +S+K +K W  + ++I        K LG G+FG V++A   +       KV  K+    S
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT-----KVAVKTMKPGS 224
Query: 58  QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSER- 116
                   E  +   L+H  +++L+     ++ +Y+I E+ AKG L   L+  +   +  
Sbjct: 225 MSVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 283
Query: 117 -RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRR 171
            +   + A +A  + +   ++ IHRD++  N+L+ A    KIADFG +     + +  R 
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
Query: 172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRI 225
                + +  PE +         D+WS G+L  E + YG  P+    + +  R +
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 85/328 (25%), Positives = 133/328 (40%), Gaps = 67/328 (20%)
Query: 2   CSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVE 60
           C EVS  EK         + K +G+G FG V+ AR +++   VALK VL +++ +   + 
Sbjct: 13  CDEVSKYEK---------LAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 62
Query: 61  HQLRREVEIQSHLRHPNILRLY--------GYFYDQKRVYLILEYAA---KGELYKELQK 109
               RE++I   L+H N++ L          Y   +  +YL+ ++      G L   L K
Sbjct: 63  AL--REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK 120
Query: 110 CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF-- 167
              F+       +  L   L Y H   ++HRD+K  N+LI   G LK+ADFG +   F  
Sbjct: 121 ---FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA-RAFSL 176
Query: 168 ------NRRRTMCGTLDYLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD 220
                 NR      TL Y PPE ++   ++   +D+W  G +  E     P  +      
Sbjct: 177 AKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236
Query: 221 TYRRIVQVDLKFPPK--PIVSS----------------------------AAKDLISQML 250
               I Q+     P+  P V +                             A DLI ++L
Sbjct: 237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 296
Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPSGV 278
           V D +QR+     L H +   +  PS +
Sbjct: 297 VLDPAQRIDSDDALNHDFFWSDPMPSDL 324

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 85/328 (25%), Positives = 133/328 (40%), Gaps = 67/328 (20%)
Query: 2   CSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVE 60
           C EVS  EK         + K +G+G FG V+ AR +++   VALK VL +++ +   + 
Sbjct: 14  CDEVSKYEK---------LAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 63
Query: 61  HQLRREVEIQSHLRHPNILRLY--------GYFYDQKRVYLILEYAA---KGELYKELQK 109
               RE++I   L+H N++ L          Y   +  +YL+ ++      G L   L K
Sbjct: 64  A--LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK 121
Query: 110 CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF-- 167
              F+       +  L   L Y H   ++HRD+K  N+LI   G LK+ADFG +   F  
Sbjct: 122 ---FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA-RAFSL 177
Query: 168 ------NRRRTMCGTLDYLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD 220
                 NR      TL Y PPE ++   ++   +D+W  G +  E     P  +      
Sbjct: 178 AKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 237
Query: 221 TYRRIVQVDLKFPPK--PIVSS----------------------------AAKDLISQML 250
               I Q+     P+  P V +                             A DLI ++L
Sbjct: 238 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 297
Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPSGV 278
           V D +QR+     L H +   +  PS +
Sbjct: 298 VLDPAQRIDSDDALNHDFFWSDPMPSDL 325

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 111/262 (42%), Gaps = 25/262 (9%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQQSQV 59
           +++   EK  +  N+   GK LG G FG V  A      + + ++ + V        +  
Sbjct: 33  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 92
Query: 60  EHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK--------- 109
           +  L  E++I SHL +H NI+ L G       V +I EY   G+L   L++         
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 152
Query: 110 -CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN 168
             +    R    + + +A+ + +   K+ IHRD+   N+L+      KI DFG +    N
Sbjct: 153 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 212
Query: 169 RRRTMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTY 222
               +      LP     PE +    +    D+WS G+L +E F  G+ P+     +  +
Sbjct: 213 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 272
Query: 223 RRIVQVDLK-----FPPKPIVS 239
            ++V+   +     F PK I S
Sbjct: 273 YKLVKDGYQMAQPAFAPKNIYS 294

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 15/226 (6%)
Query: 9   EKKRWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE 66
           EK  W +      + K LG G+FG V++A   +       KV  K+    S        E
Sbjct: 6   EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT-----KVAVKTMKPGSMSVEAFLAE 60
Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSER--RAATYVAS 124
             +   L+H  +++L+     ++ +Y+I E+ AKG L   L+  +   +   +   + A 
Sbjct: 61  ANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 119
Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYL 180
           +A  + +   ++ IHRD++  N+L+ A    KIADFG +     + +  R      + + 
Sbjct: 120 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 179
Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRI 225
            PE +         D+WS G+L  E + YG  P+    + +  R +
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 37/241 (15%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           N+ +  + +G G FG V+ AR           +VA+K+L +      Q + Q  RE  + 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ--REAALM 104
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK------CKY-FSERRAATYVA 123
           +   +PNI++L G     K + L+ EY A G+L + L+       C    S+      V+
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 124 S-----------------LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT 166
           S                 +A  + Y   +  +HRD+   N L+G    +KIADFG S + 
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 167 FNRRRTMCGTLD-----YLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSD 220
           ++         D     ++PPE +    +    D+W+ GV+ +E F YG+ P+    H +
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 221 T 221
Sbjct: 285 V 285

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 12/203 (5%)
Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALKVLFKS-QLQQSQVEHQLRREVEIQSHLRHPNIL 79
           G  +G G FG VY  +   +N  VA+K L     +   +++ Q  +E+++ +  +H N++
Sbjct: 30  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 87
Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQ---KCKYFSERRAATYVASLARALIYCHGKH 136
            L G+  D   + L+  Y   G L   L         S           A  + + H  H
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 147
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-----MCGTLDYLPPEMVESVEHD 191
            IHRDIK  N+L+      KI+DFG +  +    +      + GT  Y+ PE +   E  
Sbjct: 148 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG-EIT 206
Query: 192 ANVDIWSLGVLCYEFLYGVPPFE 214
              DI+S GV+  E + G+P  +
Sbjct: 207 PKSDIYSFGVVLLEIITGLPAVD 229

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 19  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 73
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 74  VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   K+  +
Sbjct: 193 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEE 251
Query: 257 R 257
           R
Sbjct: 252 R 252

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 114/250 (45%), Gaps = 26/250 (10%)
Query: 13  WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           W L+D      LG+G   +V+  R K++  + A+KV F +      V+ Q+R E E+   
Sbjct: 11  WLLSDI-----LGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMR-EFEVLKK 63
Query: 73  LRHPNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKY---FSERRAATYVASLAR 127
           L H NI++L+    +   +   LI+E+   G LY  L++        E      +  +  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 128 ALIYCHGKHVIHRDIKPENLL--IGAQGE--LKIADFGWSVHTFNRRR--TMCGTLDYLP 181
            + +     ++HR+IKP N++  IG  G+   K+ DFG +    +  +  ++ GT +YL 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 182 PEMVESV--------EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           P+M E          ++ A VD+WS+GV  Y    G  PF   E     + ++   +   
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 234 PKPIVSSAAK 243
           P   +S   K
Sbjct: 244 PSGAISGVQK 253

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           KR+ + DF   + +G G FG V+ A+ +       +K   + +    + E    REV+  
Sbjct: 7   KRFGM-DFKEIELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNNEKAE----REVKAL 58
Query: 71  SHLRHPNILRLYG----YFYD------------QKRVYLILEYAAKGEL--YKELQKCKY 112
           + L H NI+   G    + YD             K +++ +E+  KG L  + E ++ + 
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 113 FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRR 170
             +  A      + + + Y H K +I+RD+KP N+ +    ++KI DFG   S+    +R
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY 208
               GTL Y+ PE + S ++   VD+++LG++  E L+
Sbjct: 179 XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 247 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   K+  +
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEE 424
Query: 257 R 257
           R
Sbjct: 425 R 425

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 247 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   K+  +
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEE 424
Query: 257 R 257
           R
Sbjct: 425 R 425

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 113/273 (41%), Gaps = 27/273 (9%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 70
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ EY   G L   L+K    F+  +    +  +A  
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG S    +       T      + +  P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 249
Query: 242 AKDLISQMLVKDSSQRLP-------LHKLLEHP 267
              L+     KD + R         L KL+ +P
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 282

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 113/250 (45%), Gaps = 26/250 (10%)
Query: 13  WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           W L+D      LG+G   +V+  R K++  + A+KV F +      V+ Q+R E E+   
Sbjct: 11  WLLSDI-----LGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMR-EFEVLKK 63
Query: 73  LRHPNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKY---FSERRAATYVASLAR 127
           L H NI++L+    +   +   LI+E+   G LY  L++        E      +  +  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 128 ALIYCHGKHVIHRDIKPENLL--IGAQGE--LKIADFGWSVHTFNRRR--TMCGTLDYLP 181
            + +     ++HR+IKP N++  IG  G+   K+ DFG +    +  +   + GT +YL 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLH 183
Query: 182 PEMVESV--------EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           P+M E          ++ A VD+WS+GV  Y    G  PF   E     + ++   +   
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 234 PKPIVSSAAK 243
           P   +S   K
Sbjct: 244 PSGAISGVQK 253

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 113/273 (41%), Gaps = 27/273 (9%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 33  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 87
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ EY   G L   L+K    F+  +    +  +A  
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG S    +       T      + +  P
Sbjct: 148 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 266
Query: 242 AKDLISQMLVKDSSQRLP-------LHKLLEHP 267
              L+     KD + R         L KL+ +P
Sbjct: 267 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 299

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 26/263 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 5   WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 60
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY   + ++ ++ ++     LY  L   +  F   +        A+ +
Sbjct: 61  RKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ---LSGSILWMA 176
Query: 182 PEMVESVEHDA---NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           PE++   + +      D+++ G++ YE + G  P+    + D    +V      P    V
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 236
Query: 239 SS----AAKDLISQMLVKDSSQR 257
            S    A K L+++ L K   +R
Sbjct: 237 RSNCPKAMKRLMAECLKKKRDER 259

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 20/263 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 99
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ EY   G L   L+K    F+  +    +  +A  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG S    +       T      + +  P
Sbjct: 160 MKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 278
Query: 242 AKDLISQMLVKDSSQRLPLHKLL 264
              L+     KD + R    +++
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 26/263 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 23  WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 78
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY   + ++ ++ ++     LY  L   +  F   +        A+ +
Sbjct: 79  RKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 137
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 138 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ---LSGSILWMA 194
Query: 182 PEMVESVEHDA---NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           PE++   + +      D+++ G++ YE + G  P+    + D    +V      P    V
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 254
Query: 239 SS----AAKDLISQMLVKDSSQR 257
            S    A K L+++ L K   +R
Sbjct: 255 RSNCPKAMKRLMAECLKKKRDER 277

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 330 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   K+  +
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEE 507
Query: 257 R 257
           R
Sbjct: 508 R 508

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 26/263 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 8   WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 63
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY   + ++ ++ ++     LY  L   +  F   +        A+ +
Sbjct: 64  RKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ---LSGSILWMA 179
Query: 182 PEMVESVEHDA---NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           PE++   + +      D+++ G++ YE + G  P+    + D    +V      P    V
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 239
Query: 239 SS----AAKDLISQMLVKDSSQR 257
            S    A K L+++ L K   +R
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDER 262

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 26/263 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 30  WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 85
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY   + ++ ++ ++     LY  L   +  F   +        A+ +
Sbjct: 86  RKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 144
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 145 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ---LSGSILWMA 201
Query: 182 PEMVESVEHDA---NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           PE++   + +      D+++ G++ YE + G  P+    + D    +V      P    V
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 261
Query: 239 SS----AAKDLISQMLVKDSSQR 257
            S    A K L+++ L K   +R
Sbjct: 262 RSNCPKAMKRLMAECLKKKRDER 284

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 26/263 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 31  WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 86
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY   + ++ ++ ++     LY  L   +  F   +        A+ +
Sbjct: 87  RKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ---LSGSILWMA 202
Query: 182 PEMVESVEHDA---NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           PE++   + +      D+++ G++ YE + G  P+    + D    +V      P    V
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 262
Query: 239 SS----AAKDLISQMLVKDSSQR 257
            S    A K L+++ L K   +R
Sbjct: 263 RSNCPKAMKRLMAECLKKKRDER 285

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 26/263 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 8   WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 63
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY   + ++ ++ ++     LY  L   +  F   +        A+ +
Sbjct: 64  RKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ---LSGSILWMA 179
Query: 182 PEMVESVEHDA---NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           PE++   + +      D+++ G++ YE + G  P+    + D    +V      P    V
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 239
Query: 239 SS----AAKDLISQMLVKDSSQR 257
            S    A K L+++ L K   +R
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDER 262

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 22/231 (9%)
Query: 5   VSAKEKKRWTLNDFDIG-------KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS 57
           +S+K +K W  + ++I        K LG G+FG V++A   +       KV  K+    S
Sbjct: 164 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT-----KVAVKTMKPGS 218
Query: 58  QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSER- 116
                   E  +   L+H  +++L+     ++ +Y+I E+ AKG L   L+  +   +  
Sbjct: 219 MSVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 277
Query: 117 -RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG 175
            +   + A +A  + +   ++ IHRD++  N+L+ A    KIADFG +      R     
Sbjct: 278 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA------RVGAKF 331
Query: 176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRI 225
            + +  PE +         D+WS G+L  E + YG  P+    + +  R +
Sbjct: 332 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 382

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 26/263 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 31  WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 86
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY   + ++ ++ ++     LY  L   +  F   +        A+ +
Sbjct: 87  RKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ---LSGSILWMA 202
Query: 182 PEMVESVEHDA---NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           PE++   + +      D+++ G++ YE + G  P+    + D    +V      P    V
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 262
Query: 239 SS----AAKDLISQMLVKDSSQR 257
            S    A K L+++ L K   +R
Sbjct: 263 RSNCPKAMKRLMAECLKKKRDER 285

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 26/263 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 58
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY   + ++ ++ ++     LY  L   +  F   +        A+ +
Sbjct: 59  RKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ---LSGSILWMA 174
Query: 182 PEMVESVEHDA---NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           PE++   + +      D+++ G++ YE + G  P+    + D    +V      P    V
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 239 SS----AAKDLISQMLVKDSSQR 257
            S    A K L+++ L K   +R
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDER 257

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 26/263 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 58
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY   + ++ ++ ++     LY  L   +  F   +        A+ +
Sbjct: 59  RKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ---LSGSILWMA 174
Query: 182 PEMVESVEHDA---NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           PE++   + +      D+++ G++ YE + G  P+    + D    +V      P    V
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 239 SS----AAKDLISQMLVKDSSQR 257
            S    A K L+++ L K   +R
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDER 257

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 123/264 (46%), Gaps = 26/264 (9%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G  G + + R    N  VA+K +       +  E QL RE +      HPN++R + 
Sbjct: 32  LGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFADREVQLLRESD-----EHPNVIRYFC 85
Query: 84  YFYDQKRVYLILEY-AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI 142
              D++  Y+ +E  AA  + Y E +   +       T +      L + H  +++HRD+
Sbjct: 86  TEKDRQFQYIAIELCAATLQEYVEQKDFAHLG-LEPITLLQQTTSGLAHLHSLNIVHRDL 144
Query: 143 KPENLLI---GAQGELK--IADFGW------SVHTFNRRRTMCGTLDYLPPEMV-ESVEH 190
           KP N+LI    A G++K  I+DFG         H+F+RR  + GT  ++ PEM+ E  + 
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 191 DA--NVDIWSLGVLCYEFLY-GVPPF--EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
           +    VDI+S G + Y  +  G  PF    +  ++       +D   P K      A++L
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH-EDVIAREL 263
Query: 246 ISQMLVKDSSQRLPLHKLLEHPWI 269
           I +M+  D  +R     +L+HP+ 
Sbjct: 264 IEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 20/263 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 99
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ EY   G L   L+K    F+  +    +  +A  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG S    +       T      + +  P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 278
Query: 242 AKDLISQMLVKDSSQRLPLHKLL 264
              L+     KD + R    +++
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 20/263 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 99
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ EY   G L   L+K    F+  +    +  +A  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG S    +       T      + +  P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 278
Query: 242 AKDLISQMLVKDSSQRLPLHKLL 264
              L+     KD + R    +++
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 20/263 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 99
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ EY   G L   L+K    F+  +    +  +A  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG S    +       T      + +  P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 278
Query: 242 AKDLISQMLVKDSSQRLPLHKLL 264
              L+     KD + R    +++
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 20/263 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 99
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ EY   G L   L+K    F+  +    +  +A  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG S    +       T      + +  P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 278
Query: 242 AKDLISQMLVKDSSQRLPLHKLL 264
              L+     KD + R    +++
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 20/263 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 43  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 97
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ EY   G L   L+K    F+  +    +  +A  
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 157
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG S    +       T      + +  P
Sbjct: 158 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 276
Query: 242 AKDLISQMLVKDSSQRLPLHKLL 264
              L+     KD + R    +++
Sbjct: 277 LYQLMLDCWQKDRNNRPKFEQIV 299

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 108/227 (47%), Gaps = 38/227 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE-HQLRREVEIQSHLR 74
           ++++I   +GRG +G+VYLA +K +N  VA+K +  +++ +  ++  ++ RE+ I + L+
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKV--NRMFEDLIDCKRILREITILNRLK 85
Query: 75  HPNILRLYGYFYDQK-----RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
              I+RL+     +       +Y++LE  A  +L K  +   + +E+   T + +L    
Sbjct: 86  SDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGE 144
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-------------------------V 164
            + H   +IHRD+KP N L+     +KI DFG +                          
Sbjct: 145 KFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 165 HTFNRRRTMCG---TLDYLPPEMVESVEHDAN-VDIWSLGVLCYEFL 207
           H  N ++ +     T  Y  PE++   E+  N +DIWS G +  E L
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 247 VVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   K+  +
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEE 424
Query: 257 R 257
           R
Sbjct: 425 R 425

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 95/231 (41%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S L H NI+R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 232
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 233 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 283

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 95/231 (41%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S L H NI+R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 159 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 218
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 219 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 269

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 77
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY  KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 78  VVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   K+  +
Sbjct: 197 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEE 255
Query: 257 R 257
           R
Sbjct: 256 R 256

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 112/264 (42%), Gaps = 23/264 (8%)
Query: 24  LGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILR 80
           +G G+FG V   R K   +    VA+K L K    + Q   +   E  I     HPNI+R
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQ-RREFLSEASIMGQFEHPNIIR 79
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHVIH 139
           L G   +   V ++ E+   G L   L+     F+  +    +  +A  + Y      +H
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 139
Query: 140 RDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLD------YLPPEMVESVEHD 191
           RD+   N+L+ +    K++DFG S  +   +   T   +L       +  PE +   +  
Sbjct: 140 RDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFT 199
Query: 192 ANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           +  D WS G++ +E + +G  P+    + D    I Q D + PP P   ++   L+    
Sbjct: 200 SASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ-DYRLPPPPDCPTSLHQLMLDCW 258
Query: 251 VKDSSQ--RLP-----LHKLLEHP 267
            KD +   R P     L K++ +P
Sbjct: 259 QKDRNARPRFPQVVSALDKMIRNP 282

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 118/263 (44%), Gaps = 26/263 (9%)
Query: 13  WTLND--FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W + D    +G+ +G G FG VY   + + +  VA+K+L  +     Q++   + EV + 
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGVL 58
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARAL 129
              RH NIL   GY     ++ ++ ++     LY  L   +  F   +        A+ +
Sbjct: 59  RKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFG-------WS-VHTFNRRRTMCGTLDYLP 181
            Y H K +IHRD+K  N+ +     +KI DFG       WS  H F +   + G++ ++ 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ---LSGSILWMA 174
Query: 182 PEMVESVEHDA---NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           PE++   + +      D+++ G++ YE + G  P+    + D    +V      P    V
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 239 SS----AAKDLISQMLVKDSSQR 257
            S    A K L+++ L K   +R
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDER 257

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 105/251 (41%), Gaps = 16/251 (6%)
Query: 20  IGKPLGRGKFGHV---YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           I + +G G+FG V   +L    +    VA+K L KS   + Q       E  I     HP
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQ-RRDFLSEASIMGQFDHP 94
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGK 135
           N++ L G       V +I E+   G L   L Q    F+  +    +  +A  + Y    
Sbjct: 95  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLD------YLPPEMVES 187
           + +HRD+   N+L+ +    K++DFG S  +       T    L       +  PE ++ 
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 188 VEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
            +  +  D+WS G++ +E + YG  P+    + D    I Q D + PP     SA   L+
Sbjct: 215 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMDCPSALHQLM 273
Query: 247 SQMLVKDSSQR 257
                KD + R
Sbjct: 274 LDCWQKDRNHR 284

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 77
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  +Y++ EY  KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 78  VVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     + +  R+     + +  PE           D+W
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   K+  +
Sbjct: 197 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEE 255
Query: 257 R 257
           R
Sbjct: 256 R 256

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 112/264 (42%), Gaps = 23/264 (8%)
Query: 24  LGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILR 80
           +G G+FG V   R K   +    VA+K L     ++ +   +   E  I     HPNI+R
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHPNIIR 81
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHVIH 139
           L G   +   V ++ E+   G L   L+     F+  +    +  +A  + Y      +H
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 141
Query: 140 RDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLD------YLPPEMVESVEHD 191
           RD+   N+L+ +    K++DFG S  +   +   T   +L       +  PE +   +  
Sbjct: 142 RDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFT 201
Query: 192 ANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           +  D WS G++ +E + +G  P+    + D    I Q D + PP P   ++   L+    
Sbjct: 202 SASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ-DYRLPPPPDCPTSLHQLMLDCW 260
Query: 251 VKDSSQ--RLP-----LHKLLEHP 267
            KD +   R P     L K++ +P
Sbjct: 261 QKDRNARPRFPQVVSALDKMIRNP 284

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 110/263 (41%), Gaps = 20/263 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 99
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ EY   G L   L+K    F+  +    +  +A  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG +    +       T      + +  P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 278
Query: 242 AKDLISQMLVKDSSQRLPLHKLL 264
              L+     KD + R    +++
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 23/230 (10%)
Query: 4   EVSAKEKKRWTLNDFDIGKP-------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ 56
           EV   + KR++L +  +          LGRG FG VY  R      +VA+K L + + Q 
Sbjct: 19  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERXQG 77
Query: 57  SQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSE- 115
            ++  Q + EVE+ S   H N+LRL G+        L+  Y A G +   L++       
Sbjct: 78  GEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 135
Query: 116 ----RRAATYVASLARALIYCHG---KHVIHRDIKPENLLIGAQGELKIADFGWS----V 164
               +R    + S AR L Y H      +IHRD+K  N+L+  + E  + DFG +     
Sbjct: 136 LDWPKRQRIALGS-ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 194
Query: 165 HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFE 214
              +    + GT+ ++ PE + + +     D++  GV+  E + G   F+
Sbjct: 195 KDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 244

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPNILRL 81
           LG G FG V L R          +V  KS   +S   H   L++E+EI  +L H NI++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 82  YGYFYDQ--KRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVI 138
            G   +     + LI+E+   G L + L K K   + ++   Y   + + + Y   +  +
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYV 148
Query: 139 HRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLD-----YLPPEMVESVEHD 191
           HRD+   N+L+ ++ ++KI DFG +  + T     T+    D     Y P  +++S  + 
Sbjct: 149 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYI 208
Query: 192 ANVDIWSLGVLCYEFL 207
           A+ D+WS GV  +E L
Sbjct: 209 AS-DVWSFGVTLHELL 223

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 109/263 (41%), Gaps = 20/263 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 99
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ EY   G L   L+K    F+  +    +  +A  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG      +       T      + +  P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 278
Query: 242 AKDLISQMLVKDSSQRLPLHKLL 264
              L+     KD + R    +++
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 22  KPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           K +G G+FG VY    K S+      VA+K L     ++ +V+     E  I     H N
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMGQFSHHN 107
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKH 136
           I+RL G     K + +I EY   G L K L +K   FS  +    +  +A  + Y    +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGTLDYLP-----PEMVESVEH 190
            +HRD+   N+L+ +    K++DFG S V   +   T   +   +P     PE +   + 
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 191 DANVDIWSLGVLCYEFL-YGVPPF 213
            +  D+WS G++ +E + YG  P+
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPY 251

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 159 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAF 218
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 219 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 269

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH--QLRREVEIQSHLRHPNIL 79
           + LG G FG V L R          +V  KS   +S   H   L++E+EI  +L H NI+
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 80  RLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKH 136
           +  G   +     + LI+E+   G L + L K K   + ++   Y   + + + Y   + 
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLD-----YLPPEMVESVE 189
            +HRD+   N+L+ ++ ++KI DFG +  + T     T+    D     Y P  +++S  
Sbjct: 135 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKF 194
Query: 190 HDANVDIWSLGVLCYEFL 207
           + A+ D+WS GV  +E L
Sbjct: 195 YIAS-DVWSFGVTLHELL 211

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTLD--YLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 150 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 209
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 210 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 260

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 108/235 (45%), Gaps = 16/235 (6%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G+FG V L + K   + VA+K++     + S  E +  +E +    L HP +++ 
Sbjct: 14  KELGSGQFGVVKLGKWK-GQYDVAVKMI----KEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHR 140
           YG    +  +Y++ EY + G L   L+   K     +       +   + +      IHR
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 141 DIKPENLLIGAQGELKIADFGWSVHTFNRRR-TMCGT---LDYLPPEMVESVEHDANVDI 196
           D+   N L+     +K++DFG + +  + +  +  GT   + +  PE+    ++ +  D+
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 197 WSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           W+ G+L +E F  G  P++   +S+   ++ Q    + P       A D I Q++
Sbjct: 189 WAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH-----LASDTIYQIM 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALKVLFKS-QLQQSQVEHQLRREVEIQSHLRHPNIL 79
           G   G G FG VY  +   +N  VA+K L     +   +++ Q  +E+++ +  +H N++
Sbjct: 27  GNKXGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLV 84
Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQ---KCKYFSERRAATYVASLARALIYCHGKH 136
            L G+  D   + L+  Y   G L   L         S           A  + + H  H
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENH 144
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESVEH 190
            IHRDIK  N+L+      KI+DFG +             R + GT  Y  PE +   E 
Sbjct: 145 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSR-IVGTTAYXAPEALRG-EI 202
Query: 191 DANVDIWSLGVLCYEFLYGVPPFE 214
               DI+S GV+  E + G+P  +
Sbjct: 203 TPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 218 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 268

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 176 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF 235
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 236 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 286

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 159 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 218
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 219 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 269

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 175 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 234
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 235 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 285

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 165 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 224
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 225 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 275

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 199 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF 258
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 259 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 309

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 232
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 233 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 283

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 13/221 (5%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           ++K  TL D    K LG G FG V     + +         + K++     ++ +L  E 
Sbjct: 8   DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 63
Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
            +   L +P I+R+ G   + +   L++E A  G L K LQ+ ++  ++     V  ++ 
Sbjct: 64  NVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 122
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV------HTFNRRRTMCGTLDYLP 181
            + Y    + +HRD+   N+L+  Q   KI+DFG S       + +  +      + +  
Sbjct: 123 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYA 182
Query: 182 PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
           PE +   +  +  D+WS GVL +E F YG  P+   + S+ 
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 109/263 (41%), Gaps = 20/263 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 99
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ E    G L   L+K    F+  +    +  +A  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG S    +       T      + +  P
Sbjct: 160 MKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 278
Query: 242 AKDLISQMLVKDSSQRLPLHKLL 264
              L+     KD + R    +++
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 105/233 (45%), Gaps = 17/233 (7%)
Query: 1   ACSEVSAKE----KKRWTLNDFDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQLQ 55
           A  E+  KE    +K  TL D    K LG G FG V     + +         + K++  
Sbjct: 2   ALEEIRPKEVYLDRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN 57
Query: 56  QSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSE 115
              ++ +L  E  +   L +P I+R+ G   + +   L++E A  G L K LQ+ ++  +
Sbjct: 58  DPALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD 116
Query: 116 RRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRR 170
           +     V  ++  + Y    + +HRD+   N+L+  Q   KI+DFG S        + + 
Sbjct: 117 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176
Query: 171 RTMCG-TLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
           +T     + +  PE +   +  +  D+WS GVL +E F YG  P+   + S+ 
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        ++++E  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 218 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 268

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        +++LE  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 185 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 244
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 245 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 295

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 128/288 (44%), Gaps = 33/288 (11%)
Query: 18  FDIGKPLGRGKFGHV---YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           F +G+ LG+G+FG V    L +E  S   VA+K+L    +  S +E  LR E        
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKEFD 83
Query: 75  HPNILRLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSE------RRAATYV 122
           HP++ +L G     +         +IL +   G+L+  L   +          +    ++
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGT---L 177
             +A  + Y   ++ IHRD+   N ++     + +ADFG S  +++ +  R  C +   +
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVD-LKFPPK 235
            +L  E +    +  + D+W+ GV  +E +  G  P+   E+++ Y  ++  + LK PP+
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPE 263
Query: 236 PIVSSAAKDLISQMLVKDSSQ-------RLPLHKLLEHPWIIQNA-DP 275
            +      DL+ Q    D  Q       R+ L  +L H  ++  + DP
Sbjct: 264 CM--EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 112/273 (41%), Gaps = 27/273 (9%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 70
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ E    G L   L+K    F+  +    +  +A  
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG S    +       T      + +  P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 249
Query: 242 AKDLISQMLVKDSSQRLP-------LHKLLEHP 267
              L+     KD + R         L KL+ +P
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 282

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 24  LGRGKFGHVYLAR-EKRSNHIVALKVLFKS--QLQQSQVEHQLRREVEIQSHLRHPNILR 80
           LG G FG VY  +     N    L+V  K+  ++   Q E     E  I S   H NI+R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------ARALIYCH 133
             G        ++++E  A G+L   L++ +    + ++  +  L       A    Y  
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNR---RRTMCGTL--DYLPPEMV 185
             H IHRDI   N L+   G     KI DFG +   +     R+  C  L   ++PPE  
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 232
Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPPK 235
                 +  D WS GVL +E F  G  P+ +K + +    +       PPK
Sbjct: 233 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 283

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           ++K  TL D    K LG G FG V     + +         + K++     ++ +L  E 
Sbjct: 22  DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 77
Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
            +   L +P I+R+ G   + +   L++E A  G L K LQ+ ++  ++     V  ++ 
Sbjct: 78  NVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 136
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCG-TLDYLP 181
            + Y    + +HRD+   N+L+  Q   KI+DFG S        + + +T     + +  
Sbjct: 137 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 196
Query: 182 PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
           PE +   +  +  D+WS GVL +E F YG  P+   + S+ 
Sbjct: 197 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 237

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           ++K  TL D    K LG G FG V     + +         + K++     ++ +L  E 
Sbjct: 24  DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 79
Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
            +   L +P I+R+ G   + +   L++E A  G L K LQ+ ++  ++     V  ++ 
Sbjct: 80  NVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 138
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCG-TLDYLP 181
            + Y    + +HRD+   N+L+  Q   KI+DFG S        + + +T     + +  
Sbjct: 139 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 198
Query: 182 PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
           PE +   +  +  D+WS GVL +E F YG  P+   + S+ 
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           ++K  TL D    K LG G FG V     + +         + K++     ++ +L  E 
Sbjct: 24  DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 79
Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
            +   L +P I+R+ G   + +   L++E A  G L K LQ+ ++  ++     V  ++ 
Sbjct: 80  NVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 138
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCG-TLDYLP 181
            + Y    + +HRD+   N+L+  Q   KI+DFG S        + + +T     + +  
Sbjct: 139 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 198
Query: 182 PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
           PE +   +  +  D+WS GVL +E F YG  P+   + S+ 
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           ++K  TL D    K LG G FG V     + +         + K++     ++ +L  E 
Sbjct: 8   DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 63
Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
            +   L +P I+R+ G   + +   L++E A  G L K LQ+ ++  ++     V  ++ 
Sbjct: 64  NVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 122
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCG-TLDYLP 181
            + Y    + +HRD+   N+L+  Q   KI+DFG S        + + +T     + +  
Sbjct: 123 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 182
Query: 182 PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
           PE +   +  +  D+WS GVL +E F YG  P+   + S+ 
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 109/263 (41%), Gaps = 20/263 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEI 69
            +  I K +G G+FG V   R K   +    VA+K L     +    E Q R    E  I
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 99
Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARA 128
                HPNI+RL G     K V ++ E    G L   L+K    F+  +    +  +A  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPP 182
           + Y      +HRD+   N+LI +    K++DFG S    +       T      + +  P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 183 EMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           E +   +  +  D+WS G++ +E + YG  P+    + D  + + +   + PP     +A
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 278
Query: 242 AKDLISQMLVKDSSQRLPLHKLL 264
              L+     KD + R    +++
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           ++K  TL D    K LG G FG V     + +         + K++     ++ +L  E 
Sbjct: 2   DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 57
Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
            +   L +P I+R+ G   + +   L++E A  G L K LQ+ ++  ++     V  ++ 
Sbjct: 58  NVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 116
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCG-TLDYLP 181
            + Y    + +HRD+   N+L+  Q   KI+DFG S        + + +T     + +  
Sbjct: 117 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 176
Query: 182 PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
           PE +   +  +  D+WS GVL +E F YG  P+   + S+ 
Sbjct: 177 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 217

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           ++K  TL D    K LG G FG V     + +         + K++     ++ +L  E 
Sbjct: 366 DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 421
Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
            +   L +P I+R+ G   + +   L++E A  G L K LQ+ ++  ++     V  ++ 
Sbjct: 422 NVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 480
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCG-TLDYLP 181
            + Y    + +HRD+   N+L+  Q   KI+DFG S        + + +T     + +  
Sbjct: 481 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 540
Query: 182 PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
           PE +   +  +  D+WS GVL +E F YG  P+   + S+ 
Sbjct: 541 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           N+FD    +G G FG VY     R    VALK   +   + SQ   +   E+E  S  RH
Sbjct: 39  NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALK---RRTPESSQGIEEFETEIETLSFCRH 94
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYK-----ELQKCKYFSERRAATYVASLARALI 130
           P+++ L G+  ++  + LI +Y   G L +     +L       E+R    + + AR L 
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA-ARGLH 153
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-----MCGTLDYLPPEMV 185
           Y H + +IHRD+K  N+L+      KI DFG S       +T     + GTL Y+ PE  
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYF 213
Query: 186 ESVEHDANVDIWSLGVLCYEFL 207
                    D++S GV+ +E L
Sbjct: 214 IKGRLTEKSDVYSFGVVLFEVL 235

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           ++K  TL D    K LG G FG V     + +         + K++     ++ +L  E 
Sbjct: 4   DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 59
Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
            +   L +P I+R+ G   + +   L++E A  G L K LQ+ ++  ++     V  ++ 
Sbjct: 60  NVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCG-TLDYLP 181
            + Y    + +HRD+   N+L+  Q   KI+DFG S        + + +T     + +  
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 182 PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
           PE +   +  +  D+WS GVL +E F YG  P+   + S+ 
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           KR+ + DF   + +G G FG V+ A+ +       ++   + +    + E    REV+  
Sbjct: 8   KRFGM-DFKEIELIGSGGFGQVFKAKHRIDGKTYVIR---RVKYNNEKAE----REVKAL 59
Query: 71  SHLRHPNILRLYG----YFYD-------------------------QKRVYLILEYAAKG 101
           + L H NI+   G    + YD                          K +++ +E+  KG
Sbjct: 60  AKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKG 119
Query: 102 ELYK--ELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIAD 159
            L +  E ++ +   +  A      + + + Y H K +IHRD+KP N+ +    ++KI D
Sbjct: 120 TLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGD 179
Query: 160 FGW--SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY 208
           FG   S+    +R    GTL Y+ PE + S ++   VD+++LG++  E L+
Sbjct: 180 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 230

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 110/275 (40%), Gaps = 38/275 (13%)
Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQQSQV 59
           +++   EK  +  N+   GK LG G FG V  A      + + ++ + V        +  
Sbjct: 18  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 77
Query: 60  EHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK--------- 109
           +  L  E++I SHL +H NI+ L G       V +I EY   G+L   L++         
Sbjct: 78  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPS 137
Query: 110 --------------CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
                          +    R    + + +A+ + +   K+ IHRD+   N+L+      
Sbjct: 138 LAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 197
Query: 156 KIADFGWSVHTFNRRRTMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYG 209
           KI DFG +    N    +      LP     PE +    +    D+WS G+L +E F  G
Sbjct: 198 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 257
Query: 210 VPPFEAKEHSDTYRRIVQ-----VDLKFPPKPIVS 239
           + P+     +  + ++V+         F PK I S
Sbjct: 258 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYS 292

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           +G G FG VY  +      +  LKV+  +  Q        R EV +    RH NIL   G
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQ----FQAFRNEVAVLRKTRHVNILLFMG 99
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
           Y   +  + ++ ++     LYK L  Q+ K F   +        A+ + Y H K++IHRD
Sbjct: 100 YM-TKDNLAIVTQWCEGSSLYKHLHVQETK-FQMFQLIDIARQTAQGMDYLHAKNIIHRD 157
Query: 142 IKPENLLIGAQGELKIADFG-------WSVHTFNRRRTMCGTLDYLPPEMVESVEHDA-- 192
           +K  N+ +     +KI DFG       WS      + T  G++ ++ PE++   +++   
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT--GSVLWMAPEVIRMQDNNPFS 215
Query: 193 -NVDIWSLGVLCYEFLYGVPPFEAKEHSD 220
              D++S G++ YE + G  P+    + D
Sbjct: 216 FQSDVYSYGIVLYELMTGELPYSHINNRD 244

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           ++K  TL D    K LG G FG V     + +         + K++     ++ +L  E 
Sbjct: 367 DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 422
Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
            +   L +P I+R+ G   + +   L++E A  G L K LQ+ ++  ++     V  ++ 
Sbjct: 423 NVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 481
Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCG-TLDYLP 181
            + Y    + +HRD+   N+L+  Q   KI+DFG S        + + +T     + +  
Sbjct: 482 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 541
Query: 182 PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
           PE +   +  +  D+WS GVL +E F YG  P+   + S+ 
Sbjct: 542 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 582

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 23/230 (10%)
Query: 4   EVSAKEKKRWTLNDFDIGKP-------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ 56
           EV   + KR++L +  +          LGRG FG VY  R      +VA+K L + + Q 
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLA-DGXLVAVKRLKEERTQG 69
Query: 57  SQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSE- 115
            ++  Q + EVE+ S   H N+LRL G+        L+  Y A G +   L++       
Sbjct: 70  GEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 116 ----RRAATYVASLARALIYCHG---KHVIHRDIKPENLLIGAQGELKIADFGWS----V 164
               +R    + S AR L Y H      +IHRD+K  N+L+  + E  + DFG +     
Sbjct: 128 LDWPKRQRIALGS-ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 165 HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFE 214
              +    + G + ++ PE + + +     D++  GV+  E + G   F+
Sbjct: 187 KDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 14/241 (5%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG+G FG V++     +   VA+K L    +          +E ++   LRH  +++LY 
Sbjct: 16  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 70
Query: 84  YFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              ++  + ++ EY +KG L   L  +  KY    +     A +A  + Y    + +HRD
Sbjct: 71  VVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+G     K+ADFG +     +    R+     + +  PE           D+W
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 198 SLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQ 256
           S G+L  E    G  P+    + +   + V+   + P  P    +  DL+ Q   K+  +
Sbjct: 190 SFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEE 248
Query: 257 R 257
           R
Sbjct: 249 R 249

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           N+FD    +G G FG VY     R    VALK   +   + SQ   +   E+E  S  RH
Sbjct: 39  NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALK---RRTPESSQGIEEFETEIETLSFCRH 94
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYK-----ELQKCKYFSERRAATYVASLARALI 130
           P+++ L G+  ++  + LI +Y   G L +     +L       E+R    + + AR L 
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA-ARGLH 153
Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT-----MCGTLDYLPPEMV 185
           Y H + +IHRD+K  N+L+      KI DFG S       +T     + GTL Y+ PE  
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYF 213
Query: 186 ESVEHDANVDIWSLGVLCYEFL 207
                    D++S GV+ +E L
Sbjct: 214 IKGRLTEKSDVYSFGVVLFEVL 235

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 4/192 (2%)
Query: 32  VYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV 91
           VY A +     IVALK+  ++         + +RE      L+ P+++ ++ +     ++
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL 109
Query: 92  YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA 151
           Y+        +L   L++    +  RA   V  +  AL   H     HRD+KPEN+L+ A
Sbjct: 110 YVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169
Query: 152 QGELKIADFGWSVHTFNRRRT----MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL 207
                + DFG +  T + + T      GTL Y  PE           DI++L  + YE L
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECL 229
Query: 208 YGVPPFEAKEHS 219
            G PP++  + S
Sbjct: 230 TGSPPYQGDQLS 241

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 104/251 (41%), Gaps = 16/251 (6%)
Query: 20  IGKPLGRGKFGHV---YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           I + +G G+FG V   +L    +    VA+K L KS   + Q       E  I     HP
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQ-RRDFLSEASIMGQFDHP 68
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGK 135
           N++ L G       V +I E+   G L   L Q    F+  +    +  +A  + Y    
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 128
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLD------YLPPEMVES 187
           + +HR +   N+L+ +    K++DFG S  +       T    L       +  PE ++ 
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 188 VEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
            +  +  D+WS G++ +E + YG  P+    + D    I Q D + PP     SA   L+
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMDCPSALHQLM 247
Query: 247 SQMLVKDSSQR 257
                KD + R
Sbjct: 248 LDCWQKDRNHR 258

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 39/218 (17%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE-HQLRREVEIQSHLRHPNILRLY 82
           +GRG +G+VYLA +K +   VA+K +  +++ +  ++  ++ RE+ I + L+   I+RLY
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 83  GYF-------YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
                     +D+  +Y++LE  A  +L K  +   + +E    T + +L     + H  
Sbjct: 92  DLIIPDDLLKFDE--LYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS----------------------VHTFNRRRTM 173
            +IHRD+KP N L+     +K+ DFG +                       H  N ++ +
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208
Query: 174 CG---TLDYLPPEMVESVE-HDANVDIWSLGVLCYEFL 207
                T  Y  PE++   E +  ++DIWS G +  E L
Sbjct: 209 TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 6   SAKEKKRWTLNDFDIGKP-------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ 58
           + K +K W  +++++ +        LG G+FG V++     + H    KV  KS  Q S 
Sbjct: 6   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSM 60
Query: 59  VEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSER 116
                  E  +   L+H  ++RLY     Q+ +Y+I EY   G L   L+       +  
Sbjct: 61  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 119
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRT 172
           +     A +A  + +   ++ IHRD++  N+L+      KIADFG +     + +  R  
Sbjct: 120 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 179
Query: 173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL 207
               + +  PE +         D+WS G+L  E +
Sbjct: 180 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 6   SAKEKKRWTLNDFDIGKP-------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ 58
           + K +K W  +++++ +        LG G+FG V++     + H    KV  KS  Q S 
Sbjct: 1   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSM 55
Query: 59  VEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSER 116
                  E  +   L+H  ++RLY     Q+ +Y+I EY   G L   L+       +  
Sbjct: 56  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 114
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRT 172
           +     A +A  + +   ++ IHRD++  N+L+      KIADFG +     + +  R  
Sbjct: 115 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 174
Query: 173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL 207
               + +  PE +         D+WS G+L  E +
Sbjct: 175 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 209

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 6   SAKEKKRWTLNDFDIGKP-------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ 58
           + K +K W  +++++ +        LG G+FG V++     + H    KV  KS  Q S 
Sbjct: 2   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSM 56
Query: 59  VEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSER 116
                  E  +   L+H  ++RLY     Q+ +Y+I EY   G L   L+       +  
Sbjct: 57  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRT 172
           +     A +A  + +   ++ IHRD++  N+L+      KIADFG +     + +  R  
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 175
Query: 173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL 207
               + +  PE +         D+WS G+L  E +
Sbjct: 176 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 210

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 59/301 (19%)
Query: 9   EKKRWTL--NDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQ 62
           E  +W     +  +GK LG G+FG V  A     + R+ +      + K     S++   
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RD 72
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFS-------- 114
           L  E  +   + HP++++LYG       + LI+EYA  G L   L++ +           
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 115 ----------ERRAAT------YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIA 158
                     + RA T      +   +++ + Y     ++HRD+   N+L+    ++KI+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKIS 192
Query: 159 DFGWSVHTFNRRRTMCGTLDYLPPE--MVESV---EHDANVDIWSLGVLCYEFLY----- 208
           DFG S   +     +  +   +P +   +ES+    +    D+WS GVL +E +      
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 209 --GVPP------------FEAKEH--SDTYRRIVQVDLKFPPK-PIVSSAAKDLISQMLV 251
             G+PP             E  ++   + YR ++Q   + P K P+ +  +KDL  +M+V
Sbjct: 253 YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL-EKMMV 311
Query: 252 K 252
           K
Sbjct: 312 K 312

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 59/301 (19%)
Query: 9   EKKRWTL--NDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQ 62
           E  +W     +  +GK LG G+FG V  A     + R+ +      + K     S++   
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RD 72
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFS-------- 114
           L  E  +   + HP++++LYG       + LI+EYA  G L   L++ +           
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 115 ----------ERRAAT------YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIA 158
                     + RA T      +   +++ + Y     ++HRD+   N+L+    ++KI+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 159 DFGWSVHTFNRRRTMCGTLDYLPPE--MVESV---EHDANVDIWSLGVLCYEFLY----- 208
           DFG S   +     +  +   +P +   +ES+    +    D+WS GVL +E +      
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 209 --GVPP------------FEAKEH--SDTYRRIVQVDLKFPPK-PIVSSAAKDLISQMLV 251
             G+PP             E  ++   + YR ++Q   + P K P+ +  +KDL  +M+V
Sbjct: 253 YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL-EKMMV 311
Query: 252 K 252
           K
Sbjct: 312 K 312

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 31/276 (11%)
Query: 18  FDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQS 71
            ++GKPLGRG FG V  A      +  +   VA+K+L +     +  EH+ L  E++I  
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA---THSEHRALMSELKILI 85
Query: 72  HL-RHPNILRLYGYFYDQKR-VYLILEYAAKGEL-------------YKELQKCKYFSER 116
           H+  H N++ L G        + +I+E+   G L             YK+L K  + +  
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYK-DFLTLE 144
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRR 171
               Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +   +      R+ 
Sbjct: 145 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKG 204
Query: 172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDL 230
                L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++   
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGT 264
Query: 231 KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
           +       +      +      + SQR    +L+EH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 31/276 (11%)
Query: 18  FDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQS 71
            ++GKPLGRG FG V  A      +  +   VA+K+L +     +  EH+ L  E++I  
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA---THSEHRALMSELKILI 85
Query: 72  HL-RHPNILRLYGYFYDQKR-VYLILEYAAKGEL-------------YKELQKCKYFSER 116
           H+  H N++ L G        + +I+E+   G L             YK+L K  + +  
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYK-DFLTLE 144
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRR 171
               Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +   +      R+ 
Sbjct: 145 HLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 204
Query: 172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDL 230
                L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++   
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 264
Query: 231 KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
           +       +      +      + SQR    +L+EH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 21/266 (7%)
Query: 20  IGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           I K +G G+FG V   R K   +    VA+K L K+     Q       E  I     HP
Sbjct: 33  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQ-RRDFLSEASIMGQFDHP 90
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGK 135
           NI+ L G     K V +I EY   G L   L+K    F+  +    +  +   + Y    
Sbjct: 91  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPPEMVESVE 189
             +HRD+   N+L+ +    K++DFG S    +       T      + +  PE +   +
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 190 HDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
             +  D+WS G++ +E + YG  P+    + D  + I +   + PP      A   L+  
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EEGYRLPPPMDCPIALHQLMLD 269
Query: 249 MLVKDSSQRLP-------LHKLLEHP 267
              K+ S R         L KL+ +P
Sbjct: 270 CWQKERSDRPKFGQIVNMLDKLIRNP 295

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 82/190 (43%), Gaps = 12/190 (6%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G+FG V++     + H    KV  KS  Q S        E  +   L+H  ++RLY 
Sbjct: 21  LGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRD 141
               Q+ +Y+I EY   G L   L+       +  +     A +A  + +   ++ IHRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+      KIADFG +     + +  R      + +  PE +         D+W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 198 SLGVLCYEFL 207
           S G+L  E +
Sbjct: 195 SFGILLTEIV 204

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 82/190 (43%), Gaps = 12/190 (6%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G+FG V++     + H    KV  KS  Q S        E  +   L+H  ++RLY 
Sbjct: 16  LGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 70
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRD 141
               Q+ +Y+I EY   G L   L+       +  +     A +A  + +   ++ IHRD
Sbjct: 71  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 129
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+      KIADFG +     + +  R      + +  PE +         D+W
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 189
Query: 198 SLGVLCYEFL 207
           S G+L  E +
Sbjct: 190 SFGILLTEIV 199

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 105/242 (43%), Gaps = 29/242 (11%)
Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
           K  +L+     + LG  +FG VY               VA+K L      +  +  + R 
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRH 78
Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT----- 120
           E  +++ L+HPN++ L G     + + +I  Y + G+L++ L      S+  +       
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 138
Query: 121 -----------YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW--SVHTF 167
                       VA +A  + Y    HV+H+D+   N+L+  +  +KI+D G    V+  
Sbjct: 139 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 198
Query: 168 NRRRTMCGTL---DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYR 223
           +  + +  +L    ++ PE +   +   + DIWS GV+ +E F YG+ P+    + D   
Sbjct: 199 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258
Query: 224 RI 225
            I
Sbjct: 259 MI 260

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 29/229 (12%)
Query: 24  LGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           LG  +FG VY               VA+K L      +  +  + R E  +++ L+HPN+
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT----------------YV 122
           + L G     + + +I  Y + G+L++ L      S+  +                   V
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW--SVHTFNRRRTMCGTL--- 177
           A +A  + Y    HV+H+D+   N+L+  +  +KI+D G    V+  +  + +  +L   
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
            ++ PE +   +   + DIWS GV+ +E F YG+ P+    + D    I
Sbjct: 195 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 24  LGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           LG G FG V    Y  R+K+ +  VA+KVL K   +++  E ++ RE +I   L +P I+
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQID--VAIKVL-KQGTEKADTE-EMMREAQIMHQLDNPYIV 73
Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKHVI 138
           RL G     + + L++E A  G L+K L  K +       A  +  ++  + Y   K+ +
Sbjct: 74  RLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 139 HRDIKPENLLIGAQGELKIADFGWSVHT------FNRRRTMCGTLDYLPPEMVESVEHDA 192
           HRD+   N+L+  +   KI+DFG S         +  R      L +  PE +   +  +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 193 NVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVD-LKFPPK 235
             D+WS GV  +E L YG  P++  +  +    I Q   ++ PP+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 237

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 21/266 (7%)
Query: 20  IGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           I K +G G+FG V   R K   +    VA+K L K+     Q       E  I     HP
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQ-RRDFLSEASIMGQFDHP 75
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGK 135
           NI+ L G     K V +I EY   G L   L+K    F+  +    +  +   + Y    
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPPEMVESVE 189
             +HRD+   N+L+ +    K++DFG S    +       T      + +  PE +   +
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 190 HDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
             +  D+WS G++ +E + YG  P+    + D  + I +   + PP      A   L+  
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EEGYRLPPPMDCPIALHQLMLD 254
Query: 249 MLVKDSSQRLP-------LHKLLEHP 267
              K+ S R         L KL+ +P
Sbjct: 255 CWQKERSDRPKFGQIVNMLDKLIRNP 280

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 59/301 (19%)
Query: 9   EKKRWTL--NDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQ 62
           E  +W     +  +GK LG G+FG V  A     + R+ +      + K     S++   
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RD 72
Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFS-------- 114
           L  E  +   + HP++++LYG       + LI+EYA  G L   L++ +           
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 115 ----------ERRAAT------YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIA 158
                     + RA T      +   +++ + Y     ++HRD+   N+L+    ++KI+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 159 DFGWSVHTFNRRRTMCGTLDYLPPE--MVESV---EHDANVDIWSLGVLCYEFLY----- 208
           DFG S   +     +  +   +P +   +ES+    +    D+WS GVL +E +      
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 209 --GVPP------------FEAKEH--SDTYRRIVQVDLKFPPK-PIVSSAAKDLISQMLV 251
             G+PP             E  ++   + YR ++Q   + P K P+ +  +KDL  +M+V
Sbjct: 253 YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL-EKMMV 311
Query: 252 K 252
           K
Sbjct: 312 K 312

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQ--LRREVEIQSHLRHPN 77
           LG+G FG V L R       +  +VA+K     QLQ S  + Q   +RE++I   L    
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVK-----QLQHSGPDQQRDFQREIQILKALHSDF 72
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + L++EY   G L   LQ+ +      R   Y + + + + Y   
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           +  +HRD+   N+L+ ++  +KIADFG +         +  R      + +  PE +   
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 189 EHDANVDIWSLGVLCYEFL 207
                 D+WS GV+ YE  
Sbjct: 193 IFSRQSDVWSFGVVLYELF 211

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 21/266 (7%)
Query: 20  IGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           I K +G G+FG V   R K   +    VA+K L K+     Q       E  I     HP
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQ-RRDFLSEASIMGQFDHP 69
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGK 135
           NI+ L G     K V +I EY   G L   L+K    F+  +    +  +   + Y    
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPPEMVESVE 189
             +HRD+   N+L+ +    K++DFG S    +       T      + +  PE +   +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 190 HDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
             +  D+WS G++ +E + YG  P+    + D  + I +   + PP      A   L+  
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EEGYRLPPPMDCPIALHQLMLD 248
Query: 249 MLVKDSSQRLP-------LHKLLEHP 267
              K+ S R         L KL+ +P
Sbjct: 249 CWQKERSDRPKFGQIVNMLDKLIRNP 274

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQ--LRREVEIQSHLRHPN 77
           LG+G FG V L R       +  +VA+K     QLQ S  + Q   +RE++I   L    
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVK-----QLQHSGPDQQRDFQREIQILKALHSDF 73
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + L++EY   G L   LQ+ +      R   Y + + + + Y   
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 133
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           +  +HRD+   N+L+ ++  +KIADFG +         +  R      + +  PE +   
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 189 EHDANVDIWSLGVLCYEFL 207
                 D+WS GV+ YE  
Sbjct: 194 IFSRQSDVWSFGVVLYELF 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQ--LRREVEIQSHLRHPN 77
           LG+G FG V L R       +  +VA+K     QLQ S  + Q   +RE++I   L    
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVK-----QLQHSGPDQQRDFQREIQILKALHSDF 69
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + L++EY   G L   LQ+ +      R   Y + + + + Y   
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNR-----RRTMCGTLDYLPPEMVESV 188
           +  +HRD+   N+L+ ++  +KIADFG + +   ++     R      + +  PE +   
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 189 EHDANVDIWSLGVLCYEFL 207
                 D+WS GV+ YE  
Sbjct: 190 IFSRQSDVWSFGVVLYELF 208

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 6   SAKEKKRWTLNDFDIGKP-------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ 58
           + K +K W  +++++ +        LG G+FG V++     + H    KV  KS  Q S 
Sbjct: 2   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSM 56
Query: 59  VEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSER 116
                  E  +   L+H  ++RLY     Q+ +Y+I EY   G L   L+       +  
Sbjct: 57  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRT 172
           +     A +A  + +   ++ IHRD++  N+L+      KIADFG +     +    R  
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 175
Query: 173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL 207
               + +  PE +         D+WS G+L  E +
Sbjct: 176 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 210

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 24  LGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQ--LRREVEIQSHLRHPN 77
           LG+G FG V L R       +  +VA+K     QLQ S  + Q   +RE++I   L    
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVK-----QLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 78  ILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
           I++  G  Y   R  + L++EY   G L   LQ+ +      R   Y + + + + Y   
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYLPPEMVESV 188
           +  +HRD+   N+L+ ++  +KIADFG +         +  R      + +  PE +   
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 189 EHDANVDIWSLGVLCYEFL 207
                 D+WS GV+ YE  
Sbjct: 206 IFSRQSDVWSFGVVLYELF 224

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 6   SAKEKKRWTLNDFDIGKP-------LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ 58
           + K +K W  +++++ +        LG G+FG V++     + H    KV  KS  Q S 
Sbjct: 4   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSM 58
Query: 59  VEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSER 116
                  E  +   L+H  ++RLY     Q+ +Y+I EY   G L   L+       +  
Sbjct: 59  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 117
Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRT 172
           +     A +A  + +   ++ IHRD++  N+L+      KIADFG +     +    R  
Sbjct: 118 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 177
Query: 173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL 207
               + +  PE +         D+WS G+L  E +
Sbjct: 178 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 212

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 12/190 (6%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G+FG V++     + H    KV  KS  Q S        E  +   L+H  ++RLY 
Sbjct: 30  LGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRD 141
               Q+ +Y+I EY   G L   L+       +  +     A +A  + +   ++ IHRD
Sbjct: 85  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 143
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+      KIADFG +     +    R      + +  PE +         D+W
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 198 SLGVLCYEFL 207
           S G+L  E +
Sbjct: 204 SFGILLTEIV 213

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 127/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 38  DDYQLVRKLGRGKYSEVFEAINITNN-----ERVVVKILKPVKKKKIKREVKILENLRGG 92
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            NI++L     D   K   L+ EY    +  +  Q    F  R    Y+  L +AL YCH
Sbjct: 93  TNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIR---FYMYELLKALDYCH 149
Query: 134 GKHVIHRDIKPENLLIG-AQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            K ++HRD+KP N++I   Q +L++ D+G +   H          +  +  PE +V+   
Sbjct: 150 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 209
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F  +++ D   RI +V              +   P 
Sbjct: 210 YDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPH 269
Query: 235 ---------------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                + +VS  A DL+ ++L  D  QRL   + +EHP+ 
Sbjct: 270 FNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 12/190 (6%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G+FG V++     + H    KV  KS  Q S        E  +   L+H  ++RLY 
Sbjct: 21  LGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRD 141
               Q+ +Y+I EY   G L   L+       +  +     A +A  + +   ++ IHRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+      KIADFG +     +    R      + +  PE +         D+W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 198 SLGVLCYEFL 207
           S G+L  E +
Sbjct: 195 SFGILLTEIV 204

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 12/190 (6%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G+FG V++     + H    KV  KS  Q S        E  +   L+H  ++RLY 
Sbjct: 23  LGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 77
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRD 141
               Q+ +Y+I EY   G L   L+       +  +     A +A  + +   ++ IHRD
Sbjct: 78  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 136
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+      KIADFG +     +    R      + +  PE +         D+W
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 198 SLGVLCYEFL 207
           S G+L  E +
Sbjct: 197 SFGILLTEIV 206

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 12/190 (6%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G+FG V++     + H    KV  KS  Q S        E  +   L+H  ++RLY 
Sbjct: 21  LGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRD 141
               Q+ +Y+I EY   G L   L+       +  +     A +A  + +   ++ IHRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+      KIADFG +     +    R      + +  PE +         D+W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 198 SLGVLCYEFL 207
           S G+L  E +
Sbjct: 195 SFGILLTEIV 204

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 12/190 (6%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G+FG V++     + H    KV  KS  Q S        E  +   L+H  ++RLY 
Sbjct: 22  LGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 76
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRD 141
               Q+ +Y+I EY   G L   L+       +  +     A +A  + +   ++ IHRD
Sbjct: 77  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 135
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+      KIADFG +     +    R      + +  PE +         D+W
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 198 SLGVLCYEFL 207
           S G+L  E +
Sbjct: 196 SFGILLTEIV 205

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 127/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 43  DDYQLVRKLGRGKYSEVFEAINITNN-----ERVVVKILKPVKKKKIKREVKILENLRGG 97
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            NI++L     D   K   L+ EY    +  +  Q    F  R    Y+  L +AL YCH
Sbjct: 98  TNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIR---FYMYELLKALDYCH 154
Query: 134 GKHVIHRDIKPENLLIG-AQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            K ++HRD+KP N++I   Q +L++ D+G +   H          +  +  PE +V+   
Sbjct: 155 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 214
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F  +++ D   RI +V              +   P 
Sbjct: 215 YDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPH 274
Query: 235 ---------------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                + +VS  A DL+ ++L  D  QRL   + +EHP+ 
Sbjct: 275 FNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 82/190 (43%), Gaps = 12/190 (6%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G+FG V++     + H    KV  KS  Q S        E  +   L+H  ++RLY 
Sbjct: 17  LGAGQFGEVWMGY--YNGHT---KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 71
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRD 141
               Q+ +Y+I EY   G L   L+       +  +     A +A  + +   ++ IHR+
Sbjct: 72  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRN 130
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+      KIADFG +     + +  R      + +  PE +         D+W
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 190
Query: 198 SLGVLCYEFL 207
           S G+L  E +
Sbjct: 191 SFGILLTEIV 200

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 16/230 (6%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           D  + + LG G FG V        +     VA+K L    L Q +      REV     L
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            H N++RLYG       + ++ E A  G L   L+K + +F     + Y   +A  + Y 
Sbjct: 73  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGW--------SVHTFNRRRTMCGTLDYLPPEM 184
             K  IHRD+   NLL+  +  +KI DFG           +     R +     +  PE 
Sbjct: 132 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAWCAPES 189
Query: 185 VESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           +++       D W  GV  +E F YG  P+     S    +I +   + P
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 39/232 (16%)
Query: 13  WTLND-FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           W + D ++I   +G G +GHV  A +K    +VA+K + +        +  LR E+ I +
Sbjct: 49  WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILN 107
Query: 72  HLRHPNILRLYGYFYDQK-----RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
            L H +++++      +       +Y++LE A   +  K  +   Y +E    T + +L 
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLL 166
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS----------------------- 163
             + Y H   ++HRD+KP N L+     +K+ DFG +                       
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 164 ----VHTFNRRRTMCG---TLDYLPPEMVESVE-HDANVDIWSLGVLCYEFL 207
                HT N +R + G   T  Y  PE++   E +   +D+WS+G +  E L
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 16/230 (6%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           D  + + LG G FG V        +     VA+K L    L Q +      REV     L
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            H N++RLYG       + ++ E A  G L   L+K + +F     + Y   +A  + Y 
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGW--------SVHTFNRRRTMCGTLDYLPPEM 184
             K  IHRD+   NLL+  +  +KI DFG           +     R +     +  PE 
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAWCAPES 195
Query: 185 VESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           +++       D W  GV  +E F YG  P+     S    +I +   + P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 16/230 (6%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           D  + + LG G FG V        +     VA+K L    L Q +      REV     L
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            H N++RLYG       + ++ E A  G L   L+K + +F     + Y   +A  + Y 
Sbjct: 73  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGW--------SVHTFNRRRTMCGTLDYLPPEM 184
             K  IHRD+   NLL+  +  +KI DFG           +     R +     +  PE 
Sbjct: 132 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAWCAPES 189
Query: 185 VESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           +++       D W  GV  +E F YG  P+     S    +I +   + P
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 16/230 (6%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           D  + + LG G FG V        +     VA+K L    L Q +      REV     L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            H N++RLYG       + ++ E A  G L   L+K + +F     + Y   +A  + Y 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGW--------SVHTFNRRRTMCGTLDYLPPEM 184
             K  IHRD+   NLL+  +  +KI DFG           +     R +     +  PE 
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAWCAPES 185
Query: 185 VESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           +++       D W  GV  +E F YG  P+     S    +I +   + P
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 24  LGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           LG G FG V    Y  R+K+ +  VA+KVL K   +++  E ++ RE +I   L +P I+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID--VAIKVL-KQGTEKADTE-EMMREAQIMHQLDNPYIV 399
Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKHVI 138
           RL G     + + L++E A  G L+K L  K +       A  +  ++  + Y   K+ +
Sbjct: 400 RLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 139 HRDIKPENLLIGAQGELKIADFGWSVHT------FNRRRTMCGTLDYLPPEMVESVEHDA 192
           HR++   N+L+  +   KI+DFG S         +  R      L +  PE +   +  +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 193 NVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVD-LKFPPK 235
             D+WS GV  +E L YG  P++  +  +    I Q   ++ PP+
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 563

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 20/196 (10%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K LG G+FG V++      N  VA+K L    +           E +I   L+H  +++L
Sbjct: 15  KRLGNGQFGEVWMGT-WNGNTKVAIKTLKPGTMSP----ESFLEEAQIMKKLKHDKLVQL 69
Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRA------ATYVASLARALIYCHGK 135
           Y    ++  +Y++ EY  KG L   L+      E RA          A +A  + Y    
Sbjct: 70  YAVVSEEP-IYIVTEYMNKGSLLDFLKD----GEGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           + IHRD++  N+L+G     KIADFG +     +    R+     + +  PE        
Sbjct: 125 NYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFT 184
Query: 192 ANVDIWSLGVLCYEFL 207
              D+WS G+L  E +
Sbjct: 185 IKSDVWSFGILLTELV 200

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 16/230 (6%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           D  + + LG G FG V        +     VA+K L    L Q +      REV     L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            H N++RLYG       + ++ E A  G L   L+K + +F     + Y   +A  + Y 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGW--------SVHTFNRRRTMCGTLDYLPPEM 184
             K  IHRD+   NLL+  +  +KI DFG           +     R +     +  PE 
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAWCAPES 185
Query: 185 VESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           +++       D W  GV  +E F YG  P+     S    +I +   + P
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 128/296 (43%), Gaps = 58/296 (19%)
Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           +R    D  + + +G+G++G V+    +  N  VA+K+        S+ E    RE E+ 
Sbjct: 3   QRTVARDITLLECVGKGRYGEVWRGSWQGEN--VAVKIF------SSRDEKSWFRETELY 54
Query: 71  SH--LRHPNILRLYGY----FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS 124
           +   LRH NIL          +   +++LI  Y   G LY  LQ             V S
Sbjct: 55  NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLS 113
Query: 125 LARALIYCH-------GKHVI-HRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM--- 173
           +A  L + H       GK  I HRD+K +N+L+   G+  IAD G +V        +   
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 174 ----CGTLDYLPPEMV-ESVEHDA-----NVDIWSLGVLCYEFL-----YGV-----PPF 213
                GT  Y+ PE++ E+++ D       VDIW+ G++ +E        G+     PPF
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 214 EAKEHSD----TYRRIVQVDLKFP-------PKPIVSSAAKDLISQMLVKDSSQRL 258
                +D      R++V VD + P         P ++S AK L+ +   ++ S RL
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSARL 288

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 106/250 (42%), Gaps = 13/250 (5%)
Query: 17  DFDIGKPLGRGKFGHVY---LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           D  + + LG G FG VY       K     VA+K   K     ++   +   E  I  +L
Sbjct: 9   DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNL 66
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            HP+I++L G   +++  ++I+E    GEL   L++ K          Y   + +A+ Y 
Sbjct: 67  DHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 125
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT----FNRRRTMCGTLDYLPPEMVESV 188
              + +HRDI   N+L+ +   +K+ DFG S +     + +       + ++ PE +   
Sbjct: 126 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 185
Query: 189 EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
                 D+W   V  +E L +G  PF   E+ D    + + D + P   +       L++
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCPPVLYTLMT 244
Query: 248 QMLVKDSSQR 257
           +    D S R
Sbjct: 245 RCWDYDPSDR 254

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 93/232 (40%), Gaps = 20/232 (8%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           D  + + LG G FG V        +     VA+K L    L Q +      REV     L
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            H N++RLYG       + ++ E A  G L   L+K + +F     + Y   +A  + Y 
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGW----------SVHTFNRRRTMCGTLDYLPP 182
             K  IHRD+   NLL+  +  +KI DFG            V   +R+        +  P
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA----WCAP 193
Query: 183 EMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           E +++       D W  GV  +E F YG  P+     S    +I +   + P
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 93/232 (40%), Gaps = 20/232 (8%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           D  + + LG G FG V        +     VA+K L    L Q +      REV     L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            H N++RLYG       + ++ E A  G L   L+K + +F     + Y   +A  + Y 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGW----------SVHTFNRRRTMCGTLDYLPP 182
             K  IHRD+   NLL+  +  +KI DFG            V   +R+        +  P
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA----WCAP 183
Query: 183 EMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           E +++       D W  GV  +E F YG  P+     S    +I +   + P
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 106/250 (42%), Gaps = 13/250 (5%)
Query: 17  DFDIGKPLGRGKFGHVY---LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           D  + + LG G FG VY       K     VA+K   K     ++   +   E  I  +L
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNL 70
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            HP+I++L G   +++  ++I+E    GEL   L++ K          Y   + +A+ Y 
Sbjct: 71  DHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT----FNRRRTMCGTLDYLPPEMVESV 188
              + +HRDI   N+L+ +   +K+ DFG S +     + +       + ++ PE +   
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 189 EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
                 D+W   V  +E L +G  PF   E+ D    + + D + P   +       L++
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCPPVLYTLMT 248
Query: 248 QMLVKDSSQR 257
           +    D S R
Sbjct: 249 RCWDYDPSDR 258

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 106/250 (42%), Gaps = 13/250 (5%)
Query: 17  DFDIGKPLGRGKFGHVY---LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           D  + + LG G FG VY       K     VA+K   K     ++   +   E  I  +L
Sbjct: 25  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNL 82
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
            HP+I++L G   +++  ++I+E    GEL   L++ K          Y   + +A+ Y 
Sbjct: 83  DHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 141
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT----FNRRRTMCGTLDYLPPEMVESV 188
              + +HRDI   N+L+ +   +K+ DFG S +     + +       + ++ PE +   
Sbjct: 142 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 201
Query: 189 EHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
                 D+W   V  +E L +G  PF   E+ D    + + D + P   +       L++
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCPPVLYTLMT 260
Query: 248 QMLVKDSSQR 257
           +    D S R
Sbjct: 261 RCWDYDPSDR 270

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 123/283 (43%), Gaps = 58/283 (20%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH--LRHPNILRL 81
           +G+G++G V+    +  N  VA+K+        S+ E    RE E+ +   LRH NIL  
Sbjct: 45  VGKGRYGEVWRGSWQGEN--VAVKIF------SSRDEKSWFRETELYNTVMLRHENILGF 96
Query: 82  YGY----FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH---- 133
                   +   +++LI  Y   G LY  LQ             V S+A  L + H    
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 134 ---GKHVI-HRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM-------CGTLDYLPP 182
              GK  I HRD+K +N+L+   G+  IAD G +V        +        GT  Y+ P
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 183 EMV-ESVEHDA-----NVDIWSLGVLCYEFL-----YGV-----PPFEAKEHSD----TY 222
           E++ E+++ D       VDIW+ G++ +E        G+     PPF     +D      
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 275
Query: 223 RRIVQVDLKFP-------PKPIVSSAAKDLISQMLVKDSSQRL 258
           R++V VD + P         P ++S AK L+ +   ++ S RL
Sbjct: 276 RKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSARL 317

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 123/283 (43%), Gaps = 58/283 (20%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH--LRHPNILRL 81
           +G+G++G V+    +  N  VA+K+        S+ E    RE E+ +   LRH NIL  
Sbjct: 16  VGKGRYGEVWRGSWQGEN--VAVKIF------SSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 82  YGY----FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH---- 133
                   +   +++LI  Y   G LY  LQ             V S+A  L + H    
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 134 ---GKHVI-HRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM-------CGTLDYLPP 182
              GK  I HRD+K +N+L+   G+  IAD G +V        +        GT  Y+ P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 183 EMV-ESVEHDA-----NVDIWSLGVLCYEFL-----YGV-----PPFEAKEHSD----TY 222
           E++ E+++ D       VDIW+ G++ +E        G+     PPF     +D      
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 223 RRIVQVDLKFP-------PKPIVSSAAKDLISQMLVKDSSQRL 258
           R++V VD + P         P ++S AK L+ +   ++ S RL
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSARL 288

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 41/286 (14%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLY 82
           L  G F  VY A++  S    ALK L  ++ ++++    + +EV     L  HPNI++  
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA---IIQEVCFMKKLSGHPNIVQFC 92
Query: 83  GYFYDQKRV-------YLILEYAAKGELYKELQKCKYFSERRAATYVA---SLARALIYC 132
                 K         +L+L    KG+L + L+K +        T +       RA+ + 
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 133 HGKH--VIHRDIKPENLLIGAQGELKIADFG------------WSVH---TFNRRRTMCG 175
           H +   +IHRD+K ENLL+  QG +K+ DFG            WS           T   
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 176 TLDYLPPEMVESVEH---DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF 232
           T  Y  PE+++   +       DIW+LG + Y   +   PFE         RIV      
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE----DGAKLRIVNGKYSI 268
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKL---LEHPWIIQNADP 275
           PP     +    LI  ML  +  +RL + ++   L+     +N +P
Sbjct: 269 PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 27/274 (9%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQ-LRREVEIQSHL-RH 75
           +GKPLGRG FG V  A     +     + +    L++  +  EH+ L  E++I  H+  H
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 76  PNILRLYGYFYDQKR-VYLILEYAAKGEL-------------YKELQKCKY---FSERRA 118
            N++ L G        + +I+E+   G L             YKE  +  Y    +    
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRRTM 173
             Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +   +      R+   
Sbjct: 153 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKF 232
              L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++   + 
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 272
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                 +      +      + SQR    +L+EH
Sbjct: 273 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 112/259 (43%), Gaps = 24/259 (9%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNILR 80
           LG G +G V+  R K    + A+K   +S       + + R+  E+ SH +   HP  +R
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVK---RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 81  LYGYFYDQKRVYLILEYAAKGELYKELQKCKYFS----ERRAATYVASLARALIYCHGKH 136
           L   + +   +YL  E           Q C+ +     E +   Y+     AL + H + 
Sbjct: 122 LEQAWEEGGILYLQTELCGP----SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVEHDANV 194
           ++H D+KP N+ +G +G  K+ DFG  V   T        G   Y+ PE+++   +    
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAA 236
Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLISQMLVK 252
           D++SLG+   E    +   E     + ++++ Q  L  PP+    +SS  + ++  ML  
Sbjct: 237 DVFSLGLTILEVACNM---ELPHGGEGWQQLRQGYL--PPEFTAGLSSELRSVLVMMLEP 291
Query: 253 DSSQRLPLHKLLEHPWIIQ 271
           D   R     LL  P + Q
Sbjct: 292 DPKLRATAEALLALPVLRQ 310

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 19/220 (8%)
Query: 20  IGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQSHL 73
           I + +G G+FG V   R K   + +  VA+K L     +    E Q R    E  I    
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTL-----KVGYTEKQRRDFLCEASIMGQF 101
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYC 132
            HPN++ L G     K V +++E+   G L   L+K    F+  +    +  +A  + Y 
Sbjct: 102 DHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYL 161
Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPPEMVE 186
                +HRD+   N+L+ +    K++DFG S    +    +  T      + +  PE ++
Sbjct: 162 ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 187 SVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRI 225
             +  +  D+WS G++ +E + YG  P+    + D  + I
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 261

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 13/217 (5%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR---EVEIQSHLRHP 76
           I + +G G+FG V   R K       L V  K+ L+    E Q R    E  I     HP
Sbjct: 26  IERVIGAGEFGEVCSGRLKLPGK-RELPVAIKT-LKVGYTEKQRRDFLGEASIMGQFDHP 83
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGK 135
           NI+ L G     K V ++ EY   G L   L+K    F+  +    +  ++  + Y    
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT------LDYLPPEMVESVE 189
             +HRD+   N+LI +    K++DFG S    +       T      + +  PE +   +
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 190 HDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRI 225
             +  D+WS G++ +E + YG  P+    + D  + +
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAV 240

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 22  KPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           + LG G FG V    Y      +  +VA+K L   +    Q+    +RE+EI   L H +
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KEGCGPQLRSGWQREIEILRTLYHEH 72
Query: 78  ILRLYGYFYDQ--KRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHG 134
           I++  G   DQ  K V L++EY   G L   L + C   ++     +   +   + Y H 
Sbjct: 73  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQ--LLLFAQQICEGMAYLHA 130
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNR-RRTMCGTLDYLPPEMVESV 188
           +H IHR +   N+L+     +KI DFG +      H + R R      + +  PE ++  
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 189 EHDANVDIWSLGVLCYEFL 207
           +     D+WS GV  YE L
Sbjct: 191 KFYYASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 22  KPLGRGKFGHV----YLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           + LG G FG V    Y      +  +VA+K L   +    Q+    +RE+EI   L H +
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KEGCGPQLRSGWQREIEILRTLYHEH 71
Query: 78  ILRLYGYFYDQ--KRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHG 134
           I++  G   DQ  K V L++EY   G L   L + C   ++     +   +   + Y H 
Sbjct: 72  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQ--LLLFAQQICEGMAYLHA 129
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNR-RRTMCGTLDYLPPEMVESV 188
           +H IHR +   N+L+     +KI DFG +      H + R R      + +  PE ++  
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 189 EHDANVDIWSLGVLCYEFL 207
           +     D+WS GV  YE L
Sbjct: 190 KFYYASDVWSFGVTLYELL 208

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQ-LRREVEIQSHL-RH 75
           +GKPLGRG FG V  A     +     + +    L++  +  EH+ L  E++I  H+  H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 76  PNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCK----------------YFSERRA 118
            N++ L G        + +I+E+   G L   L+  +                + +    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRRTM 173
             Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +   +      R+   
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKF 232
              L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++   + 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                 +      +      + SQR    +L+EH
Sbjct: 271 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQ-LRREVEIQSHL-RH 75
           +GKPLGRG FG V  A     +     + +    L++  +  EH+ L  E++I  H+  H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 76  PNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCK----------------YFSERRA 118
            N++ L G        + +I+E+   G L   L+  +                + +    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRRTM 173
             Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +   +      R+   
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKF 232
              L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++   + 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                 +      +      + SQR    +L+EH
Sbjct: 271 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQ-LRREVEIQSHL-RH 75
           +GKPLGRG FG V  A     +     + +    L++  +  EH+ L  E++I  H+  H
Sbjct: 68  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 76  PNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCK----------------YFSERRA 118
            N++ L G        + +I+E+   G L   L+  +                + +    
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRRTM 173
             Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +   +      R+   
Sbjct: 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKF 232
              L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++   + 
Sbjct: 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 307
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                 +      +      + SQR    +L+EH
Sbjct: 308 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 37/279 (13%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQ-LRREVEIQSHL-RH 75
           +GKPLGRG FG V  A     +     + +    L++  +  EH+ L  E++I  H+  H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 76  PNILRLYG----------------------YFYDQKRVYLILEYAAKGELYKELQKCKYF 113
            N++ L G                       +   KR   +    A  +LYK+     + 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-----FL 136
Query: 114 SERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN----- 168
           +      Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +   +      
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           R+      L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 228 VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
              +       +      +      + SQR    +L+EH
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 113/275 (41%), Gaps = 26/275 (9%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQ-LRREVEIQSHL- 73
            ++GKPLGRG FG V  A     +     + +    L++  +  EH+ L  E++I  H+ 
Sbjct: 30  LNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 89
Query: 74  RHPNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCK---------------YFSERR 117
            H N++ L G        + +I+E+   G L   L+  +               + +   
Sbjct: 90  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEH 149
Query: 118 AATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRRT 172
              Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +          R+  
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLK 231
               L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++   +
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 232 FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                  +      +      + SQR    +L+EH
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 37/279 (13%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQ-LRREVEIQSHL-RH 75
           +GKPLGRG FG V  A     +     + +    L++  +  EH+ L  E++I  H+  H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 76  PNILRLYG----------------------YFYDQKRVYLILEYAAKGELYKELQKCKYF 113
            N++ L G                       +   KR   +    A  +LYK+     + 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-----FL 136
Query: 114 SERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN----- 168
           +      Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +   +      
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           R+      L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 228 VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
              +       +      +      + SQR    +L+EH
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 130/298 (43%), Gaps = 50/298 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+++ + +GRGK+  V+      +N            L+  + +   R    +Q+ +  
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLMGG 85
Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI++L     DQ  K   LI EY    + +K L      ++     Y+  L +AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALDYCH 142
Query: 134 GKHVIHRDIKPENLLIGAQ-GELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            + ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 202
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F   ++ D   +I +V              ++  P 
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 235 ----------KP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                     KP           +VS  A D + ++L  D  +RL   + + HP+  Q
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 24  LGRGKFGHVYLAR--EKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILR 80
           +G+G FG VY     ++  N I  A+K L  S++ + Q      RE  +   L HPN+L 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 81  LYGYFYDQKRV-YLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVI 138
           L G     + + +++L Y   G+L + ++   +  + +   ++   +AR + Y   +  +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 139 HRDIKPENLLIGAQGELKIADFGWSVHTFNRR-------RTMCGTLDYLPPEMVESVEHD 191
           HRD+   N ++     +K+ADFG +    +R        R     + +   E +++    
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT 206
Query: 192 ANVDIWSLGVLCYEFLY-GVPPF 213
              D+WS GVL +E L  G PP+
Sbjct: 207 TKSDVWSFGVLLWELLTRGAPPY 229

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 12/190 (6%)
Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYG 83
           LG G+ G V++     + H    KV  KS  Q S        E  +   L+H  ++RLY 
Sbjct: 21  LGAGQAGEVWMGY--YNGHT---KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 84  YFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRD 141
               Q+ +Y+I EY   G L   L+       +  +     A +A  + +   ++ IHRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 142 IKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIW 197
           ++  N+L+      KIADFG +          R      + +  PE +         D+W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 198 SLGVLCYEFL 207
           S G+L  E +
Sbjct: 195 SFGILLTEIV 204

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH-QLRREVEI----Q 70
           N F +G+ +G G FG +YL    ++N  VA+K      L+  + +H QL  E +I    Q
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKIYRILQ 60
Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
                PN+ R +G   D    Y +L     G   ++L    + S + +   V  LA  +I
Sbjct: 61  GGTGIPNV-RWFGVEGD----YNVLVMDLLGPSLEDL--FNFCSRKLSLKTVLMLADQMI 113
Query: 131 ----YCHGKHVIHRDIKPENLLIG---AQGELKIADFGW-------SVHT---FNRRRTM 173
               + H K  +HRDIKP+N L+G      ++ I DFG        S H    +   + +
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEA 215
            GT  Y        +E     D+ SLG +   FL G  P++ 
Sbjct: 174 TGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 21/227 (9%)
Query: 16  NDFDIGKPLGRGKFGHVY---LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           N   +GK LG G+FG V    L +E  ++  VA+K +      Q ++E  L  E      
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKD 92
Query: 73  LRHPNILRLYGYFYDQK-----RVYLILEYAAKGEL-----YKELQKC-KYFSERRAATY 121
             HPN++RL G   +       +  +IL +   G+L     Y  L+   K+   +    +
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 122 VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP 181
           +  +A  + Y   ++ +HRD+   N ++     + +ADFG S   ++      G +  +P
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 182 PE--MVESVE---HDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTY 222
            +   +ES+    + +  D+W+ GV  +E    G+ P+   ++ + Y
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 115/275 (41%), Gaps = 31/275 (11%)
Query: 20  IGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQSHL 73
           +GKPLGRG FG V  A      +  +   VA+K+L +     +  EH+ L  E++I  H+
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA---THSEHRALMSELKILIHI 89
Query: 74  -RHPNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCK--------------YFSERR 117
             H N++ L G        + +I+E+   G L   L+  +              + +   
Sbjct: 90  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEH 149
Query: 118 AATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRRT 172
              Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +          R+  
Sbjct: 150 LIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLK 231
               L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++   +
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 232 FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                  +      +      + SQR    +L+EH
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH--LRHPNIL 79
           K +G+G++G V++ + +     VA+KV F ++      E    RE EI     +RH NIL
Sbjct: 43  KQIGKGRYGEVWMGKWRGEK--VAVKVFFTTE------EASWFRETEIYQTVLMRHENIL 94
Query: 80  RLYGY----FYDQKRVYLILEYAAKGELYKELQKCKYFSE---RRAATYVASLA---RAL 129
                         ++YLI +Y   G LY  L+     ++   + A + V+ L      +
Sbjct: 95  GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 130 IYCHGKHVI-HRDIKPENLLIGAQGELKIADFGWSVHTFNRR-------RTMCGTLDYLP 181
               GK  I HRD+K +N+L+   G   IAD G +V   +          T  GT  Y+P
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 182 PEMV-ESVEHD-----ANVDIWSLGVLCYE 205
           PE++ ES+  +        D++S G++ +E
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWE 244

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 112/274 (40%), Gaps = 27/274 (9%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQ-LRREVEIQSHL-RH 75
           +GKPLGRG FG V  A     +     + +    L++  +  EH+ L  E++I  H+  H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 76  PNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCK----------------YFSERRA 118
            N++ L G        + +I+E+   G L   L+  +                + +    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRRTM 173
             Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +          R+   
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKF 232
              L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++   + 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                 +      +      + SQR    +L+EH
Sbjct: 271 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N  VA+K+L   + ++ + E        +++    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKRE-----IKILENLRGG 91
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 148
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N+LI  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 149 SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 112/274 (40%), Gaps = 27/274 (9%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQ-LRREVEIQSHL-RH 75
           +GKPLGRG FG V  A     +     + +    L++  +  EH+ L  E++I  H+  H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 76  PNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCK----------------YFSERRA 118
            N++ L G        + +I+E+   G L   L+  +                + +    
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-----RRRTM 173
             Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +          R+   
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKF 232
              L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++   + 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 261
Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                 +      +      + SQR    +L+EH
Sbjct: 262 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 38/278 (13%)
Query: 17  DFDIGKPLGRGKFGHVYLAR----EKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQS 71
           + + GK LG G FG V  A      K    I VA+K+L K +   S+ E  L  E+++ +
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSERE-ALMSELKMMT 103
Query: 72  HL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQ---------KCKYFSERRAA-- 119
            L  H NI+ L G       +YLI EY   G+L   L+         + +Y +++R    
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 120 ------------TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFG-----W 162
                        +   +A+ + +   K  +HRD+   N+L+     +KI DFG      
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 163 SVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
           S   +  R      + ++ PE +    +    D+WS G+L +E F  GV P+        
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283
Query: 222 YRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLP 259
           + +++Q   K   +P  ++    +I Q      S++ P
Sbjct: 284 FYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRP 320

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 129/298 (43%), Gaps = 50/298 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+++ + +GRGK+  V+      +N            L+  + +   R    +Q+    
Sbjct: 33  DDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLCGG 87
Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI++L     DQ  K   LI EY    + +K L      ++     Y+  L +AL YCH
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALDYCH 144
Query: 134 GKHVIHRDIKPENLLIGAQ-GELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            + ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+  +
Sbjct: 145 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 204
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F   ++ D   +I +V              ++  P 
Sbjct: 205 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 264
Query: 235 ----------KP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                     KP           +VS  A D + ++L  D  +RL   + + HP+  Q
Sbjct: 265 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 129/298 (43%), Gaps = 50/298 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+++ + +GRGK+  V+      +N            L+  + +   R    +Q+    
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLXGG 85
Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI++L     DQ  K   LI EY    + +K L      ++     Y+  L +AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALDYCH 142
Query: 134 GKHVIHRDIKPENLLIGAQ-GELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            + ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 202
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F   ++ D   +I +V              ++  P 
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 235 ----------KP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                     KP           +VS  A D + ++L  D  +RL   + + HP+  Q
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 129/298 (43%), Gaps = 50/298 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+++ + +GRGK+  V+      +N            L+  + +   R    +Q+    
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLCGG 85
Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI++L     DQ  K   LI EY    + +K L      ++     Y+  L +AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALDYCH 142
Query: 134 GKHVIHRDIKPENLLIGAQ-GELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            + ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 202
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F   ++ D   +I +V              ++  P 
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 235 ----------KP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                     KP           +VS  A D + ++L  D  +RL   + + HP+  Q
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 129/298 (43%), Gaps = 50/298 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+++ + +GRGK+  V+      +N            L+  + +   R    +Q+    
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLXGG 85
Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI++L     DQ  K   LI EY    + +K L      ++     Y+  L +AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALDYCH 142
Query: 134 GKHVIHRDIKPENLLIGAQ-GELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            + ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 202
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F   ++ D   +I +V              ++  P 
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 235 ----------KP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                     KP           +VS  A D + ++L  D  +RL   + + HP+  Q
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 129/298 (43%), Gaps = 50/298 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+++ + +GRGK+  V+      +N            L+  + +   R    +Q+    
Sbjct: 32  DDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLXGG 86
Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI++L     DQ  K   LI EY    + +K L      ++     Y+  L +AL YCH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALDYCH 143
Query: 134 GKHVIHRDIKPENLLIGAQ-GELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            + ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+  +
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 203
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F   ++ D   +I +V              ++  P 
Sbjct: 204 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 263
Query: 235 ----------KP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                     KP           +VS  A D + ++L  D  +RL   + + HP+  Q
Sbjct: 264 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 129/298 (43%), Gaps = 50/298 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+++ + +GRGK+  V+      +N            L+  + +   R    +Q+    
Sbjct: 52  DDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLXGG 106
Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI++L     DQ  K   LI EY    + +K L      ++     Y+  L +AL YCH
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALDYCH 163
Query: 134 GKHVIHRDIKPENLLIGAQ-GELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            + ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+  +
Sbjct: 164 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 223
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F   ++ D   +I +V              ++  P 
Sbjct: 224 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDPQ 283
Query: 235 ----------KP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                     KP           +VS  A D + ++L  D  +RL   + + HP+  Q
Sbjct: 284 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 341

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
            +IG+ +G+G+FG VY  R       VA++++   +  + Q++   +REV      RH N
Sbjct: 35  LEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLK-AFKREVMAYRQTRHEN 90
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS-LARALIYCHGKH 136
           ++   G       + +I        LY  ++  K   +      +A  + + + Y H K 
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 137 VIHRDIKPENLLIGAQGELKIADFGW----SVHTFNRR----RTMCGTLDYLPPEMVESV 188
           ++H+D+K +N+     G++ I DFG      V    RR    R   G L +L PE++  +
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 189 EHDA---------NVDIWSLGVLCYEFLYGVPPFEAK 216
             D          + D+++LG + YE      PF+ +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 129/298 (43%), Gaps = 50/298 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+++ + +GRGK+  V+      +N            L+  + +   R    +Q+    
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLCGG 85
Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI++L     DQ  K   LI EY    + +K L      ++     Y+  L +AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALDYCH 142
Query: 134 GKHVIHRDIKPENLLIGAQ-GELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            + ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 202
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F   ++ D   +I +V              ++  P 
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 235 ----------KP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                     KP           +VS  A D + ++L  D  +RL   + + HP+  Q
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 129/298 (43%), Gaps = 50/298 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+++ + +GRGK+  V+      +N            L+  + +   R    +Q+    
Sbjct: 32  DDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLCGG 86
Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI++L     DQ  K   LI EY    + +K L      ++     Y+  L +AL YCH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALDYCH 143
Query: 134 GKHVIHRDIKPENLLIGAQ-GELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            + ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+  +
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 203
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F   ++ D   +I +V              ++  P 
Sbjct: 204 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 263
Query: 235 ----------KP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                     KP           +VS  A D + ++L  D  +RL   + + HP+  Q
Sbjct: 264 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 129/298 (43%), Gaps = 50/298 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+++ + +GRGK+  V+      +N            L+  + +   R    +Q+    
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLXGG 85
Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI++L     DQ  K   LI EY    + +K L      ++     Y+  L +AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALDYCH 142
Query: 134 GKHVIHRDIKPENLLIGAQ-GELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
            + ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 202
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPP- 234
           +D ++D+WSLG +    ++   P F   ++ D   +I +V              ++  P 
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 235 ----------KP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                     KP           +VS  A D + ++L  D  +RL   + + HP+  Q
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 111/279 (39%), Gaps = 37/279 (13%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQ-LRREVEIQSHL-RH 75
           +GKPLGRG FG V  A     +     + +    L++  +  EH+ L  E++I  H+  H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 76  PNILRLYG----------------------YFYDQKRVYLILEYAAKGELYKELQKCKYF 113
            N++ L G                       +   KR   +    A  +LYK+     + 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-----FL 136
Query: 114 SERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN----- 168
           +      Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +          
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           R+      L ++ PE +    +    D+WS GVL +E F  G  P+   +  + + R ++
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 228 VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
              +       +      +      + SQR    +L+EH
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 86/196 (43%), Gaps = 11/196 (5%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ--LRREVEIQSHLRHPNIL 79
           + LG G FG V L     +N      V  K+       +H+   ++E++I   L H +I+
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 80  RLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           +  G   DQ  K + L++EY   G L   L +       +   +   +   + Y H +H 
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHY 138
Query: 138 IHRDIKPENLLIGAQGELKIADFGWSV-----HTFNR-RRTMCGTLDYLPPEMVESVEHD 191
           IHR++   N+L+     +KI DFG +      H + R R      + +  PE ++  +  
Sbjct: 139 IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 198
Query: 192 ANVDIWSLGVLCYEFL 207
              D+WS GV  YE L
Sbjct: 199 YASDVWSFGVTLYELL 214

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 86/196 (43%), Gaps = 11/196 (5%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ--LRREVEIQSHLRHPNIL 79
           + LG G FG V L     +N      V  K+       +H+   ++E++I   L H +I+
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 80  RLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           +  G   DQ  K + L++EY   G L   L +       +   +   +   + Y H +H 
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHSQHY 138
Query: 138 IHRDIKPENLLIGAQGELKIADFGWSV-----HTFNR-RRTMCGTLDYLPPEMVESVEHD 191
           IHR++   N+L+     +KI DFG +      H + R R      + +  PE ++  +  
Sbjct: 139 IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 198
Query: 192 ANVDIWSLGVLCYEFL 207
              D+WS GV  YE L
Sbjct: 199 YASDVWSFGVTLYELL 214

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 110/295 (37%), Gaps = 83/295 (28%)
Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           L DF+  + +GRG FG V+ A+ K  +   A+K +     + ++   ++ REV+  + L 
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 62
Query: 75  HPNILRLYGY---------------------------------------------FYDQK 89
           HP I+R +                                               F  + 
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 90  RVYLILEYAAKGELYKELQKC-----KYFSERRAAT----------YVASLARALIYCHG 134
            V  +   + K  LY ++Q C     K +  RR +               +A A+ + H 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGW---------------SVHTFNRRRTMCGTLDY 179
           K ++HRD+KP N+       +K+ DFG                 +  +       GT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLY 242
Query: 180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-DLKFP 233
           + PE +    +   VDI+SLG++ +E LY           +  R I  V +LKFP
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSF-----STQMERVRIITDVRNLKFP 292

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 32/242 (13%)
Query: 16  NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           N    GK LG G FG V  A      +  +   VA+K+L K     ++ E  L  E+++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTERE-ALMSELKVL 103
Query: 71  SHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK------CKYFS--------- 114
           S+L  H NI+ L G         +I EY   G+L   L++      C   S         
Sbjct: 104 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 163
Query: 115 ---ERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR 171
                   ++   +A+ + +   K+ IHRD+   N+L+      KI DFG + H  N   
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSN 223
Query: 172 TMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
            +      LP     PE + +  +    D+WS G+  +E F  G  P+        + ++
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 283
Query: 226 VQ 227
           ++
Sbjct: 284 IK 285

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-------QSHLR 74
           + LG G F  V+LA++  +N  VA+K++   ++     E +++    +       +  + 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 75  HPNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI-- 130
             +IL+L  +F  +    V++++ +   GE    L K KY        YV  +++ L+  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLG 143
Query: 131 --YCHGK-HVIHRDIKPENLLIGAQG------ELKIADFGWSVHTFNRRRTMCGTLDYLP 181
             Y H +  +IH DIKPEN+L+          ++KIAD G +            T +Y  
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 203
Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE-HSDT 221
           PE++         DIWS   L +E + G   FE  E HS T
Sbjct: 204 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-------QSHLR 74
           + LG G F  V+LA++  +N  VA+K++   ++     E +++    +       +  + 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 75  HPNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI-- 130
             +IL+L  +F  +    V++++ +   GE    L K KY        YV  +++ L+  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLG 143
Query: 131 --YCHGK-HVIHRDIKPENLLIGAQG------ELKIADFGWSVHTFNRRRTMCGTLDYLP 181
             Y H +  +IH DIKPEN+L+          ++KIAD G +            T +Y  
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 203
Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE-HSDT 221
           PE++         DIWS   L +E + G   FE  E HS T
Sbjct: 204 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 86/202 (42%), Gaps = 22/202 (10%)
Query: 24  LGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           LG+G FG VY    +      +   VA+K + +S   + ++E     E  +       ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 82
Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA----------TYVASLARA 128
           +RL G     +   +++E  A G+L   L+  +  +E                 A +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLD--YLPPE 183
           + Y + K  +HRD+   N ++     +KI DFG +     T   R+   G L   ++ PE
Sbjct: 143 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 202
Query: 184 MVESVEHDANVDIWSLGVLCYE 205
            ++      + D+WS GV+ +E
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWE 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 22/205 (10%)
Query: 22  KPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           + LG+G FG VY    +      +   VA+K + +S   + ++E     E  +       
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 80
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA----------TYVASLA 126
           +++RL G     +   +++E  A G+L   L+  +  +E                 A +A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLD--YLP 181
             + Y + K  +HRD+   N ++     +KI DFG +     T   R+   G L   ++ 
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 182 PEMVESVEHDANVDIWSLGVLCYEF 206
           PE ++      + D+WS GV+ +E 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 91
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    + +K+L++    ++     Y+  + +AL YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQT--LTDYDIRFYMYEILKALDYCH 148
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 22/205 (10%)
Query: 22  KPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           + LG+G FG VY    +      +   VA+K + +S   + ++E     E  +       
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 77
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA----------TYVASLA 126
           +++RL G     +   +++E  A G+L   L+  +  +E                 A +A
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLD--YLP 181
             + Y + K  +HRD+   N ++     +KI DFG +     T   R+   G L   ++ 
Sbjct: 138 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 182 PEMVESVEHDANVDIWSLGVLCYEF 206
           PE ++      + D+WS GV+ +E 
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/298 (21%), Positives = 124/298 (41%), Gaps = 50/298 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVL--FKSQLQQSQVEHQLRREVEIQSHL 73
           N F + + +G G FG V L +   +    A+KV+   K   + +++E  + ++++     
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDIN 94
Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIY 131
            +  + + +G F     + LI E      LY+ + +  Y  F       Y   + +AL Y
Sbjct: 95  NNNIV-KYHGKFMYYDHMCLIFEPLGPS-LYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 132 CHGKHVIHRDIKPENLLIG--------------AQGE-----------LKIADFGWSVHT 166
                + H D+KPEN+L+                 G+           +K+ DFG +   
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 167 FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV 226
            +   ++  T  Y  PE++ ++  D + D+WS G +  E   G   F   EH + +  ++
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME-HLAMM 271
Query: 227 QVDLKFPPKPIVSSAAKDLISQMLVKDS------------------SQRLPLHKLLEH 266
           +  ++  PK ++  A K   S+ + KD                    + LPL+K+++H
Sbjct: 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 17/218 (7%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + Y   K  
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 153
Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT-------LDYLPPEMVESVEH 190
           +HRD+   N ++  +  +K+ADFG +   +++              + ++  E +++ + 
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKF 213
Query: 191 DANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
               D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 214 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 251

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + Y   K  
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 172
Query: 138 IHRDIKPENLLIGAQGELKIADFG----------WSVHTFNRRRTMCGTLDYLPPEMVES 187
           +HRD+   N ++  +  +K+ADFG          +SVH     +     + ++  E +++
Sbjct: 173 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVKWMALESLQT 229
Query: 188 VEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
            +     D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 270

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + Y   K  
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 173
Query: 138 IHRDIKPENLLIGAQGELKIADFG----------WSVHTFNRRRTMCGTLDYLPPEMVES 187
           +HRD+   N ++  +  +K+ADFG          +SVH     +     + ++  E +++
Sbjct: 174 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVKWMALESLQT 230
Query: 188 VEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
            +     D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 271

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 91
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 148
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + Y   K  
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 146
Query: 138 IHRDIKPENLLIGAQGELKIADFG----------WSVHTFNRRRTMCGTLDYLPPEMVES 187
           +HRD+   N ++  +  +K+ADFG          +SVH     +     + ++  E +++
Sbjct: 147 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVKWMALESLQT 203
Query: 188 VEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
            +     D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 244

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 11/196 (5%)
Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ--LRREVEIQSHLRHPNIL 79
           + LG G FG V L     +N      V  K+    +  +H+   ++E++I   L H +I+
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 80  RLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           +  G   D     + L++EY   G L   L +       +   +   +   + Y H +H 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHY 155
Query: 138 IHRDIKPENLLIGAQGELKIADFGWSV------HTFNRRRTMCGTLDYLPPEMVESVEHD 191
           IHRD+   N+L+     +KI DFG +         +  R      + +  PE ++  +  
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFY 215
Query: 192 ANVDIWSLGVLCYEFL 207
              D+WS GV  YE L
Sbjct: 216 YASDVWSFGVTLYELL 231

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 23/216 (10%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKV-LFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +F +GK +G G FG + L +   +N  VA+K+   KS+  Q  +E++  +++        
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD---- 65
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHG 134
             I ++Y +    K   ++LE      L      C + FS +        L   + Y H 
Sbjct: 66  -GIPQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 135 KHVIHRDIKPENLLIGAQGE-----LKIADFGWSVH----------TFNRRRTMCGTLDY 179
           K++I+RD+KPEN LIG  G      + I DFG +             +   +++ GT  Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEA 215
           +        E     D+ +LG +   FL G  P++ 
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 91
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 148
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + Y   K  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 154
Query: 138 IHRDIKPENLLIGAQGELKIADFG----------WSVHTFNRRRTMCGTLDYLPPEMVES 187
           +HRD+   N ++  +  +K+ADFG          +SVH     +     + ++  E +++
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVKWMALESLQT 211
Query: 188 VEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
            +     D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 252

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 91
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 148
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + Y   K  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 151
Query: 138 IHRDIKPENLLIGAQGELKIADFG----------WSVHTFNRRRTMCGTLDYLPPEMVES 187
           +HRD+   N ++  +  +K+ADFG          +SVH     +     + ++  E +++
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVKWMALESLQT 208
Query: 188 VEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
            +     D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 91
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 148
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 91
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 148
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 91
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 148
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 90
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 147
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 91
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 148
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKV-LFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           +GK +G G FG + L +   +N  VA+K+   KS+  Q  +E++  +++          +
Sbjct: 4   VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAPQLHLEYRFYKQLGSAGE----GL 59
Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHV 137
            ++Y +    K   ++LE      L      C + F+ +        L   + Y H K++
Sbjct: 60  PQVYYFGPXGKYNAMVLELLGP-SLEDLFDLCDRTFTLKTVLMIAIQLLSRMEYVHSKNL 118
Query: 138 IHRDIKPENLLIGAQGELK-----IADFGWSVH----------TFNRRRTMCGTLDYLPP 182
           I+RD+KPEN LIG QG  K     I DFG +             +   +++ GT  Y+  
Sbjct: 119 IYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSI 178
Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEA 215
                 E     D+ +LG +   FL G  P++ 
Sbjct: 179 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 211

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 14/249 (5%)
Query: 20  IGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           I K +G G  G V   R +   + +  VA+K L K+   + Q       E  I     HP
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQ-RRDFLSEASIMGQFDHP 110
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGK 135
           NI+RL G     +   ++ EY   G L   L+     F+  +    +  +   + Y    
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGT---LDYLPPEMVESVE 189
             +HRD+   N+L+ +    K++DFG S       +   T  G    + +  PE +    
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 190 HDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
             +  D+WS GV+ +E L YG  P+    + D     V+   + P       A   L+  
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS-VEEGYRLPAPMGCPHALHQLMLD 289
Query: 249 MLVKDSSQR 257
              KD +QR
Sbjct: 290 CWHKDRAQR 298

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + Y   K  
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 152
Query: 138 IHRDIKPENLLIGAQGELKIADFG----------WSVHTFNRRRTMCGTLDYLPPEMVES 187
           +HRD+   N ++  +  +K+ADFG          +SVH     +     + ++  E +++
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVKWMALESLQT 209
Query: 188 VEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
            +     D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 250

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 87/205 (42%), Gaps = 22/205 (10%)
Query: 22  KPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           + LG+G FG VY    +      +   VA+K + +S   + ++E     E  +       
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 79
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA----------TYVASLA 126
           +++RL G     +   +++E  A G+L   L+  +  +E                 A +A
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTMCGTLD--YLP 181
             + Y + K  +HRD+   N ++     +KI DFG +   +     R+   G L   ++ 
Sbjct: 140 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 182 PEMVESVEHDANVDIWSLGVLCYEF 206
           PE ++      + D+WS GV+ +E 
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 42  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 96
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 153
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 154 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 213
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 214 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 273
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 274 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 90
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 147
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 91
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 148
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + Y   K  
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 153
Query: 138 IHRDIKPENLLIGAQGELKIADFG----------WSVHTFNRRRTMCGTLDYLPPEMVES 187
           +HRD+   N ++  +  +K+ADFG          +SVH     +     + ++  E +++
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVKWMALESLQT 210
Query: 188 VEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
            +     D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 251

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + Y   K  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 154
Query: 138 IHRDIKPENLLIGAQGELKIADFG----------WSVHTFNRRRTMCGTLDYLPPEMVES 187
           +HRD+   N ++  +  +K+ADFG          +SVH     +     + ++  E +++
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVKWMALESLQT 211
Query: 188 VEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
            +     D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 252

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + Y   K  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 138 IHRDIKPENLLIGAQGELKIADFG----------WSVHTFNRRRTMCGTLDYLPPEMVES 187
           +HRD+   N ++  +  +K+ADFG          +SVH     +     + ++  E +++
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVKWMALESLQT 206
Query: 188 VEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
            +     D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 22/204 (10%)
Query: 22  KPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           + LG+G FG VY    +      +   VA+K + +S   + ++E     E  +       
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 80
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA----------TYVASLA 126
           +++RL G     +   +++E  A G+L   L+  +  +E                 A +A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTMCGTLD--YLP 181
             + Y + K  +HRD+   N ++     +KI DFG +   +     R+   G L   ++ 
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 182 PEMVESVEHDANVDIWSLGVLCYE 205
           PE ++      + D+WS GV+ +E
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 22/204 (10%)
Query: 22  KPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           + LG+G FG VY    +      +   VA+K + +S   + ++E     E  +       
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 80
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA----------TYVASLA 126
           +++RL G     +   +++E  A G+L   L+  +  +E                 A +A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTMCGTLD--YLP 181
             + Y + K  +HRD+   N ++     +KI DFG +   +     R+   G L   ++ 
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 182 PEMVESVEHDANVDIWSLGVLCYE 205
           PE ++      + D+WS GV+ +E
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 50/296 (16%)
Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +D+ + + LGRGK+  V+ A    +N     + +    L+  + +   R    +++    
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENLRGG 89
Query: 76  PNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           PNI+ L     D   +   L+ E+    +  +  Q    +  R    Y+  + +AL YCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDYCH 146
Query: 134 GKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPE-MVESVE 189
              ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE +V+   
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 190 HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV-------------DLKFPPK 235
           +D ++D+WSLG +    ++   P F   ++ D   RI +V             +++  P+
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 236 ----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                                  +VS  A D + ++L  D   RL   + +EHP+ 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 14/249 (5%)
Query: 20  IGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           I K +G G  G V   R +   + +  VA+K L K+   + Q       E  I     HP
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQ-RRDFLSEASIMGQFDHP 110
Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGK 135
           NI+RL G     +   ++ EY   G L   L+     F+  +    +  +   + Y    
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGT---LDYLPPEMVESVE 189
             +HRD+   N+L+ +    K++DFG S       +   T  G    + +  PE +    
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 190 HDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
             +  D+WS GV+ +E L YG  P+    + D     V+   + P       A   L+  
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS-VEEGYRLPAPMGCPHALHQLMLD 289
Query: 249 MLVKDSSQR 257
              KD +QR
Sbjct: 290 CWHKDRAQR 298

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 22  KPLGRGKFGHVY---LAREKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           K LG G FG VY      E  +  I VA+K+L ++   ++ VE     E  I + + HP+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPH 78
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKH 136
           ++RL G       + L+ +    G L + + + K     +    +   +A+ ++Y   + 
Sbjct: 79  LVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 137
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCG---TLDYLPPEMVESVEHD 191
           ++HRD+   N+L+ +   +KI DFG +  +    +     G    + ++  E +   +  
Sbjct: 138 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 197
Query: 192 ANVDIWSLGVLCYEFL-YGVPPFEA 215
              D+WS GV  +E + +G  P++ 
Sbjct: 198 HQSDVWSYGVTIWELMTFGGKPYDG 222

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 32/242 (13%)
Query: 16  NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           N    GK LG G FG V  A      +  +   VA+K+L K     ++ E  L  E+++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTERE-ALMSELKVL 80
Query: 71  SHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK------CKYFS--------- 114
           S+L  H NI+ L G         +I EY   G+L   L++      C   S         
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 115 ---ERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR 171
                   ++   +A+ + +   K+ IHRD+   N+L+      KI DFG +    N   
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 172 TMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
            +      LP     PE + +  +    D+WS G+  +E F  G  P+        + ++
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 226 VQ 227
           ++
Sbjct: 261 IK 262

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 22  KPLGRGKFGHVY---LAREKRSNHI-VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           K LG G FG VY      E  +  I VA+K+L ++   ++ VE     E  I + + HP+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPH 101
Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKH 136
           ++RL G       + L+ +    G L + + + K     +    +   +A+ ++Y   + 
Sbjct: 102 LVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 160
Query: 137 VIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCG---TLDYLPPEMVESVEHD 191
           ++HRD+   N+L+ +   +KI DFG +  +    +     G    + ++  E +   +  
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 220
Query: 192 ANVDIWSLGVLCYEFL-YGVPPFEA 215
              D+WS GV  +E + +G  P++ 
Sbjct: 221 HQSDVWSYGVTIWELMTFGGKPYDG 245

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 32/242 (13%)
Query: 16  NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           N    GK LG G FG V  A      +  +   VA+K+L K     ++ E  L  E+++ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTERE-ALMSELKVL 96
Query: 71  SHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK------CKYFS--------- 114
           S+L  H NI+ L G         +I EY   G+L   L++      C   S         
Sbjct: 97  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 156
Query: 115 ---ERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR 171
                   ++   +A+ + +   K+ IHRD+   N+L+      KI DFG +    N   
Sbjct: 157 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 216
Query: 172 TMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
            +      LP     PE + +  +    D+WS G+  +E F  G  P+        + ++
Sbjct: 217 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 276
Query: 226 VQ 227
           ++
Sbjct: 277 IK 278

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKV-LFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +F +GK +G G FG + L +   +N  VA+K+   KS+  Q  +E++  +++        
Sbjct: 5   NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAPQLHLEYRFYKQLSATE---- 60
Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHG 134
             + ++Y +    K   ++LE      L      C + F+ +        L   + Y H 
Sbjct: 61  -GVPQVYYFGPXGKYNAMVLELLGP-SLEDLFDLCDRTFTLKTVLMIAIQLITRMEYVHT 118
Query: 135 KHVIHRDIKPENLLIGAQGE-----LKIADFGWSVH----------TFNRRRTMCGTLDY 179
           K +I+RD+KPEN L+G  G      + I DFG +             +   +++ GT  Y
Sbjct: 119 KSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARY 178
Query: 180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEA 215
           +        E     D+ +LG +   FL G  P++ 
Sbjct: 179 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 214

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + +   K  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----RTMCGT---LDYLPPEMVESVEH 190
           +HRD+   N ++  +  +K+ADFG +   +++         G    + ++  E +++ + 
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273
Query: 191 DANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
               D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 274 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 32/242 (13%)
Query: 16  NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           N    GK LG G FG V  A      +  +   VA+K+L K     ++ E  L  E+++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTERE-ALMSELKVL 103
Query: 71  SHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK------CKYFS--------- 114
           S+L  H NI+ L G         +I EY   G+L   L++      C   S         
Sbjct: 104 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 163
Query: 115 ---ERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR 171
                   ++   +A+ + +   K+ IHRD+   N+L+      KI DFG +    N   
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 223
Query: 172 TMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
            +      LP     PE + +  +    D+WS G+  +E F  G  P+        + ++
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 283
Query: 226 VQ 227
           ++
Sbjct: 284 IK 285

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 32/242 (13%)
Query: 16  NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           N    GK LG G FG V  A      +  +   VA+K+L K     ++ E  L  E+++ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTERE-ALMSELKVL 98
Query: 71  SHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK------CKYFS--------- 114
           S+L  H NI+ L G         +I EY   G+L   L++      C   S         
Sbjct: 99  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 158
Query: 115 ---ERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR 171
                   ++   +A+ + +   K+ IHRD+   N+L+      KI DFG +    N   
Sbjct: 159 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 218
Query: 172 TMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
            +      LP     PE + +  +    D+WS G+  +E F  G  P+        + ++
Sbjct: 219 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 278
Query: 226 VQ 227
           ++
Sbjct: 279 IK 280

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + +   K  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 154
Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----RTMCGT---LDYLPPEMVESVEH 190
           +HRD+   N ++  +  +K+ADFG +   +++         G    + ++  E +++ + 
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 191 DANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
               D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 252

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + +   K  
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 159
Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----RTMCGT---LDYLPPEMVESVEH 190
           +HRD+   N ++  +  +K+ADFG +   +++         G    + ++  E +++ + 
Sbjct: 160 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 219
Query: 191 DANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
               D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 220 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 257

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + +   K  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 154
Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----RTMCGT---LDYLPPEMVESVEH 190
           +HRD+   N ++  +  +K+ADFG +   +++         G    + ++  E +++ + 
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 191 DANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
               D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 252

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + +   K  
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 152
Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----RTMCGT---LDYLPPEMVESVEH 190
           +HRD+   N ++  +  +K+ADFG +   +++         G    + ++  E +++ + 
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 191 DANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
               D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 213 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 250

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 24  LGRGKFGHVY----LAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +GRG FG VY    L  + +  H  A+K L  +++       Q   E  I     HPN+L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIH-CAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 80  RLYGY-FYDQKRVYLILEYAAKGELYKELQKCKYF-SERRAATYVASLARALIYCHGKHV 137
            L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + +   K  
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 155
Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----RTMCGT---LDYLPPEMVESVEH 190
           +HRD+   N ++  +  +K+ADFG +   +++         G    + ++  E +++ + 
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 191 DANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ 227
               D+WS GVL +E +  G PP+      D    ++Q
Sbjct: 216 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 253
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	281
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-162
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-162
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-153
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-134
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-133
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-127
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-99
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-94
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-93
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-91
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-91
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-91
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-90
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-90
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-89
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-89
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-89
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-88
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-88
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-88
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-88
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-87
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-87
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-87
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-87
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-87
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-86
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-86
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-86
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-86
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-85
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-84
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-84
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-84
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-84
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-84
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-83
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-83
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-83
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-83
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-83
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-83
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-83
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-83
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-82
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-82
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-82
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-81
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-81
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-80
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-80
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-79
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-79
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-79
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-79
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-79
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-79
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-79
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-79
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-79
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-79
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-78
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-78
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-78
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-78
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-78
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-78
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-77
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-77
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-77
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-77
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-76
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-76
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-75
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-74
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-74
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-74
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-74
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-74
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-73
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-73
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-73
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-72
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-72
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-71
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-71
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-70
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-70
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-70
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-69
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-69
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-67
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-65
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-65
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-64
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-63
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-61
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-60
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-60
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-58
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-56
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-56
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-56
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-55
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-55
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-55
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-55
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-54
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-54
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-53
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-53
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-50
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-50
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-49
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-49
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-48
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-48
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-46
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-45
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-45
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-45
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-44
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-44
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-43
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-43
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-43
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-43
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-43
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-42
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-42
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-42
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-42
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-42
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-40
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-39
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-38
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-38
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-38
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-38
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-37
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-37
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-37
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-37
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-37
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-36
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-36
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-36
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-36
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-36
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-36
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-35
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-35
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-35
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-35
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-34
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-34
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-34
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-33
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-32
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-32
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-32
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-30
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-27
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-26
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-25
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-25
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-25
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-24
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-23
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-23
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-22
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-22
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-22
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-21
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-20
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-18
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  450 bits (1161), Expect = e-162
 Identities = 175/274 (63%), Positives = 222/274 (81%), Gaps = 3/274 (1%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           + ++   K+++T++DFDIG+PLG+GKFG+VYLAREK++  I+ALKVLFKSQL++  VEHQ
Sbjct: 1   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60

Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           LRRE+EIQSHLRHPNILR+Y YF+D+KR+YL+LE+A +GELYKELQK   F E+R+AT++
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF-NRRRTMCGTLDYLP 181
             LA AL YCH + VIHRDIKPENLL+G +GELKIADFGWSVH    RRRTMCGTLDYLP
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLP 180

Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           PEM+E   HD  VD+W  GVLCYEFL G+PPF++  H++T+RRIV VDLKFPP   +S  
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF--LSDG 238

Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           +KDLIS++L     QRLPL  ++EHPW+  N+  
Sbjct: 239 SKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  449 bits (1158), Expect = e-162
 Identities = 175/273 (64%), Positives = 213/273 (78%), Gaps = 3/273 (1%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           +K++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           IQSHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-FNRRRTMCGTLDYLPPEMVES 187
           L YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH   +RR  +CGTLDYLPPEM+E 
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEG 181

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
             HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLIS 239

Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYR 280
           ++L  + SQR  L ++LEHPWI  N+      +
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKPSNCQ 272

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  426 bits (1099), Expect = e-153
 Identities = 93/275 (33%), Positives = 149/275 (54%), Gaps = 6/275 (2%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
           S        + DF +G  LG+G F  VY A    +   VA+K++ K  + ++ +  +++ 
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60

Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVAS 124
           EV+I   L+HP+IL LY YF D   VYL+LE    GE+ + L+ + K FSE  A  ++  
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLP 181
           +   ++Y H   ++HRD+   NLL+     +KIADFG +        +  T+CGT +Y+ 
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180

Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           PE+     H    D+WSLG + Y  L G PPF+     +T  ++V  D + P    +S  
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF--LSIE 238

Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           AKDLI Q+L ++ + RL L  +L+HP++ +N+   
Sbjct: 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  381 bits (980), Expect = e-134
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 5/277 (1%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
            E+        +   +  G+ LG+G F   +   +  +  + A K++ KS L +     +
Sbjct: 28  KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 87

Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           +  E+ I   L H +++  +G+F D   V+++LE   +  L +  ++ K  +E  A  Y+
Sbjct: 88  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 147

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDY 179
             +     Y H   VIHRD+K  NL +    E+KI DFG +    +   R++ +CGT +Y
Sbjct: 148 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207

Query: 180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
           + PE++    H   VD+WS+G + Y  L G PPFE     +TY RI + +   P    ++
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--IN 265

Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
             A  LI +ML  D + R  +++LL   +      P+
Sbjct: 266 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  378 bits (973), Expect = e-133
 Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 5/276 (1%)

Query: 4   EVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQL 63
           E+        +   +  G+ LG+G F   +   +  +  + A K++ KS L +     ++
Sbjct: 3   EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM 62

Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA 123
             E+ I   L H +++  +G+F D   V+++LE   +  L +  ++ K  +E  A  Y+ 
Sbjct: 63  SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 122

Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYL 180
            +     Y H   VIHRD+K  NL +    E+KI DFG +    +   R++ +CGT +Y+
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 182

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
            PE++    H   VD+WS+G + Y  L G PPFE     +TY RI + +   P    ++ 
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INP 240

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
            A  LI +ML  D + R  +++LL   +      P+
Sbjct: 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  365 bits (938), Expect = e-127
 Identities = 72/309 (23%), Positives = 132/309 (42%), Gaps = 46/309 (14%)

Query: 8   KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--------- 58
            ++K   +ND+ I + L +GKF  + L  +   N   ALK   KS L++ +         
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDK 80

Query: 59  -----VEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC--- 110
                     + E++I + +++   L   G   +   VY+I EY     + K  +     
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140

Query: 111 -----KYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSV 164
                 +   +     + S+  +  Y H  K++ HRD+KP N+L+   G +K++DFG S 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200

Query: 165 HTFN-RRRTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEAKE-HSD 220
           +  + + +   GT +++PPE   +    + A VDIWSLG+  Y   Y V PF  K    +
Sbjct: 201 YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260

Query: 221 TYRRIVQVDLKFPPK-----------------PIVSSAAKDLISQMLVKDSSQRLPLHKL 263
            +  I   ++++P                     +S+   D +   L K+ ++R+     
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

Query: 264 LEHPWIIQN 272
           L+H W+   
Sbjct: 321 LKHEWLADT 329

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  291 bits (747), Expect = 6e-99
 Identities = 77/284 (27%), Positives = 124/284 (43%), Gaps = 27/284 (9%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            +   + LG G F +V L       H  ALK +   + Q      + +RE ++     HP
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRLFNHP 86

Query: 77  NILRLYGYFYDQK----RVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARA 128
           NILRL  Y   ++      +L+L +  +G L+ E+++ K    + +E +    +  + R 
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS----VHTFNRRR--------TMCGT 176
           L   H K   HRD+KP N+L+G +G+  + D G      +H    R+            T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 177 LDYLPPEMVESVEH---DANVDIWSLGVLCYEFLYGVPPFEAK-EHSDTYRRIVQVDLKF 232
           + Y  PE+     H   D   D+WSLG + Y  ++G  P++   +  D+    VQ  L  
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           P  P  SSA   L++ M+  D  QR  +  LL     +Q   P 
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  279 bits (715), Expect = 4e-94
 Identities = 91/275 (33%), Positives = 148/275 (53%), Gaps = 15/275 (5%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLR 64
              + ++    DF  GK LG G F  V LARE  ++   A+K+L K   +++++V + + 
Sbjct: 20  PPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VT 78

Query: 65  REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS 124
           RE ++ S L HP  ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A 
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-----VHTFNRRRTMCGTLDY 179
           +  AL Y HGK +IHRD+KPEN+L+     ++I DFG +          R  +  GT  Y
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198

Query: 180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
           + PE++       + D+W+LG + Y+ + G+PPF A      +++I++++  FP K    
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FF 256

Query: 240 SAAKDLISQMLVKDSSQRL------PLHKLLEHPW 268
             A+DL+ ++LV D+++RL          L  HP+
Sbjct: 257 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  276 bits (709), Expect = 4e-93
 Identities = 68/293 (23%), Positives = 124/293 (42%), Gaps = 23/293 (7%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           +E    +        + I K +G G    V+    +    I A+K +   +     ++  
Sbjct: 15  TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLD-S 72

Query: 63  LRREVEIQSHLRHPN--ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
            R E+   + L+  +  I+RLY Y    + +Y+++E     +L   L+K K        +
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKS 131

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCG 175
           Y  ++  A+   H   ++H D+KP N LI   G LK+ DFG +       T   + +  G
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 190

Query: 176 TLDYLPPEMVES-----------VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYR 223
           T++Y+PPE ++             +     D+WSLG + Y   YG  PF+   +      
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250

Query: 224 RIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
            I+  + +     I     +D++   L +D  QR+ + +LL HP++     P 
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  271 bits (696), Expect = 4e-91
 Identities = 99/263 (37%), Positives = 156/263 (59%), Gaps = 9/263 (3%)

Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQ 70
           +++L DF I + LG G FG V+L R + +    A+KVL K   ++  QVEH    E  + 
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH-TNDERLML 60

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           S + HP I+R++G F D +++++I++Y   GEL+  L+K + F    A  Y A +  AL 
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEH 190
           Y H K +I+RD+KPEN+L+   G +KI DFG++ +  +   T+CGT DY+ PE+V +  +
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPY 180

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           + ++D WS G+L YE L G  PF       TY +I+  +L+FPP    +   KDL+S+++
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF--FNEDVKDLLSRLI 238

Query: 251 VKDSSQRLPLHK-----LLEHPW 268
            +D SQRL   +     +  HPW
Sbjct: 239 TRDLSQRLGNLQNGTEDVKNHPW 261

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  272 bits (697), Expect = 7e-91
 Identities = 95/267 (35%), Positives = 142/267 (53%), Gaps = 9/267 (3%)

Query: 8   KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRRE 66
             +    L+ FD  K LG G FG V L + K S +  A+K+L K + ++  Q+EH    E
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNE 91

Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
             I   +  P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVE 186
               Y H   +I+RD+KPENLLI  QG +++ DFG++     R  T+CGT + L PE++ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIIL 211

Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
           S  ++  VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLL 269

Query: 247 SQMLVKDSSQRLPLHK-----LLEHPW 268
             +L  D ++R    K     +  H W
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  276 bits (708), Expect = 8e-91
 Identities = 91/266 (34%), Positives = 140/266 (52%), Gaps = 8/266 (3%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           + +   + LG+G FG V L ++K +    A+KV+ K Q++Q   +  L REV++   L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI++LY +F D+   YL+ E    GEL+ E+   K FSE  AA  +  +   + Y H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 136 HVIHRDIKPENLLIGAQGE---LKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVEH 190
            ++HRD+KPENLL+ ++ +   ++I DFG S H     + +   GT  Y+ PE++    +
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TY 204

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQ 248
           D   D+WS GV+ Y  L G PPF      D  +++ +    F       VS +AKDLI +
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264

Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNAD 274
           ML    S R+     L+H WI     
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTK 290

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  275 bits (706), Expect = 2e-90
 Identities = 88/270 (32%), Positives = 138/270 (51%), Gaps = 9/270 (3%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
             ++I   LG+G FG V   +++ +    A+KV+ K+  +       + REVE+   L H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDH 80

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI++L+    D    Y++ E    GEL+ E+ K K FSE  AA  +  +   + Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 136 HVIHRDIKPENLLIGAQGE---LKIADFGWSV--HTFNRRRTMCGTLDYLPPEMVESVEH 190
           +++HRD+KPEN+L+ ++ +   +KI DFG S       + +   GT  Y+ PE++    +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TY 199

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQ 248
           D   D+WS GV+ Y  L G PPF  K   D  +R+      F       +S  AKDLI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNADPSGV 278
           ML    S R+   + LEHPWI + +  +  
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPT 289

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  270 bits (692), Expect = 3e-90
 Identities = 67/280 (23%), Positives = 120/280 (42%), Gaps = 23/280 (8%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
             + I K +G G    V+    +    I A+K +   +     ++   R E+   + L+ 
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQ 66

Query: 76  PN--ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            +  I+RLY Y    + +Y+++E     +L   L+K K        +Y  ++  A+   H
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLDYLPPEMVE-- 186
              ++H D+KP N LI   G LK+ DFG +       T   + +  GT++Y+PPE ++  
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 187 ---------SVEHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPKP 236
                      +     D+WSLG + Y   YG  PF +          I+  + +     
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244

Query: 237 IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           I     +D++   L +D  QR+ + +LL HP++     P 
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  267 bits (684), Expect = 1e-89
 Identities = 88/264 (33%), Positives = 137/264 (51%), Gaps = 9/264 (3%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           ++I   LG+G FG V   +++ +    A+KV+ K+  +       + REVE+   L HPN
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPN 82

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I++L+    D    Y++ E    GEL+ E+ K K FSE  AA  +  +   + Y H  ++
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142

Query: 138 IHRDIKPENLLIGAQGE---LKIADFGWSVHTFN--RRRTMCGTLDYLPPEMVESVEHDA 192
           +HRD+KPEN+L+ ++ +   +KI DFG S       + +   GT  Y+ PE++    +D 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDE 201

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQML 250
             D+WS GV+ Y  L G PPF  K   D  +R+      F       +S  AKDLI +ML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261

Query: 251 VKDSSQRLPLHKLLEHPWIIQNAD 274
               S R+   + LEHPWI + + 
Sbjct: 262 TFHPSLRITATQCLEHPWIQKYSS 285

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  273 bits (699), Expect = 2e-89
 Identities = 90/268 (33%), Positives = 144/268 (53%), Gaps = 9/268 (3%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
             +   K LG G +G V L R+K ++   A+K++ K+ +  S    +L  EV +   L H
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS-KLLEEVAVLKLLDH 95

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI++LY +F D++  YL++E    GEL+ E+     F+E  AA  +  +   + Y H  
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 136 HVIHRDIKPENLLIGAQGE---LKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVEH 190
           +++HRD+KPENLL+ ++ +   +KI DFG S       + +   GT  Y+ PE++   ++
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KY 214

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQ 248
           D   D+WS+GV+ +  L G PPF  +   +  R++ +    F       VS  AKDLI Q
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274

Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           ML  DS +R+   + LEHPWI +     
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCSKK 302

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  265 bits (679), Expect = 4e-89
 Identities = 89/266 (33%), Positives = 133/266 (50%), Gaps = 11/266 (4%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           + +   +GRG +G V +A +K +    A K + K  ++      + ++E+EI   L HPN
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPN 67

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+RLY  F D   +YL++E    GEL++ +   + F E  AA  +  +  A+ YCH  +V
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127

Query: 138 IHRDIKPENLLIGAQGE---LKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVEHDA 192
            HRD+KPEN L         LK+ DFG +         RT  GT  Y+ P+++E   +  
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGP 186

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQML 250
             D WS GV+ Y  L G PPF A   S+   +I +    FP K    VS  A+ LI ++L
Sbjct: 187 ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLL 246

Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPS 276
            K   QR+   + LEH W  +    S
Sbjct: 247 TKSPKQRITSLQALEHEWFEKQLSSS 272

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  265 bits (679), Expect = 1e-88
 Identities = 82/266 (30%), Positives = 132/266 (49%), Gaps = 9/266 (3%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            F   + LG G F  V+L +++ +  + ALK + KS   +   +  L  E+ +   ++H 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
           NI+ L   +      YL+++  + GEL+  + +   ++E+ A+  +  +  A+ Y H   
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126

Query: 137 VIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRR-RTMCGTLDYLPPEMVESVEHDA 192
           ++HRD+KPENLL     E   + I DFG S    N    T CGT  Y+ PE++    +  
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSK 186

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQML 250
            VD WS+GV+ Y  L G PPF  +  S  + +I +   +F       +S +AKD I  +L
Sbjct: 187 AVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLL 246

Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPS 276
            KD ++R    K L HPWI  N    
Sbjct: 247 EKDPNERYTCEKALSHPWIDGNTALH 272

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  263 bits (675), Expect = 2e-88
 Identities = 79/266 (29%), Positives = 125/266 (46%), Gaps = 14/266 (5%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           F   + LG G FG V+L  E+ S     +K + K + Q      Q+  E+E+   L HPN
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPN 81

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELY----KELQKCKYFSERRAATYVASLARALIYCH 133
           I++++  F D   +Y+++E    GEL         + K  SE   A  +  +  AL Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 134 GKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRRR--TMCGTLDYLPPEMVESV 188
            +HV+H+D+KPEN+L         +KI DFG +    +        GT  Y+ PE+ +  
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR- 200

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP-IVSSAAKDLIS 247
           +     DIWS GV+ Y  L G  PF      +  ++    +  +  +   ++  A DL+ 
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLK 260

Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNA 273
           QML KD  +R    ++L H W  + A
Sbjct: 261 QMLTKDPERRPSAAQVLHHEW-FKQA 285

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  263 bits (675), Expect = 3e-88
 Identities = 78/266 (29%), Positives = 137/266 (51%), Gaps = 8/266 (3%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +D+ + LG+G F  V     K +    A K++   +L     + +L RE  I   L+HPN
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPN 66

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+RL+    ++   YL+ +    GEL++++   +++SE  A+  +  +  ++ YCH   +
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126

Query: 138 IHRDIKPENLLIGAQGE---LKIADFGWSVHTFN--RRRTMCGTLDYLPPEMVESVEHDA 192
           +HR++KPENLL+ ++ +   +K+ADFG ++   +        GT  YL PE+++   +  
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQML 250
            VDIW+ GV+ Y  L G PPF  ++    Y +I      +P      V+  AK LI  ML
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246

Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPS 276
             +  +R+   + L+ PWI      +
Sbjct: 247 TVNPKKRITADQALKVPWICNRERVA 272

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  270 bits (691), Expect = 4e-88
 Identities = 83/278 (29%), Positives = 138/278 (49%), Gaps = 18/278 (6%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV----------EHQLRR 65
             +   + LG G +G V L +EK  +   A+KV+ KSQ  + +             ++  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
           E+ +   L HPNI++L+  F D+K  YL+ E+   GEL++++     F E  AA  +  +
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWSV--HTFNRRRTMCGTLDYL 180
              + Y H  +++HRDIKPEN+L+  +     +KI DFG S       + R   GT  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IV 238
            PE+++  +++   D+WS GV+ Y  L G PPF  +   D  +++ +    F       +
Sbjct: 216 APEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274

Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           S  AK+LI  ML  D ++R    + L   WI + A+  
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNI 312

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  260 bits (668), Expect = 2e-87
 Identities = 82/263 (31%), Positives = 136/263 (51%), Gaps = 11/263 (4%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH---QLRREVEIQSHLR 74
           +++G+ LG G+F  V   R+K +    A K + K +L  S+      ++ REV I   +R
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+ L+  F ++  V LILE  + GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126

Query: 135 KHVIHRDIKPENLLIGAQGE----LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESV 188
           K + H D+KPEN+++  +      +K+ DFG +         + + GT +++ PE+V   
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF  +   +T   I  V+  F  +     S  AKD I
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 246

Query: 247 SQMLVKDSSQRLPLHKLLEHPWI 269
            ++LVKD  +R+ + + LEH WI
Sbjct: 247 RRLLVKDPKRRMTIAQSLEHSWI 269

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  262 bits (671), Expect = 4e-87
 Identities = 81/274 (29%), Positives = 136/274 (49%), Gaps = 11/274 (4%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH---QLRREVEIQSHLR 74
           +D G+ LG G+F  V   REK +    A K + K + + S+       + REV I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  +   + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132

Query: 135 KHVIHRDIKPENLLI----GAQGELKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESV 188
             + H D+KPEN+++      +  +KI DFG +         + + GT +++ PE+V   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     S+ AKD I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252

Query: 247 SQMLVKDSSQRLPLHKLLEHPWIIQNADPSGVYR 280
            ++LVKD  +R+ +   L+HPWI        + R
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSR 286

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  261 bits (669), Expect = 6e-87
 Identities = 82/270 (30%), Positives = 135/270 (50%), Gaps = 11/270 (4%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE---HQLRREVEIQSHLR 74
           +DIG+ LG G+F  V   REK +    A K + K Q + S+      ++ REV I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N++ L+  + ++  V LILE  + GEL+  L + +  SE  A +++  +   + Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133

Query: 135 KHVIHRDIKPENLLI----GAQGELKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESV 188
           K + H D+KPEN+++         +K+ DFG +    +    + + GT +++ PE+V   
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   I  V   F  +     S  AKD I
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFI 253

Query: 247 SQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
            ++LVK++ +RL + + L HPWI    +  
Sbjct: 254 RKLLVKETRKRLTIQEALRHPWITPVDNQQ 283

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  262 bits (670), Expect = 8e-87
 Identities = 79/316 (25%), Positives = 136/316 (43%), Gaps = 55/316 (17%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE--HQLRREVEIQSHL 73
             + +   +G+G +G V +A E ++  I A+K++ K++++Q   +   +++ EV +   L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQK------------------------ 109
            HPNI RLY  + D++ + L++E    G L  +L                          
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 110 ----------------CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG 153
                                E+  +  +  +  AL Y H + + HRDIKPEN L     
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 154 E--LKIADFGWSVHTFNRR-------RTMCGTLDYLPPEMVESVEH--DANVDIWSLGVL 202
              +K+ DFG S   +           T  GT  ++ PE++ +         D WS GVL
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 203 CYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQMLVKDSSQRLPL 260
            +  L G  PF     +DT  +++   L F      ++S  A+DL+S +L ++  +R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

Query: 261 HKLLEHPWIIQNADPS 276
            + L+HPWI Q +D  
Sbjct: 326 MRALQHPWISQFSDKI 341

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  262 bits (671), Expect = 9e-87
 Identities = 78/266 (29%), Positives = 137/266 (51%), Gaps = 8/266 (3%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +D+ + LG+G F  V     K +    A K++   +L     + +L RE  I   L+HPN
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPN 89

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+RL+    ++   YL+ +    GEL++++   +++SE  A+  +  +  ++ YCH   +
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149

Query: 138 IHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEHDA 192
           +HR++KPENLL+ ++ +   +K+ADFG ++   +        GT  YL PE+++   +  
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 209

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQML 250
            VDIW+ GV+ Y  L G PPF  ++    Y +I      +P      V+  AK LI  ML
Sbjct: 210 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 269

Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPS 276
             +  +R+   + L+ PWI      +
Sbjct: 270 TVNPKKRITADQALKVPWICNRERVA 295

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  262 bits (670), Expect = 2e-86
 Identities = 69/290 (23%), Positives = 123/290 (42%), Gaps = 23/290 (7%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
           SA E        + I K +G G    V+    +    I A+K +   +     ++   R 
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLD-SYRN 103

Query: 66  EVEIQSHLRHPN--ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA 123
           E+   + L+  +  I+RLY Y    + +Y+++E     +L   L+K K        +Y  
Sbjct: 104 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWK 162

Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLD 178
           ++  A+   H   ++H D+KP N LI   G LK+ DFG +       T   + +  G ++
Sbjct: 163 NMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221

Query: 179 YLPPEMVES-----------VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIV 226
           Y+PPE ++             +     D+WSLG + Y   YG  PF+   +       I+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281

Query: 227 QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
             + +     I     +D++   L +D  QR+ + +LL HP++     P 
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  263 bits (675), Expect = 3e-86
 Identities = 81/268 (30%), Positives = 142/268 (52%), Gaps = 9/268 (3%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           ++ + + LG+G F  V    +  +    A  ++   +L     + +L RE  I   L+HP
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREARICRLLKHP 70

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
           NI+RL+    ++   YLI +    GEL++++   +Y+SE  A+  +  +  A+++CH   
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 137 VIHRDIKPENLLIGAQGE---LKIADFGWSVHTFN---RRRTMCGTLDYLPPEMVESVEH 190
           V+HR++KPENLL+ ++ +   +K+ADFG ++             GT  YL PE++    +
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQ 248
              VD+W+ GV+ Y  L G PPF  ++    Y++I      FP      V+  AKDLI++
Sbjct: 191 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 250

Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           ML  + S+R+   + L+HPWI   +  +
Sbjct: 251 MLTINPSKRITAAEALKHPWISHRSTVA 278

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  261 bits (668), Expect = 3e-86
 Identities = 84/270 (31%), Positives = 135/270 (50%), Gaps = 11/270 (4%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH---QLRREVEIQSHLR 74
           +DIG+ LG G+F  V   REK +    A K + K Q + S+      ++ REV I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           HPNI+ L+  + ++  V LILE  + GEL+  L + +  SE  A +++  +   + Y H 
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133

Query: 135 KHVIHRDIKPENLLI----GAQGELKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESV 188
           K + H D+KPEN+++         +K+ DFG +    +    + + GT +++ PE+V   
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLI 246
                 D+WS+GV+ Y  L G  PF      +T   I  V   F  +     S  AKD I
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFI 253

Query: 247 SQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
            ++LVK++ +RL + + L HPWI       
Sbjct: 254 RKLLVKETRKRLTIQEALRHPWITPVDTQQ 283

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  259 bits (663), Expect = 9e-86
 Identities = 69/267 (25%), Positives = 131/267 (49%), Gaps = 9/267 (3%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++  +   + +G G FG   L +         +K +  S++   + E + RREV + +++
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE-ESRREVAVLANM 80

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIY 131
           +HPNI++    F +   +Y++++Y   G+L+K +   K   F E +   +   +  AL +
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESV 188
            H + ++HRDIK +N+ +   G +++ DFG +     T    R   GT  YL PE+ E+ 
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP-IVSSAAKDLIS 247
            ++   DIW+LG + YE       FEA    +   +I+     FPP     S   + L+S
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFPPVSLHYSYDLRSLVS 258

Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           Q+  ++   R  ++ +LE  +I +  +
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAKRIE 285

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  259 bits (662), Expect = 2e-85
 Identities = 50/296 (16%), Positives = 83/296 (28%), Gaps = 41/296 (13%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
              + +PL  G    V+L R+       ALKV             +L       + L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 77  NILRLYGYF--------------------------YDQKRVYLILEYAA-----KGELYK 105
           +                                  Y      L++  A+           
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 106 ELQKCKYFSERRAATYVAS-LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV 164
            +   +      A   + + L R       K ++H    P+NL I   G L + D     
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

Query: 165 HTFNRRRTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEA--KEHSD 220
               R       + Y P E + +        ++ W LG+  Y       PF         
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302

Query: 221 TYRRIVQ-----VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
           +++R          L F     +    K LI + L  D  +RL   + +E P  +Q
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  254 bits (651), Expect = 2e-84
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 17/276 (6%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ------VEHQLRREVEIQS 71
           ++  + LGRG    V     K +    A+K++  +            +     +EV+I  
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 72  HL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
            +  HPNI++L   +      +L+ +   KGEL+  L +    SE+     + +L   + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESV 188
             H  +++HRD+KPEN+L+     +K+ DFG+S       + R +CGT  YL PE++E  
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 198

Query: 189 EHDAN------VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSS 240
            +D +      VD+WS GV+ Y  L G PPF  ++     R I+  + +F        S 
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 258

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
             KDL+S+ LV    +R    + L HP+  Q     
Sbjct: 259 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  258 bits (660), Expect = 2e-84
 Identities = 89/273 (32%), Positives = 139/273 (50%), Gaps = 17/273 (6%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQS 71
           ++ + K LG G  G V LA E+++   VA++++ K +      +++     +  E+EI  
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
            L HP I+++   F+D +  Y++LE    GEL+ ++   K   E     Y   +  A+ Y
Sbjct: 196 KLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 132 CHGKHVIHRDIKPENLLIGAQGE---LKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVE 186
            H   +IHRD+KPEN+L+ +Q E   +KI DFG S  +   +  RT+CGT  YL PE++ 
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314

Query: 187 SVEH---DANVDIWSLGVLCYEFLYGVPPFEAKEHSDT-YRRIVQVDLKFPPKP--IVSS 240
           SV     +  VD WSLGV+ +  L G PPF       +   +I      F P+    VS 
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
            A DL+ ++LV D   R    + L HPW+    
Sbjct: 375 KALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  253 bits (648), Expect = 7e-84
 Identities = 90/278 (32%), Positives = 138/278 (49%), Gaps = 17/278 (6%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQS 71
           ++ + K LG G  G V LA E+++   VA+K++ K +      +++     +  E+EI  
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
            L HP I+++   F+D +  Y++LE    GEL+ ++   K   E     Y   +  A+ Y
Sbjct: 71  KLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 132 CHGKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVE 186
            H   +IHRD+KPEN+L+ +Q E   +KI DFG S         RT+CGT  YL PE++ 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189

Query: 187 SVE---HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT-YRRIVQVDLKFPPKP--IVSS 240
           SV    ++  VD WSLGV+ +  L G PPF       +   +I      F P+    VS 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGV 278
            A DL+ ++LV D   R    + L HPW+         
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 287

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  254 bits (651), Expect = 8e-84
 Identities = 69/273 (25%), Positives = 134/273 (49%), Gaps = 15/273 (5%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV--EHQLRREVEIQSHLRH 75
           +++ + +G+G F  V     + +    A+K++  ++   S       L+RE  I   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKEL----QKCKYFSERRAATYVASLARALIY 131
           P+I+ L   +     +Y++ E+    +L  E+         +SE  A+ Y+  +  AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 132 CHGKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTF---NRRRTMCGTLDYLPPEMV 185
           CH  ++IHRD+KP  +L+ ++     +K+  FG ++             GT  ++ PE+V
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAK 243
           +   +   VD+W  GV+ +  L G  PF        +  I++   K  P+    +S +AK
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESAK 264

Query: 244 DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           DL+ +ML+ D ++R+ +++ L HPW+ +    +
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  253 bits (648), Expect = 9e-84
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 11/270 (4%)

Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH-PNIL 79
            K LGRGKF  V     K +    A K L K +  Q     ++  E+ +    +  P ++
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA-EILHEIAVLELAKSCPRVI 92

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKEL--QKCKYFSERRAATYVASLARALIYCHGKHV 137
            L+  + +   + LILEYAA GE++     +  +  SE      +  +   + Y H  ++
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152

Query: 138 IHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEHDA 192
           +H D+KP+N+L+ +      +KI DFG S    +    R + GT +YL PE++       
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITT 212

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQML 250
             D+W++G++ Y  L    PF  +++ +TY  I QV++ +  +    VS  A D I  +L
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLL 272

Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPSGVYR 280
           VK+  +R      L H W+ Q    +  + 
Sbjct: 273 VKNPEKRPTAEICLSHSWLQQWDFENLFHP 302

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  253 bits (648), Expect = 1e-83
 Identities = 88/272 (32%), Positives = 139/272 (51%), Gaps = 22/272 (8%)

Query: 21  GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNIL 79
            KPLG G F        K+SN   A+K++ K            ++E+        HPNI+
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHPNIV 69

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIH 139
           +L+  F+DQ   +L++E    GEL++ ++K K+FSE  A+  +  L  A+ + H   V+H
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129

Query: 140 RDIKPENLLIGAQGE---LKIADFGWSVHTFNRR---RTMCGTLDYLPPEMVESVEHDAN 193
           RD+KPENLL   + +   +KI DFG++          +T C TL Y  PE++    +D +
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES 189

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDT-------YRRIVQVDLKFPPKP--IVSSAAKD 244
            D+WSLGV+ Y  L G  PF++ + S T        ++I + D  F  +    VS  AKD
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249

Query: 245 LISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           LI  +L  D ++RL +  L  + W+   +  S
Sbjct: 250 LIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  251 bits (644), Expect = 2e-83
 Identities = 65/289 (22%), Positives = 122/289 (42%), Gaps = 40/289 (13%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
            +DF+    LG+G FG V  AR    +   A+K +  ++ + S +      EV + + L 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI----LSEVMLLASLN 60

Query: 75  HPNILRLYGYFYDQKR-------------VYLILEYAAKGELYKELQKCK-YFSERRAAT 120
           H  ++R Y  + +++              +++ +EY   G LY  +              
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS----------------- 163
               +  AL Y H + +IHRD+KP N+ I     +KI DFG +                 
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 164 VHTFNRRRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY 222
             + +   +  GT  Y+  E+++   H +  +D++SLG++ +E +Y  P     E  +  
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238

Query: 223 RRIVQVDLKFPPK--PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +++  V ++FPP          K +I  ++  D ++R     LL   W+
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  253 bits (648), Expect = 2e-83
 Identities = 92/264 (34%), Positives = 137/264 (51%), Gaps = 13/264 (4%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           F++   LGRG    VY  ++K +    ALKVL K+       +  +R E+ +   L HPN
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPN 109

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I++L   F     + L+LE    GEL+  + +  Y+SER AA  V  +  A+ Y H   +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169

Query: 138 IHRDIKPENLLIGAQGE---LKIADFGWSVHTFN--RRRTMCGTLDYLPPEMVESVEHDA 192
           +HRD+KPENLL         LKIADFG S    +    +T+CGT  Y  PE++    +  
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGP 229

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAK-EHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQM 249
            VD+WS+G++ Y  L G  PF  +      +RRI+  +  F       VS  AKDL+ ++
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKL 289

Query: 250 LVKDSSQRLPLHKLLEHPWIIQNA 273
           +V D  +RL   + L+HPW+   A
Sbjct: 290 IVLDPKKRLTTFQALQHPWVTGKA 313

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  253 bits (648), Expect = 2e-83
 Identities = 78/270 (28%), Positives = 135/270 (50%), Gaps = 16/270 (5%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ-----VEHQLRREVEIQSH 72
           +D    +GRG    V     + + H  A+K++  +  + S      V    RRE  I   
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 73  LR-HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
           +  HP+I+ L   +     ++L+ +   KGEL+  L +    SE+   + + SL  A+ +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH--TFNRRRTMCGTLDYLPPEMVESVE 189
            H  +++HRD+KPEN+L+    +++++DFG+S H     + R +CGT  YL PE+++   
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSM 275

Query: 190 HDAN------VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSA 241
            + +      VD+W+ GV+ +  L G PPF  +      R I++   +F        SS 
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSST 335

Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
            KDLIS++L  D   RL   + L+HP+  +
Sbjct: 336 VKDLISRLLQVDPEARLTAEQALQHPFFER 365

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  251 bits (644), Expect = 3e-83
 Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 11/267 (4%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
             + I + LGRG+FG V+   E  S      K +      Q  V    ++E+ I +  RH
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV----KKEISILNIARH 60

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKE-LQKCKYFSERRAATYVASLARALIYCHG 134
            NIL L+  F   + + +I E+ +  ++++         +ER   +YV  +  AL + H 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 135 KHVIHRDIKPENLLIGAQGE--LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEH 190
            ++ H DI+PEN++   +    +KI +FG +         R +    +Y  PE+ +    
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP--IVSSAAKDLISQ 248
               D+WSLG L Y  L G+ PF A+ +      I+  +  F  +    +S  A D + +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNADP 275
           +LVK+   R+   + L+HPW+ Q  + 
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIER 267

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  254 bits (651), Expect = 3e-83
 Identities = 87/280 (31%), Positives = 136/280 (48%), Gaps = 17/280 (6%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEH 61
             ++     R    D+++ K +GRG FG V L R K +  + A+K+L K + +++S    
Sbjct: 56  DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 115

Query: 62  QLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATY 121
               E +I +    P +++L+  F D + +Y+++EY   G+L   +       E+ A  Y
Sbjct: 116 -FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFY 173

Query: 122 VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS----VHTFNRRRTMCGTL 177
            A +  AL   H    IHRD+KP+N+L+   G LK+ADFG           R  T  GT 
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233

Query: 178 DYLPPEMVES----VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLK 231
           DY+ PE+++S      +    D WS+GV  YE L G  PF A     TY +I+  +  L 
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293

Query: 232 FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE---HPW 268
           FP    +S  AK+LI    + D   RL  + + E   H +
Sbjct: 294 FPDDNDISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLF 332

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  250 bits (640), Expect = 4e-83
 Identities = 62/281 (22%), Positives = 116/281 (41%), Gaps = 35/281 (12%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
              DF   + +G G FG V+ A+ +       +K +  +         +  REV+  + L
Sbjct: 9   FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-------NEKAEREVKALAKL 61

Query: 74  RHPNILRLYGYFYDQ----------------KRVYLILEYAAKGELYKELQKCK--YFSE 115
            H NI+   G +                   K +++ +E+  KG L + ++K +     +
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121

Query: 116 RRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTM 173
             A      + + + Y H K +I+RD+KP N+ +    ++KI DFG    +    +R   
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181

Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKF 232
            GTL Y+ PE + S ++   VD+++LG++  E L+     FE  +     R         
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG-----II 236

Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
               I     K L+ ++L K    R    ++L    + + +
Sbjct: 237 S--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  253 bits (647), Expect = 8e-83
 Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 10/266 (3%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           + +DI + LG G FG V+   EK +  +   K +             ++ E+ I + L H
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISIMNQLHH 107

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
           P ++ L+  F D+  + LILE+ + GEL+  +    Y  SE     Y+      L + H 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 135 KHVIHRDIKPENLLIGAQGE--LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEH 190
             ++H DIKPEN++   +    +KI DFG +         +    T ++  PE+V+    
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLISQ 248
               D+W++GVL Y  L G+ PF  ++  +T + + + D +F       VS  AKD I  
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287

Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNAD 274
           +L K+  +RL +H  LEHPW+  +  
Sbjct: 288 LLQKEPRKRLTVHDALEHPWLKGDHS 313

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  250 bits (641), Expect = 2e-82
 Identities = 85/273 (31%), Positives = 132/273 (48%), Gaps = 20/273 (7%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RH 75
            +++ + +G G +        K +N   A+K++ KS+            E+EI     +H
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQH 75

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI+ L   + D K VY++ E    GEL  ++ + K+FSER A+  + ++ + + Y H +
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135

Query: 136 HVIHRDIKPENLLIGAQGE----LKIADFGWSVHTFNRR---RTMCGTLDYLPPEMVESV 188
            V+HRD+KP N+L   +      ++I DFG++           T C T +++ PE++E  
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKE---HSDTYRRIVQVDLKFPPKP--IVSSAAK 243
            +DA  DIWSLGVL Y  L G  PF         +   RI              VS  AK
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255

Query: 244 DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           DL+S+ML  D  QRL    +L HPWI+      
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  257 bits (657), Expect = 3e-82
 Identities = 77/270 (28%), Positives = 135/270 (50%), Gaps = 10/270 (3%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +DI + LG G FG V+   E+ + +  A K +        +    +R+E++  S LRHP 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE---TVRKEIQTMSVLRHPT 215

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKH 136
           ++ L+  F D   + +I E+ + GEL++++  +    SE  A  Y+  + + L + H  +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 137 VIHRDIKPENLLIGAQGE--LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEHDA 192
            +H D+KPEN++   +    LK+ DFG + H   ++  +   GT ++  PE+ E      
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLISQML 250
             D+WS+GVL Y  L G+ PF  +   +T R +   D          +S   KD I ++L
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395

Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPSGVYR 280
           + D + R+ +H+ LEHPW+     P    +
Sbjct: 396 LADPNTRMTIHQALEHPWLTPGNAPGRDSQ 425

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  251 bits (642), Expect = 4e-82
 Identities = 71/271 (26%), Positives = 134/271 (49%), Gaps = 13/271 (4%)

Query: 8   KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRRE 66
            E +    + F+I + +G+G FG V + ++  +  + A+K + K + +++++V +  + E
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-E 65

Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
           ++I   L HP ++ L+  F D++ ++++++    G+L   LQ+  +F E     ++  L 
Sbjct: 66  LQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELV 125

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR--TMCGTLDYLPPEM 184
            AL Y   + +IHRD+KP+N+L+   G + I DF  +       +  TM GT  Y+ PEM
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEM 185

Query: 185 VESVE---HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT---YRRIVQVDLKFPPKPIV 238
             S +   +   VD WSLGV  YE L G  P+  +  + +           + +P     
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA--W 243

Query: 239 SSAAKDLISQMLVKDSSQRL-PLHKLLEHPW 268
           S     L+ ++L  +  QR   L  +   P+
Sbjct: 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  249 bits (637), Expect = 2e-81
 Identities = 69/269 (25%), Positives = 134/269 (49%), Gaps = 10/269 (3%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
                + LG G+FG V+   E  +   +A K++    ++  +   +++ E+ + + L H 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE---EVKNEISVMNQLDHA 146

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELY-KELQKCKYFSERRAATYVASLARALIYCHGK 135
           N+++LY  F  +  + L++EY   GEL+ + + +    +E     ++  +   + + H  
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 136 HVIHRDIKPENLLIGAQGE--LKIADFGWSVHTFNRR--RTMCGTLDYLPPEMVESVEHD 191
           +++H D+KPEN+L   +    +KI DFG +     R   +   GT ++L PE+V      
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266

Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLISQM 249
              D+WS+GV+ Y  L G+ PF     ++T   I+        +    +S  AK+ IS++
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326

Query: 250 LVKDSSQRLPLHKLLEHPWIIQNADPSGV 278
           L+K+ S R+   + L+HPW+  +   S +
Sbjct: 327 LIKEKSWRISASEALKHPWLSDHKLHSRL 355

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  245 bits (627), Expect = 4e-81
 Identities = 78/275 (28%), Positives = 130/275 (47%), Gaps = 18/275 (6%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
              D+++   +G G +G     R K    I+  K L    + +++ +  L  EV +   L
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLREL 62

Query: 74  RHPNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLAR 127
           +HPNI+R Y    D+    +Y+++EY   G+L   + K      Y  E      +  L  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 128 ALIYCH-----GKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDY 179
           AL  CH     G  V+HRD+KP N+ +  +  +K+ DFG +    H  +  +T  GT  Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP-IV 238
           + PE +  + ++   DIWSLG L YE    +PPF A    +   +I +   KF   P   
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPYRY 240

Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           S    ++I++ML      R  + ++LE+P I+++ 
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  244 bits (626), Expect = 2e-80
 Identities = 89/294 (30%), Positives = 141/294 (47%), Gaps = 40/294 (13%)

Query: 17  DFDIGK-PLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR- 74
            + + +  LG G    V       ++   A+K++ K          ++ REVE+    + 
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS---RVFREVEMLYQCQG 69

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+L L  +F ++ R YL+ E    G +   + K ++F+E  A+  V  +A AL + H 
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 135 KHVIHRDIKPENLLIGAQGE---LKIADFGWSVH----------TFNRRRTMCGTLDYLP 181
           K + HRD+KPEN+L     +   +KI DF               +     T CG+ +Y+ 
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 182 PEMVESVE-----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT--------------- 221
           PE+VE+       +D   D+WSLGV+ Y  L G PPF  +  SD                
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249

Query: 222 YRRIVQVDLKFPPKP--IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
           +  I +   +FP K    +S AAKDLIS++LV+D+ QRL   ++L+HPW+   A
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  243 bits (623), Expect = 7e-80
 Identities = 86/259 (33%), Positives = 147/259 (56%), Gaps = 11/259 (4%)

Query: 8   KEKKRWTLNDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQQS--QVEHQ 62
           +  ++     F++ + LG+G +G V+  R+     +  I A+KVL K+ + ++     H 
Sbjct: 9   RGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH- 67

Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
            + E  I   ++HP I+ L   F    ++YLILEY + GEL+ +L++   F E  A  Y+
Sbjct: 68  TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDY 179
           A ++ AL + H K +I+RD+KPEN+++  QG +K+ DFG     +H      T CGT++Y
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187

Query: 180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
           + PE++    H+  VD WSLG L Y+ L G PPF  +    T  +I++  L  PP   ++
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY--LT 245

Query: 240 SAAKDLISQMLVKDSSQRL 258
             A+DL+ ++L ++++ RL
Sbjct: 246 QEARDLLKKLLKRNAASRL 264

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  243 bits (622), Expect = 1e-79
 Identities = 94/251 (37%), Positives = 140/251 (55%), Gaps = 7/251 (2%)

Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQ 70
           + T+NDFD  K LG+G FG V L REK +    A+K+L K   + + +V H    E  + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-TVTESRVL 59

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
            + RHP +  L   F    R+  ++EYA  GEL+  L + + F+E RA  Y A +  AL 
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVES 187
           Y H + V++RDIK ENL++   G +KI DFG     +      +T CGT +YL PE++E 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS 247
            ++   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L++
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT--LSPEAKSLLA 237

Query: 248 QMLVKDSSQRL 258
            +L KD  QRL
Sbjct: 238 GLLKKDPKQRL 248

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  245 bits (627), Expect = 2e-79
 Identities = 85/285 (29%), Positives = 136/285 (47%), Gaps = 21/285 (7%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEH 61
             V   ++ R   +DF+I K +GRG F  V + + K++  + A+K++ K   L++ +V  
Sbjct: 48  PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC 107

Query: 62  QLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAAT 120
             R E ++  +     I +L+  F D+  +YL++EY   G+L   L K  +      A  
Sbjct: 108 -FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF 166

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS----VHTFNRRRTMCGT 176
           Y+A +  A+   H    +HRDIKP+N+L+   G +++ADFG           R     GT
Sbjct: 167 YLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226

Query: 177 LDYLPPEMVESVE-------HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--Q 227
            DYL PE++++V        +    D W+LGV  YE  YG  PF A   ++TY +IV  +
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286

Query: 228 VDLKFPPKPI-VSSAAKDLISQMLVKDSSQRL---PLHKLLEHPW 268
             L  P     V   A+D I + L+     RL          HP+
Sbjct: 287 EHLSLPLVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPF 330

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  243 bits (623), Expect = 2e-79
 Identities = 89/260 (34%), Positives = 148/260 (56%), Gaps = 8/260 (3%)

Query: 4   EVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQ 62
            +          +DF   K +G+G FG V LAR K      A+KVL K   L++ + +H 
Sbjct: 26  NLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI 85

Query: 63  LR-REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATY 121
           +  R V +++ ++HP ++ L+  F    ++Y +L+Y   GEL+  LQ+ + F E RA  Y
Sbjct: 86  MSERNVLLKN-VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY 144

Query: 122 VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLD 178
            A +A AL Y H  ++++RD+KPEN+L+ +QG + + DFG     +   +   T CGT +
Sbjct: 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE 204

Query: 179 YLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV 238
           YL PE++    +D  VD W LG + YE LYG+PPF ++  ++ Y  I+   L+  P   +
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN--I 262

Query: 239 SSAAKDLISQMLVKDSSQRL 258
           +++A+ L+  +L KD ++RL
Sbjct: 263 TNSARHLLEGLLQKDRTKRL 282

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  245 bits (626), Expect = 4e-79
 Identities = 89/281 (31%), Positives = 145/281 (51%), Gaps = 19/281 (6%)

Query: 5   VSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQL 63
            S  ++ R    DF+I K +GRG FG V + + K ++ + A+K+L K + L++++     
Sbjct: 63  TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-F 121

Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYV 122
           R E ++  +     I  L+  F D   +YL+++Y   G+L   L K +    E  A  Y+
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS----VHTFNRRRTMCGTLD 178
           A +  A+   H  H +HRDIKP+N+L+   G +++ADFG           +     GT D
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241

Query: 179 YLPPEMVESVE-----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV--QVDLK 231
           Y+ PE+++++E     +    D WSLGV  YE LYG  PF A+   +TY +I+  +   +
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301

Query: 232 FPP-KPIVSSAAKDLISQMLVKDSSQRLPLHKLLE---HPW 268
           FP     VS  AKDLI + L+     RL  + + +   HP+
Sbjct: 302 FPTQVTDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPF 341

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  242 bits (620), Expect = 5e-79
 Identities = 42/297 (14%), Positives = 81/297 (27%), Gaps = 51/297 (17%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-- 74
               G  LG+        A ++ +     + V + ++   S    Q++ EV     LR  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 75  -----------------------HPNILRLYGYFYDQKRV-YLILEYAAKG-------EL 103
                                     ++R+     D   +    L    +         L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 104 YKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS 163
                  K             + R L   H   ++H  ++P ++++  +G + +  F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 164 VHTFNRRRTMCGTLDYLPPEMV-----------ESVEHDANVDIWSLGVLCYEFLYGVPP 212
           V     R     +  + PPE+                   + D W+LG++ Y       P
Sbjct: 254 VR-DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

Query: 213 FEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                       I +     P         + L+   L      RL   + +E P  
Sbjct: 313 ITKDAALGGSEWIFRSCKNIPQ------PVRALLEGFLRYPKEDRLLPLQAMETPEY 363

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  239 bits (611), Expect = 7e-79
 Identities = 76/262 (29%), Positives = 129/262 (49%), Gaps = 9/262 (3%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +D+ + LG G +G V LA  + +   VA+K++   +         +++E+ I   L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHEN 66

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           +++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG  +
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126

Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR-----TMCGTLDYLPPEMVESVEHD- 191
            HRDIKPENLL+  +  LKI+DFG +       R      MCGTL Y+ PE+++  E   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186

Query: 192 ANVDIWSLGVLCYEFLYGVPPFE-AKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
             VD+WS G++    L G  P++   +    Y    +      P   + SA   L+ ++L
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246

Query: 251 VKDSSQRLPLHKLLEHPWIIQN 272
           V++ S R+ +  + +  W  + 
Sbjct: 247 VENPSARITIPDIKKDRWYNKP 268

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  240 bits (616), Expect = 7e-79
 Identities = 83/277 (29%), Positives = 147/277 (53%), Gaps = 14/277 (5%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQQSQV 59
           +    +  ++   + F++ K LG+G FG V+L ++     +  + A+KVL K+ L+    
Sbjct: 11  THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70

Query: 60  EHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA 119
                 E +I   + HP I++L+  F  + ++YLIL++   G+L+  L K   F+E    
Sbjct: 71  VRTKM-ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129

Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGT 176
            Y+A LA AL + H   +I+RD+KPEN+L+  +G +K+ DFG S   +    +  + CGT
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT 189

Query: 177 LDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP 236
           ++Y+ PE+V    H  + D WS GVL +E L G  PF+ K+  +T   I++  L  P   
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF- 248

Query: 237 IVSSAAKDLISQMLVKDSSQRL-----PLHKLLEHPW 268
            +S  A+ L+  +  ++ + RL      + ++  H +
Sbjct: 249 -LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  241 bits (617), Expect = 8e-79
 Identities = 82/272 (30%), Positives = 140/272 (51%), Gaps = 9/272 (3%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEH 61
           ++     + +  + DF + K LG+G FG V+LA  K++N   A+K L K   L    VE 
Sbjct: 4   NKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC 63

Query: 62  QLRREVEI-QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
               E  +      HP +  ++  F  ++ ++ ++EY   G+L   +Q C  F   RA  
Sbjct: 64  -TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF 122

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTL 177
           Y A +   L + H K +++RD+K +N+L+   G +KIADFG     +    +  T CGT 
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTP 182

Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI 237
           DY+ PE++   +++ +VD WS GVL YE L G  PF  ++  + +  I   +  +P    
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-- 240

Query: 238 VSSAAKDLISQMLVKDSSQRLPLHK-LLEHPW 268
           +   AKDL+ ++ V++  +RL +   + +HP 
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  241 bits (616), Expect = 8e-79
 Identities = 87/293 (29%), Positives = 142/293 (48%), Gaps = 27/293 (9%)

Query: 3   SEVSAKEKKRWTLND-FDIGK-PLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
                 E K++ + D + + K  LG G  G V     +R+    ALK+L+ S        
Sbjct: 14  VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK------ 67

Query: 61  HQLRREVEIQSHL-RHPNILRLYGYFYDQ----KRVYLILEYAAKGELYKELQK--CKYF 113
              R+EV+        P+I+ +   + +     + + +I+E    GEL+  +Q+   + F
Sbjct: 68  --ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF 125

Query: 114 SERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRR 170
           +ER AA  +  +  A+ + H  ++ HRD+KPENLL  ++ +   LK+ DFG++  T    
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185

Query: 171 -RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT----YRRI 225
            +T C T  Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +           RRI
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245

Query: 226 VQVDLKFPPKP--IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                 FP      VS  AK LI  +L  D ++RL + + + HPWI Q+    
Sbjct: 246 RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  244 bits (625), Expect = 9e-79
 Identities = 96/273 (35%), Positives = 147/273 (53%), Gaps = 13/273 (4%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLR 64
            AK K R T+N+F+  K LG+G FG V L +EK +    A+K+L K   + + +V H   
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH-TL 196

Query: 65  REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS 124
            E  +  + RHP +  L   F    R+  ++EYA  GEL+  L + + FSE RA  Y A 
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256

Query: 125 LARALIYCHGKH-VIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYL 180
           +  AL Y H +  V++RD+K ENL++   G +KI DFG     +      +T CGT +YL
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
            PE++E  ++   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +  
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LGP 374

Query: 241 AAKDLISQMLVKDSSQRLPLHK-----LLEHPW 268
            AK L+S +L KD  QRL         +++H +
Sbjct: 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  239 bits (612), Expect = 1e-78
 Identities = 59/268 (22%), Positives = 104/268 (38%), Gaps = 10/268 (3%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
                + +    F     LG G +G V+  R K    + A+K              +L  
Sbjct: 47  DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-A 105

Query: 66  EVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVA 123
           EV     + +HP  +RL   + +   +YL  E      L +  +       E +   Y+ 
Sbjct: 106 EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLR 164

Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH--TFNRRRTMCGTLDYLP 181
               AL + H + ++H D+KP N+ +G +G  K+ DFG  V   T        G   Y+ 
Sbjct: 165 DTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMA 224

Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA 241
           PE+++   +    D++SLG+   E    +         + ++++ Q  L       +SS 
Sbjct: 225 PELLQG-SYGTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPPEFTAGLSSE 280

Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWI 269
            + ++  ML  D   R     LL  P +
Sbjct: 281 LRSVLVMMLEPDPKLRATAEALLALPVL 308

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  239 bits (612), Expect = 1e-78
 Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 9/268 (3%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           TL +F I K +GRG+F  VY A        VALK +    L  ++      +E+++   L
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARAL 129
            HPN+++ Y  F +   + ++LE A  G+L + ++  K       ER    Y   L  AL
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVE 186
            + H + V+HRDIKP N+ I A G +K+ D G             ++ GT  Y+ PE + 
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209

Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPF--EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
              ++   DIWSLG L YE      PF  +        ++I Q D    P    S   + 
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269

Query: 245 LISQMLVKDSSQRLPLHKLLEHPWIIQN 272
           L++  +  D  +R  +  + +    +  
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKRMHA 297

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  240 bits (616), Expect = 2e-78
 Identities = 84/261 (32%), Positives = 138/261 (52%), Gaps = 8/261 (3%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEH 61
           + +      R  +++F+  + LG+G FG V LAR K +  + A+KVL K   LQ   VE 
Sbjct: 10  NGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC 69

Query: 62  QLRREVEI-QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
               E  I      HP + +L+  F    R++ ++E+   G+L   +QK + F E RA  
Sbjct: 70  -TMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF 128

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTL 177
           Y A +  AL++ H K +I+RD+K +N+L+  +G  K+ADFG     +       T CGT 
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTP 188

Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI 237
           DY+ PE+++ + +   VD W++GVL YE L G  PFEA+   D +  I+  ++ +P    
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW-- 246

Query: 238 VSSAAKDLISQMLVKDSSQRL 258
           +   A  ++   + K+ + RL
Sbjct: 247 LHEDATGILKSFMTKNPTMRL 267

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  241 bits (618), Expect = 2e-78
 Identities = 85/275 (30%), Positives = 135/275 (49%), Gaps = 26/275 (9%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNI 78
             + LG G  G V     KR+    ALK+L              RREVE+     + P+I
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------ARREVELHWRASQCPHI 117

Query: 79  LRLYGYFYD----QKRVYLILEYAAKGELYKELQK--CKYFSERRAATYVASLARALIYC 132
           +R+   + +    +K + +++E    GEL+  +Q    + F+ER A+  + S+  A+ Y 
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177

Query: 133 HGKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTF--NRRRTMCGTLDYLPPEMVES 187
           H  ++ HRD+KPENLL  ++     LK+ DFG++  T   N   T C T  Y+ PE++  
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 237

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT----YRRIVQVDLKFPPKP--IVSSA 241
            ++D + D+WSLGV+ Y  L G PPF +            RI     +FP      VS  
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 297

Query: 242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
            K LI  +L  + +QR+ + + + HPWI+Q+    
Sbjct: 298 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  239 bits (612), Expect = 3e-78
 Identities = 85/276 (30%), Positives = 151/276 (54%), Gaps = 6/276 (2%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           + +++   ++  + ++ + K +G+G F  V LAR   +   VA+K++ K+QL  + ++  
Sbjct: 2   NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK- 60

Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           L REV I   L HPNI++L+     +K +YLI+EYA+ GE++  L       E+ A +  
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF 120

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RTMCGTLDYL 180
             +  A+ YCH K ++HRD+K ENLL+ A   +KIADFG+S            CG   Y 
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180

Query: 181 PPEMVESVEHD-ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
            PE+ +  ++D   VD+WSLGV+ Y  + G  PF+ +   +   R+++   + P    +S
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY--MS 238

Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           +  ++L+ + LV +  +R  L ++++  WI    + 
Sbjct: 239 TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  238 bits (610), Expect = 5e-78
 Identities = 76/262 (29%), Positives = 129/262 (49%), Gaps = 9/262 (3%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +D+ + LG G +G V LA  + +   VA+K++   +         +++E+ I   L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHEN 66

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           +++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG  +
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126

Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR-----TMCGTLDYLPPEMVESVEHD- 191
            HRDIKPENLL+  +  LKI+DFG +       R      MCGTL Y+ PE+++  E   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186

Query: 192 ANVDIWSLGVLCYEFLYGVPPFE-AKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
             VD+WS G++    L G  P++   +    Y    +      P   + SA   L+ ++L
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246

Query: 251 VKDSSQRLPLHKLLEHPWIIQN 272
           V++ S R+ +  + +  W  + 
Sbjct: 247 VENPSARITIPDIKKDRWYNKP 268

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  235 bits (603), Expect = 2e-77
 Identities = 82/271 (30%), Positives = 136/271 (50%), Gaps = 5/271 (1%)

Query: 8   KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           K   R  +  + +G  LG G FG V +   + + H VA+K+L + +++   V  +++RE+
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62

Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
           +     RHP+I++LY         ++++EY + GEL+  + K     E  A      +  
Sbjct: 63  QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRR-RTMCGTLDYLPPEMV 185
           A+ YCH   V+HRD+KPEN+L+ A    KIADFG S + +     RT CG+ +Y  PE++
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182

Query: 186 ESVEHD-ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
               +    VDIWS GV+ Y  L G  PF+ +     +++I       P    ++ +   
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY--LNRSVAT 240

Query: 245 LISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           L+  ML  D  +R  +  + EH W  Q+   
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  238 bits (609), Expect = 2e-77
 Identities = 78/258 (30%), Positives = 135/258 (52%), Gaps = 8/258 (3%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLR 64
           +   + R  L DF+    LG+G FG V L+  K ++ + A+K+L K   +Q   VE    
Sbjct: 10  NNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC-TM 68

Query: 65  REVEI-QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVA 123
            E  +     + P + +L+  F    R+Y ++EY   G+L   +Q+   F E  A  Y A
Sbjct: 69  VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA 128

Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYL 180
            +A  L +   K +I+RD+K +N+++ ++G +KIADFG     +      +T CGT DY+
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 188

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
            PE++    +  +VD W+ GVL YE L G  PFE ++  + ++ I++ ++ +P    +S 
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS--MSK 246

Query: 241 AAKDLISQMLVKDSSQRL 258
            A  +   ++ K   +RL
Sbjct: 247 EAVAICKGLMTKHPGKRL 264

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  237 bits (606), Expect = 2e-77
 Identities = 75/283 (26%), Positives = 129/283 (45%), Gaps = 19/283 (6%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-----S 57
             ++A E +      +    PLG G FG V+ A +K  N  V +K + K ++ +      
Sbjct: 13  EGLAACEGEY--SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIED 70

Query: 58  QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG-ELYKELQKCKYFSER 116
               ++  E+ I S + H NI+++   F +Q    L++E    G +L+  + +     E 
Sbjct: 71  PKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP 130

Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RTMC 174
            A+     L  A+ Y   K +IHRDIK EN++I     +K+ DFG + +    +   T C
Sbjct: 131 LASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190

Query: 175 GTLDYLPPEMVESVEHD-ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT++Y  PE++    +    +++WSLGV  Y  ++   PF            V+  +  P
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAAIHPP 244

Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
               VS     L+S +L     +R  L KL+  PW+ Q  + +
Sbjct: 245 YL--VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLA 285

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  234 bits (600), Expect = 7e-77
 Identities = 84/296 (28%), Positives = 138/296 (46%), Gaps = 34/296 (11%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ------- 58
           S        LN + +   +G+G +G V LA  +  N   A+KVL K +L +         
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 59  ----------------VEHQLRREVEIQSHLRHPNILRLYGYFYD--QKRVYLILEYAAK 100
                              Q+ +E+ I   L HPN+++L     D  +  +Y++ E   +
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122

Query: 101 GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADF 160
           G + +        SE +A  Y   L + + Y H + +IHRDIKP NLL+G  G +KIADF
Sbjct: 123 GPVMEVPTLKP-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 161 GWSVHTFNRR----RTMCGTLDYLPPEMVESVEHD---ANVDIWSLGVLCYEFLYGVPPF 213
           G S + F           GT  ++ PE +           +D+W++GV  Y F++G  PF
Sbjct: 182 GVS-NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 214 EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
             +     + +I    L+FP +P ++   KDLI++ML K+   R+ + ++  HPW+
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  233 bits (596), Expect = 6e-76
 Identities = 61/310 (19%), Positives = 114/310 (36%), Gaps = 48/310 (15%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           + + +   LG+G   +V+  R K++  + A+KV       +        RE E+   L H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNH 66

Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKEL---QKCKYFSERRAATYVASLARALI 130
            NI++L+    +   +   LI+E+   G LY  L          E      +  +   + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 131 YCHGKHVIHRDIKPENLLIG----AQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEM 184
           +     ++HR+IKP N++       Q   K+ DFG +  +    +  ++ GT +YL P+M
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 185 VESV--------EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI----------- 225
            E          ++ A VD+WS+GV  Y    G  PF   E     + +           
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 226 ------------VQVDLKFPPKPIVSSAAKD----LISQMLVKDSSQRLPLHKLLEHPWI 269
                       +      P    +S   +     +++ +L  D  +     +       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 270 IQNADPSGVY 279
           I +   S  +
Sbjct: 307 ILHRGNSHHH 316

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  232 bits (593), Expect = 6e-75
 Identities = 87/267 (32%), Positives = 131/267 (49%), Gaps = 13/267 (4%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +D  K +G G FG   L R+K +  +VA+K + +       V    +RE+     LRHPN
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV----QREIINHRSLRHPN 77

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+R          + +I+EYA+ GELY+ +     FSE  A  +   L   + YCH   +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137

Query: 138 IHRDIKPENLLIGAQ--GELKIADFGWSVHTF--NRRRTMCGTLDYLPPEMVESVEHD-A 192
            HRD+K EN L+       LKI DFG+S  +   ++ ++  GT  Y+ PE++   E+D  
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR----RIVQVDLKFPPKPIVSSAAKDLISQ 248
             D+WS GV  Y  L G  PFE  E    YR    RI+ V    P    +S     LIS+
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257

Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNADP 275
           + V D + R+ + ++  H W ++N   
Sbjct: 258 IFVADPATRISIPEIKTHSWFLKNLPA 284

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  229 bits (587), Expect = 1e-74
 Identities = 75/290 (25%), Positives = 127/290 (43%), Gaps = 31/290 (10%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           +     + +     ++ +G  LG+G FG V+          VA+KV+ ++++        
Sbjct: 18  TPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSD 77

Query: 63  ---LRREVEIQSHLR----HPNILRLYGYFYDQKRVYLILEYAAKG-ELYKELQKCKYFS 114
                 EV +   +     HP ++RL  +F  Q+   L+LE      +L+  + +     
Sbjct: 78  SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG 137

Query: 115 ERRAATYVASLARALIYCHGKHVIHRDIKPENLLI-GAQGELKIADFGWS-------VHT 166
           E  +  +   +  A+ +CH + V+HRDIK EN+LI   +G  K+ DFG            
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197

Query: 167 FNRRRTMCGTLDYLPPEMVESVEHDAN-VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI 225
           F       GT  Y PPE +   ++ A    +WSLG+L Y+ + G  PF      +  + I
Sbjct: 198 F------DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF------ERDQEI 245

Query: 226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           ++ +L FP    VS     LI + L    S R  L ++L  PW+   A+ 
Sbjct: 246 LEAELHFPAH--VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  228 bits (584), Expect = 3e-74
 Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 17/283 (6%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---V 59
           ++++  ++K    + + +G  LG G FG VY       N  VA+K + K ++        
Sbjct: 30  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 89

Query: 60  EHQLRREVEIQSHLRH--PNILRLYGYFYDQKRVYLILEYAA-KGELYKELQKCKYFSER 116
             ++  EV +   +      ++RL  +F       LILE      +L+  + +     E 
Sbjct: 90  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 149

Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLI-GAQGELKIADFGWSVHTFNRR-RTMC 174
            A ++   +  A+ +CH   V+HRDIK EN+LI   +GELK+ DFG      +       
Sbjct: 150 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 209

Query: 175 GTLDYLPPEMVESVEHDAN-VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
           GT  Y PPE +    +      +WSLG+L Y+ + G  PF      +    I++  + F 
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFR 263

Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
            +  VSS  + LI   L    S R    ++  HPW+     P 
Sbjct: 264 QR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 304

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  229 bits (585), Expect = 6e-74
 Identities = 75/279 (26%), Positives = 141/279 (50%), Gaps = 23/279 (8%)

Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVE 68
                L DFD+ + +GRG +  V L R K+++ I A+KV+ K        ++  ++ E  
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKH 61

Query: 69  I-QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
           + +    HP ++ L+  F  + R++ ++EY   G+L   +Q+ +   E  A  Y A ++ 
Sbjct: 62  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEM 184
           AL Y H + +I+RD+K +N+L+ ++G +K+ D+G     +   +   T CGT +Y+ PE+
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 181

Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPF---------EAKEHSDTYRRIVQVDLKFPPK 235
           +   ++  +VD W+LGVL +E + G  PF         +       ++ I++  ++ P  
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241

Query: 236 PIVSSAAKDLISQMLVKDSSQRLPLHK------LLEHPW 268
             +S  A  ++   L KD  +RL  H       +  HP+
Sbjct: 242 --LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  229 bits (585), Expect = 7e-74
 Identities = 92/288 (31%), Positives = 152/288 (52%), Gaps = 26/288 (9%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQLQQS-- 57
           +       ++  + +F++ K LG G +G V+L R+     +  + A+KVL K+ + Q   
Sbjct: 41  TANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK 100

Query: 58  QVEHQL--RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSE 115
             EH    R+ +E       P ++ L+  F  + +++LIL+Y   GEL+  L + + F+E
Sbjct: 101 TTEHTRTERQVLEHIRQ--SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE 158

Query: 116 RRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRR-R 171
                YV  +  AL + H   +I+RDIK EN+L+ + G + + DFG S   V     R  
Sbjct: 159 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218

Query: 172 TMCGTLDYLPPEMVESVE--HDANVDIWSLGVLCYEFLYGVPPF----EAKEHSDTYRRI 225
             CGT++Y+ P++V   +  HD  VD WSLGVL YE L G  PF    E    ++  RRI
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278

Query: 226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRL-----PLHKLLEHPW 268
           ++ +  +P +  +S+ AKDLI ++L+KD  +RL        ++ EH +
Sbjct: 279 LKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  232 bits (594), Expect = 8e-74
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 5/273 (1%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
             K   R  +  + +G  LG G FG V + + + + H VA+K+L + +++   V  ++RR
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
           E++     RHP+I++LY        +++++EY + GEL+  + K     E+ +      +
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR--RTMCGTLDYLPPE 183
              + YCH   V+HRD+KPEN+L+ A    KIADFG S    +    RT CG+ +Y  PE
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPE 185

Query: 184 MVESVEHD-ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
           ++    +    VDIWS GV+ Y  L G  PF+       +++I       P    ++ + 
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP--QYLNPSV 243

Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
             L+  ML  D  +R  +  + EH W  Q+   
Sbjct: 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDLPK 276

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  227 bits (581), Expect = 2e-73
 Identities = 82/270 (30%), Positives = 140/270 (51%), Gaps = 6/270 (2%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
              +  +  + I + LG G FG V LA   ++   VALK + +  L++S +  ++ RE+ 
Sbjct: 2   AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61

Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
               LRHP+I++LY        + +++EY A GEL+  + + K  +E     +   +  A
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVE 186
           + YCH   ++HRD+KPENLL+     +KIADFG S  +   N  +T CG+ +Y  PE++ 
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180

Query: 187 SVEHD-ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
              +    VD+WS G++ Y  L G  PF+ +   + ++++       P    +S  A+ L
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--DFLSPGAQSL 238

Query: 246 ISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           I +M+V D  QR+ + ++   PW   N   
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWFNVNLPD 268

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  225 bits (577), Expect = 3e-73
 Identities = 73/273 (26%), Positives = 129/273 (47%), Gaps = 15/273 (5%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHL 73
           +  + +G  LG G +G V    +  +    A+K+L K +L++    E  +++E+++   L
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63

Query: 74  RHPNILRLYGYFYDQ--KRVYLILEYAAKG--ELYKELQKCKYFSERRAATYVASLARAL 129
           RH N+++L    Y++  +++Y+++EY   G  E+   + + K F   +A  Y   L   L
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGL 122

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEM 184
            Y H + ++H+DIKP NLL+   G LKI+  G +            RT  G+  + PPE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 185 VESVE--HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
              ++      VDIWS GV  Y    G+ PFE       +  I +     P         
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP--GDCGPPL 240

Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
            DL+  ML  + ++R  + ++ +H W  +   P
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  228 bits (583), Expect = 5e-73
 Identities = 73/270 (27%), Positives = 139/270 (51%), Gaps = 17/270 (6%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEH 61
           +  S K      L DFD+ + +GRG +  V L R K+++ I A++V+ K        ++ 
Sbjct: 39  TRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDW 98

Query: 62  QLRREVEI-QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
            ++ E  + +    HP ++ L+  F  + R++ ++EY   G+L   +Q+ +   E  A  
Sbjct: 99  -VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF 157

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTL 177
           Y A ++ AL Y H + +I+RD+K +N+L+ ++G +K+ D+G     +   +   T CGT 
Sbjct: 158 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 217

Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPF---------EAKEHSDTYRRIVQV 228
           +Y+ PE++   ++  +VD W+LGVL +E + G  PF         +       ++ I++ 
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277

Query: 229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRL 258
            ++ P    +S  A  ++   L KD  +RL
Sbjct: 278 QIRIPRS--LSVKAASVLKSFLNKDPKERL 305

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  232 bits (594), Expect = 4e-72
 Identities = 78/261 (29%), Positives = 135/261 (51%), Gaps = 8/261 (3%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEH 61
              +   + R  L DF+    LG+G FG V L+  K ++ + A+K+L K   +Q   VE 
Sbjct: 328 KFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC 387

Query: 62  QLRREVEI-QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT 120
               E  +     + P + +L+  F    R+Y ++EY   G+L   +Q+   F E  A  
Sbjct: 388 -TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 446

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTL 177
           Y A +A  L +   K +I+RD+K +N+++ ++G +KIADFG     +      +T CGT 
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 506

Query: 178 DYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI 237
           DY+ PE++    +  +VD W+ GVL YE L G  PFE ++  + ++ I++ ++ +P    
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS-- 564

Query: 238 VSSAAKDLISQMLVKDSSQRL 258
           +S  A  +   ++ K   +RL
Sbjct: 565 MSKEAVAICKGLMTKHPGKRL 585

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  222 bits (568), Expect = 5e-72
 Identities = 78/273 (28%), Positives = 123/273 (45%), Gaps = 43/273 (15%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNI 78
             + LG G  G V     KR+    ALK+L              RREVE+     + P+I
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------ARREVELHWRASQCPHI 73

Query: 79  LRLYGYFYD----QKRVYLILEYAAKGELYKELQK--CKYFSERRAATYVASLARALIYC 132
           +R+   + +    +K + +++E    GEL+  +Q    + F+ER A+  + S+  A+ Y 
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133

Query: 133 HGKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE 189
           H  ++ HRD+KPENLL  ++     LK+ DFG                     E     +
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFG------------------FAKE-TTGEK 174

Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT----YRRIVQVDLKFPPKP--IVSSAAK 243
           +D + D+WSLGV+ Y  L G PPF +            RI     +FP      VS   K
Sbjct: 175 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 234

Query: 244 DLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
            LI  +L  + +QR+ + + + HPWI+Q+    
Sbjct: 235 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  230 bits (589), Expect = 3e-71
 Identities = 72/280 (25%), Positives = 135/280 (48%), Gaps = 15/280 (5%)

Query: 2   CSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVE 60
           C   + +     T+NDF + + +GRG FG VY  R+  +  + A+K L K ++  +    
Sbjct: 175 CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET 234

Query: 61  HQL--RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRA 118
             L  R  + + S    P I+ +   F+   ++  IL+    G+L+  L +   FSE   
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM 294

Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-RTMCGTL 177
             Y A +   L + H + V++RD+KP N+L+   G ++I+D G +     ++     GT 
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 354

Query: 178 DYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEA---KEHSDTYRRIVQVDLKFP 233
            Y+ PE+++  V +D++ D +SLG + ++ L G  PF     K+  +  R  + + ++ P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414

Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHK-----LLEHPW 268
                S   + L+  +L +D ++RL         + E P+
Sbjct: 415 DS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  222 bits (567), Expect = 9e-71
 Identities = 60/303 (19%), Positives = 114/303 (37%), Gaps = 48/303 (15%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           + + +   LG+G   +V+  R K++  + A+KV       +        RE E+   L H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNH 66

Query: 76  PNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQK---CKYFSERRAATYVASLARALI 130
            NI++L+    +   +   LI+E+   G LY  L++        E      +  +   + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 131 YCHGKHVIHRDIKPENLLIG----AQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEM 184
           +     ++HR+IKP N++       Q   K+ DFG +  +    +  ++ GT +YL P+M
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 185 VESV--------EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI----------- 225
            E          ++ A VD+WS+GV  Y    G  PF   E     + +           
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 226 ------------VQVDLKFPPKPIVSSAAKD----LISQMLVKDSSQRLPLHKLLEHPWI 269
                       +      P    +S   +     +++ +L  D  +     +       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 270 IQN 272
           I +
Sbjct: 307 ILH 309

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  220 bits (562), Expect = 1e-70
 Identities = 74/289 (25%), Positives = 116/289 (40%), Gaps = 38/289 (13%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HP 76
             + + L  G F  VY A++  S    ALK L  ++ ++++    + +EV     L  HP
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGHP 86

Query: 77  NILRLYGYFYDQKRV-------YLILEYAAKGELYKELQKCK---YFSERRAATYVASLA 126
           NI++        K         +L+L    KG+L + L+K +     S            
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 127 RALIYCHGKH--VIHRDIKPENLLIGAQGELKIADFG------------WSVHTFNRR-- 170
           RA+ + H +   +IHRD+K ENLL+  QG +K+ DFG            WS         
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 171 -RTMCGTLDYLPPEMVESVEH---DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV 226
             T   T  Y  PE+++   +       DIW+LG + Y   +   PFE         RIV
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRIV 262

Query: 227 QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
                 PP     +    LI  ML  +  +RL + +++     I  A  
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  222 bits (567), Expect = 3e-70
 Identities = 67/271 (24%), Positives = 108/271 (39%), Gaps = 26/271 (9%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RH 75
            F     LG G  G +   R    N  VA+K +               REV++      H
Sbjct: 25  SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSF------ADREVQLLRESDEH 77

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHG 134
           PN++R +    D++  Y+ +E  A   L + + QK          T +      L + H 
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 135 KHVIHRDIKPENLLIGAQGE-----LKIADFGWSVH------TFNRRRTMCGTLDYLPPE 183
            +++HRD+KP N+LI            I+DFG          +F+RR  + GT  ++ PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 184 MVESVEH---DANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFP-PKPIV 238
           M+           VDI+S G + Y  +  G  PF           +    L    P+   
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256

Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
              A++LI +M+  D  +R     +L+HP+ 
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  225 bits (574), Expect = 3e-70
 Identities = 71/262 (27%), Positives = 127/262 (48%), Gaps = 15/262 (5%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREV 67
           E +    + F   + LGRG FG V+  + K +  + A K L K +  ++   +     E 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG-AMVEK 236

Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGEL----YKELQKCKYFSERRAATYVA 123
           +I + +    I+ L   F  +  + L++     G++    Y   +    F E RA  Y A
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296

Query: 124 SLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYL 180
            +   L + H +++I+RD+KPEN+L+   G ++I+D G +V       + +   GT  ++
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT----YRRIVQVDLKFPPKP 236
            PE++   E+D +VD ++LGV  YE +    PF A+          +R+++  + +P K 
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK- 415

Query: 237 IVSSAAKDLISQMLVKDSSQRL 258
             S A+KD    +L KD  +RL
Sbjct: 416 -FSPASKDFCEALLQKDPEKRL 436

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  216 bits (552), Expect = 1e-69
 Identities = 66/286 (23%), Positives = 114/286 (39%), Gaps = 37/286 (12%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           L DF+  + LGRG FG V+ A+ K  +   A+K +     + +    ++ REV+  + L 
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLE 61

Query: 75  HPNILRLYGYFYDQKR------------VYLILEYAAKGELYKELQKCK---YFSERRAA 119
           HP I+R +  + ++              +Y+ ++   K  L   +               
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---------------V 164
                +A A+ + H K ++HRD+KP N+       +K+ DFG                 +
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 165 HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRR 224
             + R     GT  Y+ PE +    +   VDI+SLG++ +E LY  P     E   T   
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTD 239

Query: 225 IVQVDLKFPPKP-IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           +    LKFPP           ++  ML     +R     ++E+   
Sbjct: 240 VRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  223 bits (571), Expect = 2e-69
 Identities = 71/259 (27%), Positives = 127/259 (49%), Gaps = 12/259 (4%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQSQVEHQLRREV 67
           E++  T N F   + LG+G FG V   + + +  + A K L K ++ ++      L  E 
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NEK 235

Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASL 125
           +I   +    ++ L   +  +  + L+L     G+L   +       F E RA  Y A +
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEI 295

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN--RRRTMCGTLDYLPPE 183
              L   H + +++RD+KPEN+L+   G ++I+D G +VH       +   GT+ Y+ PE
Sbjct: 296 CCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 355

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT----YRRIVQVDLKFPPKPIVS 239
           +V++  +  + D W+LG L YE + G  PF+ ++         R + +V  ++  +   S
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FS 413

Query: 240 SAAKDLISQMLVKDSSQRL 258
             A+ L SQ+L KD ++RL
Sbjct: 414 PQARSLCSQLLCKDPAERL 432

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  220 bits (562), Expect = 2e-67
 Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 38/291 (13%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           T   +++ + LG G FG+V     + +   VA+K   + +L     E     E++I   L
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQ-CRQELSPKNRER-WCLEIQIMKKL 69

Query: 74  RHPNILRLY------GYFYDQKRVYLILEYAAKGELYKELQK---CKYFSERRAATYVAS 124
            HPN++                   L +EY   G+L K L +   C    E    T ++ 
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWS--VHTFNRRRTMCGTLDY 179
           ++ AL Y H   +IHRD+KPEN+++    +    KI D G++  +          GTL Y
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQY 189

Query: 180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----- 234
           L PE++E  ++   VD WS G L +E + G  PF        +   V+            
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249

Query: 235 -----------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                              I++   +  +  ML+    QR    +      
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  205 bits (524), Expect = 2e-65
 Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 33/285 (11%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL- 73
             +F   + +G G+FG V+   ++    I A+K   K  L  S  E    REV   + L 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAHAVLG 68

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK----YFSERRAATYVASLARAL 129
           +H +++R +  + +   + +  EY   G L   + +      YF E      +  + R L
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGEL-------------------KIADFGWSVHTFNRR 170
            Y H   ++H DIKP N+ I                         KI D G  V   +  
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG-HVTRISSP 187

Query: 171 RTMCGTLDYLPPEMV-ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD 229
           +   G   +L  E++ E+  H    DI++L +         P        D +  I Q  
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---GDQWHEIRQ-- 242

Query: 230 LKFPPKP-IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA 273
            + P  P ++S    +L+  M+  D  +R     L++H  ++  +
Sbjct: 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  208 bits (531), Expect = 7e-65
 Identities = 66/298 (22%), Positives = 107/298 (35%), Gaps = 57/298 (19%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-R 74
           N     K LG G  G V           VA+K +                E+++ +    
Sbjct: 15  NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDD 67

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFS-------ERRAATYVASLAR 127
           HPN++R Y      + +Y+ LE      L   ++             E    + +  +A 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 128 ALIYCHGKHVIHRDIKPENLLI-------------GAQGELKIADFGWSVH-------TF 167
            + + H   +IHRD+KP+N+L+                  + I+DFG             
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 168 NRRRTMCGTLDYLPPEMVESVEHDAN-------VDIWSLGVLCYEFL-YGVPPFEAKEHS 219
                  GT  +  PE++E   +          +DI+S+G + Y  L  G  PF      
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-----G 241

Query: 220 DTYRRIVQV--------DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           D Y R   +        ++K      + + A DLISQM+  D  +R    K+L HP  
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  203 bits (519), Expect = 3e-64
 Identities = 61/277 (22%), Positives = 108/277 (38%), Gaps = 22/277 (7%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
            +   +E+  W          +GRG FG V+  ++K++    A+K        + ++E  
Sbjct: 49  VDYEYREEVHW----MTHQPRVGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVF 96

Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
              E+   + L  P I+ LYG   +   V + +E    G L + +++     E RA  Y+
Sbjct: 97  RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYL 156

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWSVH--------TFNRRRTM 173
                 L Y H + ++H D+K +N+L+ + G    + DFG ++         +      +
Sbjct: 157 GQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP 233
            GT  ++ PE+V     DA VDIWS   +    L G  P+          +I        
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR 276

Query: 234 PKP-IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
             P   +      I + L K+   R    +L      
Sbjct: 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  199 bits (507), Expect = 5e-63
 Identities = 64/259 (24%), Positives = 122/259 (47%), Gaps = 11/259 (4%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
               +GRG F  VY   +  +   VA   L   +L +S+ + + + E E+   L+HPNI+
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEMLKGLQHPNIV 88

Query: 80  RLYGYFYD----QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           R Y  +      +K + L+ E    G L   L++ K    +   ++   + + L + H +
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 136 H--VIHRDIKPENLLI-GAQGELKIADFGWS-VHTFNRRRTMCGTLDYLPPEMVESVEHD 191
              +IHRD+K +N+ I G  G +KI D G + +   +  + + GT +++ PEM E  ++D
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYD 207

Query: 192 ANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
            +VD+++ G+   E      P+ E +  +  YRR+           +     K++I   +
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267

Query: 251 VKDSSQRLPLHKLLEHPWI 269
            ++  +R  +  LL H + 
Sbjct: 268 RQNKDERYSIKDLLNHAFF 286

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  196 bits (499), Expect = 1e-61
 Identities = 76/269 (28%), Positives = 141/269 (52%), Gaps = 15/269 (5%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQSHLRH 75
            F   + +G+G FG V+   + R+  +VA+K++    L++++ E + +++E+ + S    
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII---DLEEAEDEIEDIQQEITVLSQCDS 79

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           P + + YG +    ++++I+EY   G    +L +     E + AT +  + + L Y H +
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDA 192
             IHRDIK  N+L+   GE+K+ADFG +     T  +R T  GT  ++ PE+++   +D+
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP---KPIVSSAAKDLISQM 249
             DIWSLG+   E   G PP  ++ H     +++ +  K  P   +   S   K+ +   
Sbjct: 199 KADIWSLGITAIELARGEPPH-SELHP---MKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254

Query: 250 LVKDSSQRLPLHKLLEHPWIIQNADPSGV 278
           L K+ S R    +LL+H +I++NA  +  
Sbjct: 255 LNKEPSFRPTAKELLKHKFILRNAKKTSY 283

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  196 bits (500), Expect = 1e-60
 Identities = 40/293 (13%), Positives = 79/293 (26%), Gaps = 48/293 (16%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR--- 74
              G  LG+        A ++ +     + V + ++   S    Q++ EV     LR   
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 75  ----------------------HPNILRLYGYFYDQKRV--YLILEYAAK------GELY 104
                                    ++R+     D   +  + +              L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 105 KELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV 164
                 K             + R L   H   ++H  ++P ++++  +G + +  F   V
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 165 HTFNRRRTMCGTL----DYLPPEMVESVEHDAN-----VDIWSLGVLCYEFLYGVPPFEA 215
                  +  G      +     M+   +H         D W+LG+  Y       P   
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

Query: 216 KEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                    I +     P         + L+   L      RL   + +E P 
Sbjct: 320 DAALGGSEWIFRSCKNIPQ------PVRALLEGFLRYPKEDRLLPLQAMETPE 366

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  195 bits (496), Expect = 1e-60
 Identities = 50/292 (17%), Positives = 88/292 (30%), Gaps = 35/292 (11%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNH-----IVALKVLFKSQLQQS 57
             +  K + +       +   LG G F  VY A +   N         LKV   +   + 
Sbjct: 52  PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF 111

Query: 58  QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY----- 112
            +  QL   +           ++ Y     Q    L+ E  + G L   +   K      
Sbjct: 112 YIGTQLMERL---KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168

Query: 113 FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG-----------AQGELKIADFG 161
             +    ++   +   +   H   +IH DIKP+N ++G               L + D G
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228

Query: 162 WSVHTFNRRR-----TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAK 216
            S+      +       C T  +   EM+ +   +  +D + +    Y  L+G       
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288

Query: 217 EHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
           E  +     +    +  P         +    ML       LP   LL    
Sbjct: 289 EGGECKPEGL---FRRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  186 bits (475), Expect = 4e-58
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 15/285 (5%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
              S   +  +  ++      LG+G +G VY  R+  +   +A+K +     + S+    
Sbjct: 9   DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQP 65

Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG---ELYKELQKCKYFSERRAA 119
           L  E+ +  HL+H NI++  G F +   + + +E    G    L +        +E+   
Sbjct: 66  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125

Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGA-QGELKIADFGWSVH---TFNRRRTMCG 175
            Y   +   L Y H   ++HRDIK +N+LI    G LKI+DFG S           T  G
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG 185

Query: 176 TLDYLPPEMVESVE--HDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKF 232
           TL Y+ PE+++     +    DIWSLG    E   G PPF E  E      ++    +  
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH- 244

Query: 233 PPKP-IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           P  P  +S+ AK  I +    D  +R   + LL   ++  ++   
Sbjct: 245 PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  181 bits (461), Expect = 5e-56
 Identities = 71/266 (26%), Positives = 129/266 (48%), Gaps = 14/266 (5%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +   + +G+G  G VY A +  +   VA++ +    LQQ   +  +  E+ +    ++PN
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPN 78

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           I+     +     +++++EY A G L  ++       E + A       +AL + H   V
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 138 IHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
           IHRDIK +N+L+G  G +K+ DFG+        ++R TM GT  ++ PE+V    +   V
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK----PIVSSAAKDLISQML 250
           DIWSLG++  E + G PP+   E+    R +  +     P+      +S+  +D +++ L
Sbjct: 198 DIWSLGIMAIEMIEGEPPY-LNEN--PLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254

Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPS 276
             D  +R    +LL+H ++      S
Sbjct: 255 EMDVEKRGSAKELLQHQFLKIAKPLS 280

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  182 bits (463), Expect = 6e-56
 Identities = 79/266 (29%), Positives = 141/266 (53%), Gaps = 14/266 (5%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
            D    +G G  G V LAREK S   VA+K++    L++ Q    L  EV I    +H N
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
           ++ +Y  +   + +++++E+   G L  ++      +E + AT   ++ +AL Y H + V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162

Query: 138 IHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
           IHRDIK +++L+   G +K++DFG+         +R+++ GT  ++ PE++    +   V
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEV 222

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK----PIVSSAAKDLISQML 250
           DIWSLG++  E + G PP+   +     + + ++    PPK      VS   +D + +ML
Sbjct: 223 DIWSLGIMVIEMVDGEPPY-FSDS--PVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279

Query: 251 VKDSSQRLPLHKLLEHPWIIQNADPS 276
           V+D  +R    +LL+HP+++Q   P 
Sbjct: 280 VRDPQERATAQELLDHPFLLQTGLPE 305

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  181 bits (461), Expect = 7e-56
 Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 44/307 (14%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
           SE S+        +D+++ + +G G    V  A        VA+K +    L++ Q    
Sbjct: 2   SEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI---NLEKCQTSMD 58

Query: 63  -LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKG---ELYKELQKC-----KYF 113
            L +E++  S   HPNI+  Y  F  +  ++L+++  + G   ++ K +           
Sbjct: 59  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118

Query: 114 SERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--------VH 165
            E   AT +  +   L Y H    IHRD+K  N+L+G  G ++IADFG S        + 
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178

Query: 166 TFNRRRTMCGTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHS----- 219
               R+T  GT  ++ PE++E V  +D   DIWS G+   E   G  P+  K        
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY-HKYPPMKVLM 237

Query: 220 ----------DTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                     +T  +  ++  K+        + + +IS  L KD  +R    +LL H + 
Sbjct: 238 LTLQNDPPSLETGVQDKEMLKKY------GKSFRKMISLCLQKDPEKRPTAAELLRHKF- 290

Query: 270 IQNADPS 276
            Q A   
Sbjct: 291 FQKAKNK 297

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  179 bits (456), Expect = 2e-55
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 16/276 (5%)

Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
               +D +    LGRG +G V   R   S  I+A+K +  +    SQ + +L  +++I  
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISM 60

Query: 72  HL-RHPNILRLYGYFYDQKRVYLILEYAAKG--ELYKEL-QKCKYFSERRAATYVASLAR 127
                P  +  YG  + +  V++ +E       + YK++  K +   E        S+ +
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 128 ALIYCHGKH-VIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPE 183
           AL + H K  VIHRD+KP N+LI A G++K+ DFG S   V     +    G   Y+ PE
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPE 179

Query: 184 ----MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH-SDTYRRIVQVDLKFPPKPIV 238
                +    +    DIWSLG+   E      P+++        +++V+      P    
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239

Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           S+   D  SQ L K+S +R    +L++HP+   +  
Sbjct: 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  180 bits (459), Expect = 3e-55
 Identities = 73/292 (25%), Positives = 131/292 (44%), Gaps = 22/292 (7%)

Query: 1   ACSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
              ++S ++   +T  D      +GRG +G V     K S  I+A+K +  +     + +
Sbjct: 7   GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQ 64

Query: 61  HQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKG--ELYKELQKC--KYFSE 115
            QL  ++++       P I++ YG  + +   ++ +E  +    + YK +         E
Sbjct: 65  KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE 124

Query: 116 RRAATYVASLARALIYCHGKH-VIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRR 171
                   +  +AL +      +IHRDIKP N+L+   G +K+ DFG S   V +  + R
Sbjct: 125 EILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184

Query: 172 TMCGTLDYLPPEMVESVEH----DANVDIWSLGVLCYEFLYGVPPFEAKEHS--DTYRRI 225
              G   Y+ PE ++        D   D+WSLG+  YE   G  P+  K +S  D   ++
Sbjct: 185 DA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY-PKWNSVFDQLTQV 242

Query: 226 VQVD---LKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
           V+ D   L    +   S +  + ++  L KD S+R    +LL+HP+I+   +
Sbjct: 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  180 bits (457), Expect = 9e-55
 Identities = 69/309 (22%), Positives = 127/309 (41%), Gaps = 46/309 (14%)

Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
               +DF+    LG G  G V+    K S  ++A K++      +  + +Q+ RE+++  
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLH 86

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
               P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 146

Query: 132 CHGKH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLDYLPPEMVESVE 189
              KH ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH 206

Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR-------------------------- 223
           +    DIWS+G+   E   G  P    +  +                             
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 224 ----------------RIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHP 267
                            IV       P  + S   +D +++ L+K+ ++R  L +L+ H 
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326

Query: 268 WIIQNADPS 276
           +I ++    
Sbjct: 327 FIKRSDAEE 335

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  178 bits (454), Expect = 1e-54
 Identities = 65/280 (23%), Positives = 127/280 (45%), Gaps = 15/280 (5%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           ++ +  +ND +    +G G  G V+  R +++ H++A+K + +S     +   ++  +++
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLD 75

Query: 69  I-QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
           +       P I++ +G F     V++ +E         + +      ER       ++ +
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135

Query: 128 ALIYCHGKH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFN--RRRTMCGTLDYLPPEM 184
           AL Y   KH VIHRD+KP N+L+  +G++K+ DFG S    +   +    G   Y+ PE 
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPER 195

Query: 185 VESVE-----HDANVDIWSLGVLCYEFLYGVPPFEAKEHS--DTYRRIVQVDL-KFPPKP 236
           ++  +     +D   D+WSLG+   E   G  P+     +  +   +++Q +    P   
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPY-KNCKTDFEVLTKVLQEEPPLLPGHM 254

Query: 237 IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
             S   +  +   L KD  +R   +KLLEH +I +     
Sbjct: 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  176 bits (449), Expect = 4e-54
 Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 27/276 (9%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           ++I   LG G FG VY A+ K +  + A KV+   + +  +       E+EI +   HP 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDHPY 77

Query: 78  ILRLYGYFYDQKRVYLILEYAAKG---ELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           I++L G +Y   ++++++E+   G    +  EL +    +E +       +  AL + H 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHS 135

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-----E 186
           K +IHRD+K  N+L+  +G++++ADFG S   + T  +R +  GT  ++ PE+V     +
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195

Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY--RRIVQVDLKFPPK----PIVSS 240
              +D   DIWSLG+   E     PP     H +    R ++++    PP        S 
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP-----HHELNPMRVLLKIAKSDPPTLLTPSKWSV 250

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
             +D +   L K+   R    +LLEHP++       
Sbjct: 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  176 bits (449), Expect = 1e-53
 Identities = 69/267 (25%), Positives = 123/267 (46%), Gaps = 14/267 (5%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           F   + +G G FG VY AR+ R++ +VA+K +  S  Q ++    + +EV     LRHPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 78  ILRLYGYFYDQKRVYLILEYAAKG--ELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
            ++  G +  +   +L++EY      +L +  +K     E   A       + L Y H  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSH 173

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV---ESVEHDA 192
           ++IHRD+K  N+L+   G +K+ DFG +        +  GT  ++ PE++   +  ++D 
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSA-SIMAPANSFVGTPYWMAPEVILAMDEGQYDG 232

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK---PIVSSAAKDLISQM 249
            VD+WSLG+ C E     PP     ++     +  +     P       S   ++ +   
Sbjct: 233 KVDVWSLGITCIELAERKPPL-FNMNA--MSALYHIAQNESPALQSGHWSEYFRNFVDSC 289

Query: 250 LVKDSSQRLPLHKLLEHPWIIQNADPS 276
           L K    R     LL+H ++++   P+
Sbjct: 290 LQKIPQDRPTSEVLLKHRFVLRERPPT 316

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  174 bits (444), Expect = 3e-53
 Identities = 83/270 (30%), Positives = 135/270 (50%), Gaps = 22/270 (8%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL-FKSQLQQSQVEHQLRREVEIQSHLRHP 76
           FD+ + LG G +G VY A  K +  IVA+K +  +S LQ+      + +E+ I      P
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE------IIKEISIMQQCDSP 84

Query: 77  NILRLYGYFYDQKRVYLILEYAAKG---ELYKELQKCKYFSERRAATYVASLARALIYCH 133
           ++++ YG ++    +++++EY   G   ++ +   K    +E   AT + S  + L Y H
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLH 142

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVESVEH 190
               IHRDIK  N+L+  +G  K+ADFG +     T  +R T+ GT  ++ PE+++ + +
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK----PIVSSAAKDLI 246
           +   DIWSLG+   E   G PP+ A  H    R I  +    PP      + S    D +
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPY-ADIHP--MRAIFMIPTNPPPTFRKPELWSDNFTDFV 259

Query: 247 SQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
            Q LVK   QR    +LL+HP++      S
Sbjct: 260 KQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  168 bits (427), Expect = 1e-50
 Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 29/284 (10%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-QSHLR 74
             F++ + +G G +G VY  R  ++  + A+KV+    +   + E ++++E+ + + +  
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEE-EIKQEINMLKKYSH 79

Query: 75  HPNILRLYGYFY------DQKRVYLILEYAAKG---ELYKELQKCKYFSERRAATYVASL 125
           H NI   YG F          +++L++E+   G   +L K   K     E   A     +
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREI 138

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPP 182
            R L + H   VIHRDIK +N+L+    E+K+ DFG S     T  RR T  GT  ++ P
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198

Query: 183 EMVESVEH-----DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK-- 235
           E++   E+     D   D+WSLG+   E   G PP     H    R +  +     P+  
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-CDMHPM--RALFLIPRNPAPRLK 255

Query: 236 -PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSGV 278
               S   +  I   LVK+ SQR    +L++HP+I    +   V
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQV 299

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  166 bits (423), Expect = 5e-50
 Identities = 64/331 (19%), Positives = 113/331 (34%), Gaps = 82/331 (24%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           L DF+  + +GRG FG V+ A+ K  +   A+K +     + +    ++ REV+  + L 
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLE 62

Query: 75  HPNILRLYGYFYDQKR-------------------------------------------- 90
           HP I+R +  + +                                               
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 91  -VYLILEYAAKGELYKELQKC---------------KYFSERRAATYVASLARALIYCHG 134
            V  +   + K  LY ++Q C               +             +A A+ + H 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFG---------------WSVHTFNRRRTMCGTLDY 179
           K ++HRD+KP N+       +K+ DFG                 +  +       GT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP-IV 238
           + PE +    +   VDI+SLG++ +E LY        E       +    LKFP      
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRN--LKFPLLFTQK 298

Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                 ++  ML    ++R     ++E+   
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  167 bits (425), Expect = 1e-49
 Identities = 58/317 (18%), Positives = 105/317 (33%), Gaps = 63/317 (19%)

Query: 16  NDFDIGKPLGRG--KFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
             +++   +G+G      V LAR K +   V ++ +         V   L+ E+ +    
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLF 83

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKG---ELYKELQKCKYFSERRAATYVASLARALI 130
            HPNI+     F     ++++  + A G   +L          +E   A  +  + +AL 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKALD 142

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMC-------GTLDYL 180
           Y H    +HR +K  ++LI   G++ ++    +   +    R+R +          L +L
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 181 PPEMVESVEH--DANVDIWSLGVLCYEFLYGVPPF------------------------- 213
            PE+++      DA  DI+S+G+   E   G  PF                         
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262

Query: 214 -------------------EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
                                   + T R         P     S      + Q L ++ 
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322

Query: 255 SQRLPLHKLLEHPWIIQ 271
             R     LL H +  Q
Sbjct: 323 DARPSASTLLNHSFFKQ 339

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  165 bits (420), Expect = 1e-49
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 46/293 (15%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           +  ++    +G G +G V+  R + +  IVA+K  F        ++    RE+ +   L+
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKK-FLESEDDPVIKKIALREIRMLKQLK 60

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCH 133
           HPN++ L   F  ++R++L+ EY     +  EL +  +   E    +      +A+ +CH
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-----RRTM---CGTLDYLPPEM- 184
             + IHRD+KPEN+LI     +K+ DFG     F R              T  Y  PE+ 
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFG-----FARLLTGPSDYYDDEVATRWYRSPELL 174

Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV---------------- 228
           V   ++   VD+W++G +  E L GVP +  K   D    I +                 
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234

Query: 229 ---DLKFPPK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
               +K P            P +S  A  L+   L  D ++RL   +LL HP+
Sbjct: 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  162 bits (411), Expect = 2e-48
 Identities = 62/251 (24%), Positives = 114/251 (45%), Gaps = 11/251 (4%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
             D +I + +G G FG V+ A        VA+K+L +      +V  +  REV I   LR
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVN-EFLREVAIMKRLR 92

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC---KYFSERRAATYVASLARALIY 131
           HPNI+   G       + ++ EY ++G LY+ L K    +   ERR  +    +A+ + Y
Sbjct: 93  HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152

Query: 132 CHGKH--VIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMVE 186
            H ++  ++HR++K  NLL+  +  +K+ DFG S     TF   ++  GT +++ PE++ 
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
               +   D++S GV+ +E      P+     +     +     +      ++     +I
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272

Query: 247 SQMLVKDSSQR 257
                 +  +R
Sbjct: 273 EGCWTNEPWKR 283

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  161 bits (410), Expect = 5e-48
 Identities = 71/289 (24%), Positives = 118/289 (40%), Gaps = 36/289 (12%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ++  ++    +G G +G V   R K +  IVA+K  F        V+    RE+++   L
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKK-FLESDDDKMVKKIAMREIKLLKQL 81

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYC 132
           RH N++ L      +KR YL+ E+     +  +L+        +    Y+  +   + +C
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---TLDYLPPEM-VESV 188
           H  ++IHRDIKPEN+L+   G +K+ DFG++               T  Y  PE+ V  V
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------------D 229
           ++   VD+W++G L  E   G P F      D    I+                      
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260

Query: 230 LKFPPK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
           ++ P            P +S    DL  + L  D  +R    +LL H +
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  156 bits (396), Expect = 3e-46
 Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 17/250 (6%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           I   LG G    VYLA +   N  VA+K +F    ++ +   +  REV   S L H NI+
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIH 139
            +     +    YL++EY     L + ++     S   A  +   +   + + H   ++H
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVH 134

Query: 140 RDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVD 195
           RDIKP+N+LI +   LKI DFG     S  +  +   + GT+ Y  PE  +    D   D
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194

Query: 196 IWSLGVLCYEFLYGVPPFEAKEHSDT-----YRRIVQVDLKFPPK---PIVSSAAKDLIS 247
           I+S+G++ YE L G PPF      +T      +  +Q  +          +  +  ++I 
Sbjct: 195 IYSIGIVLYEMLVGEPPFNG----ETAVSIAIKH-IQDSVPNVTTDVRKDIPQSLSNVIL 249

Query: 248 QMLVKDSSQR 257
           +   KD + R
Sbjct: 250 RATEKDKANR 259

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  154 bits (390), Expect = 1e-45
 Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 16/226 (7%)

Query: 3   SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVL----FKSQLQQSQ 58
           SE           N+ +  K +G+G FG V+  R  +   +VA+K L     + + +  +
Sbjct: 6   SEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE 65

Query: 59  VEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERR 117
              + +REV I S+L HPNI++LYG         +++E+   G+LY  L    +      
Sbjct: 66  KFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSV 123

Query: 118 AATYVASLARALIYCHGKH--VIHRDIKPENLLIGAQGE-----LKIADFGWSVHTFNRR 170
               +  +A  + Y   ++  ++HRD++  N+ + +  E      K+ADFG S  + +  
Sbjct: 124 KLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV 183

Query: 171 RTMCGTLDYLPPEM--VESVEHDANVDIWSLGVLCYEFLYGVPPFE 214
             + G   ++ PE    E   +    D +S  ++ Y  L G  PF+
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  152 bits (385), Expect = 7e-45
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 16/213 (7%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHL 73
             +  + + +G G FG VY A        VA+K       +  SQ    +R+E ++ + L
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           +HPNI+ L G    +  + L++E+A  G L + L   K         +   +AR + Y H
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLH 122

Query: 134 GKH---VIHRDIKPENLLIGAQGE--------LKIADFGWS-VHTFNRRRTMCGTLDYLP 181
            +    +IHRD+K  N+LI  + E        LKI DFG +       + +  G   ++ 
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMA 182

Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFE 214
           PE++ +       D+WS GVL +E L G  PF 
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  152 bits (387), Expect = 8e-45
 Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 19/252 (7%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
             + ++ + +GRG FG V  A  K     VA+K +     ++         E+   S + 
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERK-----AFIVELRQLSRVN 59

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK---YFSERRAATYVASLARALIY 131
           HPNI++LYG       V L++EYA  G LY  L   +   Y++   A ++    ++ + Y
Sbjct: 60  HPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 132 CHG---KHVIHRDIKPENLLIGAQGE-LKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES 187
            H    K +IHRD+KP NLL+ A G  LKI DFG +           G+  ++ PE+ E 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEG 177

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD-TYRRIVQVDLKFPPKPI-VSSAAKDL 245
             +    D++S G++ +E +    PF+            V    + PP    +    + L
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-PPLIKNLPKPIESL 236

Query: 246 ISQMLVKDSSQR 257
           +++   KD SQR
Sbjct: 237 MTRCWSKDPSQR 248

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  152 bits (386), Expect = 2e-44
 Identities = 83/298 (27%), Positives = 130/298 (43%), Gaps = 51/298 (17%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQS 71
           +++ +     LG G +G VY A +  +N  VA+K   + +L+  +  V     REV +  
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGTAIREVSLLK 88

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
            L+H NI+ L    +   R++LI EYA   +L K + K    S R   +++  L   + +
Sbjct: 89  ELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147

Query: 132 CHGKHVIHRDIKPENLLI-----GAQGELKIADFG----WSVHTFNRRRTM---CGTLDY 179
           CH +  +HRD+KP+NLL+          LKI DFG    + +      R       TL Y
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI----RQFTHEIITLWY 203

Query: 180 LPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV---------- 228
            PPE ++ S  +  +VDIWS+  +  E L   P F      D   +I +V          
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263

Query: 229 ---DL--------KFPPKPI-------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
               L        KF  K +       +     DL++ ML  D  +R+     LEHP+
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  150 bits (381), Expect = 6e-44
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 23/222 (10%)

Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
                 D   G+ LG+G FG       + +  ++ +K L +      + +    +EV++ 
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVM 61

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARAL 129
             L HPN+L+  G  Y  KR+  I EY   G L   ++     +   +  ++   +A  +
Sbjct: 62  RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-----------------VHTFNRRRT 172
            Y H  ++IHRD+   N L+     + +ADFG +                      +R T
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFE 214
           + G   ++ PEM+    +D  VD++S G++  E +  V    
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  150 bits (381), Expect = 9e-44
 Identities = 78/292 (26%), Positives = 134/292 (45%), Gaps = 46/292 (15%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ-VEHQLRREVEIQSHL 73
           +  +     LG G +  VY  + K ++++VALK   + +L+  +       REV +   L
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALK---EIRLEHEEGAPCTAIREVSLLKDL 57

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYC 132
           +H NI+ L+   + +K + L+ EY  K +L + L  C    +      ++  L R L YC
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTMCG---TLDYLPPE-M 184
           H + V+HRD+KP+NLLI  +GELK+ADFG     S+ T    +T      TL Y PP+ +
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT----KTYDNEVVTLWYRPPDIL 172

Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV---------------- 228
           + S ++   +D+W +G + YE   G P F      +    I ++                
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232

Query: 229 ---DLKFPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                 +P           P + S   DL++++L  +   R+     ++HP+
Sbjct: 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  148 bits (377), Expect = 3e-43
 Identities = 61/245 (24%), Positives = 106/245 (43%), Gaps = 9/245 (3%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQSHLRHPNI 78
           + + +GRG  G VY A +     IVALK++    L    V    ++RE      L+ P++
Sbjct: 38  LRRLVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 79  LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVI 138
           + ++ +     ++Y+ +      +L   L++    +  RA   V  +  AL   H     
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGAT 156

Query: 139 HRDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTMCGTLDYLPPEMVESVEHDANV 194
           HRD+KPEN+L+ A     + DFG     +     +     GTL Y+ PE           
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRA 216

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLISQMLVK 252
           DI++L  + YE L G PP++  + S      +   +  P    P +  A   +I++ + K
Sbjct: 217 DIYALTCVLYECLTGSPPYQGDQLSVMGAH-INQAIPRPSTVRPGIPVAFDAVIARGMAK 275

Query: 253 DSSQR 257
           +   R
Sbjct: 276 NPEDR 280

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  148 bits (375), Expect = 3e-43
 Identities = 84/292 (28%), Positives = 139/292 (47%), Gaps = 47/292 (16%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSH 72
           +  +   + +G G +G VY A+        ALK   K +L++    +     RE+ I   
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALK---KIRLEKEDEGIPSTTIREISILKE 56

Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIY 131
           L+H NI++LY   + +KR+ L+ E+  + +L K L  C+       A +++  L   + Y
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTMCG---TLDYLPPE- 183
           CH + V+HRD+KP+NLLI  +GELKIADFG    + +      R       TL Y  P+ 
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV----RKYTHEIVTLWYRAPDV 171

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------DL 230
           ++ S ++   +DIWS+G +  E + G P F     +D   RI ++             +L
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231

Query: 231 --------KFPPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                    + P P       +  +  DL+S+ML  D +QR+   + LEH +
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  148 bits (376), Expect = 4e-43
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 53/301 (17%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ-VEHQLRREVEIQSH 72
           + + F   + LG G +  VY    K +   VALK   + +L   +       RE+ +   
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK---EVKLDSEEGTPSTAIREISLMKE 59

Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAA---KG--ELYKELQKCKYFSERRAATYVASLAR 127
           L+H NI+RLY   + + ++ L+ E+     K   +        +         +   L +
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTMCG---TLDYL 180
            L +CH   ++HRD+KP+NLLI  +G+LK+ DFG    + +       T      TL Y 
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV----NTFSSEVVTLWYR 175

Query: 181 PPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------- 228
            P+ ++ S  +  ++DIWS G +  E + G P F      +  + I  +           
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235

Query: 229 --DL--------KFPPK-----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHP 267
              L        + PP+             +     D +  +L  +   RL   + L HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295

Query: 268 W 268
           W
Sbjct: 296 W 296

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  147 bits (374), Expect = 4e-43
 Identities = 76/293 (25%), Positives = 139/293 (47%), Gaps = 47/293 (16%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSH 72
           +  ++  + +G G +G V+ A+ + ++ IVALK   + +L      V     RE+ +   
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKE 57

Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIY 131
           L+H NI+RL+   +  K++ L+ E+  + +L K    C          +++  L + L +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTMCG---TLDYLPPE- 183
           CH ++V+HRD+KP+NLLI   GELK+A+FG    + +      R       TL Y PP+ 
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----RCYSAEVVTLWYRPPDV 172

Query: 184 MVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQV-------------- 228
           +  +  +  ++D+WS G +  E    G P F   +  D  +RI ++              
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 229 --DLK-FPPK----------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
             D K +P            P +++  +DL+  +L  +  QR+   + L+HP+
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  148 bits (376), Expect = 7e-43
 Identities = 71/293 (24%), Positives = 118/293 (40%), Gaps = 46/293 (15%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--------RE 66
              ++    LG G+F  VY AR+K +N IVA+K   K +L       + +        RE
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---KIKLGH---RSEAKDGINRTALRE 62

Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASL 125
           +++   L HPNI+ L   F  +  + L+ ++    +L   ++      +      Y+   
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---TLDYLPP 182
            + L Y H   ++HRD+KP NLL+   G LK+ADFG +    +  R       T  Y  P
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 181

Query: 183 E-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------------- 228
           E +  +  +   VD+W++G +  E L  VP        D   RI +              
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241

Query: 229 DL-------KFPPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
            L        FP  P+            DLI  + + +   R+   + L+  +
Sbjct: 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  146 bits (372), Expect = 1e-42
 Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 49/301 (16%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSH 72
           +  +   + +G G +G VY A++     IVALK   + +L      +     RE+ +   
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALK---RIRLDAEDEGIPSTAIREISLLKE 75

Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIY 131
           L HPNI+ L    + ++ + L+ E+  K +L K L + K    + +   Y+  L R + +
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFG----WSVHTFNRRRTMCG---TLDYLPPE- 183
           CH   ++HRD+KP+NLLI + G LK+ADFG    + +      R+      TL Y  P+ 
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV----RSYTHEVVTLWYRAPDV 190

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------DL 230
           ++ S ++  +VDIWS+G +  E + G P F      D   +I  +             +L
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250

Query: 231 ---------KFPPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
                     F  KP             DL+S ML  D ++R+     + HP+  ++ DP
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY-FKDLDP 309

Query: 276 S 276
            
Sbjct: 310 Q 310

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  147 bits (372), Expect = 2e-42
 Identities = 51/261 (19%), Positives = 103/261 (39%), Gaps = 23/261 (8%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
               +IG+ +G+G+FG VY  R       VA++++   +  + Q++   +REV      R
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLK-AFKREVMAYRQTR 87

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCH 133
           H N++   G       + +I        LY  ++  K      +       + + + Y H
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWS--------VHTFNRRRTMCGTLDYLPPEMV 185
            K ++H+D+K +N+     G++ I DFG              ++ R   G L +L PE++
Sbjct: 148 AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 186 ESVEHDAN---------VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP 236
             +  D            D+++LG + YE      PF+ +       ++         + 
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI 266

Query: 237 IVSSAAKDLISQMLVKDSSQR 257
            +     D++      +  +R
Sbjct: 267 GMGKEISDILLFCWAFEQEER 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  145 bits (369), Expect = 2e-42
 Identities = 42/252 (16%), Positives = 86/252 (34%), Gaps = 14/252 (5%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
               +    L     G ++  R +   + + +KVL        +       E        
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSR-DFNEECPRLRIFS 65

Query: 75  HPNILRLYGYFYD--QKRVYLILEYAAKGELYKELQK--CKYFSERRAATYVASLARALI 130
           HPN+L + G           LI  +   G LY  L +       + +A  +   +AR + 
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 131 YCHGKH--VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESV 188
           + H     +    +   +++I      +I+          +         ++ PE ++  
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK--FSFQSPGRMYAPAWVAPEALQKK 183

Query: 189 EHDAN---VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
             D N    D+WS  VL +E +    PF    + +   ++    L+    P +S     L
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKL 243

Query: 246 ISQMLVKDSSQR 257
           +   + +D ++R
Sbjct: 244 MKICMNEDPAKR 255

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  146 bits (371), Expect = 2e-42
 Identities = 75/257 (29%), Positives = 123/257 (47%), Gaps = 26/257 (10%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV-EHQLRREVEIQSHLRHPNI 78
           +G+ LG G    V+LAR+ R +  VA+KVL ++ L +      + RRE +  + L HP I
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 79  LRLYGYFYDQKR----VYLILEYAAKGELYKE-LQKCKYFSERRAATYVASLARALIYCH 133
           + +Y     +       Y+++EY   G   ++ +      + +RA   +A   +AL + H
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFG------WSVHTFNRRRTMCGTLDYLPPEMVES 187
              +IHRD+KP N++I A   +K+ DFG       S ++  +   + GT  YL PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT-----YRRIVQVDLKFPPK--PIVSS 240
              DA  D++SLG + YE L G PPF      D+     Y+  V+ D   P      +S+
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG----DSPVSVAYQH-VREDPIPPSARHEGLSA 248

Query: 241 AAKDLISQMLVKDSSQR 257
               ++ + L K+   R
Sbjct: 249 DLDAVVLKALAKNPENR 265

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  145 bits (369), Expect = 4e-42
 Identities = 68/298 (22%), Positives = 120/298 (40%), Gaps = 50/298 (16%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR-----REVEI 69
            + ++    +G G +G VY AR+  S H VALK     ++               REV +
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK---SVRVPNGGGGGGGLPISTVREVAL 64

Query: 70  QSHLR---HPNILRLY-----GYFYDQKRVYLILEYAA---KGELYKELQKCKYFSERRA 118
              L    HPN++RL           + +V L+ E+     +   Y +            
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPGLPAETI 122

Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG--- 175
              +    R L + H   ++HRD+KPEN+L+ + G +K+ADFG +   ++ +  +     
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA-RIYSYQMALTPVVV 181

Query: 176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------- 228
           TL Y  PE++    +   VD+WS+G +  E     P F     +D   +I  +       
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241

Query: 229 ---------DLKFPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                       FPP+         P +  +   L+ +ML  +  +R+   + L+H +
Sbjct: 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  147 bits (373), Expect = 9e-42
 Identities = 80/294 (27%), Positives = 124/294 (42%), Gaps = 53/294 (18%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +   K +G G FG VY A+   S  +VA+K      LQ  + ++   RE++I   L H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN---RELQIMRKLDHCN 108

Query: 78  ILRLYGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS----LAR 127
           I+RL  +FY      D+  + L+L+Y  +  +Y+  +      +     YV      L R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQ-GELKIADFGWSVHTFNRRRTM----CGTLDYLPP 182
           +L Y H   + HRDIKP+NLL+      LK+ DFG S     R        C +  Y  P
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVSYIC-SRYYRAP 225

Query: 183 E-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV------------- 228
           E +  + ++ +++D+WS G +  E L G P F      D    I++V             
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285

Query: 229 ----DLKFP---PKPI-------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
               + KFP     P            A  L S++L    + RL   +   H +
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  145 bits (367), Expect = 5e-41
 Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 54/290 (18%)

Query: 22  KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL 81
           K +G G FG V+ A+   S+  VA+K +    LQ  + ++   RE++I   ++HPN++ L
Sbjct: 46  KVIGNGSFGVVFQAKLVESDE-VAIKKV----LQDKRFKN---RELQIMRIVKHPNVVDL 97

Query: 82  YGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS----LARALIY 131
             +FY      D+  + L+LEY  +  +Y+  +      +      +      L R+L Y
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156

Query: 132 CHGKHVIHRDIKPENLLIGAQ-GELKIADFGWSVHTFNRRRTM----CGTLDYLPPE-MV 185
            H   + HRDIKP+NLL+    G LK+ DFG S              C +  Y  PE + 
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFG-SAKILIAGEPNVSYIC-SRYYRAPELIF 214

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------------- 228
            +  +  N+DIWS G +  E + G P F  +   D    I++V                 
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274

Query: 229 DLKFP---PKPI-------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
           + KFP   P P            A DLIS++L    S RL   + L HP+
Sbjct: 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  139 bits (353), Expect = 5e-40
 Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 20/270 (7%)

Query: 3   SEVSAKEKKRWT--LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
              S      W        +G+ +G G FG VY  +       VA+K+L  +     Q++
Sbjct: 9   HHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ 65

Query: 61  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAA 119
              + EV +    RH NIL   GY     ++ ++ ++     LY  L   +  F  ++  
Sbjct: 66  -AFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLI 123

Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTM--C 174
                 AR + Y H K +IHRD+K  N+ +     +KI DFG +          +     
Sbjct: 124 DIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183

Query: 175 GTLDYLPPEMVESVEH---DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK 231
           G++ ++ PE++   +        D+++ G++ YE + G  P+    + D    +V     
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243

Query: 232 FPPKPIVSS----AAKDLISQMLVKDSSQR 257
            P    V S      K L+++ L K   +R
Sbjct: 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDER 273

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  138 bits (350), Expect = 3e-39
 Identities = 70/294 (23%), Positives = 125/294 (42%), Gaps = 46/294 (15%)

Query: 16  NDFDIGKPLGRGKFGHVYLARE-KRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSH 72
             ++    +G G +G V+ AR+ K     VALK   + ++Q  +  +     REV +  H
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRH 67

Query: 73  LR---HPNILRLY-----GYFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYV 122
           L    HPN++RL+          + ++ L+ E+  + +L   L K              +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDY 179
             L R L + H   V+HRD+KP+N+L+ + G++K+ADFG +   ++ +  +     TL Y
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALTSVVVTLWY 185

Query: 180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----------- 228
             PE++    +   VD+WS+G +  E     P F      D   +I+ V           
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245

Query: 229 -----DLKFPP---------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                   F              +    KDL+ + L  + ++R+  +  L HP+
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  140 bits (355), Expect = 5e-38
 Identities = 54/244 (22%), Positives = 103/244 (42%), Gaps = 21/244 (8%)

Query: 20  IGKPLGRGKFGHVYLAREKR-SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI 78
           +   +  G  G +YLA ++  +   V LK L  S   ++Q       E +  + + HP+I
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQ--AMAMAERQFLAEVVHPSI 141

Query: 79  LRLYGY-----FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           ++++ +      +     Y+++EY   G+  K  +  +      A  Y+  +  AL Y H
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKRSKG-QKLPVAEAIAYLLEILPALSYLH 199

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
              +++ D+KPEN+++  +  LK+ D G +V   N    + GT  +  PE+V +    A 
Sbjct: 200 SIGLVYNDLKPENIMLTEEQ-LKLIDLG-AVSRINSFGYLYGTPGFQAPEIVRTGPTVAT 257

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD 253
            DI+++G         +P          Y   +  D    P      +   L+ + +  D
Sbjct: 258 -DIYTVGRTLAALTLDLPTRNG-----RYVDGLPED---DPVLKTYDSYGRLLRRAIDPD 308

Query: 254 SSQR 257
             QR
Sbjct: 309 PRQR 312

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  135 bits (341), Expect = 8e-38
 Identities = 72/297 (24%), Positives = 130/297 (43%), Gaps = 54/297 (18%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ-LRREVEIQSHLR 74
           +D+ + + LGRGK+  V+ A    +N  V +K+L         V+ + ++RE++I  +LR
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-------KPVKKKKIKREIKILENLR 88

Query: 75  -HPNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
             PNI+ L     D   +   L+ E+    +  +  Q     ++     Y+  + +AL Y
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDY 145

Query: 132 CHGKHVIHRDIKPENLLI-GAQGELKIADFGW--SVHTFNRRRTMCGTLDYLPPE-MVES 187
           CH   ++HRD+KP N++I     +L++ D+G     H          +  +  PE +V+ 
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQV----DL------------ 230
             +D ++D+WSLG +    ++   P F   ++ D   RI +V    DL            
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265

Query: 231 --------KFPPKP-----------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                   +   K            +VS  A D + ++L  D   RL   + +EHP+
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  135 bits (342), Expect = 8e-38
 Identities = 81/306 (26%), Positives = 127/306 (41%), Gaps = 62/306 (20%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLR--REVEIQSH 72
           +     +G G +G V  A +KRS   VA+K L   F+S++         R  RE+ +  H
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI------FAKRAYRELLLLKH 79

Query: 73  LRHPNILRLYGYFYDQKR------VYLILEYAAKGELYKELQK------CKYFSERRAAT 120
           ++H N++ L   F            YL++ +    +L K +         +Y        
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYL------- 131

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL 180
            V  + + L Y H   V+HRD+KP NL +    ELKI DFG + H          T  Y 
Sbjct: 132 -VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR 190

Query: 181 PPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------DLKF 232
            PE ++  + ++  VDIWS+G +  E L G   F+ K++ D   +I++V        ++ 
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250

Query: 233 ----------------PPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII 270
                           P K         S  A DL+ +ML  D  +RL   + L HP+  
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

Query: 271 QNADPS 276
              DP 
Sbjct: 311 PFRDPE 316

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  134 bits (340), Expect = 2e-37
 Identities = 80/302 (26%), Positives = 129/302 (42%), Gaps = 49/302 (16%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLR--REVEIQ 70
             +   +P+G G +G V  A + R+   VA+K L   F+S+L         R  RE+ + 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL------FAKRAYRELRLL 78

Query: 71  SHLRHPNILRLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVAS 124
            H+RH N++ L   F   +        YL++ +    +L K + K +   E R    V  
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-KHEKLGEDRIQFLVYQ 136

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE- 183
           + + L Y H   +IHRD+KP NL +    ELKI DFG +    +       T  Y  PE 
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 196

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------DLKF---- 232
           ++  + +   VDIWS+G +  E + G   F+  +H D  + I++V        ++     
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256

Query: 233 ------------PPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
                         K         S  A +L+ +MLV D+ QR+   + L HP+     D
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316

Query: 275 PS 276
             
Sbjct: 317 TE 318

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  134 bits (339), Expect = 2e-37
 Identities = 68/314 (21%), Positives = 118/314 (37%), Gaps = 75/314 (23%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR---------- 64
           ++ ++    +G+G FG V+ AR +++   VALK              ++           
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--------------KVLMENEKEGFPI 61

Query: 65  ---REVEIQSHLRHPNILRLYG--------YFYDQKRVYLILEYAAKGELYKELQKCKY- 112
              RE++I   L+H N++ L          Y   +  +YL+ ++    +L   L      
Sbjct: 62  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK 120

Query: 113 FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFG----WSVHTFN 168
           F+       +  L   L Y H   ++HRD+K  N+LI   G LK+ADFG    +S+   +
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180

Query: 169 RRRTMCG---TLDYLPPEMV-ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRR 224
           +         TL Y PPE++    ++   +D+W  G +  E     P  +          
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240

Query: 225 IVQV-------------------DLKFP-----------PKPIVSSAAKDLISQMLVKDS 254
           I Q+                    L+                +    A DLI ++LV D 
Sbjct: 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 300

Query: 255 SQRLPLHKLLEHPW 268
           +QR+     L H +
Sbjct: 301 AQRIDSDDALNHDF 314

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  134 bits (339), Expect = 3e-37
 Identities = 80/304 (26%), Positives = 128/304 (42%), Gaps = 53/304 (17%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL--FKSQLQQSQVEHQLR--REVEIQSHL 73
           +     +G G +G V  A +  +   VA+K +  F+ Q       +  R  RE++I    
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT------YCQRTLREIKILLRF 82

Query: 74  RHPNILRLYGYFY-----DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           RH NI+ +            K VY++ +     +LYK L K ++ S      ++  + R 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL-KTQHLSNDHICYFLYQILRG 140

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL------PP 182
           L Y H  +V+HRD+KP NLL+    +LKI DFG +              +Y+       P
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

Query: 183 E-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------DLKF-- 232
           E M+ S  +  ++DIWS+G +  E L   P F  K + D    I+ +       DL    
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260

Query: 233 --------------PPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN 272
                            P         S A DL+ +ML  +  +R+ + + L HP++ Q 
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

Query: 273 ADPS 276
            DPS
Sbjct: 321 YDPS 324

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  132 bits (334), Expect = 5e-37
 Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 31/223 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
               + +   RG+FG V+ A+    N  VA+K+      Q  Q E     EV     ++H
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNE----YEVYSLPGMKH 77

Query: 76  PNILRLYGY----FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
            NIL+  G           ++LI  +  KG L   L+     S         ++AR L Y
Sbjct: 78  ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAY 136

Query: 132 CHGK----------HVIHRDIKPENLLIGAQGELKIADFGWSV-----HTFNRRRTMCGT 176
            H             + HRDIK +N+L+       IADFG ++      +        GT
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196

Query: 177 LDYLPPEMVE---SVEHDAN--VDIWSLGVLCYEFLYGVPPFE 214
             Y+ PE++E   + + DA   +D++++G++ +E        +
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  133 bits (336), Expect = 7e-37
 Identities = 83/300 (27%), Positives = 130/300 (43%), Gaps = 49/300 (16%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLR--REVEIQSH 72
           +    P+G G +G V  A + ++   VA+K L   F+S +      H  R  RE+ +  H
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII------HAKRTYRELRLLKH 84

Query: 73  LRHPNILRLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
           ++H N++ L   F   +       VYL+       +L   + KC+  ++      +  + 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV-KCQKLTDDHVQFLIYQIL 142

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MV 185
           R L Y H   +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIML 202

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------DLKF------ 232
             + ++  VDIWS+G +  E L G   F   +H D  + I+++        LK       
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262

Query: 233 ----------PPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                     P           +  A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  130 bits (329), Expect = 1e-36
 Identities = 34/243 (13%), Positives = 66/243 (27%), Gaps = 31/243 (12%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNIL 79
           +    G       + A +   +  VAL  +    +    V  +        S +  P + 
Sbjct: 35  LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 80  RLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIH 139
           R+    + +    ++ E+   G L +        S   A   + SLA A    H   V  
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVAL 152

Query: 140 RDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSL 199
               P  + +   G++ +A                     +P         +   DI  +
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPA-----------------TMPDA-------NPQDDIRGI 188

Query: 200 GVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKP-----IVSSAAKDLISQMLVKDS 254
           G   Y  L    P              +     P +P      +      + ++ +  D 
Sbjct: 189 GASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDG 248

Query: 255 SQR 257
             R
Sbjct: 249 GIR 251

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  130 bits (330), Expect = 3e-36
 Identities = 73/320 (22%), Positives = 118/320 (36%), Gaps = 77/320 (24%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALK-VLFKSQLQQSQVEHQLR--REVEIQSHLR 74
           +   KPLG G  G V+ A +   +  VA+K ++                 RE++I   L 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ------SVKHALREIKIIRRLD 66

Query: 75  HPNILRLY--------------GYFYDQKRVYLILEYA--------AKGELYKELQKCKY 112
           H NI++++              G   +   VY++ EY          +G L +E    + 
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE--HARL 124

Query: 113 FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWSVHTFNRRR 171
           F       Y   L R L Y H  +V+HRD+KP NL I  +   LKI DFG +        
Sbjct: 125 F------MY--QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 172 TMCGTLDYL------PPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRR 224
                 + L       P  ++    +   +D+W+ G +  E L G   F      +  + 
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236

Query: 225 IVQV-------DLKF---------------PPKPI------VSSAAKDLISQMLVKDSSQ 256
           I++        D +                P KP+      +S  A D + Q+L      
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296

Query: 257 RLPLHKLLEHPWIIQNADPS 276
           RL   + L HP++   + P 
Sbjct: 297 RLTAEEALSHPYMSIYSFPM 316

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  131 bits (332), Expect = 3e-36
 Identities = 82/319 (25%), Positives = 128/319 (40%), Gaps = 75/319 (23%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL--FKSQLQQSQVEHQLR--REVEIQSHL 73
           F +   LG G +G V  A  K +  IVA+K +  F   L        LR  RE++I  H 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL------FALRTLREIKILKHF 66

Query: 74  RHPNILRLYGYFYDQKR-----VYLILEYAAKGELYKELQK-------CKYFSERRAATY 121
           +H NI+ ++             VY+I E     +L++ +          +YF       Y
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYF------IY 119

Query: 122 VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD--- 178
                RA+   HG +VIHRD+KP NLLI +  +LK+ DFG +                  
Sbjct: 120 --QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 179 ----------YLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ 227
                     Y  PE M+ S ++   +D+WS G +  E     P F  +++      I  
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237

Query: 228 V--------DLKF----------------PPKPI------VSSAAKDLISQMLVKDSSQR 257
           +        DL+                 P  P+      V+    DL+ +MLV D ++R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297

Query: 258 LPLHKLLEHPWIIQNADPS 276
           +   + LEHP++    DP+
Sbjct: 298 ITAKEALEHPYLQTYHDPN 316

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  131 bits (330), Expect = 3e-36
 Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 32/228 (14%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
                + K +G+G++G V++ + +     VA+KV F ++      E     E+     +R
Sbjct: 36  AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRE----TEIYQTVLMR 89

Query: 75  HPNILRLYGY----FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           H NIL              ++YLI +Y   G LY  L+       +       S    L 
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLC 148

Query: 131 YCHGK--------HVIHRDIKPENLLIGAQGELKIADFGWSV-------HTFNRRRTMCG 175
           + H +         + HRD+K +N+L+   G   IAD G +V              T  G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 176 TLDYLPPEMVESVEHDAN------VDIWSLGVLCYEFLYGVPPFEAKE 217
           T  Y+PPE+++   +  +       D++S G++ +E           E
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  129 bits (327), Expect = 4e-36
 Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 36/228 (15%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ--SHLR 74
           D  + + +G+G++G V+    +     VA+K+        S+ E    RE E+     LR
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQ--GENVAVKIFS------SRDEKSWFRETELYNTVMLR 60

Query: 75  HPNILRLYGY----FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           H NIL          +   +++LI  Y   G LY  LQ             V S+A  L 
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLA 119

Query: 131 YCHGKH--------VIHRDIKPENLLIGAQGELKIADFGWSV-------HTFNRRRTMCG 175
           + H +         + HRD+K +N+L+   G+  IAD G +V                 G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 176 TLDYLPPEM------VESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE 217
           T  Y+ PE+      V+  +    VDIW+ G++ +E    +      E
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  131 bits (331), Expect = 4e-36
 Identities = 79/322 (24%), Positives = 131/322 (40%), Gaps = 74/322 (22%)

Query: 5   VSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR 64
            +A E+ R  ++ F + +  G+G FG V L +EK +   VA+K +            + R
Sbjct: 12  AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI------QDPRFRNR 65

Query: 65  --REVEIQSHLRHPNILRLYGYFY-----DQKRVYL--ILEY-----------AAKGELY 104
             + ++  + L HPNI++L  YFY     D++ +YL  ++EY             + ++ 
Sbjct: 66  ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA 125

Query: 105 KELQKCKYFSERRAATYVASLARALIYCHGK--HVIHRDIKPENLLI-GAQGELKIADFG 161
                 K F       +   L R++   H    +V HRDIKP N+L+  A G LK+ DFG
Sbjct: 126 PPPILIKVF------LF--QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177

Query: 162 WSVHTFNRRRTM----CGTLDYLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAK 216
            S    +         C +  Y  PE +  +  +   VDIWS+G +  E + G P F   
Sbjct: 178 -SAKKLSPSEPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235

Query: 217 EHSDTYRRIVQV-----------------DLKFPPK-------------PIVSSAAKDLI 246
             +     IV+V                 D+                     +  A DL+
Sbjct: 236 NSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295

Query: 247 SQMLVKDSSQRLPLHKLLEHPW 268
           S +L     +R+  ++ L HP+
Sbjct: 296 SALLQYLPEERMKPYEALCHPY 317

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  128 bits (324), Expect = 3e-35
 Identities = 49/228 (21%), Positives = 90/228 (39%), Gaps = 32/228 (14%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
                + + +G+G+FG V+  + +     VA+K+    + +    E     E+     LR
Sbjct: 41  ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFRE----AEIYQTVMLR 94

Query: 75  HPNILRLYG----YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           H NIL              +++L+ +Y   G L+  L +    +         S A  L 
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLA 153

Query: 131 YCHGKH--------VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM-------CG 175
           + H +         + HRD+K +N+L+   G   IAD G +V   +   T+        G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213

Query: 176 TLDYLPPEMVES------VEHDANVDIWSLGVLCYEFLYGVPPFEAKE 217
           T  Y+ PE+++        E     DI+++G++ +E           E
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  130 bits (328), Expect = 5e-35
 Identities = 76/313 (24%), Positives = 133/313 (42%), Gaps = 64/313 (20%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLR--REVEIQSH 72
           +   KP+G G  G V  A +   +  VA+K L   F++Q       H  R  RE+ +   
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT------HAKRAYRELVLMKC 117

Query: 73  LRHPNILRLYGYFY------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
           + H NI+ L   F       + + VYL++E      L + +Q        R +  +  + 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQML 174

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG---TLDYLPPE 183
             + + H   +IHRD+KP N+++ +   LKI DFG +  T      M     T  Y  PE
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVVTRYYRAPE 233

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------DLKF---- 232
           ++  + +  NVDIWS+G +  E +     F  +++ D + ++++         +K     
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293

Query: 233 -----------PPKP------------------IVSSAAKDLISQMLVKDSSQRLPLHKL 263
                                            + +S A+DL+S+MLV D ++R+ +   
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353

Query: 264 LEHPWIIQNADPS 276
           L+HP+I    DP+
Sbjct: 354 LQHPYINVWYDPA 366

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  127 bits (322), Expect = 8e-35
 Identities = 65/316 (20%), Positives = 108/316 (34%), Gaps = 69/316 (21%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE------HQLR--REVEI 69
           + + + +  G +G V    +      VA+K +F +      V          R  RE+ +
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 70  QSHLRHPNILRLYGYFYDQKR-----VYLILEY----------AAKGELYKELQKCKYFS 114
            +H  HPNIL L   F   +      +YL+ E             +  +    Q  +YF 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI--SPQHIQYF- 139

Query: 115 ERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC 174
                 Y   +   L   H   V+HRD+ P N+L+    ++ I DF  +           
Sbjct: 140 -----MY--HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA-REDTADANKT 191

Query: 175 G---TLDYLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-- 228
                  Y  PE +++       VD+WS G +  E       F      +   +IV+V  
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251

Query: 229 -----DLKF-----------------PPKPI------VSSAAKDLISQMLVKDSSQRLPL 260
                D+                   P +            A DLI++ML  +  +R+  
Sbjct: 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311

Query: 261 HKLLEHPWIIQNADPS 276
            + L HP+     DP 
Sbjct: 312 EQALRHPYFESLFDPL 327

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  127 bits (321), Expect = 1e-34
 Identities = 75/342 (21%), Positives = 123/342 (35%), Gaps = 101/342 (29%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSHLRH 75
           + +GK LG G FG V    +  S    ALK +          +      RE++I   L H
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL---------QDPRYKNRELDIMKVLDH 59

Query: 76  PNILRLYGYFY--------------------------------------DQKRVYLILEY 97
            NI++L  YFY                                        K + +I+EY
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 98  -----------AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPEN 146
                        +      +     +       Y   L RA+ + H   + HRDIKP+N
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIY------IY--QLFRAVGFIHSLGICHRDIKPQN 171

Query: 147 LLIGAQ-GELKIADFGWSVHTFNRRRTMCG---TLDYLPPE-MVESVEHDANVDIWSLGV 201
           LL+ ++   LK+ DFG S               +  Y  PE M+ + E+  ++D+WS+G 
Sbjct: 172 LLVNSKDNTLKLCDFG-SAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230

Query: 202 LCYEFLYGVPPFEAKEHSDTYRRIVQV-----------------DLKFPPKPIVS----- 239
           +  E + G P F  +   D   RI+Q+                 +++FP           
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290

Query: 240 -----SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                S A DL+ Q+L  +   R+  ++ + HP+     +  
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSY 332

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  127 bits (320), Expect = 2e-34
 Identities = 84/324 (25%), Positives = 135/324 (41%), Gaps = 78/324 (24%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLR--REVE 68
            L  +   KP+G G  G V  A +      VA+K L   F++Q       H  R  RE+ 
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT------HAKRAYRELV 76

Query: 69  IQSHLRHPNILRLYGYFYDQKR------VYLILEYAA-------KGELYKELQKCKYFSE 115
           +   + H NI+ L   F  QK       VY+++E          + EL  E  +  Y   
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE--RMSYL-- 132

Query: 116 RRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG 175
                Y   +   + + H   +IHRD+KP N+++ +   LKI DFG +  T      M  
Sbjct: 133 ----LY--QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTP 185

Query: 176 ---TLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV---- 228
              T  Y  PE++  + +  NVDIWS+G +  E + G   F   +H D + ++++     
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245

Query: 229 ---DLKF---------------PPKP------------------IVSSAAKDLISQMLVK 252
               +K                                      + +S A+DL+S+MLV 
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305

Query: 253 DSSQRLPLHKLLEHPWIIQNADPS 276
           D+S+R+ + + L+HP+I    DPS
Sbjct: 306 DASKRISVDEALQHPYINVWYDPS 329

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  124 bits (314), Expect = 6e-34
 Identities = 54/243 (22%), Positives = 87/243 (35%), Gaps = 43/243 (17%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ--SH 72
           L++  + + +GRG++G VY          VA+KV                 E  I     
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFS------FANRQNFINEKNIYRVPL 63

Query: 73  LRHPNILRLYGY-----FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
           + H NI R            +    L++EY   G L K L          +     S+ R
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTR 122

Query: 128 ALIYCHGKH---------VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR------- 171
            L Y H +          + HRD+   N+L+   G   I+DFG S+     R        
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 172 ----TMCGTLDYLPPEMVESV-------EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD 220
               +  GT+ Y+ PE++E              VD+++LG++ +E           E   
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242

Query: 221 TYR 223
            Y+
Sbjct: 243 EYQ 245

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  124 bits (312), Expect = 7e-33
 Identities = 71/357 (19%), Positives = 126/357 (35%), Gaps = 102/357 (28%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR--REVEIQSHLRH 75
           ++I   +G G +GHV  A +K    +VA+K   K       +    R  RE+ I + L H
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRLNH 111

Query: 76  PNILRLY-----GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
            +++++              +Y++LE A   +  K  +   Y +E    T + +L   + 
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVK 170

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFG---------------------------WS 163
           Y H   ++HRD+KP N L+     +K+ DFG                             
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 164 VHTFNRRRTMCG---TLDYLPPE-MVESVEHDANVDIWSLG-----------VLCYEFLY 208
            HT N +R + G   T  Y  PE ++    +   +D+WS+G                   
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

Query: 209 GVPPF--------------------EAKEHSDTYRRIVQV-------DL----------- 230
             P F                      + + D    I  +       D+           
Sbjct: 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350

Query: 231 --KFPPK---------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              FP +         P  S+ A  L+ +MLV + ++R+ +++ L HP+  +     
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  121 bits (305), Expect = 4e-32
 Identities = 66/317 (20%), Positives = 118/317 (37%), Gaps = 73/317 (23%)

Query: 20  IGKPLGRGKFGHVYLAREK--RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
            G  +GRG +GHVY A+ K  + +   ALK +  + +  S       RE+ +   L+HPN
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLRELKHPN 79

Query: 78  ILRLYGYFYDQ--KRVYLILEYA--------AKGELYKELQKCKYFSERRAATYVASLAR 127
           ++ L   F     ++V+L+ +YA              K  +K          + +  +  
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 128 ALIYCHGKHVIHRDIKPENLLIGA----QGELKIADFGWS------VHTFNRRRTMCGTL 177
            + Y H   V+HRD+KP N+L+      +G +KIAD G++      +        +  T 
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 178 DYLPPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD------- 229
            Y  PE ++ +  +   +DIW++G +  E L   P F  ++           D       
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259

Query: 230 -----------------------LKFPP---------------KPIVSSAAKDLISQMLV 251
                                    F                 K    S A  L+ ++L 
Sbjct: 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 319

Query: 252 KDSSQRLPLHKLLEHPW 268
            D  +R+   + ++ P+
Sbjct: 320 MDPIKRITSEQAMQDPY 336

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  120 bits (302), Expect = 7e-32
 Identities = 65/232 (28%), Positives = 102/232 (43%), Gaps = 11/232 (4%)

Query: 5   VSAKEKKRWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQ 62
             A  K +W LN  D  +G+ +GRG FG V+  R +  N +VA+K   +  L        
Sbjct: 101 HRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKF 159

Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATY 121
           L+ E  I     HPNI+RL G    ++ +Y+++E    G+    L+        +     
Sbjct: 160 LQ-EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM 218

Query: 122 VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP 181
           V   A  + Y   K  IHRD+   N L+  +  LKI+DFG S    +      G L  +P
Sbjct: 219 VGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP 278

Query: 182 -----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
                PE +    + +  D+WS G+L +E F  G  P+    +  T   + +
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  120 bits (302), Expect = 8e-32
 Identities = 73/344 (21%), Positives = 134/344 (38%), Gaps = 100/344 (29%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLR--REVEIQSH 72
           +++ K LG+G +G V+ + ++R+  +VA+K +   F++           R  RE+ I + 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST------DAQRTFREIMILTE 64

Query: 73  LR-HPNILRLYGYFY--DQKRVYLILEYAAKGELYK-------ELQKCKYFSERRAATYV 122
           L  H NI+ L       + + VYL+ +Y    +L+        E    +Y        Y 
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV------VY- 116

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFG--------------WSVHTFN 168
             L + + Y H   ++HRD+KP N+L+ A+  +K+ADFG                +    
Sbjct: 117 -QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 169 RRRTMCGTLDYL----------PPE-MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE 217
                      L           PE ++ S ++   +D+WSLG +  E L G P F    
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235

Query: 218 HSDTYRRIVQV-------DLKF-------------------------------------- 232
             +   RI+ V       D++                                       
Sbjct: 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI 295

Query: 233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
            PK   +  A DL+ ++L  + ++R+  +  L+HP++    +P+
Sbjct: 296 NPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  114 bits (288), Expect = 2e-30
 Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 42/242 (17%)

Query: 10  KKRWTLNDFDI---GKPLGRGKFGHVYLAREKRSNHI--VALKVLFKSQLQQSQVEHQLR 64
            K   L+   +    K LG G FG V     +    +  VA+K+L K++     ++ +L 
Sbjct: 8   PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELL 66

Query: 65  REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS 124
            E  +   L +P I+R+ G   + +   L++E A  G L K LQ+ ++  ++     V  
Sbjct: 67  AEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY----- 179
           ++  + Y    + +HRD+   N+L+  Q   KI+DFG S       + +    +Y     
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS-------KALRADENYYKAQT 178

Query: 180 ---LP-----PEMV-------ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYR 223
               P     PE +       +S       D+WS GVL +E F YG  P+   + S+   
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 231

Query: 224 RI 225
            +
Sbjct: 232 ML 233

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  117 bits (295), Expect = 3e-30
 Identities = 56/235 (23%), Positives = 104/235 (44%), Gaps = 13/235 (5%)

Query: 2   CSEVSAKEKKRWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV 59
                +    +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++  + 
Sbjct: 204 TIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE- 262

Query: 60  EHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC--KYFSERR 117
                +E  +   ++HPN+++L G    +   Y+I E+   G L   L++C  +  S   
Sbjct: 263 ---FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 319

Query: 118 AATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTM 173
                  ++ A+ Y   K+ IHR++   N L+G    +K+ADFG S      T+      
Sbjct: 320 LLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 379

Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
              + +  PE +   +     D+W+ GVL +E   YG+ P+   + S  Y  + +
Sbjct: 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  116 bits (292), Expect = 5e-30
 Identities = 69/352 (19%), Positives = 121/352 (34%), Gaps = 100/352 (28%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL---FKSQLQQSQVEHQLR--REVEIQSH 72
           + I   +GRG +G+VYLA +K +   VA+K +   F+  +         R  RE+ I + 
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI------DCKRILREITILNR 81

Query: 73  LRHPNILRLYGYFYDQKR-----VYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR 127
           L+   I+RLY             +Y++LE A   +L K  +   + +E    T + +L  
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL 140

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD--------- 178
              + H   +IHRD+KP N L+     +K+ DFG +    + + T               
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200

Query: 179 ----------------YLPPE-MVESVEHDANVDIWSLG--------------------- 200
                           Y  PE ++    +  ++DIWS G                     
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260

Query: 201 -------VLCYEFLYGVPPFEAKEHSDTYRRIVQV-------DLKF-------------- 232
                                 K + D    I  +       DLK               
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP 320

Query: 233 --PPKPI------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
              P  +      +S    +L+  ML  + ++R+ + + L+HP++       
Sbjct: 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  111 bits (280), Expect = 5e-29
 Identities = 53/235 (22%), Positives = 101/235 (42%), Gaps = 26/235 (11%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSN---HIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
             F +G+ LG+G+FG V  A+ K+ +     VA+K+L    +  S +E +  RE      
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFLREAACMKE 81

Query: 73  LRHPNILRLYG------YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAAT------ 120
             HP++ +L G               +IL +   G+L+  L   +               
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLD 178
           ++  +A  + Y   ++ IHRD+   N ++     + +ADFG S  +++ +  R  C +  
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK- 200

Query: 179 YLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
            LP      E +    +  + D+W+ GV  +E    G  P+   E+++ Y  ++ 
Sbjct: 201 -LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  109 bits (274), Expect = 2e-28
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 29/228 (12%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
            D  +   LG G++G VY    K+ +  VA+K L K   + +    +  +E  +   ++H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-K---EDTMEVEEFLKEAAVMKEIKH 68

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCH 133
           PN+++L G    +   Y+I E+   G L   L++C  +  S          ++ A+ Y  
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWS-VHTFNRRRTMCGTLDYLP-----PEM--- 184
            K+ IHRD+   N L+G    +K+ADFG S + T +      G     P     PE    
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK--FPIKWTAPESLAY 186

Query: 185 ----VESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
               ++S       D+W+ GVL +E   YG+ P+   + S  Y  + +
Sbjct: 187 NKFSIKS-------DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (275), Expect = 3e-28
 Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 18/223 (8%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
            +F   K LG G FG VY        ++    VA+K L ++   ++  E  +  E  + +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE--ILDEAYVMA 72

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALI 130
            + +P++ RL G       V LI +    G L   +++ K     +    +   +A+ + 
Sbjct: 73  SVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLP-----PE 183
           Y   + ++HRD+   N+L+     +KI DFG +  +    +     G    +P      E
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK--VPIKWMALE 189

Query: 184 MVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
            +    +    D+WS GV  +E   +G  P++    S+    +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  106 bits (268), Expect = 2e-27
 Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 15/221 (6%)

Query: 20  IGKPLGRGKFGHVYLAREKRSN---HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
             + +GRG FG VY      ++      A+K L        +V  Q   E  I     HP
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVS-QFLTEGIIMKDFSHP 86

Query: 77  NILRLYGY-FYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
           N+L L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + Y   
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLP-----PEMVES 187
           K  +HRD+   N ++  +  +K+ADFG +  ++          T   LP      E +++
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206

Query: 188 VEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
            +     D+WS GVL +E    G PP+      D    ++Q
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  106 bits (268), Expect = 2e-27
 Identities = 45/229 (19%), Positives = 84/229 (36%), Gaps = 23/229 (10%)

Query: 20  IGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + + LG+G FG VY        +      VA+K +        +   +   E  +     
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERI-EFLNEASVMKEFN 86

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL--------- 125
             +++RL G     +   +I+E   +G+L   L+  +            SL         
Sbjct: 87  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146

Query: 126 -ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP--- 181
            A  + Y +    +HRD+   N ++     +KI DFG +   +       G    LP   
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 182 --PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
             PE ++        D+WS GV+ +E       P++   +    R +++
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  106 bits (266), Expect = 4e-27
 Identities = 50/249 (20%), Positives = 101/249 (40%), Gaps = 27/249 (10%)

Query: 3   SEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAREKRSN---HIVALKVLFKSQLQQS 57
           SE    + +   +  N   +GK LG G+FG V     K+ +     VA+K + K      
Sbjct: 19  SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQ 77

Query: 58  QVEHQLRREVEIQSHLRHPNILRLYG-----YFYDQKRVYLILEYAAKGELYKELQKCKY 112
           +   +   E        HPN++RL G           +  +IL +   G+L+  L   + 
Sbjct: 78  REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL 137

Query: 113 FSERRAAT------YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--V 164
            +  +         ++  +A  + Y   ++ +HRD+   N ++     + +ADFG S  +
Sbjct: 138 ETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197

Query: 165 HTFNRRRTMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEH 218
           ++ +  R        +P      E +    + +  D+W+ GV  +E    G+ P+   ++
Sbjct: 198 YSGDYYRQGRIAK--MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255

Query: 219 SDTYRRIVQ 227
            + Y  ++ 
Sbjct: 256 HEMYDYLLH 264

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  105 bits (265), Expect = 7e-27
 Identities = 54/246 (21%), Positives = 89/246 (36%), Gaps = 43/246 (17%)

Query: 7   AKEKKRWTLN--DFDIGKPLGRGKFGHVYLAR---EKRSNHIVALKVLFKSQLQQSQVEH 61
           A       +      I K +G G  G V   R     + +  VA+K L     ++ + + 
Sbjct: 38  AGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD- 96

Query: 62  QLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAAT 120
               E  I     HPNI+RL G     +   ++ EY   G L   L+     F+  +   
Sbjct: 97  -FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG 155

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY- 179
            +  +   + Y      +HRD+   N+L+ +    K++DFG S       R +    D  
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS-------RVLEDDPDAA 208

Query: 180 -------LP-----PEMV-------ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHS 219
                  +P     PE +        S       D+WS GV+ +E   YG  P+    + 
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRTFSSAS-------DVWSFGVVMWEVLAYGERPYWNMTNR 261

Query: 220 DTYRRI 225
           D    +
Sbjct: 262 DVISSV 267

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  104 bits (262), Expect = 7e-27
 Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 41/233 (17%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           ++    + +G G+FG V+L      +  VA+K + +     +  E     E E+   L H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREG----AMSEEDFIEEAEVMMKLSH 62

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
           P +++LYG   +Q  + L+ E+   G L   L+  +  F+          +   + Y   
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYL------------PP 182
             VIHRD+   N L+G    +K++DFG +       R +     Y              P
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMT-------RFVLDD-QYTSSTGTKFPVKWASP 174

Query: 183 EMV-------ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           E+        +S       D+WS GVL +E F  G  P+E + +S+    I  
Sbjct: 175 EVFSFSRYSSKS-------DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  105 bits (263), Expect = 1e-26
 Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 18/223 (8%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
            +F   K LG G FG VY        ++    VA+K L ++   ++  E  +  E  + +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE--ILDEAYVMA 72

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALI 130
            + +P++ RL G       V LI +    G L   +++ K     +    +   +A+ + 
Sbjct: 73  SVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLP-----PE 183
           Y   + ++HRD+   N+L+     +KI DFG +  +    +     G    +P      E
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK--VPIKWMALE 189

Query: 184 MVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
            +    +    D+WS GV  +E   +G  P++    S+    +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  105 bits (265), Expect = 1e-26
 Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 15/221 (6%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHI---VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
             + +GRG FG VY      ++      A+K L        +V  Q   E  I     HP
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVS-QFLTEGIIMKDFSHP 150

Query: 77  NILRLYGY-FYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
           N+L L G     +    ++L Y   G+L   ++   +  + +    +   +A+ + +   
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLP-----PEMVES 187
           K  +HRD+   N ++  +  +K+ADFG +  ++          T   LP      E +++
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270

Query: 188 VEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
            +     D+WS GVL +E    G PP+      D    ++Q
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  104 bits (261), Expect = 1e-26
 Identities = 54/236 (22%), Positives = 101/236 (42%), Gaps = 23/236 (9%)

Query: 3   SEVSAKEKKRWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
           +      +  W LN  +  + + +G+G+FG V L   +   + VA+K +     +     
Sbjct: 6   AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-----KNDATA 58

Query: 61  HQLRREVEIQSHLRHPNILRLYGYFYDQK-RVYLILEYAAKGELYKELQKC--KYFSERR 117
                E  + + LRH N+++L G   ++K  +Y++ EY AKG L   L+           
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118

Query: 118 AATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTL 177
              +   +  A+ Y  G + +HRD+   N+L+      K++DFG +     +  +     
Sbjct: 119 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDT 173

Query: 178 DYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
             LP     PE +   +     D+WS G+L +E + +G  P+      D   R+ +
Sbjct: 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  104 bits (262), Expect = 1e-26
 Identities = 50/217 (23%), Positives = 84/217 (38%), Gaps = 30/217 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
                 + LG G FG V L         +  +VA+K L K+           ++E++I  
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRS-GWKQEIDILR 88

Query: 72  HLRHPNILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
            L H +I++  G   D     + L++EY   G L   L +       +   +   +   +
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGM 147

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY--------LP 181
            Y H +H IHRD+   N+L+     +KI DFG +       + +    +Y         P
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA-------KAVPEGHEYYRVREDGDSP 200

Query: 182 -----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPP 212
                PE ++  +     D+WS GV  YE   +    
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  104 bits (261), Expect = 2e-26
 Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 31/219 (14%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
                   LG+G FG V L R       +  +VA+K L +      Q +   +RE++I  
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRD--FQREIQILK 79

Query: 72  HLRHPNILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARA 128
            L    I++  G  Y   R  + L++EY   G L   LQ+ +      R   Y + + + 
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY--------L 180
           + Y   +  +HRD+   N+L+ ++  +KIADFG +       + +    DY         
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA-------KLLPLDKDYYVVREPGQS 192

Query: 181 P-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
           P     PE +         D+WS GV+ YE F Y     
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  103 bits (260), Expect = 2e-26
 Identities = 58/265 (21%), Positives = 104/265 (39%), Gaps = 43/265 (16%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
                 + LG G FG V L R       +   VA+K L K +   + +   L++E+EI  
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIA-DLKKEIEILR 78

Query: 72  HLRHPNILRLYGYFYDQKR--VYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARA 128
           +L H NI++  G   +     + LI+E+   G L + L K K   + ++   Y   + + 
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY--------L 180
           + Y   +  +HRD+   N+L+ ++ ++KI DFG +       + +    +Y         
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT-------KAIETDKEYYTVKDDRDS 191

Query: 181 P-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQVDLKFPP 234
           P     PE +   +     D+WS GV  +E   Y                        P 
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG--------PT 243

Query: 235 KPIVSSAAKDLISQMLVKDSSQRLP 259
              ++     L++ +      +RLP
Sbjct: 244 HGQMT--VTRLVNTL---KEGKRLP 263

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  104 bits (261), Expect = 3e-26
 Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 27/231 (11%)

Query: 20  IGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + + LG G FG VY  +        S   VA+K L +   +Q +++     E  I S   
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD--FLMEALIISKFN 91

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------AR 127
           H NI+R  G        ++++E  A G+L   L++ +    + ++  +  L       A 
Sbjct: 92  HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWS--VHTFNRRRTMCGTLDYLP- 181
              Y    H IHRDI   N L+   G     KI DFG +  ++  +  R   G    LP 
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK--GGCAMLPV 209

Query: 182 ----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
               PE        +  D WS GVL +E F  G  P+ +K + +    +  
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  103 bits (259), Expect = 3e-26
 Identities = 62/244 (25%), Positives = 89/244 (36%), Gaps = 42/244 (17%)

Query: 9   EKKRWTLN--DFDIGKPLGRGKFGHVYLA--REKRSNHI-VALKVLFKSQLQQSQVEHQL 63
           +     +   D  + + LG G FG V            + VA+K L    L Q +     
Sbjct: 9   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 68

Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYV 122
            REV     L H N++RLYG       + ++ E A  G L   L+K +  F     + Y 
Sbjct: 69  IREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY--- 179
             +A  + Y   K  IHRD+   NLL+  +  +KI DFG         R +    D+   
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM-------RALPQNDDHYVM 180

Query: 180 ----------LPPEMV-------ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDT 221
                       PE +        S       D W  GV  +E F YG  P+     S  
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHAS-------DTWMFGVTLWEMFTYGQEPWIGLNGSQI 233

Query: 222 YRRI 225
             +I
Sbjct: 234 LHKI 237

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  104 bits (262), Expect = 3e-26
 Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 30/237 (12%)

Query: 7   AKEKKRWTLNDFDIGKPLGRGKFGHVYLAR---EKRSNHIVALKVLFKSQLQQSQVEHQL 63
           AKE       +  I K +G G+FG V   R     +    VA+K L     ++ + +   
Sbjct: 39  AKELDA---TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD--F 93

Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYV 122
             E  I     HPNI+RL G     K V ++ EY   G L   L+K    F+  +    +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY--- 179
             +A  + Y      +HRD+   N+LI +    K++DFG         R +    +    
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG-------RVLEDDPEAAYT 206

Query: 180 -----LP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
                +P     PE +   +  +  D+WS G++ +E   YG  P+    + D  + +
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  106 bits (265), Expect = 4e-26
 Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 17/229 (7%)

Query: 9   EKKRWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE 66
            K  W +      +   LG+G FG V++         VA+K L       +       +E
Sbjct: 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPG----TMSPEAFLQE 312

Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVAS 124
            ++   LRH  +++LY     ++ +Y++ EY +KG L   L+    KY    +     A 
Sbjct: 313 AQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLP--- 181
           +A  + Y    + +HRD++  N+L+G     K+ADFG +    +   T        P   
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKW 430

Query: 182 --PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
             PE           D+WS G+L  E    G  P+    + +   ++ +
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  102 bits (256), Expect = 5e-26
 Identities = 51/232 (21%), Positives = 95/232 (40%), Gaps = 39/232 (16%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
            +  + K LG G+FG V L + K   + VA+K++ +     S  E +  +E +    L H
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEG----SMSEDEFFQEAQTMMKLSH 62

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           P +++ YG    +  +Y++ EY + G L   L+         +       +   + +   
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY------LP-----PE 183
              IHRD+   N L+     +K++DFG +       R +             P     PE
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMT-------RYVLDDQYVSSVGTKFPVKWSAPE 175

Query: 184 MV-------ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           +        +S       D+W+ G+L +E F  G  P++   +S+   ++ Q
Sbjct: 176 VFHYFKYSSKS-------DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  102 bits (257), Expect = 5e-26
 Identities = 52/223 (23%), Positives = 96/223 (43%), Gaps = 19/223 (8%)

Query: 20  IGKPLGRGKFGHVYLAR---EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
             + +G+G FG VY      + ++    A+K L     +  QVE    RE  +   L HP
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVE-AFLREGLLMRGLNHP 82

Query: 77  NILRLYGYFYDQK-RVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
           N+L L G     +   +++L Y   G+L + ++  +   + +   ++   +AR + Y   
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWS--VHT--FNRRRTMCGTLDYLP-----PEMV 185
           +  +HRD+   N ++     +K+ADFG +  +    +   +        LP      E +
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR--LPVKWTALESL 200

Query: 186 ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           ++       D+WS GVL +E    G PP+   +  D    + Q
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  104 bits (262), Expect = 6e-26
 Identities = 60/236 (25%), Positives = 116/236 (49%), Gaps = 16/236 (6%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL--FKSQLQQSQVE----HQLRREVEIQS 71
           +++ K +G+G FG V  A + + +  VALK++   K   +Q+  E      LR++ +  +
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARAL 129
                N++ +   F  +  + +  E  +   LY+ ++K K+  FS      +  S+ + L
Sbjct: 159 M----NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 130 IYCHGKHVIHRDIKPENLLIGAQG--ELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES 187
              H   +IH D+KPEN+L+  QG   +K+ DFG S +   R  T   +  Y  PE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILG 273

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
             +   +D+WSLG +  E L G P    ++  D    ++++ L  P + ++ ++ +
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL-LGMPSQKLLDASKR 328

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  102 bits (256), Expect = 6e-26
 Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 41/233 (17%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
            D    K LG G+FG V   +  R  + VA+K++ +     S  E +   E ++  +L H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEG----SMSEDEFIEEAKVMMNLSH 78

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHG 134
             +++LYG    Q+ +++I EY A G L   L++ ++ F  ++       +  A+ Y   
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY-------LP-----P 182
           K  +HRD+   N L+  QG +K++DFG S       R +    +Y        P     P
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLS-------RYVLDD-EYTSSVGSKFPVRWSPP 190

Query: 183 EM-------VESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           E+        +S       DIW+ GVL +E +  G  P+E   +S+T   I Q
Sbjct: 191 EVLMYSKFSSKS-------DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (262), Expect = 6e-26
 Identities = 52/232 (22%), Positives = 93/232 (40%), Gaps = 15/232 (6%)

Query: 3   SEVSAKEKKRWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE 60
            +     K  W +      +   LG+G FG V++         VA+K L       +   
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPG----TMSP 223

Query: 61  HQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC--KYFSERRA 118
               +E ++   LRH  +++LY     ++ +Y++ EY +KG L   L+    KY    + 
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282

Query: 119 ATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLD 178
               A +A  + Y    + +HRD++  N+L+G     K+ADFG +    +   T      
Sbjct: 283 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 342

Query: 179 Y----LPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           +      PE           D+WS G+L  E    G  P+    + +   ++
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  102 bits (256), Expect = 7e-26
 Identities = 59/243 (24%), Positives = 95/243 (39%), Gaps = 44/243 (18%)

Query: 9   EKKRWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHI---VALKVLFKSQLQQSQVEHQL 63
              ++ +   D  + + LG G FG VY             VA+K   K        E  +
Sbjct: 3   GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFM 61

Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYV 122
             E  I  +L HP+I++L G   +++  ++I+E    GEL   L++ K          Y 
Sbjct: 62  S-EAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS 119

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY--- 179
             + +A+ Y    + +HRDI   N+L+ +   +K+ DFG S       R +    DY   
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS-------RYIEDE-DYYKA 171

Query: 180 ----LP-----PEMV-------ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTY 222
               LP     PE +        S       D+W   V  +E   +G  PF   E+ D  
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTAS-------DVWMFAVCMWEILSFGKQPFFWLENKDVI 224

Query: 223 RRI 225
             +
Sbjct: 225 GVL 227

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  105 bits (264), Expect = 8e-26
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 28/227 (12%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR---EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
              ++G+ +G G+FG V+       +     VA+K          + +    +E      
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQ 447

Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIY 131
             HP+I++L G    +  V++I+E    GEL   LQ  K+         Y   L+ AL Y
Sbjct: 448 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY-------LP--- 181
              K  +HRDI   N+L+ +   +K+ DFG S       R M  +  Y       LP   
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDS-TYYKASKGKLPIKW 558

Query: 182 --PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
             PE +      +  D+W  GV  +E  ++GV PF+  +++D   RI
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  102 bits (256), Expect = 8e-26
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 31/223 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
                 + LG+G FG V + R    +  +  +VA+K L  S  +  +      RE+EI  
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILK 66

Query: 72  HLRHPNILRLYG--YFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARA 128
            L+H NI++  G  Y   ++ + LI+EY   G L   LQK K      +   Y + + + 
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY--------L 180
           + Y   K  IHRD+   N+L+  +  +KI DFG +       + +    ++         
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT-------KVLPQDKEFFKVKEPGES 179

Query: 181 P-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKE 217
           P     PE +   +     D+WS GV+ YE F Y         
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 222

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  103 bits (259), Expect = 9e-26
 Identities = 61/231 (26%), Positives = 93/231 (40%), Gaps = 27/231 (11%)

Query: 20  IGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + + LG G FG VY  +        S   VA+K L +   +Q +++     E  I S   
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD--FLMEALIISKFN 132

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------AR 127
           H NI+R  G        +++LE  A G+L   L++ +    + ++  +  L       A 
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWS--VHTFNRRRTMCGTLDYLP- 181
              Y    H IHRDI   N L+   G     KI DFG +  ++     R   G    LP 
Sbjct: 193 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK--GGCAMLPV 250

Query: 182 ----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
               PE        +  D WS GVL +E F  G  P+ +K + +    +  
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (256), Expect = 1e-25
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 31/223 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
                 + LG+G FG V + R    +  +  +VA+K L  S  +  +      RE+EI  
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILK 97

Query: 72  HLRHPNILRLYG--YFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARA 128
            L+H NI++  G  Y   ++ + LI+EY   G L   LQK K      +   Y + + + 
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY--------L 180
           + Y   K  IHRD+   N+L+  +  +KI DFG +       + +    +Y         
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT-------KVLPQDKEYYKVKEPGES 210

Query: 181 P-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKE 217
           P     PE +   +     D+WS GV+ YE F Y         
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  101 bits (253), Expect = 2e-25
 Identities = 62/242 (25%), Positives = 100/242 (41%), Gaps = 44/242 (18%)

Query: 11  KRWTLN--DFDIGK-PLGRGKFGHVYLA--REKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
           K+  L   +  I    LG G FG V     R ++    VA+KVL K   +++  E  +R 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMR- 59

Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVAS 124
           E +I   L +P I+RL G     + + L++E A  G L+K L   +        A  +  
Sbjct: 60  EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY----- 179
           ++  + Y   K+ +HRD+   N+L+  +   KI+DFG S       + +     Y     
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS-------KALGADDSYYTARS 171

Query: 180 ---LP-----PEMV-------ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYR 223
               P     PE +        S       D+WS GV  +E   YG  P++  +  +   
Sbjct: 172 AGKWPLKWYAPECINFRKFSSRS-------DVWSYGVTMWEALSYGQKPYKKMKGPEVMA 224

Query: 224 RI 225
            I
Sbjct: 225 FI 226

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  103 bits (259), Expect = 2e-25
 Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 23/237 (9%)

Query: 2   CSEVSAKEKKRWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV 59
            +      +  W LN  +  + + +G+G+FG V L   +   + VA+K +     +    
Sbjct: 177 VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-----KNDAT 229

Query: 60  EHQLRREVEIQSHLRHPNILRLYGY-FYDQKRVYLILEYAAKGELYKELQKC--KYFSER 116
                 E  + + LRH N+++L G    ++  +Y++ EY AKG L   L+          
Sbjct: 230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 289

Query: 117 RAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT 176
               +   +  A+ Y  G + +HRD+   N+L+      K++DFG +     +  +    
Sbjct: 290 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQD 344

Query: 177 LDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
              LP     PE +   +     D+WS G+L +E + +G  P+      D   R+ +
Sbjct: 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  102 bits (256), Expect = 2e-25
 Identities = 65/319 (20%), Positives = 115/319 (36%), Gaps = 73/319 (22%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR----- 74
           + + LG G F  V+LA++  +N  VA+K++ +              E+++   +      
Sbjct: 23  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RG---DKVYTEAAEDEIKLLQRVNDADNT 78

Query: 75  ------HPNILRLYGYFY--DQKRVYLILEYAAKGE-LYKELQKCKY--FSERRAATYVA 123
                   +IL+L  +F       V++++ +   GE L   ++K ++             
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138

Query: 124 SLARALIYCHGK-HVIHRDIKPENLLI------GAQGELKIADFGWSVHTFNRRRTMCGT 176
            L   L Y H +  +IH DIKPEN+L+          ++KIAD G +            T
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198

Query: 177 LDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR------RIVQVDL 230
            +Y  PE++         DIWS   L +E + G   FE  E     +      +I+++  
Sbjct: 199 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 258

Query: 231 KFPPKPIVSSAAK----------------------------------------DLISQML 250
           + P   + +                                            D +S ML
Sbjct: 259 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318

Query: 251 VKDSSQRLPLHKLLEHPWI 269
             D  +R     L+ HPW+
Sbjct: 319 QLDPRKRADAGGLVNHPWL 337

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  101 bits (254), Expect = 3e-25
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 22/220 (10%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           ++F     LGRG FG VY  R      +VA+K L + + Q    E Q + EVE+ S   H
Sbjct: 30  DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVH 86

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFS-----ERRAATYVASLARALI 130
            N+LRL G+        L+  Y A G +   L++           +R    + S AR L 
Sbjct: 87  RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS-ARGLA 145

Query: 131 YCHGK---HVIHRDIKPENLLIGAQGELKIADFG-------WSVHTFNRRRTMCGTLDYL 180
           Y H      +IHRD+K  N+L+  + E  + DFG          H       + GT+ ++
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA---VRGTIGHI 202

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD 220
            PE + + +     D++  GV+  E + G   F+    ++
Sbjct: 203 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  100 bits (251), Expect = 3e-25
 Identities = 66/243 (27%), Positives = 103/243 (42%), Gaps = 44/243 (18%)

Query: 9   EKKRWTL--NDFDIGKPLGRGKFGHVY---LAREKRSNHIVALKVLFKSQLQQSQVEHQL 63
             + + +     ++G+ +G G+FG V+       +     VA+K   K+    S  E  L
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFL 64

Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYV 122
           + E        HP+I++L G    +  V++I+E    GEL   LQ  KY         Y 
Sbjct: 65  Q-EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY--- 179
             L+ AL Y   K  +HRDI   N+L+ +   +K+ DFG S       R M  +  Y   
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDS-TYYKA 174

Query: 180 ----LP-----PEMV-------ESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTY 222
               LP     PE +        S       D+W  GV  +E  ++GV PF+  +++D  
Sbjct: 175 SKGKLPIKWMAPESINFRRFTSAS-------DVWMFGVCMWEILMHGVKPFQGVKNNDVI 227

Query: 223 RRI 225
            RI
Sbjct: 228 GRI 230

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  100 bits (251), Expect = 4e-25
 Identities = 51/240 (21%), Positives = 85/240 (35%), Gaps = 42/240 (17%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHI-------VALKVLFKSQLQQSQVEHQLRREVE 68
            D    + LG+G F  ++    +            V LKVL K+    S+          
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE---SFFEAAS 64

Query: 69  IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLAR 127
           + S L H +++  YG         L+ E+   G L   L+K K   +          LA 
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGEL--------KIADFGWSVHTFNRRRTMCGTLDY 179
           A+ +     +IH ++  +N+L+  + +         K++D G S        T+    D 
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------ITVLPK-DI 176

Query: 180 L-------PPEMVESVEHDANV----DIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           L       PP   E +E+  N+    D WS G   +E    G  P  A +     +    
Sbjct: 177 LQERIPWVPP---ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  100 bits (252), Expect = 5e-25
 Identities = 44/232 (18%), Positives = 93/232 (40%), Gaps = 21/232 (9%)

Query: 7   AKEKKRWTLNDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQ 62
           A+  K     +    K LG G FG V+        +     V +KV+     +QS     
Sbjct: 7   ARIFKE---TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-- 61

Query: 63  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATY 121
           +   +     L H +I+RL G       + L+ +Y   G L   +++ +     +    +
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120

Query: 122 VASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDY 179
              +A+ + Y     ++HR++   N+L+ +  ++++ADFG +  +   +++         
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK-- 178

Query: 180 LP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
            P      E +   ++    D+WS GV  +E   +G  P+     ++    +
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  100 bits (251), Expect = 7e-25
 Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 33/236 (13%)

Query: 20  IGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           +   LG G FG V+LA       ++   +VA+K L K   + ++ +   +RE E+ + L+
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQD--FQREAELLTMLQ 101

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL--------- 125
           H +I+R +G   + + + ++ EY   G+L + L+     ++  A     +          
Sbjct: 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 126 ------ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTL 177
                 A  ++Y  G H +HRD+   N L+G    +KI DFG S  +++ +  R   G  
Sbjct: 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV--GGR 219

Query: 178 DYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
             LP     PE +   +     D+WS GV+ +E F YG  P+    +++    I Q
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  100 bits (251), Expect = 1e-24
 Identities = 65/236 (27%), Positives = 112/236 (47%), Gaps = 14/236 (5%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ---LQQSQVEHQ-LRREVEIQSHL 73
           ++I   +G+G FG V  A ++     VA+K++ K++   L Q+Q+E + L    +  + +
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEM 114

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIY 131
           ++  I+ L  +F  +  + L+ E  +   LY  L+   +   S      +   +  AL++
Sbjct: 115 KY-YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 132 CHGK--HVIHRDIKPENLLIGAQG--ELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES 187
                  +IH D+KPEN+L+       +KI DFG S     R      +  Y  PE++  
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG 232

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
           + +D  +D+WSLG +  E   G P F      D   +IV+V L  PP  I+  A K
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LGIPPAHILDQAPK 287

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 98.8 bits (247), Expect = 2e-24
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 34/237 (14%)

Query: 20  IGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + + LG G FG V+LA        +   +VA+K L K     ++ +   +RE E+ ++L+
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKD--FQREAELLTNLQ 75

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL--------- 125
           H +I++ YG   D   + ++ EY   G+L K L+     +                    
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 126 -------ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGT 176
                  A  ++Y   +H +HRD+   N L+GA   +KI DFG S  V++ +  R    T
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 177 LDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           +  LP     PE +   +     D+WS GV+ +E F YG  P+    +++    I Q
Sbjct: 196 M--LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 98.0 bits (245), Expect = 3e-24
 Identities = 58/244 (23%), Positives = 99/244 (40%), Gaps = 47/244 (19%)

Query: 20  IGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
             + LG  +FG VY               VA+K L        + E   R E  +++ L+
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE--FRHEAMLRARLQ 70

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI---- 130
           HPN++ L G     + + +I  Y + G+L++ L      S+  +     ++  AL     
Sbjct: 71  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130

Query: 131 ------------YCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGT 176
                       Y    HV+H+D+   N+L+  +  +KI+D G    V+  +  + +  +
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 177 LDYLP-----PEM-------VESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYR 223
           L  LP     PE        ++S       DIWS GV+ +E F YG+ P+    + D   
Sbjct: 191 L--LPIRWMAPEAIMYGKFSIDS-------DIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241

Query: 224 RIVQ 227
            I  
Sbjct: 242 MIRN 245

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 98.9 bits (247), Expect = 3e-24
 Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 29/237 (12%)

Query: 7   AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR-- 64
             E      +     K +G G+FG VY    K S+    + V  K+ L+    E Q    
Sbjct: 38  TTEIHP---SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDF 93

Query: 65  -REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYV 122
             E  I     H NI+RL G     K + +I EY   G L K L++    FS  +    +
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY--- 179
             +A  + Y    + +HRD+   N+L+ +    K++DFG S       R +    +    
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS-------RVLEDDPEATYT 206

Query: 180 -----LP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
                +P     PE +   +  +  D+WS G++ +E   YG  P+    + +  + I
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 99.8 bits (249), Expect = 4e-24
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 15/228 (6%)

Query: 7   AKEKKRWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR 64
             EK  W +      + K LG G+FG V++A   + +  VA+K +    +          
Sbjct: 177 PWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSV----EAFL 231

Query: 65  REVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYV 122
            E  +   L+H  +++L+     ++ +Y+I E+ AKG L   L+  +       +   + 
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLD 178
           A +A  + +   ++ IHRD++  N+L+ A    KIADFG +       +  R      + 
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350

Query: 179 YLPPEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
           +  PE +         D+WS G+L  E   YG  P+    + +  R +
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 96.9 bits (242), Expect = 5e-24
 Identities = 53/236 (22%), Positives = 94/236 (39%), Gaps = 31/236 (13%)

Query: 9   EKKRWTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRRE 66
            +  W +      + + LG G+FG V++         VA+K L +     S        E
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQG----SMSPDAFLAE 58

Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVAS 124
             +   L+H  ++RLY     Q+ +Y+I EY   G L   L+       +  +     A 
Sbjct: 59  ANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 125 LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY----- 179
           +A  + +   ++ IHRD++  N+L+      KIADFG +       R +    +Y     
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-------RLIEDN-EYTAREG 169

Query: 180 --LP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
              P     PE +         D+WS G+L  E   +G  P+    + +  + + +
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.8 bits (244), Expect = 8e-24
 Identities = 58/252 (23%), Positives = 99/252 (39%), Gaps = 55/252 (21%)

Query: 20  IGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
             + +G G FG V+ AR           +VA+K+L +      Q +   +RE  + +   
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREAALMAEFD 108

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL--------- 125
           +PNI++L G     K + L+ EY A G+L + L+     +    +    S          
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168

Query: 126 ---------------ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFN 168
                          A  + Y   +  +HRD+   N L+G    +KIADFG S  +++ +
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 169 RRRTMCGTLDYLP-----PEM-------VESVEHDANVDIWSLGVLCYE-FLYGVPPFEA 215
             +        +P     PE         ES       D+W+ GV+ +E F YG+ P+  
Sbjct: 229 YYKADGNDA--IPIRWMPPESIFYNRYTTES-------DVWAYGVVLWEIFSYGLQPYYG 279

Query: 216 KEHSDTYRRIVQ 227
             H +    +  
Sbjct: 280 MAHEEVIYYVRD 291

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 96.5 bits (241), Expect = 2e-23
 Identities = 62/219 (28%), Positives = 89/219 (40%), Gaps = 39/219 (17%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           N+FD    +G G FG VY     R    VALK       + SQ   +   E+E  S  RH
Sbjct: 39  NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRR---TPESSQGIEEFETEIETLSFCRH 94

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL---------- 125
           P+++ L G+  ++  + LI +Y   G L + L          +     S+          
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHL--------YGSDLPTMSMSWEQRLEICI 146

Query: 126 --ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS----------VHTFNRRRTM 173
             AR L Y H + +IHRD+K  N+L+      KI DFG S          + T       
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST----VVK 202

Query: 174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPP 212
            GTL Y+ PE           D++S GV+ +E L     
Sbjct: 203 -GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 30/237 (12%)

Query: 9   EKKRWTLNDFDI---GKPLGRGKFGHVYLAREKRSNHI--VALKVLFKSQLQQSQVEHQL 63
           + K+  L   ++      LG G FG V     +       VA+KVL K   +++  E  +
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM 384

Query: 64  RREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYV 122
           R E +I   L +P I+RL G     + + L++E A  G L+K L   +        A  +
Sbjct: 385 R-EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY--- 179
             ++  + Y   K+ +HR++   N+L+  +   KI+DFG S       + +     Y   
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS-------KALGADDSYYTA 495

Query: 180 -----LP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRI 225
                 P     PE +   +  +  D+WS GV  +E   YG  P++  +  +    I
Sbjct: 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 96.2 bits (240), Expect = 2e-23
 Identities = 57/271 (21%), Positives = 100/271 (36%), Gaps = 53/271 (19%)

Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQ 53
           +       E  +W     +  +GK LG G+FG V  A       +     VA+K+L K  
Sbjct: 6   SVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KEN 64

Query: 54  LQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYF 113
              S++   L  E  +   + HP++++LYG       + LI+EYA  G L   L++ +  
Sbjct: 65  ASPSELRD-LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123

Query: 114 SERRAATYVASL------------------------ARALIYCHGKHVIHRDIKPENLLI 149
                 +  +                          ++ + Y     ++HRD+   N+L+
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV 183

Query: 150 GAQGELKIADFGWSVHTFNRRRTMCGTLDY-------LP-----PEMVESVEHDANVDIW 197
               ++KI+DFG S       R +     Y       +P      E +    +    D+W
Sbjct: 184 AEGRKMKISDFGLS-------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236

Query: 198 SLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           S GVL +E    G  P+        +  +  
Sbjct: 237 SFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 96.2 bits (240), Expect = 3e-23
 Identities = 64/261 (24%), Positives = 109/261 (41%), Gaps = 38/261 (14%)

Query: 1   ACSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFK 51
             SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L  
Sbjct: 18  GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77

Query: 52  SQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC 110
              ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L+  
Sbjct: 78  DATEKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135

Query: 111 KYFSERRAATYVASL----------------ARALIYCHGKHVIHRDIKPENLLIGAQGE 154
           +      +                       AR + Y   +  IHRD+   N+L+     
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV 195

Query: 155 LKIADFGWS--VHTFNRRRTMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-F 206
           +KIADFG +  ++  +  +        LP     PE +    +    D+WS GVL +E F
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGR--LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

Query: 207 LYGVPPFEAKEHSDTYRRIVQ 227
             G  P+      + ++ + +
Sbjct: 254 TLGGSPYPGIPVEELFKLLKE 274

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 95.4 bits (238), Expect = 5e-23
 Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 42/230 (18%)

Query: 16  NDFDIGKPLGRGKFGHVYLA-----REKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           N+   GK LG G FG V  A      ++ +   VA+K+L KS     + E  L  E++I 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKE-ALMSELKIM 103

Query: 71  SHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVAS----- 124
           SHL +H NI+ L G       V +I EY   G+L   L++     E   A  +A+     
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163

Query: 125 ---------LARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCG 175
                    +A+ + +   K+ IHRD+   N+L+      KI DFG +       R +  
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA-------RDIMN 216

Query: 176 TLDY-------LP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPP 212
             +Y       LP     PE +    +    D+WS G+L +E F  G+ P
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 95.5 bits (238), Expect = 8e-23
 Identities = 66/265 (24%), Positives = 108/265 (40%), Gaps = 48/265 (18%)

Query: 2   CSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFKS 52
            SE    E  +W    +   +GKPLG G FG V +A        + +    VA+K+L   
Sbjct: 65  VSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 124

Query: 53  QLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK 111
             ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + L+  +
Sbjct: 125 ATEKDLSD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 182

Query: 112 YFSERRAATYVASL----------------ARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
                 +                       AR + Y   +  IHRD+   N+L+     +
Sbjct: 183 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM 242

Query: 156 KIADFGWSVHTFNRRRTMCGTLDY-------LP-----PEMVESVEHDANVDIWSLGVLC 203
           KIADFG +       R +     Y       LP     PE +    +    D+WS GVL 
Sbjct: 243 KIADFGLA-------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295

Query: 204 YE-FLYGVPPFEAKEHSDTYRRIVQ 227
           +E F  G  P+      + ++ + +
Sbjct: 296 WEIFTLGGSPYPGIPVEELFKLLKE 320

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 93.4 bits (233), Expect = 2e-22
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 36/212 (16%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS-QVEHQLRREVEIQSHLRHPNILRLY 82
           +G G FG VY  +   +N  VA+K L       + +++ Q  +E+++ +  +H N++ L 
Sbjct: 39  MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96

Query: 83  GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATY--------VASLARALIYCHG 134
           G+  D   + L+  Y   G L   L                          A  + + H 
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRL-----SCLDGTPPLSWHMRCKIAQGAANGINFLHE 151

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFG------WSVHTFNRRRTMCGTLDYLPPE-M--- 184
            H IHRDIK  N+L+      KI+DFG          T    R + GT  Y+ PE +   
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV-GTTAYMAPEALRGE 210

Query: 185 --VESVEHDANVDIWSLGVLCYEFLYGVPPFE 214
              +S       DI+S GV+  E + G+P  +
Sbjct: 211 ITPKS-------DIYSFGVVLLEIITGLPAVD 235

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 93.1 bits (232), Expect = 3e-22
 Identities = 66/237 (27%), Positives = 93/237 (39%), Gaps = 30/237 (12%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR--EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL 73
           ND      +G G FG V  AR  +       A+K + K    +         E+E+   L
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHR-DFAGELEVLCKL 82

Query: 74  -RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI-- 130
             HPNI+ L G    +  +YL +EYA  G L   L+K +      A     S A  L   
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 131 --------------YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT 176
                         Y   K  IHRD+   N+L+G     KIADFG S       +    T
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---T 199

Query: 177 LDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPFEAKEHSDTYRRIVQ 227
           +  LP      E +    +  N D+WS GVL +E    G  P+     ++ Y ++ Q
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 92.7 bits (231), Expect = 4e-22
 Identities = 57/234 (24%), Positives = 89/234 (38%), Gaps = 46/234 (19%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           N    GK LG G FG V  A      +  +   VA+K+L  S     +    L  E+++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA--LMSELKVL 80

Query: 71  SHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL---- 125
           S+L  H NI+ L G         +I EY   G+L   L++ +        +         
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 126 --------------ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR 171
                         A+ + +   K+ IHRD+   N+L+      KI DFG +       R
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-------R 193

Query: 172 TMCGTLDY-------LP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPP 212
            +    +Y       LP     PE + +  +    D+WS G+  +E F  G  P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 93.2 bits (232), Expect = 4e-22
 Identities = 60/331 (18%), Positives = 114/331 (34%), Gaps = 79/331 (23%)

Query: 18  FDIGKPLGRGKFGHVYLARE-KRSNHIVALKVL--FKSQLQQSQVEHQLRREVEIQSHLR 74
           ++I   LG G FG V    +  R    VALK++       + +++E      + +   ++
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE------INVLKKIK 74

Query: 75  HP------NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLA 126
                     + +  +F     + +  E   K   ++ L++  +  +           L 
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLC 133

Query: 127 RALIYCHGKHVIHRDIKPENLLI-------------------GAQGELKIADFGWSVHTF 167
            AL + H   + H D+KPEN+L                         +++ADFG +    
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193

Query: 168 NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ 227
               T+  T  Y PPE++  +      D+WS+G + +E+  G   F+  E+ +    + +
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253

Query: 228 VDLKFPPK------------------PIVSSAAK------------------------DL 245
           +    P                       SS  +                        DL
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313

Query: 246 ISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           + +ML  D +QR+ L + L HP+        
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 92.3 bits (230), Expect = 7e-22
 Identities = 58/325 (17%), Positives = 116/325 (35%), Gaps = 81/325 (24%)

Query: 18  FDIGKPLGRGKFGHVYLAR-EKRSNHIVALKVLFKSQ---LQQSQVEHQLRREVEIQSHL 73
           ++I   LG G FG V      K     VA+K++ K+     + ++ E      +++  HL
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSE------IQVLEHL 68

Query: 74  RHP------NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASL 125
                      +++  +F     + ++ E       Y  +++  +  F           +
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQI 127

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQG-------------------ELKIADFGWSVHT 166
            +++ + H   + H D+KPEN+L                        ++K+ DFG + + 
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187

Query: 167 FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV 226
                T+  T  Y  PE++ ++      D+WS+G +  E+  G   F   +  +    + 
Sbjct: 188 DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247

Query: 227 QVDLKFPPK------------------PIVSSAAK------------------------D 244
           ++    P                       SSA +                        D
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307

Query: 245 LISQMLVKDSSQRLPLHKLLEHPWI 269
           LI +ML  D ++R+ L + L+HP+ 
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 92.4 bits (230), Expect = 1e-21
 Identities = 64/331 (19%), Positives = 119/331 (35%), Gaps = 87/331 (26%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVL--FKSQLQQSQVEHQLRREVEIQSHLRH 75
           F + + +G G FG V L +   +    A+KV+   K   + +++E       +I   +++
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE------ADILKKIQN 90

Query: 76  -----PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARA 128
                 NI++ +G F     + LI E      LY+ + +  Y  F       Y   + +A
Sbjct: 91  DDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKA 149

Query: 129 LIYCHGKHVIHRDIKPENLLI-------------------------GAQGELKIADFGWS 163
           L Y     + H D+KPEN+L+                              +K+ DFG +
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 164 VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR 223
               +   ++  T  Y  PE++ ++  D + D+WS G +  E   G   F   EH +   
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269

Query: 224 RIVQVDLKFPPKPIVSSAAK---------------------------------------- 243
            +  + ++  PK ++  A K                                        
Sbjct: 270 MMESI-IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328

Query: 244 -----DLISQMLVKDSSQRLPLHKLLEHPWI 269
                D +  +L  D + R    +LL+H ++
Sbjct: 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 91.1 bits (226), Expect = 3e-21
 Identities = 66/363 (18%), Positives = 112/363 (30%), Gaps = 117/363 (32%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR--- 74
           + + + LG G F  V+L+ + +    VA+KV+  ++            E+ +   +R   
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLKSVRNSD 94

Query: 75  --HPN---ILRLYGYFYDQ----KRVYLILEYAAKGE-LYKELQKCKY--FSERRAATYV 122
              PN   +++L   F         + ++ E    G  L K + K  Y           +
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKII 152

Query: 123 ASLARALIYCHGK-HVIHRDIKPENLLIG------------------------------- 150
             + + L Y H K  +IH DIKPEN+L+                                
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 151 ------------------AQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDA 192
                              + ++KIAD G +            T  Y   E++    ++ 
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 272

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR------RIVQVDLKFPPKPIVSS------ 240
             DIWS   + +E   G   FE     +  R       I+++  K P K IV+       
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 241 ----------------------------------AAKDLISQMLVKDSSQRLPLHKLLEH 266
                                                D +  ML     +R    + L H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 267 PWI 269
           PW+
Sbjct: 393 PWL 395

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 89.6 bits (223), Expect = 5e-21
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 35/229 (15%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           +   +GKPLGRG FG V  A      +  +   VA+K+L K     S+    L  E++I 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHR-ALMSELKIL 84

Query: 71  SHL-RHPNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKC----------------KY 112
            H+  H N++ L G        + +I+E+   G L   L+                   +
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 113 FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRR 170
            +      Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG +  ++     
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204

Query: 171 RTMCGTLDYLP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPPF 213
                    LP     PE +    +    D+WS GVL +E F  G  P+
Sbjct: 205 VRKGDAR--LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 71/265 (26%), Positives = 109/265 (41%), Gaps = 48/265 (18%)

Query: 2   CSEVSAKEKKRWTL--NDFDIGKPLGRGKFGHVYLAR-------EKRSNHIVALKVLFKS 52
            SE    E  RW L  +   +GKPLG G FG V LA        +      VA+K+L   
Sbjct: 53  VSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD 112

Query: 53  QLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK 111
             ++   +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + LQ  +
Sbjct: 113 ATEKDLSD--LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 170

Query: 112 YFSERRAATYVASL----------------ARALIYCHGKHVIHRDIKPENLLIGAQGEL 155
                 +     +                 AR + Y   K  IHRD+   N+L+     +
Sbjct: 171 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 230

Query: 156 KIADFGWSVHTFNRRRTMCGTLDY-------LP-----PEMVESVEHDANVDIWSLGVLC 203
           KIADFG +       R +     Y       LP     PE +    +    D+WS GVL 
Sbjct: 231 KIADFGLA-------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283

Query: 204 YE-FLYGVPPFEAKEHSDTYRRIVQ 227
           +E F  G  P+      + ++ + +
Sbjct: 284 WEIFTLGGSPYPGVPVEELFKLLKE 308

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 87.7 bits (218), Expect = 3e-20
 Identities = 61/235 (25%), Positives = 92/235 (39%), Gaps = 51/235 (21%)

Query: 20  IGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL- 73
            GK LG G FG V  A      +   +  VA+K+L K +   S+ E  L  E+++ + L 
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSERE-ALMSELKMMTQLG 106

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL-------- 125
            H NI+ L G       +YLI EY   G+L   L+  +         Y            
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 126 ---------------ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR 170
                          A+ + +   K  +HRD+   N+L+     +KI DFG +       
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------- 219

Query: 171 RTMCGTLDY-------LP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPP 212
           R +    +Y       LP     PE +    +    D+WS G+L +E F  GV P
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 56/241 (23%), Positives = 95/241 (39%), Gaps = 32/241 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH-QLRREVEIQSHLR 74
           N F +G+ +G G FG +YL    ++N  VA+K+      +  + +H QL  E +I   L+
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------ENVKTKHPQLLYESKIYRILQ 60

Query: 75  -HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYC 132
               I  +  +  +     L+++      L      C +  S +        +   + + 
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 133 HGKHVIHRDIKPENLLIGAQGE---LKIADFGWS---------VHT-FNRRRTMCGTLDY 179
           H K  +HRDIKP+N L+G       + I DFG +          H  +   + + GT  Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 180 LPPEMVESVE---HDANVDIWSLGVLCYEFLYGVPP---FEAKEHSDTYRRIVQVDLKFP 233
                   +E    D   D+ SLG +   FL G  P    +A      Y +I +  +   
Sbjct: 180 ASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236

Query: 234 P 234
            
Sbjct: 237 I 237

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 82.8 bits (205), Expect = 1e-18
 Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 32/241 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH-QLRREVEIQSHLR 74
           N + +G+ +G G FG +YL  +  +   VA+K+      +  + +H QL  E +I   ++
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLHIESKIYKMMQ 62

Query: 75  H-PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYC 132
               I  +     +     +++E      L      C + FS +        +   + Y 
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121

Query: 133 HGKHVIHRDIKPENLLIGAQGE---LKIADFGWS---------VHT-FNRRRTMCGTLDY 179
           H K+ IHRD+KP+N L+G   +   + I DFG +          H  +   + + GT  Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

Query: 180 LPPEMVESVE---HDANVDIWSLGVLCYEFLYGVPP---FEAKEHSDTYRRIVQVDLKFP 233
                   +E    D   D+ SLG +   F  G  P    +A      Y RI +  +  P
Sbjct: 182 ASINTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238

Query: 234 P 234
            
Sbjct: 239 I 239

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 82.8 bits (205), Expect = 2e-18
 Identities = 62/244 (25%), Positives = 96/244 (39%), Gaps = 34/244 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
            +F +GK +G G FG + L +   +N  VA+K+             QL  E      L  
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-----QLHLEYRFYKQLGS 63

Query: 76  -PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALI--- 130
              I ++Y +    K   ++LE      L      C + FS +     V  +A  LI   
Sbjct: 64  GDGIPQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLK----TVLMIAIQLISRM 118

Query: 131 -YCHGKHVIHRDIKPENLLIGAQGELK-----IADFGWS---------VH-TFNRRRTMC 174
            Y H K++I+RD+KPEN LIG  G        I DF  +          H  +   +++ 
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178

Query: 175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPP---FEAKEHSDTYRRIVQVDLK 231
           GT  Y+        E     D+ +LG +   FL G  P    +A    + Y++I      
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238

Query: 232 FPPK 235
            P +
Sbjct: 239 TPIE 242

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 81.2 bits (201), Expect = 4e-18
 Identities = 57/247 (23%), Positives = 95/247 (38%), Gaps = 42/247 (17%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEH-QLRREVEIQSHLR 74
             + +G+ +G G FG ++      +N  VA+K       +  + +  QLR E      L 
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------EPRRSDAPQLRDEYRTYKLLA 63

Query: 75  H-PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALI-- 130
               I  +Y +  +     L+++      L   L  C + FS +     VA  A+ ++  
Sbjct: 64  GCTGIPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVK----TVAMAAKQMLAR 118

Query: 131 --YCHGKHVIHRDIKPENLLIGAQGELK-----IADFGWS---------VH-TFNRRRTM 173
               H K +++RDIKP+N LIG           + DFG            H  +  ++ +
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178

Query: 174 CGTLDYLPPEMVESVE---HDANVDIWSLGVLCYEFLYGVPP---FEAKEHSDTYRRIVQ 227
            GT  Y+        E    D   D+ +LG +   FL G  P    +A  +   Y RI +
Sbjct: 179 SGTARYMSINTHLGREQSRRD---DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235

Query: 228 VDLKFPP 234
                P 
Sbjct: 236 KKQSTPL 242

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.2 bits (185), Expect = 9e-16
 Identities = 50/232 (21%), Positives = 86/232 (37%), Gaps = 43/232 (18%)

Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVL-----FKSQLQQ-SQVEHQL 63
             +W L     GK +G G FG +YLA         A  V+         L    +   ++
Sbjct: 36  GNQWVL-----GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV 90

Query: 64  RREVEIQS-----HLRHPNILRLYGY----FYDQKRVYLILEYAAKGELYKELQKCKYFS 114
            ++  I+       L +  I   YG     F  +   ++++E     +L K   +   F 
Sbjct: 91  AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFK 149

Query: 115 ERRAATYVASLARALI----YCHGKHVIHRDIKPENLLIGAQGELKI--ADFGWS----- 163
           +      V  L   ++    Y H    +H DIK  NLL+G +   ++  AD+G S     
Sbjct: 150 KS----TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205

Query: 164 ----VH-TFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG-VLCYEFLYG 209
                    N R+   GT+++   +  + V      D+  LG  +   +L G
Sbjct: 206 NGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR-WLCG 256

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 45/241 (18%), Positives = 88/241 (36%), Gaps = 48/241 (19%)

Query: 5   VSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHI--------VALKV------LF 50
           ++ K  ++W L          R   G +Y A    +            +LK+      LF
Sbjct: 36  LTDKSGRQWKL-----KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLF 90

Query: 51  KSQ--LQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV-YLILEYAAKGELYKEL 107
             Q   Q++    Q+ +  ++ S      I    G+   Q +  +L+L    +  L   L
Sbjct: 91  NEQNFFQRAAKPLQVNKWKKLYS-TPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSAL 148

Query: 108 QKC--KYFSERRAATYVASLARALI----YCHGKHVIHRDIKPENLLIGAQGELKI--AD 159
                   SER     V  +A  L+    + H    +H ++  EN+ +  + + ++  A 
Sbjct: 149 DVSPKHVLSER----SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAG 204

Query: 160 FGWS-------VH---TFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG-VLCYEFLY 208
           +G++        H       R    G L+++  ++ +        D+ SLG  +   +LY
Sbjct: 205 YGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK-WLY 263

Query: 209 G 209
           G
Sbjct: 264 G 264

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 70.6 bits (173), Expect = 3e-14
 Identities = 47/232 (20%), Positives = 87/232 (37%), Gaps = 41/232 (17%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHI-----VALKVLFKSQLQ---QSQVEHQLRREV 67
             + +G P+G+G FG +YLA    S  +       +KV          + +   +  +  
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 68  EIQSHLRHPNILRL-------YGYFYDQKRVY--LILEYAAKGELYKELQKC-KYFSERR 117
           +IQ  +R   +  L        G      + Y  +I++     +L K  +   K FS + 
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRK- 152

Query: 118 AATYVASLARALI----YCHGKHVIHRDIKPENLLIGAQGELKI--ADFGWS-------- 163
               V  L+  ++    Y H    +H DIK  NLL+  +   ++   D+G +        
Sbjct: 153 ---TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209

Query: 164 -VH-TFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLG-VLCYEFLYGVPP 212
                 + +R   GT+++   +    V      D+  LG  +   +L G  P
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ-WLTGHLP 260

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.4 bits (161), Expect = 9e-13
 Identities = 41/274 (14%), Positives = 80/274 (29%), Gaps = 64/274 (23%)

Query: 3   SEVSAKEKKRWT----LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ 58
            E S K    ++           + +G G FG V+      +   VA+K++         
Sbjct: 3   GECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVN 60

Query: 59  VEHQLR-----REVEIQSHL---------RHPNILRLYG--------------------- 83
             HQ        E+ I   L         R    + L                       
Sbjct: 61  GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120

Query: 84  ---------YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
                     F+   +++++LE+   G   ++++  K  S   A + +  L  +L     
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEA 179

Query: 135 KH-VIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDAN 193
                HRD+   N+L+      K+        T N + +   +        V  +++  +
Sbjct: 180 SLRFEHRDLHWGNVLLKKTSLKKLHY------TLNGKSSTIPSCGL----QVSIIDYTLS 229

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEH--SDTYRRI 225
                  V+  +       F        D YR +
Sbjct: 230 RLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLM 263

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 3e-09
 Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 9/103 (8%)

Query: 16  NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           +   +GKPLGRG FG V  A      +  +   VA+K+L K     S+    L  E++I 
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHR-ALMSELKIL 79

Query: 71  SHL-RHPNILRLYGYFYDQKR-VYLILEYAAKGELYKELQKCK 111
            H+  H N++ L G        + +I+E+   G L   L+  +
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 20/100 (20%)

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY------ 179
           A+ + +   +  IHRD+   N+L+  +  +KI DFG +       R +    DY      
Sbjct: 203 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------RDIYKDPDYVRKGDA 255

Query: 180 -LP-----PEMVESVEHDANVDIWSLGVLCYE-FLYGVPP 212
            LP     PE +    +    D+WS GVL +E F  G  P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	281
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.02
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.92
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.81
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.7
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.3
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.3
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.28
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.27
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.18
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.87
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.86
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.85
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.5
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.44
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.36
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.35
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.29
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.21
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.14
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.03
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.02
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.82
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.92
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	95.81
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	95.72
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.41
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.55
3ls8_A	614	Phosphatidylinositol 3-kinase catalytic subunit ty	80.56

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.3e-66  Score=424.50  Aligned_cols=258  Identities=34%  Similarity=0.617  Sum_probs=235.4

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      +...++|++++.||+|+||+||+|+++.+|+.||+|++...........+.+.+|++++++++||||+++++++.+++.+
T Consensus        28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            44568899999999999999999999999999999999766544444456789999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---  168 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---  168 (281)
                      |+||||++||+|.+++++.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....   
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999965432   


Q ss_pred             --CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          169 --RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       169 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+......++.  .++.++++||
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli  265 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--KFFPKARDLV  265 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TCCHHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--ccCHHHHHHH
Confidence              234457999999999999999999999999999999999999999999999999988888766654  6999999999


Q ss_pred             HHhcccCCCCCCChhh------hhcCCcccc
Q 038249          247 SQMLVKDSSQRLPLHK------LLEHPWIIQ  271 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~e------il~~~~~~~  271 (281)
                      .+||+.||++|||++|      |++||||+.
T Consensus       266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            9999999999999988      588999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.8e-65  Score=413.35  Aligned_cols=256  Identities=32%  Similarity=0.614  Sum_probs=217.0

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .+++|++.+.||+|+||+||+|+++.+|+.||+|++.............+.+|++++++++||||+++++++.+.+.+++
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            35899999999999999999999999999999999977665555556678999999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--cc
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RR  171 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~  171 (281)
                      ||||+ +|+|.+.+...+++++..++.++.||+.||+|||++||+||||||+||+++.++++||+|||++......  ..
T Consensus        91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence            99999 5699999998889999999999999999999999999999999999999999999999999998654332  34


Q ss_pred             cccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          172 TMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+..+.+......++.  .+|.+++++|.+||
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L  247 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK--FLSPGAAGLIKRML  247 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHS
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHc
Confidence            4679999999999988876 57899999999999999999999998888888888877665544  68999999999999


Q ss_pred             ccCCCCCCChhhhhcCCccccC
Q 038249          251 VKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       251 ~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +.||++|||++|+++||||+..
T Consensus       248 ~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          248 IVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             CSSGGGSCCHHHHHHCHHHHTT
T ss_pred             cCChhHCcCHHHHHcCcccccC
Confidence            9999999999999999999865

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-65  Score=426.57  Aligned_cols=258  Identities=25%  Similarity=0.486  Sum_probs=227.0

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++....... ...+.+.+|++++++++||||+++++++.+++.+|+
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            5789999999999999999999999999999999997765443 346778999999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           94 ILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      ||||++||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......  
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999999999999754  35799999999999999999999999999999999999999999999999998765433  


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...... +....+|.++.+||.+
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~  259 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQ  259 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHH
Confidence             23457999999999999999999999999999999999999999999988888888776543 2344789999999999


Q ss_pred             hcccCCCCCCChhhhhcCCccccCC
Q 038249          249 MLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      ||+.||++|||++|+|+||||++..
T Consensus       260 ~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          260 LFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HccCChhHCcCHHHHhcCHHhhcCC
Confidence            9999999999999999999998653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.3e-64  Score=419.67  Aligned_cols=257  Identities=27%  Similarity=0.492  Sum_probs=229.9

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++.......   .+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56999999999999999999999999999999997554332   345788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~  172 (281)
                      ||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......   ...
T Consensus       151 Ey~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          151 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             eCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            999999999999874 5999999999999999999999999999999999999999999999999998654332   345


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-cCCCCCCCCHHHHHHHHHhcc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-KFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  251 (281)
                      .+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+..... ..+.+..++.++.+||.+||+
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  309 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  309 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence            6899999999999999999999999999999999999999999888888777765432 333445689999999999999


Q ss_pred             cCCCCCCChhhhhcCCccccCCCCC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                      .||++|||++|+|+||||++...++
T Consensus       310 ~dP~~R~ta~e~l~Hp~~~~~~~p~  334 (346)
T 4fih_A          310 RDPAQRATAAELLKHPFLAKAGPPA  334 (346)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred             CChhHCcCHHHHhcCHhhcCCCCCc
Confidence            9999999999999999999876554

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.1e-63  Score=404.29  Aligned_cols=254  Identities=24%  Similarity=0.464  Sum_probs=218.9

Q ss_pred             CCc-eecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe----CCE
Q 038249           16 NDF-DIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD----QKR   90 (281)
Q Consensus        16 ~~y-~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~   90 (281)
                      .+| ++.+.||+|+||+||+|.++.++..||+|++....... ...+.+.+|++++++++|||||++++++..    .+.
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            455 78889999999999999999999999999997665433 345778999999999999999999999875    356


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCeEeCC-CCcEEEeeecCccccc
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH--VIHRDIKPENLLIGA-QGELKIADFGWSVHTF  167 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~Ni~~~~-~~~~~l~dfg~~~~~~  167 (281)
                      +++||||++||+|.++++..+.+++..++.++.||+.||+|||++|  |+||||||+|||++. +|.+||+|||++....
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            8999999999999999998889999999999999999999999998  999999999999984 7899999999986543


Q ss_pred             CC-cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH-HHHHHhhccccCCCCCCCCHHHHHH
Q 038249          168 NR-RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD-TYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       168 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                      .. ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....+.............+.++.+|
T Consensus       184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  262 (290)
T 3fpq_A          184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  262 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence            33 345679999999999875 69999999999999999999999997765544 4444544433333344678999999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCcccc
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      |.+||+.||++|||++|+|+||||++
T Consensus       263 i~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          263 IEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9.2e-63  Score=420.57  Aligned_cols=258  Identities=27%  Similarity=0.491  Sum_probs=230.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.|++.+.||+|+||.||+|+++.+|+.||||++.......   .+.+.+|+.++++++|||||++++++.+.+.+|+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            56999999999999999999999999999999997554332   345789999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~  172 (281)
                      ||++||+|.++++.. .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......   ...
T Consensus       228 Ey~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          228 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             ECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             eCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            999999999999865 5999999999999999999999999999999999999999999999999998654332   345


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc-ccCCCCCCCCHHHHHHHHHhcc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD-LKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      .+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+.... ........++.++.+||.+||+
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  386 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  386 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence            679999999999999999999999999999999999999999988888887776543 2344455789999999999999


Q ss_pred             cCCCCCCChhhhhcCCccccCCCCCC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQNADPSG  277 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~~~~~~  277 (281)
                      .||++|||+.|+|+||||++...+++
T Consensus       387 ~dP~~R~ta~ell~Hp~~~~~~~p~~  412 (423)
T 4fie_A          387 RDPAQRATAAELLKHPFLAKAGPPAS  412 (423)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred             CChhHCcCHHHHhcCHHhcCCCCCcc
Confidence            99999999999999999998765543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.5e-64  Score=411.99  Aligned_cols=258  Identities=32%  Similarity=0.616  Sum_probs=224.9

Q ss_pred             cccccCCceecceecccCceEEEEEEEc---cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      .+...++|++++.||+|+||+||+|++.   .+++.||+|++......... ...+.+|++++++++||||+++++++.+
T Consensus        19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEE
T ss_pred             ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            4456689999999999999999999984   46788999999765433222 2346789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      ++.+++||||++||+|.+++++.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999999999998899999999999999999999999999999999999999999999999999986532


Q ss_pred             C---CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHH
Q 038249          168 N---RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       168 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (281)
                      .   .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+.......+.  .+|.++.+
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~  255 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQS  255 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--cCCHHHHH
Confidence            2   234567999999999999999999999999999999999999999999999998888887665544  69999999


Q ss_pred             HHHHhcccCCCCCCCh-----hhhhcCCcccc
Q 038249          245 LISQMLVKDSSQRLPL-----HKLLEHPWIIQ  271 (281)
Q Consensus       245 li~~~l~~~p~~Rps~-----~eil~~~~~~~  271 (281)
                      ||.+||+.||++|||+     +|+++||||+.
T Consensus       256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            9999999999999984     79999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.2e-62  Score=409.13  Aligned_cols=256  Identities=25%  Similarity=0.398  Sum_probs=227.0

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .++.|++.++||+|+||+||+|+++.+|+.||||++......        .+|+.++++++|||||++++++.+++.+++
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456799999999999999999999999999999999654322        358999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-cEEEeeecCcccccCC---
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWSVHTFNR---  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-~~~l~dfg~~~~~~~~---  169 (281)
                      ||||++|++|.++++..+++++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||++......   
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999888899999999999999999999999999999999999999987 6999999998654321   


Q ss_pred             -----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC-CCCCCCCHHHH
Q 038249          170 -----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF-PPKPIVSSAAK  243 (281)
Q Consensus       170 -----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~  243 (281)
                           ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+....... ..++.++.++.
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence                 123479999999999999999999999999999999999999999888877777766654332 23457999999


Q ss_pred             HHHHHhcccCCCCCCChhhh-------------hcCCccccCCCCCC
Q 038249          244 DLISQMLVKDSSQRLPLHKL-------------LEHPWIIQNADPSG  277 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~ei-------------l~~~~~~~~~~~~~  277 (281)
                      ++|.+||+.||++|||+.|+             |+|||+.+..+|.+
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~  334 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG  334 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence            99999999999999999997             67999999988865

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-59  Score=398.98  Aligned_cols=257  Identities=28%  Similarity=0.438  Sum_probs=221.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe------CC
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD------QK   89 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~~   89 (281)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+.+|++++++++||||+++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            57999999999999999999999999999999996544 233445678899999999999999999998764      36


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-  168 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-  168 (281)
                      .+|+||||++| +|.+++...+++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... 
T Consensus       133 ~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            78999999975 7999999888999999999999999999999999999999999999999999999999999865322 


Q ss_pred             ------CcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--------
Q 038249          169 ------RRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--------  233 (281)
Q Consensus       169 ------~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  233 (281)
                            .....+||+.|+|||++.+. .++.++||||+||++++|++|.+||.+.+..+++..+.......+        
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                  22345799999999998765 468899999999999999999999999888888776654322111        


Q ss_pred             ------------C---------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          234 ------------P---------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       234 ------------~---------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                                  .         .+..+.++.+||.+||..||++|||++|+|+||||++..+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                        0         1346889999999999999999999999999999997644

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.1e-59  Score=386.48  Aligned_cols=251  Identities=25%  Similarity=0.430  Sum_probs=201.4

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-----
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-----   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----   89 (281)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++....  .....+.+.+|++++++++||||+++++++.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            467999999999999999999999999999999996543  3344567889999999999999999999987544     


Q ss_pred             -------EEEEEEeccCCCChhHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEee
Q 038249           90 -------RVYLILEYAAKGELYKELQKCKY---FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIAD  159 (281)
Q Consensus        90 -------~~~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~d  159 (281)
                             .+++||||+++++|.++++....   .+...++.++.||+.||+|||++||+||||||+||+++.+|.+||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   47999999999999999987654   44566899999999999999999999999999999999999999999


Q ss_pred             ecCcccccCC---------------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc-hHHHH
Q 038249          160 FGWSVHTFNR---------------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH-SDTYR  223 (281)
Q Consensus       160 fg~~~~~~~~---------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~  223 (281)
                      ||++......               ....+||+.|+|||++.+..++.++|||||||++|+|++   ||..... .....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            9998654322               123469999999999999999999999999999999996   6653221 12222


Q ss_pred             HHhhccccCCC-CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          224 RIVQVDLKFPP-KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       224 ~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .+...  ..++ ....+.++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       239 ~~~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          239 DVRNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHhcC--CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            22222  1211 12345678899999999999999999999999999875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-59  Score=386.16  Aligned_cols=255  Identities=22%  Similarity=0.437  Sum_probs=219.5

Q ss_pred             ccccCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      ....++|.+.+.||+|+||+||+|++.     .++..||||++...   +....+.+.+|++++++++|||||++++++.
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            345578999999999999999999875     35788999999543   3445678999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC
Q 038249           87 DQKRVYLILEYAAKGELYKELQKC-------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG  153 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~  153 (281)
                      +++.+++||||+++|+|.+++...             ..+++.+++.++.||+.||+|||+++|+||||||+||+++.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999999999999753             3589999999999999999999999999999999999999999


Q ss_pred             cEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhh
Q 038249          154 ELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQ  227 (281)
Q Consensus       154 ~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~  227 (281)
                      .+||+|||++.......     ....+|+.|+|||.+.+..++.++|||||||++|||+| |..||...+..+....+..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999986433221     22357899999999999999999999999999999998 8999999998888888777


Q ss_pred             ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          228 VDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +.. .+.+..+|.++.+|+.+||+.||++|||+.+|.  +++++-
T Consensus       246 ~~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~  287 (299)
T 4asz_A          246 GRV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL  287 (299)
T ss_dssp             TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred             CCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence            643 233347999999999999999999999999995  566643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.8e-58  Score=380.81  Aligned_cols=251  Identities=23%  Similarity=0.433  Sum_probs=214.4

Q ss_pred             ccccCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      .+..++|.+.+.||+|+||+||+|+++     .++..||||++...   +....+.+.+|++++++++|||||++++++.
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            445578999999999999999999875     35788999999543   3445678999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           87 DQKRVYLILEYAAKGELYKELQKC---------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                      +.+.+++||||+++|+|.+++...               +++++.+++.++.||+.||+|||+++|+||||||+||+++.
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence            999999999999999999998753               35899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038249          152 QGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRI  225 (281)
Q Consensus       152 ~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~  225 (281)
                      ++++||+|||++......     .....+|+.|+|||.+.+..++.++|||||||++|||+| |..||...+..+....+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999998654322     233468999999999999999999999999999999998 89999999888888877


Q ss_pred             hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ..+.. .+.+..+|.++.+|+.+||+.||++|||+.||+++
T Consensus       274 ~~g~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          274 TQGRE-LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHTCC-CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HcCCC-CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            66532 33344799999999999999999999999999863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.8e-58  Score=407.04  Aligned_cols=259  Identities=27%  Similarity=0.477  Sum_probs=224.0

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS---QVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      ..+++++|++++.||+|+||+||+|+++.+|+.||+|++........   ........++.+++.++||||+++++++.+
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            47889999999999999999999999999999999999976543222   222233445677778899999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      .+.+|+||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++....
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999996543


Q ss_pred             C-CcccccCcCCccCCcccc-CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc---hHHHHHHhhccccCCCCCCCCHHH
Q 038249          168 N-RRRTMCGTLDYLPPEMVE-SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH---SDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       168 ~-~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                      . .....+||+.|+|||++. +..|+.++|+|||||++|+|++|.+||...+.   .+....+......++  ..++.++
T Consensus       344 ~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p--~~~S~~a  421 (689)
T 3v5w_A          344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPEL  421 (689)
T ss_dssp             SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC--TTSCHHH
T ss_pred             CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC--ccCCHHH
Confidence            3 345568999999999986 45799999999999999999999999976433   234445555544444  3699999


Q ss_pred             HHHHHHhcccCCCCCCC-----hhhhhcCCcccc
Q 038249          243 KDLISQMLVKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      ++||.+||+.||++|++     ++||++||||+.
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            99999999999999998     699999999984

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-57  Score=377.15  Aligned_cols=253  Identities=22%  Similarity=0.382  Sum_probs=218.5

Q ss_pred             cccccCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ..+..+++++.+.||+|+||+||+|.+.     .+++.||||++....  .....+.+.+|+.++++++||||+++++++
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            3456688999999999999999999864     357889999986543  223356789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKC----------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI  149 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~  149 (281)
                      .+++.+++||||+++|+|.+++...                ..+++..+..++.||+.||+|||+++|+||||||+||++
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV  178 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence            9999999999999999999999643                348999999999999999999999999999999999999


Q ss_pred             CCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHH
Q 038249          150 GAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYR  223 (281)
Q Consensus       150 ~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~  223 (281)
                      +.++++||+|||++......     .....+|+.|+|||.+.+..++.++|||||||++|||+| |..||.+.+..+...
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999998654322     233568999999999999999999999999999999998 899999998888887


Q ss_pred             HHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          224 RIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .+..+.. .+.+..+|.++.+++.+||+.||++|||+.||+++
T Consensus       259 ~i~~~~~-~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQV-LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7766543 33445799999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-57  Score=372.02  Aligned_cols=248  Identities=24%  Similarity=0.395  Sum_probs=207.7

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..+++++.+.||+|+||+||+|+++.   .+|||++.... ...+..+.+.+|++++++++||||+++++++.+ +.+++
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            34789999999999999999998753   49999986544 334456789999999999999999999998765 56799


Q ss_pred             EEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC----
Q 038249           94 ILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN----  168 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~----  168 (281)
                      ||||+++|+|.+++... .++++..+..++.||+.||+|||+++|+||||||+|||++.++++||+|||++.....    
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999999764 5699999999999999999999999999999999999999999999999999865332    


Q ss_pred             -CcccccCcCCccCCccccC---CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC----CCCCCCH
Q 038249          169 -RRRTMCGTLDYLPPEMVES---VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP----PKPIVSS  240 (281)
Q Consensus       169 -~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  240 (281)
                       .....+||+.|+|||++.+   ..++.++|||||||++|||+||..||...+...............+    ....+|.
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  268 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK  268 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence             1234579999999999853   4588899999999999999999999998777666555544332222    2346889


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ++.+++.+||+.||++|||+.||+++
T Consensus       269 ~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          269 AMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999988654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.1e-57  Score=401.84  Aligned_cols=259  Identities=31%  Similarity=0.595  Sum_probs=231.7

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .+++|++++.||+|+||+||+|.++.+|+.||+|.+....   ....+.+.+|+++++.++||||+++++++.+.+.+++
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            3578999999999999999999999999999999996543   2335678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC--CcEEEeeecCcccccCC-
Q 038249           94 ILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ--GELKIADFGWSVHTFNR-  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~--~~~~l~dfg~~~~~~~~-  169 (281)
                      ||||++||+|.+++.. .+.+++.++..++.||+.||.|||++||+|+||||+||+++.+  +.+||+|||++...... 
T Consensus       232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            9999999999998864 4579999999999999999999999999999999999999854  89999999999765433 


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHHHHH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAKDLI  246 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li  246 (281)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+......++.  ...++.++.+||
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli  391 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI  391 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence             24457999999999999999999999999999999999999999999999998888776554433  356899999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      .+||+.||++|||+.|+|+||||+....+
T Consensus       392 ~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          392 RKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             HHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            99999999999999999999999976443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1e-56  Score=379.80  Aligned_cols=249  Identities=24%  Similarity=0.414  Sum_probs=205.7

Q ss_pred             CCceecceecccCceEEEEEEEc---cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~   91 (281)
                      ++|++.+.||+|+||+||+|+++   .+++.||+|.+.....     ...+.+|+++++.+ +||||+++++++.+.+.+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            67999999999999999999986   3578899999855431     23577899999988 699999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC-CcEEEeeecCcccccCC-
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-GELKIADFGWSVHTFNR-  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~-~~~~l~dfg~~~~~~~~-  169 (281)
                      ++||||++|++|.++++   .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++...... 
T Consensus        96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            99999999999999985   38999999999999999999999999999999999999877 79999999998543221 


Q ss_pred             ------------------------------cccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCc
Q 038249          170 ------------------------------RRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEH  218 (281)
Q Consensus       170 ------------------------------~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  218 (281)
                                                    ....+||+.|+|||++.+. .++.++||||+||++++|++|..||...+.
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                          1224689999999998765 488999999999999999999999854433


Q ss_pred             -hHHHHHHhhc----------------------------------------------------cccCCCCCCCCHHHHHH
Q 038249          219 -SDTYRRIVQV----------------------------------------------------DLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       219 -~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~l~~l  245 (281)
                       .+.+..+...                                                    ....+.+..+++++.+|
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence             3332222110                                                    00112234588999999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCccccC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      |++||+.||++|||++|+|+||||++-
T Consensus       333 l~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          333 LDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.5e-55  Score=365.37  Aligned_cols=262  Identities=32%  Similarity=0.610  Sum_probs=234.3

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      .....+++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+++++.++||||+++++++...+
T Consensus         9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A            9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            3455678999999999999999999999999999999999766543 344567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-  168 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-  168 (281)
                      ..++||||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..... 
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            9999999999999999998888899999999999999999999999999999999999999999999999999854332 


Q ss_pred             -CcccccCcCCccCCccccCCCCC-CcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          169 -RRRTMCGTLDYLPPEMVESVEHD-ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       169 -~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                       .....++++.|+|||.+.+..++ .++||||||+++++|++|..||.+.+..+....+..+....+.  .++.++.++|
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li  245 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLL  245 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHH
Confidence             23445789999999999877765 7899999999999999999999999988888888877665554  5899999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      ++||+.||++|||++|+++||||+...+
T Consensus       246 ~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          246 KRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            9999999999999999999999987643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-55  Score=364.33  Aligned_cols=258  Identities=37%  Similarity=0.702  Sum_probs=235.2

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      ++.+++|++.+.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus         2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            46789999999999999999999999999999999999765433333345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcc
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRR  171 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~  171 (281)
                      ++||||+++++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.+|.++|+|||++........
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~  161 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY  161 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999977666666


Q ss_pred             cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          172 TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ..++|+.|+|||++.+..++.++|+||||+++++|++|..||...+..+....+......++.  .++.++.++|.+||+
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL~  239 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLIT  239 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTC
T ss_pred             cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhc
Confidence            778999999999999989999999999999999999999999998888888888777655544  689999999999999


Q ss_pred             cCCCCCC-----ChhhhhcCCcccc
Q 038249          252 KDSSQRL-----PLHKLLEHPWIIQ  271 (281)
Q Consensus       252 ~~p~~Rp-----s~~eil~~~~~~~  271 (281)
                      .||++||     +++++++||||++
T Consensus       240 ~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          240 RDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             SCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             cCHHHcCCCcCCCHHHHhcCccccC
Confidence            9999999     8999999999974

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.7e-56  Score=371.62  Aligned_cols=257  Identities=24%  Similarity=0.426  Sum_probs=216.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCC-----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeeeeeEEEe-
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSN-----HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH-PNILRLYGYFYD-   87 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~-   87 (281)
                      .++|++++.||+|+||+||+|.+..++     +.||+|.+.....  ....+.+.+|+.+++++.| ||||++++++.+ 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            478999999999999999999987643     5799999865432  2335678999999999976 899999999876 


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           88 QKRVYLILEYAAKGELYKELQKC----------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                      ++.+++||||+++|+|.++++..                ..+++..+..++.||+.||+|||+++|+||||||+||+++.
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence            45789999999999999999753                34899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038249          152 QGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRI  225 (281)
Q Consensus       152 ~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~  225 (281)
                      ++.+||+|||++.......     ....+|+.|+|||++.+..++.++|||||||++|||+| |..||.+....+.+...
T Consensus       221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~  300 (353)
T 4ase_A          221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  300 (353)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred             CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999996543322     23457899999999999999999999999999999998 99999987766655544


Q ss_pred             hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC--CccccCC
Q 038249          226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH--PWIIQNA  273 (281)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~--~~~~~~~  273 (281)
                      .......+.+..++.++.+++.+||+.||++|||+.||++|  .+++.+.
T Consensus       301 i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          301 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            44333344445789999999999999999999999999987  5555443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.8e-54  Score=364.15  Aligned_cols=257  Identities=37%  Similarity=0.631  Sum_probs=231.3

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +.+++|++++.||+|+||+||+|+++.+|+.||+|++.............+.+|+.+++.++||||+++++++...+.++
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            56889999999999999999999999999999999997654323333456788999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CC
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NR  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~  169 (281)
                      +||||++|++|...+...+.+++..++.++.||+.||+|||++||+|+||+|+||+++.+|.++|+|||++....   ..
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            999999999999999988889999999999999999999999999999999999999999999999999986432   22


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM  249 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  249 (281)
                      ....++|+.|+|||++.+..++.++|+||||+++++|++|..||...+..+....+......++.  .++.++.++|.+|
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~l  239 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGL  239 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHH
T ss_pred             ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHH
Confidence            34457899999999999989999999999999999999999999988888888877776655544  6899999999999


Q ss_pred             cccCCCCCC-----ChhhhhcCCcccc
Q 038249          250 LVKDSSQRL-----PLHKLLEHPWIIQ  271 (281)
Q Consensus       250 l~~~p~~Rp-----s~~eil~~~~~~~  271 (281)
                      |+.||++||     +++|+++||||..
T Consensus       240 L~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          240 LKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             TCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             hhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            999999999     8999999999974

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7e-55  Score=368.82  Aligned_cols=262  Identities=33%  Similarity=0.616  Sum_probs=228.3

Q ss_pred             hhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEE
Q 038249            8 KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFY   86 (281)
Q Consensus         8 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~   86 (281)
                      ....++.+++|++.+.||+|+||+||+|+++.+++.||+|++.............+.+|..+++.+ +||||+++++++.
T Consensus        15 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           15 NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             --------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CCcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            344567889999999999999999999999999999999999765444444456678899999988 7999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           87 DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      +.+.+++||||++|++|...+...+.+++..++.++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++...
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999998643


Q ss_pred             cC---CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHH
Q 038249          167 FN---RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK  243 (281)
Q Consensus       167 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  243 (281)
                      ..   .....++|+.|+|||++.+..++.++|+||||+++++|++|..||...+..+....+......++.  .++.++.
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~  252 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLHEDAT  252 (353)
T ss_dssp             CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred             ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHH
Confidence            22   234457899999999998888999999999999999999999999999999999888887766654  5899999


Q ss_pred             HHHHHhcccCCCCCCCh------hhhhcCCcccc
Q 038249          244 DLISQMLVKDSSQRLPL------HKLLEHPWIIQ  271 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~------~eil~~~~~~~  271 (281)
                      ++|++||+.||++||++      ++|++||||++
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            99999999999999998      89999999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3e-54  Score=364.75  Aligned_cols=259  Identities=35%  Similarity=0.603  Sum_probs=236.6

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      .+..+++|++.+.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+++++.++||||+++++++.+.+.
T Consensus        36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  115 (350)
T 1rdq_E           36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            34677999999999999999999999999999999999976544333345678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      +++||||+++++|.+++...+.+++..++.++.||+.||.+||++||+|+||+|+||+++.+|.++|+|||++.......
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~  195 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999997766666


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ...++|+.|+|||++.+..++.++|+||||+++++|++|..||...+..+....+......++.  .++.++.++|.+||
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL  273 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHS
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence            6678999999999999889999999999999999999999999998888888888877665544  68999999999999


Q ss_pred             ccCCCCCCC-----hhhhhcCCcccc
Q 038249          251 VKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       251 ~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      +.||++||+     +++|++||||..
T Consensus       274 ~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          274 QVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             hcCHHhccCCccCCHHHHHhCcCcCC
Confidence            999999998     999999999974

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.2e-54  Score=362.82  Aligned_cols=261  Identities=31%  Similarity=0.590  Sum_probs=228.9

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      ....+.+++|++.+.||+|+||.||+|+++.+|+.||+|++.............+..|..+++.+ +||||+++++++.+
T Consensus        10 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~   89 (345)
T 1xjd_A           10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT   89 (345)
T ss_dssp             ------CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             ccCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence            34567889999999999999999999999999999999999765432223345577788888876 99999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      .+.+++||||++|++|.+++...+.+++..++.++.||+.||+|||++||+|+||+|+||+++.+|.++|+|||++....
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999999999999988889999999999999999999999999999999999999999999999999986432


Q ss_pred             ---CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHH
Q 038249          168 ---NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       168 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (281)
                         ......+||+.|+|||++.+..++.++|+||||+++++|++|..||...+..+....+......++.  .++.++.+
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~  247 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKD  247 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred             cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc--ccCHHHHH
Confidence               2334567899999999999988999999999999999999999999998888888888776655544  58999999


Q ss_pred             HHHHhcccCCCCCCChh-hhhcCCcccc
Q 038249          245 LISQMLVKDSSQRLPLH-KLLEHPWIIQ  271 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~-eil~~~~~~~  271 (281)
                      +|.+||+.||++||++. +|++||||+.
T Consensus       248 li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHHHhcCCHhHcCCChHHHHcCccccC
Confidence            99999999999999998 9999999975

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.9e-54  Score=352.15  Aligned_cols=263  Identities=66%  Similarity=1.159  Sum_probs=232.6

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      +..|.+++|++.+.||.|++|+||+|.+..++..+|+|++.............+.+|+.++++++||||+++++++.+.+
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (279)
T 3fdn_A            3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   82 (279)
T ss_dssp             -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence            45789999999999999999999999999999999999997655444444567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ..++|+||+++++|.+.+...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999987544332


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                       .....+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.......+.  .++.++.++|.+
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~  240 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISR  240 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHH
T ss_pred             cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC--cCCHHHHHHHHH
Confidence             34456899999999999988999999999999999999999999988888887777665554443  689999999999


Q ss_pred             hcccCCCCCCChhhhhcCCccccCCC
Q 038249          249 MLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      ||+.||++|||++|+++||||+....
T Consensus       241 ~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          241 LLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             HCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             HhccChhhCCCHHHHhhCccccCCcc
Confidence            99999999999999999999997644

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.4e-53  Score=357.02  Aligned_cols=259  Identities=29%  Similarity=0.567  Sum_probs=228.1

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCC
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQK   89 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~   89 (281)
                      ..+.+++|++.+.||+|+||.||+|+++.+++.||+|++...........+.+.+|..+++++ +||||+++++++.+.+
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            356789999999999999999999999999999999999877666666667788999999988 8999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc--
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF--  167 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~--  167 (281)
                      .+++||||+++++|.+++...+.+++..++.++.||+.||++||++||+|+||+|+||+++.++.++|+|||++....  
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999999999888889999999999999999999999999999999999999999999999999986422  


Q ss_pred             -CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCC---------CchHHHHHHhhccccCCCCCC
Q 038249          168 -NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAK---------EHSDTYRRIVQVDLKFPPKPI  237 (281)
Q Consensus       168 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~  237 (281)
                       ......++|+.|+|||++.+..++.++|+||||+++++|++|..||...         ......+.+.......+  ..
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~  241 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RS  241 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC--TT
T ss_pred             CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC--CC
Confidence             2334557899999999999989999999999999999999999999752         22234444555544444  36


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCh------hhhhcCCcccc
Q 038249          238 VSSAAKDLISQMLVKDSSQRLPL------HKLLEHPWIIQ  271 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~------~eil~~~~~~~  271 (281)
                      ++.++.++|.+||+.||++||++      +|+++||||..
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            89999999999999999999996      79999999974

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.6e-53  Score=364.64  Aligned_cols=261  Identities=28%  Similarity=0.552  Sum_probs=224.1

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      ....+.+++|++++.||+|+||+||+|+++.+++.||+|++...........+.+..|..+++++ +||||+++++++.+
T Consensus        45 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~  124 (396)
T 4dc2_A           45 ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT  124 (396)
T ss_dssp             ----CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence            34567789999999999999999999999999999999999876655555455677888888876 89999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc-
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT-  166 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~-  166 (281)
                      .+.+++||||+++++|...+...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++... 
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999999999999998888999999999999999999999999999999999999999999999999998642 


Q ss_pred             --cCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCC---------chHHHHHHhhccccCCCC
Q 038249          167 --FNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE---------HSDTYRRIVQVDLKFPPK  235 (281)
Q Consensus       167 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~  235 (281)
                        .......+||+.|+|||++.+..++.++|+||||+++++|++|..||....         .....+.+.......+. 
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~-  283 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-  283 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT-
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC-
Confidence              223455678999999999999999999999999999999999999996432         22244455555544444 


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCh------hhhhcCCcccc
Q 038249          236 PIVSSAAKDLISQMLVKDSSQRLPL------HKLLEHPWIIQ  271 (281)
Q Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~------~eil~~~~~~~  271 (281)
                       .++.++.++|++||+.||++||++      +||++||||+.
T Consensus       284 -~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          284 -SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             -TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             -cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence             689999999999999999999996      79999999974

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-53  Score=360.73  Aligned_cols=261  Identities=30%  Similarity=0.560  Sum_probs=229.8

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      ...++.+++|++.+.||+|+||.||+|+++.+++.||+|++...........+.+..|..+++.+ +||+|+++++++.+
T Consensus        13 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~   92 (353)
T 2i0e_A           13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT   92 (353)
T ss_dssp             ------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred             CcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence            44567889999999999999999999999999999999999765433333345677899999887 79999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      .+..++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+|+||+|+||+++.+|.++|+|||++....
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999999999999987889999999999999999999999999999999999999999999999999986532


Q ss_pred             ---CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHH
Q 038249          168 ---NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       168 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (281)
                         ......+||+.|+|||++.+..++.++|+||||+++++|++|..||...+..+..+.+......++.  .++.++.+
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~  250 (353)
T 2i0e_A          173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVA  250 (353)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred             cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHH
Confidence               2334567899999999999889999999999999999999999999998888888888877665554  68999999


Q ss_pred             HHHHhcccCCCCCCC-----hhhhhcCCcccc
Q 038249          245 LISQMLVKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       245 li~~~l~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      +|.+||+.||++||+     +++|++||||+.
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            999999999999995     699999999974

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.5e-53  Score=360.19  Aligned_cols=257  Identities=33%  Similarity=0.568  Sum_probs=229.1

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS---QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|.+........   ...+.+.+|+.++++++||||+++++++.+.+.+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            4679999999999999999999999999999999976543211   1235688999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC----cEEEeeecCccccc
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWSVHTF  167 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~----~~~l~dfg~~~~~~  167 (281)
                      ++||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++    .++|+|||++....
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999999888899999999999999999999999999999999999998877    79999999986543


Q ss_pred             CC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHH
Q 038249          168 NR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAK  243 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~  243 (281)
                      ..  .....+|+.|+|||++.+..++.++|+||||+++++|++|..||...+..+....+......++.  +..++.++.
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  250 (361)
T 2yab_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK  250 (361)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence            32  34456899999999999889999999999999999999999999998888888888776554442  246899999


Q ss_pred             HHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      ++|.+||..||++|||+.|+++||||+.
T Consensus       251 ~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          251 DFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            9999999999999999999999999984

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.5e-53  Score=348.98  Aligned_cols=257  Identities=26%  Similarity=0.456  Sum_probs=225.6

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|.+.......   .+.+.+|+.++++++||||+++++++...+..++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            3468999999999999999999999999999999997654333   3457889999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---c
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---R  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~  170 (281)
                      ||||+++++|.+++... .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++......   .
T Consensus        95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            99999999999999875 5899999999999999999999999999999999999999999999999987554322   2


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-cccCCCCCCCCHHHHHHHHHh
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-DLKFPPKPIVSSAAKDLISQM  249 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~  249 (281)
                      ....+++.|+|||.+.+..++.++||||||+++++|++|..||...+.......+... .........++..+.++|.+|
T Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  253 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (297)
T ss_dssp             CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred             CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence            3456899999999999989999999999999999999999999888777665554433 223334456899999999999


Q ss_pred             cccCCCCCCChhhhhcCCccccCCC
Q 038249          250 LVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       250 l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      |+.||++|||+.|+++||||+....
T Consensus       254 l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          254 LEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ccCChhHCcCHHHHhhChhhcccCc
Confidence            9999999999999999999997644

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.7e-53  Score=350.43  Aligned_cols=263  Identities=32%  Similarity=0.566  Sum_probs=220.7

Q ss_pred             hhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccc-----------------------hHHHHHHH
Q 038249            8 KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-----------------------SQVEHQLR   64 (281)
Q Consensus         8 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~-----------------------~~~~~~~~   64 (281)
                      .....+.+++|++.+.||+|+||.||+|.+..+++.||+|++.......                       ....+.+.
T Consensus         5 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (298)
T 2zv2_A            5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY   84 (298)
T ss_dssp             -----CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHH
T ss_pred             cCCCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence            3445677899999999999999999999999999999999996554221                       11235678


Q ss_pred             HHHHHHHhCCCCceeeeeeEEEe--CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCC
Q 038249           65 REVEIQSHLRHPNILRLYGYFYD--QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDI  142 (281)
Q Consensus        65 ~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di  142 (281)
                      +|++++++++||||+++++++.+  .+..++||||+++++|.++... +++++..++.++.||+.||.+||++|++|+||
T Consensus        85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  163 (298)
T 2zv2_A           85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI  163 (298)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence            99999999999999999999986  5789999999999999886544 56999999999999999999999999999999


Q ss_pred             CCCCeEeCCCCcEEEeeecCcccccCC---cccccCcCCccCCccccCCC---CCCcccHHhHHHHHHHHHhCCCCCCCC
Q 038249          143 KPENLLIGAQGELKIADFGWSVHTFNR---RRTMCGTLDYLPPEMVESVE---HDANVDIWSLGVLCYEFLYGVPPFEAK  216 (281)
Q Consensus       143 ~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~  216 (281)
                      +|+||+++.++.++|+|||++......   .....+++.|+|||.+.+..   .+.++||||||+++++|++|..||...
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            999999999999999999998654332   23456899999999987655   367899999999999999999999988


Q ss_pred             CchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          217 EHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      ........+.......+..+.++.++.++|.+||+.||++|||+.|+++||||.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            7777777776666666666679999999999999999999999999999999964

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.7e-54  Score=360.77  Aligned_cols=258  Identities=31%  Similarity=0.605  Sum_probs=224.4

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      ...+++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            45678999999999999999999999999999999999655433333345688999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      ++|+||+ +++|.+.+...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            9999999 5689999888788999999999999999999999999999999999999999999999999998654333  


Q ss_pred             cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                      ....++++.|+|||.+.+..+ +.++||||||+++++|++|..||......+....+.......  ...++.++.++|.+
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~  241 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM--PDFLSPGAQSLIRR  241 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCC--CTTSCHHHHHHHHT
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC--cccCCHHHHHHHHH
Confidence            345578999999999987775 689999999999999999999998776665544444433333  33689999999999


Q ss_pred             hcccCCCCCCChhhhhcCCccccC
Q 038249          249 MLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ||+.||++|||++|+++||||+..
T Consensus       242 ~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          242 MIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             TSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HcCCChhHCcCHHHHHhChhhccC
Confidence            999999999999999999999865

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=364.88  Aligned_cols=257  Identities=32%  Similarity=0.587  Sum_probs=229.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||+|+||+||+|.++.+|+.+|+|.+...... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            46899999999999999999999999999999999766533 33456788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC---CCCcEEEeeecCcccccCCc-
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG---AQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~---~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      |||++|++|.+.+...+.+++..+..++.||+.||.|||++||+|+||+|+||+++   .++.++|+|||++....... 
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            99999999999999888899999999999999999999999999999999999998   45789999999986544332 


Q ss_pred             --ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHHHHH
Q 038249          171 --RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAKDLI  246 (281)
Q Consensus       171 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li  246 (281)
                        ....+|+.|+|||++.+..++.++||||||+++++|++|.+||...+..+....+..+....+.  +..++.++.++|
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  248 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI  248 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence              3456899999999999989999999999999999999999999999888888888777655443  457899999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .+||+.||++|||+.|+|+||||.+.
T Consensus       249 ~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          249 NKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHcCCChhHCCCHHHHhcCccccCC
Confidence            99999999999999999999999753

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.4e-53  Score=346.54  Aligned_cols=265  Identities=66%  Similarity=1.171  Sum_probs=233.3

Q ss_pred             hhhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249            7 AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus         7 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      ......+.+++|++.+.||+|++|.||+|.+..++..+|+|.+.............+.+|+++++.++||||+++++++.
T Consensus         5 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A            5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             -----CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            34567788999999999999999999999999999999999997654333333467889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           87 DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      +.+..++|+||+++++|.+.+...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999987554


Q ss_pred             cC-CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          167 FN-RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       167 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                      .. ......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+....+.......+  ..++.++.++
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l  242 (284)
T 2vgo_A          165 PSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDGSKDL  242 (284)
T ss_dssp             SSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--TTSCHHHHHH
T ss_pred             cccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC--CcCCHHHHHH
Confidence            33 23445689999999999988899999999999999999999999998888877777766655444  3689999999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      |.+||+.||++|||++++++||||++..
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            9999999999999999999999999763

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.9e-52  Score=344.75  Aligned_cols=257  Identities=27%  Similarity=0.484  Sum_probs=214.7

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++.+.||+|++|+||+|.++.+++.||+|++..... .......+.+|+.++++++||||+++++++.+++..++|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            4789999999999999999999999999999999976553 333456788899999999999999999999999999999


Q ss_pred             EeccCCCChhHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---Cc
Q 038249           95 LEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RR  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~  170 (281)
                      |||+++ ++.+.+ ...+.+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||++.....   ..
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence            999987 555544 4467799999999999999999999999999999999999999999999999999865432   22


Q ss_pred             ccccCcCCccCCccccCCC-CCCcccHHhHHHHHHHHHhCCCC-CCCCCchHHHHHHhhcccc-----------------
Q 038249          171 RTMCGTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPP-FEAKEHSDTYRRIVQVDLK-----------------  231 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~-----------------  231 (281)
                      ....+++.|+|||.+.+.. ++.++||||||+++++|++|..| |...+..+....+......                 
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence            3446789999999987655 79999999999999999987777 5555555555544331110                 


Q ss_pred             ----------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          232 ----------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       232 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                                ....+.++.++.++|.+||+.||++|||++|+++||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                      001124788999999999999999999999999999999754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-52  Score=355.00  Aligned_cols=258  Identities=33%  Similarity=0.601  Sum_probs=215.7

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      ....++|++.+.||+|+||+||+++++.+++.||+|++.......    ..+.+|+.+++.++||||+++++++...+..
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            345689999999999999999999999999999999996554332    3477899999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc--EEEeeecCcccc--c
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE--LKIADFGWSVHT--F  167 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~--~~l~dfg~~~~~--~  167 (281)
                      ++||||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.  ++|+|||++...  .
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999999999988888999999999999999999999999999999999999987765  999999988532  2


Q ss_pred             CCcccccCcCCccCCccccCCCCCCc-ccHHhHHHHHHHHHhCCCCCCCCCch----HHHHHHhhccccCCCCCCCCHHH
Q 038249          168 NRRRTMCGTLDYLPPEMVESVEHDAN-VDIWSLGVLCYEFLYGVPPFEAKEHS----DTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       168 ~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                      .......+|+.|+|||.+.+..++.+ +||||||+++++|++|..||......    .....+.......+....++.++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  251 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC  251 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence            22344568999999999987777655 89999999999999999999875543    34444555555666666789999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .++|.+||+.||++|||+.|+++||||.++.
T Consensus       252 ~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          252 CHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            9999999999999999999999999997764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.3e-52  Score=354.98  Aligned_cols=255  Identities=31%  Similarity=0.609  Sum_probs=228.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999999999999999999765543 334567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC---cEEEeeecCcccccCCc--
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---ELKIADFGWSVHTFNRR--  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~---~~~l~dfg~~~~~~~~~--  170 (281)
                      ||+++++|.+.+.....+++..++.++.||+.||.|||++||+|+||+|+||+++.++   .++|+|||++.......  
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~  187 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW  187 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence            9999999999998888899999999999999999999999999999999999998654   59999999986544332  


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHHHHHHH
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAKDLISQ  248 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~  248 (281)
                      ....+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......++.  +..++.++.++|.+
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  267 (362)
T 2bdw_A          188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS  267 (362)
T ss_dssp             CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHH
T ss_pred             ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence            3456899999999999889999999999999999999999999998888888877776555443  34689999999999


Q ss_pred             hcccCCCCCCChhhhhcCCcccc
Q 038249          249 MLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      ||+.||++|||+.++|+||||..
T Consensus       268 ~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          268 MLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HcCCChhhCcCHHHHhcCcccCC
Confidence            99999999999999999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-52  Score=351.06  Aligned_cols=258  Identities=31%  Similarity=0.555  Sum_probs=227.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS---QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .++|++.+.||+|+||.||+|.++.+|+.+|+|++........   ...+.+.+|+.++++++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3679999999999999999999999999999999976543211   1245688999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC----cEEEeeecCccccc
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWSVHTF  167 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~----~~~l~dfg~~~~~~  167 (281)
                      ++|+||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++    .++|+|||++....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999999888899999999999999999999999999999999999999887    89999999986543


Q ss_pred             C--CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHH
Q 038249          168 N--RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAK  243 (281)
Q Consensus       168 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~  243 (281)
                      .  ......+++.|+|||.+.+..++.++||||||+++++|++|..||......+....+.......+.  ...++.++.
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (326)
T 2y0a_A          170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  249 (326)
T ss_dssp             TTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHH
Confidence            2  234456899999999999889999999999999999999999999988887777776665443332  246889999


Q ss_pred             HHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ++|.+||+.||++|||+.++|+||||+..
T Consensus       250 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          250 DFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            99999999999999999999999999854

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-52  Score=356.90  Aligned_cols=260  Identities=34%  Similarity=0.632  Sum_probs=224.1

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCceeeeeeEEEeC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI-QSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~~   88 (281)
                      ......++|++.+.||+|+||.||+|+++.+++.||+|++.............+..|..+ ++.++||||+++++++.+.
T Consensus        32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~  111 (373)
T 2r5t_A           32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA  111 (373)
T ss_dssp             CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred             CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence            456778999999999999999999999999999999999987665544444556666665 5678999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc-
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF-  167 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~-  167 (281)
                      +.+++||||++|++|.+++...+.+++..++.++.||+.||+|||++||+|+||+|+||+++.+|+++|+|||++.... 
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999999999999988889999999999999999999999999999999999999999999999999986422 


Q ss_pred             --CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          168 --NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       168 --~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                        ......+||+.|+|||++.+..++.++|+||||+++++|++|..||...+..+....+.......+.  .++.++.++
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~l  269 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP--NITNSARHL  269 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS--SSCHHHHHH
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHH
Confidence              2334567899999999999999999999999999999999999999998888888888777555543  689999999


Q ss_pred             HHHhcccCCCCCCCh----hhhhcCCcccc
Q 038249          246 ISQMLVKDSSQRLPL----HKLLEHPWIIQ  271 (281)
Q Consensus       246 i~~~l~~~p~~Rps~----~eil~~~~~~~  271 (281)
                      |.+||+.||++||++    ++|++||||+.
T Consensus       270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            999999999999997    69999999974

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.6e-53  Score=363.63  Aligned_cols=261  Identities=32%  Similarity=0.538  Sum_probs=229.1

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ......++|++.+.||+|+||+||+|+++.+++.||+|++.............+.+|+.+++.++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            44567789999999999999999999999999999999996543222222234778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .+++||||++|++|.++++.. .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            999999999999999999874 5899999999999999999999999999999999999999999999999998654332


Q ss_pred             ----cccccCcCCccCCccccCCC----CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccCCCCCCCC
Q 038249          170 ----RRTMCGTLDYLPPEMVESVE----HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPIVS  239 (281)
Q Consensus       170 ----~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~  239 (281)
                          ....+||+.|+|||++.+..    ++.++|+||||+++|+|++|..||...+..+....+....  ..++....++
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence                23567999999999987655    6789999999999999999999999988888888877643  4555556799


Q ss_pred             HHHHHHHHHhcccCCCC--CCChhhhhcCCcccc
Q 038249          240 SAAKDLISQMLVKDSSQ--RLPLHKLLEHPWIIQ  271 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~--Rps~~eil~~~~~~~  271 (281)
                      .++.++|.+||+.+|++  ||+++||++||||+.
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            99999999999999988  999999999999985

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-52  Score=351.49  Aligned_cols=257  Identities=30%  Similarity=0.557  Sum_probs=220.9

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++.+.||+|+||+||+|.+..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            58999999999999999999999999999999998654322  2235678999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-----
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-----  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-----  169 (281)
                      |||+++++|.++++....+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||++......     
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            999999999999998888999999999999999999999999999999999999999999999999998543211     


Q ss_pred             cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      .....+++.|+|||.+.+..+ +.++||||||+++++|++|..||...... ..................++.++.++|.
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence            234568999999999877665 67899999999999999999999876654 3334444444444445578999999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +||+.||++|||++|+++||||++..
T Consensus       244 ~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          244 KILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHccCChhhCcCHHHHhhChhhcccc
Confidence            99999999999999999999998763

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-52  Score=351.55  Aligned_cols=255  Identities=27%  Similarity=0.482  Sum_probs=227.5

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||+|+||.||+|.++.+++.+|+|.+....    .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            578999999999999999999999999999999986432    2345688999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC--CCcEEEeeecCcccccCC--
Q 038249           95 LEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA--QGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~--~~~~~l~dfg~~~~~~~~--  169 (281)
                      |||+++++|.+.+... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.  ++.++|+|||++......  
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            9999999999999865 46999999999999999999999999999999999999987  789999999998654332  


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAKDLIS  247 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~  247 (281)
                      .....+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+......++.  ++.++.++.++|.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  239 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD  239 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHH
Confidence            23456899999999998888899999999999999999999999998888888887776554442  2468999999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +||..||++|||+.|+|+||||++..
T Consensus       240 ~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          240 RLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             TTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHcCCChhHCcCHHHHhcChhhccCc
Confidence            99999999999999999999998763

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-52  Score=367.17  Aligned_cols=263  Identities=31%  Similarity=0.598  Sum_probs=234.3

Q ss_pred             hhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249            8 KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus         8 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      .....+.+++|++++.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~   87 (476)
T 2y94_A            8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST   87 (476)
T ss_dssp             -CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            34456778999999999999999999999999999999999976543333345678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      .+..++|+||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999999999999988889999999999999999999999999999999999999999999999999986543


Q ss_pred             CC--cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHH
Q 038249          168 NR--RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (281)
                      ..  ....++++.|+|||.+.+..+ +.++||||||+++++|++|..||...+.......+..+....+  ..++.++.+
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~  245 (476)
T 2y94_A          168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP--QYLNPSVIS  245 (476)
T ss_dssp             TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC--TTCCHHHHH
T ss_pred             ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC--ccCCHHHHH
Confidence            32  344578999999999987765 6799999999999999999999999888888888777655444  368999999


Q ss_pred             HHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          245 LISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +|.+||+.||++|||+.++++||||++.
T Consensus       246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          246 LLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            9999999999999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.6e-52  Score=355.14  Aligned_cols=261  Identities=27%  Similarity=0.528  Sum_probs=226.4

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ....+.+++|++.+.||+|+||.||+|.++.+++.||+|++...........+.+.+|+++++.++||||+++++++.+.
T Consensus         8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A            8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            34567789999999999999999999999999999999999765443333456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      +..++|+||+.|++|..++...+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.+|.++|+|||++.....
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999865432


Q ss_pred             --CcccccCcCCccCCccccC---CCCCCcccHHhHHHHHHHHHhCCCCCCCCCch---HHHHHHhhccccCCCCCCCCH
Q 038249          169 --RRRTMCGTLDYLPPEMVES---VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS---DTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       169 --~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  240 (281)
                        .....++|+.|+|||++.+   ..++.++|+||||+++|+|++|..||......   +....+.......+  ..++.
T Consensus       168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p--~~~s~  245 (384)
T 4fr4_A          168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP--SAWSQ  245 (384)
T ss_dssp             TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC--TTSCH
T ss_pred             CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC--CcCCH
Confidence              2345678999999999863   45788999999999999999999999754433   33334444433333  36899


Q ss_pred             HHHHHHHHhcccCCCCCCC-hhhhhcCCcccc
Q 038249          241 AAKDLISQMLVKDSSQRLP-LHKLLEHPWIIQ  271 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps-~~eil~~~~~~~  271 (281)
                      ++.++|.+||+.||++||+ ++++++||||..
T Consensus       246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            9999999999999999998 899999999974

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-51  Score=341.59  Aligned_cols=263  Identities=29%  Similarity=0.549  Sum_probs=235.2

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      ....++|++.+.||+|++|.||+|.+..+++.+|+|.+...........+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            45568899999999999999999999999999999999776555556677889999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---C
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---N  168 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~  168 (281)
                      ++|+||+++++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....   .
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999985532   2


Q ss_pred             CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                      ......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+....+.......+  ..++.++.++|.+
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~  248 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--KHINPVAASLIQK  248 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--TTSCHHHHHHHHH
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc--cccCHHHHHHHHH
Confidence            23345688999999999888899999999999999999999999998887777776666554443  3689999999999


Q ss_pred             hcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          249 MLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                      ||+.||++|||++++++||||.+...+.
T Consensus       249 ~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          249 MLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HcccChhhCcCHHHHhhChheecCCcCC
Confidence            9999999999999999999999886654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-52  Score=343.14  Aligned_cols=264  Identities=34%  Similarity=0.661  Sum_probs=203.0

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .-.+++|++.+.||+|++|.||+|.+..+|+.||+|.+...........+.+.+|+.++++++||||+++++++.+.+..
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            34568899999999999999999999999999999999655433333346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           92 YLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      ++|+||+++++|.+++... .++++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999999875 56999999999999999999999999999999999999999999999999998654322 


Q ss_pred             --cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          170 --RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                        .....+++.|+|||.+.+..++.++|+||||+++++|++|..||......+............  ...++.++.++|.
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~  244 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM--PSFLSIEAKDLIH  244 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC--CTTSCHHHHHHHH
T ss_pred             CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC--ccccCHHHHHHHH
Confidence              233467899999999988889999999999999999999999998877666665554443333  3358999999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCCCCCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNADPSG  277 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~~~~~  277 (281)
                      +||+.||++|||+.++++||||.+......
T Consensus       245 ~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  274 (278)
T 3cok_A          245 QLLRRNPADRLSLSSVLDHPFMSRNSSTKS  274 (278)
T ss_dssp             HHSCSSGGGSCCHHHHTTSTTTC-------
T ss_pred             HHcccCHhhCCCHHHHhcCccccCCCCccc
Confidence            999999999999999999999998755443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-52  Score=366.14  Aligned_cols=260  Identities=36%  Similarity=0.618  Sum_probs=223.6

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ...+.+++|++.+.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+++.++||||+++++++...+
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~  221 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD  221 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence            34567799999999999999999999999999999999997654444444566788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      .+++||||+++++|.+.+...+.+++..++.++.||+.||+|||+ .||+|+||+|+||+++.++.++|+|||++.....
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999999999999988889999999999999999999998 9999999999999999999999999999864322


Q ss_pred             ---CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          169 ---RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       169 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                         ......+|+.|+|||++.+..++.++||||||+++++|++|..||...+..+....+......++.  .++.++.++
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~l  379 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLGPEAKSL  379 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHH
Confidence               234457899999999999999999999999999999999999999998888888888777655544  689999999


Q ss_pred             HHHhcccCCCCCC-----ChhhhhcCCcccc
Q 038249          246 ISQMLVKDSSQRL-----PLHKLLEHPWIIQ  271 (281)
Q Consensus       246 i~~~l~~~p~~Rp-----s~~eil~~~~~~~  271 (281)
                      |.+||+.||++||     +++|+++||||..
T Consensus       380 i~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          380 LSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            9999999999999     9999999999985

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.4e-52  Score=348.30  Aligned_cols=261  Identities=33%  Similarity=0.639  Sum_probs=221.0

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhCCCCceeeeeeE
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLRHPNILRLYGY   84 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~   84 (281)
                      ....+..++|++.+.||+|+||.||+|++.   .+++.+|+|++...... .......+.+|+.++++++||||++++++
T Consensus        10 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             ---CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence            344677799999999999999999999985   68899999999765332 22234557789999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           85 FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      +...+..++||||+++++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           90 FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999999999999988889999999999999999999999999999999999999999999999999985


Q ss_pred             cccC---CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          165 HTFN---RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       165 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                      ....   ......+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.......+.  .++.+
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~  247 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP--YLTQE  247 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT--TSCHH
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHH
Confidence            4322   233456899999999998888999999999999999999999999998888888887776655543  68999


Q ss_pred             HHHHHHHhcccCCCCCC-----ChhhhhcCCcccc
Q 038249          242 AKDLISQMLVKDSSQRL-----PLHKLLEHPWIIQ  271 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rp-----s~~eil~~~~~~~  271 (281)
                      +.++|.+||..||++||     +++++++||||++
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            99999999999999999     7899999999974

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-51  Score=338.98  Aligned_cols=260  Identities=30%  Similarity=0.594  Sum_probs=230.9

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||.|++|.||+|.++.+++.+|+|++...... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            47899999999999999999999999999999999766543 34456788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc---EEEeeecCcccccCCc-
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFNRR-  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~---~~l~dfg~~~~~~~~~-  170 (281)
                      +||+++++|.+.+...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.   ++|+|||.+....... 
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            999999999999988888999999999999999999999999999999999999987665   9999999985543332 


Q ss_pred             -ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHHHHHH
Q 038249          171 -RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAKDLIS  247 (281)
Q Consensus       171 -~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~  247 (281)
                       ....+++.|+|||.+.+..++.++||||||+++++|++|..||......+....+.......+.  ...++.++.++|.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  243 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence             3356899999999999988999999999999999999999999998888888777666554443  3468999999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      +||++||++|||+.|+++||||++....
T Consensus       244 ~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          244 SMLTVNPKKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             HHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred             HHcccChhhCCCHHHHhcCccccCChhH
Confidence            9999999999999999999999976443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-52  Score=362.69  Aligned_cols=262  Identities=32%  Similarity=0.553  Sum_probs=227.1

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ...+..++|++.+.||+|+||+||+|+++.+++.||+|++.............+.+|..+++.++||||+++++++.+.+
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            34566789999999999999999999999999999999996543322222334778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           90 RVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      .+++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence            99999999999999999987 46799999999999999999999999999999999999999999999999999855432


Q ss_pred             C----cccccCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccCCCC-C
Q 038249          169 R----RRTMCGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPK-P  236 (281)
Q Consensus       169 ~----~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~-~  236 (281)
                      .    ....+||+.|+|||++.     ...++.++|+||||+++++|++|..||...+..+....+....  ..++.. .
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  307 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT  307 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence            2    22357899999999986     5568899999999999999999999999988888888776543  333332 3


Q ss_pred             CCCHHHHHHHHHhcccCCCC--CCChhhhhcCCcccc
Q 038249          237 IVSSAAKDLISQMLVKDSSQ--RLPLHKLLEHPWIIQ  271 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~--Rps~~eil~~~~~~~  271 (281)
                      .++.++.+||++||..+|++  ||+++|+++||||+.
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            58999999999999988888  999999999999974

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.5e-51  Score=352.28  Aligned_cols=261  Identities=20%  Similarity=0.318  Sum_probs=220.7

Q ss_pred             ccccCCceecceeccc--CceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           12 RWTLNDFDIGKPLGRG--KFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g--~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ....++|++++.||+|  ++|+||+|+++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            3456899999999999  999999999999999999999976643 3455677889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           90 RVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      ..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||.+....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999999999875  669999999999999999999999999999999999999999999999999864321


Q ss_pred             ----------CCcccccCcCCccCCccccC--CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc----
Q 038249          168 ----------NRRRTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK----  231 (281)
Q Consensus       168 ----------~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----  231 (281)
                                .......+++.|+|||.+.+  ..++.++|||||||++++|++|..||...+..+...........    
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence                      11233467889999999877  57899999999999999999999999887766655443322111    


Q ss_pred             ----------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          232 ----------------------------------------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       232 ----------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                                                              .+....++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                                                    0122347889999999999999999999999999999997


Q ss_pred             CC
Q 038249          272 NA  273 (281)
Q Consensus       272 ~~  273 (281)
                      ..
T Consensus       340 ~~  341 (389)
T 3gni_B          340 IK  341 (389)
T ss_dssp             C-
T ss_pred             Hh
Confidence            53

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.2e-52  Score=339.92  Aligned_cols=262  Identities=31%  Similarity=0.584  Sum_probs=223.2

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ...+..++|++.+.||+|++|.||+|.+..+|+.+|+|.+.............+.+|+..++.++||||+++++++...+
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT   84 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            45677899999999999999999999999999999999996654333334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ..++|+||+++++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999988654332


Q ss_pred             --cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          170 --RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                        .....+++.|+|||.+.+..+ +.++|+||||+++++|++|..||......+....+.......+  ..++.++.++|
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li  242 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP--EYLNRSVATLL  242 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHH
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc--hhcCHHHHHHH
Confidence              234467899999999987765 5789999999999999999999998887777777666544433  35899999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccCC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .+||+.||++|||+.++++||||++..
T Consensus       243 ~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          243 MHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHccCChhhCCCHHHHHhChhhccCc
Confidence            999999999999999999999998764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.2e-51  Score=345.76  Aligned_cols=262  Identities=29%  Similarity=0.552  Sum_probs=234.2

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      ...++|++.+.||+|+||.||++.+..+++.+++|.+...........+.+.+|+.+++.++|+||+++++++.+.+..+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            34578999999999999999999999999999999997766555566778899999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CC
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NR  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~  169 (281)
                      +|+||+++++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++....   ..
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            999999999999999888889999999999999999999999999999999999999999999999999986543   22


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM  249 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  249 (281)
                      .....+++.|+|||.+.+..++.++||||||+++++|++|..||......+....+.......+  ..++.++.++|.+|
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~  275 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--KHINPVAASLIQKM  275 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--TTSCHHHHHHHHHH
T ss_pred             ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC--ccCCHHHHHHHHHH
Confidence            3345689999999999888899999999999999999999999998887777776666554443  36899999999999


Q ss_pred             cccCCCCCCChhhhhcCCccccCCCCC
Q 038249          250 LVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       250 l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                      |+.||++|||++++++||||.+...++
T Consensus       276 l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          276 LQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             ccCChhHCcCHHHHhcCccccCCCccc
Confidence            999999999999999999999875544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-51  Score=343.75  Aligned_cols=259  Identities=27%  Similarity=0.480  Sum_probs=218.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++.+.||+|++|+||+|.+..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++...+..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            578999999999999999999999999999999986654 3344566788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      +||+++++|.+++...+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......   ..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            999999999999988888999999999999999999999999999999999999999999999999998654322   23


Q ss_pred             cccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-------------------c
Q 038249          172 TMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-------------------K  231 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~  231 (281)
                      ...+++.|+|||.+.+ ..++.++|+||||+++++|++|..||......+....+.....                   .
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            4467889999999865 6679999999999999999999999988877666544332100                   0


Q ss_pred             CCC----------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          232 FPP----------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       232 ~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      .+.          .+.++.++.++|.+||+.||++|||++|+++||||++..+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence            000          1358889999999999999999999999999999997643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-51  Score=343.94  Aligned_cols=261  Identities=28%  Similarity=0.454  Sum_probs=216.0

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ...-..++|++++.||+|+||+||+|.+. +++.||+|++..... .......+.+|++++++++||||+++++++.+.+
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            34445689999999999999999999996 589999999965432 2233466889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           90 RVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      ..++||||+++ +|.+.+... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99999999986 777777654 4599999999999999999999999999999999999999999999999999865432


Q ss_pred             ---CcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC-----------
Q 038249          169 ---RRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP-----------  233 (281)
Q Consensus       169 ---~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  233 (281)
                         ......+++.|+|||.+.+ ..++.++||||||+++++|++|..||......+....+........           
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence               2234467999999999865 5689999999999999999999999988777776655543111000           


Q ss_pred             -----------------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          234 -----------------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       234 -----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                                       ..+.++.++.++|.+||+.||++|||++|+|+||||++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                             0124778999999999999999999999999999998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.3e-52  Score=345.83  Aligned_cols=243  Identities=21%  Similarity=0.338  Sum_probs=189.0

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC----EE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK----RV   91 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~   91 (281)
                      .+|.+.+.||+|+||+||+|++.  |+.||||++....    ........|+..+.+++||||+++++++.+++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            56899999999999999999885  8899999985432    11222345666777889999999999998653    68


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK--------HVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      ++||||+++|+|.++++.. +++++.+..++.|++.||+|||++        +|+||||||+|||++.++++||+|||++
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999999875 589999999999999999999987        9999999999999999999999999998


Q ss_pred             ccccCC-------cccccCcCCccCCccccCC------CCCCcccHHhHHHHHHHHHhCCCCCCCCCc------------
Q 038249          164 VHTFNR-------RRTMCGTLDYLPPEMVESV------EHDANVDIWSLGVLCYEFLYGVPPFEAKEH------------  218 (281)
Q Consensus       164 ~~~~~~-------~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------  218 (281)
                      ......       ....+||+.|+|||++.+.      .++.++|||||||++|||+||.+|+.....            
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            654322       1234689999999998654      356789999999999999999776532111            


Q ss_pred             ---hHHHHHHhhccccCCCC-----CCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          219 ---SDTYRRIVQVDLKFPPK-----PIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       219 ---~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                         .+....+..........     ...+..+.+++.+||+.||++|||+.||++
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence               12222222222111111     012346889999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-52  Score=357.15  Aligned_cols=261  Identities=30%  Similarity=0.514  Sum_probs=224.9

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ...+..++|++.+.||+|+||+||+|+++.+|+.||+|++.............+.+|..++..++||||+++++++.+.+
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            34567799999999999999999999999999999999996544332223345778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           90 RVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      .+++||||++|++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++++||+|||++.....
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence            999999999999999999874 4799999999999999999999999999999999999999999999999999865433


Q ss_pred             C----cccccCcCCccCCcccc-------CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccCCC-
Q 038249          169 R----RRTMCGTLDYLPPEMVE-------SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPP-  234 (281)
Q Consensus       169 ~----~~~~~~~~~~~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~-  234 (281)
                      .    ....+||+.|+|||++.       ...++.++|+||||+++++|++|..||...+..+....+....  ...+. 
T Consensus       215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  294 (412)
T 2vd5_A          215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV  294 (412)
T ss_dssp             TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred             CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence            2    22357899999999986       3568899999999999999999999999988888887776532  23332 


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCC---CChhhhhcCCcccc
Q 038249          235 KPIVSSAAKDLISQMLVKDSSQR---LPLHKLLEHPWIIQ  271 (281)
Q Consensus       235 ~~~~~~~l~~li~~~l~~~p~~R---ps~~eil~~~~~~~  271 (281)
                      ...++.+++++|++||. +|++|   |+++||++||||+.
T Consensus       295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence            24689999999999999 99998   59999999999974

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-51  Score=339.88  Aligned_cols=255  Identities=31%  Similarity=0.515  Sum_probs=212.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++.+.||+|+||+||+|.+ .+++.+|+|++...... ......+.+|++++++++||||+++++++...+..++|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            47899999999999999999999 57899999999654422 22235677899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---Cc
Q 038249           95 LEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RR  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~  170 (281)
                      +||+++ +|.+++... +.+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||++.....   ..
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            999987 898888764 6699999999999999999999999999999999999999999999999998754322   22


Q ss_pred             ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc------------------
Q 038249          171 RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK------------------  231 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  231 (281)
                      ....+++.|+|||.+.+ ..++.++||||||+++++|++|..||...+..+....+......                  
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            33467999999999865 45889999999999999999999999988777666554331000                  


Q ss_pred             C---------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          232 F---------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       232 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .         .....++.++.++|.+||+.||++|||+.|+++||||+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            0         0013478999999999999999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.1e-51  Score=344.88  Aligned_cols=258  Identities=27%  Similarity=0.455  Sum_probs=226.0

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...........+.+.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45999999999999999999999999999999997665555555678899999999999999999999999999999999


Q ss_pred             eccCCCChhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCccccc
Q 038249           96 EYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMC  174 (281)
Q Consensus        96 e~~~~~~L~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  174 (281)
                      ||+.| +|.+.+. ...++++..++.++.+++.||.+||++|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus       134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-~~~~~  211 (348)
T 1u5q_A          134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANSFV  211 (348)
T ss_dssp             ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-BCCCC
T ss_pred             ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-CCccc
Confidence            99985 7777775 456799999999999999999999999999999999999999999999999999865433 34457


Q ss_pred             CcCCccCCcccc---CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          175 GTLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       175 ~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      +++.|+|||.+.   ...++.++||||||+++++|++|..||...+..+....+............++.++.++|.+||+
T Consensus       212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  291 (348)
T 1u5q_A          212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ  291 (348)
T ss_dssp             SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            899999999973   56788899999999999999999999988887777666665544444445789999999999999


Q ss_pred             cCCCCCCChhhhhcCCccccCCCC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      .||++|||++++++||||.+...+
T Consensus       292 ~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          292 KIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             SSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             cChhhCcCHHHHhhChhhhccCCc
Confidence            999999999999999999876443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-51  Score=346.50  Aligned_cols=262  Identities=29%  Similarity=0.447  Sum_probs=212.5

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ......+++|++.+.||+|++|+||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++...
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN  105 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            3455677899999999999999999999999999999999965542 333345677899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC-----CCCcEEEeeecCc
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG-----AQGELKIADFGWS  163 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~-----~~~~~~l~dfg~~  163 (281)
                      +..++||||+++ +|.+++...+.+++..++.++.||+.||.+||++||+|+||+|+||+++     .++.++|+|||++
T Consensus       106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999999999986 9999999888899999999999999999999999999999999999994     4556999999988


Q ss_pred             cccc---CCcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--C--
Q 038249          164 VHTF---NRRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--K--  235 (281)
Q Consensus       164 ~~~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~--  235 (281)
                      ....   .......+++.|+|||.+.+. .++.++||||||+++++|++|..||......+....+.........  +  
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence            5432   222334579999999998764 4799999999999999999999999988877766655432110000  0  


Q ss_pred             ------------------------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          236 ------------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       236 ------------------------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                                              ..++.++.+||.+||+.||++|||++|+|+||||++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                                    1167899999999999999999999999999999976

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.1e-51  Score=349.67  Aligned_cols=257  Identities=27%  Similarity=0.543  Sum_probs=218.7

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch--HHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS--QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      -++|++.+.||+|+||+||+|.++.+++.||+|++........  ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3679999999999999999999999999999999865432111  12456889999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc---EEEeeecCccc
Q 038249           93 LILEYAAKGELYKELQKC----KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWSVH  165 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~---~~l~dfg~~~~  165 (281)
                      +||||+++++|.+.+...    ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.   ++|+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999998877542    35899999999999999999999999999999999999987654   99999999865


Q ss_pred             ccCC---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCH
Q 038249          166 TFNR---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSS  240 (281)
Q Consensus       166 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  240 (281)
                      ....   .....+|+.|+|||++.+..++.++||||||+++++|++|..||... ..+....+.........  +..++.
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~  261 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISE  261 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCH
Confidence            4332   23456899999999999888999999999999999999999999764 34455555554443322  246899


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ++.++|.+||+.||++|||+.++|+||||++.
T Consensus       262 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          262 SAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            99999999999999999999999999999853

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.6e-51  Score=335.60  Aligned_cols=257  Identities=34%  Similarity=0.597  Sum_probs=227.1

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||+|++|.||+|.+..++..+++|++.......   .+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            467999999999999999999999999999999997654332   35688899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe---CCCCcEEEeeecCcccccCC--
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI---GAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~---~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      +||+++++|.+.+...+.+++..++.++.|++.||.+||++|++|+||+|+||++   +.++.++|+|||++......  
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            9999999999999888889999999999999999999999999999999999999   78889999999998554322  


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCC--CCCCHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLIS  247 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~  247 (281)
                      .....+++.|+|||.+.+. ++.++|+||||+++++|++|..||......+....+.......+..  ..++.++.++|.
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIR  243 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHH
T ss_pred             hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHH
Confidence            3445689999999998764 8889999999999999999999999988888887777765544431  358999999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      +||+.||++|||+.++++||||++....
T Consensus       244 ~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          244 RLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             HHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             HHccCChhhCcCHHHHhcCHHHhccccc
Confidence            9999999999999999999999976443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.9e-51  Score=343.15  Aligned_cols=258  Identities=32%  Similarity=0.550  Sum_probs=227.2

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS---QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .++|++.+.||.|++|.||+|.++.+|+.+|+|.+........   ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4679999999999999999999999999999999976543221   1245688999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC----cEEEeeecCccccc
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWSVHTF  167 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~----~~~l~dfg~~~~~~  167 (281)
                      ++|+||+++++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++    .++|+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999999888899999999999999999999999999999999999999888    79999999986543


Q ss_pred             CC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHH
Q 038249          168 NR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAK  243 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~  243 (281)
                      ..  .....+++.|+|||.+.+..++.++|+||||+++++|++|..||......+....+.......+.  ...++.++.
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (321)
T 2a2a_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK  250 (321)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHH
Confidence            32  23456899999999999889999999999999999999999999988888877777665443332  146889999


Q ss_pred             HHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ++|.+||+.||++|||+.|+++||||...
T Consensus       251 ~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          251 DFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            99999999999999999999999999854

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6e-51  Score=348.54  Aligned_cols=255  Identities=30%  Similarity=0.542  Sum_probs=225.1

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||+|+||.||+|.++.+++.+|+|.+....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999986543   22345688999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC--CCcEEEeeecCcccccCC--
Q 038249           95 LEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA--QGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~--~~~~~l~dfg~~~~~~~~--  169 (281)
                      |||+++++|.+.+...+ .+++..++.++.||+.||.|||+.|++|+||+|+||+++.  ++.++|+|||++......  
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            99999999999997654 6999999999999999999999999999999999999974  467999999998654332  


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCCCHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIVSSAAKDLIS  247 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~  247 (281)
                      .....+|+.|+|||++.+..++.++||||||+++++|++|..||...+..+....+.......+  ....++.++.++|.
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  286 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  286 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence            2344689999999999988899999999999999999999999998888777777766544333  23468999999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +||+.||++|||+.++|+||||+..
T Consensus       287 ~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          287 NLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             TTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHcCCChhHCcCHHHHhhCccccCC
Confidence            9999999999999999999999865

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.7e-51  Score=342.75  Aligned_cols=259  Identities=25%  Similarity=0.438  Sum_probs=204.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++++.||+|++|.||+|.++.+|+.||+|.+......  .....+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            357899999999999999999999999999999999654322  123457789999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           94 ILEYAAKGELYKELQKC------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      ||||+++ +|.+++...      ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            9999985 898888653      358999999999999999999999999999999999999999999999999986543


Q ss_pred             C---CcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc------------
Q 038249          168 N---RRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK------------  231 (281)
Q Consensus       168 ~---~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------  231 (281)
                      .   ......+++.|+|||.+.+ ..++.++||||||+++++|++|..||...+..+....+......            
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            2   2234567999999999865 46889999999999999999999999988877766655331100            


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          232 --------------------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       232 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                          ......++.++.++|.+||+.||++|||+.|+|+||||.+...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                00112478899999999999999999999999999999987443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7e-51  Score=333.59  Aligned_cols=260  Identities=30%  Similarity=0.551  Sum_probs=223.1

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++.+.||+|++|.||+|.+..+++.||+|.+......  ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            47899999999999999999999999999999999655432  2346788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-----
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-----  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-----  169 (281)
                      +||+++++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+......     
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            999999999999988778999999999999999999999999999999999999999999999999998543211     


Q ss_pred             cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      .....+++.|+|||.+.+..+ +.++|+||||+++++|++|..||...... ..................++.++.++|.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence            234467899999999877664 67899999999999999999999876654 3333444333333444568999999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                      +||+.||++|||+.|+++||||++..+..
T Consensus       244 ~~l~~~p~~Rps~~~il~~~~~~~~~~~~  272 (276)
T 2yex_A          244 KILVENPSARITIPDIKKDRWYNKPLKKG  272 (276)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred             HHCCCCchhCCCHHHHhcCccccChhhcc
Confidence            99999999999999999999999886543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.4e-51  Score=340.58  Aligned_cols=256  Identities=30%  Similarity=0.538  Sum_probs=223.3

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      .|+..+.||+|++|.||+|.++.+|+.||+|++......   ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            378888999999999999999999999999999654322   23567889999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cccc
Q 038249           97 YAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTM  173 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~~  173 (281)
                      |+++++|.+++... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++......   ....
T Consensus       123 ~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            99999999988764 5899999999999999999999999999999999999999999999999987544322   2345


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-cCCCCCCCCHHHHHHHHHhccc
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-KFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      .+++.|+|||.+.+..++.++||||||+++++|++|..||......+....+..... .......++.++.++|.+||+.
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  281 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR  281 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence            689999999999988899999999999999999999999988877777666655432 2223345889999999999999


Q ss_pred             CCCCCCChhhhhcCCccccCCCCC
Q 038249          253 DSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                      ||++|||+.++++||||.+...+.
T Consensus       282 dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          282 DPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             STTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             ChhhCcCHHHHhcChhhccCCCcc
Confidence            999999999999999999875554

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.2e-51  Score=344.68  Aligned_cols=256  Identities=36%  Similarity=0.614  Sum_probs=210.7

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||+|++|.||+|++..+++.||+|++....     ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            367999999999999999999999999999999986542     234577899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC---CCcEEEeeecCcccccCC--
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA---QGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~---~~~~~l~dfg~~~~~~~~--  169 (281)
                      +||+++++|.+.+...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.   ++.++|+|||++......  
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  206 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL  206 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence            999999999999998888999999999999999999999999999999999999975   889999999998654332  


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH-HHHHHhhccccCC--CCCCCCHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD-TYRRIVQVDLKFP--PKPIVSSAAKDLI  246 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~l~~li  246 (281)
                      .....+++.|+|||.+.+..++.++||||||+++++|++|..||......+ ....+........  ....++.++.++|
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  286 (349)
T 2w4o_A          207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV  286 (349)
T ss_dssp             ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence            234568999999999998889999999999999999999999997766654 4455555443322  2356899999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      .+||+.||++|||+.++|+||||......
T Consensus       287 ~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          287 RKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             HHHccCChhhCcCHHHHhcCcccCCCccc
Confidence            99999999999999999999999976543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.2e-51  Score=342.02  Aligned_cols=253  Identities=35%  Similarity=0.585  Sum_probs=200.3

Q ss_pred             CCceec---ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEE
Q 038249           16 NDFDIG---KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRV   91 (281)
Q Consensus        16 ~~y~~~---~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~   91 (281)
                      ++|++.   +.||+|+||+||+|.++.+++.||+|++....      .....+|+.+++.+. ||||+++++++.+.+..
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            456664   88999999999999999999999999985432      345678999999997 99999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC---cEEEeeecCcccccC
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---ELKIADFGWSVHTFN  168 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~---~~~l~dfg~~~~~~~  168 (281)
                      ++||||+++++|.+.+...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++   .++|+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            99999999999999999988899999999999999999999999999999999999998766   899999999864332


Q ss_pred             C---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc-------hHHHHHHhhccccCCC--CC
Q 038249          169 R---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH-------SDTYRRIVQVDLKFPP--KP  236 (281)
Q Consensus       169 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~--~~  236 (281)
                      .   .....+++.|+|||.+.+..++.++||||||+++++|++|..||...+.       .+....+..+....+.  +.
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (325)
T 3kn6_A          162 DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK  241 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred             CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence            2   2345678999999999998999999999999999999999999976443       3445555555443332  13


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      .++.++.++|.+||+.||++|||+.++++||||++...
T Consensus       242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             TSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             CCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            58999999999999999999999999999999997643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.2e-51  Score=361.00  Aligned_cols=271  Identities=33%  Similarity=0.557  Sum_probs=230.1

Q ss_pred             CcccchhhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeee
Q 038249            2 CSEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRL   81 (281)
Q Consensus         2 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~   81 (281)
                      |+..-....+....++|++.+.||+|+||+||+|.++.+++.||+|++........ ....+.+|++++++++||||+++
T Consensus         8 ~~~~~~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~   86 (486)
T 3mwu_A            8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKL   86 (486)
T ss_dssp             ------CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCCccccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeE
Confidence            33333333444456889999999999999999999999999999999965432222 24568899999999999999999


Q ss_pred             eeEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC---CCCcEEEe
Q 038249           82 YGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG---AQGELKIA  158 (281)
Q Consensus        82 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~---~~~~~~l~  158 (281)
                      ++++.+.+.+++|+||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+|+||+|+||+++   .++.++|+
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  166 (486)
T 3mwu_A           87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII  166 (486)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEE
Confidence            999999999999999999999999998888899999999999999999999999999999999999995   45679999


Q ss_pred             eecCcccccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC--CC
Q 038249          159 DFGWSVHTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PP  234 (281)
Q Consensus       159 dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~  234 (281)
                      |||++......  .....+++.|+|||++.+ .++.++||||||+++++|++|.+||...+..+....+.......  +.
T Consensus       167 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (486)
T 3mwu_A          167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ  245 (486)
T ss_dssp             SCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred             ECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            99998654332  234568999999999876 58899999999999999999999999988888888877765543  33


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          235 KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      +..++.++.++|.+||+.||++|||+.++|+||||++...
T Consensus       246 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            4568999999999999999999999999999999997643

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.9e-51  Score=371.95  Aligned_cols=260  Identities=30%  Similarity=0.563  Sum_probs=231.1

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQ   88 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~   88 (281)
                      ...+.+++|++++.||+|+||.||+|.++.+++.||+|++...........+.+..|..++..+ +|++|+++++++.+.
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM  414 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence            3456789999999999999999999999999999999999765433333345677888888887 799999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc-
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF-  167 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~-  167 (281)
                      +.+++||||+++++|..++...+.+++..++.++.||+.||+|||++||+|+||||+||+++.+++++|+|||++.... 
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999999999988889999999999999999999999999999999999999999999999999986422 


Q ss_pred             --CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          168 --NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       168 --~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                        ......+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+..+.+......++.  .++.++.+|
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~l  572 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAI  572 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT--TSCHHHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHH
Confidence              2334567899999999999999999999999999999999999999999999999998887766654  699999999


Q ss_pred             HHHhcccCCCCCCCh-----hhhhcCCcccc
Q 038249          246 ISQMLVKDSSQRLPL-----HKLLEHPWIIQ  271 (281)
Q Consensus       246 i~~~l~~~p~~Rps~-----~eil~~~~~~~  271 (281)
                      |++||+.||++||++     +||++||||+.
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            999999999999998     99999999984

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-51  Score=338.99  Aligned_cols=262  Identities=26%  Similarity=0.430  Sum_probs=210.6

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhC---CCCceeeeeeEEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQLRREVEIQSHL---RHPNILRLYGYFY   86 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~--~~~~~~~~~e~~~l~~~---~h~~i~~~~~~~~   86 (281)
                      .+..++|++.+.||+|+||+||+|.+..+++.||+|++.......  ........+|+.+++.+   +||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            345689999999999999999999999999999999986543211  01112344555555555   5999999999998


Q ss_pred             eCC-----EEEEEEeccCCCChhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEee
Q 038249           87 DQK-----RVYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIAD  159 (281)
Q Consensus        87 ~~~-----~~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~d  159 (281)
                      ...     ..++|+|++++ +|.+++.....  +++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            754     58999999975 99999987654  89999999999999999999999999999999999999999999999


Q ss_pred             ecCcccccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC----
Q 038249          160 FGWSVHTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP----  233 (281)
Q Consensus       160 fg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----  233 (281)
                      ||++......  .....+|+.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.......+    
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            9998654322  2345689999999999888999999999999999999999999998888777766544211100    


Q ss_pred             ---------------------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          234 ---------------------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       234 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                                           ..+.++.++.++|.+||+.||++|||+.|+|+||||++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence                                 01357889999999999999999999999999999998644

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.3e-51  Score=342.97  Aligned_cols=264  Identities=26%  Similarity=0.432  Sum_probs=222.0

Q ss_pred             hhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249            8 KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus         8 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      .....-.+++|++.+.||.|++|.||+|.+..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++..
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   95 (331)
T 4aaa_A           17 ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK   95 (331)
T ss_dssp             --CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             chhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence            3345567899999999999999999999999999999999986654 334445678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      .+..++||||+++++|.++....+.+++..++.++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            99999999999998898888877789999999999999999999999999999999999999999999999999985433


Q ss_pred             CC---cccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-------------
Q 038249          168 NR---RRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-------------  230 (281)
Q Consensus       168 ~~---~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------  230 (281)
                      ..   .....+++.|+|||.+.+. .++.++||||||+++++|++|..||......+....+.....             
T Consensus       176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            22   2345688999999998765 688999999999999999999999988877666554432110             


Q ss_pred             ------cCCC----------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          231 ------KFPP----------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       231 ------~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                            ..+.          .+.++.++.++|.+||+.||++|||+.|+|+||||+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                  0000          12578999999999999999999999999999999854

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-50  Score=332.88  Aligned_cols=256  Identities=31%  Similarity=0.525  Sum_probs=217.0

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|+||.||+|.+..++..+|+|++.......  ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            3478999999999999999999999999999999997654322  24568899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe---CCCCcEEEeeecCcccc
Q 038249           94 ILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI---GAQGELKIADFGWSVHT  166 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~---~~~~~~~l~dfg~~~~~  166 (281)
                      |+||+++++|.+.+..    ...+++..++.++.||+.||.+||+.|++|+||+|+||++   +.++.++|+|||++...
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999999988854    3679999999999999999999999999999999999999   45678999999998643


Q ss_pred             cCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC-CCCCCHHHH
Q 038249          167 FNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP-KPIVSSAAK  243 (281)
Q Consensus       167 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~  243 (281)
                      ...  .....+++.|+|||.+.+ .++.++||||||+++++|++|..||......+.............. ...++.++.
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV  256 (285)
T ss_dssp             ---------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred             CCcccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence            322  344568999999999864 6788999999999999999999999988877776665544333322 234789999


Q ss_pred             HHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          244 DLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ++|.+||+.||++|||+.|+|+||||++.
T Consensus       257 ~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          257 DLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence            99999999999999999999999999873

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-50  Score=337.17  Aligned_cols=257  Identities=32%  Similarity=0.564  Sum_probs=225.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|++|.||+|.+..+|+.+|+|.+.....   .....+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            34689999999999999999999999999999999965432   223567899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe---CCCCcEEEeeecCcccccCC-
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI---GAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~---~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      |+||+++++|.+.+...+.+++..++.++.||+.||.+||+.|++|+||+|+||++   +.++.++|+|||++...... 
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            99999999999999888889999999999999999999999999999999999999   77889999999998644332 


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCCCHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIVSSAAKDLIS  247 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~  247 (281)
                      .....+++.|+|||.+.+..++.++|+||||+++++|++|..||......+....+.......+  ....++.++.++|.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  243 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFIC  243 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHH
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence            2334589999999999998999999999999999999999999998888887777766654433  23568999999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +||..||++|||+.++++||||+...
T Consensus       244 ~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          244 HLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHcCCChhHCcCHHHHhcCccccCCC
Confidence            99999999999999999999998763

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.7e-51  Score=362.09  Aligned_cols=260  Identities=28%  Similarity=0.468  Sum_probs=226.0

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ...+..++|++.+.||+|+||.||+|.++.+|+.||+|++.............+.+|+++++.++||||+++++++.+.+
T Consensus       178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  257 (576)
T 2acx_A          178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD  257 (576)
T ss_dssp             TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence            44577889999999999999999999999999999999997654433333456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           90 RVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      .+++||||++|++|.+.+...+  .+++..++.++.||+.||.|||++||+|+||+|+||+++.+|.++|+|||++....
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999999999998754  39999999999999999999999999999999999999999999999999986543


Q ss_pred             CC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc----hHHHHHHhhccccCCCCCCCCHH
Q 038249          168 NR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH----SDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                      ..  ....+||+.|+|||++.+..++.++|+||||+++++|++|..||.....    .+....+......++  ..++.+
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~  415 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQ  415 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHH
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHH
Confidence            32  2345789999999999988899999999999999999999999987543    333444444433333  468999


Q ss_pred             HHHHHHHhcccCCCCCC-----ChhhhhcCCcccc
Q 038249          242 AKDLISQMLVKDSSQRL-----PLHKLLEHPWIIQ  271 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rp-----s~~eil~~~~~~~  271 (281)
                      +.++|.+||+.||++||     +++|+++||||++
T Consensus       416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            99999999999999999     7899999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-50  Score=345.46  Aligned_cols=257  Identities=29%  Similarity=0.463  Sum_probs=215.4

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-----
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-----   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----   89 (281)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            378999999999999999999999999999999986543 34455677889999999999999999999997653     


Q ss_pred             -EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           90 -RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        90 -~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                       .+++|+||+ +++|.++++. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence             469999999 6799999887 4589999999999999999999999999999999999999999999999999877655


Q ss_pred             CcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC---------------
Q 038249          169 RRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF---------------  232 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  232 (281)
                      ......+|+.|+|||.+.+ ..++.++|||||||++++|++|..||.+.+..+....+.......               
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  260 (367)
T 1cm8_A          181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  260 (367)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence            5556678999999999866 678999999999999999999999999887776665543321100               


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          233 --------------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       233 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                                    ...+..+.++.++|.+||+.||++|||++|+|+||||++..+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                          012357899999999999999999999999999999997643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-50  Score=359.30  Aligned_cols=260  Identities=32%  Similarity=0.575  Sum_probs=225.9

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch----------HHHHHHHHHHHHHHhCCCCceeeeee
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS----------QVEHQLRREVEIQSHLRHPNILRLYG   83 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~h~~i~~~~~   83 (281)
                      ..++|++++.||+|+||+||+|.++.+++.+|+|++........          ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            34789999999999999999999999999999999976543321          23467889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC---cEEEeee
Q 038249           84 YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---ELKIADF  160 (281)
Q Consensus        84 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~---~~~l~df  160 (281)
                      ++.+.+..++||||+++++|.+.+...+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++   .++|+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999998888899999999999999999999999999999999999998876   6999999


Q ss_pred             cCcccccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCC
Q 038249          161 GWSVHTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKP  236 (281)
Q Consensus       161 g~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  236 (281)
                      |++......  .....+++.|+|||++.+ .++.++||||||+++++|++|.+||...+..+....+.......+  .+.
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK  272 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence            998654332  344568999999999874 588999999999999999999999999998888888877655443  235


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      .++.++.++|.+||++||++|||++|+|+||||++...
T Consensus       273 ~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          273 NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            68999999999999999999999999999999997654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.9e-50  Score=343.30  Aligned_cols=252  Identities=24%  Similarity=0.400  Sum_probs=217.2

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----CCceeeeeeEEEeC
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-----HPNILRLYGYFYDQ   88 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----h~~i~~~~~~~~~~   88 (281)
                      .-++|++.+.||+|+||+||+|.+..+++.||+|++...    .........|+.+++.+.     ||||+++++++...
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~  108 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY  108 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence            347899999999999999999999999999999998532    233456777899999986     99999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC---------------
Q 038249           89 KRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA---------------  151 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~---------------  151 (281)
                      +..++|||++ +++|.+++....  .++...++.++.||+.||+|||+.||+|+||+|+||+++.               
T Consensus       109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence            9999999999 889999998754  4899999999999999999999999999999999999975               


Q ss_pred             ----------CCcEEEeeecCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHH
Q 038249          152 ----------QGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT  221 (281)
Q Consensus       152 ----------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  221 (281)
                                ++.++|+|||++...........+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+.
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  267 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH  267 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH
Confidence                      7889999999997666666667789999999999999999999999999999999999999988777666


Q ss_pred             HHHHhhccccCC--------------------------CC------------------CCCCHHHHHHHHHhcccCCCCC
Q 038249          222 YRRIVQVDLKFP--------------------------PK------------------PIVSSAAKDLISQMLVKDSSQR  257 (281)
Q Consensus       222 ~~~~~~~~~~~~--------------------------~~------------------~~~~~~l~~li~~~l~~~p~~R  257 (281)
                      ...+.......+                          ..                  ...+.++.+||.+||+.||++|
T Consensus       268 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  347 (360)
T 3llt_A          268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR  347 (360)
T ss_dssp             HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence            554433211111                          00                  0134778899999999999999


Q ss_pred             CChhhhhcCCccc
Q 038249          258 LPLHKLLEHPWII  270 (281)
Q Consensus       258 ps~~eil~~~~~~  270 (281)
                      ||+.|+|+||||+
T Consensus       348 pta~elL~hp~f~  360 (360)
T 3llt_A          348 PSPAELLKHKFLE  360 (360)
T ss_dssp             CCHHHHTTSGGGC
T ss_pred             CCHHHHhcCcccC
Confidence            9999999999996

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.9e-51  Score=362.38  Aligned_cols=259  Identities=35%  Similarity=0.608  Sum_probs=230.3

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++.............+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            34789999999999999999999999999999999976654433445678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe---CCCCcEEEeeecCcccccCC-
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI---GAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~---~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      |+||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+|+||+|+||++   +.++.++|+|||++...... 
T Consensus       104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            99999999999999988889999999999999999999999999999999999999   56789999999988544332 


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCCCHHHHHHH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIVSSAAKDLI  246 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li  246 (281)
                       .....+++.|+|||++.+ .++.++||||||+++|+|++|.+||...+..+....+.......+  .+..++.++.++|
T Consensus       184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  262 (484)
T 3nyv_A          184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI  262 (484)
T ss_dssp             SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHH
T ss_pred             ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHH
Confidence             234568999999999876 688999999999999999999999999988888888877655433  3456899999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccCC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .+||+.||++|||+.++|+||||++..
T Consensus       263 ~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          263 RKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHCCCChhHCcCHHHHhhChhhcccc
Confidence            999999999999999999999998764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-50  Score=358.30  Aligned_cols=259  Identities=28%  Similarity=0.432  Sum_probs=226.0

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      .....++|++.+.||+|+||.||+|+++.+|+.||+|++.............+.+|++++++++||||+++++++...+.
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            45677999999999999999999999999999999999976554333334668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           91 VYLILEYAAKGELYKELQKC----KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      +++||||++|++|...+...    ..+++..++.++.||+.||.|||++||+|+||+|+||+++.+|.++|+|||++...
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999999998763    35999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCC----chHHHHHHhhccccCCCCCCCC
Q 038249          167 FNR---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE----HSDTYRRIVQVDLKFPPKPIVS  239 (281)
Q Consensus       167 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~  239 (281)
                      ...   ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||....    ..+..+.+......++  ..++
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s  417 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFS  417 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSC
T ss_pred             cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccC
Confidence            332   233479999999999999899999999999999999999999997753    2445555555544444  4689


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----hhhhhcCCcccc
Q 038249          240 SAAKDLISQMLVKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      .++.++|.+||+.||++||+     +++|++||||+.
T Consensus       418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            99999999999999999996     589999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.6e-50  Score=332.95  Aligned_cols=264  Identities=28%  Similarity=0.470  Sum_probs=227.7

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccc------cchHHHHHHHHHHHHHHhCC-CCceeeeeeE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL------QQSQVEHQLRREVEIQSHLR-HPNILRLYGY   84 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~------~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~   84 (281)
                      .-..++|++.+.||.|++|.||+|.++.+++.||+|.+.....      ......+.+.+|+++++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            3446899999999999999999999999999999999965431      11234567789999999995 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           85 FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      +...+..++|+||+++++|.+++.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence            99999999999999999999999988889999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC--cccccCcCCccCCcccc------CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--
Q 038249          165 HTFNR--RRTMCGTLDYLPPEMVE------SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--  234 (281)
Q Consensus       165 ~~~~~--~~~~~~~~~~~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  234 (281)
                      .....  .....+++.|+|||.+.      ...++.++|+||||+++++|++|..||......+....+.......+.  
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T 1phk_A          173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE  252 (298)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc
Confidence            54332  23456889999999874      455788999999999999999999999988887777777666544432  


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          235 KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      ...++.++.++|.+||+.||++|||+.++++||||++...+
T Consensus       253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            24689999999999999999999999999999999987543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.8e-51  Score=343.68  Aligned_cols=251  Identities=34%  Similarity=0.577  Sum_probs=216.4

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .++|++.+.||.|+||.||+|.++.+|+.||+|.+......       ..+|++++.++ +||||+++++++.+.+..++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            46799999999999999999999999999999999665422       23577777777 79999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC-C---cEEEeeecCcccccCC
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-G---ELKIADFGWSVHTFNR  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~-~---~~~l~dfg~~~~~~~~  169 (281)
                      ||||++|++|.+.+...+.+++..++.++.||+.||.|||++||+|+||+|+||++..+ +   .++|+|||++......
T Consensus        94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            99999999999999988889999999999999999999999999999999999998543 2   5999999998654322


Q ss_pred             ---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCC---CchHHHHHHhhccccCC--CCCCCCHH
Q 038249          170 ---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAK---EHSDTYRRIVQVDLKFP--PKPIVSSA  241 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~--~~~~~~~~  241 (281)
                         ....++++.|+|||++.+..++.++|+||||+++++|++|..||...   ...+....+..+....+  .+..++.+
T Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  253 (342)
T 2qr7_A          174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT  253 (342)
T ss_dssp             TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred             CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence               33456899999999998877889999999999999999999999763   34455566665555443  23568999


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +.++|.+||+.||++|||+.++++||||.++
T Consensus       254 ~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          254 AKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            9999999999999999999999999999865

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.3e-50  Score=330.81  Aligned_cols=256  Identities=23%  Similarity=0.432  Sum_probs=218.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe----CCE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD----QKR   90 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~   90 (281)
                      -..|++.+.||+|++|.||+|.+..++..+++|.+...... ....+.+.+|+.++++++||||+++++++..    ...
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            35689999999999999999999999999999999765543 3446778899999999999999999999875    456


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCeEeC-CCCcEEEeeecCccccc
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH--VIHRDIKPENLLIG-AQGELKIADFGWSVHTF  167 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~Ni~~~-~~~~~~l~dfg~~~~~~  167 (281)
                      +++|+||+++++|.++++..+.++...++.++.+|+.||.+||+.|  ++|+||+|+||+++ .++.++|+|||++....
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            8999999999999999998888999999999999999999999999  99999999999998 78899999999985443


Q ss_pred             CC-cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHH-HHHhhccccCCCCCCCCHHHHHH
Q 038249          168 NR-RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY-RRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       168 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                      .. .....+++.|+|||.+.+ .++.++|+||||+++++|++|..||......... ..+.............+.++.++
T Consensus       184 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  262 (290)
T 1t4h_A          184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  262 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHH
Confidence            33 334568999999998875 5889999999999999999999999875555444 33443333333334577899999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCccccC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      |.+||+.||++|||+.++++||||++.
T Consensus       263 i~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          263 IEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHccCChhhCCCHHHHhhCcccccC
Confidence            999999999999999999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.8e-50  Score=342.66  Aligned_cols=257  Identities=30%  Similarity=0.539  Sum_probs=223.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccc-----cchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-----QQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQ   88 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~-----~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~   88 (281)
                      .++|++.+.||.|++|.||+|.++.+|+.||||++.....     ......+.+.+|+.+++++ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            3679999999999999999999999999999999865431     1123356678999999999 899999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      +..++||||+++++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999998865433


Q ss_pred             C--cccccCcCCccCCccccC------CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCC
Q 038249          169 R--RRTMCGTLDYLPPEMVES------VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIV  238 (281)
Q Consensus       169 ~--~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  238 (281)
                      .  .....+++.|+|||.+.+      ..++.++||||||+++++|++|..||...........+........  .+..+
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  332 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR  332 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence            2  344568999999999753      3578899999999999999999999988887777777666544332  22468


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      +.++.++|.+||+.||++|||+.++++||||++
T Consensus       333 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            899999999999999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-51  Score=345.24  Aligned_cols=259  Identities=31%  Similarity=0.561  Sum_probs=220.3

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ--QSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ++|++.+.||+|++|.||+|.+..++..+|+|++......  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            6799999999999999999999999999999999655321  22345678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC----------------------------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 038249           94 ILEYAAKGELYKELQKC----------------------------------------KYFSERRAATYVASLARALIYCH  133 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~----------------------------------------~~l~~~~~~~i~~~i~~~l~~Lh  133 (281)
                      ||||+++++|.++++..                                        ..+++..++.++.||+.||++||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            99999999999988521                                        12367788999999999999999


Q ss_pred             hcCceecCCCCCCeEeCCCC--cEEEeeecCcccccC-------CcccccCcCCccCCccccC--CCCCCcccHHhHHHH
Q 038249          134 GKHVIHRDIKPENLLIGAQG--ELKIADFGWSVHTFN-------RRRTMCGTLDYLPPEMVES--VEHDANVDIWSLGVL  202 (281)
Q Consensus       134 ~~~i~H~di~~~Ni~~~~~~--~~~l~dfg~~~~~~~-------~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~  202 (281)
                      +.|++|+||+|+||+++.++  .++|+|||++.....       ......+++.|+|||.+.+  ..++.++||||||++
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i  265 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL  265 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence            99999999999999998777  899999999854322       1234568999999999865  678899999999999


Q ss_pred             HHHHHhCCCCCCCCCchHHHHHHhhccccCCCC--CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          203 CYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       203 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      +++|++|..||......+....+.......+..  ..++.++.++|.+||+.||++|||+.++++||||++..+
T Consensus       266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            999999999999988888888777665444332  348899999999999999999999999999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-50  Score=346.00  Aligned_cols=258  Identities=29%  Similarity=0.495  Sum_probs=209.2

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCC-
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQK-   89 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~-   89 (281)
                      ....++|++.+.||.|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++++. ||||+++++++...+ 
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            345689999999999999999999999999999999986543 33444567788999999997 999999999997544 


Q ss_pred             -EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           90 -RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        90 -~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                       .+++||||+++ +|...+.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           84 RDVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             SCEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             CEEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence             78999999985 89888887 4689999999999999999999999999999999999999999999999999854321


Q ss_pred             ------------------------CcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHH
Q 038249          169 ------------------------RRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR  223 (281)
Q Consensus       169 ------------------------~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  223 (281)
                                              .....++|+.|+|||++.+ ..++.++|||||||++++|++|.+||.+.+..+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  241 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE  241 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                                    1122468999999999866 678999999999999999999999999888777766


Q ss_pred             HHhhcccc---------------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCC
Q 038249          224 RIVQVDLK---------------------------------------------FPPKPIVSSAAKDLISQMLVKDSSQRL  258 (281)
Q Consensus       224 ~~~~~~~~---------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp  258 (281)
                      .+......                                             ......++.++.+||.+||+.||++||
T Consensus       242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~  321 (388)
T 3oz6_A          242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI  321 (388)
T ss_dssp             HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence            55421100                                             011125789999999999999999999


Q ss_pred             ChhhhhcCCccccC
Q 038249          259 PLHKLLEHPWIIQN  272 (281)
Q Consensus       259 s~~eil~~~~~~~~  272 (281)
                      |++|+|+||||...
T Consensus       322 t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          322 SANDALKHPFVSIF  335 (388)
T ss_dssp             CHHHHTTSTTTTTT
T ss_pred             CHHHHhCCHHHHHh
Confidence            99999999999754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-50  Score=335.41  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=205.4

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||+|+||+||+|.+..+++.||||++...........+.+.+...+.+..+|+||+++++++.+.+..++|+
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999999999999999986554333333333443334444459999999999999999999999


Q ss_pred             eccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--ccc
Q 038249           96 EYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--RRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--~~~  172 (281)
                      ||+ +++|.+.+... ..+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++......  ...
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  215 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV  215 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------C
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcc
Confidence            999 55888877654 46999999999999999999999999999999999999999999999999997554332  234


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ..+|+.|+|||.+.+ .++.++||||||+++++|++|..|+...   +....+............++.++.++|.+||+.
T Consensus       216 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  291 (311)
T 3p1a_A          216 QEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEP  291 (311)
T ss_dssp             CCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred             cCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCCcccccCCCHHHHHHHHHHcCC
Confidence            458999999999876 6899999999999999999997665432   233333333222222346899999999999999


Q ss_pred             CCCCCCChhhhhcCCccccC
Q 038249          253 DSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~  272 (281)
                      ||++|||+.|+++||||+++
T Consensus       292 dP~~Rpt~~ell~hp~~~~p  311 (311)
T 3p1a_A          292 DPKLRATAEALLALPVLRQP  311 (311)
T ss_dssp             STTTSCCHHHHHTSGGGSCC
T ss_pred             ChhhCcCHHHHHhCccccCC
Confidence            99999999999999999874

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2e-50  Score=343.14  Aligned_cols=260  Identities=26%  Similarity=0.464  Sum_probs=222.8

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ..+..++|++.+.||.|++|.||+|.+..++..+|+|++....  .....+.+.+|+.++++++||||+++++++...+.
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            4566789999999999999999999999999999999997653  33445778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCCCcEEEeeecCcccccC-
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-  168 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-  168 (281)
                      .++||||+++++|.++++..+.+++..++.++.+++.||.+||+. |++|+||+|+||+++.++.++|+|||++..... 
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999999999999888899999999999999999999986 999999999999999999999999998754322 


Q ss_pred             CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHH-------------------------
Q 038249          169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR-------------------------  223 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------------------------  223 (281)
                      ......+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+...                         
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            2334568999999999999899999999999999999999999998766544322                         


Q ss_pred             -----------------HHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          224 -----------------RIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       224 -----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                                       .+............++.++.++|.+||+.||++|||+.|+|+||||++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                             1122222222233578999999999999999999999999999999865

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.8e-50  Score=356.87  Aligned_cols=255  Identities=36%  Similarity=0.628  Sum_probs=220.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++++.||+|+||+||+|.++.++..+|+|++........ ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            479999999999999999999999999999999976543222 2456889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC---CcEEEeeecCcccccCC--c
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGWSVHTFNR--R  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~---~~~~l~dfg~~~~~~~~--~  170 (281)
                      ||+++++|.+.+.....+++..++.++.||+.||.|||++||+|+||+|+||+++..   +.++|+|||++......  .
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence            999999999999888889999999999999999999999999999999999999764   45999999998654332  2


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCCCHHHHHHHHH
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIVSSAAKDLISQ  248 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~  248 (281)
                      ....+|+.|+|||++.+ .++.++||||||+++++|++|.+||...+..+....+.......+  .+..++.++.++|.+
T Consensus       196 ~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  274 (494)
T 3lij_A          196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ  274 (494)
T ss_dssp             CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred             cccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence            34568999999999864 688999999999999999999999999998888888877655443  335689999999999


Q ss_pred             hcccCCCCCCChhhhhcCCccccC
Q 038249          249 MLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ||+.||++|||+.++|+||||++.
T Consensus       275 ~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          275 MLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HCCCChhhCccHHHHhcCcccccC
Confidence            999999999999999999999863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.5e-50  Score=338.02  Aligned_cols=255  Identities=34%  Similarity=0.568  Sum_probs=211.6

Q ss_pred             CCceec-ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEE
Q 038249           16 NDFDIG-KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        16 ~~y~~~-~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ++|++. +.||+|++|+||+|.+..+++.||+|++.....   .....+.+|+++++++ +||||+++++++.+.+..++
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            678885 789999999999999999999999999965432   2235678899999885 79999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc---EEEeeecCcccccC--
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTFN--  168 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~---~~l~dfg~~~~~~~--  168 (281)
                      ||||+++++|.+++...+.+++..++.++.||+.||++||++|++|+||+|+||+++.++.   ++|+|||++.....  
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            9999999999999998888999999999999999999999999999999999999998776   99999998754321  


Q ss_pred             --------CcccccCcCCccCCccccC-----CCCCCcccHHhHHHHHHHHHhCCCCCCCCCc---------------hH
Q 038249          169 --------RRRTMCGTLDYLPPEMVES-----VEHDANVDIWSLGVLCYEFLYGVPPFEAKEH---------------SD  220 (281)
Q Consensus       169 --------~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------------~~  220 (281)
                              ......+++.|+|||.+.+     ..++.++||||||+++++|++|..||.....               ..
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence                    1123458999999999864     4578899999999999999999999977543               22


Q ss_pred             HHHHHhhccccCCC--CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          221 TYRRIVQVDLKFPP--KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       221 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      ....+.......+.  ...++.++.++|.+||+.||++|||+.|+++||||+...
T Consensus       249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            34444444443332  135889999999999999999999999999999999753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=344.14  Aligned_cols=250  Identities=27%  Similarity=0.514  Sum_probs=215.3

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccC
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      ..+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            3678999999999999999999999999996543   2335678899999999999999999999999999999999999


Q ss_pred             CCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe--CCCCcEEEeeecCcccccCC--ccccc
Q 038249          100 KGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI--GAQGELKIADFGWSVHTFNR--RRTMC  174 (281)
Q Consensus       100 ~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~--~~~~~~~l~dfg~~~~~~~~--~~~~~  174 (281)
                      +++|.+.+... ..+++..++.++.||+.||.|||+.||+|+||+|+||++  +.++.++|+|||++......  .....
T Consensus       170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  249 (373)
T 2x4f_A          170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF  249 (373)
T ss_dssp             TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence            99999888654 468999999999999999999999999999999999999  56778999999998654332  23446


Q ss_pred             CcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHHHHHHHhccc
Q 038249          175 GTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       175 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~  252 (281)
                      +++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.......+.  ...++.++.++|.+||+.
T Consensus       250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~  329 (373)
T 2x4f_A          250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIK  329 (373)
T ss_dssp             SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCS
T ss_pred             CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCC
Confidence            899999999999888999999999999999999999999998888888877766544332  246899999999999999


Q ss_pred             CCCCCCChhhhhcCCccccC
Q 038249          253 DSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~  272 (281)
                      ||++|||+.|+|+||||++.
T Consensus       330 dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          330 EKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             SGGGSCCHHHHHHSHHHHCH
T ss_pred             ChhhCCCHHHHhcCcCcCCC
Confidence            99999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-50  Score=332.81  Aligned_cols=257  Identities=32%  Similarity=0.570  Sum_probs=223.4

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS---QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      ++|++.+.||.|++|.||+|.+..+++.+|+|.+........   ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            579999999999999999999999999999999876543221   12456889999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC----cEEEeeecCcccccC
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWSVHTFN  168 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~----~~~l~dfg~~~~~~~  168 (281)
                      +|+||+++++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++    .++|+|||.+.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998888899999999999999999999999999999999999998877    899999999865433


Q ss_pred             C--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHHH
Q 038249          169 R--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAKD  244 (281)
Q Consensus       169 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~  244 (281)
                      .  .....+++.|+|||.+.+..++.++|+||||+++++|++|..||......+....+.......+.  ...++.++.+
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD  244 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred             CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHH
Confidence            2  23345889999999999888999999999999999999999999988887777766555433321  2468899999


Q ss_pred             HHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          245 LISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +|.+||+.||++|||+.++++||||++.
T Consensus       245 li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          245 FIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            9999999999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.8e-50  Score=353.55  Aligned_cols=256  Identities=28%  Similarity=0.412  Sum_probs=211.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-----
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-----   88 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----   88 (281)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            3588999999999999999999999999999999997653 3344566788999999999999999999999654     


Q ss_pred             -CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           89 -KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        89 -~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                       ..+++||||+++ +|.+.+..  .+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++....
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence             467999999987 56666654  48999999999999999999999999999999999999999999999999986544


Q ss_pred             CC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC-------------
Q 038249          168 NR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF-------------  232 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  232 (281)
                      ..  .....+|+.|+|||++.+..++.++|||||||++++|++|..||.+.+..+.+..+.......             
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence            33  234568999999999999899999999999999999999999999888777666554321100             


Q ss_pred             ------CCCCC---------------------CCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          233 ------PPKPI---------------------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       233 ------~~~~~---------------------~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                            +....                     .+.++.+||.+||..||++|||++|+|+||||+.+.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                  00000                     145789999999999999999999999999998653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.8e-51  Score=341.27  Aligned_cols=257  Identities=28%  Similarity=0.512  Sum_probs=211.5

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++.+.||+|+||+||+|.+..+++.||+|++.....  ......+.+|+.++++++||||+++++++...+..++|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            5789999999999999999999999999999999854431  11112345789999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---c
Q 038249           95 LEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---R  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~  170 (281)
                      |||+++ +|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++......   .
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            999986 888888764 45999999999999999999999999999999999999999999999999987543322   2


Q ss_pred             ccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC----------------
Q 038249          171 RTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP----------------  233 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------  233 (281)
                      ....+++.|+|||.+.+ ..++.++||||||+++++|++|..||...+..+....+........                
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            33457899999999865 5678999999999999999999999998887776665543211000                


Q ss_pred             ------------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          234 ------------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       234 ------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                                  ..+.++.++.+||.+||+.||++|||++|+|+||||.+..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence                        01247889999999999999999999999999999997644

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.7e-50  Score=340.42  Aligned_cols=262  Identities=27%  Similarity=0.448  Sum_probs=217.6

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe------
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD------   87 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------   87 (281)
                      .+++|++++.||+|++|+||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++..      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            4689999999999999999999999999999999986554322 223456789999999999999999999986      


Q ss_pred             --CCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           88 --QKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        88 --~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                        .+.+++||||+++ +|.+.+... ..+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence              4578999999987 676666553 569999999999999999999999999999999999999999999999999985


Q ss_pred             ccc-------CCcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--
Q 038249          165 HTF-------NRRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--  234 (281)
Q Consensus       165 ~~~-------~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  234 (281)
                      ...       .......+++.|+|||.+.+ ..++.++||||||+++++|++|..||...+..+....+.......+.  
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            432       11233457899999999865 45799999999999999999999999988887776665443221111  


Q ss_pred             CCC----------------------------CCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCCC
Q 038249          235 KPI----------------------------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSG  277 (281)
Q Consensus       235 ~~~----------------------------~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~~  277 (281)
                      ++.                            .+.++.++|.+||+.||++|||+.|+|+||||++...++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  323 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD  323 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence            111                            2677999999999999999999999999999998876653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-49  Score=329.40  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=219.6

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      ...-++|++.+.||+|++|.||+|.+..++..+|+|.+...........+.+.+|+.++++++||||+++++++...+..
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            34457899999999999999999999999999999999766656666678899999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      ++||||+++++|.+++...+++++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++......  
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            999999999999999998888999999999999999999999999999999999999999999999999998654322  


Q ss_pred             --cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC---CCCCCCCHHHHH
Q 038249          170 --RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF---PPKPIVSSAAKD  244 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~  244 (281)
                        .....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+............   ...+.+|..+.+
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN  246 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence              223458999999999999889999999999999999999999999887776655444432211   123468999999


Q ss_pred             HHHHhcccCCCCCCChhhhhcCCcc
Q 038249          245 LISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +|.+||+.||++||+..+.+.+.+.
T Consensus       247 li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          247 VILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             HHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHhcCCHhHccccHHHHHHHHH
Confidence            9999999999999965555544443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-50  Score=343.44  Aligned_cols=256  Identities=29%  Similarity=0.468  Sum_probs=201.2

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC------C
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ------K   89 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~   89 (281)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...      .
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            79999999999999999999999999999999986543 3344556788999999999999999999998653      5


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ..++|++++ +++|.++++. ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~  185 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE  185 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence            679999999 5699998876 56999999999999999999999999999999999999999999999999998766555


Q ss_pred             cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc-----------------
Q 038249          170 RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK-----------------  231 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  231 (281)
                      .....+|+.|+|||.+.+ ..++.++|||||||++++|++|..||.+.+..+....+......                 
T Consensus       186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~  265 (367)
T 2fst_X          186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY  265 (367)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHH
T ss_pred             CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHH
Confidence            555678999999999876 67899999999999999999999999988877666554331100                 


Q ss_pred             ------CCC------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          232 ------FPP------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       232 ------~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                            .+.      .+..+.++.+||.+||+.||++|||+.++|+||||.+...
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                  000      1246788999999999999999999999999999997643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-49  Score=331.81  Aligned_cols=261  Identities=23%  Similarity=0.433  Sum_probs=218.1

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ....+..++|++.+.||+|+||+||+|.+.  |+.+|+|++..... .....+.+.+|+.++++++||||+++++++...
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            344566789999999999999999999875  88899999876543 334456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           89 KRVYLILEYAAKGELYKELQKCKY---FSERRAATYVASLARALIYCHGKH--VIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      +..++|+||+++++|.+++...+.   +++..++.++.||+.||++||+.|  ++|+||+|+||+++.++.++|+|||++
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            999999999999999999987653   899999999999999999999999  999999999999999999999999998


Q ss_pred             ccccCC---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCH
Q 038249          164 VHTFNR---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       164 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
                      ......   .....+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+............++.
T Consensus       187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (309)
T 3p86_A          187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP  266 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            543322   23456899999999999999999999999999999999999999988888777766544444445557999


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhc--CCccccC
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLE--HPWIIQN  272 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~--~~~~~~~  272 (281)
                      ++.++|.+||+.||++|||+.++++  .+++++.
T Consensus       267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            9999999999999999999999997  5666554

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.9e-50  Score=337.35  Aligned_cols=259  Identities=25%  Similarity=0.459  Sum_probs=216.1

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CceeeeeeEEEeCC
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH--PNILRLYGYFYDQK   89 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~   89 (281)
                      .+.-++|++.+.||+|+||.||++.+. +++.||+|++..... .......+.+|+.++++++|  +||+++++++...+
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~   82 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ   82 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence            455678999999999999999999985 688999999976543 34445778899999999987  99999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ..++|||+ .+++|.+++...+.+++..++.++.||+.||.|||++||+|+||+|+||+++ ++.++|+|||++......
T Consensus        83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            99999995 5679999999988899999999999999999999999999999999999996 688999999998654332


Q ss_pred             c-----ccccCcCCccCCccccC-----------CCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccccC
Q 038249          170 R-----RTMCGTLDYLPPEMVES-----------VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLKF  232 (281)
Q Consensus       170 ~-----~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~  232 (281)
                      .     ....+|+.|+|||.+.+           ..++.++||||||+++++|++|..||...... .............
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  240 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  240 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence            2     24468999999999854           66788999999999999999999999865443 3444444444444


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      ......+.++.++|.+||+.||++|||+.++++||||+....
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            444467889999999999999999999999999999986543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.5e-51  Score=341.19  Aligned_cols=262  Identities=27%  Similarity=0.419  Sum_probs=223.0

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      ......++|++.+.||+|++|.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++....
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            34556689999999999999999999999999999999997765556666778899999999999999999999987643


Q ss_pred             ----EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           90 ----RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        90 ----~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                          ..++||||+++++|.++++..+++++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence                4599999999999999999888899999999999999999999999999999999999999999999999999854


Q ss_pred             ccCC------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCC
Q 038249          166 TFNR------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPI  237 (281)
Q Consensus       166 ~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~  237 (281)
                      ....      .....+++.|+|||.+.+..++.++||||||+++++|++|..||......+............+  ....
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence            3222      2234579999999999988999999999999999999999999998887776655544432221  1235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          238 VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      ++.++.++|.+||+.||++||++.+++.++|++.
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            8999999999999999999999999999999973

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.7e-50  Score=330.04  Aligned_cols=259  Identities=27%  Similarity=0.386  Sum_probs=207.7

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .+..++|++.+.||+|++|+||+|.+..+|+.||+|.+.... ......+.+.++...++.++||||+++++++.+.+..
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            456789999999999999999999999999999999996553 2333344555666668888999999999999999999


Q ss_pred             EEEEeccCCCChhHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           92 YLILEYAAKGELYKELQ----KCKYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      ++|+||+++ +|.+++.    ....+++..++.++.||+.||.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999986 8777665    356799999999999999999999998 9999999999999999999999999998554


Q ss_pred             cCC--cccccCcCCccCCccc----cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCC-chHHHHHHhhccccCCCCCCCC
Q 038249          167 FNR--RRTMCGTLDYLPPEMV----ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKE-HSDTYRRIVQVDLKFPPKPIVS  239 (281)
Q Consensus       167 ~~~--~~~~~~~~~~~aPE~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~  239 (281)
                      ...  .....+++.|+|||.+    .+..++.++||||||+++++|++|..||.... ....................++
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence            332  2334689999999996    56668889999999999999999999998643 3344444444433344445789


Q ss_pred             HHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .++.++|.+||+.||++|||+.++++||||+..
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            999999999999999999999999999999865

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=340.22  Aligned_cols=249  Identities=30%  Similarity=0.502  Sum_probs=214.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS-----QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+........     .....+.+|+.++++++||||+++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            689999999999999999999999999999999976542211     122346679999999999999999999999999


Q ss_pred             EEEEEeccCCC-ChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           91 VYLILEYAAKG-ELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        91 ~~~v~e~~~~~-~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .++|+|++.++ +|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  183 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG  183 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence            99999998766 99999999888999999999999999999999999999999999999999999999999998654333


Q ss_pred             --cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          170 --RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                        .....+++.|+|||.+.+..+ +.++||||||+++++|++|..||.....      ....  .......++.++.++|
T Consensus       184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~--~~~~~~~~~~~l~~li  255 (335)
T 3dls_A          184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA--AIHPPYLVSKELMSLV  255 (335)
T ss_dssp             CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTT--CCCCSSCCCHHHHHHH
T ss_pred             CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhh--ccCCCcccCHHHHHHH
Confidence              234568999999999987776 7889999999999999999999975322      1111  2223335899999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .+||++||++|||++++++||||++.
T Consensus       256 ~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          256 SGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHccCChhhCcCHHHHhcCccccCC
Confidence            99999999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.1e-50  Score=329.02  Aligned_cols=261  Identities=28%  Similarity=0.510  Sum_probs=224.3

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--CCE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--QKR   90 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~   90 (281)
                      ...++|++.+.||+|++|.||+|.++.+++.+++|.+...... ....+.+.+|+.++++++||||+++++++..  .+.
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            3568999999999999999999999999999999999765433 3446778999999999999999999998754  578


Q ss_pred             EEEEEeccCCCChhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC-----ceecCCCCCCeEeCCCCcEEEeeec
Q 038249           91 VYLILEYAAKGELYKELQKC----KYFSERRAATYVASLARALIYCHGKH-----VIHRDIKPENLLIGAQGELKIADFG  161 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~-----i~H~di~~~Ni~~~~~~~~~l~dfg  161 (281)
                      .++|+||+++++|.+++...    ..+++..++.++.||+.||.+||+.|     ++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999998753    34899999999999999999999999     9999999999999999999999999


Q ss_pred             CcccccCCc---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCC
Q 038249          162 WSVHTFNRR---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV  238 (281)
Q Consensus       162 ~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (281)
                      .+.......   ....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+...... .....+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~  240 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRY  240 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CCCTTS
T ss_pred             hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-cCCccc
Confidence            875443221   2345789999999998888999999999999999999999999988877777776665442 223368


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      +.++.++|.+||+.||++|||+.|+++|+|+.++..+
T Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  277 (279)
T 2w5a_A          241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH  277 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence            9999999999999999999999999999999987543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.7e-49  Score=342.83  Aligned_cols=257  Identities=26%  Similarity=0.449  Sum_probs=210.1

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-----
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-----   88 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----   88 (281)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++.... ......+.+.+|+.++++++|+||+++++++...     
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            3488999999999999999999999999999999996543 3444567788999999999999999999999765     


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      ...++|+|++++ +|.++++....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus       103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            579999999975 9999999888899999999999999999999999999999999999999999999999999865432


Q ss_pred             C-------------------------cccccCcCCccCCccc-cCCCCCCcccHHhHHHHHHHHHhC-----------CC
Q 038249          169 R-------------------------RRTMCGTLDYLPPEMV-ESVEHDANVDIWSLGVLCYEFLYG-----------VP  211 (281)
Q Consensus       169 ~-------------------------~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g-----------~~  211 (281)
                      .                         .....+|+.|+|||++ ....++.++|||||||++++|++|           .+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            2                         1345689999999985 666789999999999999999984           44


Q ss_pred             CCCCCCc-----------------hHHHHHHhh------------------------ccccCC-----CCCCCCHHHHHH
Q 038249          212 PFEAKEH-----------------SDTYRRIVQ------------------------VDLKFP-----PKPIVSSAAKDL  245 (281)
Q Consensus       212 p~~~~~~-----------------~~~~~~~~~------------------------~~~~~~-----~~~~~~~~l~~l  245 (281)
                      +|.+.+.                 .+....+..                        .....+     ..+.++.++.+|
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence            4443321                 111111110                        000000     013589999999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCccccC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      |.+||+.||++|||++|+|+||||++.
T Consensus       342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             HHHHhcCCcccCCCHHHHhcChhhhhc
Confidence            999999999999999999999999976

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.1e-49  Score=326.58  Aligned_cols=253  Identities=23%  Similarity=0.361  Sum_probs=210.4

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .++|++.+.||+|++|+||+|.+..+++.||+|.+....... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            378999999999999999999999999999999997654333 3356678899999999 99999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC----------------
Q 038249           94 ILEYAAKGELYKELQKC----KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG----------------  153 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~----------------  153 (281)
                      |+||+++++|.+++...    ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++                
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999999999764    6689999999999999999999999999999999999998544                


Q ss_pred             ---cEEEeeecCcccccCCcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc
Q 038249          154 ---ELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD  229 (281)
Q Consensus       154 ---~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (281)
                         .++|+|||.+...... ....+++.|+|||.+.+. .++.++||||||+++++|++|.+++...   +....+....
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~~  244 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP-QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHEIRQGR  244 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS-CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHHHHHTTC
T ss_pred             CceEEEEcccccccccCCc-cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHHHHHcCC
Confidence               7999999988654433 334589999999998765 5667999999999999999998876443   2333333332


Q ss_pred             ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          230 LKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      . ......++.++.++|.+||+.||++|||+.++++||||++..
T Consensus       245 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          245 L-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             C-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             C-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            2 122346899999999999999999999999999999999764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.4e-49  Score=328.90  Aligned_cols=257  Identities=28%  Similarity=0.493  Sum_probs=224.8

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.|++.+.||+|++|.||+|.+..+++.||+|.+.......  ..+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            67999999999999999999999999999999997654322  2467889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~  172 (281)
                      ||+++++|.+++.. +++++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+......   ...
T Consensus       100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence            99999999999876 46899999999999999999999999999999999999999999999999998554332   234


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      ..+++.|+|||.+.+..++.++|+||||+++++|++|..||......+....+..... ......++.++.++|.+||+.
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~  257 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACLNK  257 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCCSSCCHHHHHHHHHHCCS
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC-CCCccccCHHHHHHHHHHcCC
Confidence            4678999999999988899999999999999999999999988777766655544332 223346899999999999999


Q ss_pred             CCCCCCChhhhhcCCccccCCCCC
Q 038249          253 DSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       253 ~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                      ||++|||+.++++||||.+.....
T Consensus       258 dp~~Rps~~~ll~~~~~~~~~~~~  281 (303)
T 3a7i_A          258 EPSFRPTAKELLKHKFILRNAKKT  281 (303)
T ss_dssp             SGGGSCCHHHHTTCHHHHHHCCCG
T ss_pred             ChhhCcCHHHHhhChhhhcCCCcc
Confidence            999999999999999998775543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-49  Score=340.75  Aligned_cols=258  Identities=25%  Similarity=0.465  Sum_probs=216.1

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCceeeeeeEEEeCCE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR--HPNILRLYGYFYDQKR   90 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~   90 (281)
                      +...+|++.+.||+|+||.||+|.+.. ++.||+|++..... .......+.+|+.++++++  |+||+++++++...+.
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            344669999999999999999999875 88999999976543 3445677899999999996  5999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      +++||| +.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++ ++.+||+|||++...... 
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            999999 55779999999888899999999999999999999999999999999999995 689999999998654322 


Q ss_pred             ----cccccCcCCccCCccccC-----------CCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccccCC
Q 038249          170 ----RRTMCGTLDYLPPEMVES-----------VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLKFP  233 (281)
Q Consensus       170 ----~~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~  233 (281)
                          .....+|+.|+|||++.+           ..++.++||||||+++++|++|..||...... .....+........
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  288 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence                234568999999999854           36788999999999999999999999875443 44555555444444


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      .....+.++.++|.+||+.||++|||+.|+|+||||+....
T Consensus       289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            44457899999999999999999999999999999986543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.6e-50  Score=329.43  Aligned_cols=264  Identities=33%  Similarity=0.570  Sum_probs=227.2

Q ss_pred             hhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249            8 KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus         8 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      ........++|++.+.||+|++|.||+|.+..+++.||+|++....... .....+.+|++++++++||||+++++++..
T Consensus        14 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (287)
T 2wei_A           14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILED   92 (287)
T ss_dssp             HHHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeC
Confidence            3334445678999999999999999999999999999999997654332 224568899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC---cEEEeeecCcc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---ELKIADFGWSV  164 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~---~~~l~dfg~~~  164 (281)
                      .+..++|+|++++++|.+.+...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++   .++|+|||++.
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             CCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            999999999999999999998777899999999999999999999999999999999999997644   69999999876


Q ss_pred             cccCCc--ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCCCH
Q 038249          165 HTFNRR--RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIVSS  240 (281)
Q Consensus       165 ~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  240 (281)
                      ......  ....+++.|+|||.+.+ .++.++|+||||+++++|++|..||...+..+....+........  ....++.
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 2wei_A          173 CFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD  251 (287)
T ss_dssp             TBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred             eecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence            543322  23347889999999876 488899999999999999999999998888877777766654333  2346899


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      ++.++|.+||++||++|||+.++++||||++..
T Consensus       252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999999998764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.1e-49  Score=342.82  Aligned_cols=254  Identities=27%  Similarity=0.444  Sum_probs=215.3

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC------CCCceeeeeeEEEe
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL------RHPNILRLYGYFYD   87 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~   87 (281)
                      ...+|++.+.||+|+||+||+|.+..+++.||+|++....    .....+.+|+.+++.+      .|+||+++++.+..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            3467999999999999999999999999999999995432    3344566777777766      57799999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc--EEEeeecCc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE--LKIADFGWS  163 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~--~~l~dfg~~  163 (281)
                      .+.+++|+|++.+ +|.+++....  .+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.  ++|+|||++
T Consensus       171 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          171 RNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             TTEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             CCeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            9999999999965 8999887654  4899999999999999999999999999999999999999987  999999998


Q ss_pred             ccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC-----------
Q 038249          164 VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF-----------  232 (281)
Q Consensus       164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  232 (281)
                      ...........+++.|+|||.+.+..++.++|||||||++++|++|.+||...+..+....+.......           
T Consensus       250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~  329 (429)
T 3kvw_A          250 CYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA  329 (429)
T ss_dssp             EETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred             eecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence            766666666788999999999998899999999999999999999999999888776655443210000           


Q ss_pred             --------------------------------------C--------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          233 --------------------------------------P--------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       233 --------------------------------------~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                                                            +        .....+.++.+||.+||+.||++|||+.|+|+|
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H  409 (429)
T 3kvw_A          330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH  409 (429)
T ss_dssp             HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence                                                  0        001247889999999999999999999999999


Q ss_pred             CccccC
Q 038249          267 PWIIQN  272 (281)
Q Consensus       267 ~~~~~~  272 (281)
                      |||++.
T Consensus       410 pw~~~~  415 (429)
T 3kvw_A          410 PWLRRR  415 (429)
T ss_dssp             TTTC--
T ss_pred             hhhccC
Confidence            999976

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.5e-50  Score=349.31  Aligned_cols=256  Identities=25%  Similarity=0.419  Sum_probs=198.5

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-----CC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-----QK   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   89 (281)
                      .++|++++.||.|+||+||+|.++.+++.||+|++.... ......+.+.+|+.++++++||||+++++++..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            378999999999999999999999999999999996543 334446778899999999999999999999853     35


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .+++|+|+++ ++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            7899999985 589999998888999999999999999999999999999999999999999999999999998654311


Q ss_pred             ------------------------------cccccCcCCccCCccc-cCCCCCCcccHHhHHHHHHHHHh----------
Q 038249          170 ------------------------------RRTMCGTLDYLPPEMV-ESVEHDANVDIWSLGVLCYEFLY----------  208 (281)
Q Consensus       170 ------------------------------~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~----------  208 (281)
                                                    ....++|+.|+|||++ ....++.++|||||||++++|++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence                                          1233579999999975 56678999999999999999998          


Q ss_pred             -CCCCCCCCCc--------------------hHHHHHHhhc-----------------------cc------cCCCCCCC
Q 038249          209 -GVPPFEAKEH--------------------SDTYRRIVQV-----------------------DL------KFPPKPIV  238 (281)
Q Consensus       209 -g~~p~~~~~~--------------------~~~~~~~~~~-----------------------~~------~~~~~~~~  238 (281)
                       |.++|.+.+.                    .+....+...                       ..      .....+..
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             6677755431                    1111111100                       00      00012346


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +.++.+||.+||..||++|||++|+|+||||++.
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            8999999999999999999999999999999976

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.6e-52  Score=353.63  Aligned_cols=250  Identities=15%  Similarity=0.197  Sum_probs=206.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHH---HHHHhCCCCceeeee-------eE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREV---EIQSHLRHPNILRLY-------GY   84 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~---~~l~~~~h~~i~~~~-------~~   84 (281)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+   +.+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            47799999999999999999999999999999999765444445567788999   556666899999998       66


Q ss_pred             EEeCC-----------------EEEEEEeccCCCChhHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhcCceec
Q 038249           85 FYDQK-----------------RVYLILEYAAKGELYKELQKCKYFSE-------RRAATYVASLARALIYCHGKHVIHR  140 (281)
Q Consensus        85 ~~~~~-----------------~~~~v~e~~~~~~L~~~~~~~~~l~~-------~~~~~i~~~i~~~l~~Lh~~~i~H~  140 (281)
                      +...+                 ..++||||+ +++|.+++...+.+++       ..++.++.||+.||+|||++||+|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            66543                 278999999 5699999986544554       8888899999999999999999999


Q ss_pred             CCCCCCeEeCCCCcEEEeeecCcccccCCcccccCcCCccCCccccCC-----------CCCCcccHHhHHHHHHHHHhC
Q 038249          141 DIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESV-----------EHDANVDIWSLGVLCYEFLYG  209 (281)
Q Consensus       141 di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~~g  209 (281)
                      ||||+||+++.++.+||+|||++...........+ +.|+|||.+.+.           .++.++||||||+++++|++|
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg  309 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA  309 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence            99999999999999999999998765555555567 999999999877           789999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          210 VPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       210 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ..||...........+.      .....++.++.++|.+||+.||++|||+.++++||||++.
T Consensus       310 ~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          310 DLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             SCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             CCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            99997655444333222      2224689999999999999999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.9e-49  Score=337.71  Aligned_cols=255  Identities=29%  Similarity=0.433  Sum_probs=216.8

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-----CE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-----KR   90 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~   90 (281)
                      ++|++++.||+|++|.||+|.+..++..||+|++....  .....+.+.+|++++++++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            68999999999999999999999999999999996432  334456788999999999999999999999754     47


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      .++|+|++++ +|.++++.. .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++...... 
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            8999999976 899988774 5899999999999999999999999999999999999999999999999998654322 


Q ss_pred             -----cccccCcCCccCCcccc-CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC-----------
Q 038249          170 -----RRTMCGTLDYLPPEMVE-SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF-----------  232 (281)
Q Consensus       170 -----~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  232 (281)
                           .....+++.|+|||.+. +..++.++||||||+++++|++|..||...+..+....+.......           
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                 13346899999999864 4558999999999999999999999999888777666554311000           


Q ss_pred             ---------C---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          233 ---------P---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       233 ---------~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                               +         ..+.++.++.++|.+||+.||++|||+.|+|+||||++...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                     0         01357899999999999999999999999999999998643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-50  Score=337.50  Aligned_cols=262  Identities=25%  Similarity=0.410  Sum_probs=212.8

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ...++|++.+.||+|++|.||+|.+..+|+.||+|.+.......  ....+.+.+|+.++++++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34688999999999999999999999999999999986543221  1123467789999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           91 VYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .++|+||+++ +|...+... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            9999999987 888888765 46899999999999999999999999999999999999999999999999998654322


Q ss_pred             ---cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC-----CC------
Q 038249          170 ---RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF-----PP------  234 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~------  234 (281)
                         .....+++.|+|||.+.+ ..++.++||||||+++++|++|.+||...+..+....+.......     +.      
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence               234568999999999865 457889999999999999999999999888877766654421110     00      


Q ss_pred             ---------------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          235 ---------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       235 ---------------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                     ...++.++.++|.+||+.||++|||+.|+|+||||.+...+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence                           13467899999999999999999999999999999976433

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-49  Score=333.88  Aligned_cols=256  Identities=30%  Similarity=0.520  Sum_probs=220.4

Q ss_pred             CCceec-ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEEE
Q 038249           16 NDFDIG-KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        16 ~~y~~~-~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~   93 (281)
                      ++|.+. +.||+|+||.||+|.++.+++.||+|++........ ....+.+|+.+++.+. ||||+++++++...+..++
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            457777 899999999999999999999999999976543322 2456788999999995 6999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC---CCcEEEeeecCcccccC
Q 038249           94 ILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA---QGELKIADFGWSVHTFN  168 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~---~~~~~l~dfg~~~~~~~  168 (281)
                      |+||+++++|.+++...  +.+++..++.++.||+.||++||++|++|+||+|+||+++.   ++.++|+|||++.....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999998653  66999999999999999999999999999999999999988   78999999999865433


Q ss_pred             C--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCCCHHHHH
Q 038249          169 R--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIVSSAAKD  244 (281)
Q Consensus       169 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~  244 (281)
                      .  .....+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.......+  ....++.++.+
T Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  266 (327)
T 3lm5_A          187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD  266 (327)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHH
Confidence            2  2344689999999999998999999999999999999999999998888877776665443333  33568999999


Q ss_pred             HHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          245 LISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +|.+||+.||++|||++++|+||||++.
T Consensus       267 li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          267 FIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            9999999999999999999999999865

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-49  Score=341.41  Aligned_cols=253  Identities=34%  Similarity=0.587  Sum_probs=208.7

Q ss_pred             cccCCceec-ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCceeeeeeEEEe---
Q 038249           13 WTLNDFDIG-KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ-SHLRHPNILRLYGYFYD---   87 (281)
Q Consensus        13 ~~~~~y~~~-~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l-~~~~h~~i~~~~~~~~~---   87 (281)
                      ..+++|.+. +.||.|+||+||++.++.+|+.||+|++...        ..+.+|+.++ +..+||||+++++++..   
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            456788887 7899999999999999999999999998532        2355677766 45589999999999875   


Q ss_pred             -CCEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC---CCcEEEeeec
Q 038249           88 -QKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA---QGELKIADFG  161 (281)
Q Consensus        88 -~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~---~~~~~l~dfg  161 (281)
                       .+.+++||||+++++|.+++...+  .+++..++.++.||+.||.|||+.||+|+||+|+||+++.   ++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             567899999999999999998753  5999999999999999999999999999999999999998   7889999999


Q ss_pred             CcccccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH----HHHHHhhccccCC--
Q 038249          162 WSVHTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD----TYRRIVQVDLKFP--  233 (281)
Q Consensus       162 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~--  233 (281)
                      ++......  ....++|+.|+|||++.+..++.++||||||+++++|++|..||.......    ....+..+....+  
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            98654332  234568999999999998899999999999999999999999997655432    3344444444333  


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .+..++.++.+||.+||+.||++|||+.|+++||||++..
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            3356899999999999999999999999999999998753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=331.64  Aligned_cols=258  Identities=27%  Similarity=0.463  Sum_probs=216.5

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe----
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD----   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~----   87 (281)
                      ...++|++.+.||.|++|.||+|.+..+++.||+|++......    ...+.+|+.+++++ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            3457899999999999999999999999999999998654322    24577899999998 89999999999986    


Q ss_pred             --CCEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           88 --QKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        88 --~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                        .+..++|+||+++++|.+++...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              56899999999999999999864  46899999999999999999999999999999999999999999999999987


Q ss_pred             ccccCC---cccccCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCC
Q 038249          164 VHTFNR---RRTMCGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK  235 (281)
Q Consensus       164 ~~~~~~---~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (281)
                      ......   .....+++.|+|||.+.     +..++.++||||||+++++|++|..||...........+..........
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  256 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence            654322   23446889999999986     5668889999999999999999999998877776665555544433344


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      ..++.++.++|.+||+.||++|||+.++++||||++.+.
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            568999999999999999999999999999999997643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.5e-49  Score=339.00  Aligned_cols=258  Identities=32%  Similarity=0.488  Sum_probs=215.6

Q ss_pred             cccc-CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           12 RWTL-NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        12 ~~~~-~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      .|.+ ++|++.+.||.|++|.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus        37 ~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  115 (371)
T 4exu_A           37 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS  115 (371)
T ss_dssp             EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             eecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence            3444 78999999999999999999999999999999997653 344556778899999999999999999999987665


Q ss_pred             E------EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           91 V------YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        91 ~------~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      .      ++|+||+.+ +|.+.+..  .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus       116 ~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          116 LRNFYDFYLVMPFMQT-DLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             STTCCCCEEEEECCCE-EHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             cccceeEEEEEccccc-cHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            4      999999975 88777743  48999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc------------
Q 038249          165 HTFNRRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK------------  231 (281)
Q Consensus       165 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------  231 (281)
                      ..........+++.|+|||.+.+ ..++.++||||||+++++|++|..||...+..+....+......            
T Consensus       193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          193 HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             ccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            66666666678999999999876 67899999999999999999999999988777666554331100            


Q ss_pred             -----------CC------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          232 -----------FP------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       232 -----------~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                                 .+      ..+.++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                       00      0135789999999999999999999999999999998653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-49  Score=344.29  Aligned_cols=257  Identities=33%  Similarity=0.591  Sum_probs=209.2

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-----QSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      .++|++.+.||+|+||+||+|.++.+++.||+|++......     .......+.+|+.++++++||||+++++++. .+
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            47899999999999999999999999999999999765432     1122234788999999999999999999975 45


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC---cEEEeeecCcccc
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---ELKIADFGWSVHT  166 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~---~~~l~dfg~~~~~  166 (281)
                      ..++||||+++++|.+.+...+.+++..++.++.||+.||+|||++|++|+||+|+||+++.++   .++|+|||++...
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            6899999999999999998888899999999999999999999999999999999999997654   5999999998654


Q ss_pred             cCC--cccccCcCCccCCccccC---CCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccccCCC--CCCC
Q 038249          167 FNR--RRTMCGTLDYLPPEMVES---VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLKFPP--KPIV  238 (281)
Q Consensus       167 ~~~--~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~--~~~~  238 (281)
                      ...  .....+++.|+|||.+.+   ..++.++||||||+++++|++|..||...... .....+.........  +..+
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  372 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  372 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence            333  234568999999999753   56778999999999999999999999765544 333344443332221  2458


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +.++.++|.+||+.||++|||+.|+|+||||++.
T Consensus       373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            9999999999999999999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.2e-50  Score=339.07  Aligned_cols=260  Identities=28%  Similarity=0.540  Sum_probs=223.9

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchH--------------HHHHHHHHHHHHHhCCCC
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--------------VEHQLRREVEIQSHLRHP   76 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~--------------~~~~~~~e~~~l~~~~h~   76 (281)
                      ..+..++|++.+.||+|++|.||+|.+  +++.||+|.+.........              ....+.+|+.++++++||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            445678999999999999999999999  7999999999655432211              115688999999999999


Q ss_pred             ceeeeeeEEEeCCEEEEEEeccCCCChhHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCe
Q 038249           77 NILRLYGYFYDQKRVYLILEYAAKGELYKE------LQK--CKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENL  147 (281)
Q Consensus        77 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~------~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni  147 (281)
                      ||+++++++.+.+..++||||+++++|.++      +..  ...+++..++.++.||+.||.+||+ .|++|+||+|+||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            999999999999999999999999999998      665  5679999999999999999999999 9999999999999


Q ss_pred             EeCCCCcEEEeeecCcccccC-CcccccCcCCccCCccccCC-CCCC-cccHHhHHHHHHHHHhCCCCCCCCCc-hHHHH
Q 038249          148 LIGAQGELKIADFGWSVHTFN-RRRTMCGTLDYLPPEMVESV-EHDA-NVDIWSLGVLCYEFLYGVPPFEAKEH-SDTYR  223 (281)
Q Consensus       148 ~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~  223 (281)
                      +++.++.++|+|||.+..... ......+++.|+|||.+.+. .++. ++||||||+++++|++|..||..... .+...
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             EEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999999999999999865432 33445689999999999876 5655 89999999999999999999988777 66666


Q ss_pred             HHhhccccCCCC-----------------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          224 RIVQVDLKFPPK-----------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       224 ~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .+.......+..                 ..++.++.++|.+||+.||++|||+.|+++||||++.
T Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            666665544421                 4689999999999999999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.3e-50  Score=333.83  Aligned_cols=266  Identities=25%  Similarity=0.394  Sum_probs=199.3

Q ss_pred             hhhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249            7 AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus         7 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      ......+..++|++.+.||.|++|.||+|.+..+++.||+|.+.....  ....+.+.+|+.++++++||||+++++++.
T Consensus         6 ~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   83 (303)
T 2vwi_A            6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFV   83 (303)
T ss_dssp             -------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEE
T ss_pred             cccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence            344455667899999999999999999999998999999999865432  223456788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEe
Q 038249           87 DQKRVYLILEYAAKGELYKELQK--------CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIA  158 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~  158 (281)
                      ..+..++|+||+++++|.+++..        ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEE
Confidence            99999999999999999999874        3558999999999999999999999999999999999999999999999


Q ss_pred             eecCcccccCC--------cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc
Q 038249          159 DFGWSVHTFNR--------RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD  229 (281)
Q Consensus       159 dfg~~~~~~~~--------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (281)
                      |||++......        .....+++.|+|||.+.+ ..++.++||||||+++++|++|..||................
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  243 (303)
T 2vwi_A          164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND  243 (303)
T ss_dssp             CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred             eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence            99987433221        223457899999999865 567889999999999999999999998877776655444332


Q ss_pred             ccC--------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          230 LKF--------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       230 ~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      ...        .....++.++.++|.+||+.||++|||+.++++||||++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            211        112457899999999999999999999999999999997643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.3e-50  Score=337.15  Aligned_cols=252  Identities=22%  Similarity=0.375  Sum_probs=205.7

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-----
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-----   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----   89 (281)
                      +++|++.+.||+|+||.||+|+++.+|+.||+|++....  .....+.+.+|+.++++++||||+++++++.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            468999999999999999999999999999999997544  2234567899999999999999999999986543     


Q ss_pred             ----------------------------------------------------EEEEEEeccCCCChhHHHHhCCC---CC
Q 038249           90 ----------------------------------------------------RVYLILEYAAKGELYKELQKCKY---FS  114 (281)
Q Consensus        90 ----------------------------------------------------~~~~v~e~~~~~~L~~~~~~~~~---l~  114 (281)
                                                                          ..++||||+++++|.++++....   .+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999999999999987643   45


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---------------cccccCcCCc
Q 038249          115 ERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---------------RRTMCGTLDY  179 (281)
Q Consensus       115 ~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---------------~~~~~~~~~~  179 (281)
                      ...++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++......               .....+++.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            6678999999999999999999999999999999999999999999998554332               1234589999


Q ss_pred             cCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 038249          180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLP  259 (281)
Q Consensus       180 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  259 (281)
                      +|||.+.+..++.++||||||+++++|++|..|+..  .............. ......+.++.++|.+||+.||++|||
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps  319 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPE  319 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCC-cccccCChhHHHHHHHHccCCCCcCCC
Confidence            999999988999999999999999999998665421  11122222221111 011235678899999999999999999


Q ss_pred             hhhhhcCCcccc
Q 038249          260 LHKLLEHPWIIQ  271 (281)
Q Consensus       260 ~~eil~~~~~~~  271 (281)
                      +.|+++||||++
T Consensus       320 ~~~~l~~~~f~~  331 (332)
T 3qd2_B          320 ATDIIENAIFEN  331 (332)
T ss_dssp             HHHHHHSTTCCC
T ss_pred             HHHHhhchhhhc
Confidence            999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-49  Score=328.83  Aligned_cols=257  Identities=28%  Similarity=0.542  Sum_probs=217.9

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCceeeeeeEEE--eCCEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHLRHPNILRLYGYFY--DQKRV   91 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~   91 (281)
                      .++|++.+.||+|++|.||+|.+..++..+|+|++....... ......+.+|++++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            578999999999999999999999999999999996543221 233567889999999999999999999984  45688


Q ss_pred             EEEEeccCCCChhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-
Q 038249           92 YLILEYAAKGELYKELQK--CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-  168 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-  168 (281)
                      ++|+||++++ |.+.+..  ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999999885 7777765  35689999999999999999999999999999999999999999999999999854322 


Q ss_pred             ----CcccccCcCCccCCccccCCC--CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHH
Q 038249          169 ----RRRTMCGTLDYLPPEMVESVE--HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       169 ----~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                          ......+++.|+|||.+.+..  .+.++||||||+++++|++|..||...+..+....+.......+  ..++.++
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--~~~~~~l  240 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP--GDCGPPL  240 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC--SSSCHHH
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC--CccCHHH
Confidence                123445889999999987644  36789999999999999999999998888777777766654443  3689999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      .++|.+||+.||++|||+.++++||||++...
T Consensus       241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            99999999999999999999999999987643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.6e-49  Score=327.39  Aligned_cols=255  Identities=29%  Similarity=0.508  Sum_probs=216.0

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||.|++|.||+|.+..+|+.||+|.+.....     .+.+.+|+.+++.++||||+++++++...+..++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34789999999999999999999999999999999965431     2457889999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---
Q 038249           94 ILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---  169 (281)
                      |+||+++++|.+++. ....+++..++.++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||.+......   
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence            999999999999987 4567999999999999999999999999999999999999999999999999998544322   


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc-ccCCCCCCCCHHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD-LKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~  248 (281)
                      .....+++.|+|||.+.+..++.++||||||+++++|++|..||................ ........++.++.++|.+
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  261 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ  261 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred             cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence            234467889999999998889999999999999999999999998877666554443322 2222334578999999999


Q ss_pred             hcccCCCCCCChhhhhcCCccccCC
Q 038249          249 MLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      ||+.||++|||+.++++||||++..
T Consensus       262 ~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          262 CLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HccCChhhCcCHHHHHhCHHHhcCC
Confidence            9999999999999999999998764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.8e-49  Score=338.52  Aligned_cols=256  Identities=29%  Similarity=0.439  Sum_probs=209.1

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC----
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK----   89 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----   89 (281)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+    
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            4589999999999999999999999999999999997543 33444567889999999999999999999997654    


Q ss_pred             --EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           90 --RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        90 --~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                        ..++||||+++ +|.+.+..  .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence              78999999976 78887763  48999999999999999999999999999999999999999999999999986543


Q ss_pred             CC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC-------------
Q 038249          168 NR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF-------------  232 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  232 (281)
                      ..  .....+++.|+|||.+.+..++.++||||||+++++|++|..||.+.+..+....+.......             
T Consensus       179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            32  233468999999999998889999999999999999999999999887776665554321100             


Q ss_pred             ------CCCC---------------------CCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          233 ------PPKP---------------------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       233 ------~~~~---------------------~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                            +...                     ..+.++.+||.+||+.||++|||++|+|+||||+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                  0000                     0146789999999999999999999999999998653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3e-49  Score=328.05  Aligned_cols=256  Identities=27%  Similarity=0.478  Sum_probs=216.7

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++.+.||.|++|.||+|.+..+++.+++|.+.....   ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            4789999999999999999999999999999999865432   2245678899999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCc
Q 038249           95 LEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRR  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~  170 (281)
                      +||+++++|.+++.. ...+++..++.++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||++....   ...
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            999999999998875 4569999999999999999999999999999999999999999999999999864321   122


Q ss_pred             ccccCcCCccCCccc-----cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc-CCCCCCCCHHHHH
Q 038249          171 RTMCGTLDYLPPEMV-----ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK-FPPKPIVSSAAKD  244 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~-----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  244 (281)
                      ....+++.|+|||.+     .+..++.++|+||||+++++|++|..||...+..+....+...... ......++.++.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  254 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD  254 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence            334678999999997     4667888999999999999999999999988877776665554332 2233468899999


Q ss_pred             HHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          245 LISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +|.+||+.||++|||+.++++||||++..
T Consensus       255 li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          255 FLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             HHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             HHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            99999999999999999999999999764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.3e-49  Score=332.75  Aligned_cols=253  Identities=31%  Similarity=0.465  Sum_probs=212.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE-----
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR-----   90 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-----   90 (281)
                      ++|++.+.||.|++|.||+|.++.+|+.||+|.+.... ........+.+|+.+++.++||||+++++++...+.     
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            78999999999999999999999999999999996543 344456778899999999999999999999987543     


Q ss_pred             -EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           91 -VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        91 -~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                       .++||||+++ +|.+.+..  .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  179 (353)
T 3coi_A          103 DFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  179 (353)
T ss_dssp             CCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred             eEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence             4999999975 88877754  4899999999999999999999999999999999999999999999999998765555


Q ss_pred             cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc------------------
Q 038249          170 RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL------------------  230 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------  230 (281)
                      .....+++.|+|||.+.+ ..++.++||||||+++++|++|..||...+..+....+.....                  
T Consensus       180 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  259 (353)
T 3coi_A          180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY  259 (353)
T ss_dssp             ----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHH
T ss_pred             ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHH
Confidence            555678999999999876 6788999999999999999999999998877665554432100                  


Q ss_pred             ----------c-CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          231 ----------K-FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       231 ----------~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                                . ....+.++.++.++|.+||+.||++|||+.++++||||+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          260 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             HHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                      0 01123578999999999999999999999999999999865

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4e-50  Score=342.67  Aligned_cols=255  Identities=20%  Similarity=0.216  Sum_probs=199.6

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHH---HHHHhCCCCceeeee-------eEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREV---EIQSHLRHPNILRLY-------GYF   85 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~---~~l~~~~h~~i~~~~-------~~~   85 (281)
                      .+|++.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+   ..++. +|||+++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            4599999999999999999999999999999999876654555566777774   45555 799987754       454


Q ss_pred             EeC-----------------CEEEEEEeccCCCChhHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhcCceecC
Q 038249           86 YDQ-----------------KRVYLILEYAAKGELYKELQKC-KYFSERRA------ATYVASLARALIYCHGKHVIHRD  141 (281)
Q Consensus        86 ~~~-----------------~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~------~~i~~~i~~~l~~Lh~~~i~H~d  141 (281)
                      ...                 ..+++||||++ ++|.+++... ..++...+      +.++.||+.||+|||++||+|+|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            433                 34899999998 6999999863 33455555      67779999999999999999999


Q ss_pred             CCCCCeEeCCCCcEEEeeecCcccccCCcccccCcCCccCCccccC--CCCCCcccHHhHHHHHHHHHhCCCCCCCCCch
Q 038249          142 IKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS  219 (281)
Q Consensus       142 i~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  219 (281)
                      |||+||+++.++.+||+|||++...........+++.|+|||.+.+  ..++.++||||||+++++|++|..||......
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~  299 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG  299 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTT
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcc
Confidence            9999999999999999999998766554435567799999999977  67899999999999999999999999876433


Q ss_pred             HHH--H-----HHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          220 DTY--R-----RIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       220 ~~~--~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ...  .     .........+..+.++.++.++|.+||+.||++|||+.++++||||++.
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             cccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            111  0     0111222333345789999999999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.9e-49  Score=328.02  Aligned_cols=252  Identities=23%  Similarity=0.381  Sum_probs=212.5

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ..+..++|++.+.||+|+||+||+|.+..+++.+|+|.+...   .....+.+.+|++++++++||||+++++++.+.+.
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   81 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR   81 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence            456789999999999999999999999999999999998442   34456778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           91 VYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .++|+||+++++|.++++. ...+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            9999999999999999987 466999999999999999999999999999999999999999999999999998543222


Q ss_pred             cc-----------------cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHH-HHhhcccc
Q 038249          170 RR-----------------TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR-RIVQVDLK  231 (281)
Q Consensus       170 ~~-----------------~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~  231 (281)
                      ..                 ...+|+.|+|||.+.+..++.++||||||+++++|++|..|+.......... ........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            11                 3468999999999999999999999999999999999999986543321100 00000001


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          232 FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ....+.++.++.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1123468899999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.4e-49  Score=330.04  Aligned_cols=256  Identities=34%  Similarity=0.607  Sum_probs=211.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-----QSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+......     .......+.+|++++++++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            6799999999999999999999999999999998654321     1122345788999999999999999999987655 


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc---EEEeeecCccccc
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE---LKIADFGWSVHTF  167 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~---~~l~dfg~~~~~~  167 (281)
                      .++|+||+++++|.+.+.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.   ++|+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            8999999999999999988888999999999999999999999999999999999999987664   9999999986543


Q ss_pred             CCc--ccccCcCCccCCcccc---CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccccCCC--CCCCC
Q 038249          168 NRR--RTMCGTLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLKFPP--KPIVS  239 (281)
Q Consensus       168 ~~~--~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~--~~~~~  239 (281)
                      ...  ....+++.|+|||.+.   ...++.++||||||+++++|++|..||...... .....+.........  ...++
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS  248 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSC
T ss_pred             cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcC
Confidence            332  2345799999999973   566788999999999999999999999765544 333334333332211  23588


Q ss_pred             HHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .++.++|.+||+.||++|||+.++++||||++.
T Consensus       249 ~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             HHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            999999999999999999999999999999853

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.4e-49  Score=330.45  Aligned_cols=257  Identities=21%  Similarity=0.406  Sum_probs=216.4

Q ss_pred             ccccCCceecceecccCceEEEEEEE-ccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC------ceeeeeeE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLARE-KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP------NILRLYGY   84 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~------~i~~~~~~   84 (281)
                      ....++|++.+.||+|++|.||+|.+ ..+++.||+|++...    ....+.+.+|+++++.++|+      ++++++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            34457999999999999999999999 557889999998543    23456678888888888665      49999999


Q ss_pred             EEeCCEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-----------
Q 038249           85 FYDQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-----------  151 (281)
Q Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-----------  151 (281)
                      +...+..++||||+ +++|.+++...+  ++++..++.++.||+.||++||++|++|+||+|+||+++.           
T Consensus        86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence            99999999999999 779999998765  6899999999999999999999999999999999999987           


Q ss_pred             --------CCcEEEeeecCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHH
Q 038249          152 --------QGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR  223 (281)
Q Consensus       152 --------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  223 (281)
                              ++.++|+|||++...........+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+...
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             ccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                    668999999998766665666678999999999998899999999999999999999999998877766544


Q ss_pred             HHhhccccCC------------------------------------------CCCCCCHHHHHHHHHhcccCCCCCCChh
Q 038249          224 RIVQVDLKFP------------------------------------------PKPIVSSAAKDLISQMLVKDSSQRLPLH  261 (281)
Q Consensus       224 ~~~~~~~~~~------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~  261 (281)
                      .+.......+                                          .....+.++.++|.+||+.||++|||+.
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            4322111000                                          0112356789999999999999999999


Q ss_pred             hhhcCCccccCC
Q 038249          262 KLLEHPWIIQNA  273 (281)
Q Consensus       262 eil~~~~~~~~~  273 (281)
                      |+++||||++..
T Consensus       325 ell~hp~f~~~~  336 (339)
T 1z57_A          325 EALKHPFFDLLK  336 (339)
T ss_dssp             HHTTSGGGGGGG
T ss_pred             HHhcCHHHHHHh
Confidence            999999998753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.5e-48  Score=320.33  Aligned_cols=261  Identities=23%  Similarity=0.416  Sum_probs=218.0

Q ss_pred             cccchhhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHH----HHHHHHHHHHHhCCCCce
Q 038249            3 SEVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE----HQLRREVEIQSHLRHPNI   78 (281)
Q Consensus         3 ~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~----~~~~~e~~~l~~~~h~~i   78 (281)
                      ++.......++..++|++.+.||+|++|+||+|.+..+++.||+|++...........    +.+.+|+.++++++||||
T Consensus         6 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   85 (287)
T 4f0f_A            6 SEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI   85 (287)
T ss_dssp             ------CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTB
T ss_pred             CcCcchhhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCc
Confidence            3444555667888999999999999999999999999999999999865543332221    568899999999999999


Q ss_pred             eeeeeEEEeCCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCeEeCCCCc-
Q 038249           79 LRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKH--VIHRDIKPENLLIGAQGE-  154 (281)
Q Consensus        79 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~Ni~~~~~~~-  154 (281)
                      +++++++.+..  ++|+||+++++|.+.+... .++++..++.++.|++.||.+||++|  ++|+||+|+||+++.++. 
T Consensus        86 ~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~  163 (287)
T 4f0f_A           86 VKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDEN  163 (287)
T ss_dssp             CCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTT
T ss_pred             hhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCC
Confidence            99999987665  5899999999998887654 46999999999999999999999999  999999999999988876 


Q ss_pred             ----EEEeeecCcccccCCcccccCcCCccCCccc--cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHH--HHHHh
Q 038249          155 ----LKIADFGWSVHTFNRRRTMCGTLDYLPPEMV--ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT--YRRIV  226 (281)
Q Consensus       155 ----~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~  226 (281)
                          ++|+|||++...........+++.|+|||.+  ....++.++||||||+++++|++|..||......+.  .....
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  243 (287)
T 4f0f_A          164 APVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR  243 (287)
T ss_dssp             CSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred             CceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence                9999999987666666667789999999998  445578899999999999999999999987666544  33444


Q ss_pred             hccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          227 QVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ...........++.++.++|.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            444444445578999999999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.9e-49  Score=336.35  Aligned_cols=252  Identities=30%  Similarity=0.484  Sum_probs=208.5

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-----
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-----   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----   87 (281)
                      ...++|++.+.||.|+||+||+|.+..+|+.||+|++..+...       ..+|+++++.++||||+++++++..     
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            3457899999999999999999999999999999998654322       2368999999999999999999843     


Q ss_pred             ---------------------------------CCEEEEEEeccCCCChhHHHH----hCCCCCHHHHHHHHHHHHHHHH
Q 038249           88 ---------------------------------QKRVYLILEYAAKGELYKELQ----KCKYFSERRAATYVASLARALI  130 (281)
Q Consensus        88 ---------------------------------~~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~~i~~~l~  130 (281)
                                                       ....++||||+++ +|.+.+.    ....+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             3358999999986 7766654    4567999999999999999999


Q ss_pred             HHHhcCceecCCCCCCeEeC-CCCcEEEeeecCcccccC--CcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHH
Q 038249          131 YCHGKHVIHRDIKPENLLIG-AQGELKIADFGWSVHTFN--RRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEF  206 (281)
Q Consensus       131 ~Lh~~~i~H~di~~~Ni~~~-~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l  206 (281)
                      |||+.||+|+||+|+||+++ .++.++|+|||++.....  ......+++.|+|||.+.+. .++.++||||||+++++|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            99999999999999999997 688999999999865422  23445678999999998664 489999999999999999


Q ss_pred             HhCCCCCCCCCchHHHHHHhhccc-----------------cCC----------CCCCCCHHHHHHHHHhcccCCCCCCC
Q 038249          207 LYGVPPFEAKEHSDTYRRIVQVDL-----------------KFP----------PKPIVSSAAKDLISQMLVKDSSQRLP  259 (281)
Q Consensus       207 ~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps  259 (281)
                      ++|..||...+..+....+.....                 .++          ....++.++.++|.+||+.||++|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            999999998887776665543100                 011          12347889999999999999999999


Q ss_pred             hhhhhcCCccccC
Q 038249          260 LHKLLEHPWIIQN  272 (281)
Q Consensus       260 ~~eil~~~~~~~~  272 (281)
                      +.|+|+||||++.
T Consensus       316 ~~e~l~hp~f~~~  328 (383)
T 3eb0_A          316 PYEAMAHPFFDHL  328 (383)
T ss_dssp             HHHHHTSGGGHHH
T ss_pred             HHHHhcCHHHHHH
Confidence            9999999999753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-49  Score=334.01  Aligned_cols=260  Identities=33%  Similarity=0.605  Sum_probs=215.5

Q ss_pred             cccccCCceecceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCceeeeeeEE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHL-RHPNILRLYGYF   85 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~-~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~   85 (281)
                      ..+.+++|++.+.||+|+||.||+|++.   .+++.||+|++...... .......+.+|+++++++ +||||+++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            3456689999999999999999999984   47899999998654321 111223456788889988 699999999999


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                      ...+..++||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999998754


Q ss_pred             ccCC----cccccCcCCccCCccccC--CCCCCcccHHhHHHHHHHHHhCCCCCCCCCc----hHHHHHHhhccccCCCC
Q 038249          166 TFNR----RRTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPFEAKEH----SDTYRRIVQVDLKFPPK  235 (281)
Q Consensus       166 ~~~~----~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~  235 (281)
                      ....    .....+|+.|+|||.+.+  ..++.++||||||+++++|++|..||.....    ..............  .
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~  286 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--P  286 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC--C
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC--C
Confidence            3221    223468999999999875  3468899999999999999999999975433    23333333333333  3


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCC-----ChhhhhcCCccccC
Q 038249          236 PIVSSAAKDLISQMLVKDSSQRL-----PLHKLLEHPWIIQN  272 (281)
Q Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~~~~~~~  272 (281)
                      ..++..+.++|.+||..||++||     +++++++||||++.
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            46899999999999999999999     99999999999853

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.3e-48  Score=328.63  Aligned_cols=258  Identities=29%  Similarity=0.482  Sum_probs=214.9

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-----C
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-----K   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~   89 (281)
                      .++|++.+.||+|++|.||+|.+..+|+.||+|.+...  ........+.+|+.++++++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            47899999999999999999999999999999998543  2334456778999999999999999999988754     6


Q ss_pred             EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           90 RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ..++|+|++.+ +|.+.+.. +.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        88 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           88 EVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             CEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             eEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            78999999975 89998887 45899999999999999999999999999999999999999999999999998543221


Q ss_pred             -------------cccccCcCCccCCcccc-CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-----
Q 038249          170 -------------RRTMCGTLDYLPPEMVE-SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-----  230 (281)
Q Consensus       170 -------------~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----  230 (281)
                                   .....+++.|+|||.+. +..++.++||||||+++++|++|..||...+..+....+.....     
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence                         11235788999999865 46788999999999999999999999988776655443322100     


Q ss_pred             -------------------cCC------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          231 -------------------KFP------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       231 -------------------~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                                         ..+      ..+.++.++.++|.+||+.||++|||+.|+++||||+....+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence                               000      0135889999999999999999999999999999999765443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4e-48  Score=325.18  Aligned_cols=251  Identities=26%  Similarity=0.490  Sum_probs=209.0

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEe--CCEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYD--QKRV   91 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~   91 (281)
                      .++|++.+.||+|++|+||+|.+..+++.||+|++....      .+.+.+|+.++++++ ||||+++++++.+  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            478999999999999999999999999999999985432      245788999999997 9999999999987  6688


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-cEEEeeecCcccccC--
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWSVHTFN--  168 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-~~~l~dfg~~~~~~~--  168 (281)
                      ++|+||+++++|.++++.   +++..++.++.||+.||++||++|++|+||+|+||+++.++ .++|+|||++.....  
T Consensus       109 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             EEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            999999999999998865   89999999999999999999999999999999999999777 899999999864332  


Q ss_pred             CcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhh-------------ccc---
Q 038249          169 RRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQ-------------VDL---  230 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~-------------~~~---  230 (281)
                      ......+++.|+|||.+.+ ..++.++||||||+++++|++|..||...... +....+..             ...   
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  265 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  265 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence            2334567889999999876 66899999999999999999999999543332 22211111             000   


Q ss_pred             -------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          231 -------------------KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       231 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                                         .......++.++.++|.+||++||++|||++|+|+||||++..+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                               01111237899999999999999999999999999999997654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-48  Score=332.57  Aligned_cols=265  Identities=27%  Similarity=0.415  Sum_probs=205.5

Q ss_pred             hhhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249            7 AKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus         7 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      ........+++|++.+.||+|+||+||+|.+..+|+.||+|++.......    ....++++.++.++||||+++++++.
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            34455677899999999999999999999999999999999986543222    23456777788889999999999997


Q ss_pred             eCC-------EEEEEEeccCCCChhHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--hcCceecCCCCCCeEeCC-C
Q 038249           87 DQK-------RVYLILEYAAKGELYKEL----QKCKYFSERRAATYVASLARALIYCH--GKHVIHRDIKPENLLIGA-Q  152 (281)
Q Consensus        87 ~~~-------~~~~v~e~~~~~~L~~~~----~~~~~l~~~~~~~i~~~i~~~l~~Lh--~~~i~H~di~~~Ni~~~~-~  152 (281)
                      ..+       ..++||||+++ +|...+    .....++...++.++.||+.|+.+||  +.||+|+||+|+||+++. +
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTT
T ss_pred             ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCC
Confidence            533       38999999987 444433    34567899999999999999999999  999999999999999997 8


Q ss_pred             CcEEEeeecCcccccCC--cccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc
Q 038249          153 GELKIADFGWSVHTFNR--RRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD  229 (281)
Q Consensus       153 ~~~~l~dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (281)
                      +.++|+|||++......  .....+++.|+|||.+.+. .++.++||||||+++++|++|..||...+..+....+....
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             CcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            99999999998654332  2344679999999998554 48999999999999999999999999888777666554311


Q ss_pred             cc------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          230 LK------------------------------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       230 ~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                      ..                              .......+.++.++|.+||+.||++|||+.|+|+||||++..++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence            00                              001112567899999999999999999999999999999875554

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.2e-48  Score=330.52  Aligned_cols=252  Identities=25%  Similarity=0.418  Sum_probs=216.6

Q ss_pred             ccccCCceecceecccCceEEEEEEEcc-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeee
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKR-------SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYG   83 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~   83 (281)
                      .+..++|++.+.||+|+||.||+|.+..       ++..||+|.+....  .......+.+|+.+++.+ +||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            3455899999999999999999999752       45679999996543  334456789999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCe
Q 038249           84 YFYDQKRVYLILEYAAKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENL  147 (281)
Q Consensus        84 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni  147 (281)
                      ++.+.+.+++|+||+++++|.+++...+                .++...++.++.||+.||.|||++||+|+||+|+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998653                378999999999999999999999999999999999


Q ss_pred             EeCCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHH
Q 038249          148 LIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDT  221 (281)
Q Consensus       148 ~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~  221 (281)
                      +++.++.+||+|||++......     .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9999999999999998644322     222345778999999988899999999999999999998 9999998888877


Q ss_pred             HHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          222 YRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ...+..... ......++.++.++|.+||+.||++|||+.|++++
T Consensus       315 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          315 FKLLKEGHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHTTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            776655432 23334689999999999999999999999999863

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.4e-48  Score=322.19  Aligned_cols=257  Identities=24%  Similarity=0.375  Sum_probs=209.5

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ......+++|++.+.||.|++|.||+|.+..+++.||+|++...........+.+.+|+.++++++||||+++++++...
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             cCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            34556779999999999999999999999999999999999766555556667899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      +..++|+||+++++|.++++..+++++..++.++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999998754433


Q ss_pred             C----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-cCCCCCCCCHHHH
Q 038249          169 R----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-KFPPKPIVSSAAK  243 (281)
Q Consensus       169 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~  243 (281)
                      .    .....+++.|+|||.+.+..++.++|+||||+++++|++|..||...........+..... .....+.+|.++.
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  266 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD  266 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence            2    1234578999999999888899999999999999999999999987665544333332211 1122346899999


Q ss_pred             HHHHHhcccCCCCCC-Chhhhhc
Q 038249          244 DLISQMLVKDSSQRL-PLHKLLE  265 (281)
Q Consensus       244 ~li~~~l~~~p~~Rp-s~~eil~  265 (281)
                      ++|.+||+.||++|| +++++++
T Consensus       267 ~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          267 AVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999 7888775

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4e-48  Score=320.15  Aligned_cols=262  Identities=27%  Similarity=0.432  Sum_probs=213.8

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ..+..++|.....||+|++|.||+|.+..++..||+|.+....   ....+.+.+|+.+++.++||||+++++++...+.
T Consensus        17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            3455566777779999999999999999999999999986543   2335678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-CCcEEEeeecCcccc
Q 038249           91 VYLILEYAAKGELYKELQKCK---YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-QGELKIADFGWSVHT  166 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-~~~~~l~dfg~~~~~  166 (281)
                      .++|+||+++++|.+++....   .+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            999999999999999998652   4678899999999999999999999999999999999987 899999999998654


Q ss_pred             cCC---cccccCcCCccCCccccCCC--CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHH-HHhhccccCCCCCCCCH
Q 038249          167 FNR---RRTMCGTLDYLPPEMVESVE--HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR-RIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       167 ~~~---~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  240 (281)
                      ...   .....+++.|+|||.+.+..  ++.++|+||||+++++|++|..||.......... ..............++.
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (295)
T 2clq_A          174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA  253 (295)
T ss_dssp             CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred             CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence            322   23446789999999986543  7889999999999999999999997654443221 11111222223346899


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      ++.++|.+||+.||++|||+.++++||||+...+.
T Consensus       254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence            99999999999999999999999999999977543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2e-48  Score=326.15  Aligned_cols=260  Identities=22%  Similarity=0.393  Sum_probs=202.4

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ....++|++.+.||+|++|.||+|.+..++.   .||+|.+....... ...+.+.+|+.++++++||||+++++++...
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            3455889999999999999999999887765   79999996654333 3357788999999999999999999999876


Q ss_pred             CEE------EEEEeccCCCChhHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEE
Q 038249           89 KRV------YLILEYAAKGELYKELQKCK------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELK  156 (281)
Q Consensus        89 ~~~------~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~  156 (281)
                      +..      ++|+||+++++|.+++....      .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence            654      99999999999999986432      589999999999999999999999999999999999999999999


Q ss_pred             EeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccc
Q 038249          157 IADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDL  230 (281)
Q Consensus       157 l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~  230 (281)
                      |+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+.....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            99999986543221     22345678999999988889999999999999999999 9999999888888777765542


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCCCCCCC-------hhhhhcCCccccCC
Q 038249          231 KFPPKPIVSSAAKDLISQMLVKDSSQRLP-------LHKLLEHPWIIQNA  273 (281)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps-------~~eil~~~~~~~~~  273 (281)
                       ....+.++.++.++|.+||+.||++|||       +++++.|||+....
T Consensus       258 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          258 -LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             -CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence             3334478999999999999999999999       88889999998763

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.4e-48  Score=332.91  Aligned_cols=256  Identities=28%  Similarity=0.421  Sum_probs=212.2

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CC-----ceeeeeeEEEe
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HP-----NILRLYGYFYD   87 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~-----~i~~~~~~~~~   87 (281)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....    .....+..|+.+++.+. |+     +++++.+++..
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3588999999999999999999999999999999995432    33455667777777774 44     59999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hcCceecCCCCCCeEeC--CCCcEEEeeec
Q 038249           88 QKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCH--GKHVIHRDIKPENLLIG--AQGELKIADFG  161 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh--~~~i~H~di~~~Ni~~~--~~~~~~l~dfg  161 (281)
                      .+..++||||+++ +|.+++...  +.+++..++.++.||+.||.+||  +.||+|+||+|+||+++  .++.++|+|||
T Consensus       128 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            9999999999976 999998865  45899999999999999999999  57999999999999995  46789999999


Q ss_pred             CcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--------
Q 038249          162 WSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--------  233 (281)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  233 (281)
                      ++...........+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.......+        
T Consensus       207 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  286 (382)
T 2vx3_A          207 SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP  286 (382)
T ss_dssp             TCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred             CceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence            997766555667789999999999998999999999999999999999999998887776655443211000        


Q ss_pred             ---------------------------CC--CC-------------------------CCHHHHHHHHHhcccCCCCCCC
Q 038249          234 ---------------------------PK--PI-------------------------VSSAAKDLISQMLVKDSSQRLP  259 (281)
Q Consensus       234 ---------------------------~~--~~-------------------------~~~~l~~li~~~l~~~p~~Rps  259 (281)
                                                 ..  ..                         .+.++.+||.+||+.||++|||
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt  366 (382)
T 2vx3_A          287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ  366 (382)
T ss_dssp             THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence                                       00  00                         0137899999999999999999


Q ss_pred             hhhhhcCCccccCCC
Q 038249          260 LHKLLEHPWIIQNAD  274 (281)
Q Consensus       260 ~~eil~~~~~~~~~~  274 (281)
                      +.|+|+||||++..+
T Consensus       367 a~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          367 PYYALQHSFFKKTAD  381 (382)
T ss_dssp             HHHHTTSGGGCC---
T ss_pred             HHHHhcCcccccCCC
Confidence            999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=325.66  Aligned_cols=253  Identities=22%  Similarity=0.344  Sum_probs=217.5

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      ...+..++|++.+.||+|+||.||+|.+..+++   .||+|.+....  .....+.+.+|+.++++++||||+++++++.
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  120 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVT  120 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            345667899999999999999999999986554   49999996543  3344567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           87 DQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                      +.+..++||||+++++|.++++.. +.+++..++.++.+|+.||.+||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999999999754 5799999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCC
Q 038249          166 TFNRR------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIV  238 (281)
Q Consensus       166 ~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (281)
                      .....      ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+... ...+....+
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~  279 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGC  279 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCc
Confidence            43321      12234668999999988889999999999999999998 99999988888877776654 233444579


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +.++.++|.+||+.||++|||+.++++
T Consensus       280 ~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          280 PHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6e-49  Score=338.02  Aligned_cols=253  Identities=23%  Similarity=0.358  Sum_probs=207.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--------CCceeeeeeEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR--------HPNILRLYGYF   85 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~--------h~~i~~~~~~~   85 (281)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++...    ....+.+.+|+.+++.++        |+||+++++.+
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            347899999999999999999999999999999999543    234566788999998885        78899999998


Q ss_pred             E----eCCEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCCC-----
Q 038249           86 Y----DQKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQG-----  153 (281)
Q Consensus        86 ~----~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~-----  153 (281)
                      .    .....++||||+.+ ++.+.+...  ..+++..++.++.||+.||.|||++ ||+|+||||+||+++.++     
T Consensus       111 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          111 KISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             EEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             eecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence            7    45689999999955 666655443  4699999999999999999999998 999999999999999775     


Q ss_pred             --------------------------------------------cEEEeeecCcccccCCcccccCcCCccCCccccCCC
Q 038249          154 --------------------------------------------ELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE  189 (281)
Q Consensus       154 --------------------------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~  189 (281)
                                                                  .++|+|||++...........+|+.|+|||++.+..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~  269 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG  269 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSC
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCC
Confidence                                                        799999999876666666667899999999999888


Q ss_pred             CCCcccHHhHHHHHHHHHhCCCCCCCCCch------HHHHHHhhccccC-------------------------------
Q 038249          190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHS------DTYRRIVQVDLKF-------------------------------  232 (281)
Q Consensus       190 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~-------------------------------  232 (281)
                      ++.++||||||+++++|++|..||...+..      .....+.......                               
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            999999999999999999999999765532      1111111100000                               


Q ss_pred             ---------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          233 ---------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       233 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                               ......+.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                     001123457889999999999999999999999999974

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.9e-48  Score=315.69  Aligned_cols=249  Identities=22%  Similarity=0.406  Sum_probs=216.5

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .+..++|++.+.||+|++|.||+|.+. +++.||+|++.......    +.+.+|++++++++||||+++++++.+.+..
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            345589999999999999999999997 47789999997654332    4578899999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           92 YLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      ++||||+++++|.+++... +.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999999999764 45899999999999999999999999999999999999999999999999998644322 


Q ss_pred             ---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          170 ---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                         .....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+....+..... .......+.++.++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  239 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-LYKPRLASTHVYQI  239 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCCTTSCHHHHHH
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc-CCCCCcCCHHHHHH
Confidence               223345678999999988889999999999999999999 9999999888887777765532 33334689999999


Q ss_pred             HHHhcccCCCCCCChhhhhcC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~  266 (281)
                      +.+||+.||++|||+.+++++
T Consensus       240 i~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          240 MNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999964

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=324.60  Aligned_cols=257  Identities=28%  Similarity=0.410  Sum_probs=209.5

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE-------
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY-------   86 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-------   86 (281)
                      ..++|++.+.||+|++|.||+|.+..+++.||+|.+...   .....+.+.+|+.++++++||||+++++++.       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            347899999999999999999999999999999998644   3444567889999999999999999999873       


Q ss_pred             -------eCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC-CCCcEEEe
Q 038249           87 -------DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIA  158 (281)
Q Consensus        87 -------~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~-~~~~~~l~  158 (281)
                             +....++|+||+++ +|.++++. +++++..++.++.||+.||++||++|++|+||+|+||+++ .++.++|+
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             C----CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence                   34688999999985 99998876 4589999999999999999999999999999999999997 56799999


Q ss_pred             eecCcccccCC------cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc
Q 038249          159 DFGWSVHTFNR------RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK  231 (281)
Q Consensus       159 dfg~~~~~~~~------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  231 (281)
                      |||++......      .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+..+....+......
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998654221      223346888999998754 67889999999999999999999999988776666554432110


Q ss_pred             C----------------------C------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          232 F----------------------P------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       232 ~----------------------~------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      .                      +      ..+.++.++.++|.+||+.||++|||+.++++||||+....+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            0                      0      013589999999999999999999999999999999977544

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.6e-48  Score=330.46  Aligned_cols=260  Identities=24%  Similarity=0.413  Sum_probs=209.5

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccc--------cchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL--------QQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ..++|++.+.||.|++|.||+|.+.. +..||+|++.....        ......+.+.+|++++++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            34889999999999999999999875 89999999855432        1233457789999999999999999999998


Q ss_pred             Ee-----CCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEee
Q 038249           86 YD-----QKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIAD  159 (281)
Q Consensus        86 ~~-----~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~d  159 (281)
                      ..     ....++|+||+++ +|.+.+... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence            54     3478999999985 777777654 4699999999999999999999999999999999999999999999999


Q ss_pred             ecCcccccCC--cccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc-----
Q 038249          160 FGWSVHTFNR--RRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK-----  231 (281)
Q Consensus       160 fg~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  231 (281)
                      ||++......  .....+++.|+|||.+.+ ..++.++||||||+++++|++|..||...+..+....+......     
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            9998643222  334467889999999866 67899999999999999999999999988776665554331100     


Q ss_pred             -------------------CC------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          232 -------------------FP------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       232 -------------------~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                         .+      ..+..+..+.++|.+||+.||++|||+.|+++||||++...+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                               00      013468889999999999999999999999999999976443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=325.37  Aligned_cols=254  Identities=23%  Similarity=0.389  Sum_probs=209.6

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC--
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK--   89 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--   89 (281)
                      ...-++|++.+.||+|+||+||+|.+..+++.||+|++........  .+.+.+|++++++++||||+++++++....  
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            3445789999999999999999999999999999999965443222  355778999999999999999999998755  


Q ss_pred             EEEEEEeccCCCChhHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe----CCCCcEEEeeecC
Q 038249           90 RVYLILEYAAKGELYKELQKCKY---FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI----GAQGELKIADFGW  162 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~----~~~~~~~l~dfg~  162 (281)
                      ..++||||+++++|.++++....   +++..++.++.||+.||++||+.|++|+||+|+||++    +.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            78999999999999999986533   8999999999999999999999999999999999999    7788899999999


Q ss_pred             cccccCC--cccccCcCCccCCcccc--------CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch----HHHHHHhhc
Q 038249          163 SVHTFNR--RRTMCGTLDYLPPEMVE--------SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS----DTYRRIVQV  228 (281)
Q Consensus       163 ~~~~~~~--~~~~~~~~~~~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~  228 (281)
                      +......  .....+++.|+|||.+.        +..++.++||||||+++++|++|..||......    +....+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            8654333  23456899999999875        567888999999999999999999999754432    333333333


Q ss_pred             ccc-------------------CCCC----CCCCHHHHHHHHHhcccCCCCCCChhhhhcCC
Q 038249          229 DLK-------------------FPPK----PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHP  267 (281)
Q Consensus       229 ~~~-------------------~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~  267 (281)
                      ...                   .+..    ..++..+.++|.+||+.||++|||++|+|+||
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            211                   1111    12455789999999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-47  Score=321.75  Aligned_cols=261  Identities=26%  Similarity=0.423  Sum_probs=213.8

Q ss_pred             ccccCCceecceecccCceEEEEEEEc-cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeeeeeEEE-
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREK-RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL---RHPNILRLYGYFY-   86 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~---~h~~i~~~~~~~~-   86 (281)
                      ....++|++.+.||+|++|.||+|.+. .+++.||+|.+........ ....+.+|+.+++.+   +||||+++++++. 
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            344588999999999999999999995 6788999999865432211 112344555555544   8999999999987 


Q ss_pred             ----eCCEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeee
Q 038249           87 ----DQKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADF  160 (281)
Q Consensus        87 ----~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~df  160 (281)
                          .....++|+||+++ +|.+++....  .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             EECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence                45688999999985 9999988653  4899999999999999999999999999999999999999999999999


Q ss_pred             cCcccccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc-----cC-
Q 038249          161 GWSVHTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-----KF-  232 (281)
Q Consensus       161 g~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~-  232 (281)
                      |++......  .....+++.|+|||.+.+..++.++||||||+++++|++|..||......+....+.....     .+ 
T Consensus       165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             cccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            998654322  2345678999999999888899999999999999999999999998887776665543100     00 


Q ss_pred             -------------------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          233 -------------------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       233 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                                         .....++.++.++|.+||+.||++|||+.++++||||++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                               012358899999999999999999999999999999987643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=330.80  Aligned_cols=258  Identities=24%  Similarity=0.356  Sum_probs=217.6

Q ss_pred             hcccccCCceecceecccCceEEEEEE-----EccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeE
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGY   84 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~-----~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~   84 (281)
                      ...+..++|++.+.||+|+||+||+|.     +..++..||+|++....  .......+.+|+.++++++||||++++++
T Consensus        65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            345556889999999999999999999     44567889999985432  33345568889999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChhHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC---c
Q 038249           85 FYDQKRVYLILEYAAKGELYKELQKCK-------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG---E  154 (281)
Q Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~---~  154 (281)
                      +.+.+..++||||+++++|.++++..+       .+++..++.++.||+.||+|||++||+|+||+|+||+++.++   .
T Consensus       143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence            999999999999999999999997643       489999999999999999999999999999999999999555   5


Q ss_pred             EEEeeecCccccc-----CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhc
Q 038249          155 LKIADFGWSVHTF-----NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQV  228 (281)
Q Consensus       155 ~~l~dfg~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  228 (281)
                      ++|+|||++....     .......+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+...
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999985321     12223456889999999988889999999999999999998 99999998888877777665


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccc
Q 038249          229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                      .. ......++.++.++|.+||+.||++|||+.+|+++.+..
T Consensus       303 ~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          303 GR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            43 233447899999999999999999999999999876554

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.8e-48  Score=315.95  Aligned_cols=252  Identities=26%  Similarity=0.447  Sum_probs=209.0

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-SQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      .+..++|++.+.||+|++|.||+|.+.  ++.+|+|++....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            456789999999999999999999986  8889999986543222 2234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---ceecCCCCCCeEeCC--------CCcEEEee
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH---VIHRDIKPENLLIGA--------QGELKIAD  159 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~---i~H~di~~~Ni~~~~--------~~~~~l~d  159 (281)
                      .++|+||+++++|.++++. +.+++..++.++.|++.||.+||++|   ++|+||+|+||+++.        ++.++|+|
T Consensus        81 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             eEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999999998865 46899999999999999999999999   899999999999986        67899999


Q ss_pred             ecCcccccCC-cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCC
Q 038249          160 FGWSVHTFNR-RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIV  238 (281)
Q Consensus       160 fg~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (281)
                      ||.+...... .....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+...............+....+
T Consensus       160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence            9998643332 234568999999999988889999999999999999999999999888877777766666555666679


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +.++.++|.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            9999999999999999999999999864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.4e-48  Score=328.53  Aligned_cols=257  Identities=23%  Similarity=0.432  Sum_probs=214.1

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc------eeeeee
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSN-HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN------ILRLYG   83 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~-~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~------i~~~~~   83 (281)
                      ..+..++|++.+.||+|++|+||+|.+..++ ..||+|++...    ....+.+.+|+.+++.++|++      ++.+.+
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            3445689999999999999999999998777 68999998543    233456778888888887655      899999


Q ss_pred             EEEeCCEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe------------
Q 038249           84 YFYDQKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI------------  149 (281)
Q Consensus        84 ~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~------------  149 (281)
                      ++...+..++||||+. +++.+.+...  .++++..++.++.||+.||.+||++||+|+||+|+||++            
T Consensus        90 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           90 WFNFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eeeeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence            9999999999999995 4676666554  369999999999999999999999999999999999999            


Q ss_pred             -------CCCCcEEEeeecCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHH
Q 038249          150 -------GAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY  222 (281)
Q Consensus       150 -------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  222 (281)
                             +.++.++|+|||++...........+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+..
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                   5678999999999876666666677899999999999889999999999999999999999999887776655


Q ss_pred             HHHhhccccCC------------------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCh
Q 038249          223 RRIVQVDLKFP------------------------------------------PKPIVSSAAKDLISQMLVKDSSQRLPL  260 (281)
Q Consensus       223 ~~~~~~~~~~~------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~  260 (281)
                      ..+.......+                                          .....+.++.++|.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  328 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL  328 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence            44332211100                                          011124578999999999999999999


Q ss_pred             hhhhcCCccccC
Q 038249          261 HKLLEHPWIIQN  272 (281)
Q Consensus       261 ~eil~~~~~~~~  272 (281)
                      .|+++||||.+.
T Consensus       329 ~e~l~hp~f~~~  340 (355)
T 2eu9_A          329 AEALLHPFFAGL  340 (355)
T ss_dssp             HHHTTSGGGGGC
T ss_pred             HHHhcChhhcCC
Confidence            999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-47  Score=320.35  Aligned_cols=262  Identities=26%  Similarity=0.460  Sum_probs=213.9

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCceeeeeeEEEeC
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR--HPNILRLYGYFYDQ   88 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~   88 (281)
                      ..+..++|++.+.||+|++|.||++.+. +++.+|+|++..... .......+.+|+.++++++  |+||+++++++...
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            3445578999999999999999999986 588899999976543 3345677889999999997  59999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           89 KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      +..++||| +.+++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++ ++.++|+|||++.....
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            99999999 45779999999888899999999999999999999999999999999999995 58999999999865433


Q ss_pred             Cc-----ccccCcCCccCCccccC-----------CCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhcccc
Q 038249          169 RR-----RTMCGTLDYLPPEMVES-----------VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLK  231 (281)
Q Consensus       169 ~~-----~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~  231 (281)
                      ..     ....+++.|+|||.+.+           ..++.++||||||+++++|++|..||...... ............
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  258 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  258 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence            21     23457999999999865           46788999999999999999999999765443 334444443333


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCC
Q 038249          232 FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS  276 (281)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~  276 (281)
                      .......+.++.++|.+||+.||++|||+.|+++||||+....+.
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  303 (313)
T 3cek_A          259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV  303 (313)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred             cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence            333445789999999999999999999999999999999875554

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.3e-48  Score=322.02  Aligned_cols=258  Identities=22%  Similarity=0.370  Sum_probs=220.7

Q ss_pred             hhhhcccccCCceecceecccCceEEEEEEE-----ccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceee
Q 038249            7 AKEKKRWTLNDFDIGKPLGRGKFGHVYLARE-----KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILR   80 (281)
Q Consensus         7 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-----~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~   80 (281)
                      ......+..++|++.+.||+|+||.||+|.+     ..+++.||+|.+....  .....+.+.+|+.+++++ +||||++
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~   91 (313)
T 1t46_A           14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVN   91 (313)
T ss_dssp             CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeee
Confidence            3344555668999999999999999999996     3467889999996543  223356788999999999 9999999


Q ss_pred             eeeEEEeCCEEEEEEeccCCCChhHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCC
Q 038249           81 LYGYFYDQKRVYLILEYAAKGELYKELQKCK------------------YFSERRAATYVASLARALIYCHGKHVIHRDI  142 (281)
Q Consensus        81 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~------------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di  142 (281)
                      +++++...+..++|+||+++++|.+++....                  .+++..++.++.||+.||.+||++|++|+||
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl  171 (313)
T 1t46_A           92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL  171 (313)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence            9999999999999999999999999997653                  4899999999999999999999999999999


Q ss_pred             CCCCeEeCCCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCC
Q 038249          143 KPENLLIGAQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAK  216 (281)
Q Consensus       143 ~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~  216 (281)
                      +|+||+++.++.++|+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...
T Consensus       172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999999999999999986543332     22335678999999988889999999999999999998 99999888


Q ss_pred             CchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          217 EHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .....................++.++.++|.+||+.||++|||+.+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            77766666555544455555789999999999999999999999999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.6e-48  Score=329.94  Aligned_cols=254  Identities=24%  Similarity=0.433  Sum_probs=215.3

Q ss_pred             cccccCCceecceecccCceEEEEEEE-----ccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLARE-----KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGY   84 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~-----~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~   84 (281)
                      -.+..++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++ +||||++++++
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            345568999999999999999999994     4566899999996543  233356788999999999 78999999999


Q ss_pred             EEeCC-EEEEEEeccCCCChhHHHHhCCC---------------------------------------------------
Q 038249           85 FYDQK-RVYLILEYAAKGELYKELQKCKY---------------------------------------------------  112 (281)
Q Consensus        85 ~~~~~-~~~~v~e~~~~~~L~~~~~~~~~---------------------------------------------------  112 (281)
                      +.+.+ ..++|+||+++++|.+++.....                                                   
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            88754 48999999999999999976532                                                   


Q ss_pred             ---------------CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-----ccc
Q 038249          113 ---------------FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-----RRT  172 (281)
Q Consensus       113 ---------------l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-----~~~  172 (281)
                                     +++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......     ...
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence                           899999999999999999999999999999999999999999999999998644222     123


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ..+++.|+|||.+.+..++.++||||||+++++|++ |..||......+.................++.++.++|.+||+
T Consensus       255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  334 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  334 (359)
T ss_dssp             CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            346788999999988889999999999999999998 9999988877666655555444444555789999999999999


Q ss_pred             cCCCCCCChhhhhcC
Q 038249          252 KDSSQRLPLHKLLEH  266 (281)
Q Consensus       252 ~~p~~Rps~~eil~~  266 (281)
                      .||++|||+.++++|
T Consensus       335 ~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          335 GEPSQRPTFSELVEH  349 (359)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8.2e-48  Score=314.14  Aligned_cols=250  Identities=20%  Similarity=0.372  Sum_probs=216.3

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ..+..++|++.+.||+|++|.||+|.++ ++..+|+|.+.......    +.+.+|++++++++||||+++++++.+.+.
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYP   77 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence            3566789999999999999999999887 56779999996554332    457889999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           91 VYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999999999765 35999999999999999999999999999999999999999999999999998544332


Q ss_pred             c----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHH
Q 038249          170 R----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       170 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (281)
                      .    ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+....+...... ......+.++.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~  236 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-YRPHLASDTIYQ  236 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-CCCTTSCHHHHH
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-CCCCcChHHHHH
Confidence            2    22335667999999988889999999999999999998 99999988888777766655432 233468999999


Q ss_pred             HHHHhcccCCCCCCChhhhhcC
Q 038249          245 LISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +|.+||+.||++|||+.+++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999975

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-47  Score=315.84  Aligned_cols=249  Identities=25%  Similarity=0.424  Sum_probs=213.6

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .+..++|++.+.||+|++|.||++.+. ++..||+|++.......    +.+.+|+.++++++|+||+++++++.+.+..
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence            345579999999999999999999887 56789999997654332    4578899999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           92 YLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      ++||||+++++|.+++.. ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999999999986 456999999999999999999999999999999999999999999999999998644332 


Q ss_pred             ---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          170 ---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                         .....+++.|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+..... .......+.++.++
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  253 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-LYRPHLASEKVYTI  253 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHH
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC-CCCCCcCCHHHHHH
Confidence               222345678999999988889999999999999999998 9999999888887777766533 23334689999999


Q ss_pred             HHHhcccCCCCCCChhhhhcC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~  266 (281)
                      |.+||+.||++|||+.+++++
T Consensus       254 i~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          254 MYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999975

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.7e-48  Score=314.21  Aligned_cols=250  Identities=16%  Similarity=0.288  Sum_probs=218.0

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--   88 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--   88 (281)
                      ..+.+++|++.+.||+|++|.||+|.+.  ++.+|+|++..... .....+.+.+|+.++++++||||+++++++.+.  
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            4567899999999999999999999986  88899999976543 334456789999999999999999999999876  


Q ss_pred             CEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           89 KRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKH--VIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      +..++|+||+++++|.+++...+  .+++..++.++.||+.||.+||+.|  ++|+||+|+||+++.++.++++|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            78899999999999999998765  4899999999999999999999999  9999999999999999999999998864


Q ss_pred             cccCCcccccCcCCccCCccccCCCCCC---cccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          165 HTFNRRRTMCGTLDYLPPEMVESVEHDA---NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                      ..  ......+++.|+|||.+.+..++.   ++||||||+++++|++|..||......+.................++.+
T Consensus       162 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3kmu_A          162 SF--QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH  239 (271)
T ss_dssp             TT--SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred             ee--cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence            42  223346789999999987665544   7999999999999999999999888888777766655555555679999


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhc
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +.++|.+||+.||++|||++++++
T Consensus       240 ~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          240 VSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.6e-48  Score=330.18  Aligned_cols=254  Identities=30%  Similarity=0.466  Sum_probs=206.3

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-   89 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-   89 (281)
                      ......+|++.+.||+|+||+||+|++..++. +|+|++......       ..+|+++++.++||||+++++++...+ 
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence            34455789999999999999999999987665 888888544321       235899999999999999999996543 


Q ss_pred             -----EEEEEEeccCCCChhHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC-CCCcEEEeee
Q 038249           90 -----RVYLILEYAAKGELYKEL---QKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADF  160 (281)
Q Consensus        90 -----~~~~v~e~~~~~~L~~~~---~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~-~~~~~~l~df  160 (281)
                           .+++||||++++.+....   .....+++..++.++.||+.||.|||++||+|+||+|+||+++ .++.++|+||
T Consensus       107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence                 388999999874333322   2346799999999999999999999999999999999999999 7899999999


Q ss_pred             cCcccccC--CcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--------
Q 038249          161 GWSVHTFN--RRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--------  229 (281)
Q Consensus       161 g~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------  229 (281)
                      |++.....  ......+++.|+|||.+.+. .++.++|||||||++++|++|..||.+.+..+....+....        
T Consensus       187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865422  23345679999999998654 58999999999999999999999999888776665544310        


Q ss_pred             ---------ccCC----------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          230 ---------LKFP----------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       230 ---------~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                               ...+          ..+.++.++.++|.+||+.||++|||+.|+++||||++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence                     0111          112478999999999999999999999999999999965

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-47  Score=318.41  Aligned_cols=250  Identities=25%  Similarity=0.497  Sum_probs=204.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--------
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--------   87 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--------   87 (281)
                      ++|++.+.||+|++|.||+|++..+++.||+|.+...    ....+.+.+|+.++++++||||+++++++.+        
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            6799999999999999999999999999999998543    3445678899999999999999999998865        


Q ss_pred             -----CCEEEEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeec
Q 038249           88 -----QKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFG  161 (281)
Q Consensus        88 -----~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg  161 (281)
                           .+..++|+||+++++|.+++...+ .+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence                 457899999999999999998643 57889999999999999999999999999999999999999999999999


Q ss_pred             CcccccC-----------------CcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCC-CchHHH
Q 038249          162 WSVHTFN-----------------RRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAK-EHSDTY  222 (281)
Q Consensus       162 ~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~  222 (281)
                      .+.....                 ......+++.|+|||.+.+. .++.++||||||+++++|++   ||... +..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            8854321                 12234578899999998754 68899999999999999998   44432 223334


Q ss_pred             HHHhhccccCC--CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          223 RRIVQVDLKFP--PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       223 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ..+.......+  .....+..+.++|.+||+.||++|||+.++++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            44433333222  223567889999999999999999999999999999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-48  Score=325.84  Aligned_cols=255  Identities=23%  Similarity=0.378  Sum_probs=216.0

Q ss_pred             cccccCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGY   84 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~   84 (281)
                      ..+..++|++.+.||.|++|.||+|.+.     .++..||+|.+....  .....+.+.+|+.+++++ +||||++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            3445589999999999999999999983     356689999996442  223346788999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChhHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q 038249           85 FYDQKRVYLILEYAAKGELYKELQKCK-----------------------YFSERRAATYVASLARALIYCHGKHVIHRD  141 (281)
Q Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~~~-----------------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~d  141 (281)
                      +...+..++||||+++++|.+++....                       .+++..++.++.||+.||.+||++|++|+|
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  197 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  197 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            999999999999999999999998653                       278999999999999999999999999999


Q ss_pred             CCCCCeEeCCCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCC
Q 038249          142 IKPENLLIGAQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEA  215 (281)
Q Consensus       142 i~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~  215 (281)
                      |+|+||+++.++.++|+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999999986443222     22345778999999988889999999999999999998 9999998


Q ss_pred             CCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCC
Q 038249          216 KEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHP  267 (281)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~  267 (281)
                      ......................++.++.++|.+||+.||++|||+.+++++.
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            8777666666555555555557899999999999999999999999999753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.1e-47  Score=315.38  Aligned_cols=254  Identities=29%  Similarity=0.479  Sum_probs=208.2

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      ...+.+|++.+.||+|++|.||+|.+..+|+.+|+|++.............+.+|+.++++++||||+++++++...+..
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            44668999999999999999999999999999999999765545556667889999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           92 YLILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      ++|+||+++++|.++++.    ...+++..++.++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999999864    4568999999999999999999999999999999999999999999999999875433


Q ss_pred             CC---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc--hHHHHHHhhccccCCCCCCCCHHH
Q 038249          168 NR---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH--SDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       168 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                      ..   .....+++.|+|||.+.+..++.++|+||||+++++|++|..||.....  .+....+............++.++
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  267 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  267 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence            22   2234578899999999988899999999999999999999999975433  234444444443333345689999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .++|.+||+.||++|||+.++++
T Consensus       268 ~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          268 RQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.1e-48  Score=321.05  Aligned_cols=253  Identities=22%  Similarity=0.376  Sum_probs=217.5

Q ss_pred             cccccCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ..+..++|++.+.||.|++|.||+|.+.     .++..||+|.+....  .....+.+.+|++++++++||||+++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            3455689999999999999999999984     345789999996543  334457788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCceecC
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKCKY------------------------FSERRAATYVASLARALIYCHGKHVIHRD  141 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~~~------------------------l~~~~~~~i~~~i~~~l~~Lh~~~i~H~d  141 (281)
                      .+.+..++|+||+++++|.+++.....                        +++..++.++.||+.||.+||++|++|+|
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d  175 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD  175 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence            999999999999999999999986543                        89999999999999999999999999999


Q ss_pred             CCCCCeEeCCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCC
Q 038249          142 IKPENLLIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEA  215 (281)
Q Consensus       142 i~~~Ni~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~  215 (281)
                      |+|+||+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..||..
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999998544322     123345778999999988889999999999999999999 9999998


Q ss_pred             CCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          216 KEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ....+....+..... ......++.++.++|.+||+.||++|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          256 IPPERLFNLLKTGHR-MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCGGGHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHhhcCCc-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            888777766655432 33334789999999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=326.55  Aligned_cols=252  Identities=26%  Similarity=0.413  Sum_probs=217.4

Q ss_pred             ccccCCceecceecccCceEEEEEEEccC-------CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeee
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRS-------NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYG   83 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~-------~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~   83 (281)
                      .+..++|++.+.||+|+||.||+|.+..+       +..||+|++....  .......+.+|+++++++ +||||+++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            44458999999999999999999998643       3579999986543  334456788999999999 9999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCe
Q 038249           84 YFYDQKRVYLILEYAAKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENL  147 (281)
Q Consensus        84 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni  147 (281)
                      ++...+..++||||+++++|.+++....                .+++..++.++.||+.||.+||+.|++|+||+|+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999999998753                489999999999999999999999999999999999


Q ss_pred             EeCCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHH
Q 038249          148 LIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDT  221 (281)
Q Consensus       148 ~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~  221 (281)
                      +++.++.++|+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+.
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999998654322     223346778999999999899999999999999999998 9999998888777


Q ss_pred             HHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          222 YRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ...+..... ......++.++.++|.+||+.||++|||+.+++++
T Consensus       303 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          303 FKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHTTCC-CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCC-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            776655432 33344789999999999999999999999999974

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-47  Score=331.21  Aligned_cols=250  Identities=29%  Similarity=0.488  Sum_probs=206.2

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC------C
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ------K   89 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~   89 (281)
                      .+|++.+.||+|+||.||+|++..+|+.||||++.....       ...+|+++++.++|+||+++++++...      .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            479999999999999999999999999999999865431       133689999999999999999998542      2


Q ss_pred             EEEEEEeccCCCChhHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC-CcEEEeeecCcc
Q 038249           90 RVYLILEYAAKGELYKELQ----KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-GELKIADFGWSV  164 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~-~~~~l~dfg~~~  164 (281)
                      .+++|+||+++ ++.+.+.    ....+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||++.
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            46799999987 6665554    34679999999999999999999999999999999999999965 568999999986


Q ss_pred             cccCC--cccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-------------
Q 038249          165 HTFNR--RRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-------------  228 (281)
Q Consensus       165 ~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------  228 (281)
                      .....  .....+++.|+|||++.+. .++.++|||||||++++|++|..||.+.+..+.+..+...             
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            54322  2345689999999998654 6899999999999999999999999988776665544331             


Q ss_pred             ----cccCCC----------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          229 ----DLKFPP----------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       229 ----~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                          ...++.          .+.++.++.+||.+||+.||++|||+.|+++||||++..
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                011111          134689999999999999999999999999999998653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.6e-48  Score=331.59  Aligned_cols=259  Identities=25%  Similarity=0.383  Sum_probs=210.1

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----------CCce
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-----------HPNI   78 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----------h~~i   78 (281)
                      ...+..++|++.+.||+|++|+||+|++..+++.||+|++....    .....+.+|+.+++++.           |+||
T Consensus        13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i   88 (373)
T 1q8y_A           13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   88 (373)
T ss_dssp             TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchH
Confidence            34556789999999999999999999999999999999986432    23456778888888775           7899


Q ss_pred             eeeeeEEEeCC----EEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCC
Q 038249           79 LRLYGYFYDQK----RVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGA  151 (281)
Q Consensus        79 ~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~  151 (281)
                      +++++++...+    .+++|+|++ +++|.+++...  ..+++..++.++.||+.||++||++ ||+|+||+|+||+++.
T Consensus        89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI  167 (373)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred             HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence            99999998654    789999999 77999999863  4599999999999999999999998 9999999999999953


Q ss_pred             ------CCcEEEeeecCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch------
Q 038249          152 ------QGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS------  219 (281)
Q Consensus       152 ------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------  219 (281)
                            .+.++|+|||++...........+|+.|+|||.+.+..++.++||||||+++++|++|..||...+..      
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence                  34799999999876666556667899999999999888999999999999999999999999865422      


Q ss_pred             HHHHHHhhccc----------------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 038249          220 DTYRRIVQVDL----------------------------------------KFPPKPIVSSAAKDLISQMLVKDSSQRLP  259 (281)
Q Consensus       220 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps  259 (281)
                      +....+.....                                        .......++.++.+||.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            12222111000                                        00111234578899999999999999999


Q ss_pred             hhhhhcCCccccCC
Q 038249          260 LHKLLEHPWIIQNA  273 (281)
Q Consensus       260 ~~eil~~~~~~~~~  273 (281)
                      +.|+|+||||++..
T Consensus       328 ~~ell~hp~f~~~~  341 (373)
T 1q8y_A          328 AGGLVNHPWLKDTL  341 (373)
T ss_dssp             HHHHHTCGGGTTCT
T ss_pred             HHHHhhChhhhccc
Confidence            99999999999863

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.2e-48  Score=325.30  Aligned_cols=253  Identities=32%  Similarity=0.547  Sum_probs=186.1

Q ss_pred             cccCCceecc-eecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe----
Q 038249           13 WTLNDFDIGK-PLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD----   87 (281)
Q Consensus        13 ~~~~~y~~~~-~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----   87 (281)
                      ...++|++.+ .||.|++|+||+|.++.+++.||+|++....    ..   ..+....++.++||||+++++++..    
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KA---RQEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HH---HHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            3458999965 6999999999999999999999999985432    11   2223344667799999999999976    


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC---CcEEEeeecC
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ---GELKIADFGW  162 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~---~~~~l~dfg~  162 (281)
                      ....++||||+++++|.+++...+  .+++..++.++.||+.||.+||++|++|+||+|+||+++.+   +.++|+|||+
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            456899999999999999998764  69999999999999999999999999999999999999864   4599999999


Q ss_pred             cccccCC-cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHH----HHHhhccc--cCCCC
Q 038249          163 SVHTFNR-RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY----RRIVQVDL--KFPPK  235 (281)
Q Consensus       163 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~--~~~~~  235 (281)
                      +...... .....+++.|+|||.+.+..++.++||||||+++++|++|..||.........    ..+.....  ..+..
T Consensus       178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (336)
T 3fhr_A          178 AKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW  257 (336)
T ss_dssp             CEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred             ceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence            8654332 34456799999999998888899999999999999999999999766554432    22222222  22233


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ..++.++.++|.+||+.||++|||+.|+++||||++.
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            5689999999999999999999999999999999876

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=319.53  Aligned_cols=261  Identities=25%  Similarity=0.436  Sum_probs=202.4

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      .....+++|++.+.||.|++|.||+|.++.+|+.||+|++..... .....+.+.++..+++.++||||+++++++...+
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            345567899999999999999999999999999999999976542 2333444555666788889999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           90 RVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      ..++||||+ ++.+..+... ...+++..++.++.+|+.||.+||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus        98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            999999999 4456555543 46799999999999999999999995 99999999999999999999999999885433


Q ss_pred             CC--cccccCcCCccCCcccc-----CCCCCCcccHHhHHHHHHHHHhCCCCCCCCC-chHHHHHHhhccc-cCCCCCCC
Q 038249          168 NR--RRTMCGTLDYLPPEMVE-----SVEHDANVDIWSLGVLCYEFLYGVPPFEAKE-HSDTYRRIVQVDL-KFPPKPIV  238 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~-~~~~~~~~  238 (281)
                      ..  .....+++.|+|||.+.     ...++.++||||||+++++|++|..||.... ..+.......... ..+....+
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (318)
T 2dyl_A          177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF  256 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred             CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence            22  23346889999999984     5567889999999999999999999998743 3444444444332 23333468


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +.++.++|.+||+.||.+|||+.++++||||++.
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            9999999999999999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-47  Score=323.91  Aligned_cols=252  Identities=23%  Similarity=0.401  Sum_probs=217.8

Q ss_pred             cccccCCceecceecccCceEEEEEEEcc-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ..+..++|++.+.||+|+||.||+|.+..     +++.||+|.+....  .....+.+.+|+.++++++||||+++++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            35566899999999999999999999983     45889999996543  334467789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKC------------------------KYFSERRAATYVASLARALIYCHGKHVIHRD  141 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~d  141 (281)
                      ...+..++||||+++++|.+++...                        ..+++..++.++.||+.||.+||++|++|+|
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9999999999999999999999763                        4689999999999999999999999999999


Q ss_pred             CCCCCeEeCCCCcEEEeeecCcccccC-----CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCC
Q 038249          142 IKPENLLIGAQGELKIADFGWSVHTFN-----RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEA  215 (281)
Q Consensus       142 i~~~Ni~~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~  215 (281)
                      |+|+||+++.++.++|+|||++.....     ......+++.|+|||.+.+..++.++|+||||+++++|++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999998754322     1233456888999999988889999999999999999998 9999998


Q ss_pred             CCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          216 KEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ....+....+...... .....++.++.++|.+||+.||++|||+.++++
T Consensus       280 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          280 MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            8888777776665432 223468999999999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.7e-48  Score=322.53  Aligned_cols=261  Identities=25%  Similarity=0.425  Sum_probs=194.5

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCceeeeeeEEEeC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE-IQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ...+..++|++.+.||+|+||.||+|.++.+|+.||+|.+.... .. .....+..|+. +++.++||||+++++++...
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~   93 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE   93 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-Cc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence            34556699999999999999999999999999999999996543 22 22334444554 77788999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           89 KRVYLILEYAAKGELYKELQK-----CKYFSERRAATYVASLARALIYCHGK-HVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      +..++|+||+++ +|.+++..     ...+++..++.++.+++.||.+||+. |++|+||+|+||+++.++.++|+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            999999999986 88877763     56799999999999999999999998 999999999999999999999999999


Q ss_pred             cccccCC--cccccCcCCccCCccc----cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhcccc---C
Q 038249          163 SVHTFNR--RRTMCGTLDYLPPEMV----ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLK---F  232 (281)
Q Consensus       163 ~~~~~~~--~~~~~~~~~~~aPE~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~---~  232 (281)
                      +......  .....+++.|+|||.+    .+..++.++||||||+++++|++|..||...... +...........   .
T Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3aln_A          173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN  252 (327)
T ss_dssp             SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred             ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence            8654332  2233688999999998    4566889999999999999999999999765432 222222222111   1


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          233 PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .....++.++.++|.+||+.||++|||+.++++||||.+..
T Consensus       253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence            11235889999999999999999999999999999998653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.4e-48  Score=330.05  Aligned_cols=251  Identities=24%  Similarity=0.424  Sum_probs=216.5

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .+..++|++.+.||+|+||.||+|.++.+++.||+|.+....  .......+.+|++++++++||||+++++++...+..
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            344578999999999999999999999999999999986442  234456688999999999999999999999998999


Q ss_pred             EEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           92 YLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      ++||||+++++|.+++... ..++...++.++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++.......
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999999999999765 358999999999999999999999999999999999999999999999999986533322


Q ss_pred             c-----cccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHH
Q 038249          171 R-----TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       171 ~-----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (281)
                      .     ...+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+..+. ..+....++.++.+
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  346 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLPCPELCPDAVFR  346 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHH
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence            1     1224667999999988889999999999999999998 999999888777766655442 33344568999999


Q ss_pred             HHHHhcccCCCCCCChhhhhc
Q 038249          245 LISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~  265 (281)
                      ++.+||+.||++|||+.++++
T Consensus       347 li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          347 LMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=331.30  Aligned_cols=254  Identities=27%  Similarity=0.507  Sum_probs=193.6

Q ss_pred             CCcee-cceecccCceEEEEEEEc--cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--CCE
Q 038249           16 NDFDI-GKPLGRGKFGHVYLAREK--RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--QKR   90 (281)
Q Consensus        16 ~~y~~-~~~ig~g~~~~v~~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~   90 (281)
                      +.|++ +++||+|+||+||+|+++  .++..||+|.+......     ..+.+|+.++++++||||+++++++..  ...
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            45777 558999999999999976  56888999999654322     246789999999999999999999964  678


Q ss_pred             EEEEEeccCCCChhHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe----CCCCcEEE
Q 038249           91 VYLILEYAAKGELYKELQKC---------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI----GAQGELKI  157 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~----~~~~~~~l  157 (281)
                      +++|+||+++ +|.+.+...         ..+++..++.++.||+.||.|||++||+|+||+|+||++    +.++.++|
T Consensus        95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999999976 787777532         248999999999999999999999999999999999999    67789999


Q ss_pred             eeecCcccccCC------cccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCch---------HH
Q 038249          158 ADFGWSVHTFNR------RRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHS---------DT  221 (281)
Q Consensus       158 ~dfg~~~~~~~~------~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~  221 (281)
                      +|||++......      .....+|+.|+|||++.+. .++.++|||||||++++|++|.+||......         +.
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            999998654322      2335679999999998764 5899999999999999999999999765442         22


Q ss_pred             HHHHhhcc--ccCCC----------------------------------CCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          222 YRRIVQVD--LKFPP----------------------------------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       222 ~~~~~~~~--~~~~~----------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ...+....  .....                                  ....+.++.+||.+||+.||++|||++|+|+
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            22222110  00000                                  0113678999999999999999999999999


Q ss_pred             CCccccCCCC
Q 038249          266 HPWIIQNADP  275 (281)
Q Consensus       266 ~~~~~~~~~~  275 (281)
                      ||||.+.+.+
T Consensus       334 hp~f~~~~~~  343 (405)
T 3rgf_A          334 DPYFLEDPLP  343 (405)
T ss_dssp             SGGGTSSSCC
T ss_pred             ChhhccCCCC
Confidence            9999987554

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.9e-47  Score=313.04  Aligned_cols=252  Identities=25%  Similarity=0.413  Sum_probs=207.0

Q ss_pred             cccccCCceecceecccCceEEEEEEEccC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRS---NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      ..+..++|++.+.||+|+||.||+|.+..+   +..+++|.+....  .....+.+.+|+.++++++||||+++++++. 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   86 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   86 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence            445668999999999999999999998754   4569999985432  3445667889999999999999999999974 


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      .+..++||||+++++|.+++...+ .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            567789999999999999998654 6899999999999999999999999999999999999999999999999998654


Q ss_pred             cCCc----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          167 FNRR----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       167 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                      ....    ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+..... .+..+.++.+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~  245 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-LPMPPNCPPT  245 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CCCCTTCCHH
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-CCCCCCCCHH
Confidence            3322    22345678999999988889999999999999999996 9999998888877776655432 2334578999


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhcC
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +.++|.+||+.||++|||+.+++++
T Consensus       246 l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          246 LYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999863

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.5e-47  Score=331.31  Aligned_cols=246  Identities=23%  Similarity=0.431  Sum_probs=212.8

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-E
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-R   90 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~   90 (281)
                      .+..++|++.+.||+|+||.||++.+.  ++.||||.+....     ..+.+.+|++++++++||||+++++++.+.. .
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            355689999999999999999999886  7799999996543     2356889999999999999999999987655 7


Q ss_pred             EEEEEeccCCCChhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           91 VYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      .++||||+++++|.+++...+.  ++...++.++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++.....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999999986543  79999999999999999999999999999999999999999999999999875544


Q ss_pred             CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      ......+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+..+. ..+....++.++.++|.
T Consensus       342 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~  420 (450)
T 1k9a_A          342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPPAVYDVMK  420 (450)
T ss_dssp             -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-CCCCCTTCCHHHHHHHH
T ss_pred             cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCHHHHHHHH
Confidence            4444466889999999998899999999999999999998 999999888887777665543 33344579999999999


Q ss_pred             HhcccCCCCCCChhhhhc
Q 038249          248 QMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~  265 (281)
                      +||+.||++|||+.++++
T Consensus       421 ~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          421 NCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHH
Confidence            999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.7e-48  Score=323.51  Aligned_cols=257  Identities=30%  Similarity=0.466  Sum_probs=214.5

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCC--CCceeeeeeEE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS---QVEHQLRREVEIQSHLR--HPNILRLYGYF   85 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~---~~~~~~~~e~~~l~~~~--h~~i~~~~~~~   85 (281)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|.+........   .....+.+|+.+++++.  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            33456889999999999999999999999999999999976543210   11233567888899886  59999999999


Q ss_pred             EeCCEEEEEEeccCC-CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC-CCCcEEEeeecCc
Q 038249           86 YDQKRVYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWS  163 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~-~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~-~~~~~~l~dfg~~  163 (281)
                      ...+..++|+|++.+ ++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++ .++.++|+|||++
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            999999999999976 79999999888899999999999999999999999999999999999999 6789999999998


Q ss_pred             ccccCC-cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          164 VHTFNR-RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       164 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                      ...... .....+++.|+|||.+.+..+ +.++||||||+++++|++|..||....      .......  .....++.+
T Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~--~~~~~~~~~  269 (320)
T 3a99_A          198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV--FFRQRVSSE  269 (320)
T ss_dssp             EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC--CCSSCCCHH
T ss_pred             cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccc--cccccCCHH
Confidence            654333 234468999999999876665 678999999999999999999996432      1222222  223468999


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      +.++|.+||+.||++|||++++++||||++...+
T Consensus       270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence            9999999999999999999999999999987543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.3e-47  Score=320.26  Aligned_cols=253  Identities=27%  Similarity=0.416  Sum_probs=215.0

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEE--EEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEe
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIV--ALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYD   87 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~--~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   87 (281)
                      +.+..++|++.+.||+|++|.||+|.+..++..+  ++|.+....  .....+.+.+|+++++++ +||||+++++++.+
T Consensus        20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            4567799999999999999999999999888865  899886432  233346688999999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           88 QKRVYLILEYAAKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                      .+..++||||+++++|.+++...+                .+++..++.++.||+.||.+||++|++|+||+|+||+++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence            999999999999999999997654                6899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeecCcccccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhc
Q 038249          152 QGELKIADFGWSVHTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQV  228 (281)
Q Consensus       152 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  228 (281)
                      ++.++|+|||++......  .....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+...
T Consensus       178 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             CCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            999999999997543222  223345778999999988888999999999999999998 99999988887777766554


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          229 DLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      . .......++.++.++|.+||+.||++|||+.+++++
T Consensus       258 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          258 Y-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             C-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2 233344689999999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.8e-47  Score=314.12  Aligned_cols=251  Identities=23%  Similarity=0.396  Sum_probs=218.7

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      .-....++|++.+.||+|++|+||+|.+..++..+|+|.+..+.    ...+.+.+|+.++++++||||+++++++.+.+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            34456689999999999999999999999999999999996543    22456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           90 RVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      ..++|+||+++++|.+++...  ..+++..++.++.+|+.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999999999864  448999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHH
Q 038249          168 NRR----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       168 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                      ...    ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+... ........++.++
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  241 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKV  241 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHHH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-CCCCCCCCCCHHH
Confidence            332    22335678999999988889999999999999999999 99999988877776666544 2333445789999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .++|.+||+.||++|||+.++++
T Consensus       242 ~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          242 YELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhCCChhhCcCHHHHHH
Confidence            99999999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.6e-47  Score=319.96  Aligned_cols=255  Identities=26%  Similarity=0.442  Sum_probs=216.1

Q ss_pred             hhcccc--cCCceecceecccCceEEEEEEEc-------cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCce
Q 038249            9 EKKRWT--LNDFDIGKPLGRGKFGHVYLAREK-------RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNI   78 (281)
Q Consensus         9 ~~~~~~--~~~y~~~~~ig~g~~~~v~~~~~~-------~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i   78 (281)
                      +.+.|.  .++|++.+.||+|+||.||+|.+.       .++..||+|.+....  .......+.+|+.+++++ +||||
T Consensus        26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~i  103 (334)
T 2pvf_A           26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNI  103 (334)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCE
Confidence            344444  489999999999999999999986       356789999996543  334456788999999999 89999


Q ss_pred             eeeeeEEEeCCEEEEEEeccCCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCC
Q 038249           79 LRLYGYFYDQKRVYLILEYAAKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDI  142 (281)
Q Consensus        79 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di  142 (281)
                      +++++++...+..++|+||+++++|.+++....                .+++..++.++.||+.||.+||+.|++|+||
T Consensus       104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  183 (334)
T 2pvf_A          104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL  183 (334)
T ss_dssp             CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence            999999999999999999999999999998654                3899999999999999999999999999999


Q ss_pred             CCCCeEeCCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCC
Q 038249          143 KPENLLIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAK  216 (281)
Q Consensus       143 ~~~Ni~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~  216 (281)
                      +|+||+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..||...
T Consensus       184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            999999999999999999998644332     222345778999999988888999999999999999999 99999988


Q ss_pred             CchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          217 EHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ...+....+..... ......++.++.++|.+||+.||++|||+.+++++
T Consensus       264 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          264 PVEELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CHHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            87777766655432 23334789999999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.3e-47  Score=313.56  Aligned_cols=254  Identities=22%  Similarity=0.333  Sum_probs=213.1

Q ss_pred             hhcccccCCceecc-eecccCceEEEEEEE--ccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249            9 EKKRWTLNDFDIGK-PLGRGKFGHVYLARE--KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus         9 ~~~~~~~~~y~~~~-~ig~g~~~~v~~~~~--~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ....+..++|++.+ .||.|++|.||+|.+  ..+++.+|+|.+.... ......+.+.+|+++++.++||||+++++++
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34455568899998 999999999999955  5567889999996553 2334467789999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                       ..+..++|+||+++++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence             5677899999999999999999888899999999999999999999999999999999999999999999999999855


Q ss_pred             ccCCc------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCC
Q 038249          166 TFNRR------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIV  238 (281)
Q Consensus       166 ~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (281)
                      .....      ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+..... ......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  245 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-MGCPAGC  245 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CCCCTTC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Confidence            43221      12234678999999988888899999999999999998 9999998888777666655432 2233468


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +.++.++|.+||+.||++|||+.++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.2e-47  Score=315.82  Aligned_cols=253  Identities=23%  Similarity=0.406  Sum_probs=206.9

Q ss_pred             hcccccCCceecceecccCceEEEEEE----EccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ...+..++|++.+.||+|+||+||+|+    +..+++.||+|++...   .....+.+.+|++++++++||||+++++++
T Consensus         4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   80 (295)
T 3ugc_A            4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVC   80 (295)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            356777999999999999999999998    5668899999998543   344456788999999999999999999998


Q ss_pred             Ee--CCEEEEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           86 YD--QKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        86 ~~--~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      ..  ....++||||+++++|.+++...+ .+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            64  356899999999999999998754 499999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH---------------H
Q 038249          163 SVHTFNR------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD---------------T  221 (281)
Q Consensus       163 ~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------~  221 (281)
                      +......      .....++..|+|||.+.+..++.++||||||+++++|++|..|+.......               .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            8654322      122345667999999988899999999999999999999999885432110               1


Q ss_pred             HHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          222 YRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ...........+....++.++.++|.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            11112222234445578999999999999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4e-47  Score=319.52  Aligned_cols=254  Identities=24%  Similarity=0.415  Sum_probs=218.3

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCc-----EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeee
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNH-----IVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYG   83 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~-----~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~   83 (281)
                      ...+..++|++.+.||.|+||.||+|.+..++.     .+|+|.+....  .....+.+.+|+.+++.+ +||||+++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            445566899999999999999999999987664     79999986543  233456788999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChhHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe
Q 038249           84 YFYDQKRVYLILEYAAKGELYKELQKC--------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI  149 (281)
Q Consensus        84 ~~~~~~~~~~v~e~~~~~~L~~~~~~~--------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~  149 (281)
                      ++...+..++||||+++++|.+++...              ..++...++.++.||+.||.+||+.|++|+||+|+||++
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL  197 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence            999999999999999999999998742              357999999999999999999999999999999999999


Q ss_pred             CCCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHH
Q 038249          150 GAQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYR  223 (281)
Q Consensus       150 ~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~  223 (281)
                      +.++.++|+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||..........
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            999999999999986443222     22345678999999988889999999999999999998 999998877776666


Q ss_pred             HHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          224 RIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ...............+.++.++|.+||+.||++|||+.++++
T Consensus       278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            665555555555578999999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.7e-47  Score=319.86  Aligned_cols=264  Identities=23%  Similarity=0.336  Sum_probs=218.3

Q ss_pred             ccchhhhcccccCCceecceecccCceEEEEEE-----EccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce
Q 038249            4 EVSAKEKKRWTLNDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI   78 (281)
Q Consensus         4 ~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~-----~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i   78 (281)
                      .++..+.+.+..++|++.+.||.|++|.||+|.     +..++..||+|.+....  .......+.+|+.++++++||||
T Consensus        18 sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i   95 (327)
T 2yfx_A           18 TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNI   95 (327)
T ss_dssp             EECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             ccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCC
Confidence            344455566778999999999999999999999     55678899999996432  33445678899999999999999


Q ss_pred             eeeeeEEEeCCEEEEEEeccCCCChhHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           79 LRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        79 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                      +++++++...+..++||||+++++|.+++....       .+++..++.++.||+.||.+||+.|++|+||+|+||+++.
T Consensus        96 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~  175 (327)
T 2yfx_A           96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC  175 (327)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred             CeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEec
Confidence            999999999999999999999999999998653       3899999999999999999999999999999999999984


Q ss_pred             C---CcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHH
Q 038249          152 Q---GELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTY  222 (281)
Q Consensus       152 ~---~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~  222 (281)
                      +   ..++|+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+..
T Consensus       176 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  255 (327)
T 2yfx_A          176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  255 (327)
T ss_dssp             SSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence            4   46999999987532221     223456789999999988889999999999999999998 99999888777776


Q ss_pred             HHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccc
Q 038249          223 RRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                      ..+..... ......++.++.++|.+||+.||++|||+.+++++.+..
T Consensus       256 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          256 EFVTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcCCC-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            66655432 233447899999999999999999999999999987765

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.4e-47  Score=325.31  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=209.1

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEc---cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ....+..++|++.+.||+|+||.||+|+++   .++..||+|.+....  .....+.+.+|+.++++++||||+++++++
T Consensus        38 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  115 (373)
T 2qol_A           38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVV  115 (373)
T ss_dssp             TSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            344566689999999999999999999987   457789999996543  334457789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      ...+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus       116 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          116 TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             eeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            99999999999999999999998753 69999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCc------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCC
Q 038249          165 HTFNRR------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPI  237 (281)
Q Consensus       165 ~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (281)
                      ......      ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+.... ..+....
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~  274 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-RLPPPMD  274 (373)
T ss_dssp             ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-ECCCCTT
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcc
Confidence            543221      11234668999999988889999999999999999997 999999888877776665442 3344447


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          238 VSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ++.++.+++.+||+.||++||++.++++
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            8999999999999999999999999886

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.6e-47  Score=315.69  Aligned_cols=248  Identities=20%  Similarity=0.343  Sum_probs=207.9

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCC-------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSN-------HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGY   84 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~-------~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~   84 (281)
                      ++..++|++.+.||+|+||+||+|.+..++       ..+++|.+....   ....+.+.+|+.++++++||||++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            456689999999999999999999999877       469999985543   2334678899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChhHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc--------E
Q 038249           85 FYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE--------L  155 (281)
Q Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~--------~  155 (281)
                      +.+.+..++||||+++++|.+++...+. +++..++.++.||+.||.+||++|++|+||+|+||+++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987654 999999999999999999999999999999999999998887        9


Q ss_pred             EEeeecCcccccCCcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhC-CCCCCCCCchHHHHHHhhccccCC
Q 038249          156 KIADFGWSVHTFNRRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYG-VPPFEAKEHSDTYRRIVQVDLKFP  233 (281)
Q Consensus       156 ~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~  233 (281)
                      +|+|||.+...... ....+++.|+|||.+.+ ..++.++||||||+++++|++| .+|+........... .......+
T Consensus       161 kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~~~~~~~  238 (289)
T 4fvq_A          161 KLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-YEDRHQLP  238 (289)
T ss_dssp             EECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCCCC
T ss_pred             eeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-hhccCCCC
Confidence            99999998544332 33456889999999876 6789999999999999999995 555555444443333 33322222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                        ...+.++.++|.+||+.||++|||+.+++++
T Consensus       239 --~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          239 --APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             --CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             --CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence              3468899999999999999999999999964

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.6e-47  Score=308.92  Aligned_cols=248  Identities=23%  Similarity=0.408  Sum_probs=215.5

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +..++|++.+.||+|++|.||++.+. ++..+|+|.+......    .+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            45689999999999999999999997 5778999999765432    246788999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           93 LILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      +|+||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            999999999999999865 56899999999999999999999999999999999999999999999999988654322  


Q ss_pred             --cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          170 --RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                        .....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+....+..... ......++.++.+++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-LYKPRLASTHVYQIM  238 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCCTTSCHHHHHHH
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-CCCCccCcHHHHHHH
Confidence              223345678999999988889999999999999999999 8999998888777776655432 223346899999999


Q ss_pred             HHhcccCCCCCCChhhhhcC
Q 038249          247 SQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~  266 (281)
                      .+||+.||++|||+.+++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999863

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=319.54  Aligned_cols=254  Identities=29%  Similarity=0.501  Sum_probs=203.8

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhC----CCCceeeeeeEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS---QVEHQLRREVEIQSHL----RHPNILRLYGYF   85 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~---~~~~~~~~e~~~l~~~----~h~~i~~~~~~~   85 (281)
                      ...++|++.+.||+|++|.||+|++..+++.||+|++........   .....+.+|+.+++++    +|+||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            345789999999999999999999999999999999965543221   1123355688888888    899999999999


Q ss_pred             EeCCEEEEEEec-cCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC-CCCcEEEeeecCc
Q 038249           86 YDQKRVYLILEY-AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG-AQGELKIADFGWS  163 (281)
Q Consensus        86 ~~~~~~~~v~e~-~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~-~~~~~~l~dfg~~  163 (281)
                      ...+..++|+|+ +.+++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++ .++.++|+|||++
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            998999999999 78889999999888899999999999999999999999999999999999999 7899999999998


Q ss_pred             ccccCC-cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          164 VHTFNR-RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       164 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                      ...... .....+++.|+|||.+.+..+ +.++||||||+++++|++|..||....      .........  ...++.+
T Consensus       188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~--~~~~~~~  259 (312)
T 2iwi_A          188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHF--PAHVSPD  259 (312)
T ss_dssp             EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCC--CTTSCHH
T ss_pred             hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCC--cccCCHH
Confidence            654332 334468899999999876665 458999999999999999999996432      122222222  2368999


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      +.++|.+||+.||++|||++|+++||||++..+
T Consensus       260 ~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          260 CCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            999999999999999999999999999998754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.9e-47  Score=317.78  Aligned_cols=253  Identities=20%  Similarity=0.346  Sum_probs=208.1

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEE----EEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIV----ALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~----~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ...+..++|++.+.||+|+||+||+|.+..+++.+    ++|.+....  .....+.+.+|+.++++++||||+++++++
T Consensus         9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   86 (327)
T 3poz_A            9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred             HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            34566789999999999999999999998777654    677664332  223346788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      ..+. .+++++++.+++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        87 ~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             ESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             ecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence            8765 67899999999999999864 569999999999999999999999999999999999999999999999999975


Q ss_pred             cccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCC
Q 038249          165 HTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIV  238 (281)
Q Consensus       165 ~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (281)
                      ......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+.... ..+....+
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~  244 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQPPIC  244 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTB
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-CCCCCccC
Confidence            432221     22345778999999999899999999999999999999 999999888777766655443 33444578


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +.++.+++.+||+.||++|||+.+++++
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          245 TIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.8e-47  Score=311.23  Aligned_cols=246  Identities=22%  Similarity=0.421  Sum_probs=206.1

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC-CE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ-KR   90 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~   90 (281)
                      .+..++|++.+.||+|++|.||++.+.  |+.+|+|.+....     ..+.+.+|+.++++++||||+++++++.+. +.
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            456689999999999999999999886  8899999986442     245688899999999999999999987654 47


Q ss_pred             EEEEEeccCCCChhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           91 VYLILEYAAKGELYKELQKCKY--FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      .++|+||+++++|.+++...+.  +++..++.++.+++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            8999999999999999986543  89999999999999999999999999999999999999999999999999876555


Q ss_pred             CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      ......+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+....+.... .......++.++.++|.
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  248 (278)
T 1byg_A          170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPPAVYEVMK  248 (278)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-CCCCCTTCCHHHHHHHH
T ss_pred             cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCcccCCHHHHHHHH
Confidence            5555567889999999988889999999999999999998 999999888777776665542 23334578999999999


Q ss_pred             HhcccCCCCCCChhhhhc
Q 038249          248 QMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~  265 (281)
                      +||+.||++|||+.++++
T Consensus       249 ~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          249 NCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCChhhCCCHHHHHH
Confidence            999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.8e-47  Score=319.47  Aligned_cols=253  Identities=17%  Similarity=0.285  Sum_probs=211.6

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcE----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHI----VALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~----~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ...+..++|++.+.||+|+||+||+|.+..+++.    +++|.+.....  ......+.+|+.++++++||||+++++++
T Consensus         7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (325)
T 3kex_A            7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLC   84 (325)
T ss_dssp             CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            3456778999999999999999999999988876    66676643321  11123466789999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      . .+..++|+||+.+++|.+.+... +.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        85 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           85 P-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             C-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             c-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence            6 45688999999999999999864 568999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCC
Q 038249          165 HTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIV  238 (281)
Q Consensus       165 ~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (281)
                      ......     ....++..|+|||.+.+..++.++||||||+++++|++ |..||......+....+..... ......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  242 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-LAQPQIC  242 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-CCCCTTB
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-CCCCCcC
Confidence            543322     23346778999999988889999999999999999999 9999998888777776665432 2333368


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +.++.++|.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          243 TIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8899999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.7e-47  Score=317.47  Aligned_cols=246  Identities=24%  Similarity=0.339  Sum_probs=207.2

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~   91 (281)
                      ..-++|++.+.||.|+||+||+|.+..+++.||+|++......     ..+.+|+++++++ +|+||+++++++...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            3447899999999999999999999999999999998654322     2477899999999 999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc-----EEEeeecCccc
Q 038249           92 YLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE-----LKIADFGWSVH  165 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~-----~~l~dfg~~~~  165 (281)
                      ++||||+ +++|.+++... +.+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.     ++|+|||++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999999 88999999863 67999999999999999999999999999999999999998887     99999999864


Q ss_pred             ccCC----------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHH---HHHHhhccccC
Q 038249          166 TFNR----------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT---YRRIVQVDLKF  232 (281)
Q Consensus       166 ~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~  232 (281)
                      ....          .....+|+.|+|||.+.+..++.++||||||+++++|++|..||......+.   ...+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            3222          1345689999999999999999999999999999999999999988654433   33332222222


Q ss_pred             CC---CCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          233 PP---KPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       233 ~~---~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +.   ....| ++.+++..||+.||.+||++.+|++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11   12355 9999999999999999999988876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.4e-46  Score=309.98  Aligned_cols=248  Identities=21%  Similarity=0.289  Sum_probs=208.7

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKR   90 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~   90 (281)
                      .+..++|++.+.||+|++|.||+|.+..+++.||+|++......     ..+.+|+..++.+ +|+|++++++++.....
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            44567899999999999999999999999999999998644322     2467789999999 79999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc-----EEEeeecCcc
Q 038249           91 VYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE-----LKIADFGWSV  164 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~-----~~l~dfg~~~  164 (281)
                      .++|+||+ +++|.++++.. .++++..++.++.||+.||.+||++|++|+||+|+||+++.++.     ++|+|||++.
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999999 88999999875 45999999999999999999999999999999999999987776     9999999985


Q ss_pred             cccCC----------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch---HHHHHHhhcccc
Q 038249          165 HTFNR----------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS---DTYRRIVQVDLK  231 (281)
Q Consensus       165 ~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~  231 (281)
                      .....          .....+++.|+|||.+.+..++.++||||||+++++|++|..||......   +....+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            43322          23446899999999999988999999999999999999999999875433   333333222211


Q ss_pred             CC---CCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          232 FP---PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       232 ~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .+   ....++.++.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            11   12368999999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.8e-46  Score=312.99  Aligned_cols=255  Identities=20%  Similarity=0.323  Sum_probs=208.5

Q ss_pred             hcccccCCceecceecccCceEEEEEEEcc---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKR---SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      ...+..++|++.+.||.|++|.||+|.+..   ++..||+|.+..... .....+.+.+|+.++++++||||+++++++.
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            344556899999999999999999998875   455899999976543 3344567889999999999999999999998


Q ss_pred             eCC-----EEEEEEeccCCCChhHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcE
Q 038249           87 DQK-----RVYLILEYAAKGELYKELQ------KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGEL  155 (281)
Q Consensus        87 ~~~-----~~~~v~e~~~~~~L~~~~~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~  155 (281)
                      ..+     ..++|+||+++++|.+++.      ....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence            654     3599999999999999984      33569999999999999999999999999999999999999999999


Q ss_pred             EEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhcc
Q 038249          156 KIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVD  229 (281)
Q Consensus       156 ~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~  229 (281)
                      +|+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+....
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            99999998544322     123345778999999998899999999999999999999 999999888888777766553


Q ss_pred             ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          230 LKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      . ......++.++.++|.+||+.||++|||+.+++++
T Consensus       267 ~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 R-LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             C-CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             C-CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2 23334689999999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.3e-47  Score=316.39  Aligned_cols=254  Identities=24%  Similarity=0.424  Sum_probs=213.7

Q ss_pred             cccccCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGY   84 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~   84 (281)
                      ..+..++|++.+.||.|++|.||+|.+.     .+++.||+|.+....  .....+.+.+|+.+++++ +||||++++++
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            3455689999999999999999999964     466889999996543  233456788999999999 78999999999


Q ss_pred             EEeCC-EEEEEEeccCCCChhHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCe
Q 038249           85 FYDQK-RVYLILEYAAKGELYKELQKCKY----------------FSERRAATYVASLARALIYCHGKHVIHRDIKPENL  147 (281)
Q Consensus        85 ~~~~~-~~~~v~e~~~~~~L~~~~~~~~~----------------l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni  147 (281)
                      +...+ ..++|+||+++++|.+++.....                +++..++.++.||+.||.+||+.|++|+||+|+||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni  179 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  179 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence            87654 58999999999999999987543                78999999999999999999999999999999999


Q ss_pred             EeCCCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHH
Q 038249          148 LIGAQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDT  221 (281)
Q Consensus       148 ~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~  221 (281)
                      +++.++.++|+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+.
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            99999999999999986543221     22346778999999988889999999999999999998 9999988776555


Q ss_pred             HHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          222 YRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ................++.++.++|.+||+.||++|||+.+++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            444433333334444689999999999999999999999999975

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-46  Score=311.64  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=207.2

Q ss_pred             hcccccCCceecceecccCceEEEEEE----EccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ...+..++|++.+.||+|++|.||+|.    +..+++.||+|.+......  ...+.+.+|+.+++.++||||+++++++
T Consensus        15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (302)
T 4e5w_A           15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGIC   92 (302)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence            345556789999999999999999999    5678999999999654322  2245688999999999999999999999


Q ss_pred             EeC--CEEEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           86 YDQ--KRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        86 ~~~--~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      ...  ..+++|+||+++++|.+++.. ...+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||+
T Consensus        93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence            876  678999999999999999954 45699999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCC--------------CchHHH
Q 038249          163 SVHTFNR------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAK--------------EHSDTY  222 (281)
Q Consensus       163 ~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------------~~~~~~  222 (281)
                      +......      .....++..|+|||.+.+..++.++|+||||+++++|++|..|+...              ......
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            8654332      22345677899999998888889999999999999999998875321              111122


Q ss_pred             HHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          223 RRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ..........+....++.++.++|.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            2222223334445579999999999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=314.82  Aligned_cols=249  Identities=29%  Similarity=0.495  Sum_probs=204.1

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe----CCE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD----QKR   90 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~   90 (281)
                      -++|++.+.||+|++|.||++.+..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++..    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            36799999999999999999999999999999998543   33445678899999999999999999999873    347


Q ss_pred             EEEEEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           91 VYLILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      .++|+||+++++|.+++..    ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            8999999999999998875    466999999999999999999999999999999999999999999999999987543


Q ss_pred             cCCc------------ccccCcCCccCCccccCCC---CCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccc
Q 038249          167 FNRR------------RTMCGTLDYLPPEMVESVE---HDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDL  230 (281)
Q Consensus       167 ~~~~------------~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~  230 (281)
                      ....            ....+++.|+|||.+.+..   ++.++||||||+++++|++|..||...... ...........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  264 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL  264 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence            2111            1234688999999986544   688999999999999999999999542111 11112222233


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          231 KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ..+....++.++.++|.+||+.||++|||+.+++++
T Consensus       265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            445556789999999999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-46  Score=312.95  Aligned_cols=255  Identities=23%  Similarity=0.326  Sum_probs=212.2

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeE
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSN----HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGY   84 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~----~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~   84 (281)
                      .......++|++.+.||+|++|.||+|.+..++    ..||+|.+....  .......+.+|+.++++++||||++++++
T Consensus        37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  114 (333)
T 1mqb_A           37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGV  114 (333)
T ss_dssp             -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            334556688999999999999999999987653    359999986543  33445678899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249           85 FYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      +...+..++||||+++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus       115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          115 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             ECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             EecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence            99999999999999999999999764 56999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCc------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCC
Q 038249          164 VHTFNRR------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKP  236 (281)
Q Consensus       164 ~~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (281)
                      .......      ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+.... ..+...
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-~~~~~~  273 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RLPTPM  273 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCT
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-cCCCcc
Confidence            6543221      12234678999999988889999999999999999998 999999888877776665542 233344


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .++.++.++|.+||+.||++||++.+++++
T Consensus       274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          274 DCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.1e-47  Score=312.06  Aligned_cols=254  Identities=24%  Similarity=0.355  Sum_probs=209.1

Q ss_pred             cccccCCceecceecccCceEEEEEEEcc-CCc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKR-SNH--IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~--~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      ..+..++|++.+.||.|++|+||+|.+.. ++.  .||+|.+...........+.+.+|++++++++||||+++++++..
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            34556899999999999999999998753 333  589999876554455566788999999999999999999999887


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      .. .++|+||+++++|.+++... +.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            65 78999999999999998764 56899999999999999999999999999999999999999999999999997554


Q ss_pred             cCCc------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCC
Q 038249          167 FNRR------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS  239 (281)
Q Consensus       167 ~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (281)
                      ....      ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+.......+....++
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            3221      22345678999999988888899999999999999999 9999999888888877766655556666799


Q ss_pred             HHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          240 SAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .++.++|.+||+.||++|||+.++++
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999999996

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=314.12  Aligned_cols=252  Identities=20%  Similarity=0.348  Sum_probs=209.7

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCcEE----EEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIV----ALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~----~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ...+..++|++.+.||+|+||.||+|.+..+++.+    ++|.+....  .......+.+|+.++++++||||+++++++
T Consensus         9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   86 (327)
T 3lzb_A            9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred             hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence            44566789999999999999999999999888765    566554332  222346688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      ..+. .+++++++.+++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        87 ~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             ESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             ecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            8765 78899999999999999764 569999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCC
Q 038249          165 HTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIV  238 (281)
Q Consensus       165 ~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (281)
                      ......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+.... ..+....+
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~  244 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQPPIC  244 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTB
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCccC
Confidence            532221     22335678999999998899999999999999999999 999999888877776665543 33444578


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          239 SSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +.++.++|.+||+.||++|||+.|+++
T Consensus       245 ~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          245 TIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999996

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-46  Score=307.63  Aligned_cols=252  Identities=24%  Similarity=0.326  Sum_probs=213.8

Q ss_pred             ccccCCceecc-eecccCceEEEEEEEc--cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           12 RWTLNDFDIGK-PLGRGKFGHVYLAREK--RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        12 ~~~~~~y~~~~-~ig~g~~~~v~~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      .+..++|.+.+ .||+|++|.||+|.+.  .++..||+|.+....  .....+.+.+|++++++++||||+++++++ ..
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~   81 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA   81 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence            34557788887 9999999999999864  467789999996543  334467788999999999999999999998 55


Q ss_pred             CEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           89 KRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      +..++|+||+++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            6789999999999999998654 569999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCH
Q 038249          168 NRR------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS  240 (281)
Q Consensus       168 ~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
                      ...      ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+....+..... ......++.
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~  240 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-MECPPECPP  240 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-CCCCTTCCH
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc-CCCCCCcCH
Confidence            221      22335788999999988888999999999999999998 9999998888777766655432 223347899


Q ss_pred             HHHHHHHHhcccCCCCCCChhhhhcCC
Q 038249          241 AAKDLISQMLVKDSSQRLPLHKLLEHP  267 (281)
Q Consensus       241 ~l~~li~~~l~~~p~~Rps~~eil~~~  267 (281)
                      ++.++|.+||+.||++|||+.+++++.
T Consensus       241 ~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          241 ELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            999999999999999999999999763

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.2e-46  Score=306.80  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=212.1

Q ss_pred             cccccCCceecceecccCceEEEEEEEccC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRS---NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      ..+..++|++.+.||+|++|+||+|.+...   +..||+|.+....  .....+.+.+|+.++++++||||+++++++.+
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            355668999999999999999999997643   3459999986543  23345778899999999999999999999765


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                       +..++|+||+++++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence             4568999999999999999765 45999999999999999999999999999999999999999999999999998654


Q ss_pred             cCCc----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          167 FNRR----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       167 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                      ....    ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+..... .+....++.+
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  242 (281)
T 3cc6_A          164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR-LPKPDLCPPV  242 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC-CCCCTTCCHH
T ss_pred             ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC-CCCCCCCCHH
Confidence            3322    23345778999999988889999999999999999998 9999988877777666555432 3334468999


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhcC
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +.++|.+||+.||++|||+.+++++
T Consensus       243 l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCchhCcCHHHHHHH
Confidence            9999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.3e-46  Score=308.90  Aligned_cols=253  Identities=24%  Similarity=0.443  Sum_probs=201.9

Q ss_pred             hhhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249            8 KEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus         8 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      ++...+.-++|++.+.||+|+||+||++++..   .+|+|++.... ......+.+.+|+.++++++||||++++++. .
T Consensus        16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~   90 (289)
T 3og7_A           16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T   90 (289)
T ss_dssp             --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred             CCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence            44455666899999999999999999998753   49999986554 3344567789999999999999999999965 5


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      .+..++|+||+++++|.+.+... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence            56789999999999999999644 56999999999999999999999999999999999999999999999999987543


Q ss_pred             cC-----CcccccCcCCccCCcccc---CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC----C
Q 038249          167 FN-----RRRTMCGTLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP----P  234 (281)
Q Consensus       167 ~~-----~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~  234 (281)
                      ..     ......+++.|+|||.+.   +..++.++||||||+++++|++|..||......+............+    .
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV  250 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence            22     122345799999999986   56678899999999999999999999988776665554433322111    1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          235 KPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ...++.++.++|.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          251 RSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2368899999999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.2e-46  Score=313.55  Aligned_cols=252  Identities=18%  Similarity=0.329  Sum_probs=216.5

Q ss_pred             ccccCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      .+..++|++.+.||+|++|.||+|.+.     .+++.||+|.+....  .......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            444588999999999999999999987     357889999986543  2334566889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEE
Q 038249           87 DQKRVYLILEYAAKGELYKELQKC----------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELK  156 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~  156 (281)
                      +.+..++||||+++++|.+++...          .++++..++.++.||+.||.+||++|++|+||+|+||+++.++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence            999999999999999999998752          3579999999999999999999999999999999999999999999


Q ss_pred             EeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccc
Q 038249          157 IADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDL  230 (281)
Q Consensus       157 l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~  230 (281)
                      |+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  258 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  258 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence            99999986443221     22345778999999988889999999999999999999 8999998888877777665543


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          231 KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      . .....++.++.++|.+||+.||++|||+.+++++
T Consensus       259 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          259 L-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2 2334789999999999999999999999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-46  Score=306.74  Aligned_cols=247  Identities=22%  Similarity=0.390  Sum_probs=207.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE-
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV-   91 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~-   91 (281)
                      ..|++.+.||+|+||+||+|.+..++.   .+|+|.+...  ......+.+.+|+.++++++||||+++++++...+.. 
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            356677999999999999999876554   7999998543  2334467788999999999999999999999876554 


Q ss_pred             EEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC--
Q 038249           92 YLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN--  168 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~--  168 (281)
                      ++|+||+.+++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....  
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999999987 45689999999999999999999999999999999999999999999999999854322  


Q ss_pred             -----CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHH
Q 038249          169 -----RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       169 -----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                           ......+++.|+|||.+.+..++.++||||||+++++|++ +.+||...+..+....+.... ..+....++.++
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  257 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-RLPQPEYCPDSL  257 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-CCCCCTTCCHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-CCCCCccchHHH
Confidence                 2233456789999999999899999999999999999999 555666666666665555443 334445789999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .++|.+||+.||++|||+.++++
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-46  Score=315.59  Aligned_cols=254  Identities=22%  Similarity=0.382  Sum_probs=211.5

Q ss_pred             hcccccCCceecceecccCceEEEEEE----EccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAR----EKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF   85 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (281)
                      ...+..++|++.+.||+|++|.||+|.    +..+++.||+|.+...   .....+.+.+|++++++++|+||+++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   93 (327)
T 3lxl_A           17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVS   93 (327)
T ss_dssp             CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence            344667899999999999999999999    4668899999998654   334456788999999999999999999988


Q ss_pred             E--eCCEEEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           86 Y--DQKRVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        86 ~--~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      .  +.+..++|+||+++++|.++++. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence            7  45678999999999999999986 35699999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch--------------HHH
Q 038249          163 SVHTFNRR------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS--------------DTY  222 (281)
Q Consensus       163 ~~~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------------~~~  222 (281)
                      +.......      ....+++.|+|||.+.+..++.++||||||+++++|++|..||......              ...
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            86543221      2234677799999998888899999999999999999999998543322              112


Q ss_pred             HHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          223 RRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ..........+....++.++.++|.+||+.||++|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22222233344455789999999999999999999999999753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2e-46  Score=330.69  Aligned_cols=247  Identities=23%  Similarity=0.410  Sum_probs=215.9

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|+||.||+|.++.++..||+|.+......    .+.+.+|+.++++++||||+++++++...+..++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            447899999999999999999999999999999999655422    3568899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           94 ILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      ||||+++++|.+++...  ..++...++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++....... 
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            99999999999999864  458999999999999999999999999999999999999999999999999986543322 


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                         ....+++.|+|||.+....++.++||||||+++++|++ |..||...+..+....+... ...+....++.++.++|
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li  452 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKVYELM  452 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHH
Confidence               22335678999999988889999999999999999998 99999988887777665543 23344457899999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      .+||+.||++|||+.+|++
T Consensus       453 ~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          453 RACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCcChhHCcCHHHHHH
Confidence            9999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-46  Score=308.66  Aligned_cols=244  Identities=27%  Similarity=0.483  Sum_probs=199.8

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .+..++|++.+.||+|+||.||++++.  ++.+|+|.+...     ...+.+.+|++++++++||||+++++++.+  ..
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~   74 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PV   74 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence            356689999999999999999999886  788999998532     234568899999999999999999998764  47


Q ss_pred             EEEEeccCCCChhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---cCceecCCCCCCeEeCCCCc-EEEeeecCcc
Q 038249           92 YLILEYAAKGELYKELQKCK---YFSERRAATYVASLARALIYCHG---KHVIHRDIKPENLLIGAQGE-LKIADFGWSV  164 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~~i~~~l~~Lh~---~~i~H~di~~~Ni~~~~~~~-~~l~dfg~~~  164 (281)
                      ++||||+++++|.+++....   .++...++.++.||+.||.+||+   +|++|+||+|+||+++.++. ++|+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            89999999999999998764   37899999999999999999999   89999999999999998886 7999999986


Q ss_pred             cccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHH--HHHHhhccccCCCCCCCCHHH
Q 038249          165 HTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT--YRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l  242 (281)
                      ..........+++.|+|||.+.+..++.++||||||+++++|++|..||........  ....... ...+....++.++
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  233 (307)
T 2eva_A          155 DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-TRPPLIKNLPKPI  233 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-CCCCCBTTCCHHH
T ss_pred             ccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC-CCCCcccccCHHH
Confidence            655555555689999999999998999999999999999999999999986544332  2222222 2223334689999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .++|.+||+.||++|||+.++++
T Consensus       234 ~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.8e-46  Score=325.21  Aligned_cols=246  Identities=21%  Similarity=0.383  Sum_probs=212.6

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +..++|++.+.||+|+||.||+|.+. ++..||||.+......    .+.+.+|++++++++||||+++++++. .+..+
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            34478999999999999999999987 4678999999754422    356889999999999999999999986 56789


Q ss_pred             EEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           93 LILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      +||||+++++|.++++..  ..++...++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... 
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            999999999999999754  35899999999999999999999999999999999999999999999999998654322 


Q ss_pred             ---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          170 ---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                         .....+++.|+|||.+....++.++||||||+++++|++ |..||...+..+....+..+ ...+....++.++.++
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~l  417 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELYNI  417 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCCTTSCHHHHHH
T ss_pred             eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHH
Confidence               122345678999999988889999999999999999999 99999998888877776554 2334445789999999


Q ss_pred             HHHhcccCCCCCCChhhhhc
Q 038249          246 ISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~  265 (281)
                      |.+||+.||++|||+++|++
T Consensus       418 i~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          418 MMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHH
Confidence            99999999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=317.37  Aligned_cols=251  Identities=20%  Similarity=0.265  Sum_probs=198.8

Q ss_pred             ccCCceecceecccCceEEEEEEEcc---CCcEEEEEEeecccccchH--------HHHHHHHHHHHHHhCCCCceeeee
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKR---SNHIVALKVLFKSQLQQSQ--------VEHQLRREVEIQSHLRHPNILRLY   82 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~lK~~~~~~~~~~~--------~~~~~~~e~~~l~~~~h~~i~~~~   82 (281)
                      ..++|++.+.||+|+||.||+|.+..   ++..+|+|++.........        ....+.+|+..++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            34789999999999999999999987   7888999998655321111        112355788889999999999999


Q ss_pred             eEEEe----CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC--cEE
Q 038249           83 GYFYD----QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG--ELK  156 (281)
Q Consensus        83 ~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~--~~~  156 (281)
                      +++..    ....++||||+ +++|.+++...+.+++..++.++.||+.||+|||+.|++|+||+|+||+++.++  .++
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            99987    77899999999 889999998877899999999999999999999999999999999999999887  999


Q ss_pred             EeeecCcccccCC----------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHH
Q 038249          157 IADFGWSVHTFNR----------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRI  225 (281)
Q Consensus       157 l~dfg~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~  225 (281)
                      |+|||++......          .....+++.|+|||.+.+..++.++||||||+++++|++|..||...... ......
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            9999998543221          13446899999999999888999999999999999999999999653222 222111


Q ss_pred             hhc-cccCC-------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          226 VQV-DLKFP-------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       226 ~~~-~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ... ....+       ....++.++.++|.+||+.||++|||++++++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            111 11111       11268899999999999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.8e-47  Score=317.03  Aligned_cols=249  Identities=27%  Similarity=0.362  Sum_probs=205.5

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|++|.||+|.++ +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            4588999999999999999999975 68899999986543   2235678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           94 ILEYAAKGELYKELQKCK----YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      |+||+++++|.+++....    .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999999987543    4899999999999999999999999999999999999999999999999998543221


Q ss_pred             -----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHH---H----HHhhcccc------
Q 038249          170 -----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY---R----RIVQVDLK------  231 (281)
Q Consensus       170 -----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~----~~~~~~~~------  231 (281)
                           .....+++.|+|||.+.+..++.++||||||+++++|++|..||......+..   .    ........      
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence                 12334789999999998888999999999999999999999999765443211   1    01111110      


Q ss_pred             --CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          232 --FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       232 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                        ....+..+.++.+++.+||+.||++|||+.|++++
T Consensus       273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              01112245678999999999999999999999975

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-46  Score=314.36  Aligned_cols=247  Identities=24%  Similarity=0.322  Sum_probs=197.6

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC--
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK--   89 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--   89 (281)
                      .+..++|++.+.||+|+||+||+|++.  ++.||+|++....    ........|+.++++++||||+++++++....  
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            345589999999999999999999887  7899999995443    22334566888999999999999999998743  


Q ss_pred             --EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc----------CceecCCCCCCeEeCCCCcEEE
Q 038249           90 --RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK----------HVIHRDIKPENLLIGAQGELKI  157 (281)
Q Consensus        90 --~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~----------~i~H~di~~~Ni~~~~~~~~~l  157 (281)
                        .+++||||+++++|.++++.. .+++..++.++.||+.||.|||+.          |++|+||+|+||+++.++.+||
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             CceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence              479999999999999999875 489999999999999999999999          9999999999999999999999


Q ss_pred             eeecCcccccCC-----cccccCcCCccCCccccCC-----CCCCcccHHhHHHHHHHHHhCCCCCCCCCch--------
Q 038249          158 ADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESV-----EHDANVDIWSLGVLCYEFLYGVPPFEAKEHS--------  219 (281)
Q Consensus       158 ~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------  219 (281)
                      +|||++......     .....+++.|+|||.+.+.     .++.++||||||+++++|++|..||......        
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            999998543222     2234689999999998763     4456789999999999999999999754321        


Q ss_pred             -------HHHHHHhhccccCCCCC------CCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          220 -------DTYRRIVQVDLKFPPKP------IVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       220 -------~~~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                             .............+...      ..+.++.++|.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                   11111111111111110      12345999999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.7e-46  Score=303.89  Aligned_cols=245  Identities=20%  Similarity=0.366  Sum_probs=210.0

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|++|.||+|.+. ++..+|+|.+......    .+.+.+|++++++++||||+++++++.+ +..++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            3488999999999999999999986 5678999998654322    3467889999999999999999999764 56889


Q ss_pred             EEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           94 ILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      |+||+++++|.+++....  .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999999999997643  68999999999999999999999999999999999999999999999999986543322 


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                         ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+.... .......++.++.++|
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li  243 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-RMVRPDNCPEELYQLM  243 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-CCCCcccccHHHHHHH
Confidence               22345678999999988888999999999999999999 999999888877776665542 2233347899999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      .+||+.||++|||+.++++
T Consensus       244 ~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          244 RLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhccChhhCCCHHHHHH
Confidence            9999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.6e-46  Score=306.42  Aligned_cols=248  Identities=20%  Similarity=0.352  Sum_probs=207.0

Q ss_pred             cCCceecceecccCceEEEEEEEccCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE-eCCE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSN---HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY-DQKR   90 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~   90 (281)
                      ..+|++.+.||+|+||.||+|.+..++   ..+++|.+...  ......+.+.+|+.++++++||||+++++++. ..+.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            467999999999999999999976443   35889988643  23344567889999999999999999999864 4567


Q ss_pred             EEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           91 VYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      .++|+||+++++|.++++.. ..++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            89999999999999999764 45899999999999999999999999999999999999999999999999998644322


Q ss_pred             -------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          170 -------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       170 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                             .....+++.|+|||.+.+..++.++|+||||+++++|++ +.+||......+............ ....++.+
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  260 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPDP  260 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC-CCTTCCHH
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC-CCccCCHH
Confidence                   222345678999999988889999999999999999999 677888777777766665554332 23468999


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhc
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +.++|.+||+.||++|||+.++++
T Consensus       261 l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          261 LYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.4e-46  Score=305.25  Aligned_cols=244  Identities=25%  Similarity=0.404  Sum_probs=207.3

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--------
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--------   87 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--------   87 (281)
                      .+|++.+.||.|++|.||+|.+..+++.||+|.+....       ..+.+|++++++++||||+++++++..        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            67999999999999999999999999999999996543       235679999999999999999998864        


Q ss_pred             --------CCEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEE
Q 038249           88 --------QKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKI  157 (281)
Q Consensus        88 --------~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l  157 (281)
                              ....++|+||+++++|.+++...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence                    44689999999999999999754  56999999999999999999999999999999999999999999999


Q ss_pred             eeecCcccccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCC
Q 038249          158 ADFGWSVHTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK  235 (281)
Q Consensus       158 ~dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (281)
                      +|||++......  .....+++.|+|||.+.+..++.++|+||||+++++|++|..|+..  .......+....    ..
T Consensus       164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~~~----~~  237 (284)
T 2a19_B          164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDGI----IS  237 (284)
T ss_dssp             CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTTC----CC
T ss_pred             CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhccc----cc
Confidence            999987554332  3344689999999999888899999999999999999999888642  122222222221    22


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ..++.++.++|.+||+.||++|||+.|++++.+..+.
T Consensus       238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            3688999999999999999999999999998776544

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.8e-45  Score=303.23  Aligned_cols=245  Identities=21%  Similarity=0.311  Sum_probs=203.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE-EeCCEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF-YDQKRVYL   93 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~~   93 (281)
                      .++|++.+.||+|++|.||+|.+..+++.||+|++......     ..+.+|+.+++.++|++++..+..+ ...+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            47899999999999999999999999999999998654422     2477899999999987766555544 56788899


Q ss_pred             EEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC---CCCcEEEeeecCcccccCC
Q 038249           94 ILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG---AQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~---~~~~~~l~dfg~~~~~~~~  169 (281)
                      |+||+ +++|.+++.. ...+++..++.++.||+.||.+||++|++|+||+|+||+++   .++.++|+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 8899999974 45699999999999999999999999999999999999994   8889999999998543332


Q ss_pred             ----------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCc---hHHHHHHhhccccCC---
Q 038249          170 ----------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEH---SDTYRRIVQVDLKFP---  233 (281)
Q Consensus       170 ----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~---  233 (281)
                                .....+++.|+|||.+.+..++.++||||||+++++|++|..||.....   .+....+.......+   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence                      2344689999999999998999999999999999999999999986433   233333333222222   


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ....+|.++.++|.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            12368999999999999999999999999885

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.8e-45  Score=304.96  Aligned_cols=237  Identities=33%  Similarity=0.589  Sum_probs=193.0

Q ss_pred             hcccccCCceec-ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCceeeeeeEEEe
Q 038249           10 KKRWTLNDFDIG-KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ-SHLRHPNILRLYGYFYD   87 (281)
Q Consensus        10 ~~~~~~~~y~~~-~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l-~~~~h~~i~~~~~~~~~   87 (281)
                      ...-.+++|.+. +.||.|++|.||+|.++.+++.||+|.+...        ....+|+.++ +..+||||+++++++..
T Consensus        11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            344466889988 7899999999999999999999999998532        2355677776 66699999999999987


Q ss_pred             ----CCEEEEEEeccCCCChhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC---CCcEEEe
Q 038249           88 ----QKRVYLILEYAAKGELYKELQKCK--YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA---QGELKIA  158 (281)
Q Consensus        88 ----~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~---~~~~~l~  158 (281)
                          ....++||||+++++|.+++....  .+++..++.++.||+.||.+||+.|++|+||+|+||+++.   ++.++|+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence                678999999999999999998754  6999999999999999999999999999999999999998   7889999


Q ss_pred             eecCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc----cccCCC
Q 038249          159 DFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV----DLKFPP  234 (281)
Q Consensus       159 dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~  234 (281)
                      |||++....                   +..++.++||||||+++++|++|..||...............    ....+.
T Consensus       163 Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  223 (299)
T 3m2w_A          163 DFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  223 (299)
T ss_dssp             CCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred             ccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence            999874322                   235677899999999999999999999766554433222111    111111


Q ss_pred             --CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          235 --KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       235 --~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                        ...++.++.++|.+||+.||++|||+.|+++||||++..
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence              135889999999999999999999999999999998763

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.3e-46  Score=309.97  Aligned_cols=251  Identities=22%  Similarity=0.357  Sum_probs=206.2

Q ss_pred             ccccCCceecceecccCceEEEEEEE----ccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLARE----KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~----~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      .+.-+.|++++.||+|+||+||++.+    ..+++.||+|++....  .......+.+|+.++++++||||+++++++.+
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCED  104 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence            34334459999999999999988754    4578899999997553  33446778999999999999999999999987


Q ss_pred             --CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           88 --QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        88 --~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                        ...+++||||+++++|.+++...+ +++..++.++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence              468899999999999999998755 89999999999999999999999999999999999999999999999999865


Q ss_pred             ccCC------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH--------------HHHHH
Q 038249          166 TFNR------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD--------------TYRRI  225 (281)
Q Consensus       166 ~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------~~~~~  225 (281)
                      ....      .....+++.|+|||.+.+..++.++||||||+++++|++|..||.......              .....
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            4332      223346778999999988888899999999999999999999986532211              11222


Q ss_pred             hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .......+....++.++.++|.+||+.||++|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2223334445578999999999999999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.6e-46  Score=316.76  Aligned_cols=250  Identities=20%  Similarity=0.300  Sum_probs=198.5

Q ss_pred             cCCceecceecccCceEEEEEEEccC-----CcEEEEEEeecccccchHH--------HHHHHHHHHHHHhCCCCceeee
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRS-----NHIVALKVLFKSQLQQSQV--------EHQLRREVEIQSHLRHPNILRL   81 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~-----~~~~~lK~~~~~~~~~~~~--------~~~~~~e~~~l~~~~h~~i~~~   81 (281)
                      .++|++.+.||+|+||.||+|.+..+     ++.||+|++..........        ......++..++.++|+||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            35899999999999999999999865     5789999986543111100        0123345566778899999999


Q ss_pred             eeEEEeC----CEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC--CCCc
Q 038249           82 YGYFYDQ----KRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG--AQGE  154 (281)
Q Consensus        82 ~~~~~~~----~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~--~~~~  154 (281)
                      ++++...    ...++||||+ +++|.+++... +.+++..++.++.||+.||.|||+.||+|+||+|+||+++  .++.
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence            9998764    5689999999 88999999875 6799999999999999999999999999999999999999  8899


Q ss_pred             EEEeeecCcccccCC----------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHH
Q 038249          155 LKIADFGWSVHTFNR----------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRR  224 (281)
Q Consensus       155 ~~l~dfg~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  224 (281)
                      ++|+|||++......          .....+|+.|+|||.+.+..++.++||||||+++++|++|..||...........
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            999999998543221          1233489999999999998899999999999999999999999986433332221


Q ss_pred             Hhhccc---------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          225 IVQVDL---------KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       225 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ......         .......++.++.+++..||+.||++||++.+|++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          273 DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            111100         00112468999999999999999999999999885

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=310.51  Aligned_cols=246  Identities=26%  Similarity=0.390  Sum_probs=189.8

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEE------
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFY------   86 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~------   86 (281)
                      .-.+|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++++. ||||+++++++.      
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            335899999999999999999999999999999998544   2344567889999999996 999999999984      


Q ss_pred             --eCCEEEEEEeccCCCChhHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCeEeCCCCcEEEee
Q 038249           87 --DQKRVYLILEYAAKGELYKELQK---CKYFSERRAATYVASLARALIYCHGKH--VIHRDIKPENLLIGAQGELKIAD  159 (281)
Q Consensus        87 --~~~~~~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~Ni~~~~~~~~~l~d  159 (281)
                        ....+++++||++| +|.+++..   .+++++..++.++.||+.||.+||+.|  ++|+||+|+||+++.++.++|+|
T Consensus       103 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          103 DTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TTSSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ccCCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence              34468999999974 88888764   456999999999999999999999999  99999999999999999999999


Q ss_pred             ecCcccccCCcc---------------cccCcCCccCCccc---cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHH
Q 038249          160 FGWSVHTFNRRR---------------TMCGTLDYLPPEMV---ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT  221 (281)
Q Consensus       160 fg~~~~~~~~~~---------------~~~~~~~~~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  221 (281)
                      ||++........               ...+++.|+|||.+   .+..++.++||||||+++++|++|..||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            999865433211               33578899999998   566788899999999999999999999976554433


Q ss_pred             HHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCC
Q 038249          222 YRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHP  267 (281)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~  267 (281)
                      .    ......+.....+..+.++|.+||+.||++|||+.|++++-
T Consensus       262 ~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          262 V----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             h----cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            2    22333444556788999999999999999999999999863

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.8e-45  Score=303.15  Aligned_cols=245  Identities=21%  Similarity=0.302  Sum_probs=200.0

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEE-EeCCEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYF-YDQKRVYL   93 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~~   93 (281)
                      .++|++.+.||+|++|.||+|.+..+++.||+|++......     ..+.+|+.+++.++|++++..+..+ ...+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            37899999999999999999999999999999987544322     2467789999999887766655554 66788999


Q ss_pred             EEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe---CCCCcEEEeeecCcccccCC
Q 038249           94 ILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI---GAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~---~~~~~~~l~dfg~~~~~~~~  169 (281)
                      |+||+ +++|.+++.. .+.+++..++.++.||+.||.+||++|++|+||+|+||++   +.++.++|+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999 8899999985 4569999999999999999999999999999999999999   78899999999998543322


Q ss_pred             ----------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch---HHHHHHhhccccCC---
Q 038249          170 ----------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS---DTYRRIVQVDLKFP---  233 (281)
Q Consensus       170 ----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~---  233 (281)
                                .....+++.|+|||.+.+..++.++||||||+++++|++|..||......   .....+.......+   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence                      22446899999999999989999999999999999999999999765443   33333332222222   


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ....+|.++.++|.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            11357899999999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.5e-46  Score=310.32  Aligned_cols=258  Identities=22%  Similarity=0.397  Sum_probs=207.5

Q ss_pred             cchhhhcccccCCceecceecccCceEEEEEEE----ccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceee
Q 038249            5 VSAKEKKRWTLNDFDIGKPLGRGKFGHVYLARE----KRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILR   80 (281)
Q Consensus         5 ~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~----~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~   80 (281)
                      ..+.....+..++|++++.||+|++|.||+|.+    ..+++.||+|.+...   .....+.+.+|++++++++||||++
T Consensus        30 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~  106 (326)
T 2w1i_A           30 FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVK  106 (326)
T ss_dssp             -------CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hcccCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeee
Confidence            345556677788999999999999999999984    567899999998653   3344567899999999999999999


Q ss_pred             eeeEEEeCC--EEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEE
Q 038249           81 LYGYFYDQK--RVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKI  157 (281)
Q Consensus        81 ~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l  157 (281)
                      +++++...+  ..++|+||+++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|
T Consensus       107 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL  186 (326)
T 2w1i_A          107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI  186 (326)
T ss_dssp             EEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEE
T ss_pred             EEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEE
Confidence            999987543  789999999999999999875 45899999999999999999999999999999999999999999999


Q ss_pred             eeecCcccccCCc------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCch-----------H
Q 038249          158 ADFGWSVHTFNRR------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHS-----------D  220 (281)
Q Consensus       158 ~dfg~~~~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------~  220 (281)
                      +|||++.......      ....++..|+|||.+.+..++.++||||||+++++|++|..|+......           .
T Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~  266 (326)
T 2w1i_A          187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ  266 (326)
T ss_dssp             CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTH
T ss_pred             ecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchh
Confidence            9999986543322      2234566799999998888899999999999999999999887532110           0


Q ss_pred             ----HHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          221 ----TYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       221 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                          ............+....++.++.++|.+||+.||++|||+.++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                111122222233344578999999999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-45  Score=304.51  Aligned_cols=245  Identities=27%  Similarity=0.445  Sum_probs=194.0

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCceeeeeeEEEe--
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH--LRHPNILRLYGYFYD--   87 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~--~~h~~i~~~~~~~~~--   87 (281)
                      ....++|++.+.||+|+||+||+|++  +++.||+|++....      ......|.+++..  ++||||+++++++..  
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            45568999999999999999999988  48899999985432      2234455666555  799999999998754  


Q ss_pred             --CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hcCceecCCCCCCeEeCCCCcEEE
Q 038249           88 --QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH--------GKHVIHRDIKPENLLIGAQGELKI  157 (281)
Q Consensus        88 --~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~i~H~di~~~Ni~~~~~~~~~l  157 (281)
                        ....++|+||+++++|.++++. ..+++..++.++.||+.||.|||        +.|++|+||+|+||+++.++.++|
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              3468999999999999999966 45899999999999999999999        999999999999999999999999


Q ss_pred             eeecCcccccCC-------cccccCcCCccCCccccCC------CCCCcccHHhHHHHHHHHHhC----------CCCCC
Q 038249          158 ADFGWSVHTFNR-------RRTMCGTLDYLPPEMVESV------EHDANVDIWSLGVLCYEFLYG----------VPPFE  214 (281)
Q Consensus       158 ~dfg~~~~~~~~-------~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g----------~~p~~  214 (281)
                      +|||++......       .....+|+.|+|||.+.+.      .++.++||||||+++++|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999998543222       1223689999999998766      344689999999999999999          88885


Q ss_pred             CCCch----HHHHHHhhccccCCCC------CCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          215 AKEHS----DTYRRIVQVDLKFPPK------PIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       215 ~~~~~----~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .....    .............+..      ...+.++.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            53221    2222222221111111      114467999999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.1e-45  Score=320.94  Aligned_cols=251  Identities=23%  Similarity=0.419  Sum_probs=210.8

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +..++|++.+.||+|+||.||+|.+.. +..||+|.+......    .+.+.+|++++++++||||+++++++.+ +..+
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            334789999999999999999999984 467999999765422    2468899999999999999999999876 6789


Q ss_pred             EEEeccCCCChhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           93 LILEYAAKGELYKELQK--CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      +||||+++++|.+++..  ...+++..++.++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++...... 
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            99999999999999974  356899999999999999999999999999999999999999999999999998654322 


Q ss_pred             ---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          170 ---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                         .....++..|+|||.+....++.++||||||+++++|++ |..||......+....+..+. ..+....++.++.++
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~l  413 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPESLHDL  413 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTSCHHHHHH
T ss_pred             eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHH
Confidence               122345678999999988889999999999999999999 999999888887777665542 233345789999999


Q ss_pred             HHHhcccCCCCCCChhhhhc--CCccc
Q 038249          246 ISQMLVKDSSQRLPLHKLLE--HPWII  270 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~--~~~~~  270 (281)
                      |.+||+.||++|||++++++  ..++.
T Consensus       414 i~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          414 MCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            99999999999999999986  35554

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.5e-47  Score=316.97  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=203.0

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      ....++|++.+.||+|++|.||+|.+. +++.||+|++........  ...+.+|+.+++.++||||+++++++...+..
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            345689999999999999999999865 688999999865432211  23578899999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhc---CceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           92 YLILEYAAKGELYKELQKCK----YFSERRAATYVASLARALIYCHGK---HVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~~i~~~l~~Lh~~---~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      ++|+||+++++|.+++....    ++++..++.++.||+.||.+||+.   |++|+||+|+||+++.++.++|+|||++.
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            99999999999999998643    489999999999999999999999   99999999999999999999999999986


Q ss_pred             cccCC----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCC----CCchHHHHHHhhcccc-----
Q 038249          165 HTFNR----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEA----KEHSDTYRRIVQVDLK-----  231 (281)
Q Consensus       165 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~----~~~~~~~~~~~~~~~~-----  231 (281)
                      .....    .....+++.|+|||.+.+..++.++||||||+++++|++|..||..    ................     
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE  262 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred             ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence            43322    2234489999999999888899999999999999999999999952    1111111111111000     


Q ss_pred             --------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCC
Q 038249          232 --------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHP  267 (281)
Q Consensus       232 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~  267 (281)
                              .......+.++.+++.+||+.||++|||+.+++++-
T Consensus       263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence                    000111336799999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=321.65  Aligned_cols=251  Identities=24%  Similarity=0.392  Sum_probs=205.4

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC--E
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK--R   90 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~   90 (281)
                      ..-++|++.+.||+|+||+||+|.+..+|+.||+|++........  .+.+.+|++++++++||||+++++++...+  .
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence            445789999999999999999999999999999999965443222  355678999999999999999999998755  7


Q ss_pred             EEEEEeccCCCChhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe----CCCCcEEEeeecCc
Q 038249           91 VYLILEYAAKGELYKELQKCK---YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI----GAQGELKIADFGWS  163 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~----~~~~~~~l~dfg~~  163 (281)
                      .++||||+++++|.++++...   .+++..++.++.||+.||.|||+.||+|+||+|+||++    +.++.++|+|||++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            899999999999999997643   38999999999999999999999999999999999999    77788999999998


Q ss_pred             ccccCC--cccccCcCCccCCccccC--------CCCCCcccHHhHHHHHHHHHhCCCCCCCCC----chHHHHHHhhcc
Q 038249          164 VHTFNR--RRTMCGTLDYLPPEMVES--------VEHDANVDIWSLGVLCYEFLYGVPPFEAKE----HSDTYRRIVQVD  229 (281)
Q Consensus       164 ~~~~~~--~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~  229 (281)
                      ......  .....+++.|+|||.+.+        ..++.++||||||+++++|++|..||....    ..+....+..+.
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            654332  234568999999999854        456778999999999999999999997533    234444444332


Q ss_pred             cc-------------------CCCC----CCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          230 LK-------------------FPPK----PIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       230 ~~-------------------~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ..                   .+..    ..++..+.++|.+||+.||++||++.++++
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            11                   1111    124557889999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=313.87  Aligned_cols=248  Identities=20%  Similarity=0.351  Sum_probs=202.1

Q ss_pred             CCceecceecccCceEEEEEEEccCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-CCEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSN---HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-QKRV   91 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   91 (281)
                      ..|++.+.||+|+||+||+|.+..++   ..+|+|.+...  ......+.+.+|+.++++++||||+++++++.. .+..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            35788999999999999999986543   35889988543  233446778899999999999999999998754 5678


Q ss_pred             EEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           92 YLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      ++|+||+++++|.++++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... 
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999999865 45899999999999999999999999999999999999999999999999998643222 


Q ss_pred             ------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHH
Q 038249          170 ------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       170 ------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                            .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+..+.. ......++.++
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l  325 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQPEYCPDPL  325 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-CCCCTTCCHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHH
Confidence                  122345678999999988899999999999999999999 7888988777776666655443 23334689999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhcC
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .+++.+||+.||++|||+.+++++
T Consensus       326 ~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999863

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=311.89  Aligned_cols=242  Identities=18%  Similarity=0.270  Sum_probs=200.0

Q ss_pred             cCCceecceecccCceEEEEEEEcc--------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceee------
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKR--------SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILR------   80 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~--------~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~------   80 (281)
                      -++|++.+.||+|++|.||+|.+..        +++.||+|.+...        ..+.+|++++++++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            3789999999999999999999987        3789999998643        24678999999999999887      


Q ss_pred             ---------eeeEEEe-CCEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeE
Q 038249           81 ---------LYGYFYD-QKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLL  148 (281)
Q Consensus        81 ---------~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~  148 (281)
                               +++++.. .+..++||||+ +++|.+++...  ..+++..++.++.||+.||.+||++|++|+||+|+||+
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5677766 77899999999 88999999876  67999999999999999999999999999999999999


Q ss_pred             eCCCC--cEEEeeecCcccccCC----------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCC
Q 038249          149 IGAQG--ELKIADFGWSVHTFNR----------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAK  216 (281)
Q Consensus       149 ~~~~~--~~~l~dfg~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  216 (281)
                      ++.++  .++|+|||++......          .....+++.|+|||.+.+..++.++||||||+++++|++|..||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  8999999998543322          12336899999999999989999999999999999999999999876


Q ss_pred             C-chHHHHHHhh----ccccCC----CCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          217 E-HSDTYRRIVQ----VDLKFP----PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       217 ~-~~~~~~~~~~----~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      . ..........    ......    ....++.++.++|.+||+.||++|||+.++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            4 2222222211    111111    11247899999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.1e-45  Score=316.93  Aligned_cols=246  Identities=26%  Similarity=0.375  Sum_probs=192.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +.|.+.+.||+|+||+||.+ ...+|+.||||++....      .+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            45666789999999999875 44579999999985532      23467799999876 899999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC-------------Cc
Q 038249           95 LEYAAKGELYKELQKCKYF-------SERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-------------GE  154 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l-------~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~-------------~~  154 (281)
                      +||+++ +|.+++......       ++..++.++.||+.||+|||+.||+|+||+|+||+++.+             +.
T Consensus        88 ~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            999965 999999875432       233457899999999999999999999999999999754             48


Q ss_pred             EEEeeecCcccccCCc-------ccccCcCCccCCccccC-------CCCCCcccHHhHHHHHHHHHh-CCCCCCCCCch
Q 038249          155 LKIADFGWSVHTFNRR-------RTMCGTLDYLPPEMVES-------VEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHS  219 (281)
Q Consensus       155 ~~l~dfg~~~~~~~~~-------~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~  219 (281)
                      ++|+|||++.......       ....+|+.|+|||++.+       ..++.++|||||||++++|++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999986543321       23468999999999865       567889999999999999998 99999765544


Q ss_pred             HHHHHHhhccccCCCCC-----CCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          220 DTYRRIVQVDLKFPPKP-----IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       220 ~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      +  ..+.......+...     .++.++.++|.+||+.||++|||+.++++||||..
T Consensus       247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            3  22333322222211     24578999999999999999999999999999964

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.1e-45  Score=315.38  Aligned_cols=248  Identities=25%  Similarity=0.379  Sum_probs=194.9

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .+|++.+.||.|++|+|+. ....+++.||||++.......      ..+|+++++++ +||||+++++++.+.+..++|
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~------~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSF------ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEE------CHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHH------HHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            5699999999999999764 444578999999996544322      45689999999 799999999999999999999


Q ss_pred             EeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC-----CcEEEeeecCcccccC
Q 038249           95 LEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-----GELKIADFGWSVHTFN  168 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~-----~~~~l~dfg~~~~~~~  168 (281)
                      ||++++ +|.+++.... .++...++.++.||+.||.|||++||+|+||+|+||+++.+     ..++|+|||++.....
T Consensus        97 ~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A           97 IELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             EECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            999975 9999998654 35666778999999999999999999999999999999532     2588999999865432


Q ss_pred             C------cccccCcCCccCCcccc---CCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCC-CCCC
Q 038249          169 R------RRTMCGTLDYLPPEMVE---SVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFP-PKPI  237 (281)
Q Consensus       169 ~------~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~  237 (281)
                      .      .....+|+.|+|||++.   ...++.++|||||||++++|++ |..||.................... ....
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  255 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH  255 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence            2      23356899999999986   4556779999999999999999 9999976555443332222211111 1122


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          238 VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      .+..+.++|.+||+.||++|||+.++++||||..
T Consensus       256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            4456899999999999999999999999999974

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=308.60  Aligned_cols=252  Identities=20%  Similarity=0.358  Sum_probs=209.6

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ....+..++|++.+.||+|++|.||+|.+..   .+++|++....... ...+.+.+|+.++++++|+||+++++++.+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            3344556999999999999999999999874   39999986543222 1234466789999999999999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           89 KRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      +..++|+||+++++|.+++...+ .+++..++.++.||+.||++||+.|++|+||+|+||+++ ++.++|+|||++....
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            99999999999999999998764 699999999999999999999999999999999999997 7899999999864321


Q ss_pred             --------CCcccccCcCCccCCccccC---------CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc
Q 038249          168 --------NRRRTMCGTLDYLPPEMVES---------VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL  230 (281)
Q Consensus       168 --------~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (281)
                              .......+++.|+|||.+.+         ..++.++||||||+++++|++|..||...........+.....
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  260 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK  260 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence                    11233457889999999864         3467899999999999999999999998888777776665544


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          231 KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .......++.++.++|.+||+.||++|||+.++++
T Consensus       261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            44444468899999999999999999999999996

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7.4e-45  Score=328.69  Aligned_cols=241  Identities=23%  Similarity=0.344  Sum_probs=205.7

Q ss_pred             ceecccCceEEEEEEEc--cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccC
Q 038249           22 KPLGRGKFGHVYLAREK--RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      +.||+|+||.||+|.+.  .+++.||||++..... .....+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            47999999999999654  5668899999965532 33345678999999999999999999999864 56789999999


Q ss_pred             CCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc------ccc
Q 038249          100 KGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR------RTM  173 (281)
Q Consensus       100 ~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~------~~~  173 (281)
                      +++|.++++..+.+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.......      ...
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  532 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  532 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence            99999999988889999999999999999999999999999999999999999999999999985432221      222


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      .+++.|+|||++.+..++.++||||||+++++|++ |..||......+....+..+.. ......++.++.++|.+||+.
T Consensus       533 ~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~  611 (635)
T 4fl3_A          533 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-MGCPAGCPREMYDLMNLCWTY  611 (635)
T ss_dssp             --CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCC
Confidence            35678999999998899999999999999999998 9999999888887777766543 233347899999999999999


Q ss_pred             CCCCCCChhhhhc
Q 038249          253 DSSQRLPLHKLLE  265 (281)
Q Consensus       253 ~p~~Rps~~eil~  265 (281)
                      ||++||++.++++
T Consensus       612 dP~~RPs~~~l~~  624 (635)
T 4fl3_A          612 DVENRPGFAAVEL  624 (635)
T ss_dssp             STTTSCCHHHHHH
T ss_pred             CHhHCcCHHHHHH
Confidence            9999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.8e-45  Score=322.62  Aligned_cols=246  Identities=24%  Similarity=0.421  Sum_probs=211.9

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +..++|++.+.||+|+||.||+|.+.. +..||||++......    .+.+.+|++++++++|+||+++++++.+ +..+
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            344789999999999999999999984 467999999765432    2468899999999999999999999876 6789


Q ss_pred             EEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           93 LILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      +||||+++++|.++++..  ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++...... 
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            999999999999999743  56899999999999999999999999999999999999999999999999998654322 


Q ss_pred             ---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          170 ---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                         .....++..|+|||.+....++.++||||||+++|+|++ |..||......+....+..+. ..+....++.++.++
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~l  496 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPESLHDL  496 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHH
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHH
Confidence               122345678999999988889999999999999999999 999999888887777665542 233345789999999


Q ss_pred             HHHhcccCCCCCCChhhhhc
Q 038249          246 ISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~  265 (281)
                      |.+||+.||++|||+++|++
T Consensus       497 i~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          497 MCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.9e-46  Score=332.37  Aligned_cols=258  Identities=26%  Similarity=0.390  Sum_probs=206.6

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe----
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD----   87 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----   87 (281)
                      ...+++|++.+.||.|+||.||+|.+..+|+.||+|++....  .......+.+|++++++++||||+++++++..    
T Consensus        10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            345689999999999999999999999999999999986542  33445678899999999999999999998765    


Q ss_pred             --CCEEEEEEeccCCCChhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCc---EEEee
Q 038249           88 --QKRVYLILEYAAKGELYKELQKCK---YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGE---LKIAD  159 (281)
Q Consensus        88 --~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~---~~l~d  159 (281)
                        .+..++|+||+++++|.+++....   .+++..++.++.+|+.||.|||+.|++|+||+|+||+++.++.   ++|+|
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              667899999999999999998754   5899999999999999999999999999999999999997765   99999


Q ss_pred             ecCcccccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHH---------H---
Q 038249          160 FGWSVHTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRR---------I---  225 (281)
Q Consensus       160 fg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---------~---  225 (281)
                      ||.+......  .....+++.|+|||.+.+..++.++||||||+++++|++|..||........+..         .   
T Consensus       168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            9998654333  2345689999999999999999999999999999999999999976533322100         0   


Q ss_pred             --hhccccCC--------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          226 --VQVDLKFP--------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       226 --~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                        ..+...+.        ....++.++.++|.+||..||++|||+.++++||||+.
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence              00111110        11225688999999999999999999999999999984

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=324.94  Aligned_cols=246  Identities=24%  Similarity=0.326  Sum_probs=206.2

Q ss_pred             CCceecc-eecccCceEEEEEEEcc--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           16 NDFDIGK-PLGRGKFGHVYLAREKR--SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        16 ~~y~~~~-~ig~g~~~~v~~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +++.+.+ .||+|+||.||+|.++.  ++..||||++.....  ....+.+.+|++++++++||||+++++++.. +..+
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            4455555 89999999999998863  456799999965432  2234678899999999999999999999876 5689


Q ss_pred             EEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           93 LILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      +||||+++++|.+++... ..+++..++.++.||+.||+|||++||+|+||+|+||+++.++.+||+|||++....... 
T Consensus       412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            999999999999998754 459999999999999999999999999999999999999999999999999986543221 


Q ss_pred             -----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHH
Q 038249          171 -----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD  244 (281)
Q Consensus       171 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (281)
                           ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.. .+....++.++.+
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~~  570 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-MECPPECPPELYA  570 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-CCCCTTCCHHHHH
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCCCCcCCHHHHH
Confidence                 11234578999999988899999999999999999998 9999999888888777766532 2333469999999


Q ss_pred             HHHHhcccCCCCCCChhhhhc
Q 038249          245 LISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~  265 (281)
                      +|.+||+.||++||++.++++
T Consensus       571 li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          571 LMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.5e-45  Score=302.68  Aligned_cols=246  Identities=25%  Similarity=0.391  Sum_probs=200.0

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeeccc-ccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      |...+.||+|++|.||+|.+  +++.+|+|++.... .......+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            34459999999999999987  48899999986533 2234456778999999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC----
Q 038249           97 YAAKGELYKELQK---CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR----  169 (281)
Q Consensus        97 ~~~~~~L~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~----  169 (281)
                      |+++++|.+++..   ..++++..++.++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||++......    
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            9999999999874   356899999999999999999999999999999999999999999999999987543322    


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHH----hhccc---------cCCCC
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI----VQVDL---------KFPPK  235 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~---------~~~~~  235 (281)
                       .....+++.|+|||.+.+ .++.++|+||||+++++|++|..||......+....+    .....         .....
T Consensus       191 ~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD  269 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred             cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence             223467899999999865 4788999999999999999999999875544322111    11100         00111


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          236 PIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ...+.++.+++.+||+.||++|||+.+++++
T Consensus       270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2345679999999999999999999999863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-44  Score=301.20  Aligned_cols=247  Identities=26%  Similarity=0.445  Sum_probs=194.9

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCceeeeeeEEEeC
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH--LRHPNILRLYGYFYDQ   88 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~--~~h~~i~~~~~~~~~~   88 (281)
                      .....++|++.+.||+|+||.||+|++.  ++.||+|++....    .  .....+.+++..  ++||||+++++++...
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----E--ASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----H--HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----c--chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            3444578999999999999999999886  8899999985432    1  223334444444  4899999999999887


Q ss_pred             ----CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceecCCCCCCeEeCCCCcEE
Q 038249           89 ----KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK--------HVIHRDIKPENLLIGAQGELK  156 (281)
Q Consensus        89 ----~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------~i~H~di~~~Ni~~~~~~~~~  156 (281)
                          ...++||||+++++|.++++.. .+++..++.++.+++.||.+||+.        |++|+||+|+||+++.++.++
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence                7899999999999999999775 589999999999999999999998        999999999999999999999


Q ss_pred             EeeecCcccccCCc-------ccccCcCCccCCccccCCCCCCc------ccHHhHHHHHHHHHhC----------CCCC
Q 038249          157 IADFGWSVHTFNRR-------RTMCGTLDYLPPEMVESVEHDAN------VDIWSLGVLCYEFLYG----------VPPF  213 (281)
Q Consensus       157 l~dfg~~~~~~~~~-------~~~~~~~~~~aPE~~~~~~~~~~------~Di~slG~~l~~l~~g----------~~p~  213 (281)
                      |+|||++.......       ....+++.|+|||.+.+...+..      +||||||+++|+|++|          ..||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99999985432221       23468999999999987776655      9999999999999999          6777


Q ss_pred             CCCCch----HHHHHHhhccccCCCC------CCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          214 EAKEHS----DTYRRIVQVDLKFPPK------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       214 ~~~~~~----~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      ......    .............+..      ..++.++.++|.+||+.||++|||+.+++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            543221    2222222211111111      1355679999999999999999999999964

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.1e-43  Score=310.99  Aligned_cols=246  Identities=21%  Similarity=0.294  Sum_probs=203.8

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeeeeeEEEeCCEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH-PNILRLYGYFYDQKRVY   92 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~   92 (281)
                      ..++|++.+.||.|+||.||+|.+..+++.||||++......     ..+..|+.+++.++| +++..+..++...+..+
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            347899999999999999999999999999999987654322     236778999999977 56666667777888999


Q ss_pred             EEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEe---CCCCcEEEeeecCcccccC
Q 038249           93 LILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLI---GAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~---~~~~~~~l~dfg~~~~~~~  168 (281)
                      +||||+ +++|.++++. .+.+++..++.++.||+.||.|||++||+|+||+|+||++   +.++.++|+|||++.....
T Consensus        80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999999 8899999985 4569999999999999999999999999999999999999   5889999999999865433


Q ss_pred             Cc----------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH---HHHHHhhccccCC--
Q 038249          169 RR----------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD---TYRRIVQVDLKFP--  233 (281)
Q Consensus       169 ~~----------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~--  233 (281)
                      ..          ....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......   .+..+........  
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            22          24568999999999999999999999999999999999999998755432   2222222211111  


Q ss_pred             -CCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          234 -PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       234 -~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                       ....++.++.++|..||+.||++||++.+|++
T Consensus       239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             11358899999999999999999999988775

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=304.08  Aligned_cols=258  Identities=23%  Similarity=0.369  Sum_probs=192.8

Q ss_pred             hhcccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-
Q 038249            9 EKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-   87 (281)
Q Consensus         9 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-   87 (281)
                      ....+.+++|++.+.||+|+||.||+|++  +++.||+|++......    ......++..++.++|+||+++++.+.. 
T Consensus         6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A            6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheeccccc
Confidence            44567889999999999999999999977  4899999999644311    1122334444556899999999986542 


Q ss_pred             ----CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---------CceecCCCCCCeEeCCCCc
Q 038249           88 ----QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK---------HVIHRDIKPENLLIGAQGE  154 (281)
Q Consensus        88 ----~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---------~i~H~di~~~Ni~~~~~~~  154 (281)
                          ...+++||||+++++|.++++... .++..++.++.||+.||.|||+.         |++|+||+|+||+++.++.
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence                336789999999999999998755 58999999999999999999999         9999999999999999999


Q ss_pred             EEEeeecCcccccCC-----------cccccCcCCccCCccccC-------CCCCCcccHHhHHHHHHHHHhCCCCCCCC
Q 038249          155 LKIADFGWSVHTFNR-----------RRTMCGTLDYLPPEMVES-------VEHDANVDIWSLGVLCYEFLYGVPPFEAK  216 (281)
Q Consensus       155 ~~l~dfg~~~~~~~~-----------~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~  216 (281)
                      ++|+|||++......           .....+|+.|+|||.+.+       ..++.++||||||+++++|++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            999999998644321           123458999999999876       34566899999999999999997665322


Q ss_pred             Cc-h----------------HHHHHHhhccccCCC-C------CCCCHHHHHHHHHhcccCCCCCCChhhhhc------C
Q 038249          217 EH-S----------------DTYRRIVQVDLKFPP-K------PIVSSAAKDLISQMLVKDSSQRLPLHKLLE------H  266 (281)
Q Consensus       217 ~~-~----------------~~~~~~~~~~~~~~~-~------~~~~~~l~~li~~~l~~~p~~Rps~~eil~------~  266 (281)
                      .. .                +............+. .      ...+.++.++|.+||+.||++|||+.|+++      +
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            11 1                111111111111111 1      113447999999999999999999999954      6


Q ss_pred             CccccCC
Q 038249          267 PWIIQNA  273 (281)
Q Consensus       267 ~~~~~~~  273 (281)
                      +|-+++-
T Consensus       319 ~~~~~~~  325 (336)
T 3g2f_A          319 IWERNKS  325 (336)
T ss_dssp             CCCC---
T ss_pred             HHHhccc
Confidence            7777663

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.5e-44  Score=322.84  Aligned_cols=250  Identities=26%  Similarity=0.419  Sum_probs=211.5

Q ss_pred             ccccCCceecceecccCceEEEEEEEccC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRS---NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ....++|++.+.||+|+||.||+|.+..+   +..+|+|.+....  .....+.+.+|+.++++++||||+++++++. .
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            34457899999999999999999998754   4569999885432  3445577889999999999999999999985 4


Q ss_pred             CEEEEEEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           89 KRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      +..++||||+++++|.++++..+ .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            56899999999999999998654 68999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHH
Q 038249          168 NRR----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA  242 (281)
Q Consensus       168 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (281)
                      ...    ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+..... .+..+.++.++
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~l  621 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-LPMPPNCPPTL  621 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC-CCCCTTCCHHH
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCccccHHH
Confidence            332    12345678999999988889999999999999999996 9999998888887777665432 23344789999


Q ss_pred             HHHHHHhcccCCCCCCChhhhhc
Q 038249          243 KDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .++|.+||+.||++|||+.++++
T Consensus       622 ~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          622 YSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-45  Score=317.14  Aligned_cols=248  Identities=17%  Similarity=0.196  Sum_probs=196.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-Cc---------eeeeeeE-
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH-PN---------ILRLYGY-   84 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~---------i~~~~~~-   84 (281)
                      .+|+..+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.++| ++         ++...++ 
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            458899999999999999999999999999999874443343345678889999998876 21         1111111 


Q ss_pred             -----------EEe-----CCEEEEEEeccCCCChhHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q 038249           85 -----------FYD-----QKRVYLILEYAAKGELYKELQK-------CKYFSERRAATYVASLARALIYCHGKHVIHRD  141 (281)
Q Consensus        85 -----------~~~-----~~~~~~v~e~~~~~~L~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~d  141 (281)
                                 +..     ...++++++.. +++|.++++.       .+.+++..++.++.||+.||+|||++||+|+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence                       111     12457778876 4589888851       23477889999999999999999999999999


Q ss_pred             CCCCCeEeCCCCcEEEeeecCcccccCCcccccCcCCccCCccc----------cCCCCCCcccHHhHHHHHHHHHhCCC
Q 038249          142 IKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV----------ESVEHDANVDIWSLGVLCYEFLYGVP  211 (281)
Q Consensus       142 i~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Di~slG~~l~~l~~g~~  211 (281)
                      |||+||+++.++.+||+|||++...........+ +.|+|||.+          .+..++.++||||||+++|+|++|..
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~  315 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL  315 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred             cccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence            9999999999999999999998765555555667 999999998          55567889999999999999999999


Q ss_pred             CCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          212 PFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       212 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                      ||......+....+.      .....+|.++.++|.+||+.||++||++.++++||||++
T Consensus       316 Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          316 PNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             CCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             CCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            998766554433332      223368899999999999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=305.22  Aligned_cols=242  Identities=19%  Similarity=0.285  Sum_probs=195.4

Q ss_pred             ccccCCceecceecccCceEEEEE-----EEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCceeeeee
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLA-----REKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNILRLYG   83 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~-----~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~---h~~i~~~~~   83 (281)
                      ...-++|++.+.||+|+||+||+|     .+..+++.||+|++....      ...+..|+++++.+.   |+|++++++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            344578999999999999999999     467789999999996542      234566777777776   899999999


Q ss_pred             EEEeCCEEEEEEeccCCCChhHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-------
Q 038249           84 YFYDQKRVYLILEYAAKGELYKELQK-----CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-------  151 (281)
Q Consensus        84 ~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-------  151 (281)
                      ++...+..++||||+++++|.++++.     ...+++..++.++.||+.||+|||+.||+|+||||+||+++.       
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999999974     456999999999999999999999999999999999999998       


Q ss_pred             ----CCcEEEeeecCccccc-----CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHH
Q 038249          152 ----QGELKIADFGWSVHTF-----NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTY  222 (281)
Q Consensus       152 ----~~~~~l~dfg~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  222 (281)
                          ++.++|+|||++....     .......+|+.|+|||.+.+..++.++||||||+++++|++|..||.........
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence                8999999999985432     1223456899999999999988999999999999999999999998543331100


Q ss_pred             HHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          223 RRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                         .  .... .....++.+.+++..||+.+|.+|++..+.+.
T Consensus       295 ---~--~~~~-~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          295 ---P--EGLF-RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             ---E--CSCC-TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             ---e--chhc-cccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence               0  0011 11134678999999999999999976544443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.4e-44  Score=300.24  Aligned_cols=243  Identities=22%  Similarity=0.364  Sum_probs=196.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCceeeeeeEEEeCC---
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH--LRHPNILRLYGYFYDQK---   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~--~~h~~i~~~~~~~~~~~---   89 (281)
                      .++|++.+.||+|++|.||+|++.  ++.||+|.+....      ...+.+|+++++.  ++||||+++++++....   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            478999999999999999999984  8899999985432      2456678888877  78999999999998765   


Q ss_pred             -EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hcCceecCCCCCCeEeCCCCcEEEeee
Q 038249           90 -RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH--------GKHVIHRDIKPENLLIGAQGELKIADF  160 (281)
Q Consensus        90 -~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~i~H~di~~~Ni~~~~~~~~~l~df  160 (281)
                       ..++|+||+++++|.++++.. .+++..++.++.||+.||.+||        +.|++|+||+|+||+++.++.++|+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence             889999999999999999874 5899999999999999999999        899999999999999999999999999


Q ss_pred             cCcccccCC-------cccccCcCCccCCccccCCC------CCCcccHHhHHHHHHHHHhC----------CCCCCCCC
Q 038249          161 GWSVHTFNR-------RRTMCGTLDYLPPEMVESVE------HDANVDIWSLGVLCYEFLYG----------VPPFEAKE  217 (281)
Q Consensus       161 g~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g----------~~p~~~~~  217 (281)
                      |++......       .....+++.|+|||.+.+..      ++.++||||||+++++|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            998544332       23346899999999987653      23679999999999999999          78886543


Q ss_pred             c-----hHHHHHHhhccccCCCC-----CCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          218 H-----SDTYRRIVQVDLKFPPK-----PIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       218 ~-----~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .     ......+..........     ...+..+.++|.+||+.||++|||+.+++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            2     22222232222211111     1234579999999999999999999999964

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-43  Score=290.82  Aligned_cols=226  Identities=15%  Similarity=0.105  Sum_probs=191.0

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+..+++++||||+++++++...+..+
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44578999999999999999999999999999999998766555666678899999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCccc
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT  172 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~  172 (281)
                      +||||++|++|.++++.+  ....++..++.||+.||+|||++||+|+||||+||+++.+|.++|++++.          
T Consensus       108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~----------  175 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----------  175 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC----------
T ss_pred             EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc----------
Confidence            999999999999999654  36667899999999999999999999999999999999999999984432          


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHH---hhccccC--CCCCCCCHHHHHHHH
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI---VQVDLKF--PPKPIVSSAAKDLIS  247 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~--~~~~~~~~~l~~li~  247 (281)
                             ++       .++.++||||||+++|+|++|..||...+..+.....   .......  ...+.++.++.++|.
T Consensus       176 -------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  241 (286)
T 3uqc_A          176 -------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA  241 (286)
T ss_dssp             -------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHH
T ss_pred             -------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHH
Confidence                   22       3678999999999999999999999876654422111   1111100  112468999999999


Q ss_pred             HhcccCCCCCCChhhhhc
Q 038249          248 QMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~  265 (281)
                      +||+.||++| |+.|+++
T Consensus       242 ~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          242 RSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHCTTSSCC-CHHHHHH
T ss_pred             HHcccCCccC-CHHHHHH
Confidence            9999999999 9999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.1e-45  Score=307.14  Aligned_cols=248  Identities=16%  Similarity=0.200  Sum_probs=191.8

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCC---------CCc
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ-----QSQVEHQLRREVEIQSHLR---------HPN   77 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~---------h~~   77 (281)
                      .+..++|++.+.||+|+||+||+|++  +|+.||+|++......     .....+.+.+|+.+++.++         |+|
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n   93 (336)
T 2vuw_A           16 CLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG   93 (336)
T ss_dssp             HSCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred             hcccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence            45568999999999999999999998  5899999999765421     1122355778888888775         666


Q ss_pred             eeeeeeEE-----------------Ee-------------CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHH
Q 038249           78 ILRLYGYF-----------------YD-------------QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLAR  127 (281)
Q Consensus        78 i~~~~~~~-----------------~~-------------~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~  127 (281)
                      ++++.+++                 ..             .+..++||||++++++.+.+.. +.+++..++.++.||+.
T Consensus        94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred             hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence            66666654                 22             6789999999999977766654 55899999999999999


Q ss_pred             HHHHHH-hcCceecCCCCCCeEeCCCC--------------------cEEEeeecCcccccCCcccccCcCCccCCcccc
Q 038249          128 ALIYCH-GKHVIHRDIKPENLLIGAQG--------------------ELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVE  186 (281)
Q Consensus       128 ~l~~Lh-~~~i~H~di~~~Ni~~~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~  186 (281)
                      ||+||| ++||+|+||||+||+++.++                    .+||+|||++......  ...+|+.|+|||++.
T Consensus       173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGC
T ss_pred             HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhc
Confidence            999999 99999999999999999887                    8999999998755432  347899999999998


Q ss_pred             CCCCCCcccHHhHHHH-HHHHHhCCCCCCCCCc-hHHHHHHhhc-cccCCC----CCCCCHHHHHHHHHhcccCCCCCCC
Q 038249          187 SVEHDANVDIWSLGVL-CYEFLYGVPPFEAKEH-SDTYRRIVQV-DLKFPP----KPIVSSAAKDLISQMLVKDSSQRLP  259 (281)
Q Consensus       187 ~~~~~~~~Di~slG~~-l~~l~~g~~p~~~~~~-~~~~~~~~~~-~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps  259 (281)
                      +.. +.++|||||+++ .+++++|..||..... ......+... ......    .+.++.++.+||.+||+.|     |
T Consensus       251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s  324 (336)
T 2vuw_A          251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S  324 (336)
T ss_dssp             CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred             CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence            766 889999998877 5567789888843211 1122222211 111111    1236788999999999976     9


Q ss_pred             hhhhh-cCCccc
Q 038249          260 LHKLL-EHPWII  270 (281)
Q Consensus       260 ~~eil-~~~~~~  270 (281)
                      ++|+| +||||+
T Consensus       325 a~e~l~~Hp~f~  336 (336)
T 2vuw_A          325 ATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHCGGGC
T ss_pred             HHHHHhcCCCcC
Confidence            99999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-43  Score=321.76  Aligned_cols=242  Identities=20%  Similarity=0.347  Sum_probs=198.8

Q ss_pred             ccCCceecceecccCceEEEEEEEcc-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE--
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKR-SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR--   90 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~--   90 (281)
                      ..++|++.+.||+|+||.||++.+.. +++.||||.+....  .......+.+|++++++++||||+++++++...+.  
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            34899999999999999999999986 78999999986432  33445678899999999999999999999987654  


Q ss_pred             ---EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           91 ---VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        91 ---~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                         .++||||++|++|.+.+..  .+++..++.++.||+.||.|||++||+|+||||+||+++.+ .++|+|||++....
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence               7999999999999988765  68999999999999999999999999999999999999875 89999999986554


Q ss_pred             CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          168 NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      .. ....+|+.|+|||.+.+.. +.++||||||+++++|++|..|+........        .........+..+.++|.
T Consensus       233 ~~-~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~  302 (681)
T 2pzi_A          233 SF-GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKTYDSYGRLLR  302 (681)
T ss_dssp             CC-SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------CTTCHHHHHCHHHHHHHH
T ss_pred             cC-CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------cccccccccCHHHHHHHh
Confidence            33 4556899999999986654 7899999999999999999888764221110        000000124578999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccc
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~  270 (281)
                      +||++||++||+..+.+.++|+.
T Consensus       303 ~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          303 RAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             hhccCChhhCCCHHHHHHHHHHH
Confidence            99999999999988888888764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2e-34  Score=257.19  Aligned_cols=186  Identities=15%  Similarity=0.086  Sum_probs=134.5

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccc-------cchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeCCEE
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-------QQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~-------~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~   91 (281)
                      -....+.|+.+....++....|+.+++|++.....       ..+...+.+.+|+++|+++ .|+||+++++++++++..
T Consensus       238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~  317 (569)
T 4azs_A          238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG  317 (569)
T ss_dssp             EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred             hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence            34456677777777777777899999999965432       1234456789999999999 699999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      |+||||++|++|.++++..++++..   .|+.||+.||+|+|++||+||||||+|||++.+|++||+|||++......  
T Consensus       318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            9999999999999999998888775   47889999999999999999999999999999999999999998654332  


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhC
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYG  209 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g  209 (281)
                       ....+||+.|+|||++.+. +...+|+|++|++++.+.++
T Consensus       395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred             cccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence             3345689999999998764 56679999999988766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=3.8e-28  Score=215.59  Aligned_cols=182  Identities=15%  Similarity=0.150  Sum_probs=142.6

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccccc-----hHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ-----SQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      ..+.||+|+||+||++..  .+..+++|.........     ....+.+.+|++++++++||||+++..+....+..++|
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            456899999999999944  47889999875433322     22245578999999999999999766666677778999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc----
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR----  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~----  170 (281)
                      |||+++++|.++++.        +..++.||+.||.|||++||+|+||||+||+++.  .+||+|||++.......    
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            999999999999887        5689999999999999999999999999999988  99999999987654421    


Q ss_pred             ------ccccCcCCccCCccccC--CCCCCcccHHhHHHHHHHHHhCCCCC
Q 038249          171 ------RTMCGTLDYLPPEMVES--VEHDANVDIWSLGVLCYEFLYGVPPF  213 (281)
Q Consensus       171 ------~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~  213 (281)
                            ....+|+.|+|||++..  ..|+...|+|+..+-..+-..+..+|
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                  24568999999999876  55677789999888888777665544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1e-25  Score=184.36  Aligned_cols=144  Identities=19%  Similarity=0.211  Sum_probs=114.7

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccccch---------------HHHHHHHHHHHHHHhCCCCceeeeeeE
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS---------------QVEHQLRREVEIQSHLRHPNILRLYGY   84 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~---------------~~~~~~~~e~~~l~~~~h~~i~~~~~~   84 (281)
                      +++.||.|++|.||+|.+ .+|+.+|+|.+........               .....+.+|+.++++++  | +++.++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~  169 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV  169 (282)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred             ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence            449999999999999999 7899999999864332110               23466889999999999  5 666666


Q ss_pred             EEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           85 FYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      +.. +..++||||++|++|.+ +..      .....++.||+.||.+||+.|++|+||+|+||+++ ++.++|+|||++.
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred             Eec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence            544 45699999999999988 422      23557999999999999999999999999999999 9999999999885


Q ss_pred             cccCCcccccCcCCccCCcccc
Q 038249          165 HTFNRRRTMCGTLDYLPPEMVE  186 (281)
Q Consensus       165 ~~~~~~~~~~~~~~~~aPE~~~  186 (281)
                      .          +..+.|||.+.
T Consensus       241 ~----------~~~~~a~e~l~  252 (282)
T 1zar_A          241 E----------VGEEGWREILE  252 (282)
T ss_dssp             E----------TTSTTHHHHHH
T ss_pred             E----------CCCCCHHHHHH
Confidence            3          33456777763

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1.4e-21  Score=157.86  Aligned_cols=141  Identities=15%  Similarity=0.194  Sum_probs=106.7

Q ss_pred             ceecceecccCceEEEEEEEccCCcE--EEEEEeeccccc---------------------chHHHHHHHHHHHHHHhCC
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHI--VALKVLFKSQLQ---------------------QSQVEHQLRREVEIQSHLR   74 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~--~~lK~~~~~~~~---------------------~~~~~~~~~~e~~~l~~~~   74 (281)
                      |++.+.||.|++|.||+|.+..+|+.  ||||++......                     .......+.+|+..++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67899999999999999999778999  999997543211                     0112235778999999998


Q ss_pred             CCceeeeeeEEEeCCEEEEEEeccCC-C----ChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCCeE
Q 038249           75 HPNILRLYGYFYDQKRVYLILEYAAK-G----ELYKELQKCKYFSERRAATYVASLARALIYCH-GKHVIHRDIKPENLL  148 (281)
Q Consensus        75 h~~i~~~~~~~~~~~~~~~v~e~~~~-~----~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~i~H~di~~~Ni~  148 (281)
                      |+++....-+..  +..++||||+.+ +    +|.+....   .++..+..++.||+.++.+|| +.|++|+||+|+||+
T Consensus       129 ~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NIL  203 (258)
T 1zth_A          129 EAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIM  203 (258)
T ss_dssp             HTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEE
T ss_pred             hCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEE
Confidence            775422222222  345799999942 3    56555433   235567899999999999999 999999999999999


Q ss_pred             eCCCCcEEEeeecCccc
Q 038249          149 IGAQGELKIADFGWSVH  165 (281)
Q Consensus       149 ~~~~~~~~l~dfg~~~~  165 (281)
                      ++.  .++|+|||++..
T Consensus       204 l~~--~~~liDFG~a~~  218 (258)
T 1zth_A          204 YID--KVYFIDMGQAVT  218 (258)
T ss_dssp             ESS--SEEECCCTTCEE
T ss_pred             EcC--cEEEEECccccc
Confidence            988  999999999854

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=1.8e-18  Score=145.54  Aligned_cols=139  Identities=15%  Similarity=0.168  Sum_probs=98.7

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeeccccc---------------chH----HHHHHHHHHHHHHhCCCCce
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ---------------QSQ----VEHQLRREVEIQSHLRHPNI   78 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~---------------~~~----~~~~~~~e~~~l~~~~h~~i   78 (281)
                      |.+++.||.|++|.||+|.+. +|+.||||++......               ...    .......|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            889999999999999999986 6899999987533210               000    01112345666666644433


Q ss_pred             eeeeeEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-----
Q 038249           79 LRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-----  153 (281)
Q Consensus        79 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-----  153 (281)
                      ....-+...  ..++||||++|.+|..+..      ...+..++.||+.+|.+||+.|++|+||||.|||++.+|     
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            222112122  2269999999988765432      223567889999999999999999999999999998876     


Q ss_pred             -----cEEEeeecCccc
Q 038249          154 -----ELKIADFGWSVH  165 (281)
Q Consensus       154 -----~~~l~dfg~~~~  165 (281)
                           .+.++||+-+..
T Consensus       248 ~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TSEEEEEEECCCTTCEE
T ss_pred             cccccceEEEEeCCccc
Confidence                 389999997643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=3.6e-13  Score=108.74  Aligned_cols=140  Identities=15%  Similarity=0.133  Sum_probs=109.5

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~   92 (281)
                      .+..|++...++.|+.+.||++...  +..+++|.........   ...+.+|+..++.+. +..+.+++++....+..+
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            3467999999999999999999754  6789999986432111   124677888888874 567888999988888999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG--------------------------------------  134 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~--------------------------------------  134 (281)
                      +|||+++|.+|.+.+.     +......++.++..++..||+                                      
T Consensus        87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999988876532     122344678899999999998                                      


Q ss_pred             ---------------------cCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          135 ---------------------KHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       135 ---------------------~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                                           ..++|+|++|.||+++.++.+.|+||+.+
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                                 45899999999999977656679999865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.27  E-value=4.2e-11  Score=96.26  Aligned_cols=134  Identities=17%  Similarity=0.157  Sum_probs=96.0

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeeeeeEEEeCCEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN--ILRLYGYFYDQKRVY   92 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~--i~~~~~~~~~~~~~~   92 (281)
                      +..|.+....+.|..+.||++.. .+|..+++|......      ...+..|+..++.+.+.+  +.+++++....+..+
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            45677665555777799999965 356779999975431      123566777777774433  556888888778899


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH------------------------------------  136 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------------------------------------  136 (281)
                      +||||++|.++.  ...   .+.   ..++.++...+..||+..                                    
T Consensus        92 ~v~e~i~G~~l~--~~~---~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH---LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             EEEECCSSEETT--TSC---CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEEEecCCcccC--cCc---CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999999998874  211   222   245666777777777643                                    


Q ss_pred             ----------------------ceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          137 ----------------------VIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       137 ----------------------i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                                            ++|+|++|.||+++.++.+.++||+.+
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence                                  999999999999987666679999975

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=3.6e-11  Score=101.48  Aligned_cols=141  Identities=17%  Similarity=0.277  Sum_probs=104.2

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEee--cccccchHHHHHHHHHHHHHHhCCC--CceeeeeeEEEeC---CE
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLF--KSQLQQSQVEHQLRREVEIQSHLRH--PNILRLYGYFYDQ---KR   90 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~--~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~---~~   90 (281)
                      ....+.|+.|.++.||++...  +..+++|+..  .....  .....+.+|+.+++.+..  ..+.+++.++.+.   +.
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            345678999999999998765  4678899875  32211  123457788988888864  4577788877665   45


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG------------------------------------  134 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~------------------------------------  134 (281)
                      .++||||++|.++.+.  ....++......++.++..+|..||+                                    
T Consensus       116 ~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             eEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            7899999999877541  11236788888999999999999997                                    


Q ss_pred             ----------------------cCceecCCCCCCeEeCCCCc--EEEeeecCcc
Q 038249          135 ----------------------KHVIHRDIKPENLLIGAQGE--LKIADFGWSV  164 (281)
Q Consensus       135 ----------------------~~i~H~di~~~Ni~~~~~~~--~~l~dfg~~~  164 (281)
                                            ..++|+|+++.||+++.++.  +.++||+.+.
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence                                  36899999999999997753  6899999874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.02  E-value=5.2e-10  Score=92.13  Aligned_cols=180  Identities=18%  Similarity=0.161  Sum_probs=116.8

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCc--eeeeeeEEEeCC---EEEEE
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPN--ILRLYGYFYDQK---RVYLI   94 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~--i~~~~~~~~~~~---~~~~v   94 (281)
                      .+.++.|..+.||++.     ..+++|.....     .....+.+|...++.+ .+..  +.+++......+   ..++|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4568999999999873     45889986322     3345688899988877 3333  333433332222   34789


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG----------------------------------------  134 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~----------------------------------------  134 (281)
                      |++++|.++.....  ..++.++...++.++...+..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988875433  236777777888888888888885                                        


Q ss_pred             ------------------cCceecCCCCCCeEeCC--CCcEEEeeecCcccccCCcccccCcCCc---cCCccc----cC
Q 038249          135 ------------------KHVIHRDIKPENLLIGA--QGELKIADFGWSVHTFNRRRTMCGTLDY---LPPEMV----ES  187 (281)
Q Consensus       135 ------------------~~i~H~di~~~Ni~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~---~aPE~~----~~  187 (281)
                                        ..++|+|++|.||+++.  ++.+.++||+.+........... ....   ..|+..    ..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~-~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS-LMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT-TCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH-HHhhccccCHHHHHHHHHH
Confidence                              13699999999999988  45678999998643322110000 0000   122211    11


Q ss_pred             C-CCC---------CcccHHhHHHHHHHHHhCCCCC
Q 038249          188 V-EHD---------ANVDIWSLGVLCYEFLYGVPPF  213 (281)
Q Consensus       188 ~-~~~---------~~~Di~slG~~l~~l~~g~~p~  213 (281)
                      . ..+         ...+.|+++.+++.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1 111         1268899999999999997765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.81  E-value=8.3e-08  Score=77.42  Aligned_cols=130  Identities=18%  Similarity=0.162  Sum_probs=91.8

Q ss_pred             ecccCc-eEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEEEEEeccCCC
Q 038249           24 LGRGKF-GHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVYLILEYAAKG  101 (281)
Q Consensus        24 ig~g~~-~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~e~~~~~  101 (281)
                      +..|.. +.||+......+..+++|.-...      ....+..|...++.+. +-.+.+++.++.+.+..++||++++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            344444 47899888777778999986332      2345777888887773 333667788888889999999999998


Q ss_pred             ChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 038249          102 ELYKELQKCKYFSERRAATYVASLARALIYCHGK----------------------------------------------  135 (281)
Q Consensus       102 ~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~----------------------------------------------  135 (281)
                      ++.+.....    ......+..++...+..||+.                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            877665431    112234445555555555531                                              


Q ss_pred             ------------CceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          136 ------------HVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       136 ------------~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                                  .++|+|+++.||+++.++.+-|+||+.+
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a  221 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV  221 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence                        2689999999999988777779999876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.70  E-value=2.9e-07  Score=75.75  Aligned_cols=132  Identities=18%  Similarity=0.154  Sum_probs=88.8

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---ceeeeeeEEE-eCCEEEEEEe
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP---NILRLYGYFY-DQKRVYLILE   96 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~---~i~~~~~~~~-~~~~~~~v~e   96 (281)
                      .+.++.|....||.+     +..+++|....     ......+..|...++.+.+.   .+.+++.+.. ..+..++||+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456788999999988     56688998521     23345688899999988642   3555666653 3456789999


Q ss_pred             ccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 038249           97 YAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG------------------------------------------  134 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~------------------------------------------  134 (281)
                      +++|.++....-  ..++......++.++...+..||+                                          
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988866321  113344444444444444444443                                          


Q ss_pred             ------------------cCceecCCCCCCeEeCC---CCc-EEEeeecCcc
Q 038249          135 ------------------KHVIHRDIKPENLLIGA---QGE-LKIADFGWSV  164 (281)
Q Consensus       135 ------------------~~i~H~di~~~Ni~~~~---~~~-~~l~dfg~~~  164 (281)
                                        ..++|+|+++.||+++.   ++. +.|+||+.+.
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                              14599999999999987   455 4899999764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.30  E-value=8.8e-06  Score=62.28  Aligned_cols=134  Identities=16%  Similarity=0.088  Sum_probs=89.3

Q ss_pred             ChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccccCcCCc
Q 038249          102 ELYKELQKC-KYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDY  179 (281)
Q Consensus       102 ~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (281)
                      +|.+.++.. .|++++++|.++.|.+.+|..+-. ..-...=+.|..|++..+|++.+.+ ..+         ......+
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s---------~~~~~~~  103 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AAD---------DAGEPPP  103 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-ccc---------cccccCC
Confidence            688888754 679999999999999999877632 2212333567899999999998763 111         0123356


Q ss_pred             cCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc-------
Q 038249          180 LPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK-------  252 (281)
Q Consensus       180 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-------  252 (281)
                      .+||... ...+.+.-|||||+++|.-+--..|                   ......++++|.+||..|...       
T Consensus       104 ~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~~d~~~~  163 (229)
T 2yle_A          104 VAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTVEADGSN  163 (229)
T ss_dssp             ---CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCCC-----
T ss_pred             CChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhcccccccc
Confidence            6787753 3445678899999999988743222                   111235899999999999865       


Q ss_pred             ------------------CCCCCCChhhhhc
Q 038249          253 ------------------DSSQRLPLHKLLE  265 (281)
Q Consensus       253 ------------------~p~~Rps~~eil~  265 (281)
                                        .+..|+++++|++
T Consensus       164 DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          164 DEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ---------------CCSCCCCCCSHHHHHH
T ss_pred             cccccccccccccccccccccCcCCHHHHHH
Confidence                              2468888888885

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.30  E-value=1.6e-05  Score=66.00  Aligned_cols=29  Identities=21%  Similarity=0.374  Sum_probs=26.6

Q ss_pred             cCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          135 KHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       135 ~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                      ..++|+|+++.||+++.++.+.++||+.+
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            57999999999999988889999999975

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.28  E-value=2e-06  Score=73.35  Aligned_cols=80  Identities=13%  Similarity=0.145  Sum_probs=46.7

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccc-cch---HHHHHHHHHHHHHHhCCC--C-ceeeeeeEEEeCCEEE
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL-QQS---QVEHQLRREVEIQSHLRH--P-NILRLYGYFYDQKRVY   92 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~-~~~---~~~~~~~~e~~~l~~~~h--~-~i~~~~~~~~~~~~~~   92 (281)
                      ..+.||.|..+.||++....++..+++|....... ...   .....+..|.+.++.+..  + .+.+++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            45789999999999997665678899998643211 000   011234557777766532  2 34445543  344457


Q ss_pred             EEEeccCCC
Q 038249           93 LILEYAAKG  101 (281)
Q Consensus        93 ~v~e~~~~~  101 (281)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999774

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.18  E-value=7.7e-06  Score=68.58  Aligned_cols=82  Identities=7%  Similarity=0.088  Sum_probs=51.0

Q ss_pred             eccee-cccCceEEEEEEEc--c----CCcEEEEEEeeccc---ccchHHHHHHHHHHHHHHhCCC---CceeeeeeEEE
Q 038249           20 IGKPL-GRGKFGHVYLAREK--R----SNHIVALKVLFKSQ---LQQSQVEHQLRREVEIQSHLRH---PNILRLYGYFY   86 (281)
Q Consensus        20 ~~~~i-g~g~~~~v~~~~~~--~----~~~~~~lK~~~~~~---~~~~~~~~~~~~e~~~l~~~~h---~~i~~~~~~~~   86 (281)
                      ..+.| +.|..+.+|++...  .    ++..+++|......   ...   ...+..|+..++.+..   -.+.+++.+..
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~  100 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIET  100 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence            45677 88999999988654  1    15678999875432   101   1234556666655532   24556666655


Q ss_pred             eC---CEEEEEEeccCCCChh
Q 038249           87 DQ---KRVYLILEYAAKGELY  104 (281)
Q Consensus        87 ~~---~~~~~v~e~~~~~~L~  104 (281)
                      +.   +..++|||+++|.++.
T Consensus       101 ~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          101 TGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSTTTSSCEEEEECCCCBCCC
T ss_pred             CCCccCCceEEEEecCCCChh
Confidence            44   3568999999987654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.87  E-value=3.5e-05  Score=62.99  Aligned_cols=74  Identities=11%  Similarity=0.042  Sum_probs=41.7

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eeeeeEEEeCCEEEEEEe
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI-LRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-~~~~~~~~~~~~~~~v~e   96 (281)
                      +.-.+.|+.|....+|++      ..+++|+........    ....+|+..++.+...++ .+++..  +.+.-+++++
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e   87 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR   87 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence            333788999999999999      348899875421110    012235554544422222 344443  3333468899


Q ss_pred             cc-CCCCh
Q 038249           97 YA-AKGEL  103 (281)
Q Consensus        97 ~~-~~~~L  103 (281)
                      |+ +|.++
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 76555

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.86  E-value=7.2e-05  Score=64.18  Aligned_cols=31  Identities=16%  Similarity=0.370  Sum_probs=27.0

Q ss_pred             hcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249          134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus       134 ~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                      ...++|||++|.|||++.++ +.++||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            46799999999999998877 99999987743

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.85  E-value=0.00042  Score=56.82  Aligned_cols=76  Identities=22%  Similarity=0.280  Sum_probs=57.3

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCceeeeeeEEEeCCEEEEEEe
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR---HPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      -.+.|+.|....+|++..  ++..+++|......      ...+..|...++.+.   ...+.+++......+..++|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            457789999999999875  36788999875321      344667777776663   3567788888777788999999


Q ss_pred             ccCCCCh
Q 038249           97 YAAKGEL  103 (281)
Q Consensus        97 ~~~~~~L  103 (281)
                      |++|.++
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.50  E-value=0.0009  Score=54.97  Aligned_cols=138  Identities=17%  Similarity=0.140  Sum_probs=73.5

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----CCceeeee-e--EEEeCCEE
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-----HPNILRLY-G--YFYDQKRV   91 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----h~~i~~~~-~--~~~~~~~~   91 (281)
                      -.+.|+.|....+|.+...  +..+++|...... ..    ..+..|...++.+.     -|.++... +  +....+..
T Consensus        26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~-~~----~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-EK----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             EEEEECC---EEEEEEEES--SCCEEEEEECC----C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             EeeccCCCcccceEEEEeC--CccEEEEEeCCCC-CH----HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            3566778888999998765  3368899985421 11    12334454444442     23333211 1  12234677


Q ss_pred             EEEEeccCCCChhH----H----------HH-hC---C-C----CC---HHHHHH------------HHHHHHHHHHHHH
Q 038249           92 YLILEYAAKGELYK----E----------LQ-KC---K-Y----FS---ERRAAT------------YVASLARALIYCH  133 (281)
Q Consensus        92 ~~v~e~~~~~~L~~----~----------~~-~~---~-~----l~---~~~~~~------------i~~~i~~~l~~Lh  133 (281)
                      +++++|++|.++..    .          +. ..   . +    ..   +.....            +...+...++.+.
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            89999999865421    0          01 00   0 0    01   011000            0011333445554


Q ss_pred             h-------cCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249          134 G-------KHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus       134 ~-------~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      +       .+++|+|+++.||+++.++.+.++||+.+.
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            2       468999999999999877666899998763

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.44  E-value=0.00027  Score=59.60  Aligned_cols=140  Identities=18%  Similarity=0.188  Sum_probs=79.9

Q ss_pred             CCceecceecccCceEEEEEEEcc-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeeeeeEEEe
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKR-------SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN-ILRLYGYFYD   87 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~   87 (281)
                      +..+ .+.|..|....+|++....       ++..+++|+..... ..   ...+.+|.++++.+...+ ..++++.+. 
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~-  124 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QG---VDSLVLESVMFAILAERSLGPQLYGVFP-  124 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEET-
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-ch---HHHHHHHHHHHHHHHhcCCCCeEEEEcC-
Confidence            3444 4678888889999998752       35789999863211 11   234557777776663222 244555443 


Q ss_pred             CCEEEEEEeccCCCChhHH----------H----H---hC-----CCCC--HHHHHHHHHHHHH----------------
Q 038249           88 QKRVYLILEYAAKGELYKE----------L----Q---KC-----KYFS--ERRAATYVASLAR----------------  127 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~----------~----~---~~-----~~l~--~~~~~~i~~~i~~----------------  127 (281)
                       +  ..|+||++|.++...          +    +   ..     ++..  ..++..+..++-.                
T Consensus       125 -~--g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  201 (379)
T 3feg_A          125 -E--GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS  201 (379)
T ss_dssp             -T--EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred             -C--ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence             3  289999998665310          1    1   11     1122  3455555544422                


Q ss_pred             ---HHHHHH----h----cCceecCCCCCCeEeCCC----CcEEEeeecCcc
Q 038249          128 ---ALIYCH----G----KHVIHRDIKPENLLIGAQ----GELKIADFGWSV  164 (281)
Q Consensus       128 ---~l~~Lh----~----~~i~H~di~~~Ni~~~~~----~~~~l~dfg~~~  164 (281)
                         .+..|.    .    ..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               223332    2    258999999999999876    689999999763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.36  E-value=0.00043  Score=59.46  Aligned_cols=75  Identities=25%  Similarity=0.327  Sum_probs=46.7

Q ss_pred             ecceecccCceEEEEEEEcc-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eeeeeEEEeCCEE
Q 038249           20 IGKPLGRGKFGHVYLAREKR-------SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI-LRLYGYFYDQKRV   91 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-~~~~~~~~~~~~~   91 (281)
                      -.+.|+.|....+|++....       ++..+++|+.....  .   ...+.+|...++.+...++ .++++.+.  +  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence            35678889999999998753       25779999984321  1   0223457776666632233 44555443  2  


Q ss_pred             EEEEeccCCCCh
Q 038249           92 YLILEYAAKGEL  103 (281)
Q Consensus        92 ~~v~e~~~~~~L  103 (281)
                      ..|++|++|.++
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            278999987544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.35  E-value=0.0016  Score=53.55  Aligned_cols=76  Identities=12%  Similarity=0.187  Sum_probs=44.0

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--ceeeeeeE-----EEeCCEEEEE
Q 038249           22 KPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP--NILRLYGY-----FYDQKRVYLI   94 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~--~i~~~~~~-----~~~~~~~~~v   94 (281)
                      ..++ |....||.+... +|+.+++|........ .   ..+..|...++.+...  .+.+++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~-~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWT-A---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSC-H---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCC-H---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 788899988654 4567999998543221 1   2344455555544211  13333332     2235667889


Q ss_pred             EeccCCCCh
Q 038249           95 LEYAAKGEL  103 (281)
Q Consensus        95 ~e~~~~~~L  103 (281)
                      +++++|.++
T Consensus       106 ~~~i~G~~~  114 (328)
T 1zyl_A          106 FPSVGGRQF  114 (328)
T ss_dssp             EECCCCEEC
T ss_pred             EEecCCCCC
Confidence            999988543

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.29  E-value=0.0029  Score=51.08  Aligned_cols=80  Identities=15%  Similarity=0.150  Sum_probs=52.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---ceeeeeeEEEeCCEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP---NILRLYGYFYDQKRVY   92 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~---~i~~~~~~~~~~~~~~   92 (281)
                      .+..-++.+|.|..+.||++... +|+.+++|+........   ...+..|+..|+.+...   .+.+++..  +.  -+
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~   86 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RT   86 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TE
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ce
Confidence            34566788999999999999875 68899999864433221   12356788777776321   23333333  22  36


Q ss_pred             EEEeccCCCCh
Q 038249           93 LILEYAAKGEL  103 (281)
Q Consensus        93 ~v~e~~~~~~L  103 (281)
                      +|+||.++...
T Consensus        87 lv~e~l~~~~~   97 (288)
T 3f7w_A           87 LAMEWVDERPP   97 (288)
T ss_dssp             EEEECCCCCCC
T ss_pred             EEEEeecccCC
Confidence            88999887654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.21  E-value=0.00069  Score=56.01  Aligned_cols=31  Identities=26%  Similarity=0.359  Sum_probs=26.6

Q ss_pred             cCceecCCCCCCeEeCCC----CcEEEeeecCccc
Q 038249          135 KHVIHRDIKPENLLIGAQ----GELKIADFGWSVH  165 (281)
Q Consensus       135 ~~i~H~di~~~Ni~~~~~----~~~~l~dfg~~~~  165 (281)
                      ..++|||+.+.|||++.+    +.+.++||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            479999999999999875    6899999997643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.14  E-value=0.0076  Score=49.94  Aligned_cols=30  Identities=27%  Similarity=0.460  Sum_probs=26.6

Q ss_pred             cCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249          135 KHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus       135 ~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      ..++|+|+.+.||+++.++.+.++||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            468999999999999988889999998753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.03  E-value=0.004  Score=53.86  Aligned_cols=76  Identities=16%  Similarity=0.184  Sum_probs=46.1

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eeeeeEEEeCCEEEEEEecc
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI-LRLYGYFYDQKRVYLILEYA   98 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-~~~~~~~~~~~~~~~v~e~~   98 (281)
                      -.+.|+.|....+|++.....+..+++|+..... ..  .. ...+|..+++.+...++ .++++.+  .+.  .|++|+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~--~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE--II-NREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS--CS-CHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh--hc-CHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEee
Confidence            3567889999999999886445788999874321 10  00 01357777777754444 4555555  233  499999


Q ss_pred             CCCCh
Q 038249           99 AKGEL  103 (281)
Q Consensus        99 ~~~~L  103 (281)
                      +|.++
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87554

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.02  E-value=0.0018  Score=54.30  Aligned_cols=76  Identities=16%  Similarity=0.082  Sum_probs=40.8

Q ss_pred             ecceecccCceEEEEEEEcc--------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeeeeeEEEeCCE
Q 038249           20 IGKPLGRGKFGHVYLAREKR--------SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN-ILRLYGYFYDQKR   90 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~--------~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~~   90 (281)
                      -.+.|+.|....+|++....        .+..+++|+......   .. .....|...++.+...+ ..++++..  .+ 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---EL-YNTISEFEVYKTMSKYKIAPQLLNTF--NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GT-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ce-ecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence            35677888889999998763        126788998743211   00 01234555555553222 33444433  23 


Q ss_pred             EEEEEeccCCCCh
Q 038249           91 VYLILEYAAKGEL  103 (281)
Q Consensus        91 ~~~v~e~~~~~~L  103 (281)
                       ++|++|++|.++
T Consensus       110 -~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 -GRIEEWLYGDPL  121 (369)
T ss_dssp             -EEEEECCCSEEC
T ss_pred             -cEEEEEecCCcC
Confidence             579999988644

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.92  E-value=0.01  Score=50.66  Aligned_cols=76  Identities=13%  Similarity=0.100  Sum_probs=44.6

Q ss_pred             ecceecccCceEEEEEEEccC-------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeeeeeEEEeCCEE
Q 038249           20 IGKPLGRGKFGHVYLAREKRS-------NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN-ILRLYGYFYDQKRV   91 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~-------~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~~~   91 (281)
                      -++.+..|....+|++.....       +..+++|+..... ..   .-...+|..+++.+...+ ..++++.+  .+  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~---~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK---FYDSKVELDVFRYLSNINIAPNIIADF--PE--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C---CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch---hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence            356778888999999987631       5779999974321 10   011234555555553222 23444432  33  


Q ss_pred             EEEEeccCCCCh
Q 038249           92 YLILEYAAKGEL  103 (281)
Q Consensus        92 ~~v~e~~~~~~L  103 (281)
                      +.|++|++|.+|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            578999998764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=95.81  E-value=0.027  Score=43.01  Aligned_cols=116  Identities=9%  Similarity=0.100  Sum_probs=77.1

Q ss_pred             CCCceeeeeeEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC
Q 038249           74 RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG  153 (281)
Q Consensus        74 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~  153 (281)
                      .||+.+.. .+-...+.+.+.++.-+...-...++.   .+....++++..|+....+++  .-+|--++|+|++++.++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~---~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS---FTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG---SCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh---cCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCC
Confidence            67888876 566677777676665543322222443   688899999999988774443  337889999999999999


Q ss_pred             cEEEeeecCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCC
Q 038249          154 ELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFE  214 (281)
Q Consensus       154 ~~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  214 (281)
                      .+++.-.|....              ++|     ...+...=.-..=+++..+++++..|+
T Consensus       117 ~p~i~~RGik~~--------------l~P-----~~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          117 LPIAKTRGLQNV--------------VDP-----LPVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CEEESCCEETTT--------------BSC-----CCCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CEEEEEccCccC--------------CCC-----CCCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999988775311              122     122222233356677778888877763

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=95.72  E-value=0.063  Score=41.13  Aligned_cols=83  Identities=13%  Similarity=0.081  Sum_probs=62.1

Q ss_pred             CCCceeeeeeEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHhcCceecCCCCCCeEeCCC
Q 038249           74 RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI-YCHGKHVIHRDIKPENLLIGAQ  152 (281)
Q Consensus        74 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~-~Lh~~~i~H~di~~~Ni~~~~~  152 (281)
                      .||++  ...+-.+.+.+.+.++..++..-...++.   .+..+.++++..|+.... ++  ..-+|--++|+|++++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~---~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK---TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT---SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh---cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            57888  55666777888887777655433444443   688899999988887655 33  445788999999999999


Q ss_pred             CcEEEeeecCc
Q 038249          153 GELKIADFGWS  163 (281)
Q Consensus       153 ~~~~l~dfg~~  163 (281)
                      +.+++...|..
T Consensus       121 ~~p~i~hRGi~  131 (219)
T 4ano_A          121 LEPFFLHVGVK  131 (219)
T ss_dssp             CCEEESCCEET
T ss_pred             CcEEEEEcCCc
Confidence            99999988853

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.41  E-value=0.058  Score=45.72  Aligned_cols=28  Identities=29%  Similarity=0.541  Sum_probs=24.2

Q ss_pred             ceecCCCCCCeEe------CCCCcEEEeeecCcc
Q 038249          137 VIHRDIKPENLLI------GAQGELKIADFGWSV  164 (281)
Q Consensus       137 i~H~di~~~Ni~~------~~~~~~~l~dfg~~~  164 (281)
                      ++|+|+.+.||++      +.++.+.++||.++.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6799999999999      456789999999873

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.55  E-value=0.07  Score=46.17  Aligned_cols=64  Identities=9%  Similarity=0.097  Sum_probs=18.8

Q ss_pred             eecceecccCceEEEEEEEccCCcEEEE------EEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249           19 DIGKPLGRGKFGHVYLAREKRSNHIVAL------KVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus        19 ~~~~~ig~g~~~~v~~~~~~~~~~~~~l------K~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      .+.+.||   ||.||.+.....+.+||+      |........ .+....+.++..+.+.++|+|+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~-~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS-EKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccccc-ccccccccccccccccccccccCCCcceEE
Confidence            4566776   999999998765567888      665443322 233456777888888899999999988765

>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A

Probab=80.56  E-value=31  Score=30.75  Aligned_cols=120  Identities=22%  Similarity=0.226  Sum_probs=64.0

Q ss_pred             ccCCcE--EEEEEeecccccchHHHHHHHHHHH-HHHhCCCCceeeeeeEEEeCCEEEEEEeccCCCChhHHHHhCCC--
Q 038249           38 KRSNHI--VALKVLFKSQLQQSQVEHQLRREVE-IQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--  112 (281)
Q Consensus        38 ~~~~~~--~~lK~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--  112 (281)
                      ..+|..  +++|.-  +..-++...-++...++ ++++-+-.--++.+.+...+....++ |++++.++.+.+...+.  
T Consensus       360 gsDG~~y~~i~K~g--DDLRQD~~~~Ql~~l~n~il~~~~ldL~i~~Y~Vipls~~~GlI-E~V~~~tl~~il~~~~~l~  436 (614)
T 3ls8_A          360 TEDGGKYPVIFKHG--DDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFM-QFIQSVPVAEVLDTEGSIQ  436 (614)
T ss_dssp             ETTSCEEEEEEEES--SCCHHHHHHHHHHHHHHHHHHHTTCCCCCCCCCEEESSSSEEEE-ECCCCEEHHHHHHHTSSHH
T ss_pred             ccCCCEEEEEEecC--CcchHHHHHHHHHHHHHHHHHhcCCCceeeccEEEEecCCCceE-EEeCCccHHHHHHccChHH
Confidence            334544  556652  33333443333333332 33332222335667777766666665 67766666665543211  


Q ss_pred             ---------------CCHHHHHHHHHHHH--HHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249          113 ---------------FSERRAATYVASLA--RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus       113 ---------------l~~~~~~~i~~~i~--~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                                     ........++..++  ..+-|+=  |+  ||=+++|||++.+|++.=+|||...
T Consensus       437 ~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YIL--Gi--gDRH~~NILld~tG~v~HIDFG~~f  501 (614)
T 3ls8_A          437 NFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYIL--GV--GDRHLDNLLLTKTGKLFHIDFGYIL  501 (614)
T ss_dssp             HHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHH--TC--CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred             HHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheee--ec--cCCCCcceeEcCCCCEeeeehHHhh
Confidence                           01222233333332  2233332  33  4888999999999999999999874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	281
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-100
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-84
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-82
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-81
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-81
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-80
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-78
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-78
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-78
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-78
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-78
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-78
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-78
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-77
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-75
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-75
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-73
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-73
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-73
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-72
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-71
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-69
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-69
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-67
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-66
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-66
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-64
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-63
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-63
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-63
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-62
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-61
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-61
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-60
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-60
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-60
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-60
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-60
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-60
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-58
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-58
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-56
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-56
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-55
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-53
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-46
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-42
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-24

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  291 bits (746), Expect = e-100
 Identities = 175/264 (66%), Positives = 211/264 (79%), Gaps = 3/264 (1%)

Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           ++W L DF+IG+PLG+GKFG+VYLAREK+S  I+ALKVLFK+QL+++ VEHQLRREVEIQ
Sbjct: 1   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           SHLRHPNILRLYGYF+D  RVYLILEYA  G +Y+ELQK   F E+R ATY+  LA AL 
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLDYLPPEMVESVE 189
           YCH K VIHRDIKPENLL+G+ GELKIADFGWSVH  + RR T+CGTLDYLPPEM+E   
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 190 HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
           HD  VD+WSLGVLCYEFL G PPFEA  + +TY+RI +V+  FP    V+  A+DLIS++
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISRL 238

Query: 250 LVKDSSQRLPLHKLLEHPWIIQNA 273
           L  + SQR  L ++LEHPWI  N+
Sbjct: 239 LKHNPSQRPMLREVLEHPWITANS 262

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  252 bits (645), Expect = 5e-84
 Identities = 69/262 (26%), Positives = 118/262 (45%), Gaps = 4/262 (1%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           F   + +G G FG VY AR+ R++ +VA+K +  S  Q ++    + +EV     LRHPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 78  ILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHV 137
            ++  G +  +   +L++EY             K   E   A       + L Y H  ++
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 138 IHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESV---EHDANV 194
           IHRD+K  N+L+   G +K+ DFG +        +  GT  ++ PE++ ++   ++D  V
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSA-SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 195 DIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDS 254
           D+WSLG+ C E     PP            I Q +         S   ++ +   L K  
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255

Query: 255 SQRLPLHKLLEHPWIIQNADPS 276
             R     LL+H ++++   P+
Sbjct: 256 QDRPTSEVLLKHRFVLRERPPT 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (634), Expect = 1e-82
 Identities = 87/266 (32%), Positives = 142/266 (53%), Gaps = 7/266 (2%)

Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           ++    DF  GK LG G F  V LARE  ++   A+K+L K  + +      + RE ++ 
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           S L HP  ++LY  F D +++Y  L YA  GEL K ++K   F E     Y A +  AL 
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLDYLPPEMV 185
           Y HGK +IHRD+KPEN+L+     ++I DFG +          R  +  GT  Y+ PE++
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
                  + D+W+LG + Y+ + G+PPF A      +++I++++  FP K      A+DL
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDL 240

Query: 246 ISQMLVKDSSQRLPLHKLLEHPWIIQ 271
           + ++LV D+++RL   ++  +  +  
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  246 bits (628), Expect = 6e-81
 Identities = 80/274 (29%), Positives = 136/274 (49%), Gaps = 10/274 (3%)

Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           K    L+ +DI + LG G FG V+   E+ + +  A K +        +    +R+E++ 
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE---TVRKEIQT 76

Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARA 128
            S LRHP ++ L+  F D   + +I E+ + GEL++++  +    SE  A  Y+  + + 
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQ--GELKIADFGWSVH--TFNRRRTMCGTLDYLPPEM 184
           L + H  + +H D+KPEN++   +   ELK+ DFG + H       +   GT ++  PE+
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196

Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAA 242
            E        D+WS+GVL Y  L G+ PF  +   +T R +   D          +S   
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256

Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           KD I ++L+ D + R+ +H+ LEHPW+     P 
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  244 bits (624), Expect = 7e-81
 Identities = 95/262 (36%), Positives = 151/262 (57%), Gaps = 7/262 (2%)

Query: 13  WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           ++L DF I + LG G FG V+L R + +    A+KVL K  + + +       E  + S 
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
           + HP I+R++G F D +++++I++Y   GEL+  L+K + F    A  Y A +  AL Y 
Sbjct: 61  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 133 HGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDA 192
           H K +I+RD+KPEN+L+   G +KI DFG++ +  +   T+CGT DY+ PE+V +  ++ 
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNK 180

Query: 193 NVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK 252
           ++D WS G+L YE L G  PF       TY +I+  +L+FPP    +   KDL+S+++ +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF--FNEDVKDLLSRLITR 238

Query: 253 DSSQRLP-----LHKLLEHPWI 269
           D SQRL         +  HPW 
Sbjct: 239 DLSQRLGNLQNGTEDVKNHPWF 260

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (615), Expect = 5e-80
 Identities = 78/265 (29%), Positives = 131/265 (49%), Gaps = 9/265 (3%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + D+D+ + LG G +G V LA  + +   VA+K++   +         +++E+ I   L 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 61

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H N+++ YG+  +    YL LEY + GEL+  ++      E  A  +   L   ++Y HG
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLDYLPPEMVESVE 189
             + HRDIKPENLL+  +  LKI+DFG +              MCGTL Y+ PE+++  E
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 190 HDAN-VDIWSLGVLCYEFLYGVPPFEAKEHSDT-YRRIVQVDLKFPPKPIVSSAAKDLIS 247
             A  VD+WS G++    L G  P++    S   Y    +      P   + SA   L+ 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 248 QMLVKDSSQRLPLHKLLEHPWIIQN 272
           ++LV++ S R+ +  + +  W  + 
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKP 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  238 bits (609), Expect = 1e-78
 Identities = 82/268 (30%), Positives = 140/268 (52%), Gaps = 9/268 (3%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           + +D    LG G F  V LA +KR+  +VA+K + K  L+    E  +  E+ +   ++H
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKH 66

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           PNI+ L   +     +YLI++  + GEL+  + +  +++ER A+  +  +  A+ Y H  
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 136 HVIHRDIKPENLLI---GAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESVEH 190
            ++HRD+KPENLL        ++ I+DFG S      +   T CGT  Y+ PE++    +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLISQ 248
              VD WS+GV+ Y  L G PPF  +  +  + +I++ + +F       +S +AKD I  
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246

Query: 249 MLVKDSSQRLPLHKLLEHPWIIQNADPS 276
           ++ KD  +R    + L+HPWI  +    
Sbjct: 247 LMEKDPEKRFTCEQALQHPWIAGDTALD 274

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  239 bits (612), Expect = 1e-78
 Identities = 78/267 (29%), Positives = 133/267 (49%), Gaps = 10/267 (3%)

Query: 10  KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           K+    + +DI + LG G FG V+   EK +  +   K +          ++ ++ E+ I
Sbjct: 23  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISI 79

Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARA 128
            + L HP ++ L+  F D+  + LILE+ + GEL+  +    Y  SE     Y+      
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQ--GELKIADFGWS--VHTFNRRRTMCGTLDYLPPEM 184
           L + H   ++H DIKPEN++   +    +KI DFG +  ++     +    T ++  PE+
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199

Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAA 242
           V+        D+W++GVL Y  L G+ PF  ++  +T + + + D +F       VS  A
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259

Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWI 269
           KD I  +L K+  +RL +H  LEHPW+
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWL 286

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (606), Expect = 2e-78
 Identities = 74/268 (27%), Positives = 130/268 (48%), Gaps = 13/268 (4%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            ++I   LG G FG VY A+ K ++ + A KV+     ++ +       E++I +   HP
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMVEIDILASCDHP 69

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGK 135
           NI++L   FY +  +++++E+ A G +   + +  +  +E +          AL Y H  
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 136 HVIHRDIKPENLLIGAQGELKIADFGWS---VHTFNRRRTMCGTLDYLPPEMV-----ES 187
            +IHRD+K  N+L    G++K+ADFG S     T  RR +  GT  ++ PE+V     + 
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI-VSSAAKDLI 246
             +D   D+WSLG+   E     PP           +I + +     +P   SS  KD +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249

Query: 247 SQMLVKDSSQRLPLHKLLEHPWIIQNAD 274
            + L K+   R    +LL+HP++  +++
Sbjct: 250 KKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (604), Expect = 4e-78
 Identities = 74/282 (26%), Positives = 137/282 (48%), Gaps = 17/282 (6%)

Query: 4   EVSAKEKKRWTLND----FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV 59
           E+  K +   ++ D    +   + +G+G  G VY A +  +   VA++ +   Q  + + 
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE- 62

Query: 60  EHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAA 119
              +  E+ +    ++PNI+     +     +++++EY A G L   + +     E + A
Sbjct: 63  --LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIA 119

Query: 120 TYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGT 176
                  +AL + H   VIHRDIK +N+L+G  G +K+ DFG+        ++R TM GT
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179

Query: 177 LDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ---VDLKFP 233
             ++ PE+V    +   VDIWSLG++  E + G PP+  +        I      +L+ P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239

Query: 234 PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
            K  +S+  +D +++ L  D  +R    +LL+H + ++ A P
Sbjct: 240 EK--LSAIFRDFLNRCLDMDVEKRGSAKELLQHQF-LKIAKP 278

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (601), Expect = 6e-78
 Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 16/267 (5%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
           D+++   +G G +G     R K    I+  K L    + +++ +  L  EV +   L+HP
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHP 63

Query: 77  NILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKC----KYFSERRAATYVASLARALI 130
           NI+R Y    D+    +Y+++EY   G+L   + K     +Y  E      +  L  AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 131 YCH-----GKHVIHRDIKPENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPP 182
            CH     G  V+HRD+KP N+ +  +  +K+ DFG +    H  +  +   GT  Y+ P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 183 EMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAA 242
           E +  + ++   DIWSLG L YE    +PPF A    +   +I +   +  P    S   
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY-SDEL 242

Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWI 269
            ++I++ML      R  + ++LE+P I
Sbjct: 243 NEIITRMLNLKDYHRPSVEEILENPLI 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (605), Expect = 7e-78
 Identities = 71/307 (23%), Positives = 129/307 (42%), Gaps = 47/307 (15%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           +DF+    LG G  G V+    K S  ++A K++      +  + +Q+ RE+++      
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNS 63

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGK 135
           P I+  YG FY    + + +E+   G L + L+K     E+       ++ + L Y   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 136 H-VIHRDIKPENLLIGAQGELKIADFGWSVHTFN-RRRTMCGTLDYLPPEMVESVEHDAN 193
           H ++HRD+KP N+L+ ++GE+K+ DFG S    +    +  GT  Y+ PE ++   +   
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183

Query: 194 VDIWSLGVLCYEFLYGVPPFEAKEHSD--------------------------------- 220
            DIWS+G+   E   G  P    +  +                                 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243

Query: 221 ---------TYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ 271
                        IV       P  + S   +D +++ L+K+ ++R  L +L+ H + I+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF-IK 302

Query: 272 NADPSGV 278
            +D   V
Sbjct: 303 RSDAEEV 309

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (604), Expect = 9e-78
 Identities = 71/266 (26%), Positives = 128/266 (48%), Gaps = 11/266 (4%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            + I + LGRG+FG V+   E  S      K +      Q  V    ++E+ I +  RH 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV----KKEISILNIARHR 61

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY-FSERRAATYVASLARALIYCHGK 135
           NIL L+  F   + + +I E+ +  ++++ +    +  +ER   +YV  +  AL + H  
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 136 HVIHRDIKPENLLIGAQGE--LKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESVEHD 191
           ++ H DI+PEN++   +    +KI +FG +  +   +  R +    +Y  PE+ +     
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 192 ANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI--VSSAAKDLISQM 249
              D+WSLG L Y  L G+ PF A+ +      I+  +  F  +    +S  A D + ++
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241

Query: 250 LVKDSSQRLPLHKLLEHPWIIQNADP 275
           LVK+   R+   + L+HPW+ Q  + 
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIER 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (599), Expect = 5e-77
 Identities = 81/260 (31%), Positives = 136/260 (52%), Gaps = 7/260 (2%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQ-LQQSQVEHQLRREVEIQSHL 73
           + DF + K LG+G FG V+LA  K++N   A+K L K   L    VE  +  +  +    
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
            HP +  ++  F  ++ ++ ++EY   G+L   +Q C  F   RA  Y A +   L + H
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRRRTMCGTLDYLPPEMVESVEH 190
            K +++RD+K +N+L+   G +KIADFG          +  T CGT DY+ PE++   ++
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
           + +VD WS GVL YE L G  PF  ++  + +  I   +  +P    +   AKDL+ ++ 
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW--LEKEAKDLLVKLF 238

Query: 251 VKDSSQRLPLHK-LLEHPWI 269
           V++  +RL +   + +HP  
Sbjct: 239 VREPEKRLGVRGDIRQHPLF 258

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 3e-75
 Identities = 95/266 (35%), Positives = 142/266 (53%), Gaps = 10/266 (3%)

Query: 12  RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           + T+NDFD  K LG+G FG V L REK +    A+K+L K  +           E  +  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
           + RHP +  L   F    R+  ++EYA  GEL+  L + + F+E RA  Y A +  AL Y
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM---CGTLDYLPPEMVESV 188
            H + V++RDIK ENL++   G +KI DFG      +   TM   CGT +YL PE++E  
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           ++   VD W LGV+ YE + G  PF  ++H   +  I+  +++FP    +S  AK L++ 
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT--LSPEAKSLLAG 238

Query: 249 MLVKDSSQRLP-----LHKLLEHPWI 269
           +L KD  QRL        +++EH + 
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  228 bits (582), Expect = 4e-75
 Identities = 76/270 (28%), Positives = 128/270 (47%), Gaps = 17/270 (6%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE------HQLRREVEIQ 70
           +++  + LGRG    V     K +    A+K++  +       E          +EV+I 
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 71  SHLR-HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARAL 129
             +  HPNI++L   +      +L+ +   KGEL+  L +    SE+     + +L   +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 130 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVES 187
              H  +++HRD+KPEN+L+     +K+ DFG+S  +    + R +CGT  YL PE++E 
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 183

Query: 188 VEHDAN------VDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVS 239
             +D +      VD+WS GV+ Y  L G PPF  ++     R I+  + +F        S
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243

Query: 240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
              KDL+S+ LV    +R    + L HP+ 
Sbjct: 244 DTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 3e-73
 Identities = 82/271 (30%), Positives = 141/271 (52%), Gaps = 12/271 (4%)

Query: 11  KRWTLND-FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ---VEHQLRRE 66
           ++  ++D +D G+ LG G+F  V   REK +    A K + K + + S+       + RE
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
           V I   ++HPN++ L+  + ++  V LILE  A GEL+  L + +  +E  A  ++  + 
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGE----LKIADFGWS--VHTFNRRRTMCGTLDYL 180
             + Y H   + H D+KPEN+++  +      +KI DFG +  +   N  + + GT +++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIV 238
            PE+V         D+WS+GV+ Y  L G  PF      +T   +  V+ +F  +     
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243

Query: 239 SSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
           S+ AKD I ++LVKD  +R+ +   L+HPWI
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  226 bits (576), Expect = 6e-73
 Identities = 72/268 (26%), Positives = 131/268 (48%), Gaps = 13/268 (4%)

Query: 14  TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE---IQ 70
           T+NDF + + +GRG FG VY  R+  +  + A+K L K +++  Q E     E     + 
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALI 130
           S    P I+ +   F+   ++  IL+    G+L+  L +   FSE     Y A +   L 
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM-CGTLDYLPPEMVES-V 188
           + H + V++RD+KP N+L+   G ++I+D G +     ++     GT  Y+ PE+++  V
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 181

Query: 189 EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAKDLI 246
            +D++ D +SLG + ++ L G  PF   +  D +  I ++ L    +     S   + L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLL 240

Query: 247 SQMLVKDSSQRLPLHK-----LLEHPWI 269
             +L +D ++RL         + E P+ 
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  225 bits (573), Expect = 8e-73
 Identities = 91/269 (33%), Positives = 140/269 (52%), Gaps = 7/269 (2%)

Query: 6   SAKEKKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRR 65
               +    L+ FD  K LG G FG V L + K S +  A+K+L K ++ + +       
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN 90

Query: 66  EVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASL 125
           E  I   +  P +++L   F D   +Y+++EY A GE++  L++   FSE  A  Y A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMV 185
                Y H   +I+RD+KPENLLI  QG +++ DFG++     R  T+CGT + L PE++
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEII 210

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL 245
            S  ++  VD W+LGVL YE   G PPF A +    Y +IV   ++FP     SS  KDL
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDL 268

Query: 246 ISQMLVKDSSQRLP-----LHKLLEHPWI 269
           +  +L  D ++R       ++ +  H W 
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 3e-72
 Identities = 64/261 (24%), Positives = 121/261 (46%), Gaps = 11/261 (4%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
                 +GRG F  VY   +  +   VA   L   +L +S+ + + + E E+   L+HPN
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEMLKGLQHPN 69

Query: 78  ILRLYGYFYD----QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCH 133
           I+R Y  +      +K + L+ E    G L   L++ K    +   ++   + + L + H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 134 --GKHVIHRDIKPENLLI-GAQGELKIADFGWS-VHTFNRRRTMCGTLDYLPPEMVESVE 189
                +IHRD+K +N+ I G  G +KI D G + +   +  + + GT +++ PEM E  +
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-K 188

Query: 190 HDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +D +VD+++ G+   E      P+ E +  +  YRR+           +     K++I  
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248

Query: 249 MLVKDSSQRLPLHKLLEHPWI 269
            + ++  +R  +  LL H + 
Sbjct: 249 CIRQNKDERYSIKDLLNHAFF 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  219 bits (559), Expect = 2e-71
 Identities = 71/266 (26%), Positives = 119/266 (44%), Gaps = 12/266 (4%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           + +++G+ LG G    V+LAR+ R +  VA+KVL     +      + RRE +  + L H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 76  PNILRLYGYFYDQ----KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
           P I+ +Y     +       Y+++EY     L   +      + +RA   +A   +AL +
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH------TFNRRRTMCGTLDYLPPEMV 185
            H   +IHRD+KP N++I A   +K+ DFG +        +  +   + GT  YL PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 186 ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--PIVSSAAK 243
                DA  D++SLG + YE L G PPF          + V+ D   P      +S+   
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 244 DLISQMLVKDSSQRLPLHKLLEHPWI 269
            ++ + L K+   R      +    +
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLV 272

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 1e-69
 Identities = 59/273 (21%), Positives = 117/273 (42%), Gaps = 18/273 (6%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
               +G+ +G G FG VY  +       VA+K+L  +     Q++   + EV +    RH
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRH 63

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHG 134
            NIL   G +    ++ ++ ++     LY  L   +  F   +        A+ + Y H 
Sbjct: 64  VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVH-----TFNRRRTMCGTLDYLPPEMVESVE 189
           K +IHRD+K  N+ +     +KI DFG +         ++   + G++ ++ PE++   +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 190 ---HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP----KPIVSSAA 242
              +    D+++ G++ YE + G  P+    + D    +V      P     +     A 
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242

Query: 243 KDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
           K L+++ L K   +R    ++L    ++  + P
Sbjct: 243 KRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 4e-69
 Identities = 86/286 (30%), Positives = 141/286 (49%), Gaps = 27/286 (9%)

Query: 10  KKRWTLNDFDI-GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           KK   ++D+ +  + LG G  G V     KR+    ALK+L            + RREVE
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 56

Query: 69  IQSHL-RHPNILRLYGYFYD----QKRVYLILEYAAKGELYKELQKC--KYFSERRAATY 121
           +     + P+I+R+   + +    +K + +++E    GEL+  +Q    + F+ER A+  
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 122 VASLARALIYCHGKHVIHRDIKPENLLI---GAQGELKIADFGWS--VHTFNRRRTMCGT 176
           + S+  A+ Y H  ++ HRD+KPENLL         LK+ DFG++    + N   T C T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176

Query: 177 LDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYR------RIVQVDL 230
             Y+ PE++   ++D + D+WSLGV+ Y  L G PPF +              R+ Q + 
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236

Query: 231 KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
             P    VS   K LI  +L  + +QR+ + + + HPWI+Q+    
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 2e-67
 Identities = 60/260 (23%), Positives = 111/260 (42%), Gaps = 14/260 (5%)

Query: 13  WTLN--DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           W LN  +  + + +G+G+FG V L   +   + VA+K +      Q         E  + 
Sbjct: 2   WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQ-----AFLAEASVM 54

Query: 71  SHLRHPNILRLYGYFYDQK-RVYLILEYAAKGELYKELQK--CKYFSERRAATYVASLAR 127
           + LRH N+++L G   ++K  +Y++ EY AKG L   L+              +   +  
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVES 187
           A+ Y  G + +HRD+   N+L+      K++DFG +    + + T    + +  PE +  
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE 174

Query: 188 VEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
            +     D+WS G+L +E   +G  P+      D   R+ +   K         A  +++
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVM 233

Query: 247 SQMLVKDSSQRLPLHKLLEH 266
                 D++ R    +L E 
Sbjct: 234 KNCWHLDAAMRPSFLQLREQ 253

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 2e-66
 Identities = 67/257 (26%), Positives = 117/257 (45%), Gaps = 12/257 (4%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
            D    K LG G+FG V   +  R  + VA+K++ +     S  E +   E ++  +L H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEG----SMSEDEFIEEAKVMMNLSH 58

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHG 134
             +++LYG    Q+ +++I EY A G L   L+     F  ++       +  A+ Y   
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT----MCGTLDYLPPEMVESVEH 190
           K  +HRD+   N L+  QG +K++DFG S +  +   T        + + PPE++   + 
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 191 DANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
            +  DIW+ GVL +E    G  P+E   +S+T   I Q  L+     + S     ++   
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYSC 237

Query: 250 LVKDSSQRLPLHKLLEH 266
             + + +R     LL +
Sbjct: 238 WHEKADERPTFKILLSN 254

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 4e-66
 Identities = 64/285 (22%), Positives = 108/285 (37%), Gaps = 32/285 (11%)

Query: 24  LGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQ--VEHQLRREVEIQSHLRHPNILRL 81
           LG G+F  VY AR+K +N IVA+K +      +++  +     RE+++   L HPNI+ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 82  YGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRD 141
              F  +  + L+ ++                +      Y+    + L Y H   ++HRD
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125

Query: 142 IKPENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVESVE-HDANVDIW 197
           +KP NLL+   G LK+ADFG +               T  Y  PE++     +   VD+W
Sbjct: 126 LKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMW 185

Query: 198 SLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK---------------------- 235
           ++G +  E L  VP        D   RI +       +                      
Sbjct: 186 AVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 245

Query: 236 ----PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                       DLI  + + +   R+   + L+  +      P+
Sbjct: 246 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 1e-65
 Identities = 77/269 (28%), Positives = 118/269 (43%), Gaps = 17/269 (6%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ---QSQVEHQLRREVEIQSH 72
           + + +G  LG G FG VY       N  VA+K + K ++    +     ++  EV +   
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 73  LR--HPNILRLYGYFYDQKRVYLILEYAA-KGELYKELQKCKYFSERRAATYVASLARAL 129
           +      ++RL  +F       LILE      +L+  + +     E  A ++   +  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 130 IYCHGKHVIHRDIKPENLLIGAQ-GELKIADFGWSVH-TFNRRRTMCGTLDYLPPEMVES 187
            +CH   V+HRDIK EN+LI    GELK+ DFG              GT  Y PPE +  
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183

Query: 188 VE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
              H  +  +WSLG+L Y+ + G  PFE  E       I++  + F  +  VSS  + LI
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR--VSSECQHLI 235

Query: 247 SQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
              L    S R    ++  HPW+     P
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  200 bits (509), Expect = 9e-64
 Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 23/280 (8%)

Query: 11  KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREV 67
           K   ++   I + +G G+FG V     K        VA+K L     ++         E 
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEA 78

Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYK-ELQKCKYFSERRAATYVASLA 126
            I     HPN++ L G       V +I E+   G L     Q    F+  +    +  +A
Sbjct: 79  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--------VHTFNRRRTMCGTLD 178
             + Y    + +HRD+   N+L+ +    K++DFG S          T+         + 
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198

Query: 179 YLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPI 237
           +  PE ++  +  +  D+WS G++ +E + YG  P+    + D    I Q D + PP   
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMD 257

Query: 238 VSSAAKDLISQMLVKDSSQRLP-------LHKLLEHPWII 270
             SA   L+     KD + R         L K++ +P  +
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSL 297

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 1e-63
 Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 19/272 (6%)

Query: 9   EKKRWTLNDFDIGKPLGRGKFGHVYLA--REKRSNHIVALKVLFKSQLQQSQVEHQLRRE 66
           ++K  TL D    K LG G FG V     + K+    VA+K+L K++     ++ +L  E
Sbjct: 4   DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAE 58

Query: 67  VEIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
             +   L +P I+R+ G    +    L++E A  G L K LQ+ ++  ++     V  ++
Sbjct: 59  ANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS------VHTFNRRRTMCGTLDYL 180
             + Y    + +HRD+   N+L+  Q   KI+DFG S       + +  +      + + 
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

Query: 181 PPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS 239
            PE +   +  +  D+WS GVL +E   YG  P+   + S+    + +   +        
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCP 236

Query: 240 SAAKDLISQMLVKDSSQRLP---LHKLLEHPW 268
               DL++     D   R     +   L + +
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 3e-63
 Identities = 89/280 (31%), Positives = 147/280 (52%), Gaps = 18/280 (6%)

Query: 8   KEKKRWTLNDFDIGKPLGRGKFGHVYLARE---KRSNHIVALKVLFKSQL-QQSQVEHQL 63
              ++  + +F++ K LG G +G V+L R+     +  + A+KVL K+ + Q+++     
Sbjct: 16  GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 75

Query: 64  RREVEIQSHLRH-PNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           R E ++  H+R  P ++ L+  F  + +++LIL+Y   GEL+  L + + F+E     YV
Sbjct: 76  RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT----MCGTLD 178
             +  AL + H   +I+RDIK EN+L+ + G + + DFG S              CGT++
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 179 YLPPEMVESVE--HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK- 235
           Y+ P++V   +  HD  VD WSLGVL YE L G  PF      ++   I +  LK  P  
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255

Query: 236 -PIVSSAAKDLISQMLVKDSSQRLPLHK-----LLEHPWI 269
              +S+ AKDLI ++L+KD  +RL         + EH + 
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 5e-63
 Identities = 68/308 (22%), Positives = 116/308 (37%), Gaps = 47/308 (15%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           ++ ++    +G+G FG V+ AR +++   VALK +     ++        RE++I   L+
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI-TALREIKILQLLK 67

Query: 75  HPNILRLYGYFYDQK--------RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLA 126
           H N++ L      +          +YL+ ++               F+       +  L 
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127

Query: 127 RALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS-------VHTFNRRRTMCGTLDY 179
             L Y H   ++HRD+K  N+LI   G LK+ADFG +           NR      TL Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 180 LPPEMV-ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--- 235
            PPE++    ++   +D+W  G +  E     P  +          I Q+     P+   
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247

Query: 236 ---------------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
                                       +    A DLI ++LV D +QR+     L H +
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307

Query: 269 IIQNADPS 276
              +  PS
Sbjct: 308 FWSDPMPS 315

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 5e-63
 Identities = 56/257 (21%), Positives = 106/257 (41%), Gaps = 12/257 (4%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           ++    + +G G+FG V+L     +   VA+K + +     +  E     E E+   L H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREG----AMSEEDFIEEAEVMMKLSH 59

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGELYK-ELQKCKYFSERRAATYVASLARALIYCHG 134
           P +++LYG   +Q  + L+ E+   G L      +   F+          +   + Y   
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM----CGTLDYLPPEMVESVEH 190
             VIHRD+   N L+G    +K++DFG +    + + T        + +  PE+     +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 191 DANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQM 249
            +  D+WS GVL +E    G  P+E + +S+    I     +     + S+    +++  
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIMNHC 238

Query: 250 LVKDSSQRLPLHKLLEH 266
             +    R    +LL  
Sbjct: 239 WKERPEDRPAFSRLLRQ 255

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 3e-62
 Identities = 60/263 (22%), Positives = 94/263 (35%), Gaps = 12/263 (4%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQS 71
             D  + + LG G FG V        +     VA+K L    L Q +      REV    
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYK-ELQKCKYFSERRAATYVASLARALI 130
            L H N++RLYG       + ++ E A  G L     +   +F     + Y   +A  + 
Sbjct: 67  SLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH------TFNRRRTMCGTLDYLPPEM 184
           Y   K  IHRD+   NLL+  +  +KI DFG           +  +        +  PE 
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 185 VESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
           +++       D W  GV  +E   YG  P+     S    +I +   + P          
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245

Query: 244 DLISQMLVKDSSQRLPLHKLLEH 266
           +++ Q        R     L + 
Sbjct: 246 NVMVQCWAHKPEDRPTFVALRDF 268

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  194 bits (493), Expect = 2e-61
 Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 33/286 (11%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           +  +   + +G G +G VY A+        ALK +   +  +  +     RE+ I   L+
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDE-GIPSTTIREISILKELK 58

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H NI++LY   + +KR+ L+ E+  +                 A +++  L   + YCH 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVESVE-H 190
           + V+HRD+KP+NLLI  +GELKIADFG +        +      TL Y  P+++   + +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--------------- 235
              +DIWS+G +  E + G P F     +D   RI ++      K               
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 236 ------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                         +  +  DL+S+ML  D +QR+   + LEH + 
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 6e-61
 Identities = 73/298 (24%), Positives = 120/298 (40%), Gaps = 41/298 (13%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN 77
           +     +G G +G V  A +  +   VA+K +   + Q      +  RE++I    RH N
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRFRHEN 67

Query: 78  ILRLYGYFYD---QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           I+ +         ++   + L     G    +L K ++ S      ++  + R L Y H 
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 127

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVH------TFNRRRTMCGTLDYLPPE-MVES 187
            +V+HRD+KP NLL+    +LKI DFG +                  T  Y  PE M+ S
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187

Query: 188 VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK------------ 235
             +  ++DIWS+G +  E L   P F  K + D    I+ +      +            
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247

Query: 236 -----------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                            P   S A DL+ +ML  +  +R+ + + L HP++ Q  DPS
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-60
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 21/272 (7%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL- 73
            ND      +G G FG V  AR K+    +   +    +            E+E+   L 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 74  RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY----------------FSERR 117
            HPNI+ L G    +  +YL +EYA  G L   L+K +                  S ++
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 118 AATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCG 175
              + A +AR + Y   K  IHRD+   N+L+G     KIADFG S     + ++     
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPP 234
            + ++  E +    +  N D+WS GVL +E +  G  P+     ++ Y ++ Q   +   
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEK 247

Query: 235 KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                    DL+ Q   +   +R    ++L  
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 3e-60
 Identities = 60/293 (20%), Positives = 107/293 (36%), Gaps = 39/293 (13%)

Query: 11  KRWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHI-----VALKVLFKSQLQQSQVEHQL 63
            +W     + + GK LG G FG V  A     +       VA+K+L +      +    L
Sbjct: 30  LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EAL 87

Query: 64  RREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCK----------- 111
             E+++ + L  H NI+ L G       +YLI EY   G+L   L+  +           
Sbjct: 88  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147

Query: 112 ------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIAD 159
                         +      +   +A+ + +   K  +HRD+   N+L+     +KI D
Sbjct: 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 207

Query: 160 FGWSVH-----TFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPF 213
           FG +        +  R      + ++ PE +    +    D+WS G+L +E    GV P+
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267

Query: 214 EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                   + +++Q   K       +     ++      DS +R     L   
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 3e-60
 Identities = 58/270 (21%), Positives = 110/270 (40%), Gaps = 17/270 (6%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
               +   LG+G FG V++         VA+K L    +          +E ++   LRH
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRH 71

Query: 76  PNILRLYGYFYDQKRVYLILEYAAKGEL--YKELQKCKYFSERRAATYVASLARALIYCH 133
             +++LY     ++ +Y++ EY +KG L  + + +  KY    +     A +A  + Y  
Sbjct: 72  EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVESVE 189
             + +HRD++  N+L+G     K+ADFG +       +  R+     + +  PE      
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 190 HDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
                D+WS G+L  E    G  P+    + +   ++ +   + P  P    +  DL+ Q
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQ 249

Query: 249 MLVKDSSQRLPLHKLLE--HPWIIQNADPS 276
              K+  +R     L      +   + +P 
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDY-FTSTEPQ 278

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 3e-60
 Identities = 66/291 (22%), Positives = 121/291 (41%), Gaps = 38/291 (13%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNH-IVALKVLFKSQLQQSQVEHQLRREVEIQSHL- 73
             ++    +G G +G V+ AR+ ++    VALK + + Q  +  +     REV +  HL 
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 65

Query: 74  --RHPNILRLYGYFYDQK-----RVYLILEYAAKGEL-YKELQKCKYFSERRAATYVASL 125
              HPN++RL+      +     ++ L+ E+  +    Y +               +  L
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS--VHTFNRRRTMCGTLDYLPPE 183
            R L + H   V+HRD+KP+N+L+ + G++K+ADFG +          ++  TL Y  PE
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI------ 237
           ++    +   VD+WS+G +  E     P F      D   +I+ V      +        
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 238 -------------------VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWI 269
                              +    KDL+ + L  + ++R+  +  L HP+ 
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  191 bits (485), Expect = 3e-60
 Identities = 56/262 (21%), Positives = 107/262 (40%), Gaps = 12/262 (4%)

Query: 12  RWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEI 69
           +W +   D  +   LG G++G VY    K+ +  VA+K L +  ++  +      +E  +
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAV 66

Query: 70  QSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLAR 127
              ++HPN+++L G    +   Y+I E+   G L   L++C  +  S          ++ 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPE 183
           A+ Y   K+ IHRD+   N L+G    +K+ADFG S      T+         + +  PE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK 243
            +   +     D+W+ GVL +E                   +++ D +            
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246

Query: 244 DLISQMLVKDSSQRLPLHKLLE 265
           +L+      + S R    ++ +
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQ 268

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 4e-60
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 33/293 (11%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           + +F   + +G G +G VY AR K +  +VALK + +   +   V     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKG-ELYKELQKCKYFSERRAATYVASLARALIYCH 133
           HPNI++L    + + ++YL+ E+  +  + + +             +Y+  L + L +CH
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 134 GKHVIHRDIKPENLLIGAQGELKIADFGWSVH---TFNRRRTMCGTLDYLPPEMVESVEH 190
              V+HRD+KP+NLLI  +G +K+ADFG +               TL Y  PE++   ++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 191 -DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK-------------- 235
               VDIWSLG +  E +     F      D   RI +                      
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 236 -------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
                        P +    + L+SQML  D ++R+     L HP+      P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-60
 Identities = 53/265 (20%), Positives = 101/265 (38%), Gaps = 16/265 (6%)

Query: 10  KKRWTL--NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREV 67
           +  W +      + + LG G+FG V++      +  VA+K L +     S        E 
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG----SMSPDAFLAEA 59

Query: 68  EIQSHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--FSERRAATYVASL 125
            +   L+H  ++RLY     +  +Y+I EY   G L   L+       +  +     A +
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 126 ARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV----HTFNRRRTMCGTLDYLP 181
           A  + +   ++ IHRD++  N+L+      KIADFG +     + +  R      + +  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 182 PEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSS 240
           PE +         D+WS G+L  E + +G  P+    + +  + + +   +         
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPDNCPE 237

Query: 241 AAKDLISQMLVKDSSQRLPLHKLLE 265
               L+     +    R     L  
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRS 262

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 5e-60
 Identities = 78/304 (25%), Positives = 129/304 (42%), Gaps = 40/304 (13%)

Query: 10  KKRWTLND-FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVE 68
           K  W +   +   +P+G G +G V  A + R+   VA+K L++    +   + +  RE+ 
Sbjct: 11  KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RAYRELR 69

Query: 69  IQSHLRHPNILRLYGYFYDQKR------VYLILEYAAKGELYKELQKCKYFSERRAATYV 122
           +  H+RH N++ L   F   +        YL++ +   G    +L K +   E R    V
Sbjct: 70  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLV 127

Query: 123 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPP 182
             + + L Y H   +IHRD+KP NL +    ELKI DFG +    +       T  Y  P
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAP 187

Query: 183 EMV-ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK------ 235
           E++   + +   VDIWS+G +  E + G   F+  +H D  + I++V    P +      
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247

Query: 236 -----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN 272
                                     S  A +L+ +MLV D+ QR+   + L HP+    
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

Query: 273 ADPS 276
            D  
Sbjct: 308 HDTE 311

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (487), Expect = 6e-60
 Identities = 74/295 (25%), Positives = 123/295 (41%), Gaps = 35/295 (11%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
             +    P+G G +G V  A + ++   VA+K L +        + +  RE+ +  H++H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTYRELRLLKHMKH 76

Query: 76  PNILRLYGYFYDQKRV----YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
            N++ L   F   + +     + L     G     + KC+  ++      +  + R L Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPE-MVESVEH 190
            H   +IHRD+KP NL +    ELKI DFG + HT +       T  Y  PE M+  + +
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHY 196

Query: 191 DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--------------- 235
           +  VDIWS+G +  E L G   F   +H D  + I+++      +               
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256

Query: 236 --------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
                            +  A DL+ +MLV DS +R+   + L H +  Q  DP 
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 9e-60
 Identities = 67/293 (22%), Positives = 129/293 (44%), Gaps = 33/293 (11%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           +  ++  + +G G +G V+ A+ + ++ IVALK +      +        RE+ +   L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS-SALREICLLKELK 59

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           H NI+RL+   +  K++ L+ E+  +                   +++  L + L +CH 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSV---HTFNRRRTMCGTLDYLPPEMVESVE-H 190
           ++V+HRD+KP+NLLI   GELK+A+FG +               TL Y PP+++   + +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 191 DANVDIWSLGVLCYEFLYG-VPPFEAKEHSDTYRRIVQVDLKFPPK-------------- 235
             ++D+WS G +  E      P F   +  D  +RI ++      +              
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 236 -------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP 275
                        P +++  +DL+  +L  +  QR+   + L+HP+      P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 9e-60
 Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 47/300 (15%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHP 76
            +   K +G G FG VY A+   S  +VA+K + +        +    RE++I   L H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHC 73

Query: 77  NILRLYGYFY------DQKRVYLILEYAAKG---ELYKELQKCKYFSERRAATYVASLAR 127
           NI+RL  +FY      D+  + L+L+Y  +          +  +         Y+  L R
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 128 ALIYCHGKHVIHRDIKPENLLIGAQGEL-KIADFGWSVHTFNRRR---TMCGTLDYLPPE 183
           +L Y H   + HRDIKP+NLL+     + K+ DFG +            +C      P  
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193

Query: 184 MVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--------------- 228
           +  + ++ +++D+WS G +  E L G P F      D    I++V               
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 229 --DLKFP----------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPS 276
             + KFP           +P     A  L S++L    + RL   +   H +  +  DP+
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-59
 Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 18/279 (6%)

Query: 16  NDFDIGK-PLGRGKFGHVYLA--REKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
           ++  I    LG G FG V     R ++    VA+KVL +   +      ++ RE +I   
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQ 65

Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYKEL-QKCKYFSERRAATYVASLARALIY 131
           L +P I+RL G    +  + L++E A  G L+K L  K +       A  +  ++  + Y
Sbjct: 66  LDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSV------HTFNRRRTMCGTLDYLPPEMV 185
              K+ +HRD+   N+L+  +   KI+DFG S         +  R      L +  PE +
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 186 ESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
              +  +  D+WS GV  +E L YG  P++  +  +    I Q   +    P        
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECPPELYA 243

Query: 245 LISQMLVKDSSQRLP---LHKLLEHPWIIQNADPSGVYR 280
           L+S   +     R     + + +   +    +   G + 
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 282

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-58
 Identities = 46/258 (17%), Positives = 97/258 (37%), Gaps = 9/258 (3%)

Query: 17  DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFK--SQLQQSQVEHQLRREVEIQSHLR 74
           +F   K LG G FG VY          V + V  K   +    +   ++  E  + + + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 75  HPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
           +P++ RL G         +         L    +       +    +   +A+ + Y   
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 135 KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTM-----CGTLDYLPPEMVESVE 189
           + ++HRD+   N+L+     +KI DFG +       +          + ++  E +    
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189

Query: 190 HDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ 248
           +    D+WS GV  +E + +G  P++    S+    + +   + P  PI +     ++ +
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQPPICTIDVYMIMVK 248

Query: 249 MLVKDSSQRLPLHKLLEH 266
             + D+  R    +L+  
Sbjct: 249 CWMIDADSRPKFRELIIE 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (473), Expect = 2e-58
 Identities = 52/287 (18%), Positives = 101/287 (35%), Gaps = 28/287 (9%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
           N + +G+ +G G FG +YL  +  +   VA+K+             QL  E +I   ++ 
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQG 61

Query: 76  PNILRLYGYFY-DQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG 134
              +    +   +     +++E              + FS +        +   + Y H 
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 135 KHVIHRDIKPENLLI---GAQGELKIADFGWS----------VHTFNRRRTMCGTLDYLP 181
           K+ IHRD+KP+N L+        + I DFG +             +   + + GT  Y  
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI---- 237
                 +E     D+ SLG +   F  G  P++  + +   ++  ++  K    PI    
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241

Query: 238 --VSSAAKDLISQMLVKDSSQRLP---LHKLLEHPWIIQNADPSGVY 279
               S     ++         +     L +L  + +  Q      V+
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 1e-57
 Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 13/260 (5%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSH 72
              ++G+ +G G+FG V+        +    VA+K           V  +  +E      
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 64

Query: 73  LRHPNILRLYGYFYDQKRVYLILEYAAKGELYK-ELQKCKYFSERRAATYVASLARALIY 131
             HP+I++L G   +   V++I+E    GEL      +           Y   L+ AL Y
Sbjct: 65  FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 132 CHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH----TFNRRRTMCGTLDYLPPEMVES 187
              K  +HRDI   N+L+ +   +K+ DFG S +    T+ +       + ++ PE +  
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 188 VEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI 246
               +  D+W  GV  +E L +GV PF+  +++D   RI   + + P  P        L+
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLM 242

Query: 247 SQMLVKDSSQRLPLHKLLEH 266
           ++    D S+R    +L   
Sbjct: 243 TKCWAYDPSRRPRFTELKAQ 262

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-56
 Identities = 57/288 (19%), Positives = 108/288 (37%), Gaps = 34/288 (11%)

Query: 10  KKRWTL--NDFDIGKPLGRGKFGHVYLAR-----EKRSNHIVALKVLFKSQLQQSQVEHQ 62
             +W    N    GK LG G FG V  A      +  +   VA+K+L  S          
Sbjct: 15  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REA 72

Query: 63  LRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY--------- 112
           L  E+++ S+L  H NI+ L G         +I EY   G+L   L++ +          
Sbjct: 73  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132

Query: 113 ---------FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWS 163
                           ++   +A+ + +   K+ IHRD+   N+L+      KI DFG +
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 164 VHTFNRRRTM-----CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKE 217
               N    +        + ++ PE + +  +    D+WS G+  +E    G  P+    
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 218 HSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE 265
               + ++++   +        +   D++      D  +R    ++++
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (458), Expect = 5e-56
 Identities = 61/289 (21%), Positives = 116/289 (40%), Gaps = 41/289 (14%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
           N+ +  + +G G FG V+ AR           +VA+K+L +     + ++   +RE  + 
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 70

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY------------------ 112
           +   +PNI++L G     K + L+ EY A G+L + L+                      
Sbjct: 71  AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 113 ------FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT 166
                  S          +A  + Y   +  +HRD+   N L+G    +KIADFG S + 
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 167 FNRRR-----TMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSD 220
           ++             + ++PPE +    +    D+W+ GV+ +E   YG+ P+    H +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 221 TYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLP---LHKLLEH 266
               +   ++   P         +L+     K  + R     +H++L+ 
Sbjct: 251 VIYYVRDGNILACP-ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 6e-56
 Identities = 72/310 (23%), Positives = 127/310 (40%), Gaps = 52/310 (16%)

Query: 15  LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR 74
           L  +   KP+G G  G V  A +   +  VA+K L +    Q+  + +  RE+ +   + 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAYRELVLMKCVN 74

Query: 75  HPNILRLYGYFYDQK------RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
           H NI+ L   F  QK       VYL++E                    R +  +  +   
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---IQMELDHERMSYLLYQMLCG 131

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT--MCGTLDYLPPEMVE 186
           + + H   +IHRD+KP N+++ +   LKI DFG +              T  Y  PE++ 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 187 SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK----------- 235
            + +  NVDIWS+G +  E +     F  +++ D + ++++      P+           
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 236 -----------------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                                         + +S A+DL+S+MLV D ++R+ +   L+H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311

Query: 267 PWIIQNADPS 276
           P+I    DP+
Sbjct: 312 PYINVWYDPA 321

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-55
 Identities = 61/270 (22%), Positives = 108/270 (40%), Gaps = 20/270 (7%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQLQQSQVEHQLRREVEIQS 71
           +     K +G G+FG VY    K S+      VA+K L     ++ +V+     E  I  
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMG 64

Query: 72  HLRHPNILRLYGYFYDQKRVYLILEYAAKGELYK-ELQKCKYFSERRAATYVASLARALI 130
              H NI+RL G     K + +I EY   G L K   +K   FS  +    +  +A  + 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 131 YCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN------RRRTMCGTLDYLPPEM 184
           Y    + +HRD+   N+L+ +    K++DFG S    +              + +  PE 
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 185 VESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKD 244
           +   +  +  D+WS G++ +E +        +  +    + +    + P      SA   
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244

Query: 245 LISQMLVKDSSQRLP-------LHKLLEHP 267
           L+ Q   ++ ++R         L KL+  P
Sbjct: 245 LMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  178 bits (451), Expect = 1e-54
 Identities = 68/296 (22%), Positives = 133/296 (44%), Gaps = 52/296 (17%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR- 74
           +D+ + + LGRGK+  V+ A    +N  V +K+L   + +      +++RE++I  +LR 
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK------KIKREIKILENLRG 88

Query: 75  HPNILRLYGYFYDQ--KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYC 132
            PNI+ L     D   +   L+ E+    +  +  Q     ++     Y+  + +AL YC
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYC 145

Query: 133 HGKHVIHRDIKPENLLIGAQG-ELKIADFGWS--VHTFNRRRTMCGTLDYLPPEMVESVE 189
           H   ++HRD+KP N++I  +  +L++ D+G +   H          +  +  PE++   +
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205

Query: 190 -HDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQV-------------DLKFPP 234
            +D ++D+WSLG +    ++   PF    ++ D   RI +V             +++  P
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 235 K----------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPW 268
           +                       +VS  A D + ++L  D   RL   + +EHP+
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-53
 Identities = 70/290 (24%), Positives = 121/290 (41%), Gaps = 35/290 (12%)

Query: 9   EKKRWTL--NDFDIGKPLGRGKFGHVYLAREKRSNH-------IVALKVLFKSQLQQSQV 59
           E  RW L  +   +GKPLG G FG V LA     +         VA+K+L     ++   
Sbjct: 4   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 63

Query: 60  EHQLRREVEIQSHL-RHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKY------ 112
           +  L  E+E+   + +H NI+ L G       +Y+I+EYA+KG L + LQ  +       
Sbjct: 64  D--LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121

Query: 113 ----------FSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW 162
                      S +   +    +AR + Y   K  IHRD+   N+L+     +KIADFG 
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 181

Query: 163 S-----VHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAK 216
           +     +  + +       + ++ PE +    +    D+WS GVL +E    G  P+   
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241

Query: 217 EHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
              + ++ + +   +       ++    ++        SQR    +L+E 
Sbjct: 242 PVEELFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  167 bits (424), Expect = 4e-51
 Identities = 50/287 (17%), Positives = 94/287 (32%), Gaps = 30/287 (10%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH-P 76
           + +G+ +G G FG ++      +N  VA+K   +          QLR E      L    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCT 61

Query: 77  NILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH 136
            I  +Y +  +     L+++              + FS +  A     +   +   H K 
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 137 VIHRDIKPENLLIGAQ-----GELKIADFGWS----------VHTFNRRRTMCGTLDYLP 181
           +++RDIKP+N LIG         + + DFG               +  ++ + GT  Y+ 
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 182 PEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPI---- 237
                  E     D+ +LG +   FL G  P++  + +   ++  ++  K    P+    
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 238 --VSSAAKDLISQMLVKDSSQRLP---LHKLLEHPWIIQNADPSGVY 279
                     +                L  L        N      +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 6e-51
 Identities = 47/272 (17%), Positives = 99/272 (36%), Gaps = 24/272 (8%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ 70
               + + LG+G FG VY    K          VA+K + ++   + ++E     E  + 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVM 77

Query: 71  SHLRHPNILRLYGYFYDQKRVYLILEYAAKGELYKELQKCKYF----------SERRAAT 120
                 +++RL G     +   +I+E   +G+L   L+  +            S  +   
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 121 YVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW-----SVHTFNRRRTMCG 175
               +A  + Y +    +HRD+   N ++     +KI DFG          + +      
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 176 TLDYLPPEMVESVEHDANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPP 234
            + ++ PE ++        D+WS GV+ +E       P++   +    R +++  L   P
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257

Query: 235 KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
                    +L+      +   R    +++  
Sbjct: 258 DNC-PDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 2e-50
 Identities = 49/256 (19%), Positives = 99/256 (38%), Gaps = 16/256 (6%)

Query: 24  LGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILR 80
           +GRG FG VY      ++      A+K L +          Q   E  I     HPN+L 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPNVLS 92

Query: 81  LYGYFYD-QKRVYLILEYAAKGELYK-ELQKCKYFSERRAATYVASLARALIYCHGKHVI 138
           L G     +    ++L Y   G+L      +    + +    +   +A+ + +   K  +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152

Query: 139 HRDIKPENLLIGAQGELKIADFGWS-------VHTFNRRRTMCGTLDYLPPEMVESVEHD 191
           HRD+   N ++  +  +K+ADFG +         + + +      + ++  E +++ +  
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212

Query: 192 ANVDIWSLGVLCYEFL-YGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML 250
              D+WS GVL +E +  G PP+      D    ++Q   +            +++ +  
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVMLKCW 271

Query: 251 VKDSSQRLPLHKLLEH 266
              +  R    +L+  
Sbjct: 272 HPKAEMRPSFSELVSR 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 6e-50
 Identities = 57/288 (19%), Positives = 108/288 (37%), Gaps = 31/288 (10%)

Query: 9   EKKRWTL--NDFDIGKPLGRGKFGHVYLAREKRSNH-----IVALKVLFKSQLQQSQVEH 61
           +  +W    +   +GKPLGRG FG V  A     +       VA+K+L +          
Sbjct: 4   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 63

Query: 62  QLRREVEIQSHLRHPNILRLYGYFY-DQKRVYLILEYAAKGELYKELQKCK--------- 111
            +     +     H N++ L G        + +I+E+   G L   L+  +         
Sbjct: 64  -MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122

Query: 112 -------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV 164
                  + +      Y   +A+ + +   +  IHRD+   N+L+  +  +KI DFG + 
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 182

Query: 165 H-----TFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGV-PPFEAKEH 218
                  + R+      L ++ PE +    +    D+WS GVL +E       P+   + 
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242

Query: 219 SDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH 266
            + + R ++   +       +      +      + SQR    +L+EH
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-46
 Identities = 51/295 (17%), Positives = 100/295 (33%), Gaps = 52/295 (17%)

Query: 16  NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH 75
               + + +G+G+FG V+  + +     VA+K+    + +    E     E+     LRH
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFRE----AEIYQTVMLRH 56

Query: 76  PNILRLYGYFYDQ----KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIY 131
            NIL              +++L+ +Y   G L+  L +     E        S A  L +
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAH 115

Query: 132 CH--------GKHVIHRDIKPENLLIGAQGELKIADFG-------WSVHTFNRRRTMCGT 176
            H           + HRD+K +N+L+   G   IAD G        +           GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 177 LDYLPPEMVES------VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIV---- 226
             Y+ PE+++        E     DI+++G++ +E           E        +    
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 227 -------------QVDLKFPPKPI---VSSAAKDLISQMLVKDSSQRLPLHKLLE 265
                        ++    P +            ++ +    + + RL   ++ +
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  145 bits (366), Expect = 7e-42
 Identities = 59/317 (18%), Positives = 106/317 (33%), Gaps = 65/317 (20%)

Query: 18  FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLR-------REVEIQ 70
           + + + LG G F  V+LA++  +N  VA+K++   ++     E +++        +   +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 71  SHLRHPNILRLYGYFYDQKRVYLIL-----EYAAKGELYKELQKCKYFSERRAATYVASL 125
             +   +IL+L  +F  +    + +               +  + +             L
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 126 ARALIYCHGKH-VIHRDIKPENLLIGAQG------ELKIADFGWSVHTFNRRRTMCGTLD 178
              L Y H +  +IH DIKPEN+L+          ++KIAD G +            T +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 179 YLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL-------- 230
           Y  PE++         DIWS   L +E + G   FE  E     +    +          
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 231 --------------------------------------KFPPKPIVSSAAKDLISQMLVK 252
                                                 K+      +    D +S ML  
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 253 DSSQRLPLHKLLEHPWI 269
           D  +R     L+ HPW+
Sbjct: 315 DPRKRADAGGLVNHPWL 331

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 93.7 bits (232), Expect = 6e-24
 Identities = 28/192 (14%), Positives = 56/192 (29%), Gaps = 20/192 (10%)

Query: 20  IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQV-------EHQLRREVEIQSH 72
           IGK +G GK   V+    ++      +K          +V       +          + 
Sbjct: 4   IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 73  LRHPNILRLYG----YFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARA 128
                + +L G      Y  +   +++E            +            +  +   
Sbjct: 63  NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEE 115

Query: 129 LIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESV 188
           +   + + ++H D+   N+L+  +G + I DF  SV             D        S 
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174

Query: 189 EHDANVDIWSLG 200
            +    DI S  
Sbjct: 175 TYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	281
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.67
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.16
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.13
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.26
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.24
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.09

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-66  Score=416.46  Aligned_cols=259  Identities=67%  Similarity=1.170  Sum_probs=237.2

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .|.+++|++++.||+|+||+||+|+++.+++.||+|++...........+.+.+|++++++++||||+++++++.+++.+
T Consensus         2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   81 (263)
T d2j4za1           2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   81 (263)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence            68899999999999999999999999999999999999766544444556788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-c
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-R  170 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-~  170 (281)
                      ++||||+++++|.+++...+++++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++...... .
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~  161 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  161 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence            999999999999999998888999999999999999999999999999999999999999999999999998665443 3


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......+.  .+|.++.++|.+||
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L  239 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLL  239 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHT
T ss_pred             cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHc
Confidence            4457899999999999999999999999999999999999999998888888888777655544  68999999999999


Q ss_pred             ccCCCCCCChhhhhcCCccccC
Q 038249          251 VKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       251 ~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ++||++|||++|+|+||||.++
T Consensus       240 ~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         240 KHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             CSSGGGSCCHHHHHTCHHHHHH
T ss_pred             cCCHhHCcCHHHHHcCcCcCCc
Confidence            9999999999999999999754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-63  Score=403.04  Aligned_cols=258  Identities=30%  Similarity=0.556  Sum_probs=222.9

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++......  ...+.+.+|++++++++||||+++++++.+++.+++|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            57899999999999999999999999999999999655422  2345688999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-----
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-----  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-----  169 (281)
                      |||+++++|.++++..+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......     
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            999999999999988888999999999999999999999999999999999999999999999999998653221     


Q ss_pred             cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCch-HHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHS-DTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..................++.++.+||.
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  241 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence            234578999999999987775 56799999999999999999999775544 3344444444444445678999999999


Q ss_pred             HhcccCCCCCCChhhhhcCCccccCCC
Q 038249          248 QMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      +||+.||++|||++|+|+||||+++.+
T Consensus       242 ~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         242 KILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence            999999999999999999999998754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-62  Score=405.32  Aligned_cols=257  Identities=37%  Similarity=0.701  Sum_probs=237.9

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      |.+++|++++.||+|+||+||+|+++.+|+.||+|++...........+.+.+|+.++++++||||+++++++.+.+.++
T Consensus         1 ~sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CchhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            56889999999999999999999999999999999997654444444567889999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCccc
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRT  172 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~  172 (281)
                      +||||++|++|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~  160 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT  160 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999887777777


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......+.  .++.++.++|.+||..
T Consensus       161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~  238 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLITR  238 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCS
T ss_pred             ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhh
Confidence            88999999999999999999999999999999999999999999998988888887665544  6999999999999999


Q ss_pred             CCCCCC-----ChhhhhcCCcccc
Q 038249          253 DSSQRL-----PLHKLLEHPWIIQ  271 (281)
Q Consensus       253 ~p~~Rp-----s~~eil~~~~~~~  271 (281)
                      ||.+|+     |++++++||||++
T Consensus       239 dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         239 DLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             CHHhccccchhhHHHHHcCccccc
Confidence            999996     8999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-62  Score=402.30  Aligned_cols=258  Identities=34%  Similarity=0.605  Sum_probs=231.0

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++...........+.+.+|++++++++||||+++++++.+.+.++
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            34578999999999999999999999999999999997655444444567899999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---  169 (281)
                      +||||++|++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++......   
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999998654322   


Q ss_pred             --cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          170 --RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......++.  .++.++++||+
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~  242 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVE  242 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT--TCCHHHHHHHH
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc--cCCHHHHHHHH
Confidence              23356899999999999999999999999999999999999999998888888888877665543  68999999999


Q ss_pred             HhcccCCCCCCChhh------hhcCCccccC
Q 038249          248 QMLVKDSSQRLPLHK------LLEHPWIIQN  272 (281)
Q Consensus       248 ~~l~~~p~~Rps~~e------il~~~~~~~~  272 (281)
                      +||+.||++|||++|      +++||||+..
T Consensus       243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            999999999999998      5789999753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-62  Score=399.10  Aligned_cols=254  Identities=26%  Similarity=0.466  Sum_probs=225.5

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      ++|++.+.||+|+||+||+|.++.+|+.||+|++.......   .+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            46999999999999999999999999999999997554332   356889999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---Cccc
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RRRT  172 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~~~  172 (281)
                      ||++|++|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++.+|++||+|||++.....   ....
T Consensus        97 Ey~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            999999999988764 599999999999999999999999999999999999999999999999999865432   2345


Q ss_pred             ccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc-cccCCCCCCCCHHHHHHHHHhcc
Q 038249          173 MCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV-DLKFPPKPIVSSAAKDLISQMLV  251 (281)
Q Consensus       173 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~  251 (281)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+........ ......+..++.++++||.+||+
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  255 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence            56999999999999999999999999999999999999999988877766655443 33444455789999999999999


Q ss_pred             cCCCCCCChhhhhcCCccccCC
Q 038249          252 KDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       252 ~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      +||++|||+.|+|+||||+...
T Consensus       256 ~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         256 MDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CChhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999998543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.5e-62  Score=401.91  Aligned_cols=258  Identities=27%  Similarity=0.436  Sum_probs=232.6

Q ss_pred             CceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEe
Q 038249           17 DFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILE   96 (281)
Q Consensus        17 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   96 (281)
                      .|+.++.||+|+||+||+|+++.+|+.||||++...........+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            39999999999999999999999999999999987766666667789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCcccccCc
Q 038249           97 YAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGT  176 (281)
Q Consensus        97 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (281)
                      |+++++|..++...+++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... .....||
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-~~~~~GT  174 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANSFVGT  174 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-BCCCCSC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-CCccccC
Confidence            999999988888778899999999999999999999999999999999999999999999999999865433 3456799


Q ss_pred             CCccCCccccC---CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 038249          177 LDYLPPEMVES---VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKD  253 (281)
Q Consensus       177 ~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  253 (281)
                      +.|+|||++.+   ..++.++|||||||++|+|++|..||.+.+..+....+............+|.++.+||.+||+.|
T Consensus       175 ~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d  254 (309)
T d1u5ra_         175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI  254 (309)
T ss_dssp             GGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSS
T ss_pred             ccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCC
Confidence            99999999853   457889999999999999999999999888888877777766555555678999999999999999


Q ss_pred             CCCCCChhhhhcCCccccCCCC
Q 038249          254 SSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       254 p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      |++|||++|+|+||||.+...+
T Consensus       255 P~~Rpt~~ell~Hp~~~~~~~~  276 (309)
T d1u5ra_         255 PQDRPTSEVLLKHRFVLRERPP  276 (309)
T ss_dssp             GGGSCCHHHHTTCHHHHSCCCT
T ss_pred             hhHCcCHHHHHhCHHhcCCCCc
Confidence            9999999999999999876443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-61  Score=402.91  Aligned_cols=258  Identities=36%  Similarity=0.633  Sum_probs=235.3

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      ++++++|++++.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+.++++++||||+++++++.+.+.+
T Consensus         1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            46789999999999999999999999999999999999766543333456688999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---
Q 038249           92 YLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---  168 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---  168 (281)
                      ++||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++.....   
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999865433   


Q ss_pred             CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          169 RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                      .....+||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..+....+......++.  .++.++.+||++
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~  238 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAG  238 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHh
Confidence            234467899999999999999999999999999999999999999999999988888887766554  699999999999


Q ss_pred             hcccCCCCCCC-----hhhhhcCCcccc
Q 038249          249 MLVKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       249 ~l~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      ||++||++|++     ++|+++||||++
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             hccCCchhhcccccccHHHHHcCccccc
Confidence            99999999995     899999999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-61  Score=392.51  Aligned_cols=254  Identities=28%  Similarity=0.517  Sum_probs=215.7

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe--CCEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD--QKRV   91 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~   91 (281)
                      +.++|++.+.||+|+||+||+|+++.+|+.||+|.+...... +...+.+.+|++++++++||||+++++++.+  ++.+
T Consensus         2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            357899999999999999999999999999999999776544 3446778899999999999999999999864  4578


Q ss_pred             EEEEeccCCCChhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC-----ceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           92 YLILEYAAKGELYKELQK----CKYFSERRAATYVASLARALIYCHGKH-----VIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      ++||||+++++|.+++..    ...+++..++.++.||+.||.|||+.|     |+||||||+||+++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            999999999999998863    457999999999999999999999876     99999999999999999999999999


Q ss_pred             cccccCC---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCC
Q 038249          163 SVHTFNR---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVS  239 (281)
Q Consensus       163 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (281)
                      +......   .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....... ....+|
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s  239 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-IPYRYS  239 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-CCTTSC
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCcccC
Confidence            8654332   234578999999999999999999999999999999999999999988888888777665432 234789


Q ss_pred             HHHHHHHHHhcccCCCCCCChhhhhcCCcc
Q 038249          240 SAAKDLISQMLVKDSSQRLPLHKLLEHPWI  269 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps~~eil~~~~~  269 (281)
                      +++.++|.+||+.||++|||+.|+|+|||+
T Consensus       240 ~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         240 DELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            999999999999999999999999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-61  Score=396.50  Aligned_cols=255  Identities=32%  Similarity=0.618  Sum_probs=214.7

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.|++.+.||+|+||+||+|+++.+|+.||+|++.......  ....+.+|+.++++++||||+++++++.+++.+++||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56999999999999999999999999999999997654332  2356788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC---CCCcEEEeeecCcccccCC--c
Q 038249           96 EYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG---AQGELKIADFGWSVHTFNR--R  170 (281)
Q Consensus        96 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~---~~~~~~l~dfg~~~~~~~~--~  170 (281)
                      ||++|++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||++.   .++.+||+|||++......  .
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            9999999999999888899999999999999999999999999999999999995   4789999999998654332  3


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCCCHHHHHHHHH
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIVSSAAKDLISQ  248 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~  248 (281)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.......+  ..+.+|.++.+||.+
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  246 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH  246 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence            445789999999999999999999999999999999999999999888888888777655443  335789999999999


Q ss_pred             hcccCCCCCCChhhhhcCCccccC
Q 038249          249 MLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ||++||++|||++|+++||||+..
T Consensus       247 ~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         247 LMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999854

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-61  Score=393.54  Aligned_cols=254  Identities=28%  Similarity=0.476  Sum_probs=223.8

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLIL   95 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   95 (281)
                      +.|++++.||+|+||+||+|+++.+|..||+|++.....   ...+.+.+|++++++++||||+++++++.+++.+++||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            358999999999999999999999999999999865432   22456788999999999999999999999999999999


Q ss_pred             eccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           96 EYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        96 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      ||+++++|.+++.+ .+++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......   ..
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            99999999998764 567999999999999999999999999999999999999999999999999998543322   23


Q ss_pred             cccCcCCccCCccc-----cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc-CCCCCCCCHHHHHH
Q 038249          172 TMCGTLDYLPPEMV-----ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK-FPPKPIVSSAAKDL  245 (281)
Q Consensus       172 ~~~~~~~~~aPE~~-----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  245 (281)
                      ...||+.|+|||++     .+..++.++|||||||++|+|++|..||...+..+....+...... ......++.++.+|
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l  248 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF  248 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            56789999999997     3456789999999999999999999999998888888777665432 33345689999999


Q ss_pred             HHHhcccCCCCCCChhhhhcCCccccC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      |.+||++||++|||+.|+|+||||+..
T Consensus       249 i~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         249 LKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999854

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-61  Score=403.36  Aligned_cols=259  Identities=35%  Similarity=0.603  Sum_probs=236.9

Q ss_pred             cccccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ....+++|++++.||+|+||+||+|+++.+|+.||||++...........+.+.+|+++++.++||||+++++++.+.+.
T Consensus        36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  115 (350)
T d1rdqe_          36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc
Confidence            34557899999999999999999999999999999999976544433445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR  170 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~  170 (281)
                      .++|+||+.+++|...+...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|++||+|||++....+..
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~  195 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999998877777


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+.  .++.++.++|++||
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L  273 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHS
T ss_pred             ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHh
Confidence            7778999999999999999999999999999999999999999998888888888777655443  69999999999999


Q ss_pred             ccCCCCCC-----ChhhhhcCCcccc
Q 038249          251 VKDSSQRL-----PLHKLLEHPWIIQ  271 (281)
Q Consensus       251 ~~~p~~Rp-----s~~eil~~~~~~~  271 (281)
                      +.||++|+     |++|+++||||+.
T Consensus       274 ~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         274 QVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             hhCHHhccccccccHHHHHcCccccC
Confidence            99999995     8999999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-60  Score=400.59  Aligned_cols=258  Identities=30%  Similarity=0.587  Sum_probs=229.8

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .+++|++++.||+|+||+||+|+++.+|+.||+|++....   ....+.+.+|++++++++||||+++++++.+.+.+++
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4679999999999999999999999999999999996543   2335678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC--CCcEEEeeecCcccccCC-
Q 038249           94 ILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA--QGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~--~~~~~l~dfg~~~~~~~~-  169 (281)
                      ||||++|++|.+++. ..+.+++..++.++.||+.||.|||++||+|+||||+||+++.  ++.+||+|||++...... 
T Consensus       101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999999999999985 4467999999999999999999999999999999999999964  578999999998654433 


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHHHHH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAKDLI  246 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li  246 (281)
                       .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......+.  .+.++.++.+||
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  260 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI  260 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred             ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence             33467899999999999999999999999999999999999999998888888888776654443  246899999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                      .+||+.||++|||++|+|+||||++...
T Consensus       261 ~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         261 RKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             HHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             HHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            9999999999999999999999987643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-60  Score=385.97  Aligned_cols=251  Identities=24%  Similarity=0.461  Sum_probs=217.3

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe----CCEEEE
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD----QKRVYL   93 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~~   93 (281)
                      |++.+.||+|+||+||+|.++.+++.||+|.+....... ...+.+.+|++++++++||||+++++++..    ...+++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            477889999999999999999999999999997665433 345678999999999999999999999875    456899


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCeEeC-CCCcEEEeeecCcccccCC-
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKH--VIHRDIKPENLLIG-AQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~Ni~~~-~~~~~~l~dfg~~~~~~~~-  169 (281)
                      ||||+++++|.+++++.+.+++..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++...... 
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~  169 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF  169 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence            9999999999999998888999999999999999999999998  99999999999996 4789999999998654333 


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH-HHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD-TYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ..+.+..+..........+.++.++|.+
T Consensus       170 ~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  248 (270)
T d1t4ha_         170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG  248 (270)
T ss_dssp             BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred             cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHH
Confidence            345579999999999875 58999999999999999999999998765544 4455554433333344688999999999


Q ss_pred             hcccCCCCCCChhhhhcCCccc
Q 038249          249 MLVKDSSQRLPLHKLLEHPWII  270 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~~~~~  270 (281)
                      ||++||++|||++|+|+||||+
T Consensus       249 ~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         249 CIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-61  Score=400.00  Aligned_cols=258  Identities=26%  Similarity=0.468  Sum_probs=220.0

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +.-++|++++.||+|+||+||+|+++.+|+.||+|++....  .......+.+|+.++++++||||+++++++.+.+.++
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45678999999999999999999999999999999997543  2233567889999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-c
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-R  170 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-~  170 (281)
                      +||||++|++|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||+++.++++||+|||++...... .
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  160 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  160 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc
Confidence            999999999999999988889999999999999999999997 59999999999999999999999999998654332 3


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHH--------------------------
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRR--------------------------  224 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------------------------  224 (281)
                      ...+||+.|+|||++.+..++.++||||+||++++|++|..||...+..+....                          
T Consensus       161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY  240 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred             ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence            455799999999999999999999999999999999999999977554332110                          


Q ss_pred             ----------------HhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          225 ----------------IVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       225 ----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                                      .............++.++.+||.+||+.||++|||++|+|+||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                            000111111122467899999999999999999999999999999865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-60  Score=390.97  Aligned_cols=257  Identities=31%  Similarity=0.562  Sum_probs=229.2

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS---QVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++........   ...+.+.+|+.++++++||||+++++++.+.+.++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            579999999999999999999999999999999975543221   22467889999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC----cEEEeeecCcccccC
Q 038249           93 LILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG----ELKIADFGWSVHTFN  168 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~----~~~l~dfg~~~~~~~  168 (281)
                      +||||+++++|.+++...+.+++..++.++.||+.||+|||++||+|+||||+||+++.++    .+|++|||++.....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            9999999999999999888899999999999999999999999999999999999998877    599999999865433


Q ss_pred             --CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHHH
Q 038249          169 --RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAKD  244 (281)
Q Consensus       169 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~  244 (281)
                        ......+++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+.......+.  .+.+|.++.+
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  249 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD  249 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred             CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHH
Confidence              234457899999999999989999999999999999999999999999888888887776554442  2468999999


Q ss_pred             HHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          245 LISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       245 li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      ||++||+.||++|||++|+|+||||+..
T Consensus       250 li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         250 FIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999853

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-59  Score=382.09  Aligned_cols=258  Identities=29%  Similarity=0.490  Sum_probs=228.5

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccc------hHHHHHHHHHHHHHHhCC-CCceeeeeeEEEe
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ------SQVEHQLRREVEIQSHLR-HPNILRLYGYFYD   87 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~------~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~   87 (281)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.......      ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999999999999999997654321      233456789999999997 9999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      ++.+++||||+++++|.++++..+++++..++.++.||+.||+|||++||+|+||+|+||+++.++.+||+|||++....
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999986543


Q ss_pred             CC--cccccCcCCccCCcccc------CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCC
Q 038249          168 NR--RRTMCGTLDYLPPEMVE------SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPI  237 (281)
Q Consensus       168 ~~--~~~~~~~~~~~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~  237 (281)
                      ..  .....||+.|+|||.+.      ...++.++||||+||++++|++|..||...+..+....+..+....+  ....
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            32  34456899999999874      33467899999999999999999999999988888877777655433  3347


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          238 VSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      +|++++++|.+||++||++|||++|+|+||||++.
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            99999999999999999999999999999999874

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.9e-60  Score=395.16  Aligned_cols=256  Identities=30%  Similarity=0.535  Sum_probs=228.9

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .+++|++++.||+|+||+||+|+++.+|+.||+|++....   ......+.+|+.++++++||||+++++++.+++.+++
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i  103 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  103 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3567999999999999999999999999999999986543   2234568899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC--CCCcEEEeeecCcccccCC-
Q 038249           94 ILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG--AQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~--~~~~~~l~dfg~~~~~~~~-  169 (281)
                      ||||++|++|.+.+... .++++.+++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||++...... 
T Consensus       104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999999999887654 4699999999999999999999999999999999999998  5689999999998765433 


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC--CCCCCCHHHHHHH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP--PKPIVSSAAKDLI  246 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li  246 (281)
                       .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......+  ..+.++.++.+||
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  263 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI  263 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence             3345789999999999999999999999999999999999999999999888888877665444  3356899999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                      .+||+.||++|||+.|+|+||||+..
T Consensus       264 ~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         264 KNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-60  Score=390.98  Aligned_cols=255  Identities=31%  Similarity=0.602  Sum_probs=226.5

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCceeeeeeEEEeCCEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQ-SHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l-~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      +++|++++.||+|+||+||+|+++.+|+.||||++...........+.+..|..++ +.++||||+++++++.+++.+++
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            57899999999999999999999999999999999765433333334455566655 47899999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc---CCc
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF---NRR  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~---~~~  170 (281)
                      ||||+++|+|.+++.....+++.+++.++.||+.||+|||++|++|+||+|+|||++.++++||+|||++....   ...
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999986432   223


Q ss_pred             ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 038249          171 RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQML  250 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (281)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......+.  .+|.++.+||++||
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L  238 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLF  238 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHS
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHhc
Confidence            4457899999999999999999999999999999999999999999988888888777655443  68999999999999


Q ss_pred             ccCCCCCCChh-hhhcCCcccc
Q 038249          251 VKDSSQRLPLH-KLLEHPWIIQ  271 (281)
Q Consensus       251 ~~~p~~Rps~~-eil~~~~~~~  271 (281)
                      +.||++|||+. ++++||||++
T Consensus       239 ~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         239 VREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             CSSGGGSBTTBSCGGGSGGGTT
T ss_pred             ccCCCCCcCHHHHHHhCchhcc
Confidence            99999999996 8999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.7e-59  Score=393.31  Aligned_cols=258  Identities=27%  Similarity=0.454  Sum_probs=219.6

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHH---HHHHHHHHHHHhCCCCceeeeeeEEEeCCE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVE---HQLRREVEIQSHLRHPNILRLYGYFYDQKR   90 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~---~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (281)
                      ++++|++.+.||+|+||.||+|+++.+|+.||+|++...........   .....++.+++.++||||+++++++.+.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            67899999999999999999999999999999999965543322222   223345777888899999999999999999


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC-C
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN-R  169 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~-~  169 (281)
                      +++||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..... .
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~  161 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  161 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence            999999999999999999888899999999999999999999999999999999999999999999999999865433 3


Q ss_pred             cccccCcCCccCCcccc-CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhh-ccccCCCCCCCCHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVE-SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ-VDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  247 (281)
                      .....||+.|+|||++. +..++.++|||||||++|+|++|..||......+....... .......+..++.++.+||.
T Consensus       162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (364)
T d1omwa3         162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE  241 (364)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred             ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence            44567999999999986 45689999999999999999999999987665444332221 12223334469999999999


Q ss_pred             HhcccCCCCCCC-----hhhhhcCCcccc
Q 038249          248 QMLVKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       248 ~~l~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      +||+.||++|||     ++|+++||||++
T Consensus       242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         242 GLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            999999999999     799999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-59  Score=387.40  Aligned_cols=256  Identities=27%  Similarity=0.482  Sum_probs=228.2

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      .+++|++++.||+|+||+||+|.++.+|+.||+|++.....    ....+.+|+++++.++||||+++++++.+.+.+++
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            36889999999999999999999999999999999965432    23457899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC--CcEEEeeecCcccccCC-
Q 038249           94 ILEYAAKGELYKELQKCK-YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ--GELKIADFGWSVHTFNR-  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~--~~~~l~dfg~~~~~~~~-  169 (281)
                      ||||++|++|.+++...+ ++++.+++.++.||+.||+|||++||+||||+|+||+++.+  ..++++|||++...... 
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            999999999999998765 69999999999999999999999999999999999999855  47999999998654333 


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCC--CCCCCHHHHHHH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPP--KPIVSSAAKDLI  246 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li  246 (281)
                       .....+++.|+|||...+..++.++|||||||++|+|++|..||...+..+....+......++.  .+.++.++.+||
T Consensus       159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T d1tkia_         159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence             34456899999999999999999999999999999999999999999998888888777654442  246899999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccCC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .+||..||++|||++|+|+||||++..
T Consensus       239 ~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         239 DRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHccCChhHCcCHHHHhcCHhhccCc
Confidence            999999999999999999999998653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-58  Score=377.81  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=214.3

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEec
Q 038249           20 IGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQ--SQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEY   97 (281)
Q Consensus        20 ~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   97 (281)
                      .++.||+|+||+||+|+++.+|+.||+|++.......  ....+.+.+|+.++++++||||+++++++..++.+++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4678999999999999999999999999986554322  22235688999999999999999999999999999999999


Q ss_pred             cCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---ccccc
Q 038249           98 AAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RRTMC  174 (281)
Q Consensus        98 ~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~~~~  174 (281)
                      +.++++..+......+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++......   .....
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            999888777777778999999999999999999999999999999999999999999999999998654332   23456


Q ss_pred             CcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC--------------------C
Q 038249          175 GTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--------------------P  233 (281)
Q Consensus       175 ~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------~  233 (281)
                      +|+.|+|||.+.. ..++.++|||||||++++|++|.+||...+..+....+.......                    +
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            8999999999754 457899999999999999999999999888887776654321100                    0


Q ss_pred             C------CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          234 P------KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       234 ~------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      .      .+..+.++.+||.+||+.||++|||++|+|+||||++.+.+
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            0      12468899999999999999999999999999999987543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-57  Score=371.94  Aligned_cols=260  Identities=30%  Similarity=0.486  Sum_probs=214.5

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++.... ........+.+|++++++++||||+++++++.+++.+++|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            578999999999999999999999999999999996543 2223346788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC---Cc
Q 038249           95 LEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN---RR  170 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~---~~  170 (281)
                      |||+.++.+...... .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+.....   ..
T Consensus        80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred             EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence            999977544433333 45699999999999999999999999999999999999999999999999999855432   23


Q ss_pred             ccccCcCCccCCccccCCC-CCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc------------------
Q 038249          171 RTMCGTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK------------------  231 (281)
Q Consensus       171 ~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  231 (281)
                      ....+++.|+|||.+.... ++.++|+||||+++++|++|+.||...+..+....+......                  
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            3446899999999876655 578999999999999999999999988777665544321100                  


Q ss_pred             CC---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          232 FP---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       232 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      .+         ..+.++.++.+||++||.+||++|||++|+|+||||++..+|
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            00         012467899999999999999999999999999999987554

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=369.48  Aligned_cols=252  Identities=30%  Similarity=0.495  Sum_probs=213.1

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCC--CCceeeeeeEEEeCCE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQS---QVEHQLRREVEIQSHLR--HPNILRLYGYFYDQKR   90 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~---~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~   90 (281)
                      ++|++++.||+|+||+||+|+++.+|+.||||++........   .....+.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            579999999999999999999999999999999975543211   11123567899999886  8999999999999999


Q ss_pred             EEEEEeccCC-CChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC-CcEEEeeecCcccccC
Q 038249           91 VYLILEYAAK-GELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ-GELKIADFGWSVHTFN  168 (281)
Q Consensus        91 ~~~v~e~~~~-~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~-~~~~l~dfg~~~~~~~  168 (281)
                      .++|||++.+ +++.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999976 5788888888889999999999999999999999999999999999999865 7899999999865433


Q ss_pred             C-cccccCcCCccCCccccCCCC-CCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          169 R-RRTMCGTLDYLPPEMVESVEH-DANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       169 ~-~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                      . .....||+.|+|||.+.+..+ +.++|||||||++|+|++|..||...+      .+.......  ...+|.++.++|
T Consensus       164 ~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~--~~~~s~~~~~li  235 (273)
T d1xwsa_         164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF--RQRVSSECQHLI  235 (273)
T ss_dssp             SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC--SSCCCHHHHHHH
T ss_pred             ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCC--CCCCCHHHHHHH
Confidence            3 344578999999999876665 567899999999999999999996532      233333333  346999999999


Q ss_pred             HHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          247 SQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                      .+||+.||++|||++|+|+||||++...|
T Consensus       236 ~~~L~~dp~~R~s~~eil~hp~~~~~~~p  264 (273)
T d1xwsa_         236 RWCLALRPSDRPTFEEIQNHPWMQDVLLP  264 (273)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             HHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence            99999999999999999999999986543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=373.48  Aligned_cols=255  Identities=33%  Similarity=0.576  Sum_probs=211.8

Q ss_pred             cccccCCceecc-eecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHH-hCCCCceeeeeeEEEe-
Q 038249           11 KRWTLNDFDIGK-PLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQS-HLRHPNILRLYGYFYD-   87 (281)
Q Consensus        11 ~~~~~~~y~~~~-~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~-   87 (281)
                      +...+++|++.+ .||+|+||+||+|+++.+++.||||++...        ..+.+|+.++. ..+||||+++++++.+ 
T Consensus         6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            344568999875 599999999999999999999999998532        23567888765 4589999999999875 


Q ss_pred             ---CCEEEEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC---CCcEEEee
Q 038249           88 ---QKRVYLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA---QGELKIAD  159 (281)
Q Consensus        88 ---~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~---~~~~~l~d  159 (281)
                         ...+++||||++||+|.+++...  ..+++.+++.++.||+.||+|||+.||+||||||+||+++.   ++.+||+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence               46789999999999999999864  36999999999999999999999999999999999999985   45799999


Q ss_pred             ecCccccc--CCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHH----hhccccCC
Q 038249          160 FGWSVHTF--NRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRI----VQVDLKFP  233 (281)
Q Consensus       160 fg~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~  233 (281)
                      ||++....  .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+    ......++
T Consensus       158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            99986543  3334567999999999999999999999999999999999999999877665554433    22232232


Q ss_pred             C--CCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          234 P--KPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       234 ~--~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                      .  ...++.++.+||.+||+.||++|||++|+++||||++..
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            2  134889999999999999999999999999999998653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-56  Score=367.44  Aligned_cols=255  Identities=29%  Similarity=0.436  Sum_probs=215.2

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++++.||+|+||+||+|+++ +|+.||+|++...... ....+.+.+|+.++++++||||+++++.+..++..+++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            579999999999999999999997 7899999999665432 22346788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      ++++.++.+..+.+..+.+++..++.++.||+.||+|||++||+|+||||+||+++.++.+|++|||.+......   ..
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            999988777777777788999999999999999999999999999999999999999999999999998553322   23


Q ss_pred             cccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc-------------------
Q 038249          172 TMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK-------------------  231 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  231 (281)
                      ...+++.|.|||.+.+ ..++.++|+||||+++++|++|..||...+..+....+......                   
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            3457889999999865 45689999999999999999999999988777766554321100                   


Q ss_pred             --------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCcccc
Q 038249          232 --------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQ  271 (281)
Q Consensus       232 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~  271 (281)
                              ....+.++.++.+||++||++||++|||++|+|+||||++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                    0011347889999999999999999999999999999985

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-56  Score=365.45  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=212.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|+||+||+|.++.+++.||+|++..+...    .+.+.+|++++++++||||+++++++.+.+.+++
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            447899999999999999999999999999999998655422    3458899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-
Q 038249           94 ILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-  170 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-  170 (281)
                      ||||+++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999999998754  568999999999999999999999999999999999999999999999999987644332 


Q ss_pred             ---ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCC-CCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          171 ---RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       171 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                         ....+++.|+|||.+.+..++.++||||||+++|+|++|..|+ ...+..+....+ ......+....+|.++.+||
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li  249 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYELM  249 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHH
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCccchHHHHHHH
Confidence               2234678899999999889999999999999999999966655 444444444444 33344445557999999999


Q ss_pred             HHhcccCCCCCCChhhhhc
Q 038249          247 SQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~  265 (281)
                      .+||+.||++|||+.|+++
T Consensus       250 ~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         250 RACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.4e-56  Score=364.50  Aligned_cols=254  Identities=23%  Similarity=0.372  Sum_probs=210.5

Q ss_pred             hcccccCCceecceecccCceEEEEEEEccCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEE
Q 038249           10 KKRWTLNDFDIGKPLGRGKFGHVYLAREKRSNH---IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFY   86 (281)
Q Consensus        10 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (281)
                      ...+..++|++.+.||+|+||+||+|.++.+++   .+|+|.+....  .....+.+.+|++++++++||||+++++++.
T Consensus        20 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~   97 (299)
T d1jpaa_          20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVT   97 (299)
T ss_dssp             SCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             chhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            344567899999999999999999999987664   58888875443  3344567899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           87 DQKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                      .++.+++||||+++++|.+++... +.+++.++..++.||+.||.|||++|++||||||+||+++.++++||+|||++..
T Consensus        98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_          98 KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence            999999999999999999988764 5699999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc--------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCC
Q 038249          166 TFNRR--------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKP  236 (281)
Q Consensus       166 ~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (281)
                      .....        ....+|+.|+|||.+.+..++.++|||||||++|||+| |..||...+..+....+..+. ..+...
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~  256 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY-RLPPPM  256 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCT
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCc
Confidence            43221        12346889999999999999999999999999999997 899999988888777766543 334445


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          237 IVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .++.++.+++.+||+.||++|||+.||++.
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            799999999999999999999999999864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.4e-56  Score=362.51  Aligned_cols=254  Identities=28%  Similarity=0.436  Sum_probs=215.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC----E
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK----R   90 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~   90 (281)
                      -++|++.+.||+|+||+||+|++..+|+.||+|++.............+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999999999999999998766666666778999999999999999999999997643    4


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC--
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN--  168 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~--  168 (281)
                      .++||||++|++|.+.+...+++++.+++.++.||+.||+|||++||+|+||||+||+++.++..+++|||.+.....  
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            899999999999999999888999999999999999999999999999999999999999999999999998643322  


Q ss_pred             ----CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC--CCCCCCCHHH
Q 038249          169 ----RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF--PPKPIVSSAA  242 (281)
Q Consensus       169 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l  242 (281)
                          ......||+.|+|||++.+..++.++||||||+++|+|++|.+||...+..+............  ...+.+|.++
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  245 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL  245 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence                1233468999999999999999999999999999999999999999888887776665544332  2345689999


Q ss_pred             HHHHHHhcccCCCCCCC-hhhhhcCCcc
Q 038249          243 KDLISQMLVKDSSQRLP-LHKLLEHPWI  269 (281)
Q Consensus       243 ~~li~~~l~~~p~~Rps-~~eil~~~~~  269 (281)
                      .++|.+||++||++||+ ++++ .++|+
T Consensus       246 ~~li~~~L~~dp~~R~~sa~~l-~~~l~  272 (277)
T d1o6ya_         246 DAVVLKALAKNPENRYQTAAEM-RADLV  272 (277)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred             HHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence            99999999999999995 5554 45554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=355.46  Aligned_cols=247  Identities=26%  Similarity=0.438  Sum_probs=218.1

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|+||+||+|+++ ++..||||++......    .+.+.+|+.++++++||||+++++++.+++.+++
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            4578999999999999999999986 6788999999765533    2468899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---
Q 038249           94 ILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---  169 (281)
                      ||||+++|+|..++.. ...+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++......   
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            9999999999888654 456899999999999999999999999999999999999999999999999998543322   


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                       .....+|+.|+|||.+.+..++.++||||||+++|||+| |..||...+..+....+..+. ..+.+...+.++.++|.
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccccHHHHHHHH
Confidence             223457889999999998899999999999999999998 899999999888887776653 33444579999999999


Q ss_pred             HhcccCCCCCCChhhhhcC
Q 038249          248 QMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~  266 (281)
                      +||++||++|||+++|++|
T Consensus       236 ~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         236 SCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=369.73  Aligned_cols=250  Identities=24%  Similarity=0.388  Sum_probs=214.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCc-----EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNH-----IVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQ   88 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~-----~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~   88 (281)
                      .++|++++.||+|+||+||+|++..+++     .||+|.+....  .......+.+|+.+++++ +||||+++++++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            3789999999999999999999986543     58999885443  223345688899999988 899999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 038249           89 KRVYLILEYAAKGELYKELQKC-----------------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPE  145 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~  145 (281)
                      +.+++||||+++|+|.++++..                       ..+++..++.++.||+.||+|||++||+||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            9999999999999999999754                       24899999999999999999999999999999999


Q ss_pred             CeEeCCCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCch
Q 038249          146 NLLIGAQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHS  219 (281)
Q Consensus       146 Ni~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~  219 (281)
                      ||+++.++++||+|||++.......     ....+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999986543332     23446899999999999999999999999999999997 89999988887


Q ss_pred             HHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          220 DTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +....+.......+.+..+|+++.+||.+||+.||++|||++||++|
T Consensus       274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            77777666655555666899999999999999999999999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=366.93  Aligned_cols=262  Identities=26%  Similarity=0.431  Sum_probs=215.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-------
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-------   87 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------   87 (281)
                      +++|++++.||+|+||+||+|+++.+|+.||||++..+... ......+.+|+.++++++|||++++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            58899999999999999999999999999999998665432 2334567889999999999999999998854       


Q ss_pred             -CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           88 -QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        88 -~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                       .+.+++|||++.++.+.........+++..++.++.||+.||.|||+.||+||||||+||+++.++.++++|||++...
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence             3468999999988766666666677999999999999999999999999999999999999999999999999998433


Q ss_pred             c-------CCcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCCCC--C
Q 038249          167 F-------NRRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFPPK--P  236 (281)
Q Consensus       167 ~-------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~  236 (281)
                      .       .......+|+.|+|||.+.+. .++.++|||||||++++|++|..||.+.+.......+..........  .
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            2       122334689999999998654 68899999999999999999999998887776665544322111110  0


Q ss_pred             ----------------------------CCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCCCC
Q 038249          237 ----------------------------IVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADPSG  277 (281)
Q Consensus       237 ----------------------------~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~~~  277 (281)
                                                  ..+.++.+||.+||++||++|||++|+|+||||+..+.|+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~  316 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD  316 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence                                        13667889999999999999999999999999998877763

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=356.66  Aligned_cols=247  Identities=23%  Similarity=0.417  Sum_probs=207.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|+||+||+|+++ +++.||||++......    .+.+.+|++++++++||||+++++++..++..++
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence            4578999999999999999999987 5678999998654422    2468899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---
Q 038249           94 ILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---  169 (281)
                      ||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+||+++.++++||+|||++......   
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            99999999999988654 56899999999999999999999999999999999999999999999999998654332   


Q ss_pred             -cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          170 -RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       170 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                       .....+|+.|+|||++.+..++.++||||||+++|||+| |.+|+...+..+....+..+.. ...+...+.++.+++.
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-LYKPRLASTHVYQIMN  236 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC-CCCCTTSCHHHHHHHH
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC-CCCccccCHHHHHHHH
Confidence             223457889999999999999999999999999999998 5777777777777776655432 3333468999999999


Q ss_pred             HhcccCCCCCCChhhhhcC
Q 038249          248 QMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~  266 (281)
                      +||+.||++|||++||+++
T Consensus       237 ~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=359.29  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=207.5

Q ss_pred             ceecccCceEEEEEEEcc--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEEEeccC
Q 038249           22 KPLGRGKFGHVYLAREKR--SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        22 ~~ig~g~~~~v~~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      +.||+|+||+||+|.++.  +++.||+|++.... .+....+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            579999999999998754  45689999986544 334456778999999999999999999999865 45689999999


Q ss_pred             CCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC------cccc
Q 038249          100 KGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR------RRTM  173 (281)
Q Consensus       100 ~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~------~~~~  173 (281)
                      +|+|.+++....++++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||++......      ....
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            9999999999888999999999999999999999999999999999999999999999999998643322      1234


Q ss_pred             cCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 038249          174 CGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVK  252 (281)
Q Consensus       174 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (281)
                      .+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..+.. .+.+..+|.++.++|.+||+.
T Consensus       171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~~~~~~~li~~cl~~  249 (277)
T d1xbba_         171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-MGCPAGCPREMYDLMNLCWTY  249 (277)
T ss_dssp             CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-CCCCcccCHHHHHHHHHHcCC
Confidence            57889999999988889999999999999999997 8999999888877777665432 233447999999999999999


Q ss_pred             CCCCCCChhhhh---cCCcc
Q 038249          253 DSSQRLPLHKLL---EHPWI  269 (281)
Q Consensus       253 ~p~~Rps~~eil---~~~~~  269 (281)
                      ||++|||+.+|+   +++|+
T Consensus       250 dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         250 DVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             STTTSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHhhCHHh
Confidence            999999999984   56554

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=358.01  Aligned_cols=249  Identities=24%  Similarity=0.407  Sum_probs=207.9

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +..++|++.+.||+|+||+||+|+++   ..||||++....... ...+.+.+|+.++++++||||+++++++.+ +.++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~   79 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA   79 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence            34578999999999999999999765   359999997654333 346778999999999999999999998754 5679


Q ss_pred             EEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           93 LILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      +||||+++++|.+++... .++++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......  
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999999754 56999999999999999999999999999999999999999999999999998654322  


Q ss_pred             ---cccccCcCCccCCccccC---CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC----CCCCCC
Q 038249          170 ---RRTMCGTLDYLPPEMVES---VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP----PKPIVS  239 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~  239 (281)
                         .....+|+.|+|||++.+   ..++.++||||||+++|+|+||..||...+...............+    ....+|
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  239 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP  239 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence               233468999999999854   3478899999999999999999999998777766555444332222    234689


Q ss_pred             HHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          240 SAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +++.+++.+||+.||++|||+.||+++
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=363.57  Aligned_cols=257  Identities=24%  Similarity=0.373  Sum_probs=209.3

Q ss_pred             cCCceecceecccCceEEEEEEEccC-CcEEEEEEeecccccchHHHHHHHHHHHHHH---hCCCCceeeeeeEEEe---
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRS-NHIVALKVLFKSQLQQSQVEHQLRREVEIQS---HLRHPNILRLYGYFYD---   87 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~-~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~---~~~h~~i~~~~~~~~~---   87 (281)
                      -++|++++.||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+++   ..+||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            47899999999999999999999766 56799999865433221 1123445555554   4589999999999853   


Q ss_pred             --CCEEEEEEeccCCCChhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249           88 --QKRVYLILEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus        88 --~~~~~~v~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                        ...+++++|+++++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||++.
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              347899999999876654443 33568999999999999999999999999999999999999999999999999975


Q ss_pred             cccC--CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc-----------
Q 038249          165 HTFN--RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK-----------  231 (281)
Q Consensus       165 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  231 (281)
                      ....  ......||+.|+|||++.+..++.++|||||||++++|++|.+||...+..+....+......           
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  244 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  244 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence            4332  334567899999999999999999999999999999999999999988887776665432100           


Q ss_pred             --------------CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          232 --------------FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       232 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                                    ......++.++.+||.+||++||++|||++|+|+||||++-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                          00123478899999999999999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=356.98  Aligned_cols=251  Identities=20%  Similarity=0.354  Sum_probs=213.4

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   93 (281)
                      ..++|++.+.||+|+||+||+|.++ ++..||||++......    .+.+.+|++++++++||||+++++++.+ +..++
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            3489999999999999999999987 5778999999654422    3468899999999999999999998755 56689


Q ss_pred             EEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC--
Q 038249           94 ILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR--  169 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~--  169 (281)
                      ||||+++|+|.+.+...  .++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......  
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            99999999999877543  35899999999999999999999999999999999999999999999999998654332  


Q ss_pred             --cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhC-CCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHH
Q 038249          170 --RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYG-VPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLI  246 (281)
Q Consensus       170 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  246 (281)
                        .....+++.|+|||.+....++.++||||||+++|+|+|| .+|+...+..+....+..+. ..+....++.++.+++
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li  243 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-RMVRPDNCPEELYQLM  243 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CCCCcccChHHHHHHH
Confidence              2334578899999999888899999999999999999985 55666666667666665543 2333457999999999


Q ss_pred             HHhcccCCCCCCChhhhhc--CCcccc
Q 038249          247 SQMLVKDSSQRLPLHKLLE--HPWIIQ  271 (281)
Q Consensus       247 ~~~l~~~p~~Rps~~eil~--~~~~~~  271 (281)
                      .+||+.||++|||++++++  ++||..
T Consensus       244 ~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         244 RLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999999999998  788754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-55  Score=367.09  Aligned_cols=255  Identities=29%  Similarity=0.462  Sum_probs=213.2

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC-----
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK-----   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----   89 (281)
                      -++|++++.||+|+||+||+|.++.+|+.||+|++.... ......+.+.+|++++++++||||+++++++...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            389999999999999999999999999999999997654 34445677889999999999999999999997654     


Q ss_pred             -EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           90 -RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        90 -~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                       .+++||||+ +.+|....+. +.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++++|||++.....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             579999999 5577777765 4699999999999999999999999999999999999999999999999999988777


Q ss_pred             CcccccCcCCccCCccccC-CCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccC---------------
Q 038249          169 RRRTMCGTLDYLPPEMVES-VEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKF---------------  232 (281)
Q Consensus       169 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  232 (281)
                      ......+++.|+|||.+.+ ..++.++||||+||++++|++|.+||...+..+............               
T Consensus       174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (346)
T d1cm8a_         174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  253 (346)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence            7777889999999999765 456889999999999999999999998877666554433211100               


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccC
Q 038249          233 --------------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQN  272 (281)
Q Consensus       233 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~  272 (281)
                                    ......+.++.+||++||..||++|||++|+|+||||++-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                          0113578899999999999999999999999999999863

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-55  Score=356.25  Aligned_cols=252  Identities=24%  Similarity=0.331  Sum_probs=214.1

Q ss_pred             cCCceecce-ecccCceEEEEEEEcc--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           15 LNDFDIGKP-LGRGKFGHVYLAREKR--SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        15 ~~~y~~~~~-ig~g~~~~v~~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      -++|.+.+. ||+|+||+||+|.++.  ++..||||++....  .....+.+.+|++++++++||||+++++++.. +.+
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence            366888885 9999999999998764  34579999986543  33445678999999999999999999999865 567


Q ss_pred             EEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           92 YLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      ++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++...... 
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            899999999999998765 457999999999999999999999999999999999999999999999999998654322 


Q ss_pred             -----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHH
Q 038249          170 -----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAK  243 (281)
Q Consensus       170 -----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  243 (281)
                           .....+|+.|+|||.+....++.++||||||+++|||+| |..||...+..+....+..+.. .+.++.+|.++.
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~  242 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-MECPPECPPELY  242 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-CCCCTTCCHHHH
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCcCCHHHH
Confidence                 123457889999999988899999999999999999997 9999999888887777766543 333457999999


Q ss_pred             HHHHHhcccCCCCCCChhhh---hcCCccc
Q 038249          244 DLISQMLVKDSSQRLPLHKL---LEHPWII  270 (281)
Q Consensus       244 ~li~~~l~~~p~~Rps~~ei---l~~~~~~  270 (281)
                      ++|.+||+.||++|||+.+|   |+++|+.
T Consensus       243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999888   5677764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-54  Score=353.50  Aligned_cols=259  Identities=25%  Similarity=0.441  Sum_probs=219.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   94 (281)
                      +++|++++.||+|+||+||+|+++.+++.||||++..... .......+.+|+.+++.++||||+++++++.+....+++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            5789999999999999999999999999999999976653 334467788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC---cc
Q 038249           95 LEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR---RR  171 (281)
Q Consensus        95 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~---~~  171 (281)
                      ++++.++++..++...+.+++..++.++.|++.||+|||++||+|+||||+||+++.++.++++|||.+......   ..
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            999999999988888888999999999999999999999999999999999999999999999999998654332   23


Q ss_pred             cccCcCCccCCccccCCC-CCCcccHHhHHHHHHHHHhCCCCC-CCCCchHHHHHHhhccc-------------------
Q 038249          172 TMCGTLDYLPPEMVESVE-HDANVDIWSLGVLCYEFLYGVPPF-EAKEHSDTYRRIVQVDL-------------------  230 (281)
Q Consensus       172 ~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~-------------------  230 (281)
                      ...+++.|.|||.+.+.. ++.++|||||||++++|++|..|| ...+..+....+.....                   
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            344677899999886655 688999999999999999999885 44444444444322111                   


Q ss_pred             --------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          231 --------KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       231 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                              .....+.++.++.+||++||++||++|||++|+|+||||++.-.
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                    00111347789999999999999999999999999999987643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-54  Score=350.13  Aligned_cols=251  Identities=23%  Similarity=0.334  Sum_probs=207.6

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSN----HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~----~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      ....++|++.+.||+|+||+||+|.++.++    ..||||.+....  .......+.+|++++++++||||+++++++.+
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~   80 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK   80 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence            345678999999999999999999988654    469999986543  22334568899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                      .+..++|+||+.++++.+.+... +.+++.++..++.||+.|++|||+++|+||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence            99999999999999998887654 56999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhC-CCCCCCCCchHHHHHHhhccccCCCCCCCC
Q 038249          167 FNR------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYG-VPPFEAKEHSDTYRRIVQVDLKFPPKPIVS  239 (281)
Q Consensus       167 ~~~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (281)
                      ...      .....+|+.|+|||.+.+..++.++||||||+++|||+++ .+|+......+....+..+ ...+....++
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~  239 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMDCP  239 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCB
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-CCCCCchhhH
Confidence            322      1223578899999999999999999999999999999985 5556656666666555444 3344455799


Q ss_pred             HHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          240 SAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       240 ~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      .++.++|.+||+.||++|||+.||++
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=352.63  Aligned_cols=253  Identities=23%  Similarity=0.412  Sum_probs=210.5

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRVY   92 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (281)
                      +..++|++++.||+|+||+||+|+++++ +.||||++......    .+.+.+|+.++++++|+||+++++++.+ +.++
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            4459999999999999999999999854 56999999655432    2468899999999999999999999855 5578


Q ss_pred             EEEeccCCCChhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           93 LILEYAAKGELYKELQK--CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        93 ~v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      +||||+++|+|.+++..  .+.+++.+++.++.+|+.||+|||++|++|+||+|+||+++.++.+||+|||++...... 
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99999999999988754  356999999999999999999999999999999999999999999999999998654322 


Q ss_pred             ---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhC-CCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          170 ---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYG-VPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                         .....+++.|+|||.+....++.++||||||+++|+|++| .+|+......+....+... ...+....+++++.++
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~l  246 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDL  246 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHH
T ss_pred             ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCCcccCHHHHHH
Confidence               2335678999999999999999999999999999999995 4555555555566555443 3344556799999999


Q ss_pred             HHHhcccCCCCCCChhhhhc--CCccccC
Q 038249          246 ISQMLVKDSSQRLPLHKLLE--HPWIIQN  272 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~--~~~~~~~  272 (281)
                      |.+||+.||++|||+++|++  ++||...
T Consensus       247 i~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         247 MCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            99999999999999999997  8888765

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-54  Score=361.96  Aligned_cols=262  Identities=27%  Similarity=0.420  Sum_probs=217.5

Q ss_pred             cccc-CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC--
Q 038249           12 RWTL-NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ--   88 (281)
Q Consensus        12 ~~~~-~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--   88 (281)
                      +|.+ ++|++++.||+|+||+||+|+++.+|+.||||++..... +....+.+.+|++++++++|||++++++++...  
T Consensus        13 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~   91 (348)
T d2gfsa1          13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   91 (348)
T ss_dssp             EEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             cccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence            4553 789999999999999999999999999999999976543 334456788999999999999999999998632  


Q ss_pred             ---CEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           89 ---KRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        89 ---~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                         ...+++++++.+++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||.+..
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             cccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence               234556667778899999866 4599999999999999999999999999999999999999999999999999877


Q ss_pred             ccCCcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccccCC-----------
Q 038249          166 TFNRRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLKFP-----------  233 (281)
Q Consensus       166 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  233 (281)
                      .........+++.|+|||...+. .++.++||||||+++++|++|.+||.+.+.......+........           
T Consensus       171 ~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             CTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             cCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence            76666777889999999986554 468899999999999999999999988877766655543311110           


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCCC
Q 038249          234 ------------------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNADP  275 (281)
Q Consensus       234 ------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~~  275 (281)
                                        .....+.++.+||++||..||++|||++|+|+||||++...+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~  310 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  310 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence                              012478899999999999999999999999999999976443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-54  Score=349.92  Aligned_cols=252  Identities=24%  Similarity=0.356  Sum_probs=208.7

Q ss_pred             cccCCceecceecccCceEEEEEEEccC-C--cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRS-N--HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~-~--~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      +..++|++.+.||+|+||+||+|++..+ +  ..||||++...........+.+.+|+.++++++||||+++++++.+ +
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            4457899999999999999999987643 2  3689999877665566667789999999999999999999999976 4


Q ss_pred             EEEEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccC
Q 038249           90 RVYLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFN  168 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~  168 (281)
                      ..++|+||++++++.+.+.. .+++++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            66899999999999887765 35699999999999999999999999999999999999999999999999999865433


Q ss_pred             Cc------ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          169 RR------RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       169 ~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                      ..      ....++..|+|||.+.+..++.++||||||+++|||++ |.+||...+..+....+.......+....+|.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD  243 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence            21      22346778999999999899999999999999999997 899999999999888887766666666789999


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhc
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +.++|.+||++||++|||+.+|++
T Consensus       244 l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         244 IYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999973

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=358.55  Aligned_cols=261  Identities=33%  Similarity=0.587  Sum_probs=218.6

Q ss_pred             cccccCCceecceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhCCC-CceeeeeeEE
Q 038249           11 KRWTLNDFDIGKPLGRGKFGHVYLAREK---RSNHIVALKVLFKSQLQ-QSQVEHQLRREVEIQSHLRH-PNILRLYGYF   85 (281)
Q Consensus        11 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~lK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~   85 (281)
                      .+..+++|++++.||+|+||+||+|++.   .+|+.||||.+...... .....+.+.+|++++++++| |||+++++++
T Consensus        19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~   98 (322)
T d1vzoa_          19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   98 (322)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence            3456799999999999999999999974   46889999998654432 22223457789999999977 8999999999


Q ss_pred             EeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccc
Q 038249           86 YDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVH  165 (281)
Q Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~  165 (281)
                      .+.+.+++++||+.+++|.+.+...+.+++..++.++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999854


Q ss_pred             ccC----CcccccCcCCccCCccccCC--CCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcc--ccCCCCCC
Q 038249          166 TFN----RRRTMCGTLDYLPPEMVESV--EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVD--LKFPPKPI  237 (281)
Q Consensus       166 ~~~----~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~  237 (281)
                      ...    ......+++.|++||.+.+.  .++.++|||||||++++|++|..||...+..+....+....  ...+....
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence            322    22345689999999998554  46789999999999999999999998776655544443321  12223346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----hhhhhcCCcccc
Q 038249          238 VSSAAKDLISQMLVKDSSQRLP-----LHKLLEHPWIIQ  271 (281)
Q Consensus       238 ~~~~l~~li~~~l~~~p~~Rps-----~~eil~~~~~~~  271 (281)
                      ++.++.++|++||++||++|||     ++|+++||||++
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            9999999999999999999994     899999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-53  Score=356.51  Aligned_cols=252  Identities=29%  Similarity=0.449  Sum_probs=207.9

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC------C
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ------K   89 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~   89 (281)
                      -+|+.+++||+|+||+||+|+++.+|+.||||++......       ..+|++++++++|+||+++++++...      .
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            3699999999999999999999999999999999655322       23689999999999999999998642      3


Q ss_pred             EEEEEEeccCCCChhHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-cEEEeeecCccc
Q 038249           90 RVYLILEYAAKGELYKE---LQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWSVH  165 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~---~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-~~~l~dfg~~~~  165 (281)
                      ++++||||++++.+..+   ......+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            58999999987543333   23456799999999999999999999999999999999999999875 899999999865


Q ss_pred             ccC--CcccccCcCCccCCcccc-CCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhc--------------
Q 038249          166 TFN--RRRTMCGTLDYLPPEMVE-SVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQV--------------  228 (281)
Q Consensus       166 ~~~--~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------  228 (281)
                      ...  ......+++.|+|||.+. ...++.++||||+||++++|++|..||...+..+....+...              
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             ccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            432  234457899999999875 456899999999999999999999999888777665554321              


Q ss_pred             ---cccC----------CCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          229 ---DLKF----------PPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       229 ---~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                         ....          ...+..+.++.+||.+||..||++|||+.|+|+||||++..+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence               0000          112357889999999999999999999999999999987544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=355.72  Aligned_cols=258  Identities=28%  Similarity=0.436  Sum_probs=209.2

Q ss_pred             ccc-CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC--
Q 038249           13 WTL-NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK--   89 (281)
Q Consensus        13 ~~~-~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--   89 (281)
                      |.+ ++|++++.||+|+||+||+|.++.+|+.||||++....  .....+.+.+|++++++++||||+++++++....  
T Consensus         4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence            444 67999999999999999999999999999999996543  3344567889999999999999999999987543  


Q ss_pred             ---EEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccc
Q 038249           90 ---RVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHT  166 (281)
Q Consensus        90 ---~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~  166 (281)
                         .+++++ ++.+++|.++++.. .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        82 ~~~~~~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          82 QMKDVYLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             TCCCEEEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccceEEEEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence               345554 55688999999875 5999999999999999999999999999999999999999999999999998543


Q ss_pred             cCC------cccccCcCCccCCccc-cCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhcccc--------
Q 038249          167 FNR------RRTMCGTLDYLPPEMV-ESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDLK--------  231 (281)
Q Consensus       167 ~~~------~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  231 (281)
                      ...      .....+++.|+|||.+ ....++.++||||+||++++|++|..||...+..+...........        
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            222      2345688999999997 4556788999999999999999999999887765554433221000        


Q ss_pred             ------------CC---------CCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCCC
Q 038249          232 ------------FP---------PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNAD  274 (281)
Q Consensus       232 ------------~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~~  274 (281)
                                  .+         ..+.++.++.+||.+||+.||++|||++|+|+||||++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                        00         12357789999999999999999999999999999995533

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-54  Score=346.87  Aligned_cols=246  Identities=22%  Similarity=0.426  Sum_probs=207.0

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-CCEE
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-QKRV   91 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   91 (281)
                      +.+++|++++.||+|+||.||+|.++  |+.||+|++..+.     ..+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            45689999999999999999999986  7889999995442     23568899999999999999999999865 4668


Q ss_pred             EEEEeccCCCChhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC
Q 038249           92 YLILEYAAKGELYKELQKC--KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~  169 (281)
                      ++|+||+++|+|.+++...  ..+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++++|||++......
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            9999999999999998654  34899999999999999999999999999999999999999999999999999876666


Q ss_pred             cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 038249          170 RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDLISQ  248 (281)
Q Consensus       170 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (281)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+..+. ..+....++.++.++|.+
T Consensus       157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~  235 (262)
T d1byga_         157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPPAVYEVMKN  235 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-CCCCCTTCCHHHHHHHHH
T ss_pred             CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCccCCHHHHHHHHH
Confidence            666778899999999988899999999999999999998 799999888888887776543 333444789999999999


Q ss_pred             hcccCCCCCCChhhhhcC
Q 038249          249 MLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       249 ~l~~~p~~Rps~~eil~~  266 (281)
                      ||..||++|||+.+++++
T Consensus       236 cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         236 CWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HcccCHhHCcCHHHHHHH
Confidence            999999999999999863

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-52  Score=350.77  Aligned_cols=251  Identities=25%  Similarity=0.481  Sum_probs=206.6

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEe--CCE
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYD--QKR   90 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~   90 (281)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++....      .+.+.+|+++++++. ||||+++++++..  ...
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            4478999999999999999999999999999999985432      245788999999995 9999999999974  457


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCC-cEEEeeecCcccccC-
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQG-ELKIADFGWSVHTFN-  168 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~-~~~l~dfg~~~~~~~-  168 (281)
                      +++||||+++++|....   +.+++..++.++.||+.||+|||++||+|+||||+|||++.++ .++++|||++..... 
T Consensus       107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            89999999999987664   3599999999999999999999999999999999999998765 689999999865433 


Q ss_pred             -CcccccCcCCccCCccccCC-CCCCcccHHhHHHHHHHHHhCCCCCCCCCchH-HHHHHhhc-------------c---
Q 038249          169 -RRRTMCGTLDYLPPEMVESV-EHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD-TYRRIVQV-------------D---  229 (281)
Q Consensus       169 -~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~-------------~---  229 (281)
                       ......+|+.|+|||.+.+. .++.++|+||+||++++|++|..||....... ....+...             .   
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence             34455689999999997654 47899999999999999999999997655432 11111100             0   


Q ss_pred             -------------------ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          230 -------------------LKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       230 -------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                                         ........++.++.+||++||.+||++|||++|+|+||||+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                               00111123788999999999999999999999999999998753

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=358.70  Aligned_cols=256  Identities=27%  Similarity=0.410  Sum_probs=205.3

Q ss_pred             ccCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe------
Q 038249           14 TLNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD------   87 (281)
Q Consensus        14 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------   87 (281)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++..... +......+.+|+.++++++||||+++++++..      
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            45889999999999999999999999999999999976653 34445678899999999999999999999963      


Q ss_pred             CCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           88 QKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      ...+|+||||+.++ +...+.  ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++++|||++....
T Consensus        94 ~~~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          94 FQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             CCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            36899999999775 444443  358999999999999999999999999999999999999999999999999875433


Q ss_pred             C--CcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhhccc---------------
Q 038249          168 N--RRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQVDL---------------  230 (281)
Q Consensus       168 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  230 (281)
                      .  ......+|+.|+|||.+.+..+++++||||+||++++|++|+.||.+.+.......+.....               
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            2  23444689999999999999999999999999999999999999988776655544332110               


Q ss_pred             -------cCCCC------------------CCCCHHHHHHHHHhcccCCCCCCChhhhhcCCccccCC
Q 038249          231 -------KFPPK------------------PIVSSAAKDLISQMLVKDSSQRLPLHKLLEHPWIIQNA  273 (281)
Q Consensus       231 -------~~~~~------------------~~~~~~l~~li~~~l~~~p~~Rps~~eil~~~~~~~~~  273 (281)
                             .....                  ...+.++.+||++||.+||++|||++|+|+||||++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                   00000                  01356789999999999999999999999999999754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=343.51  Aligned_cols=248  Identities=25%  Similarity=0.418  Sum_probs=206.0

Q ss_pred             cCCceecceecccCceEEEEEEEccCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCCEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSN---HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQKRV   91 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (281)
                      .++|++++.||+|+||+||+|++..++   ..||+|.+...  ......+.+.+|+.++++++||||+++++++. .+.+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            378999999999999999999987553   45888887543  23444677899999999999999999999986 4678


Q ss_pred             EEEEeccCCCChhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCC-
Q 038249           92 YLILEYAAKGELYKELQK-CKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~-  169 (281)
                      ++||||+++++|..++.. ..++++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...... 
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            999999999999988765 456999999999999999999999999999999999999999999999999998654322 


Q ss_pred             ---cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHHHHHH
Q 038249          170 ---RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSAAKDL  245 (281)
Q Consensus       170 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (281)
                         .....+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+..+.. .+.++.+|.++.+|
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~l  241 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-LPMPPNCPPTLYSL  241 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CCCCTTCCHHHHHH
T ss_pred             ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHH
Confidence               233457889999999999999999999999999999987 8999999999888887766543 34455799999999


Q ss_pred             HHHhcccCCCCCCChhhhhcC
Q 038249          246 ISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       246 i~~~l~~~p~~Rps~~eil~~  266 (281)
                      |.+||+.||++|||+.||+++
T Consensus       242 i~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         242 MTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-53  Score=348.56  Aligned_cols=252  Identities=27%  Similarity=0.399  Sum_probs=213.9

Q ss_pred             ccccCCceecceecccCceEEEEEEEccCCcE--EEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeC
Q 038249           12 RWTLNDFDIGKPLGRGKFGHVYLAREKRSNHI--VALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQ   88 (281)
Q Consensus        12 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~--~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~   88 (281)
                      .+.+++|++.+.||+|+||+||+|.++.+|..  ||||.+....  .....+.+.+|+++++++ +||||+++++++.+.
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            46779999999999999999999999988875  6677764332  233456789999999998 799999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCC
Q 038249           89 KRVYLILEYAAKGELYKELQKC----------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQ  152 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~  152 (281)
                      +..++||||+++|+|.+++...                ..+++..++.++.||+.||.|||+.|++||||+|+||+++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999999999998643                458999999999999999999999999999999999999999


Q ss_pred             CcEEEeeecCcccccCC--cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhC-CCCCCCCCchHHHHHHhhcc
Q 038249          153 GELKIADFGWSVHTFNR--RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYG-VPPFEAKEHSDTYRRIVQVD  229 (281)
Q Consensus       153 ~~~~l~dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~  229 (281)
                      +.+||+|||++......  .....+|..|+|||.+.+..++.++||||||+++|+|++| .+||...+..+....+..+.
T Consensus       164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            99999999998543322  2334578999999999988999999999999999999986 46788888888887776543


Q ss_pred             ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          230 LKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                       ..+.+..+++++.+||.+||+.||++|||++||+++
T Consensus       244 -~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         244 -RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             334445799999999999999999999999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-53  Score=349.40  Aligned_cols=250  Identities=20%  Similarity=0.352  Sum_probs=207.8

Q ss_pred             cccCCceecceecccCceEEEEEEEccCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeC
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKRSNH----IVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQ   88 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (281)
                      ++-++|++++.||+|+||+||+|.+..+|+    .||+|.+....  .....+.+.+|+.++++++||||+++++++.++
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            445789999999999999999999988876    57788775432  222356789999999999999999999999875


Q ss_pred             CEEEEEEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCccccc
Q 038249           89 KRVYLILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTF  167 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~  167 (281)
                      + .+++++++.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             C-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            4 56778888888988877654 579999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHHHhhccccCCCCCCCCHH
Q 038249          168 NRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRRIVQVDLKFPPKPIVSSA  241 (281)
Q Consensus       168 ~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
                      ...     ....+|+.|+|||.+.+..++.++||||||+++|+|+| |.+||...+..+....+..+. ..+..+.++.+
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~~p~~~~~~  241 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQPPICTID  241 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CCCCCTTBCHH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCcccCHH
Confidence            221     22347899999999988899999999999999999998 899999888888777666543 23344579999


Q ss_pred             HHHHHHHhcccCCCCCCChhhhhcC
Q 038249          242 AKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       242 l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      +.+++.+||+.||++|||+.||+++
T Consensus       242 ~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         242 VYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999999999999976

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=342.98  Aligned_cols=253  Identities=27%  Similarity=0.453  Sum_probs=212.3

Q ss_pred             hccccc--CCceecceecccCceEEEEEEEccCC-------cEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCcee
Q 038249           10 KKRWTL--NDFDIGKPLGRGKFGHVYLAREKRSN-------HIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNIL   79 (281)
Q Consensus        10 ~~~~~~--~~y~~~~~ig~g~~~~v~~~~~~~~~-------~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~   79 (281)
                      .++|.+  ++|++++.||+|+||.||+|++..++       ..||||++..+.  .......+.+|...++++ +||||+
T Consensus         5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv   82 (299)
T d1fgka_           5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNII   82 (299)
T ss_dssp             CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEE
Confidence            345755  89999999999999999999987554       469999996554  233356678888888887 899999


Q ss_pred             eeeeEEEeCCEEEEEEeccCCCChhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCC
Q 038249           80 RLYGYFYDQKRVYLILEYAAKGELYKELQKCK----------------YFSERRAATYVASLARALIYCHGKHVIHRDIK  143 (281)
Q Consensus        80 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~  143 (281)
                      ++++++.+++.+++||||+++|+|.+++....                .+++..++.++.||+.||+|||+.|++|||||
T Consensus        83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK  162 (299)
T d1fgka_          83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA  162 (299)
T ss_dssp             CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence            99999999999999999999999999997543                48999999999999999999999999999999


Q ss_pred             CCCeEeCCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCC
Q 038249          144 PENLLIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKE  217 (281)
Q Consensus       144 ~~Ni~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~  217 (281)
                      |+||+++.++.+||+|||++......     .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+
T Consensus       163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            99999999999999999998654332     233467889999999999999999999999999999997 799999888


Q ss_pred             chHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          218 HSDTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ..+....+..+ ...+....++.++.+||.+||+.||++|||+.||++
T Consensus       243 ~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         243 VEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcC-CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            88777766554 334445579999999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=343.87  Aligned_cols=250  Identities=24%  Similarity=0.419  Sum_probs=200.7

Q ss_pred             cCCceecceecccCceEEEEEEEccC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRS-----NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQ   88 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~   88 (281)
                      .++|++++.||+|+||.||+|.+...     ++.||+|++.....  ....+.+.+|...+.++ +|+||+.+++++...
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            37899999999999999999998653     46799999865432  22345566777777666 689999999987654


Q ss_pred             -CEEEEEEeccCCCChhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC
Q 038249           89 -KRVYLILEYAAKGELYKELQKC----------------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA  151 (281)
Q Consensus        89 -~~~~~v~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~  151 (281)
                       +.+++||||+++++|.+++...                ..+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence             5689999999999999999643                24889999999999999999999999999999999999999


Q ss_pred             CCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhC-CCCCCCCCchHHHHHH
Q 038249          152 QGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYG-VPPFEAKEHSDTYRRI  225 (281)
Q Consensus       152 ~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~  225 (281)
                      ++++||+|||++......     .....||+.|+|||.+.+..++.++|||||||++|+|++| .+||......+.....
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999998643322     2234689999999999999999999999999999999986 5688877766665554


Q ss_pred             hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhcC
Q 038249          226 VQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~  266 (281)
                      .......+....+++++.++|.+||+.||++|||+.||++|
T Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44434444455789999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-52  Score=342.83  Aligned_cols=248  Identities=23%  Similarity=0.390  Sum_probs=214.1

Q ss_pred             cCCceecceecccCceEEEEEEEcc-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK   89 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (281)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++....  .......+.+|++++++++||||+++++++...+
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            3689999999999999999999863     45789999986543  3344567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChhHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 038249           90 RVYLILEYAAKGELYKELQKCK------------------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPE  145 (281)
Q Consensus        90 ~~~~v~e~~~~~~L~~~~~~~~------------------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~  145 (281)
                      ..++++||+++++|.+++....                        .++...++.++.||+.||+|||+.|++||||||+
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence            9999999999999999986432                        3789999999999999999999999999999999


Q ss_pred             CeEeCCCCcEEEeeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCC-CCCCCCCch
Q 038249          146 NLLIGAQGELKIADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGV-PPFEAKEHS  219 (281)
Q Consensus       146 Ni~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~-~p~~~~~~~  219 (281)
                      ||+++.++.+||+|||++......     .....+++.|+|||.+.+..++.++||||||+++|+|++|. +||...+..
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            999999999999999998543222     22345788999999999999999999999999999999884 689888888


Q ss_pred             HHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          220 DTYRRIVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +....+..+.. .+....++.++.+||.+||+.||++|||+.||++
T Consensus       250 e~~~~v~~~~~-~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         250 EVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88888776653 2334478999999999999999999999999964

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=341.35  Aligned_cols=249  Identities=22%  Similarity=0.376  Sum_probs=215.3

Q ss_pred             cCCceecceecccCceEEEEEEEc-----cCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeeeeeEEEeC
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREK-----RSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHL-RHPNILRLYGYFYDQ   88 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~   88 (281)
                      .++|++++.||+|+||.||+|++.     .+++.||||++.....  ......+.+|+.+++++ +||||+++++++.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            489999999999999999999874     3567899999965542  23355788999999998 699999999999999


Q ss_pred             CEEEEEEeccCCCChhHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeC
Q 038249           89 KRVYLILEYAAKGELYKELQKCK------------------YFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIG  150 (281)
Q Consensus        89 ~~~~~v~e~~~~~~L~~~~~~~~------------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~  150 (281)
                      +..++||||+++++|.+++....                  .+++..++.++.||+.|++|||++|++|+||||+||+++
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence            99999999999999999987542                  589999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeecCcccccCCc-----ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHh-CCCCCCCCCchHHHHH
Q 038249          151 AQGELKIADFGWSVHTFNRR-----RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLY-GVPPFEAKEHSDTYRR  224 (281)
Q Consensus       151 ~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~  224 (281)
                      .++.++++|||.+.......     ....+|+.|+|||.+....++.++||||||+++|+|++ |.+|+......+.+..
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999986543322     23457899999999998899999999999999999998 6777877777777666


Q ss_pred             HhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          225 IVQVDLKFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      +.............+.++.+||.+||++||++|||+++|++
T Consensus       260 ~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            65555555555578999999999999999999999999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-52  Score=341.45  Aligned_cols=256  Identities=18%  Similarity=0.325  Sum_probs=219.7

Q ss_pred             cccCCceecceecccCceEEEEEEEcc-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe
Q 038249           13 WTLNDFDIGKPLGRGKFGHVYLAREKR-----SNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD   87 (281)
Q Consensus        13 ~~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (281)
                      +..++|++++.||+|+||+||+|.++.     +++.||||++....  .......+.+|++++++++||||+++++++..
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            334899999999999999999999863     35789999996543  33445678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChhHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEE
Q 038249           88 QKRVYLILEYAAKGELYKELQKC----------KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKI  157 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l  157 (281)
                      .+..++|+||+++|+|.+++...          ..++...+..++.+++.||.|||+++|+||||+|+||+++.++++||
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence            99999999999999999988532          24789999999999999999999999999999999999999999999


Q ss_pred             eeecCcccccCC-----cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhC-CCCCCCCCchHHHHHHhhcccc
Q 038249          158 ADFGWSVHTFNR-----RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYG-VPPFEAKEHSDTYRRIVQVDLK  231 (281)
Q Consensus       158 ~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~  231 (281)
                      +|||++......     .....+++.|+|||.+.+..++.++||||||+++|+|++| .+||...+..+....+..+.. 
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~-  253 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-  253 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC-
Confidence            999998654332     2223578999999999999999999999999999999997 588998888888887766543 


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc------CCcccc
Q 038249          232 FPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE------HPWIIQ  271 (281)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~------~~~~~~  271 (281)
                      .+....++.++.++|.+||+.||++|||+++|++      +|+|++
T Consensus       254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            3334578999999999999999999999999997      566654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-50  Score=331.01  Aligned_cols=243  Identities=19%  Similarity=0.330  Sum_probs=200.3

Q ss_pred             cceecccCceEEEEEEEccCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEe-CCEEEEEEe
Q 038249           21 GKPLGRGKFGHVYLAREKRSN---HIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYD-QKRVYLILE   96 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~e   96 (281)
                      .+.||+|+||+||+|.+..++   ..||||.+...  .+......+.+|++++++++||||+++++++.. ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            678999999999999987643   35899998543  344456779999999999999999999999876 568999999


Q ss_pred             ccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecCcccccCCc-----
Q 038249           97 YAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRR-----  170 (281)
Q Consensus        97 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~~~~~~~-----  170 (281)
                      |+++++|.+++... ..++...++.++.|++.||.|||+.+|+||||+|+||+++.++.+||+|||++.......     
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence            99999999988755 457788999999999999999999999999999999999999999999999986543221     


Q ss_pred             --ccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCC-CCchHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 038249          171 --RTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEA-KEHSDTYRRIVQVDLKFPPKPIVSSAAKDLIS  247 (281)
Q Consensus       171 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  247 (281)
                        ....+|+.|+|||.+....++.++||||||+++|+|++|..||.. .+..+....+..+. .......+++++.++|.
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-CCCCCTTCCHHHHHHHH
T ss_pred             ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCcccCcHHHHHHHH
Confidence              223578899999999988999999999999999999997666654 33334444444443 23344578999999999


Q ss_pred             HhcccCCCCCCChhhhhcC
Q 038249          248 QMLVKDSSQRLPLHKLLEH  266 (281)
Q Consensus       248 ~~l~~~p~~Rps~~eil~~  266 (281)
                      +||+.||++|||+.||+++
T Consensus       269 ~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-49  Score=326.50  Aligned_cols=255  Identities=20%  Similarity=0.284  Sum_probs=201.3

Q ss_pred             CCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeeeeeEEEeCCEEEEE
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPN-ILRLYGYFYDQKRVYLI   94 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~~~~~v   94 (281)
                      ++|++++.||+|+||+||+|++..+|+.||||++......     ..+..|+++++.++|++ |+.+.+++.+.+..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            5799999999999999999999999999999998654322     23678999999998766 55566667788899999


Q ss_pred             EeccCCCChhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC---CCcEEEeeecCcccccCC-
Q 038249           95 LEYAAKGELYKELQ-KCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA---QGELKIADFGWSVHTFNR-  169 (281)
Q Consensus        95 ~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~---~~~~~l~dfg~~~~~~~~-  169 (281)
                      ||++++ ++...+. ..+.+++..+..++.|++.||+|||++||+||||||+||+++.   +..++++|||++...... 
T Consensus        82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            999965 5655554 4567999999999999999999999999999999999999864   457999999998653321 


Q ss_pred             ---------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHHHHHHhh---ccccCC---C
Q 038249          170 ---------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDTYRRIVQ---VDLKFP---P  234 (281)
Q Consensus       170 ---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~---~  234 (281)
                               .....||+.|+|||.+.+..++.++|||||||++++|++|..||......+.......   .....+   .
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  240 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence                     2334689999999999999999999999999999999999999987665544322211   111111   1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChh---hhhcCCccccCCCCC
Q 038249          235 KPIVSSAAKDLISQMLVKDSSQRLPLH---KLLEHPWIIQNADPS  276 (281)
Q Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~---eil~~~~~~~~~~~~  276 (281)
                      .+.+|.++.+++.+||+.||++||++.   ++|+++|.+++....
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~  285 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD  285 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCS
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCC
Confidence            246899999999999999999999976   457788776654443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-47  Score=314.05  Aligned_cols=245  Identities=22%  Similarity=0.292  Sum_probs=202.1

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeeeeeEEEeCCEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH-PNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~   93 (281)
                      -++|++++.||+|+||+||+|++..+|+.||+|++......     ..+.+|++.++.+.| +|++.+++++......++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            36899999999999999999999999999999988544321     236678888888865 899999999999999999


Q ss_pred             EEeccCCCChhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCC-----CCcEEEeeecCccccc
Q 038249           94 ILEYAAKGELYKELQKC-KYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGA-----QGELKIADFGWSVHTF  167 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~-----~~~~~l~dfg~~~~~~  167 (281)
                      |||++ +++|.+++... ..++...+..++.|++.||++||+.||+||||||+||+++.     ++.++|+|||++....
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999 56998888765 46999999999999999999999999999999999999974     5689999999985432


Q ss_pred             CC----------cccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchHH---HHHHhhccccCC-
Q 038249          168 NR----------RRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSDT---YRRIVQVDLKFP-  233 (281)
Q Consensus       168 ~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~-  233 (281)
                      ..          .....||+.|+|||.+.+..++.++||||||+++++|++|..||........   ...+.......+ 
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            21          2234689999999999999999999999999999999999999986554432   222222111111 


Q ss_pred             --CCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          234 --PKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       234 --~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                        ..+.+|+++.+++..|+..+|++||+++.+.+
T Consensus       238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence              12358899999999999999999999776653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-48  Score=318.70  Aligned_cols=244  Identities=21%  Similarity=0.331  Sum_probs=188.8

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeeeeeEEEeCC----E
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNILRLYGYFYDQK----R   90 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~   90 (281)
                      .++|.+.+.||+|+||+||+|++.  |+.||||++..+.    ........|+..+++++||||+++++++.+.+    .
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            357899999999999999999874  8899999985432    11222334566667789999999999998643    6


Q ss_pred             EEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------cCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           91 VYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG--------KHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        91 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~--------~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      +++||||+++++|.+++++. ++++..++.++.+++.||++||+        +||+|+||||+||+++.++.+||+|||+
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            89999999999999999875 58999999999999999999996        5999999999999999999999999998


Q ss_pred             cccccCC-------cccccCcCCccCCccccCCC------CCCcccHHhHHHHHHHHHhCCCCCCCCC------------
Q 038249          163 SVHTFNR-------RRTMCGTLDYLPPEMVESVE------HDANVDIWSLGVLCYEFLYGVPPFEAKE------------  217 (281)
Q Consensus       163 ~~~~~~~-------~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~------------  217 (281)
                      +......       .....||+.|+|||.+.+..      ++.++|||||||++|+|++|..|+....            
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            8543221       23456899999999986543      4568999999999999999987763311            


Q ss_pred             --chHHHHHHhhccccCCCC------CCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          218 --HSDTYRRIVQVDLKFPPK------PIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       218 --~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                        ..+............+..      ...+.++.+++.+||+.||++|||+.||++
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence              112222222211111111      012245899999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.6e-47  Score=319.03  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=197.4

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----------CCceeeeee
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-----------HPNILRLYG   83 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----------h~~i~~~~~   83 (281)
                      -.+|++++.||+|+||+||+|+++.+|+.||||++..+.    ...+...+|+.+++.+.           |+||+++++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            356999999999999999999999999999999996543    22345677888777764           578999998


Q ss_pred             EEEe--CCEEEEEEeccCCCChhHH-HH--hCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCeEeCCCCc---
Q 038249           84 YFYD--QKRVYLILEYAAKGELYKE-LQ--KCKYFSERRAATYVASLARALIYCHG-KHVIHRDIKPENLLIGAQGE---  154 (281)
Q Consensus        84 ~~~~--~~~~~~v~e~~~~~~L~~~-~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~Ni~~~~~~~---  154 (281)
                      ++..  ....+.++.+......... ..  ....+++..++.++.||+.|+++||+ .||+|+||||+|||++.++.   
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence            8864  3566666666655433222 22  33568999999999999999999997 89999999999999987653   


Q ss_pred             ---EEEeeecCcccccCCcccccCcCCccCCccccCCCCCCcccHHhHHHHHHHHHhCCCCCCCCCchH------HHHHH
Q 038249          155 ---LKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVEHDANVDIWSLGVLCYEFLYGVPPFEAKEHSD------TYRRI  225 (281)
Q Consensus       155 ---~~l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~  225 (281)
                         ++++|||.+...........+++.|+|||.+....++.++|+||+|+++++|++|+.||...+...      .....
T Consensus       168 ~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~  247 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  247 (362)
T ss_dssp             EEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             cceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence               999999998776666677789999999999988899999999999999999999999997543321      11100


Q ss_pred             hh--cc---------------------c-----------------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhhhhc
Q 038249          226 VQ--VD---------------------L-----------------KFPPKPIVSSAAKDLISQMLVKDSSQRLPLHKLLE  265 (281)
Q Consensus       226 ~~--~~---------------------~-----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  265 (281)
                      ..  +.                     .                 ........+.++.+||.+||.+||++|||++|+|+
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00  00                     0                 00001124567899999999999999999999999


Q ss_pred             CCccccCCC
Q 038249          266 HPWIIQNAD  274 (281)
Q Consensus       266 ~~~~~~~~~  274 (281)
                      ||||++...
T Consensus       328 Hp~f~~~~~  336 (362)
T d1q8ya_         328 HPWLKDTLG  336 (362)
T ss_dssp             CGGGTTCTT
T ss_pred             CcccCCCCC
Confidence            999996643

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=5.7e-26  Score=173.66  Aligned_cols=167  Identities=18%  Similarity=0.171  Sum_probs=119.7

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeeccccc---------------chHHHHHHHHHHHHHHhCCCCceeeee
Q 038249           18 FDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQ---------------QSQVEHQLRREVEIQSHLRHPNILRLY   82 (281)
Q Consensus        18 y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~---------------~~~~~~~~~~e~~~l~~~~h~~i~~~~   82 (281)
                      +.+++.||+|+||+||+|.+. +|+.||||++......               ..........|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457899999999999999986 6889999987532210               111223455688889999999998877


Q ss_pred             eEEEeCCEEEEEEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCeEeCCCCcEEEeeecC
Q 038249           83 GYFYDQKRVYLILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGW  162 (281)
Q Consensus        83 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~Ni~~~~~~~~~l~dfg~  162 (281)
                      +...    .+++||++++..+..       ++...+..++.|++.++.+||++||+|+||||+||+++.+ .++|+|||.
T Consensus        81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6532    268999998865433       4555677899999999999999999999999999999865 589999998


Q ss_pred             cccccCCcccccCcCCccCCc-----cccCCCCCCcccHHhHHHH
Q 038249          163 SVHTFNRRRTMCGTLDYLPPE-----MVESVEHDANVDIWSLGVL  202 (281)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~aPE-----~~~~~~~~~~~Di~slG~~  202 (281)
                      +.........     .|....     .+....++..+|+||+.--
T Consensus       149 a~~~~~~~~~-----~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         149 SVEVGEEGWR-----EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CEETTSTTHH-----HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             cccCCCCCcH-----HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            8554322110     111100     0123456778999996543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.67  E-value=1.2e-07  Score=74.15  Aligned_cols=139  Identities=15%  Similarity=0.124  Sum_probs=89.3

Q ss_pred             cCCceecceecccCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeeeeeEEEeCCEEEE
Q 038249           15 LNDFDIGKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLR-HPNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        15 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~   93 (281)
                      ++.|+..+..+.++.+.||++..  ++..+++|.........   ...+.+|...+..+. +-.+.+++.+...++..++
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            46788888776677789998854  46678899875443221   123455666665553 3335667777778889999


Q ss_pred             EEeccCCCChhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 038249           94 ILEYAAKGELYKELQKCKYFSERRAATYVASLARALIYCHG---------------------------------------  134 (281)
Q Consensus        94 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------------------------------------  134 (281)
                      ||++.+|.++.+......  .   ...++.++...+..||+                                       
T Consensus        88 v~~~l~G~~~~~~~~~~~--~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDEQ--S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHTTTCS--C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             EEEecccccccccccccc--c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            999999977754432111  1   11122223333333331                                       


Q ss_pred             --------------------cCceecCCCCCCeEeCCCCcEEEeeecCc
Q 038249          135 --------------------KHVIHRDIKPENLLIGAQGELKIADFGWS  163 (281)
Q Consensus       135 --------------------~~i~H~di~~~Ni~~~~~~~~~l~dfg~~  163 (281)
                                          ..++|+|+.|.||++++++..-|+||+.+
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a  211 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence                                12789999999999987766679999865

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.16  E-value=2.7e-06  Score=70.33  Aligned_cols=81  Identities=12%  Similarity=0.169  Sum_probs=45.4

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeecccc--cc--hHHHHHHHHHHHHHHhC-CC--CceeeeeeEEEeCCEEEE
Q 038249           21 GKPLGRGKFGHVYLAREKRSNHIVALKVLFKSQL--QQ--SQVEHQLRREVEIQSHL-RH--PNILRLYGYFYDQKRVYL   93 (281)
Q Consensus        21 ~~~ig~g~~~~v~~~~~~~~~~~~~lK~~~~~~~--~~--~~~~~~~~~e~~~l~~~-~h--~~i~~~~~~~~~~~~~~~   93 (281)
                      .+.||.|....||++.+..+++.+++|.......  ..  .........|.+.++.+ .+  ..+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            5678999999999999887788899997532110  00  00011133455555544 22  334555544  3445578


Q ss_pred             EEeccCCCCh
Q 038249           94 ILEYAAKGEL  103 (281)
Q Consensus        94 v~e~~~~~~L  103 (281)
                      |||+.++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.13  E-value=3.2e-06  Score=65.36  Aligned_cols=74  Identities=16%  Similarity=0.157  Sum_probs=47.9

Q ss_pred             eecccC-ceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CceeeeeeEEEeCCEEEEEEeccC
Q 038249           23 PLGRGK-FGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH--PNILRLYGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        23 ~ig~g~-~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~~v~e~~~   99 (281)
                      .+..|. .+.||++... ++..+++|........      .+..|...++.+..  -.+.+++.+..+++..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            334444 4688988765 4666888986443322      24455555555422  235667777778888999999998


Q ss_pred             CCCh
Q 038249          100 KGEL  103 (281)
Q Consensus       100 ~~~L  103 (281)
                      |.++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            8765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.26  E-value=0.00029  Score=57.84  Aligned_cols=78  Identities=24%  Similarity=0.354  Sum_probs=48.3

Q ss_pred             CCceecceecccCceEEEEEEEccC-------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eeeeeEEEe
Q 038249           16 NDFDIGKPLGRGKFGHVYLAREKRS-------NHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRHPNI-LRLYGYFYD   87 (281)
Q Consensus        16 ~~y~~~~~ig~g~~~~v~~~~~~~~-------~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-~~~~~~~~~   87 (281)
                      ++.++ +.|+.|-.-.+|++.....       ...+++++.-...  ..   ....+|..+++.+.-.++ .++++++. 
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~---idr~~E~~i~~~ls~~gl~Pkll~~~~-  115 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TE---SHLVAESVIFTLLSERHLGPKLYGIFS-  115 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CH---HHHHHHHHHHHHHHHTTSSSCEEEEET-
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hh---hHHHHHHHHHHHHHhCCCCCeEEEEcC-
Confidence            44444 6789999999999987632       3567777764221  11   234467777766643333 35666553 


Q ss_pred             CCEEEEEEeccCCCCh
Q 038249           88 QKRVYLILEYAAKGEL  103 (281)
Q Consensus        88 ~~~~~~v~e~~~~~~L  103 (281)
                       +  +.|++|++|.++
T Consensus       116 -~--g~I~efi~g~~l  128 (395)
T d1nw1a_         116 -G--GRLEEYIPSRPL  128 (395)
T ss_dssp             -T--EEEECCCCEEEC
T ss_pred             -C--ceEEEEeccccC
Confidence             2  578999987644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.24  E-value=0.0013  Score=52.28  Aligned_cols=71  Identities=11%  Similarity=0.144  Sum_probs=42.5

Q ss_pred             cCceEEEEEEEccCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC---C--ceeee--eeEEEeCCEEEEEEeccC
Q 038249           27 GKFGHVYLAREKRSNHIVALKVLFKSQLQQSQVEHQLRREVEIQSHLRH---P--NILRL--YGYFYDQKRVYLILEYAA   99 (281)
Q Consensus        27 g~~~~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~~e~~~l~~~~h---~--~i~~~--~~~~~~~~~~~~v~e~~~   99 (281)
                      +....||++... +|..+++|+..+....    .+.+..|...+..+..   |  ..+..  -..+...+..+.++++.+
T Consensus        33 s~EN~vy~v~~~-dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          33 SYENRVYQFQDE-DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             CSSSEEEEECCT-TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cccceeEEEEcC-CCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            334689999875 6888999998654322    2335556666555531   1  11111  123345677889999987


Q ss_pred             CCC
Q 038249          100 KGE  102 (281)
Q Consensus       100 ~~~  102 (281)
                      |..
T Consensus       108 G~~  110 (325)
T d1zyla1         108 GRQ  110 (325)
T ss_dssp             CEE
T ss_pred             CcC
Confidence            654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.09  E-value=0.0025  Score=50.16  Aligned_cols=30  Identities=23%  Similarity=0.345  Sum_probs=26.8

Q ss_pred             cCceecCCCCCCeEeCCCCcEEEeeecCcc
Q 038249          135 KHVIHRDIKPENLLIGAQGELKIADFGWSV  164 (281)
Q Consensus       135 ~~i~H~di~~~Ni~~~~~~~~~l~dfg~~~  164 (281)
                      .|++|+|+.++||+++.+...-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            579999999999999988777899999763